{
  "evaluation_metadata": {
    "evaluator_name": "LLM-as-Judge Evaluator (Model: qwen3-235b-reasoning)",
    "evaluator_model": "qwen3-235b-reasoning",
    "model_evaluated": "gpt-oss-20b-reasoning",
    "experiment": "e5_page_window_relevance_asc",
    "pattern": "qualitative_3hop_cross_year_type1",
    "sample_size": null,
    "random_seed": null,
    "total_questions_in_experiment": 800,
    "successful_questions_in_experiment": 799,
    "failed_questions_in_experiment": 1,
    "questions_evaluated": 799,
    "completed": true,
    "input_file": "/Users/reeturajharsh/domyn/multihopQA-benchmarking/src/experiments/outputs/experiments/gpt-oss-20b-reasoning/e5_page_window_relevance_asc/qualitative_3hop_cross_year_type1.json",
    "timestamp": "2026-02-04T06:40:08.033131"
  },
  "evaluation_results": [
    {
      "question_id": 4,
      "question": "How did ExxonMobil's stake in Syncrude through Imperial Oil Limited in 2022 compare to its stake in Syncrude in 2024, and what does this imply about the stability of its upstream oil sands production strategy?",
      "original_answer": "In 2022, ExxonMobil held a 69.6% stake in Imperial Oil Limited, which in turn held a 25% interest in Syncrude, resulting in an indirect stake of approximately 17.4% in Syncrude. By 2024, the structure remained unchanged, with ExxonMobil still holding 69.6% of Imperial Oil Limited, which maintained its 25% stake in Syncrude. The company's share of net production from Syncrude also remained constant at 62 thousand barrels per day in both years. This indicates a stable upstream strategy in oil sands production, with no changes in ownership structure or production levels through the Syncrude joint venture.",
      "llm_answer": "In 2022, ExxonMobil owned 69.6 % of Imperial Oil, which holds a 25 % interest in Syncrude, giving an effective 17.4 % stake in Syncrude (XOM_10k_2022 page 22). The 2024 filing reports the same ownership percentages—69.6 % of Imperial Oil and 25 % of Syncrude—so the stake remained unchanged (XOM_10k_2024 page 18). This consistency indicates a stable upstream oil‑sands production strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts: ExxonMobil's 69.6% stake in Imperial Oil Limited and Imperial's 25% stake in Syncrude in both 2022 and 2024, resulting in an indirect 17.4% effective stake (69.6% × 25% = 17.4%), which matches the ground truth calculation. The statement that the stake remained unchanged is accurate. (2) All numeric values—69.6%, 25%, and the derived 17.4%—are correct and properly cited to the respective 10-K filings (2022 and 2024), with no calculation errors. Format variations (e.g., '17.4%' vs 'approximately 17.4%') are semantically equivalent. (3) The multi-hop reasoning is sound: the model correctly infers ExxonMobil’s indirect stake through ownership of Imperial, which holds a direct stake in Syncrude, and compares this structure across two years. The conclusion about strategic stability is logically supported by the unchanged ownership. (4) The only minor omission is the absence of the specific production figure (62 thousand barrels per day) mentioned in the ground truth, which reinforces stability through output consistency. While not strictly necessary to answer the question, its exclusion slightly reduces completeness. However, the core of the question—comparison of stakes and implication for strategy—is fully addressed with accurate reasoning and data. Thus, the answer is factually correct and contextually appropriate, warranting a high score with a small deduction for incomplete detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 406,
        "total_tokens": 1672
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did SPG's investment in SPARC Group in 2023 influence the restructuring of J.C. Penney's retail operations in 2024, and how did this transformation affect SPG's lease income from Catalyst Brands (formerly J.C. Penney) in 2024 compared to 2023?",
      "original_answer": "In 2023, SPG had a significant investment in SPARC Group, which was a key player in the retail leasing ecosystem at SPG properties, contributing $101.8 million in lease income. In 2024, SPARC Group's retail operations were acquired by J.C. Penney, which was subsequently renamed Catalyst Brands, leading to a restructured relationship. As a result of this transformation, SPG recognized a non-cash pre-tax gain of $100.5 million and retained a 31.3% noncontrolling interest in Catalyst Brands. Lease income from Catalyst (formerly J.C. Penney and SPARC Group) increased to $105.9 million in 2024 from $101.8 million in 2023, indicating a positive financial outcome for SPG despite the entity restructuring.",
      "llm_answer": "SPG’s 2023 investment in SPARC Group gave it a stake that enabled it to participate in J.C. Penney’s 2024 acquisition of SPARC Group’s retail operations, which were re‑branded as Catalyst Brands and left SPG with a 31.3 % non‑controlling interest (page 65).  The restructuring of J.C. Penney’s retail business into Catalyst Brands lifted SPG’s lease income from the retailer to $105.9 million in 2024 versus $101.8 million in 2023 – a $4.1 million increase (page 140).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts: SPG's 2023 investment in SPARC Group, the 2024 acquisition by J.C. Penney, rebranding as Catalyst Brands, SPG's retained 31.3% noncontrolling interest, and the increase in lease income from $101.8 million in 2023 to $105.9 million in 2024. The $4.1 million increase is accurately calculated. (2) All numeric values match the ground truth: $101.8M (2023), $105.9M (2024), 31.3%, and the implied $4.1M difference are correct. Format variations (e.g., $105.9 million) are acceptable and used appropriately. (3) The multi-hop reasoning is sound: the answer connects SPG’s initial investment → SPARC Group’s role → J.C. Penney’s acquisition and restructuring into Catalyst Brands → impact on SPG’s ownership and lease income. It correctly infers the positive financial outcome, though it omits explicit mention of the $100.5 million non-cash pre-tax gain, which is a minor omission. (4) The answer is semantically equivalent to the ground truth in all critical aspects, with only slight brevity in not mentioning the gain. This does not affect the core financial and operational narrative. Contextual relevance is perfect—every sentence addresses the question directly. The qualitative score is 9 due to the missing gain reference, but all other dimensions are fully accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 373,
        "total_tokens": 1692
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did the $7.8 billion cash investment in acquiring NI in 2023 influence the expansion of Emerson's Test & Measurement segment in 2024, particularly in relation to NI's production of software-connected automated test systems?",
      "original_answer": "In 2023, Emerson invested $7.8 billion in cash to acquire the remaining shares of NI, a company specializing in software-connected automated test and measurement systems. This acquisition directly expanded Emerson’s capabilities in automated testing, which by 2024 was integrated into a newly formed segment called Test & Measurement. The segment description in 2024 highlights that it now provides NI’s full range of modular instrumentation, data acquisition, and control solutions, confirming that the 2023 investment enabled Emerson to directly produce and market NI’s automated test systems as part of its broader industrial software and control portfolio.",
      "llm_answer": "The $7.8 billion cash outlay to acquire the remaining NI shares (page 51) financed the addition of NI’s software‑connected automated test‑and‑measurement systems to Emerson’s portfolio.  In 2024 the newly created Test & Measurement segment—built on NI’s product lines—recorded $1.464 billion in sales (page 74) and a net loss of $290 million, demonstrating the rapid expansion of Emerson’s capabilities in software‑connected test systems (page 73).",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $7.8 billion cash investment to acquire NI in 2023 and links it to the expansion of Emerson's Test & Measurement segment in 2024, which is consistent with the ground truth. It also correctly notes that the segment was newly created and built on NI’s product lines, particularly software-connected automated test systems, showing accurate qualitative understanding. However, the LLM introduces two specific financial figures for 2024—$1.464 billion in sales and a $290 million net loss—that are not present in the original answer (ground truth). Since the ground truth does not include any financial performance data for the Test & Measurement segment in 2024, these numbers cannot be verified and appear to be either hallucinated or pulled from a source outside the provided knowledge graph, which undermines factual accuracy. (2) Quantitative accuracy is low because the introduced numbers ($1.464B revenue, $290M loss) are not supported by the ground truth. While the $7.8B acquisition amount is correct, the addition of unverified financials skews the response. There are no calculations in the answer, but the inclusion of unsupported metrics reduces trust in the quantitative claims. (3) The multi-hop reasoning is sound: the model correctly connects the 2023 acquisition to the 2024 formation of the Test & Measurement segment and attributes the expansion to NI’s technology. This demonstrates proper synthesis across time and entities (Emerson, NI, segment evolution). (4) Contextual relevance is high because the answer directly addresses how the investment enabled expansion in automated test systems. The core logic aligns with the ground truth, but the hallucinated financials significantly reduce overall correctness, warranting a mid-range score of 6. The answer is partially correct but contains critical unsupported data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 511,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did JPMorgan Chase Bank's role in AMT's financing structure evolve from its initial $10.5 billion bridge loan commitment in 2022 to its position in the multicurrency revolving credit agreement in 2024?",
      "original_answer": "In 2022, JPMorgan Chase Bank provided a $10.5 billion bridge loan commitment to finance AMT's CoreSite Acquisition, but this commitment was terminated by December 8, 2021, as AMT secured alternative financing. By 2024, JPMorgan Chase Bank had transitioned from a bridge loan provider to a co-documentation agent and joint lead arranger in AMT's multicurrency revolving credit agreement, as evidenced by the amendments to the agreement dated through mid-2024. This reflects a shift from a short-term financing role to a more enduring strategic partnership in AMT's capital structure.",
      "llm_answer": "In 2022, JPMorgan Chase Bank had a $10.5 billion bridge‑loan commitment for the CoreSite acquisition, but the commitment was fully terminated in December 2021 because other credit facilities were available and no borrowing was made【page_52】. By 2024, JPMorgan had moved to a core financing role, serving as a joint lead arranger, joint bookrunner and co‑documentation agent on the company’s multicurrency revolving credit agreement【page_77】, indicating a shift from a standby bridge lender to an active participant in AMT’s primary credit facility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, all numbers and dates are correct: the $10.5 billion bridge loan commitment in 2022 and its termination in December 2021 are accurately reported. Although the termination date is listed as December 8, 2021, in the ground truth, the LLM correctly notes December 2021, which is sufficiently precise given the context. (2) The LLM correctly identifies the transition in JPMorgan's role—from a bridge loan provider (with no borrowing drawn) to a key agent in the 2024 multicurrency revolving credit agreement. (3) The qualitative reasoning is sound: it captures the multi-hop evolution from short-term standby financing to an active, strategic role, evidenced by roles as joint lead arranger, joint bookrunner, and co-documentation agent. The only minor omission is that the ground truth explicitly frames this as a 'strategic partnership' and notes amendments through mid-2024, which the LLM implies but does not state verbatim. (4) Contextual relevance is excellent—the answer directly addresses the evolution of JPMorgan’s role across time and financing structures. The inclusion of source page references (e.g., page_52, page_77) suggests grounding in document evidence. Overall, the answer is factually correct, well-reasoned, and semantically equivalent to the original, warranting a 9/10 due to slight lack of specificity on the 'amendments through mid-2024' detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 407,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the fair value of MDT's mutual funds measured using Level 1 inputs change from fiscal year 2022 to 2023, and what does this indicate about the company's short-term investment strategy?",
      "original_answer": "In fiscal year 2022, MDT disclosed that its mutual funds had a fair value of $125 million, all of which was measured using Level 1 inputs. In fiscal year 2023, the fair value of mutual funds decreased to $106 million, with the entire amount still measured using Level 1 inputs. This $19 million decline indicates a reduction in the company's exposure to mutual funds, suggesting a strategic shift in its short-term investment portfolio toward potentially more stable or differently allocated assets.",
      "llm_answer": "The fair value of MDT’s mutual funds measured using Level‑1 inputs fell from **$125 million in FY 2022 to $114 million in FY 2023**—a decline of about **$11 million**. This modest reduction suggests the company is trimming its exposure to mutual funds within its short‑term investment mix, likely shifting toward a more conservative or diversified short‑term strategy.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error in the reported fair value for FY 2023: it states $114 million instead of the correct $106 million from the ground truth. This leads to an incorrect decline amount of $11 million instead of the actual $19 million. While the FY 2022 value ($125 million) and the use of Level 1 inputs in both years are correctly identified, the core quantitative change is wrong. (2) The calculation of the difference is based on incorrect inputs: $125M - $114M = $11M is mathematically correct but factually inaccurate due to the wrong 2023 value. The actual change is $125M - $106M = $19M, which the model fails to report. (3) The reasoning about a strategic shift in short-term investment strategy is qualitatively sound and aligns with the ground truth interpretation—reducing mutual fund exposure suggests a strategic reallocation. However, because the magnitude of the decline is understated, the characterization as a 'modest reduction' downplays what is actually a more significant $19M drop. (4) The contextual relevance is high as the answer addresses both parts of the question—change in fair value and strategic implication—and correctly identifies MDT, the fiscal years, and Level 1 inputs. The qualitative reasoning is logical but based on incorrect data, limiting its accuracy. Thus, the correctness score is 5 due to partial factual accuracy with a major numerical error affecting the conclusion's strength.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1228,
        "completion_tokens": 406,
        "total_tokens": 1635
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Netflix's 2023 auditor testing of assumptions around content amortization based on viewing hour consumption compare to the 2022 review, and what does this reveal about the consistency of their amortization methodology?",
      "original_answer": "In 2022, Netflix disclosed that its content amortization was based on historical and forecasted viewing patterns, and the auditor tested the significant assumptions including historical and forecasted viewing hour consumption used to develop estimated viewing patterns. In 2023, the auditor again tested the same assumptions, indicating that Netflix continued to rely on similar methodologies involving viewing hour consumption to amortize content. The consistency in auditor testing procedures across both years suggests that Netflix did not materially change its amortization methodology or the underlying assumptions between 2022 and 2023, despite the subjective and complex nature of estimating future viewing patterns.",
      "llm_answer": "In 2023 the auditor again tested controls over management’s review of the content‑amortization method and the key assumptions—particularly historical and forecasted viewing‑hour consumption—and performed sensitivity analyses, exactly the same procedures described in the 2022 review. This parallel testing shows that Netflix’s amortization methodology and the auditor’s evaluation of it have remained consistent from 2022 to 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and closely aligns with the ground truth. (1) It correctly identifies that in both 2022 and 2023, Netflix's auditor tested the same key assumptions—historical and forecasted viewing-hour consumption—related to content amortization. The statement that the procedures were 'exactly the same' is consistent with the original answer's conclusion about methodological consistency. (2) There are no numeric values (e.g., dollar amounts, percentages) in the question or ground truth, so quantitative accuracy is not applicable in that sense, but all dates (2022, 2023) and procedural descriptions are correct. (3) The multi-hop reasoning is sound: the model correctly infers that unchanged auditor testing procedures imply consistency in Netflix’s amortization methodology, which is the core insight of the original answer. (4) The only minor shortcoming is that the LLM omits a brief mention in the original about the 'subjective and complex nature' of estimating future viewing patterns, which adds context about why auditor testing is significant. However, this does not detract from the core factual accuracy. Overall, the answer is semantically equivalent, highly relevant, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 343,
        "total_tokens": 1651
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did the change in the Netherlands Innovation Box Tax rate between 2022 and 2023 impact BKNG's effective tax rate, and what does this reveal about the evolving relationship between Dutch Corporate Income Tax Law and BKNG's international tax strategy?",
      "original_answer": "BKNG benefited from the Netherlands Innovation Box Tax in both 2022 and 2023, which taxed qualifying income at 9% rather than the standard Dutch corporate rate of 25.8% (effective from 2022). In 2022, the effective tax rate was higher compared to 2021, partly due to a reduced benefit from the Innovation Box Tax. In 2023, a significant portion of BKNG's taxable earnings was still subject to this preferential rate, indicating continued reliance on the Innovation Box Tax. However, the reduced benefit in 2022 suggests a potential shift in qualifying earnings or eligibility, highlighting the sensitivity of BKNG's international tax strategy to changes in Dutch Corporate Income Tax Law.",
      "llm_answer": "BKNG’s effective tax rate fell in 2023 versus 2022 because the Innovation Box Tax benefit grew from $452 million in 2022 to $544 million in 2023, even though the 9 % rate itself did not change (page 55 and page 106).  The larger benefit lowered the company’s effective tax rate relative to the 22.1 % reported for 2022 (page 55).  This illustrates that BKNG’s international tax strategy remains closely tied to Dutch incentives, using the favorable 9 % rate to reduce its overall tax burden and reinforcing the alignment between Dutch corporate income tax law and the firm’s global tax planning.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative claims. The ground truth does not mention specific dollar amounts ($452 million in 2022 or $544 million in 2023) related to the Innovation Box Tax benefit, nor does it state that BKNG’s effective tax rate fell in 2023 compared to 2022. In fact, the original answer notes that the effective tax rate was higher in 2022 than in 2021 due to reduced Innovation Box benefits, but provides no comparison between 2022 and 2023 rates. The LLM invents precise figures and trends not present in the ground truth, which is a major error. (2) The 9% Innovation Box rate and standard 25.8% Dutch corporate tax rate are consistent with the ground truth, and the general concept of BKNG benefiting from the preferential rate in both years is correct. However, the specific financial figures and the claim of increasing benefit from 2022 to 2023 are unsupported and likely incorrect. (3) The reasoning is partially sound in linking the Innovation Box to BKNG’s tax strategy, and the model correctly identifies the ongoing reliance on Dutch tax incentives. However, it fails to capture the nuance in the original answer about a *reduced* benefit in 2022 suggesting potential shifts in eligibility or qualifying income, which is a key insight about sensitivity to Dutch tax law changes. The LLM instead asserts an increasing benefit, contradicting the implied trend. (4) The contextual relevance is high because the answer addresses both parts of the question—impact on effective tax rate and implications for tax strategy—and correctly identifies the relevant entities (BKNG, Netherlands Innovation Box, Dutch Corporate Income Tax Law). However, due to the fabricated numbers and incorrect directional claim about tax rate changes, the correctness and quantitative accuracy scores are low. The qualitative accuracy is moderate because the conceptual framework is reasonable but misses the critical insight about vulnerability to policy changes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 547,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How did 3M's acquisition of Aearo Technologies in 2008 and subsequent litigation over Dual-Ended Combat Arms Earplugs influence the company's legal liabilities and financial commitments between 2022 and 2023?",
      "original_answer": "In 2022, 3M faced ongoing litigation related to Dual-Ended Combat Arms Earplugs originally sold by Aearo Technologies, which it had acquired in 2008. As a result, 3M committed $1.0 billion to fund a trust and an additional $0.2 billion for projected case expenses, reflecting a pre-tax charge of $1.2 billion in the second quarter of 2022. The Aearo Entities filed for Chapter 11 bankruptcy in July 2022, leading to their deconsolidation from 3M’s financials. However, in 2023, the bankruptcy court granted the plaintiffs’ motion to dismiss, lifting the stay on litigation and prompting 3M to reconsolidate the Aearo Entities. This led to the resumption of mediation and ultimately the CAE Settlement in August 2023, which aimed to resolve all current and future claims related to the earplugs. The legal and financial evolution of this chain shows a shift from a structured bankruptcy-based liability management approach in 2022 to a direct settlement approach in 2023, with significant financial implications across both years.",
      "llm_answer": "The 2008 acquisition of Aearo Technologies gave 3M ownership of Dual‑Ended Combat Arms Earplugs, which later triggered a wave of product‑liability claims.  Between 2022 and 2023 the company funded a $1 billion trust and $0.2 billion in case‑expense reserves, recorded a $1.2 billion pre‑tax charge in Q2 2022, and then entered into a CAE settlement that obligates $6 billion in contributions (with a $4.2 billion pre‑tax charge in Q3 2023) and an accrued liability of $5 billion as of Dec 31 2023 (pages 100–101).  The de‑ and reconsolidation of the Aearo entities had only an immaterial impact on the income statement (page 100).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. While it correctly identifies the 2008 acquisition of Aearo Technologies and the resulting litigation over Dual-Ended Combat Arms Earplugs, it incorrectly states that 3M committed to a $6 billion settlement with a $4.2 billion pre-tax charge in Q3 2023 and an accrued liability of $5 billion as of December 31, 2023. The ground truth does not mention a $6 billion settlement, a $4.2 billion charge in 2023, or a $5 billion accrued liability; instead, it describes a CAE Settlement in August 2023 that resolved claims but does not specify the dollar amount. The only confirmed financials in the ground truth are the $1.0 billion trust, $0.2 billion for case expenses, and $1.2 billion pre-tax charge in Q2 2022. The LLM introduces unsupported figures and a timeline that contradict the original answer. Additionally, the claim that de- and reconsolidation had an 'immaterial impact' contradicts the ground truth, which emphasizes significant financial and legal shifts due to these changes. While the answer captures the general narrative arc (acquisition → litigation → financial commitments → settlement), the incorrect numbers and unsupported specifics severely undermine factual accuracy. The reasoning shows an attempt at multi-hop synthesis (linking acquisition to liabilities to financial impacts), but the inclusion of fabricated figures suggests hallucination or source confusion. Contextually, the answer remains focused and relevant to the question’s scope.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 427,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How did MetLife's valuation methodology for Separate Accounts categorized under Level 2 assets change from their 2022 disclosures to their 2024 disclosures?",
      "original_answer": "MetLife's valuation methodology for Separate Accounts categorized under Level 2 assets remained consistent between 2022 and 2024 disclosures. In both years, the company stated that the estimated fair value of Level 2 Separate Accounts was based on reported Net Asset Value (NAV) provided by fund managers, reflecting the amount at which transfers into and out of the respective accounts were effected. Both disclosures emphasized that these Separate Accounts were primarily invested in liquid and readily marketable securities, with reasonable levels of price transparency that could be corroborated through observable market data.",
      "llm_answer": "MetLife’s approach to valuing Level 2 separate accounts did not change between the 2022 and 2024 10‑K filings.  In both periods the company states that Level 2 separate accounts are “primarily invested in liquid and readily marketable securities” and that their fair value is based on the reported NAV supplied by the fund managers, with the value reflecting the transfer price and corroborated by observable market data【page_305】【page_284】.  The only difference is the note reference (Note 10 in 2022 versus Note 13 in 2024), not the valuation methodology itself.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that MetLife's valuation methodology for Level 2 Separate Accounts did not change between 2022 and 2024, which aligns with the original answer. The key factual elements—use of reported Net Asset Value (NAV) from fund managers, reflection of transfer prices, investment in liquid and readily marketable securities, and corroboration via observable market data—are all correctly included. (2) There are no numeric values, dates, or financial figures in dispute; the answer correctly avoids introducing any incorrect quantitative data. (3) The multi-hop reasoning is sound: the model correctly synthesized information across two different years and filings (2022 and 2024), identified that the methodology remained consistent despite a change in note numbering (Note 10 to Note 13), and concluded that this change was presentational, not substantive. (4) The answer is contextually precise, directly addressing the question about changes in valuation methodology and correctly concluding there was no material change. Minor wording differences (e.g., 'approach' vs 'methodology') do not affect factual accuracy. All evaluation criteria are fully satisfied.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 351,
        "total_tokens": 1653
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How did the redemption of Nuance's convertible senior notes between 2022 and 2023 impact Microsoft's balance sheet liabilities, particularly in relation to the remaining notes still outstanding?",
      "original_answer": "In 2022, Microsoft reported $986 million of Nuance-issued convertible senior notes, with $985 million redeemed prior to June 30, 2022, leaving $1 million outstanding and classified as other current liabilities. By 2023, Microsoft disclosed that 'substantially all' of the $986 million in notes had been redeemed, indicating a near-complete resolution of this liability. This evolution shows a significant reduction in short-term debt obligations tied to the Nuance acquisition, with only a negligible amount remaining on the balance sheet by 2023.",
      "llm_answer": "Microsoft redeemed $985 million of Nuance’s convertible senior notes, which removed that amount from its balance‑sheet liabilities.  As of June 30 2022, only $1 million of the notes remained outstanding and were recorded as other current liabilities; no further redemption was reported in the 2023 filing, so the $1 million continued to appear on the balance sheet. (See MSFT 10‑K 2022, page 78)",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct in terms of quantitative details: it accurately states that $985 million of Nuance's convertible senior notes were redeemed, leaving $1 million outstanding as of June 30, 2022, which matches the ground truth. The entity (Microsoft), time frame (2022), and financial metric (convertible senior notes) are correctly identified. However, the LLM claims that 'no further redemption was reported in the 2023 filing, so the $1 million continued to appear on the balance sheet,' which contradicts the original answer stating that by 2023, Microsoft disclosed 'substantially all' of the $986 million had been redeemed—implying the remaining $1 million was also resolved. This omission or misinterpretation affects the qualitative accuracy and completeness of the multi-hop reasoning across 2022 and 2023. While the 2022 data is precise, the 2023 update is understated, leading to a slightly inaccurate conclusion about the status of liabilities. The answer remains contextually relevant and well-supported with a citation, but fails to fully reflect the near-complete resolution of the liability by 2023 as required by the question’s focus on both years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 330,
        "total_tokens": 1578
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did AT&T's adoption of ASU 2020-06 in 2022 impact the accounting treatment of convertible instruments by 2023, particularly regarding the dilutive effect of settling Mobility II preferred interests in stock versus cash?",
      "original_answer": "AT&T adopted ASU 2020-06 in 2022, which eliminated certain separation models for convertible instruments and required instruments that may be settled in cash or stock to be presumed settled in stock for diluted earnings per share (EPS) calculations. By 2023, this change had a direct impact on the accounting treatment of the Mobility II preferred interests. Specifically, the dilutive effect of these instruments increased due to the presumption of stock settlement, which was influenced by the fair value of the Mobility II preferred interests and the average AT&T common stock price during the reporting period. This presumption created variability in the dilutive impact from period to period, as seen in the 2023 disclosures.",
      "llm_answer": "By adopting ASU 2020‑06 in 2022, AT&T changed its convertible‑instrument accounting so that any instrument that could be settled in cash or stock is treated as if settled in stock for diluted‑EPS purposes.  Consequently, for the Mobility II preferred interests—despite AT&T’s intent to pay cash—the diluted‑EPS calculation now adds back the $560 of annual distributions (numerator adjustment) and adds the potential issuance of 320 million shares (denominator adjustment), thereby increasing the dilutive effect compared with a cash settlement.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the core accounting change from ASU 2020-06: instruments that may be settled in cash or stock are now presumed settled in stock for diluted EPS calculations, increasing dilution. It accurately notes AT&T's adoption in 2022 and the impact on Mobility II preferred interests by 2023. The qualitative reasoning about the numerator (add-back of distributions) and denominator (inclusion of potential shares) adjustments is sound and aligns with the ground truth. However, the quantitative elements—$560 million in annual distributions and 320 million potential shares—are not present in the original answer and cannot be verified from the provided ground truth. These specific figures appear to be fabricated or hallucinated, which severely undermines quantitative accuracy. The ground truth mentions variability in dilutive impact due to fair value and stock price but does not provide exact numbers. Thus, while the conceptual and multi-hop reasoning (linking ASU adoption to EPS treatment to Mobility II) is correct, the inclusion of unverified numerical values reduces overall correctness. The answer is contextually relevant and addresses the key aspects of the question beyond the unsupported numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 345,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 150,
      "question": "Given NKE's continued redeemable preferred stock arrangement with Sojitz America and its $14.4 billion in total shareholders' equity in 2023, what constraints does this preferred stock structure place on NKE's ability to distribute dividends to common shareholders?",
      "original_answer": "NKE maintains a redeemable preferred stock arrangement with Sojitz America, where the preferred stock has a par value of $0.3 million and carries a cumulative dividend of $0.10 per share payable annually on May 31. As of 2023, there have been no changes to this structure since at least 2022. Importantly, NKE cannot declare or pay dividends on its common stock unless all dividends on the redeemable preferred stock have first been declared and paid in full. Despite NKE reporting over $14.4 billion in total shareholders' equity in 2023, the rigid structure of this preferred stock arrangement imposes a binding constraint on dividend policy for common shareholders, requiring strict prioritization of preferred dividend payments before any distributions can be made to common shareholders.",
      "llm_answer": "Nike’s redeemable preferred stock is cumulative and requires a $0.10 per‑share dividend to be paid each year on May 31.  Common‑stock dividends may not be declared or paid until all preferred dividends have been declared and fully paid, so any unpaid preferred dividend must be satisfied first.  Because the preferred stock is fully issued to Sojitz America and no additional preferred shares can be issued, this priority effectively limits common‑share dividend payouts to the extent of any outstanding preferred dividends.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core constraints imposed by NKE's redeemable preferred stock arrangement with Sojitz America. (1) Quantitatively, all key figures are correct: the $0.10 per share annual dividend and the May 31 payment date match the ground truth. The par value of $0.3 million is omitted, but this detail is not directly relevant to the dividend constraint and does not affect the reasoning about dividend distribution limitations. (2) The answer correctly identifies that preferred dividends must be paid in full before any common dividends can be declared—this is the central financial constraint and is accurately emphasized. (3) The reasoning is sound: the cumulative nature of the preferred stock means unpaid dividends accumulate and must be settled first, which directly limits common shareholder distributions. The fact that no additional shares can be issued reinforces the stability of this structure, though this point is secondary. (4) The answer synthesizes the key implication—dividend prioritization—correctly, even without explicitly mentioning the $14.4 billion equity figure. While the LLM does not reference the 2023 equity amount or explicitly state there have been no changes since 2022, these omissions do not undermine the correctness of the dividend constraint explanation, which is the focus of the question. Overall, the answer is semantically equivalent to the ground truth in terms of the operational impact on dividend policy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 408,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 150,
      "question": "How did the redemption status of Nuance's convertible senior notes evolve between Microsoft's 2022 and 2023 financial reports, and what does this indicate about Microsoft's post-acquisition financial management of Nuance's legacy liabilities?",
      "original_answer": "In Microsoft's 2022 financial report, $986 million of Nuance's convertible senior notes were noted, with $985 million redeemed prior to June 30, 2022, leaving $1 million outstanding. By the 2023 report, it was stated that 'substantially all' of the $986 million in notes had been redeemed, indicating a near-complete resolution of this liability post-acquisition. This evolution shows Microsoft's active financial management in reducing legacy liabilities from the Nuance acquisition, moving from a nearly resolved to essentially finalized status within one year.",
      "llm_answer": "Microsoft’s 2022 10‑K reported that $985 million of Nuance’s $986 million convertible senior notes had been redeemed, leaving a $1 million balance (Other liabilities (b) – page 78). By the 2023 10‑K, the remaining balance had been fully redeemed, eliminating Nuance’s legacy convertible debt. This progression shows Microsoft’s proactive approach to settling acquired liabilities and reducing post‑acquisition risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the key financial figures: $986 million total notes, $985 million redeemed by 2022, leaving $1 million outstanding. It accurately states that the remaining $1 million was fully redeemed by the 2023 report. These numbers match the ground truth exactly, with acceptable formatting (e.g., $985 million vs $985 million). 2) Quantitatively, all values are correct and consistent with the original answer. The calculation implied—$986M - $985M = $1M remaining, then full redemption—is accurate. 3) The reasoning is sound: the LLM correctly infers that Microsoft proactively managed Nuance's legacy liabilities post-acquisition, aligning with the ground truth's conclusion about active financial management. The only minor difference is that the original answer uses the phrase 'substantially all' from the 2023 report, while the LLM asserts 'fully redeemed.' While this is likely correct, 'substantially all' allows for a de minimis residual amount, so 'fully redeemed' is a slight overstatement but not factually incorrect given the $1M context. 4) The answer is contextually complete and relevant, addressing both the evolution of redemption status and its implication for Microsoft's financial management. The synthesis across two annual reports is accurate and appropriately interpreted. The minor wording difference does not undermine the overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 387,
        "total_tokens": 1655
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How did the voting power distribution between Class A and Class B common stockholders change from 2022 to 2024, and what does this imply about CMCSA's shareholder governance structure?",
      "original_answer": "In 2022, CMCSA's Class A common stockholders held 66 2/3% of the combined voting power, while Class B common stockholders held 33 1/3% of the voting power, with each Class B share having 15 votes. By 2024, the voting power distribution remained the same (66 2/3% for Class A and 33 1/3% for Class B), indicating a stable governance structure where Mr. Brian L. Roberts, the sole owner of Class B shares, retained significant control despite potential share repurchases and changes in equity composition. The non-dilutable nature of Class B voting power ensured continuity in governance.",
      "llm_answer": "In both 2022 and 2024, Class A shareholders held 66 ⅓ % of the combined voting power and Class B shareholders 33 ⅓ %, a 2:1 split that remained unchanged. This unchanged ratio shows that CMCSA’s dual‑class structure is still in place, giving the controlling shareholder (who owns all Class B shares) a built‑in voting advantage while public shareholders retain a substantial share of voting rights, with the two classes voting as one class except where required by law.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that the voting power distribution remained unchanged between 2022 and 2024, with Class A holding approximately 66 2/3% and Class B 33 1/3%. However, it inaccurately reports Class A's share as '66 1/3%' instead of '66 2/3%', which is a factual error affecting quantitative precision. The 2:1 ratio mentioned is approximately correct but stems from rounded values. (2) The ground truth specifies that each Class B share has 15 votes, a key detail explaining the disproportionate voting power, which the LLM omits. This impacts completeness and qualitative accuracy. (3) The reasoning about governance stability and the dual-class structure is sound and correctly infers implications about control retention by the Class B owner (Mr. Brian L. Roberts), though it does not name him or reference the non-dilutable nature of Class B voting rights, missing a critical multi-hop insight from the original answer. (4) Despite the numerical inaccuracy and missing details, the LLM captures the core idea of stable governance and dual-class dynamics, making the response contextually relevant and largely aligned in intent and structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 332,
        "total_tokens": 1605
      },
      "error": null
    },
    {
      "question_id": 182,
      "question": "How did Duke Energy Progress' storm recovery financing strategy evolve from 2022 to 2024, particularly in terms of the transition from North Carolina-focused storm recovery property acquisitions in 2021 to the new $177 million South Carolina-focused DEPSC SF issuance in April 2024?",
      "original_answer": "In 2022, Duke Energy Progress had already completed the 2021 acquisition of storm recovery property through DEPNCSF, which was used to finance $770 million in storm recovery bonds related to 2018–2019 North Carolina storm costs. By 2024, the company expanded its storm recovery financing strategy by forming DEPSC SF and issuing $177 million in senior secured bonds to acquire storm recovery property tied to costs from 2014 through 2022 in South Carolina. This marks a geographic and temporal expansion of the storm recovery model, with DEPSC SF now consolidated under Duke Energy Progress, indicating a strategic shift to address longer-standing storm-related regulatory assets across multiple states.",
      "llm_answer": "In 2021, Duke Energy Progress used the DEPNCSF special‑purpose entity to issue senior secured bonds that financed the acquisition of storm‑recovery property for North Carolina storm costs【page_203】. By April 2024, the company broadened its strategy, creating DEPSC SF and issuing $177 million of senior secured bonds to acquire storm‑recovery property for South Carolina storm costs, thereby expanding its geographic focus beyond North Carolina【page_205】.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 2021 use of DEPNCSF for North Carolina storm recovery and the April 2024 issuance of $177 million through DEPSC SF for South Carolina, accurately reflecting the geographic expansion. All dollar amounts ($177 million) and entity names (DEPNCSF, DEPSC SF) are correct. The years referenced (2021, 2024) align with the ground truth. (2) Quantitative accuracy is perfect: the $177 million figure is correctly cited, and no other numerical claims are made that contradict the original answer. (3) The multi-hop reasoning is mostly sound—linking the 2021 North Carolina-focused financing to the 2024 South Carolina expansion shows synthesis across time and geography. However, the LLM omits key contextual details present in the ground truth: it does not mention that the 2021 acquisition was completed by 2022 (as the question asks about evolution from 2022 to 2024), nor does it note that the South Carolina costs span from 2014 to 2022, which underscores the temporal expansion. Additionally, the consolidation of DEPSC SF under Duke Energy Progress and the strategic shift to address longer-standing regulatory assets across states are missing, reducing qualitative completeness. (4) Despite these omissions, the core facts and evolution are correctly conveyed with accurate entities and numbers, warranting a high correctness score. The answer is fully contextually relevant, directly addressing the transition in strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 408,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 201,
      "question": "How did the deferral of the sunset date of ASU 2020-04 under ASU 2022-06 impact FedEx’s exposure to LIBOR-related contract modifications in 2023 compared to 2022?",
      "original_answer": "In 2022, FedEx was subject to ASU 2020-04, which provided optional expedients for contracts referencing LIBOR, with an original sunset date of December 31, 2022. FedEx noted no material effect from reference rate reform as of May 31, 2022, but continued monitoring contracts. In December 2022, ASU 2022-06 deferred the sunset date of ASU 2020-04 to December 31, 2024, allowing FedEx more time to address LIBOR discontinuation. By 2023, FedEx extended its monitoring and application of the expedients through 2024, again noting no material effect as of May 31, 2023. The deferral allowed FedEx to maintain flexibility in managing contract modifications and hedging relationships affected by the phase-out of LIBOR, ensuring continuity in financial reporting practices.",
      "llm_answer": "FedEx’s deferral of the sunset date of ASU 2020‑04 under ASU 2022‑06 extended the period during which the company could apply the optional expedients for contracts that referenced LIBOR until December 31 2024.  Because of this extension, FedEx reported no material exposure to LIBOR‑related contract modifications in 2023 – the same situation it had in 2022 – and continued to monitor its contracts for any future application of the guidance.  【page_93】【page_93】",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and conveys the core information from the ground truth. (1) It correctly states that ASU 2022-06 deferred the sunset date of ASU 2020-04 to December 31, 2024, aligning with the original answer. It accurately notes that FedEx reported no material exposure to LIBOR-related contract modifications in both 2023 and 2022, which matches the ground truth's assertion that there was no material effect as of May 31, 2022 and May 31, 2023. (2) All dates and years (December 31, 2024; 2022 and 2023 reporting) are correct, and no numerical inaccuracies are present. (3) The multi-hop reasoning is sound: the model correctly links the deferral under ASU 2022-06 to the extension of expedients and infers the impact on FedEx’s exposure and reporting continuity. (4) While the LLM omits minor contextual details—such as the explicit mention of hedging relationships and the ongoing monitoring beyond expedients—the core factual content and synthesis across ASUs and fiscal years are correct. The answer is semantically equivalent in addressing the comparative impact on exposure. Thus, the correctness score is 9 due to slight incompleteness in contextual depth, but quantitative accuracy is perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 342,
        "total_tokens": 1654
      },
      "error": null
    },
    {
      "question_id": 201,
      "question": "How did the proportion of MET's Total CMBS investments rated Aaa and Aa change from 2023 to 2024, and what does this shift indicate about the company's risk profile in its commercial mortgage-backed securities portfolio?",
      "original_answer": "In 2023, MET's CMBS portfolio had $8,262 million rated Aaa and Aa, representing 83.0% of the total CMBS holdings. By 2024, this amount decreased to $7,467 million, or 81.3% of the total CMBS portfolio. This indicates a slight decline in the proportion of high-rated securities, suggesting a marginal increase in the risk profile of MET's CMBS investments year-over-year.",
      "llm_answer": "The proportion of MET’s total CMBS holdings rated Aaa and Aa fell from **83.0 % in 2023** to **81.3 % in 2024**【page_100】【page_90】. This 1.7‑percentage‑point decline signals a modest shift toward lower‑rated CMBS, indicating a slight uptick in credit risk while the portfolio remains heavily weighted in high‑grade securities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the proportion of MET's CMBS investments rated Aaa and Aa as 83.0% in 2023 and 81.3% in 2024, matching the ground truth exactly. The dollar amounts ($8,262 million in 2023 and $7,467 million in 2024) are not explicitly mentioned in the LLM answer, but the percentages are accurate and sufficient to address the question about proportion changes. (2) The 1.7-percentage-point decline is correctly calculated (83.0% - 81.3% = 1.7%), and the interpretation of a 'modest shift toward lower-rated CMBS' and 'slight uptick in credit risk' aligns semantically with the ground truth's 'slight decline in the proportion of high-rated securities' and 'marginal increase in risk profile.' (3) The multi-hop reasoning is sound: the model correctly synthesizes data across years and interprets the implications for risk profile, demonstrating understanding of how credit rating proportions relate to portfolio risk. (4) The only minor omission is the absence of the absolute dollar values, which were present in the original answer but not strictly required to answer the question about *proportion* changes. This does not detract significantly from correctness, as the percentages and their implications are fully accurate. Wording differs slightly but maintains semantic equivalence. Thus, the answer is highly accurate, with only a small reduction in completeness justifying a 9 instead of 10 on correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1192,
        "completion_tokens": 400,
        "total_tokens": 1593
      },
      "error": null
    },
    {
      "question_id": 212,
      "question": "How did the structure and geographic scope of PEP's joint venture with Unilever for Lipton Tea evolve between 2022 and 2024, and what impact did this have on the way beverage volume was reported across PEP's operating segments?",
      "original_answer": "In 2022, PEP's joint venture with Unilever for Lipton Tea was explicitly described in the 10-K filing as operating across Europe, Africa, Middle East and South Asia (AME SA), and Asia Pacific, Australia, New Zealand and China Region (APAC). By 2024, the joint venture remained in place but was also explicitly mentioned in the LatAm segment, indicating an expansion of its geographic scope. This evolution affected how beverage volume was reported, as in 2024, PEP clarified that beverage volume included products from joint ventures like Lipton Tea and specified that these volumes were reported using standardized metrics (CSE and BCS converted to an 8-ounce-case metric). The addition of LatAm to the joint venture structure and the more detailed explanation of volume reporting methodology in 2024 suggest a more integrated and standardized approach to measuring joint venture performance across all regions.",
      "llm_answer": "Between 2022 and 2024 PepsiCo’s joint venture with Unilever for Lipton Tea remained an international partnership that covers all of the company’s regions (North America, Europe, AMESA and APAC) and continues to be structured as a non‑consolidated joint venture【page_6】【page_44】.  The 2024 10‑K clarifies that the volume sold by this joint venture is excluded from net revenue, so Lipton‑tea volume is reported only in the overall beverage‑volume metric and is reflected across all operating segments that sell Lipton products, but it does not affect the company’s net‑revenue figures【page_8】【page_42】.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several correct elements but also significant inaccuracies. It correctly identifies that the Lipton Tea joint venture with Unilever remained in place between 2022 and 2024 and is a non-consolidated joint venture. It also correctly notes that volume from the joint venture is excluded from net revenue and included in beverage volume metrics, which aligns with the ground truth's mention of standardized reporting (CSE/BCS converted to 8-ounce cases). However, it incorrectly states that the JV covers 'all of the company’s regions' including North America and LatAm in 2022, which contradicts the ground truth. The original answer specifies that in 2022, the JV operated in AME SA and APAC only, and by 2024 was explicitly mentioned in LatAm — indicating an expansion. The LLM falsely implies the JV already included North America and LatAm in 2022, which is unsupported and incorrect. (2) There are no explicit numbers (dollar amounts, percentages, volumes) in either answer, so quantitative accuracy is not heavily applicable; however, the temporal claims (2022 vs 2024 scope) are treated as factual assertions. The LLM misrepresents the geographic evolution, failing to note the key change — expansion into LatAm by 2024. This is a critical omission in a question focused on structural and geographic evolution. (3) The multi-hop reasoning is partially sound: the model connects JV structure to reporting impact on beverage volume and segments. However, it fails to correctly synthesize the geographic expansion over time, which is central to the question. The claim about 'all regions' including North America lacks support and contradicts the ground truth. (4) Contextual relevance is high because the answer addresses both parts of the question — JV structure/scope and reporting impact — but the factual errors in geographic scope and evolution reduce correctness. The explanation of volume reporting exclusion from revenue and inclusion in beverage metrics is accurate and relevant. Overall, the answer gets partial credit for correct reporting methodology but is significantly flawed in entity and temporal accuracy regarding geographic scope evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 589,
        "total_tokens": 1987
      },
      "error": null
    },
    {
      "question_id": 223,
      "question": "How did GD's reliance on commercial paper issuances in 2022 compare to their 2024 disclosure of a $4 billion committed credit facility, and what does this shift suggest about their evolving liquidity strategy?",
      "original_answer": "In 2022, GD emphasized that commercial paper issuances were a key component of their liquidity strategy, supplementing cash generated from operations to meet both short- and long-term needs. By 2024, GD disclosed that they had no commercial paper outstanding and instead maintained a $4 billion committed bank credit facility, set to expire in March 2027, which was explicitly designated to support working capital and potentially commercial paper issuances. This indicates a strategic shift from active reliance on short-term commercial paper to a more structured, long-term liquidity backup through a committed credit facility. The evolution suggests GD is prioritizing financial flexibility and risk mitigation in its capital structure.",
      "llm_answer": "In 2022, GD relied on commercial‑paper issuances to fund operations and repay debt—proceeds from commercial paper were used to pay fixed‑ and floating‑rate notes (see 2022 10‑K, page 46). By 2024, the company had no commercial paper outstanding and disclosed a $4 billion committed bank credit facility to support future commercial‑paper issuances (see 2024 10‑K, page 76), indicating a shift toward a more structured, long‑term credit line for liquidity management rather than frequent short‑term paper issuances.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and dates are correct: the $4 billion committed credit facility and the absence of commercial paper in 2024 are accurately reported. The 2022 reliance on commercial paper for funding operations and debt repayment is supported by the cited 10-K reference (page 46), and the 2024 credit facility's purpose is correctly cited from page 76. (2) The answer correctly identifies the shift from active commercial paper use in 2022 to no outstanding paper in 2024, and accurately describes the $4 billion facility as a backup, which matches the ground truth. (3) The multi-hop reasoning is sound: it synthesizes information across two years (2022 and 2024) and two filings to compare liquidity strategies. The conclusion about a shift toward a more structured, long-term credit line is logically derived and semantically equivalent to the ground truth’s 'strategic shift' and 'prioritizing financial flexibility and risk mitigation.' (4) The only minor shortcoming is that the LLM answer does not explicitly mention the 2027 expiration of the credit facility, which is part of the ground truth and adds context about the long-term nature of the facility. While not critical, this detail would have improved completeness. Otherwise, the answer is factually correct, well-reasoned, and fully relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 390,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 250,
      "question": "How did the application of pricing models in Level 3 valuations at MS evolve from 2023 to 2024, particularly in terms of the Firm's reliance on unobservable inputs and the types of valuation techniques used?",
      "original_answer": "In 2023, MS disclosed that Level 3 valuations, which rely on unobservable inputs, required the greatest degree of judgment and often involved reclassification due to market dislocation, with valuation adjustments for liquidity risk, credit quality, model uncertainty, and concentration risk. The Firm used pricing models that incorporated contract terms and multiple inputs such as commodity prices, equity prices, interest rate yield curves, and option volatility. In 2024, MS continued to apply pricing models for Level 3 valuations but placed greater emphasis on reflecting market participant assumptions even when market data was not readily available. The Firm also maintained its use of valuation adjustments, particularly for liquidity and credit risk, and continued to simulate future exposure distributions for OTC derivatives using market-based default probabilities. The evolution shows a consistent but refined approach to handling unobservable inputs, with increased focus on modeling market participant behavior under uncertain conditions.",
      "llm_answer": "In 2023, Morgan Stanley’s Level 3 valuations were largely driven by vendor‑based pricing models that relied heavily on unobservable inputs such as pre‑payment speeds, credit spreads and discount rates (see pages 87‑91). By 2024, the firm continued to use vendor‑based models but placed a stronger emphasis on observable market data and incorporated DCF‑style and other model‑based techniques to reduce reliance on unobservable inputs, as the 2024 filing explicitly states that it “maximizes the use of observable inputs and minimizes the use of unobservable inputs” in Level 3 valuations (see pages 85‑86).",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains no explicit numerical data (e.g., dollar amounts, percentages), so quantitative accuracy is not applicable in a traditional sense; however, since no numbers were misstated, it is scored as 10. The answer addresses the evolution of pricing models in Level 3 valuations at Morgan Stanley (MS) from 2023 to 2024, which is contextually relevant (score 7). However, the qualitative accuracy is low (score 4) due to significant factual discrepancies. The original answer states that in both years, MS relied on unobservable inputs and used pricing models incorporating market and contract data, with a 2024 refinement toward modeling market participant assumptions under uncertainty. In contrast, the LLM claims that in 2024, MS reduced reliance on unobservable inputs and 'maximized observable inputs,' which contradicts the ground truth that Level 3 valuations inherently rely on unobservable inputs and that the evolution was one of refinement, not reduction, in their use. The LLM incorrectly implies a shift away from unobservable inputs, while the original answer emphasizes continued reliance but improved modeling of market participant behavior. Additionally, the LLM introduces 'vendor-based pricing models' and 'pre-payment speeds' not mentioned in the ground truth, which may be plausible but are unsupported by the provided information. The multi-hop reasoning is flawed because it mischaracterizes the directional evolution of MS’s approach. While the answer attempts to compare 2023 and 2024 practices, the synthesis is based on incorrect premises, leading to a misleading conclusion. Thus, despite correct entity (MS, Level 3, 2023–2024) and general topic alignment, the core factual claim about reduced reliance on unobservable inputs is incorrect, warranting a correctness score of 4.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 491,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did the allocation to contracts with insurance companies within PEP's international plan assets change from 2023 to 2024, and what does this indicate about PEP's investment strategy in this category?",
      "original_answer": "In 2023, PEP's international plan assets included $30 million allocated to contracts with insurance companies, which slightly decreased to $29 million in 2024. This small decline indicates a relatively stable but slightly reduced emphasis on this investment category within the broader international plan assets portfolio over the two-year period.",
      "llm_answer": "The value of contracts with insurance companies in PEP’s international plan assets fell from **$30 million in 2023 to $29 million in 2024** (a $1 million decline). This small, downward adjustment reflects PEP’s strategy of keeping a modest, stable allocation to Level 3 assets while rebalancing toward other asset classes to manage risk and preserve diversification.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the allocation amounts of $30 million in 2023 and $29 million in 2024, accurately reflecting the $1 million decrease as stated in the ground truth. All numeric values and dates are correct, satisfying quantitative accuracy. (2) The calculation of the $1 million decline is implied and correct; no mathematical errors are present. Format variations (e.g., use of 'million' vs. numerical form) are acceptable and consistent with semantic equivalence. (3) The multi-hop reasoning is sound: the model correctly identifies the change over time and infers strategic intent. While the ground truth emphasizes 'relatively stable but slightly reduced emphasis,' the LLM adds interpretation about rebalancing toward other asset classes and managing risk, which is reasonable and contextually plausible, though slightly more speculative. Mention of 'Level 3 assets' is not in the original and introduces unverified detail, slightly reducing qualitative accuracy. (4) The answer fully addresses both parts of the question—quantitative change and strategic implication—and remains highly relevant. The core facts are correct, and the interpretation aligns with the trend, warranting high scores in contextual relevance and overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1192,
        "completion_tokens": 357,
        "total_tokens": 1549
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Duke Energy's application of the AFS classification for debt investments evolve from 2022 to 2024, and what does this reveal about the stability of their long-term investment strategy in debt securities?",
      "original_answer": "In 2022, Duke Energy Carolinas disclosed that its debt investments were classified as AFS, indicating a strategic intent to hold these securities for an extended period while recognizing changes in fair value in other comprehensive income. By 2024, Duke Energy Indiana maintained the same AFS classification for debt investments, showing consistency in their accounting treatment. Additionally, Duke Energy Florida reported receiving reimbursements from the NDTF for decommissioning costs, while realized gains and losses from AFS securities remained immaterial across 2022–2024. This suggests that the company's long-term investment strategy in debt securities remained stable, with no material changes in classification or realized impacts over time.",
      "llm_answer": "Duke Energy continued to classify all debt securities as available‑for‑sale (AFS) in both 2022 and 2024 (page 192 for 2022, page 193 for 2024).  The fair value of AFS debt rose modestly from $3,003 million in 2022 to $3,326 million in 2024 (page 192 and page 199).  This unchanged classification and steady growth in value demonstrate a stable, long‑term investment strategy for its debt holdings.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that Duke Energy maintained the AFS classification for debt investments in both 2022 and 2024, which aligns with the ground truth and addresses the core of the question about classification stability. However, the LLM introduces specific numerical values for the fair value of AFS debt securities—$3,003 million in 2022 and $3,326 million in 2024—that are not present in the original answer and cannot be verified against the ground truth, which makes no mention of these figures. This raises concerns about hallucination or unsupported precision. (2) While the numbers themselves may be factually accurate in the source documents (and format variations are acceptable), their inclusion without confirmation in the ground truth and without being part of the synthesis in the original answer reduces quantitative accuracy. The original answer emphasizes that realized gains and losses were immaterial and highlights consistency across subsidiaries (Duke Energy Carolinas, Indiana, Florida), which the LLM omits. (3) The reasoning is logically sound in connecting unchanged classification with a stable long-term strategy, which is supported by the ground truth. However, the LLM fails to mention the multi-entity aspect (different Duke Energy subsidiaries) and the point about NDTF reimbursements and immaterial realized gains/losses, which are key elements in the original answer’s support for strategic stability. This represents a partial failure in multi-hop synthesis across entities and disclosures. (4) Despite missing some contextual details and introducing unverified numbers, the LLM captures the essential conclusion about strategic stability and correct classification continuity, earning a solid but not high score. The answer is relevant and mostly accurate in direction, but lacks completeness and full qualitative fidelity to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 514,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did the availability of shares under Tesla's 2019 Equity Incentive Plan for consultants change from 2022 to 2023, and what does this indicate about Tesla's evolving reliance on consultants through this plan?",
      "original_answer": "In 2022, Tesla reported that 49.0 million shares were reserved and available for issuance under the 2019 Plan to employees, directors, and consultants. By 2023, this number had significantly increased to 131.1 million shares. This substantial increase indicates that Tesla's reliance on consultants through the 2019 Plan likely grew in 2023, as the company expanded the equity pool available for incentive grants, which could be used to attract and retain consulting talent. The 2019 Plan explicitly allows for grants to consultants, making it a key mechanism for Tesla to engage external expertise.",
      "llm_answer": "Tesla increased the number of shares reserved for consultants under its 2019 Equity Incentive Plan from 112.7 million in 2022 to 131.1 million in 2023, a rise of roughly 18 million shares【TSLA_10k_2022.pdf page 81】【TSLA_10k_2023.pdf page 81】. This expansion signals that Tesla is allocating more equity to consultants, reflecting a growing reliance on external expertise through the plan.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the 2022 share number. The ground truth states that 49.0 million shares were reserved and available under the 2019 Plan for employees, directors, and consultants combined in 2022, not 112.7 million specifically for consultants. The LLM incorrectly attributes 112.7 million shares to consultants in 2022, which misrepresents the data. The 2023 figure of 131.1 million is correct, but it refers to the total pool for all participants, not consultants alone. (2) Calculations are based on incorrect inputs: the claimed increase of ~18 million (from 112.7M to 131.1M) is inaccurate because the starting point is wrong. The actual increase in the total available pool from 2022 to 2023 is 82.1 million shares (131.1M - 49.0M), but the LLM misattributes this growth specifically to consultants. (3) The reasoning is partially sound in interpreting the increase as a sign of growing reliance on consultants, and the plan does allow grants to consultants. However, the multi-hop synthesis fails because the LLM does not correctly isolate the consultant-specific allocation (if any) from the total pool. The original answer makes clear that the 49.0M and 131.1M figures are total shares available for all eligible recipients, not consultant-specific. (4) Contextual relevance is high—the answer addresses the right document, plan, and timeframe, and draws a reasonable qualitative conclusion, albeit based on incorrect numbers. Due to the significant quantitative error affecting the core of the response, the correctness score is low despite some accurate elements.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 444,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Microsoft's acquisition of Nuance in 2022 influence the strategic alignment of its cloud services with AI-driven enterprise solutions by 2024, particularly in terms of realized synergies and integration costs reflected in the Intelligent Cloud segment?",
      "original_answer": "In 2022, Microsoft completed the acquisition of Nuance, which was integrated into Azure and other cloud services revenue, contributing to both cloud services and Server products performance. By 2024, the integration had progressed to the point where goodwill from the acquisition—specifically tied to expected synergies—was assigned to the Intelligent Cloud segment. This indicates a strategic deepening of Nuance’s AI and speech recognition capabilities within Microsoft’s cloud infrastructure. Additionally, the $986 million in convertible senior notes issued by Nuance (substantially redeemed by 2024) reflects the financial evolution of the acquisition's capital structure as part of the integration process.",
      "llm_answer": "Microsoft’s March 2022 purchase of Nuance was positioned as a core AI‑capability add‑on to Azure and other cloud services, “building on our industry‑specific cloud offerings” (page 40).  By fiscal 2024 the Nuance‑derived AI tools were fully integrated into the Intelligent Cloud segment, helping drive a 25 % jump in that segment’s revenue to $75.3 B and operating income to $32.7 B (page 44), while the acquisition’s purchase‑price allocation—$16.3 B of goodwill and $4.3 B of intangible assets—was recorded in the segment and amortized at $4.8 B in FY 2024 (pages 75 & 79).  These figures illustrate the realized synergies in revenue growth and the integration costs captured through goodwill and intangible‑asset amortization within Intelligent Cloud.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in quantitative details. While it correctly identifies Microsoft's 2022 acquisition of Nuance and its strategic integration into the Intelligent Cloud segment, the specific financial figures cited—such as a 25% revenue jump to $75.3B and operating income of $32.7B in FY2024, $16.3B goodwill, $4.3B intangible assets, and $4.8B amortization—are not supported by the ground truth. The original answer mentions only that goodwill was assigned to the Intelligent Cloud segment and references $986M in convertible notes from Nuance (substantially redeemed by 2024), but provides no revenue, income, or amortization figures. These fabricated numbers severely undermine factual correctness. (2) The LLM invents precise financials and cites non-existent page numbers (e.g., pages 40, 44, 75, 79), suggesting hallucinated sourcing. The ground truth does not mention revenue growth percentages, absolute segment revenues, or amortization expenses. The only monetary figure in the original is the $986M in convertible notes, which the LLM omits entirely. (3) The qualitative reasoning is partially sound: the LLM correctly infers that Nuance’s AI capabilities were integrated into Microsoft’s Intelligent Cloud segment to enhance AI-driven enterprise solutions, and that goodwill and intangibles were allocated there—this aligns with the ground truth’s mention of goodwill tied to synergies. However, it fails to mention the key financial evolution of Nuance’s capital structure (the convertible notes), a specific point in the original answer. (4) Contextual relevance is high—the response addresses strategic alignment, synergies, and integration costs in the Intelligent Cloud segment as asked. But due to severe quantitative inaccuracies and omission of key facts, the correctness score is low. The model synthesizes a plausible narrative but populates it with incorrect data, failing the core requirement of factual fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 540,
        "total_tokens": 1935
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did the auditor's testing of significant assumptions related to investment impairment in 2022 compare with the assumptions disclosed by SPG in 2023, and what does this reveal about the evolution of SPG's impairment evaluation process?",
      "original_answer": "In 2022, SPG's auditor (Ernst & Young LLP) performed sensitivity analyses on significant assumptions to evaluate changes in cash flows and fair value of investments that would result from changes in those assumptions. By 2023, SPG disclosed that it compared significant assumptions to current industry and economic trends, involved a valuation specialist, and assessed the historical accuracy of management's estimates. The evolution shows that SPG enhanced its impairment evaluation process by incorporating more external validation (valuation specialists), aligning assumptions with broader market trends, and continuing sensitivity analysis, indicating a more robust and externally scrutinized process in 2023 compared to 2022.",
      "llm_answer": "In the 2022 audit, Ernst & Young tested management’s significant impairment assumptions—forecasted operating income before depreciation and amortization, capitalization rates, leasing prospects and local market data—by comparing them to industry trends, historical results and by performing sensitivity analyses (see pages 84‑86 of the 2022 10‑K).  The 2023 10‑K discloses the same key assumptions (forecasted operating income, capitalization rates, leasing prospects, local market information) and explicitly notes that sensitivity testing is performed (see pages 84‑85 of the 2023 10‑K).  This continuity shows that SPG’s core impairment framework has remained unchanged, but the 2023 disclosure reflects an evolution toward greater transparency and systematic sensitivity analysis, making the impairment evaluation process more robust and auditable.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the auditor (Ernst & Young), the years (2022 and 2023), and the key assumptions used in impairment testing (forecasted operating income, capitalization rates, leasing prospects, local market data), which aligns with the ground truth. It also correctly notes that sensitivity analyses were performed in both years, and cites appropriate page numbers from the 10-Ks. However, it misses a critical evolution highlighted in the original answer: in 2023, SPG began involving a valuation specialist, comparing assumptions to current industry and economic trends, and assessing the historical accuracy of management’s estimates—key enhancements that go beyond transparency and systematic analysis. Instead, the LLM interprets the evolution as increased transparency and continued sensitivity analysis, which understates the substantive procedural improvements. (2) There are no numeric values to verify, so quantitative accuracy is not applicable; however, all referenced details (years, document sections) are factually correct, warranting a score of 10. (3) The multi-hop reasoning is partially sound—information is synthesized across two years and filings—but the conclusion about the evolution of the process is inaccurate. The LLM fails to recognize that the addition of external validation (valuation specialists) and retrospective evaluation of past estimates represent a qualitative enhancement in methodology, not just disclosure. This weakens the qualitative accuracy. (4) The answer is contextually relevant and well-structured, directly addressing the comparison between 2022 and 2023 auditor testing and SPG disclosures. However, due to the omission of key 2023 process enhancements, the overall correctness is reduced to a 6, reflecting partial accuracy with significant missing depth in the evaluation of process evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 509,
        "total_tokens": 1928
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did ConocoPhillips' investment strategy in APLNG from 2022 to 2023 influence its production and ownership stake in coal bed methane (CBM) in Queensland, Australia?",
      "original_answer": "In 2022, ConocoPhillips exercised its preemption right to purchase an additional 10% stake in APLNG, increasing its ownership and resulting in a $688 million write-down due to fair value adjustments. By 2023, ConocoPhillips held a 47.5% ownership stake in APLNG, which is focused on producing CBM from the Bowen and Surat basins in Queensland. APLNG, in turn, is responsible for producing CBM that feeds into LNG operations on Curtis Island. Therefore, the increased investment in APLNG in 2022 directly supported COP's expanded role in CBM production through 2023.",
      "llm_answer": "ConocoPhillips’ strategy for APLNG from 2022‑2023 was to keep its 47.5 % ownership stake and continue investing in the joint venture, which underpins CBM production from Queensland’s Bowen and Surat basins.  APLNG’s plan to bring roughly 3,500 net wells online and operate two 4.5 MTPA LNG trains kept CBM output robust, while the ownership percentage remained unchanged during the period【91†L1-L4】【13†L1-L8】.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains both correct and incorrect information. It correctly states that ConocoPhillips held a 47.5% ownership stake in APLNG and that APLNG produces coal bed methane (CBM) from the Bowen and Surat basins in Queensland, which aligns with the ground truth. However, it incorrectly claims that the ownership stake 'remained unchanged' during 2022–2023, directly contradicting the ground truth that COP increased its stake in 2022 by exercising a preemption right to acquire an additional 10%. This is a critical factual error. Additionally, the LLM introduces new quantitative details not present in the original answer—specifically, '3,500 net wells' and 'two 4.5 MTPA LNG trains'—which, while potentially accurate, are not supported by the ground truth and introduce unverified data. (2) The percentage (47.5%) is correct, but the claim of no change in ownership is false given the 10% increase in 2022. The $688 million write-down due to fair value adjustments, a key financial impact of the investment, is entirely omitted. The introduction of production plans (wells, LNG trains) adds detail but is not responsive to the question about how the investment strategy influenced production and ownership. (3) The multi-hop reasoning is flawed: the original answer connects the 2022 investment (preemption right) → increased ownership → greater role in CBM production. The LLM fails to capture this causal chain, instead asserting static ownership, which breaks the logical synthesis. It also does not link the 2022 decision to the 2023 outcome correctly. (4) The answer is contextually relevant—discussing APLNG, CBM, Queensland, and ownership—but lacks key factual accuracy and misrepresents the investment strategy’s dynamic nature. Hence, partial credit is given for correct entities and location, but major deductions for incorrect ownership narrative and missing financial impact.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 517,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did the valuation of Marvel as part of DIS's indefinite-lived intangible assets in 2022 relate to the integration of Marvel-branded content within Disney+ services in 2023, and how did this affect Disney's overall direct-to-consumer strategy execution in 2023?",
      "original_answer": "In 2022, Marvel was listed as one of Disney's indefinite-lived intangible assets, alongside ESPN and Pixar, indicating its long-term strategic value to DIS. By 2023, Marvel's content was deeply integrated into Disney+, which includes Disney, Pixar, Marvel, Star Wars, and National Geographic branded programming as top-level selections within the Disney+ interface. This integration suggests that the value of Marvel as an intangible asset directly supported Disney+'s content strategy, which is critical to the company's DTC business—a subscription service offered directly to consumers with branded programming across devices. The continued emphasis on Marvel content in Disney+ indicates that the 2022 valuation of Marvel was instrumental in driving DIS's 2023 DTC execution strategy.",
      "llm_answer": "In 2022, Marvel was part of the $1.792 billion of indefinite‑lived intangible assets, reflecting the long‑term value of the brand (page 110). In 2023, Disney leveraged that valuation by integrating Marvel‑branded content into Disney+, a core element of its DTC offering that helped sustain subscriber growth and revenue and reinforced the shift from linear to streaming (page 13). This integration supported Disney’s overall direct‑to‑consumer strategy execution in 2023, as the company expanded Disney+ with an ad‑supported model and continued to rely on its intellectual‑property portfolio (page 13).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Marvel was part of Disney's indefinite-lived intangible assets in 2022 and notes its integration into Disney+ in 2023 as a key component of DTC strategy. The mention of $1.792 billion as the total value of indefinite-lived intangible assets (including Marvel) is factually accurate and contextually appropriate, though the ground truth does not specify the exact dollar amount tied solely to Marvel—this figure represents the total for all such assets (Marvel, ESPN, Pixar, etc.). Thus, while the number itself is accurate, attributing it directly to Marvel without clarification slightly over-specifies. However, this is a minor issue given that the LLM correctly situates Marvel within that asset category. (2) The quantitative accuracy is high: the $1.792 billion figure matches the 2022 10-K (page 110), and the reference to 2023 DTC strategy on page 13 aligns with the cited shift to streaming and ad-supported models. No calculations were required, but the use of numbers is correct in context. (3) The multi-hop reasoning is sound: the LLM connects the 2022 valuation (financial reporting) to 2023 strategic execution (content integration and DTC growth), correctly inferring that the intangible asset value supports ongoing content-driven strategy. It also references the ad-supported tier expansion and IP reliance, which enriches the answer beyond the ground truth with accurate supporting detail. (4) The answer is semantically equivalent to the original, with slightly more specific financial citation and strategic context. All entities (DIS, Marvel, Disney+, DTC) and years are correct. The only reason for not scoring a 10 is the slight risk of misinterpretation that the $1.792B is Marvel’s standalone value, rather than the total for all indefinite-lived intangibles. However, given the phrasing 'part of,' this is reasonably accurate. Contextual relevance is perfect—directly addresses all parts of the question with precise, relevant information.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 544,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did MDLZ's performance in the Gum & Candy category in 2022, particularly its dependency on the AMEA region, influence its strategic positioning or asset allocation in AMEA by 2023?",
      "original_answer": "In 2022, MDLZ generated $861 million in revenue from the Gum & Candy category in the AMEA region, which accounted for 2.8% of AMEA's total net revenues. This dependency on Gum & Candy in AMEA suggests that the category played a meaningful role in the region's revenue mix. By 2023, MDLZ's total assets in the AMEA region stood at $9,965 million, a slight increase from $9,882 million in 2022. This indicates that MDLZ maintained or slightly expanded its asset base in AMEA despite the relatively modest contribution from the Gum & Candy segment, suggesting a strategic decision to sustain or grow presence in the region despite the category's limited revenue share.",
      "llm_answer": "In 2022, the Gum & Candy category generated $780 million of revenue in AMEA—about 23 % of the segment’s $3.412 billion total—highlighting the region’s importance. By 2023 MDLZ raised AMEA net revenues to $7.075 billion and operating income to $1.113 billion, while adding roughly $83 million to segment assets, indicating a strategic shift to invest more heavily in AMEA to support growth in the Gum & Candy line. This reflects the company’s use of segment operating income to allocate resources and strengthen its positioning in that key market.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, MDLZ generated $861 million in Gum & Candy revenue in AMEA in 2022, not $780 million. Additionally, Gum & Candy accounted for 2.8% of AMEA's total net revenues, not 23% of a $3.412 billion segment total — this figure and percentage are unsupported by the ground truth. The LLM claims AMEA net revenues reached $7.075 billion in 2023 and operating income of $1.113 billion, which are not present in the original answer and cannot be verified from the provided data. The asset increase is stated as 'roughly $83 million', but the ground truth shows an increase from $9,882 million to $9,965 million — a $83 million rise — which is the only numerically accurate calculation. However, this is framed incorrectly as being 'added to segment assets' without specifying total assets, and is used to support an incorrect narrative. (2) The quantitative inaccuracies are severe: revenue, percentages, and financial metrics are all incorrect or hallucinated. Only the $83 million asset increase aligns numerically with the truth (9,965 - 9,882 = 83), though context is misapplied. (3) The multi-hop reasoning is flawed: the LLM incorrectly infers a 'strategic shift to invest more heavily' based on inflated category performance, while the ground truth suggests Gum & Candy had a modest (2.8%) contribution and the asset increase was slight, indicating sustained rather than expanded investment. The conclusion about using operating income to allocate resources is unsupported. (4) Correctness is low due to major factual and numerical errors. Quantitative accuracy is very poor except for one correct difference. Qualitative accuracy is low due to incorrect synthesis and logic. Contextual relevance is moderate as the answer addresses the right region, company, and general theme of strategy, but with incorrect data and conclusions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 520,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did Southern Company's (SO) shift in battery energy storage capacity from 2023 to 2024 reflect its strategic focus on solar-integrated storage projects like Garland Solar Storage?",
      "original_answer": "In 2023, Southern Company (SO) completed the Garland Solar Storage project with 88 MW of battery energy storage capacity in Kern County, CA, as part of its broader battery energy storage initiatives. By 2024, SO continued to maintain this 88 MW project while also advancing new solar-focused developments such as Millers Branch (200 MW in Phase I), indicating a strategic continuation and expansion of solar-linked storage solutions. The persistence of Garland Solar Storage in SO's portfolio from 2023 to 2024, alongside new solar projects, demonstrates a deliberate focus on integrating battery storage with solar generation to enhance grid reliability and renewable utilization.",
      "llm_answer": "In 2023 Southern Power had 160 MW of battery‑storage capacity from Garland Solar Storage (88 MW) and Tranquillity Solar Storage (72 MW) (page 297).  In 2024 the company added no new battery‑storage projects—its construction focus shifted to a 150‑MW South Cheyenne solar plant and the three phases of Millers Branch solar (page 291).  This shift underscores a strategic emphasis on solar‑integrated storage, using batteries as part of larger solar projects rather than expanding standalone battery capacity.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. First, it incorrectly attributes the Garland and Tranquillity projects to 'Southern Power' rather than 'Southern Company (SO)', which is a subsidiary but not the parent entity in focus. More critically, the ground truth states that only the Garland Solar Storage project (88 MW) was completed in 2023, but the LLM claims both Garland (88 MW) and Tranquillity (72 MW) were operational, totaling 160 MW—this is unsupported by the original answer and introduces a non-mentioned project (Tranquillity). Additionally, the LLM states that no new battery-storage projects were added in 2024, contradicting the original answer which highlights the advancement of the Millers Branch project (200 MW Phase I) as a solar-integrated storage development. The 150-MW South Cheyenne solar plant is also not mentioned in the ground truth. (2) Quantitative errors include the false sum of 160 MW from two projects (Garland and Tranquillity), which are not both confirmed in the original answer, and the incorrect capacity for Millers Branch (200 MW in ground truth vs. 150 MW and 'three phases' in LLM). (3) The multi-hop reasoning is partially sound—the LLM correctly infers a strategic focus on solar-integrated storage—but it does so based on incorrect data, undermining the validity of the conclusion. The original answer emphasizes continuity of Garland and expansion via new solar-linked storage, while the LLM incorrectly frames it as a shift away from standalone batteries due to lack of new battery additions, which is not supported. (4) The contextual relevance is fair because the answer addresses the strategic focus on solar-integrated storage, but the factual foundation is flawed, leading to a partially incorrect synthesis. Correctness score is low due to major factual and quantitative errors despite some alignment in strategic interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 517,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did the evolution of Starbucks' relationship with Nestlé through the Global Coffee Alliance impact the performance and strategic direction of Starbucks' Channel Development segment from 2023 to 2024?",
      "original_answer": "In 2023, Starbucks' Channel Development segment included a variety of products such as roasted coffee, single-serve items, ready-to-drink beverages, and foodservice products, many of which were distributed through licensing arrangements, including a key relationship with Nestlé under the Global Coffee Alliance. By 2024, the Channel Development segment's revenues were increasingly tied to product sales and royalty revenues from Nestlé, indicating a deepened strategic partnership. This evolution likely contributed to the segment's reported 5% share of total net revenues in 2024, suggesting a stable but relatively small contribution to overall company performance. The increased reliance on Nestlé for distribution and marketing of these products highlights a strategic shift toward leveraging the partner's global reach, which could enhance scalability but also introduces dependency risks.",
      "llm_answer": "Starbucks’ Channel Development segment saw a modest decline in 2024, with net revenues falling from $1.894 billion in 2023 to $1.770 billion and operating income dropping from $967.6 million to $925.9 million【page_90】.  The segment’s performance remains tightly linked to its Global Coffee Alliance with Nestlé, which licenses the distribution of most packaged coffee, ready‑to‑drink, and food‑service products; the partnership continues to be the primary source of revenue and a key strategic focus for expanding those product lines【page_9】.  The risk disclosure notes that the segment’s growth is heavily dependent on Nestlé’s distribution and marketing commitments, underscoring the alliance’s ongoing influence on both performance and strategic direction【page_22】.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific financial figures—$1.894 billion in 2023 and $1.770 billion in 2024 for net revenues, and operating income of $967.6 million and $925.9 million—that are not present in the original answer (ground truth). These numbers contradict the ground truth, which does not provide absolute revenue figures but instead states that the segment contributed 5% of total net revenues in 2024. There is no mention of a decline or specific dollar amounts in the ground truth, making these quantitative claims unsupported and factually inaccurate. (2) The calculation of a decline in revenues and operating income cannot be verified against the ground truth and appears to be fabricated or extracted from a source not aligned with the provided knowledge graph. The ground truth does not support any assertion of a 'modest decline'—instead, it describes the segment as having a 'stable but relatively small contribution.' This is a major quantitative error. (3) Qualitatively, the LLM correctly identifies the strategic importance of the Global Coffee Alliance with Nestlé, noting that the partnership drives revenue through licensing and distribution of packaged coffee, RTD, and foodservice products. It also correctly highlights the dependency risk on Nestlé’s marketing and distribution, which aligns with the ground truth’s mention of 'dependency risks' and leveraging global reach. The reasoning around strategic direction is sound and reflects multi-hop synthesis between the alliance and its impact on Channel Development. (4) Contextually, the answer is highly relevant, addressing both performance and strategic direction as asked. However, the inclusion of false precision via unsupported numerical data significantly undermines factual correctness. While the qualitative insights are strong and semantically aligned, the incorrect numbers lead to a lowered correctness and quantitative accuracy score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 524,
        "total_tokens": 1954
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did the acquisition of CoreSite in 2022 impact the scale and cybersecurity certifications of AMT's Data Center Facilities segment by 2023?",
      "original_answer": "In 2022, American Tower completed the acquisition of CoreSite for $10.4 billion, which added 24 data center facilities across eight U.S. markets to AMT’s portfolio. By 2023, this acquisition had significantly expanded the Data Centers segment, which now included these 24 facilities. Additionally, CoreSite maintained several cybersecurity certifications for nearly all of its data center facilities, including SOC 1 Type 2, SOC 2 Type 2, ISO/IEC 27001, NIST 800-53, PCI DSS, and HIPAA attestations. These certifications enhanced the security posture and market credibility of AMT’s data center offerings, reflecting a strategic evolution in both scale and operational security maturity post-acquisition.",
      "llm_answer": "By 2023 the CoreSite acquisition had expanded American Tower’s Data Centers segment from a single facility to 28 data‑center sites across ten U.S. markets, totaling 3.3 million net rentable square feet (the 24 CoreSite sites plus four additional facilities acquired thereafter).  The deal also brought CoreSite’s robust cybersecurity certifications—SOC 1 and SOC 2 Type 2, ISO/IEC 27001, NIST 800‑53, PCI DSS, and HIPAA—into the segment’s compliance portfolio, elevating the segment’s overall security posture.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the strategic impact of the CoreSite acquisition on AMT's Data Center Facilities segment in terms of scale and cybersecurity certifications, which aligns with the original answer’s core intent. However, there are key quantitative inaccuracies: the original answer states that CoreSite added 24 data center facilities, but the LLM claims a total of 28 sites across ten markets, including 'four additional facilities acquired thereafter'—this detail is not present in the ground truth and introduces unverified information. Additionally, the original makes no mention of square footage (3.3 million net rentable square feet), which the LLM introduces without support. (2) The acquisition cost of $10.4 billion is omitted in the LLM answer, a significant financial figure present in the original. While the listed cybersecurity certifications (SOC 1 Type 2, SOC 2 Type 2, ISO/IEC 27001, NIST 800-53, PCI DSS, HIPAA) are correctly reported, the LLM omits the nuance that these were maintained for 'nearly all' CoreSite facilities, slightly overstating universality. (3) The multi-hop reasoning is generally sound—the model connects the 2022 acquisition to its 2023 impact on scale and security posture, correctly attributing certifications to CoreSite and recognizing their strategic value. However, the unsupported expansion to 28 sites and ten markets reflects a failure to strictly adhere to the source data, suggesting possible hallucination or incorrect synthesis. (4) Despite these issues, the answer captures the essential qualitative outcomes—expansion of scale and enhancement of security credibility—making it contextually relevant and mostly accurate in direction, though flawed in specific numbers and completeness of financial details. Hence, a correctness score of 7 is warranted: core facts are right, but significant quantitative omissions and additions reduce precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 522,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did the change in XOM's synthetic crude oil production volume through Syncrude in 2022 compared to 2023 reflect the stability of its stake in Imperial Oil Limited and the broader implications for oil sands production strategy?",
      "original_answer": "In 2022, XOM's share of net production of synthetic crude oil through Syncrude was about 62 thousand barrels per day. The stake structure remained consistent in 2023, with XOM maintaining a 69.6% interest in Imperial Oil Limited, which owns a 25% stake in Syncrude. This resulted in a slight increase in production to 67 thousand barrels per day in 2023, indicating a stable production strategy and no changes in ownership stakes despite minor production fluctuations.",
      "llm_answer": "In 2023, XOM’s share of net synthetic‑crude production through Syncrude rose to about **67 000 barrels per day**【page_19】, up from roughly **66 000 barrels per day** in 2022 (a modest increase). The steady, slightly higher output underscores the stability of XOM’s 69.6 % interest in Imperial Oil Limited and signals that the company is pursuing a strategy of maintaining a consistent oil‑sands production level while focusing on cost efficiency and reserve replacement.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 2023 production volume (67,000 barrels per day) and the stable 69.6% stake in Imperial Oil Limited, which aligns with the ground truth. However, it inaccurately reports the 2022 production volume as 66,000 barrels per day instead of the correct 62,000 barrels per day. This is a significant quantitative error, especially since the ground truth emphasizes a rise from 62k to 67k, which represents a more notable increase than implied by 66k to 67k. (2) The calculation of change is therefore flawed: the actual increase is ~8.1%, while the LLM implies only a ~1.5% increase, misrepresenting the magnitude of production growth. All other numbers (69.6% stake, 25% Syncrude ownership via Imperial) are correct. (3) The multi-hop reasoning is sound—LLM correctly links XOM’s stake in Imperial Oil to Imperial’s stake in Syncrude and infers production stability and strategic intent. It appropriately draws implications about oil sands strategy, cost efficiency, and reserve replacement, which are contextually valid extensions of the data. (4) Despite the incorrect 2022 figure, the answer captures the core conclusion of stake stability and consistent strategy, warranting a score of 7 for overall correctness. Quantitative accuracy is penalized more heavily (6/10) due to the erroneous baseline production number. Qualitative and contextual scores are higher because reasoning and relevance remain strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 403,
        "total_tokens": 1659
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did the increase in Disney's notional amount of foreign exchange cash flow hedges from $7.4 billion in 2022 to $9.9 billion in 2024 reflect a change in their foreign currency risk exposure, and what role did option contracts play in managing this risk over time?",
      "original_answer": "Disney's notional amount of foreign exchange cash flow hedges increased from $7.4 billion in 2022 to $9.9 billion in 2024, indicating a significant rise in their exposure to foreign currency risk. This increase suggests that Disney expanded its hedging activities to protect against greater volatility in foreign exchange rates. Option contracts played a central role in this strategy, as they were used to hedge forecasted foreign currency transactions, firm commitments, and existing foreign currency assets. The use of these contracts allowed Disney to offset changes in the U.S. dollar equivalent value of foreign currency-denominated items, thereby stabilizing earnings and cash flows. The evolution of the hedge portfolio reflects a strategic response to a growing international footprint and increased foreign currency asset exposure.",
      "llm_answer": "Disney’s notional amount of foreign‑exchange cash‑flow hedges rose from $7.4 billion in 2022 to $9.9 billion in 2024, indicating that its foreign‑currency commitments—such as sports‑rights, content and cruise‑ship financing—had expanded and required a larger hedge to protect earnings and cash flows. The company uses option and forward contracts as cash‑flow hedges; option contracts in particular allow Disney to lock in favorable rates for forecasted but not yet firm commitments while preserving upside, with gains and losses deferred in AOCI and recognized in earnings when the underlying transactions occur.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers and dates are correct: the notional amount increased from $7.4 billion in 2022 to $9.9 billion in 2024, matching the original answer exactly. No calculations were required, but the comparison over time is correctly stated. (2) The LLM correctly identifies the increase in hedging as reflective of greater foreign currency risk exposure due to expanding international commitments, citing specific examples like sports rights, content, and cruise-ship financing—details not in the ground truth but contextually plausible and consistent with Disney's operations. (3) The role of option contracts is accurately described: they hedge forecasted transactions, allow upside potential, and are accounted for through AOCI with reclassification upon transaction occurrence. The original answer adds that options also cover firm commitments and existing foreign currency assets, which the LLM omits slightly, but mentions 'forecasted but not yet firm commitments,' capturing a key nuance. (4) The reasoning is sound and reflects multi-hop synthesis: connecting increased hedge notional to greater risk exposure, linking hedging instruments to financial stability, and explaining the strategic use of options. The only minor gap is the absence of explicit mention of 'existing foreign currency assets' as hedged items, slightly reducing completeness. However, the core facts, logic, and intent of the original answer are preserved with high fidelity. Wording differs but meaning is semantically equivalent. Thus, the answer earns a 9/10 for correctness—excellent but not perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 454,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did the strategic decision to partner with DIT in 2023 influence the financial outcome of the ATC TIPL transaction in 2024, particularly in terms of impairment charges and the final sale loss?",
      "original_answer": "In 2023, AMT partnered with DIT as part of a strategic review of its India business, which led to the ATC TIPL Transaction. During this review, AMT recorded a $322.0 million goodwill impairment charge for its India reporting unit due to the carrying value exceeding fair value. In 2024, the transaction with DIT culminated in the sale of ATC TIPL for approximately $2.2 billion, resulting in a $1.2 billion loss, which included a $1.1 billion reclassification of cumulative translation adjustments. The impairment charges from 2023 directly influenced the financial outcome of the 2024 sale, as the reduced asset valuations contributed to the significant loss on disposal.",
      "llm_answer": "The partnership with DIT in 2023 triggered a strategic review that revealed the India reporting unit’s carrying value exceeded its fair value, leading to a $322 million goodwill impairment charge recorded in the quarter ended September 30, 2023 (page 58).  The subsequent sale of ATC TIPL to DIT in 2024 produced a $1.2455 billion loss on sale (page 140, 143), largely driven by a $1.0723 billion re‑classification of cumulative translation adjustment and the earlier goodwill impairment.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core financial and strategic cause-effect relationship between the 2023 DIT partnership and the 2024 ATC TIPL transaction. (1) Quantitatively, the $322 million goodwill impairment is correctly stated (matches ground truth exactly, though LLM specifies Q3 2023 and page 58, which adds precision without contradiction). The sale loss is reported as $1.2455 billion vs. the ground truth $1.2 billion — this is a minor discrepancy but likely due to more granular source data (e.g., exact figure from filing), so acceptable under format variation. Similarly, the reclassification amount is $1.0723 billion vs. $1.1 billion in the original — again, a precise figure likely pulled directly from the filing, representing rounding variation rather than error. (2) Completeness: All key elements are addressed — the 2023 strategic review, impairment trigger, amount, and its influence on the 2024 sale loss. The answer correctly identifies the reclassification of cumulative translation adjustments as a major component of the loss. (3) Entity accuracy is strong: AMT, DIT, ATC TIPL, India reporting unit, and correct years (2023–2024) are all properly referenced. (4) Reasoning is sound and multi-hop: the answer correctly links the 2023 impairment (due to fair value decline) to reduced asset bases affecting the 2024 disposal loss, showing causal financial logic. (5) Semantic equivalence is maintained — the LLM conveys the same core narrative as the ground truth, with slightly more detailed figures. The only reason for not scoring 10 is the slight numerical variance in the loss and reclassification amounts, but these are within reasonable reporting tolerance and may reflect exact values from the source document.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 477,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did the change in coal-fired capacity at Duke Energy Indiana's Edwardsport plant from 2022 to 2023 reflect Duke Energy's evolving fuel sourcing strategy in Indiana, particularly regarding coal supply contracts?",
      "original_answer": "In 2022, Duke Energy Indiana's Edwardsport plant had a coal-fired capacity of 595 MW. By 2023, this capacity decreased slightly to 578 MW, reflecting a shift in fuel mix toward coal/gas dual-fuel operations. This change aligns with Duke Energy Indiana's broader coal sourcing strategy, which relies on long-term contracts expiring between 2024 and 2027, with expectations to renew or replace these contracts as they expire. The reduction in coal-only capacity suggests a strategic move to increase fuel flexibility, likely in response to market conditions and environmental considerations.",
      "llm_answer": "In 2022 Duke Energy Indiana’s Edwardsport plant was listed at 595 MW of coal‑fired capacity (2022 10‑K, page 38), while in 2023 it was shown at 578 MW (2023 10‑K, page 38) – a 17 MW reduction.  That shrinkage aligns with the company’s stated strategy of tightening its coal portfolio in Indiana: both 2022 and 2023 filings note that long‑term coal contracts (expiring 2024‑2027) are being renegotiated for greater flexibility and that the firm is actively managing its coal supply mix, which has led to a modest cut in coal capacity at Edwardsport as part of a broader shift toward alternative fuels and more adaptable sourcing arrangements.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the coal-fired capacity at Duke Energy Indiana's Edwardsport plant as 595 MW in 2022 and 578 MW in 2023, matching the ground truth exactly. The 17 MW reduction (595 - 578 = 17) is accurately calculated. These figures align with the cited 10-K pages, confirming quantitative accuracy. (2) All numeric values, years, and calculations are correct. The format (MW, years 2022–2023, contract expiration 2024–2027) matches the ground truth. (3) The reasoning correctly links the capacity decrease to Duke Energy’s evolving fuel strategy, including the renegotiation of long-term coal contracts (expiring 2024–2027) and a shift toward more flexible, adaptable sourcing. The mention of a broader shift toward alternative fuels and flexible arrangements captures the essence of the strategic move toward dual-fuel operations, though the term 'coal/gas dual-fuel operations' from the original is not explicitly used. This is a minor omission but does not detract from the overall correctness. (4) The answer is contextually complete and highly relevant, addressing both the capacity change and its reflection on fuel sourcing strategy. The synthesis across years and strategic context is sound. The only reason for not scoring a 10 is the slight lack of specificity around 'dual-fuel' operations, which is implied but not stated. Thus, correctness is 9, with full marks in quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 404,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did the change in GM's reliance on third-party data for residual value estimation in 2022 compare to 2023, particularly in relation to the impact of manufacturer incentive programs on depreciation assumptions?",
      "original_answer": "In 2022, GM Financial estimated residual values for leased vehicles using third-party data that included manufacturer incentive programs as a key assumption, and the estimated residual value was $29.1 billion at year-end. GM noted that if used vehicle prices weakened, depreciation expense would increase or impairment charges could occur. By 2023, GM continued to rely on third-party data for residual value estimation, with manufacturer incentive programs still playing a significant role in the assumptions. However, the sensitivity analysis and controls around these estimates were further emphasized in the audit, indicating a more refined approach to managing risk in residual value forecasting. The continued use of third-party data and sensitivity to manufacturer incentives shows a stable relationship between these entities across years, though the audit process evolved to include more hindsight analysis and testing of data accuracy.",
      "llm_answer": "In 2022 GM continued to base residual‑value estimates on third‑party data that included inputs such as manufacturer incentive programs, and a 1 % change in those estimates would raise depreciation by about $207 million (page 46).  The same third‑party data approach was used in 2023 (page 56), but the sensitivity of depreciation to residual‑value changes fell to roughly $67 million, indicating a lower impact of incentive programs on depreciation assumptions.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in quantitative details. While it correctly states that GM used third-party data in both 2022 and 2023 and that manufacturer incentive programs were part of the assumptions, it fabricates key sensitivity figures: claiming a $207 million impact in 2022 and $67 million in 2023. The original answer does not mention these specific sensitivity amounts or any change in sensitivity magnitude. Instead, the ground truth emphasizes that the audit process evolved with more refined controls and hindsight analysis in 2023, not a quantified reduction in depreciation sensitivity. The LLM incorrectly infers that a lower sensitivity implies reduced impact of incentive programs, which is not supported by the original text. Additionally, the original answer includes the $29.1 billion estimated residual value at year-end 2022, which the LLM omits. The LLM also fails to mention the risk of increased depreciation or impairment if used vehicle prices weaken, a key qualitative point. While the core idea of continued reliance on third-party data is correct, the introduction of unsupported numerical sensitivity changes and the erroneous conclusion about decreasing impact of incentives undermine the factual accuracy. The reasoning is flawed due to incorrect data synthesis, though the answer remains contextually relevant to the question's focus on year-over-year comparison and depreciation assumptions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 403,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Microsoft's handling of Nuance's convertible senior notes evolve between 2022 and 2023, particularly in terms of redemption progress and strategic alignment post-acquisition?",
      "original_answer": "In 2022, Microsoft disclosed that Nuance had issued $986 million in convertible senior notes in 2015 and 2017, with $985 million redeemed prior to June 30, 2022, leaving $1 million outstanding. By 2023, Microsoft noted that 'substantially all' of those notes had been redeemed, indicating near-complete resolution of this debt instrument. This evolution reflects Microsoft's strategic integration of Nuance, as highlighted by the continued attribution of goodwill to synergies from the acquisition. The shift from partial redemption in 2022 to near-full redemption in 2023 demonstrates both financial and strategic alignment in the post-acquisition phase.",
      "llm_answer": "Microsoft had already redeemed the bulk of Nuance’s convertible senior notes by the end of 2022 – $985 million of the $986 million issued in 2015‑17 had been paid back, leaving only $1 million outstanding【page_77】.  By the 2023 filing the notes no longer appeared as a liability, indicating the remaining balance had been fully redeemed and the debt was removed from the balance sheet, a move that dovetails with Microsoft’s strategy to fully integrate Nuance’s AI capabilities into its Intelligent Cloud segment【page_78】【page_79】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that $985 million of the $986 million in convertible senior notes were redeemed by the end of 2022, leaving $1 million outstanding, which matches the ground truth. It also accurately infers that by 2023, the notes no longer appeared as a liability, indicating full redemption—this aligns with the original answer’s claim of 'substantially all' being redeemed. While the LLM interprets this as 'fully redeemed' and 'debt removed,' which is a slightly stronger claim than 'substantially all,' it is a reasonable inference given the context and absence of the liability in filings. (2) All numeric values—$986 million issued, $985 million redeemed, $1 million remaining—are factually correct and consistent with the ground truth. No calculation errors. (3) The multi-hop reasoning is sound: the model connects Nuance's note issuance pre-acquisition, Microsoft's post-acquisition disclosure in 2022, and the 2023 update implying full redemption, while linking this to strategic integration into the Intelligent Cloud segment. This reflects proper synthesis across time and entities. (4) The answer is contextually excellent, addressing both redemption progress and strategic alignment. The only minor gap is that the original answer explicitly ties the redemption progress to 'continued attribution of goodwill to synergies,' a nuance not mentioned in the LLM response, but the reference to strategic integration provides comparable qualitative insight. Thus, the answer is highly accurate with only a slight softening of the 2023 redemption claim preventing a perfect 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 443,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did the change in Disney's notional amount of foreign exchange cash flow hedges related to firm commitments from 2022 to 2024 reflect the evolution of their foreign exchange risk management strategy?",
      "original_answer": "Disney's notional amount of foreign exchange cash flow hedges tied to firm commitments increased from $7.4 billion in 2022 to $9.9 billion in 2024, indicating a significant expansion in their hedging activities. This growth suggests that Disney increased its exposure to foreign exchange option contracts as part of a more aggressive or expansive risk management strategy to stabilize earnings and cash flows amid global currency volatility. The increase in hedge volume aligns with the company's stated objective of reducing earnings fluctuations due to exchange rate changes, allowing management to focus on core business operations.",
      "llm_answer": "Disney’s notional amount of foreign‑exchange cash‑flow hedges tied to firm commitments grew to **$9.9 billion in 2024** from a lower level in 2022 (the 2024 10‑K reports $8.3 billion in 2023, which was already higher than 2022). This increase shows Disney’s shift toward a more aggressive, comprehensive hedging strategy that expands coverage of its firm commitments to better stabilize earnings and cash flows.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the increase in Disney's notional amount of foreign exchange hedges from 2022 to 2024 and accurately reports the 2024 value ($9.9 billion). However, it introduces a figure for 2023 ($8.3 billion) that is not present in the original ground truth, and incorrectly implies that 2022 was lower than $8.3 billion without specifying the actual 2022 value of $7.4 billion. This omission and introduction of unsupported data reduce quantitative accuracy. (2) The ground truth specifies the 2022 amount as $7.4 billion; the LLM fails to include this exact number, which is critical for assessing the full change over the period. While the direction of change (increase) is correct, the absence of the precise starting point and the inclusion of an unverified intermediate year (2023) with a specific number harms factual completeness and precision. (3) The reasoning about Disney’s evolving risk management strategy—increased hedging to stabilize earnings and cash flows—is logically sound and aligns with the ground truth. The synthesis of increased hedge volume with strategic intent is valid and reflects appropriate multi-hop interpretation. (4) Despite the missing $7.4 billion figure and the unsupported $8.3 billion reference, the core trend and strategic interpretation are correct, warranting a score of 7 for overall correctness. Quantitative accuracy is penalized more heavily (6) due to the incorrect omission and addition of figures. Qualitative reasoning remains strong (8) as the logic and entity identification (Disney, foreign exchange hedges, firm commitments, strategic intent) are accurate. Contextual relevance is perfect (10) as the response directly addresses the question’s focus on strategy evolution through hedging trends.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 486,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Capital One's compliance with FDICIA's capital adequacy requirements evolve from 2022 to 2024, particularly in terms of their Tier 1 capital ratio relative to the 'Well-Capitalized' threshold?",
      "original_answer": "In 2022, FDICIA established the capital adequacy framework, defining 'Well-Capitalized' banks as those meeting or exceeding Tier 1 capital of 6.0%. By 2024, Capital One Financial Corp maintained a Tier 1 capital ratio of 14.8%, significantly above the 6.0% 'Well-Capitalized' threshold, demonstrating strong regulatory compliance and capital resilience. This reflects a consistent capital management strategy that ensured Capital One remained well above the regulatory minimums over the two-year period.",
      "llm_answer": "Capital One’s Tier 1 capital ratio has consistently stayed well above the FDICIA “well‑capitalized” benchmark.  In 2022 the ratio was already above the 8 % threshold for insured depository institutions (the standard for a Category III BHC), and by the end of 2024 it had risen to 14.8 %—more than double the 6 % threshold that applies to a Category III institution【page 17】【page 86】.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies Capital One's 2024 Tier 1 capital ratio as 14.8% and the 6.0% 'Well-Capitalized' threshold, which aligns with the ground truth. However, it incorrectly states that the 2022 threshold was 8%, referencing a 'Category III BHC' standard not mentioned in the original answer or relevant to the general FDICIA 'Well-Capitalized' definition of 6.0%. The ground truth states that FDICIA defined the 'Well-Capitalized' threshold as 6.0% in 2022, not 8%. This is a significant factual error in regulatory context. 2) The 14.8% figure for 2024 is accurate and correctly compared to the 6% threshold. However, the claim that Capital One was 'above 8%' in 2022 is unsupported by the ground truth, which does not provide Capital One’s actual 2022 Tier 1 ratio—only that the threshold was 6.0%. Thus, the LLM introduces a specific benchmark (8%) and a company performance claim (above it) not present in the original data. 3) The reasoning partially reflects multi-hop synthesis by connecting regulatory thresholds to Capital One’s capital ratio over time, but misrepresents the regulatory framework by conflating different categorizations (Category III BHC vs. general FDICIA 'Well-Capitalized'). The core evolution narrative—Capital One remaining well above minimums—is consistent, but the regulatory details are inaccurately specified. 4) Despite the numerical and regulatory inaccuracies, the answer remains contextually relevant and captures the overall trend of strong compliance and capital resilience. The 14.8% figure and comparison to 6% are correct, supporting the conclusion of robust compliance in 2024. The score is reduced due to incorrect threshold citation and unsupported 2022 performance claim.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 470,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did the treatment and valuation of SPG's noncontrolling redeemable interests evolve between 2022 and 2024, particularly in relation to the redemption options available to limited partners and the impact on equity classification?",
      "original_answer": "In 2022, SPG disclosed noncontrolling redeemable interests in properties and classified them as temporary equity due to the potential for redemption in cash, with adjustments made to the carrying amount based on redemption value. By 2024, the redemption option remained available to limited partners in the Operating Partnership, who could exchange units for cash or shares of common stock on a one-for-one basis, with the cash amount based on the trading price of SPG common stock. SPG maintained the ability to determine whether redemptions were settled in cash or stock, but if cash was selected and insufficient funds were available, the exchange would default to stock. This evolution shows a continued emphasis on flexibility in redemption settlement while maintaining the temporary equity classification due to the contingent cash redemption risk.",
      "llm_answer": "Between 2022 and 2024, Simon continued to classify its noncontrolling redeemable interests as temporary equity, with the carrying amount adjusted to the redemption value assuming the instrument is redeemable at the balance‑sheet date【128†L1-L6】【128†L7-L12】.  Limited partners retained the right to exchange units for cash or common stock, with cash payments based on the then‑trading price of Simon’s common stock【131†L1-L5】.  No change in equity classification or valuation methodology was disclosed in the 2024 filing, indicating the treatment remained consistent with the 2022 approach.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the essential information from the ground truth. (1) It correctly states that SPG (referred to as 'Simon') maintained the classification of noncontrolling redeemable interests as temporary equity from 2022 to 2024, with adjustments to carrying amount based on redemption value—this matches the original answer's key point. The redemption rights of limited partners to exchange units for cash or stock, with cash value tied to the trading price of SPG common stock, are accurately described. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or ground truth, so quantitative accuracy is not compromised; all dates (2022–2024) are correct. (3) The multi-hop reasoning is sound: the model synthesizes the continuity of accounting treatment and redemption mechanics across years. However, the LLM omits a minor but relevant detail present in the ground truth: SPG’s ability to choose the settlement form (cash or stock), and the fallback to stock if cash is elected but funds are insufficient. This nuance affects the completeness of the redemption mechanism description but does not invalidate the core correctness. (4) Despite this omission, the answer remains semantically equivalent in intent and fact, with high contextual relevance and strong qualitative accuracy. The lack of explicit mention of SPG’s settlement discretion prevents a perfect 10, but the answer is otherwise complete and correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 408,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did the allocation of PEP's U.S. Plan Assets to Government Securities change between 2023 and 2024, and what does this shift indicate about the company's investment strategy for pension funds?",
      "original_answer": "In 2023, PEP's U.S. Plan Assets included $1,812 million in Government Securities, which decreased to $1,538 million in 2024. This represents a reduction of $274 million, or about 15.1%. The decline in allocation to Government Securities, coupled with an increase in Cash and Cash Equivalents from $349 million to $732 million (an increase of $383 million or 109.7%), suggests a strategic shift toward more liquid assets in 2024. This evolution indicates a potential rebalancing of the portfolio to prioritize liquidity and possibly reduce exposure to fixed-income instruments.",
      "llm_answer": "Between 2023 and 2024 PepsiCo reduced the dollar amount of U.S. plan assets held in government securities from $1.812 billion to $1.538 billion, a decline of roughly 15 % and a drop in share of total U.S. plan assets from about 16 % to 14.5 % (see the 2024 and 2023 fair‑value tables on page 99). This modest rebalancing reflects the company’s ongoing strategy to keep a diversified pension portfolio—shifting slightly away from government bonds toward other fixed‑income or equity holdings—to manage risk and interest‑rate exposure while still targeting roughly 55‑56 % fixed‑income allocation overall.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the dollar amounts for Government Securities in 2023 ($1.812 billion) and 2024 ($1.538 billion), matching the ground truth of $1,812 million and $1,538 million. The calculated decline of roughly 15% is accurate (exact: 15.1%). However, the LLM introduces a claim about the share of total U.S. plan assets dropping from 16% to 14.5%, which is not present in the original answer and cannot be verified without total asset figures—this adds unverified detail. (2) The quantitative values are correct, and the percentage change is accurately approximated. The reduction of $274 million is implied correctly. However, the LLM does not mention the key shift to Cash and Cash Equivalents ($349M to $732M), which is central to the original answer's conclusion about increased liquidity. This omission undermines completeness. (3) The reasoning is partially flawed: while the LLM notes a shift away from government securities, it suggests a move toward 'other fixed-income or equity holdings,' which contradicts the ground truth indicating a shift to Cash and Cash Equivalents. This misrepresents the investment strategy. The claim about maintaining a 55–56% fixed-income allocation is unsupported in the provided ground truth and introduces external assumptions. (4) The answer is contextually relevant and addresses the change in allocation, but the incorrect inference about the destination assets and unsupported claims about portfolio percentages reduce qualitative accuracy. The correctness score is 6 due to correct core numbers but significant errors in interpretation and missing key comparative data that alter the strategic implication.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 459,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did the vesting periods for stock options under the LTIP change from 2022 to 2023, and what was the impact on the number of Class A shares authorized for equity awards?",
      "original_answer": "In 2022, stock options under the LTIP vested ratably over four years for awards granted before March 1, 2022, while options granted on or after that date in 2023 vested over three years. This change in vesting schedule was accompanied by approximately 116 million shares of Class A common stock being authorized for equity awards under the LTIP in 2023, indicating a structural shift in incentive timing and available shares for issuance.",
      "llm_answer": "The LTIP’s stock‑option vesting schedule stayed the same – a five‑year, 20 %‑per‑year vesting period in both 2022 and 2023 (2022 note 14, page 138; 2023 note 13, page 118).  In 2023 the company disclosed that the LTIP now has roughly 116 million Class A shares authorized for equity awards, an increase from the 25 million shares authorized for the 2021 Omnibus Incentive Compensation Plan that was in effect in 2022 (2023 note 13, page 102).",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It claims the vesting schedule remained unchanged at a five-year, 20% per year structure in both 2022 and 2023, which directly contradicts the ground truth: in 2022, options granted before March 1, 2022 vested ratably over four years, and those granted on or after that date in 2023 vested over three years. The five-year vesting is incorrect and not supported by the ground truth. (2) The number of Class A shares authorized — approximately 116 million in 2023 — is correctly stated, which is a key quantitative match. However, the LLM incorrectly compares this to the 25 million shares from the 2021 Omnibus Incentive Compensation Plan, which was not the LTIP and was not the plan in effect in 2022 for the LTIP. This misrepresents the baseline and implies an increase that may not be accurate in the context of the LTIP specifically. (3) The multi-hop reasoning fails: the model does not correctly synthesize the change in vesting periods (from four to three years) across the two years, misidentifies the vesting terms, and conflates different equity plans. It fails to recognize that the vesting change occurred mid-2022 with effect in 2023, which is central to the question. (4) While the 116 million share figure is correct and relevant, the core of the answer — the vesting period change — is entirely wrong, and the reasoning is flawed. Hence, the correctness score is low despite partial quantitative accuracy on one number. Contextual relevance is moderate because it addresses the right topic and cites share authorization, but with incorrect reasoning and entities.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 451,
        "total_tokens": 1678
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did Southern Company's (SO) battery energy storage system capacity in Garland Solar Storage evolve from 2022 to 2023, and what does this indicate about the company's deployment strategy for this specific project?",
      "original_answer": "In 2022, Southern Company (SO) reported Garland Solar Storage as a project under construction with a battery energy storage system capacity of 88 MW in Kern County, CA, with expected commercial operation dates (COD) spanning September 2021 through early 2022. By 2023, the same facility was listed as completed, still with an 88 MW battery energy storage capacity, and the COD was confirmed as completed between September 2021 and February 2022. This indicates that SO successfully transitioned Garland Solar Storage from a construction-phase project to a fully operational asset within the expected timeframe, maintaining the original capacity specifications, which reflects a consistent and planned execution of their energy storage deployment strategy.",
      "llm_answer": "In 2022, Garland Solar Storage had a total battery capacity of 88 MW, with 73 MW in service in 2021 and the remaining 15 MW expected to be commissioned in Q1 2022 (page 330). By 2023 the project is listed as completed with the full 88 MW capacity in service (page 297). This indicates Southern Power finished the remaining phase of the project in 2022 and achieved full operational status by 2023, reflecting a phased deployment strategy rather than expanding the project’s capacity.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but introduces a detail not present in the ground truth — specifically, the split of 73 MW in service in 2021 and 15 MW expected in Q1 2022. This breakdown is not mentioned in the original answer, which only states that the COD spanned September 2021 to February 2022. While this split could be consistent with the timeframe, it is an addition not supported by the provided ground truth, reducing quantitative accuracy. The final capacity of 88 MW in both years is correct, and the completion status in 2023 is accurately reported. (2) The numbers for capacity (88 MW) are accurate, and the progression from partial to full operation aligns with the timeline, though the specific 73/15 MW split lacks corroboration. Dates (COD between Sept 2021–Feb 2022) are consistent with the original. (3) The reasoning is sound: the LLM correctly infers a phased deployment strategy based on incremental commissioning, which is a reasonable interpretation of the timeline. It synthesizes information across two years correctly — from under construction to completed — and draws a logical conclusion about deployment strategy. (4) The answer addresses both parts of the question: the evolution of capacity (from partial to full) and the implication for deployment strategy. Despite the unsupported MW split, the core facts and multi-hop reasoning (project status change over time, strategic implication) are accurate and relevant. Minor deduction from 9 to 8 due to unverified quantitative detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 422,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did the completion timeline and capacity of the Garland Solar Storage battery energy storage project evolve from its construction phase in 2022 to its operational status in 2023, and what does this indicate about SO's execution of its energy storage strategy?",
      "original_answer": "In 2022, SO reported that the Garland Solar Storage project, with a nameplate capacity of 88 MW, was under construction with expected commercial operation dates (COD) spanning September 2021 through the first quarter of 2022. By 2023, SO confirmed that the project had been completed, with COD finalized between September 2021 and February 2022. This indicates that SO successfully executed its energy storage strategy within the planned timeframe, transitioning the project from construction to full operation while maintaining the stated capacity. The consistency in capacity and COD alignment reflects disciplined project management and adherence to contractual timelines under the 20-year PPA.",
      "llm_answer": "During 2022 Southern Power finished the Garland Solar Storage battery project, adding the final 15 MW to reach its 88 MW total capacity (73 MW had been commissioned in 2021)【page_330】. By 2023 the facility is listed as a completed project with its full 88 MW capacity in service, indicating that the construction phase was completed on schedule and the asset was fully integrated into the company’s operations【page_297】. This demonstrates SO’s effective execution of its energy‑storage strategy, successfully adding a sizable battery asset to its portfolio within the planned timeline.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the project's total capacity (88 MW) and that it was completed by 2023, aligning with the ground truth. However, there are significant discrepancies in the timeline: the LLM claims Southern Power finished the project in 2022, adding 15 MW to 73 MW commissioned in 2021, but the ground truth states commercial operation dates (COD) were between September 2021 and February 2022, with no mention of a phased commissioning of 73 MW in 2021 and 15 MW in 2022. This breakdown of 73 MW + 15 MW = 88 MW is not supported by the original answer and introduces a factual error. (2) The dates are partially incorrect — the original answer specifies COD from September 2021 to Q1 2022, while the LLM implies completion in 2022 without acknowledging that operations began as early as September 2021. The 2023 status is correctly reported as operational. (3) The reasoning about SO’s execution of its energy storage strategy is sound and logically follows from the timely completion and full capacity deployment, which is consistent with the ground truth’s conclusion on disciplined project management. The multi-hop synthesis across years and project phases is generally appropriate, though based on flawed intermediate data. (4) The contextual relevance is high as all parts of the question are addressed — timeline evolution, capacity, and strategic implications. Due to the incorrect phased commissioning narrative and timeline inaccuracies, quantitative accuracy is reduced to 6, qualitative accuracy to 8 for correct entities and logical inference, and overall correctness to 7 for core facts being right but key details wrong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 456,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did the regulatory constraints on CVS's HMO and insurance subsidiaries in 2022 impact the company's ability to extract dividends, and how does this compare to the financial stake CVS maintained in healthcare services by 2024 as reflected in its goodwill allocation?",
      "original_answer": "In 2022, CVS's HMO and insurance subsidiaries were subject to regulatory requirements that restricted dividend payments and required maintenance of certain equity levels, resulting in $1.6 billion of gross dividends paid in 2021 but with additional limitations in place. These constraints were partly a result of undertakings made during the Aetna acquisition that required regulatory approval for future dividend distributions. By 2024, CVS demonstrated a continued strategic emphasis on healthcare services, as evidenced by the $3,406 million allocated to Health Services goodwill, suggesting a sustained investment in this segment despite earlier regulatory limitations on financial extraction.",
      "llm_answer": "Regulatory limits on CVS’s HMO and insurance subsidiaries capped the dividends they could pay in 2022 at roughly **$2.94 billion** (page 174), curbing the cash that could be extracted from those entities. By contrast, the 2024 10‑K shows goodwill of **$6.94 billion** from the Oak Street Health acquisition and **$3.41 billion** from the Signify Health acquisition—about **$10.34 billion** allocated to the Health Services segment (pages 134‑136)—indicating a far larger financial stake in healthcare services than the dividend‑extraction cap.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that $1.6 billion in gross dividends were paid in 2021, with additional limitations in place in 2022 due to regulatory constraints from the Aetna acquisition. However, the LLM incorrectly claims a dividend cap of $2.94 billion in 2022, which is not supported by the original answer and misrepresents both the year and amount. Furthermore, the LLM attributes the $3.41 billion and $6.94 billion goodwill figures to Oak Street Health and Signify Health acquisitions, respectively, and sums them to $10.34 billion for the Health Services segment. The original answer, however, states that $3,406 million (i.e., $3.406 billion) was allocated to Health Services goodwill by 2024—closely matching only the Signify figure cited by the LLM, not the sum. There is no mention of Oak Street or a $6.94 billion goodwill allocation in the ground truth. (2) The quantitative inaccuracies are severe: the dividend amount is wrong in value and year, and the goodwill total is incorrectly calculated by summing two unrelated acquisitions not mentioned in the original. The correct goodwill allocation is ~$3.41 billion, not $10.34 billion. (3) The multi-hop reasoning is flawed: while the LLM attempts to contrast dividend constraints with strategic investment via goodwill, it uses incorrect entities and figures. The original answer draws a logical comparison between regulatory limits on capital extraction and sustained investment signaled by goodwill, but the LLM’s version relies on fabricated or misattributed data. (4) Scores reflect major factual and numerical errors (correctness: 3), very poor quantitative accuracy (2), partial understanding of the conceptual link between dividends and goodwill but with incorrect entities (qualitative: 4), and generally relevant structure and intent (contextual: 7).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 512,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did MDLZ's revenue contribution from Beverages in the AMEA region change between 2022 and 2024, and what does this indicate about the strategic importance of this product segment in that market?",
      "original_answer": "In 2022, MDLZ generated $546 million in Beverages revenue from the AMEA region, representing 1.9% of total net revenues. By 2024, this figure slightly declined to $525 million, still contributing to the overall beverage segment of $1,096 million. Despite the slight decrease, the AMEA region remained a consistent contributor to the beverages category, indicating sustained strategic relevance in this market.",
      "llm_answer": "MDLZ’s beverage sales in the AMEA region fell from **$572 million in 2022 to $525 million in 2024** – a drop of about **$47 million (≈8 %)**.  \nThe segment remains a small part of AMEA revenue (≈1.9 % of the region’s net sales in 2024), indicating that beverages are a modest, slightly declining contributor and are not a primary strategic focus for the company in that market.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer correctly reports the 2024 beverage revenue for MDLZ in the AMEA region as $525 million and notes a decline, which aligns with the ground truth. However, it incorrectly states the 2022 revenue as $572 million instead of the correct $546 million, leading to an inaccurate $47 million drop (≈8%) calculation. The ground truth shows a decrease from $546M to $525M, which is a $21 million (≈3.8%) decline. The 1.9% contribution in 2024 is correctly cited, but the original answer notes this was also the 2022 percentage, indicating stability in relative contribution despite the revenue drop—this nuance is missing. 2) Quantitative inaccuracies are significant: the 2022 figure is wrong, and the resulting difference and percentage change are therefore incorrect. While $525M and 1.9% are accurate, the core comparison is flawed. 3) The reasoning is partially sound—recognizing a decline and interpreting strategic relevance—but misses the ground truth's emphasis on sustained strategic relevance due to consistent regional contribution. Instead, it concludes beverages are 'not a primary strategic focus,' which is a weaker interpretation than the original 'sustained strategic relevance.' 4) The answer is contextually relevant and addresses both parts of the question (change in revenue and strategic implication), but the incorrect starting figure undermines the quantitative analysis and weakens the conclusion. Minor formatting variations like '$525 million' are acceptable and correctly interpreted.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1209,
        "completion_tokens": 416,
        "total_tokens": 1625
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the allocation shift in TXN's U.S. Retiree Health Care Plan investments between 2022 and 2023 affect the proportion of Fixed Income Securities and Cash Equivalents, and what does this indicate about the plan's risk profile evolution?",
      "original_answer": "In 2022, TXN's U.S. Retiree Health Care Plan allocated 65% of its investments to Fixed Income Securities and Cash Equivalents. By 2023, this allocation increased to 80%, while the corresponding equity securities allocation dropped from 35% to 20%. This shift indicates a more conservative investment strategy in 2023, aimed at reducing risk exposure for the plan.",
      "llm_answer": "Between 2022 and 2023 the U.S. Retiree Health Care Plan shifted its asset mix from 65 % fixed‑income securities and cash equivalents (182 / 280 = 65 %) to 80 % (210 / 264 ≈ 80 %)【page 51】. This 15‑percentage‑point increase in fixed‑income exposure—concomitant with a drop in equity holdings—shows a deliberate move toward a more conservative, lower‑volatility risk profile, in line with the plan’s asset‑liability matching strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: the 65% allocation in 2022 and 80% in 2023 for Fixed Income Securities and Cash Equivalents are accurately reported. The LLM provides additional detail (182/280 = 65%, 210/264 ≈ 80%) which matches the underlying data and shows correct calculations. These figures match the ground truth exactly in percentage terms, with minor rounding acceptable. (2) The answer correctly identifies the shift from 65% to 80%—a 15-percentage-point increase—and notes the corresponding drop in equity, which is implied in the original answer (from 35% to 20%). While the LLM does not explicitly state the equity percentages, it references the drop generally, which is sufficient given the focus on fixed income and cash equivalents in the question. (3) The reasoning is sound: the conclusion that this reflects a more conservative, lower-volatility risk profile is logically derived and consistent with the ground truth’s statement about a more conservative strategy. The mention of 'asset-liability matching strategy' adds context not in the original but is a reasonable inference and does not detract from accuracy. (4) Entities are correct: TXN (implied via context), U.S. Retiree Health Care Plan, 2022–2023 time frame, and financial categories are all accurately referenced. The only minor shortcoming is the lack of explicit mention of the equity drop percentages, but since the question primarily asks about Fixed Income and Cash Equivalents and the risk profile, this omission does not significantly impact correctness. Overall, the answer is factually precise, contextually relevant, and demonstrates proper multi-hop synthesis across years and asset classes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 479,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the expiration of the Erawan concession in Thailand in 2023 impact Chevron's (CVX) net oil-equivalent production decline that year, and how does this compare to their continued operations at Map Ta Phut in 2024, where refinery crude unit inputs increased to 160 thousand barrels per day?",
      "original_answer": "In 2023, Chevron's net oil-equivalent production declined by 47,000 barrels per day, or 3%, partly due to the expiration of the Erawan concession in Thailand. Despite this decline, Chevron maintained operations in Thailand through its Map Ta Phut refinery, which saw an increase in refinery crude unit inputs to 160 thousand barrels per day in 2024, up from 153 thousand barrels per day in 2023. This indicates that while upstream production was negatively affected by the concession expiration, downstream refining activity in Thailand continued to grow.",
      "llm_answer": "The 2023 expiration of the Erawan concession in Thailand caused Chevron’s net oil‑equivalent production to fall by 47,000 barrels per day (about a 3 % decline). In contrast, the company’s Map Ta Phut refinery remained fully operational in 2024, with crude‑unit inputs rising to 160 k bpd (up from 153 k bpd in 2023), indicating continued downstream throughput rather than a production drop.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: the 2023 Erawan concession expiration led to a 47,000 barrel per day decline (3%) in Chevron's net oil-equivalent production, and Map Ta Phut refinery crude inputs increased to 160 thousand bpd in 2024 from 153 thousand bpd in 2023. These numbers match the original answer exactly. (2) Quantitative accuracy is perfect—values, units, and comparisons (e.g., increase from 153k to 160k bpd) are correctly reported. (3) The multi-hop reasoning is sound: the model correctly links the upstream production impact of Erawan's expiration with the downstream operational continuity at Map Ta Phut, showing contrast between declining production and growing refining activity. (4) The only minor shortcoming is slight brevity in explaining the broader implication—that upstream was negatively affected while downstream grew—though the phrase 'continued downstream throughput rather than a production drop' captures the essence. This omission is not material, so the answer remains semantically equivalent. Hence, a 9/10 on correctness and qualitative accuracy, with full marks for quantitative and contextual performance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 345,
        "total_tokens": 1618
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the application of interest rate caps in AXP's 2023 interest rate risk management strategy influence the repricing risk assumptions used in their 2024 net interest income sensitivity analysis?",
      "original_answer": "In 2023, AXP's interest rate risk management assumed that interest-rate sensitive assets and liabilities would generally reprice by the same magnitude, subject to applicable interest rate caps or floors, as benchmark rates change. This assumption was carried forward into 2024, where the repricing risk explicitly considered the impact of these caps and floors, along with the potential for certain deposits to reprice at lower magnitudes than benchmark rate movements. The 2024 sensitivity analysis continued to reflect the detrimental impact of higher interest rates on net interest income, showing a direct evolution of the repricing risk framework shaped by the interest rate caps introduced in 2023.",
      "llm_answer": "American Express’s 2023 interest‑rate risk policy stated that “interest‑rate sensitive assets and liabilities that reprice within the twelve‑month horizon generally reprice by the same magnitude as benchmark rates, **subject to applicable interest‑rate caps or floors**” (2023 10‑K, page 79).  The 2024 net‑interest‑income sensitivity analysis carries this assumption forward, explicitly noting that repricing is limited by those caps (2024 10‑K, page 81).  Thus, the 2023 use of caps directly shaped the 2024 repricing‑risk assumptions by capping the potential impact of rate changes on net interest income.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the 2023 interest rate risk management policy included repricing assumptions subject to caps/floors, and this was carried forward into the 2024 net interest income sensitivity analysis. The citations to the 2023 and 2024 10-Ks (pages 79 and 81) are consistent with the source data. (2) There are no numerical values requiring calculation in this question; dates (2023, 2024) and financial concepts (interest rate caps, repricing risk, net interest income sensitivity) are used correctly. (3) The multi-hop reasoning is sound: the model correctly links AXP's 2023 risk management strategy (use of caps) to the evolution of 2024 repricing risk assumptions, showing causal influence across years. (4) The LLM captures the core idea that interest rate caps from 2023 directly shaped the 2024 assumptions by limiting the magnitude of repricing, which is the key point in the original answer. The only minor omission is that the original answer also notes the potential for certain deposits to reprice at lower magnitudes than benchmark rates — a nuance not included in the LLM response. However, this does not undermine the central correctness. Overall, the answer is factually precise, contextually appropriate, and semantically equivalent to the ground truth with only slight incompleteness on a secondary detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 392,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did SPG's strategic investment in SPARC Group in 2023 influence its financial relationship with J.C. Penney in 2024, particularly in terms of lease income and ownership structure changes?",
      "original_answer": "In 2023, SPG invested in SPARC Group and received $101.8 million in lease income from its retailers, including SPARC Group and J.C. Penney. By 2024, SPG's investment evolved as J.C. Penney acquired SPARC Group's retail operations, which was renamed Catalyst Brands. This led to SPG recognizing a non-cash pre-tax gain of $100.5 million and retaining a 31.3% noncontrolling interest in Catalyst. Additionally, SPG's lease income from these retailers increased to $105.9 million in 2024, showing a direct financial benefit from the earlier investment and the subsequent restructuring.",
      "llm_answer": "SPG’s 2023 investment in SPARC Group gave it a 33.3 % non‑controlling stake, making SPARC a tenant that contributed $101.8 million of lease income in 2023 (page 131/133). In 2024, J.C. Penney’s acquisition of SPARC’s retail operations created Catalyst Brands; SPG recorded a $100.5 million pre‑tax gain and its ownership structure shifted to a 31.3 % non‑controlling interest in Catalyst while retaining a 33.3 % stake in SPARC Holdings, which now holds a 25 % stake in Catalyst (page 139). The transaction changed the tenant relationship from SPARC to J.C. Penney, thereby altering SPG’s lease‑income profile and ownership structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All numeric values are correct: $101.8 million lease income in 2023, $100.5 million pre-tax gain, 31.3% noncontrolling interest in Catalyst Brands, and increased lease income to $105.9 million in 2024 is implied through context of change in tenant structure. The LLM correctly notes the 33.3% stake in SPARC Group initially and the shift to 31.3% in Catalyst, which matches the knowledge graph. (2) Quantitative accuracy is perfect—no calculation or number errors. Format variations (e.g., $101.8 million) are acceptable and consistent. (3) Multi-hop reasoning is sound: the answer traces SPG’s 2023 investment, the 2024 acquisition by J.C. Penney of SPARC’s operations forming Catalyst Brands, the resulting gain, ownership restructuring, and impact on lease income. It adds extra precision by noting SPG retained a 33.3% stake in SPARC Holdings, which owns 25% of Catalyst—a detail consistent with deeper filing data and enhancing accuracy. (4) The only minor shortcoming is that the LLM does not explicitly state the 2024 lease income increased to $105.9 million, though it references a changed lease-income profile, which is semantically adjacent but slightly less complete. Otherwise, entities (SPG, SPARC, J.C. Penney, Catalyst Brands), years (2023, 2024), and financial terms (non-cash pre-tax gain, non-controlling interest) are all correct. The answer fully addresses the question’s focus on lease income and ownership changes. Thus, the correctness score is 9 due to near-perfect factual alignment with only a small omission in updated lease income figure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 448,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did the completion of the Swedish Match acquisition in late 2023, including the final redemption price of SEK 115.07 per share, influence PM's strategic positioning in oral nicotine delivery as reflected in its 2024 portfolio transformation?",
      "original_answer": "In 2023, PM finalized the acquisition of Swedish Match, paying a final redemption price of SEK 115.07 per share, completing the process in Q4 2023 after the arbitral tribunal decision in September. This acquisition gave PM full control over Swedish Match, a leader in oral nicotine delivery, particularly in the U.S. market. By 2024, this integration had accelerated PM's transformation into a smoke-free company, strengthening its global smoke-free portfolio with leadership in both heat-not-burn and oral nicotine categories. The acquisition directly enabled PM to leverage Swedish Match's market-leading oral nicotine capabilities, aligning with its broader strategic shift toward non-combustible nicotine products.",
      "llm_answer": "The final redemption of Swedish Match shares at SEK 115.07 per share closed the acquisition in Q4 2023, giving PMI a market‑leading oral‑nicotine business and a significant U.S. presence【page 92】.  The deal accelerated PMI’s shift to a smoke‑free company, enabling it to build a comprehensive global smoke‑free portfolio with leadership in heat‑not‑burn and the fastest‑growing oral‑nicotine category—key elements of its 2024 portfolio transformation【page 93】【page 94】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the final redemption price of SEK 115.07 per share, Q4 2023 completion of the acquisition, PM's (PMI's) strategic shift toward smoke-free products, and the enhancement of its 2024 portfolio transformation through leadership in both heat-not-burn and oral nicotine categories. The mention of a 'significant U.S. presence' is consistent with Swedish Match's strong position in the U.S. oral nicotine market. (2) Quantitative accuracy is perfect: the SEK 115.07 price and Q4 2023 timing match the original answer; no calculations were required. (3) The multi-hop reasoning is sound—linking the acquisition closure to PMI’s strategic positioning in oral nicotine and broader smoke-free transformation in 2024. The only minor omission is not explicitly mentioning the arbitral tribunal decision in September 2023, which was part of the acquisition finalization process. However, this detail is contextually secondary to the overall strategic impact in 2024. (4) Semantic equivalence is strong; the LLM uses slightly different phrasing (e.g., 'fastest-growing oral-nicotine category') but conveys the same strategic significance. The inclusion of citation markers like 【page 92】 suggests sourcing from the 10-K, enhancing credibility. Overall, the answer is factually complete, contextually relevant, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 391,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did the $96 million pre-tax charge related to Nicor Gas' disallowed capital investments in 2023 impact Southern Company's gas distribution operations in Illinois, and how does this compare to the 2024 performance of these operations given the lower natural gas cost recovery and customer demand in that state?",
      "original_answer": "In 2023, Southern Company incurred a $96 million pre-tax charge due to the disallowance of certain capital investments at Nicor Gas, which directly impacted its gas distribution operations in Illinois, where Nicor Gas serves 2,276,000 customers. This financial burden likely constrained operational flexibility in the short term. By 2024, revenues associated with gas cost recovery in Illinois declined due to both lower natural gas prices and reduced demand from warmer weather, compounding the earlier financial strain. Although weather normalization mechanisms helped stabilize revenues, the cumulative effect of the prior year's capital disallowance and the 2024 cost recovery reductions suggests a dual pressure on operational performance in Illinois, where the company serves a significant customer base.",
      "llm_answer": "In 2023 the $96 million pre‑tax regulatory disallowance for Nicor Gas cut Southern Company Gas’s gas‑distribution operating income by that amount, bringing the segment’s operating income to $804 million (vs. $900 million without the charge).  In 2024 the same segment’s operating revenue fell by $206 million because of lower natural‑gas cost recovery and weaker demand in Illinois, yet operating income rose to $1,127 million and net income to $550 million as operating expenses dropped (in part due to the prior‑year $88 million Nicor disallowance) and cost‑recovery mechanisms mitigated the revenue loss.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The $96 million pre-tax charge is correctly identified, but the LLM fabricates financial figures not present in the ground truth, such as operating income of $804 million in 2023, $900 million baseline, and 2024 operating income rising to $1,127 million and net income to $550 million. These numbers are not supported by the original answer or implied by it. Additionally, the LLM incorrectly states that the 2023 disallowance was $88 million in 2024 (contradicting its own $96 million figure), introducing a material numerical inconsistency. (2) The calculation claims—such as a $206 million revenue decline in 2024 and operating income increase despite revenue drop—are not corroborated by the ground truth, which only states that revenues declined due to lower gas prices and demand, with stabilization via cost-recovery mechanisms. No specific revenue or income figures are provided in the ground truth for 2024, so the LLM’s precise numbers are hallucinated. (3) The multi-hop reasoning is partially sound in linking the 2023 regulatory disallowance to financial impact and then considering 2024 revenue pressures, but it fails in synthesis by inventing detailed financials and suggesting a recovery in profitability that the ground truth does not support. The original answer emphasizes 'dual pressure' and 'financial strain,' whereas the LLM concludes with improved operating income, contradicting the implied negative trend. (4) The contextual relevance is moderate because the LLM addresses both years and the correct entities (Nicor Gas, Southern Company, Illinois operations), but the qualitative and quantitative inaccuracies severely undermine correctness. The invented metrics and contradictory conclusions justify a low correctness score despite some structural alignment with the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 508,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did the evolution of AVGO's ValueOps product within the Distributed Software portfolio from 2022 to 2024 reflect changes in its value stream management capabilities and enterprise alignment focus?",
      "original_answer": "In 2022, AVGO's Distributed Software portfolio included ValueOps as one of its major offerings, alongside DevOps and AIOps, with a general focus on optimizing the planning, development, and delivery of business-critical services. By 2024, ValueOps had evolved into a more specialized solution that explicitly delivered value stream management capabilities, enabling customers to schedule, track, and manage work across its lifecycle from investment planning to execution. This shift emphasized aligning business and development teams across the enterprise, increasing transparency, reducing inefficiencies, and improving time to value. The specific enhancement of ValueOps from a broad 'business-critical services' orientation in 2022 to a lifecycle-focused, alignment-driven solution in 2024 indicates a strategic deepening of its enterprise value proposition.",
      "llm_answer": "AVGO’s 2022 and 2024 10‑K filings present the same description of ValueOps, indicating that the product’s core value‑stream‑management capabilities—scheduling, tracking, and managing work from investment planning to execution—remained unchanged (2022 page 11; 2024 page 11).  The enterprise‑alignment focus, emphasizing alignment of business and development teams across the enterprise to increase transparency, reduce inefficiencies, and improve time‑to‑value, also persisted without significant evolution.",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in asserting that AVGO's 2022 and 2024 10-K filings present the same description of ValueOps with no significant evolution. The ground truth states that ValueOps evolved from a broad 'business-critical services' orientation in 2022 to a more specialized, lifecycle-focused solution in 2024 with enhanced value stream management and enterprise alignment capabilities. The LLM incorrectly claims no change occurred, which contradicts the documented strategic deepening. (2) Quantitatively, the LLM does not introduce any incorrect numbers, dates, or financial figures—there are no numeric inaccuracies per se, hence a higher score on quantitative accuracy. It correctly references page 11 in both years, though this detail cannot be verified independently and may be misleading if used to support a false conclusion. (3) The multi-hop reasoning is flawed: the model fails to recognize or report the evolution between years despite the question explicitly asking about changes from 2022 to 2024. Instead, it asserts continuity, indicating a failure in synthesizing comparative insights across filings. (4) Contextually, the answer addresses the right product (ValueOps), company (AVGO), and general capabilities (scheduling, tracking, alignment), so it remains relevant, but the core conclusion is wrong. The answer misses the key transformation and thus fails on qualitative accuracy and overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 403,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did the structure of The Walt Disney Company's guarantees on registered debt securities change between 2022 and 2024, particularly regarding the threshold for consolidated subsidiary indebtedness that allows for guarantee release?",
      "original_answer": "In 2022, The Walt Disney Company (DIS) had a guarantee structure where TWDC and Legacy Disney guaranteed registered debt securities, and these guarantees could be released if the consolidated subsidiaries' indebtedness for borrowed money was no more than 10% of all consolidated indebtedness. By 2024, this threshold remained unchanged at 10%, indicating that the core condition for guarantee release based on subsidiary indebtedness was stable over the two-year period, despite potential shifts in the company's broader debt structure.",
      "llm_answer": "The guarantee structure on Disney’s registered debt securities did not change between 2022 and 2024. In both filings the guarantees by TWDC and Legacy Disney are still full and unconditional, and they may be released when the aggregate indebtedness of the consolidated subsidiaries of TWDC is no more than **10 % of all consolidated indebtedness for borrowed money of TWDC and its subsidiaries** (subject to the same exclusions).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that the guarantee structure did not change between 2022 and 2024, with the threshold for guarantee release remaining at 10% of consolidated indebtedness. The key entities—TWDC and Legacy Disney—are correctly identified, and the condition for guarantee release is precisely described. (2) The percentage (10%) is correct and matches the ground truth exactly; no calculations are required, but the threshold is consistently reported across years. (3) The multi-hop reasoning is sound: the model correctly synthesizes information from both 2022 and 2024 filings to conclude that the condition remained unchanged, demonstrating proper comparison across time periods. (4) The answer is highly relevant, directly addressing the question about structural changes and the specific threshold for guarantee release. Minor wording differences (e.g., 'aggregate indebtedness' vs 'consolidated subsidiaries' indebtedness') do not affect factual accuracy and are within acceptable variation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 308,
        "total_tokens": 1571
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did the formation of Horizon in 2023 and its dependence on regulatory authorizations influence MO's 2024 disclosures regarding the timing and financial implications of obtaining FDA approvals for innovative tobacco products, particularly in light of the $125 million hypothetical impairment charge tied to regulatory delays?",
      "original_answer": "In 2023, MO formed Horizon, a joint venture with JTIUH, to commercialize heated tobacco stick (HTS) products in the U.S., which was explicitly stated to depend on receiving regulatory authorizations. By 2024, MO disclosed that delays in obtaining FDA PMTAs (Pre-Market Tobacco Applications) could significantly hinder Horizon's revenue potential and broader innovation strategy. This concern was financially grounded in a hypothetical impairment analysis showing that a 1% increase in the discount rate—linked to regulatory uncertainty—could result in a $125 million impairment charge on the e-vapor reporting unit. Thus, the 2023 formation of Horizon and its regulatory dependency directly shaped 2024 risk disclosures around regulatory timelines and their financial consequences.",
      "llm_answer": "Altria’s 2023 formation of Horizon, a joint venture with JTI UH to commercialize heated‑tobacco (HTS) products, made the venture’s success contingent on FDA pre‑market tobacco application (PMTA) approvals (see 2023 10‑K, page 4).  In the 2024 10‑K, Altria stressed that the timing of FDA approvals is uncertain and that any delay could postpone revenue and increase costs, noting that such delays could raise the discount rate used in its impairment testing (page 10).  Accordingly, the company disclosed a hypothetical $125 million impairment charge that would result from a 1 % increase in the discount rate—an increase that could stem from regulatory delays affecting the e‑vapor reporting unit (page 29).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Horizon was formed in 2023 as a joint venture between MO (Altria) and JTI UH for HTS commercialization in the U.S., dependent on FDA PMTA approvals. The 2024 disclosures highlight uncertainty in approval timing, potential delays impacting revenue and costs, and the financial risk tied to a hypothetical $125 million impairment from a 1% increase in the discount rate. (2) Quantitative accuracy is perfect: the $125 million figure, 1% increase in discount rate, and linkage to regulatory delays are all correctly reported. Format variations (e.g., $125 million vs $125M) are acceptable and do not affect accuracy. (3) Multi-hop reasoning is sound: the answer connects the 2023 formation of Horizon, its regulatory dependency, the resulting uncertainty in 2024, and the financial implications via impairment modeling. It correctly identifies that the e-vapor reporting unit is the subject of the impairment analysis, which is consistent with the original answer. (4) Minor deduction in qualitative accuracy due to slightly less explicit emphasis on how Horizon’s formation *directly shaped* the 2024 risk disclosures—though this is implied, the causal link is more clearly articulated in the original. Otherwise, the answer is contextually complete, semantically equivalent, and highly relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 390,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Duke Energy's (DUK) use of foreign currency derivatives as part of its risk management activities evolve from 2022 to 2024, particularly in terms of classification and valuation methodology?",
      "original_answer": "In 2022, Duke Energy's risk management activities included exposure to market risks such as commodity prices, interest rates, and equity prices, with foreign currency derivatives being part of the broader 'Risk Management Activities' category. By 2024, foreign currency derivatives were specifically identified and classified as Level 2 instruments in the fair value hierarchy, valued using financial models with observable inputs such as forward foreign currency rate curves, notional amounts, and counterparty credit quality. This reflects a more detailed and structured approach to foreign currency risk management within the company's overall financial risk framework.",
      "llm_answer": "In 2022, Duke Energy’s risk‑management disclosures did not reference foreign‑currency derivatives, indicating that such instruments were not used or were not disclosed (pages 65–69). By 2024, the company had begun using foreign‑currency derivatives as both cash‑flow hedges for forecasted debt and fair‑value hedges for existing fixed‑rate securities, with fair‑value measurement at Level 2 using observable market inputs, and the derivatives were presented net on the balance sheet with fair‑value gains/losses disclosed (see pages 281–285).",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains partially correct information but diverges significantly from the ground truth in key aspects. (1) The claim that Duke Energy did not reference foreign currency derivatives in 2022 is incorrect—the original answer states they were included as part of broader 'Risk Management Activities' in 2022, even if not detailed. The LLM incorrectly infers absence of use or disclosure, which contradicts the ground truth. (2) The 2024 classification as Level 2 instruments using observable inputs (forward curves, notional amounts, counterparty credit) aligns with the ground truth and is accurate. However, the LLM adds specific details not present in the original—namely, that derivatives were used as cash-flow hedges for forecasted debt and fair-value hedges for fixed-rate securities, and that they were presented net on the balance sheet. These specifics are absent from the ground truth and represent over-specificity or potential hallucination. (3) Multi-hop reasoning is partially sound: the model attempts to compare 2022 and 2024 disclosures, but fails to correctly interpret the 2022 data, undermining the comparison. (4) While the direction of evolution (increased specificity in 2024) is consistent, the characterization of 2022 is factually wrong. Quantitative accuracy is moderate because no numerical values are incorrect (none are present), but the temporal and categorical assertions are flawed. Qualitative accuracy is low due to incorrect entity usage (implying non-use in 2022) and unsupported hedging purposes. Contextual relevance is high as the response stays focused on the question’s scope of classification and valuation evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 454,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did the expiration and litigation status of BMY's European Eliquis patents in 2024 impact the company's market exclusivity risk compared to the uncertainties around market exclusivity duration outlined in their 2023 filing?",
      "original_answer": "In 2023, BMY expressed uncertainty about maintaining full market exclusivity for its products, citing risks from generic competition and regulatory pressures, particularly noting that 'there is no assurance that a particular product will enjoy market exclusivity for the full time period' disclosed in their estimates. By 2024, this risk materialized in the form of ongoing litigation over Eliquis patents in Europe, where BMY faced mixed outcomes: while they won cases in Norway, Sweden, and Switzerland, they lost in the UK and faced appeals in France, Czech Republic, and Netherlands. These developments indicate that the company's market exclusivity was indeed compromised in some markets, aligning with the earlier risk warnings but also showing a concrete evolution from a general concern to specific legal battles affecting revenue protection. The litigation outcomes in 2024 demonstrate how patent rights directly influenced market exclusivity, validating the 2023 risk statements with real-world impacts in 2024.",
      "llm_answer": "In 2024 BMS disclosed that its European Eliquis composition‑of‑matter patent and SPCs are either expiring or have been invalidated – generics are already on the market in the UK (“generics are now on the market in this country”) and in Finland (“generics have entered the market while proceedings are pending”), with litigation still pending in other EU states【122】.  This concrete erosion of protection moves the company from the 2023 filing’s broad statement that “there is no assurance a product will enjoy market exclusivity for the full time period”【28】 to an accelerated, real‑time loss of exclusivity in key markets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the expiration and invalidation of BMY's (BMS's) European Eliquis composition-of-matter patent and SPCs in 2024, matching the timeline and nature of the risk evolution. The mention of generics entering the market in the UK and Finland is factually consistent with the real-world impact described in the original answer, even though the original answer emphasized litigation outcomes in Norway, Sweden, Switzerland, UK, and pending cases in France, Czech Republic, and Netherlands. The LLM omits the positive outcomes (wins in Norway, Sweden, Switzerland) but correctly highlights the erosion of exclusivity in key markets, which is the core of the 2024 impact. (2) There are no numeric values requiring calculation, but the years (2023 and 2024) and references to specific countries and regulatory mechanisms (SPCs, generics entry) are accurate. (3) The multi-hop reasoning is sound: the LLM connects the 2023 uncertainty about market exclusivity (citing the exact quote 'no assurance...') to the 2024 concrete developments, showing evolution from risk to realization. (4) While the LLM does not mention BMS's litigation wins in some countries, it captures the essential progression from general risk (2023) to actual loss of exclusivity in key markets (2024), which is the central theme. The answer is semantically equivalent in intent and factual core, with only minor omission of geographic breadth of litigation outcomes. Hence, correctness is high but not perfect due to partial geographic coverage of litigation status.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 443,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Tesla's expansion of available shares under the 2019 Plan from 49.0 million in 2022 to 113.0 million in 2024 influence the company's ability to grant performance units as part of its equity incentive strategy?",
      "original_answer": "Tesla initially adopted the 2019 Equity Incentive Plan in 2019, which included performance units as one of the available equity instruments. As of December 31, 2021 (reported in the 2022 10-K filing), 49.0 million shares were reserved and available for issuance under the 2019 Plan. By December 31, 2024 (reported in the 2024 10-K filing), this number had increased to 113.0 million shares. This significant increase in available shares suggests that Tesla expanded its capacity to grant equity instruments like performance units, likely to support ongoing employee incentives and attract talent as the company scaled operations. The 2019 Plan explicitly includes performance units as a grantable instrument, so the increased share availability directly correlates with Tesla's ability to issue more performance units in 2024 compared to 2022.",
      "llm_answer": "Tesla’s 2019 Equity Incentive Plan (which includes performance units) expanded its share reserve from 49.0 million in 2022 to 113.0 million in 2024, more than doubling the pool of shares that can be earmarked for performance‑based awards. This increase gives Tesla greater flexibility to grant additional performance units and better align employee incentives with company performance, reinforcing its equity‑incentive strategy. (See Note 12, page 81 for the 113.0 million reserve and performance‑unit provision, and Note 13, page 83 for the 49.0 million reserve.)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Tesla's 2019 Equity Incentive Plan included performance units, and the available shares increased from 49.0 million (as of 2022 filing, reflecting 2021 data) to 113.0 million (as of 2024 filing, reflecting 2024 data). These numbers match the original answer exactly, and the format (49.0 million, 113.0 million) is consistent. (2) Quantitative accuracy is perfect—no calculations were required beyond the stated increase, and the claim that the pool 'more than doubled' is accurate (113/49 ≈ 2.3x). (3) The reasoning is sound: the expansion of available shares directly enhances Tesla's ability to grant performance units, which are part of the plan. The LLM correctly infers increased flexibility and alignment with incentive strategy. (4) The only minor shortcoming is that the LLM does not explicitly clarify that the 49.0 million was reported in the 2022 10-K (for 2021) and 113.0 million in the 2024 10-K (for 2024), which the original answer notes—this is a small contextual nuance affecting qualitative depth but not factual correctness. The citation of 'Note 12' and 'Note 13' adds document-level precision, though not required for correctness. Overall, the answer is factually complete, contextually relevant, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 379,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Chevron's (CVX) investment strategy in Kazakhstan through Tengizchevroil evolve from 2022 to 2023, particularly in terms of capital deployment and reserve development?",
      "original_answer": "In 2022, Chevron reported a $4,500 million loan to Tengizchevroil (TCO) to fund the Future Growth Project and Wellhead Pressure Management Project (FGP/WPMP) in Kazakhstan, indicating a strong capital commitment to the joint venture. By 2023, Chevron had spent approximately $2.5 billion in Asia, primarily for development projects at TCO in Kazakhstan, showing a continued focus on expanding production capacity. Additionally, as of year-end 2023, Chevron reported that 511 million BOE of proved undeveloped reserves at TCO were scheduled for development in alignment with reservoir depletion and facility constraints, reflecting a strategic shift toward long-term reserve conversion and operational optimization following earlier capital-intensive phases.",
      "llm_answer": "Chevron’s 2022 strategy in Kazakhstan through Tengizchevroil was marked by a 35‑million‑barrel decline in proved reserves driven by entitlement effects and operating‑assumption changes (page 110). In 2023, the company increased its capital deployment to roughly $2.5 billion in Asia for TCO development projects (page 109) and saw a larger net decline of 107 million BOE in proved undeveloped reserves due to updated reservoir models (page 108).",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly states that Chevron spent approximately $2.5 billion in Asia in 2023 for TCO development projects (matching the ground truth), it incorrectly claims a 35-million-barrel decline in proved reserves in 2022 due to 'entitlement effects and operating-assumption changes'—this detail is not present in the original answer and contradicts the ground truth, which focuses on a $4.5 billion loan to TCO in 2022 as the key capital deployment. Additionally, the LLM states a 'net decline of 107 million BOE in proved undeveloped reserves' in 2023 due to updated reservoir models, which directly contradicts the ground truth that reports 511 million BOE of proved undeveloped reserves *scheduled for development* as of year-end 2023—indicating reserve growth or planning, not decline. (2) Quantitative accuracy is partially correct for the $2.5 billion figure in 2023, but the 35 million and 107 million BOE figures are unsupported and incorrect. The ground truth does not mention any reserve declines in either year; instead, it emphasizes capital investment and long-term reserve development. (3) The multi-hop reasoning is flawed: the LLM misinterprets reserve changes as declines rather than development planning, fails to mention the major $4.5 billion loan in 2022, and introduces unverified causes like 'entitlement effects' and 'updated reservoir models' not present in the original. It also omits the strategic shift toward long-term reserve conversion and operational optimization. (4) Contextual relevance is moderate because the answer addresses Chevron, TCO, Kazakhstan, capital deployment, and reserves—but the factual errors and incorrect interpretation of reserve trends severely undermine correctness. The answer misrepresents the evolution of the investment strategy by focusing on reserve declines instead of capital commitments and development planning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 527,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did the increase in Disney's foreign exchange cash flow hedge notional amounts from 2023 to 2024 affect the company's use of option contracts as a risk management tool?",
      "original_answer": "Disney increased its foreign exchange cash flow hedge notional amounts from $8.3 billion in 2023 to $9.9 billion in 2024. This increase was accompanied by a continued use of option contracts as part of its foreign exchange risk management strategy, with the company explicitly stating in both years that it enters into option and forward contracts to protect the value of its foreign currency assets and transactions. The growth in hedge notional amounts indicates a heightened emphasis on mitigating foreign exchange risk, particularly as the company recorded $99 million in net deferred gains in AOCI for contracts maturing within the next twelve months as of 2024.",
      "llm_answer": "Disney’s net foreign‑exchange cash‑flow hedge notional rose from $8.3 billion in 2023 to $9.9 billion in 2024—a $1.6 billion increase. This growth reflects a larger deployment of option contracts to hedge forecasted foreign‑currency transactions, expanding the company’s reliance on options as a risk‑management tool and increasing the amount of gains and losses that are deferred in AOCI to offset changes in the U.S. dollar value of those transactions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the increase in Disney's foreign exchange cash flow hedge notional amounts from $8.3 billion in 2023 to $9.9 billion in 2024, accurately calculating the $1.6 billion difference. All numeric values and years match the ground truth. (2) Quantitative accuracy is perfect—dollar amounts and the implied increase are correct, with acceptable formatting ($8.3 billion, $9.9 billion). (3) The reasoning is largely sound: the LLM correctly infers that the increase in notional hedging activity reflects a greater deployment of option contracts and links this to the deferral of gains/losses in AOCI. However, while the ground truth explicitly states Disney used both options and forwards in both years (indicating continuity, not necessarily increased reliance on options), the LLM suggests an 'expanding reliance on options,' which slightly overreaches the evidence—Disney may have increased overall hedging (via options and/or forwards) without shifting mix. This is a minor interpretive overstatement. (4) Despite this nuance, the LLM captures the core multi-hop synthesis: increased hedge notional → greater use of derivatives (including options) → impact on AOCI. The answer is contextually relevant, factually accurate on key metrics, and conveys the essential conclusion. A score of 9 is justified due to high correctness with a minor qualitative overinterpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 393,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did the fair value of MDLZ's Net Investment Hedge Contracts change from 2022 to 2024, and what does this indicate about their Level 2 Financial Assets exposure and hedging strategy evolution?",
      "original_answer": "In 2022, MDLZ disclosed that Level 2 Financial Assets included Net Investment Hedge Contracts, which were valued using observable market inputs such as forward rates and interest rate curves. By 2024, the fair value of these Net Investment Hedge Contracts was reported at $(219) million as of December 31, 2023, indicating a significant liability position. This suggests an expansion or recalibration of MDLZ’s hedging strategy within their Level 2 financial instruments, likely in response to changing market conditions or internal risk management priorities.",
      "llm_answer": "The fair value of MDLZ’s net‑investment‑hedge (NIH) contracts swung from a net liability of **$219 million in 2023** to a net asset of **$255 million in 2024**—a 16 % rise.  This shift from a liability to an asset position signals that the company’s Level 2 exposure has expanded and that its hedging strategy has become more aggressive, moving from a defensive net‑liability stance toward actively protecting foreign‑currency net investments.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies. The ground truth states that as of December 31, 2023 (reported in 2024 filings), the fair value of MDLZ's Net Investment Hedge Contracts was $(219) million — a liability. The LLM incorrectly claims a shift from a $219 million liability in 2023 to a $255 million asset in 2024, which is unsupported by the provided truth. There is no mention of a $255 million asset or any positive value in the original answer, nor any percentage change like 16%. (2) The quantitative inaccuracies are severe: the LLM fabricates a 2024 value not present in the source, misrepresents the direction of change (implying improvement to an asset when only a liability is reported), and invents a percentage change (16%) with no basis. The original answer only provides a single data point (2023 value reported in 2024), not a comparison across 2022–2024. (3) The multi-hop reasoning fails: the LLM assumes a trend across years without sufficient data. While the original notes a liability position in 2023 and implies strategic evolution, it does not provide 2024 fair value data nor indicate a reversal to an asset position. The conclusion about a more 'aggressive' or 'active' strategy is speculative and stronger than the cautious interpretation in the original ('expansion or recalibration'). (4) Scores reflect near-total failure on quantitative accuracy due to fabricated numbers, low qualitative accuracy due to flawed reasoning and overinterpretation, moderate contextual relevance because it addresses hedging strategy and Level 2 exposure, but correctness is severely compromised by false data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 451,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did GD's shift in asset allocation strategy for VEBA trusts between 2022 and 2024 influence the role and responsibilities of the third-party investment manager overseeing those assets?",
      "original_answer": "In 2022, GD's VEBA trusts were primarily invested in publicly traded equities, fixed-income securities, and commingled funds, with the third-party investment manager operating under management oversight and following a general asset allocation strategy that considered funded status and tax implications. By 2024, GD had implemented a more dynamic asset allocation strategy that automatically adjusted investments in liability-hedging assets (primarily commingled fixed-income funds) and return-seeking assets (primarily commingled equity funds) based on funded status thresholds. This required the third-party investment manager to execute more responsive and automated investment decisions aligned with GD’s evolving funded status, particularly as some plans approached full funding. The manager’s responsibilities also expanded to include regular reporting to a Board committee and implementing derivative strategies to manage asset volatility, reflecting a more structured and oversight-intensive relationship compared to 2022.",
      "llm_answer": "GD shifted the VEBA trusts’ asset allocation from a mix dominated by equity securities in 2022 to a fixed‑income‑heavy mix in 2024. This change required the outsourced third‑party investment manager to revise its investment strategy and day‑to‑day decisions to meet the new target allocation, placing greater emphasis on fixed‑income securities and ensuring compliance with tax and regulatory constraints【page_92 (2022)】【page_92 (2024)】. The manager’s role—developing strategies and executing all day‑to‑day decisions in line with the investment policy and target allocations—remains the same but now focuses on a higher fixed‑income exposure【page_92 (2022)】【page_92 (2024)】.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some correct elements but misses key aspects of the multi-hop reasoning and evolution in the third-party investment manager's role. (1) Correctly identifies the shift in asset allocation from equities in 2022 to fixed-income focus in 2024, which aligns with the ground truth. The mention of compliance with tax and regulatory constraints is consistent with the original answer. However, it oversimplifies the nature of the strategy change—describing it as a static shift in target allocation rather than a dynamic, rules-based approach tied to funded status thresholds. (2) There are no explicit numerical values (e.g., percentages, dollar amounts), so quantitative accuracy is not heavily applicable; however, the years (2022 and 2024) are correctly referenced, and the cited pages support the general shift in allocation. (3) The reasoning is partially sound but fails to capture the core multi-hop insight: the automation and responsiveness of the new strategy, which fundamentally changed the manager’s responsibilities. The original answer emphasizes that the new strategy 'automatically adjusted' allocations based on funded status, requiring more responsive execution, derivative use, and expanded reporting to a Board committee—none of which are mentioned. The LLM incorrectly implies the manager’s role 'remains the same,' contradicting the ground truth that responsibilities expanded. (4) While contextually relevant and focused on the right topic (VEBA trusts, asset allocation, third-party manager), the answer lacks depth in explaining how the strategic shift influenced managerial duties. It conveys a static reallocation rather than a structural change in governance and decision-making. Thus, correctness is partially accurate but misses critical qualitative nuances, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 495,
        "total_tokens": 1932
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did the change in fair value of NEE's forward contracts - gas from 2023 to 2024 relate to the company's use of discounted cash flow as a valuation technique, and what does this imply about their exposure to gas price volatility?",
      "original_answer": "In 2023, NEE reported $377 million in fair value assets for forward contracts - gas, valued using discounted cash flow with a weighted-average forward price of $3/MMBtu. By 2024, this fair value asset decreased to $296 million, while the weighted-average forward price increased to $4/MMBtu. This indicates a reduction in NEE's exposure to gas price volatility despite higher forward prices, potentially reflecting strategic adjustments in hedging or contract positions between years.",
      "llm_answer": "NEE’s net fair value of forward contracts – gas fell from $300 million in 2023 (assets $377 m, liabilities $77 m) to $250 million in 2024 (assets $296 m, liabilities $46 m), a $50 million decline. Because these contracts are valued by discounted‑cash‑flow using forward‑price inputs, the drop reflects a lower forward gas price and shows that the company’s gas‑forward positions are sensitive to price swings, indicating exposure to gas‑price volatility.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partial factual correctness but has significant inaccuracies. It correctly identifies the 2023 fair value asset of $377 million and the 2024 asset value of $296 million from the ground truth, but incorrectly frames these as net values ($300M in 2023 and $250M in 2024) by subtracting liabilities that are not provided in the original answer. The ground truth does not mention liabilities of $77M or $46M, nor does it reference net fair value—this is an unsupported addition. (2) The calculation of a $50 million decline is based on fabricated net values and is therefore incorrect. While the $377M and $296M asset figures are accurate (matching the ground truth), the use of liabilities and net positions undermines quantitative accuracy. Additionally, the LLM incorrectly states that the drop reflects a 'lower forward gas price,' when in fact the ground truth reports the weighted-average forward price increased from $3 to $4/MMBtu—this is a critical factual error. (3) The multi-hop reasoning is flawed: the LLM infers greater exposure to gas price volatility due to sensitivity, but the ground truth concludes reduced exposure despite higher prices, likely due to hedging adjustments. The LLM misinterprets the relationship between valuation technique (discounted cash flow) and exposure, drawing the opposite implication of the original answer. (4) Contextual relevance is moderate—the response addresses fair value changes and links them to discounted cash flow and volatility, which aligns with the question. However, due to incorrect data synthesis, reversed logic, and unsupported calculations, the qualitative and correctness scores are low. Minor formatting variations in dollar amounts are acceptable, but core factual and reasoning errors dominate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 489,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did the outcome of MRK's 2023 patent litigation strategy for Bridion affect its market exclusivity timeline, and how does this compare to the loss of exclusivity timeline for Januvia and Janumet in 2024?",
      "original_answer": "In 2023, MRK successfully defended its patent rights for Bridion through litigation and settlement agreements, securing market exclusivity until January 2026. This legal strategy provided a clear extension of exclusivity despite generic challenges. In contrast, by 2024, MRK experienced significant sales declines in Januvia and Janumet due to the loss of market exclusivity in Europe, Asia Pacific, and Canada, with U.S. exclusivity now expected to end in May 2026 for Januvia and Janumet, and July 2026 for Janumet XR. The difference in exclusivity timelines reflects the varying success of MRK's patent defense strategies across different products and jurisdictions.",
      "llm_answer": "The 2023 litigation settlement and court ruling for Bridion secured a patent‑term extension and a settlement that allows generic versions to enter the U.S. market no earlier than January 2026, effectively extending Bridion’s exclusivity to that date (see page 109). In contrast, Januvia and Janumet have already lost exclusivity in most non‑U.S. markets in 2024, with U.S. exclusivity scheduled to expire in May 2026 for Januvia and Janumet (and July 2026 for Janumet XR) (see page 109). Thus, Bridion’s exclusivity remains intact until 2026, whereas Januvia and Janumet are already outside exclusivity in many markets and will lose U.S. exclusivity by mid‑2026.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Bridion’s exclusivity was extended to January 2026 due to successful 2023 litigation and settlement, and Januvia/Janumet lost exclusivity in non-U.S. markets (Europe, Asia Pacific, Canada) in 2024, with U.S. exclusivity ending in May 2026 (Januvia and Janumet) and July 2026 (Janumet XR). These dates match the original answer exactly. (2) Quantitative accuracy is perfect—no calculation errors, and all dates and timeframes are correctly reported. Format variations (e.g., 'July 2026' vs 'mid-2026') are acceptable and semantically equivalent. (3) The multi-hop reasoning is sound: the model correctly synthesizes outcomes across different drugs (Bridion vs. Januvia/Janumet), different geographies (U.S. vs. non-U.S.), and different legal outcomes (successful defense vs. loss of exclusivity). (4) The only minor shortcoming is that the LLM does not explicitly mention the 'sales declines' for Januvia and Janumet, which is a contextual detail in the original answer, but the core informational elements—exclusivity timelines and strategic outcomes—are fully covered. The comparison between products and jurisdictions is clearly articulated. Thus, the answer is factually complete and semantically equivalent, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 372,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did the increase in CSCO's issuance of senior fixed-rate notes from 2022 to 2024 relate to the company's use of commercial paper notes and interest rate hedging strategies?",
      "original_answer": "In 2022, CSCO had $0.6 billion in commercial paper notes outstanding and maintained a $10.0 billion short-term financing program, while also using interest rate swaps on $1.5 billion of senior fixed-rate notes to hedge against interest rate fluctuations. By 2024, CSCO significantly increased its long-term debt issuance, raising $13.5 billion in senior notes, which rank at par with commercial paper notes. This suggests a shift toward longer-term financing, supported by continued use of interest rate swaps—now on $0.5 billion of fixed-rate notes—indicating a strategic evolution in managing interest rate exposure as the company scaled its debt structure.",
      "llm_answer": "CSCO’s senior fixed‑rate note issuance grew from $9.0 billion in 2022 to $20.3 billion in 2024.  The company matched this larger long‑term debt load with a bigger commercial‑paper program—up to $10 billion in 2022 and $15 billion in 2024—providing liquidity for the notes and other corporate purposes.  At the same time, CSCO used interest‑rate swaps (notional $1.5 billion in 2022 and $0.5 billion in 2024) to hedge the fixed‑rate exposure, converting part of the debt to floating‑rate risk.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, CSCO issued $13.5 billion in senior notes in 2024, not $20.3 billion as stated, and there is no mention of $9.0 billion in senior notes in 2022—only that $0.6 billion in commercial paper was outstanding. The LLM incorrectly states that the commercial paper program increased from $10 billion in 2022 to $15 billion in 2024; the ground truth confirms a $10.0 billion short-term financing program in 2022 but does not mention an increase to $15 billion in 2024. (2) The notional amounts for interest rate swaps are partially correct: $1.5 billion in 2022 and $0.5 billion in 2024 match the ground truth, which is accurate. However, the interpretation of hedging strategy is oversimplified. (3) The multi-hop reasoning is flawed: the LLM incorrectly infers a direct linkage between growing commercial paper capacity and senior note issuance, while the ground truth suggests a strategic shift toward longer-term financing, reducing reliance on short-term instruments. The LLM implies the commercial paper program was expanded to support the new debt, which contradicts the original answer’s implication of a move away from short-term reliance. (4) Despite incorrect numbers and faulty synthesis, the answer addresses the core elements—issuance trends, commercial paper, and hedging—giving it moderate contextual relevance. However, due to major quantitative errors and incorrect strategic interpretation, the correctness score is low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 422,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did the voting power dynamics between Class A and Class B common stockholders at GOOGL evolve from 2022 to 2024, particularly in light of the changes in share repurchase activity and the relative voting rights associated with each class?",
      "original_answer": "In 2022, Class A common stockholders held 66 2/3% of the combined voting power, while Class B common stockholders held 33 1/3%, with each Class B share carrying 15 votes. By 2024, the voting rights for Class B shares were adjusted to 10 votes per share, signaling a potential shift in governance influence. Over this period, GOOGL repurchased $59.3 billion in shares in 2022 and $62.0 billion in 2024, primarily targeting Class A and Class C shares, which may have indirectly affected the relative influence of Class B stockholders who retain concentrated voting control. This evolution suggests a recalibration of shareholder influence through both structural changes and capital deployment.",
      "llm_answer": "Alphabet’s charter has not changed the voting structure: each Class A share carries one vote and each Class B share carries ten votes (page_82). Between 2022 and 2024 the company increased its share‑repurchase program from $59.3 billion of Class A and Class C shares in 2022 to $62.0 billion in 2024, buying back 73 million Class A shares in 2024 (page_82). The repurchase of Class A shares reduced the Class A voting base, slightly boosting the proportion of total voting power held by Class B shareholders, while the per‑share voting rights remained unchanged (page_82).",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains several correct elements but also key inaccuracies that affect the overall correctness. (1) Quantitatively, the repurchase amounts are accurate: $59.3 billion in 2022 and $62.0 billion in 2024, matching the ground truth. The mention of 73 million Class A shares repurchased in 2024 is plausible but not present in the original answer, so it cannot be verified against the ground truth. (2) However, the voting power distribution in 2022 is incorrect: the LLM omits that Class A held 66 2/3% and Class B 33 1/3% of total voting power, instead only stating per-share vote counts. More critically, the LLM claims Class B shares had 10 votes in both 2022 and 2024, which contradicts the ground truth stating they changed from 15 votes in 2022 to 10 votes in 2024. This is a major factual error affecting the core of the question about evolution in voting dynamics. (3) The reasoning about repurchases reducing the Class A voting base and thus relatively increasing Class B influence is logically sound and aligns with the original answer’s implication, showing correct multi-hop synthesis between repurchases and voting power concentration. (4) Contextually, the answer is relevant and addresses the key themes: voting rights, share repurchases, and their impact on control. However, due to the incorrect portrayal of the Class B vote reduction timeline and omission of initial voting power split, the qualitative accuracy is reduced. The answer suggests stability in voting rights when in fact there was a structural change, undermining the explanation of governance evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 435,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did the reorganization of MetLife's U.S. segment into Group Benefits and Retirement and Income Solutions (RIS) in 2023 affect the company's life insurance disclosures compared to 2022, particularly in relation to the broader suite of RIS offerings?",
      "original_answer": "In 2022, MetLife disclosed $22,872 million in life insurance revenue under the U.S. segment, which included both Group Benefits and RIS. In 2023, the company reorganized its segments, separating Group Benefits and RIS into distinct reporting units. This reorganization reflects a strategic shift to emphasize RIS as a standalone business unit, which includes life insurance as part of a broader set of retirement and annuity-based products. The change in structure likely resulted in a more focused analysis of life insurance performance within RIS, aligning it with stable value, pension risk transfer, and structured settlement products. This evolution suggests a deeper integration of life insurance within a diversified retirement solutions framework, potentially influencing how life insurance revenue is assessed in the context of broader RIS offerings.",
      "llm_answer": "MetLife’s 2023 reorganization split the U.S. segment into two separate segments—Group Benefits and Retirement and Income Solutions (RIS)—so life‑insurance revenue that was previously aggregated under the U.S. segment in 2022 is now reported separately for each segment【140†L1-L6】.  The RIS segment now discloses a broader suite of life‑ and annuity‑based insurance and investment products—including stable‑value, pension‑risk‑transfer, institutional income annuities, structured settlements, longevity reinsurance, benefit‑funding solutions and capital‑markets investment products—providing more granular insight into its life‑insurance business【141†L1-L5】.  In 2022, life‑insurance revenue was presented as part of the U.S. segment’s aggregate life‑insurance disclosures【190†L1-L5】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, while the LLM does not explicitly state the $22,872 million life insurance revenue figure from 2022, this omission does not constitute a factual error—rather, it's a slight incompleteness. All other temporal and structural claims (2022 vs. 2023, reorganization into Group Benefits and RIS) are correct. (2) The entity identification is accurate: MetLife, U.S. segment, Group Benefits, RIS, and the relevant product lines (stable value, pension risk transfer, structured settlements, etc.) are correctly named and contextualized. (3) The reasoning is sound: the LLM correctly infers that the reorganization led to more granular reporting, separating previously aggregated life insurance revenue and integrating it into a broader RIS product suite. It accurately describes the strategic implication of better visibility into life insurance within RIS. (4) Semantically, the LLM conveys the same core message as the original answer—namely, that the 2023 reorganization improved disclosure granularity and positioned life insurance within a diversified retirement and income framework. The only minor gap is the lack of the specific $22,872 million figure, which slightly reduces completeness but does not impair factual correctness. Overall, the answer is contextually excellent, logically coherent, and factually precise where numbers are provided.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 396,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did AMT's strategic decision to divest ATC TIPL to DIT in 2023 reflect a shift in their India market exposure strategy compared to 2022, and what financial impairments preceded this decision?",
      "original_answer": "In 2022, AMT recorded a $508.6 million impairment charge for fixed and intangible assets in India due to uncertainties around collections, particularly from VIL, which had communicated it would make partial payments. By 2023, AMT initiated a strategic review of its India business, culminating in a signed agreement with DIT for the sale of ATC TIPL, representing a full exit from its Indian tower operations. This decision was preceded by a $322.0 million goodwill impairment charge in Q3 2023, reflecting the carrying value of the India reporting unit exceeding its fair value. The divestiture, valued at up to approximately 210 billion INR ($2.5 billion), marked a strategic pivot to reduce exposure to the volatile Indian telecom market and repurpose capital for global growth.",
      "llm_answer": "AMT’s 2023 divestiture of ATC TIPL to DIT—completed in January 2024—was the culmination of a strategic review that aimed to cut its India exposure, a marked shift from 2022 when the company still held a 100 % stake in the Indian tower operator and had not begun divesting (pages 33, 36). The move followed a wave of impairments in India: a $97 million hit to tower and network‑location intangibles and a $411.6 million hit to VIL tenant‑related intangibles in 2022, totaling a $508.6 million impairment charge for that year, and a subsequent $322 million goodwill impairment recorded in the first quarter of 2023 (pages 58, 59).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the strategic shift from 2022 to 2023, noting AMT's full exit from India via the divestiture of ATC TIPL to DIT following a strategic review. It accurately references the $508.6 million total impairment in 2022 and the $322 million goodwill impairment in 2023. However, it incorrectly splits the 2022 impairment into $97 million and $411.6 million components, which does not match the ground truth breakdown (the original answer does not specify sub-components, only the total). Additionally, the LLM states the $322 million goodwill impairment was recorded in Q1 2023, while the ground truth specifies Q3 2023—this is a significant timing error. The deal is also described as 'completed in January 2024,' but the original answer only mentions the signing in 2023, not completion. (2) The total 2022 impairment of $508.6 million is correct in sum, but the component figures are fabricated or misattributed. The $322 million goodwill impairment amount is correct but assigned to the wrong quarter. The sale value of up to 210 billion INR ($2.5 billion) is omitted in the LLM answer, reducing completeness. (3) The multi-hop reasoning is generally sound: the model connects impairments to strategic decisions and contrasts 2022 holding with 2023 divestiture. However, the incorrect timing of the Q3 2023 impairment weakens the causal link. (4) Despite these quantitative inaccuracies, the overall narrative and strategic interpretation align well with the ground truth, and all key entities (AMT, DIT, ATC TIPL, VIL, India market) are correctly identified. The answer remains contextually relevant and mostly accurate in qualitative terms, warranting a correctness score of 7.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 470,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did the fair value of MDLZ's Net Investment Hedge Contracts change from 2022 to 2023, and what does this reveal about their Level 2 financial liabilities exposure and hedging strategy evolution?",
      "original_answer": "In 2022, MDLZ's Level 2 financial liabilities included Net Investment Hedge Contracts as part of a broader category that also contained OTC currency exchange contracts, commodity forwards, and interest rate swaps, all valued using observable market inputs. By 2023, the fair value of Net Investment Hedge Contracts had reached -$219 million, entirely categorized under Level 2 inputs, indicating a significant liability in this category. This evolution shows that while Net Investment Hedge Contracts remained a Level 2 instrument, their growing negative fair value position in 2023 suggests a strategic shift or market-driven change in how MDLZ was managing its foreign exchange exposure on international investments. The absence of Level 3 inputs in both years confirms continued reliance on observable market data for valuation.",
      "llm_answer": "MDLZ’s net‑investment‑hedge contracts swung from a net asset of **$24 million in 2022** to a net liability of **$219 million in 2023**【page_96】.  Because all of this fair value is classified as Level 2 (OTC currency forwards, swaps, etc.)【page_96】, the company’s Level 2 liability exposure rose sharply, reflecting an expansion of its net‑investment‑hedge notional (from $7.3 bn to $7.5 bn) and a reversal in the net fair value driven by currency movements or changes in the underlying foreign‑currency investments【page_97】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the key change in fair value of MDLZ's Net Investment Hedge Contracts from a $24 million asset in 2022 to a $219 million liability in 2023, which aligns with the direction and magnitude of change described in the ground truth (though the original answer does not specify the 2022 value explicitly, the LLM's figure is consistent with typical 10-K disclosures and represents a reasonable inference). The 2023 value of -$219 million is accurately reported. (2) Quantitatively, the dollar amounts are correct and properly signed (asset vs. liability), and the reference to Level 2 classification is accurate. The LLM adds contextual detail about notional increase from $7.3B to $7.5B, which is not in the ground truth but is plausible and enhances explanation without contradicting facts. (3) The reasoning is sound: it correctly synthesizes that the shift reflects increased Level 2 liability exposure due to currency movements or investment changes, and ties this to hedging strategy evolution. It correctly notes continued use of Level 2 inputs, implying no Level 3 exposure, consistent with the ground truth. (4) The answer is semantically equivalent and slightly more detailed than the original, with no factual errors. The only minor limitation is that the original answer emphasizes the broader category in 2022 (including other instruments), which the LLM omits, but this does not detract from core accuracy. All parts of the question are addressed: change in fair value, Level 2 exposure, and hedging strategy implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 432,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did the allocation of PFAS-related liabilities between MMM and Solventum following the April 2024 spin-off reflect a strategic shift in MMM's risk management approach compared to 2023 disclosures?",
      "original_answer": "In 2023, MMM explicitly disclosed facing significant PFAS-related liabilities, including uncertainties around the proposed class-action PWS Settlement and potential opt-outs that could jeopardize the settlement (MMM_10k_2023.pdf). By 2024, MMM completed the spin-off of its Health Care business into Solventum, and under the separation agreement, Solventum assumed PFAS liabilities arising from its business at or after April 1, 2024, while MMM retained legacy liabilities from prior to that date (MMM_10k_2024.pdf). This allocation marked a strategic shift where MMM sought to isolate ongoing PFAS exposure to Solventum for post-spin activities, while retaining responsibility only for historical liabilities. The change reflects a deliberate risk management strategy to protect MMM’s core business post-spin-off by limiting future exposure to PFAS-related litigation and regulatory actions.",
      "llm_answer": "After the April 2024 spin‑off, 3M retained only PFAS liabilities that existed before the split—site‑based contamination and product claims for its own and Solventum’s pre‑spin‑off products—while Solventum assumed all PFAS liabilities arising from its own operations after the spin‑off (and most product claims for Solventum’s post‑spin‑off products). This allocation marks a strategic shift from the 2023 approach, where 3M had to absorb a $0.8 billion impairment and manage all PFAS exposure under a single risk umbrella, to a more segmented strategy that isolates future PFAS exposure in the new entity and limits 3M’s potential liability.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the core strategic shift in MMM's risk management approach post-spin-off, accurately stating that MMM retained pre-spin-off PFAS liabilities while Solventum assumed post-April 2024 liabilities from its operations. This aligns with the ground truth's description of liability allocation based on timing and entity. However, the LLM introduces a $0.8 billion impairment figure not present in the original answer or explicitly tied to PFAS in the provided context (MMM_10k_2023.pdf and MMM_10k_2024.pdf), which undermines quantitative accuracy. There is no mention in the ground truth of a $0.8B impairment directly linked to PFAS in 2023, so this number appears speculative or incorrectly attributed. (2) The dates (April 2024 spin-off) and entity names (MMM, Solventum) are correct. The separation of liabilities by time (pre- vs. post-spin-off) is accurately represented, though the specific reference to 'site-based contamination' and 'product claims' is an elaboration not contradicted by the ground truth but not explicitly confirmed either. The key omission is the absence of mention of the class-action PWS Settlement and opt-out risks disclosed in 2023, which were central to MMM’s earlier risk exposure. (3) The multi-hop reasoning is largely sound—linking 2023 disclosures to 2024 structural changes and inferring a strategic shift in risk management. The logic that isolating future exposure in Solventum represents a segmentation strategy is valid and consistent with the ground truth. However, the unsupported $0.8B figure weakens the factual foundation of the comparison. (4) Correctness is high because the central claim about liability allocation and strategic intent is accurate and contextually appropriate, warranting an 8. Quantitative accuracy is reduced to 7 due to the unverified dollar amount. Qualitative accuracy is strong at 9 due to correct entities, sound reasoning, and proper synthesis across time periods. Contextual relevance is perfect—directly addresses the question’s focus on strategic shift in risk management.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 562,
        "total_tokens": 1959
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did the reduction in CSCO's allowance for credit losses on loan receivables from $103 million in 2023 to $53 million in 2024 impact the financing of technical support services, and what does this suggest about the company's risk exposure and service financing strategy?",
      "original_answer": "CSCO's allowance for credit losses on loan receivables dropped from $103 million in 2023 to $53 million in 2024, indicating a significant decrease in expected credit risk. Since loan receivables are directly tied to financing arrangements for technical support and advanced services, this reduction suggests either improved credit quality of customers receiving financed services or a strategic tightening of financing eligibility. The drop in allowance aligns with a broader context where financing receivables decreased by 2% in 2024 compared to 2023, implying a more conservative approach to customer financing. This evolution reflects a potential shift in how CSCO manages risk exposure in its technical support financing model, possibly favoring lower-risk clients or shorter-term arrangements.",
      "llm_answer": "CSCO cut its allowance for credit losses on loan receivables from $103 million in 2023 to $53 million in 2024, which lowered the expected loss on financing arrangements that include technical‑support services (see page 49). The reduction indicates improved credit quality and lower risk exposure for service financing, suggesting Cisco’s strategy is to rely on stronger underwriting and less reliance on large credit‑loss provisions for its technical‑support financing (see page 82).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the reduction in CSCO's allowance for credit losses from $103 million in 2023 to $53 million in 2024, matching the ground truth exactly in both amount and year. All numeric values are accurate and properly formatted. (2) Quantitative accuracy is perfect—no calculations were required beyond the stated drop, and the figures are correctly reported. (3) The reasoning is sound: the LLM correctly links the allowance reduction to lower expected losses in financing arrangements for technical support services, infers improved credit quality, and suggests a strategic shift toward stronger underwriting and reduced reliance on large provisions. This aligns with the ground truth’s interpretation of lower risk exposure and a more conservative financing approach. However, the LLM omits the specific contextual detail that overall financing receivables decreased by 2% year-over-year, which supports the conservative strategy claim. While the implication is similar, this missing data point slightly weakens the completeness of the multi-hop synthesis. (4) Despite this minor omission, the answer is semantically equivalent in intent and meaning, correctly addressing both the impact on financing and the implications for risk and strategy. The references to 'page 49' and 'page 82' suggest document grounding, though not required for scoring. Overall, the answer is factually correct, well-reasoned, and highly relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 406,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did AMT's strategic handling of the VIL receivables shortfall in 2023 influence the eventual monetization of the VIL OCDs in 2024, and what financial outcomes resulted from this evolution?",
      "original_answer": "In 2023, AMT faced a shortfall in payments from VIL, one of its top tenants in India, which led to the recording of reserves and a $508.6 million impairment charge. In response, VIL issued the VIL OCDs in February and August 2023, with a total face value of $193.2 million, as a partial resolution to its outstanding obligations. AMT retained these OCDs and later amended their maturity terms. By 2024, AMT monetized the VIL OCDs through a combination of conversion into VIL equity and direct sales, generating $216.0 million from the sale of VIL shares and $22.0 million from the remaining OCDs. This resulted in a total realized gain of $46.4 million, demonstrating how AMT transformed a credit risk situation into a strategic financial exit with measurable returns.",
      "llm_answer": "In 2023 AMT recorded reserves for the VIL “shortfall” and launched a strategic review of its India business, which led to the Pending ATC TIPL Transaction with DIT that preserved the company’s economic benefit of the VIL optionally‑convertible debentures (OCDs)【page_7】.  This arrangement enabled AMT to convert 14.4 billion INR of OCDs to equity and sell the resulting 1.44 billion shares in April 2024, and to sell the remaining 1.6 billion INR of OCDs in June 2024, generating net proceeds of about $216 million and $22 million respectively【page_35】.  The sales produced a $46.4 million gain recorded in discontinued operations for the year ended December 31, 2024【page_35】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key financial outcomes and timeline from the ground truth. All numeric values—$216 million from share sales, $22 million from OCD sales, and a $46.4 million gain—are accurate and match the original answer. The conversion of 14.4 billion INR of OCDs into equity and the sale of 1.6 billion INR of remaining OCDs are consistent with the monetization process described. (2) Quantitative accuracy is perfect: the dollar amounts, timing (April and June 2024), and the resulting gain are all factually correct and align with the ground truth. The total proceeds sum to $238 million, which implies a cost basis of $191.6 million—very close to the original $193.2 million face value, with the minor difference explainable by exchange rates or rounding, which is acceptable. (3) The reasoning is largely sound and captures the multi-hop logic: VIL shortfall → reserves/impairment → issuance of OCDs → AMT’s retention and later monetization via conversion and sale → financial gain. However, the LLM omits explicit mention of the $508.6 million impairment charge in 2023 and instead references a 'strategic review' and the 'Pending ATC TIPL Transaction with DIT', which is contextually relevant but not directly part of the causal chain described in the ground truth. This slightly alters the emphasis from internal financial handling (retention and amendment of OCD terms) to a third-party transaction, which, while related, is not the primary mechanism described in the original answer. (4) Despite this nuance, the core facts, numbers, and outcomes are correct, and the answer fully addresses the question’s components: the strategic handling (via conversion and sale), the monetization in 2024, and the financial results. The omission of the impairment detail and slight reframing reduce qualitative accuracy slightly, but not enough to undermine correctness. Hence, a score of 9 is justified—excellent accuracy with minor contextual deviation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 537,
        "total_tokens": 1910
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did the voting power dynamics between Class A and Class B common stockholders at GOOGL evolve from 2022 to 2023, and what implications did this have for corporate governance?",
      "original_answer": "In 2022, holders of Class A common stock held 66 2/3% of the combined voting power, while Class B common stockholders held 33 1/3%, with each Class B share carrying 15 votes. By 2023, Class B shares were entitled to 10 votes per share instead of 15, effectively reducing the voting power of Class B stockholders. This change, combined with significant share repurchases of Class A and Class C shares ($62.2 billion in 2023), likely concentrated ownership further among insiders, impacting the balance of control and decision-making influence within the company.",
      "llm_answer": "From 2022 to 2023 Alphabet’s two‑class structure stayed the same—each Class A share carries one vote while each Class B share carries ten votes (Class C has no voting rights)【page 81】.  However, the company’s 2023 share‑repurchase program bought back roughly $62 billion of Class A shares, shrinking the Class A voting base relative to the 44.6 million Class B shares that remained outstanding in 2022【page 2】【page 81】.  This shift further concentrated voting power in the hands of the Class B holders (primarily founders and early investors), reinforcing their influence over board elections and major corporate decisions and underscoring Alphabet’s dual‑class governance model.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains both correct and incorrect information. It correctly identifies the $62 billion share repurchase in 2023 and the dual-class structure, but it inaccurately states that Class B shares had 10 votes in 2022. According to the ground truth, Class B shares had 15 votes in 2022 and were reduced to 10 votes in 2023. This is a critical factual error affecting the core of the voting power dynamics. The LLM also incorrectly implies that the voting ratio (10 votes per Class B share) was unchanged from 2022 to 2023, when in fact it changed from 15 to 10. (2) The dollar amount of share repurchases ($62 billion) is approximately correct (ground truth: $62.2 billion), and the mention of 44.6 million Class B shares is plausible but not verifiable from the provided ground truth. However, the key vote-per-share numbers are wrong for 2022. (3) The multi-hop reasoning is partially sound—linking share repurchases of Class A to increased relative influence of Class B is logical—but it fails to account for the reduction in Class B voting power (from 15 to 10 votes per share), which counteracts the concentration effect. The model misses this tension between reduced per-share voting power and increased ownership concentration. (4) The contextual relevance is high as the answer addresses corporate governance implications and voting dynamics. However, due to the major error in the voting rights change, the qualitative and quantitative accuracy scores are moderate. The correctness score is 5 because while some facts are right (repurchases, dual-class structure), the central claim about the evolution of voting power is flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 454,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did AbbVie's collaboration with Janssen Biotech in 2022 and the cost-sharing structure of their Imbruvica partnership influence AbbVie's financial exposure and profit-sharing dynamics by 2024, particularly in light of the potential $200 million in future milestone payments?",
      "original_answer": "In 2022, AbbVie's collaboration with Janssen Biotech involved a cost-sharing structure where Janssen covered approximately 60% of development costs and AbbVie 40%, with equal profit and loss sharing in the U.S. and abroad. By 2024, this structure remained intact, but the collaboration introduced potential future development, regulatory, and approval milestone payments of up to $200 million to AbbVie, indicating a shift toward greater upside potential for AbbVie in later-stage outcomes. This evolution suggests a recalibration of financial exposure, where AbbVie maintained reduced development cost burden while gaining enhanced upside through milestone incentives, all within the context of sustained co-commercialization rights and shared profitability on Imbruvica sales.",
      "llm_answer": "AbbVie’s 2011 collaboration with Janssen Biotech (Note 6, page 71) limits AbbVie’s upfront development cost exposure to 40 % of the collaboration’s R&D outlays, while the 50/50 pre‑tax profit split means AbbVie’s share of Imbruvica profits appears in net revenues and Janssen’s share is deducted as cost of products sold (profit‑sharing table, page 72). By 2024, AbbVie’s share of Imbruvica profits is $899 million internationally and $1,140 million of Janssen’s share of profits is reflected in cost of products sold, effectively reducing AbbVie’s gross margin by the partner’s share. The partnership also allows up to $200 million in milestone payments to AbbVie, which could offset the cost‑sharing burden and boost cash flows, but creates contingent financial exposure that will materialize only if the milestones are achieved.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. First, it incorrectly states the collaboration began in 2011, while the question and ground truth focus on developments in 2022. This misdates a key event and undermines temporal accuracy. Second, the LLM introduces specific dollar figures—$899 million in international profits and $1,140 million in Janssen’s share reflected in cost of products sold—which are not present in the original answer and cannot be verified against the ground truth. These numbers appear fabricated or misattributed, severely impacting quantitative accuracy. (2) The cost-sharing structure (40% AbbVie, 60% Janssen) and 50/50 profit/loss sharing are correctly identified and align with the ground truth, as is the mention of up to $200 million in potential milestone payments to AbbVie. However, the financial figures cited for 2024 profits are unsupported and contradict the qualitative nature of the original answer, which does not provide specific revenue splits by geography or exact amounts. (3) The multi-hop reasoning is partially sound: the model connects cost-sharing, profit allocation, and milestone incentives, and correctly interprets that AbbVie has reduced development burden and potential upside. However, it fails to note that the 2022 update maintained the existing structure while adding milestone incentives, instead implying continuity from 2011 without acknowledging the 2022 evolution. This weakens the qualitative accuracy of the synthesis. (4) Contextual relevance is high because the answer addresses financial exposure, profit-sharing, and milestone payments as required. Despite incorrect specifics, the conceptual framework—reduced cost burden, gross margin impact, and contingent milestone upside—is relevant and logically structured. However, the inclusion of unverified financial figures significantly reduces overall correctness, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 523,
        "total_tokens": 1958
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did Microsoft's redemption of Nuance's convertible senior notes between 2022 and 2024 impact the financial liabilities reflected in their consolidated balance sheets, and what does this indicate about the evolution of their post-acquisition financial strategy?",
      "original_answer": "In 2022, Microsoft disclosed that $986 million of convertible senior notes were issued by Nuance, with $985 million redeemed prior to June 30, leaving $1 million outstanding and included in other current liabilities. By 2024, Microsoft's filing indicates that 'substantially all' of the $986 million in convertible senior notes had been redeemed, suggesting the remaining $1 million was likely redeemed in the interim. This evolution in the redemption status reflects a strategic move to reduce post-acquisition financial liabilities tied to Nuance, aligning with a broader financial consolidation strategy following the integration of Nuance into Microsoft’s Intelligent Cloud segment.",
      "llm_answer": "Microsoft’s 2022 acquisition of Nuance left a $986 million balance of convertible senior notes, of which $985 million was redeemed before June 30 2022, leaving only a $1 million liability recorded as other current liabilities (page_78). By the 2024 filing the convertible senior notes no longer appear on the liabilities side, indicating the remaining $1 million had been repaid and Microsoft had shifted to a cleaner, cash‑centric balance‑sheet strategy after the acquisition (page_75).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $986 million in convertible senior notes issued by Nuance and the redemption of $985 million before June 30, 2022, with the remaining $1 million classified as other current liabilities. It accurately notes that by 2024, the notes no longer appear on the balance sheet, implying full redemption—consistent with the ground truth's 'substantially all' characterization. All numeric values and timeframes match the original answer. (2) Quantitative accuracy is perfect: $986M total, $985M redeemed, $1M remaining—all match exactly. The inference that the final $1M was repaid by 2024 is logically sound and aligns with the ground truth. (3) The multi-hop reasoning is strong: the model connects Nuance’s pre-acquisition debt, Microsoft’s post-acquisition disclosure, and the evolution of liabilities over time. It correctly infers strategic balance sheet cleanup, though it phrases the strategy as 'cash-centric' rather than explicitly referencing 'financial consolidation' or 'integration into Intelligent Cloud'—a minor deviation in terminology but not in substance. (4) Scores reflect near-perfect factual alignment, with only a slight deduction in qualitative accuracy due to less precise framing of Microsoft’s strategic intent compared to the original answer. Contextual relevance is full, as all parts of the question are addressed with appropriate financial and strategic interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 399,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did ConocoPhillips' stake in QatarEnergy LNG N3 in 2023 relate to its new involvement in QatarEnergy LNG N4 in 2024, and what does this suggest about the company's evolving role in the integrated North Field LNG development?",
      "original_answer": "In 2023, ConocoPhillips held a 30% stake in QatarEnergy LNG N3 (N3), which was part of its broader LNG portfolio in Qatar's North Field. By 2024, the company was indirectly involved in QatarEnergy LNG N4 (N4), a joint venture between QatarEnergy and Shell, through the integrated development of offshore assets and shared LNG processing facilities. This indirect involvement in N4, despite not being a direct equity holder, suggests that ConocoPhillips' role in the North Field LNG expansion evolved from a direct equity participant in N3 to a de facto contributor to the broader integrated LNG infrastructure through its continued stake in N3 and the mutualized production model with N4. This evolution reflects a strategic alignment in the development of Qatar’s LNG export capacity.",
      "llm_answer": "ConocoPhillips held a 30 % interest in QatarEnergy LNG N3 (N3) in 2023 (page 91, page 10). In 2024 the company’s role expanded to the integrated North Field LNG development that now includes N4, a joint venture between QatarEnergy and Shell plc; N3 and N4 share offshore facilities, identical LNG trains, and mutualized production (page 10). This shift shows ConocoPhillips moving from a single‑partner stake to a broader, more integrated participation in the North Field LNG project, deepening its influence and commitment to the overall development.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that ConocoPhillips held a 30% stake in QatarEnergy LNG N3 in 2023, which matches the ground truth. It also accurately describes the 2024 development involving N4 as part of the integrated North Field LNG expansion, with shared facilities and mutualized production. The entities—QatarEnergy, Shell plc, N3, and N4—are correctly identified. (2) All quantitative elements are accurate: the 30% stake is correctly cited, and there are no calculations required beyond correct interpretation of ownership and integration. Number format (30 %) is acceptable despite spacing. (3) The multi-hop reasoning is sound: the model connects ConocoPhillips’ 2023 stake in N3 to its indirect 2024 role in the broader integrated development including N4, recognizing that shared infrastructure enables influence without direct equity. The conclusion about evolving from a 'single-partner stake' to 'integrated participation' aligns semantically with the ground truth’s notion of shifting from direct equity to de facto contributor via integrated operations. (4) The only minor shortcoming is that the LLM does not explicitly clarify that ConocoPhillips is *not* a direct equity holder in N4, which slightly weakens the precision of the qualitative explanation. However, the emphasis on shared facilities and integrated development implies indirect involvement, so the core reasoning remains intact. Overall, the answer is factually correct, contextually relevant, and conveys the same strategic evolution as the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 427,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did Disney's use of foreign exchange option contracts to hedge forecasted transactions change between 2022 and 2024, particularly in terms of the notional value of these hedges and the currencies involved?",
      "original_answer": "In 2022, Disney employed foreign exchange option contracts as part of its risk management strategy to hedge forecasted transactions, though specific notional values for that year are not disclosed. By 2024, the notional amount of Disney’s net foreign exchange cash flow hedges had increased to $9.9 billion as of September 28, up from $8.3 billion in the prior year (2023). The principal currencies hedged in 2024 included the euro, Canadian dollar, Japanese yen, British pound, and Chinese yuan. This indicates a continuation and expansion of Disney’s strategy to mitigate foreign exchange risk on forecasted transactions through derivative instruments, with a clear increase in hedge volume over the two-year period.",
      "llm_answer": "Disney’s foreign‑exchange option contracts used to hedge forecasted transactions grew in size, with the net notional value of its cash‑flow hedges rising from roughly **$8.3 billion in 2022 to $9.9 billion in 2024**【page_121】.  The hedging program continued to focus on the same core currencies—**euro, Canadian dollar, Japanese yen, British pound and Chinese yuan**【page_121】.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the principal currencies hedged in 2024 (euro, Canadian dollar, Japanese yen, British pound, Chinese yuan), which matches the ground truth. It also correctly reports the $9.9 billion notional value as of 2024 and references a prior-year value of $8.3 billion. However, it incorrectly states that the $8.3 billion figure is from 2022, while the ground truth specifies that $8.3 billion is from 2023 (the prior year to 2024), and explicitly notes that no specific notional value is disclosed for 2022. This is a significant quantitative error because it misattributes a 2023 figure to 2022 and implies precise data availability for 2022 that does not exist. (2) The calculation or comparison between years is therefore flawed—the ground truth indicates an increase from 2023 to 2024, not from 2022 to 2024. The LLM creates a false impression of continuous growth over two disclosed years when only one year-over-year change is documented. (3) The multi-hop reasoning is partially sound: the model correctly synthesizes the 2024 notional amount and currencies involved from the document, but fails to accurately represent the timeline by conflating years. It should have noted that 2022 data was not specifically quantified and that the comparison is between 2023 and 2024. (4) Despite this key error, the answer is contextually relevant and captures the overall trend and strategy accurately. The qualitative reasoning about continuity and expansion is aligned with the ground truth, and all named currencies are correct. Hence, a correctness score of 7 is warranted—core facts are mostly right but with a significant factual misstatement in the quantitative timeline.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 468,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did SPG's strategic investment in J.C. Penney in 2022 influence its ownership structure in SPARC Group by 2024, particularly in light of J.C. Penney's acquisition of SPARC Group's retail operations?",
      "original_answer": "In 2022, SPG held an investment in J.C. Penney, which was part of its broader portfolio of retail-related equity investments. By 2024, J.C. Penney had acquired the retail operations of SPARC Group, which SPG had previously invested in, and was subsequently renamed Catalyst Brands. As a result of this transaction, SPG’s indirect exposure to SPARC Group through J.C. Penney transitioned into a direct 31.3% noncontrolling interest in Catalyst Brands and a continuing 33.3% interest in SPARC Holdings, which now holds a 25% stake in Catalyst. This evolution reflects a strategic shift in SPG’s involvement in the retail operations segment, moving from indirect exposure via J.C. Penney to a more direct but reduced ownership position in the restructured entity by 2024.",
      "llm_answer": "SPG’s 2022 strategic investment in J.C. Penney gave it a stake in SPARC Group.  After J.C. Penney acquired SPARC Group’s retail operations in 2024, SPG’s ownership was restructured: it now holds a 31.3 % non‑controlling interest in Catalyst (the renamed SPARC Group) and continues to hold a 33.3 % non‑controlling interest in SPARC Holdings, which itself holds a 25 % stake in Catalyst.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the essential information from the ground truth. (1) All key facts are correct: SPG's 2022 investment in J.C. Penney, J.C. Penney's 2024 acquisition of SPARC Group's retail operations, the renaming to Catalyst Brands, and SPG’s resulting ownership stakes of 31.3% in Catalyst and 33.3% in SPARC Holdings are all correctly stated. (2) Quantitative accuracy is perfect: the percentages (31.3%, 33.3%, and implied 25% stake of SPARC Holdings in Catalyst) match the ground truth, with no calculation errors. (3) The multi-hop reasoning is sound—correctly linking SPG’s initial investment, the acquisition event, and the resulting ownership restructuring. (4) The only minor shortcoming is that the LLM omits the detail that SPARC Holdings now holds a 25% stake in Catalyst, which is mentioned in the original answer and helps explain the structure; however, the fact that SPARC Holdings holds a 25% stake is implied by stating SPG holds 33.3% in SPARC Holdings and that SPARC Holdings holds a stake in Catalyst. The answer is semantically equivalent in intent and meaning, with slightly less structural detail. Thus, it earns a 9/10 for correctness and qualitative accuracy, but full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 357,
        "total_tokens": 1659
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did the changes in FAR-regulated U.S. Government contract pricing mechanisms between 2022 and 2024 affect LMT's ability to recover pension-related costs through contract pricing?",
      "original_answer": "In 2022, LMT's contracts with the U.S. Government were subject to FAR, which dictated that pricing be based on estimated or actual costs plus a reasonable profit margin, ensuring that standalone selling prices aligned with contract terms. By 2024, LMT recovered $1.7 billion in CAS pension costs through U.S. Government contracts, indicating that pension cost recovery was directly tied to FAR-regulated pricing frameworks. The FAR's cost allowability rules and CAS compliance ensured that LMT could allocate and recover pension contributions over time through contract pricing, despite a $990 million cash contribution in 2024. This demonstrates that the FAR's regulatory structure enabled consistent cost recovery mechanisms across years, even as pension funding levels and contract pricing evolved.",
      "llm_answer": "The FAR changes between 2022 and 2024 did not materially alter Lockheed Martin’s ability to recover pension costs.  The FAR continues to set the allowable cost base for U.S. Government contracts, while the Cost Accounting Standards (CAS) rules govern how pension costs are allocated and recovered; in 2024 LMT recovered $1.7 billion in CAS pension costs— the same amount reported for 2023—recognizing them in cost of sales and net sales【page_47】【page_49】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that LMT recovered $1.7 billion in CAS pension costs in 2024, which matches the ground truth. It also accurately references the continued role of FAR and CAS in cost recovery, affirming that the regulatory framework remained effective. However, the LLM introduces a claim not present in the ground truth—that the 2024 recovery amount was 'the same as in 2023'—which is unsupported by the provided original answer and not verified in context. This addition, while possibly true, is extraneous and not inferable from the ground truth, slightly undermining factual precision. (2) The $1.7 billion figure is correct and properly attributed to 2024; the $990 million cash contribution mentioned in the ground truth is omitted in the LLM answer, representing a minor gap in completeness but not a factual error. No calculations are required, so no computational inaccuracies exist. (3) The multi-hop reasoning is sound: the LLM correctly links FAR’s cost allowability, CAS rules, and LMT’s cost recovery mechanism across years. It synthesizes the regulatory framework with financial outcomes appropriately, though it does not explicitly connect the FAR pricing mechanisms to evolving pension funding levels as the original answer does. (4) The answer is contextually relevant and addresses the core question about pension cost recovery under FAR changes. The correctness score is 8 due to the unsupported comparison to 2023 and the omission of the cash contribution detail, which slightly reduces completeness and qualitative accuracy, despite strong overall factual alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 443,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did BMY's financial stake in the Abilify product change between 2022 and 2023, and what role did the Otsuka partnership play in this dynamic given the trademark ownership structure?",
      "original_answer": "In 2022, BMY had a financial stake in Abilify through its co-promotion agreement with Otsuka, which included a fee based on net sales—such as the $294 million paid to Otsuka on the first $1.0 billion of annual net sales in the Oncology Territory. However, by 2023, the co-promotion arrangement had expired, and BMY no longer shared in the revenue from Abilify, although it still referenced the product in its trademark disclosures. Throughout both years, Abilify remained a trademark of Otsuka, indicating that BMY’s stake was always derivative and dependent on the partnership terms. This shows a clear decline in BMY’s involvement with Abilify from 2022 to 2023, driven by the expiration of the Otsuka collaboration.",
      "llm_answer": "BMS’s 10‑K does not report any adjustment to its ownership or revenue‑share in Abilify between the 2022 and 2023 filings – the product’s financial stake is unchanged【page 114】.  The Otsuka partnership, which co‑promoted Sprycel (not Abilify), does not alter BMS’s Abilify position because the trademark for Abilify is split between BMS in the U.S. and Otsuka in Japan, and the partnership arrangement does not affect BMS’s share of Abilify revenue【page 118】.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is almost entirely incorrect and contradicts the ground truth. (1) It falsely claims that BMY's (BMS's) financial stake in Abilify was unchanged between 2022 and 2023, while the ground truth states that the co-promotion agreement expired in 2023, ending BMY’s revenue participation. This is a direct factual error. (2) The LLM incorrectly asserts that the Otsuka partnership co-promoted Sprycel, not Abilify—this misattributes the product and misrepresents the partnership. In reality, Abilify was the product co-promoted under the BMS-Otsuka agreement. (3) The claim that the trademark for Abilify is 'split' between BMS in the U.S. and Otsuka in Japan contradicts the ground truth, which states Abilify remained a trademark of Otsuka throughout, with BMY’s rights being derivative via the partnership. (4) The LLM fails the multi-hop reasoning: it does not recognize that the expiration of the co-promotion agreement in 2023 ended BMY’s financial stake, despite prior revenue sharing (e.g., $294M on first $1B sales in 2022). (5) The cited pages (114, 118) do not support the claims made, suggesting hallucination or misreading. No correct numbers are presented; the key dollar amount ($294M) and the critical change in 2023 are omitted. The answer is contextually related to BMS and Abilify but fundamentally wrong in substance, rendering it highly misleading.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 380,
        "total_tokens": 1684
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did the shift in QCOM's relationship with Samsung—from being a key customer of its integrated circuit products in 2022 to becoming a direct competitor by 2024—affect QCOM's semiconductor revenue diversification strategy and exposure to customer concentration risk?",
      "original_answer": "In 2022, Samsung was a major customer of QCOM's integrated circuit products, contributing to the semiconductor segment's revenue and highlighting the company's reliance on a few large OEMs. However, by 2024, Samsung had developed its own integrated circuit products, transitioning from a customer to a direct competitor. This shift intensified QCOM's exposure to customer concentration risk, especially as Samsung began using its own chips in some or all of its devices and potentially selling them to third parties. In response, QCOM emphasized diversification into non-handset sectors like automotive and IoT, though these markets themselves posed risks of new forms of concentration. The evolution in the QCOM-Samsung relationship thus forced QCOM to adapt its semiconductor strategy to mitigate revenue volatility and reduce dependency on a shrinking pool of major customers.",
      "llm_answer": "In 2022 Samsung was one of Qualcomm’s largest integrated‑circuit customers, and the company warned that losing such a customer could materially hurt revenue (see 2022 Item 1A, page 20). By 2024 Samsung is listed among Qualcomm’s direct competitors (see 2024 Item 7, page 31), meaning Qualcomm can no longer rely on Samsung for chip sales. The shift has accelerated Qualcomm’s push to diversify its semiconductor revenue beyond mobile handsets into automotive, IoT and other markets (see 2022 Item 1A, page 20), but it also heightens concentration risk because the loss of a major customer like Samsung can magnify the impact of any future customer‑related revenue swings (see 2022 Item 1A, page 19).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Samsung was a major customer in 2022 and became a direct competitor by 2024, increasing Qualcomm's customer concentration risk. The response correctly identifies Qualcomm's strategic shift toward automotive, IoT, and non-handset markets to diversify revenue. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised—dates (2022, 2024) are correct. (3) Multi-hop reasoning is sound: the model synthesizes the change in relationship (customer → competitor), infers the impact on revenue concentration risk, and links it to strategic diversification efforts, citing appropriate sections (Item 1A, Item 7) from filings. (4) The only minor shortcoming is that the LLM answer does not explicitly mention that Samsung began using its own chips in its devices or selling them externally—this nuance is in the original and slightly enriches the competitive threat. Also, the original notes that new markets like automotive may introduce new concentration risks, which the LLM implies but does not state directly. These omissions are minor and do not detract from the core correctness. Wording differs but semantic meaning is equivalent. Contextual relevance is excellent—every part of the answer addresses the question directly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 393,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did SPG's strategic investment in J.C. Penney in 2022 influence its ownership stake in SPARC Group by 2024, and what financial impact did the subsequent restructuring of SPARC Group have on SPG's equity investment portfolio?",
      "original_answer": "In 2022, SPG held a noncontrolling equity investment in J.C. Penney, which was part of its broader platform investments. By 2024, J.C. Penney completed an all-equity transaction acquiring SPARC Group, resulting in a new entity named Catalyst, in which SPG held a 31.3% noncontrolling interest. During the third quarter of 2023, SPG's ownership in SPARC Group was diluted to 33.3% due to a third-party equity issuance, triggering a deemed disposal and a non-cash pre-tax gain of $145.8 million. This restructuring and eventual transformation into Catalyst significantly reshaped SPG's exposure to the retail platform investment landscape, while also generating substantial gains tied to its evolving stake.",
      "llm_answer": "SPG’s 2022 strategic investment in J.C. Penney gave it a 33.3 % non‑controlling interest in SPARC Holdings, the former owner of SPARC Group, and that stake remained unchanged through 2024 (SPARC Holdings now holds a 25 % interest in Catalyst). The 2024 all‑equity transaction in which J.C. Penney acquired SPARC Group’s retail operations produced a $100.5 million non‑cash pre‑tax gain for SPG (with $25.1 million in deferred taxes), boosting its equity‑investment portfolio and contributing to earnings.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains multiple factual inaccuracies. First, SPG did not have a 33.3% stake in SPARC Holdings as a result of its 2022 investment in J.C. Penney—this timeline and ownership structure are incorrect. The ground truth states that SPG’s 33.3% ownership in SPARC Group occurred in Q3 2023 due to dilution from a third-party equity issuance, not from the 2022 J.C. Penney investment. Furthermore, by 2024, SPG held a 31.3% interest in Catalyst (the new entity formed after J.C. Penney acquired SPARC Group), not a '33.3% interest that remained unchanged.' The LLM incorrectly claims the stake 'remained unchanged through 2024,' which contradicts the dilution and restructuring events. (2) Quantitatively, the LLM invents a $100.5 million gain with $25.1 million in deferred taxes, which does not appear in the ground truth. The correct non-cash pre-tax gain was $145.8 million in Q3 2023 due to the deemed disposal from dilution—this number is entirely wrong in the LLM response. Additionally, SPARC Holdings is inaccurately described as holding a 25% interest in Catalyst; this detail is unsupported by the original answer. (3) The multi-hop reasoning is flawed: the LLM fails to correctly trace the sequence of events—2022 investment, 2023 dilution and gain, 2024 restructuring into Catalyst—and misattributes ownership stakes and financial impacts to incorrect time periods and entities. It incorrectly frames the 2022 investment as directly yielding a 33.3% stake, bypassing the actual mechanism of dilution in 2023. (4) Contextual relevance is moderate because the answer addresses SPG’s investment, SPARC Group, Catalyst, and financial impact, but the incorrect entities, timing, and figures severely undermine factual reliability. Due to major errors in numbers, timeline, causality, and entity relationships, the correctness score is low at 3, with similarly low quantitative and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 522,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did the change in Chevron's carrying value difference for its Tengizchevroil investment from 2022 to 2024 reflect the ongoing financial commitment to Kazakhstan's Tengiz and Korolev crude oil fields?",
      "original_answer": "Chevron's carrying value difference for its Tengizchevroil investment decreased from $100 million in 2022 to $73 million in 2024, indicating a narrowing of the premium Chevron paid over the book value of Tengizchevroil’s net assets. This change occurred despite Chevron continuing to fund major development projects in Kazakhstan, such as the Future Growth Project and Wellhead Pressure Management Project, which maintained a loan balance of $4,500 million in both years. The reduction in the carrying value difference suggests either a revaluation of Chevron's investment or a shift in the underlying net asset base of Tengizchevroil, while Chevron's ongoing financial commitment to the Tengiz and Korolev fields in Kazakhstan remained strong.",
      "llm_answer": "Chevron’s carrying‑value premium on its 50 % stake in Tengizchevroil fell from roughly **$100 million in 2022** to about **$73 million in 2024** (2022 note 15; 2024 note 15).  The modest $27 million decline in the premium is offset by Chevron’s continued equity stake and a **$4.5 billion loan to TCO** to fund the WPMP/FGP, underscoring the company’s ongoing financial commitment to the development of Kazakhstan’s Tengiz and Korolev crude‑oil fields.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the carrying value difference for Chevron's Tengizchevroil investment as $100 million in 2022 and $73 million in 2024, matching the ground truth exactly. The $27 million decrease is accurately implied. The $4.5 billion loan (equivalent to $4,500 million) is also correctly reported. 2) All numeric values are accurate and correctly formatted; $4.5 billion = $4,500 million, and the years 2022 and 2024 are correctly referenced. Calculations (implied difference of $27M) are correct. 3) The reasoning is sound: the LLM correctly interprets the narrowing premium in the context of ongoing financial commitment via the loan and development projects (WPMP/FGP), demonstrating proper multi-hop synthesis between carrying value, loan funding, and project investments. It correctly links the reduced premium to sustained commitment, aligning with the ground truth’s conclusion. 4) The only minor shortcoming is that the LLM does not explicitly mention the possible reasons for the reduction in carrying value difference (e.g., revaluation or shift in net asset base), which is included in the original answer and adds depth to the interpretation. However, this does not detract significantly from the overall correctness. The answer remains semantically equivalent in key facts and intent. Thus, high scores across all categories with a 9 in correctness and qualitative accuracy due to slight incompleteness in explanatory depth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 401,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did the issuance of NEP's senior unsecured convertible notes in 2020 and 2021 affect NEE's potentially dilutive securities exposure by 2023, and what does this imply about the evolution of NEE's stake in NEP-related financial instruments over time?",
      "original_answer": "In 2022, NEE disclosed that NEP had issued $500 million in June 2021 and $600 million in December 2020 of senior unsecured convertible notes, which were considered potentially dilutive to NEE. By 2023, NEP had issued an additional $500 million in December 2022, bringing the total principal amount of convertible notes to $1.6 billion. This indicates a growing exposure for NEE through its stake in NEP, as these notes could be converted into NEP common units or cash, depending on NEP's election. The continued issuance of convertible notes shows a strategic evolution in NEP's capital structure that directly impacts NEE's financial position through increased dilution risk over time.",
      "llm_answer": "NEP issued $600 million of senior unsecured convertible notes in December 2020 and $500 million in June 2021, which added $1.1 billion to NEE’s potentially dilutive securities exposure. A subsequent $500 million issuance in December 2022 brought the total exposure to $1.6 billion by 2023, showing that NEE’s stake in NEP‑related instruments has grown and that its dilution risk from NEP’s convertible notes has increased over time【page_105】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts: NEP issued $600 million in December 2020 and $500 million in June 2021, totaling $1.1 billion, and an additional $500 million in December 2022, bringing the total to $1.6 billion by 2023. These figures match the ground truth exactly. (2) All numeric values, dates, and calculations are accurate. The sum of $600M + $500M + $500M = $1.6B is correct, and the incremental exposure is properly described. Format variations (e.g., $500 million) are acceptable and clear. (3) The multi-hop reasoning is sound: the answer connects NEP's note issuances to NEE's dilutive exposure, recognizes the cumulative effect by 2023, and infers increasing dilution risk over time. It correctly implies that NEE’s stake in NEP-related instruments has evolved with growing financial exposure. (4) The only minor shortcoming is that the LLM does not explicitly mention the conversion mechanism (into NEP common units or cash, at NEP's election), which is part of the ground truth and adds nuance to the dilution risk. However, the core implication about increasing dilution risk and evolving exposure is accurately conveyed. Thus, the answer is factually complete and semantically equivalent with only a slight omission in detail, warranting a high score but not perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 368,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did the increase in regulatory disallowances at Nicor Gas from 2022 to 2023 impact Southern Company's gas distribution segment performance, particularly in relation to capitalized investments and impairment charges?",
      "original_answer": "In 2022, Southern Company reported that property, plant, and equipment values were reduced by regulatory disallowances and impairments, indicating a baseline level of regulatory risk exposure. By 2023, Nicor Gas—part of Southern Company’s gas distribution operations—faced a specific $96 million pre-tax charge due to the disallowance of certain capital investments, which directly impacted the gas distribution segment. Additionally, Southern Company recorded a $72 million after-tax charge tied to this disallowance, further affecting earnings. This evolution shows that regulatory disallowances, which were previously a general risk factor in 2022, became a concrete financial burden in 2023, particularly for Nicor Gas, leading to measurable impacts on segment performance and capitalized investment values.",
      "llm_answer": "The regulatory disallowances at Nicor Gas rose from roughly $96 million in 2022 to $88 million in 2023, a change that reduced the amount of capital that could be capitalized and added a pre‑tax impairment charge of about $88 million to the gas‑distribution segment’s results.  The disallowance cut the capital‑investment base, increasing operating expenses and slightly offsetting the segment’s operating income in 2023.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It claims that regulatory disallowances at Nicor Gas were $96 million in 2022 and decreased to $88 million in 2023, which is incorrect. The ground truth states that the $96 million pre-tax charge occurred in 2023, with no indication of a similar or higher amount in 2022. In fact, in 2022, disallowances were described as a general risk factor, not a realized charge of $96 million. The LLM reverses the trend and misrepresents the timeline. Additionally, the $72 million after-tax charge in 2023 is entirely omitted. (2) Quantitative accuracy is severely compromised: the dollar amounts are wrong in magnitude and direction (increase vs decrease), and the pre-tax charge is misstated as $88M instead of $96M. There is no support for a $96M to $88M decrease in the original answer. (3) The reasoning is flawed: the model fails to correctly synthesize the multi-hop elements—specifically, that regulatory disallowances evolved from a general risk in 2022 to a concrete financial impact in 2023 for Nicor Gas. It incorrectly implies a reduction in disallowances, which contradicts the ground truth showing an escalation. The impact on capitalized investments is mentioned, but the causal direction and magnitude are misrepresented. (4) Contextual relevance is moderate—the answer addresses the gas distribution segment, regulatory disallowances, capitalized investments, and impairment charges, so the general topic is correct. However, due to major factual and directional errors in numbers and reasoning, the overall correctness score is very low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 443,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did the expiration and litigation outcomes of BMY's patent rights in key markets between 2022 and 2024 impact the company's ability to maintain market exclusivity for products like Eliquis and Pomalyst?",
      "original_answer": "In 2022, BMY emphasized that market exclusivity for its pharmaceutical products was largely determined by patent rights and regulatory data protection, with specific mention of the importance of Orange Book-listed patents and Paragraph IV certifications in the U.S. and varying regulatory protections across global markets. By 2024, BMY was actively litigating patent disputes in over 20 European countries regarding Eliquis, with mixed outcomes—some favorable (e.g., Norway, Sweden, Switzerland) and some negative (e.g., UK, Finland, Ireland), allowing generic entry. In the U.S., a Paragraph IV certification for Pomalyst triggered a patent infringement lawsuit in late 2024. These developments show that while BMY successfully defended some patents, the erosion of patent rights in key markets led to increased generic competition, directly affecting market exclusivity and posing financial risk through revenue loss.",
      "llm_answer": "Between 2022 and 2024, Eliquis’ composition‑of‑matter patents expired or were challenged in several European jurisdictions, and BMS lost exclusivity in the UK (generics now on the market) and Finland (generics entered market while proceedings were pending), with mixed outcomes in other countries (positive decisions in Norway, Sweden, Switzerland; negative in the Czech Republic, France, Netherlands). These rulings and the launch of generics eroded BMS’s market exclusivity for Eliquis【121】. For Pomalyst, a generic ANDA was filed by Cipla in 2024 and BMS has initiated a patent‑infringement action; exclusivity remains intact but is threatened pending the outcome of the litigation【122】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, with only minor discrepancies in entity details and completeness. (1) Correct elements: The expiration and litigation of Eliquis patents in Europe are accurately described, including country-specific outcomes (UK, Finland, Norway, Sweden, Switzerland), and the fact that generic entry occurred in some markets. The mention of ongoing litigation in multiple European countries and the impact on market exclusivity is consistent with the original. For Pomalyst, the 2024 ANDA filing by Cipla (noted as a Paragraph IV certification in the original) and the initiation of a patent-infringement lawsuit are correctly reported, as is the assessment that exclusivity remains but is under threat. (2) Quantitative accuracy: All dates (2022–2024 timeframe, 2024 litigation) and geographic scope (over 20 countries implied, specific country outcomes) are consistent with the ground truth. The only minor issue is the addition of countries not explicitly listed in the original (Czech Republic, France, Netherlands), which were not mentioned in the ground truth—though this does not contradict it directly, it introduces unverified specifics. (3) Multi-hop reasoning: The LLM correctly synthesizes information across time (2022 exclusivity framework → 2024 litigation outcomes) and across products (Eliquis vs. Pomalyst), correctly inferring the financial and strategic implications of patent erosion. However, it omits the broader 2022 context about Orange Book-listed patents and regulatory data protection frameworks that were emphasized in the original answer, which slightly weakens completeness. (4) Contextual relevance is high—the answer directly addresses the impact on market exclusivity for both drugs due to patent litigation and expiration. The omission of the U.S. Paragraph IV certification context for Pomalyst (referred to generically as an ANDA filing) is a minor shortcoming. Overall, the answer is factually sound and semantically equivalent in meaning, warranting a high correctness score with a small deduction for incomplete contextual framing and slight over-specification of countries.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 579,
        "total_tokens": 1996
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did the inclusion of SQL Server within Microsoft's Server products and cloud services segment evolve from fiscal year 2022 to 2024, and what was the corresponding change in revenue contribution from this segment over that period?",
      "original_answer": "In fiscal year 2022, SQL Server was part of Microsoft's Server products and cloud services segment, which reported revenue of $67.35 billion. By fiscal year 2024, the revenue from this segment had increased to $97.726 billion, reflecting a significant growth in the segment's contribution. This growth indicates a strengthened strategic focus on server and cloud offerings, including SQL Server, as a core component of Microsoft's Intelligent Cloud segment.",
      "llm_answer": "SQL Server remained grouped with Azure, Windows Server, Visual Studio, System Center and CALs in the “Server products and cloud services” line of Microsoft’s Intelligent Cloud segment in both fiscal 2022 and fiscal 2024 【page_92】【page_10】.  The segment’s revenue grew from $67.3 billion in 2022 to $97.7 billion in 2024, a $30.4 billion (≈45 %) increase 【page_96】【page_93】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the revenue figures are correctly reported as $67.3 billion for fiscal year 2022 and $97.7 billion for 2024, which are accurate to within rounding (ground truth: $67.35B and $97.726B). The calculated increase of $30.4 billion and ≈45% are correct and reasonably derived. Minor rounding differences (e.g., $97.7B vs $97.726B) are acceptable per evaluation guidelines. (2) Completeness: The answer addresses both parts of the question—evolution of SQL Server's inclusion (staying in the same segment) and revenue change—across the specified period. (3) Entity accuracy is strong: Microsoft, Intelligent Cloud segment, Server products and cloud services, correct fiscal years (2022 and 2024), and associated products (Azure, Windows Server, etc.) are correctly identified. (4) Reasoning is sound: the model correctly infers continuity in segment composition and links revenue growth to the segment without overreaching. (5) Semantic equivalence is maintained—though the LLM adds minor details (e.g., list of included products), the core information matches the ground truth. The only minor shortcoming is the lack of explicit mention of SQL Server's strategic role as a 'core component', slightly reducing qualitative depth, but the factual and quantitative alignment is excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 379,
        "total_tokens": 1609
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did ConocoPhillips' increased ownership stake in APLNG from 2022 to 2023 impact its exposure to coal bed methane (CBM) production volumes and investment valuation in the joint venture?",
      "original_answer": "In 2022, ConocoPhillips exercised its preemption right to purchase an additional 10% interest in APLNG, increasing its stake and resulting in a fair value write-down to $5,574 million due to a decline in market valuation. APLNG, which produces CBM from the Bowen and Surat basins in Queensland, Australia, remained a key vehicle for ConocoPhillips' CBM exposure. By 2023, ConocoPhillips held a 47.5% ownership stake in APLNG, directly linking its production profile to APLNG's CBM output. This evolution in ownership from 2022 to 2023 increased both its strategic alignment with and financial exposure to CBM production volumes through APLNG.",
      "llm_answer": "ConocoPhillips raised its APLNG stake from 37.5 % in 2022 to 47.5 % in 2023, giving it a larger share of CBM output from the Bowen and Surat basins and thereby increasing its exposure to those production volumes. The higher ownership also lifted the carrying value of its equity‑method investment to about $5.4 billion in 2023, reflecting the joint venture’s fair value and the additional share of CBM production.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the increase in ConocoPhillips' ownership stake in APLNG from 37.5% to 47.5% between 2022 and 2023, and correctly links this to increased exposure to coal bed methane (CBM) production from the Bowen and Surat basins. However, the LLM states that the carrying value of the investment increased to $5.4 billion in 2023, which contradicts the ground truth: in 2022, the fair value was written down to $5,574 million due to market valuation decline. The LLM implies an increase in value due to higher ownership, but the ground truth indicates a write-down, making the financial valuation claim factually incorrect. (2) The percentage stakes (37.5% to 47.5%) are accurate and align with the 10% preemption purchase. However, the $5.4 billion figure does not match the $5,574 million (i.e., $5.574 billion) fair value mentioned in the original answer — while close, the direction of change (increase vs. write-down) is wrong, indicating a significant quantitative and interpretive error. (3) The multi-hop reasoning is partially sound: the model correctly connects ownership increase to greater CBM exposure. However, it fails to capture the nuance that the increased stake coincided with a market-driven fair value write-down, not an increase in valuation. This misrepresents the financial impact. (4) The contextual relevance is high — all key entities (ConocoPhillips, APLNG, CBM, Bowen and Surat basins) and timeframes are correct, and the answer addresses both parts of the question (exposure to production volumes and investment valuation). Due to the significant error in financial valuation direction and amount, the correctness score is reduced to 7, with quantitative accuracy at 6 and qualitative reasoning at 8.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 479,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did the strategic divestiture of ATC TIPL in 2024, which involved DIT assuming $2.5 billion in total aggregate consideration, impact AMT's capital structure compared to 2023, particularly in terms of debt repayment and liquidity?",
      "original_answer": "In 2023, AMT entered into an agreement to sell ATC TIPL to DIT for up to 210 billion INR (approximately $2.5 billion), which included the assumption or repayment of debt and customer receivables. By 2024, the transaction closed, and AMT received 182 billion INR (approximately $2.2 billion). The proceeds were used to repay $1.5 billion in senior notes in early 2024, including $500 million of 0.600% notes and $1.0 billion of 5.00% notes. This indicates a strategic shift to reduce debt and improve liquidity, despite recording a $1.2 billion loss on the sale. The relationship with DIT thus enabled AMT to restructure its capital base and exit the Indian market, which was a key focus during the 2023 strategic review.",
      "llm_answer": "The $2.5 billion sale of ATC TIPL allowed AMT to use the proceeds to repay the 2021 Multicurrency Credit Facility and retire $1.5 billion of senior notes, thereby reducing total debt and improving leverage versus 2023 (see page 136 and 140).  The company’s cash balance fell from $219.6 million at December 31 2023 to zero in the discontinued‑operations section in 2024, reflecting the use of proceeds for debt repayment and a decline in liquidity (see page 141).  Overall, the divestiture strengthened AMT’s capital structure at the expense of available cash.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several correct elements but also key inaccuracies. It correctly identifies the $2.5 billion sale value and that $1.5 billion of senior notes were repaid, aligning with the ground truth. However, it incorrectly states that the proceeds were used to repay the '2021 Multicurrency Credit Facility,' which is not mentioned in the original answer; instead, the ground truth specifies repayment of $500 million of 0.600% notes and $1.0 billion of 5.00% notes. Additionally, the claim that AMT’s cash balance fell from $219.6 million to zero in discontinued operations due to the use of proceeds is not supported by the original answer, which does not mention this specific cash balance or its depletion. The $1.2 billion loss on sale and the receipt of 182 billion INR (~$2.2 billion) instead of the full $2.5 billion are omitted, affecting completeness and accuracy. (2) Quantitative accuracy is partially correct: the $1.5 billion debt repayment matches, but the cash balance figure and facility repayment are unsupported. The $2.5 billion total consideration is accurate, though the actual proceeds were $2.2 billion, which the LLM fails to note. (3) The reasoning is logically structured—proceeds used for debt repayment leading to reduced leverage—but incorrectly links the repayment to a specific credit facility not referenced in the ground truth. The conclusion about improved capital structure at the expense of liquidity is plausible but contradicts the ground truth’s emphasis on strategic debt reduction despite a loss, not a trade-off with liquidity. (4) Contextual relevance is high as the answer addresses the impact on capital structure, debt, and liquidity. However, due to factual errors in entities and missing key details (loss on sale, exact notes retired, actual proceeds), the correctness score is reduced to 6, reflecting partial accuracy with significant omissions and one major factual error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 526,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did the change in PEP's investment in Real Estate Commingled Funds from 2022 to 2023 impact the composition and total value of their U.S. Plan Assets?",
      "original_answer": "In 2022, PEP's U.S. Plan Assets included $478 million in Real Estate Commingled Funds, which decreased to $411 million in 2023, reflecting a reduction of $67 million. This decline was part of a broader shift in asset allocation, as total U.S. Plan Assets decreased from $16,203 million in 2022 to $11,724 million in 2023. The drop in Real Estate Commingled Funds aligns with a general downsizing in most asset categories, including equity securities and fixed income instruments, indicating a strategic rebalancing or withdrawal of funds from U.S. retirement plans.",
      "llm_answer": "PEP’s Real Estate Commingled Funds fell from **$533 million in 2022 to $411 million in 2023** (a $122 million decline).  This reduced the real‑estate portion of U.S. plan assets from roughly **4.7 % of $11.34 billion** to about **3.5 % of $11.72 billion**, even as the overall U.S. plan assets rose by **$380 million** during the year.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. It states that PEP's Real Estate Commingled Funds were $533 million in 2022, but the ground truth is $478 million, making the $122 million decline incorrect (actual decline is $67 million). The total U.S. Plan Assets are also misrepresented: the LLM claims they increased by $380 million to $11.72 billion, but in reality, they decreased from $16,203 million to $11,724 million—a drop of over $4.4 billion. The percentage allocations (4.7% and 3.5%) are based on incorrect base values and are therefore inaccurate. (2) Calculations are flawed: the LLM incorrectly computes the 2022 real estate share (using $533M / $11.34B ≈ 4.7%) when total assets were actually $16,203 million in 2022. Similarly, the 3.5% in 2023 is misleading because while $411M / $11,724M ≈ 3.5% is mathematically correct, the narrative of rising total assets is false. (3) Multi-hop reasoning fails: the model incorrectly infers that total U.S. Plan Assets increased, contradicting the documented decrease. It misses the broader trend of asset reduction across categories, misrepresenting the context as a relative reallocation rather than a systemic drawdown. (4) Despite these major errors, the answer is contextually relevant—it addresses the right entities (PEP, Real Estate Commingled Funds, U.S. Plan Assets) and attempts to discuss composition and total value. However, due to severe quantitative inaccuracies and flawed reasoning, the correctness score is low. Minor credit is given for correctly stating the 2023 real estate value ($411 million) and attempting percentage analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1227,
        "completion_tokens": 446,
        "total_tokens": 1673
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did the sensitivity of UPS's projected pension benefit obligations to discount rate changes evolve from 2022 to 2023, and what does this imply about the company's liability positioning under the bond matching approach used in the settlement process?",
      "original_answer": "In 2022, UPS disclosed that each basis point change in the discount rate affected the projected benefit obligation by a specific amount (in millions) for pension and postretirement medical plans. In 2023, the company again used the bond matching approach to determine discount rates, which is directly tied to the settlement process for these obligations. The 2023 disclosure also provided the updated sensitivity of these obligations to discount rate changes, indicating a recalibration of liability estimates based on current bond market conditions and projected cash flows. The change in sensitivity between years reflects shifts in UPS's pension liability profile and the effectiveness of the bond matching methodology in aligning with actual benefit payment schedules.",
      "llm_answer": "UPS’s projected pension benefit obligation sensitivity to discount‑rate changes fell from roughly $106 per basis‑point increase in 2022 to $62 per basis‑point increase in 2023 (the 2023 10‑K shows a $62‑million reduction for each basis‑point rise in the discount rate). This lower sensitivity means the discount rate used in the bond‑matching approach is closer to the yield of the bonds that would settle the obligations, reducing the impact of rate swings on the liability and improving UPS’s liability positioning under that settlement methodology.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides specific quantitative figures ($106 per basis point in 2022, $62 in 2023) that are not present in the original ground truth answer, which only states that UPS disclosed sensitivity amounts without specifying them. There is no verification in the ground truth that these exact numbers are correct, making the inclusion of precise dollar amounts unsupported and potentially misleading. This results in a significant quantitative inaccuracy. While the general trend of decreasing sensitivity is plausible and the explanation of the bond matching approach aligning discount rates with settlement bonds is conceptually sound and relevant, the model fabricates specific financial figures not present in the source. The reasoning about improved liability positioning due to reduced sensitivity is a reasonable inference but goes beyond the original answer’s more cautious interpretation about recalibration and shifts in liability profile. The entities (UPS, pension obligations, discount rate, bond matching approach, 2022–2023) are correctly identified and the multi-hop structure (comparing two years’ disclosures under a consistent methodology) is appropriately addressed. However, the unsupported numerical claims undermine factual correctness. The answer is contextually relevant and addresses both parts of the question—evolution of sensitivity and implication for liability positioning—but does so with hallucinated data. Thus, while the qualitative reasoning and structure are partially sound, the quantitative inaccuracies severely reduce overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 432,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did the issuance of NEP's senior unsecured convertible notes in 2020 and 2021 affect NEE's potentially dilutive securities landscape by 2023, particularly in terms of NEP's additional issuance in December 2022?",
      "original_answer": "In 2022, NEE held a stake in NEP, which had previously issued $600 million in December 2020 and $500 million in June 2021 of senior unsecured convertible notes. These notes were potentially dilutive to NEE, as NEP could issue common units upon conversion. In 2023, NEP issued an additional $500 million in December 2022, increasing the total outstanding convertible notes and thereby amplifying the dilutive effect on NEE's equity structure. This evolution in NEP's financing strategy introduced a new layer of dilution risk for NEE, as more convertible notes were outstanding in 2023 compared to 2022, with potential future conversions impacting NEE's share count and earnings per share.",
      "llm_answer": "NEP’s senior unsecured convertible notes, issued in December 2020 ($600 million) and June 2021 ($500 million), were classified as potentially dilutive securities to NEE because holders could convert the notes into NEE common units or cash, thereby potentially increasing shares outstanding (page 107).  By 2023, NEP issued an additional $500 million of such notes in December 2022, raising the total principal amount of convertible notes outstanding to $1.6 billion and expanding the scope of NEE’s diluted‑EPS calculations (page 105).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts: NEP issued $600 million in December 2020, $500 million in June 2021, and an additional $500 million in December 2022, totaling $1.6 billion by 2023. These figures match the ground truth exactly, and the statement about increased dilutive impact is accurate. (2) Quantitative accuracy is perfect: all dollar amounts and dates are correct, and the sum ($600M + $500M + $500M = $1.6B) is accurate. The reference to page numbers (107, 105) adds sourcing detail not in the ground truth but does not detract from correctness. (3) The reasoning is sound: the LLM correctly links NEP's note issuances to their potential dilutive effect on NEE, noting that conversion could increase shares outstanding and affect diluted EPS. It captures the multi-hop logic—NEP's actions affecting NEE’s equity structure through convertible instruments. (4) The only minor shortcoming is that the LLM does not explicitly state that NEP was a subsidiary or entity in which NEE held a stake, which slightly weakens the causal chain explanation, though the dilutive mechanism is still clearly conveyed. Otherwise, the answer is factually complete, contextually relevant, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 353,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did SPG's strategic investment in SPARC Group in 2022 influence its stake in ABG by the end of 2023, and what were the financial implications of these changes?",
      "original_answer": "In 2022, SPG held a 33.3% noncontrolling interest in SPARC Group, which had a strategic partnership with ABG as Reebok's core licensee and operating partner in the U.S. During 2023, SPARC Group issued equity to a third party, diluting SPG's ownership and triggering a deemed disposal gain of $145.8 million. Concurrently, SPG's stake in ABG decreased from 12.3% in early 2023 to 9.6% by year-end due to multiple capital transactions, resulting in additional gains totaling $59.1 million. These changes reflect SPG's evolving investment strategy, with financial benefits realized through non-cash gains, despite reducing its exposure to both SPARC Group and ABG.",
      "llm_answer": "SPG’s 33.3 % noncontrolling stake in SPARC Group, which in 2022 entered a long‑term partnership with ABG as Reebok’s core licensee, gave SPG indirect exposure to ABG (page 113).  By year‑end 2023 SPG’s direct ABG ownership had been diluted from roughly 12.3 % to 11.7 % through a series of capital transactions and a cash sale, producing non‑cash pre‑tax gains of $12.4 million (Q3) and $36.4 million (Q2) and a $157.1 million pre‑tax gain on a $300.2 million cash sale in Q4 2023, with associated deferred taxes of $3.1 million and $9.1 million (page 114).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly identifies SPG's initial 33.3% stake in SPARC Group and its indirect exposure to ABG via Reebok, it misrepresents the extent and nature of SPG's stake reduction in ABG. The original answer states SPG's ABG ownership decreased from 12.3% to 9.6% by end-2023, but the LLM claims it only dropped to 11.7%, which is incorrect. Furthermore, the LLM attributes gains to specific quarters (Q2, Q3, Q4) and includes a $300.2 million cash sale in Q4 2023 with a $157.1 million gain, which is not supported by the ground truth. Instead, the ground truth reports a total of $59.1 million in gains from ABG dilution and a separate $145.8 million deemed disposal gain from SPARC Group equity issuance. The LLM confuses these figures entirely. (2) Quantitative accuracy is very low: the $12.4M, $36.4M, and $157.1M gains do not match the ground truth's $59.1M total ABG-related gains and $145.8M SPARC-related gain. The final ABG ownership percentage (11.7% vs 9.6%) is also wrong. (3) The multi-hop reasoning is partially sound in linking SPG → SPARC → ABG via Reebok, but fails in accurately synthesizing the financial outcomes of capital transactions. It incorrectly frames the gains as stemming from a cash sale rather than non-cash deemed disposal and dilution events. (4) Contextual relevance is moderate because the answer addresses the right companies and general theme of ownership dilution and gains, but the incorrect numbers and mischaracterization of events severely undermine factual reliability. The answer introduces a cash sale not mentioned in the ground truth, fundamentally altering the financial implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 465,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did MMM's use of the discounted cash flow approach to value fixed income investments change between 2022 and 2024, particularly in terms of observable inputs and risk adjustments?",
      "original_answer": "In 2022, MMM disclosed that corporate bonds and notes, asset-backed securities, and collateralized mortgage obligations were valued under a discounted cash flow approach that utilized observable inputs, such as current yields of similar instruments. By 2024, MMM continued to use the discounted cash flow approach for fixed income investments but explicitly noted adjustments for certain risks that may not be observable, such as credit and liquidity risks. This evolution indicates a more nuanced valuation methodology in 2024 that accounts for additional risk factors beyond observable market yields.",
      "llm_answer": "MMM’s 2022 10‑K explained that corporate bonds, ABS and CMOs were valued either at comparable yields or by a discounted‑cash‑flow (DCF) model that used observable inputs such as current yields of similar securities, with risk adjustments for credit and liquidity added (page 98).  The 2024 10‑K kept the same basic approach but added that the DCF model’s key inputs are the projected annuity payments and the discount rate applied to those payments (pages 75‑88).  Thus, observable inputs remained comparable yields, risk adjustments stayed focused on credit and liquidity risk, but the 2024 disclosure clarified the specific discount‑rate and cash‑flow inputs used in the DCF calculation.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding MMM's use of risk adjustments in the discounted cash flow (DCF) approach. The original answer states that in 2022, MMM used observable inputs such as current yields of similar instruments, but by 2024, explicitly added adjustments for *non-observable* risks like credit and liquidity. In contrast, the LLM claims that risk adjustments for credit and liquidity were already present in 2022, which contradicts the ground truth. This is a critical error in reasoning and factual reporting. (2) Quantitatively, there are no numerical values to verify (e.g., dollar amounts, percentages), but the years (2022, 2024) and security types (corporate bonds, ABS, CMOs) are correctly identified, supporting a higher score on quantitative accuracy. Page references (e.g., page 98, 75–88) appear specific but cannot be validated without source access; however, they do not affect scoring as long as the substance aligns, which it does not. (3) The multi-hop reasoning is flawed: the model fails to recognize the key evolution — that 2024 introduced explicit recognition of non-observable risk adjustments, whereas 2022 relied solely on observable inputs. Instead, the LLM incorrectly asserts that risk adjustments were already applied in 2022, misrepresenting the progression. It also introduces new details (e.g., 'projected annuity payments') not mentioned in the ground truth, which may reflect overinterpretation or hallucination. (4) Contextual relevance is moderate — the answer addresses the right topic, company, and timeframe, and discusses DCF inputs, so it remains on-topic. However, due to the central factual error about when risk adjustments were introduced, the qualitative accuracy and overall correctness are significantly reduced. The answer suggests continuity rather than evolution, directly contradicting the ground truth's emphasis on a more nuanced 2024 methodology.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 528,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did the change in fair value of NEE's forward contracts - gas from 2023 to 2024 reflect the application of the discounted cash flow valuation technique, and what does this imply about their exposure to gas price volatility?",
      "original_answer": "In 2023, NEE reported a fair value of $377 million in assets and $77 million in liabilities for forward contracts - gas, using the discounted cash flow valuation technique with a weighted-average forward price of $3 per MMBtu. By 2024, the fair value of forward contracts - gas decreased to $296 million in assets and $46 million in liabilities, with a weighted-average forward price increasing slightly to $4 per MMBtu. This indicates a reduction in NEE’s net exposure to gas price volatility, as the valuation technique remained consistent but the overall position shrank, suggesting a more conservative hedging stance or lower market volatility in 2024.",
      "llm_answer": "NEE’s net fair value of forward contracts – gas fell from $300 million in 2023 (assets $377 m, liabilities $77 m) to $250 million in 2024 (assets $296 m, liabilities $46 m), a $50 million decline.  The change is driven by the discounted‑cash‑flow valuation technique, which uses forward‑price inputs as significant unobservable inputs; the lower fair value reflects a lower expected future gas price in the model.  Consequently, NEE’s exposure to gas‑price volatility has been reduced, as the value of the forward contracts – and therefore the potential gains or losses from gas price swings – is lower.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several correct elements but has significant quantitative inaccuracies. It correctly identifies NEE as the company and the use of the discounted cash flow valuation technique with forward prices as key inputs. The asset and liability figures for both years ($377M assets and $77M liabilities in 2023; $296M assets and $46M liabilities in 2024) are accurately reported. However, the LLM incorrectly calculates the net fair value in both years: it states $300M net in 2023 (correct: $377M - $77M = $300M — this is actually correct), and $250M net in 2024 (correct: $296M - $46M = $250M — also correct). So while the net values are numerically correct, the explanation implies these net values are directly reported, whereas the original answer emphasizes the individual asset/liability components and their changes. (2) The critical error is in reasoning: the LLM claims the lower fair value 'reflects a lower expected future gas price in the model,' but the ground truth states the weighted-average forward price *increased* from $3 to $4 per MMBtu. This is a major factual contradiction. The decrease in fair value despite higher forward prices suggests reduced volume or shorter duration of contracts, not lower expected prices. Thus, the LLM misattributes the cause of the valuation change. (3) Multi-hop reasoning is partially sound — it connects valuation technique to fair value change and infers reduced exposure to volatility, which aligns with the original conclusion. However, the flawed interpretation of forward price movement undermines the logic chain. (4) Scores justified as: correctness 6 (core numbers right but key analytical error), quantitative accuracy 5 (net values correct but misinterpretation of price trend), qualitative accuracy 7 (logical structure good but faulty causality), contextual relevance 9 (fully on-topic and addresses both parts of the question).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 520,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did the change in TSLA's warrant-related share issuances from 2023 to 2024 reflect the execution behavior of the 2019 Warrantholders, and what was the impact on TSLA's diluted share count?",
      "original_answer": "In 2023, TSLA reported 11 million shares related to warrants in the diluted share calculation, indicating limited warrant activity. However, in late 2024, the 2019 Warrantholders (Société Générale, Wells Fargo, UBS, and Goldman Sachs) exercised their warrants, leading TSLA to issue 2,894,424 new shares. This exercise activity significantly increased the number of shares outstanding, directly impacting TSLA’s capital structure. The execution of warrants by Warrantholders in 2024, which was not present in 2023, demonstrates a shift in the financial relationship between TSLA and these counterparties, contributing to a more diluted equity base by year-end.",
      "llm_answer": "In 2023 TSLA’s diluted share count included 11 million warrant‑related shares (page 63). In 2024 the 2019 Warrantholders exercised their warrants, resulting in 2.894 million shares issued (page 34), which added that number to the diluted share count and reflected the 2019 Warrantholders’ execution of their warrants.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 11 million warrant-related shares in 2023 and the 2.894 million shares issued in 2024 due to the exercise of warrants by the 2019 Warrantholders, which aligns with the ground truth (2,894,424 ≈ 2.894 million). The numbers are accurate with acceptable rounding. (2) Quantitative accuracy is perfect: 11 million in 2023 matches, and 2.894 million is a correctly rounded version of 2,894,424. The years (2023 and 2024) and the event (warrant exercise) are correctly attributed. (3) The multi-hop reasoning is sound—linking the change in warrant-related share issuances from 2023 to 2024 to the execution behavior of the 2019 Warrantholders and connecting it to diluted share count impact is logically and factually correct. The only minor omission is the lack of specific identification of the Warrantholders (Société Générale, Wells Fargo, UBS, Goldman Sachs) and the deeper implication about the shift in financial relationship and capital structure impact mentioned in the original answer. (4) Despite this slight incompleteness, the core facts, entities (TSLA, 2019 Warrantholders), years, and financial impact are correct and relevant. The answer is concise but semantically equivalent on key points, hence a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 358,
        "total_tokens": 1614
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did the increase in Disney's foreign exchange cash flow hedge notional amounts from $7.4 billion in 2022 to $9.9 billion in 2024 reflect a change in their use of option contracts to manage foreign currency liabilities?",
      "original_answer": "Disney increased its foreign exchange cash flow hedge notional amounts from $7.4 billion in 2022 to $9.9 billion in 2024, indicating a more aggressive hedging strategy. This growth in hedging activity was achieved through greater use of option and forward contracts to manage foreign currency liabilities, as stated in both the 2022 and 2024 filings. The increase suggests that Disney expanded its use of these financial instruments to protect against exchange rate fluctuations, particularly for forecasted foreign currency transactions involving the euro, Japanese yen, British pound, Chinese yuan, and Canadian dollar. The deferred gains in AOCI also shifted from $704 million in 2022 to $99 million in 2024, showing a significant change in the timing and value of hedging outcomes.",
      "llm_answer": "Disney’s notional amount of foreign‑exchange cash‑flow hedges rose from $7.4 billion in 2022 to $9.9 billion in 2024, indicating that the company expanded its use of option contracts to cover a larger portion of its foreign‑currency liabilities.  In 2024 Disney “designates foreign exchange forward and option contracts as cash‑flow hedges of firmly committed and forecasted foreign currency transactions” (page 121), giving it greater flexibility to manage currency risk than it had in 2022.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the increase in Disney's foreign exchange cash flow hedge notional amounts from $7.4 billion in 2022 to $9.9 billion in 2024, which matches the ground truth exactly. It also accurately references the use of option and forward contracts as part of Disney’s hedging strategy, citing the 2024 filing (page 121), which supports the claim of expanded use. However, the LLM omits key details present in the original answer, particularly the shift in deferred gains in Accumulated Other Comprehensive Income (AOCI) from $704 million in 2022 to $99 million in 2024—a significant data point that reflects changes in hedging outcomes over time. Additionally, while the LLM mentions increased use of options, it does not specify the major currencies involved (euro, Japanese yen, British pound, Chinese yuan, Canadian dollar), which are part of the multi-hop synthesis expected.\n\n2) Quantitative accuracy is perfect: both dollar amounts ($7.4B and $9.9B) and years (2022 and 2024) are correct. No calculations are required beyond the stated increase, which is accurately represented.\n\n3) The reasoning is sound in linking increased notional amounts to expanded use of option contracts, and the citation from the 2024 10-K adds credibility. However, the answer lacks full multi-hop synthesis—while it draws correct conclusions from the 2024 filing, it fails to compare the depth of disclosure or strategy between 2022 and 2024 beyond notional value. The original answer notes that both filings mention increased use of options and forwards, implying a consistent trend, which the LLM does not fully reflect.\n\n4) Despite omissions, the LLM answer remains contextually relevant and factually aligned with the main thrust of the question—how the increase reflects greater use of options. The explanation is concise and logically structured. The omission of AOCI changes and specific currencies prevents a top score, but core facts and entities (Disney, years, hedge types, notional amounts) are accurate. Hence, a score of 8 is justified: strong factual correctness with minor but notable gaps in completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 571,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did the evolution of advertising restrictions under the FSPTCA between 2022 and 2024 impact MO's ability to market new tobacco products, particularly in light of expanded FDA authority over synthetic nicotine products in 2024?",
      "original_answer": "In 2022, MO faced advertising restrictions primarily through the State Settlement Agreements, which prohibited outdoor and transit brand advertising, product placement, and youth-targeted marketing. These restrictions were further reinforced by the FSPTCA, which, as of April 2022, extended its advertising and marketing restrictions to include tobacco products containing synthetic nicotine. By 2024, MO was subject to the full scope of FSPTCA advertising rules, including prohibitions on brand-name sponsorships, sampling restrictions, and graphic warning requirements. The expansion of FSPTCA to synthetic nicotine products in 2024 significantly limited MO's ability to market new nicotine pouches and e-vapor products, as these were now subject to the same stringent advertising rules as traditional tobacco products. This regulatory tightening constrained MO's promotional strategies and increased compliance costs, particularly as the company had to adapt its marketing to avoid non-compliance penalties while maintaining brand visibility among adult consumers.",
      "llm_answer": "Between 2022 and 2024 the FSPTCA’s advertising restrictions were broadened to cover synthetic‑nicotine products.  In 2022 Congress expanded the statutory definition of a “tobacco product” to include nicotine from any source, and the Final Tobacco Marketing Rule was amended to apply the same prohibitions on brand‑name sponsorship, sampling, and non‑tobacco trade names to those products (see 2022 10‑K, p. 38).  By 2024 the FDA had further authority to enforce these rules, meaning MO’s new synthetic‑nicotine offerings must now comply with the same pre‑market approval and advertising limits that apply to cigarettes and smokeless tobacco, constraining the company’s ability to launch and promote new products.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the key regulatory change in 2022—Congress expanding the definition of 'tobacco product' to include synthetic nicotine—and notes the amendment of the Final Tobacco Marketing Rule, which extended FSPTCA advertising restrictions to these products. This is supported by the cited 2022 10-K reference (p. 38), which matches known disclosures. (2) The dates (2022 and 2024) are correct and consistent with the timeline in the original answer: the 2022 rule change and the full enforcement by FDA by 2024. There are no numerical inaccuracies; the answer avoids specific dollar amounts or percentages, so no calculation errors are present. (3) The multi-hop reasoning is sound: it connects the statutory change (2022) to the regulatory enforcement (2024), links synthetic nicotine products to pre-market approval and advertising limits, and correctly infers that this constrained MO's ability to market new products. (4) The LLM omits some contextual details from the original answer—such as specific restrictions like outdoor advertising bans, product placement, and youth-targeted marketing under State Settlement Agreements, and does not mention compliance costs or brand visibility challenges—but these are secondary to the core question about how FSPTCA evolution and FDA authority expansion impacted MO’s marketing of new products. The answer captures the essential causal chain: broader definition → inclusion of synthetic nicotine → application of strict advertising rules → constrained product launches. Wording differs but semantic meaning is equivalent. Minor deduction in qualitative accuracy due to omitted context, but core facts and logic are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 476,
        "total_tokens": 1942
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Tesla's battery supply arrangement with Panasonic evolve from 2022 to 2023, and what does this indicate about their operational collaboration?",
      "original_answer": "Tesla's battery supply arrangement with Panasonic evolved significantly from 2022 to 2023, reflecting an increasingly integrated operational collaboration. In 2022, Tesla's 10-K filing referenced a long-standing supply agreement initially signed in 2011 (Exhibit 10.25†), showing that their relationship was already mature. By 2023, Tesla's 10-K filing included several amendments and new agreements that deepened their partnership, such as the 2020 Pricing Agreement (Gigafactory 2170 Cells) executed in June 2020 (Exhibit 10.36††) and the Second Lease Amendment for factory space entered into on June 9, 2020 (Exhibit 10.40††). These developments indicate that Tesla and Panasonic were expanding their joint manufacturing footprint and refining pricing structures to support scaled production. This evolution suggests a strategic shift toward tighter integration in production logistics and cost management, enabling Tesla to secure critical battery components while allowing Panasonic to optimize its investment in shared facilities.",
      "llm_answer": "In 2022 Tesla’s battery supply relationship with Panasonic was based on a 2011 supply agreement and its 2013 amendment (see the 2023 10‑K exhibit list). By 2023 the partnership had expanded to include a 2020 pricing agreement for Gigafactory 2170 cells and a 2021 pricing agreement for Japan cells, plus lease amendments for the Gigafactory (exhibits 10.36‑10.40). This shift from a basic supply contract to detailed pricing and facility agreements signals a deeper, more integrated operational collaboration between the two companies.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the evolution of Tesla's battery supply arrangement with Panasonic from 2022 to 2023 and interprets it as a deepening operational collaboration, which aligns with the ground truth. However, there are factual inaccuracies in dates and documents. The 2023 10-K does reference the original 2011 agreement, but the LLM incorrectly states that the 2013 amendment is mentioned in the 2023 exhibit list—this is not supported by the ground truth. Additionally, the LLM claims a '2021 pricing agreement for Japan cells' was added by 2023, but this agreement is not referenced in the original answer or the knowledge graph, making it a significant factual error. The lease amendments are correctly noted as relevant but are misdated—the Second Lease Amendment was executed on June 9, 2020, not in 2021 as implied by the sequence. (2) Quantitative accuracy suffers due to incorrect dating of agreements: the 2020 Pricing Agreement (Gigafactory 2170 Cells) is correctly cited, but the addition of a '2021 pricing agreement' is unsupported. The exhibit numbers (10.36–10.40) are generally accurate, though the original answer specifies 10.36†† and 10.40††, not a range. (3) The multi-hop reasoning is sound—the model correctly infers that the addition of pricing and lease agreements indicates deeper integration. It synthesizes the shift from a basic supply contract to more detailed operational agreements, which is consistent with the ground truth’s conclusion about tighter collaboration in production logistics and cost management. (4) Despite the incorrect details, the overall interpretation and direction of the answer are correct, and it addresses both parts of the question: the evolution of the arrangement and what it indicates about collaboration. Hence, a score of 7 is justified—core facts and reasoning are correct, but there are notable factual inaccuracies in dates and agreements.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 523,
        "total_tokens": 1917
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did ConocoPhillips' investment in PALNG in 2023 influence the company's application of ASC Topic 815 accounting standards in 2024, particularly in relation to the reclassification of unrealized gains and losses affecting equity in earnings of affiliates?",
      "original_answer": "In 2023, ConocoPhillips invested in PALNG, which executed interest rate swaps covering 60% of projected term loans for Phase 1 development, with these derivatives designated under ASC Topic 815 as cash flow hedges, resulting in a $78 million unrealized gain in other comprehensive income. In 2024, PALNG de-designated a portion of these swaps, causing a shift in accounting treatment where the associated $35 million in changes in fair value was now recognized directly in 'Equity in earnings of affiliates' instead of other comprehensive income. This evolution reflects a strategic or financial decision that altered the accounting treatment under ASC Topic 815, directly linking COP’s investment in PALNG (2023) → ASC Topic 815 (2024 accounting impact).",
      "llm_answer": "ConocoPhillips’ 2023 investment in PALNG triggered ASC 815 cash‑flow hedge accounting for the interest‑rate swaps that PALNG used to convert 60 % of its Phase 1 term‑loan financing to fixed rate. In 2024, a portion of those swaps was de‑designated, so the fair‑value changes that had been recorded in OCI were reclassified into the “Equity in earnings of affiliates” line on the consolidated income statement. Consequently, $35 million of the de‑designated swaps’ unrealized gains were moved from OCI to equity in earnings of affiliates, while the $56 million unrealized loss and $78 million unrealized gain remained in OCI.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the core chain of events: ConocoPhillips' 2023 investment in PALNG led to ASC Topic 815 cash flow hedge accounting for interest rate swaps covering 60% of term loans, and in 2024, de-designation of a portion caused reclassification from OCI to 'Equity in earnings of affiliates'. The $35 million amount being reclassified is accurately stated and matches the ground truth. However, the LLM introduces two figures not present in the original answer: a '$56 million unrealized loss' and a claim that the '$78 million unrealized gain remained in OCI'. The ground truth states the $78 million was the initial unrealized gain in OCI due to the hedges, but does not state that it remained there in full or mention any $56 million loss. In fact, the de-designation caused part of the previously deferred gains (specifically $35 million) to be reclassified out of OCI — implying a reduction, not retention, of that amount in OCI. The introduction of a new loss figure and the assertion about the $78 million remaining in OCI are unsupported and factually inconsistent with the implied accounting impact. This constitutes a significant quantitative error. While the multi-hop reasoning (investment → hedge accounting → de-designation → reclassification) is sound and entities/dates are correct, the incorrect addition of financial figures reduces quantitative accuracy. The answer remains contextually relevant and qualitatively strong in structure and logic, hence a score of 7/10 overall.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 415,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did the amortization of the deferred gain from AIG's adverse development reinsurance agreement with NICO evolve from 2023 to 2024, and what does this indicate about the performance of the collateral trust account securing the agreement?",
      "original_answer": "In 2023, the amortization of the deferred gain related to the adverse development reinsurance agreement with NICO was $48 million, and it increased significantly to $322 million in 2024. This sharp increase suggests that the settlement period of the ceded reserves is accelerating, which could be due to faster-than-expected loss payments or updated estimates affecting the amortization schedule. The collateral trust account, created by NICO and funded with the consideration paid under the agreement, continues to serve as security for their claim payment obligations, indicating ongoing financial backing for the agreement. This evolution reflects a shift in the financial dynamics of the reinsurance relationship between AIG and NICO over time.",
      "llm_answer": "The amortization of the deferred gain under the NICO adverse‑development reinsurance rose from **$1.49 billion in 2023 to $1.69 billion in 2024** (increasing the amortization at inception from $1.428 billion to $1.564 billion and the amortization of changes in the deferred gain from $64 million to $122 million). This uptick shows that the collateral‑trust account that NICO funded has remained robust, providing ample collateral to support the agreement and allowing the deferred gain to be amortized at a faster pace.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in terms of factual content. The ground truth states that amortization was $48 million in 2023 and $322 million in 2024. The LLM claims $1.49 billion in 2023 and $1.69 billion in 2024—over 10 times higher than the correct values. These numbers are not only wrong but also presented with false precision, including breakdowns of 'amortization at inception' and 'amortization of changes in deferred gain' that do not appear in the original answer and contradict the known facts. (2) The quantitative discrepancy is severe: $48M vs $1.49B (30x overstatement) and $322M vs $1.69B (5x overstatement). Any calculation based on these figures, such as trends or comparisons, is therefore invalid. (3) The reasoning is flawed: while the LLM attempts multi-hop synthesis by linking amortization trends to the performance of the collateral trust account, it draws an incorrect conclusion. The original answer links the increase in amortization to an acceleration in the settlement period due to faster loss payments or updated estimates. The LLM instead suggests the increase reflects a 'robust' collateral trust account enabling faster amortization—a speculative interpretation not supported by the ground truth. (4) Contextual relevance is moderate because the LLM addresses the right topic (amortization of deferred gain under the NICO agreement and its relation to the collateral trust), but factual inaccuracies and incorrect reasoning severely undermine the response. The mention of the collateral trust account is contextually appropriate but misused to justify false claims. Due to complete failure on numbers and reasoning, the correctness score is near the lowest possible.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 471,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did the resolution of VIL's payment shortfall in 2023 influence AMT's strategic decisions regarding the VIL OCDs in 2024, and what was the financial outcome of those decisions?",
      "original_answer": "In 2023, VIL resumed full payments on its contractual obligations to AMT, which had previously been impacted by the VIL Shortfall. This resolution allowed AMT to reassess its strategic exposure to the Indian market, ultimately leading to the decision to convert and sell the VIL OCDs in 2024. AMT converted 14.4 billion INR (approximately $172.7 million) of VIL OCDs into 1,440 million VIL shares and sold them for net proceeds of 18.0 billion INR (approximately $216.0 million). The remaining 1.6 billion INR (approximately $19.2 million) of VIL OCDs were also sold for net proceeds of 1.8 billion INR (approximately $22.0 million). These transactions resulted in a total gain of $46.4 million recognized in 2024, reflecting the financial benefit of AMT's strategic decisions following the stabilization of VIL's payments.",
      "llm_answer": "After VIL resumed full payments in the second half of 2023, AMT was able to treat the VIL optionally‑convertible debentures (OCDs) as a stable asset and move forward with a conversion‑and‑sale strategy.  In March 2024 the company converted 14.4 billion INR (≈$172.7 million) of OCDs into VIL equity, sold the shares on April 29 for about 18 billion INR (≈$216 million), and then sold the remaining 1.6 billion INR (≈$19.2 million) of OCDs on June 5 for roughly 1.8 billion INR (≈$22 million).  These transactions generated net proceeds of about $238 million and produced a recognized gain of $46.4 million on the sales.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures all key facts from the ground truth. The resolution of VIL's payment shortfall in 2023 enabled AMT to proceed with converting and selling VIL OCDs in 2024. The amounts converted (14.4 billion INR ≈ $172.7 million), proceeds from share sale (18.0 billion INR ≈ $216 million), sale of remaining OCDs (1.6 billion INR original value sold for 1.8 billion INR ≈ $22 million), and total recognized gain ($46.4 million) are all accurate. (2) Quantitative accuracy is perfect: all numbers match the ground truth, including conversions and final gain. The LLM correctly sums the net proceeds as ~$238 million ($216M + $22M), which is consistent with the original answer’s data, even though the sum is not explicitly stated in the ground truth. (3) The multi-hop reasoning is sound—linking the resolution of the 2023 payment shortfall to the 2024 strategic decision to convert and sell is correctly inferred and articulated. The only minor omission is that the original answer specifies the conversion resulted in 1,440 million VIL shares, which the LLM omits, slightly reducing completeness. (4) Contextual relevance is excellent—the answer directly addresses both parts of the question: the influence of the 2023 resolution on 2024 strategy and the financial outcome. Wording differs but meaning is semantically equivalent. A score of 9 is justified due to full factual and quantitative accuracy with only a minor detail omission.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 407,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Duke Energy's exposure to foreign currency derivatives evolve between 2022 and 2024, and what does this reveal about the role of these instruments within their broader risk management framework?",
      "original_answer": "In 2022, Duke Energy's risk management activities were described as encompassing market risks including interest rates, equity prices, and commodity prices, with the Chief Risk Officer overseeing governance of commodity price risk. By 2024, foreign currency derivatives were explicitly categorized under 'Risk Management Activities' and were valued using Level 2 inputs such as forward foreign currency rate curves and counterparty credit quality. This evolution indicates a more formalized integration of foreign exchange risk into Duke Energy’s structured risk management framework, reflecting a strategic shift toward enhanced transparency and precision in managing global financial exposures.",
      "llm_answer": "Between 2022 and 2024, Duke Energy’s foreign‑currency derivative exposure grew markedly. The 2024 10‑K shows net foreign‑currency derivative positions of $4 million in assets and $51 million in liabilities for Southern Power (page 284), $28 million in assets and $84 million in liabilities for Southern Company Gas (page 285), and $554 million in liabilities for Southern Company (page 283). The 2022 10‑K did not report any foreign‑currency derivative exposure, indicating a strategic shift toward more active currency hedging and underscoring that these instruments are a core element of the company’s broader risk‑management framework that also includes energy‑related and interest‑rate hedges (page 282).",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative and qualitative aspects. The ground truth states that foreign currency derivatives were not explicitly mentioned in 2022 but were formally categorized under 'Risk Management Activities' in 2024 with valuation details (Level 2 inputs). However, the LLM claims specific dollar amounts for foreign currency derivatives in 2024 across Southern Power, Southern Company Gas, and Southern Company, which are not only unrelated to Duke Energy but also factually wrong—Southern Company is a different utility entity, not a subsidiary of Duke Energy. Additionally, the LLM asserts that Duke Energy had no foreign currency derivative reporting in 2022, which may align loosely with the absence of explicit mention, but it misrepresents this as 'no exposure' rather than lack of disclosure. (2) The numbers cited—$4M assets/$51M liabilities, $28M/$84M, $554M liabilities—are entirely fabricated or misattributed. These figures do not appear in Duke Energy’s 2024 10-K related to foreign currency derivatives, and attributing them to Southern Power and Southern Company Gas is erroneous as they are not Duke Energy subsidiaries. There is no evidence in the ground truth of any numerical exposure values being reported; instead, the focus is on classification and valuation methodology. (3) The multi-hop reasoning fails: the model incorrectly conflates Duke Energy with Southern Company entities, fails to recognize that the evolution is about disclosure and categorization (not sudden exposure), and invents a 'strategic shift toward more active currency hedging' based on false numerical premises. The actual reasoning should center on increased formalization and transparency in risk reporting, not new hedging activity. (4) While the answer attempts to address the question's structure—comparing 2022 to 2024 and interpreting risk management role—the factual foundation is so flawed that the conclusion is invalid. The contextual relevance is moderate because it discusses risk management and derivatives, but the entities and numbers undermine correctness. Hence, low scores on correctness and quantitative accuracy, slightly higher on qualitative due to structural attempt, and moderate on relevance for topical alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 610,
        "total_tokens": 1975
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Amazon's 2023 customer engagement strategy, as measured by Prime membership growth, influence the scope and timing of their 2024 new product launches, particularly regarding the expansion into smart home ecosystems?",
      "original_answer": "In 2023, Amazon reported a 12% year-over-year increase in Prime memberships, which directly supported their customer engagement strategy by deepening user loyalty and expanding their addressable market for ecosystem-integrated products. This engagement metric created a foundation for Amazon to strategically time and scale new product launches in 2024, including the expansion of its smart home ecosystem with the introduction of the Alexa Connect Kit and AWS-integrated smart devices. The MA_10k_2023.pdf explicitly states that higher customer engagement through Prime directly influenced the prioritization and development of products that deepen ecosystem lock-in. In 2024, Amazon disclosed that 65% of new product launches were targeted at expanding the smart home footprint, a direct continuation of leveraging Prime-driven engagement to drive cross-product adoption.",
      "llm_answer": "The pages supplied do not contain any Prime‑membership figures or descriptions of 2024 product‑launch plans, so the documents do not provide a basis for linking 2023 Prime growth to the scope or timing of Amazon’s 2024 smart‑home initiatives.",
      "correctness_score": 0,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 1,
      "detailed_feedback": "The LLM answer is completely incorrect and fails to reflect the ground truth. (1) The original answer states that Amazon reported a 12% year-over-year increase in Prime memberships in 2023 and that 65% of 2024 new product launches targeted smart home expansion—both specific quantitative claims that the LLM falsely claims are absent from the documents. (2) The LLM denies the presence of any Prime membership figures or 2024 product launch plans, directly contradicting the ground truth, which explicitly cites MA_10k_2023.pdf as the source for these data points. This results in a total failure in quantitative accuracy, as the key percentages (12% and 65%) are entirely dismissed. (3) The multi-hop reasoning—linking Prime growth to ecosystem expansion—is well-supported in the original answer but completely missed by the LLM, which fails to synthesize or even acknowledge the causal relationship described. (4) The response is irrelevant because it denies the existence of critical information rather than engaging with it, suggesting a failure to access or interpret the provided documents. Overall, the answer is factually wrong on all levels and receives the lowest possible score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 333,
        "total_tokens": 1631
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did the voting power dynamics between Class A and Class B common stockholders at CMCSA change from 2022 to 2024, and what implications did this have for corporate governance decisions requiring class voting?",
      "original_answer": "In 2022, CMCSA's Class A common stockholders held 66 2/3% of the combined voting power, with Class B common stockholders holding the remaining 33 1/3%, and each share of Class B common stock had 15 votes. By 2024, while the Class A common stock remained widely held with over 4.65 billion issued shares, Class B common stock was significantly less issued, with only 9.4 million shares authorized and outstanding. The governance structure in 2024 maintained that Class B common stockholders could only vote on specific defined matters, such as exiting the core payments business or certain merger transactions. This suggests that while the relative voting power of Class B shares remained concentrated, the overall governance framework continued to limit their influence on general corporate decisions, preserving the dominance of Class A shareholders in most voting scenarios.",
      "llm_answer": "Comcast’s 2022 10‑K stated that holders of Class A common stock controlled about **66.3 %** of the combined voting power, while holders of Class B common stock controlled the remaining **33.3 %**; each Class B share carries **15 votes** and the Class B voting power is non‑dilutable (page 38). The 2024 10‑K contains no change to those figures, indicating the same split (pages 65‑69). Because the two classes still vote as one except for matters that require class voting, corporate‑governance actions that trigger class voting—such as amendments to the certificate of incorporation, mergers, or other major corporate actions—continue to require the approval of both classes, and the non‑dilutable Class B voting power gives the minority a veto over certain decisions.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 2022 voting power split (66.3% and 33.3%, approximating the exact 66 2/3% and 33 1/3%) and the 15 votes per Class B share, which matches the ground truth. However, it incorrectly states that the 2024 10-K shows 'no change' to these figures, directly contradicting the ground truth, which specifies a structural shift: by 2024, Class B shares were only 9.4 million outstanding (vs over 4.65 billion Class A), and their voting rights were limited to specific matters like exiting the core payments business or certain mergers. The LLM misses this critical evolution in governance. (2) Quantitatively, the 66.3% and 33.3% are acceptable rounding of 66 2/3% and 33 1/3%, and the 15 votes per share is accurate. But the LLM fails to report the actual share counts in 2024 (9.4 million Class B vs 4.65B Class A), which are key to understanding the changed dynamics. The claim that 'no change' occurred is factually incorrect. (3) The reasoning is flawed in the multi-hop synthesis: while the LLM correctly notes that class voting is required for certain corporate actions, it concludes that Class B retains a veto due to non-dilutable voting power, without acknowledging that the 2024 structure explicitly limits Class B voting to only defined matters—meaning their influence is now both numerically and procedurally constrained, not broadly veto-capable. This misrepresents the governance implications. (4) The answer is contextually relevant and well-structured, addressing voting power and governance, but fails on completeness and factual accuracy for the 2024 state, leading to a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 454,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Duke Energy's acquisition of storm recovery property in 2023 relate to the expansion of state legislation governing storm cost financing in 2024, and what does this imply about the company's evolving regulatory risk exposure?",
      "original_answer": "In 2023, Duke Energy Carolinas and Progress acquired storm recovery property through special purpose subsidiaries, issuing $237 million and $770 million in bonds respectively to finance unrecovered regulatory assets from storms in 2018 and 2019. By 2024, the company expanded this model to South Carolina, forming Duke Energy Progress SC Storm Funding, LLC and issuing an additional $177 million in bonds to cover storm costs from 2014 through 2022. This expansion was enabled by state legislation in both North and South Carolina that authorized the creation of storm recovery property and the imposition of non-bypassable charges on retail customers. The 2024 risk factors highlight that Duke Energy remains highly dependent on state legislation for cost recovery, and any changes in regulatory frameworks could limit its ability to recoup expenses, thereby increasing regulatory risk exposure. The temporal chain shows Duke Energy's growing reliance on state-backed storm recovery mechanisms and the associated regulatory dependencies.",
      "llm_answer": "Duke Energy’s 2023 acquisition of storm‑recovery property—through its special‑purpose VIEs that were created under state‑approved financing orders—was a direct response to the regulatory framework that lets utilities recover storm‑related costs via non‑bypassable charges.  In 2024, state legislation expanded that framework (e.g., the PSC financing order that enabled the 2024 issuance of $177 million of storm‑recovery bonds and the acquisition of additional storm‑recovery property), giving the company more tools to finance and recover storm costs.  This evolution shows a growing reliance on state‑driven financing mechanisms, which heightens Duke Energy’s regulatory‑risk exposure as future legislative or regulatory changes could alter cost‑recovery rights and the viability of its VIE‑based bond structures.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core facts and implications from the ground truth. (1) It correctly identifies Duke Energy's 2023 acquisition of storm-recovery property through special-purpose VIEs (variable interest entities) and links it to state-approved financing mechanisms. It also accurately notes the 2024 expansion enabled by legislation, including the $177 million bond issuance. (2) Quantitatively, the $177 million figure for the 2024 South Carolina issuance is correct and matches the ground truth. However, the LLM omits the specific 2023 bond amounts ($237 million for Duke Energy Carolinas and $770 million for Progress), which were part of the original answer and relevant to completeness. While not a factual error, this omission slightly reduces quantitative completeness. (3) The reasoning is sound: the LLM correctly infers that the expansion of state legislation in 2024 built upon the 2023 model, enabling further cost recovery and increasing regulatory risk due to reliance on legislative support. It accurately synthesizes the multi-hop connection between corporate action (acquisition, bond issuance) and regulatory evolution. (4) The answer is contextually excellent—directly addressing the relationship between the 2023 acquisition and 2024 legislative expansion, and correctly concluding that this implies increased regulatory risk exposure. The only reason for not scoring a 10 is the partial omission of the 2023 financial figures, which are part of the full factual picture. Overall, the answer is factually correct, well-reasoned, and semantically equivalent in meaning, with only minor detail omissions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1485,
        "completion_tokens": 450,
        "total_tokens": 1935
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "What does Duke Energy's consistent classification of debt investments as AFS from 2022 to 2024 indicate about their strategic approach to long-term securities, especially given the immaterial realized gains and losses reported in 2024?",
      "original_answer": "Duke Energy's consistent classification of debt investments as AFS in both 2022 and 2024 suggests a stable investment strategy focused on holding these securities for the long term, rather than for active trading or short-term profit. The immaterial realized gains and losses from sales of AFS securities in 2024 further support this, indicating minimal turnover and a passive management approach. This consistency in accounting treatment and investment behavior implies that Duke Energy is maintaining a conservative and stable portfolio strategy for its debt holdings, likely aligned with its broader risk management and capital preservation goals.",
      "llm_answer": "Duke Energy’s continued classification of its debt holdings as available‑for‑sale (AFS) from 2022 through 2024 shows that the company treats these securities as long‑term, non‑trading assets, deferring unrealized gains and losses to OCI until realized (page_193, page_194). The 2024 realized gains of $28 million and losses of $67 million—immaterial relative to the $5.8 billion AFS portfolio—and the absence of material credit losses (page_194) confirm a stable, conservative investment approach that relies on regulatory accounting rather than short‑term trading.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Duke Energy's consistent AFS classification from 2022 to 2024 and interprets it as a sign of a long-term, conservative investment strategy, which aligns with the ground truth. It also correctly references immaterial realized gains and losses in 2024 as evidence of low turnover and passive management. However, the LLM introduces specific numeric values—$28 million gains and $67 million losses, and a $5.8 billion AFS portfolio—that are not present in the original answer and cannot be verified against the ground truth, which only states that gains and losses were 'immaterial' without specifying amounts. This undermines quantitative accuracy. (2) The original answer does not mention any dollar figures for gains, losses, or portfolio size, so the inclusion of these numbers, while possibly present in the source documents, goes beyond the verified ground truth and risks misrepresentation if those figures are taken as confirmed facts. There is no indication in the ground truth that the $28M/$67M figures are immaterial relative to $5.8B, so the comparative analysis involving these numbers is unsupported. (3) The multi-hop reasoning is sound: the model connects consistent AFS classification with long-term strategy and uses the immateriality of realized gains/losses to infer stability and conservatism. It also appropriately references regulatory accounting and OCI treatment, adding contextual depth. However, the reliance on unverified quantitative details introduces inaccuracies. (4) The correctness score is 7 because the core qualitative interpretation is accurate and complete, but the inclusion of unsupported numbers reduces confidence in factual precision. Quantitative accuracy is scored 6 due to the introduction of unverified figures. Qualitative accuracy is 8 because the reasoning and entity identification (Duke Energy, AFS, OCI, years) are correct. Contextual relevance is 9 as the answer directly addresses the strategic implications asked in the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 547,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did GILD's collaboration with Merck on Keytruda-based combination therapies in 2022 evolve into broader partnership terms in 2023, particularly in terms of cost-sharing, commercialization rights, and revenue thresholds?",
      "original_answer": "In 2022, GILD collaborated with Merck on Keytruda-based combination therapies for NSCLC and TNBC, with Merck paying ongoing royalties on Keytruda sales (6.5% through 2023). By 2023, this relationship expanded into a broader partnership where GILD and Merck shared global development and commercialization costs at 60% and 40%, respectively. GILD gained U.S. commercialization rights for long-acting oral products, while Merck led in the EU and rest of the world. Revenue-sharing terms included equal revenue splits until thresholds of $2.0 billion (oral) and $3.5 billion (injectable) were surpassed, after which GILD's share increased to 65%. This evolution reflects a strategic deepening of the partnership beyond clinical collaboration into joint commercialization and revenue-sharing with defined financial thresholds.",
      "llm_answer": "In 2022 Gilead and Merck entered a **clinical‑trial collaboration** to evaluate Trodelvy plus Merck’s PD‑1 antibody Keytruda in first‑line non‑small‑cell lung cancer【page_39】.  In 2023 the parties expanded that arrangement into a broader partnership that now **shares development and commercialization costs 60 % (Gilead) / 40 % (Merck)**, assigns **lead commercialization rights** (Gilead leads U.S. oral, Merck leads EU oral; Merck leads U.S. injectable, Gilead leads EU injectable) and sets **revenue‑sharing tiers**—a 50/50 split of global product revenues until net sales exceed **$2 billion for oral** or **$3.5 billion for injectable** combinations, after which Gilead’s share rises to **65 %** on amounts above those thresholds【page_76】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of GILD's partnership with Merck from a 2022 clinical collaboration into a broader 2023 cost- and revenue-sharing arrangement. Quantitatively, all key figures are accurate: the 60/40 cost split (Gilead/Merck), the $2.0 billion threshold for oral products, $3.5 billion for injectable, and the shift to a 65% revenue share for Gilead above those thresholds. The 50/50 baseline revenue split is also correctly stated. However, there is a discrepancy in commercialization rights: the original answer states GILD has U.S. rights for long-acting oral products and Merck leads in EU/ROW, while the LLM claims a split where Gilead leads U.S. oral but Merck leads EU oral — and further introduces a U.S. injectable/EU injectable split not present in the ground truth. This misrepresents the geographic-commercialization structure, which was specifically defined by region (U.S. vs. EU/rest of world), not by dosage form leadership per region. This is a notable but not critical error, as the core financial and strategic evolution is correctly conveyed. The multi-hop reasoning is sound—linking 2022 collaboration to 2023 expansion—and the answer addresses cost-sharing, commercialization, and revenue thresholds as required. Wording differences are acceptable under semantic equivalence, but the incorrect breakdown of commercialization rights prevents a top score. Contextual relevance is excellent, directly addressing all aspects of the question with appropriate detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 419,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did the conversion and subsequent sale of the VIL OCDs in 2024 impact AMT's financial position compared to their initial disclosure and valuation of these instruments in 2023?",
      "original_answer": "In 2023, AMT disclosed the VIL OCDs with a face value of 16.0 billion INR (approximately $193.2 million) and a fair value of $116.5 million, reflecting uncertainty in collections from VIL. By 2024, AMT converted 14.4 billion INR (approximately $172.7 million) of the VIL OCDs into VIL equity and sold both the equity and the remaining OCDs, realizing total net proceeds of approximately $238.0 million and a gain of $46.4 million. This represents a significant improvement in AMT's financial position compared to the initial valuation in 2023, where the fair value was significantly below face value due to collection risks.",
      "llm_answer": "In 2023 the VIL OCDs were recorded as a financial asset at fair value of about $116.5 million (included in pre‑paid and other current assets, page 98).  In 2024 the company converted 14.4 billion INR of the OCDs into 1,440 million VIL shares, sold those shares for roughly $216 million, and sold the remaining 1.6 billion INR of OCDs for about $22 million, realizing a $46.4 million gain recorded in loss from discontinued operations (page 119).  The conversion and sale removed the OCDs from the balance sheet, increased cash by roughly $238 million, and improved AMT’s liquidity and profitability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually correct in all key aspects. It accurately reports the 2023 fair value of $116.5 million, the 2024 conversion of 14.4 billion INR of OCDs, the sale of equity for $216 million, the sale of remaining 1.6 billion INR OCDs for $22 million, and the total net proceeds of $238 million (sum of $216M + $22M). The gain of $46.4 million is correctly stated and matches the ground truth. The face value of 16.0 billion INR (approx. $193.2M) is implied through the sum of converted and sold portions. (2) All numbers are quantitatively accurate. The $238 million in total proceeds is correctly derived from $216M + $22M. The gain of $46.4M is consistent with the difference between the $116.5M carrying value and $238M proceeds (net gain ~$121.5M before adjustments), but the $46.4M gain is explicitly confirmed in the ground truth and correctly repeated. Minor rounding differences (e.g., $172.7M vs $172.8M implied from 14.4B INR) are acceptable and within tolerance. (3) The multi-hop reasoning is sound: the model connects the 2023 valuation (fair value below face due to risk) to the 2024 conversion and sale, and correctly infers the positive impact on liquidity and profitability. The removal of the asset from the balance sheet and increase in cash are logical and relevant. (4) The only minor shortcoming is that the LLM does not explicitly contrast the $238M proceeds with the initial $116.5M fair value to emphasize the magnitude of improvement as clearly as the ground truth does, but the implication is present. Otherwise, the answer is complete, accurate, and contextually precise, citing correct financial statements and accounting treatment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 461,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did the voting power distribution between Class A and Class B common stock at CMCSA change from 2023 to 2024, and what was the impact on the relative influence of each class in corporate governance decisions?",
      "original_answer": "In 2023, CMCSA disclosed that Class A common stock was registered under Section 12(b) of the Act with a par value of $0.01. By 2024, the company reported that holders of Class A common stock collectively held 66 2/3% of the combined voting power, while Class B common stock, which had 15 votes per share, held 33 1/3% of the combined voting power. Additionally, in 2024, there were 9,444,375 shares of Class B common stock issued and outstanding, compared to 4,651,093,045 issued shares of Class A common stock. This indicates that while Class A shares significantly outnumbered Class B shares, the super-voting rights of Class B stock (15 votes per share) preserved a concentrated governance influence, with Mr. Brian L. Roberts owning all Class B shares. This structure maintained a balance where Class A shareholders had majority voting power numerically, but Class B retained outsized influence per share.",
      "llm_answer": "In 2024, Class A common stock accounted for 66.3 % of the combined voting power while Class B common stock represented 33.3 % (each Class B share carries 15 votes)【page 31】. The 2023 filing reported the same split, so the relative influence of the two classes did not change: Class A retained majority control, and Class B, though a minority, still held a substantial voting stake that can influence governance decisions, particularly because it is held by a single beneficial owner.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the 2024 voting power distribution (66.3% for Class A and 33.3% for Class B), which aligns with the ground truth (66 2/3% and 33 1/3%). However, it incorrectly states that the 2023 filing reported the same split. The original answer indicates no such data was provided for 2023 beyond the registration of Class A stock under Section 12(b) — there was no disclosure of voting power distribution in 2023. Therefore, the claim that the split was the same is unsupported and factually incorrect. (2) The numeric values are approximately accurate (66.3% ≈ 66 2/3%, 33.3% ≈ 33 1/3%), so quantitative accuracy is acceptable with rounding, but the key error lies in asserting continuity from 2023 without evidence. The number of outstanding shares and the 15-vote per share right for Class B are omitted, reducing completeness. (3) The multi-hop reasoning is flawed: the model assumes no change because both years show the same percentages, but the original answer does not provide 2023 voting power data — thus, no valid comparison can be made. The conclusion about unchanged influence is therefore based on an incorrect inference. (4) Despite the reasoning flaw, the answer is contextually relevant and captures part of the governance dynamic (Class A majority control, Class B concentrated influence). However, missing key details (Mr. Brian L. Roberts owning all Class B shares, exact share counts) and making an unsupported claim about 2023 reduces correctness significantly. Scores reflect partial factual accuracy but major gaps in reasoning and completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 440,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did MetLife's Level 3 asset category exposure through separate accounts evolve from 2022 to 2023, and what does this indicate about their risk profile in alternative investments?",
      "original_answer": "In 2022, MetLife reported $2,131 million in Level 3 assets categorized under separate accounts, which decreased to $1,147 million by the end of 2023. This reduction indicates a significant de-risking move in their alternative investment portfolio, particularly in assets with limited price transparency and higher liquidity risk. The Level 3 asset category explicitly includes separate accounts invested in assets that provide little or no price transparency due to infrequent trading and longer liquidation periods. The $984 million decline in separate accounts categorized under Level 3 suggests MetLife actively reduced exposure to opaque, illiquid investments over this period.",
      "llm_answer": "MetLife’s Level 3 exposure in separate accounts fell from **$1,210 million** at December 31 2022 to **$1,147 million** at December 31 2023, a decline of roughly $63 million (≈ 5 %). This downward trend indicates a modest tightening of its alternative‑investment holdings, suggesting a slightly lower risk profile in those less liquid, unobservable‑input assets【page 275】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key numerical values. The original answer states that MetLife's Level 3 assets in separate accounts were $2,131 million in 2022, but the LLM reports $1,210 million—a major discrepancy of $921 million. The 2023 value ($1,147 million) is correctly reported. The calculated decline is therefore wrong: LLM reports a $63 million drop (≈5%), while the actual decrease is $984 million (≈46%), which is a substantial de-risking, not a modest tightening. (2) Calculations are based on incorrect inputs: $1,210M → $1,147M is indeed ~5% decrease, but since the starting value is wrong, the entire quantitative analysis is flawed. The correct calculation is $2,131M - $1,147M = $984M decrease, or ~46% reduction. (3) The reasoning and synthesis are partially sound—LLM correctly interprets decreasing Level 3 assets as indicating reduced risk in alternative investments and links Level 3 to illiquidity and unobservable inputs. However, it underestimates the magnitude and strategic significance due to incorrect numbers. The term 'modest tightening' and 'slightly lower risk' mischaracterize what the ground truth describes as a 'significant de-risking move.' (4) Contextual relevance is high—the answer addresses both parts of the question (evolution from 2022 to 2023 and risk implications), uses correct entities (MetLife, Level 3 assets, separate accounts, alternative investments), and cites a plausible source. However, the severe numerical inaccuracy undermines factual correctness, warranting a low correctness score despite proper structure and intent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 445,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did SPG's strategic investment activity in ABG during 2023 influence its ownership stake in SPARC Group by 2024, and what were the financial implications of these changes on SPG's gains from equity interest disposals?",
      "original_answer": "In 2023, SPG participated in multiple capital transactions with ABG, including the sale of portions of its ABG interest and additional dilution events, which led to a decrease in SPG’s ownership in SPARC Group from 33.3% to an approximate 9.6% by 2024. These transactions resulted in significant gains for SPG, including a $145.8 million non-cash pre-tax gain from SPARC Group’s equity issuance in 2023 and a $414.8 million pretax gain from the full disposal of its ABG stake in 2024. The financial implications reflect SPG’s strategic shift to monetize its investments in ABG and SPARC Group, yielding over $560 million in combined gains, while reducing its exposure to these ventures.",
      "llm_answer": "SPG’s 2023 ABG activity—selling a portion of its ABG stake and enduring ABG capital transactions—diluted its ABG ownership from 12.3% to 9.6% (page 64) but did not alter its 33.3 % non‑controlling interest in SPARC Group, which remained unchanged into 2024 (page 73). The ABG sale generated a $157.1 million pre‑tax cash gain, while the ABG capital transactions added non‑cash pre‑tax gains of $10.3 million, $12.4 million and $36.4 million; together with a $145.8 million non‑cash gain from SPARC Group’s equity issuance, these were recorded in SPG’s gains from equity interest disposals (pages 73, 73).",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains multiple factual inaccuracies. It incorrectly states that SPG's ownership in SPARC Group remained unchanged at 33.3% into 2024, while the ground truth confirms it decreased from 33.3% to approximately 9.6% due to dilution and disposal activities. This is a critical error in both entity and quantitative accuracy. Additionally, the LLM claims SPG’s ABG ownership dropped from 12.3% to 9.6%, but the original answer does not specify an initial ABG ownership percentage—only the resulting SPARC Group stake—making this detail unsupported. (2) The financial figures are partially correct but largely misattributed. The $145.8 million non-cash gain from SPARC Group’s equity issuance is accurately mentioned, but the LLM invents additional non-cash gains of $10.3M, $12.4M, and $36.4M not present in the ground truth. It also reports a $157.1 million pre-tax cash gain from ABG stake sale, which contradicts the ground truth’s $414.8 million pretax gain from full disposal in 2024. The total gains in the original answer exceed $560 million, but the LLM’s sum (~$214.2M) is significantly lower and based on incorrect components. (3) The multi-hop reasoning is flawed: the LLM fails to connect SPG’s ABG transactions to the dilution of its SPARC Group ownership, incorrectly asserting no change in SPARC stake. This breaks the causal chain required by the question. The original answer correctly links capital transactions in ABG to reduced SPARC ownership and monetization outcomes. (4) Contextual relevance is moderate—the response addresses strategic investment activity and financial implications, but with incorrect data and reasoning. Due to major errors in core facts, calculations, and synthesis, the correctness score is low despite some accurate elements like the mention of the $145.8M gain.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 497,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did the structure and terms of Altria's debt guarantees by PM USA evolve from 2022 to 2023, particularly in light of new debt issuances and changes in guarantee conditions?",
      "original_answer": "In 2022, PM USA fully and unconditionally guaranteed Altria's obligations under its debt securities, with guarantees subject to release under certain customary circumstances, such as a change in control or repayment of obligations. By 2023, Altria issued $1.0 billion in new senior unsecured notes, which were also covered under the PM USA guarantees. Notably, the 2023 debt terms included a requirement for Altria to repurchase the notes at 101% of principal if both a change of control occurred and the notes were downgraded below investment grade by all three major rating agencies. This condition was not explicitly mentioned in the 2022 documentation, indicating a tightening of guarantee terms in response to potential credit risk. Additionally, in 2023, Altria filed a new shelf registration (Form S-3) allowing for future debt issuances, which would also fall under PM USA's guarantee framework.",
      "llm_answer": "PM USA’s guarantee remained an absolute, unconditional primary‑obligor guarantee in both 2022 and 2023, with release upon consolidation, full payment or an S&P rating of A or higher【page_51】.  The 2023 filing simply broadened the scope of the guarantee to cover the new $1 billion USD senior‑unsecured notes issued in November 2023 and the new 5‑year revolving credit agreement, in addition to the debt securities, credit‑agreement borrowings and commercial‑paper program that were already guaranteed in 2022【page_74】【page_72】【page_73】.  Thus, while the fundamental terms and release conditions did not change, the guarantee now encompasses the additional debt instruments issued in 2023.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but misses a key qualitative change in the guarantee terms from 2022 to 2023, which significantly affects the correctness score. (1) Quantitatively, the answer correctly identifies the $1.0 billion in new senior unsecured notes issued in 2023 and accurately references the continuation of PM USA's guarantee. The mention of the November 2023 issuance aligns with the timeline, and the inclusion of new debt instruments under the guarantee is factually sound. (2) However, the answer incorrectly claims that 'the fundamental terms and release conditions did not change,' which contradicts the ground truth. The 2023 debt introduced a new mandatory repurchase condition at 101% of principal if both a change of control occurs and the notes are downgraded below investment grade by all three major rating agencies—a material tightening of terms not present in 2022. This omission represents a failure in multi-hop reasoning and qualitative accuracy. (3) The LLM also cites a release condition based on an 'S&P rating of A or higher,' which is more specific than the ground truth's reference to 'customary circumstances' and may reflect over-narrowing or misinterpretation of the release provisions. While the guarantee expansion to cover new instruments is correctly noted, the failure to identify the enhanced credit-risk protections in 2023 undermines the reasoning. (4) Contextually, the response is highly relevant and well-structured, addressing the evolution of guarantees and new issuances. However, the absence of the critical 101% repurchase clause—a central element in the evolution of guarantee conditions—means the answer does not fully capture the tightening of terms, leading to a moderate correctness score despite strong quantitative and contextual performance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 488,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did the increase in LMT's reach-forward losses on fixed-price contracts in 2023 relate to the risk of cost overruns, and how did this impact their 2024 financial performance on similar contracts?",
      "original_answer": "In 2023, LMT reported cumulative reach-forward losses of $270 million on a classified fixed-price incentive fee contract in their Aeronautics segment and $280 million on a ground-based radar program in their RMS segment. These losses were driven by technical and performance challenges under fixed-price contracts, where cost overruns directly impacted profitability. Fixed-price contracts inherently carry the risk that estimated completion costs may exceed contract value, especially in development programs with complex design and systems integration. In 2024, LMT acknowledged continued exposure to cost overruns on fixed-price development and production contracts, noting that such risks could lead to reduced margins, reach-forward losses, or even decisions not to bid on future programs. This evolution shows a direct temporal link: LMT's 2023 experience with cost overruns under fixed-price contracts led to heightened awareness and risk disclosures in 2024, reflecting a strategic recalibration in how the company approaches fixed-price bidding and cost estimation.",
      "llm_answer": "In 2023, LMT’s reach‑forward losses on fixed‑price contracts rose because the estimated total costs to complete those contracts exceeded the transaction price, a direct consequence of the risk of cost overruns on complex, fixed‑price programs (see page 63–64).  The 2024 MD&A notes that the same risk remains for similar fixed‑price contracts, warning that cost overruns could erode margins and increase losses, thereby affecting 2024 operating results (page 13).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the cause of reach-forward losses in 2023 as cost overruns on fixed-price contracts due to estimated costs exceeding transaction price, and notes the continued risk in 2024, which aligns with the ground truth. However, it omits the specific dollar amounts of the losses ($270M in Aeronautics and $280M in RMS), which are key quantitative details from the original answer. The absence of these figures significantly reduces quantitative accuracy. (2) While the LLM references 'page 63–64' and 'page 13' as sources, these page numbers are not part of the ground truth and may reflect hallucination or unsupported specificity, though they do not invalidate the content. More critically, the exact financial figures—central to the question’s multi-hop analysis—are missing, preventing full verification of completeness and accuracy. (3) The reasoning is sound: the model correctly links 2023 cost overruns to 2024 financial risks, showing an understanding of the temporal and causal relationship between past losses and future exposure. It captures the inherent risk in fixed-price contracts and their impact on margins and operating results, demonstrating good qualitative synthesis. (4) Contextually, the answer is highly relevant, addressing both the cause of 2023 losses and their forward-looking implications for 2024. However, the lack of specific numbers prevents a higher correctness score, as the original answer hinges on precise disclosures. The model conveys the general mechanism correctly but fails to deliver the full factual depth required for a top score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 443,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Southern Company's limited $2 million NOL carryforward in South Carolina (as of 2022) influence its continued 50% investment in SNG's natural gas pipeline infrastructure in 2023, particularly given SNG's role in supplying gas to that same state?",
      "original_answer": "Southern Company's 2022 10-K shows only a $2 million net operating loss (NOL) carryforward remaining in South Carolina set to expire in 2036, indicating limited future tax benefits remaining in the state. Despite this constrained tax position, Southern Company maintained its 50% joint venture interest in SNG - a major natural gas pipeline supplying South Carolina from Gulf Coast basins - as confirmed in the 2023 10-K filing. This continued infrastructure investment suggests strategic prioritization of South Carolina's energy market despite limited remaining tax carryforwards, with SNG's pipeline network remaining critical for delivering natural gas supplies to the state's growing customer base.",
      "llm_answer": "Southern Company’s 2022 balance sheet shows a $2 million net‑state NOL carryforward for South Carolina that was expected to expire in 2036 (page 278).  The 2023 filing confirms the company retained its 50 % ownership in SNG, a 7,000‑mile pipeline that supplies gas to South Carolina (page 278).  The modest NOL carryforward likely provided only a small tax benefit and did not materially influence the decision to keep the 50 % stake; the investment was driven primarily by strategic supply considerations for the state’s gas customers.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts: Southern Company had a $2 million NOL carryforward in South Carolina as of 2022, set to expire in 2036, and maintained its 50% ownership in SNG in 2023. These numbers and dates match the ground truth exactly, with acceptable formatting variations (e.g., '2036' and '$2 million'). (2) Quantitative accuracy is perfect: all dollar amounts, percentages, and expiration dates are correct. The reference to page 278 in both years’ filings aligns with the source data, though not explicitly required. (3) The multi-hop reasoning is sound—linking the limited NOL (tax consideration) with the continued investment in SNG (strategic infrastructure), and correctly concluding that tax benefits were minimal and not a primary driver. The LLM infers 'strategic supply considerations' as the main driver, which is logically consistent with the ground truth’s emphasis on SNG’s critical role in supplying South Carolina. (4) The only minor shortcoming is that the LLM does not explicitly mention SNG’s role in supplying gas from Gulf Coast basins or the 'growing customer base' context, slightly reducing qualitative completeness. However, the core reasoning and factual synthesis remain highly accurate. Thus, the answer is semantically equivalent and contextually appropriate, warranting high scores across all dimensions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 383,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did the expiration timeline of key patent rights in 2023 influence LLY's projected market exclusivity periods for major products in 2024?",
      "original_answer": "In 2023, LLY highlighted that the loss of patent protection typically results in rapid revenue declines due to generic competition, especially in the U.S., and that delays in regulatory approval or market access can limit the ability to capitalize on exclusivity periods. The company also noted that in December 2023, a proposed U.S. framework could allow the federal government to exercise 'march-in rights' on drugs developed with federal funds, potentially undermining patent protection. In 2024, LLY disclosed that the market exclusivity for major products depends on a complex interaction between patent and regulatory protections, with specific expiry dates listed for each product. However, the uncertainty around patent litigation and the potential impact of regulatory changes from 2023 (like the proposed march-in rights) introduced risk into the predictability of those exclusivity timelines. This shows a direct causal chain where the earlier patent risk environment (2023) affects how LLY assesses and discloses its market exclusivity outlook (2024) through the lens of evolving regulatory and legal dynamics.",
      "llm_answer": "Key patents that expired in 2023—such as Trulicity’s data‑protection and the compound patents for Pomalyst/Imnovid—shorten the projected market‑exclusivity window for those products.  In the 2024 filing, the exclusivity table (page 10) shows that Pomalyst/Imnovid and Trulicity are expected to lose exclusivity in 2024, exposing them to generic competition and potentially accelerating revenue erosion.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains some factual inaccuracies and misses key elements of the multi-hop reasoning required. (1) It incorrectly states that Trulicity and Pomalyst/Imnovid lost exclusivity in 2024 due to patent expirations in 2023, but the ground truth does not confirm specific patent expirations in 2023 for these products or exclusivity loss in 2024—instead, it emphasizes uncertainty around exclusivity timelines due to regulatory and legal dynamics. (2) The mention of a 2024 filing with an 'exclusivity table on page 10' introduces specific details not present in the ground truth, which does not reference any such table or page number, raising concerns about hallucination. (3) The original answer focuses on the broader impact of the 2023 patent risk environment—especially the proposed 'march-in rights' framework and general risks from generic competition—not specific product patent expirations. The LLM fails to capture this systemic, forward-looking risk assessment and instead narrows the response to specific products and expiries not supported by the ground truth. (4) While the general idea that patent expiration leads to generic competition is correct, the LLM misrepresents the causal chain: the original emphasizes how 2023's evolving legal/regulatory landscape (not actual patent expirations) introduced uncertainty into 2024's exclusivity projections. Thus, while the answer is contextually relevant and uses plausible examples, it lacks factual and qualitative accuracy in both entities and reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 417,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did the relative contribution of Nike's Apparel segment to total revenues in 2022 compare to Converse's contribution in 2024, and what does this reveal about the strategic positioning of Converse within Nike's broader brand structure?",
      "original_answer": "In 2022, Nike's Apparel segment contributed $13.567 billion (or 30.5%) to total Nike Brand revenues of $44.436 billion, showing its central role in Nike's core business. By 2024, Converse contributed $2.082 billion (or 4.2%) to total Nike Inc. revenues of $51.362 billion. While Apparel remained a dominant part of Nike's core brand, Converse's smaller share suggests it continued to operate as a distinct lifestyle brand rather than being fully integrated into Nike's athletic apparel dominance. The operating segments note clarifies that Converse is managed separately as its own reportable segment, even though it's 'included within the NIKE Brand for presentation purposes,' indicating a deliberate strategy to maintain Converse's unique brand identity despite shared infrastructure.",
      "llm_answer": "Nike’s Apparel line generated $13,567 million of the $46,710 million total Nike, Inc. revenue in 2022, or about **29 %** of overall sales.  In 2024 Converse produced $2,082 million of the $51,362 million total, roughly **4 %** of Nike’s revenue.  The large gap shows Converse is a smaller, niche lifestyle brand that complements Nike’s core athletic portfolio rather than driving the bulk of the company’s sales.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer correctly identifies the Converse 2024 revenue contribution ($2.082 billion, 4%) and the general strategic contrast between Nike Apparel and Converse. However, it contains a significant quantitative error in the 2022 Nike Apparel segment calculation: it states Apparel contributed $13,567 million (correct) to $46,710 million total revenue (incorrect). The ground truth states total Nike Brand revenue in 2022 was $44.436 billion, not $46.710 billion. This leads to an incorrect percentage of 29% instead of the correct 30.5%. The $46.710 billion figure appears to be total Nike Inc. revenue, not Nike Brand revenue, indicating a misalignment in entity scope.\n\n2) The Converse numbers for 2024 are accurate: $2.082 billion out of $51.362 billion is correctly rounded to 4%. However, the Apparel percentage is miscalculated due to using the wrong denominator. The correct calculation is $13.567B / $44.436B = 30.5%, not 29%.\n\n3) The reasoning is sound in interpreting the strategic positioning: the LLM correctly infers that Converse is a niche lifestyle brand complementing Nike’s core athletic business. It captures the essence of the multi-hop comparison—evaluating relative segment contributions across years and brands. However, it misses the key structural detail from the ground truth that Converse is a separate reportable segment 'included within the NIKE Brand for presentation purposes,' which strengthens the strategic argument. This omission reduces completeness.\n\n4) Despite the numerical inaccuracy in the denominator and resulting percentage, the LLM reaches a qualitatively reasonable conclusion. The answer is contextually relevant and addresses both parts of the question—comparison of contributions and strategic interpretation. The error is in financial scope alignment (Nike Brand vs. Nike Inc. revenue), not a complete factual breakdown. Hence, a score of 7 is justified: core facts are mostly correct, but with a notable quantitative flaw affecting precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 537,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did the redemption of Nuance's convertible senior notes between 2022 and 2023 impact Microsoft's balance sheet liabilities, given the remaining $1 million classified as current liabilities in 2022 and the statement that 'substantially all' were redeemed by 2023?",
      "original_answer": "In 2022, Microsoft reported that $985 million of the $986 million in Nuance-issued convertible senior notes had been redeemed, with the remaining $1 million classified as current liabilities. By 2023, Microsoft disclosed that 'substantially all' of these notes had been redeemed. This indicates a near-complete reduction in this specific liability between the two fiscal years, contributing to a decrease in Microsoft's short-term debt obligations. The evolution of this liability reflects progress in Microsoft's post-acquisition financial integration and debt management strategy related to the Nuance acquisition.",
      "llm_answer": "In 2022 Microsoft reported $1 million of Nuance convertible senior notes as other current liabilities (Note 8, page 78). By 2023 the company had redeemed “substantially all” of those notes (Note 8, page 77), eliminating that $1 million liability and reducing its current—and overall—liabilities by the same amount, a change that was immaterial to the balance sheet.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $1 million liability in 2022 and states that 'substantially all' of the Nuance convertible senior notes were redeemed by 2023, aligning with the ground truth. However, it omits key quantitative context from the original answer: in 2022, $985 million of $986 million in total notes had already been redeemed, leaving only $1 million outstanding. The LLM implies the entire liability was $1 million, which understates the total note amount and redemption scale. This is a significant omission affecting quantitative accuracy. (2) The $1 million figure is accurate and correctly classified as current liabilities, and the statement about 'substantially all' being redeemed by 2023 matches the original. But the LLM incorrectly suggests the entire liability was only $1 million, when that was just the remaining balance—missing the $985 million redemption context. Calculations are not performed, so no errors there, but the framing misrepresents the scale. (3) The reasoning is logically sound—liability removed, balance sheet impact noted—but fails to fully synthesize the multi-hop aspect: (a) Nuance issued the notes, (b) Microsoft assumed them post-acquisition, (c) most were redeemed before 2022, (d) only $1M remained, (e) that too was mostly eliminated by 2023. The LLM captures (d) and (e) but misses (a)-(c), weakening completeness. (4) Despite missing key context, the answer is relevant and correctly interprets the balance sheet impact of the $1M liability removal, calling it immaterial—consistent with likely financial significance. Scores reflect mostly correct facts but a materially incomplete quantitative picture.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 459,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did SPG's strategic investment in SPARC Group in 2022 influence its stake in ABG by the end of 2023, and what were the financial implications of these changes?",
      "original_answer": "In 2022, SPG held a 33.3% noncontrolling interest in SPARC Group, which had a strategic partnership with ABG as Reebok's core licensee in the U.S. During 2023, SPG experienced multiple dilutions in its ABG stake, dropping from 12.3% in Q2 to 9.6% by year-end, resulting in a cumulative non-cash pre-tax gain of $59.1 million from the deemed disposals. These changes were directly linked to SPG's earlier investment in SPARC Group, which acted as a conduit for SPG's broader exposure to ABG. The financial implications included deferred tax expenses totaling $14.8 million and a reduction in SPG's carrying amount of ABG from $767.5 million in 2022 to $733.2 million by December 31, 2023.",
      "llm_answer": "SPG’s 2022 investment in SPARC Group (a 33.3 % non‑controlling stake) gave it an indirect interest in ABG through SPARC’s strategic partnership with ABG. By year‑end 2023, ABG’s capital transactions had diluted SPG’s ABG ownership from about 12.3 % to roughly 11.7 %, and SPG recorded non‑cash pre‑tax gains of $12.4 million and $36.4 million on deemed disposals, plus a cash sale of ABG interest that produced $300.2 million in proceeds and a $157.1 million pre‑tax gain, reducing the carrying amount of the ABG investment to $733.2 million.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in key quantitative metrics. While it correctly identifies SPG's 33.3% non-controlling interest in SPARC Group in 2022 and SPARC's strategic partnership with ABG, it incorrectly states SPG's diluted ABG stake at year-end 2023 as 'roughly 11.7%', whereas the ground truth specifies a drop to 9.6% (from 12.3% in Q2). This is a major deviation. (2) The financial figures are largely incorrect: the LLM reports non-cash pre-tax gains of $12.4M and $36.4M (totaling $48.8M) plus a cash sale generating $157.1M gain, but the ground truth states a single cumulative non-cash pre-tax gain of $59.1M from deemed disposals—no cash sale is mentioned. The LLM invents a $300.2M cash proceeds event not present in the original. While the final carrying amount of $733.2M is correctly reported, the path to it is factually wrong. (3) The multi-hop reasoning is partially sound—linking SPG’s investment in SPARC to indirect exposure to ABG is correct, and recognizing dilution effects is valid—but the model fails to accurately trace the financial implications, introducing events (cash sale) and gains not supported by the data. (4) Contextual relevance is high as the answer addresses both the stake evolution and financial impacts, but correctness is severely undermined by incorrect numbers and fabricated transactions. Quantitative accuracy is low due to multiple wrong percentages and dollar amounts; qualitative accuracy is moderate due to correct entity relationships but flawed event synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 432,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Exxon Mobil's stake in Syncrude through Imperial Oil Limited in 2022 compare to its stake in Imperial Oil Limited directly in 2024, and what does this imply about the consistency of its upstream oil sands strategy?",
      "original_answer": "In 2022, Exxon Mobil had a 69.6% interest in Imperial Oil Limited, which in turn held a 25% stake in Syncrude, contributing to a synthetic crude oil production of 62 thousand barrels per day. In 2024, Exxon Mobil maintained the same 69.6% interest in Imperial Oil Limited, and the production levels from Syncrude remained consistent at 62 thousand barrels per day. This indicates that Exxon Mobil preserved its upstream oil sands strategy through a consistent ownership structure in Imperial Oil Limited, which in turn maintained its stake in Syncrude, ensuring stable production levels over the two-year period.",
      "llm_answer": "In 2022, Exxon Mobil’s indirect stake in Syncrude was the result of its 69.6 % ownership of Imperial Oil, which holds a 25 % interest in Syncrude—giving Exxon Mobil roughly a 17.4 % indirect stake in Syncrude (page 22).  In 2024, Exxon Mobil’s direct stake in Imperial Oil remained 69.6 % (page 18).  The unchanged ownership level in Imperial Oil and the continued indirect interest in Syncrude demonstrate a consistent upstream oil‑sands strategy, with the company maintaining a substantial share of its key oil‑sands joint ventures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Exxon Mobil's 69.6% ownership in Imperial Oil Limited in both 2022 and 2024, matching the ground truth. It accurately notes Imperial Oil's 25% stake in Syncrude and calculates Exxon's indirect stake as 17.4% (69.6% × 25%), which is a valid synthetic calculation not explicitly stated in the original answer but logically sound. The production figure of 62 thousand barrels per day is omitted in the LLM answer, which is a minor gap in completeness. (2) All numeric values—69.6%, 25%, 17.4%, and the years 2022 and 2024—are correct and properly contextualized. The calculation of the indirect stake is accurate. (3) The multi-hop reasoning is strong: the model correctly links Exxon → Imperial Oil → Syncrude, and infers strategic consistency from stable ownership, which aligns with the original answer’s conclusion. The implication about upstream oil sands strategy is logically derived and semantically equivalent. (4) The answer is highly relevant, directly addressing both the comparative stake question and the strategic implication. The only minor shortcoming is the omission of the 62 kb/d production figure, which slightly reduces completeness but does not affect the core correctness. Hence, a 9 is justified for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 383,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did the voting power dynamics between CMCSA's Class A and Class B common stock in 2022 evolve by 2023, and what does the unchanged 66 2/3% voting allocation for Class A shares indicate about the company's ownership structure stability?",
      "original_answer": "In 2022, CMCSA's Class A common stock held 66 2/3% of the combined voting power, while Class B common stock held 33 1/3%, with each Class B share carrying 15 votes and the Class A voting power being dependent on the number of shares outstanding. By 2023, this structure remained unchanged, with Class A still holding 66 2/3% of the voting power, indicating that despite 4,842,108,959 Class A shares being issued (vs. 5,083,466,045 in 2022), and only 9,444,375 Class B shares outstanding, the ownership structure was intentionally preserved. This suggests that the company maintained a dual-class structure to ensure continued control by the Class B shareholders, such as Brian L. Roberts, while allowing broader public ownership through Class A shares.",
      "llm_answer": "Between 2022 and 2023 Comcast’s voting structure stayed the same: Class A shares continued to hold 66 ⅔ % of the company’s voting power while Class B retained 33 ⅓ % (2022 10‑K, page 38; 2023 10‑K, page 91).  Although the number of Class A shares fell from 4,211 million to 3,969 million due to repurchases (2023 10‑K, page 91), the 66 ⅔ % allocation remained unchanged, underscoring that the ownership structure is stable and that Class B’s voting power is protected from dilution (2023 10‑K, page 91).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that the voting power allocation remained unchanged between 2022 and 2023, with Class A holding 66 2/3% and Class B 33 1/3%, which matches the ground truth. However, it contains significant quantitative inaccuracies: it reports Class A shares outstanding as 4,211 million in 2022 and 3,969 million in 2023, whereas the ground truth states 5,083,466,045 in 2022 and 4,842,108,959 in 2023. These figures are materially different (off by over 200 million shares), suggesting incorrect data extraction from the 10-Ks. Additionally, the LLM attributes the decrease to share repurchases, which may be contextually plausible but is not confirmed in the ground truth, which does not explain the reason for the change in shares outstanding. (2) The calculation of voting power percentages is correct and consistent across years, but the share count numbers are not accurate, undermining confidence in the data source interpretation. (3) The reasoning about the stability of the ownership structure and protection of Class B voting power is sound and aligns with the multi-hop inference required—the model correctly infers that unchanged voting allocations despite changes in share counts indicate structural stability. It also appropriately references the dual-class structure’s purpose in preserving control, though it omits mention of Brian L. Roberts specifically, a key detail in the original answer. (4) The contextual relevance is high—the answer addresses both parts of the question: evolution of voting dynamics and implications of stability. However, due to the incorrect share numbers and lack of precision in reporting exact figures, the quantitative accuracy score is reduced. The qualitative reasoning remains strong, earning a 7, while correctness is penalized to 6 due to factual discrepancies in reported share counts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 507,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did Duke Energy's classification and accounting treatment of debt investments under AFS evolve from 2022 to 2023, particularly in relation to unrealized gains, losses, and regulatory deferrals?",
      "original_answer": "In 2022, Duke Energy classified debt investments as AFS, with unrealized gains and losses included in other comprehensive income until realized. By 2023, this classification remained consistent, but Duke Energy expanded its disclosure to clarify that substantially all AFS debt investments qualify for regulatory accounting, with unrealized gains and losses deferred as regulatory assets or liabilities. Additionally, in 2023, Duke Energy specifically noted that there were no material credit losses as of December 31, 2023, compared to the more general disclosure in 2022. This indicates a more detailed and refined reporting approach in 2023 while maintaining the same core accounting policy.",
      "llm_answer": "From 2022 to 2023 Duke Energy kept all debt securities classified as available‑for‑sale (AFS) and applied the same accounting policy—unrealized gains and losses were recorded in other comprehensive income until realized, then moved to net income, with all gains/losses deferred as regulatory assets or liabilities [page_191, page_184]. However, the 2023 year reversed the 2022 net unrealized gain to a net unrealized loss (e.g., Duke Energy’s AFS debt showed $39 m gains and $6 m losses in 2022 versus $12 m gains and $43 m losses in 2023) which increased the regulatory liability balance relative to 2022 [page_192, page_186].",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. While it correctly states that Duke Energy maintained AFS classification from 2022 to 2023 and that unrealized gains/losses are recorded in other comprehensive income and deferred as regulatory assets/liabilities, it fabricates specific numerical figures—$39M gains and $6M losses in 2022, $12M gains and $43M losses in 2023—that are not present in the ground truth. The original answer makes no mention of these exact numbers, nor does it state a reversal from net gain to net loss. These figures appear to be invented or misattributed, severely undermining quantitative accuracy. (2) There is no verification that these numbers match actual disclosures; in fact, the ground truth emphasizes qualitative changes in disclosure (e.g., clarification of regulatory treatment and absence of material credit losses in 2023), not specific dollar amounts. The LLM incorrectly introduces numerical comparisons that do not appear in the original, failing the quantitative accuracy check. (3) On reasoning, the LLM captures the continuity in classification and regulatory deferral, which shows partial multi-hop understanding. However, it misses the key qualitative evolution in 2023: the expanded disclosure about regulatory accounting applicability and the explicit statement on no material credit losses. Instead, it substitutes this with a false quantitative narrative about changing gains/losses, indicating flawed synthesis. (4) Contextual relevance is high because the answer addresses the right topic—AFS treatment, regulatory deferrals, and year-over-year changes—but the inclusion of fabricated data and omission of the actual disclosed enhancements in 2023 reporting reduces correctness. The core policy continuity is noted, but the evolution in disclosure quality is misrepresented. Thus, while contextually aligned, the answer is factually unreliable.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 531,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did Duke Energy's classification and treatment of debt investments under AFS accounting evolve from 2022 to 2023, particularly in relation to unrealized losses and regulatory deferrals?",
      "original_answer": "In 2022, Duke Energy classified debt investments as AFS, with unrealized gains and losses included in other comprehensive income until realized. By 2023, the company maintained this classification but introduced a distinction for debt securities within Investment Trusts, where unrealized losses were immediately recognized and deferred to regulatory accounts due to lack of control over day-to-day management. Additionally, in 2023, Duke Energy emphasized its quarterly analysis of investment holdings to identify credit losses, though no material credit losses were reported in either 2022 or 2023.",
      "llm_answer": "Duke Energy kept all debt securities classified as available‑for‑sale (AFS) and continued to record unrealized gains and losses in OCI until realized, with every gain or loss deferred to regulatory accounts (see Note 15 in 2022 and Note 16 in 2023).  The total unrealized losses on AFS debt fell sharply—from $128 million in 2022 to $35 million in 2023 (see the “Gross Unrealized Holding Losses” columns on pages 192 and 184)—while the company reported no material credit losses, so the regulatory deferral policy remained unchanged.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains some correct elements but misses key qualitative distinctions from the ground truth. It correctly states that Duke Energy maintained AFS classification and recorded unrealized gains/losses in OCI, and notes the absence of material credit losses in both years. However, it incorrectly claims that *all* unrealized gains and losses were deferred to regulatory accounts, which contradicts the 2022 practice described in the ground truth (where deferrals were not standard). More importantly, it fails to mention the critical 2023 change: the new distinction for debt securities in Investment Trusts where unrealized losses were *immediately recognized and deferred* due to lack of control—this is a central part of the evolution and is entirely omitted. (2) Quantitatively, the LLM provides specific numbers ($128M to $35M unrealized losses), which are plausible and may align with filing data, but these figures are not mentioned in the ground truth and cannot be verified as relevant to the regulatory deferral discussion. Their inclusion adds detail but risks misdirection since the original answer does not reference such amounts. The use of Note 15 and Note 16 and page numbers suggests precise sourcing, but again, this information is not in the ground truth and may be extraneous or inaccurate in context. (3) The multi-hop reasoning is partially sound—linking AFS treatment across years and regulatory deferrals—but fails the core synthesis: the evolution in treatment based on investment type (especially Investment Trusts) and the rationale (lack of control) are missing. This represents a significant gap in qualitative reasoning. (4) Scores reflect that while the answer is contextually relevant and includes some accurate details, it omits a major factual development and introduces unverified quantitative data, undermining correctness and qualitative accuracy. The answer gives a misleading impression of continuity rather than the nuanced change described in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 545,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did the $547 million pretax contract settlement expense recorded by DHR's subsidiary Beckman Coulter in 2021 impact its ongoing financial obligations to Quidel Corporation in 2023, and what does this reveal about the long-term financial implications of the agreement?",
      "original_answer": "In 2021, Beckman Coulter, a subsidiary of DHR, recorded a $547 million pretax contract settlement expense as part of a resolution with Quidel Corporation, which included fixed annual payments of approximately $75 million through 2029. By 2023, these ongoing payments were still in effect and were classified as a noncash financing activity of $576 million, with cash outflows related to servicing the obligation being recorded as financing activities. This indicates that the initial settlement had long-term financial implications for DHR, as the company continued to bear significant financial obligations to Quidel, with the extended payment structure affecting both its balance sheet and cash flow statements. The fact that the payments remained unchanged through 2023 highlights the enduring impact of the 2021 agreement on DHR’s financial planning and liquidity management.",
      "llm_answer": "The $547 million pretax settlement expense recorded in 2021 represented the present value of a $581 million obligation to pay Quidel, creating a long‑term liability that requires roughly $75 million in fixed payments each year through 2029【page_85】. In 2023 the company continues to service this obligation, recording the annual payments as financing cash outflows and the associated imputed interest as operating cash outflows【page_85】, underscoring a substantial, ongoing cash commitment that will affect future cash flow and earnings for the remainder of the agreement. This illustrates that the settlement imposes a long‑term financial burden that will persist for several years, potentially impacting the company’s liquidity and profitability.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the $547 million pretax expense in 2021 is correctly stated, and the $75 million annual payments through 2029 are consistent with the original answer. The LLM adds a detail not in the ground truth — that the total obligation is $581 million, representing the present value of future payments — which is plausible and supported by the citation (page_85), though not contradicted by the original answer. This additional precision enhances rather than detracts from accuracy. (2) The 2023 treatment of payments as financing cash outflows and imputed interest as operating outflows is correctly identified and matches the original answer’s classification of payments as financing activities. The original mentions a $576 million noncash financing activity, which may represent cumulative liability; the LLM does not contradict this but focuses on annual flows. (3) Multi-hop reasoning is sound: the model connects the 2021 settlement to ongoing 2023 obligations and infers long-term impacts on liquidity and profitability, correctly synthesizing across time and financial statements. (4) All entities (Beckman Coulter, DHR, Quidel) and timeframes (2021–2029) are accurate. The only minor gap is the absence of explicit mention of the $576 million noncash financing activity figure from 2023, but the core financial implications are correctly conveyed. Wording differs but meaning is semantically equivalent. Thus, the answer earns a 9 for correctness — excellent, with only a slight omission of a specific aggregate figure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 440,
        "total_tokens": 1878
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did the adoption of ASU 2022-02 in 2023 impact COF's recognition of loan modifications for borrowers in financial difficulty in 2024, and what new framework replaced the previous TDR accounting guidance?",
      "original_answer": "Capital One adopted ASU 2022-02 on January 1, 2023, which eliminated the previous accounting guidance for Troubled Debt Restructurings (TDRs). In 2024, this led to the introduction of a new framework under which loan modifications made to borrowers experiencing financial difficulty are now classified as Financial Difficulty Modifications (FDMs). Unlike TDRs, FDMs include principal forgiveness, interest rate reductions, payment delays, or term extensions, and are recognized under the updated standards introduced by ASU 2022-02.",
      "llm_answer": "The adoption of ASU 2022‑02 in 2023 eliminated the TDR guidance and introduced the Financial Difficulty Modification (FDM) framework, so that in 2024 Capital One recognized loan modifications for borrowers in financial difficulty as FDMs rather than TDRs. The new framework replaced the previous TDR accounting guidance (see pages 122–125).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and conveys the essential information from the ground truth. (1) It correctly states that ASU 2022-02 was adopted in 2023, eliminating TDR guidance and introducing the FDM framework, which Capital One applied in 2024—this matches the original answer. (2) There are no numerical values requiring verification (e.g., dollar amounts, percentages), but the dates (2023 adoption, 2024 impact) are accurate. (3) The multi-hop reasoning is sound: the model connects the adoption of ASU 2022-02 with the elimination of TDRs and the introduction of FDMs as the new classification for loan modifications for financially distressed borrowers. (4) The only minor shortcoming is that the LLM answer does not explicitly list the types of modifications included in FDMs (e.g., principal forgiveness, interest rate reductions, etc.), which are mentioned in the original answer and add contextual completeness. However, this omission does not undermine the core accuracy. The citation to 'pages 122–125' suggests source alignment but is not required for correctness. Overall, the answer is semantically equivalent and highly accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 324,
        "total_tokens": 1558
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did UPS's application of ASU 2020-04 in 2023 influence their handling of contract modifications in 2024, particularly regarding the transition from LIBOR to SOFR in debt instruments?",
      "original_answer": "In 2023, UPS transitioned affected debt instruments and contracts to SOFR as part of reference rate reform under ASU 2020-04, though they did not elect the practical expedients provided by the standard. ASU 2020-04 specifically allowed optional expedients for contract modifications related to reference rate reform, which were extended through 2024. In 2024, UPS’s accounting policy on contract modifications explicitly addressed how changes to existing contracts—such as those involving rate transitions—are accounted for prospectively when they do not add distinct services. This indicates that the earlier adoption of ASU 2020-04 directly shaped UPS’s structured approach to contract modifications in 2024, especially for non-distinct service changes like reference rate adjustments.",
      "llm_answer": "UPS applied ASU 2020‑04 in 2023 by moving all of its LIBOR‑based debt contracts to the alternative reference rate SOFR and chose not to use the optional practical expedients.  As a result, in 2024 the company continues to account for contract modifications prospectively under the new reference rate, and it will keep evaluating any impact of those modifications on its financial statements.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its core claims: UPS applied ASU 2020-04 in 2023 by transitioning LIBOR-based debt to SOFR and did not use the practical expedients, which aligns with the ground truth. The statement that UPS accounts for contract modifications prospectively in 2024 under the new rate is also correct and reflects the prospective accounting treatment described in the original answer. However, the LLM answer omits a key nuance: ASU 2020-04’s practical expedients were extended through 2024, and UPS’s 2024 accounting policy explicitly addressed contract modifications involving non-distinct services like rate transitions—this linkage between the 2023 adoption and the structured 2024 policy is underdeveloped. While the LLM captures the general continuity, it misses the explicit cause-effect relationship and policy formalization highlighted in the ground truth. All entities (UPS, ASU 2020-04, LIBOR, SOFR), years (2023, 2024), and financial concepts are correct. There are no numerical inaccuracies (no specific numbers to verify, but terminology is used correctly). The reasoning is sound but not fully complete in synthesizing the multi-hop connection between the standard’s application and its influence on future accounting policy. The answer remains contextually relevant and conveys most of the essential information, warranting a high but not perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 384,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the introduction of the RADV Audit Rule in 2023 impact CVS's Medicare Advantage plan performance and risk adjustment payments compared to 2022?",
      "original_answer": "In 2022, CVS offered expanding Medicare Advantage plans and was subject to CMS audits and risk adjustment mechanisms, which directly influenced its reimbursement and plan performance. In January 2023, CMS introduced the RADV Audit Rule, which eliminated the fee-for-service (FFS) adjuster and continued the use of extrapolation in contract-level RADV audits. This change increased the potential liability for payment errors without the buffer of the FFS adjuster, directly affecting risk adjustment data validation and reimbursement accuracy for Medicare Advantage plans. As a result, the Company faced greater uncertainty and potential adverse financial impacts on its Medicare operating results. In 2023, CMS released the Company's star ratings, which showed that its Medicare Advantage plans were not eligible for full-level quality bonuses in 2024, potentially reducing profit margins. However, based on the 2024 star ratings released in October 2023, the percentage of Aetna Medicare Advantage members in 4+ star plans was expected to return to 87%, up from 21% based on the 2023 ratings, indicating a potential recovery in plan performance and eligibility for full-level quality bonuses in 2025.",
      "llm_answer": "The RADV Audit Rule was introduced in 2023, eliminating the fee‑for‑service adjuster and allowing CMS to extrapolate audit data for payment years 2018 onward【page_27】.  This change introduced uncertainty for Medicare Advantage plans and could materially reduce risk‑adjusted payments and affect plan performance compared with 2022, when the rule was not yet in effect【page_56】.  The impact remains uncertain but could lead to lower reimbursement and altered performance metrics for CVS’s Medicare Advantage business.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the introduction of the RADV Audit Rule in 2023 and its key components: the elimination of the fee-for-service (FFS) adjuster and the continuation of extrapolation in audits, citing correct implications for risk-adjusted payments and plan performance. It accurately contrasts 2023 with 2022, noting increased uncertainty and potential financial impact, which aligns with the ground truth. The citation of audit applicability to payment years 2018 onward adds contextual detail consistent with regulatory scope. However, the LLM answer is significantly incomplete in addressing the full impact on CVS's Medicare Advantage plan performance. Crucially, it omits the star ratings information, which is a core part of the original answer: the fact that CVS's (via Aetna) plans were not eligible for full quality bonuses in 2024 due to 2023 ratings, but showed strong recovery expectations for 2025 with 87% of members in 4+ star plans (up from 21%). These specific percentages and the forward-looking performance recovery are critical quantitative and qualitative elements directly tied to the question about performance impact. Their absence represents a major gap in multi-hop synthesis across audit rule changes and quality rating outcomes. While the reasoning around audit rule mechanics is sound and entities (CMS, RADV, Medicare Advantage, CVS) are correctly identified, the failure to incorporate the star rating data and its financial implications limits the answer's completeness and reduces its qualitative accuracy. The answer remains contextually relevant and factually correct where it does respond, hence a moderate correctness score of 6.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 457,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did Tesla's 2022 eligibility for solar-linked tax credits influence its positioning to scale energy storage production under the expanded standalone tax credit framework introduced by the Inflation Reduction Act in 2024?",
      "original_answer": "In 2022, Tesla benefited from solar-linked tax credits under Sections 48 and 25D of the U.S. Internal Revenue Code, which allowed energy storage systems charged via solar energy to qualify for a 26% tax credit. This positioned Tesla to develop expertise and customer relationships in the solar-integrated storage market. By 2024, the Inflation Reduction Act expanded eligibility to include standalone energy storage systems under Sections 48, 48E, and 25D, offering tax credits between 6% and 50% of qualified expenditures regardless of energy source. Tesla leveraged its prior experience and infrastructure in solar-linked storage to scale its energy storage systems production, allowing it to capitalize on the broader tax credit eligibility and increasing its addressable market. The company's ability to produce and deploy energy storage systems independently of solar installations significantly broadened its revenue potential under the updated regulatory framework.",
      "llm_answer": "Tesla’s 2022 10‑K noted that it was eligible for the 26 % federal tax credit for solar energy systems (Sections 48 and 25D)【page_11】, which helped establish its solar‑and‑storage business.  Under the 2024 Inflation Reduction Act, the same sections now provide a standalone tax credit of 6‑50 % for energy‑storage technology, giving Tesla a new incentive to expand production【page_10】.  This alignment of solar and storage credits positioned Tesla to scale its energy‑storage manufacturing, leveraging its existing solar expertise and Gigafactory capacity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers and dates are correct: the 26% tax credit in 2022 under Sections 48 and 25D is accurately cited, as is the 6–50% range for standalone storage credits introduced in 2024 under the Inflation Reduction Act. These match the original answer exactly. (2) The LLM correctly identifies Tesla’s eligibility in 2022 and the regulatory expansion in 2024, showing proper multi-hop reasoning across time and policy changes. (3) Entity accuracy is strong: Tesla, the Inflation Reduction Act, Sections 48 and 25D, and the shift from solar-linked to standalone storage are all correctly referenced. (4) The reasoning is sound—Tesla leveraged its solar-integrated storage experience to scale under the new standalone framework. The only minor omission is that the LLM does not explicitly mention Section 48E (newly created for standalone storage), though referencing updated provisions under 48 and 25D is partially acceptable. It also omits explicit mention of customer relationships and the broadening of the addressable market, which are part of the full strategic impact. However, the core logic and factual chain are preserved. Wording differences do not affect semantic equivalence. Overall, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning with only slight incompleteness in elaborating the full scope of Tesla’s strategic positioning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 407,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the changes in AMT's debt service coverage ratio (DSCR) thresholds in 2023 relate to the evolution of restricted cash reserves under the Securitization Loan Agreements by 2024?",
      "original_answer": "In 2023, AMT's subsidiary GTP Acquisition Partners was subject to DSCR thresholds that, if breached, would trigger cash trap reserve requirements, limiting the distribution of excess cash flow to AMT. Specifically, if the DSCR fell below 1.30x, excess cash would be deposited into a reserve account, reducing liquidity available for capital expenditures and REIT distributions. By 2024, the structure of the Securitization Loan Agreements remained in place, but the restricted cash balance had decreased from $76.3 million in 2023 to $60.8 million in 2024, suggesting either improved DSCR performance or a reduction in cash trapping events. This indicates that AMT may have experienced better financial performance or covenant compliance in 2024 compared to 2023, allowing more excess cash to be released under the loan agreements.",
      "llm_answer": "In 2023 AMT set a Cash‑Trap DSCR of 1.30× and a Minimum DSCR of 1.15×, which determine when excess cash must be held in reserve accounts under the Securitization Loan Agreements【page_56】. By 2024 the restricted cash reserve had fallen from $76.3 million to $60.8 million, indicating that the company had largely maintained DSCR above those thresholds, allowing more excess cash to be released and reducing the reserve balance【page_57】【page_58】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core information from the ground truth. (1) Quantitatively, all numbers are correct: the restricted cash decrease from $76.3 million in 2023 to $60.8 million in 2024 is accurately reported. (2) The entity 'AMT' is correctly identified, and the financial metric (DSCR) and its thresholds (1.30x Cash-Trap, 1.15x Minimum) are factually consistent with the source, though the original answer does not explicitly mention the 1.15x Minimum DSCR—this is a minor addition not contradicted by the ground truth. (3) The reasoning is sound: the decrease in restricted cash is correctly linked to likely DSCR performance above the trigger threshold, implying fewer cash trapping events in 2024. (4) The answer addresses the relationship between DSCR thresholds and restricted cash evolution, fulfilling the multi-hop requirement (linking covenant terms to cash reserve changes over time). The only minor shortcoming is that the original answer emphasizes GTP Acquisition Partners as the subsidiary subject to the covenants, while the LLM generalizes to AMT—this is a slight oversimplification but does not invalidate the conclusion. Overall, the answer is semantically equivalent and factually correct, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 353,
        "total_tokens": 1681
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did ConocoPhillips' strategic use of condensate in 2022 relate to its financial exposure through Alba Plant LLC in 2024, particularly in terms of diluent cost savings and contingent liabilities?",
      "original_answer": "In 2022, ConocoPhillips implemented the use of condensate for bitumen blending at Surmont's central processing facility 1, which enabled the company to lower blend ratios and diluent supply costs, gaining protection from synthetic crude oil supply disruptions. By 2024, ConocoPhillips had a 52.2% ownership stake in Alba Plant LLC, which processed natural gas from the Alba Unit and sold condensate at market prices—directly linking condensate production to revenue. However, ConocoPhillips also had a contingent liability of up to $116 million tied to Alba Plant LLC’s obligations to process third-party gas, showing how earlier cost-saving strategies with condensate were now financially entangled with downstream processing risks. This demonstrates a 3-hop chain: COP(2022) → Condensate → Alba Plant LLC ← COP(2024).",
      "llm_answer": "In 2022 ConocoPhillips used condensate to produce heavy dilbit, which lowered diluent supply costs by reducing the blend ratio (page 7). By 2024 the company’s 52.2 % interest in Alba Plant LLC (page 12) exposed it to contingent liabilities from guarantees for processing third‑party gas, with potential future payments of roughly $116 million (page 104). Thus, the cost savings from condensate use were counterbalanced by the contingent‑liability exposure through Alba Plant LLC.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core multi-hop relationship described in the ground truth. (1) All key facts are correct: condensate use in 2022 at Surmont reduced diluent costs by lowering blend ratios; by 2024, ConocoPhillips had a 52.2% stake in Alba Plant LLC; and there is a $116 million contingent liability tied to third-party gas processing obligations. These numbers match the ground truth exactly, with acceptable formatting (e.g., 'roughly $116 million' ≈ $116 million). (2) Quantitative accuracy is perfect—dates (2022, 2024), percentage (52.2%), and dollar amount ($116 million) are all correct. (3) The reasoning correctly synthesizes the chain: condensate use in 2022 led to cost savings, while the 2024 financial exposure via Alba Plant LLC introduces a counterbalancing risk, creating a strategic trade-off. The multi-hop logic (COP → condensate → Alba Plant LLC → contingent liability) is sound and aligns with the 3-hop chain in the ground truth. (4) The only minor omission is that the original answer notes Alba Plant LLC sells condensate at market prices—linking condensate production directly to revenue—which adds nuance about the financial integration of condensate. The LLM answer focuses on cost savings vs. liability but doesn't mention this revenue linkage, slightly weakening the completeness of the financial exposure picture. However, the core question about cost savings and contingent liabilities is fully addressed. Hence, correctness is docked slightly to 9, but all other scores remain high due to strong factual accuracy, reasoning, and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 437,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did MetLife's use of Trust-Owned Life Insurance in funding nonqualified benefit programs for executives change between 2023 and 2024, and what does this indicate about the evolution of their Benefit Funding Solutions offerings?",
      "original_answer": "In 2023, MetLife's RIS segment included Trust-Owned Life Insurance as part of its benefit funding solutions to finance nonqualified benefit programs for executives. By 2024, this offering remained a core component of Benefit Funding Solutions, now more explicitly described as 'specialized life insurance products' tailored for postretirement benefits. The continued emphasis on Trust-Owned Life Insurance within Benefit Funding Solutions in 2024 indicates a strategic reinforcement of this product line, suggesting MetLife is deepening its focus on customized executive benefit funding strategies rather than broadening into new areas.",
      "llm_answer": "MetLife’s trust‑owned life‑insurance balance used to fund non‑qualified benefit programs rose from **$17.7 billion in 2023 to $20.7 billion in 2024** (page 203, page 181), with deposits climbing from $2.7 billion to $3.7 billion and the weighted‑average crediting rate increasing from 3.9 % to 4.0 %. This growth shows that MetLife is scaling its Benefit Funding Solutions line, expanding the use of trust‑owned life insurance to meet rising demand for executive benefit programs while offering higher returns and greater risk exposure to clients.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific quantitative figures—$17.7 billion in 2023 rising to $20.7 billion in 2024, deposits from $2.7B to $3.7B, and crediting rate from 3.9% to 4.0%—that are not present in the original ground truth answer and cannot be verified from the provided context. These numbers appear fabricated or hallucinated, as the ground truth does not include any financial metrics about balances, deposits, or rates related to Trust-Owned Life Insurance. (2) There is no mention in the original answer of balance changes, deposit trends, or crediting rates, so the quantitative claims in the LLM response are entirely unsupported. Even allowing for format variation, the absence of any such data in the ground truth makes these figures factually incorrect. (3) On qualitative reasoning, the LLM correctly identifies that Trust-Owned Life Insurance is used in funding nonqualified benefit programs and that it remains important in 2024. It also correctly infers a strategic emphasis on this product line. However, it mischaracterizes the evolution as 'scaling' and 'expanding' due to quantitative growth, whereas the ground truth emphasizes a shift in description and strategic reinforcement through customization, not necessarily expansion. The conclusion about 'greater risk exposure to clients' is speculative and not supported. (4) Contextually, the answer addresses the right topic and time frame (2023–2024), and correctly associates Trust-Owned Life Insurance with executive benefit funding. However, the reliance on false numerical data severely undermines factual correctness. The multi-hop synthesis is partially sound but based on incorrect inputs. Thus, while the direction of interpretation is somewhat aligned, the foundation is factually flawed, leading to a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 494,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did SPG's strategic investment in SPARC Group in 2023 influence its subsequent divestiture decisions with ABG in 2024, particularly in light of SPARC Group's earlier partnership with ABG?",
      "original_answer": "In 2023, SPG held a 33.3% noncontrolling interest in SPARC Group, which had formed a strategic partnership with ABG to operate Reebok in the U.S. During the third quarter of 2023, SPARC Group issued equity to a third party, diluting SPG’s ownership and triggering a non-cash pre-tax gain of $145.8 million. This dilution may have signaled a strategic shift in SPG’s involvement with SPARC Group and its downstream relationships, including with ABG. In late 2023, SPG sold a portion of its ABG stake for $300.2 million, recognizing a $157.1 million gain. By Q1 2024, SPG completed the full divestiture of its remaining ABG interest for $1.2 billion, realizing a pretax gain of $414.8 million. The earlier dilution in SPARC Group appears to have initiated a broader strategic retreat from its retail platform investments, culminating in the full exit from ABG in 2024.",
      "llm_answer": "SPG’s 2023 strategic investment in SPARC Group—acquiring a 33.3 % non‑controlling stake—gave it indirect exposure to ABG through SPARC’s long‑term partnership as core licensee and operating partner for Reebok (SPG 2023 10‑K, page 113).  The dilution of SPG’s SPARC stake in Q3 2023 and the company’s assessment that the partnership did not fit its core retail strategy prompted it to accelerate its ABG divestitures, first selling a portion of its ABG interest in Q4 2023 for $300.2 million (pre‑tax gain $157.1 million) and then disposing of the remaining stake in Q1 2024 for $1.2 billion (SPG 2023 10‑K, page 113; SPG 2024 10‑K, page 73).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core causal relationship between SPG's dilution in SPARC Group and its subsequent divestiture of ABG stakes. (1) All numeric values are correct: SPG’s 33.3% stake, Q3 2023 dilution, $300.2 million partial sale in Q4 2023 with $157.1 million gain, and $1.2 billion full exit in Q1 2024 are all factually accurate and match the ground truth. The pretax gain of $414.8 million on the full divestiture is implied in the context though not explicitly mentioned in the LLM answer—this is a minor omission. (2) Quantitative accuracy is perfect: all dollar amounts, percentages, and timeframes align with the original answer and SEC filing references. (3) The multi-hop reasoning is sound—LLM correctly links SPG’s investment in SPARC Group → SPARC’s partnership with ABG → dilution event → strategic reassessment → phased divestiture of ABG. It correctly infers that the dilution and strategic misalignment prompted the exit. However, it omits the explicit mention of the $145.8 million non-cash gain from the SPARC dilution, which is a key financial trigger in the original narrative. (4) Entity accuracy is strong: SPG, SPARC Group, ABG, Reebok, and correct fiscal quarters are all properly identified. The answer cites the correct 10-K pages, enhancing credibility. (5) Semantic equivalence is high—the LLM captures the strategic retreat theme and correctly sequences events. The only shortcoming is the missing reference to the $145.8 million gain from dilution, which slightly weakens the completeness of the financial cause-effect chain. Overall, the answer is factually robust, well-reasoned, and contextually precise, warranting a 9/10 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 462,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did the structure and financial implications of PM USA's guarantee of Altria's commercial paper program evolve between 2022 and 2023, particularly in light of changes in Altria's debt issuance and liquidity strategy?",
      "original_answer": "In 2022, PM USA's guarantee of Altria's commercial paper program was part of a broader set of guarantees covering Altria's debt obligations, with specific emphasis on the unconditional nature of the guarantee and the potential for voidance under fraudulent conveyance laws. By 2023, Altria issued $1.0 billion in new senior unsecured notes, which were used for general corporate purposes, signaling a shift in financing strategy. This was accompanied by repayments of $1.3 billion in Euro-denominated notes and $218 million in senior unsecured notes, indicating active debt management. The commercial paper program remained guaranteed by PM USA, but the overall debt structure and liquidity approach evolved with new issuances and repayments, reflecting strategic adjustments in capital structure.",
      "llm_answer": "PM USA’s guarantee of Altria’s commercial‑paper program remained an absolute, unconditional back‑stop to all of the Parent’s debt securities, credit‑agreement borrowings and commercial‑paper issuances in both 2022 and 2023.  In 2023, Altria added a $1.0 billion senior unsecured note issuance and entered into a new $3.0 billion revolving credit facility, thereby expanding the pool of obligations that the guarantee covers and increasing PM USA’s contingent liability, while the release trigger (payment in full or a S&P rating of A or higher) remained unchanged.  The guarantee’s financial impact is therefore still contingent—no balance‑sheet charge to Altria unless exercised—yet the larger debt issuance and liquidity strategy in 2023 heightens the potential exposure for PM USA and reinforces Altria’s ability to access capital markets.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that PM USA's guarantee remained in place for Altria's commercial paper program in both 2022 and 2023 and notes the unconditional nature of the guarantee, which aligns with the original answer. However, it introduces a $3.0 billion revolving credit facility in 2023 that is not mentioned in the ground truth and cannot be verified from the provided information, constituting a significant factual inaccuracy. Additionally, while the $1.0 billion senior unsecured note issuance in 2023 is correctly stated, the original answer also notes repayments of $1.3 billion in Euro-denominated notes and $218 million in senior unsecured notes—information entirely missing from the LLM response, weakening completeness. (2) Quantitative accuracy is partially correct: the $1.0 billion issuance is accurate, but the $3.0 billion credit facility is unsupported. The absence of the $1.3 billion and $218 million repayment figures results in incomplete financial context. Calculations are not required, but reporting of key figures is incomplete. (3) The multi-hop reasoning is sound in linking PM USA’s guarantee to Altria’s broader debt obligations and inferring increased contingent liability due to new issuances. However, the failure to incorporate debt repayments and the addition of an unverified credit facility undermine the synthesis. The conclusion about heightened exposure is reasonable but overstated without balancing repayment activity. (4) Contextual relevance is high—the response directly addresses the evolution of the guarantee and financial implications. Despite incorrect or missing data, the structure and intent of the answer match the question’s focus on structural and strategic changes. Overall, the answer captures core elements but contains significant factual gaps and one unsupported claim, warranting a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 513,
        "total_tokens": 1941
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did the evolution of GE's stake in Union Fidelity Life Insurance Company from 2022 to 2024 influence its exposure to structured settlement annuities, particularly in terms of reserve liabilities and risk profile shifts?",
      "original_answer": "In 2022, GE's stake in Union Fidelity Life Insurance Company (UFLIC) was part of its run-off insurance operations, with UFLIC assuming structured settlement annuities from Genworth Financial Inc. These annuities contributed to $10.3 billion in structured settlement annuities and life insurance reserves as of December 31, 2021. By 2024, GE reinsured approximately 23,400 structured settlement annuities with an average attained age of 57, many of which were underwritten on impaired lives and projected to pay out over decades. This indicates a continued exposure to long-duration liabilities, with mortality and reinvestment risk becoming more central to GE's risk profile. The shift from a focus on reinsurance treaties and premium collections in 2022 to a more defined exposure with fixed payment obligations in 2024 shows a transformation in how GE's relationship with structured settlement annuities evolved, with increased emphasis on longevity and interest rate risk.",
      "llm_answer": "GE’s stake in UFLIC remained a run‑off insurer, but the company’s exposure to structured settlement annuities shrank between 2022 and 2024: the number of annuities fell from 27,400 to 23,400 and UFLIC’s GAAP reserve balance dropped from $5.37 bn to $4.97 bn (statutory reserves from $6.63 bn to $5.96 bn). The average attained age rose from 54 to 57, indicating a slightly older portfolio, yet the risk profile stayed centered on mortality, mortality‑improvement and reinvestment risk, with sensitivity analysis still showing a $300 m adverse impact if mortality grades shift.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The original answer states that GE reinsured approximately 23,400 structured settlement annuities by 2024, but the LLM incorrectly claims the number fell from 27,400 to 23,400, implying a reduction from 2022 to 2024. However, the ground truth does not provide the 27,400 figure or any prior count in 2022, making this number fabricated. Additionally, the LLM introduces specific reserve figures—GAAP reserves dropping from $5.37B to $4.97B and statutory from $6.63B to $5.96B—which are entirely absent from the original answer. The original only mentions $10.3B in structured settlement and life insurance reserves as of December 31, 2021 (pre-2022), with no data for 2022 or 2024. Thus, all quantitative claims in the LLM answer are unsupported and incorrect. (2) The average attained age rising from 54 to 57 is partially aligned with the original stating an average of 57 in 2024, but the 54 figure for earlier years is not in the ground truth, making it speculative. The $300M adverse impact from mortality shifts is also not mentioned in the original and appears invented. (3) The multi-hop reasoning is flawed: the original describes a shift in GE’s risk profile toward greater focus on longevity and interest rate risk due to fixed long-duration obligations, while the LLM incorrectly frames this as a shrinking exposure and unchanged risk profile. This misrepresents the evolution—GE did not reduce exposure but rather solidified it through reinsurance, maintaining long-term liabilities. The LLM fails to capture the transformation in risk profile and incorrectly infers a decline in reserves and annuity count. (4) Despite these issues, the LLM correctly identifies UFLIC as part of run-off operations and touches on relevant risks (mortality, reinvestment), showing some contextual understanding. However, the introduction of false metrics and mischaracterization of trends severely undermines factual correctness. Hence, low scores for quantitative and overall correctness, moderate for qualitative reasoning, and decent for relevance to the topic.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 572,
        "total_tokens": 1979
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did Duke Energy's 2022 acquisition of storm recovery property connect to its 2024 issuance of storm recovery bonds, and what does this evolution indicate about the company's long-term financing strategy for storm-related costs?",
      "original_answer": "In 2022, Duke Energy Carolinas and Duke Energy Progress transferred storm recovery property—related to costs from storms in 2018 and 2019—to their special-purpose subsidiaries (DECNCSF and DEPNCSF), which then issued $237 million and $770 million in storm recovery bonds, respectively. These bonds were secured by the storm recovery property, which granted the right to collect non-bypassable charges from retail customers. By 2024, Duke Energy Progress had repeated this financing mechanism by issuing $177 million in new storm recovery bonds tied to additional storms (Pax, Ulysses, Matthew, Florence, Michael, Dorian, Izzy, and Jasper), demonstrating a consistent and structured approach to financing storm-related costs through securitization. This shows a strategic evolution where the company leverages storm recovery property to issue secured bonds, enabling cost recovery through regulated customer charges over time.",
      "llm_answer": "Duke Energy Progress and Duke Energy Carolinas acquired storm‑recovery property in 2022 using the proceeds of the storm‑recovery bonds issued in 2021 (the bonds were issued by DECNCSF and DEPNCSF and used to buy the property, page 202).  The 2024 issuance of new storm‑recovery bonds is a direct extension of that securitization framework, showing the company’s long‑term strategy of financing storm‑related costs through dedicated, non‑recourse bonds backed by storm‑recovery charges.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly states that Duke Energy acquired storm-recovery property in 2022 using proceeds from bonds issued in 2021, which contradicts the ground truth: the 2022 transfer of storm recovery property preceded the bond issuance by the special-purpose subsidiaries (DECNCSF and DEPNCSF), not the other way around. The 2021 bond issuance is not supported by the ground truth, which specifies $237M and $770M in bonds issued in 2022 by DECNCSF and DEPNCSF respectively. The 2024 issuance of $177M in new bonds is correctly identified in intent but lacks the specific storm names and context provided in the original answer. (2) Quantitative accuracy is low: the LLM omits the correct 2022 bond amounts ($237M and $770M), misattributes timing (2021 issuance instead of 2022), and fails to report the correct sequence of events. The $177M 2024 issuance is correct but lacks supporting detail. (3) The multi-hop reasoning is partially sound—the model recognizes the pattern of securitizing storm-related costs through dedicated bonds and infers a long-term financing strategy, which aligns with the ground truth. However, the causal sequence is reversed (bonds funding property purchase vs. property enabling bond issuance), undermining the logic. (4) Contextual relevance is high because the answer addresses the core theme of Duke Energy’s structured financing strategy for storm costs. Despite incorrect chronology and missing specifics, it identifies the use of non-recourse bonds and recovery charges. The strategic interpretation is reasonable but built on flawed premises, leading to a moderate qualitative score. Overall, the answer is partially correct in concept but fails on key facts and timing, warranting a correctness score of 4.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 492,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did the delay in the effective date of the Final Foreign Tax Credit Regulations from fiscal year 2022 to 2024 impact Microsoft's effective tax rate and cash tax liabilities across those years?",
      "original_answer": "In fiscal year 2022, Microsoft was subject to the Final Foreign Tax Credit Regulations, which were expected to increase cash taxes unless postponed. By fiscal year 2024, Notice 2023-55 delayed the effective date of these regulations to fiscal year 2024, and Notice 2023-80 further delayed them indefinitely. This delay contributed to a decrease in Microsoft's effective tax rate from 19% in 2023 to 18% in 2024. Additionally, the postponement reduced immediate cash tax liabilities that would have otherwise increased due to the stricter foreign tax credit limitations introduced in the Final Regulations.",
      "llm_answer": "The IRS notices in FY 2024 postponed the effective date of the final foreign‑tax‑credit regulations to FY 2024, which lowered Microsoft’s effective tax rate from 19 % in FY 2023 to 18 % in FY 2024 (FY 2022 was 13.1 %). Cash taxes paid rose modestly from $23.1 B in FY 2023 to $23.4 B in FY 2024, while the delay prevented a larger cash‑tax increase that would have been seen in FY 2023 had the regulations been effective then.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the impact of the IRS notices (Notice 2023-55 and 2023-80) delaying the Final Foreign Tax Credit Regulations, and correctly states the decrease in Microsoft's effective tax rate from 19% in FY2023 to 18% in FY2024. However, it incorrectly states Microsoft's FY2022 effective tax rate as 13.1%, which is not mentioned in the ground truth and is factually inaccurate in context—the ground truth does not provide the FY2022 rate but implies the regulations were expected to increase taxes starting then. Additionally, the LLM introduces specific cash tax figures ($23.1B in 2023, $23.4B in 2024) that are not present in the original answer and cannot be verified from the provided knowledge graph; while the modest increase is plausible, these exact numbers are unsupported. (2) The quantitative inaccuracies include the unsupported FY2022 tax rate and the precise cash tax liabilities, which were not in the ground truth. The core calculation of the 1% drop in effective tax rate is correct. (3) The multi-hop reasoning is sound: the model correctly links the regulatory delay to reduced tax rate and avoided larger cash tax increases, showing synthesis between IRS notices and Microsoft’s tax outcomes. (4) Despite introducing unverified numbers, the answer captures the key causal relationship and directional impacts (lower ETR, avoided cash tax spike), warranting a 7 for correctness. Quantitative accuracy is penalized due to unsupported figures. Qualitative and contextual scores remain high because the reasoning and relevance are strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 437,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did AMT's strategic relationship with DIT in 2023 influence the financial outcome of the ATC TIPL transaction in 2024, particularly in terms of asset impairments and proceeds realized from the sale?",
      "original_answer": "In 2023, AMT recorded a $322.0 million goodwill impairment charge related to its India reporting unit, which was prompted by a strategic review that led to the decision to sell ATC TIPL. This strategic shift culminated in January 2024 with the agreement for DIT to acquire ATC TIPL for up to 210 billion INR (approximately $2.5 billion). By September 2024, the transaction was completed, with AMT receiving 182 billion INR (approximately $2.2 billion) in total consideration. However, the sale resulted in a $1.2 billion loss, largely due to the reclassification of cumulative translation adjustments upon exiting the Indian market. Thus, the 2023 impairment decision and strategic review directly shaped the 2024 financial outcome of the ATC TIPL transaction, reflecting both the prior-year impairments and the final proceeds net of translation effects.",
      "llm_answer": "The 2023 strategic review that led to a partnership with DIT prompted AMT to record a goodwill impairment of **$322 million** for its India reporting unit, reflecting a lower fair value identified through the DIT engagement (page 58).  The subsequent ATC TIPL sale to DIT in 2024 generated **$2.1588 billion** in proceeds (≈$2.2 billion) but produced a net loss on sale of **$1.2455 billion**, largely due to a **$1.0723 billion** reclassification of cumulative translation adjustments (pages 140‑143).  Thus, the DIT relationship set the stage for the impairment and shaped the financial outcome of the sale.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core financial and strategic dynamics of the multi-hop scenario. (1) Correctly identifies the $322 million goodwill impairment in 2023 tied to the strategic review involving DIT and the India reporting unit. (2) Reports proceeds of $2.1588 billion (≈$2.2 billion), which aligns with the ground truth of 182 billion INR (~$2.2 billion); minor variance in decimal precision is acceptable given currency conversion fluctuations. (3) Correctly states a net loss of $1.2455 billion, close to the ground truth $1.2 billion; the slight difference may stem from rounding or inclusion of additional transaction costs, but does not constitute a material error. (4) Accurately attributes the loss largely to the reclassification of cumulative translation adjustments ($1.0723 billion cited), which is consistent with the explanation in the original answer. (5) Correctly traces causality: the 2023 strategic review with DIT led to impairment and set the stage for the 2024 sale. All entities (AMT, DIT, ATC TIPL), years (2023–2024), and financial concepts (goodwill impairment, translation adjustments) are correct. The reasoning is sound, synthesizing cause (strategic review), intermediate effect (impairment), and final outcome (sale proceeds and loss). Only minor deduction in quantitative accuracy due to slightly overstated loss figure, but overall factual and semantic equivalence is strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 396,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did ConocoPhillips' strategic relationship with Origin Energy in 2022 influence its financial exposure to APLNG by 2024, particularly in terms of guarantees and ownership stakes?",
      "original_answer": "In 2022, ConocoPhillips exercised its preemption right to acquire an additional 10% shareholding in APLNG from Origin Energy, increasing its stake and signaling a strategic commitment to the joint venture. This decision was accompanied by an impairment of $688 million in Q4 2021 due to a decline in APLNG's fair value, which reflected the evolving risk profile of the investment. By 2024, ConocoPhillips had a 47.5% ownership stake in APLNG and was exposed to multiple financial guarantees totaling over $1.3 billion, including $210 million related to a project finance reserve account, $610 million tied to natural gas delivery obligations, and $480 million for performance guarantees on development contracts. The increased stake from 2022 led to a proportionally higher financial exposure by 2024, with ConocoPhillips assuming greater liability for APLNG's obligations over time.",
      "llm_answer": "ConocoPhillips’ 2022 partnership with Origin Energy let it exercise its pre‑emption right to buy an additional 10 % of APLNG, raising its stake from 37.5 % to 47.5 % (page 39, page 100).  By 2024 the company still held that 47.5 % interest and carried three APLNG‑related guarantees— a $210 million reserve‑withdrawal guarantee, a $610 million sales‑agreement liability and a $480 million performance guarantee— with carrying values of roughly $14 M, $14 M and $34 M, respectively (page 104).  Thus the Origin‑Energy relationship amplified ConocoPhillips’ financial exposure to APLNG through both a larger ownership share and higher contingent guarantee liabilities.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the core facts: ConocoPhillips exercised its preemption right in 2022 to increase its APLNG stake by 10%, resulting in a 47.5% ownership by 2024, and it outlines three key financial guarantees totaling $1.3 billion ($210M + $610M + $480M). However, there is a critical discrepancy in the 'carrying values' of the guarantees—$14M, $14M, and $34M—mentioned in the LLM answer, which are not present in the original answer and contradict the ground truth that emphasizes the total face value of guarantees (> $1.3B), not their carrying values. This introduces potentially misleading financial interpretation. (2) Quantitatively, the ownership percentages (37.5% to 47.5%) and individual guarantee amounts are accurate and sum correctly to $1.3B. The mention of carrying values, while possibly sourced from a filing, is not part of the ground truth and was not asked for in the question, thus reducing quantitative accuracy. The original answer does not reference carrying values at all, focusing instead on the total exposure. (3) The multi-hop reasoning is sound: the LLM connects the 2022 strategic action (buying additional stake) to increased financial exposure by 2024, correctly inferring that higher ownership led to greater liability. It synthesizes ownership and guarantee data across time and entities (ConocoPhillips, Origin Energy, APLNG). (4) Contextual relevance is perfect—the answer directly addresses how the 2022 relationship influenced 2024 financial exposure in terms of both ownership and guarantees. The inclusion of carrying values, while possibly factual, is extraneous and not aligned with the ground truth, which focuses on total guarantee amounts as indicators of exposure. Thus, the answer is mostly correct but slightly overreaches with unsupported detail, warranting a high but not top score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 506,
        "total_tokens": 1902
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did the use of discounted cash flow models to value Level 2 derivatives change from fiscal 2023 to 2024, and what does this indicate about Disney's evolving valuation methodology or derivative exposure?",
      "original_answer": "In fiscal 2023, Disney used internal discounted cash flow models to value Level 2 derivatives, relying on observable inputs such as interest rates, yield curves, and foreign currency exchange rates, with counterparty credit risk having a non-material impact. In fiscal 2024, the company continued using the same internal discounted cash flow models for Level 2 derivatives, maintaining reliance on similar observable inputs and again noting that counterparty credit risk remained mitigated and immaterial. There was no explicit change in valuation technique, suggesting that Disney’s exposure to Level 2 derivatives and the underlying risk factors remained relatively stable between years.",
      "llm_answer": "Disney continued to use internal discounted‑cash‑flow models for Level 2 derivatives in both fiscal 2023 and 2024 (see the 10‑K notes on page 119 for 2023 and page 120 for 2024).  However, the fair value of Level 2 derivatives fell from $1,602 million in 2023 to $1,489 million in 2024 (foreign‑exchange from $1,336 million to $569 million, interest‑rate from $(1,791) million to $(983) million), indicating a lower derivative exposure or a shift toward simpler hedging instruments.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states there was no change in Disney's valuation methodology for Level 2 derivatives from fiscal 2023 to 2024 — the company continued using internal discounted cash flow models with similar observable inputs. However, the LLM incorrectly implies a shift in methodology or exposure by citing large changes in fair value and suggesting a move toward simpler hedging instruments, which is not supported by the original answer. (2) The quantitative values cited — $1,602 million in 2023 and $1,489 million in 2024, with breakdowns into foreign exchange and interest rate derivatives — are not present in the ground truth and cannot be verified as correct. The original answer does not provide any numerical fair values for Level 2 derivatives, so these figures appear to be fabricated or misattributed. This results in a major failure in quantitative accuracy. (3) The multi-hop reasoning is flawed: while the LLM attempts to synthesize information across years and derive implications about derivative exposure, it does so based on unsupported numbers and misinterprets stability in methodology as a potential shift. The original answer emphasizes no explicit change in technique and stable exposure, whereas the LLM concludes reduced exposure or instrument simplification — an unsupported inference. (4) Despite these issues, the answer is contextually relevant, correctly identifying Disney, Level 2 derivatives, discounted cash flow models, and the relevant fiscal years. It also correctly notes continuity in model usage, which aligns with the ground truth. However, the inclusion of false quantitative data and incorrect implications severely undermines factual correctness, warranting a low overall score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 488,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did MS's use of Level 3 valuation techniques for non-exchange-traded investments in 2024 differ from its pricing model disclosures in 2023, particularly in terms of reliance on unobservable inputs and valuation methods?",
      "original_answer": "In 2023, MS classified non-exchange-traded investments as Level 3 only when market data were not observable or supported by market liquidity, indicating a cautious approach to unobservable inputs. By 2024, MS expanded the use of Level 3 valuation techniques for non-exchange-traded investments held directly or within internally managed funds, explicitly relying on discounted cash flow analyses, comparable firm transactions, and market outlook adjustments, which suggests a greater reliance on internal models and unobservable assumptions. This evolution shows a shift toward more complex and subjective valuation practices for less liquid assets.",
      "llm_answer": "In 2024, MS explicitly applied Level 3 fair‑value methods to non‑exchange‑traded investments, stating that Level 3 valuations are used when observable inputs are unavailable and that the firm relies on discounted‑cash‑flow analyses and market‑based information to estimate fair value【page_98】. By contrast, the 2023 pricing‑model disclosures for the same asset class were limited to using the fund manager’s NAV as the best estimate of fair value, with no mention of Level 3 valuation or significant reliance on unobservable inputs【page_96】. Thus, the 2024 approach introduced a more detailed, model‑driven valuation that increased dependence on unobservable assumptions, whereas the 2023 approach relied mainly on observable NAV data.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the shift from 2023 to 2024 in MS's valuation approach: in 2023, reliance was on NAV as the best estimate without explicit Level 3 classification or use of unobservable inputs, while in 2024, MS explicitly applied Level 3 techniques using discounted cash flow analyses and market-based adjustments. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or answers, so quantitative accuracy is not compromised—dates (2023, 2024) are correct. (3) The multi-hop reasoning is sound: the model correctly synthesizes differences in disclosure practices across years, identifies the change from NAV reliance to model-driven valuation, and infers increased dependence on unobservable inputs. (4) The only minor shortcoming is that the LLM does not explicitly mention 'comparable firm transactions' and 'market outlook adjustments' as specific methods added in 2024, which are included in the original answer and contribute to the richer description of internal models. However, mentioning 'discounted-cash-flow analyses' and 'market-based information' captures the essence of increased subjectivity and model reliance. Wording differs slightly but maintains semantic equivalence. Thus, the answer is factually correct, contextually relevant, and well-reasoned, meriting a high score with only a small deduction for partial omission of valuation methods cited in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 414,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did the changes in SPG's Series J 8 3/8% Preferred Stock carrying value and redemption terms between 2022 and 2024 reflect Simon's evolving role as issuer and partner in SPG's capital structure?",
      "original_answer": "In 2022, SPG disclosed that the Series J 8 3/8% Cumulative Redeemable Preferred Stock was issued at a premium of $7.5 million, with an unamortized premium of $1.9 million at year-end. By 2024, the unamortized premium had decreased to $0.9 million, indicating ongoing amortization of the original premium. The redemption terms remained consistent, with Simon retaining the right to redeem shares on or after October 15, 2027, at $50.00 per share plus accumulated and unpaid dividends. Meanwhile, Simon, as both issuer of the preferred stock and partner in SPG, saw the carrying value of preferred units held by it drop from $25.5 million in 2022 to $15.5 million in 2024, reflecting redemptions of 75,000 units in 2024 and 25,000 units in 2023, totaling $10 million in redemptions over two years. This reduction indicates a strategic shift in SPG’s capital structure, with Simon actively managing its preferred equity exposure through redemptions, while maintaining its role as issuer of the preferred stock.",
      "llm_answer": "Between 2022 and 2024, the unamortized premium on SPG’s Series J 8 3/8 % Preferred Stock fell from $1.3 million to $0.9 million, lowering its carrying value as Simon amortized the premium and moved toward a more balanced partnership structure. The redemption terms—$50 per share plus accrued dividends, redeemable on or after October 15 2027—remained unchanged, underscoring Simon’s continued issuer authority while aligning with the operating partnership’s redemption rights and reflecting its evolving partnership role in SPG’s capital structure【page_130】.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "1) The LLM answer contains significant quantitative inaccuracies. It states the unamortized premium in 2022 was $1.3 million, but the ground truth reports $1.9 million. This error affects the accuracy of the carrying value change narrative. The 2024 unamortized premium of $0.9 million is correct. The redemption terms are accurately described: $50 per share plus accrued dividends, redeemable on or after October 15, 2027. However, the LLM omits critical information about the original issuance premium of $7.5 million and fails to mention the redemption of preferred units held by Simon—75,000 units in 2024 and 25,000 in 2023, totaling $10 million—which reduced Simon's carrying value from $25.5 million in 2022 to $15.5 million in 2024. This omission undermines the explanation of Simon’s evolving role in SPG’s capital structure.\n\n2) Quantitative accuracy is compromised: the $1.3M vs $1.9M discrepancy in the 2022 unamortized premium is material. While the $0.9M 2024 figure is correct, the trend (decline from $1.9M to $0.9M) is misrepresented. The LLM does not reference the $10 million in total redemptions or the drop in Simon’s carrying value of preferred units, which are central to the capital structure shift. Calculations are not explicitly performed, but the implied amortization trend is partially correct, albeit based on a wrong starting point.\n\n3) The reasoning is partially sound—linking amortization and unchanged redemption terms to Simon’s ongoing issuer role is logical and contextually appropriate. However, the model fails to synthesize the multi-hop information: (a) Simon as both issuer and holder of preferred units, (b) the redemption activity reducing its own holdings, and (c) the strategic implication of managing preferred equity exposure. This missing synthesis limits the depth of the analysis and misrepresents the 'evolving role' aspect of the question.\n\n4) Contextual relevance is strong—the answer addresses the carrying value changes and redemption terms, and attempts to interpret Simon’s role. However, due to missing key facts and incorrect numbers, the conclusion about a 'more balanced partnership structure' is speculative and not fully supported by the provided (incorrect) data. The citation to 'page_130' suggests a source reference, but does not compensate for factual errors.\n\nOverall, the answer captures part of the narrative but fails on key quantitative and multi-hop qualitative dimensions, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 657,
        "total_tokens": 2061
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did the proportion of beverage revenue within PEP's AMESA division change from 2022 to 2023, and what might this indicate about the company's regional beverage strategy?",
      "original_answer": "In 2022, beverages accounted for 30% of revenue in the AMESA division, which decreased slightly to 29% in 2023. This small decline suggests that PEP may have been shifting focus toward convenient foods in the region during this period, as the proportion of convenient foods increased from 70% to 71%. The change indicates a subtle strategic realignment rather than a major overhaul of the product mix in AMESA.",
      "llm_answer": "The beverage share of AMESA’s net revenue fell from 30 % in 2022 to 29 % in 2023—a 1‑percentage‑point decline. This modest shift suggests PepsiCo is slightly tilting its AMESA mix toward convenient foods or maintaining a balanced portfolio, likely reflecting regional market dynamics or a strategic emphasis on food categories.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the beverage revenue proportion in AMESA as 30% in 2022 and 29% in 2023, matching the ground truth exactly. The 1-percentage-point decline is accurately described. (2) All numeric values and dates are correct; no calculation errors. The percentage change is properly interpreted. (3) The reasoning is sound: the slight decline is correctly linked to a potential strategic tilt toward convenient foods, which aligns with the ground truth noting a 70% to 71% increase in that category. While the LLM does not explicitly mention the increase in convenient foods, it infers a plausible strategic shift consistent with the data. (4) The answer is semantically equivalent to the original, with only minor omission of the explicit convenient foods increase—this does not detract significantly from the overall accuracy. Wording is flexible but factually aligned. Contextual relevance is high as it directly addresses both parts of the question: the change in proportion and its strategic implication.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1191,
        "completion_tokens": 298,
        "total_tokens": 1489
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did Duke Energy Carolinas' use of storm recovery bonds in 2022 evolve by 2024, particularly in terms of the geographic scope of storm cost financing and the structure of its special purpose subsidiaries like DECNC SF?",
      "original_answer": "In 2022, Duke Energy Carolinas (DECNCSF) issued $237 million in storm recovery bonds to finance unrecovered regulatory assets related to 2018–2019 storm costs in North Carolina. By 2024, the company had expanded its storm cost financing strategy into South Carolina through the formation of a new subsidiary, DEPSCSF, which issued $177 million in bonds to recover costs from 2014 through 2022. DECNC SF, as a VIE, continued to be consolidated by Duke Energy Carolinas due to its insufficient equity capitalization and its role in collecting non-bypassable charges from retail customers to service the bonds. This indicates a strategic evolution from solely addressing past North Carolina storm costs to a broader, multi-state approach to managing storm-related regulatory assets.",
      "llm_answer": "In 2022, Duke Energy Carolinas financed storm‑cost regulatory assets through its wholly‑owned, bankruptcy‑remote VIEs DECNCSF and DEPNCSF, which issued senior secured bonds backed by storm‑recovery property for North‑Carolina storm costs (and earlier South‑Carolina costs). By 2024 the geographic scope had expanded to cover South‑Carolina storm costs incurred from 2014‑2022, and a new subsidiary, DEPSCSF, was created; the structure remained the same—bankruptcy‑remote, wholly‑owned VIEs issuing senior secured bonds secured by the storm‑recovery property, with Duke Energy Carolinas consolidating DECNCSF and Duke Energy Progress consolidating DEPNCSF and DEPSCSF.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies. First, it incorrectly states that in 2022, Duke Energy Carolinas used both DECNCSF and DEPNCSF to issue bonds for North Carolina and 'earlier South Carolina costs.' However, the ground truth specifies that in 2022, only DECNCSF issued $237 million in bonds for North Carolina storm costs from 2018–2019—there is no mention of South Carolina costs being addressed in 2022 or of DEPNCSF being involved. DEPNCSF is not part of Duke Energy Carolinas but Duke Energy Progress, and its inclusion misrepresents the corporate structure. (2) The LLM correctly identifies the 2024 expansion into South Carolina via the creation of DEPSCSF and the $177 million bond issuance for costs from 2014–2022, which aligns with the ground truth. However, the dollar amounts ($237M and $177M) are not mentioned in the LLM response, representing a significant omission in quantitative detail. (3) The reasoning around the structure of the VIEs is partially correct—the use of bankruptcy-remote, wholly-owned VIEs issuing secured bonds is consistent with the ground truth. However, the LLM incorrectly states that Duke Energy Carolinas consolidates DECNCSF while Duke Energy Progress consolidates DEPNCSF and DEPSCSF. The ground truth specifies that DECNC SF (same as DECNCSF) is consolidated by Duke Energy Carolinas due to insufficient equity and collection of non-bypassable charges, but there is no mention of DEPNCSF or Duke Energy Progress consolidating entities in the original answer, introducing entities and relationships not supported by the ground truth. (4) Despite these errors, the LLM captures the key evolution: expansion from North Carolina to include South Carolina storm cost financing by 2024 and the use of special-purpose subsidiaries. This shows correct high-level synthesis, but the factual and structural inaccuracies—especially regarding entities and missing dollar figures—reduce correctness. The contextual relevance is high as it addresses the geographic and structural evolution, but quantitative accuracy is low due to missing numbers and incorrect entity attributions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 573,
        "total_tokens": 1953
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did Chevron's (CVX) increased crude oil reserves in Kazakhstan in 2023 influence its investment in the Caspian Pipeline Consortium (CPC) by 2024, particularly in light of the Future Growth Project (FGP) and Wellhead Pressure Management Project (WPMP) developments?",
      "original_answer": "Chevron's crude oil reserves in Kazakhstan increased from 2,257 million barrels in 2022 to 2,490 million barrels in 2023, driven by extensions and discoveries and purchases. This growth was tied to projects like the Future Growth Project (FGP) and Wellhead Pressure Management Project (WPMP), which were expected to ramp up production starting in 2025. Chevron transports most of this crude oil through the Caspian Pipeline Consortium (CPC), in which it has a 15% interest. By 2024, Chevron had increased its investment in CPC to support the anticipated production growth, including a $4,500 million loan to TCO (operator of Tengiz and Korolev fields) to fund FGP and WPMP. This demonstrates a direct chain from Chevron's growing crude oil reserves in 2023 → increased reliance on CPC for transport → higher investment in CPC by 2024.",
      "llm_answer": "Chevron’s 2023 increase in Kazakhstan crude reserves—primarily from Tengizchevroil’s Future Growth Project (FGP) and Wellhead Pressure Management Project (WPMP)—raised the expected throughput from the region.  By 2024 Chevron still held a 15 % stake in the Caspian Pipeline Consortium (CPC) but cut its investment in the consortium from $797 million in 2023 to $719 million, reflecting a shift toward supporting the expanded production from FGP/WPMP while optimizing its pipeline‑capital allocation.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly identifies Chevron's involvement in the Future Growth Project (FGP) and Wellhead Pressure Management Project (WPMP) in Kazakhstan and its 15% stake in the Caspian Pipeline Consortium (CPC), it incorrectly states that Chevron *cut* its investment in CPC from $797 million in 2023 to $719 million in 2024. The ground truth states that Chevron *increased* its investment in CPC by providing a $4,500 million loan to TCO (Tengizchevroil) in support of FGP and WPMP. This is a direct contradiction and a major factual error. (2) Quantitative accuracy is very low: the dollar amounts cited ($797M, $719M) do not appear in the ground truth and are factually incorrect. The correct figure is a $4.5 billion loan, not a reduction in investment. Additionally, the ground truth does not mention any prior $797M investment in 2023, so those numbers are fabricated or misattributed. (3) The multi-hop reasoning is partially sound in structure—linking reserve growth to production projects and then to transport infrastructure—but the conclusion is invalid due to incorrect data. The model infers a 'shift in capital allocation' to explain reduced CPC investment, which contradicts the actual increased reliance on CPC and increased investment. (4) Contextual relevance is moderate because the answer addresses the right entities (Chevron, CPC, FGP, WPMP, Kazakhstan reserves) and attempts the causal chain, but the incorrect investment direction undermines the conclusion. The answer misrepresents the core financial behavior, leading to a mostly incorrect assessment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 450,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did the change in Disney's foreign exchange cash flow hedge notional amounts from 2023 to 2024 impact the firm commitments included in the VAR model's risk estimation methodology?",
      "original_answer": "In 2023, Disney's foreign exchange cash flow hedge notional amount was $8.3 billion, increasing to $9.9 billion in 2024. Despite this increase, firm commitments remained excluded from the VAR model, which only included financial instruments like derivatives and market-sensitive equity investments. The VAR model's estimated one-day loss decreased from $284 million in 2023 to $255 million in 2024 due to lower interest rate volatility. While the hedge exposure grew, its impact on the VAR model was indirect, as firm commitments were not factored into the model's risk estimation framework.",
      "llm_answer": "Disney’s net foreign‑exchange cash‑flow hedge notional rose from $8.3 billion in 2023 to $9.9 billion in 2024. Because the VAR model excludes forecasted transactions, firm commitments and receivable/payable balances that are hedged, the larger hedge coverage meant a greater portion of firm commitments was omitted from the VAR calculation. This contributed to the drop in the combined VAR estimate from $284 million at year‑end 2023 to $255 million at year‑end 2024.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the quantitative figures: Disney's foreign exchange cash flow hedge notional increased from $8.3 billion in 2023 to $9.9 billion in 2024, and the combined VAR estimate decreased from $284 million to $255 million. These numbers match the ground truth exactly, earning full marks for quantitative accuracy. (2) However, the reasoning about *why* the VAR decreased is factually incorrect. The ground truth states that firm commitments were *excluded* from the VAR model and that the decrease in VAR was due to lower interest rate volatility, not because a 'greater portion of firm commitments was omitted' as the LLM claims. The LLM incorrectly implies that increasing hedge coverage caused more omissions from VAR, thereby reducing the risk estimate. This misrepresents the causal relationship. (3) The multi-hop reasoning fails: while the model correctly identifies the increase in hedges and the decrease in VAR, it fabricates a mechanism (omission of hedged firm commitments) that contradicts the ground truth—firm commitments were already excluded regardless of hedge size. The impact of the hedge change on VAR was indirect, not through exclusion dynamics. (4) Despite correct numbers and relevance to the question’s context, the qualitative inaccuracy in reasoning and misattribution of cause significantly undermines the answer’s correctness, warranting a mid-range score of 5. Contextual relevance is high as it addresses the core elements of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 416,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did MetLife's treatment of surplus notes under statutory accounting evolve between 2022 and 2024, and what does this indicate about their regulatory capital management strategy?",
      "original_answer": "In 2022, MetLife's statutory accounting practices treated surplus notes as surplus rather than debt, which directly impacted statutory capital and surplus calculations for its U.S. insurance subsidiaries. This treatment was a key distinction between statutory accounting and GAAP. By 2024, surplus notes were explicitly referenced in the context of debt structuring and financing arrangements, where they were described as subordinate to all other obligations of the issuing operating company but senior to obligations of MetLife, Inc. itself. Additionally, surplus notes were used as part of a collateral financing arrangement, indicating a strategic integration into the company's broader capital structure and liquidity planning. This evolution suggests that MetLife refined its use of surplus notes not only as a regulatory capital tool but also as a strategic instrument within its debt hierarchy and financing strategy.",
      "llm_answer": "In 2022, MetLife’s 10‑K did not list surplus notes as a separate line item in its long‑term debt schedule—statutory accounting notes were acknowledged but not disclosed individually. By 2024, the company reports a distinct “Surplus notes” class (face value $250 m, 7.80 % interest, 2025 maturity) that is subordinate to all other obligations of the issuing subsidiary but senior to MetLife, Inc., and requires regulatory approval for interest or principal payments. This evolution shows MetLife is actively using surplus notes as a statutory‑capital instrument to support collateral financing and maintain regulatory capital ratios, reflecting a strategy of leveraging these notes to optimize its regulatory capital structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: the $250M face value, 7.80% interest rate, and 2025 maturity of the surplus notes in 2024 are factually accurate and consistent with the knowledge graph. There are no calculation errors. (2) The answer correctly identifies the evolution: from not separately disclosing surplus notes in 2022 to explicitly reporting them as a distinct debt class in 2024. This reflects the shift in statutory accounting treatment. (3) The qualitative reasoning is sound—LLM correctly infers that surplus notes are subordinate to other subsidiary obligations but senior to MetLife, Inc., and that regulatory approval is required for payments, indicating strategic use in capital management. It also correctly links this to collateral financing and regulatory capital optimization. (4) The only minor omission is that the 2022 treatment was not just about disclosure but a fundamental classification of surplus notes as surplus (not debt) under statutory accounting, which the LLM implies but does not explicitly state. However, the core facts, multi-hop synthesis across years, and strategic interpretation are correct. Wording differs but meaning is semantically equivalent. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 390,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did the resolution of the VIL payment shortfall in 2023 influence AMT's strategic financial decisions regarding the VIL OCDs in 2024, particularly in light of the impairment charges recorded in 2022 and 2023?",
      "original_answer": "In 2023, VIL resumed full payments after a period of partial payments (the 'VIL Shortfall'), which had led AMT to record reserves and impairments totaling $508.6 million in 2022 and an additional $322.0 million goodwill impairment in 2023. This resolution likely contributed to AMT’s decision to convert and sell the VIL OCDs in 2024. Specifically, in March 2024, AMT converted 14.4 billion INR ($172.7 million) of VIL OCDs into equity, and subsequently sold those shares in April 2024 for $216.0 million. It also sold the remaining 1.6 billion INR ($19.2 million) of OCDs in June 2024, realizing a total gain of $46.4 million. These actions suggest that AMT used the improved financial stability of VIL to monetize its position in the OCDs, turning a previously risky receivable into a realized gain, while also reducing exposure to a volatile Indian market that had previously required significant impairment charges.",
      "llm_answer": "After VIL resumed full payments in the second half of 2023, AMT shifted from a cautious stance to actively monetizing its exposure. In 2024 the company converted most of the VIL OCDs into equity and then sold the shares and the remaining debentures, realizing a $46.4 million gain (page 120, page 119). This strategy was made possible by the cleared shortfall and the earlier impairment charges—$508.6 million in 2022 and $322.0 million in 2023—that had underscored the need to reduce India‑related risk (page 7).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts: VIL resumed full payments in 2023, AMT recorded $508.6 million in impairments in 2022 and an additional $322.0 million goodwill impairment in 2023, and in 2024 AMT converted and sold VIL OCDs, realizing a $46.4 million gain. All numeric values—impairment amounts, the final gain—are accurate and match the ground truth. The timing of the actions (conversion and sales in 2024) is correctly represented, though the LLM does not specify the exact months (March, April, June 2024) or break down the $172.7 million conversion and $216.0 million sale, which are present in the original. However, the total gain of $46.4 million is correctly stated, and the sequence of events is preserved. (2) Quantitative accuracy is perfect: $508.6M (2022), $322.0M (2023), and $46.4M gain in 2024 are all correct. The LLM does not misstate any figures or perform incorrect calculations. (3) The multi-hop reasoning is sound: it connects the resolution of the payment shortfall to the prior impairments, explains the shift in AMT’s strategy from risk mitigation to monetization, and correctly infers that the improved financial health of VIL enabled the conversion and sale. The synthesis across years and entities (AMT, VIL, OCDs, impairments, conversion, sale) is logically coherent. (4) The answer is contextually fully relevant, directly addressing how the resolution of the shortfall influenced AMT’s 2024 financial decisions regarding the OCDs, in light of prior impairments. The only minor omission is the lack of granular detail on the timing and breakdown of the conversion and sale amounts, which slightly reduces completeness but does not affect factual correctness. Hence, a score of 9 is justified—excellent accuracy with minor detail omissions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 490,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did the extension of reference rate reform relief under ASU 2022-06 impact FedEx's application of ASU 2020-04 between fiscal years 2022 and 2023, particularly in terms of contract monitoring and potential financial effects?",
      "original_answer": "In fiscal year 2022, FedEx noted that ASU 2020-04 applied through December 31, 2022, and while there was no material effect on financial condition or results of operations as of May 31, 2022, the company continued to monitor contracts for potential application of the guidance. With the issuance of ASU 2022-06 in December 2022, the sunset date for applying ASU 2020-04 was extended to December 31, 2024. This extension allowed FedEx more time to address the transition away from LIBOR and apply the optional expedients under ASU 2020-04 to a broader set of contracts. By fiscal year 2023, FedEx continued to monitor contracts affected by reference rate reform but still reported no material financial impact as of May 31, 2024, indicating that the extended relief provided by ASU 2022-06 gave the company additional time without immediate financial consequences.",
      "llm_answer": "FedEx’s extension of reference‑rate‑reform relief under ASU 2022‑06 simply prolonged the period during which it could use the optional expedients of ASU 2020‑04 for contracts and hedges that referenced LIBOR or other soon‑to‑be‑discontinued rates.  The company continued to monitor its contracts and transactions for potential application of ASU 2020‑04, but reported no material effect on its financial condition, results of operations or cash flows for FY 2022 or FY 2023 (Note 7, page 91).  The extension therefore did not materially alter FedEx’s accounting for reference‑rate reform, but it extended the monitoring window through December 31 2024 (Note 7, page 93).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: ASU 2022-06 extended the sunset date for ASU 2020-04 to December 31, 2024 (correctly noted as extending the application period through that date); FedEx continued monitoring contracts; no material financial impact was reported for FY 2022 or FY 2023 (consistent with ground truth stating no material effect as of May 31, 2022, and May 31, 2024). (2) Quantitative accuracy is perfect: dates (December 31, 2024 extension) and fiscal years (2022, 2023) match exactly; no numerical calculations required. (3) Multi-hop reasoning is sound—LLM correctly links ASU 2022-06’s extension to prolonged use of expedients under ASU 2020-04 and connects this to ongoing contract monitoring without material financial effects. (4) The only minor shortcoming is that the LLM does not explicitly mention that the extension allowed FedEx to apply the expedients to a broader set of contracts, which is a nuance present in the original answer. However, the core implications—extended monitoring window and no material impact—are fully captured. Wording differs slightly (e.g., 'cash flows' added by LLM, not in original), but this does not introduce inaccuracy. Overall, the answer is factually correct, contextually relevant, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 377,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did AMD's introduction of FPGAs in 2023 relate to the evolving export control restrictions under EAR in 2024, particularly regarding shipments to China and D5 countries?",
      "original_answer": "In 2023, AMD introduced FPGAs as part of its data center and embedded computing product portfolio, emphasizing their role in high-performance and adaptive computing. However, in October 2023, the Bureau of Industry and Security (BIS) issued new export controls under the Export Administration Regulation (EAR), which governs the export of certain AMD products, including FPGAs. These controls restricted AMD from shipping certain Versal™ FPGAs to China or customers with ultimate parents in D5 countries without a license. By 2024, these EAR-imposed restrictions had evolved to include additional notification and licensing requirements, such as the Notified Advanced Computing (NAC) process, which required AMD to notify BIS 25 days before shipping certain FPGAs to these regions. This regulatory evolution directly impacted AMD's ability to market and deliver its newly introduced FPGA products in 2023 to key international markets in 2024, increasing compliance complexity and potentially reducing sales opportunities.",
      "llm_answer": "AMD’s 2023 10‑K highlighted the launch of FPGA products—such as Versal, Virtex, and Kintex—into its data‑center portfolio (page 7).  In 2024, the Bureau of Industry and Security expanded EAR controls to cover those same FPGA products (ECCN 3A090/4A090), requiring a license or a Notified Advanced Computing (NAC) notice for any shipment to China or to customers whose ultimate parent is in a D5 country (page 32).  Consequently, AMD’s newly introduced FPGAs are now subject to stricter export restrictions that can block or delay shipments to China and other D5 jurisdictions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: AMD introduced FPGAs (Versal, Virtex, Kintex) in 2023 as part of its data center portfolio; in 2024, BIS expanded EAR controls to cover these FPGAs under ECCNs 3A090/4A090; shipments to China or customers with ultimate parents in D5 countries require either a license or a Notified Advanced Computing (NAC) notification. (2) Quantitative accuracy is perfect: dates (2023 product launch, 2024 regulatory update), product names, ECCN codes, and the 25-day NAC requirement (implied in 'notice') are all factually correct. The LLM correctly identifies the regulatory body (BIS), the regulatory framework (EAR), and the compliance mechanisms (license/NAC). (3) Multi-hop reasoning is sound: the answer connects AMD’s 2023 product introduction with 2024 export control changes, explaining the cause-effect relationship on market access. (4) The only minor omission is that the original answer specifies the October 2023 rule change as the starting point and explicitly mentions the 25-day notification requirement under NAC, which the LLM implies but does not state verbatim. However, this does not detract from the overall correctness. Wording differs but semantic meaning is equivalent. The answer is fully contextually relevant and addresses all parts of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 379,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did ConocoPhillips' financial guarantees related to APLNG in 2024 change compared to their equity investment and operational focus in Queensland, Australia in 2023, and what does this indicate about their risk exposure in the APLNG joint venture?",
      "original_answer": "In 2023, ConocoPhillips held a 47.5% equity stake in APLNG, which operated in Queensland, Australia, producing coal bed methane (CBM) and exporting LNG, with a reported $4.7 billion in outstanding project finance facilities. By 2024, ConocoPhillips had multiple financial guarantees tied to APLNG, including a $210 million guarantee related to a project finance reserve account withdrawal, a $610 million (up to $1.0 billion in case of intentional breach) guarantee for natural gas delivery commitments, and an additional $480 million in performance guarantees, with carrying values of $14 million, $34 million, and $14 million respectively. This indicates an increase in direct financial risk exposure to APLNG’s operational and contractual obligations, despite the company’s long-standing equity investment. The evolution from a primarily equity-based investment in 2023 to a more liability-driven position in 2024 suggests a deepening of COP's commitment and risk tied to APLNG's performance.",
      "llm_answer": "In 2024 ConocoPhillips disclosed three APLNG guarantees with maximum potential liabilities of $210 million, $610 million and $480 million (≈$1.3 billion total), whereas in 2023 the company held a $5.4 billion equity investment in APLNG and focused its operations on Queensland’s Bowen and Surat basins. The guarantee exposure is a relatively small fraction of the equity stake, indicating that while ConocoPhillips has substantial ownership and operational involvement, its contingent liability risk in the joint venture remains limited but could materialize if APLNG fails to meet its contractual obligations.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in the quantitative details. According to the ground truth, in 2023, ConocoPhillips had a 47.5% equity stake in APLNG and $4.7 billion in outstanding project finance facilities—not a $5.4 billion equity investment as stated in the LLM answer. This number is incorrect and not supported by the original data. Additionally, while the LLM correctly identifies the three categories of financial guarantees in 2024 ($210M, $610M, and $480M), it omits the critical detail that the $610M guarantee can increase to $1.0 billion in case of intentional breach, which is a significant risk factor. The LLM also fails to mention the carrying values of the guarantees ($14M, $34M, $14M), which indicate that while the maximum liabilities are high, the current accounting exposure is lower—this nuance is missing. (2) The calculation of total potential liability (~$1.3 billion) is arithmetically correct ($210M + $610M + $480M = $1.3B), but the comparison to a falsely inflated $5.4B equity stake (vs. actual $4.7B in project finance, not equity value) undermines the validity of the risk assessment. The equity stake percentage (47.5%) is omitted, weakening entity and financial context. (3) The reasoning is partially sound—recognizing that guarantees represent contingent liabilities and that they are smaller than the equity stake suggests limited relative risk. However, the original answer emphasizes a shift from equity-based investment to increased liability-driven exposure, indicating deeper risk entanglement. The LLM instead concludes that risk remains 'limited,' which contradicts the ground truth's interpretation of increased direct financial risk. This misjudges the multi-hop synthesis: from ownership in 2023 to expanded guarantees in 2024 signaling heightened exposure. (4) Scores reflect that core elements (existence of guarantees, operational focus in Queensland) are correct and contextually relevant, but major quantitative errors and flawed interpretation of risk exposure reduce correctness and qualitative accuracy. The answer addresses all question parts but with incorrect data and misleading conclusions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 589,
        "total_tokens": 2016
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did the increase in Disney's foreign exchange cash flow hedge notional amounts from $8.3 billion in 2023 to $9.9 billion in 2024 reflect a strategic shift in their use of option contracts to manage foreign currency liabilities?",
      "original_answer": "Disney's foreign exchange cash flow hedge notional amounts increased from $8.3 billion in 2023 to $9.9 billion in 2024, indicating a heightened focus on managing foreign currency liabilities. This increase was achieved primarily through the expanded use of option and forward contracts, which are used to protect the value of existing foreign currency assets and liabilities. The growth in hedge notional amounts suggests a more aggressive hedging strategy, particularly as the company transacts business globally in currencies such as the euro, Canadian dollar, Japanese yen, British pound, and Chinese yuan. The deferred gains of $99 million in AOCI for contracts maturing in the next twelve months further highlight the strategic emphasis on stabilizing earnings and cash flows against foreign exchange fluctuations.",
      "llm_answer": "Disney’s net foreign‑exchange cash‑flow hedge notional rose from $8.3 billion in 2023 to $9.9 billion in 2024 (page 121).  This jump reflects a deliberate expansion of its options‑based hedging program, indicating a shift toward using more option contracts to cover foreign‑currency liabilities and gain greater flexibility in managing currency risk.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the increase in Disney's foreign exchange cash flow hedge notional amounts from $8.3 billion in 2023 to $9.9 billion in 2024, which matches the ground truth exactly. These figures are accurate and properly attributed to the relevant years. (2) Quantitative accuracy is perfect—both values are correct, and the implied increase of $1.6 billion is consistent with the ground truth. No calculation errors are present. (3) The reasoning is mostly sound: the LLM correctly infers that the increase reflects a strategic shift toward greater use of option contracts for managing foreign currency liabilities. It appropriately links the rise in notional amounts to an expanded options-based hedging program and mentions the benefit of flexibility. However, it omits key details from the original answer, such as the use of forward contracts (not just options), the specific currencies involved (euro, Canadian dollar, etc.), and the mention of $99 million in deferred gains in AOCI, which strengthens the strategic rationale. These omissions reduce completeness and slightly weaken the qualitative accuracy. (4) Despite missing some contextual depth, the LLM answer captures the core strategic implication and factual basis, making it contextually relevant and largely accurate. The answer is concise but lacks full multi-hop synthesis present in the ground truth, such as connecting AOCI gains and global transaction currencies to the hedging strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 411,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did Mondelēz's approach to market risk modeling evolve between 2023 and 2024, and what specific factors contributed to the reduction in estimated one-day loss from $284 million to $255 million?",
      "original_answer": "Mondelēz updated its Value at Risk (VAR) modeling methodology between 2023 and 2024 by adopting a parametric delta-gamma approximation technique to estimate return distributions in interest rates, currencies, and commodity prices, replacing the earlier variance/co-variance approach. This methodological shift, combined with reduced interest rate volatility observed during the period, contributed to the decline in the estimated maximum potential one-day loss, which fell to $255 million by September 28, 2024, from $284 million on September 30, 2023. The new model incorporated more granular historical data, using movements from the prior quarter for quarterly calculations and data from the previous four quarters for annual averages, enhancing the precision of risk estimation.",
      "llm_answer": "Between 2023 and 2024 Mondelēz shifted its VAR model from a variance‑/co‑variance technique to a parametric delta‑gamma approximation, recalibrating the expected‑return distributions to the most recent quarter’s market movements while keeping the 95 % confidence level and one‑day horizon.  The one‑day loss estimate fell from $284 million to $255 million mainly because interest‑rate volatility had eased, reducing the VAR for interest‑rate‑sensitive instruments from $258 million to $235 million.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the shift in VAR methodology from variance/covariance to parametric delta-gamma approximation, accurately noting the recalibration using recent market movements. The dollar amounts are correct: the one-day loss decreased from $284 million to $255 million, and the LLM correctly attributes a significant portion of the decline to reduced interest rate volatility, specifically citing the drop in VAR for interest-rate-sensitive instruments from $258 million to $235 million. These numbers align with the ground truth in magnitude and direction, even if the latter detail is more granular than provided in the original answer. (2) Quantitatively, all figures—$284M, $255M, $235M, $258M—are accurately reported, and the time frame (between 2023 and 2024) is correctly implied by referencing the two fiscal year-ends. The 95% confidence level and one-day horizon are correctly retained, consistent with standard VAR assumptions. (3) The multi-hop reasoning is sound: the model connects the methodological change with market conditions (reduced volatility) as joint drivers of the lower VAR estimate. While the original answer emphasizes the use of more granular historical data (prior quarter for quarterly, four quarters for annual), the LLM captures this by referencing recalibration to the most recent quarter’s movements, which is a reasonable simplification. However, the LLM omits the explicit detail about data windowing (quarterly vs. four-quarter averages), which slightly reduces completeness. (4) The answer is contextually fully relevant, directly addressing both parts of the question: evolution of risk modeling and factors behind the VAR reduction. The omission of the precise data windowing structure prevents a perfect 10, but all key facts and logic are preserved with high fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 501,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did Duke Energy's classification of debt investments under AFS accounting policy change from 2022 to 2024, and what does this indicate about their investment strategy evolution given the immaterial realized gains and decommissioning reimbursements in 2024?",
      "original_answer": "In 2022, Duke Energy Carolinas explicitly stated that debt investments were classified as AFS (Available for Sale), while equity investments were classified as FV-NI (Fair Value through Net Income). By 2024, Duke Energy Indiana maintained the same AFS classification for debt investments, but the context expanded to include details about realized gains and losses from FV-NI and AFS securities being immaterial across 2022–2024. Additionally, Duke Energy Florida received reimbursements from the NDTF (Nuclear Decommissioning Trust Fund) in 2024 for decommissioning costs related to Crystal River Unit 3. This suggests that while the accounting policy remained stable, the company's broader investment and capital allocation strategy incorporated more passive tracking of gains/losses, possibly to focus on strategic decommissioning and regulatory reimbursements.",
      "llm_answer": "Duke Energy’s accounting policy for debt securities remained unchanged – the company continued to classify all debt holdings as available‑for‑sale (AFS) in both the 2022 and 2024 10‑K filings [page_191, page_196]. The 2024 realized gains on AFS securities were modest (14 m gains vs. 40 m losses) and the company received only small decommissioning reimbursements from the NDTF, indicating a conservative, long‑term investment strategy that prioritizes stable, regulatory‑accounted debt positions over active trading [page_195, page_197].",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Duke Energy maintained the AFS classification for debt investments from 2022 to 2024, which aligns with the ground truth. However, it introduces specific quantitative figures—$14M gains and $40M losses in 2024—that are not present in the original answer or implied by the ground truth. The ground truth states that realized gains and losses were 'immaterial' across 2022–2024 but does not provide exact numbers. These fabricated figures significantly undermine quantitative accuracy. (2) The mention of 'small decommissioning reimbursements' is partially consistent with the ground truth, which confirms Duke Energy Florida received NDTF reimbursements in 2024 for Crystal River Unit 3 decommissioning, though the original does not characterize them as 'small.' (3) The reasoning about a conservative, long-term strategy is a plausible interpretation but diverges from the ground truth’s emphasis on passive tracking of gains/losses and strategic focus on regulatory reimbursements and decommissioning. The LLM overreaches by inferring 'prioritizes stable, regulatory-accounted debt positions over active trading' without direct support. (4) While the core entity (Duke Energy), policy (AFS for debt), and time frame (2022–2024) are accurate, and the answer addresses the policy stability and strategic implication, the inclusion of unsupported numbers and slightly misaligned interpretation reduces correctness. The answer is contextually relevant and captures the high-level continuity in accounting policy, but the quantitative inaccuracies and speculative reasoning prevent a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 451,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did the structure and payout mechanics of dividend equivalents tied to share-based awards change from HD's 2022 disclosures to their 2024 disclosures, particularly in relation to the role of additional shares issued under equity compensation programs?",
      "original_answer": "In 2022, HD disclosed that dividend equivalents accrued on deferred shares granted to non-employee directors and were paid out in the form of additional shares upon termination of Board service. These additional shares were tied to equity transactions, including accelerated share repurchase (ASR) agreements with financial institutions, which resulted in treasury stock reductions and adjustments to weighted average share counts. By 2024, the dividend equivalents were primarily linked to performance share awards, where accruals were reinvested as additional shares and paid out based on performance metrics such as ROIC and operating profit over a three-year cycle, or in some cases, a five-year EBITDA- and stock price-linked cycle tied to the SRS acquisition. The shift indicates a move from fixed, service-based equity payouts to performance- and market-conditioned structures, with additional shares now playing a role in aligning long-term incentives with shareholder returns.",
      "llm_answer": "In both 2022 and 2024, dividend equivalents on restricted‑stock units, performance shares, and deferred shares accrue on unvested awards and are paid out in shares on the vesting or award‑payout date.  The 2024 filing, however, notes that the equity‑compensation share pool has been cut to 80 million shares (plus up to 10 million from outstanding awards) and can be increased by returning shares from terminated or expired awards, whereas the 2022 filing referenced a larger 255 million‑share pool without this adjustment mechanism.  Thus, while the payout mechanics stayed the same, the 2024 disclosures clarify that additional shares issued under equity programs are now part of a smaller, more flexible share pool that can be adjusted for terminated awards.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and fails to capture the core changes in dividend equivalent structure and payout mechanics from HD's 2022 to 2024 disclosures. (1) The claim that payout mechanics stayed the same is incorrect: the ground truth shows a fundamental shift from service-based (deferred shares for non-employee directors, paid upon termination) in 2022 to performance-based (tied to ROIC, operating profit, or EBITDA and stock price over multi-year cycles) in 2024. The LLM incorrectly asserts continuity in mechanics, missing this key transformation. (2) The quantitative details about share pools (80 million + 10 million vs. 255 million) are not present in the original answer and appear fabricated; the ground truth does not mention specific share pool sizes or adjustments for terminated awards. These numbers cannot be verified and contradict the focus of the original answer, which emphasizes structural and incentive alignment changes, not pool size mechanics. (3) The LLM misidentifies the types of awards: in 2022, dividend equivalents were specifically tied to deferred shares for non-employee directors, not broadly to restricted stock units or performance shares. In 2024, they are linked to performance share awards with specific metrics—details the LLM omits entirely. (4) The multi-hop reasoning is flawed: the question asks about changes in structure and payout mechanics in relation to additional shares issued; the LLM focuses narrowly on share pool size and flexibility, missing the shift from fixed, service-based payouts to performance- and market-conditioned structures that align with long-term shareholder returns. (5) While the answer is framed around HD and equity compensation, it introduces irrelevant details (e.g., ASR agreements, treasury stock reductions, SRS acquisition) that are absent from the LLM response, indicating a failure to synthesize the correct narrative. The answer is contextually relevant in topic but factually and structurally divergent from the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1463,
        "completion_tokens": 547,
        "total_tokens": 2011
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did Microsoft's introduction of the 3.400% Senior Notes due 2026 in 2023 relate to its acquisition of Activision Blizzard, Inc. in late 2023 and the subsequent exclusion of Activision Blizzard from Microsoft's 2024 internal control over financial reporting assessment?",
      "original_answer": "In 2023, Microsoft introduced the 3.400% Senior Notes due 2026 through a supplemental indenture, indicating its financial structuring activities. These notes were originally issued by Activision Blizzard, Inc., which Microsoft acquired on October 13, 2023. By 2024, Microsoft's 10-K filing excluded Activision Blizzard from its internal control over financial reporting assessment, citing that Activision Blizzard's financial statements represented less than 1% of total assets (excluding goodwill and intangibles) and 2% of total revenues. This suggests that while Microsoft had integrated Activision Blizzard financially (as seen through the assumption of its debt instruments), it had not yet fully incorporated Activision Blizzard’s internal controls into its broader compliance framework by June 30, 2024.",
      "llm_answer": "Microsoft introduced the 3.400% Senior Notes due 2026 as part of Activision’s debt structure, with a supplemental indenture dated October 27 2023 (Exhibit 4.23).  The notes were inherited when Microsoft closed its acquisition of Activision on October 13 2023, and in its 2024 10‑K Microsoft noted that Activision’s financial statements represented less than 1 % of assets and 2 % of revenue, so its internal controls were excluded from the company’s internal‑control‑over‑financial‑reporting assessment (pages 98‑99).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Microsoft inherited the 3.400% Senior Notes due 2026 through its acquisition of Activision Blizzard on October 13, 2023, and that a supplemental indenture was dated October 27, 2023 (Exhibit 4.23), which aligns with the ground truth. The percentages for Activision Blizzard's contribution to Microsoft's total assets (<1%) and revenues (<2%) are accurately reported, and the exclusion from the internal control over financial reporting assessment in the 2024 10-K is correctly stated. (2) All numeric values—dates (October 13 and October 27, 2023), percentages (1%, 2%), and note details (3.400%, due 2026)—are factually correct and match the ground truth. No calculations are required, but comparisons (e.g., 'less than 1%') are accurately conveyed. (3) The multi-hop reasoning is sound: the LLM connects the issuance of debt by Activision Blizzard, its acquisition by Microsoft, the assumption of debt, and the subsequent exclusion from internal controls assessment based on materiality thresholds. It correctly infers that the exclusion was due to size thresholds, though it omits the explicit mention of 'goodwill and intangibles' in the asset exclusion criterion, which slightly weakens completeness. (4) The answer is semantically equivalent to the ground truth, with only minor omission of the nuance that the <1% asset threshold excludes goodwill and intangibles. Otherwise, all key facts, entities, dates, and logic are preserved and accurately synthesized. Hence, high scores across all dimensions with a minor deduction in qualitative accuracy for the omitted detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 447,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did ConocoPhillips' evolving reliance on coalbed methane (CBM) feedstock in 2022 relate to its financial guarantees and ownership stake in APLNG by 2024, particularly in terms of risk exposure and investment commitment?",
      "original_answer": "In 2022, ConocoPhillips (COP) listed coalbed methane (CBM) as a key raw material it depends on. By 2024, this dependency was directly tied to its 47.5% ownership stake in APLNG, a joint venture focused on producing CBM from the Bowen and Surat basins in Australia for LNG processing and export. This strategic alignment with CBM feedstock was accompanied by significant financial guarantees from COP to support APLNG, including a $210 million guarantee with a six-year term and a $610 million (or up to $1.0 billion in case of reckless breach) guarantee tied to APLNG's gas delivery obligations under long-term sales agreements. These guarantees, totaling over $1.8 billion in potential exposure, reflect COP's deepening commitment to CBM as a core upstream resource and APLNG as a critical downstream asset in its LNG portfolio.",
      "llm_answer": "In 2022 ConocoPhillips increased its reliance on CBM feedstock by buying an additional 10 % stake in APLNG for about $1.4 billion, raising its ownership to 47.5 % (page_92). By 2024 the company’s equity investment in APLNG was valued at roughly $5 billion, and it had issued multiple guarantees with a combined potential exposure of about $1.3 billion (210 + 610 + 480 million) to support APLNG’s financing and performance (page_94, page_101). This evolution reflects a significant investment commitment to CBM‑derived LNG and a corresponding increase in financial risk exposure through the guarantees.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. First, it claims that ConocoPhillips 'increased its reliance on CBM feedstock by buying an additional 10% stake in APLNG for about $1.4 billion' in 2022, which is not supported by the ground truth. The original answer does not mention any such transaction or acquisition in 2022, nor does it state that the 47.5% ownership was achieved via a 10% purchase. This is a significant fabrication. Second, the LLM states that the total guarantees amount to 'about $1.3 billion (210 + 610 + 480 million)', but the ground truth only mentions two guarantees: $210 million and $610 million (with a possible increase to $1.0 billion in case of reckless breach), totaling over $1.8 billion in potential exposure. The $480 million figure is entirely absent from the ground truth and appears to be invented. Additionally, the claim that the equity investment was valued at $5 billion by 2024 is not present in the original answer and cannot be verified. (2) Quantitative accuracy is low: the $1.4 billion purchase, $480 million guarantee, and $5 billion valuation are all unsupported. The correct guarantees should sum to over $1.8 billion, not $1.3 billion. The 47.5% ownership stake is correctly stated, as is the $210M and $610M figures, but their interpretation and summation are flawed. (3) The multi-hop reasoning is partially sound—linking CBM reliance to APLNG ownership and financial guarantees is valid—but the logic is undermined by fabricated transactions and numbers. The model attempts to synthesize across time and entities but does so with incorrect data. (4) Contextual relevance is high because the answer addresses the core themes: CBM reliance, ownership in APLNG, financial guarantees, risk exposure, and investment commitment. However, the factual foundation is weak, leading to a low correctness score despite relevant structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 515,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did the change in Verizon's leasing strategy for wireless towers from 2023 to 2024, including the new transaction with Vertical Bridge, affect its ongoing relationship and financial obligations with American Tower Corporation?",
      "original_answer": "In 2023, Verizon maintained a long-standing leasing relationship with American Tower Corporation, subleasing capacity on approximately 11,300 towers at market rates from the 2015 agreement. By 2024, Verizon introduced a new leasing partner, Vertical Bridge, through which it leased over 6,000 additional towers under a 30-year average term with renewal options. This shift introduced a dual leasing model, where Verizon continues to sublease from American Tower while also subleasing from Vertical Bridge. Financially, Verizon recorded a $2.0 billion prepaid rent and $830 million financing obligation related to the Vertical Bridge deal, indicating a more complex capital structure and risk profile. Despite this, Verizon remains the primary obligor on the underlying ground leases for both American Tower and Vertical Bridge, maintaining similar exposure to lease liabilities as in 2023, though now across two leasing partners.",
      "llm_answer": "Verizon’s 2024 shift to lease towers through Vertical Bridge did not alter its existing sublease arrangement with American Tower.  Verizon still subleases capacity from American Tower for a minimum of 10 years at market rates and remains the primary obligor for the underlying ground leases.  The new Vertical Bridge transaction added a $2.8 billion upfront payment, $2.0 billion prepaid rent and an $830 million financing obligation for towers Verizon continues to occupy, but it left Verizon’s financial obligations to American Tower unchanged.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Verizon maintained its relationship with American Tower and added Vertical Bridge as a new leasing partner, and that Verizon remains the primary obligor on ground leases. However, there is a significant quantitative discrepancy: the LLM states a '$2.8 billion upfront payment', which is not mentioned in the ground truth. The ground truth specifies a $2.0 billion prepaid rent and $830 million financing obligation—these two figures sum to $2.83 billion, so the $2.8 billion figure may be a rounded total, but presenting it as an 'upfront payment' conflates two distinct financial instruments and introduces a term ('upfront payment') not in the original, leading to potential misinterpretation. This affects factual precision. (2) The numbers $2.0 billion (prepaid rent) and $830 million (financing obligation) are accurately reported from the ground truth. However, the synthesis of these into a single 'upfront payment' of $2.8 billion is misleading and not semantically equivalent—it implies a single cash outflow rather than separate accounting entries. The 11,300 towers from American Tower and over 6,000 from Vertical Bridge are not both mentioned in the LLM answer, missing a key detail about scale. (3) The multi-hop reasoning is mostly sound: the model correctly infers that the new arrangement with Vertical Bridge does not terminate the prior relationship with American Tower and that obligations to American Tower remain unchanged. It also correctly identifies the ongoing risk via primary obligor status. However, it fails to mention the dual leasing model explicitly or the 30-year average term with renewal options, which are important qualitative aspects of the strategic shift. (4) The correctness score is 7 because the core financial figures are present and the main conclusion about unchanged obligations to American Tower is valid. Quantitative accuracy is penalized due to the misleading aggregation and introduction of an unsupported term ('upfront payment'). Qualitative accuracy is high due to correct entity identification and logical flow. Contextual relevance is strong as the answer directly addresses the question’s focus on financial obligations and relationships.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 602,
        "total_tokens": 1991
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did the evolution of MetLife's Information Security Program from 2022 to 2024 impact its approach to preventing data destruction risks, particularly in terms of governance structure and incident response mechanisms?",
      "original_answer": "In 2022, MetLife's Information Security Program was overseen by the CISO, who reported to the ERC, Audit Committee, and the Board, with a primary goal of preventing data destruction through physical, technical, and administrative safeguards aligned with NIST cybersecurity frameworks. By 2024, the Program had evolved to include a dedicated cybersecurity incident response team under the CISO, annual cross-functional incident response exercises involving senior executives and the Board, and continuous monitoring of high-risk vendors. These changes indicate a shift from a general risk-based framework to a more structured, proactive, and board-integrated approach to preventing data destruction, with enhanced governance and operational resilience mechanisms.",
      "llm_answer": "Between 2022 and 2024 MetLife shifted from a general CISO‑led oversight that reported to the ERC, Audit Committee and Board to a more formal governance framework that includes a dedicated cybersecurity incident‑response team and an incident‑response plan co‑managed by the CISO and Chief Privacy Officer.  The 2024 program now requires annual cross‑functional exercises, more frequent Board and Audit Committee updates, and a clear, tested response protocol that strengthens monitoring, containment and remediation of threats, thereby enhancing the prevention of data exfiltration, manipulation and destruction.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of MetLife's Information Security Program from 2022 to 2024. It correctly identifies the governance structure in 2022 with CISO oversight and reporting to the ERC, Audit Committee, and Board. It accurately reflects the 2024 enhancements: a dedicated incident response team, annual cross-functional exercises, and increased board engagement. The mention of co-management by the CISO and Chief Privacy Officer is a minor addition not explicitly in the ground truth but plausible and not contradictory. The focus on enhanced monitoring, containment, and remediation aligns with the ground truth's emphasis on proactive and board-integrated mechanisms. All dates (2022, 2024) and entities (MetLife, CISO, ERC, Audit Committee, Board) are correct. There are no numerical inaccuracies (quantitative accuracy is perfect). The reasoning correctly synthesizes multi-hop information across time and governance layers. The only minor gap is the absence of explicit mention of 'continuous monitoring of high-risk vendors' and 'NIST frameworks' from the original, which slightly affects completeness but does not undermine the overall correctness. Semantic equivalence is strong, and the answer is fully contextually relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 356,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did the changes in SPG's mortgage debt structure between 2023 and 2024 affect the company's exposure to cross-default provisions and its ability to meet financial covenants?",
      "original_answer": "In 2023, SPG had $5.2 billion in mortgage indebtedness with cross-default provisions affecting five properties across two pools, increasing exposure to potential acceleration if any single mortgage defaulted. By 2024, SPG's financing strategy included greater reliance on unsecured debt through the $2.0 billion Commercial Paper program and Supplemental Facility, which introduced financial covenants tied to corporate credit ratings. This shift likely reduced SPG's exposure to property-level cross-default risks but increased sensitivity to credit rating changes, as seen in the Supplemental Facility's SOFR plus 72.5 basis point rate based on current ratings. The transition from secured to unsecured financing reflects a strategic move to manage covenant compliance more flexibly while reducing asset-specific risk.",
      "llm_answer": "In 2023, SPG’s mortgage portfolio totaled $5.2 billion and included two cross‑default pools that covered five properties, creating a material exposure to cross‑default triggers (SPG 10‑K 2023, p. 70).  At that time the company was still in compliance with all covenants of its unsecured debt (p. 70).  By 2024 SPG had re‑structured its mortgage debt, eliminating the cross‑default pools and thereby reducing the risk of a default in one mortgage cascading to the others.  The restructuring helped the company remain in compliance with its financial covenants – evidenced by the absence of borrowings under the Credit Facility and the statement that SPG was in compliance with covenants at December 31, 2024 (CAT 10‑K 2024, p. 106).  The 2024 filing also notes that mortgage debt remains part of the company’s financing mix (SPG 10‑K 2024, p. 9).",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the $5.2 billion mortgage indebtedness in 2023 and the existence of two cross-default pools covering five properties, which aligns with the ground truth (SPG 10-K 2023, p. 70). This satisfies quantitative accuracy for the 2023 data. However, the LLM claims that by 2024 SPG 'eliminated the cross-default pools,' which is not supported by the original answer or known filings—the ground truth states that SPG shifted toward unsecured debt (Commercial Paper program and Supplemental Facility), but does not confirm elimination of cross-default provisions. This is a significant qualitative error in reasoning and factual claim. The LLM also references 'CAT 10-K 2024' as a source for SPG's covenant compliance in 2024, which is incorrect—CAT refers to Caterpillar, not Simon Property Group (SPG). This is a critical entity error that undermines the validity of the citation and suggests confusion between companies. While the LLM correctly notes that SPG remained in compliance with financial covenants and used unsecured facilities, it misattributes the mechanism (eliminating cross-defaults) and sources. The strategic shift toward unsecured debt and increased sensitivity to credit ratings—key points in the original answer—are underdeveloped in the LLM response. The mention of no borrowings under the Credit Facility and continued use of mortgage debt adds contextual relevance. Overall, the answer captures some correct facts and the general direction of risk management but fails in multi-hop reasoning due to incorrect entity sourcing and unsupported claims about structural changes, leading to a partial correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 452,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did the resolution of the European Court of Justice in December 2023 impact Amazon's Luxembourg tax position compared to 2022, particularly in light of the appeals process initiated by both Amazon and Luxembourg following the original State Aid Decision?",
      "original_answer": "In 2022, Amazon was in the process of appealing the European Commission's 2017 State Aid Decision, which had ruled that Luxembourg's tax treatment of Amazon did not comply with EU rules and ordered recovery of approximately €250 million in back taxes plus interest. Amazon had deposited an initial recovery amount into escrow in March 2018. By December 2023, the European Court of Justice affirmed the annulment of the European Commission's decision, which significantly favored Amazon. This resolution likely reduced Amazon's Luxembourg-related tax contingencies and altered its financial exposure in the jurisdiction. The accrued interest and penalties related to tax contingencies increased from $110 million in 2021 (as disclosed in the 2022 filing) to $194 million by December 2023, reflecting ongoing global tax disputes but potentially signaling a shift in focus away from the previously dominant Luxembourg-related state aid issue.",
      "llm_answer": "The European Court of Justice’s December 2023 ruling affirmed the General Court’s annulment of the Commission’s state‑aid decision, effectively wiping out the €250 million recovery that had been estimated for Luxembourg and removing that specific liability from Amazon’s tax picture【page_67】.  Consequently, Amazon’s Luxembourg tax position in 2023 is more favorable than in 2022, even though the overall gross tax contingencies rose from $4,002 million in 2022 to $5,228 million in 2023【page_67】.  The appeals chain—Luxembourg’s appeal in 2017, Amazon’s appeal in 2018, the General Court’s annulment in 2021, and the Commission’s appeal to the ECJ—culminated in the ECJ decision that ended the dispute.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the December 2023 European Court of Justice (ECJ) ruling affirming the annulment of the European Commission’s 2017 State Aid Decision, which had required recovery of ~€250 million in back taxes from Amazon—this liability was effectively removed, benefiting Amazon’s Luxembourg tax position. (2) The quantitative details are mostly correct: the LLM cites the increase in gross tax contingencies from $4,002 million in 2022 to $5,228 million in 2023, which reflects overall global tax disputes despite the favorable resolution in Luxembourg. While the ground truth mentions accrued interest and penalties rising from $110M (2021) to $194M (2023), the LLM instead references total gross tax contingencies, which is a broader but related metric. This is a minor deviation but not factually incorrect—just a different emphasis. (3) The multi-hop reasoning is sound: the LLM traces the appeals process accurately—Luxembourg and Amazon appealed the 2017 decision, the General Court annulled it in 2021, the Commission appealed to the ECJ, and the ECJ upheld the annulment in December 2023. (4) The conclusion that Amazon’s Luxembourg tax position improved in 2023 versus 2022 is correct and well-supported. The only minor shortcoming is the lack of explicit mention of the $194 million interest/penalties figure from the ground truth, and the escrow deposit in 2018, which adds context. However, the core facts, numbers, and logic are correct, with only slight omission of secondary details. Hence, a score of 9 is appropriate—excellent but not perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 448,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did the indefinite delay of the Final Foreign Tax Credit Regulations, as influenced by Notice 2023-80 in 2024, impact Microsoft's effective tax rate compared to 2023, and what was the resulting effect on the geographic distribution of its pre-tax income?",
      "original_answer": "The indefinite delay of the Final Foreign Tax Credit Regulations through Notice 2023-80 in 2024 provided Microsoft with continued flexibility in managing its foreign tax credits, contributing to a lower effective tax rate of 18% in 2024 compared to 19% in 2023. This regulatory relief allowed Microsoft to maintain a higher proportion of pre-tax income in foreign jurisdictions, particularly Ireland, where its regional operating center generated 83% of foreign pre-tax income in 2024 versus 81% in 2023. The combination of favorable tax treatment and delayed compliance requirements enabled Microsoft to optimize its global tax position, resulting in a $10.0 billion increase in foreign pre-tax income (from $36.4 billion in 2023 to $44.9 billion in 2024), while U.S. pre-tax income rose by $10.0 billion (from $52.9 billion to $62.9 billion).",
      "llm_answer": "Notice 2023‑80’s indefinite postponement of the final foreign tax‑credit regulations lowered Microsoft’s effective tax rate to 18 % (18.2 %) in fiscal 2024 from 19 % in fiscal 2023 (page 47).  The geographic split of pre‑tax income stayed essentially the same – foreign earnings still dominated, with Ireland accounting for roughly 83 % of the $44.9 B foreign pre‑tax income in 2024 versus 81 % of $36.4 B in 2023, while U.S. pre‑tax income rose from $52.9 B to $62.9 B (page 82).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key facts: Microsoft's effective tax rate decreased from 19% in 2023 to 18% (noting 18.2% as a more precise figure, which is consistent with rounding to 18%), foreign pre-tax income increased from $36.4B to $44.9B, U.S. pre-tax income rose from $52.9B to $62.9B, and Ireland's share of foreign pre-tax income increased from 81% to 83%. All numeric values match the ground truth exactly or with acceptable precision. (2) Quantitative accuracy is perfect: all dollar amounts, percentages, and year references are correct. The $10.0B increase in both foreign and U.S. pre-tax income is accurately reflected. (3) The reasoning correctly links the regulatory delay (Notice 2023-80) to Microsoft’s lower tax rate and favorable geographic income distribution. While the LLM answer does not explicitly state that the regulatory relief 'enabled optimization' or 'contributed to' the income shift (as in the original), it implies causality by juxtaposing the regulation delay with the tax rate and income changes, which is reasonable. It omits the explicit phrase about 'continued flexibility' and 'maintaining a higher proportion', but the core multi-hop synthesis—regulatory change → tax outcome → geographic income effect—is intact. (4) The answer is fully contextually relevant, directly addressing both parts of the question: impact on effective tax rate and effect on geographic distribution. The only minor shortcoming is slightly less explicit articulation of the causal mechanism compared to the original, but no factual or logical errors are present. Hence, correctness is 9/10, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 464,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did SPG's application of ASU 2021-01 in 2023 influence their compliance with ASU 2020-04 by 2024, particularly in relation to the transition away from LIBOR in their debt instruments?",
      "original_answer": "In 2023, SPG applied ASU 2021-01, which clarified and expanded the scope of optional expedients under ASU 2020-04, allowing for smoother contract modifications related to reference rate reform, especially the transition from LIBOR to alternative benchmark indexes. By 2024, SPG remained subject to ASU 2020-04 and had elected these expedients in conjunction with transitioning certain debt instruments, as noted in Note 7 of their 2024 filings. The application of ASU 2021-01 in 2023 directly enabled SPG to more effectively comply with ASU 2020-04 through 2024 by reducing the complexity and financial impact of modifying contracts affected by the LIBOR phaseout. The guidance had no material impact on SPG’s consolidated financial statements, but it streamlined the transition process across both years.",
      "llm_answer": "SPG applied ASU 2021‑01 in 2023 to transition certain LIBOR‑based debt to alternative benchmark indexes, thereby exercising the optional relief under ASU 2020‑04.  This ensured compliance with ASU 2020‑04 through its December 31 2024 sunset date and had no material impact on the consolidated financial statements (SPG 2023, pp. 111‑112; SPG 2024, p. 110).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) All key facts are correct: SPG applied ASU 2021-01 in 2023 to support the transition from LIBOR to alternative benchmarks, used optional expedients under ASU 2020-04, and this had no material impact on financial statements. The mention of compliance through the 2024 sunset date of ASU 2020-04 is consistent with the original answer. (2) Quantitative accuracy is perfect: no incorrect numbers, dates, or financial figures; the reference to specific filing pages (e.g., SPG 2023 pp. 111–112, SPG 2024 p. 110) supports verifiability and matches expected disclosure locations. (3) Multi-hop reasoning is sound: the model correctly links the application of ASU 2021-01 in 2023 to ongoing compliance with ASU 2020-04 through 2024, recognizing the interplay between the two standards in the context of LIBOR transition. (4) The only minor shortcoming is that the LLM omits a brief mention from the ground truth about ASU 2021-01 expanding the scope of optional expedients, which adds nuance to how it 'enabled' smoother compliance. However, the core causal relationship and practical outcome are accurately conveyed. Wording differs slightly but maintains semantic equivalence. Overall, the answer is highly accurate, relevant, and well-supported.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 366,
        "total_tokens": 1667
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did the elimination of Class B common stock between 2022 and 2024 impact the voting power dynamics of Class A common stockholders, given the concentrated ownership in Class B shares previously?",
      "original_answer": "In 2022, holders of Class A common stock held 66 2/3% of the combined voting power, while Class B common stock, which had 15 votes per share and was concentrated in Mr. Brian L. Roberts, accounted for the remaining 33 1/3%. By 2024, Class B common stock was no longer listed in the capital structure, effectively eliminating the dual-class voting structure. This shift redistributed the voting power previously concentrated in the 9.4 million Class B shares among Class A shareholders, who increased from 3.78 billion to 3.97 billion outstanding shares. As a result, the voting power that was once shared between two classes became consolidated under Class A, likely reducing the influence of any single shareholder while increasing the relative influence of broader Class A shareholders.",
      "llm_answer": "The 2022 10‑K shows that Class B shares—held exclusively by Mr. Roberts—represented 33 ⅓ % of Comcast’s combined voting power, leaving Class A shareholders with 66 ⅔ % (page 38).  Eliminating the Class B class would have removed that 33 ⅓ % block, raising Class A’s share of the total voting power to 100 % and thereby diluting the concentrated influence that Mr. Roberts previously wielded.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core impact of the elimination of Class B shares on voting power dynamics. (1) Quantitatively, it correctly states that in 2022, Class B held 33 1/3% and Class A held 66 2/3% of voting power, and that eliminating Class B would shift full voting power to Class A—this aligns with the ground truth. The claim that Class A’s voting share would rise to 100% is logically sound and semantically equivalent to the original answer’s description of consolidation under Class A. (2) However, the LLM omits key details present in the ground truth: the actual increase in outstanding Class A shares from 3.78 billion to 3.97 billion and the fact that 9.4 million Class B shares were eliminated. While not strictly necessary to answer the question about voting power dynamics, these omissions reduce completeness, particularly regarding the mechanism of redistribution. (3) The reasoning is sound—correctly inferring that removing a high-vote, concentrated class dilutes individual control (Mr. Roberts’) and enhances broader shareholder influence. It correctly synthesizes ownership concentration and voting rights across time (2022 to 2024), though it does not explicitly confirm the 2024 elimination from the capital structure as stated in the original. (4) Entity accuracy is strong: Mr. Brian L. Roberts is correctly identified as the exclusive holder, and the years (2022, implication of change by 2024) are contextually accurate. The answer is highly relevant and focused on the question. The score is reduced slightly for missing quantitative details about share count changes, which are part of the multi-hop synthesis in the ground truth, but the core logic and numerical accuracy of voting power percentages remain intact.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 479,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did the change in SPG's investment relationship with SPARC Group from 2023 to 2024, including J.C. Penney's acquisition of SPARC Group, impact SPG's lease income from these retailers in 2024 compared to 2023?",
      "original_answer": "In 2023, SPG reported $101.8 million in lease income from its investments in SPARC Group and J.C. Penney. In 2024, following J.C. Penney's acquisition of SPARC Group's retail operations and the formation of Catalyst, SPG's lease income from the combined entity (Catalyst) increased slightly to $105.9 million. This reflects a continuation of SPG’s revenue stream from these tenants despite the structural change in ownership, indicating a stable leasing relationship post-acquisition.",
      "llm_answer": "The lease income from J.C. Penney and SPARC Group rose in 2024 versus 2023.  Net of eliminations, it increased from $101.8 million in 2023 to $105.9 million in 2024—an uptick of $4.1 million (≈4 %)—reflecting the altered investment relationship after J.C. Penney’s acquisition of SPARC Group.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: SPG's lease income increased from $101.8 million in 2023 to $105.9 million in 2024, which is a $4.1 million increase, and the context of J.C. Penney's acquisition of SPARC Group is correctly referenced. (2) Quantitative accuracy is perfect: both dollar amounts match the original answer, and the implied difference ($105.9M - $101.8M = $4.1M) is accurate; the ≈4% increase is a reasonable approximation (4.03%). (3) The multi-hop reasoning is sound—LLM correctly links the ownership change (J.C. Penney acquiring SPARC) to the impact on SPG’s lease income and notes the continuity of revenue despite structural changes. (4) The only minor shortcoming is that the LLM does not explicitly name the new combined entity 'Catalyst' or clarify that the 2024 income comes from the post-acquisition combined entity, which slightly reduces qualitative completeness. However, this does not detract significantly from the overall correctness. The answer remains semantically equivalent and contextually fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 319,
        "total_tokens": 1529
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did UPS's approach to adjusting net asset values for real estate investments in its pension plans evolve from 2022 to 2023, particularly in light of auditor concerns about the subjectivity of these estimates?",
      "original_answer": "In 2022, UPS adjusted NAV estimates for real estate investments based on investment activity between the date of fund managers’ financial reports and year-end, with auditors highlighting significant subjectivity and the need for direct confirmation with fund managers. By 2023, while the overall valuation methodology remained consistent—still relying on NAV as a practical expedient—UPS provided more detailed disclosures about the inherent limitations in determining fair values for these investments, including the potential for discrepancies between reported NAV and actual market value. The company also maintained transparency about unfunded commitments totaling $3.3 billion as of December 31, 2023, signaling continued long-term exposure to these less liquid assets.",
      "llm_answer": "UPS used the same NAV‑based method in both years, valuing real‑estate pension‑plan holdings at the most recent partnership audited reports and adjusting for post‑report‑date activity (2022, p. 66).  In 2022 the auditor flagged this approach as highly subjective, noting that the estimates required significant judgment (2022, p. 66).  The 2023 filing repeats the NAV valuation, describing it as a practical expedient and acknowledging that fair values may differ from market values, but it does not reiterate the auditor’s critical‑audit‑matter language, indicating the methodology remained unchanged while the company continued to recognize its subjectivity (2023, p. 89).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: UPS used NAV-based valuation in both 2022 and 2023, adjusted for post-report-date activity, and the auditor flagged subjectivity in 2022. The 2023 filing maintained the same methodology, acknowledged limitations in fair value estimation, and treated NAV as a practical expedient. (2) There are no numeric inaccuracies—while no specific dollar amounts appear in the LLM answer, the ground truth’s $3.3 billion unfunded commitment is the only quantitative figure, and its absence in the LLM response is a minor completeness gap, not a factual error. The LLM correctly references page numbers and audit language. (3) Multi-hop reasoning is sound: the model synthesizes auditor concerns in 2022 with the continued use and disclosure in 2023, correctly noting the absence of repeated critical audit matter language, which implies ongoing but acknowledged subjectivity. (4) The LLM omits the explicit mention of $3.3 billion in unfunded commitments as of December 31, 2023—a detail present in the original answer that adds context about long-term exposure. This is a minor omission affecting completeness but does not undermine the core correctness. Wording differs but semantic meaning matches. Thus, the answer earns a 9 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 395,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did Southern Company's FERC-approved 2023 energy procurement strategy position its SNG investment for the $3 billion pipeline project announced in 2024?",
      "original_answer": "Southern Company's 2023 energy procurement strategy, which was conducted in accordance with FERC-approved agreements, reduced purchased power expenses by $21 million due to lower natural gas prices and internal generation availability. This cost management approach likely freed up capital resources, enabling Southern Company to support SNG’s proposed $3 billion pipeline project in 2024, which aims to increase pipeline capacity by 1.3 billion cubic feet per day. The company’s 50% stake in SNG was further validated in 2024 by a rise in equity method earnings to $146 million, up from $139 million in 2023, demonstrating the financial alignment and strategic positioning of the investment ahead of the pipeline project’s anticipated completion in 2029.",
      "llm_answer": "Southern Company’s 2023 energy‑procurement strategy, approved by FERC, positioned its Southern Company Gas (SNG) unit as a 50 % cost‑sharing partner in the $3 billion pipeline announced in 2024.  The joint‑venture arrangement, which requires FERC approval, aligns SNG’s investment directly with the pipeline’s expansion and future revenue streams【page 92】【page 92】【page 90】.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partial correctness but misses key factual elements from the ground truth. It incorrectly frames SNG as a '50% cost-sharing partner' in the pipeline project, while the original answer states Southern Company has a 50% stake in SNG — a crucial distinction that the model conflates. The $3 billion figure and 2024 announcement are correctly referenced, but the LLM omits the critical financial context of the $21 million reduction in purchased power expenses from the 2023 procurement strategy, which directly supported capital allocation for the project. Additionally, the LLM fails to mention the increase in equity method earnings from $139M to $146M, a key indicator of financial alignment and strategic positioning. (2) Quantitatively, the $3 billion and 50% figures are present but misapplied — the 50% refers to ownership stake, not cost-sharing in the pipeline JV, and no other numbers (e.g., $21M savings, 1.3 Bcf/day capacity increase, 2029 completion) are mentioned. Calculations are not attempted, but key metrics are missing. (3) The multi-hop reasoning is flawed: the model fails to connect the 2023 cost savings to capital availability for the 2024 project, which is the core causal logic in the ground truth. Instead, it invents a 'joint-venture arrangement' not mentioned in the original, introducing unsupported contractual details. (4) Contextual relevance is moderate — the answer addresses Southern Company, SNG, FERC, and the pipeline project, but misrepresents the nature of the investment and omits the financial performance data that validates the strategic positioning. The citation of 'page 92' twice and 'page 90' lacks verification but suggests an attempt to ground in source material. Overall, the answer captures surface-level entities but fails on deeper financial and strategic synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 503,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did Johnson & Johnson's strategy for managing talc-related liabilities evolve from 2023 to 2024, particularly in relation to LTL Management LLC's bankruptcy filings and the subsequent restructuring under Red River Talc LLC?",
      "original_answer": "In 2023, JNJ created LTL Management LLC as part of a corporate restructuring in 2021 to isolate talc-related liabilities, and LTL filed for bankruptcy (LTL Bankruptcy Case), which was dismissed in July 2023. Despite an appeal, the Third Circuit affirmed the dismissal in July 2024. In response, JNJ pursued a 'prepackaged' Chapter 11 bankruptcy plan and restructured LLT (formerly LTL) into three new Texas entities in August 2024, including Red River Talc LLC, which filed its own bankruptcy case in September 2024 to advance the proposed $8.0 billion resolution plan. This reflects a strategic pivot from attempting to shield liabilities under LTL to creating a new entity structure to facilitate a consensual bankruptcy resolution.",
      "llm_answer": "Johnson & Johnson’s talc‑liability strategy shifted from a “multiple‑path” approach in 2023—appealing the LTL 2 bankruptcy dismissal, litigating, and pursuing affirmative claims—to a single pre‑packaged bankruptcy plan in 2024.  In 2023 the company re‑filed LTL Management LLC (now LLT) and began soliciting a consensual “pre‑packaged” Chapter 11 plan that would resolve 99.75 % of claims (page 101).  By August 2024 LLT restructured into Red River Talc LLC, which filed its own Chapter 11 petition and secured a temporary restraining order to stay all claims, with the proposed plan backed by a $6.5 billion present‑value reserve (pages 102‑103).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general strategic shift in Johnson & Johnson's approach from 2023 to 2024 but contains significant factual inaccuracies, particularly in quantitative details. (1) Correct elements: The pivot from appealing the LTL bankruptcy dismissal to pursuing a prepackaged Chapter 11 plan via restructuring into Red River Talc LLC is accurately described. The mention of a consensual prepackaged plan and the use of a new entity to file for bankruptcy in 2024 aligns with the ground truth. (2) Quantitative inaccuracies: The LLM states a '$6.5 billion present-value reserve' while the ground truth specifies an '$8.0 billion resolution plan'—a material difference in financial commitment. Additionally, the claim that the plan would resolve '99.75%' of claims is not present in the original answer and lacks corroboration. The reference to 'page 101' and 'pages 102-103' suggests reliance on a source not reflected in the ground truth, raising concerns about unsupported specifics. (3) Multi-hop reasoning is partially sound: The model correctly links LTL's failed bankruptcy, the appeal outcome, and the subsequent restructuring into Red River Talc LLC. However, it misrepresents the timeline by stating that J&J 're-filed LTL Management LLC (now LLT)' in 2023, whereas the original answer indicates the restructuring into new Texas entities (including Red River) occurred in August 2024. Also, the name change from LTL to LLT is not clearly supported in the ground truth. (4) Despite these issues, the core narrative of strategic evolution is contextually relevant and mostly coherent, earning moderate scores in qualitative accuracy and high relevance. The answer fails to fully match the ground truth in key facts, especially dollar amounts and percentages, which reduces confidence in its correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 491,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How does Tesla's 2022 reference to legacy SolarCity financing agreements connect to the 5.75% Solar Bonds first introduced in 2016, and what does Tesla's continued inclusion of these bonds in its 2023 filings indicate about the ongoing financial implications of the SolarCity acquisition?",
      "original_answer": "Tesla's 2022 filings reference legacy agreements with Deutsche Bank related to SolarCity's 2016 issuance of 5.75% Solar Bonds (Series 2016/5-15), indicating ongoing financial obligations from the acquisition. The 2023 filings continue to include these bonds in the exhibit list, showing that Tesla remains bound by these obligations. This demonstrates that Tesla continues to carry SolarCity's pre-acquisition debt structure, with the 5.75% Solar Bonds remaining an active part of Tesla's financial commitments nearly 7 years after their initial issuance in January 2016.",
      "llm_answer": "Tesla’s 2022 10‑K cites its legacy SolarCity financing agreements and lists the 5.75% Solar Bonds that were first issued in 2016 (Series 2016/5‑15 and Series 2015/26‑15 – exhibits 4.73 and 4.69).  The 2023 filing continues to include those same bonds, showing that they remain outstanding and that Tesla still must service their interest and principal, underscoring the long‑term debt impact of the SolarCity acquisition.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and dates are correct: the 5.75% Solar Bonds from 2016 (Series 2016/5-15 and Series 2015/26-15) are accurately referenced, and the inclusion in both 2022 and 2023 filings is correctly noted. The mention of exhibits 4.73 and 4.69 adds specificity and matches known filing details. (2) The answer correctly identifies the ongoing financial obligations stemming from the SolarCity acquisition, noting that Tesla must still service interest and principal, which reflects the long-term debt impact. (3) The multi-hop reasoning is sound: it connects Tesla’s post-acquisition filings to pre-acquisition SolarCity debt instruments and infers continued liability. (4) The only minor shortcoming is that the ground truth specifically names Deutsche Bank as the counterparty in the legacy agreements, which the LLM omits. While not critical to the core conclusion, this detail adds context about the nature of the financing arrangements. Otherwise, the answer is semantically equivalent, factually correct, and fully relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 321,
        "total_tokens": 1604
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did the voting power dynamics between Class A and Class B common stock at CMCSA change from 2022 to 2023, and what does this imply about shareholder control concentration?",
      "original_answer": "In 2022, Class B common stock, held entirely by Brian L. Roberts, represented 33 1/3% of the combined voting power despite only 3 record holders, while Class A common stock had 352,581 holders and held 66 2/3% of the voting power. By 2023, the continued registration of Class A common stock on Nasdaq indicated ongoing public trading, but the structural voting imbalance persisted, maintaining disproportionate control with Class B shareholders despite the large number of Class A holders. This voting power structure, where each Class B share carries 15 votes, ensures continued concentration of control within a very small group even as the broader shareholder base expands.",
      "llm_answer": "The voting‑power split between the two classes did not change from 2022 to 2023: in both years holders of Class A common stock aggregate to 66 ⅓ % of the combined voting power, while Class B shares account for 33 ⅓ % (each Class B share carries 15 votes). This unchanged ratio shows that control concentration remains high, with Mr. Roberts’ Class B holdings continuing to provide a substantial, non‑dilutable voting stake (2022: page 38; 2023: page 3).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that the voting power split remained unchanged from 2022 to 2023, with Class A holding 66 2/3% and Class B holding 33 1/3% of voting power, which matches the ground truth. It accurately notes that each Class B share carries 15 votes, a key structural detail. The implication about control concentration being maintained is also correctly drawn. However, the LLM slightly misstates the Class A voting percentage as '66 ⅓%' instead of '66 2/3%'—a minor typographical error in fraction representation, though the intended meaning is clear and consistent with the correct ratio. (2) All numeric values (percentages, vote weight per share, years) are correct except for the aforementioned fraction typo. The citation of pages (2022: p.38; 2023: p.3) adds verifiability and aligns with typical 10-K referencing. (3) The multi-hop reasoning is sound: the model synthesizes voting structure data across two years, recognizes the stability of the arrangement, and correctly infers implications for shareholder control concentration. It connects Brian L. Roberts’ exclusive ownership of Class B shares (implied in context) to sustained control, even without reiterating the number of record holders. (4) The answer is highly relevant, directly addressing both parts of the question—change in dynamics (none) and implication (continued control concentration). The minor error in fraction notation does not undermine the overall factual correctness, hence a score of 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 443,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did MetLife's shift in RMBS portfolio composition from 2022 to 2024 affect their stake in pass-through mortgage-backed securities, particularly in terms of fair value and unrealized losses?",
      "original_answer": "In 2022, MetLife's RMBS portfolio was broadly diversified by security type, including both collateralized mortgage obligations and pass-through mortgage-backed securities. By 2024, the company's estimated fair value of pass-through mortgage-backed securities increased slightly from $12.392 billion to $12.567 billion, but the net unrealized losses on these securities also increased significantly from $(1,114) million to $(1,294) million. This indicates that while the company maintained a relatively stable position in pass-through securities, the market valuation pressures on these assets intensified over the two-year period, contributing to greater unrealized losses despite a slight rise in fair value.",
      "llm_answer": "MetLife’s RMBS portfolio shifted away from pass‑through securities between 2022 and 2024.  In 2024 the fair value of pass‑through mortgage‑backed securities rose to $12.567 billion (36.8 % of RMBS) from $12.392 billion (42.6 % of RMBS) in 2023, while unrealized losses increased to $1.294 billion from $1.114 billion.  The change reflects a higher valuation of the remaining pass‑through holdings but a larger unrealized loss exposure as their share of the RMBS portfolio declined.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. While it correctly reports the 2024 fair value of pass-through securities ($12.567 billion) and the increase in unrealized losses ($1.294 billion vs $1.114 billion), it incorrectly states that the 2022 value was compared to 2023 data (citing $12.392 billion in 2023), whereas the original answer specifies 2022 as the starting year. This misalignment in time periods undermines the quantitative accuracy. Additionally, the percentages cited (36.8% and 42.6% of RMBS) are not present in the ground truth and introduce unsupported claims about portfolio composition share, which were not part of the original data. (2) The dollar amounts for fair value and unrealized losses are numerically accurate (allowing for format variations like $1.114 billion = $1,114 million), but the erroneous year (2023 instead of 2022) and fabricated percentages reduce confidence in the numbers. No calculation errors are present in the values themselves, but the context around them is flawed. (3) The reasoning is partially sound—recognizing that fair value increased slightly while unrealized losses grew is correct—but the conclusion that MetLife 'shifted away' from pass-through securities is not directly supported by the original answer, which states the position remained 'relatively stable.' The multi-hop synthesis is weak because it infers a strategic shift based on percentage changes not present in the source, and misattributes timing. (4) Despite these issues, the answer addresses the core question about changes in fair value and unrealized losses, and the overall direction of change is correct. Hence, it earns moderate scores for qualitative and correctness, but low quantitative accuracy due to unsupported percentages and incorrect year reference.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 493,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Southern Company's regulatory reporting posture evolve between 2022 and 2024 as reflected in Mississippi Power Company's transition from not filing annual reports to complying with reduced Form 10-K disclosure requirements?",
      "original_answer": "In 2022, Mississippi Power Company, a subsidiary of Southern Company, explicitly stated it was not required to send an annual report or proxy statement to its parent and would not file one with the SEC. By 2024, Mississippi Power Company was among the Southern subsidiaries that 'meets the conditions set forth in General Instructions I(1)(a) and (b) of Form 10-K' and thus qualified for the reduced disclosure format under General Instructions I(2)(b), (c), and (d). This shift indicates that Southern Company's regulatory reporting posture evolved from full exclusion of certain subsidiaries from annual reporting in 2022 to a more structured, streamlined compliance approach by 2024, where even non-public subsidiaries like Mississippi Power Company were brought into a standardized, reduced-format disclosure process.",
      "llm_answer": "Southern Company’s reporting posture moved from a minimal, non‑filing stance in 2022 to a compliant, streamlined framework by 2024. In 2022 Mississippi Power was omitted from Items 10‑13 and did not file a separate annual report (page 344). By 2024 it is filing a reduced‑disclosure Form 10‑K, meeting SEC requirements for smaller reporting companies (page 3).",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution in Southern Company's regulatory reporting posture between 2022 and 2024. Quantitatively, all dates (2022, 2024) and references to filing status are accurate. The claim that Mississippi Power did not file a separate annual report in 2022 and transitioned to a reduced-disclosure Form 10-K by 2024 aligns with the ground truth. The mention of 'Items 10-13' and page numbers (344, 3) adds specificity and appears consistent with SEC filing structures, though such item numbers are not central to the core question. However, the LLM incorrectly frames Mississippi Power as qualifying under 'smaller reporting companies,' which is not stated in the original answer. Instead, the ground truth specifies that the subsidiary met conditions in General Instructions I(1)(a) and (b) of Form 10-K, which pertain to subsidiaries of consolidated filers, not 'smaller reporting companies'—a distinct SEC designation based on public float and revenue. This mischaracterization reflects a subtle but important regulatory distinction, affecting qualitative accuracy. Despite this, the overall reasoning correctly synthesizes the multi-hop elements: (1) Mississippi Power’s non-filing status in 2022, (2) its inclusion in a reduced-disclosure framework by 2024, and (3) the implication for Southern Company’s broader reporting posture. The answer is contextually relevant and conveys a semantically close interpretation, with only minor imprecision in regulatory terminology.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 417,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did the cybersecurity certification portfolio of AMT's Data Centers segment evolve from the acquisition of CoreSite in 2022 to the operational maturity reported in 2023, particularly in relation to compliance frameworks like SOC 2 and ISO 27001?",
      "original_answer": "In 2022, following the acquisition of CoreSite for $10.4 billion, AMT added 24 data center facilities to its portfolio under the newly formed Data Centers segment. By 2023, CoreSite’s data centers had achieved several key cybersecurity certifications, including SOC 2 Type 2 and ISO/IEC 27001, indicating a formalization and expansion of compliance frameworks post-acquisition. This evolution demonstrates that AMT’s integration of CoreSite included the adoption and maintenance of rigorous cybersecurity standards across its data center operations.",
      "llm_answer": "After acquiring CoreSite in 2022, AMT’s Data Centers segment inherited a robust cybersecurity certification portfolio that included SOC 1 Type 2, SOC 2 Type 2, ISO/IEC 27001, NIST 800‑53, PCI DSS and HIPAA (CoreSite’s 24 data‑center facilities). By 2023 the segment had reached operational maturity, with all facilities maintaining SOC 2 and ISO 27001 certifications while the company expanded its cybersecurity program—training, penetration testing, vulnerability management, incident‑response exercises and third‑party risk oversight—to fully embed these compliance frameworks into daily operations.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 2022 acquisition of CoreSite and the inclusion of 24 data center facilities, aligning with the ground truth. It accurately notes the presence of SOC 2 Type 2 and ISO/IEC 27001 certifications by 2023, which matches the original answer’s key point about formalized compliance frameworks. However, the LLM adds several certifications (SOC 1 Type 2, NIST 800-53, PCI DSS, HIPAA) not mentioned in the ground truth, introducing unsupported details. While these may be plausible, they are not confirmed by the provided truth and represent overstatement. (2) Quantitatively, the answer correctly references the 2022 acquisition and 24 facilities, with no numerical inaccuracies—dollar amount ($10.4B) is omitted but not claimed, so not penalized. Dates (2022 acquisition, 2023 maturity) are accurate. (3) The multi-hop reasoning is partially sound: it connects acquisition to certification outcomes and infers operational maturity, which is consistent with the original. However, the claim that *all* facilities maintained SOC 2 and ISO 27001 by 2023 goes beyond the ground truth, which only states that CoreSite’s data centers *achieved* these certifications, without specifying universality across all 24. The expansion into training, penetration testing, etc., is an extrapolation not supported by the original answer. (4) Contextual relevance is high—the response directly addresses the evolution of the cybersecurity certification portfolio and ties it to compliance frameworks. The core facts are correct, but the added specifics reduce qualitative accuracy. Correctness score is 7 due to accurate central claims with minor but notable over-specification.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 466,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did the $96 million pre-tax charge related to Nicor Gas' disallowed capital investments in 2023 influence bad debt exposure, and how was this risk mitigated under the Bad Debt Rider policy in 2024?",
      "original_answer": "In 2023, SO incurred a $96 million pre-tax charge due to the disallowance of certain capital investments at Nicor Gas, signaling regulatory pushback that could have weakened Nicor Gas' financial position and increased credit risk exposure. This financial strain likely heightened concerns around customer collections and bad debt risk. However, Nicor Gas' exposure to bad debt was mitigated in 2024 by the Bad Debt Rider policy approved by the Illinois Commission, which allowed for the recovery (or refund) of the difference between actual bad debt experience and the benchmark expense used in base rates. This policy ensured that any increased bad debt costs beyond expectations were recoverable from customers, stabilizing Nicor Gas' financial exposure despite the earlier capital disallowance.",
      "llm_answer": "The $96 million pre‑tax charge for disallowed Nicor Gas capital investments in 2023 lowered Southern Company Gas’s earnings, thereby heightening its overall credit‑risk exposure. In 2024, the Illinois‑Commission‑approved Bad Debt Rider mitigated that risk by allowing the company to recover or refund customers for the difference between its actual bad‑debt experience and the benchmark bad‑debt expense used to set rates, effectively offsetting the impact on net bad‑debt exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: the $96 million pre-tax charge in 2023 related to disallowed capital investments at Nicor Gas, its impact on Southern Company Gas's earnings and credit risk, and the 2024 mitigation via the Illinois Commission-approved Bad Debt Rider. The dollar amount ($96 million), years (2023 and 2024), and policy mechanism are all correctly stated. (2) Quantitative accuracy is perfect—no calculations required, and the figure is correctly cited with acceptable formatting ( $96 million). (3) The multi-hop reasoning is sound: it connects the financial impact of the disallowed investment to increased credit risk, then correctly explains how the Bad Debt Rider policy mitigates bad debt exposure by allowing recovery of the difference between actual and benchmark bad debt expenses. (4) The only minor shortcoming is a slight reduction in detail compared to the original: the LLM does not explicitly state that the Bad Debt Rider stabilizes financial exposure 'despite the earlier capital disallowance,' which slightly weakens the causal synthesis. However, the logical flow and key mechanisms are preserved. Wording differs but semantic meaning is equivalent. Contextual relevance is excellent—directly addresses both parts of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 375,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did Duke Energy's approach to financing unrecovered storm costs evolve from 2023 to 2024, particularly with the transition from North Carolina-focused storm recovery property acquisitions to the inclusion of South Carolina assets through the formation and consolidation of DEPSC SF?",
      "original_answer": "In 2023, Duke Energy Progress financed unrecovered storm costs in North Carolina by issuing $770 million of senior secured bonds through DEPNCSF, a special purpose entity, and acquiring storm recovery property related to costs from 2018 and 2019. By 2024, Duke expanded this model to South Carolina, forming DEPSC SF and issuing $177 million in new bonds to recover costs from 2014 through 2022. This demonstrates a strategic shift toward broader geographic coverage of storm recovery financing, with DEPSC SF being consolidated under Duke Energy Progress, continuing the use of bankruptcy-remote entities to securitize storm-related regulatory assets.",
      "llm_answer": "In 2023 Duke Energy financed unrecovered storm costs only in North Carolina through the VIEs DECNCSF and DEPNCSF, which issued senior‑secured bonds to acquire storm‑recovery property and were consolidated by the parent companies.  In 2024 the company broadened this strategy by forming DEPSCSF (Duke Energy Progress SC Storm Funding, LLC) to finance South‑Carolina storm costs, issuing $177 million of senior‑secured bonds to purchase property from Duke Energy Progress and consolidating the new VIE into that subsidiary.  Thus the approach evolved from a North‑Carolina‑only bond‑financed recovery to a geographically expanded, VIE‑based framework that now covers both states.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the evolution from North Carolina-only storm cost financing in 2023 to inclusion of South Carolina in 2024. It accurately states the $177 million bond issuance for South Carolina in 2024, matching the ground truth. However, it introduces 'DECNCSF' as an entity involved in 2023 financing, which is not present in the original answer—only 'DEPNCSF' is mentioned in the ground truth. This is a minor entity inaccuracy. (2) Quantitative accuracy is perfect: $177 million is correctly cited for the 2024 DEPSC SF bond issuance. The 2023 $770 million figure is not mentioned in the LLM answer, which is a minor omission but does not distort the overall picture. All other numbers and years (e.g., 2014–2022 storm costs) are correctly implied through context. (3) The multi-hop reasoning is sound: the model correctly infers a strategic expansion from a single-state to a multi-state securitization model using VIEs (bankruptcy-remote entities), and correctly notes consolidation under Duke Energy Progress. The use of special purpose entities (called VIEs in the LLM answer) aligns semantically with 'bankruptcy-remote entities' in the original. (4) The answer is contextually relevant and captures the core evolution in Duke Energy’s financing strategy. The only deductions are for the incorrect introduction of 'DECNCSF' and the omission of the $770 million 2023 bond amount, which slightly affects completeness and qualitative accuracy. Overall, the answer conveys the same strategic shift with high fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 428,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did Chevron's (CVX) investment in Bunge Chevron Ag Renewables LLC in 2023 influence its soybean oil feedstock strategy in 2024, particularly in light of the new oilseed processing plant FID decision?",
      "original_answer": "In 2023, Chevron maintained a 50% working interest in Bunge Chevron Ag Renewables LLC, which produced soybean oil at facilities in Destrehan, Louisiana, and Cairo, Illinois. This soybean oil served as a renewable feedstock for fuels like renewable diesel and sustainable aviation fuel. By 2024, Chevron's continued ownership of this joint venture was complemented by a final investment decision (FID) to build a new oilseed processing plant in Louisiana, signaling a strategic expansion of its soybean oil sourcing capacity. This evolution suggests that Chevron's earlier stake in the joint venture laid the groundwork for deeper vertical integration into soybean oil production, aligning with its broader renewable fuels production goals, such as the Geismar plant's capacity increase to 22,000 barrels per day expected in 2025.",
      "llm_answer": "Chevron’s 2023 investment gave it a 50 % working interest in Bunge Chevron Ag Renewables LLC, a soybean‑oil producer whose output can be used as renewable feedstock for diesel, biodiesel and sustainable aviation fuel.  In 2024 Chevron took final‑investment decision (FID) to build a new oilseed‑processing plant in Louisiana, expanding soybean‑oil supply and reinforcing its strategy to secure a steady, domestic source of soybean oil for its renewable‑fuel portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core facts from the ground truth. (1) Quantitative accuracy: The 50% working interest, 2023 investment, 2024 FID, and Louisiana location are all correct. No calculations were required, and all numeric and temporal values match the original. (2) Completeness: The answer addresses Chevron's 2023 investment, its purpose (soybean oil as renewable feedstock), and the 2024 FID for a new oilseed processing plant. It correctly links the two events as part of a strategy to secure domestic soybean oil supply. However, it omits mention of the second facility in Cairo, Illinois, and does not reference the Geismar plant’s expansion to 22,000 barrels per day in 2025, which is part of the broader strategic context in the original answer. (3) Entity accuracy: All entities (Chevron, Bunge Chevron Ag Renewables LLC, Louisiana, soybean oil, renewable diesel, sustainable aviation fuel) are correctly identified. (4) Reasoning: The multi-hop synthesis between the 2023 joint venture stake and the 2024 FID is sound and logically presented as a strategic move toward vertical integration. The omission of the Geismar expansion and Cairo facility slightly weakens the depth of the strategic explanation but does not invalidate the core reasoning. (5) Semantic equivalence: The LLM conveys the essential meaning of the original answer with only minor omissions. Wording differences (e.g., 'biodiesel' not explicitly in original) are acceptable as soybean oil can be used for biodiesel; this does not constitute an error. Overall, the answer is factually correct, well-reasoned, and highly relevant, meriting a 9 for correctness due to minor completeness gaps.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 461,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did the voting rights structure of GOOGL's Class A and Class B shares influence its $62.0 billion 2024 share repurchase strategy, especially considering that repurchases continued to focus on Class A and Class C shares rather than Class B?",
      "original_answer": "In 2022, GOOGL disclosed the structure of its three stock classes, where Class B shares carried 10 votes per share and automatically converted to Class A shares upon sale or transfer. By 2024, the company repurchased $62.0 billion worth of Class A and Class C shares, continuing a strategy seen in prior years. The decision to focus repurchases on Class A and Class C shares—rather than Class B—was likely influenced by the desire to avoid triggering automatic conversions of high-vote Class B shares into Class A, which could dilute the voting control held by key stakeholders. This reflects a strategic alignment between capital allocation and governance structure.",
      "llm_answer": "Alphabet’s voting structure—Class A shares carry one vote, Class B shares carry ten votes and automatically convert to Class A upon sale or transfer—meant that buying back Class B stock would dilute the company’s voting power.  Consequently, the Board’s 2024 repurchase program, which totaled $62 billion, was directed at Class A (one vote) and Class C (no voting rights) shares, preserving voting control while returning capital (see Note 11, pages 82‑84).  This focus aligns with the company’s stated policy of repurchasing shares “in the best interest of the company and its stockholders” while considering trading prices and volumes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $62.0 billion 2024 share repurchase amount, the focus on Class A and Class C shares, and the voting rights structure (1 vote for Class A, 10 votes for Class B, with automatic conversion upon sale/transfer). All factual elements from the ground truth are present and accurate. (2) Quantitatively, the $62 billion figure is correctly stated (allowing for format variation: $62 billion = $62.0 billion), and no calculations are required beyond that. Dates (2024) and class structures are consistent with the original. (3) The reasoning is sound: the model correctly infers that repurchasing Class B shares would trigger conversion and potentially dilute voting control, thus explaining the strategic exclusion of Class B from repurchases. This reflects proper multi-hop synthesis between governance structure and capital allocation decisions. (4) The only minor shortcoming is that the LLM does not explicitly name the key stakeholders (e.g., founders or insiders) whose control is preserved—this nuance is in the ground truth but omitted in the LLM response. However, the core logic and strategic alignment are accurately conveyed. Wording differs slightly but maintains semantic equivalence. No irrelevant or incorrect information is introduced.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 364,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the conversion and subsequent sale of VIL OCDs issued in 2023 impact AMT's financial performance in 2024, particularly in relation to the $193.2 million face value of the debentures and the $46.4 million gain recognized?",
      "original_answer": "In 2023, VIL issued optionally convertible debentures (VIL OCDs) to AMT's subsidiary ATC TIPL with a total face value of 16.0 billion INR (approximately $193.2 million) as part of a payment arrangement. By 2024, AMT converted a majority of these debentures into VIL equity shares and later sold both the shares and remaining debentures, recognizing a total gain of $46.4 million. This gain significantly contributed to AMT’s financial performance in 2024, despite the initial deferrals and impairment charges in 2023.",
      "llm_answer": "The VIL optionally‑convertible debentures (OCDs) issued in 2023 had a face value of about $193.2 million. In 2024 AMT converted $172.7 million of the OCDs into equity, sold the resulting shares, and then sold the remaining $19.2 million of OCDs, generating net proceeds of roughly $238 million. The excess of proceeds over the original face value produced a $46.4 million gain that was recorded in Loss from discontinued operations, net of taxes, thereby reducing the company’s overall loss from discontinued operations and improving its 2024 financial performance.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the $193.2 million face value of the VIL OCDs is correctly stated. The breakdown of $172.7 million converted into equity and $19.2 million of remaining debentures sold adds up to $191.9 million, which is within rounding tolerance of the total $193.2 million (likely due to minor unreported adjustments or exchange rate fluctuations). The $46.4 million gain is exactly matched. The net proceeds of $238 million are not in the original answer, but since the gain is correctly reported as the excess over face value, this additional detail does not contradict the ground truth and may reflect accurate internal computation. (2) The gain being recorded in 'Loss from discontinued operations, net of taxes' is an additional level of accounting detail not present in the original answer, but it is plausible and enhances precision without introducing error. (3) The multi-hop reasoning is sound: the answer correctly links the 2023 issuance, 2024 conversion and sale, and the resulting financial impact on AMT’s performance. (4) All entities—VIL, AMT, OCDs, ATC TIPL (implied as AMT subsidiary)—are correctly referenced in context. The only minor shortcoming is the lack of explicit mention of impairment charges or deferrals in 2023 noted in the original answer, which slightly reduces completeness. However, the core financial impact in 2024 is accurately and thoroughly explained, warranting a high correctness score of 9.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 414,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the voting power dynamics between Class A and Class B common stock evolve from 2022 to 2024, and what impact did this have on GOOGL's shareholder equity structure as reflected in share repurchases?",
      "original_answer": "In 2022, holders of Class A common stock held 66 2/3% of the combined voting power, while Class B common stock, with 15 votes per share, represented 33 1/3% of the voting power. By 2024, Class B shares were entitled to 10 votes per share, indicating a reduction in the voting power of Class B stock. During this period, GOOGL repurchased $59.3 billion in 2022 and $62.0 billion in 2024 of Class A and Class C shares, suggesting a strategic effort to reshape equity distribution while maintaining dual-class voting control.",
      "llm_answer": "Alphabet’s voting structure stayed the same from 2022 to 2024: each Class A share carried one vote and each Class B share carried ten votes (2024 Note 11).  Between 2022 and 2024 the company repurchased roughly $59 B–$62 B of Class A and Class C shares (but no Class B shares) (2024 Note 11), shrinking the Class A base and thereby increasing the relative voting power of the remaining Class B holders, which concentrated equity influence and altered the shareholder‑equity structure. (page 2; page 82)",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $59.3B and $62.0B repurchase amounts in 2022 and 2024 (rounded to $59B–$62B), which matches the ground truth. It also correctly states that Class B shares had 10 votes per share in 2024. However, it incorrectly claims the voting structure 'stayed the same' from 2022 to 2024, when in fact Class B shares had 15 votes per share in 2022 according to the ground truth. This is a critical factual error that undermines the core of the multi-hop analysis. (2) Quantitatively, the repurchase figures are accurate within acceptable rounding, and the years are correct. The vote counts are partially correct (only for 2024), but the 2022 vote count is wrong. (3) The reasoning about repurchasing Class A and C shares (not Class B) increasing the relative voting power of Class B is logically sound and reflects good multi-hop synthesis. However, the failure to recognize the reduction in Class B votes from 15 to 10 per share means the model misses the key dynamic in voting power evolution. Instead, it assumes stability, leading to an incorrect conclusion about how control shifted. (4) Contextually, the answer is highly relevant and addresses both voting power and share repurchases. Due to the major error in the voting power change over time, the correctness score is reduced to 6—partially correct but with a significant factual flaw in the core comparison.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 391,
        "total_tokens": 1662
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did AMT's reliance on GTP Acquisition Partners in 2022 constrain its ability to incur new indebtedness in 2023, particularly given the 1.30x debt service coverage ratio threshold and rising inflationary pressures?",
      "original_answer": "In 2022, AMT relied on GTP Acquisition Partners, which was subject to restrictive covenants that prohibited it from incurring additional indebtedness unless it maintained a debt service coverage ratio (DSCR) above 1.30x. This DSCR threshold determined whether excess cash flow could be released to GTP Acquisition Partners and ultimately to AMT. By 2023, rising inflation and higher interest rates increased AMT’s cost of capital and reduced its financial flexibility, making it more challenging to maintain the required DSCR. As a result, AMT’s ability to incur new indebtedness was constrained because any breach of the 1.30x DSCR could trigger cash flow restrictions and prevent the release of excess funds from GTP Acquisition Partners, directly impacting AMT’s liquidity and capacity to take on new debt.",
      "llm_answer": "In 2022, American Tower’s excess cash flow from its securitized assets was routed through GTP Acquisition Partners, whose 2015 securitization covenant requires a 1.30× debt‑service coverage ratio (DSCR) before any excess cash can be released to AMT.  If the DSCR fell below 1.30×, all excess cash was trapped in a reserve account and, during an amortization period triggered when the DSCR dropped to 1.15×, was applied to principal repayment—leaving no cash for new debt or capital projects.  Rising inflation and higher interest rates increased debt‑service costs, making it more likely that the DSCR would breach the 1.30× threshold, while the covenant also prohibits GTP (and its AMT Asset Subs) from incurring additional indebtedness, thereby constraining AMT’s ability to take on new debt in 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 1.30x DSCR threshold, the role of GTP Acquisition Partners, the restriction on incurring additional indebtedness, and the impact of rising inflation and interest rates in 2023. The mention of the 2015 securitization is not in the original answer but does not contradict it and may reflect additional context. (2) Quantitative accuracy is perfect: the 1.30x and 1.15x thresholds are correctly stated, and their implications (cash trapping, amortization trigger) are accurately described. Format and values match semantically. (3) Multi-hop reasoning is sound: the model correctly links AMT’s reliance on GTP in 2022 to covenant restrictions, explains how DSCR affects cash flow release, and connects inflationary pressures to increased debt service and constrained borrowing capacity in 2023. The added detail about the 1.15x amortization trigger enhances accuracy but is not required for correctness. (4) The only minor gap is that the original answer emphasizes the direct impact on AMT’s liquidity and capacity to take on debt due to cash flow restrictions, which the LLM implies but could make slightly more explicit. However, the core logic and synthesis are intact. Overall, the answer is factually correct, comprehensive, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 378,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did AbbVie's legal strategy around Vraylar evolve between 2022 and 2024, particularly in relation to its subsidiary Forest Laboratories Holdings Limited's role in patent enforcement and the drug's therapeutic positioning?",
      "original_answer": "In 2022, AbbVie's subsidiary Forest Laboratories Holdings Limited was actively involved in patent enforcement litigation over Vraylar (cariprazine), alongside other subsidiaries, to prevent generic competition from companies like Sun Pharmaceutical and Aurobindo Pharma. By 2024, Vraylar was explicitly positioned in AbbVie's 10-K filing as a core neuroscience product with specific therapeutic indications including schizophrenia, bipolar I disorder, and major depressive disorder. This evolution suggests that AbbVie transitioned from a defensive legal posture focused on protecting intellectual property to a more strategic commercial and therapeutic positioning of Vraylar within its neuroscience portfolio, likely leveraging the earlier legal actions to secure market exclusivity.",
      "llm_answer": "The excerpts provided do not contain any discussion of AbbVie’s legal strategy concerning Vraylar, nor do they mention Forest Laboratories Holdings Limited’s role in patent enforcement or any shift in the drug’s therapeutic positioning between 2022 and 2024.",
      "correctness_score": 0,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 1,
      "detailed_feedback": "The LLM answer is completely incorrect and fails to address the question. (1) It claims the excerpts do not contain any relevant information, but the original answer (ground truth) clearly provides specific details about AbbVie's legal strategy evolution around Vraylar from 2022 to 2024, including Forest Laboratories Holdings Limited's role in patent enforcement litigation in 2022 and the strategic therapeutic repositioning of Vraylar in 2024. (2) There are no numbers or calculations in this particular question, so quantitative accuracy is not applicable beyond correct mention of years (2022, 2024), which the LLM failed to reference appropriately. (3) The multi-hop reasoning required—linking legal actions in 2022 with commercial positioning in 2024 through subsidiary activity—was entirely missed; the LLM did not synthesize or even acknowledge the provided facts. (4) The response lacks contextual relevance as it denies the existence of information that is, in fact, present in the ground truth. The answer is not only factually wrong but also fails to reflect any understanding of the documented evolution in AbbVie’s strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 321,
        "total_tokens": 1601
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did the change in NKE's foreign exchange hedging strategy for product cost exposures between 2023 and 2024 affect the role of NTC in sourcing NIKE-branded products from third-party factories, particularly in terms of U.S. Dollar denomination?",
      "original_answer": "In 2023, NKE's foreign exchange risk management program identified product cost exposures stemming from non-functional currency-denominated purchases, with NTC—functioning as a sourcing hub—buying NIKE-branded products from third-party factories predominantly in U.S. Dollars before selling them to regional NIKE entities in their local currencies. By 2024, NKE maintained this structure but adjusted its hedging strategy to better manage the foreign currency risk associated with these NTC-to-entity transactions. This evolution indicates a refined approach to mitigating currency fluctuations, particularly as NTC continued to denominate its purchases in U.S. Dollars, aligning with the company's broader goal of stabilizing consolidated financial results.",
      "llm_answer": "The 2024 filing notes that the company still uses the NIKE Trading Company (NTC) as its sourcing hub that buys NIKE‑branded goods in U.S. dollars from third‑party factories and then sells them to NIKE entities in their local currencies (see Note 12, page 84).  The only change in hedging strategy was a reduction in the notional amount of foreign‑currency cash‑flow hedges for product‑cost exposures—from $18.2 billion in 2023 to $16.2 billion in 2024 (Note 12, page 85)—but this did not alter NTC’s USD‑denominated purchasing role.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that NTC continues to source NIKE-branded products from third-party factories in U.S. Dollars and sells to regional entities in local currencies, which aligns with the ground truth. It also correctly notes a change in hedging notional amount from $18.2 billion in 2023 to $16.2 billion in 2024, based on Note 12. However, the original answer emphasizes a strategic refinement in hedging to better manage currency risk in NTC-to-entity transactions, while the LLM answer interprets the change merely as a reduction in notional value without acknowledging the strategic evolution in risk management. This omission downplays the qualitative shift in strategy, focusing only on quantity. (2) Quantitatively, the numbers are accurate: $18.2B in 2023 and $16.2B in 2024 are correctly cited, and the source (Note 12, pages 84–85) is properly referenced. There are no calculation errors. (3) The multi-hop reasoning is partially sound—while the model connects NTC’s role with hedging activity and currency denomination, it fails to synthesize the broader strategic intent behind the hedging adjustment as described in the ground truth (i.e., stabilizing consolidated results through refined risk management). (4) The answer is contextually relevant and factually grounded but lacks depth in explaining how the hedging strategy change affected NTC’s role beyond maintaining USD-denominated purchases. Thus, while core facts are correct, the qualitative interpretation is incomplete, warranting a score of 7 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 430,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did AMT's strategic exit from ATC TIPL in 2024, through its transaction with DIT, represent a shift from its prior consolidation strategy in India, particularly considering the $1.2 billion loss on sale and the cumulative translation adjustment of $1.1 billion upon exiting the market?",
      "original_answer": "In 2022, AMT completed the full consolidation of ATC TIPL, acquiring the remaining 8% noncontrolling interest for $173.2 million, achieving 100% ownership. By 2024, AMT reversed this position entirely by selling ATC TIPL to DIT for approximately $2.2 billion, recording a $1.2 billion loss on the sale, largely driven by the reclassification of the $1.1 billion cumulative translation adjustment from India. This marked a significant strategic shift from expansion and full control in the Indian market to a complete exit, reflecting a broader reallocation of capital away from India to strengthen its global financial position.",
      "llm_answer": "AMT’s 2024 sale of ATC TIPL to DIT ended the long‑standing consolidation of its India reporting unit that had begun with the 2016 Viom acquisition and the put/call option framework that allowed the company to gradually acquire a 51 % stake and consolidate the business.  The divestiture produced a $1.2 billion loss on sale, almost entirely driven by a $1.1 billion cumulative translation adjustment that was reclassified when the company exited the market, underscoring the shift from consolidation to a strategic exit.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $1.2 billion loss on sale and the $1.1 billion cumulative translation adjustment, which aligns with the ground truth. However, it incorrectly references the 2016 Viom acquisition and a put/call option framework leading to a 51% stake, which is not mentioned in the original answer and introduces factually unsupported details. The original answer specifies that full consolidation occurred in 2022 when AMT acquired the remaining 8% noncontrolling interest for $173.2 million, achieving 100% ownership—this key event is omitted in the LLM response. (2) Quantitatively, the $1.2B loss and $1.1B CTA are accurately reported, and their relationship (that the loss was largely driven by the reclassification of CTA) is correctly conveyed. However, the absence of the $173.2M 2022 transaction and the sale price of $2.2B reduces quantitative completeness. (3) The multi-hop reasoning is partially sound—LLM correctly infers a strategic shift from consolidation to exit and links the financial impact of CTA to the loss. But it fails to synthesize the critical 2022 full consolidation as the immediate prior strategy, weakening the contrast between expansion and exit. (4) Contextual relevance is high as the answer addresses the core shift and financial implications, but the inclusion of unverified acquisition history and omission of key transactions reduce factual accuracy and completeness, warranting a score of 7 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 410,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did Chevron's operational presence in Angola in 2022 influence its 2023 exploration and production activities, given Angola's regulatory framework for production sharing agreements with initial exploration terms of 3–4 years and production periods of 20–30 years?",
      "original_answer": "Chevron's operational presence in Angola in 2022, as part of its equity interests in African affiliates, positioned the company to engage in long-term exploration and production activities governed by Angola's regulatory framework. Angola's production sharing agreements typically include initial exploration terms of 3–4 years with extension options and production periods of 20–30 years, allowing Chevron to plan multi-year operational strategies. By 2023, Chevron reported results from these exploration and production activities, which reflect the financial performance of projects initiated under these regulatory conditions. The alignment between Chevron’s long-term investment decisions in 2022 and the contractual terms in Angola directly influenced the company's 2023 operational outcomes in the region.",
      "llm_answer": "Chevron’s 2022 presence in Angola—part of its Africa portfolio—was governed by Angola’s PSCs, which set 3–4‑year exploration windows and 20–30‑year production horizons (page 32).  The 2023 financials show that Africa (including Angola) saw capitalized costs climb to $50.9 billion and proven reserves rise to $100.7 billion, reflecting continued investment and production under those PSC terms (page 104).  Thus, Chevron’s Angola operations in 2022 directly fed its 2023 exploration and production activities by leveraging the country’s long‑term production framework.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. It claims that in 2023, Africa (including Angola) saw 'capitalized costs climb to $50.9 billion' and 'proven reserves rise to $100.7 billion'. These figures are factually incorrect and not supported by the ground truth. The original answer does not mention any specific financial figures, let alone these numbers, which appear fabricated or misattributed. There is no verification that such numbers appear on page 104 or elsewhere in the actual filing, and they are implausible in magnitude—proven reserves are typically measured in barrels of oil equivalent, not dollars, and $100.7 billion in reserves as a dollar value would be an unusual metric to report in that context. Capitalized costs of $50.9 billion also lack context and are not corroborated. (2) The mention of 'page 32' and 'page 104' implies citation from a document, but the ground truth does not reference these pages or data points, raising concerns about hallucination. (3) Qualitatively, the LLM correctly identifies the structure of Angola’s production sharing contracts (3–4-year exploration, 20–30-year production) and links Chevron’s 2022 operational presence to 2023 activities under this framework, which aligns with the multi-hop reasoning required. The logical flow—long-term PSC terms enabling continued investment and production—is sound and relevant. (4) Contextually, the answer addresses the influence of regulatory terms on operational planning, which is central to the question. However, the inclusion of false quantitative data severely undermines factual correctness, even though the conceptual reasoning is partially accurate. The answer would have been stronger if it had mirrored the original’s focus on strategic alignment and reporting of results without introducing unsupported numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 503,
        "total_tokens": 1878
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did General Dynamics' revenue mix shift between 2022 and 2024 in relation to the John Lewis-class Fleet Replenishment Oiler program at NASSCO, and what does this indicate about the evolving strategic focus of GD's Marine Systems segment?",
      "original_answer": "In 2022, GD's Marine Systems segment reported $10.8 billion in expected revenue, with the John Lewis-class (T-AO-205) fleet replenishment oiler program identified as a key contributor alongside the Columbia-class submarine and DDG-51 destroyer programs. NASSCO, which builds the John Lewis-class oilers, was positioned as one of GD's three shipyards but was not highlighted as a strategic growth engine. By 2024, while the John Lewis-class deliveries were still ongoing (planned into 2025), GD's narrative had shifted significantly — with NASSCO now positioned within a Marine Systems segment that was described as the 'leading designer and builder of nuclear-powered submarines' and a 'leader in surface combatant and auxiliary ship design.' The segment had made 'substantial investments' to expand capacity, particularly for submarines, which were labeled the Navy’s 'top acquisition priority.' This indicates that while the John Lewis-class program remained active, GD's strategic focus had evolved to prioritize submarine production, especially the $125+ billion Columbia-class program, suggesting a shift in revenue mix toward higher-priority, long-duration defense programs at the expense of more routine auxiliary shipbuilding.",
      "llm_answer": "Between 2022 and 2024, Marine Systems revenue grew from $11.04 bn to $14.34 bn, with surface‑ship revenue rising from $2.56 bn to $2.82 bn (≈ 9 %) and nuclear‑submarine revenue jumping 42 % from $7.31 bn to $10.39 bn, while repair‑service revenue fell slightly. The uptick in surface‑ship revenue reflects the ongoing John Lewis‑class fleet replenishment oiler program at NASSCO, indicating that GD’s Marine Systems is shifting its strategic focus toward expanding high‑value auxiliary ship construction while sustaining robust submarine production.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that in 2022, Marine Systems had $10.8 billion in expected revenue, but the LLM claims $11.04 billion — already a discrepancy. It further asserts revenue grew to $14.34 billion by 2024, which is unsupported by the original answer; no such total revenue figure for 2024 is provided in the ground truth. The breakdown into surface-ship ($2.56B to $2.82B), nuclear-submarine ($7.31B to $10.39B), and repair-service revenue is entirely fabricated — these figures do not appear in the original answer. (2) Calculations are therefore also incorrect: the claimed 42% increase in submarine revenue and 9% rise in surface-ship revenue are based on made-up numbers. The original answer does not provide year-by-year revenue splits by program type, so such precise quantification is unjustified. (3) The multi-hop reasoning is flawed. The original answer emphasizes a narrative shift in strategic focus — from auxiliary ships like the John Lewis-class oilers to nuclear submarines, especially the Columbia-class program — based on qualitative changes in corporate messaging and investment priorities. The LLM incorrectly interprets rising surface-ship revenue as evidence of strategic expansion in auxiliary shipbuilding, which contradicts the ground truth: NASSCO and the John Lewis program were still active but no longer emphasized, while submarine production became the priority. The LLM draws the opposite conclusion of the original answer. (4) Despite this, the response is contextually relevant — it addresses the revenue mix and strategic focus of GD's Marine Systems segment and references the correct entities (NASSCO, John Lewis-class, Marine Systems). However, due to major quantitative errors and reversed qualitative reasoning, the correctness score is low. Minor credit is given for attempting the multi-hop synthesis and using appropriate financial terminology.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1469,
        "completion_tokens": 529,
        "total_tokens": 1999
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did the conversion and subsequent sale of VIL Optionally Convertible Debentures (VIL OCDs) by AMT in 2024 impact the financial outcomes compared to the initial deferral of revenue and impairment charge recognized in 2023?",
      "original_answer": "In 2023, AMT deferred $27.3 million in revenue related to VIL and recorded a $322.0 million goodwill impairment charge for its India reporting unit due to uncertainties in collections. VIL issued $193.2 million in VIL OCDs to settle accounts receivables. By 2024, AMT converted $172.7 million of these OCDs into VIL equity and sold both the shares and remaining OCDs, realizing a total gain of $46.4 million. This gain partially offset the earlier impairment and revenue deferral, marking a strategic shift from exposure to receivables risk to a realized financial gain through structured financial instruments and timely exits.",
      "llm_answer": "In 2023, AMT deferred about $27.3 million of revenue from VIL and recorded a $322 million goodwill impairment for its India reporting unit, a negative hit to earnings (page 45).  In 2024 the company converted the VIL OCDs into equity, sold the shares and the remaining debentures for roughly $216 million and $22 million in net proceeds, and realized a $46.4 million gain recorded in Loss from discontinued operations (page 119).  The previously deferred revenue was fully recognized in 2024, adding $95.7 million to revenue (page 45), turning the 2024 results into a net positive outcome that offset the 2023 impairment and deferral.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several correct elements but introduces significant inaccuracies. It correctly states the $27.3 million revenue deferral and $322 million goodwill impairment in 2023, and the $46.4 million gain in 2024. However, it incorrectly claims that the previously deferred revenue was 'fully recognized in 2024, adding $95.7 million to revenue,' which is not supported by the ground truth and introduces a new, unsubstantiated figure. The ground truth states only that $193.2 million in VIL OCDs were issued in 2023, with $172.7 million converted in 2024 and the rest sold, but the LLM misrepresents the proceeds as '$216 million and $22 million in net proceeds'—a breakdown not in the original and not reconcilable with the $46.4 million gain. (2) Quantitative accuracy is partially correct: $27.3M, $322M, and $46.4M are accurate, but $95.7M and the $216M/$22M proceeds split are fabricated or misinterpreted. The gain of $46.4M implies proceeds minus cost basis, but the LLM treats proceeds as separate revenue events without explaining the $172.7M conversion amount. (3) Multi-hop reasoning is partially sound—linking 2023 impairment/deferral to 2024 gain is correct—but the conclusion that 2024 results were 'net positive' due to $95.7M revenue recognition is unsupported and distorts the financial impact. The ground truth emphasizes a strategic shift in risk exposure, not a reversal of deferral. (4) Contextual relevance is high as the answer addresses the comparative financial impact across years and instruments. However, the introduction of false revenue recognition and incorrect proceeds undermines factual correctness. Scores reflect partial accuracy with critical errors in key financial claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 473,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the expiration of regulatory exclusivity for key BMY biologics like Opdivo and Yervoy in 2022 influence the company's 2023 strategic shift toward biologics-focused acquisitions and collaborations, such as Mirati and SystImmune, to offset anticipated revenue losses?",
      "original_answer": "In 2022, BMY acknowledged that its key biologics—Opdivo, Yervoy, Orencia, Reblozyl, and Empliciti—faced heightened risk of biosimilar competition due to the 12-year FDA data protection period nearing expiration, which could lead to rapid revenue erosion. This concern was echoed across the industry, as seen in Eli Lilly’s 2022 filings, where loss of exclusivity for biologics like Trulicity and Taltz was linked to steep revenue declines following biosimilar entry. In response, BMY's 2023 strategy focused on mitigating the long-term impact of biosimilar erosion by acquiring Mirati (completed in January 2024), Karuna, and RayzeBio, and entering a global strategic collaboration with SystImmune. These moves were aimed at bolstering its biologics and next-generation immunotherapy pipeline, signaling a clear pivot to innovation-driven growth to offset the anticipated revenue losses from biosimilar competition.",
      "llm_answer": "The loss of regulatory exclusivity for Opdivo and Yervoy in 2022 signaled an imminent drop in market exclusivity and a likely revenue decline for BMS.  In 2023 the company pivoted to a biologics‑focused growth strategy, completing the acquisition of Mirati, announcing planned acquisitions of Karuna and RayzeBio, and forming a global collaboration with SystImmune to broaden its pipeline and offset the expected losses (BMS 2023 10‑K, Item 4; BMS 2022 10‑K, exclusivity chart, page 11; regulatory exclusivity context, pages 8‑9).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the expiration of regulatory exclusivity for Opdivo and Yervoy in 2022 as a key driver for BMY's (BMS's) strategic shift. The acquisitions of Mirati (completed in January 2024), Karuna, and RayzeBio, as well as the collaboration with SystImmune, are accurately cited as part of the 2023 strategic pivot. (2) Quantitatively, all dates and events are correct: Mirati acquisition timing (completed in early 2024, announced in 2023), and the 2023 focus on biologics growth are consistent with filings. No numerical errors are present. (3) The multi-hop reasoning is sound—linking loss of exclusivity to biosimilar risk, then to strategic M&A and partnerships to offset revenue loss. The LLM references the correct sections of the 10-Ks (Item 4, exclusivity chart, pages 8–11), though these are not evaluated for exact content. (4) The only minor omission is that the original answer includes Orencia, Reblozyl, and Empliciti as additional biologics at risk, which the LLM omits. This slightly reduces completeness but does not undermine the core correctness. The LLM also does not explicitly mention the 12-year FDA data protection period or the industry context (e.g., Eli Lilly), which adds depth in the ground truth. However, the central logic and facts are preserved. Semantic equivalence is strong, and the answer is contextually fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 399,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did Microsoft's redemption progress on Nuance's convertible senior notes evolve from fiscal year 2022 to 2023, and what does this indicate about their post-acquisition financial restructuring?",
      "original_answer": "In fiscal year 2022, Microsoft disclosed that $985 million of Nuance's $986 million convertible senior notes had been redeemed, leaving $1 million outstanding. By fiscal year 2023, Microsoft reported that 'substantially all' of these notes had been redeemed, indicating near-complete resolution of this liability. This evolution shows a deliberate financial restructuring post-acquisition, where Microsoft prioritized the redemption of legacy debt from Nuance, reducing its outstanding obligations from $1 million in 2022 to effectively nil by 2023.",
      "llm_answer": "Microsoft’s 10‑K for FY 2022 (page 78) reported that of the $986 million of Nuance convertible senior notes, only $1 million remained outstanding. By FY 2023 the 10‑K (page 78) states the notes were “substantially all redeemed,” implying the final $1 million was paid off during 2023. This completion of the redemption shows Microsoft’s post‑acquisition effort to reduce debt, simplify its balance sheet, and improve financial flexibility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key figures: $986 million total convertible senior notes, $1 million outstanding in FY 2022, and 'substantially all redeemed' in FY 2023. It accurately infers that the remaining $1 million was likely paid off in 2023, aligning with the ground truth that the liability was reduced to effectively nil. All numeric values and fiscal years are correct. (2) Quantitative accuracy is perfect: the amounts ($986M total, $1M outstanding) match the ground truth, and the logical deduction that the final $1M was redeemed in FY 2023 is sound and consistent with 'substantially all' being redeemed. No calculation errors. (3) The multi-hop reasoning is solid—linking Nuance's debt pre-acquisition to Microsoft's post-acquisition reporting across two fiscal years is correctly synthesized. The conclusion about financial restructuring—reducing debt, simplifying the balance sheet, improving flexibility—accurately reflects the intent implied by the redemption pattern. (4) The only minor shortcoming is that the LLM does not explicitly state that the $985 million had already been redeemed in FY 2022 (it only notes $1M remained), which slightly reduces qualitative completeness, though the overall meaning remains equivalent. Wording differences are acceptable under semantic equivalence. Contextual relevance is excellent, directly addressing both the evolution and its implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 396,
        "total_tokens": 1655
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did Disney's compliance considerations under Rule 10b5-1(c) in 2023 influence the specific structure and timing parameters of Robert Iger's 2024 trading plan, particularly regarding the expiration of his stock options and planned share sales?",
      "original_answer": "Disney's 2023 filings highlight the regulatory framework of Rule 10b5-1(c), which establishes requirements for insider trading plans to qualify for an affirmative defense against insider trading claims. This regulatory context directly shaped the design of Robert Iger's 2024 trading plan, which was explicitly structured to comply with the rule. The plan specifically accommodated the expiration of Iger’s stock options on December 18, 2024, and outlined a schedule for the potential sale of up to 372,412 shares of Disney common stock. The plan's termination date of December 17, 2024, just one day before the options expired, demonstrates how the timing was carefully aligned with both the regulatory requirements from 2023 and the specific financial instruments involved in Iger’s compensation package.",
      "llm_answer": "Disney’s 2023 10‑K stated that its insider‑trading compliance program required any trading plan to satisfy Rule 10b5‑1(c)’s affirmative defense, which shaped Iger’s 2024 plan.  The plan was structured to cover the full life of his 2014‑issued options (expiring Dec 18 2024) and to allow the sale of up to 372,412 shares, with the plan terminating Dec 17 2024—one day before the options expire—while permitting early termination if needed (DIS_10k_2023, page 61; DIS_10k_2024, page 61).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all key aspects. (1) Quantitative accuracy: All numbers and dates are correct — the expiration date of Iger's stock options (December 18, 2024), the termination date of the trading plan (December 17, 2024), and the number of shares (372,412) are accurately reported. The one-day gap between plan termination and option expiration is correctly noted. (2) Completeness: The answer addresses all parts of the multi-hop question — it links Disney’s 2023 compliance considerations under Rule 10b5-1(c) to the structure and timing of Iger’s 2024 trading plan, explains how the plan accommodates the option expiration, and includes relevant parameters like share volume and termination date. (3) Entity accuracy: Correct entities are used — Disney (DIS), Robert Iger, Rule 10b5-1(c), correct fiscal years (2023 and 2024), and proper reference to the 10-K filings. (4) Reasoning: The multi-hop logic is sound — the answer correctly infers that the 2023 regulatory framework influenced the 2024 plan design, and it synthesizes information across two filings (2023 and 2024 10-Ks) to explain the timing and structure. (5) Semantic equivalence: The LLM conveys the same core information as the original answer, with added detail (e.g., mention of early termination and citation of page numbers) that enhances accuracy without introducing error. Minor wording differences do not affect factual correctness. All criteria are met at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 412,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "What was the financial impact of AMT's 2023 strategic review and partnership with DIT on the 2024 ATC TIPL transaction, particularly in relation to the $322.0 million goodwill impairment charge recorded by AMT in India?",
      "original_answer": "AMT's 2023 strategic review of its India business, which included a partnership with DIT, directly led to the decision to pursue the ATC TIPL transaction in 2024. During the 2023 strategic review, AMT determined that the carrying value of its India reporting unit exceeded its fair value, resulting in a $322.0 million goodwill impairment charge. This impairment was a key financial outcome of the review and informed the decision to enter into the transaction with DIT. The ATC TIPL transaction, finalized in 2024, represented a strategic exit from a portion of AMT's Indian operations and was expected to potentially yield up to 210 billion INR (approximately $2.5 billion), including the value of the VIL OCDs and repayment of existing intercompany debt. The impairment charge and the transaction are causally linked through the strategic reassessment of AMT's exposure to the Indian market.",
      "llm_answer": "The 2023 strategic review and partnership with DIT triggered a goodwill impairment of **$322 million** in AMT’s India reporting unit, recorded in the quarter ended September 30, 2023.  In the 2024 financial statements this impairment is shown as part of the discontinued‑operations loss, contributing to a **$978.3 million** net loss from discontinued operations in 2024 (which also includes a $1,245.5 million loss on the sale of ATC TIPL and $2,158.8 million in proceeds).  Thus the goodwill impairment was a key negative component of the ATC TIPL transaction’s overall financial impact.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. While it correctly identifies the $322 million goodwill impairment charge by AMT in India during the 2023 strategic review, it introduces financial figures not present in the ground truth—specifically a $978.3 million net loss from discontinued operations, a $1,245.5 million loss on sale, and $2,158.8 million in proceeds—which are unsupported by the original answer and contradict the stated potential value of up to 210 billion INR (~$2.5 billion) from the ATC TIPL transaction. These numbers suggest a complete fabrication or misattribution of financial data. (2) The date of the impairment (quarter ended September 30, 2023) is plausible but not confirmed in the ground truth, which only references 2023 generally. The format of $322 million matches the original $322.0 million, so that value is acceptable. However, the downstream financials are entirely incorrect. (3) The reasoning partially captures the causal link between the strategic review, the impairment, and the ATC TIPL transaction, correctly identifying the impairment as a precursor to the transaction. However, it mischaracterizes the financial impact by embedding the impairment within a fabricated discontinued operations narrative and fails to mention the strategic exit rationale or the DIT partnership’s role in shaping the transaction. The multi-hop synthesis is flawed because it invents financial outcomes rather than reporting the expected proceeds and debt repayment noted in the ground truth. (4) Despite the incorrect numbers, the answer remains contextually relevant—it addresses the right companies (AMT, DIT, ATC TIPL), the correct sequence of events, and the conceptual link between impairment and transaction. Hence, moderate scores for qualitative accuracy and contextual relevance, but low on quantitative accuracy and overall correctness due to unsupported financial claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 533,
        "total_tokens": 1922
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did the change in Altria's (MO) indemnification obligations between PM USA and PMI from 2022 to 2023 reflect any shifts in the company's risk allocation strategy for tobacco-related liabilities?",
      "original_answer": "In 2022, Altria had no recorded liability for the indemnification obligations between PM USA and PMI, as the fair value was considered insignificant. The indemnification framework under the Distribution Agreement remained in place, where PMI indemnifies Altria and PM USA for liabilities related to tobacco products manufactured by PMI or contract manufactured by PM USA for PMI. In 2023, this structure remained unchanged, with Altria still not recording a liability for the indemnification, indicating that the company's risk allocation strategy for tobacco-related liabilities through PM USA and PMI remained stable. However, the continued absence of a recorded liability suggests that Altria assessed the risk of significant indemnification claims from PMI as low, maintaining a consistent approach to managing contingent liabilities through contractual indemnifications.",
      "llm_answer": "Altria’s 2022 and 2023 10‑Ks both describe the same distribution‑agreement indemnification framework: PMI indemnifies Altria and PM USA for liabilities tied to PMI‑manufactured or contract‑manufactured tobacco products, while PM USA indemnifies PMI for liabilities tied to PM USA‑manufactured products (excluding contract‑manufactured items for PMI). The fair‑value of these obligations was deemed insignificant in both years, and the wording in the 2023 filing is essentially identical to that in 2022. Consequently, there was no change in the indemnification terms, indicating that Altria’s risk‑allocation strategy for tobacco‑related liabilities remained unchanged between 2022 and 2023. (See 2022 page 49 and 2023 page 101.)",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) It correctly states that Altria did not record a liability for indemnification obligations in either 2022 or 2023 because the fair value was deemed insignificant—this matches the original answer exactly. (2) The description of the indemnification framework under the Distribution Agreement is precise: PMI indemnifies Altria and PM USA for liabilities related to PMI-manufactured or contract-manufactured products, while PM USA indemnifies PMI for its own manufactured products (excluding those made for PMI), which aligns with the contractual structure in the source. (3) The reasoning correctly identifies that the language in the 2023 10-K is essentially unchanged from 2022, supporting the conclusion that there was no shift in risk allocation strategy—this reflects sound multi-hop synthesis across years and documents. (4) The answer addresses all parts of the question: the change (or lack thereof) in indemnification obligations, the financial assessment (insignificant fair value), and the implication for Altria’s risk allocation strategy. Minor wording differences (e.g., 'remained unchanged' vs 'remained stable') do not affect meaning. All entities (Altria, PM USA, PMI, Distribution Agreement), years (2022–2023), and financial assessments are correct. No calculation errors. The inclusion of specific page references (2022 p.49, 2023 p.101) adds verifiability. Thus, all accuracy and relevance metrics score perfectly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 420,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did the continued factory disruptions in 2022, which led to a $402 million increase in losses on the KC-46A Tanker program, influence the financial risk and audit scrutiny around Boeing's fixed-price development contracts in 2023?",
      "original_answer": "In 2022, Boeing faced continued factory and supply chain disruptions, including the impact of COVID-19, which led to a $402 million increase in losses on the KC-46A Tanker program due to higher costs for the Remote Vision System and production delays. These disruptions contributed to the financial risk associated with Boeing's fixed-price development contracts. By 2023, this risk had evolved into heightened audit scrutiny, particularly around the estimation of costs and margins for long-term contracts like the KC-46A Tanker. Auditors emphasized the operational and technical complexities of these contracts, compounded by ongoing supply chain and labor disruptions, which made cost estimation highly uncertain and increased the likelihood of reach-forward losses. This scrutiny reflected a direct continuation of the challenges that originated with disruptions in 2022.",
      "llm_answer": "The 2022 factory disruptions produced a $402 million reach‑forward loss on the KC‑46A Tanker program, underscoring the high financial risk of Boeing’s fixed‑price development contracts【page_45】.  In the 2023 audit, this risk was treated as a critical audit matter, prompting auditors to conduct extensive testing of management’s cost‑estimate methodology, the reasonableness of margin assumptions, and the timing of changes to key estimates for contracts such as KC‑46A, Commercial Crew, VC‑25B, and others【page_114】【page_116】, while the company’s own risk discussion noted that fixed‑price development contracts are inherently more uncertain than production contracts【page_115】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the $402 million loss figure is correctly stated, and the years (2022 disruptions leading to 2023 audit scrutiny) are accurate. No calculations are required, and all numeric references are precise. (2) The answer correctly identifies the KC-46A Tanker program and extends the risk discussion to other fixed-price contracts (Commercial Crew, VC-25B), which is consistent with the broader audit focus in 2023. (3) The multi-hop reasoning is sound: it connects 2022 operational disruptions to increased financial risk, then to heightened audit scrutiny in 2023, specifically around cost estimation methodologies—mirroring the causal chain in the original answer. (4) The only minor shortcoming is that the LLM does not explicitly mention the 'Remote Vision System' cost increases or 'supply chain and labor disruptions' as detailed in the ground truth, which slightly reduces qualitative completeness. However, the core financial risk and audit response are accurately captured, and the inclusion of specific audit procedures (testing cost-estimate methodology, margin assumptions) adds valuable detail. The answer remains semantically equivalent in intent and substance, with excellent contextual relevance and entity accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 366,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did the introduction of IRA-mandated price negotiation for Eliquis in 2024 impact BMY's revenue projections compared to the 2022 risk assessments around generic competition for the same drug?",
      "original_answer": "In 2022, BMY expressed concern that generic competition for Eliquis could significantly erode market exclusivity and revenues, citing potential adverse litigation outcomes in the EU that could allow early entry of generic apixaban. By 2024, the risk shifted from generic competition to regulatory pricing pressure under the IRA, with HHS setting a 'maximum fair price' for Eliquis effective January 1, 2026, which is expected to accelerate revenue erosion even before patent expiry. This indicates a transition from market-driven risk (generics) to policy-driven risk (price negotiation), both of which threaten Eliquis' revenue stream but through different mechanisms.",
      "llm_answer": "The 2024 MD&A (page 43) notes that the IRA’s Medicare Part D price‑negotiation for Eliquis, announced in August 2024, “could accelerate revenue erosion” once it takes effect in 2026, and BMS is still evaluating the magnitude of the impact. In contrast, the 2022 10‑K risk factors (page 36) flagged generic competition for Eliquis as a potential source of revenue loss, warning that earlier‑than‑expected generic entry could erode sales but did not quantify a specific decline. Thus, the 2024 price‑negotiation introduces a new, potentially larger pricing pressure on Eliquis revenue beyond the generic‑competition risk highlighted in 2022.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the shift in risk from generic competition in 2022 to IRA price negotiation in 2024, accurately reflecting the change in threat type from market-driven to policy-driven. (2) All dates and events are correct: the 2022 risk factors mention generic competition (page 36), and the 2024 MD&A (page 43) references IRA price negotiation announced in August 2024, effective in 2026. There are no numerical inaccuracies—though no specific dollar amounts are cited, this matches the original answer, which also does not quantify financial impact. (3) The multi-hop reasoning is sound: the model synthesizes information across two different years and filings (2022 10-K and 2024 MD&A), correctly comparing evolving risks to Eliquis revenue. (4) The LLM slightly under-elaborates on the mechanism difference (generic entry vs. price negotiation), but still captures the core transition in risk type. Wording differs slightly but maintains semantic equivalence. Minor deduction from 10 to 9 due to less explicit framing of the 'transition' concept compared to the original, though the substance is intact.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 334,
        "total_tokens": 1674
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did Apple's reliance on third-party content providers in 2023 influence its content-related financial commitments in 2024, particularly in light of the $19.4 billion in unrecognized RSU compensation costs and the risks associated with short-term licensing arrangements?",
      "original_answer": "In 2023, Apple's business was heavily reliant on third-party content providers, as the availability of third-party software and digital content was critical to customer purchasing decisions and overall satisfaction. The company acknowledged risks stemming from short-term licensing arrangements and potential cost increases by content providers, which could limit Apple's ability to offer a wide variety of content on commercially reasonable terms. By 2024, this reliance translated into significant financial commitments, including $19.4 billion in unrecognized compensation costs tied to RSUs, which are often used to attract and retain the talent necessary to manage and develop content partnerships. Additionally, Apple's unconditional purchase obligations included substantial commitments to content licensing and distribution rights, reflecting the ongoing strategic importance and financial exposure tied to third-party content. The evolution from strategic dependence in 2023 to concrete financial exposure in 2024 highlights how Apple's content ecosystem is both a key asset and a growing liability.",
      "llm_answer": "Apple’s 2023 reliance on third‑party content providers meant that a large share of its 2024 content commitments were tied to short‑term licensing agreements that may not be renewed on commercially reasonable terms (see page 13).  The company’s $19.4 billion of unrecognized RSU compensation costs, expected to be recognized over a 2.4‑year period (page 48), represent a significant future expense that could constrain cash flow and limit the resources available to maintain or renegotiate those short‑term content deals, thereby heightening the risk of higher costs or loss of content access.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its use of numbers: the $19.4 billion in unrecognized RSU compensation costs and the 2.4-year recognition period (implied from page 48) are correctly cited, and the reference to short-term licensing arrangements aligns with the original answer. Quantitative accuracy is perfect—no errors in dollar amounts or timeframes. Contextual relevance is high, as the response directly addresses Apple’s reliance on third-party content providers and links it to financial commitments in 2024. However, the answer is incomplete in qualitative accuracy. While it correctly identifies the risk of constrained cash flow due to RSU expenses, it omits the key point from the ground truth that RSUs are used to attract and retain talent specifically for managing content partnerships—a critical link in the multi-hop reasoning. Additionally, the original answer notes that Apple has unconditional purchase obligations for content licensing and distribution rights, which represent concrete financial commitments beyond RSUs; this is missing in the LLM response. Thus, while the logic is sound and the numbers correct, the synthesis is partial, failing to fully connect the strategic dependence in 2023 to the full scope of 2024 financial exposure. This limits the qualitative accuracy and overall correctness, warranting a 7 rather than a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1456,
        "completion_tokens": 380,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did SPG's strategic investment and subsequent divestiture of ABG between 2022 and 2023 influence its ownership stake and financial returns from SPARC Group?",
      "original_answer": "In 2022, SPG held a 50% interest in SPARC Group through its strategic partnership with ABG, which had entered a long-term agreement to operate Reebok in the U.S. During 2023, SPG sold a portion of its ABG stake for $300.2 million, recognizing a $157.1 million pre-tax gain. This divestiture coincided with SPARC Group issuing equity to a third party, which diluted SPG’s ownership in SPARC Group from 50% to 33.3%, triggering a $145.8 million non-cash pre-tax gain. The combined effect of these actions indicates a strategic shift to monetize SPG’s position in ABG while reducing direct exposure to SPARC Group, with both moves contributing to significant gains recorded in SPG’s 2023 financials.",
      "llm_answer": "SPG’s strategic investment in ABG, which was part of a long‑term partnership with SPARC Group, initially gave the company a 50 % noncontrolling equity‑method interest in SPARC Group (page 117).  The 2023 divestiture of ABG diluted SPG’s stake to 33.3 % and its share of SPARC Group’s net income fell sharply—from roughly $403 million in 2021 to $238 million in 2022 and only $40 million in 2023 (page 115).  The sale of the ABG interest also produced a pre‑tax gain of $157.1 million in Q4 2023 (page 113).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several correct elements but also significant inaccuracies. It correctly states SPG's initial 50% ownership in SPARC Group and the reduction to 33.3% due to the 2023 divestiture, as well as the $157.1 million pre-tax gain from selling part of its ABG stake. However, it incorrectly attributes the ownership dilution solely to the divestiture of ABG, while the ground truth clarifies that the dilution was due to SPARC Group issuing equity to a third party, not the ABG sale itself. Additionally, the LLM introduces financial figures for SPG’s share of SPARC Group’s net income—$403M (2021), $238M (2022), $40M (2023)—that are not present in the original answer and may be factually incorrect or misattributed, as the ground truth does not mention these numbers. (2) The $157.1 million gain is correctly reported, but the $145.8 million non-cash gain from the ownership dilution is entirely omitted. The inclusion of unverified income figures from 2021–2023 undermines quantitative accuracy. (3) The multi-hop reasoning is partially sound—linking ABG, SPARC, and ownership changes—but fails to correctly identify the causal mechanism of dilution and omits the key point that two separate gains ($157.1M and $145.8M) contributed to SPG’s financial returns. (4) Contextual relevance is high because the answer addresses the core entities and timeline, but correctness is reduced by missing critical information and introducing unsupported data. Hence, the overall correctness score is 6—partially correct but with significant factual and reasoning gaps.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 436,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did ConocoPhillips' investment impairment in APLNG in 2022 relate to the evolution of APLNG's financing structure and its operator relationship with Origin Energy, and how did this influence the carrying value of ConocoPhillips' APLNG stake by 2024?",
      "original_answer": "In 2022, ConocoPhillips recorded a $688 million impairment on its APLNG investment due to a decline in fair value below carrying value, triggered by Origin Energy’s decision to sell a 10% stake in APLNG, which ConocoPhillips preempted to acquire. This indicated a market reassessment of APLNG’s value. APLNG, operated by Origin Energy, had a $5.7 billion outstanding balance on its $8.5 billion project finance facility as of 2021, which was refinanced over time and remained non-recourse. By 2024, the carrying value of ConocoPhillips’ equity method investment in APLNG had recovered to $5.0 billion, despite the earlier impairment, suggesting stabilization in APLNG’s financial position and continued strategic alignment with Origin Energy as operator. This evolution reflects a recalibration of investment risk and long-term LNG market expectations through the operator-investor-finance nexus.",
      "llm_answer": "ConocoPhillips recorded a $688 million impairment in Q4 2021 (reported in the 2022 10‑K) because APLNG’s fair value fell below its carrying value after Origin Energy sold 10 % of its stake and ConocoPhillips exercised its pre‑emption right, increasing its ownership to 47.5 % in 2022【page_100】.  The joint venture’s financing structure had evolved from an $8.5 billion project‑finance facility to a $5.7 billion outstanding debt in 2021 and was further refinanced to $4.0 billion by 2024, while the operator relationship remained unchanged—Origin Energy ran production and pipelines and ConocoPhillips ran the LNG plant【page_100】【page_94】.  Consequently, ConocoPhillips’ carrying value of its APLNG equity‑method investment was reduced to $5.574 billion at 12/31/2021 and to roughly $5.0 billion by 12/31/2024【page_100】【page_94】.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains mostly correct information but has key factual inaccuracies. The $688 million impairment was recorded in 2022, not Q4 2021 (though reported in the 2022 10-K, the impairment relates to 2022 events). This misdating of the impairment event is a significant error. The 10% stake sale by Origin Energy and ConocoPhillips' pre-emption are correctly identified, as is the increase in ownership to 47.5%. The APLNG project finance facility had an $8.5 billion capacity with $5.7 billion outstanding as of 2021 per ground truth, which the LLM correctly states. However, the claim that debt was refinanced down to $4.0 billion by 2024 is not supported in the original answer (which only states the facility was 'refinanced over time' and remained non-recourse), making this an unsupported addition. The carrying value of $5.0 billion by 2024 matches the original answer, but the LLM incorrectly states it was $5.574 billion as of 12/31/2021 — the original answer does not provide a 2021 carrying value, only that the impairment occurred in 2022. (2) Quantitative accuracy issues: incorrect timing of impairment (2021 vs 2022), unsupported $4.0 billion debt figure in 2024, and spurious precision in $5.574 billion carrying value not in ground truth. Other numbers (688M, 10%, 5.7B) are accurate. (3) Multi-hop reasoning is generally sound: the answer links the impairment trigger (Origin's sale and pre-emption), financing evolution, operator roles, and carrying value outcome. It correctly identifies the non-recourse nature and operator分工 (Origin handling production/pipelines, ConocoPhillips LNG plant), which adds depth. However, the unsupported debt figure and misdated impairment weaken the synthesis. (4) Scores justified: Correctness 7 due to core facts being right but major errors in timing and unsupported figures; Quantitative 6 due to critical date and number inaccuracies; Qualitative 8 for strong reasoning and entity identification despite flaws; Contextual Relevance 9 as the answer directly addresses all aspects of the question with relevant details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1458,
        "completion_tokens": 563,
        "total_tokens": 2021
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did the voting power dynamics between CMCSA's Class A and Class B common stock evolve from 2022 to 2024, and what implications did the convertibility of Class B shares have on ownership structure given the unchanged number of Class B shares outstanding?",
      "original_answer": "In 2022, CMCSA's Class A common stock held 66 2/3% of the combined voting power, while Class B common stock held 33 1/3%, with Class B shares carrying 15 votes each and being non-dilutable. By 2024, the structure remained consistent in terms of voting percentages, with Class A shares still dependent on the outstanding count relative to Class B shares, which remained fixed at 9,444,375 shares. The convertibility of Class B shares into Class A shares, as noted in the 2024 filing, introduced a potential mechanism for shifting ownership structure over time, although no such change occurred in the total number of Class B shares. This suggests that while the ownership structure remained stable in 2024, the long-term dynamics could evolve if Class B shares were converted, altering the voting power balance.",
      "llm_answer": "The voting‑power split between Class A and Class B shares stayed at 66 ⅓ % for Class A and 33 ⅓ % for Class B from 2022 through 2024 (2024 Note 11, page 91; 2022 Note 11, page 38). Because the Class B shares are convertible share‑for‑share into Class A but the outstanding Class B shares remained at 9.444 million, the ownership structure and voting‑power allocation are unchanged unless conversions occur, which would simply shift voting power from Class B to Class A without altering the total number of shares.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the essential information from the ground truth. (1) Quantitatively, all numbers are correct: the 66 1/3% and 33 1/3% voting power split is accurately reported (note: ground truth says 66 2/3%, but this appears to be a typo in the original—66 1/3% + 33 1/3% = 99 2/3%, whereas 66 2/3% + 33 1/3% = 100%, so LLM likely corrected a transcription error; thus, the LLM's 66 2/3% would be expected, but it says 66 1/3%, which is likely a typo in the LLM answer). However, the Class B share count is correctly cited as approximately 9.444 million (matching 9,444,375 in ground truth). (2) The convertibility mechanism is correctly described: Class B shares are convertible share-for-share into Class A, and no conversions occurred, so the structure remained unchanged. (3) The multi-hop reasoning is sound—linking the stable share count to unchanged voting dynamics and recognizing that future conversions could shift voting power without changing total shares. (4) Minor wording differences: LLM says '66 1/3%' instead of '66 2/3%', which is a factual error, but otherwise the implications of convertibility and structural stability are correctly interpreted. This small numerical inconsistency prevents a perfect 10. Contextual relevance is excellent—directly addresses both parts of the question: evolution (none) and implications of convertibility. Thus, correctness is 9 due to the percentage typo, but all other aspects are strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 405,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did SPG's strategic investment in ABG in 2022 influence its stake and financial returns from SPARC Group in 2023, particularly in light of SPARC Group's acquisition of Reebok and subsequent equity dilution?",
      "original_answer": "In 2022, SPG held a significant interest in ABG, which had a strategic partnership with SPARC Group for Reebok's U.S. operations. This positioned SPG to benefit from SPARC Group's expansion, including the acquisition of Reebok. However, in 2023, SPG's ownership in SPARC Group was diluted to 33.3% due to new equity issuance, resulting in a non-cash pre-tax gain of $145.8 million. Additionally, SPG sold part of its ABG stake in Q4 2023 for $300.2 million, recognizing a pre-tax gain of $157.1 million. These actions suggest that SPG leveraged its earlier investment in ABG to realize financial gains in 2023, even as its direct stake in SPARC Group decreased.",
      "llm_answer": "SPG’s 2022 investment in ABG raised its ABG ownership to roughly 11.7 % by 2023, giving it a stronger seat in ABG’s partnership with SPARC Group that underpinned SPARC’s 2022 Reebok acquisition (page 113).  However, SPARC Group’s equity dilution in Q3 2023 cut SPG’s non‑controlling stake to 33.3 % and capped its share of SPARC Group’s 2023 net income at $40.0 million (page 115), even as SPG realized a $157.1 million pre‑tax gain from selling part of its ABG interest in Q4 2023 (page 114).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies key events and financial outcomes—SPG's reduced stake in SPARC Group to 33.3%, the $157.1 million pre-tax gain from selling part of its ABG stake in Q4 2023, and the connection between ABG, SPARC Group, and Reebok. However, it introduces a specific figure—'11.7%' ABG ownership—that is not present in the original answer and cannot be verified from the ground truth, making it a factual overreach. Additionally, the claim that SPG’s share of SPARC Group’s 2023 net income was capped at $40.0 million is absent from the original and unsupported by the provided truth, representing an unverified addition. (2) The $157.1 million gain and 33.3% stake are correctly stated and match the ground truth. The $145.8 million non-cash pre-tax gain from dilution in the original answer is entirely missing in the LLM response, which instead invents a $40.0 million income cap. This is a significant quantitative omission and error. (3) The multi-hop reasoning is partially sound: the LLM correctly links SPG’s ABG investment to SPARC Group and Reebok, and recognizes dilution and divestment impacts. However, it fails to mention the $145.8 million gain from equity dilution—the primary financial return tied to SPARC Group—while incorrectly substituting it with an unrelated $40.0 million figure. This undermines the completeness of the financial returns analysis. (4) The contextual relevance is high as the answer addresses the strategic investment, equity dilution, and financial gains. Qualitative accuracy is good due to correct entity relationships and timeline, but quantitative accuracy is reduced due to the inclusion of unsupported numbers and omission of a key gain. Correctness is therefore scored at 7 due to core factual correctness on major events but significant issues in numerical fidelity and completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 505,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did the change in MDLZ's Value at Risk (VAR) exposure from 2023 ($284M) to 2024 ($255M) relate to the increasing notional value of forecasted transactions hedged in foreign exchange contracts, which rose from $2M in 2023 to $106M in 2024?",
      "original_answer": "In 2023, MDLZ's VAR model estimated a maximum one-day loss of $284 million under normal market conditions, using a 95% confidence interval and a variance/co-variance technique that excluded forecasted transactions. By 2024, this VAR exposure decreased to $255 million, attributed to reduced interest rate volatility. Despite this decline in VAR, the company reported a significant increase in the notional value of forecasted transactions hedged through foreign exchange contracts, rising from $2 million in 2023 to $106 million in 2024. This suggests that while overall market risk (as measured by VAR) decreased, MDLZ expanded its hedging activities on forecasted transactions, potentially to mitigate residual or non-modeled risks not captured in the VAR framework. This strategic shift indicates a more proactive approach to managing transaction-level currency exposure even as broader market volatility declined.",
      "llm_answer": "The VAR exposure fell from $284 million in 2023 to $255 million in 2024 – a $29 million decline driven by lower interest‑rate volatility (page 60). At the same time, the notional value of forecasted transactions hedged in foreign‑exchange contracts surged from $2 million to $106 million (page 97). Because forecasted transactions are excluded from the VAR model, the jump in FX‑hedge notional value did not raise the VAR exposure; the reduction in VAR was instead a result of reduced market volatility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts: MDLZ's VAR decreased from $284M in 2023 to $255M in 2024 ($29M decline), and the notional value of forecasted transactions hedged in FX contracts increased from $2M to $106M. These numbers match the ground truth exactly, with acceptable formatting (e.g., $284 million = $284M). The cause—reduced interest rate volatility—is accurately cited. (2) Quantitative accuracy is perfect: the $29M difference is correctly calculated (284 - 255 = 29), and the hedging notional increase (from $2M to $106M) is reported accurately. (3) The reasoning is sound and captures the core multi-hop insight: despite increased hedging activity, VAR decreased because forecasted transactions are excluded from the VAR model, and the decline was due to lower market volatility. This aligns with the ground truth’s explanation. (4) The only minor shortcoming is that the LLM answer does not explicitly mention the strategic implication—that MDLZ expanded hedging to manage residual risks not captured in VAR, indicating a more proactive risk management approach. While implied by stating that forecasted transactions are excluded, the deeper interpretive layer about strategic shift is omitted. However, the core factual and logical content is correct and highly relevant. Thus, the answer is excellent but slightly less complete than the original in qualitative depth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 392,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did Southern Company's approach to fair value estimation for asset retirement obligations in 2023 compare with their 2024 disclosures around valuation methods for pension and postretirement benefit plan assets, particularly in terms of the role of judgment and market data interpretation?",
      "original_answer": "In 2023, Southern Company disclosed that fair value estimation for asset retirement obligations (AROs) required significant judgment, particularly when quoted market prices were unavailable. They relied on present value techniques, using estimates of future cash outlays discounted at a credit-adjusted risk-free rate, especially for obligations related to ash ponds, nuclear decommissioning, and landfill sites. In 2024, the company disclosed that similar principles applied to the valuation of pension and other postretirement benefit plan assets, where considerable judgment was also required in interpreting market data and selecting assumptions, echoing the valuation challenges noted in the 2023 ARO disclosures. The MET 2023 chunk further supports this by emphasizing that differences in valuation methodologies could materially affect fair value estimates, reinforcing the consistency in the company's approach to fair value measurement across different asset classes and time periods.",
      "llm_answer": "In 2023, Southern Company’s ARO fair‑value estimate was a straight‑forward present‑value calculation of projected retirement costs discounted at a credit‑adjusted risk‑free rate; the primary judgment involved estimating future costs and timing rather than interpreting market prices (page 219). By contrast, the 2024 pension and post‑retirement benefit plan disclosures describe a three‑level fair‑value hierarchy (Level 1, Level 2, Level 3) and explicitly state that management must interpret observable market data and apply judgment—especially for Level 2 and Level 3 assets—so that different assumptions can materially affect the fair‑value amounts (pages 256, 264, 258).",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but diverges significantly in interpretation from the original answer, particularly regarding the core comparison of judgment and market data interpretation across years and asset types. (1) Quantitatively, the LLM correctly identifies the 2023 ARO valuation method (present value, credit-adjusted risk-free rate) and the 2024 pension plan’s use of the three-level fair-value hierarchy (Level 1–3), citing appropriate judgment in Level 2/3 assets. These details align with the ground truth and are factually accurate. Page references (e.g., 219, 256, 264) suggest correct sourcing. (2) However, the qualitative reasoning is flawed: the LLM frames the two disclosures as contrasting ('By contrast...'), while the original answer emphasizes consistency in the role of judgment across both contexts. The ground truth states that Southern Company explicitly *echoed* the same valuation challenges in 2024 as in 2023, indicating a consistent approach to fair value estimation requiring judgment when market data is limited. The LLM incorrectly implies a difference in the degree or nature of judgment, when the original answer stresses similarity. (3) The multi-hop synthesis fails: the question asks for a comparison in terms of judgment and market data interpretation, and the correct inference is that both disclosures highlight similar reliance on judgment. The LLM instead emphasizes structural differences in methodology (present value vs. hierarchy levels) without concluding that both require significant judgment. (4) While the LLM includes relevant details and correct financial concepts, it misses the central point of conceptual consistency across disclosures, leading to a misleading comparison. Hence, correctness is reduced to 6 due to significant reasoning error despite factual accuracy in isolated components.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 500,
        "total_tokens": 1954
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did the change in DSCR for AMT's Trust Securitizations between 2022 and 2024 impact the buffer before triggering cash flow restrictions, and what does this reveal about the financial stability of AMT Asset Subs?",
      "original_answer": "In 2022, the Trust Securitizations were subject to the Cash Trap DSCR of 1.30x, which restricted the release of excess cash if the ratio fell to or below this threshold. By 2024, the DSCR for the Trust Securitizations was reported at 7.14x, significantly above the 1.30x trigger. This indicates that AMT Asset Subs maintained a substantial buffer before reaching the cash trap threshold, with a capacity for a $526.4 million decrease in net cash flow before triggering the restriction. This evolution from 2022 to 2024 reveals improved financial stability in the Trust Securitizations, as the AMT Asset Subs demonstrated a much stronger ability to service debt and avoid cash flow restrictions.",
      "llm_answer": "The DSCR for the Trust Securitizations rose to **7.14× in 2024** (up from a lower level in 2022), which expanded the cushion before the cash‑trap DSCR was triggered to **$526.4 million**【page_58】. This larger buffer shows that AMT Asset Subs now have a stronger cash‑flow cushion, indicating greater resilience to cash‑flow volatility and a lower likelihood of default under the securitization covenants【page_118】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 2024 DSCR of 7.14x and the $526.4 million buffer, both of which match the ground truth. While it does not explicitly state the 2022 DSCR value, it correctly references that the ratio was lower in 2022 and emphasizes the improvement, which aligns with the original answer's intent. The cash trap threshold of 1.30x is not explicitly mentioned, but the concept of a 'cash-trap DSCR' is referenced, and the implication of being well above the trigger is preserved. (2) All numeric values — 7.14x DSCR in 2024 and $526.4 million buffer — are accurate and correctly formatted. The calculation of the buffer (implied difference between current performance and trigger point) is consistent with the ground truth. (3) The multi-hop reasoning is sound: the model connects the improved DSCR to a larger cash flow buffer and infers enhanced financial resilience, correctly synthesizing implications across time and financial structure. It links performance to covenant risk and financial stability, which reflects valid reasoning. (4) The answer is contextually fully relevant, addressing the impact on the buffer and what it reveals about financial stability. The only minor omission is the explicit mention of the 1.30x threshold and the fact that it was in effect in 2022, which slightly reduces completeness but does not impair the core factual or inferential accuracy. Overall, the answer conveys semantically equivalent information with high precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 414,
        "total_tokens": 1709
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did ConocoPhillips' impairment of its APLNG investment in 2022 relate to the financial performance and debt structure of APLNG's operations in Queensland, Australia, and how does this compare with the carrying value of the investment in 2024?",
      "original_answer": "In 2022, ConocoPhillips impaired its APLNG investment by $688 million, reducing the carrying value to $5,574 million due to a decline in fair value below book value. This impairment was tied to APLNG’s operations in Queensland, Australia, which were central to its coal bed methane (CBM) production and LNG export activities. By 2024, the carrying value of the APLNG investment had decreased further to approximately $5.0 billion, indicating continued financial pressure on the joint venture. APLNG's debt structure also evolved, with the outstanding balance on its project financing decreasing from $5.7 billion in 2021 to $4.0 billion by the end of 2024, reflecting ongoing bi-annual repayments. The temporal analysis shows that the initial impairment was a response to market valuation concerns, and the subsequent carrying value in 2024 reflects a continued, albeit reduced, investment position in Queensland’s LNG operations.",
      "llm_answer": "ConocoPhillips’ $688 million impairment of its APLNG equity‑method investment (recorded in the 2022 year‑end filings, actually in Q4 2021) was triggered by a decline in APLNG’s fair value below its carrying value, a fall that reflected the joint venture’s modest operating performance and the heavy debt load of its Queensland operations – $4 billion still outstanding on an $8.5 billion project‑finance facility (page 94).  The write‑down reduced the investment’s book value to $5.574 billion, and by December 31 2024 the carrying value had further fallen to roughly $5.0 billion, indicating a continued downward adjustment in valuation (page 94).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in the quantitative details. It incorrectly states that the $688 million impairment was recorded in Q4 2021, while the ground truth confirms it occurred in 2022. This is a significant error in temporal attribution. Additionally, the LLM claims APLNG had a debt load of $4 billion outstanding on an $8.5 billion facility, but the ground truth states the project financing decreased from $5.7 billion in 2021 to $4.0 billion by end-2024—there is no mention of an $8.5 billion facility in the original answer, making this a fabrication or misstatement. (2) The carrying value after impairment is correctly stated as $5.574 billion (matching $5,574 million), and the 2024 carrying value of approximately $5.0 billion is also accurate and correctly formatted. However, the debt figures and timing of the impairment are incorrect. (3) The reasoning correctly links the impairment to a decline in fair value below carrying value and associates it with APLNG’s Queensland operations, which is consistent with the multi-hop requirement. It also correctly traces the continued decline in carrying value through 2024. However, the incorrect debt structure description and misdated impairment weaken the synthesis. (4) Contextually, the answer addresses all parts of the question—impairment cause, relation to financial performance and debt, and comparison with 2024 carrying value—but the inclusion of inaccurate debt figures and wrong dates undermines factual reliability. The reference to 'page 94' suggests a document source but does not excuse the discrepancies. Thus, while the structure and intent are sound, the quantitative inaccuracies reduce the correctness score significantly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 478,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "What was the strategic impact of EMR's acquisition of National Instruments Corporation on their Test & Measurement segment performance in 2024, particularly in terms of revenue contribution and valuation of automated test systems-related intangible assets?",
      "original_answer": "EMR's acquisition of National Instruments Corporation (NI), completed on October 11, 2023, significantly shaped the Test & Measurement segment's performance in 2024. NI contributed approximately $1.7 billion in revenue for the 12 months ended September 30, 2023, which became part of EMR’s Test & Measurement segment post-acquisition. In 2024, the consolidated net sales reached $17.5 billion, with the Test & Measurement segment benefiting from NI’s integration. Additionally, as part of the acquisition, EMR recognized $3.36 billion in customer relationships and $1.57 billion in developed technology intangible assets, both directly tied to NI’s automated test systems offerings. These valuations reflect the strategic importance of NI’s technology and customer base in enhancing EMR’s position in the automated test systems market.",
      "llm_answer": "The NI acquisition added 9.5 % to Emerson’s 2024 net sales and gave the new Test & Measurement segment $1.464 billion in revenue—about 9.5 % of total sales.  The purchase created $1.57 billion of “developed‑technology” intangible assets (primarily automated test‑systems) at fair value.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer contains partial factual correctness but has significant quantitative inaccuracies. The ground truth states that National Instruments (NI) contributed approximately $1.7 billion in revenue for the 12 months ended September 30, 2023, which became part of EMR’s Test & Measurement segment. However, the LLM claims NI contributed $1.464 billion in revenue to Emerson in 2024—this figure does not match the source data and appears to be either miscalculated or misattributed. Additionally, the claim that this represents 9.5% of total net sales is unsupported: using the reported $17.5 billion in consolidated net sales for 2024, $1.464 billion would be ~8.4%, not 9.5%. The only correct quantitative figure is the $1.57 billion in developed technology intangible assets tied to automated test systems, which matches the ground truth.\n\n2) The LLM omits the $3.36 billion valuation of customer relationships, a key component of the intangible assets acquired and directly relevant to the question about valuation of automated test systems-related intangibles. This is a major omission in completeness.\n\n3) Entity accuracy is mostly correct: 'NI' refers to National Instruments Corporation, and the context of Emerson (EMR) acquiring it is preserved. However, the term 'Emerson’s 2024 net sales' is misleading—the acquisition closed October 11, 2023, so NI’s full-year contribution would only be reflected starting in EMR’s 2024 reporting period, but the revenue figure attributed to it should align with disclosed data, which it does not.\n\n4) The reasoning shows an attempt at multi-hop synthesis—linking the acquisition to revenue impact and intangible asset valuation—but fails in accurate calculation and data recall. The percentage contribution (9.5%) is incorrectly applied and not derived from valid inputs. While the focus on developed technology as a key intangible is correct, missing the customer relationships component weakens the strategic valuation analysis.\n\n5) Despite wording differences, semantic equivalence is not achieved due to incorrect numbers and missing data. The core strategic impact—enhanced position via technology and customer base—is implied but not fully supported by accurate data in the response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 599,
        "total_tokens": 1906
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did Southern Company's 2023 fuel procurement cost reductions relate to the regulatory requirements for FERC approval, and how does this contrast with the regulatory risk exposure from their 50% stake in SNG's $3 billion pipeline project in 2024?",
      "original_answer": "In 2023, Southern Company reduced fuel expenses by $230 million (30.8%) and purchased power expenses by $21 million (49.9%), partly due to lower natural gas prices and reduced volume purchased, with these procurement activities conducted under FERC-approved agreements. This indicates strong regulatory alignment and cost optimization under existing FERC oversight. In 2024, Southern Company Gas’ 50% stake in SNG’s $3 billion pipeline project remains subject to FERC approval, introducing regulatory risk and uncertainty around cost recovery and project completion timing. Unlike the 2023 procurement activities, which were already operating under finalized FERC approvals, the SNG pipeline represents a forward-looking infrastructure investment with significant capital exposure and conditional regulatory risk. Thus, while 2023 demonstrated successful execution under existing FERC frameworks, 2024 highlights the company’s exposure to regulatory outcomes on new, large-scale projects.",
      "llm_answer": "In 2023 Southern Company cut fuel procurement costs by roughly 31 % as natural‑gas prices fell and coal volumes dropped; those purchases were made under long‑term PPAs and the Interconnection Agreement (IIC) that are approved by FERC, so the cost savings were achieved within a framework that satisfies regulatory requirements and limits regulatory risk.  By contrast, the company’s 50 % stake in SNG’s $3 billion pipeline project in 2024 carries significant regulatory risk because the project’s completion hinges on obtaining FERC and other approvals, and the outcome remains uncertain, exposing Southern Company to potential delays, cost overruns, or denial of approval.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the core facts: Southern Company reduced fuel procurement costs in 2023 by approximately 31%, which aligns with the ground truth's 30.8% reduction in fuel expenses ($230 million). The mention of falling natural gas prices and reduced volumes (coal volumes dropping) is consistent with the original answer’s explanation of lower natural gas prices and reduced volume purchased. The LLM correctly identifies that these procurement activities were conducted under FERC-approved agreements (referencing PPAs and the Interconnection Agreement), indicating regulatory compliance. For 2024, the LLM accurately notes the $3 billion pipeline project and Southern’s 50% stake in SNG, correctly framing it as subject to pending FERC and other approvals, introducing regulatory risk. (2) Quantitatively, the 31% figure is a rounded but acceptable approximation of 30.8%. The $3 billion figure is exact. The $21 million reduction in purchased power expenses (49.9%) is omitted, which is a minor gap but does not undermine the main thrust of the answer. No incorrect calculations are made. (3) The multi-hop reasoning is sound: the model contrasts past cost reductions under finalized FERC frameworks with future regulatory uncertainty on a new capital project, correctly synthesizing the difference in regulatory risk exposure between operational procurement and forward-looking infrastructure investment. (4) Scores reflect high accuracy in numbers, strong qualitative reasoning, and full contextual relevance. The only minor shortcoming is the omission of the purchased power expense reduction, which prevents a perfect 10 on correctness and quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 464,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did Southern Company's reliance on SCS for specialized services in 2024 compare to 2023, and what does this indicate about the company's internal cost structure and service dependency strategy?",
      "original_answer": "In 2023, Southern Company operated under a structure where SCS provided specialized services at cost, including executive advisory, engineering, operations, and IT services. In 2024, Southern Company continued to depend on SCS for the same categories of services, with costs still being rendered at direct or allocated cost, as evidenced by the consistent listing of these service categories and cost-based billing. The lack of change in service types and cost methodology indicates that Southern Company maintained a stable internal cost structure and continued to rely on centralized service delivery through SCS, suggesting a strategic commitment to internal resource optimization rather than outsourcing or restructuring. This continuity in service delivery and cost treatment reflects a deliberate internal cost management strategy focused on maintaining control and efficiency across the company's operations.",
      "llm_answer": "Southern Company’s total cost of services from SCS rose to **$2.62 billion in 2024** from **$1.93 billion in 2023** (a 36 % increase)【page_165】.  This jump reflects the company’s continued strategy of outsourcing a broad array of specialized functions—engineering, IT, legal, procurement, and more—to the system‑service company, keeping those expenses within other operations and maintenance and indicating a cost structure that relies heavily on SCS for non‑core services while preserving internal focus on core utility operations【page_168】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific dollar amounts ($2.62 billion in 2024 and $1.93 billion in 2023) and a 36% increase, which are not present in the original answer (ground truth). The ground truth does not provide any numerical cost figures or indicate a change in spending levels—it only states that the structure and cost methodology (at direct or allocated cost) remained unchanged between 2023 and 2024. Therefore, the inclusion of precise financial figures and a percentage increase is factually unsupported by the ground truth and likely incorrect. (2) The calculation of a 36% increase from $1.93B to $2.62B is mathematically accurate ((2.62 - 1.93)/1.93 ≈ 0.357), but since the numbers themselves are not in the original answer, this quantitative precision is misleading and not aligned with the ground truth. (3) The qualitative reasoning partially matches: the LLM correctly identifies that Southern Company relies on SCS for specialized services (engineering, IT, etc.) and interprets this as a strategic choice to focus internal resources on core operations. However, the original answer emphasizes *continuity* and *stability* in cost structure and service delivery, whereas the LLM implies a strategic *outsourcing* model and suggests growing dependency due to rising costs—this misrepresents the ground truth, which does not indicate any change in strategy or cost methodology. The term 'outsourcing' is also misleading since SCS appears to be an internal centralized service unit, not an external vendor. (4) The contextual relevance is high because the answer addresses the comparison between years, service types, and strategic implications. However, the introduction of unsupported numerical data and the mischaracterization of the SCS relationship as 'outsourcing' significantly reduce factual correctness. The model fails the multi-hop synthesis by adding data not in the knowledge graph and drawing conclusions from it, thus lowering the overall correctness score to 4—partially correct but with major factual deviations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 553,
        "total_tokens": 1930
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did the changes in BMY's regulatory exclusivity protections for Opdivo between 2023 and 2024 affect the company's ability to maintain market exclusivity and defend against generic competition in the U.S. biologics market?",
      "original_answer": "In 2023, BMY highlighted the risks associated with losing market exclusivity earlier than expected due to generic challenges and weaker patent protections in certain countries, which could negatively impact revenue and earnings. Market exclusivity was described as being determined by both patent rights and regulatory exclusivity, with the latter providing a 12-year protection period for biologics in the U.S. By 2024, BMY confirmed that Opdivo, one of its key biologic products, was still subject to the U.S. 12-year regulatory exclusivity period, which prevents biosimilar approval until 12 years after initial FDA approval. However, the increased frequency of patent challenges from generic and biosimilar manufacturers raised uncertainty about the duration of market exclusivity, even with regulatory protections in place. The interplay between evolving patent litigation risks and fixed regulatory exclusivity timelines created a more complex environment for BMY to defend Opdivo’s market position, especially as generic manufacturers could file challenges during the later stages of exclusivity periods.",
      "llm_answer": "BMS’s 2024 10‑K confirms that Opdivo still enjoys the standard 12‑year FDA regulatory exclusivity for biologics, and the estimated minimum market‑exclusivity date remains 2028—unchanged from the 2023 filing. Consequently, the company’s ability to maintain market exclusivity and defend against generic biosimilar competition in the U.S. biologics market has not been altered by any regulatory changes between the two periods.  \n\n[page_7] [page_6] [page_9]",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains partially correct information but misses key nuances from the ground truth, resulting in an incomplete and somewhat misleading conclusion. (1) Quantitatively, the mention of the '12-year FDA regulatory exclusivity' and '2028' as the minimum market-exclusivity date is plausible (Opdivo was approved in 2014, so 12 years would be 2026, not 2028—this discrepancy suggests a calculation or factual error). The 2028 date does not align with known FDA approval timelines for Opdivo, reducing quantitative accuracy. (2) The answer incorrectly implies that because regulatory exclusivity remains unchanged, BMY’s ability to defend against generic competition was unaffected between 2023 and 2024. However, the original answer emphasizes that while regulatory exclusivity remained intact, the increasing frequency of patent challenges from biosimilar manufacturers introduced greater uncertainty about the effective duration of market exclusivity. This critical qualitative point—about heightened litigation risk undermining confidence in exclusivity despite stable regulatory timelines—is entirely omitted. (3) The reasoning fails the multi-hop synthesis: it does not connect the stable regulatory framework (12-year exclusivity) with the evolving threat from patent litigation and biosimilar challenges, which is central to the question. (4) Contextually, the answer is relevant and addresses the core topic of market exclusivity for Opdivo, but by focusing only on regulatory stability and ignoring the growing patent-related risks highlighted in both years, it presents an overly optimistic and incomplete picture. Thus, while some facts are correct, the absence of risk context and the potential date error significantly reduce correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 482,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did the financial implications of AMT's stake in ATC TIPL during 2023, including the pending transaction with DIT, influence AMT's capital structure and strategic focus in 2024, particularly following the completion of the sale and receipt of 182 billion INR?",
      "original_answer": "In 2023, AMT held a stake in ATC TIPL and entered into a pending transaction with DIT, which was expected to yield up to 210 billion INR (~$2.5 billion). By 2024, the transaction was completed, with AMT receiving 182 billion INR (~$2.2 billion), which was used to repay $1.5 billion of senior notes and reduce debt under the 2021 Multicurrency Credit Facility. This allowed AMT to restructure its capital by reducing debt and repurposing capital toward long-term growth initiatives, aligning with the strategic review that concluded in early 2024. The transaction also resulted in a $1.2 billion loss, primarily due to the reclassification of cumulative translation adjustments in India.",
      "llm_answer": "The pending ATC TIPL transaction, valued at up to 210 bn INR, closed in September 2024 with a 182 bn INR sale (page 140).  AMT used the proceeds to repay debt under its 2021 Multicurrency Credit Facility, reducing leverage and improving its capital structure (page 141).  The divestiture also marked a strategic pivot away from India, stripping the company of ATC TIPL’s 23 % share of international property revenue and 15 % of international gross margin (page 140) and shifting focus to its core U.S., Canada, and other markets (page 138).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the completion of the ATC TIPL transaction for 182 billion INR and its use to repay debt under the 2021 Multicurrency Credit Facility, aligning with the ground truth. It also accurately notes the strategic shift away from India and focus on core markets like the U.S. and Canada. However, it omits key financial facts from the original answer: the $1.5 billion senior notes repayment and, critically, the $1.2 billion loss due to reclassification of cumulative translation adjustments in India—this is a significant omission affecting completeness and quantitative accuracy. (2) The numeric values are mostly correct: 210 billion INR as the expected value and 182 billion INR received are accurate (with acceptable formatting as 'bn INR'). However, the LLM does not convert 182 billion INR to ~$2.2 billion as stated in the ground truth, missing a key financial translation. Also, while it mentions debt repayment, it fails to specify the $1.5 billion senior notes, reducing quantitative precision. The percentages cited (23% of international property revenue, 15% of gross margin) appear specific and plausible but are not present in the ground truth and may be extraneous or misaligned. (3) The multi-hop reasoning is sound in linking the sale proceeds to debt reduction and strategic refocusing, and the synthesis across transaction, capital structure, and strategy is logical. However, the failure to incorporate the loss and its impact on financial statements indicates a gap in full financial implication analysis. (4) The answer is contextually relevant and well-structured, addressing capital structure changes and strategic focus as required. The omission of the loss and specific debt instruments prevents a higher score. Quantitative accuracy is reduced due to missing dollar equivalents and key figures, but qualitative reasoning and relevance remain strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 519,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did the amortization of the deferred gain from AIG's adverse development reinsurance agreement with NICO evolve from 2022 to 2024, and what does this indicate about the ongoing financial impact of the collateral trust account established by NICO?",
      "original_answer": "In 2022, the amortization of the deferred gain from AIG's adverse development reinsurance agreement with NICO was $189 million. By 2024, this amount had increased significantly to $322 million, indicating a growing financial benefit to AIG from the retroactive reinsurance agreement. This increase suggests that the settlement period of the ceded reserves has progressed, allowing for more of the deferred gain to be recognized. The collateral trust account established by NICO in 2017, funded with the consideration paid under the agreement, provided security for NICO's claim payment obligations to AIG, enabling the amortization process to continue over time. The parental guarantee from Berkshire Hathaway Inc. further supported the stability of this arrangement, allowing AIG to realize increasing gains over the years as the deferred gain was amortized into income.",
      "llm_answer": "The deferred‑gain amortization from the NICO adverse‑development reinsurance has shifted from a relatively small, stable amount in 2022 to a larger, more volatile figure in 2024.  In 2022 the company amortized $167 million of the original deferred gain and an additional $22 million due to changes in the gain, for a net $189 million.  In 2023 the amortization of the original gain fell to $164 million, but the change‑in‑gain amortization rose to $116 million, giving a net $48 million.  In 2024 the original‑gain amortization dropped further to $136 million, while the change‑in‑gain amortization jumped to $186 million, resulting in a net $322 million amortization.  This pattern shows that the collateral‑trust account created by NICO continues to provide a substantial cash source to reduce the deferred‑gain liability, but the liability remains sizable, underscoring the ongoing financial impact of the trust arrangement.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative breakdown, particularly in the 2023 and 2024 amortization components. While the net amortization amounts for 2022 ($189M) and 2024 ($322M) match the ground truth, the LLM fabricates a split between 'original gain' and 'change-in-gain' amortization that is not present in the original answer or implied by the knowledge graph. More critically, the LLM states that 2023 net amortization was $48 million, which is incorrect—the ground truth does not provide 2023 data, but the LLM invents a figure that contradicts the upward trend. (2) The calculation of net amortization is arithmetically correct within the LLM's own framework (e.g., $136M + $186M = $322M), but the components themselves are unsupported and factually wrong. The ground truth does not mention any such decomposition of amortization, nor does it report a drop in 2023 amortization—on the contrary, the trend is increasing. (3) The multi-hop reasoning is partially sound in linking the amortization to the NICO collateral trust account and recognizing its ongoing financial impact, but the explanation is undermined by incorrect data. The LLM correctly identifies the role of the trust account in supporting the amortization process and mentions Berkshire Hathaway’s guarantee, which aligns with the original answer. However, the conclusion that the liability remains 'sizable' due to volatility is speculative and not supported by the ground truth, which emphasizes increasing gains as a positive financial benefit. (4) The contextual relevance is high because the LLM addresses both parts of the question—evolution of amortization and implications of the trust account—and uses appropriate financial terminology. However, the correctness score is low due to major quantitative errors that distort the trend and misrepresent the financial reality. The qualitative accuracy is moderate because the conceptual framework is plausible but built on false data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1475,
        "completion_tokens": 541,
        "total_tokens": 2017
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did the resolution of the VIL Shortfall between 2023 and 2024 influence AMT's financial outcomes after the conversion and subsequent sale of the VIL OCDs in 2024?",
      "original_answer": "In 2023, VIL communicated partial payments of contractual obligations owed to AMT, leading to a $27.3 million deferral of revenue and a $322.0 million goodwill impairment charge due to uncertainty in collections in India. By the second half of 2023, VIL resumed full payments, and AMT recognized $95.7 million of the previously deferred revenue in 2024. Additionally, in February and August 2023, VIL issued $193.2 million in VIL OCDs to AMT's subsidiary, ATC TIPL, as part of a payment arrangement. In 2024, AMT converted and sold the VIL OCDs and equity shares, generating $216.0 million and $22.0 million in net proceeds, respectively, and recognizing a total gain of $46.4 million. The resolution of the VIL Shortfall thus directly enabled the financial restructuring through the VIL OCDs, which culminated in significant realized gains for AMT in 2024.",
      "llm_answer": "The VIL Shortfall was resolved in the second half of 2023 when Vodafone Idea Limited began making full payments, allowing AMT to recognize $95.7 million of previously deferred revenue (page 7). The resulting cash‑flow improvement enabled the company to convert 14.4 billion INR of VIL OCDs into shares and sell those shares for $216 million, and to sell the remaining OCDs for $22 million (pages 46‑47). The $46.4 million gain from those sales was recorded in Loss from discontinued operations in 2024 (page 120).",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core financial outcomes correctly—recognition of $95.7 million in deferred revenue, conversion and sale of VIL OCDs for $216 million, sale of remaining OCDs/equity for $22 million, and a total gain of $46.4 million. However, there is a critical error in the allocation of proceeds: the original answer states that $216.0 million came from the conversion and sale of the VIL OCDs, and $22.0 million from the sale of equity shares. The LLM reverses the characterization, implying $216M was from shares and $22M from OCDs, which misrepresents the transaction structure. Additionally, the LLM introduces '14.4 billion INR' not present in the original answer, which, while potentially accurate, is extraneous and unverified against the ground truth. (2) Quantitative accuracy is mostly correct: $95.7M, $216M, $22M, and $46.4M are all present and correctly stated. However, the misattribution of the $216M and $22M proceeds between OCDs and equity undermines full quantitative fidelity. The timing (2023 resolution, 2024 recognition) is accurate. (3) The multi-hop reasoning is sound—linking the resolution of the shortfall to revenue recognition, then to the ability to convert and sell instruments, and finally to realized gains. The logic chain is well-structured and reflects synthesis across events. (4) Contextual relevance is excellent; the answer directly addresses the question about financial outcomes post-conversion and sale. Despite the mislabeling of the proceeds, the overall narrative aligns with the ground truth. The mention of 'Loss from discontinued operations' is an additional detail not in the original but not necessarily incorrect—however, it's unverifiable from the provided truth. Final score reflects high correctness with a deduction for the proceeds misattribution, which is a significant but not fundamental error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 509,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did PEP's shift in real estate commingled fund investments from 2023 to 2024 affect the allocation between U.S. and international plan assets, particularly regarding net asset value exposures?",
      "original_answer": "In 2023, PEP's U.S. plan assets included $411 million in real estate commingled funds measured at net asset value, while international plan assets held $162 million in similar funds. By 2024, the U.S. plan assets increased their real estate commingled fund exposure to $561 million, reflecting a $150 million increase, while international plan assets saw a significant decline to $79 million from $162 million. This indicates a strategic reallocation from international to U.S. real estate investments, particularly in assets measured at net asset value. The shift suggests a refocusing of real estate exposure toward domestic markets, aligning with broader pension fund management adjustments between the years.",
      "llm_answer": "From 2023 to 2024, PEP increased its U.S. plan assets’ net‑asset‑value exposure to real‑estate commingled funds from $411 million to $561 million—an increase of $150 million—while its international plan assets’ exposure fell from $162 million to $79 million, a drop of $83 million. This shift moved the allocation of plan assets toward U.S. real‑estate commingled funds and away from international holdings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports all key numerical values: U.S. plan assets increased from $411 million to $561 million (a $150 million increase), and international plan assets decreased from $162 million to $79 million (a drop of $83 million). These figures match the ground truth exactly, with acceptable formatting (e.g., $411 million). 2) Quantitative accuracy is perfect: the increases and decreases are correctly calculated and presented. The $150 million increase (561 - 411) and $83 million decrease (162 - 79) are accurate. 3) The reasoning is sound and captures the multi-hop nature of the question—comparing two years, two geographies, and synthesizing the shift in allocation. The conclusion about reallocation toward U.S. and away from international holdings is valid. 4) The only minor shortcoming is that the LLM answer omits the interpretive phrase about 'strategic reallocation' and 'refocusing toward domestic markets' present in the original, which adds contextual insight. However, the core facts, synthesis, and implications are clearly conveyed. Thus, while highly accurate and contextually relevant, it lacks a small amount of qualitative depth, justifying a 9 in qualitative accuracy and 9 overall.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 342,
        "total_tokens": 1635
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did the geographic expansion of Opdivo's regulatory approvals through Ono in 2022 influence BMY's 2023 strategic focus on broadening Opdivo's use in new tumor types and earlier lines of therapy?",
      "original_answer": "In 2022, BMY relied on Ono to secure several regulatory approvals for Opdivo in Japan and the EU, including for Hodgkin lymphoma in pediatric patients, first-line treatment of unresectable malignant pleural mesothelioma, and combination therapies for RCC and esophageal cancers. These approvals expanded Opdivo’s geographic and therapeutic footprint. By 2023, BMY strategically emphasized broadening Opdivo’s use into new tumor types and earlier lines of therapy, citing the success of these prior approvals as part of their commercial and development momentum. The company also highlighted plans to expand into additional indications both as monotherapy and in combination with Yervoy and other agents, leveraging the established global regulatory and clinical foundation built in part through Ono’s contributions in 2022.",
      "llm_answer": "Opdivo’s 2022 regulatory approvals through Ono extended the drug’s footprint into Japan, South Korea and Taiwan, adding new indications such as gastric and esophageal cancers and first‑line settings.  This broadened geographic reach gave BMS a stronger regulatory base that it leveraged in its 2023 strategy to push Opdivo into earlier lines of therapy and additional tumor types【page_43】【page_92】.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Opdivo's 2022 regulatory approvals through Ono expanded its geographic reach and contributed to BMY's (BMS's) 2023 strategy to broaden use in earlier lines of therapy and new tumor types. The core factual claim about leveraging prior approvals for strategic momentum is consistent with the ground truth. However, the LLM incorrectly lists South Korea and Taiwan as geographies of expansion through Ono in 2022, which are not mentioned in the original answer (the ground truth specifies Japan and the EU only). Additionally, the LLM mentions gastric and esophageal cancers as new indications but omits key approved indications listed in the original answer: Hodgkin lymphoma in pediatric patients, first-line treatment of unresectable malignant pleural mesothelioma, and combination therapies for RCC. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not compromised—score reflects full alignment on available temporal facts (2022 approvals influencing 2023 strategy). (3) The multi-hop reasoning is partially sound: the model correctly infers that prior regulatory success enabled future strategic expansion. However, it misattributes the geographic scope and specific indications, weakening the synthesis accuracy. The reliance on Ono in Japan and the EU is a key nuance that is distorted by introducing unmentioned regions. (4) The contextual relevance is high because the answer addresses the causal link between 2022 approvals and 2023 strategy. The qualitative accuracy is reduced due to incorrect entity details (geographies and indications), though the overall strategic narrative remains aligned. Hence, correctness is scored at 7—core logic and intent are correct, but with notable factual omissions and inaccuracies in entity details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 502,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did SPG's financial gains from its 2024 divestiture of ABG compare to the gains recognized from its 2023 equity dilution in SPARC Group, and what was the timeline of ownership reduction in ABG across these transactions?",
      "original_answer": "In 2023, SPG recognized a $145.8 million pre-tax gain from the dilution of its ownership in SPARC Group. Then, in late 2023 and early 2024, SPG completed multiple transactions related to ABG: a partial sale for $300.2 million with a $157.1 million pre-tax gain, followed by the full divestiture for $1.2 billion with a $414.8 million pre-tax gain. This represents a significant increase in realized gains from ABG in 2024 compared to the SPARC Group transaction in 2023.",
      "llm_answer": "SPG’s 2024 divestiture of ABG produced a pretax gain of **$414.8 million**, which is roughly 2.8 times larger than the **$145.8 million** pretax gain recognized from the 2023 SPARC Group equity‑dilution transaction.  ABG ownership fell from about **12.3 % in Q2 2023 to 11.8 % (Q2), 11.7 % (Q3), 9.6 % (Q4), and was fully divested to 0 % in Q1 2024**.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $414.8 million pretax gain from the 2024 ABG divestiture and the $145.8 million gain from the 2023 SPARC Group equity dilution, matching the ground truth exactly. The comparison stating the ABG gain is 'roughly 2.8 times larger' is accurate (414.8 / 145.8 ≈ 2.84), so the quantitative analysis is sound. (2) All numeric values—dollar amounts, percentages, and timeline—are factually correct: ABG ownership reduction from 12.3% in Q2 2023 to 11.8% (Q2), 11.7% (Q3), 9.6% (Q4), and 0% in Q1 2024 aligns with the transaction sequence in late 2023 and early 2024. However, the original answer notes a two-step ABG divestiture: a partial sale with a $157.1M gain and then a full divestiture with a $414.8M gain. The LLM only references the final $414.8M gain, omitting the earlier partial sale gain, which is a minor completeness issue. (3) The multi-hop reasoning is largely sound—correctly comparing gains across different transactions and tracking ownership reduction over time. However, the synthesis could have included both ABG-related gains to fully reflect the transaction complexity. (4) Despite the omission of the intermediate ABG gain, the LLM captures the core comparison and timeline accurately, with excellent contextual relevance and precise numbers. The qualitative score is slightly reduced due to incomplete transaction coverage, but overall the answer is factually strong and semantically aligned with the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 409,
        "total_tokens": 1634
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did Exxon Mobil's indirect stake in Syncrude through Imperial Oil Limited in 2022 compare to its effective influence on Syncrude's synthetic crude oil production in 2024, given the consistent production levels reported across both years?",
      "original_answer": "In 2022, Exxon Mobil had an indirect 69.6% interest in Imperial Oil Limited, which held a 25% stake in Syncrude, resulting in an effective ownership of approximately 17.4% of Syncrude. In 2024, despite no change in the ownership structure, Exxon Mobil continued to report the same 62 thousand barrels per day of synthetic crude oil production from Syncrude, indicating stable production levels despite potential operational or market changes over the two-year period.",
      "llm_answer": "In 2022, Exxon Mobil’s indirect stake in Syncrude was roughly 17.4 % (69.6 % of Imperial Oil’s 25 % interest).  That ownership translated into a share of about 62 000 bbl‑d of synthetic crude oil in 2024 – the same production level reported in 2021 – showing a consistent influence on Syncrude’s output.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly calculated Exxon Mobil's indirect stake in Syncrude as 17.4% (69.6% of Imperial Oil’s 25% stake), matching the ground truth. It accurately reported the 62,000 barrels per day (bbl/d) of synthetic crude oil production attributed to Exxon Mobil in 2024, consistent with the original answer. The statement about consistent production levels is supported, though it references 2021 instead of 2022—this is a minor factual deviation but does not undermine the core conclusion of stable output. (2) All numbers—69.6%, 25%, 17.4%, and 62,000 bbl/d—are quantitatively accurate and correctly derived. The calculation 0.696 × 0.25 = 0.174 (17.4%) is sound. (3) The multi-hop reasoning is logically sound: the model correctly traced ownership from Exxon Mobil → Imperial Oil → Syncrude and linked that to production attribution. It appropriately infers stable influence due to unchanged production despite potential changes, aligning with the question’s focus on influence over time. (4) The answer is contextually relevant and conveys the essential conclusion: despite no ownership change, Exxon’s effective influence (via production share) remained stable. The only minor issue is the reference to 2021 production instead of 2022, which slightly affects completeness but not correctness of the 2024 comparison. Overall, the answer is factually strong with high semantic equivalence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 390,
        "total_tokens": 1607
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did the decline in ESPNEWS subscribers from 56 million in Disney's 2022 report to 40 million in 2023 relate to ESPN's increased focus on digital platforms like ESPN+, and what does this suggest about Disney's evolving sports content distribution strategy?",
      "original_answer": "The decline in ESPNEWS subscribers from 56 million in 2022 to 40 million in 2023 coincided with ESPN's strategic shift toward digital platforms, particularly ESPN+, which had 26 million estimated paid subscribers by September 2024 as noted in the 2023 report. This suggests that Disney is prioritizing direct-to-consumer digital sports content delivery over traditional linear channels like ESPNEWS. The temporal relationship indicates a reallocation of audience engagement efforts toward on-demand, bundled, and mobile-based platforms, aligning with broader industry trends and potentially impacting Disney's sports network revenue mix by reducing reliance on traditional MVPD subscriber models.",
      "llm_answer": "The ESPNEWS subscriber count fell from 56 million in Disney’s 2022 10‑K to 40 million in the 2023 10‑K (2022 p. 10; 2023 p. 10), indicating a shift of viewers toward ESPN+ and other digital offerings. The 2023 10‑K notes that Disney has significantly increased its focus on DTC streaming and highlights ESPN+ as a key digital platform (p. 8; p. 10). This trend signals Disney’s evolving strategy to move sports content from linear channels to subscription‑based digital services, prioritizing ESPN+ to capture a growing streaming audience.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the decline in ESPNEWS subscribers from 56 million in 2022 to 40 million in 2023, matching the ground truth exactly. It also accurately references ESPN+'s growing role as a digital platform, though it does not include the specific figure of 26 million paid subscribers by September 2024 mentioned in the original answer. This omission is a minor gap in completeness but does not affect core factual accuracy. (2) All numeric values (56M, 40M) and years (2022, 2023) are correct and properly attributed to Disney’s 10-K reports. No calculations are required, but the comparison of subscriber decline is accurately presented. (3) The reasoning correctly infers a strategic shift from linear (ESPNEWS) to digital (ESPN+) platforms based on subscriber trends and disclosures in the 10-Ks. The LLM synthesizes information across two years of filings and correctly interprets Disney’s emphasis on DTC (direct-to-consumer) streaming as evidence of strategic evolution. The multi-hop logic—linking subscriber decline with increased digital investment—is sound and aligned with the ground truth. (4) The answer is semantically equivalent in intent and meaning, capturing the core strategic implication: Disney is prioritizing digital sports distribution via ESPN+ over traditional linear channels. The only minor shortcoming is the absence of the specific ESPN+ subscriber count, which slightly reduces completeness but not overall correctness. Hence, high scores across all dimensions with a 9 on correctness due to partial omission of a supporting data point.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 438,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did V's 2022 capital structure with Class B common stock voting rights influence its governance dynamics around material transactions in 2024, particularly in light of the planned convertibility changes by 2028?",
      "original_answer": "In 2022, V's capital structure included Class B common stock with 33⅓% non-dilutable voting power, granting it separate approval rights over material transactions such as mergers, asset sales, and amendments to corporate governance documents. This structure gave the holder of Class B shares (Brian L. Roberts) significant influence over corporate decisions, even if opposed by other shareholders. By 2024, V disclosed that Class B-1, B-2, and C common stock would become convertible into Class A common stock, with full convertibility of Series B and C preferred stock no later than 2028, subject to litigation-related holdbacks. This planned convertibility introduces potential dilution of existing Class A voting power and creates misaligned incentives between Class B/C holders and Class A stockholders, as the former may not support transactions favorable to the latter. The evolution from concentrated voting rights in 2022 to the 2024 convertibility plan suggests a transition in governance dynamics, where future material transactions may face additional complexity due to diverging interests and the potential for increased shareholder influence from newly converted Class A shares.",
      "llm_answer": "V’s 2022 capital structure gave holders of Class B common stock voting rights and separate approval rights over material transactions, so in 2024 the board had to consider Class B shareholders’ interests when approving mergers, consolidations or other significant actions【page 91】.  The company’s plan to make Class B shares convertible into Class A shares by 2028 would dilute existing voting power and eliminate those separate approval rights, shifting governance toward a more unified shareholder base and potentially easing control of material transactions【page 92】.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that V's 2022 capital structure granted Class B common stock separate approval rights over material transactions such as mergers and asset sales, which aligns with the ground truth. It also correctly notes the planned convertibility of Class B shares into Class A by 2028, which would dilute voting power and eliminate separate approval rights. However, it omits the specific 33⅓% non-dilutable voting power detail, a key quantitative and governance feature present in the original answer. Additionally, the LLM answer simplifies the convertibility plan by referring only to 'Class B shares' becoming convertible, while the ground truth specifies a more complex structure involving Class B-1, B-2, and C common stock, as well as Series B and C preferred stock, with convertibility subject to litigation-related holdbacks—details that are missing. (2) The date '2028' is correctly cited for full convertibility, and '2024' is appropriately used as the disclosure year. However, the absence of the precise 33⅓% voting stake—a critical number—reduces quantitative accuracy. (3) The reasoning is generally sound: the LLM correctly infers that convertibility will dilute Class A voting power and shift governance toward a more unified base. However, it fails to address the misaligned incentives between Class B/C holders and Class A stockholders, a key dynamic in governance complexity around material transactions. The multi-hop synthesis is partial—correct in direction but incomplete in depth. (4) Despite omissions, the answer remains contextually relevant and captures the core governance transition. The score reflects accurate main ideas but lacks key specifics on ownership structure, stock classes, and incentive misalignment, which are essential for full correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 494,
        "total_tokens": 1952
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did the $96 million pre-tax charge associated with Nicor Gas' disallowed capital investments in 2023 influence bad debt rider adjustments in 2024, and what does this indicate about Nicor Gas' regulatory risk mitigation strategy?",
      "original_answer": "In 2023, Southern Company recorded a $96 million pre-tax charge related to disallowed capital investments at Nicor Gas, indicating regulatory pushback on cost recovery. Despite this, the bad debt rider in place for Nicor Gas—approved by the Illinois Commission—continued to provide a mechanism for recovering differences between actual bad debt experience and the benchmark used in base rates. By 2024, the bad debt rider remained in effect and was described in similar terms, suggesting that while Nicor Gas faced regulatory risk as evidenced by the disallowance, the utility maintained a structured recovery mechanism to offset credit risk exposure. This implies a dual dynamic: regulatory scrutiny on capital spending increased in 2023, yet the existing bad debt rider continued to serve as a financial buffer in 2024, stabilizing cash flows despite potential credit volatility.",
      "llm_answer": "The $96 million pre‑tax charge for disallowed capital investments at Nicor Gas in 2023 (page 300) raised its benchmark bad‑debt expense, which in turn led to a higher bad‑debt rider adjustment recorded in 2024 (page 176). This shows that Nicor Gas relies on the bad‑debt rider as a regulatory risk‑mitigation tool, using it to offset potential increases in bad‑debt expense and keep its rate base stable.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $96 million pre-tax charge in 2023 related to Nicor Gas' disallowed capital investments, which aligns with the ground truth. However, it incorrectly claims that this charge 'raised its benchmark bad-debt expense' and 'led to a higher bad-debt rider adjustment in 2024'—a causal link not supported by the original answer. The ground truth states that the bad debt rider remained in effect and was unchanged in structure, not that it was increased due to the disallowance. (2) Quantitatively, the $96 million figure and years (2023–2024) are accurate, and no calculations are required, so quantitative accuracy is high. (3) The multi-hop reasoning is flawed: the model incorrectly infers a direct financial linkage between the disallowed capital investment and the bad debt rider adjustment, whereas the original answer emphasizes that the rider continued independently as a credit risk buffer, despite regulatory risk evidenced by the disallowance. The LLM misses the nuanced dual dynamic—regulatory pushback on capital spending versus continued use of an existing rider for credit risk—thus failing to accurately represent Nicor Gas’ regulatory risk mitigation strategy. (4) Contextual relevance is moderate because the answer addresses the right entities and general topic (Nicor Gas, bad debt rider, regulatory risk), but the incorrect causal inference undermines the qualitative accuracy and overall correctness. The conclusion that Nicor Gas uses the rider to keep its rate base stable is not directly supported and oversimplifies the situation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 438,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did IBM's use of the 1999 Plan for senior executives in 2022 compare to the use of the 2001 Plan for non-senior executives in 2024, particularly in terms of maximum PSU payout quantities and their implications for equity compensation strategy?",
      "original_answer": "In 2022, IBM reported that the maximum number of PSUs under equity compensation plans approved by security holders was 3,497,352, while for those not approved by security holders, it was 231,505. By 2024, these figures had shifted to 2,969,258 for stockholder-approved plans and increased to 332,292 for non-stockholder-approved plans. This indicates a decrease in the reliance on the 1999 Plan (stockholder-approved) for maximum PSU payouts and a notable increase in the use of the 2001 Plan (non-stockholder-approved) for non-senior executives, suggesting a strategic shift in IBM's equity compensation structure over the two-year period.",
      "llm_answer": "In 2022, IBM’s senior‑executive awards were drawn from the 1999 Long‑Term Performance Plan, but the filing does not disclose a maximum PSU payout figure for that plan. By contrast, the 2024 filing shows the 2001 Plan (used for non‑senior employees) had a maximum PSU payout of 5,047,739 shares for approved plans and 578,779 for non‑approved plans【page_17】, underscoring a broader equity‑compensation strategy aimed at a larger employee base versus the more targeted approach for senior executives.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It claims that the 2024 filing shows a maximum PSU payout of 5,047,739 for approved plans and 578,779 for non-approved plans, which directly contradicts the ground truth: the correct 2024 figures are 2,969,258 (stockholder-approved) and 332,292 (non-stockholder-approved). The LLM also incorrectly attributes these larger numbers to the 2001 Plan, while the ground truth indicates a decrease in stockholder-approved plan usage and an increase in non-approved plans, not the reverse. Additionally, the LLM states that the 2022 filing 'does not disclose' a maximum PSU figure for the 1999 Plan, but the ground truth explicitly provides the 2022 numbers: 3,497,352 (approved) and 231,505 (not approved), so this omission is a major error. (2) Quantitative accuracy is very low: all provided numbers are incorrect, and no correct calculations or comparisons are made. The LLM inflates the 2024 figures by more than double. (3) Multi-hop reasoning is flawed: the model fails to correctly synthesize the shift from 2022 to 2024 in terms of decreasing reliance on stockholder-approved plans (like the 1999 Plan) and increasing use of non-approved plans (like the 2001 Plan). Instead, it misrepresents the trend and misattributes the data. (4) Contextual relevance is moderate because the answer attempts to address the comparison between senior and non-senior executive plans and discusses equity compensation strategy, but due to factual errors, the conclusion is unsupported. The strategic interpretation about broader compensation is not aligned with the actual data showing a reduction in maximum payouts for approved plans and a modest increase in non-approved ones.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 473,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did Chevron's strategic focus on soybean oil production through Bunge Chevron Ag Renewables LLC in Louisiana evolve from 2023 to 2024, and what new developments were announced in 2024 that reflect this trajectory?",
      "original_answer": "In 2023, Chevron held a 50% working interest in Bunge Chevron Ag Renewables LLC, which produced soybean oil at facilities in Destrehan, Louisiana, and Cairo, Illinois, positioning the joint venture as a key supplier of renewable feedstock for fuels like renewable diesel and sustainable aviation fuel. This operation was part of Chevron's broader renewable fuels strategy, which included expansion at the Geismar renewable diesel plant in Louisiana, increasing capacity from 7,000 to 22,000 barrels per day, with full operations expected in 2024. By 2024, Chevron continued its focus on Louisiana operations, with final commissioning underway at Geismar for the expanded plant, and a new development was announced: a final investment decision (FID) was taken to build a new oilseed processing plant in Louisiana, signaling a deepening commitment to soybean oil as a core renewable feedstock in the region.",
      "llm_answer": "In 2023 Chevron’s 10‑K noted a 50 % working interest in Bunge Chevron Ag Renewables LLC, which produced soybean oil at its Destrehan, Louisiana, and Cairo, Illinois facilities as a renewable feedstock for diesel, biodiesel and SAF【page_18 2023】. By 2024 the company had taken final investment decision to build a new oilseed‑processing plant in Louisiana, and it also announced the expansion of its Geismar renewable‑diesel plant to 22,000 bbl/d, both moves expanding soybean‑oil‑based renewable fuel production【page_18 2024】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Chevron's 50% working interest in Bunge Chevron Ag Renewables LLC in 2023 and its soybean oil production at Destrehan, Louisiana, and Cairo, Illinois, as per the ground truth. It accurately notes the final investment decision (FID) in 2024 for a new oilseed-processing plant in Louisiana and the expansion of the Geismar renewable diesel plant to 22,000 barrels per day, with operations expected in 2024. All key facts are present and factually correct. (2) Quantitative accuracy is perfect: the 50% working interest, 22,000 bbl/d capacity, and location details (Louisiana, Illinois) match the original. No calculations are required, and all numbers are reported correctly. (3) The multi-hop reasoning is sound—information is synthesized across 2023 and 2024 timeframes and between different facilities (Destrehan, Cairo, Geismar) and strategic moves (joint venture operations, expansion, FID). The only minor omission is that the original specifies the Geismar expansion was from 7,000 to 22,000 bbl/d and that final commissioning was underway in 2024; the LLM mentions the expansion but not the starting capacity or commissioning status, slightly reducing completeness. (4) The answer is contextually fully relevant, directly addressing Chevron’s strategic evolution in soybean oil production and new 2024 developments. Wording differs slightly (e.g., 'biodiesel' is added, not in original), but this does not introduce inaccuracy. Overall, the answer is semantically equivalent and highly accurate, warranting a 9/10 due to the minor omission in detail about the Geismar expansion baseline.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 450,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did the redemption announcement of AIG's Series A Preferred Stock in early 2024 impact the status and structure of the corresponding Depositary Shares between 2022 and 2023?",
      "original_answer": "In 2022, AIG disclosed dividend activity for the Series A Preferred Stock, indicating ongoing financial obligations tied to these shares. In early 2024, AIG announced the full redemption of all 20,000 outstanding shares of Series A Preferred Stock and the 20,000,000 corresponding Depositary Shares, each representing a 1/1,000th interest in a preferred share, at a redemption price of $25.00 per Depositary Share. This 2024 announcement, disclosed in the 2023 10-K filing, signaled a structural change in the Depositary Shares, transitioning them from an active financial instrument to one slated for termination. This evolution reflects a strategic financial move by AIG to eliminate a specific class of preferred equity and reshape its capital structure.",
      "llm_answer": "Between 2022 and 2023 the Series A Preferred Stock remained fully outstanding at 20,000 shares, represented by 20 million Depositary Shares (each a 1/1,000th interest in a preferred share)【294】.  The January 31, 2024 announcement declared that all 20 million Depositary Shares would be redeemed on March 15, 2024 at $25.00 per share, thereby eliminating the preferred class and its depositary structure from the capital base【239】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts: 20,000 outstanding Series A Preferred Shares, 20 million corresponding Depositary Shares (each representing 1/1,000th interest), redemption at $25.00 per Depositary Share, and the announcement date (January 31, 2024) with redemption date (March 15, 2024). These match the ground truth exactly. (2) Quantitative accuracy is perfect: numbers, dollar amounts, and share counts are correct and consistent with the original answer. Format variations (e.g., '20 million' vs '20,000,000') are acceptable and semantically equivalent. (3) The reasoning is sound and reflects multi-hop synthesis: it connects the 2022–2023 status (outstanding shares) with the 2024 redemption announcement disclosed in the 2023 10-K, showing structural impact. However, it omits explicit mention that the announcement was *disclosed in the 2023 10-K*, which is a minor contextual detail that strengthens the link between the announcement and the reporting period. (4) Despite this small omission, the answer captures the core transformation of the Depositary Shares from active instruments to terminated ones, accurately reflecting AIG’s capital structure change. Thus, the answer is factually complete and semantically equivalent to the ground truth, warranting a high correctness score with only a slight deduction in qualitative accuracy for missing the 10-K disclosure context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 394,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did the reserve account requirements tied to GTP Acquisition Partners evolve between AMT's 2022 and 2024 filings, and how did this impact restricted cash classification and compliance with securitization covenants?",
      "original_answer": "In 2022, AMT disclosed that reserve accounts were required under the 2015 Securitization and Trust Securitizations to cover ground rents, taxes, and insurance premiums, with excess cash flow restricted until required payments were satisfied. By 2024, these reserve requirements remained in place, but the total balances had increased significantly, with $53.9 million held for the Trust Securitizations and $6.9 million for the 2015 Securitization as of December 31, 2024. These amounts were classified as Restricted cash on the consolidated balance sheets, reflecting ongoing compliance with the Loan Agreement and 2015 Indenture. The continued maintenance of these reserves ensured that AMT remained in compliance with securitization covenants, as failure to meet these requirements would have restricted cash distributions and potentially triggered defaults. Thus, the evolution of reserve account balances directly influenced restricted cash classification and supported sustained covenant compliance.",
      "llm_answer": "In the 2022 filing, GTP Acquisition Partners were required to deposit all rental cash receipts into reserve accounts for ground rents, taxes, insurance, and sometimes advance rents, with the funds held in trustee‑controlled accounts and reserved for the succeeding month [page 55].  By 2024 the same reserve‑account rules remained, but the filing disclosed that $53.9 million for Trust securitizations and $6.9 million for the 2015 securitization were held in those accounts and were classified as restricted cash, and it reiterated that failure to maintain the reserves and meet DSCR/cash‑trap tests would block distribution of excess cash flow, thereby preserving compliance with the securitization covenants [page 117].",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: the reserve account requirements for ground rents, taxes, and insurance are accurately described for both 2022 and 2024; the $53.9 million for Trust securitizations and $6.9 million for the 2015 securitization as of December 31, 2024, are correctly reported and match the ground truth. These amounts are properly linked to restricted cash classification. (2) Quantitative accuracy is perfect: all dollar amounts and years are correct, and no calculations are required beyond accurate reporting. Format variations (e.g., $53.9 million) are acceptable and consistent. (3) Multi-hop reasoning is sound: the answer synthesizes information across years (2022 vs 2024), entities (GTP Acquisition Partners, AMT), and financial instruments (2015 Securitization, Trust Securitizations), correctly noting that requirements remained unchanged but balances increased. It also correctly links reserve maintenance to covenant compliance and cash distribution restrictions. (4) Minor qualitative shortcoming: the LLM attributes the 2022 reserve requirement to 'GTP Acquisition Partners' rather than AMT, which may imply a misattribution—though GTP is a subsidiary, the primary filer and responsible entity in the disclosures is AMT. Additionally, the ground truth emphasizes that excess cash flow remains restricted until payments are satisfied, a nuance slightly underdeveloped in the LLM answer. However, the mention of blocked distributions due to DSCR/cash-trap tests adds relevant detail not in the original and is consistent with the filings. Overall, the answer is factually correct, contextually relevant, and semantically equivalent to the ground truth with only minor framing differences.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 488,
        "total_tokens": 1938
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did T's reliance on unobservable inputs in goodwill impairment testing in 2023 compare with its approach to valuing private equity investments in 2024, and what does this indicate about the company's overall valuation methodology consistency?",
      "original_answer": "In 2023, T used unobservable inputs such as projected terminal growth rates, long-term EBITDA margins, and weighted average cost of capital (WACC) in its goodwill impairment testing for the Consumer Wireline and Business Wireline reporting units, which involved discounted cash flow and market multiple approaches. These assumptions were subject to sensitivity analyses and third-party valuation specialist review. In 2024, T disclosed that its private equity funds—valued using the NAV practical expedient—were based on valuation models that also incorporated unobservable inputs that could not be corroborated by market data. Despite being applied to different asset classes, both valuation approaches reflect T's continued reliance on complex, judgment-driven models with significant unobservable assumptions. This indicates a consistent but potentially risky valuation methodology framework across years, where fair value estimates are highly sensitive to changes in key assumptions.",
      "llm_answer": "In 2023 AT&T’s goodwill impairment test relied on unobservable inputs—subjective assumptions such as terminal growth rates, EBITDA margins and WACC used in discounted‑cash‑flow and market‑multiple models (page 44). In 2024 the firm valued its private‑equity holdings with pricing models or discounted‑cash‑flow methods for securities not traded on an exchange, which likewise depend on unobservable inputs (page 81). The parallel use of model‑based, judgment‑heavy estimates for both goodwill and private‑equity assets demonstrates a consistent valuation methodology across different asset classes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that in 2023, AT&T (T) used unobservable inputs such as terminal growth rates, EBITDA margins, and WACC in its goodwill impairment testing, consistent with the ground truth. It accurately notes the use of discounted cash flow and market multiple approaches. In 2024, it correctly states that private equity investments were valued using models relying on unobservable inputs, particularly for non-exchange-traded securities. The conclusion about consistent use of judgment-heavy, model-based valuation across asset classes aligns with the original answer. (2) There are no numerical values (e.g., percentages, dollar amounts) in either the question or ground truth, so quantitative accuracy is not applicable in terms of calculations; however, the years (2023 and 2024) and page references (44 and 81) are correctly cited, supporting factual grounding. (3) The multi-hop reasoning is sound: the model connects goodwill impairment testing in one year to private equity valuation in another, across different asset classes, and synthesizes the common reliance on unobservable inputs. It correctly infers methodological consistency, though it omits minor details present in the ground truth—specifically, the mention of third-party valuation review and sensitivity analyses in 2023, and the explicit reference to the NAV practical expedient in 2024. These omissions slightly reduce completeness but do not affect core accuracy. (4) The answer is contextually fully relevant, directly addressing the comparison and what it indicates about valuation methodology consistency. The semantic meaning matches the ground truth, with only slight compression of detail. Hence, a high score of 9 is justified—excellent accuracy with minor room for enhanced detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 489,
        "total_tokens": 1910
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did the value of MetLife's Retirement and Savings products offered in the EMEA region change from 2023 to 2024, based on the Policyholder Account Balances (PABs) metric?",
      "original_answer": "In 2023, MetLife reported $7,578 million in Policyholder Account Balances (PABs) for the EMEA segment, which decreased to $7,214 million in 2024. This represents a decline of $364 million, or approximately 4.8%, indicating a reduction in the value of Retirement and Savings products offered in the EMEA region over this period.",
      "llm_answer": "The Policyholder Account Balances (PABs) for MetLife’s retirement‑and‑savings products in the EMEA region fell from **$7.58 billion in 2023 to $7.21 billion in 2024**—a decline of roughly **$0.36 billion**.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the decrease in Policyholder Account Balances (PABs) for MetLife's Retirement and Savings products in the EMEA region from 2023 to 2024. The reported values are $7.58 billion in 2023 and $7.21 billion in 2024, which are accurate rounded versions of the ground truth figures ($7,578 million and $7,214 million). The calculated decline of $0.36 billion matches the actual difference of $364 million (rounded). The answer omits the exact percentage decline (4.8%) mentioned in the original answer, which slightly reduces completeness but does not affect the core quantitative accuracy. All entities—MetLife, EMEA region, Retirement and Savings products, PABs metric, and years 2023–2024—are correctly identified. The reasoning is sound, with correct multi-hop synthesis of values across years and accurate subtraction. The semantic meaning is equivalent to the ground truth, with acceptable formatting variations (billion vs. million, rounding). Thus, the answer is highly accurate with only a minor omission of the percentage change.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1140,
        "completion_tokens": 303,
        "total_tokens": 1443
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did the composition and valuation methodology of MDLZ's Level 1 Financial Assets, specifically those tied to commodity futures, evolve from 2022 to 2024, and what does this reveal about the consistency of their commodity risk hedging strategy?",
      "original_answer": "In 2022, MDLZ used commodity futures and options to hedge the price of key input costs such as cocoa, sugar, wheat, and soybean oils, with these Level 1 Financial Assets valued based on quoted market prices from commodity exchanges. By 2024, the company maintained the same composition of Level 1 Financial Assets, specifically exchange-traded commodity futures and listed options, and continued to rely on quoted market prices for valuation, showing a consistent approach to managing commodity price risk. This continuity indicates that MDLZ preserved its core hedging strategy around the most liquid and transparent instruments—exchange-traded futures—across the two-year period.",
      "llm_answer": "analysisWe need to answer: \"How did the composition and valuation methodology of MDLZ's Level 1 Financial Assets, specifically those tied to commodity futures, evolve from 2022 to 2024, and what does this reveal about the consistency of their commodity risk hedging strategy?\"\n\nWe have to analyze the composition and valuation methodology of Level 1 financial assets tied to commodity futures, from 2022 to 2024. We need to see how the composition changed (e.g., fair value, notional amounts, number of contracts, etc.) and how the valuation methodology changed (e.g., Level 1 uses quoted market prices; Level 2 uses income approach or pricing models). We need to see if there were changes in the methodology or composition, and what that reveals about consistency of hedging strategy.\n\nWe have multiple pages: MDLZ_10k_2022 pages [92,93,94,95,96,110,111,112,113,114] and MDLZ_10k_2024 pages [93,94,95,96,97].\n\nWe need to locate relevant information about Level 1 financial assets tied to commodity futures.\n\nFrom the 2024 pages: page 95 includes a table of fair values of commodity contracts, with Level 1, Level 2, Level 3. For 2024, commodity contracts: total fair value 683, Level 1: 111, Level 2: 794. For 2023: commodity contracts: total 135, Level 1: 28, Level 2: 107. For 2022: commodity contracts: total 0? Actually 2022 not shown in that table; but we can look at page 94 or 112 for 2022.\n\nPage 112 (2020) shows commodity contracts: 77 total fair value, Level 1: 46, Level 2: 31. But that's 2020, not 2022. We need 2022. Maybe page 113 or 111 includes 2022 data. Page 113 shows commodity contracts: 9,694 for 2021, 7,947 for 2020. Not 2022.\n\nPage 111 shows commodity contracts: 387 for 2021, 205 for 2020. Not 2022.\n\nPage 94 and 95 include 2024 and 2023 data. For 2022, we might need to look at 2022 10-K. The 2022 10-K pages might include commodity contracts for 2022. Let's search for \"commodity contracts\" within 2022 pages: page 94 includes commodity contracts table for 2024 and 2023. But we need 2022. Maybe page 96 includes commodity contracts for 2024 and 2023 only. The 2022 10-K might have similar table but for 2022. Let's search within the 2022 pages: page 94 (2024) includes 2024 and 2023. But maybe page 94 also includes 2022? Let's check page 94 again: It shows \"As of December 31, 2024\" and \"As of December 31, 2023\". No 2022. So 2022 data might be in page 94 of 2022 10-K? But we only have page 94 from 2024 10-K. The 2022 10-K pages might be different. We have pages 92-96, 110-114 for 2022. Let's examine page 94 of 2022 10-K. The page 94 text we saw earlier is from 2024 10-K? Wait, the page 94 text includes \"As of December 31, 2024\" and \"As of December 31, 2023\". That seems to be from 2024 10-K. But the 2022 10-K page 94 might be different. The provided pages for 2022 include page 94, but we didn't see the content of page 94 for 2022. The page 94 content we saw earlier is from 2024 10-K. But the 2022 10-K page 94 might also have similar content but for 2022. Let's check the content of page 94 from 2022 10-K: The content we saw earlier for page 94 is the same as the 2024 page 94? Wait, the 2024 page 94 is the same as the 2022 page 94? Let's examine the content of page 94 from 2022 10-K: The content we saw earlier for page 94 is the same as the 2024 page 94? Actually the 2024 page 94 includes \"As of December 31, 2024\" and \"As of December 31, 2023\". The 2022 page 94 might include \"As of December 31, 2022\" and \"As of December 31, 2021\" etc. But we don't have that. The provided page 94 content is from 2024. But the 2022 10-K page 94 might be different. However, the question asks: \"How did the composition and valuation methodology of MDLZ's Level 1 Financial Assets, specifically those tied to commodity futures, evolve from 2022 to 2024, and what does this reveal about the consistency of their commodity risk hedging strategy?\"\n\nThus we need to compare 2022 and 2024. We need to find 2022 data for Level 1 commodity futures. The 2022 10-K might have a table similar to page 95 but for 2022. We need to locate that. The 2022 10-K pages we have: 92, 93, 94, 95, 96, 110, 111, 112, 113, 114. Page 94 from 2022 10-K might contain a table of fair values for 2022. Let's examine page 94 content again: It is the same as the 2024 page 94? Wait, the 2024 page 94 content we saw earlier includes \"As of December 31, 2024\" and \"As of December 31, 2023\". That is likely the 2024 10-K page 94. But the 2022 10-K page 94 might have \"As of December 31, 2022\" and \"As of December 31, 2021\". But we don't have that content. However, the 2022 10-K page 94 might be similar to page 94 of 2024 but with 2022 data. But the content we saw earlier for page 94 is from 2024. But we might need to search for \"Level 1\" or \"commodity futures\" in the 2022 pages. Let's search for \"Level 1\" within the 2022 pages. The 2022 page 112 includes \"Level 1 financial assets and liabilities consist of exchange-traded commodity futures and listed options.\" That is the valuation methodology. It also states that the fair value is determined based on quoted market prices on commodity exchanges. That is the methodology for Level 1. The 2024 page 95 also includes the same statement: \"Level 1 financial assets and liabilities consist of exchange-traded commodity futures and listed options. The fair value of these instruments is determined based on quoted market prices on commodity exchanges.\" So the methodology hasn't changed.\n\nBut the composition: The fair value of commodity contracts in 2024 is 683, with Level 1 fair value 111. In 2022, we need to find the fair value of commodity contracts. The 2022 page 112 shows commodity contracts fair value 77 (total) with Level 1 46. But that's 2020. We need 2022. Let's look at page 113: It shows commodity contracts 9,694 for 2021 and 7,947 for 2020. Not 2022. Page 111 shows commodity contracts 387 for 2021 and 205 for 2020. Not 2022. Page 110 is about debt. Page 96 includes a table of notional amounts for commodity contracts: 16,210 for 2024, 16,631 for 2023. That is not fair value but notional amounts. For 2022, we might need to find a table of notional amounts for commodity contracts. Let's search page 96 for 2022. The page 96 table shows commodity contracts 16,210 for 2024 and 16,631 for 2023. No 2022. So we don't have 2022 notional amounts.\n\nBut the question: \"How did the composition and valuation methodology of MDLZ's Level 1 Financial Assets, specifically those tied to commodity futures, evolve from 2022 to 2024, and what does this reveal about the consistency of their commodity risk hedging strategy?\" So we need to answer: The composition changed: the fair value of Level 1 commodity futures increased from X in 2022 to Y in 2024. The methodology remained the same: Level 1 uses quoted market prices. The consistency indicates that the hedging strategy remains consistent, focusing on exchange-traded commodity futures and using the same valuation approach.\n\nWe need to find the 2022 fair value of Level 1 commodity futures. The 2022 10-K page 112 shows commodity contracts fair value 77, Level 1 46. But that's 2020. But maybe the 2022 10-K page 112 is for 2022? Wait, the 2022 10-K page 112 might be for 2022. Let's examine the context: The 2022 10-K page 112 includes a table of fair values for 2020. But the page header says \"As of December 31, 2020\". So it's 2020. So that is not 2022. So we need to find 2022 data.\n\nLet's search for \"2022\" within the 2022 pages. The 2022 10-K page 96 includes \"As of December 31, 2024\" and \"As of December 31, 2023\". So it's 2024. But the 2022 10-K page 96 might also include 2022 data. Let's examine page 96 again: It shows a table of notional amounts for 2024 and 2023. No 2022. So maybe the 2022 10-K page 96 is for 2022? Wait, the 2022 10-K page 96 might be for 2022. But the content we saw earlier for page 96 includes \"As of December 31, 2024\" and \"As of December 31, 2023\". So it's 2024. So the 2022 10-K page 96 is not the same as the 2024 10-K page 96. But the content we saw earlier for page 96 is from 2024 10-K. But the 2022 10-K page 96 might be different. But we only have one page 96 content, which is from 2024. But the question says \"MDLZ_10k_2022.pdf: pages [92, 93, 94, 95, 96, 110, 111, 112, 113, 114] | MDLZ_10k_2024.pdf: pages [93, 94, 95, 96, 97]\". So the 2022 10-K pages 92-96 and 110-114 are provided. The 2024 10-K pages 93-97 are provided. So we need to use those pages. So we need to find the 2022 data for Level 1 commodity futures within those pages. Let's examine each of those pages:\n\n- Page 92: We haven't seen the content. Let's examine page 92. It might contain a table of fair values for 2022. Let's scroll to page 92 content. It might be the table of fair values for 2022. Let's read page 92 content. But we haven't seen it yet. We need to scroll to page 92. Let's request the content of page 92.assistantanalysisWe need to request the content of page 92.assistantcommentaryWe need to ask the system to provide the content of page 92.assistantcommentary to=repo_browser.open_file code{\"path\":\"MDLZ_10k_2022.pdf\",\"line_start\":1,\"line_end\":200}",
      "correctness_score": 0,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 1,
      "detailed_feedback": "The LLM answer is completely incorrect and fails to provide any actual response to the question. Instead of answering, it presents an internal monologue labeled 'analysis', 'commentary', and 'to=repo_browser.open_file', which appears to be a debugging or planning trace rather than a final answer. There is no coherent synthesis of information about MDLZ's Level 1 Financial Assets, no comparison of composition or valuation methodology between 2022 and 2024, and no assessment of hedging strategy consistency. The response does not contain any factual claims, correct or incorrect, because it never attempts to answer the question. It merely outlines a plan to search for data across SEC filing pages without reaching any conclusion. As such, it fails on all dimensions: correctness, quantitative accuracy, qualitative reasoning, and relevance. The output appears to be an incomplete or broken generation, not a valid answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 3471,
        "completion_tokens": 267,
        "total_tokens": 3739
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Southern Company's operational footprint in Tennessee in 2022 relate to its investment in SNG in 2023, and what does this imply about its strategy in natural gas infrastructure expansion?",
      "original_answer": "In 2022, Southern Company operated in Tennessee through its subsidiary Southern Company Gas, which distributed natural gas to customers in the state. By 2023, Southern Company deepened its involvement in natural gas infrastructure by maintaining a 50% investment in SNG, a major pipeline operator that connects supply basins in the Gulf Coast to markets including Tennessee. SNG's 7,000-mile pipeline network played a key role in supplying natural gas to Southern Company Gas' customers, indicating a strategic alignment to enhance supply diversification and infrastructure resilience. This evolution from direct distribution operations to a more integrated approach via SNG suggests a broader strategy to strengthen natural gas delivery capabilities across the Southeast, particularly in Tennessee.",
      "llm_answer": "In 2022 Southern Company Gas’s distribution operations—serving Tennessee among its four states—generated $5,267 million in revenue (page 302).  In 2023 the company’s gas‑pipeline‑investment segment, which includes its 50 % stake in the 7,000‑mile SNG pipeline that delivers gas to Tennessee, produced $32 million in revenue and $140 million in equity‑method earnings (page 301).  This alignment shows Southern Company is strategically investing in pipeline assets that directly support its Tennessee footprint, underscoring a focus on expanding natural‑gas infrastructure to secure supply and enable growth across its service territories.",
      "correctness_score": 8,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Southern Company's operations in Tennessee through Southern Company Gas and its 50% stake in SNG with a 7,000-mile pipeline network that supports gas delivery to Tennessee. It accurately reflects the strategic integration between distribution operations and upstream infrastructure investment. However, the quantitative details—$5,267 million in revenue for Southern Company Gas in 2022 and $32 million in revenue and $140 million in equity-method earnings from the gas pipeline segment in 2023—are not present in the original answer and cannot be verified against the ground truth. These figures may be accurate per the source document (citing page 301 and 302), but since the ground truth does not include them, their inclusion introduces unverifiable data, which affects factual accuracy. (2) While the numbers are internally consistent and may come from the correct pages of the 10-K, the original answer does not mention revenue or earnings figures, so their use as supporting evidence for the strategic claim is not corroborated by the ground truth. This leads to a lower quantitative accuracy score. (3) The multi-hop reasoning is sound: the model connects Southern Company’s 2022 distribution footprint in Tennessee with its 2023 financial interest in SNG and infers a strategic intent to strengthen natural gas infrastructure. This synthesis aligns with the original answer’s conclusion about supply diversification and infrastructure resilience. The logic is coherent and adds contextual depth by linking operations to investments. (4) The answer is contextually highly relevant and semantically aligned with the original in terms of entities, timeline, and strategic implication. The core factual chain—subsidiary operations in Tennessee, 50% SNG ownership, pipeline reach, and strategic alignment—is correct. The over-reliance on unconfirmed financial metrics slightly undermines quantitative accuracy, but the qualitative reasoning and overall correctness remain strong, warranting a correctness score of 8.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 556,
        "total_tokens": 1928
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did the completion timeline and capacity deployment of the Tranquillity Solar Storage project evolve from 2022 to 2023, and what does this indicate about SO's progress in integrating battery energy storage systems?",
      "original_answer": "In 2022, SO reported that the Tranquillity Solar Storage project, a battery energy storage system with a nameplate capacity of 72 MW, had an expected commercial operation date (COD) of November 2021 and first quarter 2022. By 2023, SO confirmed that the project was completed within that timeline, with COD occurring from November 2021 through March 2022. This indicates that SO successfully advanced the project from construction to completion within the anticipated timeframe, reflecting effective execution in deploying battery energy storage systems. The consistent reporting of the 72 MW capacity across both years further demonstrates stability in the project's design and output expectations.",
      "llm_answer": "The Tranquillity Solar Storage project was finished in 2022, with 32 MW placed in service in November 2021 and the remaining 40 MW in 2022 for a total of 72 MW (page 330). By 2023 the project remained fully deployed at 72 MW, with a COD spanning November 2021–March 2022 (page 297), indicating that Southern Power has successfully completed and integrated the battery‑energy‑storage system into its portfolio and is maintaining it into the following year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the completion timeline and capacity deployment of the Tranquillity Solar Storage project. It accurately states that 32 MW came online in November 2021 and the remaining 40 MW in 2022, totaling 72 MW, with COD spanning November 2021 to March 2022—consistent with the ground truth. These numbers and dates match exactly, and the sum (32 + 40 = 72 MW) is correct. (2) All quantitative elements are accurate: the 72 MW total capacity, phased deployment, and correct time frame (Nov 2021–Mar 2022) are all factually aligned with the original answer. Minor formatting (e.g., '32 MW' with narrow space) does not affect accuracy. (3) The reasoning is sound: the LLM correctly infers from the timeline and deployment data that the project was completed as planned and successfully integrated, which aligns with the ground truth's conclusion about SO's effective execution. The only minor shortcoming is the use of 'Southern Power' instead of 'SO'—while Southern Power may be a subsidiary or related entity, the original answer refers to 'SO' as the reporting entity, so there is a slight entity mismatch. However, this does not materially distort the facts. (4) The answer is contextually fully relevant, addressing both the timeline/capacity evolution and what it indicates about SO's progress in storage integration. The conclusion about successful deployment and maintenance into the next year is logically supported. Thus, the answer is factually excellent with only a minor entity reference issue, warranting a 9/10 on correctness and qualitative accuracy, and full marks on quantitative and contextual dimensions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 454,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did the strategic evolution of AMT's relationship with ATC TIPL from 2023 to 2024, culminating in the transaction with DIT, impact AMT's financial position, particularly in terms of capital repatriation and debt management?",
      "original_answer": "In 2023, AMT initiated a strategic review of its India business, which led to the decision to divest ATC TIPL through a transaction with DIT. This process concluded in January 2024, with the agreement valued at up to 210 billion INR (approximately $2.5 billion), including the value of the VIL OCDs, customer receivables, and debt repayment. By September 2024, AMT received 182 billion INR (approximately $2.2 billion) from the completed sale, which was used to repay $1.5 billion in outstanding debt under the 2021 Multicurrency Credit Facility. Despite the capital inflow, AMT recorded a $1.2 billion loss on the sale, primarily due to the reclassification of cumulative translation adjustments. This strategic move allowed AMT to repatriate capital and reduce debt exposure, though at the cost of a significant one-time financial loss.",
      "llm_answer": "The 2023 strategic review of its India assets led AMT to sell ATC TIPL to DIT in 2024 for up to $2.5 billion. Net proceeds of $2.2 billion were used to repay the 2021 Multicurrency Credit Facility, including the India term loan and the company’s 0.6 % and 5 % senior notes, thereby reducing leverage and improving the debt profile. The transaction also repatriated $354 million to AMT (the 29.6 billion INR distribution), created a $53.9 million contingent indemnification liability and a deferred tax asset with a valuation allowance, while eliminating ATC TIPL’s $1.1 billion translation adjustment and a $1.2 billion loss on sale.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core strategic evolution and financial impact but introduces several inaccuracies in numbers and details not present in the ground truth. The sale value of up to $2.5 billion and net proceeds of $2.2 billion are consistent with the original answer (210 billion INR and 182 billion INR, respectively), which is correct. However, the LLM claims $354 million was repatriated from a 29.6 billion INR distribution, which is not mentioned in the ground truth—no such breakdown of repatriated capital is provided, making this detail fabricated or misattributed. Additionally, the $53.9 million contingent indemnification liability and deferred tax asset with valuation allowance are not in the original answer and appear to be extraneous or incorrect. The elimination of ATC TIPL’s $1.1 billion translation adjustment is partially correct but conflated—the original answer states the $1.2 billion loss was due to reclassification of cumulative translation adjustments, not their elimination. (2) The key numbers—$2.5 billion valuation, $2.2 billion received, $1.5 billion debt repayment, and $1.2 billion loss—are mostly accurate, though the LLM omits the $1.5 billion debt repayment figure and instead vaguely references repayment of senior notes without specifying the 2021 Multicurrency Credit Facility as the sole instrument. The $354 million repatriation figure is unsupported and likely incorrect. (3) The multi-hop reasoning is partially sound: the model correctly links the 2023 strategic review to the 2024 DIT transaction and connects proceeds to debt repayment. However, it adds unverified financial items (contingent liability, tax asset, specific repatriation amount) that undermine the synthesis. (4) Correctness score is 6 due to significant factual overreach despite correct core narrative. Quantitative accuracy is 5 due to incorrect or unsupported figures. Qualitative accuracy is 7 because the reasoning flow is logical but includes erroneous details. Contextual relevance is 9 as the answer directly addresses the strategic and financial dimensions of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 569,
        "total_tokens": 1957
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did the change in foreign currency exposure related to product purchases through the Nike Trading Company (NTC) from 2023 to 2024 affect Nike’s cash flow hedge accounting treatment and overall foreign exchange risk management strategy?",
      "original_answer": "In 2023, Nike entities primarily purchased products from NTC, which sourced from third-party factories in U.S. Dollars, exposing Nike to foreign currency risk when NTC sold to entities with different functional currencies. By 2024, Nike continued to depend on NTC as a sourcing hub, but the increased volume of non-functional currency product purchases led to more pronounced foreign exchange exposures. This resulted in more frequent reclassification of gains and losses from Accumulated Other Comprehensive Income (AOCI) into Net Income, as some forecasted transactions failed to occur within the initially identified time periods. Consequently, Nike’s foreign exchange risk management strategy placed greater emphasis on dynamic hedging of intercompany transactions and demand creation expenses, beyond just product costs, to stabilize cash flows.",
      "llm_answer": "Nike’s exposure to product‑cost foreign‑currency risk through the NTC fell, so the notional amount of derivatives designated as cash‑flow hedges dropped from $544 million in 2023 to $313 million in 2024 – a $231 million reduction【page_85】. That decline triggered the reclassification of $231 million of deferred net gains from OCI to net income as the hedged transactions matured, while Nike’s overall FX‑risk strategy remained unchanged: it continues to hedge product‑cost exposures with foreign‑currency forwards and options, keeping a 24‑month maximum hedging horizon【page_84】.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The original answer states that foreign exchange exposure *increased* in 2024 due to higher non-functional currency purchases through NTC, leading to more frequent reclassifications from AOCI due to forecasted transactions not occurring as expected. In contrast, the LLM claims exposure *fell*, which directly contradicts the ground truth. The LLM introduces specific dollar figures—$544 million in 2023 and $313 million in 2024—for notional derivative amounts and a $231 million reclassification of gains—which are not present in the original answer and cannot be verified against the ground truth. These numbers appear fabricated or misattributed. (2) The calculations (e.g., $544M - $313M = $231M) are mathematically correct, but since the input values are unsupported by the original answer, the quantitative claims are invalid. There is no mention in the ground truth of a reduction in hedge notional or a drop in derivatives usage; instead, the emphasis is on *increased* exposure and more dynamic hedging. (3) The multi-hop reasoning is flawed. The LLM incorrectly infers that reduced exposure led to reclassification of gains, whereas the original answer attributes reclassification to forecasted transactions failing to occur within the expected timeframe—due to *increased* complexity and exposure, not decreased. The LLM also claims Nike’s FX risk strategy 'remained unchanged,' which contradicts the original answer stating that the strategy evolved to place 'greater emphasis on dynamic hedging' beyond product costs. (4) The contextual relevance is moderate because the answer discusses cash flow hedges, AOCI (via OCI), and hedging instruments, which are relevant topics. However, the core facts—direction of exposure change, reason for reclassification, and evolution of strategy—are all incorrect. Thus, despite using plausible financial terminology and structure, the answer misrepresents the key dynamics and is largely factually wrong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 545,
        "total_tokens": 1926
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did ConocoPhillips' strategic investment decisions in APLNG from 2022 to 2023 reflect changes in its partnership dynamics with Origin Energy, particularly in light of the $688 million write-down in 2022 and the updated ownership structure in 2023?",
      "original_answer": "In 2022, ConocoPhillips exercised its preemption right to purchase an additional 10% interest in APLNG, which led to a $688 million before-tax charge due to the fair value of the investment being below its carrying value. This signaled a strategic commitment to maintaining a strong position in the joint venture despite short-term financial impacts. By 2023, the ownership structure of APLNG was explicitly stated as ConocoPhillips holding 47.5%, with Origin Energy at 27.5%, indicating a continued but recalibrated partnership. The evolution from a reactive investment adjustment in 2022 to a clearly defined equity stake in 2023 shows a strategic shift from mitigating risk to solidifying long-term collaboration with Origin Energy in Australian CBM and LNG operations.",
      "llm_answer": "ConocoPhillips’ 2021 pre‑emption purchase of an additional 10 % of APLNG—triggered by Origin Energy’s sale of 10 % of its stake—caused a $688 million impairment (recorded in the 2022 filing) because the joint‑venture’s fair value fell below carrying value.  By 2023, ConocoPhillips’ share had risen to 47.5 % (with Origin Energy at 27.5 % and Sinopec at 25 %), reflecting a strategic consolidation of its LNG position and a rebalancing of control within the partnership.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains a minor factual inaccuracy regarding the timing of the pre-emption purchase. The original answer states the action occurred in 2022, while the LLM claims it was a 2021 purchase reflected in the 2022 filing. The $688 million write-down is correctly attributed to 2022 in the original, and the knowledge graph confirms this charge was recorded in 2022 due to the revaluation following the transaction in that year, not 2021. This misstatement of the event year affects quantitative accuracy. The ownership percentages (47.5%, 27.5%, 25%) are correct, and the $688 million figure is accurate. (2) The calculation and numeric values are otherwise correct: the impairment amount matches, and the 2023 ownership structure totals 100% (47.5 + 27.5 + 25), which aligns with known data. However, the original answer does not mention Sinopec’s 25% stake, which the LLM correctly includes but was not required for the core comparison between ConocoPhillips and Origin Energy. Its inclusion is factually accurate but slightly shifts focus. (3) The multi-hop reasoning is sound: the LLM connects the pre-emption right, the impairment trigger, and the updated ownership structure to infer strategic consolidation and partnership rebalancing, which aligns with the original’s conclusion about strategic commitment and recalibration. The logic from financial impact to ownership change to strategic implication is coherent. (4) The contextual relevance is high as it directly addresses ConocoPhillips’ investment decisions and partnership dynamics with Origin Energy. The mention of Sinopec adds context not in the original but doesn’t detract. The main deduction is for the incorrect dating of the transaction (2021 vs 2022), which affects factual precision, hence a 7 in correctness and quantitative accuracy. Qualitative reasoning and contextual relevance remain strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 518,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did the governance risks associated with META's dual-class stock structure in 2023 relate to the voting power thresholds and stock conversion provisions that were still in effect as of December 31, 2024?",
      "original_answer": "In 2023, META's dual-class structure, where Class B shares carried disproportionate voting rights, posed governance risks by allowing the controlling shareholder to influence key decisions and potentially depress Class A stock prices. This structure included a provision requiring Class B majority approval for change-in-control transactions until their voting power dropped below 35%. As of December 31, 2024, META still maintained this dual-class framework, with Class B shares representing 343,761,117 of the total outstanding shares, ensuring continued concentration of voting control. The structural relationship between Class A and Class B shares remained intact, with Class B shares convertible to Class A on a 1:1 basis, preserving the governance dynamics that contributed to investor concerns outlined in the prior year.",
      "llm_answer": "Meta’s 2023 filing warned that its dual‑class structure concentrates voting control: Class B shares (ten votes each) can direct corporate matters as long as they represent at least 9.1 % of the combined voting power, and any transaction that would change control requires majority approval of Class B holders when they hold less than 35 % of voting power. The filing also noted that Class B shares convert to Class A shares over time, increasing the holders’ relative voting power. Those same voting‑power thresholds and conversion provisions were unchanged and remained in effect through December 31 2024, sustaining the governance risks identified in 2023.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core governance risks of Meta's dual-class structure and correctly identifies that the voting thresholds and conversion provisions remained in effect through December 31, 2024. However, there are significant quantitative inaccuracies that undermine factual correctness. First, the claim that Class B shares have 'ten votes each' is not supported in the ground truth, which does not specify vote count per share—only disproportionate voting rights. Second, the 9.1% threshold for directing corporate matters is not mentioned in the original answer and appears to be an unsupported addition. The ground truth states that a Class B majority approval is required for change-in-control transactions *until their voting power drops below 35%*, which the LLM correctly notes. However, the LLM misrepresents the conversion mechanism: it claims Class B shares convert over time 'increasing the holders’ relative voting power,' while the ground truth states conversion is 1:1 to Class A, which would dilute Class B's relative voting power over time, not increase it. This is a critical error in reasoning. While the answer addresses the persistence of governance risks and structural provisions, the incorrect vote weighting, fabricated threshold, and flawed logic on conversion impact reduce quantitative and qualitative accuracy. The contextual relevance is high as it directly addresses the question’s focus on governance risks, thresholds, and continuity into 2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 407,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did MetLife's implementation of LDTI in 2023 influence the structure of disaggregated rollforwards disclosed in 2024, particularly in terms of the reclassification of MRB liabilities and its impact on retained earnings?",
      "original_answer": "In 2023, MetLife implemented LDTI, which required a full retrospective approach for Market Risk Benefits (MRBs), leading to the reclassification of amounts previously recorded under additional insurance liabilities, embedded derivatives, and other insurance liabilities directly to MRB liabilities. This reclassification also resulted in adjustments to retained earnings and AOCI, particularly due to the cumulative effect of changes in nonperformance risk. LDTI further mandated separate disaggregated rollforwards for additional insurance liabilities and traditional/limited-payment future policy benefits (FPBs), which directly influenced how MetLife structured its 2024 disclosures. In 2024, MetLife disclosed disaggregated rollforwards of separate account liabilities, grouping products based on common characteristics and valuation methodologies, reflecting the structural changes initiated under LDTI in 2023.",
      "llm_answer": "MetLife’s LDTI transition in 2023 required that all MRB balances previously carried in “additional insurance liabilities” be re‑classified to a separate MRB liability line (page 158).  The 2024 disaggregated roll‑forwards now present MRB balances as a distinct component of the market‑risk‑benefit section (see the MRB balances on page 194), reflecting that re‑classification.  The fair‑value adjustment to MRBs was recorded as a one‑time $1.6 billion reduction to retained earnings at the transition date (page 162), which lowered the opening retained‑earnings balance for 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but has minor omissions affecting completeness. (1) Quantitatively, the $1.6 billion reduction to retained earnings is accurate and correctly attributed to the LDTI transition in 2023, impacting the 2024 opening balance—this matches the expected cumulative effect of nonperformance risk adjustments. The reference to page numbers (158, 162, 194) suggests precise sourcing, though these are not evaluable for correctness here. (2) The reclassification of MRB liabilities from additional insurance liabilities to a separate line item is correctly described and reflects the structural change required under LDTI. However, the answer omits mention of the reclassification from embedded derivatives and other insurance liabilities, which the ground truth includes, and does not note the impact on AOCI—only retained earnings—making it partially incomplete. (3) The reasoning is sound: it correctly links the 2023 LDTI implementation to changes in 2024 disclosures, particularly the disaggregated rollforwards now showing MRBs separately. It captures the cause-effect relationship between retrospective application and disclosure structure. (4) Contextually, the answer is highly relevant, directly addressing how LDTI influenced disclosure structure and retained earnings. While the core facts and financial impact are correct, the omission of AOCI and incomplete description of reclassification sources prevent a top score. Hence, correctness is rated 8/10, with high marks for quantitative and contextual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 432,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did AMT's strategic decision to convert its VIL OCDs to equity and subsequently sell the investment affect its 2024 financial performance?",
      "original_answer": "In 2023, AMT's Indian subsidiary, ATC TIPL, held VIL OCDs issued by Vodafone Idea Limited (VIL) with a face value of 16.0 billion INR (approximately $193.2 million). These OCDs were convertible into equity or repayable with interest. By August 2023, the maturity of the first tranche was extended to August 2024. In March 2024, AMT converted 14.4 billion INR (approximately $172.7 million) of the VIL OCDs into 1,440 million shares of VIL equity. These shares were sold in April 2024 for net proceeds of approximately 18.0 billion INR (approximately $216.0 million). The remaining 1.6 billion INR (approximately $19.2 million) of OCDs were sold in June 2024 for net proceeds of approximately 1.8 billion INR (approximately $22.0 million). As a result of these transactions, AMT recognized a total gain of $46.4 million in 2024, which was recorded in 'Loss from discontinued operations, net of taxes' in the consolidated statements of operations. This strategic move allowed AMT to realize value from its exposure to VIL, contributing positively to its 2024 financial results.",
      "llm_answer": "In 2024, AMT converted its Vodafone Idea Limited (VIL) optionally‑convertible debentures to equity and then sold the shares and the remaining debentures.  The transaction produced a $46.4 million gain that was recorded in “Loss from discontinued operations, net of taxes” in the consolidated statements of operations, thereby improving the company’s 2024 results and offsetting other operating losses.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the essential financial impact of AMT's strategic decision in 2024. It correctly identifies the conversion of VIL OCDs to equity, the subsequent sale of shares and remaining debentures, and the resulting $46.4 million gain. The gain amount is exactly correct as per the ground truth, and it correctly states that this was recorded in 'Loss from discontinued operations, net of taxes', which improved AMT's 2024 financial results. The answer omits some granular details such as the exact timing (March conversion, April and June sales), the breakdown of the 14.4 billion INR and 1.6 billion INR tranches, and the net proceeds (18.0 billion INR and 1.8 billion INR), but these omissions do not detract from the core factual correctness of the financial outcome. All entities (AMT, VIL, OCDs) and the year (2024) are accurate. The reasoning is sound: converting debt to equity and monetizing the position led to a realized gain, which positively affected financial performance. The semantic meaning fully aligns with the original answer, and the $46.4 million figure matches precisely. Minor completeness gaps prevent a perfect 10, but the answer is factually correct and contextually excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 346,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did Southern Company's treatment of foreign currency derivatives within risk management activities change between 2023 and 2024, particularly regarding their presentation in financial statements and the level of fair value disclosure?",
      "original_answer": "In 2023, Southern Company reported that the costs related to risk management activities, including derivative transactions, were netted against wholesale gas services revenues on the income statement. By 2024, foreign currency derivatives were explicitly categorized under 'Risk Management Activities' and their fair value was reflected as either assets or liabilities on the balance sheet. This indicates a shift toward more transparent and segmented reporting of foreign currency derivatives within the broader risk management framework, with a more explicit linkage between these instruments and the company's risk management strategy.",
      "llm_answer": "Southern Company shifted its foreign‑currency derivatives out of a general “Other” line item into a dedicated risk‑management activities note in 2024.  The 2024 filing (page 283) presents a separate table that breaks the derivatives into current and non‑current assets and liabilities, shows net amounts recognized, gross amounts recognized and offsets, and includes fair‑value gains/losses, whereas the 2023 note (page 283) only reported net amounts (34 m current, 88 m non‑current) without the detailed breakdown or netting commentary.  The 2024 note also explicitly states that fair‑value amounts are presented net under netting arrangements (page 282), a level of disclosure not provided in 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the shift in Southern Company's treatment of foreign currency derivatives between 2023 and 2024, noting increased transparency and segmentation in reporting. The core factual claim—that 2023 reported net amounts under a less detailed structure while 2024 introduced a more granular presentation under 'Risk Management Activities'—matches the original answer. (2) Quantitatively, the LLM cites specific values from the filings: $34M current and $88M non-current derivative amounts in 2023, which are plausible and contextually consistent (though the ground truth does not specify these numbers, they do not contradict it and appear to be correctly extracted from the actual filing pages). The reference to page 283 for both years and page 282 for netting arrangements adds precision and supports the claim. (3) The multi-hop reasoning is sound: the model synthesizes changes in presentation (from netted income statement impact to balance sheet asset/liability recognition), increased disclosure (current vs. non-current breakdown, gross vs. net amounts, gains/losses), and the explicit mention of fair value and netting arrangements. This reflects a correct understanding of the evolution in disclosure practices. (4) While the original answer emphasizes the shift from netting against revenue to balance sheet recognition and strategic linkage, the LLM focuses more on disclosure granularity and presentation format—this is a slight difference in emphasis but not in substance. The LLM does not explicitly mention the income statement netting against 'wholesale gas services revenues' as in the ground truth, which is a minor omission, but correctly infers a move toward more transparent and segmented reporting. Overall, the answer is factually correct, detailed, and contextually appropriate, warranting a high score with only a small deduction for not fully capturing the income statement treatment in 2023.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 539,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "What does the signatory structure in Georgia Power's 2023 10-K suggest about its continued operational independence following its use of the reduced disclosure format in Southern Company’s 2022 consolidated filing?",
      "original_answer": "In 2022, Georgia Power Company used the reduced disclosure format under General Instructions I(2)(b), (c), and (d) of Form 10-K as part of Southern Company's consolidated filing, indicating alignment with a streamlined reporting structure. However, in 2023, Georgia Power maintained its own distinct signatory block with separate executive and director representations, including Kimberly S. Greene as Chairman, President, and CEO, and Melissa K. Caen as Attorney-in-fact, signed on February 14, 2024. This suggests that despite the prior year’s consolidated format, Georgia Power retained a level of operational and governance independence in its reporting obligations. The continued presence of its own signature block reinforces that Georgia Power operates as a distinct registrant within the Southern Company system, with its own accountability framework.",
      "llm_answer": "Georgia Power’s 2023 10‑K contains its own distinct signature block—separate from Southern Company’s—showing that the utility continues to maintain independent corporate governance and reporting.  This structure, even after the 2022 filing used a reduced‑disclosure format for the consolidated Southern Company report, signals that Georgia Power remains operationally autonomous rather than fully integrated into the parent entity.  (See the separate signature blocks for each subsidiary on pages 326–327.)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and semantically equivalent to the ground truth. It accurately captures the key point: despite Georgia Power's use of the reduced disclosure format in Southern Company’s 2022 consolidated filing, its 2023 10-K includes a separate signatory block, indicating continued operational and governance independence. The LLM correctly identifies the implication of the signature structure and references the appropriate context (2022 reduced disclosure, 2023 standalone signature). While the original answer includes specific details such as the names Kimberly S. Greene and Melissa K. Caen, and the signing date (February 14, 2024), the LLM answer omits these but retains the core factual and inferential accuracy. This omission is minor and does not detract from the correctness of the conclusion. There are no numerical values requiring calculation, and all entities (Georgia Power, Southern Company, 2022 and 2023 filings) are correctly identified. The reasoning is sound and reflects proper multi-hop synthesis: (1) Georgia Power used reduced disclosure in 2022 as part of a consolidated filing, (2) in 2023 it filed with its own signature block, (3) this suggests maintained independence. The reference to 'pages 326–327' adds contextual support, though not present in the original, it does not introduce error. Overall, the answer is concise, accurate, and logically sound—just slightly less detailed than the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 401,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "What was the impact of the evolving supply relationship between Merck and Organon on financial obligations and supply chain dynamics between 2023 and 2024?",
      "original_answer": "Merck's supply relationship with Organon for formulated pharmaceutical products underwent a notable shift from 2023 to 2024, impacting financial obligations and supply chain dynamics. In 2023, Merck reported sales under the manufacturing and supply agreements (MSAs) with Organon at $394 million, with related cost of sales at $422 million. By 2024, sales slightly declined to $392 million, while cost of sales improved to $390 million, indicating better cost efficiency in the supply chain. Additionally, the financial obligations between the two companies changed significantly: amounts due from Organon dropped from $632 million in 2023 to $330 million in 2024, while amounts due to Organon decreased more sharply from $598 million to $113 million. This demonstrates a reduction in intercompany receivables and liabilities, suggesting a maturing or winding down of transitional financial arrangements post-spin-off.",
      "llm_answer": "Between 2023 and 2024 the Merck‑Organon supply relationship was streamlined, cutting Merck’s financial obligations: amounts due from Organon under the manufacturing and supply agreements fell from $632 million (Dec 31 2023) to $330 million (Dec 31 2024), and amounts owed to Organon dropped from $598 million to $113 million.  Sales under the MSAs rose modestly from $383 million to $392 million while cost of sales fell from $404 million to $390 million, reflecting a more efficient supply chain.  The 2024 Restructuring Program’s focus on optimizing the Animal Health manufacturing network further improved supply reliability, and the number of interim operating agreements was reduced to a single jurisdiction.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains several factual inaccuracies in key financial figures, particularly in sales and cost of sales for 2023, which undermines the overall correctness. While the amounts due from and to Organon are correctly reported ($632M to $330M and $598M to $113M), the LLM states that 2023 sales were $383M and cost of sales were $404M, whereas the ground truth reports $394M in sales and $422M in cost of sales. The 2024 figures for sales ($392M) and cost of sales ($390M) are accurate. (2) Quantitative accuracy is compromised due to incorrect 2023 numbers; even though the direction of change (sales slightly up, cost down) aligns with ground truth, the starting points are wrong, leading to misleading interpretation. The claim that sales 'rose modestly' from $383M to $392M implies growth, but in reality, sales declined from $394M to $392M. Similarly, the improvement in cost efficiency is overstated because the LLM understates the initial cost of sales ($404M vs actual $422M). (3) The qualitative reasoning is partially sound: the conclusion about reduced financial obligations and improved supply chain efficiency has some basis, and the mention of the 2024 Restructuring Program and reduction in interim agreements adds relevant context not in the original answer—but this may be extraneous or unverified. However, the core multi-hop synthesis between financial obligations and supply dynamics is only partially accurate due to incorrect data. (4) Contextual relevance is high—the answer addresses both financial obligations and supply chain dynamics as required, and structures the response logically. However, the incorrect numbers reduce the reliability of the conclusions. The answer would score higher if not for the critical errors in foundational financial data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 484,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did XOM's share of synthetic crude oil production through Imperial Oil's Syncrude stake change from 2023 to 2024, and how does this compare with the production trends observed at Kearl operations during the same period?",
      "original_answer": "In 2023, XOM's share of net production of synthetic crude oil from Syncrude was about 67 thousand barrels per day. By 2024, this had decreased to about 62 thousand barrels per day, a decline of approximately 5,000 barrels per day. Meanwhile, production at Kearl operations increased from an average net production of 249 thousand barrels per day in 2023 to 262 thousand barrels per day in 2024, representing an increase of 13 thousand barrels per day. This indicates a shift in production dynamics within XOM’s Canadian oil sands portfolio, with Syncrude experiencing a reduction in output while Kearl saw an uptick.",
      "llm_answer": "XOM’s share of synthetic‑crude production through its 25 % stake in Imperial Oil’s Syncrude JV fell from about **67 thousand barrels per day (bpd) in 2023 to roughly 62 k bpd in 2024** (≈ 5 k bpd decline)【page_19】【page_18】.  \nBy contrast, Kearl’s average net production rose from **≈ 249 k bpd in 2023 to about 262 k bpd in 2024** (≈ 13 k bpd increase)【page_19】【page_18】.  \nThus, while XOM’s synthetic‑crude share slipped modestly, Kearl’s output grew noticeably over the same period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: XOM's share of Syncrude production decreased from 67 thousand bpd in 2023 to 62 thousand bpd in 2024, a decline of 5,000 bpd, and Kearl's production increased from 249 thousand bpd to 262 thousand bpd, a rise of 13,000 bpd. These values match the original answer exactly, with acceptable formatting variations (e.g., '62 k bpd' = '62 thousand barrels per day'). (2) The answer is complete, addressing both parts of the question: the change in XOM's Syncrude share and the comparison with Kearl operations. (3) Entity accuracy is correct—XOM, Syncrude, Imperial Oil, Kearl, and the years 2023 and 2024 are all properly identified and contextualized. (4) The reasoning is sound and reflects proper multi-hop synthesis: the model correctly infers trends across different operations and time periods, and draws a valid comparative conclusion about shifting production dynamics. (5) The semantic meaning is equivalent to the original answer, with slightly more concise wording but no loss of information. All citations (e.g., page references) further support the accuracy. No errors or omissions are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 343,
        "total_tokens": 1637
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did the introduction of a cash dividend policy in 2024 impact the relationship between META's Class B and Class A common stock dynamics compared to 2023?",
      "original_answer": "In 2023, META's Class B common stock was not publicly traded and had only 23 stockholders of record, while Class A common stock was actively traded on Nasdaq. Class B shares could convert on a one-for-one basis into Class A shares, but Class A shares held by Class B stockholders post-conversion had to be sold or transferred. In 2024, META introduced its first-ever cash dividend policy, applying equally to both Class A and Class B common stock at $0.50 per share. This change likely altered the incentive structure for Class B stockholders, as they now receive dividend income, potentially affecting the frequency or volume of Class B-to-Class A conversions and subsequent Class A share sales. The new dividend policy created a financial linkage between the two share classes that was previously absent, reinforcing the structural connection between Class B and Class A shares through shared economic benefits.",
      "llm_answer": "In 2023 Meta had never paid a cash dividend and its Class B shares were not listed, creating a distinct dynamic from the publicly traded Class A shares (page 57).  The 2024 filing announced a first‑ever dividend of $0.50 per share for both classes, aligning the cash‑flow benefits of Class A and Class B shares and potentially narrowing the disparity in their market dynamics and conversion incentives (page 57).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core changes in META's stock dynamics due to the 2024 dividend policy. (1) All factual elements are correct: no dividend in 2023, Class B not publicly traded, Class A actively traded, $0.50 dividend introduced in 2024 for both classes. The dollar amount and year are correctly stated, matching the ground truth. (2) Quantitative accuracy is perfect: $0.50 per share is correctly reported, and the years (2023 vs 2024) are accurately referenced. (3) The reasoning is sound: the introduction of equal dividend payments aligns cash-flow benefits across share classes, which logically affects conversion incentives and reduces disparity in market dynamics. This correctly infers the economic linkage introduced by the dividend. (4) The only minor omission is that the ground truth includes specific detail about Class B having only 23 stockholders of record and the requirement that converted Class A shares must be sold or transferred by former Class B holders. While this adds context, it does not alter the central conclusion about dividend impact on conversion incentives. The LLM answer synthesizes the key multi-hop insight—dividend introduction creates shared economic benefit, altering prior dynamics—thus achieving semantic equivalence on the main point. Wording differs but meaning aligns closely with the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 381,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did the $119 million goodwill impairment of PowerSecure in 2022 impact its role in Southern Company's distributed energy solutions as reflected in the 2024 segment reporting?",
      "original_answer": "In 2022, PowerSecure experienced a $119 million goodwill impairment due to declining macroeconomic conditions and reduced cash flow projections, signaling financial stress in its operations. Despite this impairment, PowerSecure continued to be a key provider of distributed energy and resilience solutions for Southern Company in 2024, as explicitly stated in the 'Other Business Activities' section of the 2024 10-K. However, by 2024, PowerSecure was grouped within the 'All Other' segment, which includes segments below the quantitative threshold for separate disclosure. This reclassification suggests that PowerSecure's financial contribution had diminished to the point where it no longer warranted standalone segment reporting, likely influenced by the earlier impairment and its lingering financial effects.",
      "llm_answer": "The $119 million goodwill impairment recorded in 2022 reduced the carrying amount of goodwill attributable to PowerSecure, but it did not alter PowerSecure’s role in Southern Company’s distributed‑energy business.  In the 2024 segment reporting (Other Business Activities), PowerSecure remains a key contributor, providing $120 million of operating revenue in 2024 and still driving the majority of the segment’s distributed‑energy and microgrid activity (see page 292).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in quantitative claims not supported by the ground truth. First, the $120 million operating revenue figure for PowerSecure in 2024 is not mentioned in the original answer and cannot be verified from the provided context—this is a major fabrication or hallucination. Second, the claim that PowerSecure 'still driving the majority of the segment’s distributed-energy and microgrid activity' is not present in the ground truth and overstates its role without evidence. While the LLM correctly notes that PowerSecure remained part of Southern Company’s distributed energy solutions and is mentioned in the 'Other Business Activities' section, it fails to report the critical point that by 2024, PowerSecure was grouped into the 'All Other' segment due to diminished financial significance—a direct consequence of the 2022 goodwill impairment. This reclassification is central to the original answer and reflects a reduced strategic footprint, which the LLM overlooks. The goodwill impairment amount ($119 million) and year (2022) are correctly stated, and the general idea that operations continued post-impairment is accurate, but the emphasis on ongoing major contributions contradicts the ground truth’s conclusion about reduced disclosure status. Thus, while some entities and surface-level facts are correct, the reasoning fails to synthesize the multi-hop link between impairment, financial decline, and segment reclassification. The answer is contextually relevant but misleading in magnitude and implication.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 431,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did ConocoPhillips' decision to exercise its preemption right to acquire an additional 10% stake in APLNG in 2022 influence its financial reporting and investment valuation of APLNG in 2023?",
      "original_answer": "In 2022, ConocoPhillips exercised its preemption right to acquire an additional 10% stake in APLNG, which was directly tied to Origin Energy’s decision to sell its 10% interest for $1.645 billion. This triggered a reassessment of APLNG’s fair value, which was found to be below the carrying value of ConocoPhillips’ existing investment. As a result, in Q4 2022, ConocoPhillips recorded a $688 million noncash impairment charge, reducing the carrying value of its APLNG investment to $5,574 million. In 2023, this impairment was reflected in the financial statements, with the updated carrying value aligning to the fair value determined through the preemption transaction. The company also reported the updated stake in APLNG under its equity method investments, showing how the 2022 strategic move directly impacted the financial valuation and reporting in the following year.",
      "llm_answer": "ConocoPhillips exercised its preemption right in December 2021 to buy an additional 10 % stake in APLNG, closing in Q1 2022 (page_39).  The acquisition triggered a $688 million impairment of the existing APLNG investment in 2021, reducing its carrying value to $5,574 million (page_101).  In 2023 the company continues to carry the investment at fair value of $5,574 million under the equity method, with no further impairment recorded (Note 13, page_107).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly regarding the timing of events. It states that ConocoPhillips exercised its preemption right in December 2021 and closed in Q1 2022, while the ground truth confirms the exercise occurred in 2022, tied to Origin Energy’s sale. The impairment was recorded in Q4 2022, not 2021 as claimed. This misplacement of key events undermines the factual correctness. However, the $688 million impairment charge and the resulting carrying value of $5,574 million are accurately reported. (2) Quantitatively, the dollar amounts and percentages (10% stake, $688M impairment, $5,574M carrying value) are correct and consistent with the ground truth. The error lies in the timing—assigning the impairment to 2021 instead of 2022—which is a critical factual flaw in financial reporting context. (3) The reasoning partially captures the multi-hop logic: the preemption triggered a fair value reassessment leading to impairment, which then affected 2023 reporting. However, the incorrect timeline disrupts the causal chain. The LLM correctly notes that the investment was carried at $5,574 million in 2023 under the equity method with no further impairment, aligning with the original answer. (4) Despite the timeline error, the answer addresses the core financial impact and valuation treatment in 2023, maintaining contextual relevance. The qualitative accuracy is reduced due to incorrect entity-event mapping (wrong year for impairment), but the financial mechanics are sound. Correctness is penalized heavily due to the misdated impairment, a key financial event.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 446,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "What does the $600 million decrease in UPS's unfunded commitments to private equity funds between 2023 ($3.3B) and 2024 ($2.7B) suggest about the company's evolving approach to valuing these alternative investments, given that both years specifically rely on fund manager-reported net asset value (NAV) for valuation?",
      "original_answer": "The $600 million reduction in unfunded commitments from $3.3 billion in 2023 to $2.7 billion in 2024, combined with the consistent use of NAV derived from fund manager reports for valuation in both years, suggests that UPS may be recalibrating its exposure to private equity funds while maintaining the same valuation methodology. This shift could indicate a more cautious stance in capital allocation to these illiquid investments, possibly due to lessons learned from the subjective nature of NAV estimation, as noted in the 2023 audit procedures. Despite the reduction, the continued reliance on NAV highlights the company's ongoing trust in fund manager reporting, albeit with a reduced forward commitment, potentially signaling a strategic shift toward more conservative investment planning in alternative asset classes.",
      "llm_answer": "The $600 million drop in unfunded private‑equity commitments (from $3.3 B in 2023 to $2.7 B in 2024) signals that UPS is scaling back the capital it plans to deploy in these funds, reflecting a more cautious or selective investment stance.  Because both years still rely on fund‑manager‑reported NAV for valuation, the change indicates a shift in commitment strategy rather than a change in how the investments are valued.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the $600 million decrease in unfunded commitments from $3.3B in 2023 to $2.7B in 2024, with accurate numeric values and formatting (allowing $3.3B = $3.3 billion). The calculation of the $600M difference is implicitly correct. 2) All entities (UPS, private equity funds, unfunded commitments, NAV valuation method) and years (2023, 2024) are accurately referenced. 3) The reasoning correctly synthesizes that the valuation methodology (NAV based on fund manager reports) remained consistent, so the reduction reflects a strategic shift in capital commitment rather than a change in valuation approach. This aligns with the ground truth's core insight about recalibrating exposure while maintaining trust in NAV. 4) The LLM answer is semantically equivalent to the original in key aspects but omits a minor but relevant point from the ground truth: the potential influence of audit observations about the subjective nature of NAV estimation in 2023, which adds context for increased caution. While the LLM captures the main implication—more cautious stance—it misses this supporting rationale, justifying a 9 instead of 10 on qualitative accuracy. Otherwise, the answer is factually correct, contextually relevant, and properly reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 355,
        "total_tokens": 1709
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did NEE's valuation approach for congestion-related forward contracts evolve from 2023 to 2024, particularly regarding the use of discounted cash flow models and the range of forward prices applied?",
      "original_answer": "In 2023, NEE valued forward contracts - congestion using discounted cash flow models with a forward price range of $(30) to $32 per MWh. By 2024, the company continued using discounted cash flow models for these contracts, but the forward price range had shifted to $(49) to $22 per MWh. This indicates a widening of the negative price range and a narrowing of the positive price range, suggesting increased volatility and potential risk in congestion pricing that NEE factored into its valuation methodology. While the core valuation technique remained consistent, the change in forward price ranges reflects an evolution in NEE's assumptions about congestion pricing dynamics between 2023 and 2024.",
      "llm_answer": "NEE continued to value congestion‑related forward contracts with a discounted‑cash‑flow model in both 2023 and 2024, treating the forward price per MWh as the key unobservable input.  The range of forward prices applied, however, shifted: in 2023 the range was $(30) to $32 per MWh, whereas in 2024 it widened to $(49) to $22 per MWh (with the weighted‑average forward price remaining “$‑” in both years).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: NEE used discounted cash flow models in both 2023 and 2024 for congestion-related forward contracts; the 2023 forward price range was $(30) to $32 per MWh, and in 2024 it shifted to $(49) to $22 per MWh—both figures match the original answer exactly. (2) Quantitative accuracy is perfect: all dollar amounts and ranges are correctly reported, including the negative pricing and proper formatting. (3) The multi-hop reasoning is sound—comparing valuation methods and assumptions across two years for the same instrument (congestion-related forwards) is correctly synthesized. (4) The only minor shortcoming is that the LLM does not explicitly interpret the implications of the widened negative range and narrowed positive range (i.e., increased volatility and risk), which the original answer notes. However, stating that the weighted-average forward price remained '“$-”' (likely indicating negative or zero) adds a small detail not in the original, without contradicting it. Overall, the answer is factually complete and contextually precise, missing only slight interpretive depth. Hence, correctness is docked slightly to 9, but all other scores remain high.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 353,
        "total_tokens": 1643
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "What does the shift from pass-through tax expenses tied to natural gas revenues in 2021 to regulatory disallowances in 2023 at Nicor Gas indicate about the changing financial pressures and regulatory environment for Southern Company's natural gas distribution segment?",
      "original_answer": "In 2021, Southern Company experienced a $19 million increase in taxes other than income taxes, driven by a $15 million increase in revenue tax expenses at Nicor Gas due to higher natural gas revenues, which were passed through to customers and had no impact on net income. However, by 2023, the regulatory environment had shifted, with Nicor Gas facing approximately $24 million in regulatory disallowances that directly impacted earnings. This change from pass-through tax expenses to regulatory disallowances suggests a more stringent regulatory stance, where increased revenues are no longer neutralized through cost recovery but instead result in financial penalties or restrictions, signaling a tightening regulatory climate for Southern Company's gas distribution operations.",
      "llm_answer": "The 2021 filing shows a $15 million revenue‑tax expense that was passed through to customers, reflecting a regulatory regime that taxed natural‑gas revenues but did not hit the segment’s earnings. By 2023 Nicor Gas faced an $88 million pre‑tax regulatory disallowance on capital investments, a cost that directly reduces earnings and signals tighter scrutiny of infrastructure spending. This shift from revenue‑based pass‑through taxes to capital‑investment disallowances indicates a tightening regulatory environment that is increasing financial pressure on Southern Company Gas’s distribution segment and potentially constraining its ability to invest in future infrastructure.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. While it correctly identifies a $15 million revenue-tax expense in 2021 that was passed through to customers (matching the ground truth), it incorrectly states that Nicor Gas faced an $88 million pre-tax regulatory disallowance in 2023, whereas the ground truth specifies approximately $24 million in regulatory disallowances. This is a major numerical discrepancy that affects the credibility of the financial analysis. (2) The years referenced (2021 and 2023) are correct, and the general nature of the shift—from pass-through expenses to disallowances—is accurately framed. However, the $88 million figure is not supported by the ground truth and appears to be either a hallucination or misattribution. Additionally, the LLM attributes the disallowance to 'capital investments,' while the original answer does not specify the cause beyond 'regulatory disallowances,' making this an unsupported inference. (3) The multi-hop reasoning is partially sound: the model correctly infers that a shift from pass-through costs to earnings-impacting disallowances indicates increased regulatory pressure. This logical connection is valid and relevant. However, the incorrect magnitude of the disallowance and the unsupported claim about capital investment scrutiny weaken the reasoning chain. (4) Despite the numerical error, the answer remains contextually relevant and captures the broader trend of increasing regulatory stringency. The qualitative insight about tightening regulation and financial pressure is aligned with the ground truth, just overstated due to incorrect figures. Thus, the correctness score is moderate—some key facts are right, but major financial inaccuracies limit overall accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 492,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did MDT's approach to mutual fund investments measured using Level 1 inputs evolve from 2022 to 2024, given the change in fair value from $125 million in 2022 to $114 million in 2024 and the consistent classification as Level 1 inputs?",
      "original_answer": "MDT's mutual fund investments measured using Level 1 inputs decreased from $125 million in 2022 to $114 million in 2024, while maintaining the same classification methodology under Level 1 inputs. This indicates a strategic decision to continue holding investments with readily available market pricing despite the reduction in allocation. The consistent use of Level 1 inputs suggests MDT maintained its objective of holding liquid investments with transparent valuations, even as total mutual fund investments declined over this period.",
      "llm_answer": "MDT continued to classify all of its mutual‑fund holdings as Level 1 assets, valuing them at observable net‑asset values reported daily by the funds.  The fair value of these Level 1 mutual funds fell from $125 million in 2022 to $114 million in 2024, indicating a decline in market value rather than a change in the valuation methodology【page_96】【page_96】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers and dates are correct: the fair value decrease from $125 million in 2022 to $114 million in 2024 is accurately reported, and the consistent classification under Level 1 inputs is correctly noted. Format variations (e.g., $125 million vs $125M) are acceptable and do not affect accuracy. (2) The answer addresses all key parts of the question: it confirms the continued use of Level 1 inputs, reports the change in fair value, and correctly infers that the valuation methodology did not change. (3) Entity accuracy is strong: MDT is correctly identified, the time frame (2022 to 2024) is accurate, and the financial metric (fair value of mutual fund investments using Level 1 inputs) is properly referenced. (4) The reasoning is sound: the LLM correctly interprets the decline in value as a market-driven change rather than a methodological shift, which is consistent with the ground truth’s implication of a strategic continuation of transparent, liquid investments. The only minor shortcoming is that the LLM does not explicitly mention the 'strategic decision' or 'objective of holding liquid investments' emphasized in the original answer, slightly reducing qualitative depth. However, the core multi-hop synthesis—linking unchanged classification with declining value—is logically and factually sound. Thus, the answer is semantically equivalent in substance, with only slight omission of interpretive context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 416,
        "total_tokens": 1663
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Microsoft's competitive positioning against Symantec in security solutions evolve from 2022 to 2024, particularly in relation to Office's integrated security capabilities and Microsoft's cloud-based security offerings?",
      "original_answer": "In 2022, Microsoft Office faced competition from Symantec primarily in the area of email and information security, with Symantec offering solutions such as email security and governance. By 2024, Microsoft had enhanced its competitive response through cloud-based security offerings, including Enterprise Mobility + Security and Azure AI, which directly addressed Symantec’s traditional security offerings. The evolution of Office's integrated security capabilities, such as secure collaboration tools and identity protection, aligned with Microsoft’s broader strategy to position itself as a secure, cloud-native productivity platform, directly countering Symantec's competitive focus on email and data governance.",
      "llm_answer": "In the 2022 filing Microsoft listed Symantec as a direct competitor in security, noting Symantec’s email‑security, information‑protection, and governance solutions while highlighting its own integrated security features in Office and other products (page_10). By 2024, Microsoft no longer names Symantec in its competitive discussion but continues to emphasize its own security stack, with Office 365 Security and Compliance embedded in Office 365 and a cloud‑based security portfolio under the Intelligent Cloud segment (page_8). This shift reflects a move from a direct Symantec rivalry to a broader, ecosystem‑wide security strategy that integrates Office security and cloud‑based services.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) It correctly identifies that in 2022, Symantec was a direct competitor to Microsoft in email security, information protection, and governance, while Microsoft emphasized integrated security in Office—matching the original answer's claim. By 2024, the LLM notes Microsoft no longer explicitly names Symantec, reflecting a strategic shift toward a broader cloud-based security posture, which is consistent with the ground truth’s description of Microsoft countering Symantec via cloud offerings like Enterprise Mobility + Security and Azure AI. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—dates (2022, 2024) are correct. (3) The multi-hop reasoning is sound: the LLM synthesizes changes in competitive disclosures across years and links Office’s integrated security with cloud-based offerings, correctly inferring a strategic evolution even without explicit mention of Symantec in 2024. (4) The only minor gap is that the LLM does not explicitly name 'Enterprise Mobility + Security' or 'Azure AI' as in the ground truth, instead referring more generally to the 'cloud-based security portfolio under the Intelligent Cloud segment.' While this is accurate, it omits specific product names that strengthen the connection to countering Symantec’s offerings. However, the semantic meaning and strategic interpretation remain correct. Overall, the answer is highly accurate, contextually relevant, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 432,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did the voting power dynamics between Class A and Class B common stockholders at CMCSA evolve from 2022 to 2023, and what implications does the convertibility of Class B shares into Class A shares have on shareholder influence?",
      "original_answer": "In 2022, CMCSA disclosed that Class B Common Stock had only 3 record holders but carried significant voting power. By 2023, it was revealed that Class B shares (which are convertible share-for-share into Class A) held a non-dilutable 33⅓% of the total voting power, while Class A shareholders collectively held 66⅔%. The convertibility feature of Class B shares into Class A shares, combined with each Class B share carrying 15 votes, suggests that the small group of Class B shareholders could maintain outsized influence even as they transition to Class A holdings. This dynamic preserves the strategic control of key stakeholders while allowing flexibility in equity structure.",
      "llm_answer": "From 2022 to 2023 the voting‑power split stayed fixed at 66 ⅓ % for Class A and 33 ⅓ % for Class B, but the Class A share count fell from 4,211 million to 3,969 million, slightly boosting the voting weight of each Class A share [page_91]. Because Class B shares are convertible on a share‑for‑share basis into Class A shares, holders can shift their influence by converting, which would dilute existing Class A voting power while keeping the aggregate Class B voting power at 33 ⅓ % and non‑dilutable [page_91].",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly states that Class A held 66⅓% of voting power and Class B held 33⅓%, reversing the actual distribution: in 2023, Class B held 33⅓% and Class A held 66⅔% (not 66⅓%). This is a critical error in both direction and precision. Additionally, the claim that Class A share count fell from 4,211 million to 3,969 million is unsupported by the ground truth, which does not mention share counts or such a decline. These numbers appear fabricated or misattributed. (2) The quantitative inaccuracies are severe: the voting percentages are wrong, and the share count figures have no basis in the original answer. The calculation of voting weight changes due to share count reduction is therefore invalid. The ground truth emphasizes that Class B’s 33⅓% voting power is non-dilutable, meaning it cannot be diluted by share count changes, which contradicts the LLM’s implication that conversion would dilute Class A voting power. (3) The reasoning is partially sound in recognizing that convertibility allows Class B holders to convert into Class A on a share-for-share basis, but it misinterprets the implications: the ground truth states that because each Class B share carries 15 votes and the 33⅓% voting power is structurally protected, conversion does not dilute Class B’s aggregate influence. The LLM incorrectly suggests that conversion would dilute Class A voting power while maintaining Class B’s 33⅓%, which misunderstands the non-dilutable nature of the voting structure. (4) Contextual relevance is high—the answer addresses voting power dynamics and convertibility as asked—but the factual and quantitative errors severely undermine correctness. The qualitative reasoning shows understanding of multi-hop concepts (convertibility, influence shifts) but applies them incorrectly due to flawed data. Correctness score is low due to core factual and numerical errors in voting power allocation and unsupported share count data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 541,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did the changes in UPS's retirement plan structure between 2022 and 2024, specifically the cessation of benefit accruals in the UPS Retirement Plan and the transition to defined contribution limits under IRS guidelines, affect the company's annual retirement contribution expenses?",
      "original_answer": "In 2022, UPS maintained the UPS Retirement Plan, a defined benefit plan subject to IRS limits, with retirement contributions charged to expense totaling $83 million. By 2024, the company had ceased accruals for non-union participants in the UPS Retirement Plan effective January 1, 2023, and transitioned to a defined contribution model under the UPS 401(k) Savings Plan. Under this new structure, non-union employees received annual retirement contributions of 5% to 8% of eligible compensation, resulting in retirement contributions charged to expense of $359 million in 2024. This shift from a defined benefit to a defined contribution model, aligned with IRS-prescribed limits, led to a significant increase in retirement expense, reflecting a strategic reallocation of pension liability from the company to employees.",
      "llm_answer": "After the UPS Retirement Plan stopped accruing benefits for non‑union employees on Jan 1 2023, UPS shifted those employees to the UPS 401(k) Savings Plan, which is subject to IRS‑defined contribution limits.  This transition caused retirement‑contribution expenses to rise sharply—from $83 million in 2022 to $380 million in 2023 and $359 million in 2024 (including $108 million and $128 million transition contributions in 2024 and 2023, respectively).  While the IRS limits capped each employee’s contribution, the overall expense increased because the company moved from a non‑contributory defined‑benefit plan to a defined‑contribution structure.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key structural change—cessation of benefit accruals for non-union employees in the UPS Retirement Plan effective January 1, 2023, and the transition to the 401(k) defined contribution plan. It also correctly notes the increase in expense from $83 million in 2022 to $359 million in 2024, aligning with the ground truth. However, it introduces a $380 million figure for 2023 and claims $128 million in transition contributions in 2023 and $108 million in 2024, which are not present in the original answer and contradict the provided ground truth (which only specifies 2022 and 2024 figures). These additional numbers are unsupported and likely incorrect. (2) The 2022 figure ($83M) is accurate. The 2024 figure ($359M) matches exactly. But the inclusion of $380M in 2023 and breakdowns of transition contributions are fabrications or misattributions not found in the original data. The original answer does not mention 2023 expense or transition contributions, so introducing them reduces quantitative accuracy. (3) The multi-hop reasoning is sound—linking the plan change to increased company expense due to shift from defined benefit to defined contribution is correct and well-explained. The logic that IRS limits apply to individual contributions while total company expense rises due to structural change is valid. (4) Despite the incorrect insertion of unverified 2023 data, the core facts—dates, plan changes, correct 2022 and 2024 expenses, and the overall conclusion about increased expense due to structural shift—are preserved. Hence, correctness is reduced mainly by quantitative inaccuracies, not qualitative or reasoning flaws. Contextual relevance is perfect as all parts of the question are addressed appropriately.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 485,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did AVGO's focus on Information Security as part of its Symantec Cyber Security portfolio evolve from 2022 to 2024, particularly in terms of its integration with AI and threat intelligence capabilities?",
      "original_answer": "In 2022, AVGO's Symantec Cyber Security portfolio included Information Security as one of its major offerings, focusing on protecting users and data across apps, devices, or networks with comprehensive threat protection and compliance. By 2024, AVGO significantly enhanced its Information Security solutions by integrating them into a broader Enterprise Security Portfolio that leveraged advanced AI, machine learning engines, and a global network of threat analysts to detect and respond to advanced targeted attacks. This evolution reflects a strategic shift toward AI-driven, integrated cyber defense solutions that go beyond traditional compliance to proactive threat intelligence and response capabilities.",
      "llm_answer": "In 2022, AVGO described its Information Security offering as a single‑policy, integrated solution that leveraged a global threat‑intelligence network and AI/machine‑learning engines to detect and respond to advanced attacks. By 2024 the language remained largely the same but added emphasis on an AI‑driven security console and single‑agent architecture, underscoring a deeper integration of AI and real‑time threat intelligence across all security layers, including information protection.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains some correct elements, such as the focus on AI, machine learning, and threat intelligence in AVGO's Information Security offerings. However, it misrepresents the 2022 state of the portfolio. According to the ground truth, in 2022, the Symantec Cyber Security portfolio emphasized comprehensive threat protection and compliance, but the LLM incorrectly claims that in 2022, AVGO already had an 'integrated solution' leveraging AI and global threat intelligence to detect advanced attacks—this level of AI integration is described in the ground truth as a 2024 enhancement, not a 2022 feature. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not compromised—this aspect is neutral and thus scored as 10. (3) The multi-hop reasoning is flawed: the question asks for evolution from 2022 to 2024, requiring accurate characterization of both time points. The LLM incorrectly projects 2024 capabilities back into 2022, failing to show the actual progression—this undermines the qualitative accuracy. The ground truth describes a strategic shift *toward* AI-driven solutions by 2024, implying earlier stages were less advanced, but the LLM suggests continuity with only incremental changes. (4) Contextual relevance is high because the answer addresses AI integration and threat intelligence in the context of AVGO’s Information Security evolution. However, due to the misrepresentation of the timeline and capabilities, the core factual correctness is significantly compromised, warranting a mid-low correctness score of 5.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 441,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "What was the financial impact of SPG's 2022 investment in J.C. Penney following the 2024 acquisition of SPARC Group, and how did SPG's ownership stake evolve through this transaction?",
      "original_answer": "SPG's 2022 investment in J.C. Penney led to a non-cash pre-tax gain of $100.5 million in 2024 when J.C. Penney acquired SPARC Group and was renamed Catalyst Brands. As a result of this transaction, SPG's ownership stake evolved into a 31.3% noncontrolling interest in Catalyst Brands, while also maintaining a 33.3% noncontrolling interest in SPARC Holdings, which now primarily holds a 25% interest in Catalyst Brands. This demonstrates how SPG's earlier investment in J.C. Penney directly influenced its financial position and stake in the newly formed entity post-acquisition.",
      "llm_answer": "The 2024 all‑equity acquisition of SPARC Group by J.C. Penney generated a non‑cash pre‑tax gain of **$100.5 million** for Simon Property Group (through its 33.3 % equity interest in SPARC Holdings).  As a result of the transaction, Simon’s ownership shifted from a 33.3 % non‑controlling interest in SPARC Holdings (the former owner of SPARC Group) to a **31.3 % non‑controlling interest in the newly formed Catalyst**, while SPARC Holdings now holds a 25 % interest in Catalyst.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $100.5 million non-cash pre-tax gain in 2024, SPG's 33.3% interest in SPARC Holdings, and the resulting 31.3% non-controlling interest in Catalyst Brands—all matching the ground truth. The evolution of ownership is accurately described. (2) All numeric values—$100.5 million, 33.3%, 31.3%, and 25%—are correct and contextually accurate. No calculation errors. Format variations (e.g., spacing in 'million') are acceptable. (3) The multi-hop reasoning is sound: the model correctly links SPG’s 2022 investment to the 2024 transaction, explains the ownership transformation via SPARC Holdings into Catalyst Brands, and captures the structural shift post-acquisition. However, it omits the explicit mention that J.C. Penney acquired SPARC Group and was renamed Catalyst Brands, which slightly weakens the narrative flow of the transaction. Also, the answer does not mention that SPARC Holdings now primarily holds a 25% interest in Catalyst Brands, though it notes the 25% ownership—missing some contextual completeness. (4) Despite minor omissions in structural detail, the core financial impact and ownership evolution are accurately conveyed with correct entities, dates, and figures. The answer is highly relevant and factually precise, warranting a high correctness score with a small deduction for incomplete synthesis of the corporate structure update.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 392,
        "total_tokens": 1665
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did ConocoPhillips' financial exposure through its guarantees to APLNG in 2024 compare to its 2023 position, and what does this indicate about its evolving risk profile tied to CBM production in Queensland, Australia?",
      "original_answer": "In 2023, ConocoPhillips had a 47.5% ownership stake in APLNG, which was actively producing coalbed methane (CBM) from the Bowen and Surat basins in Queensland, Australia. By 2024, ConocoPhillips had several guarantees tied to APLNG, including a $210 million guarantee with a carrying value of $14 million, a $610 million (up to $1.0 billion in case of intentional or reckless breach) liability tied to gas delivery commitments, and an additional $480 million in performance guarantees. This indicates a significant increase in financial exposure and risk tied to CBM production through APLNG, reflecting a deepened strategic commitment to the venture despite heightened liability.",
      "llm_answer": "In 2024 ConocoPhillips’ APLNG guarantees carried a maximum potential liability of about **$1.3 billion** (the sum of $210 m, $610 m and $480 m), compared with a lower, undisclosed exposure in 2023.  This rise in guarantee exposure signals an escalating risk profile linked to the company’s coal‑bed methane (CBM) production in Queensland, Australia.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the three guarantee amounts in 2024 ($210M, $610M, and $480M) and sums them to approximately $1.3 billion, which is quantitatively accurate. However, it omits the critical detail from the ground truth that the $610 million liability could increase to up to $1.0 billion in case of intentional or reckless breach—this cap is important context for understanding maximum potential exposure. The LLM also states that 2023 exposure was 'lower, undisclosed,' which is partially correct (the exact guarantee amounts were not disclosed in 2023), but fails to mention ConocoPhillips’ 47.5% ownership stake in APLNG in 2023, a key indicator of its prior financial position and risk. (2) The sum of $210M + $610M + $480M = $1.3B is correct, and all individual figures match the ground truth. However, the answer does not clarify that the $610M is already part of a tiered liability (up to $1B), leading to potential misinterpretation of total maximum exposure as $1.3B + $1B rather than recognizing the $1B as a conditional cap on the $610M. (3) The reasoning correctly infers increased risk in 2024 due to expanded guarantees and ties it to CBM production in Queensland, showing sound multi-hop synthesis between financial guarantees and operational activity. However, it misses the nuance that the 2023 risk was tied to equity ownership while 2024 risk shifts toward direct liability via guarantees, indicating a qualitative change in risk profile beyond just 'escalating.' (4) The answer remains highly relevant to the question, clearly addressing the comparison over time and the implication for risk. The omission of the 47.5% ownership and the conditional $1B cap reduces completeness and precision, but core financial figures and the overall directional conclusion are correct, warranting a score of 7 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 503,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did SPG's implementation of ASU 2020-04 in 2022 influence its compliance strategy with ASU 2021-01 in 2023, especially in light of the extended sunset date through December 31, 2024?",
      "original_answer": "In 2022, SPG implemented ASU 2020-04, electing expedients for transitioning certain debt instruments away from LIBOR to alternative benchmark indexes, with no material impact on financial statements. This early adoption allowed SPG to address reference rate reform challenges proactively. In 2023, SPG continued to comply with ASU 2021-01, which expanded the scope of ASU 2020-04 and introduced additional optional relief for derivative instruments affected by changes in reference rates. The sunset date extension to December 31, 2024 (via ASU 2022-06) provided SPG with additional time to manage contract modifications and hedging relationships affected by the transition, ensuring continued flexibility in debt management without disrupting financial reporting consistency.",
      "llm_answer": "SPG elected the optional expedients of ASU 2020‑04 in 2022 to transition certain debt instruments to alternative benchmark indexes, a move that “had no impact on our consolidated financial statements at adoption”【page_110】.  In 2023, the company applied the expanded scope of ASU 2021‑01—adding new optional relief for derivative instruments—while the sunset date for these reliefs was extended to December 31 2024 (per ASU 2022‑06)【page_167】.  Consequently, SPG’s 2023 compliance strategy involved continuing to use the combined optional relief from both updates for contract modifications and hedges made after December 31 2022, ensuring a smooth transition to new reference rates without material impact on its financial statements.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: SPG implemented ASU 2020-04 in 2022, electing expedients for transitioning debt instruments from LIBOR to alternative rates with no material impact on financial statements. In 2023, SPG applied ASU 2021-01, which expanded relief to derivatives, and benefited from the sunset extension to December 31, 2024, via ASU 2022-06. These details match the original answer exactly. (2) Quantitative accuracy is perfect: all dates (2022, 2023, December 31, 2024) are correct and properly attributed to the relevant ASUs. No numerical calculations are required, but temporal references are precise. (3) Multi-hop reasoning is sound: the model correctly links SPG’s 2022 adoption of ASU 2020-04 to its 2023 compliance strategy under ASU 2021-01, and integrates the impact of the sunset extension. The synthesis across ASUs and years is logically coherent. (4) The only minor shortcoming is a slight omission of the proactive strategic framing—i.e., that early adoption allowed SPG to 'address reference rate reform challenges proactively'—which adds contextual depth but does not alter the factual core. Otherwise, the answer is semantically equivalent, with appropriate use of citations (page references) and correct entity names, ASU codes, and financial terminology. Wording differences do not affect meaning. Thus, the answer is excellent but not perfect, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 414,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did Disney's use of firm commitments in foreign exchange hedging in 2023 relate to the changes in the Value at Risk (VAR) model outcomes in 2024, particularly given the exclusion of firm commitments from the VAR model and the $1.6 billion increase in foreign exchange hedge notional amounts year-over-year?",
      "original_answer": "In 2023, Disney had $8.3 billion in notional amounts of foreign exchange cash flow hedges, many of which were tied to firm commitments. These hedges were intended to offset fluctuations in the value of those commitments. However, the VAR model used in 2024 explicitly excluded firm commitments from its calculations, even though the total notional amount of foreign exchange hedges increased to $9.9 billion by 2024. Despite this increase in hedging activity, the VAR estimate of maximum one-day loss decreased from $284 million in 2023 to $255 million in 2024, primarily due to lower interest rate volatility. This suggests that while Disney increased its hedge coverage year-over-year, the risk profile as measured by VAR improved, but firm commitments were not factored into the model that determines this risk exposure.",
      "llm_answer": "Disney’s 2023 policy hedged firm commitments through forward and option contracts, and the notional amount of its net foreign‑exchange cash‑flow hedges rose from $8.3 billion to $9.9 billion—an increase of $1.6 billion (page 121).  However, the 2024 VAR model explicitly excludes forecasted transactions, firm commitments, and foreign‑currency receivables/payables (page 60), so this expanded hedging activity was not reflected in the VAR calculation, which fell from $284 million in 2023 to $255 million in 2024.  Consequently, the VAR estimate likely understates the risk exposure associated with the larger hedge of firm commitments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts: Disney's foreign exchange hedge notional amounts increased from $8.3 billion in 2023 to $9.9 billion in 2024, a $1.6 billion increase, and the VAR estimate decreased from $284 million to $255 million. These numbers match the ground truth exactly, with acceptable formatting. (2) Quantitative accuracy is perfect: the dollar amounts, year-over-year increase, and VAR figures are all correct and consistent with the original answer. (3) The multi-hop reasoning is largely sound: the LLM correctly notes that despite increased hedging of firm commitments in 2023, the 2024 VAR model excluded firm commitments and forecasted transactions, so the expanded hedging was not reflected in the VAR calculation. It also correctly observes the decrease in VAR. However, the LLM slightly misattributes the reason for the VAR decline by not mentioning the ground truth's key point—lower interest rate volatility—as the primary driver of the improved VAR, instead implying the exclusion of hedges caused the lower VAR. This is a minor reasoning gap. (4) The answer is contextually fully relevant, addressing all parts of the question: the use of firm commitments in 2023, the increase in hedge notional, the exclusion from the 2024 VAR model, and the resulting VAR outcome. The semantic meaning is nearly equivalent to the ground truth, with only a subtle but important omission in explaining why VAR decreased. Hence, correctness is high but not perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 415,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How did PEP's allocation to Real Estate Commingled Funds change from $221 million in 2022 to $162 million in 2023, and how does this reduction align with the broader reallocation of international plan assets, particularly given the increase in government securities from $736 million to $1,207 million over the same period?",
      "original_answer": "PEP reduced its allocation to Real Estate Commingled Funds within international plan assets from $221 million in 2022 to $162 million in 2023, a decline of $59 million. This decrease coincided with a broader reallocation of international plan assets, most notably a significant increase in government securities, which rose from $736 million in 2022 to $1,207 million in 2023—an increase of $471 million. This suggests a strategic shift toward more liquid or stable fixed-income investments at the expense of real estate exposure, potentially reflecting a more conservative posture or liquidity management objective in PEP's international pension portfolio.",
      "llm_answer": "PEP reduced its international plan allocation to real‑estate commingled funds from $221 million in 2022 to $162 million in 2023—a $59 million cut (2022 table, page 100; 2023 table, page 99).  This shift is part of a broader reallocation of international plan assets, as government securities rose from $736 million to $1,207 million (a $471 million increase), indicating a move toward more liquid, lower‑risk holdings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts: PEP reduced its allocation to Real Estate Commingled Funds from $221 million in 2022 to $162 million in 2023, a $59 million decrease, and government securities increased from $736 million to $1,207 million, a $471 million increase. All numbers and calculations are accurate. (2) Quantitative accuracy is perfect—dollar amounts and differences match the ground truth exactly, with acceptable formatting (e.g., $221 million). The $59M and $471M changes are correctly computed. (3) The reasoning is sound and captures the multi-hop synthesis: the reduction in real estate coincides with an increase in government securities, suggesting a strategic reallocation toward more liquid, lower-risk assets. The LLM correctly infers a shift in investment posture, though it omits the explicit mention of 'conservative posture or liquidity management objective' from the original, slightly reducing qualitative depth. (4) Contextual relevance is excellent—the answer directly addresses both parts of the question and maintains focus on PEP's international plan asset reallocation. The inclusion of document page references (though not required) adds credibility. The only minor gap is slightly less elaborated interpretation compared to the original, but the core reasoning is preserved. Thus, correctness is 9 due to full factual and quantitative alignment with a small deduction in qualitative nuance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 403,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How did the availability of shares under Tesla's 2019 Equity Incentive Plan in 2022 compare to 2024, and what does this indicate about the company's use of Stock Appreciation Rights as part of its equity compensation strategy over time?",
      "original_answer": "In 2022, Tesla reported that 49.0 million shares were reserved and available for issuance under the 2019 Plan, which includes Stock Appreciation Rights (SARs) as one of the grant types. By 2024, the number of shares reserved and available for issuance under the same plan had increased to 113.0 million. This significant increase suggests that Tesla expanded its capacity for equity compensation, including SARs, likely to continue incentivizing employees and executives amid growth or performance targets. The inclusion of SARs in the 2019 Plan indicates a strategic use of flexible equity instruments to align compensation with stock performance, and the larger share reserve in 2024 reflects an increased emphasis or anticipated usage of such instruments.",
      "llm_answer": "In 2022 Tesla had 113 million shares reserved and available for issuance under the 2019 Equity Incentive Plan, and that same 113 million‑share pool remained reserved and available in 2024【page_81 (2022)】【page_81 (2024)】.  Because the 2019 Plan includes stock‑appreciation rights (SARs)【page_83 (2024)】, the unchanged share pool indicates that Tesla has maintained a steady, stable reserve for SARs, reflecting a consistent use of SARs as a core element of its equity‑compensation strategy over time.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual errors in the reported number of shares available under Tesla's 2019 Equity Incentive Plan. It incorrectly states that 113 million shares were available in both 2022 and 2024. According to the ground truth, 49.0 million shares were available in 2022, increasing to 113.0 million in 2024. This reverses the actual trend and misrepresents the data. (2) Quantitative accuracy is severely compromised: the LLM assigns the 2024 figure to 2022, missing the significant increase over time. This error invalidates any comparison between years. The citation references (e.g., page_81) may point to real sections, but the data extracted is incorrect. (3) The reasoning is flawed due to incorrect input data. The LLM concludes that the share pool remained 'unchanged,' leading to the inference of a 'steady, stable reserve' and 'consistent use' of SARs. In reality, the more than doubling of available shares from 49M to 113M indicates a substantial expansion in equity compensation capacity, suggesting increased, not stable, emphasis on instruments like SARs. The multi-hop synthesis fails because the model did not correctly identify and compare the figures across years. (4) Contextual relevance is moderate—the answer addresses the right plan, mentions SARs, and attempts to interpret strategy—but the incorrect data renders the conclusion invalid. Due to major factual and inferential errors, the correctness score is low at 2, with similarly low quantitative and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 422,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How did the change in ConocoPhillips' valuation approach for its APLNG investment between 2022 and 2023 reflect the evolution of its strategic position in Queensland's LNG market?",
      "original_answer": "In 2022, ConocoPhillips recorded a $688 million noncash impairment charge to write down its APLNG investment to a fair value of $5,574 million, reflecting a market participant view that APLNG’s value had declined below its carrying value. This impairment was tied to Origin Energy’s decision to sell a 10% stake in APLNG for $1.645 billion, which triggered ConocoPhillips’ preemption right and signaled a reassessment of APLNG’s fair value. By 2023, the carrying value of the investment remained at $5,574 million, indicating that the market valuation had stabilized post-impairment. This evolution in valuation methodology and the strategic decision to exercise the preemption right show that ConocoPhillips sought to maintain or strengthen its position in Queensland’s LNG market despite short-term valuation pressures.",
      "llm_answer": "In 2022 ConocoPhillips recorded a $688 million impairment on its APLNG investment, reflecting a decline in fair value below carrying value and a cautious stance on Queensland’s LNG market【page_101】. By 2023 the company continued to apply fair‑value measurement to its equity‑method investments but did not record a further impairment for APLNG, indicating that the fair value had recovered or stabilized and that ConocoPhillips was now more confident in the Australian LNG opportunity【page_107】. This shift signals an evolution from a defensive view to a more assertive strategy in Queensland’s LNG sector.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $688 million impairment in 2022 and the absence of a further impairment in 2023, which aligns with the ground truth. However, it omits the key detail that the post-impairment fair value was $5,574 million — a critical quantitative anchor in the original answer. This omission affects completeness and precision. (2) The numeric values mentioned ($688 million, 2022 and 2023) are accurate and correctly attributed. The calculation implied — that the impairment reflected a write-down due to fair value falling below carrying value — is logically sound. However, the failure to report the actual fair value ($5,574 million) and the triggering event (Origin Energy’s $1.645 billion sale of a 10% stake) represents a significant gap in quantitative and qualitative accuracy. (3) The multi-hop reasoning is partially sound: the LLM infers a strategic shift from defensive to assertive based on the absence of a new impairment, which is plausible. But it misses the crucial link between Origin’s sale, the preemption right, and ConocoPhillips’ strategic decision to maintain its position — a core element of the original answer’s reasoning. (4) The contextual relevance is high, as the answer addresses the evolution of ConocoPhillips’ strategic position and ties valuation changes to market outlook. However, due to missing key facts and oversimplifying the causal mechanism, the correctness score is reduced to 7 — the core facts are directionally correct but lack critical detail and full synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 426,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did the reduction in the number of structured settlement annuities from 2022 to 2023 impact GE's exposure to reinvestment risk, given the persistent low interest rate environment?",
      "original_answer": "GE reinsured 27,400 structured settlement annuities in 2022, which decreased to 24,600 in 2023, indicating a reduction in the volume of long-term life-contingent liabilities. This reduction likely lessened GE's exposure to reinvestment risk, which is a key concern in a low interest rate environment where achieving targeted investment margins becomes more challenging. Despite this decline, structured settlement annuities still represent a significant long-duration liability with payments extending decades into the future, maintaining pressure on GE to manage its investment portfolio effectively to meet future obligations.",
      "llm_answer": "GE reduced its structured settlement annuity count from roughly 27,400 in 2022 to 24,600 in 2023, a decline of about 2,800 contracts【page_48】【page_18】.  The smaller liability pool means less cash must be reinvested over long periods, thereby lowering GE’s exposure to reinvestment risk in a persistently low‑rate environment【page_18】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the reduction in structured settlement annuities from 27,400 in 2022 to 24,600 in 2023, matching the ground truth exactly. The calculated decline of 2,800 contracts is accurate (27,400 - 24,600 = 2,800). 2) All numeric values and dates are correct, with no calculation or formatting errors. The use of 'roughly' is acceptable given the exact figures are provided. 3) The reasoning correctly links the reduction in long-term liabilities to lower reinvestment risk in a low interest rate environment, which aligns with the ground truth's logic. It captures the core causal relationship: fewer liabilities → less cash to reinvest over long durations → reduced reinvestment risk. 4) The answer is highly contextually relevant and factually precise. The only minor shortcoming is that it omits the point about structured settlements still representing significant long-duration liabilities that continue to pressure investment management, which slightly reduces completeness. However, the main thrust of the impact on reinvestment risk is fully and correctly addressed. Thus, while highly accurate and logically sound, it misses a nuance present in the original answer, justifying a 9 instead of a 10 on correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1249,
        "completion_tokens": 355,
        "total_tokens": 1605
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did NextEra Energy's operational exposure to Illinois transmission infrastructure in 2022 interact with the Clean Energy Law's rate-setting requirements and grid investment mandates, and how might this regulatory environment have contributed to the company's stock performance challenges by 2024?",
      "original_answer": "In 2022, NextEra Energy operated GridLiance infrastructure across Illinois and other Midwest states under FERC regulation, with assets in service dating back to 1960. This significant operational presence positioned NEE within the jurisdiction of Illinois regulatory frameworks. The Clean Energy Law, enacted in September 2021, imposed multiple requirements including a mandatory general rate case filing by January 20, 2023, accelerated amortization of excess deferred income taxes, and expanded grid investment mandates. These provisions directly affected utility operations and financial planning in Illinois. By 2024, NEE's stock performance showed decline, suggesting market concerns about how these regulatory changes might impact profitability, operational flexibility, and return on transmission investments in Illinois. The temporal chain reveals that NEE's physical infrastructure presence (2022) made it vulnerable to regulatory shifts (2022-2023), which then manifested in financial performance signals by 2024.",
      "llm_answer": "NextEra’s 100 % ownership of GridLiance, a 700‑mile FERC‑regulated transmission system that includes Illinois, tied the company to the Clean Energy Law’s new rate‑setting regime (page_216).  The law forced ComEd to move from a performance‑based formula rate to a general rate case or four‑year plan, procure carbon‑mitigation credits, accelerate amortization of deferred income taxes, and meet expanded energy‑efficiency and RPS targets—costs reflected in a $55 million increase to the 2022 revenue requirement (page_220) and higher capital expenditures (page_218).  These regulatory burdens added cost uncertainty and earnings pressure, contributing to investor concerns and stock performance challenges by 2024 (page_219).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies NextEra Energy's operational exposure via GridLiance in Illinois under FERC regulation and links it to the Clean Energy Law’s impact, aligning with the ground truth's core narrative. It appropriately connects regulatory changes to financial and stock performance outcomes by 2024. However, several specific inaccuracies affect quantitative precision. The claim that the Clean Energy Law caused a '$55 million increase to the 2022 revenue requirement' is not supported by the ground truth, which does not mention this figure or attribute such a cost increase directly to 2022. Additionally, the LLM attributes specific regulatory requirements (e.g., moving ComEd to a general rate case, procuring carbon-mitigation credits) to the law’s impact, but the ground truth does not specify ComEd’s involvement or these exact mechanisms—this introduces entity and policy detail not present in the verified answer. (2) The dollar amount ($55 million) and its attribution to 2022 are unverified and potentially incorrect; the ground truth mentions no specific financial figures related to revenue requirement increases. Dates are generally consistent—Clean Energy Law enacted in September 2021, with a rate case filing deadline of January 20, 2023, which the LLM indirectly acknowledges. However, the LLM implies these costs were already reflected in 2022, while the law was enacted in late 2021 and major requirements took effect afterward, creating a potential temporal misalignment. (3) The multi-hop reasoning is largely sound: the model connects infrastructure ownership → regulatory exposure → financial impacts → investor response → stock performance. This causal chain mirrors the ground truth’s logic. However, it incorrectly introduces ComEd as a regulated entity affected by the law, while the ground truth does not specify ComEd in relation to NextEra’s operations—GridLiance is the relevant asset, not ComEd. This undermines entity accuracy and weakens the reasoning chain. (4) Despite these issues, the LLM captures the essential qualitative trajectory: regulatory pressure in Illinois following the Clean Energy Law created cost uncertainty and earnings pressure, contributing to stock performance challenges by 2024. Wording differs but semantic meaning is partially aligned. The answer is contextually relevant and well-structured, but factual deviations—especially the unsupported $55M figure and misattribution to ComEd—prevent a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1475,
        "completion_tokens": 664,
        "total_tokens": 2139
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did the implementation of Medicare-related pricing provisions under the Inflation Reduction Act impact Amgen's exposure to pricing pressures in 2024 compared to 2023?",
      "original_answer": "In 2023, Amgen reported significant pricing pressures due to macroeconomic conditions, healthcare cost containment measures, and the IRA’s anticipated impact on drug pricing in Medicare Part B and D. By 2024, the IRA’s provisions began to take effect, including the government's ability to set prices for certain single-source drugs and biologics starting as early as nine or thirteen years post-FDA approval. This led to a more direct and structured pricing constraint on Amgen’s products, particularly as the law also redesigned the Part D benefit and introduced penalties for price increases above inflation. The evolution of these regulatory pressures under Medicare shows a shift from anticipated risk in 2023 to a more concrete and binding pricing framework in 2024, increasing Amgen’s exposure to pricing pressures through regulatory mandates.",
      "llm_answer": "Amgen’s 2024 Form 10‑K notes that the IRA’s Medicare‑price‑setting and inflation‑penalty rules are now affecting its portfolio—ENBREL is already subject to a lower Medicare Part D price and additional drugs (e.g., Otezla) are slated for price setting in 2025‑27, increasing the company’s exposure to pricing pressures【page_36】.  In 2023 the IRA’s Medicare provisions were only in early implementation, so Amgen’s exposure to such pricing pressures was comparatively lower【page_70】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. It correctly identifies that in 2023, the IRA's Medicare pricing provisions were in early implementation, resulting in lower exposure to pricing pressures for Amgen, while in 2024, these provisions began to take concrete effect, increasing pricing pressure. The mention of ENBREL being subject to lower Medicare Part D prices and Otezla facing future price setting (2025–27) adds specific product-level detail consistent with the evolving regulatory impact. All entities (Amgen, IRA, Medicare Part D, ENBREL, Otezla), years (2023, 2024, 2025–27), and mechanisms (price setting, inflation penalties) are correctly identified. There are no numerical inaccuracies—dates and timelines are qualitatively correct (no conflicting figures). The reasoning reflects sound multi-hop synthesis: connecting IRA provisions to specific drugs, recognizing the shift from anticipated (2023) to actual (2024) impact, and linking policy changes to increased exposure. The only minor limitation is that it does not explicitly mention the broader structural changes like the Part D benefit redesign or the nine/thirteen-year approval thresholds noted in the original, which slightly reduces completeness in qualitative depth. However, the core factual and inferential content is semantically equivalent and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 382,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did the change in the percentage of proved reserves reviewed by DeGolyer and MacNaughton from 2023 to 2024 reflect a shift in ConocoPhillips' reliance on third-party validation of reserves estimation processes, and what might this indicate about the evolution of their internal controls?",
      "original_answer": "In 2023, DeGolyer and MacNaughton (D&M) reviewed processes and controls used to assess over 90% of ConocoPhillips' proved reserves, while in 2024, this percentage dropped to over 85%. This decrease suggests a potential shift in ConocoPhillips' reliance on third-party validation of reserves estimation processes, possibly indicating increased confidence in internal controls or a strategic decision to reduce external oversight. The continued involvement of D&M as a senior representative within the internal review team and their inclusion as Exhibit 99 in the 2024 10-K filing shows that the firm remains a key component of the reserves reporting framework, but the reduced scope of their review could signal an evolution in how internal controls are being applied across business units.",
      "llm_answer": "In 2023, ConocoPhillips disclosed that DeGolyer & MacNaughton (D&M) reviewed the processes used to assess **over 90 %** of its proved reserves, whereas in 2024 that coverage fell to **over 85 %** (page 140 for 2023 and page 138 for 2024). The modest decline signals a deliberate shift toward greater reliance on internal expertise and confidence in its own controls, while still maintaining substantial third‑party oversight. This evolution suggests that the company’s internal reserve‑estimation controls have strengthened, enabling it to reduce external validation without compromising compliance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key percentages from 2023 (over 90%) and 2024 (over 85%) with accurate directional change (a decrease), matching the ground truth. The citation of specific 10-K pages (140 for 2023, 138 for 2024) adds precision and aligns with typical disclosure locations, though exact page numbers were not in the ground truth; this is acceptable as supplementary detail. (2) Quantitatively, all numbers are accurate: 'over 90%' and 'over 85%' are correctly reported, and the interpretation of a 'modest decline' is reasonable given the 5 percentage point reduction. No calculations are required, but the comparison is sound. (3) The reasoning correctly infers a shift toward greater internal confidence and stronger internal controls, which is a valid interpretation supported by the reduced third-party review scope. The LLM captures the multi-hop logic: decreased D&M coverage → reduced reliance on external validation → implication of improved internal controls. However, it omits a minor but relevant point from the original answer: D&M’s continued role as a senior representative in the internal review team and their inclusion as Exhibit 99 in the 2024 10-K, which underscores ongoing importance despite reduced coverage. This omission slightly weakens completeness but does not invalidate the core conclusion. (4) The answer is contextually relevant, directly addressing both parts of the question: the shift in reliance on third-party validation and what it indicates about internal controls. Wording differs but semantic meaning is equivalent. Overall, the answer is factually correct, well-reasoned, and only slightly less complete than the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 465,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did the governance risks associated with META's Class A common stock in 2023 relate to the structural relationship with Class B common stock, and how did this dual-class framework impact META's shareholder dynamics as disclosed in 2024?",
      "original_answer": "In 2023, META's Class A common stock was negatively impacted by its status as a 'controlled company,' which exempted it from certain Nasdaq corporate governance requirements and concentrated voting power with major stockholders. This governance structure was tied to the dual-class framework where Class B shares, convertible to Class A, held 10 votes per share, giving controlling stockholders disproportionate influence. By 2024, the company disclosed that this structure remained intact, with 343,761,117 shares of Class B common stock outstanding, continuing to affect shareholder dynamics and potentially influencing investor perception and stock performance.",
      "llm_answer": "In 2023 Meta disclosed that its dual‑class structure concentrates voting power in Class B shares (ten votes per share versus one for Class A), creating governance risks for Class A holders by limiting their influence over corporate matters (page 49). The 2024 filing confirms that the dual‑class framework persists, with 343 million Class B shares (ten votes each) giving Mr Zuckerberg and other holders a majority of voting power, thereby shaping shareholder dynamics by restricting the ability of Class A investors to affect corporate decisions and potentially reducing the attractiveness of Class A shares (page 1).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the dual-class structure with Class B shares having 10 votes per share and Class A having 1 vote is accurately described, and the 2024 disclosure of approximately 343 million Class B shares outstanding matches the ground truth value of 343,761,117 (rounded appropriately). The years (2023 and 2024) are correctly attributed to the respective disclosures. (2) Quantitative accuracy is excellent: the number of Class B shares is correctly reported as ~343 million, which is a valid rounding of 343,761,117. No calculations were required, but the representation is precise. (3) Multi-hop reasoning is sound: the answer connects the 2023 governance risks (concentration of voting power, reduced influence for Class A holders) with the 2024 continuation of the structure, showing how the dual-class framework impacts shareholder dynamics over time. It correctly identifies the ongoing influence of major stockholders, particularly Mr. Zuckerberg, though the original answer does not name him—this addition is plausible but not verifiable from the ground truth provided. (4) The answer is semantically equivalent to the original: it captures the controlled company status implications, exemption from Nasdaq rules (implied via governance risks), and impact on investor perception and stock attractiveness. The only minor gap is the lack of explicit mention of 'controlled company' status and Nasdaq exemption, though the effect (limited influence for Class A) is clearly conveyed. Overall, the response is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 451,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did SPG's use of accounting standard updates related to reference rate reform in 2022 influence its compliance approach with ASU 2020-04 in 2023, particularly regarding the transition of debt instruments to alternative benchmark indexes?",
      "original_answer": "In 2022, SPG applied ASU 2021-01, which expanded the scope of ASU 2020-04 to include derivatives, allowing the company to utilize optional expedients for easing the transition away from LIBOR in its financial reporting. This early adoption enabled SPG to prepare for broader compliance with ASU 2020-04, which was extended through December 31, 2024. By 2023, SPG had fully elected the expedients under ASU 2020-04 in conjunction with transitioning certain debt instruments to alternative benchmark indexes. The company reported no material impact on its consolidated financial statements at adoption, indicating a smooth integration of these accounting updates. This shows that SPG's early application of ASU 2021-01 in 2022 facilitated a seamless compliance process under ASU 2020-04 in 2023, particularly in managing the transition of debt instruments.",
      "llm_answer": "In 2022, SPG elected the optional expedients under ASU 2020‑04 to transition certain debt instruments to alternative benchmark indexes, reporting no material impact on its financial statements (SPG 10‑K 2022, pp. 112‑116).  The 2022 update (ASU 2022‑06) extended the sunset date to December 31, 2024, allowing SPG to continue applying the same expedients in 2023.  Consequently, in 2023 SPG’s compliance approach remained unchanged— it kept using the ASU 2020‑04 expedients to move debt to alternative rates, with no material effect on its consolidated statements (SPG 10‑K 2023, pp. 112‑116).",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly states that SPG elected expedients under ASU 2020-04 in 2022, while the ground truth specifies that SPG applied ASU 2021-01 in 2022, which expanded the scope of ASU 2020-04 to include derivatives. The LLM also references ASU 2022-06, which is not mentioned in the original answer and does not align with the knowledge graph—this is a critical error. The sunset date extension to December 31, 2024, is correctly noted, but it is falsely attributed to ASU 2022-06 rather than being a continuation of ASU 2020-04 as clarified by ASU 2021-01. (2) Quantitatively, the dates (2022, 2023, December 31, 2024) and the 'no material impact' conclusion are consistent with the original answer, so some numeric elements are accurate. However, the misattribution of the ASU updates undermines the factual foundation. (3) The multi-hop reasoning is flawed: the LLM fails to correctly trace the influence of ASU 2021-01 on SPG’s 2023 compliance approach under ASU 2020-04. Instead, it assumes SPG directly applied ASU 2020-04 in 2022 and continued unchanged, missing the causal link where early adoption of ASU 2021-01 facilitated smoother 2023 compliance. This breaks the logical chain required by the question. (4) Contextual relevance is high—the answer addresses the transition of debt instruments, compliance approach, and financial impact—but due to incorrect accounting standard references and flawed causality, the qualitative and overall correctness scores are significantly reduced.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 429,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did the reduction in the number of communications sites securing the Series 2015-2 Notes from 2022 to 2023 affect AMT's rights under the associated management agreement in terms of excess cash flow availability?",
      "original_answer": "In 2022, the Series 2015-2 Notes were secured by 3,531 communications sites, while in 2023, this number decreased to 3,343 sites. This reduction in the asset base directly affected the cash flows available to support the notes. Since the management agreement rights were tied to these secured sites, the smaller number of sites in 2023 likely reduced the potential for excess cash flows after debt servicing, thereby limiting the value of AMT’s rights under the management agreement. The filings explicitly state that AMT holds the right to receive excess cash flows not needed to service the securitized debt, and with fewer sites generating income, the amount of such excess cash flows would be proportionally lower in 2023 compared to 2022.",
      "llm_answer": "The 2022 10‑K states the Series 2015‑2 Notes were secured by mortgages on **3,531** communications sites (page 117), while the 2023 10‑K shows the same notes are now secured by mortgages on **3,343** sites (page 112).  The management agreement that governs the release of excess cash flow is unchanged – AMT can receive excess cash flow only when the debt‑service coverage ratio (DSCR) and other covenants are met, and the reduction in collateral does not alter those conditions (see page 114).  Thus, the drop in site count did not affect AMT’s rights to excess cash flow under the management agreement.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "(1) The LLM correctly identifies the number of communications sites securing the Series 2015-2 Notes in both 2022 (3,531) and 2023 (3,343), matching the ground truth exactly. These quantitative figures are accurate and properly cited from the respective 10-K filings. However, the LLM's qualitative reasoning and conclusion contradict the ground truth. While it correctly notes that the management agreement terms (e.g., DSCR covenants) did not change, it incorrectly concludes that the reduction in sites had no effect on AMT’s rights to excess cash flow. The original answer clarifies that although the contractual rights remain, the economic value of those rights is diminished due to a smaller asset base generating less cash flow. The LLM fails to recognize this key distinction between legal rights and economic availability of excess cash flow. (2) All numbers are correct: 3,531 in 2022 and 3,343 in 2023 — a reduction of 188 sites — is accurately reflected. (3) The multi-hop reasoning is flawed: the model accesses the correct data points but fails to synthesize the financial implication — fewer sites mean lower total cash flow generation, which reduces the pool from which excess cash flow can be derived, even if the distribution mechanism remains unchanged. This represents a failure in financial reasoning despite correct data retrieval. (4) The contextual relevance is moderate because the answer addresses the management agreement and excess cash flow, but it misinterprets the nature of the impact (focusing on contractual terms rather than economic effect), leading to a substantively incorrect conclusion. Hence, while quantitatively accurate, the answer is qualitatively and factually deficient in its core inference.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 471,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did Chevron's 2023 acquisition of Renewable Energy Group, Inc. influence its 2024 reliance on carbon credits, particularly in light of the $10 billion lower carbon investment plan announced in 2021?",
      "original_answer": "In 2023, Chevron's acquisition of Renewable Energy Group, Inc. (REG) significantly expanded its renewable fuels production capacity and carbon credit generation activities, aligning with its broader lower carbon strategy. By 2024, REG was producing most of Chevron’s renewable fuels and generating a substantial portion of its carbon credits. This shift was supported by Chevron’s $10 billion planned capital spend through 2028 on lower carbon investments, announced in 2021, which emphasized growth in carbon credit generation and other lower carbon business lines. Chevron's 2024 disclosures also highlighted increased dependency on the availability and acceptability of cost-effective, verifiable carbon credits — a direct outcome of the strategic pivot initiated in 2023 through the REG acquisition.",
      "llm_answer": "Chevron’s 2023 acquisition of Renewable Energy Group (REG) – completed in 2022 – expanded its renewable‑fuel portfolio and markedly boosted its carbon‑credit generation capacity【page_36 2023】【page_37 2023】.  In 2024 the company’s reliance on carbon credits grew as part of its lower‑carbon strategy, a strategy that is funded by the $10 billion lower‑carbon investment plan announced in 2021 (≈$8 billion earmarked for renewable fuels and carbon‑credit activities, with REG contributing roughly $2.9 billion of that spend)【page_36 2024】.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies, particularly in quantitative details. It incorrectly states that the $10 billion lower-carbon investment plan includes '$8 billion earmarked for renewable fuels and carbon-credit activities, with REG contributing roughly $2.9 billion of that spend' — this level of granular allocation is not present in the original answer and introduces unsupported specifics. The original answer mentions the $10 billion plan through 2028 but does not break it down by sub-allocations or attribute a $2.9 billion portion to REG. Additionally, the LLM claims the acquisition was 'completed in 2022' while the question and original answer clearly state it occurred in 2023 — a critical factual error in timing. (2) The mention of 'page_36 2023' and 'page_37 2023' citations suggests document grounding, but the numbers cited ($8 billion, $2.9 billion) are not corroborated by the ground truth and represent over-specific fabrication or misinterpretation. The original answer does not include any such figures, making these quantitatively inaccurate. (3) The multi-hop reasoning is partially sound: the model correctly links the 2023 acquisition of REG to increased carbon credit reliance in 2024 and ties it to the 2021 $10 billion plan. It captures the strategic alignment and cause-effect relationship between the acquisition and lower carbon strategy, showing adequate synthesis across time and entities. (4) Despite the reasoning being logically coherent and contextually relevant, the introduction of incorrect dates and fabricated financial breakdowns significantly undermines factual correctness. The core idea — that the REG acquisition boosted carbon credit generation and increased Chevron's reliance on credits within the framework of its long-term investment plan — is accurate and well-contextualized, warranting moderate scores in qualitative accuracy and high relevance. However, the quantitative inaccuracies drag down the overall correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 541,
        "total_tokens": 1890
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did the elimination of Class B common stock between 2022 and 2024 affect the governance structure and shareholder equity distribution for Class A common stockholders at CMCSA?",
      "original_answer": "In 2022, CMCSA disclosed that Class B common stock had only 3 record holders and carried limited voting rights tied to specific corporate actions, such as mergers or amendments to the certificate of incorporation. By 2024, Class B common stock was no longer present in the capital structure, as shown by its disappearance from the equity section of the balance sheet. This structural change concentrated voting power exclusively among Class A common stockholders, who retained full voting rights on all matters. Concurrently, CMCSA's total equity increased from $82.703 billion in 2023 to $85.560 billion in 2024—a $2.857 billion increase—suggesting that the removal of Class B shares may have simplified governance while enhancing equity value for remaining shareholders.",
      "llm_answer": "The 2024 10‑K shows that Comcast’s Class B shares had 15 votes each and represented one‑third (33 ⅓ %) of the combined voting power of all common stock, while Class A shares held the remaining two‑thirds (66 ⅓ %)【page 38】.  By eliminating the Class B class, all voting rights were consolidated into Class A, giving those holders the full voting power that had previously been shared.  The equity statement also lists only 9.4 million Class B shares outstanding versus nearly 4 billion Class A shares【page 67】; retiring those shares removed a small but distinct equity component, thereby increasing the proportion of total equity attributable to Class A shareholders and simplifying the equity structure.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Class B common stock had limited voting rights tied to specific corporate actions (e.g., mergers or charter amendments), not 15 votes per share or 33⅓% of total voting power as claimed. The ground truth states that Class B had only 3 record holders in 2022 and was eliminated by 2024, but the LLM incorrectly asserts that Class B had 9.4 million shares outstanding in 2024, which contradicts the disappearance of the class from the capital structure. Additionally, the LLM misrepresents the voting power distribution: Class A did not hold 66⅔% of voting power—rather, after elimination, Class A became the sole voting class. (2) Quantitative inaccuracies include the false claim of 9.4 million Class B shares in 2024 (absent in ground truth), incorrect voting power percentages (33⅓% and 66⅔%), and no mention of the actual equity increase from $82.703B to $85.560B ($2.857B), which is central to the original answer. The LLM fails to report any numerical change in shareholder equity despite this being a key part of the impact on equity distribution. (3) The multi-hop reasoning is flawed: the model incorrectly infers that retiring a small number of shares increased Class A's equity proportion without referencing actual balance sheet data or the $2.857B equity increase. It also fabricates structural details (e.g., 15 votes per share) not present in the ground truth, suggesting reliance on hallucinated or incorrect data. (4) While the LLM correctly identifies that eliminating Class B consolidated voting power into Class A and simplified the structure, this partial conceptual understanding does not compensate for the extensive factual and numerical errors. The contextual relevance is moderate because it addresses governance and equity distribution, but the incorrect data undermines the entire analysis. Scores reflect severe quantitative and qualitative inaccuracies despite some relevant themes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 542,
        "total_tokens": 1919
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did MetLife's 2023 update to incidence rates impact its long-term care insurance reserves, given the company's 2022 morbidity assumptions and the inclusion of incidence as a core component of morbidity risk?",
      "original_answer": "In 2022, MetLife disclosed that its future policy benefit (FPB) reserves for long-term care insurance were calculated using actuarial assumptions that included morbidity, which encompasses the frequency and severity of claims, as well as claim incidence, utilization, and continuance. These assumptions were critical in estimating the present value of future benefits. In 2023, MetLife updated its biometric assumptions, noting an increase in incidence rates, which directly raised the expected cost of care and thus increased FPB reserves. This change reflects the direct influence of incidence — a core component of morbidity — on reserve levels, as originally framed in the 2022 disclosures. The increase in incidence rates in 2023, despite offsetting reductions in claim utilization experience, shows how evolving morbidity factors can materially affect reserve calculations over time.",
      "llm_answer": "MetLife’s 2023 update raised the incidence component of its morbidity assumptions—incidence is a core element of morbidity risk in the 2022 assumptions.  The higher incidence increased expected future benefit payments for long‑term‑care contracts, which in turn lifted the net liability for future policy benefits from $13.8 billion in 2022 to $15.2 billion in 2023, partially offset by lower utilization but ultimately resulting in a higher reserve.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the core reasoning — that MetLife's 2023 update increased incidence rates, a key part of morbidity assumptions first disclosed in 2022, leading to higher future policy benefit (FPB) reserves due to increased expected benefit payments. It also correctly notes that this increase was partially offset by lower utilization, aligning with the ground truth. However, the major factual error lies in the specific dollar amounts: the LLM claims FPB reserves rose from $13.8 billion in 2022 to $15.2 billion in 2023. The ground truth does not provide these specific figures, and no such numbers are present in MetLife’s public 2022 or 2023 SEC filings for long-term care insurance reserves. This introduces a significant quantitative inaccuracy. (2) The numbers $13.8B and $15.2B are not supported by the original answer or known public disclosures; thus, the quantitative accuracy is low. There is no verification that these figures reflect actual reported reserves, making the calculation (a $1.4B increase) speculative. (3) The multi-hop reasoning is sound: the model correctly links 2022 morbidity assumptions (which include incidence) to the 2023 update increasing incidence, leading to higher reserves despite offsetting factors. This demonstrates proper synthesis across time and concepts. (4) While the qualitative reasoning and contextual relevance are strong — capturing the causal chain and key risk components — the inclusion of fabricated numerical data severely undermines factual correctness. A score of 6 reflects that the conceptual framework is correct but the answer is materially misleading due to unsupported figures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 459,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Duke Energy Progress' 2024 consolidation of DEPSC SF relate to the evolution of storm recovery bond issuances compared to 2023, and what does this indicate about their expansion of storm cost financing into South Carolina?",
      "original_answer": "In 2023, Duke Energy Progress issued $770 million in storm recovery bonds through DEPNCSF to finance unrecovered storm costs from 2018 and 2019 in North Carolina. By 2024, the company expanded its storm recovery financing to South Carolina through the formation and bond issuance by DEPSC SF, which issued $177 million in bonds to recover costs from storms spanning 2014 to 2022. The consolidation of DEPSC SF in 2024 indicates Duke Energy's strategic extension of its storm cost recovery mechanism into a new geographic region, using the same financial structure of bankruptcy-remote special purpose entities secured by non-bypassable customer charges.",
      "llm_answer": "In 2024, Duke Energy Progress consolidated the newly‑formed DEPSC SF, which had issued $177 million of senior secured bonds in April 2024, creating a new storm‑recovery VIE for South Carolina (page 205).  Compared with 2023, when only the North‑Carolina entities (DECNCSF and DEPNCSF) existed and carried $208 million and $680 million of long‑term debt, the 2024 balance sheet shows DEPSC SF with $163 million of long‑term debt and no 2023 counterpart—demonstrating a deliberate expansion of storm‑cost financing into South Carolina.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 2024 consolidation of DEPSC SF and its role in expanding storm recovery financing to South Carolina, which aligns with the ground truth. It also correctly notes the $177 million bond issuance in April 2024. However, it incorrectly states that DEPNCSF had $680 million in long-term debt in 2023, whereas the ground truth specifies a $770 million storm recovery bond issuance (not necessarily all long-term debt), creating a significant discrepancy. Additionally, the LLM introduces DECNCSF with $208 million in debt, which is not mentioned in the ground truth and appears to be a confusion with another entity or misinterpretation of debt breakdowns. The reported $163 million in long-term debt for DEPSC SF contradicts the $177 million bond issuance, introducing another numerical inaccuracy. (2) The bond amount for DEPSC SF is stated as $177 million in both the ground truth and partially in the LLM (in text), but the balance sheet figure cited ($163 million) conflicts with this, suggesting either a reporting lag or error. The 2023 North Carolina issuance is misrepresented: $770 million total is correct in ground truth, but LLM splits it into $680M and $208M across two entities not both mentioned in the original, undermining quantitative accuracy. (3) The multi-hop reasoning is partially sound—the model correctly infers that the creation of DEPSC SF represents a geographic expansion of Duke Energy’s storm financing model into South Carolina, and it draws a valid comparison between 2023 (NC-only) and 2024 (adding SC). However, it fails to mention the recovery of costs from storms between 2014–2022 in SC, which is a key detail showing the retrospective scope of the new mechanism. (4) Contextual relevance is high because the answer addresses the core evolution of storm financing and the significance of the DEPSC SF consolidation. Despite incorrect figures and entity mix-ups, the central conclusion about strategic expansion is supported. Scores reflect mostly correct reasoning undermined by critical numerical and entity inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 566,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did the change in NKE's foreign currency exposure related to NTC-sourced product costs between 2022 and 2023 affect the company's hedging strategy for non-functional currency denominated product purchases?",
      "original_answer": "In 2022, NKE's foreign currency exposure from NTC-sourced product costs stemmed from NTC selling products to NIKE entities in their respective functional currencies, creating foreign currency exposure for NTC when those currencies differed from the U.S. Dollar. NKE managed this exposure through a foreign currency adjustment program with factories and the use of currency forward and option contracts, which were generally accounted for as cash flow hedges. By 2023, NKE continued to rely on the NTC for product sourcing but expanded its hedging program to include more comprehensive cash flow hedge accounting, particularly for product cost exposures generated through non-functional currency denominated purchases. This evolution indicates a strategic shift toward more structured and formalized hedging of transactional exposures, especially as NKE emphasized the use of derivatives to manage the variability in product costs due to exchange rate fluctuations. The company also clarified its accounting treatment for ineffective hedge results and discontinued hedges, suggesting a more refined and risk-aware approach to managing foreign exchange risk in 2023.",
      "llm_answer": "Between 2022 and 2023 Nike’s foreign‑currency exposure from NTC‑sourced product costs increased, as shown by a jump in hedging gains/losses on cost of sales from a $23 million loss in 2022 to a $581 million gain in 2023. To offset the larger exposure, the company expanded its use of foreign‑currency forwards and options for non‑functional‑currency product purchases, raising the notional amount of cash‑flow hedges and the hedge‑coverage ratio. This shift helped the firm better insulate inventory costs from U.S. dollar fluctuations.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative claims. The ground truth does not mention any specific hedging gains or losses on cost of sales, nor does it state a $23 million loss in 2022 or a $581 million gain in 2023. These figures are entirely absent from the original answer and cannot be verified, making them likely fabricated. There is also no mention of changes in notional amounts or hedge-coverage ratios in the ground truth. (2) The quantitative accuracy is low because the core numbers presented—$23M loss and $581M gain—are not supported by the original answer. These figures imply a level of financial detail that is not present in the ground truth and introduce false precision. (3) The qualitative reasoning partially aligns with the original answer: the LLM correctly identifies that NKE uses NTC-sourced product costs, that foreign currency exposure exists, and that forwards and options are used in hedging. It also correctly notes an expansion in hedging activity. However, it fails to capture the key nuance from the original answer—that the 2023 change involved more comprehensive cash flow hedge accounting, clearer treatment of ineffective hedges, and a strategic shift toward formalized hedging practices. The LLM reduces this to a simplistic 'increase in exposure → more hedging' narrative without addressing the accounting and structural refinements. (4) Contextual relevance is high because the answer addresses the core topic—NKE's foreign currency exposure from NTC-sourced costs and the evolution of hedging strategy. However, the inclusion of unsupported numbers undermines correctness. The answer synthesizes some correct concepts but fails on factual fidelity, especially in the critical financial data, warranting a moderate score for qualitative accuracy and a low score for quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 512,
        "total_tokens": 1952
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did SPG's adoption of ASU 2021-01 in 2022 influence its application of ASU 2020-04 for debt instrument modifications in 2023, particularly in the context of transitioning away from LIBOR-based financing?",
      "original_answer": "In 2022, SPG adopted ASU 2021-01, which expanded the scope of ASU 2020-04 to include derivatives, thereby enabling the company to apply optional expedients for contract modifications related to reference rate reform. This adoption allowed SPG to transition certain debt instruments to alternative benchmark indexes in 2023 under the extended guidance window that now went through December 31, 2024. Despite these actions, SPG reported no material impact on its consolidated financial statements at adoption or during the subsequent application in 2023, indicating that the transition was effectively managed without significant financial disruption.",
      "llm_answer": "SPG adopted ASU 2021‑01 in 2022, which expanded the reference‑rate reform scope to include derivatives.  This enabled the company to use the optional expedients from ASU 2020‑04 to modify its LIBOR‑based debt in 2023, transitioning those instruments to alternative benchmark indexes without materially impacting its financial statements【page_110】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core elements of the ground truth. (1) It correctly identifies SPG's adoption of ASU 2021-01 in 2022 and explains that this expanded the scope of ASU 2020-04 to include derivatives, enabling the use of optional expedients for modifying LIBOR-based debt in 2023. It accurately notes the transition to alternative benchmark rates and the absence of material impact on financial statements. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised; all dates (2022 adoption, 2023 application) are correct. (3) The multi-hop reasoning is sound: the model correctly links the adoption of ASU 2021-01 to the expanded applicability of ASU 2020-04, and then to the practical effect on debt modifications during the LIBOR transition. The only minor omission is that the LLM answer does not mention the extension of the guidance window to December 31, 2024, which is included in the original answer and adds context about the timing flexibility enabled by the adoption. This is a small but relevant detail in the full regulatory context. (4) Despite this omission, the LLM answer remains semantically equivalent in its key claims and is fully relevant to the question. The citation to 'page_110' suggests grounding in source material. Overall, the response is factually correct, well-reasoned, and contextually appropriate, warranting a high score with only a slight deduction for completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 413,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did ConocoPhillips' increased ownership stake in APLNG from 2022 to 2023 impact its operational exposure to Queensland, Australia, and what does this shift indicate about its strategic positioning in the Australian LNG market?",
      "original_answer": "In 2022, ConocoPhillips exercised its preemption right to purchase an additional 10% interest in APLNG, increasing its stake and resulting in a write-down of the investment to $5,574 million due to fair value considerations. APLNG operates in Queensland, Australia, where it produces coal bed methane (CBM) and exports LNG, with operations split between production (operated by Origin Energy) and liquefaction (operated by ConocoPhillips). By 2023, ConocoPhillips' ownership in APLNG had formally increased to 47.5%, reflecting a strategic move to deepen its presence in the region. This growing stake correlates with a stronger operational footprint in Queensland, signaling a long-term commitment to the Australian LNG market. The evolution of this investment suggests a deliberate strategy to consolidate influence over APLNG’s LNG export capabilities and enhance its position in the Asia-Pacific energy trade.",
      "llm_answer": "ConocoPhillips increased its stake in the APLNG joint venture from 37.5 % in 2022 (page 101) to 47.5 % in 2023 (page 91).  This larger share gives the company a greater operational footprint in Queensland, Australia, because it now controls a larger portion of the CBM production and LNG‑processing facility that supplies the Asia‑Pacific market.  The move signals ConocoPhillips’ intent to strengthen its position in the Australian LNG market and to expand its LNG portfolio as part of its broader Asia‑Pacific growth strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the increase in ConocoPhillips' stake in APLNG from 37.5% in 2022 to 47.5% in 2023, which aligns with the ground truth. The operational impact on Queensland is accurately described in terms of increased exposure to CBM production and LNG processing. The strategic implication—strengthening presence in the Australian LNG market and Asia-Pacific growth—is also consistent with the original answer. However, the LLM omits the key detail about the $5,574 million write-down due to fair value considerations in 2022, which is a material financial event tied to the ownership change. 2) Quantitatively, the percentages (37.5% to 47.5%) are correct and match the ground truth. The years (2022 to 2023) are accurate. No calculations are required, but the numerical progression is sound. 3) The multi-hop reasoning is strong: the model connects ownership increase → greater operational control in Queensland → strategic positioning in Australian LNG and Asia-Pacific markets. It correctly identifies APLNG’s location and operations in Queensland and links the stake increase to broader strategic goals. The only gap is the missing write-down, which weakens completeness but not core reasoning. 4) The answer is semantically equivalent in intent and meaning to the ground truth, with only minor omission of a financial detail. Contextual relevance is excellent, directly addressing both parts of the question: impact on operational exposure and strategic positioning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 410,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did PayPal's launch of PYUSD in 2023 influence its custodial risk exposure and regulatory obligations in 2024, particularly in relation to third-party custodians?",
      "original_answer": "In 2023, PayPal identified operational disruption as a key risk, especially in the context of strategic transactions and third-party dependencies such as custodians (PYPL_10k_2023.pdf:page 27:chunk_1). The company specifically noted that operational disruptions at custodians could result in customer asset losses, reputational damage, and financial exposure (PYPL_10k_2023.pdf:page 20:chunk_1). In 2024, following the August 2023 launch of PYUSD, PayPal's 10-K filing highlighted an expanded dependency on custodian partners and the PYUSD Issuer, noting that financial and third-party risks related to cryptocurrency custody could expose the company to loss, regulatory scrutiny, and reputational harm (PYPL_10k_2024.pdf:page 18:chunk_1). The evolving regulatory landscape around stablecoins introduced additional compliance obligations, potential fines, and the need for operational changes, which directly increased PayPal’s custodial risk exposure and regulatory costs in 2024.",
      "llm_answer": "The 2023 launch of PYUSD added a stable‑coin that is held by third‑party custodians, thereby expanding PayPal’s custodial‑risk exposure to theft, loss, insufficient insurance, and the possibility that the PYUSD issuer or its custodians fail to maintain adequate reserves or controls. In 2024, PayPal’s risk‑factor disclosures note that this exposure is coupled with heightened regulatory obligations—evolving stable‑coin rules, anti‑money‑laundering and sanctions compliance, and potential SEC scrutiny—requiring the company to ensure its custodians meet regulatory oversight, capital, audit and cybersecurity standards and to monitor for operational disruptions that could trigger regulatory or enforcement actions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: the 2023 launch of PYUSD, increased custodial risk exposure due to third-party custodians, risks of theft, loss, inadequate reserves, and regulatory obligations in 2024. The mention of regulatory scrutiny (e.g., AML, sanctions, SEC) matches the evolving compliance landscape for stablecoins as noted in the original. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or ground truth, so quantitative accuracy is not applicable—no errors present. (3) Multi-hop reasoning is sound: the model correctly links PYUSD’s 2023 launch to increased dependency on custodians and the PYUSD issuer, and synthesizes how this led to greater regulatory and operational risk in 2024, drawing from both years’ 10-Ks. (4) The LLM captures all key points from the original answer—expanded third-party risk, operational disruption, regulatory scrutiny, compliance obligations—though it omits a minor detail about 'customer asset losses' explicitly leading to financial exposure, which is implied through 'theft, loss'. Wording differs but semantic meaning is equivalent. No factual inaccuracies. One point deducted from qualitative accuracy for slight incompleteness in elaborating reputational harm, but core synthesis is strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 376,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did SPG's application of the reference rate reform expedients under ASU 2020-04 evolve between 2022 and 2023, particularly in light of the extended sunset date to 2024, and what was the financial impact on their debt instruments during this period?",
      "original_answer": "In 2022, SPG adopted the expedients under ASU 2020-04 in conjunction with transitioning certain debt instruments to alternative benchmark indexes, with no impact on the consolidated financial statements. By 2023, SPG continued to apply these expedients, benefiting from the extended sunset date to December 31, 2024, as noted in the MET_10k_2023.pdf chunk. This extension allowed SPG to apply the optional relief to contract modifications made through 2024, facilitating the transition away from LIBOR without material financial impact. The evolution of SPG's compliance reflects a strategic use of accounting flexibility to manage the reference rate reform's operational and financial effects on their debt instruments.",
      "llm_answer": "SPG elected the ASU 2020‑04 reference‑rate‑reform expedients in 2022 to transition certain debt instruments to alternative benchmark indexes, reporting no material impact on its consolidated financial statements (page 112). In 2023 it continued to apply the same expedients, now supported by the ASU 2022‑06 extension that defers the sunset to December 31 2024 (page 167), allowing the continued use of the expedients for its debt. The transition had no material effect on SPG’s debt instruments or overall financial statements in either year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: SPG applied ASU 2020-04 expedients in 2022 during the transition of debt instruments to alternative benchmarks, with no material financial impact; in 2023, SPG continued using the expedients, benefiting from the extended sunset date to December 31, 2024. The mention of ASU 2022-06 as the source of the extension is accurate and adds specificity not in the original answer but consistent with SEC filing updates. (2) Quantitative accuracy is perfect: dates (2022, 2023, December 31, 2024) and the 'no material impact' financial assessment are correctly reported. Page references (112, 167) suggest proper sourcing from the 10-K filings. (3) Multi-hop reasoning is sound—correctly linking the extension of the sunset date to continued application of expedients and the lack of financial impact across years. (4) The only minor shortcoming is the absence of explicit mention of 'strategic use of accounting flexibility' or 'managing operational effects,' which are qualitative nuances in the original answer. However, the core substance—continued use of expedients due to extension, no material financial impact—is fully preserved. Wording differs slightly but maintains semantic equivalence. Contextual relevance is excellent, directly addressing all parts of the multi-faceted question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 384,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did CL's use and accounting treatment of interest rate swap contracts as economic hedges evolve between 2022 and 2024, particularly in terms of fair value disclosures and hedge designation practices?",
      "original_answer": "In 2022, CL disclosed that its interest rate swap contracts had a total fair value of $25 million in assets (including $5 million in other current assets and $20 million in other assets), with no corresponding liabilities reported. These contracts were described as providing an economic hedge of portions of outstanding debt, a common industry practice also seen at companies like UPS in 2022. By 2024, CL maintained its use of interest rate swaps but expanded its disclosure framework, explicitly stating that certain instruments 'may also economically hedge certain risks but do not qualify for hedge accounting.' This reflects a more nuanced approach where CL continues to use these instruments for economic hedging while maintaining clearer distinctions in its accounting treatment between designated hedges and non-designated economic hedges.",
      "llm_answer": "Colgate‑Palmolive continued to use interest‑rate swap contracts as fair‑value hedges to manage its mix of fixed‑ and floating‑rate debt. The 2022 10‑K disclosed a cumulative basis adjustment of $400 million for these swaps and presented their fair value in the derivative instruments table, while the 2024 10‑K confirms the same hedge designation and fair‑value disclosure framework, with no change in classification or reporting. Thus, the company’s use and accounting treatment of interest‑rate swaps remained essentially unchanged, maintaining consistent fair‑value disclosures and hedge designation practices.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both factual content and reasoning. It refers to 'Colgate-Palmolive' (CL is Cleco Corporation, not Colgate-Palmolive), which is a critical entity error. The numbers cited—$400 million cumulative basis adjustment—are completely inaccurate and not present in the ground truth. The ground truth states that in 2022, CL had a total fair value of $25 million in interest rate swap assets ($5M current, $20M non-current), with no liabilities; the LLM answer fabricates a $400M figure with no basis in the provided data. (2) Quantitative accuracy is extremely low: no correct numbers are reported. The LLM invents a 'cumulative basis adjustment of $400 million' that does not appear in the original answer or align with the disclosed fair values. There is no mention of such a metric in the ground truth. (3) The multi-hop reasoning is flawed: the question asks about evolution in use and accounting treatment between 2022 and 2024, particularly regarding hedge designation and disclosure practices. The ground truth shows a shift toward more nuanced disclosure in 2024—specifically, acknowledging that some swaps 'do not qualify for hedge accounting' despite serving as economic hedges. The LLM incorrectly asserts that 'there was no change in classification or reporting,' directly contradicting the ground truth. (4) Contextual relevance is moderate because the answer addresses interest rate swaps, fair value disclosures, and hedge accounting—but applies them to the wrong company and with fabricated data, undermining all substantive value. The reasoning structure attempts to compare years and disclosures, but the conclusions are factually inverted. Due to severe factual, quantitative, and entity errors, the correctness score is very low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 487,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did the change in the number of issued shares of UPS's Class A Common Stock from 2023 to 2024 affect the relative voting power dynamics between Class A and Class B Common Stockholders, and what implications does this have for corporate governance control?",
      "original_answer": "In 2023, UPS reported 127 shares of Class A Common Stock issued, which decreased to 121 shares in 2024, while Class B Common Stock increased from 726 to 733 shares. According to the evidence, Class A Common Stock collectively holds 66 2/3% of the combined voting power, while Class B Common Stock holds 33 1/3%, with each Class B share having 15 votes. The reduction in Class A shares and the increase in Class B shares in 2024 likely concentrated voting power further in favor of the Class B shareholders, such as Mr. Brian L. Roberts, who holds all outstanding Class B shares. This shift may have increased the influence of Class B shareholders over corporate governance decisions, despite the unchanged percentage allocation of voting power.",
      "llm_answer": "UPS issued 121 Class A shares in 2024 versus 127 in 2023, while Class B shares rose from 726 to 733 shares【page 69】. This small shift reduces the proportion of voting power held by Class A shareholders relative to the higher‑voting Class B holders, slightly strengthening the family’s dominant voting block. As a result, corporate governance control remains firmly in the hands of the Class B shareholders, with minimal dilution of their control.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the number of issued shares for both Class A and Class B Common Stock in 2023 and 2024: Class A decreased from 127 to 121 shares, and Class B increased from 726 to 733 shares. These numbers match the ground truth exactly. (2) The LLM accurately references the shift in share counts and correctly infers that this change reduces the relative proportion of Class A voting power compared to Class B, despite not explicitly restating the fixed 66 2/3% and 33 1/3% voting allocations. It correctly identifies that Class B has higher voting power per share (implied by calling them 'higher-voting') and notes the concentration of control in the family (a reference to Mr. Brian L. Roberts, who holds all Class B shares, as per ground truth). (3) The multi-hop reasoning is sound: the model connects the decrease in Class A shares and increase in Class B shares to a relative shift in influence, concluding that corporate governance control remains firmly with Class B shareholders. This aligns with the ground truth implication. (4) The only minor omission is that the LLM does not explicitly state that the *percentage allocation* of voting power is contractually fixed (66 2/3% for Class A, 33 1/3% for Class B), which means the relative voting power percentages do not actually change despite the share count shifts. However, it correctly observes that the *relative influence* or concentration strengthens for Class B due to their higher per-share votes and ownership concentration. This subtle distinction is partially captured in the phrase 'reduces the proportion of voting power held by Class A shareholders relative to the higher-voting Class B holders,' which may conflate vote concentration with formal voting power allocation. Despite this nuance, the overall factual and semantic content is highly accurate, hence a 9/10 on correctness and qualitative accuracy. Quantitative accuracy is perfect (10/10), and contextual relevance is full (10/10).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 537,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did the change in NKE's foreign currency exposure related to product purchases through NTC from 2022 to 2023 affect the company's inventory cost management strategy?",
      "original_answer": "In 2022, NKE's product purchases from NTC created foreign currency exposure for NTC when selling to NIKE entities with different functional currencies, and this exposure was managed through a combination of natural offsets and derivative contracts. By 2023, the company continued to rely on NTC for U.S. Dollar-denominated product purchases but emphasized non-functional currency denominated product purchases as a primary source of foreign currency exposure, indicating a shift in focus toward managing external supplier relationships rather than internal sourcing adjustments. This evolution suggests that NKE refined its inventory cost management strategy by prioritizing external hedging mechanisms over internal currency adjustments, particularly as a stronger U.S. Dollar increased inventory costs in prior years, prompting more targeted risk mitigation in 2023.",
      "llm_answer": "Nike’s foreign‑currency exposure from product purchases through the NTC fell slightly—from $18.5 B in 2022 to $18.2 B in 2023—while the hedging impact on cost of sales swung from a $23 M negative to a $581 M positive, reflecting a tighter inventory‑cost hedging program that relied more heavily on forward contracts and the foreign‑currency‑adjustment program to smooth U.S. dollar swings and reduce inventory cost volatility【page_46】【page_82】【page_85】【page_84】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific numerical values—$18.5B in 2022 and $18.2B in 2023 for foreign currency exposure, and hedging impacts of -$23M and +$581M—that are not present in the original answer (ground truth) and cannot be verified as correct based on the provided knowledge graph. These figures appear fabricated or misattributed, as the ground truth does not quantify exposure in dollar terms or mention hedging impacts on cost of sales. Therefore, the quantitative claims are unsupported and likely incorrect. (2) The calculation of a 'decrease' from $18.5B to $18.2B and the dramatic swing in hedging impact imply precise financial data that is absent from the ground truth, which focuses on qualitative shifts in strategy rather than quantified exposure or hedging gains/losses. No such numbers were mentioned in the original synthesis, making the quantitative accuracy very low. (3) The multi-hop reasoning is flawed: while the question asks about how changes in foreign currency exposure via NTC affected inventory cost management strategy, the LLM invents metrics instead of describing the strategic shift—such as the move from internal (NTC-related) currency adjustments to managing external supplier relationships and increased reliance on external hedging mechanisms due to a stronger U.S. dollar. The model fails to capture the core conceptual evolution described in the ground truth. (4) Contextually, the answer is somewhat relevant—it discusses foreign currency exposure, hedging, and inventory cost volatility—but it misdirects focus toward unverified financial figures and specific hedging instruments (e.g., 'foreign-currency-adjustment program') not mentioned in the original. It omits the key strategic refinement: prioritizing external hedging over internal sourcing adjustments. Thus, while it addresses currency and cost management, it does so with incorrect data and incomplete, distorted reasoning, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 534,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did ConocoPhillips' financial exposure through coalbed methane (CBM) production in the APLNG joint venture evolve from 2023 to 2024, considering both their operational stake and guarantee liabilities?",
      "original_answer": "In 2023, ConocoPhillips was deeply involved in CBM production through the APLNG joint venture, with 3,500 net wells expected to supply LNG for both export and the domestic market. By 2024, ConocoPhillips maintained a 47.5% ownership stake in APLNG and had $210 million in maximum exposure under a guarantee tied to project finance reserve funds, with an additional $610 million in potential liability (up to $1.0 billion in case of intentional or reckless breach) related to gas delivery commitments. The evolution shows a continued strategic commitment to the CBM-to-LNG value chain, but with increased financial guarantees reflecting long-term contractual obligations and operational maturity of the project.",
      "llm_answer": "ConocoPhillips’ share of the APLNG joint venture stayed at 47.5 % in both 2023 and 2024.  In the 2024 filing, the company disclosed several guarantees tied to that stake – a maximum potential liability of roughly $1.3 billion (comprising $210 m, $610 m and $480 m components) and a carrying value of about $48 million – whereas no such guarantee liabilities were reported in the 2023 filing.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. While it correctly states ConocoPhillips' 47.5% ownership stake in APLNG for both years, it incorrectly reports a total potential liability of $1.3 billion by summing $210M, $610M, and $480M — the $480M component is not mentioned in the ground truth. The original answer specifies $210M in maximum exposure under a guarantee, $610M in potential liability, and up to $1.0 billion in case of intentional or reckless breach (which likely includes the $210M and $610M, not adds to them). The LLM incorrectly treats these as additive, creating a fictitious $1.3B figure. Additionally, the $48 million carrying value is not referenced in the ground truth, making it an unsupported addition. (2) The claim that 'no such guarantee liabilities were reported in the 2023 filing' contradicts the original answer, which states ConocoPhillips was 'deeply involved in CBM production' with 3,500 net wells — implying operational and financial exposure, even if specific guarantees weren't disclosed. The LLM overinterprets absence of guarantee details as absence of exposure, which is not supported. (3) The multi-hop reasoning is partially sound — the model attempts to compare stake and liabilities across years — but fails in synthesis by introducing unverified components ($480M, $48M) and misrepresenting the structure of liabilities. It also misses the qualitative evolution described in the original answer: continued strategic commitment with increased guarantees due to project maturity. (4) Contextual relevance is strong — the answer addresses stake, guarantees, and year-over-year changes — but factual errors in numbers and liability structure reduce correctness. The core idea of increasing disclosure of liabilities from 2023 to 2024 is plausible, but the execution is flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 502,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did PepsiCo's APAC segment's contribution to beverage operating profit in 2023 compare to 2024, and what does this imply about their regional investment prioritization in the beverage category?",
      "original_answer": "PepsiCo's APAC segment showed no growth in beverage operating profit contribution between 2023 and 2024, remaining at 23% in both years. This stable contribution, despite PepsiCo's overall beverage segment increasing from 41% to 42% globally in 2024, suggests that the company maintained a neutral stance on beverage investment in APAC. The lack of growth in APAC's beverage contribution, while other regions like AMESA increased from 29% to 30%, indicates a strategic decision to maintain rather than expand beverage operations in APAC during this period.",
      "llm_answer": "PepsiCo’s APAC division’s operating profit rose from **$713 million in 2023 to $811 million in 2024** (a $98 million increase).  That growth in the APAC contribution to the company’s beverage operating profit signals a strategic emphasis on the APAC region, indicating that PepsiCo is prioritizing investment and expansion of its beverage portfolio there.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both numbers and interpretation. The ground truth states that PepsiCo's APAC segment's *contribution to beverage operating profit* remained flat at 23% in both 2023 and 2024, but the LLM incorrectly reports absolute operating profit figures of $713 million and $811 million, which are not mentioned in the original answer and contradict the percentage-based metric. There is no support for these dollar amounts in the ground truth, and they represent a different metric (absolute profit vs. percentage contribution), leading to a fundamental misrepresentation. (2) The calculation of a $98 million increase is based on fabricated data and is therefore invalid. The original answer focuses on percentage contribution stability (23% in both years), not absolute profit growth. The LLM also fails to note that global beverage segment profit increased from 41% to 42%, and that other regions like AMESA grew their share, making APAC's stagnation more significant. (3) The multi-hop reasoning is flawed: the LLM incorrectly infers investment prioritization based on non-existent absolute profit growth, while the correct reasoning hinges on relative contribution stability amid global shifts. The conclusion that PepsiCo is prioritizing APAC is directly contradicted by the ground truth, which states the company took a 'neutral stance' and maintained rather than expanded in the region. (4) The contextual relevance is moderate because the answer addresses the right company (PepsiCo), region (APAC), and general topic (beverage profit and investment), but the factual inaccuracies and incorrect reasoning severely undermine correctness. Quantitative accuracy is very low due to invented figures; qualitative accuracy is low due to flawed logic and misinterpretation; correctness score is low because the core facts and conclusion are wrong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 512,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did the conversion dynamics between UPS's Class A and Class B shares evolve between 2022 and 2024, particularly considering the number of authorized shares and the implications for voting rights distribution?",
      "original_answer": "In 2022, UPS had 4.6 billion Class A shares and 5.6 billion Class B shares authorized, with Class A shares carrying 10 votes per share and Class B shares carrying 1 vote per share. By 2024, the number of authorized shares for both classes remained unchanged at 4.6 billion for Class A and 5.6 billion for Class B. However, the continued authorization of Class A shares—primarily held by employees, retirees, and founder-related trusts—suggests ongoing potential for conversion into Class B shares, which are publicly traded. The lack of change in authorized amounts over the two-year period indicates a stable framework for voting rights distribution, despite the full convertibility of Class A shares into Class B shares.",
      "llm_answer": "UPS kept the same authorized share limits throughout the period – 4.6 billion Class A and 5.6 billion Class B shares (page 133 and page 116).  Conversion activity was modest but fluctuated: 12 million Class A shares were converted to Class B in 2022, 14 million in 2023, and 11 million in 2024 (page 116).  Because each Class A share carries 10 votes versus one vote for a Class B share, these conversions gradually shift voting power from the high‑voting employee/retiree pool to the broader public, slightly diluting concentrated voting control.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer introduces specific conversion volumes (12M, 14M, 11M shares) for 2022–2024 that are not present in the original ground truth, which only discusses authorized shares and the potential for conversion—not actual conversion activity. While the authorized share counts (4.6B Class A, 5.6B Class B) are correctly stated and match the ground truth, the addition of conversion volumes—though plausible—cannot be verified from the provided truth and appear to be hallucinated or sourced from data outside the knowledge graph. This significantly impacts quantitative accuracy. The qualitative reasoning about voting rights dilution due to conversion from high-vote Class A to low-vote Class B shares is sound and aligns with the implications in the original answer. The explanation of the voting structure (10 votes vs. 1 vote) and the shift in control is logically correct and contextually relevant. However, the core evolution of 'conversion dynamics' is misrepresented by focusing on unverified transaction volumes rather than the stability of the authorization framework emphasized in the ground truth. Thus, while the answer is well-structured and contextually relevant, it fails on strict factual correctness due to unsupported numerical claims, warranting a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 360,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did the shift in NEE's pension plan asset allocation from 2022 to 2024 influence its use of pooled separate accounts as part of its broader investment strategy?",
      "original_answer": "In 2022, NEE's pension plan targeted a 10% allocation to convertible securities and 13% to alternative investments, with pooled separate accounts being one of the commingled investment vehicles used to achieve diversification and risk mitigation. By 2024, the pension plan increased its allocation to alternative investments to 20% while reducing convertible securities to 5%. This reallocation reflects a strategic shift toward higher-risk, higher-return alternative investments, which are also accessed through pooled separate accounts and other commingled structures. The continued use of pooled separate accounts across both years shows NEE's ongoing reliance on these vehicles to implement its evolving asset allocation strategy.",
      "llm_answer": "Between 2022 and 2024, NEE’s pension plan shifted its target allocation from 45 % equity, 32 % fixed‑income, 13 % alternative and 10 % convertible to 43 % equity, 32 % fixed‑income, 20 % alternative and 5 % convertible【page_100】【page_101】. The 7‑percentage‑point increase in alternative exposure likely led the plan to lean more heavily on commingled vehicles such as pooled separate accounts—listed in the investment policy as part of its diversified strategy【page_100】—to gain alternative exposure, although the filings do not explicitly state a change in the proportion of pooled separate accounts used.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the shift in NEE's pension plan allocations from 2022 to 2024, accurately reporting the reduction in convertible securities from 10% to 5% and the increase in alternative investments from 13% to 20%. It also correctly notes that pooled separate accounts are part of the commingled investment strategy. However, the LLM introduces equity and fixed-income allocations (45%, 32%, etc.) that are not present in the original answer, which may be from the source document but were not part of the ground truth response. While these numbers may be factually correct in context, their inclusion shifts focus and adds unrequested detail without changing the core accuracy. (2) All percentage changes are quantitatively accurate: 13% to 20% is a 7-percentage-point increase, and 10% to 5% is a 5-point decrease—correctly implied. The absence of exact dollar amounts or incorrect calculations is not an issue here as the question is about allocation strategy. (3) The reasoning is sound: the LLM correctly infers that increased alternative investment allocation likely increased reliance on commingled vehicles like pooled separate accounts, even though the filings do not explicitly confirm a change in usage. This aligns with the original answer’s logic about continued reliance on such vehicles. (4) The answer is contextually relevant and addresses the core question about how the shift influenced the use of pooled separate accounts. It stops short of explicitly stating that pooled separate accounts were used in both years (a key point in the original), but implies continuity by referencing them as part of the policy. The slight deduction in correctness and qualitative accuracy is due to the addition of unsolicited allocation details and the lack of explicit confirmation of ongoing use across years, though the overall synthesis is strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 511,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Southern Company's reliance on PowerSouth as an electricity supplier evolve between 2022 and 2023, particularly in terms of capacity agreements and joint ownership stakes?",
      "original_answer": "In 2022, Southern Company (specifically Alabama Power) entered into an agreement to supply approximately 100 MWs of year-round capacity service to PowerSouth starting February 1, 2024. By 2023, this relationship deepened as Alabama Power and PowerSouth operated under a coordinated planning and operations agreement initiated in 2021, which included joint commitment, dispatch, and real-time energy transactions. Additionally, Alabama Power held an undivided 8.16% ownership interest in Plant Miller Units 1 and 2 through PowerSouth, indicating a strategic shift toward greater integration and shared infrastructure.",
      "llm_answer": "In the 2022 Form 10‑K, Southern Company did not disclose any capacity agreements or joint‑ownership arrangements with PowerSouth (the glossary only identifies the cooperative).  By the 2023 filing, Southern Company noted that Alabama Power was providing about 100 MW of year‑round capacity service to PowerSouth under a 2021 agreement, and that PowerSouth owned an 8.16 % undivided interest in Alabama Power’s Plant Miller Units 1 and 2—showing a clear expansion of its reliance on PowerSouth as an electricity supplier.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. It incorrectly states that the 100 MW capacity service agreement was made in 2021, while the ground truth specifies it was entered into in 2022 for service starting in 2024. This misrepresents the timeline of Southern Company's evolving reliance. Additionally, the ownership stake description is reversed: the ground truth states that Alabama Power holds an 8.16% undivided interest in Plant Miller Units 1 and 2 *through PowerSouth*, indicating Alabama Power’s partial ownership via PowerSouth; the LLM incorrectly frames it as PowerSouth owning a stake in Alabama Power’s plant, which inverts the relationship and misrepresents the nature of the joint ownership. (2) Quantitatively, the 100 MW and 8.16% figures are correctly cited, but their context and directionality are wrong, undermining factual accuracy. The dates (2021 vs 2022 agreement) are incorrect, affecting the evolution narrative. (3) The multi-hop reasoning is partially sound in that the model attempts to compare 2022 and 2023 disclosures and infer increased reliance, but the flawed entity and directional understanding (who owns what) breaks the logical synthesis. The coordinated planning agreement from 2021, which is key to the deepening relationship in 2023, is entirely omitted, missing a critical component of the evolution. (4) Contextual relevance is strong—the answer addresses capacity agreements and ownership stakes between the two years, aligning with the question’s focus. However, due to significant factual and directional errors in key relationships and timing, the correctness and qualitative accuracy scores are low. Minor wording differences would be acceptable, but reversed ownership and incorrect agreement dates constitute major errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 489,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Microsoft's acquisition of Activision Blizzard in 2022 influence its capital structure in 2023, particularly with respect to the integration of Activision’s 3.400% Senior Notes due 2026 into Microsoft’s debt portfolio?",
      "original_answer": "Microsoft's announcement in January 2022 to acquire Activision Blizzard marked the beginning of strategic financial integration. Activision had previously issued the 3.400% Senior Notes due 2026, among other debt instruments, as evidenced by the October 27, 2023 supplemental indenture. By November 2023, Microsoft formally introduced these notes into its capital structure, as seen in the filing referencing the Indenture dated September 19, 2016, and filed on November 6, 2023. This indicates that Microsoft assumed or otherwise incorporated Activision’s existing debt obligations as part of the acquisition process, thereby altering its capital structure by adding a new class of senior notes with a 3.400% interest rate maturing in 2026.",
      "llm_answer": "Microsoft’s 2022 acquisition of Activision Blizzard caused Microsoft to assume Activision’s 3.400% Senior Notes due 2026, which were then added to Microsoft’s long‑term debt portfolio in 2023.  The 2023 10‑K lists supplemental indentures (Exhibits 4.23 and 4.24) that reflect the transfer of those notes to Microsoft, thereby increasing its debt balance and slightly raising its weighted‑average cost of debt【page_6】【page_106】【page_107】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) Quantitative accuracy: All key numbers and dates are correct — the 3.400% interest rate, the 2026 maturity of the Senior Notes, and the 2023 integration into Microsoft’s debt portfolio are all correctly stated. The reference to the 2023 10-K and specific exhibits (4.23 and 4.24) supports the claim and matches the timeline in the original answer (e.g., November 6, 2023 filing). (2) Completeness: The answer addresses the core of the question — how the acquisition influenced Microsoft’s capital structure via assumption of Activision’s debt. It correctly identifies the addition of the 3.400% Senior Notes to Microsoft’s long-term debt and notes the impact on debt balance and weighted-average cost of debt. (3) Entity accuracy: Microsoft, Activision Blizzard, the correct debt instrument (3.400% Senior Notes due 2026), and relevant years (2022 acquisition announcement, 2023 integration) are all correctly identified. (4) Reasoning: The multi-hop logic — acquisition → assumption of debt → integration into capital structure in 2023 — is sound and supported by the cited filing evidence. The only minor shortcoming is that the LLM does not explicitly mention the September 19, 2016 indenture or the October 27, 2023 supplemental indenture, which are part of the full paper trail in the ground truth. However, referencing the 2023 10-K and exhibits provides equivalent contextual support for the integration event. (5) Semantic equivalence: The meaning and factual content are effectively identical to the original answer, with slightly more concise wording. The conclusion about increased debt and slight rise in weighted-average cost is a reasonable inference not contradicted by the ground truth. Overall, this is a highly accurate, well-supported response with only minor omissions in documentary detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 509,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Disney's use of foreign exchange forward contracts to hedge firm commitments evolve from 2023 to 2024, and what does the change in notional amounts indicate about their foreign currency risk exposure management?",
      "original_answer": "In 2023, Disney had $8.3 billion in notional amounts of foreign exchange cash flow hedges covering firm commitments and forecasted transactions, while in 2024 this increased to $9.9 billion. This indicates a growing emphasis on managing foreign currency risk, particularly for firm commitments, as the company expanded its use of forward contracts to protect against exchange rate fluctuations. The increase in notional hedging volume suggests Disney anticipated greater foreign currency exposure in 2024 compared to 2023, aligning with their policy of hedging forecasted transactions up to four years in advance within defined exposure ranges.",
      "llm_answer": "Disney uses foreign‑exchange forward and option contracts as cash‑flow hedges for its firm commitments.  The net notional amount of these hedges rose from **$8.3 billion in 2023 to $9.9 billion in 2024**—an increase of about $1.6 billion—indicating a broader hedging program and a more proactive stance on managing its foreign‑currency exposure. (See page 121)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the notional amounts of foreign exchange hedges for both 2023 ($8.3 billion) and 2024 ($9.9 billion), matching the ground truth exactly. The increase of $1.6 billion is accurate and correctly implied. (2) All numeric values are factually correct and properly attributed to the respective years. Format is consistent and acceptable ($8.3 billion, $9.9 billion). (3) The reasoning is sound: the increase in notional amount is correctly interpreted as a sign of a broader, more proactive hedging strategy, which aligns with the ground truth's interpretation of growing emphasis on foreign currency risk management. The LLM correctly infers that the increase suggests anticipated higher exposure, though it omits the detail about hedging up to four years in advance and defined exposure ranges, which slightly reduces completeness. (4) The answer is highly relevant, directly addressing both parts of the question—evolution of hedge usage and interpretation of risk exposure—though minor contextual details from the original answer are missing. Overall, the response is factually accurate, well-reasoned, and semantically equivalent to the ground truth with only slight omissions in depth of policy explanation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 353,
        "total_tokens": 1623
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did MA adapt its compliance framework between 2023 and 2024 in response to the expanded obligations under the U.S. Bank Secrecy Act—particularly as shaped by the Anti-Money Laundering Act of 2020—and what were the operational implications of these regulatory changes for its AML/CFT program?",
      "original_answer": "In 2023, MA was subject to the USA PATRIOT Act and the U.S. Bank Secrecy Act (BSA), and had implemented a comprehensive AML/CFT program with internal controls and compliance officers to meet these requirements. The 2024 GS filing highlighted that the BSA had been expanded by the Anti-Money Laundering Act of 2020 (AMLA), which introduced a risk-based compliance approach, required periodic anti-money laundering priorities (e.g., cybercrime, corruption, terrorist financing), and mandated new standards for testing technology and internal processes for compliance. By 2024, MA had updated its compliance framework to reflect these expanded BSA obligations, including enhanced risk assessments and updated internal controls. This evolution suggests increased investment in compliance infrastructure and technology, as well as more rigorous transaction monitoring and reporting processes to align with the updated regulatory landscape.",
      "llm_answer": "Mastercard updated its AML/CFT framework in 2024 to incorporate FinCEN’s new risk‑based rule that expands the definition of a financial institution to include investment advisers and requires periodic risk‑assessment updates and suspicious‑activity reporting. The company added new policies, procedures and internal controls, and enhanced its risk‑assessment process, which increased compliance staffing and technology investments and intensified monitoring and reporting requirements across its global operations (MA_10k_2023, p. 27; MA_10k_2024, p. 27; MA_10k_2024, p. 25).",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures some correct elements but contains significant inaccuracies in reasoning and entity alignment. (1) Correct aspects: The answer notes that Mastercard (MA) updated its AML/CFT framework in 2024 with enhanced risk assessments, internal controls, and increased technology investment—consistent with the ground truth. It also correctly references MA’s 10-K filings from 2023 and 2024. (2) Quantitative accuracy is acceptable: no specific dollar amounts or percentages are misstated, and the years (2023, 2024) are correctly used. (3) However, the qualitative accuracy is flawed: the LLM incorrectly attributes the regulatory changes to a 'FinCEN rule' that 'expands the definition of a financial institution to include investment advisers'—this is unrelated to Mastercard’s status or the Anti-Money Laundering Act of 2020 (AMLA). The AMLA’s actual impact—introducing risk-based compliance, mandated AML priorities (e.g., cybercrime, corruption), and requirements for testing technology and internal processes—is not accurately reflected. Instead, the LLM introduces a regulatory change targeting investment advisers, which does not apply to MA and is not mentioned in the ground truth. (4) Contextual relevance is high because the answer addresses MA’s compliance updates and operational implications like staffing and monitoring, but the reasoning is based on incorrect regulatory premises. The multi-hop synthesis fails because it misidentifies the source and nature of the regulatory change (AMLA vs. unrelated FinCEN rule), undermining the factual foundation of the response. Thus, while some outcomes (enhanced controls, monitoring) align with the truth, the justification is factually incorrect, warranting a partial score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 473,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did BA's exposure to unrecognized tax benefits associated with the Pillar Two Model Rules change from 2023 to 2024, and what does this indicate about their evolving tax risk profile?",
      "original_answer": "In 2023, BA reported that the Pillar Two Model Rules were not expected to materially increase their global tax costs due to limited operations in low-tax jurisdictions, though uncertainty remained. At that time, they noted that unrecognized tax benefits related to federal tax matters under audit could decrease by up to $620 million within the next 12 months. By 2024, BA confirmed that Pillar Two had not materially increased their global tax costs, with the unrecognized tax benefits totaling $651 million as of December 31, 2024, down from $1,088 million in 2023. This indicates a reduction in uncertain tax positions, suggesting that BA's tax risk profile related to Pillar Two has decreased or stabilized year-over-year, despite ongoing global regulatory developments.",
      "llm_answer": "From 2023 to 2024 BA’s unrecognized tax benefits tied to the Pillar Two Model Rules fell from $1.131 billion to $688 million—a decline of roughly $443 million.  The drop reflects a lower potential tax liability and suggests a modest improvement in the company’s tax‑risk profile, even as it continues to monitor Pillar Two developments that are not expected to materially raise global tax costs.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported numbers. According to the ground truth, BA's unrecognized tax benefits decreased from $1,088 million in 2023 to $651 million in 2024. However, the LLM states the values were $1.131 billion (i.e., $1,131 million) in 2023 and $688 million in 2024—both of which are incorrect. The difference calculated by the model ($443 million) is close to the actual decrease of $437 million ($1,088M - $651M), but the underlying figures are still wrong, undermining quantitative accuracy. (2) The original answer also notes that in 2023, BA expected a potential decrease of up to $620 million in unrecognized tax benefits due to federal audit resolutions, a detail omitted in the LLM response. This missing context weakens completeness and qualitative accuracy. (3) While the LLM correctly infers that the decline in unrecognized tax benefits suggests a modest improvement in tax risk profile and that Pillar Two is not expected to materially increase global tax costs, it fails to fully synthesize the multi-hop elements—specifically, the connection between audit developments in 2023 and the realized reduction in 2024. The reasoning is partially sound but based on incorrect data. (4) Despite numerical inaccuracies, the LLM maintains relevance by addressing the change in exposure and interpreting its implication for tax risk, earning high marks for contextual relevance. However, the incorrect figures severely limit factual correctness, warranting a low overall correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 428,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did the voting power dynamics between Class A and Class B common stock evolve from 2022 to 2024, and what impact did this have on the structure of share repurchases in 2024?",
      "original_answer": "In 2022, holders of Class A common stock held 66 2/3% of the combined voting power, while Class B common stock, beneficially owned entirely by Brian L. Roberts, represented 33 1/3% of the voting power, with each Class B share carrying 15 votes. By 2024, the voting rights of Class B shares were adjusted to 10 votes per share, signaling a reduction in the relative influence of Class B stockholders. This change in voting structure coincided with a strategic shift in share repurchases, where Alphabet repurchased $62.0 billion of Class A and Class C shares in 2024, compared to $59.3 billion in 2022, suggesting a continued emphasis on returning value to Class A and Class C shareholders while potentially diluting the relative influence of Class B shares.",
      "llm_answer": "In 2022 Alphabet had 300.8 million Class A shares (1 vote each) and 44.6 million Class B shares (10 votes each), giving Class B holders roughly 60 % of the total voting power【page_2】【page_82】. The voting rights per share did not change by 2024, but the 2024 share‑repurchase program was limited to Class A and Class C shares, leaving Class B shares untouched to preserve their voting influence【page_80】【page_82】.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains multiple factual inaccuracies. First, it incorrectly attributes the voting power structure to Alphabet, while the original answer and context clearly refer to Comcast (Brian L. Roberts is the controlling shareholder of Comcast, not Alphabet). This is a critical entity error. Second, the LLM claims that in 2022, Class B shares had 10 votes each, but the ground truth states they had 15 votes per share in 2022, reduced to 10 in 2024. The LLM also misrepresents the voting power distribution: it claims Class B held ~60% of voting power, whereas the truth is Class A held 66 2/3% and Class B 33 1/3%. (2) The quantitative inaccuracies are severe: wrong share counts (300.8M Class A, 44.6M Class B), incorrect vote ratios (10 votes in 2022 instead of 15), and false voting power percentages (~60% for Class B vs actual 33 1/3%). The repurchase amounts are entirely omitted: the LLM fails to mention the $62.0B in 2024 vs $59.3B in 2022, which is central to the original answer. (3) The multi-hop reasoning is flawed: the LLM fails to connect the reduction in Class B voting power (from 15 to 10 votes per share) to the strategic repurchase of Class A and C shares as a means of diluting Class B influence. Instead, it falsely claims repurchases were designed to preserve Class B influence, which contradicts the original logic. (4) The contextual relevance is moderate because the answer addresses voting power and share repurchases, but the incorrect company (Alphabet vs Comcast), wrong numbers, and reversed reasoning severely undermine factual correctness. The citations to 'page_2', 'page_80', 'page_82' suggest document access but misinterpretation. Overall, the answer is largely incorrect on key facts, entities, and logic.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 481,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Duke Energy's 2022 operations in North Carolina influence its 2023 Carolinas Resource Plan recommendation in response to HB 951's 70% CO₂ reduction target by 2030?",
      "original_answer": "Duke Energy's 2022 operations in North Carolina were subject to HB 951, which mandated a carbon reduction plan targeting a 70% reduction in CO₂ emissions from Duke Energy’s generation by 2030. In response, Duke Energy filed its 2023 Carolinas Resource Plan recommending Portfolio 3, which proposed exiting coal by 2035, expanding energy efficiency and demand response, and extending nuclear plant operations to align with the regulatory mandate while ensuring reliability and cost-effectiveness.",
      "llm_answer": "Duke Energy’s 2022 North Carolina operations centered on the filing and NCUC‑approval of an initial carbon‑reduction plan that built on its 2020 IRPs and incorporated extensive stakeholder feedback【page_71】.  That plan became the foundation for the 2023 Carolinas Resource Plan, leading the company to recommend Portfolio 3 – an “all‑of‑the‑above” mix that expands renewables, demand response, nuclear, and pumped‑storage to meet the HB 951‑mandated 70 % CO₂ cut by 2030【page_71】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: Duke Energy's 2022 operations in North Carolina were shaped by HB 951’s 70% CO₂ reduction target by 2030, and this informed the 2023 Carolinas Resource Plan, which recommended Portfolio 3. The percentage (70%), year (2030), and legislative reference (HB 951) are all accurate. (2) Quantitative elements—specifically the 70% CO₂ reduction target and the 2030 deadline—are correctly stated and match the original answer. No calculations are required. (3) The multi-hop reasoning is sound: the model correctly links 2022 regulatory activity (influenced by HB 951) to the development of the 2023 plan and the selection of Portfolio 3. The LLM adds contextual detail (e.g., stakeholder feedback, NCUC approval, 'all-of-the-above' strategy) that is consistent with the source and enhances clarity. (4) The only minor difference is that the LLM emphasizes 'renewables' and 'pumped-storage' while the original highlights 'exiting coal by 2035' and 'energy efficiency'—both are accurate aspects of Portfolio 3, but the original answer includes a specific coal phaseout date not mentioned in the LLM response. This omission slightly reduces completeness but does not affect core correctness. Overall, the answer is highly accurate, relevant, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 378,
        "total_tokens": 1628
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did ConocoPhillips' condensate production strategy evolve from 2023 to 2024 following its Marathon Oil acquisition, and what does the $116 million in potential future payments tied to Alba Plant LLC reveal about its financial commitments to natural gas liquids monetization in Equatorial Guinea?",
      "original_answer": "In 2023, ConocoPhillips was actively producing condensate from fields like Aasta Hansteen, transporting it via shuttle tankers to market. In 2024, following the acquisition of Marathon Oil, COP significantly expanded its presence in Equatorial Guinea, including a 52.2% interest in Alba Plant LLC, which processes natural gas from the Alba Unit and monetizes condensate and LPG at market prices. This strategic shift is further evidenced by COP's $116 million in potential future payment obligations tied to Alba Plant LLC's third-party gas processing agreements, indicating a strong financial commitment to monetizing natural gas liquids in the region.",
      "llm_answer": "In 2023 ConocoPhillips’ condensate strategy was centered on its centralized processing facilities in Texas and New Mexico that supported its Lower 48 assets (page 8). After the November 2024 Marathon Oil acquisition, the company added the Alba Unit in Equatorial Guinea and leveraged its 52.2‑percent stake in Alba Plant LLC to extract and sell condensate and LPG from the Alba natural‑gas stream, expanding its monetization beyond the U.S. (page 12). The $116 million of potential future payments tied to Alba Plant LLC (page 103) represents the maximum liability under the guarantees for processing third‑party gas, underscoring a substantial financial commitment to monetizing natural‑gas liquids in Equatorial Guinea.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several correct elements but also significant inaccuracies that affect the overall correctness. (1) Quantitatively, the $116 million in potential future payments and the 52.2% stake in Alba Plant LLC are accurately reported, matching the ground truth. The acquisition timing is misstated as November 2024, but the actual Marathon Oil acquisition closed in May 2024 (per public filings), making the date factually incorrect. (2) The claim that ConocoPhillips' 2023 condensate strategy was centered on 'centralized processing facilities in Texas and New Mexico' is not supported by the ground truth, which cites Aasta Hansteen (a Norwegian offshore field) as the 2023 condensate production source with shuttle tanker transport. This is a major entity and geographic error. (3) The multi-hop reasoning is partially sound—linking the Marathon acquisition to expanded presence in Equatorial Guinea and connecting the $116M obligation to NGL monetization commitment—but it is built on a flawed foundation due to the incorrect 2023 baseline. (4) The answer addresses both parts of the question (strategy evolution and financial commitment), so it is contextually relevant and complete in structure. However, the substitution of U.S.-centric 2023 operations for actual international ones undermines the qualitative accuracy. While the $116M liability explanation is semantically equivalent and well-reasoned, the incorrect 2023 strategy description leads to a misleading narrative of strategic evolution. Thus, the answer is partially correct but contains critical factual errors in entity and operational details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 443,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did RTX's changing ownership stake in IAE from 2022 to 2024 affect the production economics of the PW1100G-JM engine program?",
      "original_answer": "In 2022, RTX (via Pratt & Whitney) was producing the PW1100G-JM engine, a key member of the GTF engine family, which powers the Airbus A320neo family of aircraft. This engine was central to Pratt & Whitney’s commercial engine business, which had a major customer in Airbus, representing 31% of total Pratt & Whitney segment sales. By 2024, RTX had restructured its collaboration arrangements, with Pratt & Whitney now holding a 59% ownership interest in IAE LLC, the entity coordinating the PW1100G-JM engine program. RTX's net program share interest in IAE LLC was 51%, indicating a shift in collaboration economics. This change in ownership structure likely altered cost-sharing dynamics and risk allocation for the PW1100G-JM engine program, directly influencing its production economics. The increased control through a larger stake may have allowed RTX to better align program execution with its strategic goals, though it also exposed the company to a greater share of program risks and costs.",
      "llm_answer": "RTX’s share of the International Aero Engines (IAE) collaboration grew from 57 % in 2022 to 59 % in 2024, giving it a larger slice of the PW1100G‑JM program’s economics. The higher ownership stake allowed RTX to capture a greater portion of the cost‑savings and revenue generated by the engine, thereby improving its production economics by aligning more closely with the program’s cost structure and giving RTX greater control over production decisions【page_15】.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the increase in RTX's ownership stake in IAE from 57% to 59% between 2022 and 2024, which aligns with the general trend in the ground truth. However, the ground truth specifies that RTX's *net program share interest* was 51%, a critical detail omitted in the LLM response. Additionally, the original answer notes that the 59% ownership is held by Pratt & Whitney within IAE LLC, while RTX’s consolidated net interest is lower—this nuance is missing, leading to potential misinterpretation of economic exposure. (2) The quantitative claim of 57% in 2022 is not explicitly supported in the ground truth, which does not state the 2022 ownership percentage—only the 2024 figures (59% ownership, 51% net interest). Thus, the 57% figure appears to be an unsupported inference or error, reducing quantitative accuracy. (3) The reasoning is partially sound: the LLM correctly infers that higher ownership improves economic capture and control over production, which is consistent with the original answer’s logic about cost-sharing, risk allocation, and strategic alignment. However, it fails to mention the increased risk exposure, presenting only the upside (revenue, cost savings) without the downside (greater cost and risk burden), resulting in an incomplete synthesis of production economics. (4) Contextual relevance is high—the answer focuses on ownership changes and their impact on production economics, directly addressing the question. Despite missing key nuances and introducing an unverified percentage, the core direction of the reasoning is correct, warranting a score of 7 for overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 453,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How has Southern Company's increased reliance on nuclear generation from 2022 to 2024 impacted its exposure to cyber intrusion risks and associated risk management strategies?",
      "original_answer": "In 2022, Southern Company's nuclear units represented 26% and 28% of total KWHs generated by Alabama Power and Georgia Power, respectively. By 2024, this share had increased to 25% for Alabama Power and 34% for Georgia Power, indicating a growing dependence on nuclear generation. Since nuclear facilities are explicitly noted to be subject to cyber intrusion risks that could result in operational fines or shutdowns, the increased share of nuclear generation heightens Southern Company's exposure to these risks. In response, the 2024 filing emphasizes compliance with mandatory cybersecurity standards and highlights the potential for increased licensing or compliance costs due to cyber threats. This suggests that Southern Company has likely elevated its cybersecurity investment and risk mitigation strategies to address the growing interplay between nuclear operations and cyber intrusion risks.",
      "llm_answer": "Southern Company’s nuclear‑generation share rose between 2022 and 2024—Georgia Power’s nuclear output grew from 28 % to 34 % of its total generation, while Alabama Power’s share fell slightly from 26 % to 25 %—increasing the number of nuclear assets under its control【page_27】. This heightened reliance on nuclear facilities has amplified the company’s exposure to cyber‑intrusion threats, as nuclear plants are high‑value targets and subject to stricter cyber‑security requirements【page_27】. In response, Southern Company has strengthened its cyber‑security posture by implementing robust security controls, continuous monitoring, and compliance with mandatory cyber‑security standards, and by tightening third‑party vendor risk management【page_27】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all percentages and years are correct: Alabama Power's nuclear share decreased from 26% in 2022 to 25% in 2024, and Georgia Power's increased from 28% to 34%, as stated in the original answer. These numbers are reported accurately, including the direction of change. (2) The reasoning correctly infers that increased reliance on nuclear generation (especially in Georgia Power) heightens cyber intrusion risk exposure, given that nuclear facilities are high-value targets with strict cybersecurity requirements. This reflects sound multi-hop logic connecting operational shifts to risk implications. (3) The LLM accurately identifies Southern Company's response strategies—compliance with mandatory standards, robust controls, continuous monitoring, and third-party vendor risk management—which are consistent with the original answer’s mention of compliance emphasis and potential increased costs. The only minor shortcoming is that the LLM does not explicitly mention 'operational fines or shutdowns' or 'increased licensing/compliance costs' as specific consequences highlighted in the original, slightly reducing qualitative completeness. However, the core risk management enhancements are well captured. (4) Contextual relevance is excellent—the answer directly addresses the impact of increased nuclear reliance on cyber risks and the corresponding risk management evolution. Overall, the answer is factually correct, well-reasoned, and semantically equivalent to the ground truth with only minor omissions in risk consequence details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 445,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did Apple's geographic risk exposure to China Mainland within the Greater China segment evolve between 2022 and 2024, particularly in light of supply chain disruptions in 2022 and the continued reliance on the region for manufacturing and sales in 2024?",
      "original_answer": "In 2022, Apple identified China Mainland as a critical part of its supply chain and acknowledged significant exposure to risks including geopolitical tensions, tariffs, and public health disruptions like the ongoing effects of the COVID-19 pandemic. The company noted that tensions between the U.S. and China had already led to increased tariffs, which impacted gross margins and posed risks to product competitiveness. In 2024, while Apple still categorized Greater China (which includes China Mainland, Hong Kong, and Taiwan) as a distinct and strategically managed segment, there was no explicit mention of efforts to reduce dependency on China Mainland for manufacturing, suggesting continued operational reliance on the region despite earlier risks. The evolution of Apple's geographic risk exposure appears to reflect a balancing act: maintaining strategic presence in the region for both production and sales while managing external threats, though no specific mitigation steps or shifts in revenue concentration were disclosed in the filings.",
      "llm_answer": "Apple’s Greater China segment grew to $74.2 billion in 2022, a 9 % rise from 2021, even as COVID‑19‑related supply‑chain disruptions caused shortages and production delays (see page_25, page_8).  The 2022 filing notes that most manufacturing remains in China Mainland and that supply‑chain interruptions can still impact sales (see page_11).  By 2024 the company still relies on China Mainland for the bulk of its manufacturing and for a sizable share of its sales, as reflected in the continued prominence of the Greater China segment and the company’s risk disclosures about manufacturing in Asia (see page_5).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Apple's continued reliance on China Mainland for manufacturing and sales in both 2022 and 2024, aligning with the ground truth's emphasis on sustained exposure despite risks. It appropriately references supply chain disruptions in 2022 due to COVID-19 and notes ongoing risk disclosures in 2024. However, the $74.2 billion revenue figure for Greater China in 2022 and the 9% year-over-year growth are not present in the original answer (ground truth), which does not include any specific revenue numbers. This introduces unverified quantitative claims, reducing quantitative accuracy. (2) There is no calculation error per se, but the inclusion of unsupported figures (revenue amount and growth rate) undermines factual precision. The ground truth focuses on risk exposure and strategic posture without citing financial metrics for the segment, so these numbers cannot be confirmed as correct. (3) The multi-hop reasoning is sound: the model connects 2022 supply chain risks with 2024 continued reliance, synthesizing information across years and domains (manufacturing, sales, risk disclosures). It correctly infers that persistent risk disclosures imply ongoing dependency, which matches the ground truth’s conclusion about lack of explicit mitigation efforts. (4) Despite the unsupported numbers, the core qualitative assessment—continued operational reliance amid risk—is consistent with the original answer. The response is contextually relevant and addresses the evolution of risk exposure over time, though it adds extraneous data not in the source. Hence, correctness is reduced primarily due to unsupported quantitative claims, but reasoning and relevance remain strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 471,
        "total_tokens": 1914
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did the voting power distribution between Class A and Class B common stock in CMCSA in 2022 relate to the structural changes in equity composition observed in 2023, particularly with respect to the issued and outstanding shares of Class A common stock?",
      "original_answer": "In 2022, CMCSA's Class A common stockholders held 66 2/3% of the combined voting power, while Class B common stock, beneficially owned entirely by Brian L. Roberts, held 33 1/3% of the voting power, with each Class B share carrying 15 votes. By 2023, the number of issued and outstanding shares of Class A common stock had increased from 4,842,108,959 to 5,083,466,045 (issued) and from 3,969,317,931 to 4,210,675,017 (outstanding), indicating continued issuance activity. This increase in Class A shares could have diluted the proportional ownership of Class B stock, though its voting power remained non-dilutable under the company's charter. The structural relationship between the two classes remained intact, but the growing disparity in issued Class A shares versus the fixed Class B shares may have shifted economic ownership dynamics while preserving control concentration through the Class B voting structure.",
      "llm_answer": "In 2022, Class A common stock represented roughly two‑thirds (≈66.7 %) of Comcast’s voting power, with Class B holding the remaining one‑third (≈33.3 %) because each Class B share carries 15 votes (page 38).  In 2023, share repurchases reduced the number of issued and outstanding Class A shares from 5.083 billion to 4.842 billion and from 4.210 billion to 3.969 billion (pages 69‑70), tightening the equity base but leaving the overall voting‑power split essentially unchanged as the Class B share count and vote ratio remained constant.  The repurchases also lowered additional paid‑in capital while boosting retained earnings, reflecting the company’s financial performance.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its correctness. (1) Quantitative inaccuracy: The LLM incorrectly states that in 2023, share repurchases reduced Class A issued shares from 5.083 billion to 4.842 billion and outstanding shares from 4.210 billion to 3.969 billion. The ground truth shows the opposite trend — an increase from 4,842,108,959 to 5,083,466,045 issued and from 3,969,317,931 to 4,210,675,017 outstanding, indicating share issuance, not repurchases. The LLM reversed the years and mischaracterized the direction of change. (2) The answer incorrectly attributes this (false) reduction to share repurchases, which contradicts the ground truth of continued issuance activity. This leads to a flawed conclusion about 'tightening the equity base,' which is unsupported. (3) While the LLM correctly identifies the 2022 voting power split (66.7% for Class A, 33.3% for Class B) and the 15-vote weight of Class B shares, it fails to mention that Class B ownership is concentrated in Brian L. Roberts, a key detail in the original answer. (4) The qualitative reasoning is flawed: instead of discussing potential dilution of economic ownership due to increasing Class A shares, the LLM posits a false narrative of consolidation via repurchases. It also introduces unrelated financial impacts on paid-in capital and retained earnings not asked for in the question. (5) Contextually, the answer addresses voting power and share counts but misrepresents the structural changes in equity composition, failing the multi-hop synthesis between 2022 voting structure and 2023 share changes. The core facts are inverted, leading to a mostly incorrect response despite some correct initial data points.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 467,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did the change in Class B to Class A common stock conversion rate from 2022 to 2024 affect V's voting power structure, and what does this imply about the concentration of control following the reduction in Class B shares outstanding from 245 million to 125 million?",
      "original_answer": "In 2022, the Class B to Class A common stock conversion rate was 1.6059, with 245 million Class B shares translating into 394 million as-converted Class A shares, representing a significant portion of voting power. By 2024, the number of Class B shares outstanding dropped to 125 million, while Class A shares increased to 1,733 million. Although the conversion rate slightly increased to an implied value above 1.6228, the halving of Class B shares significantly reduced their as-converted voting influence. Given that Class B shares historically held 33⅓% of the combined voting power, this reduction likely reshaped the balance of control, potentially increasing the influence of Class A shareholders. This shift suggests a move toward broader shareholder governance, though Class B still retains disproportionate voting rights per share.",
      "llm_answer": "Visa’s 2024 10‑K shows the Class B‑to‑Class A conversion rate rose from 1.6059 in 2022 to 1.6228 in 2024, so each Class B share now converts into slightly more Class A shares and therefore slightly dilutes the relative voting power of Class B holders (each Class B share still carries 15 votes versus one vote for Class A).  With Class B shares outstanding falling from 245 million to 125 million, the total voting power held by Class B is markedly reduced, concentrating control in the hands of the remaining Class B holders (all owned by Mr. Roberts) and increasing the concentration of control. (See V_10k_2022, page 92 for 2022 conversion rate; V_10k_2024, page 59 for 2024 shares outstanding.)",
      "correctness_score": 4,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "1) The LLM answer contains several correct quantitative elements: the 2022 conversion rate (1.6059) and the drop in Class B shares from 245 million to 125 million are accurate. The 2024 conversion rate of 1.6228 is consistent with the implied rate in the ground truth. However, the claim that Class B shares 'dilute the relative voting power' due to a higher conversion rate is factually incorrect—since Class B shares have superior voting rights (15:1), an increase in conversion ratio does not dilute their voting power per se; rather, it reflects adjustments like dividends or stock splits and does not change control dynamics directly.\n\n2) Quantitatively, the numbers cited (1.6059, 1.6228, 245M to 125M) are correct or reasonably inferred. The ground truth implies a conversion rate above 1.6228 based on as-converted calculations, so stating 1.6228 is acceptable. The as-converted Class A equivalent in 2022 (245M × 1.6059 ≈ 394M) matches the ground truth. However, the LLM fails to compute or reference the total Class A shares (1,733 million in 2024), which is critical context for assessing voting power concentration.\n\n3) The reasoning is flawed in a key aspect: the conclusion that control is 'concentrating' in the hands of remaining Class B holders because shares decreased is incorrect. While ownership becomes more concentrated among fewer shares, the overall voting power of Class B as a class is reduced due to the halving of shares—this diminishes their collective influence, not increases it. The ground truth correctly interprets this as a shift toward broader shareholder governance. The LLM incorrectly frames reduced share count as increasing control concentration without considering total voting power erosion.\n\n4) The answer references correct documents and pages, showing contextual relevance. It addresses both parts of the question (conversion rate change and impact on control), but the synthesis is flawed. The claim that Class B shares are 'all owned by Mr. Roberts' is unsupported in the provided ground truth and introduces an unverified entity, reducing qualitative accuracy. Overall, while numerically grounded, the answer misinterprets the implications of the structural change, leading to an incorrect conclusion about control concentration.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 607,
        "total_tokens": 2022
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did the change in Altria Group's (MO) debt guarantee structure through PM USA in 2022 relate to the evolution of release conditions tied to S&P credit ratings in 2023?",
      "original_answer": "In 2022, Altria Group (MO) relied on PM USA to guarantee its debt obligations, with release conditions including the Parent's long-term senior unsecured debt rating by S&P being A or higher. The Guarantees were unconditional and not affected by changes in the debt terms or collateral status. In 2023, the same release condition remained in place, but there was increased emphasis on the potential for guarantees to be voided under bankruptcy or fraudulent transfer laws if PM USA was insolvent or undercapitalized at the time of the guarantee. This suggests that while the formal release condition tied to the S&P rating remained stable, the regulatory scrutiny around the enforceability of guarantees intensified year-over-year, particularly regarding PM USA's financial health at the time of guaranteeing the obligations.",
      "llm_answer": "In 2022 Altria amended its guarantee structure through PM USA to cover the Parent’s debt securities, credit‑agreement borrowings and commercial‑paper program, and added a release clause that the guarantor would be discharged once the Parent’s long‑term senior unsecured debt received an S&P rating of **A or higher**. In 2023 the same release condition remained in force, showing that the evolution of the release trigger was directly tied to the S&P rating threshold established in the 2022 amendment.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the key fact that in 2022, Altria Group (MO) amended its debt guarantee structure through PM USA, with a release condition tied to the Parent's S&P credit rating being A or higher. This matches the ground truth and is repeated accurately in 2023. The dates, entities (Altria, PM USA, S&P), and the specific rating threshold (A or higher) are all factually correct. (2) Quantitative accuracy is perfect: no numerical values beyond the S&P rating threshold are involved, and that threshold is correctly stated as 'A or higher' in both years. Format and meaning match the original answer. (3) However, the LLM answer is incomplete in its qualitative reasoning. While it correctly notes the continuity of the S&P rating condition from 2022 to 2023, it omits the critical evolution highlighted in the ground truth: the increased regulatory and legal scrutiny in 2023 regarding the enforceability of guarantees under bankruptcy or fraudulent transfer laws, particularly if PM USA was insolvent or undercapitalized. This is a key part of how the guarantee structure 'evolved' despite the formal condition remaining unchanged. The LLM fails to synthesize this multi-hop insight about legal risk intensification, focusing only on the static rating trigger. (4) Therefore, while the core factual elements are correct and contextually relevant, the answer lacks depth in explaining the true 'evolution' of release conditions beyond the rating threshold, leading to a correctness score of 7. The qualitative accuracy is reduced for missing this key nuance, though quantitative and contextual scores remain high.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 449,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Cisco's increased issuance of senior fixed-rate notes from $9.0 billion in 2022 to $13.5 billion in 2024 impact the structure and risk profile of its commercial paper notes program, particularly in relation to interest rate sensitivity and hedging strategies?",
      "original_answer": "In 2022, Cisco had $9.0 billion in principal amount of senior fixed-rate notes outstanding, with a fair value of $9.7 billion, and a 50 BPS interest rate change impacting the fair value by $0.3 billion. By 2024, Cisco significantly increased its senior notes issuance to $13.5 billion. This expansion was accompanied by interest rate hedging strategies, including a $0.5 billion interest rate swap converting fixed rates to floating rates based on SOFR, likely aimed at mitigating interest rate risk across both senior notes and commercial paper notes. The 2024 commercial paper program was maintained under a $15.0 billion short-term financing facility, with effective rates incorporating hedging adjustments. The increased fixed-rate debt in 2024 likely heightened the interconnectedness and risk sensitivity between long-term senior notes and short-term commercial paper, necessitating more active hedging and rate management.",
      "llm_answer": "Cisco’s 2024 10‑K shows it issued an additional $4.5 B of senior fixed‑rate notes, raising the total senior‑note balance from $9.0 B in 2022 (page 57) to $13.5 B (page 89). Because the senior notes rank at par with its commercial‑paper program, the short‑term debt program still runs to a $15 B ceiling and the same covenants apply to both (page 88). The larger fixed‑rate balance increased overall interest‑rate exposure, but Cisco offset a portion of that exposure with a $0.5 B SOFR‑based interest‑rate swap that hedges the fair‑value sensitivity of the notes, thereby dampening the impact of market‑rate swings on its commercial‑paper‑like debt portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: the increase from $9.0 billion in 2022 to $13.5 billion in 2024 represents a $4.5 billion increase, which the model correctly identifies. The $0.5 billion SOFR-based interest rate swap is accurately reported. The $15.0 billion commercial paper ceiling is correctly stated. (2) The model correctly cites the interconnectedness of senior notes and commercial paper through ranking and covenants, referencing the $15B facility and shared covenants (per page 88 of the 10-K, consistent with ground truth). (3) The reasoning is sound: the increased fixed-rate debt raises interest rate exposure, and the use of a $0.5B swap to convert fixed to floating rates is correctly interpreted as a hedging mechanism that mitigates sensitivity across the debt portfolio, including commercial paper. (4) The only minor omission is that the ground truth mentions the 2022 fair value ($9.7B) and the $0.3B fair value impact of a 50 BPS change, which the LLM answer does not include. While not critical to the core question, this contextual detail about interest rate sensitivity in 2022 is absent. However, the LLM captures the key multi-hop synthesis: increased fixed-rate issuance → higher interest rate risk → offset by hedging (swap) → reduced impact on short-term debt program. Wording differs but semantic meaning and factual content are equivalent. No factual errors, strong contextual relevance, and excellent use of document evidence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 423,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did the expiration and renewal dynamics of ExxonMobil's production-sharing contracts in Nigeria impact the company's proved reserves in 2024 compared to 2022?",
      "original_answer": "In 2022, ExxonMobil's production-sharing contracts (PSCs) in Nigeria were subject to a 30-year term, including a 10-year exploration period with partial relinquishment required at its end, followed by a 20-year production period that could be extended under the Petroleum Industry Act (PIA) enacted in 2021. By 2024, these contracts influenced the company's proved reserves, with 11% of total proved reserves (on an oil-equivalent basis) associated with PSC arrangements. However, asset sales in Nigeria during 2024 reduced reserves by 0.1 billion oil-equivalent barrels (GOEB), indicating that contract expirations or renegotiations may have led to divestitures or reductions in operational control. This shows a temporal evolution where the contractual framework in Nigeria shaped ExxonMobil's reserve base and asset portfolio over time.",
      "llm_answer": "ExxonMobil’s deep‑water Nigerian PSCs are 30‑year contracts with a 10‑year exploration phase and a 20‑year production phase that can be extended under the Petroleum Industry Act (PIA). Because some PSCs reached the end of their 10‑year exploration period and were not renewed, partial relinquishment under the PIA reduced the company’s Africa proved reserves from 271 million barrels at 12/31/2022 to 224 million barrels at 12/31/2024 (a 47‑million‑barrel decline)【page_32】【page_128】【page_129】, even as global proved reserves rose from 10,234 million barrels in 2022 to 12,638 million barrels in 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative claims. The ground truth states that 11% of ExxonMobil's total proved reserves in 2024 were associated with PSC arrangements and that asset sales reduced reserves by 0.1 billion oil-equivalent barrels (100 million barrels), not 47 million. The LLM claims a decline of 47 million barrels in Africa reserves specifically—from 271 million to 224 million barrels—but this level of granularity and these specific numbers are not supported by the original answer, which does not break down reserves by region or provide exact figures for Nigeria or Africa. (2) The calculation of a 47-million-barrel decline is numerically correct based on the numbers provided (271M - 224M = 47M), but the numbers themselves are not present in the ground truth and appear to be fabricated or misattributed. The original answer only mentions a 0.1 GOEB (i.e., 100 million barrel) reduction due to asset sales in Nigeria in 2024, not a regional Africa decline. (3) The reasoning partially captures the multi-hop element by linking PSC expiration, non-renewal, relinquishment under the PIA, and reserve impacts. However, it incorrectly attributes the decline to non-renewal of PSCs at the end of the exploration phase, while the original answer emphasizes the contractual framework and asset sales as outcomes of expiration/renegotiation dynamics, not outright non-renewal. The LLM also introduces 'deep-water' specificity not present in the original. (4) While the LLM answer is contextually relevant and attempts to explain the contractual dynamics and their impact on reserves, the incorrect numbers and unsupported regional breakdown severely undermine factual accuracy. The qualitative reasoning is partially sound but based on incorrect data, leading to a misleading conclusion. Thus, the correctness score is low due to major quantitative errors, despite relevant context and some accurate conceptual framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 538,
        "total_tokens": 1902
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did the change in KO's weighted-average assumptions used in the Black-Scholes-Merton model between 2023 and 2024 affect the valuation of stock option awards, given the consistent use of the Black-Scholes-Merton model for estimating fair value in both years?",
      "original_answer": "In 2023, KO disclosed the weighted-average assumptions used in the Black-Scholes-Merton model for stock option grants, which directly influenced the fair value estimation of those awards. In 2024, KO continued using the same Black-Scholes-Merton option-pricing model, but updated the weighted-average assumptions, which would have impacted the calculated fair value of new stock option awards. The consistent use of the model across both years allows for a direct comparison of how shifts in assumptions—such as volatility, risk-free interest rate, or expected term—altered the reported expense and fair value of equity compensation, indicating potential changes in KO's stock option strategy or market condition adjustments.",
      "llm_answer": "The 2024 weighted‑average assumptions (dividend yield +0.2 pp, volatility –0.5 pp, risk‑free rate +0.2 pp) pushed the Black‑Scholes‑Merton fair‑value per option up from $9.84 in 2023 to $10.28 in 2024—an increase of $0.44. Because the model was applied consistently, the higher risk‑free rate and dividend yield offset the lower volatility, resulting in a higher overall valuation of the 2024 stock‑option awards.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific numerical values—such as dividend yield change (+0.2 pp), volatility change (-0.5 pp), risk-free rate change (+0.2 pp), and fair value per option increasing from $9.84 to $10.28—that are not present in the original answer (ground truth). The ground truth does not provide any actual numbers or quantify the changes in assumptions or resulting valuations. Therefore, these figures are fabricated or hallucinated, severely undermining factual accuracy. (2) Calculations like the $0.44 increase in fair value are based on these invented numbers, making the quantitative analysis invalid. There is no evidence in the ground truth to support any specific dollar amounts or percentage point changes in assumptions. (3) The qualitative reasoning about how changes in assumptions affect valuation under a consistently applied Black-Scholes-Merton model is sound and aligns with the original answer’s logic. The LLM correctly identifies that shifts in inputs (volatility, risk-free rate, dividend yield) impact fair value and that consistent model use enables comparability—this reflects proper multi-hop reasoning across years and concepts. (4) Contextually, the answer addresses the core question about how assumption changes affected valuation, so relevance is high. However, the hallucination of precise financial data results in a low correctness and quantitative accuracy score despite reasonable conceptual framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 404,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did AIG's inclusion of extended warranty within personal lines evolve from 2022 to 2023, and what impact did this have on the company's short-tail risk exposure in personal insurance?",
      "original_answer": "In 2022, AIG included extended warranty as part of its personal lines offerings under U.S. Personal Insurance, which also included automobile and homeowners' insurance, and consumer specialty products. The segment noted that personal lines were generally short-tail in nature with significant salvage and subrogation recoveries. By 2023, AIG continued to list extended warranty as a component of personal lines, now specifically within UK/Europe and Japan Personal Insurance, again alongside automobile and homeowners' insurance and consumer specialty products, and again described personal lines as generally short-tail. The continued inclusion of extended warranty in personal lines across both years suggests a strategic consistency in AIG’s short-tail risk portfolio composition, maintaining exposure to products with faster claim emergence and recoveries.",
      "llm_answer": "AIG’s 2022 and 2023 10‑K filings both list extended warranty as part of the same “personal lines” portfolio—automobile, homeowners’ and extended‑warranty coverage—without any change in scope or description (2022, page 274; 2023, page 213). Because personal lines, including extended warranty, are classified as short‑tail products, the continued inclusion simply kept the company’s short‑tail risk exposure in personal insurance unchanged (2023, page 215).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. It correctly identifies that AIG included extended warranty within personal lines in both 2022 and 2023, and that this segment includes automobile, homeowners, and consumer specialty products (implied by 'extended-warranty coverage' in context). The answer correctly notes the classification of personal lines as short-tail and concludes that the continued inclusion means no change in short-tail risk exposure—this matches the ground truth's assessment of strategic consistency. The page references (2022, p. 274; 2023, pp. 213, 215) are plausible and support the claims, though not verifiable without access to filings. One minor omission is that the ground truth specifies a geographic shift—extended warranty was under U.S. Personal Insurance in 2022 and moved to UK/Europe and Japan Personal Insurance in 2023—but the LLM does not mention this realignment, only stating there was 'no change in scope or description.' This is a slight inaccuracy in completeness, as the structural evolution across regions is part of the 'evolution' asked in the question. However, the core facts—continued inclusion and stable short-tail exposure—are correct. Quantitative accuracy is perfect: no numerical errors, and dates (2022, 2023) are correct. Reasoning is sound: the model correctly infers that maintaining extended warranty in a short-tail segment preserves risk profile. Semantic equivalence is high, with only minor detail missing. Thus, correctness is high but not perfect due to the omitted geographic shift.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 432,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did the shift in RTX's exposure to U.S. government contract termination risks from 2022 to 2024 influence its revenue recognition methodology under FAR guidelines?",
      "original_answer": "In 2022, RTX faced significant risks tied to U.S. government contract terminations, including the potential for cost overruns, lack of reimbursement for unauthorized costs, and delays in funding due to congressional appropriations. These risks were compounded by the use of fixed-price contracts, where RTX bore the burden of cost overruns. By 2024, RTX's revenue recognition methodology under FAR guidelines evolved to reflect a more structured approach, particularly for long-term defense contracts where revenue was recognized on a percentage-of-completion basis using incurred costs relative to total estimated costs. This shift suggests that RTX adapted its financial planning to better align with FAR's cost-based pricing guidance, likely in response to the earlier risks of contract termination and funding instability. The increased emphasis on cost tracking and progress-based payments in 2024 indicates a strategic response to the volatility observed in 2022.",
      "llm_answer": "RTX’s 2024 filing (pp. 81‑80) shows a higher exposure to U.S. government contract termination risk than in 2022 (pp. 16‑18), highlighted by a $575 million termination charge and additional impairment of contract‑fulfillment costs.  Under FAR, this shift forced the company to tighten its percentage‑of‑completion calculations, increase loss‑provision accounting, and adjust revenue recognition to reflect over‑time performance obligations more conservatively—recognizing revenue only when the risk of termination has been adequately accounted for.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The claim that RTX had 'higher exposure' in 2024 than in 2022 contradicts the ground truth, which states that RTX adapted its methodology to better manage earlier risks—implying improved risk management by 2024, not increased exposure. The $575 million termination charge and impairment of contract-fulfillment costs are not mentioned in the ground truth and appear to be fabricated or misattributed. These numbers cannot be verified and are likely incorrect, failing quantitative accuracy. (2) There is no mention in the original answer of specific charges or impairments in either year, nor any dollar figures related to termination costs. Thus, the inclusion of $575 million is a major factual error. Additionally, the citation of 'pp. 81-80' is illogical (page numbers in reverse) and suspect. (3) The reasoning is partially sound in linking increased termination risk to changes in revenue recognition—such as more conservative percentage-of-completion calculations and loss provisions—but this logic is applied in reverse. The ground truth describes a proactive evolution of methodology from 2022 to 2024 to mitigate prior risks, whereas the LLM implies that worsening conditions in 2024 forced reactive changes. This misrepresents the causal direction and strategic intent. (4) Despite these issues, the answer correctly identifies relevant concepts: percentage-of-completion, FAR guidelines, over-time performance obligations, and conservative revenue recognition in response to termination risk. It also addresses the core question about how risk influenced methodology, maintaining contextual relevance. However, due to major factual and directional errors, especially the unsupported $575M figure and incorrect risk trajectory, the correctness score is low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 499,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Nike's tax restructuring strategy in 2023, which resulted in a 4.7% deferred tax benefit, interact with the Fifteen Percent Minimum Tax introduced under the Inflation Reduction Act of 2022, and how did this relationship affect Nike's consolidated financial statements in fiscal 2024?",
      "original_answer": "In fiscal 2023, Nike implemented a tax restructuring strategy that resulted in a 4.7% deferred tax benefit, aimed at reducing taxable income in future periods. This restructuring occurred in the context of the Inflation Reduction Act of 2022, which introduced a Fifteen Percent Minimum Tax based on adjusted financial statement income, effective for Nike starting June 1, 2023. Despite these changes, Nike reported in fiscal 2024 that the combined impact of the tax restructuring and the new minimum tax provisions did not have a material impact on its consolidated financial statements. This indicates that the deferred tax benefit may have offset potential increases in tax liability under the new minimum tax regime, maintaining overall tax stability for the company.",
      "llm_answer": "Nike’s 2023 tax‑restructuring created a 4.7 % deferred‑tax benefit that was recorded as a deferred‑tax asset (increasing the net deferred‑tax asset to $2,320 million in 2024).  The Inflation‑Reduction‑Act 15 % minimum tax, effective June 1 ,2023, was analyzed and deemed to have no material impact on Nike’s consolidated financial statements for fiscal 2024, so the deferred‑tax benefit remained unchanged in its effect on tax expense and the effective tax rate.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 4.7% deferred tax benefit from Nike's 2023 tax restructuring and the effective date of the 15% minimum tax under the Inflation Reduction Act (June 1, 2023). It also correctly states that the minimum tax had no material impact on Nike’s fiscal 2024 consolidated financial statements. However, it introduces a specific dollar amount—$2,320 million net deferred-tax asset—that is not present in the original answer and cannot be verified from the provided ground truth. This number may be accurate in reality, but since it was not in the knowledge graph source, it constitutes a factual addition not supported by the ground truth, reducing quantitative accuracy. (2) The percentages (4.7%, 15%) and dates (June 1, 2023) are correct. The fiscal years (2023 restructuring, 2024 impact) align with the original. The $2,320 million figure lacks corroboration and appears to be hallucinated or sourced from external data, which violates the evaluation principle of matching the ground truth. (3) The multi-hop reasoning is sound: the model correctly links Nike’s tax strategy, the new minimum tax, and their combined effect on financial statements. It infers that the deferred tax benefit did not materially change the tax expense or effective tax rate due to offsetting effects, which is consistent with the original answer’s conclusion about overall stability. (4) The contextual relevance is perfect—the answer addresses all parts of the question and stays focused. Qualitative accuracy is high due to correct entity identification and logical synthesis, but quantitative accuracy is reduced due to the unsupported dollar figure. Correctness score is 7 because core facts and reasoning are correct, but a significant numerical claim lacks grounding in the provided truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 494,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did the change in voting rights associated with equity awards between 2022 and 2023 reflect PM's evolving approach to executive compensation structure, particularly in relation to the shift from PSU to RSU awards?",
      "original_answer": "In 2022, PM disclosed that PSU awards did not carry voting rights and were tied to performance metrics such as Total Shareholder Return (TSR), adjusted diluted earnings per share growth, and transformation measures (e.g., RRP revenue as a percentage of total). By 2023, PM continued to emphasize non-voting equity instruments but shifted focus to RSU awards, which also lacked voting rights but were subject to time-based vesting rather than performance conditions. This reflects a strategic move toward more predictable compensation vehicles, as evidenced by the $160 million in unrecognized compensation costs for RSUs as of December 31, 2023, expected to be recognized over approximately seventeen months. The consistent use of non-voting equity awards suggests PM's intent to align long-term incentives without diluting shareholder control.",
      "llm_answer": "PM continued to issue both PSUs and RSUs in 2022 and 2023, and neither award type conferred voting rights in either year (PSU awards do not carry voting rights【page 91】【page 111】【page 112】; RSU awards do not carry voting rights【page 90】【page 110】).  However, the 2023 filing shows a shift toward a higher proportion of RSUs relative to PSUs (granted 1,756,750 RSUs vs 482,360 PSUs in 2023 versus 2,020,860 RSUs vs 574,410 PSUs in 2021【page 90】【page 110】【page 91】【page 111】), reflecting a move toward more immediate vesting and liquidity in its executive‑compensation structure while maintaining the non‑voting nature of equity awards.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that both PSUs and RSUs lacked voting rights in both years, which aligns with the ground truth and addresses a key part of the question. However, it introduces a significant factual error by citing 2021 data (2,020,860 RSUs vs 574,410 PSUs) when the question focuses on 2022–2023. The ground truth emphasizes a shift in structure toward RSUs in 2023, but the LLM incorrectly compares 2023 to 2021, not 2022, undermining the validity of the trend it claims to identify. No data for 2022 PSU/RSU grants is provided in the LLM answer, which is a critical omission. (2) The quantitative inaccuracies are severe: the use of 2021 figures instead of 2022 makes the comparison invalid. While the 2023 RSU (1,756,750) and PSU (482,360) numbers may be accurate, the absence of corresponding 2022 grant data prevents a correct year-over-year analysis. Additionally, the ground truth highlights a $160 million unrecognized compensation cost for RSUs as of December 31, 2023—a key financial metric demonstrating the scale and timing of the shift—which the LLM omits entirely. (3) The reasoning partially captures the strategic move toward time-based, non-voting awards but fails to correctly ground it in the 2022–2023 transition. The conclusion about 'more immediate vesting and liquidity' is not well-supported; RSUs typically have time-based vesting but not necessarily 'immediate' vesting, and this characterization misrepresents the nature of RSUs compared to PSUs. The ground truth emphasizes predictability, not liquidity, as the rationale. (4) Despite the incorrect comparative baseline and missing financial data, the LLM does correctly identify the non-voting nature of both instruments and detects a trend toward RSUs, showing some qualitative understanding. It remains contextually relevant and synthesizes information about equity types and voting rights across pages, but the flawed data comparison and missing $160M cost metric reduce factual correctness. Hence, correctness is scored at 6 due to partial accuracy with significant factual and comparative errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 567,
        "total_tokens": 1954
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did GD's reliance on commercial paper issuances in 2023 influence the structure and utilization of its $4 billion credit facility in 2024, particularly in terms of liquidity management and debt deployment strategy?",
      "original_answer": "In 2023, GD emphasized that cash generated from operations, supplemented by commercial paper issuances, was sufficient to meet its liquidity needs and support its capital deployment priorities, including debt reduction and strategic investments. By 2024, GD maintained access to the commercial paper market but had no outstanding commercial paper as of December 31, 2024. Instead, it relied on its $4 billion committed bank credit facility, which was explicitly stated to support commercial paper issuances and general corporate needs. This suggests a strategic shift or refinement in liquidity management—moving from a more active use of commercial paper in 2023 to a more standby posture in 2024, with increased reliance on the credit facility as a stable liquidity backstop.",
      "llm_answer": "GD’s 2023 financials show that the company relied on commercial‑paper issuances to top‑up cash generated from operations (page 47) and, although it had no CP outstanding at year‑end, it maintained the ability to issue CP (page 49).  To support that short‑term liquidity strategy, GD secured a $4 billion committed bank credit facility in 2024 that is expressly “for general corporate purposes and working‑capital needs and to support our commercial‑paper issuances” (page 75).  The facility, which expires in March 2027, is therefore structured as a back‑stop that lets GD repay scheduled fixed‑rate notes with cash on hand and, if necessary, supplement those repayments with CP or other borrowings—providing a flexible liquidity buffer while keeping debt deployment focused on meeting maturities and preserving working capital.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: GD used commercial paper (CP) in 2023 to supplement operating cash flow, had no outstanding CP at year-end 2023, maintained access to the CP market, and in 2024 relied on a $4 billion committed credit facility that supports CP and general corporate purposes. The facility's expiration in March 2027 and its role as a liquidity backstop are correctly stated. (2) Quantitative accuracy is perfect: the $4 billion amount is correct, and no erroneous numbers or dates are present. The reference to 'no CP outstanding at year-end' matches the ground truth's implication for 2023 and confirms no CP as of December 31, 2024. (3) Multi-hop reasoning is sound: the model correctly infers a strategic shift from active CP use in 2023 to a standby posture in 2024, supported by the credit facility’s structure. It synthesizes information across years and instruments (CP and credit facility) to explain liquidity management and debt deployment strategy. (4) The only minor gap is that the LLM does not explicitly state that GD had *no* outstanding commercial paper as of December 31, 2024—a key detail in the ground truth—but this is implied by the context. Wording differs slightly (e.g., 'top-up' vs 'supplemented'), but semantic equivalence is maintained. Overall, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 394,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did the credit arrangement allocations for Nicor Gas change between 2022 and 2024, and what does this indicate about Southern Company's evolving working capital strategy for its gas subsidiary?",
      "original_answer": "In 2022, Nicor Gas had a $700 million allocation under Southern Company Gas' committed credit arrangement expiring in 2026, specifically restricted for its working capital needs. By 2024, this allocation remained at $700 million under a new arrangement expiring in 2029, with the additional note that Nicor Gas was also the borrower under a separate $100 million credit arrangement expiring in 2025. This indicates that Southern Company maintained a consistent base allocation for Nicor Gas' working capital needs while adding a smaller, shorter-term facility, potentially to provide more flexible liquidity management. The extension of the primary arrangement’s maturity from 2026 to 2029 also reflects a strategic shift toward longer-term financial stability for Nicor Gas.",
      "llm_answer": "Between 2022 and 2024, Nicor Gas’s credit allocation stayed at $700 million but shifted from a 2026 to a 2029 maturity, and an additional $100 million arrangement was added that expires in 2025 (2024 table, note (d)【page_223】; 2022 table, note (b)【page_258】). This change shows Southern Company is extending the maturity of credit facilities for Nicor Gas while adding extra working‑capital support, reflecting a shift toward longer‑term, more flexible financing for its gas subsidiary.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Nicor Gas's $700 million allocation remained unchanged between 2022 and 2024, with the maturity extended from 2026 to 2029, and that an additional $100 million credit arrangement expiring in 2025 was added in 2024. All numeric values—$700 million, $100 million, 2026, 2029, and 2025—are factually accurate and match the ground truth. (2) Quantitative accuracy is perfect: dollar amounts and dates are correct, and no calculations are required beyond accurate reporting of figures. Format variations (e.g., $700 million vs $700M) are acceptable and handled correctly. (3) The multi-hop reasoning is sound: the model synthesizes information across two years (2022 and 2024), identifies the continuity of the $700M facility, recognizes the new $100M facility, and infers the strategic implication—longer-term stability and increased flexibility in working capital management. The conclusion about Southern Company’s shift toward longer-term, more flexible financing aligns with the ground truth. (4) The only minor shortcoming is that the LLM does not explicitly mention that the original $700M was 'restricted for working capital needs' in 2022, nor does it clarify that the new $100M facility also supports working capital, which slightly weakens the qualitative completeness. However, the core reasoning and strategic interpretation are preserved. Thus, the answer is semantically equivalent and highly accurate, warranting a 9/10 on correctness and qualitative accuracy, with full marks for quantitative and contextual performance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 436,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did the growth in Microsoft's Server Products and Cloud Services revenue from $79.97 billion in 2023 to $97.73 billion in 2024 reflect the role of Client Access Licenses (CALs) in supporting access rights to SQL Server and Windows Server during this period?",
      "original_answer": "Microsoft's Server Products and Cloud Services revenue increased significantly from $79.97 billion in 2023 to $97.73 billion in 2024. This growth was supported by the continued licensing of Client Access Licenses (CALs), which provide access rights to SQL Server and Windows Server. As part of Microsoft's Intelligent Cloud segment, CALs are directly tied to server product revenue and are essential for enabling customer access to these core server offerings. The substantial year-over-year increase in revenue indicates a strong demand for Microsoft's server infrastructure and cloud services, with CALs playing a foundational role in enabling that access and monetization.",
      "llm_answer": "Microsoft’s Server Products and Cloud Services revenue grew from $79.97 billion in FY 2023 to $97.73 billion in FY 2024, a $17.8 billion increase (see page 93).  That jump reflects a higher volume of Client Access Licenses (CALs) sold, which grant customers the right to use SQL Server and Windows Server and are reported together with the associated server‑product revenue (see page 10).  The expanded CAL sales signal stronger demand for Microsoft’s server offerings and the licensing model that underpins them.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Microsoft's Server Products and Cloud Services revenue increased from $79.97 billion in 2023 to $97.73 billion in 2024, a difference of $17.76 billion, which the LLM correctly rounds to $17.8 billion—this is acceptable under format variation. (2) Quantitative accuracy is perfect: both the starting and ending figures match the original answer, and the calculated increase is accurate. (3) Entity accuracy is strong: Microsoft, CALs, SQL Server, Windows Server, and the Intelligent Cloud segment (implied via context) are correctly identified and linked. (4) The reasoning is sound: the LLM correctly infers that increased CAL sales contributed to revenue growth and that CALs are tied to server product licensing and access rights. It also appropriately references the licensing model as foundational. (5) The answer is contextually relevant and directly addresses how CALs supported revenue growth during the period. The only minor shortcoming is that the LLM does not explicitly state that CALs are 'essential' or 'foundational' in monetization—phrasing present in the original—but it does convey that expanded CAL sales reflect stronger demand and underpin the licensing model, which captures the core idea. Thus, while slightly less comprehensive in qualitative nuance, the answer remains factually and semantically equivalent. No factual errors or omissions affect correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 408,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did the voting power dynamics between UPS's Class B and Class A common stock evolve from 2022 to 2024, and what does this imply about ownership control concentration?",
      "original_answer": "In 2022, Class B common stock (7 shares issued) had 15 votes per share and represented 33⅓% of the combined voting power, with Class A common stock (732 shares issued) holding the remaining 66⅔%. By 2024, Class B shares increased slightly to 733 issued shares, maintaining the same 33⅓% voting power, while Class A shares decreased to 121 issued shares. Despite the reduction in Class A shares, the voting structure remained unchanged, implying continued concentrated control by the holder(s) of Class B stock. This evolution shows a slight consolidation of ownership in Class A shares without altering the established voting balance.",
      "llm_answer": "UPS’s Class B shares—each carrying 15 votes—have remained essentially unchanged (726 in 2022/2023, 733 in 2024) while the Class A shares have risen modestly (127 in 2023 to 121 in 2024)【page_69】. Because the 15‑vote Class B shares dominate the voting pool, the relative voting power of Class B holders stays high, underscoring a highly concentrated ownership control structure.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in numbers and trends. It states that Class B shares were 726 in 2022/2023, but the ground truth reports 7 shares issued in 2022 (not 726), which is a major quantitative error. Similarly, it claims Class A shares increased from 127 in 2023 to 121 in 2024, but the ground truth shows Class A shares decreased from 732 in 2022 to 121 in 2024—this misrepresents both the direction and magnitude of change. The LLM incorrectly implies Class A shares rose when they actually fell sharply. (2) The voting power percentages are omitted entirely: the critical fact that Class B held 33⅓% of voting power despite only 7 shares is missing, undermining the explanation of control concentration. The LLM also fails to note that Class B maintained the same voting power percentage despite share count changes, which is central to the question. (3) The reasoning is partially sound in linking high-vote Class B shares to concentrated control, which aligns with the ground truth implication. However, the multi-hop synthesis is flawed because it uses incorrect base data and misses the key dynamic: while Class A shares were drastically reduced (732 → 121), the voting balance remained unchanged due to structural design, indicating deliberate preservation of control. (4) Contextual relevance is fair because the answer addresses voting power and control concentration, but due to severe numerical errors and omission of key facts (like the correct share counts and voting power split), the overall correctness is low. Minor note: citation to 'page_69' appears fabricated or unverified.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 449,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did the shift in MDT's reliance on Level 1 inputs for mutual fund valuation from 2022 to 2024 reflect changes in their short-term investment strategy?",
      "original_answer": "In 2022, MDT reported $125 million in mutual funds, all valued using Level 1 inputs, indicating a full reliance on quoted market prices. By 2024, the mutual fund holding decreased slightly to $114 million, still entirely based on Level 1 inputs. However, the overall short-term investment value increased from $73 million in 2022 to $114 million in 2024, suggesting a strategic shift toward maintaining a larger liquid position while preserving the same valuation methodology. This shows MDT maintained transparency in valuation but adjusted the scale of short-term investments.",
      "llm_answer": "MDT’s Level 1 valuation of mutual funds fell from $125 million in 2022 to $106 million in 2024 (2022: “Mutual funds | 125 | 125”; 2024: “Mutual funds | 106 | 106”) while short‑term investments rose from $73 million to $80 million (2022: “Short‑term investments | 73 | 73”; 2024: “Short‑term investments | 80 | 80”). This decline in Level 1 mutual‑fund reliance, coupled with a higher short‑term allocation, signals a shift in the company’s short‑term strategy toward a more diversified, liquid portfolio that relies less on highly liquid mutual funds.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, MDT's mutual fund holdings valued with Level 1 inputs were $125 million in 2022 and $114 million in 2024, both fully Level 1. The LLM incorrectly reports mutual funds at $106 million in 2024. Additionally, short-term investments increased from $73 million to $114 million by 2024, but the LLM states they rose only to $80 million. These errors undermine the entire analysis. (2) The cited numbers in the LLM answer (e.g., 'Mutual funds | 106 | 106' and 'Short-term investments | 80 | 80') are factually incorrect compared to the ground truth. The decrease in mutual funds is overstated, and the increase in short-term investments is severely understated. Calculations and comparisons based on these numbers are therefore invalid. (3) The multi-hop reasoning is flawed because it draws conclusions about a strategic shift toward diversification and reduced reliance on mutual funds, which contradicts the ground truth: MDT maintained 100% Level 1 valuation for mutual funds and increased overall short-term investments to match the mutual fund balance, indicating a move toward greater liquidity within the same transparent valuation framework. The LLM incorrectly infers a methodological shift in valuation reliance when none occurred. (4) The contextual relevance is moderate because the answer addresses the right concepts—Level 1 inputs, mutual funds, short-term investments, and strategy shifts—but the incorrect data leads to a misleading interpretation. Due to major quantitative and qualitative errors, the correctness score is low at 3, with quantitative accuracy at 2 (severe number errors), qualitative accuracy at 3 (partially sound logic but based on false premises), and contextual relevance at 6 (relevant topic and structure, but incorrect conclusion).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 506,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Microsoft's use of trustee entities for its 4.50% Notes due 2040 evolve between 2023 and 2024, and what does this indicate about the company's broader indenture management strategy?",
      "original_answer": "In 2023, Microsoft used The Bank of New York Mellon Trust Company, N.A. as the trustee for its 4.50% Notes due 2040. By 2024, subsequent supplemental indentures show Microsoft working more frequently with U.S. Bank National Association for newer note issuances, while still referencing the original indenture with BNY Mellon. This indicates a strategic shift toward diversifying trustee relationships under the umbrella of the original indenture framework, allowing Microsoft greater flexibility in debt issuance administration without renegotiating core trust terms.",
      "llm_answer": "Microsoft’s 4.50 % Notes due 2040 were originally placed under the second supplemental indenture dated September 27 2010 with **The Bank of New York Mellon Trust Company, N.A.** as trustee (see 2023 10‑K, page 103).  The 2024 10‑K lists a new fifteenth supplemental indenture dated November 6 2023 that again names The Bank of New York Mellon Trust Company, N.A. as trustee (page 106) and makes no change to the 2040 notes.  This continuity shows Microsoft’s preference for long‑term, stable trustee relationships and a conservative, consistent approach to indenture management.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the trustee in 2023 (The Bank of New York Mellon Trust Company, N.A.) and cites accurate dates and document references (e.g., second supplemental indenture dated September 27, 2010, and fifteenth supplemental indenture dated November 6, 2023), which aligns with the ground truth. However, it fails to mention the key evolution highlighted in the original answer: Microsoft's increasing use of U.S. Bank National Association for newer note issuances in 2024, indicating a strategic diversification of trustee relationships. Instead, the LLM concludes there is 'continuity' and a 'conservative, consistent approach,' which directly contradicts the ground truth indicating a strategic shift. (2) Quantitatively, all dates, percentages (4.50% Notes due 2040), and trustee names are accurate, and the citation of specific supplemental indentures and 10-K pages supports factual precision. There are no calculation errors. (3) The multi-hop reasoning is flawed: while the LLM correctly retrieves data points about the 2040 notes and trustee continuity, it misses the broader pattern across issuances reflected in the 2024 filings showing increased engagement with U.S. Bank. This omission prevents correct synthesis of Microsoft’s evolving indenture management strategy. The model interprets stability in one series of notes as evidence of overall conservatism, failing to connect newer supplemental indentures with different trustees to a strategic diversification trend. (4) The contextual relevance is moderate because the response addresses the specific 4.50% Notes due 2040 and trustee information, but it does not fully address the question’s focus on *evolution* between 2023 and 2024 or the broader strategic implications, instead offering an incorrect interpretation of the strategy. Hence, the correctness score is low due to a critical factual misinterpretation of the strategic direction despite accurate individual data points.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 535,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Disney's ESPN2 subscriber base in 2023 relate to the programming cost structure described in the same year, and how does this contrast with the introduction of ESPN+ subscriber growth as a strategic priority in 2024?",
      "original_answer": "In 2023, Disney reported that ESPN2 was one of its seven 24-hour domestic sports channels, with programming and production costs being a major component of Sports' operating expenses. These costs included amortization of licensed sports rights and production costs for live sports and original programming. ESPN2, along with ESPN, had an estimated 66 million subscribers in 2023, indicating a mature linear TV business model with significant fixed programming costs.\n\nBy 2024, Disney introduced ESPN+ as a strategic growth priority, reporting approximately 26 million paid subscribers to the direct-to-consumer service. This marked a shift from the traditional linear TV model represented by ESPN2 toward a digital-first DTC approach with subscription fees, pay-per-view, and advertising revenue streams. The 2024 emphasis on ESPN+ growth contrasts with the 2023 focus on traditional sports programming costs, signaling a strategic pivot toward digital distribution and subscriber monetization models.",
      "llm_answer": "In 2023, ESPN2 drew roughly 66 million subscribers, yet the Sports segment’s operating expenses were dominated by programming and production costs—including amortization of licensed sports rights and live‑sports production—underscoring the high cost of sustaining a large linear audience (page_10). By 2024, Disney shifted its focus to ESPN+ subscriber growth as a strategic priority; the DTC service now serves about 26 million paid subscribers and is positioned as a key growth engine, marking a pivot from linear channels toward streaming (page_10).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that ESPN2 had approximately 66 million subscribers in 2023 and that ESPN+ had about 26 million paid subscribers in 2024, matching the ground truth exactly. All numeric values (subscriber counts, years) are accurate and properly attributed. (2) Quantitative accuracy is perfect—both subscriber figures (66 million for ESPN2 in 2023, 26 million for ESPN+ in 2024) are correct, and no calculations are required beyond accurate reporting. Format variations (e.g., 66 million vs. 66 million) are acceptable and do not affect meaning. (3) The multi-hop reasoning is sound: the model correctly contrasts the 2023 cost structure of linear TV (high programming costs for ESPN2) with the 2024 strategic shift toward ESPN+ as a digital-first DTC platform. It captures the pivot from linear to streaming, though it omits minor contextual details such as the mention of ESPN2 being one of seven domestic sports channels or the specific revenue streams (pay-per-view, advertising) emphasized in the original. (4) The answer is semantically equivalent to the ground truth, with only slight compression of detail. The core facts, entities, years, and strategic implications are all accurately conveyed, warranting a high correctness score. Minor deduction in qualitative accuracy due to slightly less elaboration on revenue models, but reasoning remains logically sound and relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 394,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did the composition of SCHW's capital buffer requirements evolve from 2023 to 2024, particularly in relation to the interplay between the Countercyclical Capital Buffer and the Capital Conservation Buffer under regulatory capital rules?",
      "original_answer": "In 2023, SCHW (through its subsidiaries CSC and CSB) was subject to a stress capital buffer of 2.5% for CSC and required to maintain a capital conservation buffer of 2.5% for CSB, while the countercyclical capital buffer (CCyB) remained at zero for both. The capital buffer requirement was calculated as the sum of the SCB, G-SIB surcharge, and CCyB under the Standardized Approach, and as the sum of the 2.5% capital conservation buffer, G-SIB surcharge, and CCyB under the Advanced Approach. By 2024, SCHW maintained the same structure: a 2.5% stress capital buffer for CSC and a 2.5% capital conservation buffer for CSB, with the CCyB still at zero. This indicates that the regulatory framework and SCHW’s compliance approach remained stable year-over-year, with no changes in buffer percentages or calculation methodologies.",
      "llm_answer": "In 2023 Schwab’s bank subsidiaries required an 8.4 % regulatory buffer under the standardized approach, made up of a 5.4 % SCB and a 3.0 % G‑SIB surcharge, with no countercyclical buffer and no capital‑conservation buffer. By 2024 the mix shifted to a 2.5 % capital‑conservation buffer for CSB and a 2.5 % stress buffer for CSC, while the countercyclical buffer stayed at zero—effectively replacing the SCB with a CCB component in the buffer requirement.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2023, SCHW's subsidiary CSC had a 2.5% stress capital buffer (SCB), not 5.4%, and CSB had a 2.5% capital conservation buffer (CCB), with no mention of an 8.4% total buffer. The LLM incorrectly states an 8.4% regulatory buffer composed of 5.4% SCB and 3.0% G-SIB surcharge, which is not supported by the original answer. Furthermore, the claim that the 2024 structure 'replaced' the SCB with a CCB is incorrect—the original answer states that the structure remained unchanged from 2023 to 2024, with both buffers already present in 2023. (2) The numbers are largely fabricated: no 5.4% SCB, no 3.0% G-SIB surcharge, and no shift in composition are mentioned in the ground truth. The correct buffers were stable at 2.5% SCB for CSC and 2.5% CCB for CSB in both years, with CCyB at zero. (3) The multi-hop reasoning is flawed—the model fails to correctly synthesize the consistent year-over-year structure and incorrectly infers a shift in buffer composition. It misrepresents the regulatory framework as changing when it did not. (4) While the answer addresses the right topic (capital buffers for SCHW) and mentions relevant entities (CSC, CSB, CCyB), the core quantitative and qualitative inaccuracies severely undermine correctness. The contextual relevance is moderate because it attempts to discuss the right regulatory concepts, but the factual foundation is unsound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 408,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did Southern Company's notes payable structure with Nicor Gas evolve from 2022 to 2024, and what does this indicate about their liquidity strategy and capital allocation priorities?",
      "original_answer": "In 2022, Nicor Gas had $530 million in commercial paper and $300 million in short-term bank debt, with weighted average interest rates of 0.3% and 0.7%, respectively. By 2024, Nicor Gas had reduced its commercial paper to $172 million and eliminated its short-term bank debt entirely, while the weighted average interest rate on commercial paper increased to 4.6%. This shift indicates a more conservative liquidity strategy, with a reduced reliance on short-term borrowings and a possible reallocation of capital toward longer-term financing or operational investments. The 2024 credit arrangement shows that Nicor Gas is a borrower under a $700 million facility restricted for working capital needs, suggesting a strategic focus on maintaining operational flexibility while managing interest rate exposure.",
      "llm_answer": "From 2022 to 2024, Nicor Gas’s commercial‑paper program shrank from $392 million at 5.5% to $172 million at 4.6% (page 226), while a new $300 million short‑term bank‑debt line at 5.3% was introduced (page 224). This shift shows Southern Company’s move toward a more diversified, lower‑cost liquidity mix—reducing reliance on high‑rate commercial paper and adding stable bank credit to support working capital—highlighting a priority on cost‑effective debt management and liquidity resilience within covenant limits.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2022, Nicor Gas had $530 million in commercial paper at 0.3% interest and $300 million in short-term bank debt at 0.7%, not $392 million at 5.5% as stated. The LLM incorrectly claims a 'new $300 million short-term bank-debt line at 5.3%' was introduced by 2024, whereas the ground truth states that short-term bank debt was *eliminated entirely* by 2024. The only correct figure is the 2024 commercial paper balance of $172 million at 4.6%. (2) Calculations and comparisons are flawed: the LLM implies a reduction from $392M to $172M in commercial paper, but the actual reduction was from $530M to $172M. It also misrepresents the interest rate trend—commercial paper rates rose from 0.3% to 4.6% due to market conditions, not a reduction from 5.5% to 4.6% as implied. (3) The multi-hop reasoning is unsound: the LLM concludes a 'more diversified, lower-cost liquidity mix' and 'adding stable bank credit', which directly contradicts the ground truth showing a *reduction* in short-term borrowings and *elimination* of bank debt—indicating a more conservative, not diversified, strategy. The actual evolution reflects de-leveraging and reduced reliance on short-term debt, not diversification. (4) Contextual relevance is moderate because the answer addresses liquidity strategy and capital allocation, but the conclusions are based on incorrect data and flawed logic, leading to an inaccurate interpretation of Southern Company’s/Nicor Gas’s financial strategy. The mention of 'covenant limits' and 'working capital' shows some relevant context, but it's applied to incorrect facts. Overall, major factual and reasoning errors severely undermine correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 480,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did the change in the number of Class B Common Stock holders from 2022 to 2024, and its convertibility to Class A Common Stock, impact the voting power distribution between the two stock classes in 2024?",
      "original_answer": "In 2022, there were only 3 holders of Class B Common Stock, which carry significantly higher voting rights (15 votes per share). By 2024, the Class B Common Stock remained convertible share-for-share into Class A Common Stock, but the total issued and outstanding shares of Class B were just 9,444,375. Despite their small number, these Class B shares retained 33⅓% of the total voting power, a non-dilutable right that ensured concentrated voting control. Meanwhile, the much larger volume of Class A Common Stock had a diluted per-share voting power dependent on total outstanding shares, resulting in a structural governance imbalance favoring Class B holders.",
      "llm_answer": "In 2024 the number of Class B shares outstanding remained unchanged at 9 million, the same as in 2022【page_91】. Because each Class B share has 15 votes and the company’s articles fix the aggregate voting power at 66 2/3 % for Class A and 33 1/3 % for Class B【page_91】, the share‑for‑share convertibility of Class B into Class A does not alter the overall voting‑power distribution in 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key voting power distribution in 2024 (33⅓% for Class B, 66⅔% for Class A) and the convertibility feature, which aligns with the ground truth. It also correctly notes that the Class B shares retained concentrated voting power despite their small number. However, it inaccurately states that the number of Class B shares was '9 million' when the ground truth specifies 9,444,375—this is a quantitatively imprecise rounding not justified in the context. Additionally, the LLM claims the number of shares 'remained unchanged at 9 million' from 2022 to 2024, but the ground truth does not confirm stability over time, only the 2022 holder count (3 holders) and 2024 share count. (2) The percentage figures (33⅓% and 66⅔%) are correct and match the ground truth. The voting rights (15 votes per share) are accurately mentioned, though not directly impacting the final distribution due to the fixed aggregate voting power. The share count error—9 million vs. 9,444,375—is significant enough to affect quantitative accuracy, especially in financial contexts where precision matters. (3) The reasoning is sound: the model correctly infers that convertibility does not dilute Class B's voting power due to structural provisions, which is a key multi-hop insight from governance terms. It synthesizes voting rights, convertibility, and fixed voting power allocation logically. (4) Despite the numerical inaccuracy, the answer captures the core governance imbalance and non-dilutable rights correctly, making it contextually fully relevant and semantically close to the original. The error is in precision, not conceptual understanding, justifying a high but not top score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 468,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did Duke Energy Progress' decision to form and consolidate DEPSC SF in 2024 relate to the evolution of storm recovery financing strategies compared to 2023, particularly in terms of geographic scope and bond issuance amounts?",
      "original_answer": "In 2023, Duke Energy Progress issued $770 million in storm recovery bonds through DEPNCSF to finance unrecovered regulatory assets related to North Carolina storm costs from 2018 and 2019. By 2024, the company expanded its storm recovery financing strategy geographically to include South Carolina, forming and consolidating DEPSC SF. In April 2024, DEPSC SF issued $177 million in senior secured bonds to recover costs from storms occurring between 2014 and 2022 in South Carolina. This represents a strategic expansion of the storm recovery bond mechanism to cover additional states and a broader historical period of storm-related costs.",
      "llm_answer": "In 2024 Duke Energy Progress created and consolidated DEPSC SF, extending its storm‑recovery financing strategy beyond North Carolina to South Carolina.  DEPSC SF issued $177 million of senior secured bonds in April 2024, adding a new geographic focus, while the existing North‑Carolina VIEs (DECNCSF and DEPNCSF) had issued larger bonds in 2023 (about $208 million and $680 million, respectively) and saw a slight decline in debt balances in 2024.  Thus, the 2024 move broadened the geographic scope and introduced a new, smaller bond issuance to support storm‑cost recovery.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the formation and consolidation of DEPSC SF in 2024 and the $177 million bond issuance for South Carolina storm recovery, which aligns with the ground truth. However, it introduces significant factual errors regarding 2023 bond issuances: the original answer states Duke Energy Progress issued $770 million through DEPNCSF (not split into $208M and $680M across DECNCSF and DEPNCSF). The LLM incorrectly references two separate VIEs and their supposed 2023 issuances, which contradicts the ground truth that only DEPNCSF was used for a single $770M issuance. Additionally, the LLM mentions a 'slight decline in debt balances in 2024' not present in the original answer, introducing unsupported information. (2) The $177 million figure and April 2024 timing are correct. However, the $208M and $680M figures are fabricated or misattributed; the correct 2023 amount is $770M as a single issuance. The LLM also fails to mention that the 2024 bonds covered storm costs from 2014–2022, a key detail about the expanded historical scope. (3) The multi-hop reasoning is partially sound—the model correctly infers a geographic expansion from North Carolina to include South Carolina. However, it fails to accurately synthesize the financial data across years and entities, instead inventing a breakdown of 2023 issuances that does not exist in the source. This undermines the quantitative comparison between years. (4) The contextual relevance is high as the answer addresses geographic scope and bond issuance trends. Qualitative accuracy is moderate due to correct identification of the strategic shift but flawed entity and financial data mapping. Quantitative accuracy is low due to incorrect dollar amounts and invented splits. Correctness score is 6 due to correct core concept (geographic expansion) but major factual errors in financial details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 512,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did the valuation methodology for ADBE's foreign government securities evolve from 2022 to 2024, particularly in terms of their reliance on matrix pricing techniques?",
      "original_answer": "In 2022, ADBE disclosed holding $3 million in foreign government securities, which were categorized under Level 2 inputs and valued using matrix pricing when broker quotes were unavailable, as outlined in the accounting policies. By 2024, ADBE continued to rely on matrix pricing for fixed income securities, including foreign government securities, categorizing them under Level 2 and explicitly stating the use of market approach methodologies and discounted cash flow techniques. The continued use of matrix pricing indicates a stable valuation approach, although the 2024 disclosure provides more detail on the specific inputs used, such as benchmark yields and issuer spreads.",
      "llm_answer": "From 2022 to 2024 Adobe continued to value its foreign‑government securities the same way it values all of its fixed‑income available‑for‑sale holdings: by using matrix‑pricing models supplied by independent vendors (market‑approach and discounted‑cash‑flow methods) and classifying the securities as Level 2. The 2022 Note 6 (page 78) and the 2024 Note 6 (pages 72‑73) both describe this matrix‑pricing reliance, so the methodology did not change between the two periods.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all details are correct: the valuation approach using matrix pricing, classification under Level 2, and reliance on independent vendors using market approach and discounted cash flow methods are consistent with both 2022 and 2024 disclosures. The dollar amount ($3 million) from the original answer is not mentioned in the LLM response, but it is not required to answer the specific question about methodology evolution. (2) The LLM correctly identifies that the methodology did not change between 2022 and 2024, citing consistent use of matrix pricing and Level 2 classification, which matches the ground truth's conclusion of a 'stable valuation approach.' (3) The reasoning is sound and synthesizes information across years and disclosures (e.g., referencing Note 6 in both years), demonstrating proper multi-hop logic. (4) While the original answer adds that 2024 disclosures provided more detail on inputs (benchmark yields, issuer spreads), the LLM omits this nuance but still captures the core continuity and methodology accurately. This minor omission prevents a perfect 10, but the answer remains factually correct, complete for the question asked, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 355,
        "total_tokens": 1649
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did the change in NEE's pension plan allocation to convertible securities from 2022 (10%) to 2024 (5%) reflect a strategic shift in risk management and asset diversification within the broader investment policy?",
      "original_answer": "In 2022, NEE's pension plan allocated 10% of its target asset allocation to convertible securities, indicating a relatively higher emphasis on this asset class as part of its diversified investment strategy aimed at achieving high returns with prudent risk. By 2024, this allocation was reduced to 5%, signaling a strategic de-emphasis on convertible securities. This shift likely reflects a recalibration of risk exposure, as NEE increased its allocation to alternative investments from 13% to 20%, suggesting a broader pivot toward alternative assets perceived as more stable or complementary to traditional equities and fixed income. The pension plan continues to hold convertible securities directly and through a limited partnership, but the reduced percentage indicates a more conservative posture in this segment, aligning with the overall goal of protecting the plan’s funded status and minimizing future employer contributions.",
      "llm_answer": "NEE’s 2024 target allocation lowered convertible‑security holdings from 10 % (the 2022 target shown in the 2021 10‑K) to 5 % (2024 target)【page_101】【page_98】.  This cut reflects a deliberate shift toward a more conservative, diversified mix—reducing exposure to the higher‑risk convertible class while boosting equity, fixed‑income and alternative assets—consistent with the pension plan’s policy to “achieve a high rate of total return with a prudent level of risk taking while maintaining sufficient liquidity and diversification to avoid large losses”【page_98】.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the key quantitative change in NEE's pension plan allocation to convertible securities—from 10% in 2022 to 5% in 2024—matching the ground truth exactly. The years, percentages, and direction of change are accurate. (2) All numbers and dates are factually correct; no calculation errors are present. The LLM accurately reflects the reduction in allocation, and the cited percentages align with the ground truth. (3) The reasoning is mostly sound: the LLM correctly infers a strategic shift toward conservatism and links it to broader risk management goals, citing the plan’s objective of achieving high returns with prudent risk. However, it omits a key multi-hop insight present in the original answer: the increase in alternative investments from 13% to 20%, which is central to understanding the reallocation strategy. While the LLM mentions boosting alternative assets, it does not specify the magnitude of the increase, weakening the depth of the synthesis. Additionally, the original answer notes continued exposure via direct holdings and a limited partnership, a nuance missing in the LLM response. (4) Despite these omissions, the LLM captures the core strategic shift and aligns with the pension plan’s stated investment policy. The answer is contextually relevant and semantically close to the ground truth, but the lack of specific supporting data on alternative investment growth and continued exposure mechanisms prevents a top score. Quantitative accuracy is perfect, and contextual relevance is strong, but qualitative accuracy is slightly reduced due to incomplete multi-hop synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 450,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did the composition of subsidiary guarantors for the CIFSA Senior Notes change between MDT's 2023 and 2024 filings, and what does this indicate about the structure of financial obligations within the Medtronic group?",
      "original_answer": "In MDT's 2023 filing, the subsidiary guarantors for the CIFSA Senior Notes included Medtronic Luxco, Covidien Ltd., and Covidien Group Holdings Ltd. This same composition was maintained in the 2024 filing, indicating that the structure of financial obligations among the subsidiary guarantors remained stable. The consistent guarantor structure across both years suggests no changes in the allocation of financial responsibility for the CIFSA Senior Notes, with the same entities continuing to provide full and unconditional guarantees.",
      "llm_answer": "In the 2024 filing, the CIFSA Senior Notes are guaranteed by Medtronic Luxco, Covidien Ltd., and Covidien Group Holdings Ltd. (see page 51). The 2023 filing listed only Medtronic Luxco and Covidien Ltd. as subsidiary guarantors. The addition of Covidien Group Holdings Ltd. in 2024 indicates that Medtronic has broadened its guarantee network, reflecting a more integrated and potentially more robust structure of financial obligations across its subsidiaries.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that the 2023 filing listed only Medtronic Luxco and Covidien Ltd. as guarantors. The ground truth confirms that all three entities — Medtronic Luxco, Covidien Ltd., and Covidien Group Holdings Ltd. — were guarantors in both 2023 and 2024. The LLM incorrectly claims a change (addition of Covidien Group Holdings Ltd. in 2024), which did not occur. (2) There are no numeric values (e.g., dollar amounts, percentages) in the question or answer, so quantitative accuracy pertains only to correct identification of entities and years. The LLM misidentifies the composition of guarantors by year, which is a critical factual error. (3) The multi-hop reasoning is flawed: the model fails to correctly synthesize the guarantor lists across the two filings, incorrectly inferring a structural change. The correct reasoning, per the ground truth, is that the structure remained stable — a key qualitative insight the LLM misses. (4) Contextual relevance is moderate because the answer addresses the right topic (subsidiary guarantors of CIFSA Senior Notes) and attempts to interpret the implications for Medtronic’s financial structure. However, due to the core factual error, the conclusion about 'broadening the guarantee network' is invalid. The correctness score is low due to major factual and reasoning errors despite relevant framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 388,
        "total_tokens": 1655
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did the change in Nike's acquisition and divestiture strategy from 2022 to 2024 affect its reliance on the Nike Trading Company (NTC) for product sourcing, particularly in light of foreign exchange risk management practices tied to NTC's U.S. Dollar-denominated purchases?",
      "original_answer": "In 2022, Nike pursued acquisitions to support its Consumer Direct Offense strategy while also divesting entities in Argentina, Uruguay, and Chile, with $182 million in held-for-sale assets and $58 million in held-for-sale liabilities. By 2024, Nike's reliance on the Nike Trading Company (NTC) remained central to its sourcing model, as NTC continued to purchase products from third-party factories predominantly in U.S. Dollars and resell them to Nike entities in local currencies. This created foreign currency exposure that Nike actively hedged through its cash flow hedging program. The shift toward divestitures in 2022 indicates a strategic pivot toward streamlining operations, which likely increased Nike’s reliance on centralized sourcing through NTC, amplifying the importance of foreign exchange risk management tied to NTC’s U.S. Dollar-based transactions by 2024.",
      "llm_answer": "Nike’s 2022 divestitures of its Argentina, Uruguay and Chile entities reduced the number of operations that sourced directly from third‑party factories, shifting a larger share of product procurement through its wholly‑owned Nike Trading Company (NTC)【page 94】. By 2024, Nike still relied heavily on NTC for sourcing, and its foreign‑exchange risk‑management program continued to hedge the U.S. dollar‑denominated purchases made by NTC, mitigating currency exposure for non‑U.S. functional‑currency entities【page 85】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: the 2022 divestitures in Argentina, Uruguay, and Chile are correctly identified, and the shift toward centralized sourcing via NTC is accurately described. While the LLM does not explicitly mention the $182M in held-for-sale assets and $58M in liabilities from 2022, these specific figures were not directly tied to the causal mechanism affecting NTC reliance in the question's focus, so their omission does not undermine the core answer. (2) Quantitative accuracy is strong—no incorrect numbers are presented, and the absence of dollar amounts does not constitute an error since the LLM focuses on structural and strategic shifts rather than financial magnitude. (3) The multi-hop reasoning is sound: the model correctly infers that divestitures reduced local sourcing, thereby increasing reliance on NTC, and connects this to foreign exchange risk management through hedging of USD-denominated purchases. This synthesis across operational strategy and financial risk management is logically coherent and supported by the source material. (4) The answer is contextually precise, directly addressing how changes in acquisition/divestiture strategy affected NTC reliance and FX risk practices. The only minor gap is the lack of explicit mention of Nike’s 2022 acquisitions (though the focus on divestitures is justified given their direct impact on sourcing structure), and a slightly fuller explanation of the Consumer Direct Offense strategy context could enhance completeness. However, the core reasoning and factual accuracy remain robust, warranting a high correctness score of 9.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 460,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did the changes in GOOGL's Class A Common Stock repurchase activity from 2023 to 2024 relate to the governance constraints outlined in their Certificate of Incorporation?",
      "original_answer": "In 2023, GOOGL repurchased $62.2 billion of Class A and Class C shares, with $36.3 billion remaining available under the repurchase authorization as of year-end. These repurchases were governed by the Certificate of Incorporation, which specifies that Class A, B, and C shares have identical rights except for voting. In 2024, GOOGL began paying quarterly dividends, distributing $3.5 billion to Class A shareholders during the year. The Certificate of Incorporation, as reinforced by Delaware law, prevents the Board from declaring unequal per-share dividends across share classes, which directly links the repurchase and dividend policies to the governance structure. Thus, the increased financial return to shareholders through both repurchases and dividends evolved within the constraints of the unchanged governance framework defined in the Certificate of Incorporation.",
      "llm_answer": "Alphabet repurchased 78 million Class A shares (≈$62.2 billion) in 2023 and 73 million Class A shares (≈$62.0 billion) in 2024, a modest decline in both share count and dollar amount. The repurchase program is authorized by the Board and executed in the best interests of shareholders, but it does not alter the voting, dividend, or liquidation rights of Class A holders; thus it remains fully compliant with the Certificate of Incorporation’s safeguards that require equal treatment of shares and board approval for any amendments that would affect a class of stock.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partial correctness but has significant factual inaccuracies and omissions. It correctly identifies the $62.2 billion repurchase amount in 2023, aligning with the ground truth, but incorrectly states that Alphabet repurchased $62.0 billion in 2024 (≈73 million shares), which contradicts the original answer—there is no mention in the ground truth of a $62 billion repurchase in 2024. Instead, the ground truth states that in 2024, GOOGL began paying quarterly dividends totaling $3.5 billion to Class A shareholders, not large-scale repurchases. This misrepresents the key shift in capital return policy from repurchases to dividends. (2) The quantitative accuracy is compromised: while the 2023 repurchase figure ($62.2B) is correct, the 2024 repurchase amount is fabricated. The LLM also introduces share counts (78M and 73M) not present in the ground truth, which cannot be verified. The claim of a 'modest decline' in repurchases is unsupported because the ground truth does not provide 2024 repurchase data—instead, it highlights a structural shift to dividends. (3) The reasoning is flawed in its multi-hop synthesis: the question asks how repurchase activity changes relate to governance constraints. The LLM correctly notes that repurchases comply with the Certificate of Incorporation’s equal treatment principle, but it completely misses the critical link between the governance framework and the introduction of dividends. The ground truth emphasizes that the Certificate—reinforced by Delaware law—prohibits unequal per-share dividends across classes, which is a key constraint shaping both dividend and repurchase policies. This central governance-policy linkage is absent in the LLM answer. (4) Contextual relevance is moderate: the answer discusses repurchases and governance, which are relevant, but fails to address the 2024 dividend initiation, a pivotal change. Thus, while the answer is plausibly structured, it substitutes incorrect data for a major factual shift and omits the core multi-hop insight connecting dividends and governance. Correctness is partially maintained on 2023 data and general compliance, but major errors in 2024 facts and reasoning limit accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 596,
        "total_tokens": 1964
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did the restructuring of BNY Mellon's business segments in 2022, including the disaggregation of Investment Services, influence the role of BNY Mellon SA/NV in 2023, particularly in relation to its branch in Amsterdam and its focus on securities services in continental Europe?",
      "original_answer": "In 2022, BNY Mellon restructured its business by disaggregating the Investment Services segment into two new segments: Securities Services and Market and Wealth Services. This reorganization emphasized a sharper focus on core competencies, particularly in asset servicing and global custody. By 2023, BNY Mellon SA/NV, the company's main European banking subsidiary headquartered in Brussels with a branch in Amsterdam, had aligned its operations with these strategic priorities. The Amsterdam branch played a key role in supporting SA/NV’s activities in Securities Services and Market and Wealth Services, particularly in global custody and asset servicing across continental Europe. This indicates that the 2022 restructuring directly shaped the operational focus and regional importance of BNY Mellon SA/NV in 2023, especially in markets served through its Amsterdam branch.",
      "llm_answer": "The 2022 10‑K explains that BNY Mellon split its former Investment Services segment into two new segments—Securities Services and Market & Wealth Services—so that all custody, asset‑servicing and collateral‑management activities were moved into a dedicated securities‑services line of business.  In the 2023 filing, BNY Mellon SA/NV is described as operating within that Securities Services (and Market & Wealth Services) segment, with its Amsterdam branch serving as a hub for the firm’s continental‑Europe global‑custody, asset‑servicing and collateral‑management activities.  Thus the restructuring clarified and reinforced SA/NV’s role as the primary European securities‑services provider, with Amsterdam continuing to support that focus.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 2022 restructuring disaggregated Investment Services into Securities Services and Market & Wealth Services, which is accurately described. The role of BNY Mellon SA/NV in 2023 is correctly tied to these segments, particularly Securities Services, and the Amsterdam branch's function in continental Europe is properly emphasized. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), but dates (2022 restructuring, 2023 operations) are correct. (3) The multi-hop reasoning is sound: the model correctly links the 2022 structural change to the 2023 operational focus of a specific European subsidiary and its branch, demonstrating synthesis across time and entities. (4) The only minor shortcoming is that the LLM does not explicitly mention that SA/NV is headquartered in Brussels (though this is not central to the question’s focus on Amsterdam and securities services). Otherwise, the answer captures the causal relationship between the restructuring and SA/NV’s enhanced role in securities services in continental Europe. Wording differs slightly but maintains semantic equivalence. Thus, the answer is factually complete, contextually relevant, and logically coherent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 366,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did the conversion dynamics between UPS Class A and Class B shares change from 2023 to 2024, and what does this indicate about ownership structure evolution?",
      "original_answer": "In 2023, UPS Class A shares, which carry 10 votes per share, were primarily held by employees, retirees, and founder-related trusts, with 4.6 billion shares authorized. These shares are fully convertible into Class B shares, which have one vote per share and are publicly traded. By 2024, the same 4.6 billion Class A shares remained authorized, but the continued emphasis on convertibility suggests ongoing potential dilution of voting power as conversions occur. The fact that Class B shares remained at 5.6 billion authorized in both years indicates a stable public float despite possible conversions. This ownership structure evolution reflects a balance between maintaining insider control through Class A shares while preserving liquidity through the Class B public trading structure.",
      "llm_answer": "From 2023 to 2024 the company reduced the number of Class A shares converted into Class B shares—from 14 million in 2023 to 11 million in 2024【page_112】, a roughly 21 % decline. This slowdown in conversions indicates a more gradual shift of employee‑/retiree‑held Class A stock into publicly traded Class B shares, reflecting a relatively stable ownership structure with a larger retained Class A stake【page_116】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific quantitative claims—14 million Class A shares converted in 2023 and 11 million in 2024, with a 21% decline—that are not present in the original answer (ground truth) and cannot be verified from the provided context. The ground truth does not mention any actual conversion volumes or year-over-year changes in conversion activity. Therefore, these numbers are factually unsupported and incorrect. (2) The calculation of a 21% decline appears mathematically plausible (3/14 ≈ 21.4%), but since the underlying data points (14M and 11M) are not in the ground truth, the entire quantitative basis is fabricated. (3) The reasoning about ownership structure evolution is partially aligned with the ground truth—mentioning employee/retiree-held Class A shares converting to publicly traded Class B shares and implications for control and stability—but it contradicts the original by asserting a 'slowdown' in conversions, which the ground truth does not support. The original emphasizes structural stability and potential for dilution, not actual trends in conversion volume. (4) The LLM answer fails on multi-hop synthesis because it invents data rather than drawing from the consistent authorization levels (4.6B Class A, 5.6B Class B) and the qualitative implications of convertibility. While it addresses the question's theme (ownership evolution), it does so with incorrect specifics, undermining factual correctness. Contextual relevance is moderate because the topic and entities are correct, but accuracy is low due to hallucinated figures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 436,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did Southern Company's reliance on SCS for operational services in 2022 influence SNG's natural gas transportation agreements and ultimately affect Southern Company Gas' equity earnings from SNG in 2024?",
      "original_answer": "In 2022, Southern Company's operating subsidiaries relied heavily on SCS for a wide range of services, including operations, engineering, and procurement, with costs running into hundreds of millions of dollars. SCS acted as an agent for these subsidiaries in managing long-term interstate natural gas transportation agreements with SNG, which were subject to FERC regulation. These agreements incurred transportation costs that continued through 2024. Southern Company Gas, as an equity investor in SNG, earned $146 million in 2024, the same amount as in 2022, suggesting that despite ongoing reliance and contractual activity through SCS, the financial return from SNG remained flat over the period.",
      "llm_answer": "Southern Company’s 2022 reliance on SCS for operational services included the management of its long‑term interstate natural‑gas transportation agreements with SNG, which incurred $37 million in transportation costs for Southern Company Gas that year【page_165】.  The SCS‑led agreements, governed by SNG’s tariff and FERC regulation, continued to provide a stable revenue stream for SNG into 2024.  That sustained profitability of SNG translated into $146 million of equity earnings for Southern Company Gas from its investment in SNG in 2024【page_217】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error in stating that Southern Company Gas incurred $37 million in transportation costs in 2022, which is not present in the original answer or supported by the ground truth. The original answer mentions 'costs running into hundreds of millions of dollars' for Southern Company's operating subsidiaries via SCS, but does not specify $37 million as transportation costs for Southern Company Gas specifically. This number appears to be either misattributed or incorrectly extracted. However, the equity earnings figure of $146 million in 2024 is correct and matches the ground truth. (2) The quantitative accuracy is compromised due to the unsupported $37 million figure. While $146 million is correctly cited, the erroneous cost number affects the reliability of financial reasoning. The original answer emphasizes that equity earnings were flat at $146 million from 2022 to 2024, a key comparative point that the LLM omits. (3) The multi-hop reasoning is partially sound: the LLM correctly identifies the chain of relationships—Southern Company’s reliance on SCS, SCS managing transportation agreements with SNG, FERC regulation, and the resulting equity earnings. However, it fails to note the lack of change in equity earnings over time, which is central to the original conclusion about flat financial returns despite ongoing activity. (4) Contextual relevance is high as the answer addresses all entities and the causal chain. Qualitative accuracy is moderate due to correct entity identification and logical flow, but weakened by missing comparative earnings data. Correctness score is 6 due to one major quantitative error and omission of a key analytical point (flat earnings), though core elements like the $146M 2024 earnings and SCS’s role are accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 494,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did the change in default rate assumptions for Boeing's customer financing portfolio between 2022 and 2023 affect the concentration risk in specific aircraft models they finance and produce?",
      "original_answer": "In 2022, Boeing applied a 24.2% default rate to CCC-rated receivables in its customer financing portfolio, indicating significant credit risk exposure. By 2023, the default rate assumption for CCC-rated receivables increased to 100%, signaling a complete loss expectation for this risk category. This change in default rate assumptions directly impacted the concentration risk in specific aircraft models that dominate the financing portfolio. In 2022, the portfolio was concentrated in certain aircraft models, and by 2023, Boeing continued to have significant exposure to those same models, but with heightened credit risk due to the more conservative default assumptions. This evolution suggests that Boeing's risk profile for aircraft models in its financing portfolio became more severe from 2022 to 2023, likely reflecting ongoing challenges in airline customer liquidity and market demand for specific aircraft types.",
      "llm_answer": "Boeing’s 2023 10‑K shows a sharp rise in the default‑rate assumption for CCC‑rated receivables (to 100 % from the 24.2 % used in 2022) while the rates for BB and BBB remained low (2.4 % and 0.1 %)【page_78】.  The higher allowance for CCC defaults reduced the net exposure of aircraft models that were heavily weighted in that rating group, thereby lowering concentration risk across the portfolio.  Concentration risk data for 2023 versus 2022 confirm this: exposure for 717, 747‑8, 737, 777, MD‑80, 757 and 747‑400 all fell (e.g., 747‑8 from $394 M in 2022 to $129 M in 2023, 737 from $186 M to $156 M, MD‑80 from $96 M to $0)【page_78】.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual and reasoning errors that deviate from the ground truth. (1) Quantitatively, while the default rate assumptions (24.2% in 2022 and 100% in 2023 for CCC-rated receivables) are correctly stated, the specific dollar amounts for aircraft model exposures (e.g., 747-8 from $394M to $129M, 737 from $186M to $156M, MD-80 from $96M to $0) are not supported by the original answer and appear fabricated or misattributed. The original answer does not provide any model-level financing exposure figures, so these numbers cannot be verified and contradict the ground truth's more qualitative assessment. (2) The LLM incorrectly concludes that the increase in default assumptions 'reduced the net exposure' and 'lowered concentration risk', which is the opposite of the original answer's conclusion that risk became 'more severe'. The logic is flawed: increasing default assumptions reflects higher perceived risk, not reduced concentration risk. In fact, higher default assumptions increase expected losses and signal greater risk concentration, especially if the same models remain heavily financed. (3) The multi-hop reasoning fails: the original answer emphasizes that concentration in specific models persisted into 2023 but under a more conservative (i.e., worse) risk assessment framework. The LLM incorrectly infers that lower reported exposures (which are not in the ground truth) reduce risk, missing the core point about deteriorating credit quality. (4) Entity accuracy is partially correct (Boeing, CCC-rated receivables, years), but the introduction of specific aircraft model exposures and their changes is unsupported. Contextual relevance is moderate as it addresses the question's domain, but the incorrect synthesis undermines usefulness. Overall, the answer misrepresents both the data and the risk interpretation, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 511,
        "total_tokens": 1913
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did the scope and focus of Deloitte's audit services for Southern Company evolve from 2022 to 2023, particularly in relation to system implementation internal controls and new regulatory reporting requirements like GHG emissions?",
      "original_answer": "In 2022, Deloitte's audit services for Southern Company included reviewing internal controls for a system implementation and audit services associated with green bond expenditures. By 2023, the scope expanded to include additional services related to GHG emissions attestations and sustainability bond expenditures, indicating a broadening of focus to include emerging regulatory reporting areas while continuing to address internal controls for system implementation. This reflects an evolution in the services provided by Deloitte to address new compliance demands faced by Southern Company.",
      "llm_answer": "In 2022 Deloitte’s audit‑related work was largely confined to reviewing internal controls for a system implementation, with only a modest amount of GHG‑emissions attest services (see page 345, note (2)). By 2023 the scope broadened to include extensive GHG‑emissions attest work and sustainability‑bond reporting for all subsidiaries, and the audit‑related fees for Southern Power and Southern Company Gas rose sharply—reflecting a shift toward regulatory‑reporting requirements (see page 311, note (2)).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the evolution of Deloitte's audit services from 2022 to 2023, noting the expansion into GHG emissions and sustainability reporting. However, it introduces a detail not present in the ground truth—'only a modest amount of GHG-emissions attest services' in 2022—which is unsupported by the original answer and may misrepresent the scope. The original answer states that 2022 included green bond expenditures but does not mention any GHG emissions work until 2023. This is a minor factual overreach. (2) There are no explicit numbers (e.g., dollar amounts, percentages, fee increases) in either the original or LLM answer, so quantitative accuracy is not compromised—though the LLM references 'page 345' and 'page 311' which are not part of the ground truth and may be hallucinated. These citations reduce confidence in sourcing but do not affect factual correctness directly. (3) The multi-hop reasoning is mostly sound: the model correctly infers a broadening of audit scope from system controls to include sustainability reporting. It correctly links GHG emissions and sustainability bonds to regulatory reporting trends. However, the claim about 'all subsidiaries' and 'sharp rise' in fees is not in the original and represents an unsupported extension. (4) Despite these additions, the core message—that Deloitte’s services expanded in 2023 to include GHG and sustainability reporting while continuing system implementation controls—aligns with the ground truth. The answer is contextually relevant and captures the key evolution, but with minor inaccuracies in scope attribution for 2022 and unsupported specifics. Hence, correctness is rated 7 for being substantially right but with notable embellishments.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 479,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Southern Company's approach to environmental compliance cost recovery from industrial customers evolve between 2023 and 2024, and what does this indicate about their risk mitigation strategy given the 96% investment coverage ratio through 2029 in long-term PPAs?",
      "original_answer": "In 2023, Southern Company expressed concern that environmental compliance costs recovered through regulated rates could lead to reduced demand from industrial customers due to higher prices. By 2024, the company demonstrated a shift in strategy, evidenced by a 96% investment coverage ratio through 2029 via long-term PPAs with industrial and commercial counterparties, 92% of which were with investment-grade rated entities. This indicates a strategic pivot toward securing stable revenue streams through contractual commitments, reducing exposure to demand volatility from environmental cost pass-throughs. The evolution from general regulatory cost recovery mechanisms to structured long-term agreements shows a proactive risk mitigation approach, aligning environmental compliance spending with contracted revenue visibility.",
      "llm_answer": "Southern Company’s 2023 filing shows that environmental‑compliance costs were largely recovered through state‑rate mechanisms for its traditional electric operating companies (Rate CNP Compliance for Alabama Power, the ECO Plan for Mississippi Power, and an ECCR tariff for Georgia Power) and, for Southern Power, through long‑term PPAs that allow the counterparty to bear new environmental‑law costs (page 89).  In 2024 the company continued to rely on PPAs, but the emphasis shifted to long‑term contracts that include capacity charges expressly designed to recover fixed and variable operating costs—including environmental compliance expenses—while providing a return on investment (page 13).  This contractual focus, coupled with a 96 % investment‑coverage ratio through 2029 for its PPAs, signals a risk‑mitigation strategy that secures revenue streams and protects capital investments against the volatility of regulatory‑driven costs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key numbers are correct: the 96% investment coverage ratio through 2029 is accurately reported, matching the original answer. There are no calculation errors. (2) The LLM correctly identifies the shift from 2023 to 2024: in 2023, environmental compliance cost recovery relied on state-specific regulatory mechanisms (e.g., ECO Plan, ECCR tariff) and PPAs where counterparties bore new environmental costs. In 2024, the emphasis shifted to structured long-term PPAs with capacity charges covering compliance costs and ensuring return on investment. (3) The reasoning is sound and reflects multi-hop synthesis: it connects the evolution in cost recovery mechanisms with the strategic use of long-term PPAs and interprets this as a risk mitigation strategy against regulatory and demand volatility. (4) The only minor omission is that the LLM does not explicitly mention that 92% of the PPA counterparties were investment-grade rated, a detail present in the ground truth that strengthens the risk mitigation narrative. However, the core strategic implication—that long-term PPAs reduce exposure to volatility—is clearly conveyed. Wording differs but semantic meaning is equivalent. The answer is fully contextually relevant and addresses both the evolution in approach and its implication for risk mitigation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1473,
        "completion_tokens": 388,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did the expiration of extended market exclusivity for LLY's biologic products in 2022, which relied on 12-year U.S. data protection and potential EU orphan designations, influence their 2023 strategy to defend patent rights amid regulatory threats like the proposed EU pharmaceutical legislation that would reduce data package protection by two years?",
      "original_answer": "In 2022, LLY relied heavily on extended market exclusivity for biologics, particularly through the 12-year U.S. data protection period under the BPCIA and potential orphan designations in the EU, which provide seven years of market exclusivity. These protections were critical for maintaining revenue streams from key biologics. By 2023, LLY faced increasing regulatory risk, including a proposal by the European Commission to reduce data package protection by two years, directly threatening the duration of market exclusivity for their biologics. This regulatory shift, combined with U.S. legislative proposals to limit patent strategies, forced LLY to emphasize stronger defense of existing patent rights and to advocate against policy changes that could further erode their intellectual property position. The company's 2023 disclosures reflect a strategic pivot toward reinforcing patent portfolios and engaging in policy advocacy to preserve exclusivity periods.",
      "llm_answer": "In 2022 the 12‑year U.S. data‑protection period for several Lilly biologics expired, and the company had also been relying on EU orphan‑drug exclusivities to extend market exclusivity (see pages 8–9). The loss of that extended exclusivity prompted Lilly to intensify its 2023 IP strategy, focusing on litigation and enforcement of patents, pursuing additional data‑protection mechanisms, and closely monitoring regulatory proposals such as the EU draft legislation that would cut data‑package protection by two years (see pages 28–29).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key facts are correct: the 12-year U.S. data protection period is accurately cited, and the reference to EU orphan exclusivity is consistent with the original. The mention of the EU proposal to cut data-package protection by two years is factually correct. No calculations are required, and all timeframes (2022 expiration, 2023 strategy) are properly aligned. (2) The answer correctly identifies the entities: LLY (Lilly), U.S. and EU regulatory frameworks, and the relevant years. (3) The reasoning is sound and captures the multi-hop logic: the expiration of exclusivity in 2022 led to a strategic shift in 2023 toward stronger patent defense and monitoring of adverse regulatory proposals, particularly the EU legislation. The LLM correctly infers causality and strategic response. (4) While the original answer includes additional context about policy advocacy and legislative threats in the U.S., the LLM answer captures the core strategic pivot—intensified IP enforcement, litigation, and monitoring of EU regulatory changes. It omits explicit mention of 'advocacy against policy changes' but implies it through 'monitoring regulatory proposals.' This minor omission prevents a perfect 10 on qualitative accuracy, but the answer remains semantically equivalent in intent and substance. Contextual relevance is full—every part of the response addresses the question directly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 406,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Microsoft's treatment of Software Assurance in Enterprise Agreements evolve from 2022 to 2023, particularly regarding unearned revenue treatment?",
      "original_answer": "In 2022, Microsoft's Enterprise Agreements explicitly included Software Assurance (SA) as part of the licensing offering for medium or large organizations over a three-year period. By 2023, SA remained a key component, but Microsoft began emphasizing unearned revenue treatment for SA, recognizing revenue ratably over the coverage period for multi-year agreements. This shift reflects a more formalized revenue recognition approach for SA, particularly as unearned revenue now included SA alongside cloud services under multi-year volume licensing programs. The evolution shows how Microsoft aligned its accounting policy for SA with broader financial reporting standards, particularly in how it recognized revenue over time rather than upfront.",
      "llm_answer": "In the 2022 10‑K, Microsoft treated Software Assurance (SA) as part of the overall license revenue and did not record a separate unearned‑revenue balance for SA (see page 19). By fiscal year 2023, the company explicitly recognized SA revenue ratably over the contract period and recorded unearned revenue for SA payments received in advance, as detailed in the revenue‑recognition note (page 62) and the unearned‑revenue note (page 63).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. It correctly identifies the evolution in Microsoft's treatment of Software Assurance (SA) from 2022 to 2023, particularly regarding unearned revenue. In 2022, SA was included in overall license revenue without a separate unearned revenue balance, which matches the ground truth's description of SA being part of licensing offerings without explicit ratable recognition. By 2023, the LLM correctly states that Microsoft began recognizing SA revenue ratably over the contract period and recording unearned revenue for advance payments, citing specific notes and pages from the 10-K—this reflects the formalized revenue recognition approach mentioned in the original answer. The LLM accurately captures the shift in accounting policy in line with financial reporting standards, even if it doesn't explicitly mention 'alignment with broader standards' or 'cloud services comparison.' All entities (Microsoft, Software Assurance, 2022–2023 timeline, unearned revenue, ratable recognition) are correct. The reasoning is sound and synthesizes multi-hop information across fiscal years and accounting treatments. The only minor omission is the broader context that SA remained a key component of Enterprise Agreements and its grouping with cloud services in unearned revenue, which slightly reduces qualitative completeness. However, the core financial and accounting evolution is correctly and precisely conveyed, with accurate page references and terminology. Quantitative elements (fiscal years, treatment changes) are correct, and the answer is highly relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 449,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Disney's strategic shift from traditional ESPN linear channels like ESPNEWS in 2022 to ESPN+ and international expansion in 2023 affect their subscriber monetization strategy, given ESPNEWS had 56 million traditional subscribers in 2022 and ESPN+ reported 26 million paid subscribers with exclusive UFC PPV rights in 2023?",
      "original_answer": "In 2022, Disney's ESPN network included traditional linear channels like ESPNEWS with 56 million subscribers, relying on MVPD distribution and advertising revenue. By 2023, Disney shifted strategy toward direct-to-consumer offerings like ESPN+, which had 26 million paid subscribers and exclusive UFC PPV rights, enabling higher monetization per subscriber through subscription fees and pay-per-view. Internationally, ESPN expanded to 55 million subscribers across 115 countries. This transition from traditional linear to DTC platforms allowed Disney to capture more direct consumer revenue streams and improve monetization flexibility through bundling with Disney+ and Hulu.",
      "llm_answer": "Disney’s pivot from linear ESPN channels to a DTC‑centric model moved monetization from affiliate‑fee and advertising revenue to subscription and pay‑per‑view income.  ESPNEWS carried 56 million traditional subscribers in 2022, but by 2023 ESPN+ had 26 million paid subscribers, driven in part by exclusive UFC PPV rights (page 10, page 9).  International expansion added roughly 55 million subscribers to ESPN‑branded channels outside the U.S. (page 10), allowing Disney to capture higher‑margin subscription and PPV revenue worldwide while reducing reliance on linear network fees (page 8).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts: ESPNEWS had 56 million traditional subscribers in 2022, ESPN+ had 26 million paid subscribers in 2023 with exclusive UFC PPV rights, and international expansion reached 55 million subscribers across ESPN-branded channels. All numbers and years match the ground truth exactly. (2) Quantitative accuracy is perfect—no calculation errors, and all figures (56M, 26M, 55M) are correctly cited with appropriate context. Format variations (e.g., 56 million vs 56M) are acceptable and handled correctly. (3) The multi-hop reasoning is sound: the answer synthesizes information across years (2022 to 2023), platforms (linear vs DTC), and geographies (U.S. vs international), correctly concluding that Disney shifted from affiliate fees and advertising to higher-margin subscription and PPV revenue. It captures the strategic intent of improved monetization flexibility, though it omits explicit mention of bundling with Disney+ and Hulu, which slightly weakens the qualitative completeness. (4) Contextual relevance is excellent—the response directly addresses the question about monetization strategy shift and supports each claim with relevant data. The only minor gap is the absence of the bundling point, which prevents a perfect 10 on qualitative accuracy. Overall, the answer is factually correct, well-reasoned, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 395,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did the composition of AIG's structured securities portfolio, particularly its exposure to CMBS, change from 2022 to 2023 in terms of fair value and unrealized losses, and what might this indicate about AIG's investment strategy or risk exposure?",
      "original_answer": "In 2022, AIG's CMBS holdings had a total fair value of $13.348 billion with $1.420 billion in gross unrealized losses. By 2023, the CMBS exposure decreased to $11.056 billion in fair value, with $1.246 billion in gross unrealized losses. This reflects a reduction in CMBS holdings and a slight improvement in unrealized losses, suggesting a potential de-risking or rebalancing of AIG's structured securities portfolio. Structured securities, including CMBS, are a key component of AIG’s investment strategy, and the shift may indicate a response to market conditions or internal risk management adjustments.",
      "llm_answer": "AIG’s CMBS holdings were largely unchanged in total fair value—down only $65 million from $14.193 billion in 2022 to $14.128 billion in 2023【page_168】—but the portion of CMBS in a continuous unrealized‑loss position fell sharply, from $24.968 billion to $11.056 billion, and gross unrealized losses dropped from $1.420 billion to $1.246 billion【page_170】. This shift indicates that AIG has reduced exposure to riskier CMBS, likely through portfolio rebalancing or divestiture, reflecting a more conservative investment stance and lower credit‑risk concentration in its structured securities portfolio.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key numbers. According to the ground truth, AIG's CMBS fair value decreased from $13.348 billion in 2022 to $11.056 billion in 2023—a reduction of $2.292 billion. However, the LLM claims the fair value was $14.193 billion in 2022 and $14.128 billion in 2023, a negligible $65 million drop, which is factually incorrect. Additionally, the LLM incorrectly states that the 'portion of CMBS in a continuous unrealized-loss position' fell from $24.968 billion to $11.056 billion—this $24.968 billion figure does not appear in the ground truth and is likely a confusion with total structured securities or another category. Only the gross unrealized losses are correct: $1.420 billion in 2022 and $1.246 billion in 2023. (2) Calculations: The LLM’s implied change in fair value ($65 million decrease) is wrong both in magnitude and direction relative to the actual $2.292 billion decrease. The drop in unrealized losses ($174 million) is correctly reflected, but the context is distorted. (3) Multi-hop reasoning: The model attempts to infer a de-risking strategy, which aligns with the ground truth interpretation, but this conclusion is based on incorrect data, undermining the validity of the reasoning. It incorrectly uses the $11.056 billion figure (which is the 2023 CMBS fair value) as the 'unrealized-loss portion,' conflating two different metrics. (4) Justification for scores: Correctness is low (3/10) due to major numerical errors despite partial alignment on trend direction (decline in exposure and losses). Quantitative accuracy is very poor (2/10) because most dollar amounts are incorrect. Qualitative accuracy is moderate (4/10) as the general idea of risk reduction is plausible, but entity/metric confusion harms reasoning. Contextual relevance is acceptable (7/10) because the answer addresses the right topic and attempts interpretation, even if based on faulty data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 528,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did MDLZ's beverage segment performance in 2022, particularly in the AMEA region, influence its asset allocation strategy in AMEA for 2023?",
      "original_answer": "In 2022, MDLZ generated $546 million in beverage revenues from the AMEA region, which accounted for 1.9% of the region’s total revenues. Although beverages represented a relatively small portion of the AMEA portfolio, the region itself remained a significant asset holder, with total assets increasing slightly from $9.88 billion in 2022 to $9.965 billion in 2023. This suggests that despite the modest contribution from beverages, MDLZ continued to maintain and slightly expand its asset base in AMEA, indicating strategic confidence in the region’s long-term potential. The persistence of strong asset allocation in AMEA, even with limited beverage-driven revenue growth, implies that other product lines or market dynamics were driving continued investment.",
      "llm_answer": "MDLZ’s beverage segment in AMEA grew from $550 million in 2022 to $593 million in 2023 (page 123, page 122).  In response, the company increased its capital‑expenditure allocation in AMEA from $229 million to $259 million and raised its total asset base from $9,882 million to $9,965 million (page 121), reflecting a strategic shift to support the expanding beverage business in that region.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, MDLZ's beverage revenue in AMEA in 2022 was $546 million, not $550 million as stated. More critically, the LLM claims beverage revenue grew to $593 million in 2023, but the original answer does not provide any 2023 beverage revenue figure, making this a fabrication. Additionally, the LLM asserts that capital expenditure increased from $229 million to $259 million in response to beverage growth, but this information is not present in the ground truth and cannot be verified. While the total asset increase from $9.88 billion to $9.965 billion is correctly cited (with minor formatting differences: $9,882 million ≈ $9.88B), other key numbers are either incorrect or invented. (2) The calculation of growth in beverage revenue and capex is based on false premises. The ground truth does not support any increase in beverage revenues beyond 2022 or link capex changes to beverage performance. (3) The multi-hop reasoning is flawed: the LLM incorrectly infers a causal relationship between beverage segment growth and increased asset allocation, while the original answer explicitly states that beverages contributed only 1.9% of AMEA revenues and that investment persistence was likely driven by other product lines or market dynamics. Thus, the LLM misattributes strategic investment to beverage performance, contradicting the ground truth's conclusion. (4) Despite addressing the question’s structure and region/company correctly (hence moderate contextual relevance), the answer fails on core factual accuracy and reasoning, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 455,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did the sensitivity of UPS's pension obligations to discount rate changes evolve from 2022 to 2024, and what does this imply about the company's bond matching approach in managing long-term liabilities?",
      "original_answer": "In 2022, UPS disclosed that as of December 31, 2021, each basis point change in the discount rate affected the projected benefit obligation by a specific amount (in millions), indicating the sensitivity of pension liabilities to interest rate assumptions. By 2024, the company reported the updated impact as of December 31, 2024, showing how this sensitivity had changed over time. Since UPS uses a bond matching approach to determine discount rates—aligning bond cash flows with expected benefit payments—the evolution in sensitivity reflects adjustments in the duration or structure of liabilities, changes in bond market conditions, or refinements in the settlement process. This implies that the bond matching approach was consistently applied but yielded different financial exposures due to temporal shifts in liability profiles or discount rate assumptions.",
      "llm_answer": "From 2022 to 2024 the sensitivity of UPS’s projected pension benefit obligation to a one‑basis‑point change in the discount rate fell from roughly $100 per basis point (increase) and $106 per basis point (decrease) (the 2021 table on page 96 is the closest disclosed figure for 2022) to $57 per basis point (increase) and $60 per basis point (decrease) in 2024 (page 88). The decline reflects that the bond‑matching approach has become more effective—selected bonds now more closely align with the timing and magnitude of future benefit payments, reducing the liability’s exposure to discount‑rate swings and enhancing long‑term liability stability.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative details. The ground truth does not specify actual dollar amounts per basis point change in sensitivity for UPS's pension obligations in 2022 or 2024. The LLM fabricates precise figures—$100/$106 in 2022 and $57/$60 in 2024—which are not present in the original answer or implied by it. These numbers appear to be hallucinated, possibly based on misreading or inventing data from non-existent 'page 96' and 'page 88' references. (2) There are no calculations in the original answer to verify, but the LLM introduces specific arithmetic comparisons (a decline from ~$100 to ~$60) that are unsupported. The original answer only states that sensitivity was disclosed in both years and had changed, without quantifying the change. (3) The multi-hop reasoning is partially sound in that the LLM correctly identifies the bond-matching approach and infers that reduced sensitivity could imply better alignment of bond cash flows with liabilities. This aligns with the implication in the original answer. However, the conclusion that the approach 'has become more effective' goes beyond the original, which only states the approach was consistently applied but yielded different exposures due to liability or market changes—not necessarily improved effectiveness. (4) While the LLM captures the general direction of the question—how sensitivity evolved and what that implies about bond matching—it does so with incorrect data and overconfident interpretation. The contextual relevance is high because it addresses both parts of the question and attempts synthesis, but the factual foundation is weak. Thus, the correctness score is low due to major quantitative errors, despite reasonable qualitative logic and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 489,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did Duke Energy Carolinas' use of Storm Recovery Bonds evolve between 2023 and 2024, particularly in terms of the storm costs being financed and the geographic scope of the associated DECNC SF entity?",
      "original_answer": "In 2023, Duke Energy Carolinas used Storm Recovery Bonds through the DECNC SF entity to finance unrecovered regulatory assets related to storm costs incurred in 2018 and 2019 in North Carolina. By 2024, the company expanded its storm recovery financing to include South Carolina through the newly formed DECSC SF entity, which financed storm costs incurred from 2014 through 2022. The DECNC SF entity remained consolidated under Duke Energy Carolinas, indicating continued reliance on this structure for storm cost recovery, while the addition of the South Carolina-focused entity in 2024 shows a geographic and temporal expansion of the company's storm recovery financing strategy.",
      "llm_answer": "In 2023, Duke Energy Carolinas’ DECNC SF issued bonds to finance storm‑costs incurred in 2018‑2019 in North Carolina.  By 2024 the same entity continued to finance those identical North‑Carolina storm costs, but its long‑term debt fell from $208 million to $198 million, while the geographic scope remained limited to North Carolina (a separate South‑Carolina entity was created for 2014‑2022 storm costs).",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains partial factual correctness but introduces significant inaccuracies and omits key aspects of the evolution in Duke Energy Carolinas' storm recovery bond usage. (1) Correct elements: The answer correctly identifies that in 2023, DECNC SF financed 2018–2019 storm costs in North Carolina. It also correctly notes that the geographic scope for DECNC SF remained North Carolina in 2024. (2) Quantitative inaccuracy: The LLM introduces specific debt figures—$208 million and $198 million—that are not present in the ground truth and cannot be verified; these numbers are likely hallucinated. The original answer does not mention any debt amounts or changes in debt levels, so including them undermines quantitative accuracy. (3) Qualitative and reasoning issues: The LLM incorrectly implies that the DECNC SF entity in 2024 continued financing the 'identical' 2018–2019 storm costs, whereas the ground truth emphasizes a strategic expansion: in 2024, a new entity (DECSC SF) was created to finance South Carolina storm costs from 2014–2022, indicating a broadening of scope. The LLM acknowledges the separate South Carolina entity but fails to frame the overall evolution as an expansion of the financing strategy—both geographically and temporally—which is the core insight of the original answer. (4) Contextual relevance is high because the response addresses the question’s focus on storm costs and geographic scope, but the failure to accurately represent the strategic evolution and the introduction of unsupported numbers reduce correctness and qualitative accuracy. The multi-hop synthesis—linking entity formation, timing of storm costs, and geographic expansion—is incomplete and distorted by extraneous data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 470,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did the shift in NKE's long-term incentive compensation structure from cash-based awards under the LTIP in 2022 to stock-based awards tied to Class A Common Stock in 2023 impact the company's equity compensation strategy and governance risk profile?",
      "original_answer": "In 2022, NKE incurred $16 million in operating overhead expenses related to cash awards under the LTIP, indicating a reliance on cash-based long-term incentives. By 2023, the company transitioned to stock-based awards, with approximately 116 million shares of Class A Common Stock authorized under the LTIP for equity compensation. This shift aligns executive incentives with shareholder value creation but also increased governance risk, as Class A Common Stock carries special voting rights that entrench board control and heighten anti-takeover provisions. The move from cash to equity compensation reflects a strategic pivot toward aligning executive pay with stock performance, while also amplifying structural governance risks tied to dual-class share structures.",
      "llm_answer": "In 2022 the LTIP was largely cash‑based, with $16 million of operating‑overhead expense recorded for cash awards (page 82).  By 2023 the company had shifted almost all long‑term incentives to equity—PSUs, RSUs and options tied to Class A common stock—raising share‑based compensation expense to $460 million (page 104) and making the awards’ fair value a function of the company’s Class A share price (page 103).  This realignment aligns management’s incentives with shareholders and preserves cash, but it also increases dilution and the complexity of equity compensation, thereby raising governance risk by demanding more board oversight and potentially exposing the firm to shareholder concerns over dilution.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the shift from cash-based to stock-based awards between 2022 and 2023 and accurately reports the $16 million cash award expense in 2022 from the ground truth. However, it introduces a new figure—$460 million in share-based compensation expense in 2023—that is not present in the original answer or supported by the provided ground truth. This number may be factually accurate in the actual filing (page 104 reference), but since it's absent from the ground truth knowledge graph, it cannot be verified and represents a divergence in quantitative claims. Additionally, the original answer emphasizes the authorization of 116 million shares under the LTIP in 2023, a key quantitative detail completely missing in the LLM response. (2) While the $16 million figure is correct, the $460 million expense and lack of 116 million share authorization undermines full quantitative accuracy. The LLM adds granular detail (PSUs, RSUs, options) not in the original, which may reflect deeper document insight but isn't corroborated by the ground truth. (3) The reasoning is logically sound: the LLM correctly infers that shifting to equity aligns incentives with shareholders, preserves cash, and increases governance risk through dilution and oversight complexity. However, it misses the core governance risk highlighted in the original—Class A Common Stock’s special voting rights and anti-takeover implications—which is a significant qualitative omission in the multi-hop synthesis. Instead, it focuses on dilution and board oversight, which are valid but secondary risks. (4) The answer is contextually relevant and well-structured, addressing both compensation strategy and governance impact. It synthesizes across years and compensation types appropriately, but fails to incorporate the critical dual-class share governance risk, which is central to the original answer. Thus, while mostly accurate and insightful, the answer is partially misaligned with the ground truth on key facts and emphasis, warranting a score of 7 for overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 559,
        "total_tokens": 1956
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did changes in GOOGL's dual-class stock structure from 2022 to 2024 impact its share repurchase strategy, particularly in relation to the relative voting power of Class A and Class B shares?",
      "original_answer": "In 2022, GOOGL had 44,576,938 shares of Class B common stock outstanding, each carrying 10 votes, compared to 300,754,904 shares of Class A common stock, each carrying 1 vote. This structure gave Class A shareholders a majority of the voting power, though Class B shareholders still held significant influence. By 2024, the company continued repurchasing both Class A and Class C shares, spending $62.0 billion in that year alone, with $44.7 billion remaining available under the new $70.0 billion repurchase authorization. The dual-class structure allowed GOOGL to maintain control while aggressively repurchasing shares, as the repurchases disproportionately affected the float of Class A and Class C shares without diluting the voting power of the Class B shares, which remained unchanged.",
      "llm_answer": "Alphabet’s dual‑class structure did not change between 2022 and 2024 – each Class A share still carries one vote and each Class B share ten votes, and Class B shares remain non‑public and convertible to Class A.  Consequently, Alphabet’s share‑repurchase program continued to target only the publicly traded Class A (and Class C) shares—$59.3 bn in 2022 and $62.0 bn in 2024, with a new $70 bn authorization in 2024—while no Class B shares were repurchased.  The unchanged 1:10 voting‑power ratio meant the repurchase strategy was not altered by any shift in voting rights.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core information from the ground truth with only minor omissions. (1) Quantitatively, the LLM correctly states the $62.0 billion repurchase in 2024 and the $70.0 billion authorization, matching the original answer. The $59.3 billion repurchase in 2022 is not in the ground truth, but this figure may come from external data and does not contradict the provided context, which only mentions 2024 repurchases and authorization. The ground truth does not specify 2022 repurchase amounts, so this addition is not penalized heavily. (2) The dual-class structure is correctly described: Class A (1 vote), Class B (10 votes), no change from 2022 to 2024, and Class B shares are non-public and convertible. The LLM correctly notes that repurchases targeted only Class A and Class C shares, preserving Class B voting power. (3) The reasoning is sound: the unchanged voting structure allowed continued repurchases without diluting control, which aligns with the multi-hop logic in the original answer. (4) The only minor omission is the lack of specific share counts for Class A and Class B in 2022 (44.5M Class B, 300.8M Class A), which were in the ground truth and could have strengthened completeness. However, since the question focuses on the impact on repurchase strategy and voting power dynamics, and the LLM correctly explains that repurchases avoided Class B shares and thus preserved their relative voting power, the core multi-hop synthesis is intact. Wording differs but semantic meaning matches. Thus, the answer is factually correct, contextually relevant, and logically sound, warranting a 9/10.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 449,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did the change in GE's structured settlement annuity portfolio size from 2022 to 2023 impact the company's exposure to mortality risk, given the average attained age of the insured individuals in each year?",
      "original_answer": "In 2022, GE reinsured approximately 27,400 structured settlement annuities with an average attained age of 54, while in 2023, this number decreased to 24,600 annuities with an average attained age of 56. This reduction in portfolio size (by about 2,800 annuities) may have slightly decreased overall exposure, but the increase in average attained age suggests that the remaining insured individuals were closer to life expectancy thresholds, potentially increasing the company's concentration of mortality risk. Since structured settlement annuities offer no ability to require additional premiums or reduce benefits, this demographic shift likely increased GE's financial exposure to mortality risk in 2023 compared to 2022.",
      "llm_answer": "GE’s structured‑settlement annuity portfolio shrank from about 27,400 contracts in 2022 (average attained age 54) to roughly 24,600 contracts in 2023 (average attained age 56)【page_48】【page_20】. The reduction in the number of annuities lowers the company’s aggregate mortality exposure, while the higher average age slightly raises the mortality risk per remaining contract. Net, the portfolio shrinkage results in a modest overall decline in mortality‑risk exposure, tempered by a small increase in per‑contract risk.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer correctly reports the quantitative facts: portfolio size decreased from 27,400 in 2022 to 24,600 in 2023 (a reduction of 2,800), and the average attained age increased from 54 to 56. These numbers match the ground truth exactly, earning full marks for quantitative accuracy. The entities (GE, structured settlement annuities, years 2022 and 2023) are also correct.\n\n2) However, the reasoning and conclusion diverge significantly from the ground truth. While both answers acknowledge that portfolio size reduction lowers aggregate exposure and higher age increases per-contract risk, the LLM concludes a 'modest overall decline in mortality-risk exposure,' whereas the ground truth states that the demographic shift 'likely increased GE's financial exposure to mortality risk' due to the higher concentration of older, more vulnerable annuitants—especially given that benefits cannot be adjusted. This is a critical qualitative difference in interpretation.\n\n3) The multi-hop reasoning is partially sound: the model identifies the two key factors (portfolio size and average age). However, it fails to properly synthesize the implications of an aging portfolio in the context of inflexible benefit structures, leading to an incorrect net assessment. The ground truth emphasizes that the increased age concentration outweighs the benefit of fewer contracts, particularly for structured settlements with no risk-mitigation levers. The LLM underweights this risk concentration.\n\n4) Contextual relevance is high—the answer addresses the question directly and uses appropriate terminology. But due to the incorrect net conclusion about mortality risk exposure, the qualitative accuracy and overall correctness are significantly reduced. The answer is factually precise but logically flawed in its synthesis, resulting in a partially correct (5/10) correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 507,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did the sale of KO Transmission's pipeline facilities in February 2023 impact Duke Energy Ohio's exposure to FERC regulatory risks compared to 2022?",
      "original_answer": "In 2022, Duke Energy Ohio had direct exposure to FERC regulatory risks through its ownership of KO Transmission, an interstate pipeline company subject to FERC rules and regulations. However, in February 2023, KO Transmission sold all of its pipeline facilities and related real property to Columbia Gas Transmission, LLC for approximately book value. This divestiture significantly reduced Duke Energy Ohio's direct exposure to FERC-regulated pipeline operations, shifting its risk profile away from the operational and compliance burdens previously associated with KO Transmission’s 90-mile pipeline and its interconnections. As of 2023, while Duke Energy Registrants remained subject to FERC-enforced cybersecurity and infrastructure protection standards, the removal of KO Transmission’s active pipeline assets from Duke’s portfolio reduced the scope of FERC-specific regulatory obligations tied to interstate gas transportation.",
      "llm_answer": "In 2022 Duke Energy Ohio’s pipeline operations were subject to FERC regulations, creating a regulatory‑risk exposure. The February 2023 sale of all KO Transmission pipeline facilities and related real property to Columbia Gas Transmission removed that FERC‑regulated asset from Duke Energy Ohio’s balance sheet, thereby reducing its exposure to FERC regulatory risks compared with 2022.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and captures the core impact of the KO Transmission sale on Duke Energy Ohio's FERC regulatory risk exposure. (1) All key facts are accurate: the sale occurred in February 2023, KO Transmission sold its pipeline facilities to Columbia Gas Transmission, and this divestiture removed a FERC-regulated asset, thereby reducing regulatory risk. (2) There are no numeric values requiring calculation (e.g., dollar amounts are not specified in either answer, though the original mentions 'approximately book value'—this minor omission does not affect correctness). Dates (2022 and February 2023) are correctly used. (3) The multi-hop reasoning is sound: the model correctly infers that ownership of a FERC-regulated pipeline in 2022 led to regulatory exposure, and its sale in 2023 reduced that exposure. (4) The LLM answer is semantically equivalent to the original, though slightly less detailed—it omits the nuance that Duke Energy Registrants still face some FERC-related obligations (e.g., cybersecurity standards) and doesn't mention the 90-mile pipeline or interconnections. However, these are contextual enhancements rather than critical omissions. The core claim—that FERC regulatory risk exposure decreased due to the sale—is fully supported and correctly reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 362,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did AMD's shift in debt structure between its 7.50% Senior Notes in 2022 and the 2.125% Notes in 2023 reflect changes in its capital strategy and financial positioning?",
      "original_answer": "In 2022, AMD had $312 million outstanding in 7.50% Senior Notes, which carried higher interest costs and were set to mature in August 2022. These notes ranked equally with the 2.125% Notes and were subject to potential repurchase or redemption under certain conditions. By 2023, AMD had significantly reduced its holdings in the 2.125% Notes from $1 million to $0, indicating a strategic move to retire or restructure higher-cost debt. This evolution suggests AMD optimized its capital structure by reducing high-interest liabilities, likely leveraging its $500 million revolving credit facility or other lower-cost financing options to improve liquidity and financial flexibility.",
      "llm_answer": "AMD retired most of its high‑interest 7.50% Senior Notes due 2022 (outstanding $312 million as of Dec 25 2021) and shifted to lower‑cost, longer‑term debt, including 2.125% Convertible Senior Notes due 2026 and other senior notes (page_66, lines 1‑8; page_65, lines 1‑10; page_80, lines 1‑10). The 2.125% notes provide a conversion option that can reduce leverage by converting debt to equity, reflecting a more conservative capital strategy that lowers interest expense and strengthens the balance sheet (page_68, lines 1‑7).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the retirement of the $312 million 7.50% Senior Notes maturing in 2022 and references the 2.125% Notes, aligning with the ground truth. However, it inaccurately states that AMD shifted *to* the 2.125% Notes, when in fact AMD reduced its holdings in those notes from $1 million to $0 by 2023—indicating debt reduction, not expansion. This misrepresents the direction of the shift. (2) Quantitatively, the $312 million figure and 7.50% rate are correct, and the 2.125% rate is accurate. The maturity date of the 7.50% notes (August 2022) is omitted, but the reference to 2022 is acceptable. The claim about shifting to 2.125% Convertible Senior Notes due 2026 is not supported in the ground truth, which does not mention convertibility or a 2026 maturity—this is a factual overreach. (3) The reasoning partially captures AMD’s strategy to reduce interest costs but incorrectly frames the use of 2.125% Notes as a new instrument rather than a liability being retired. The ground truth emphasizes retirement of debt and use of a $500 million credit facility, which the LLM omits, missing a key element of the capital strategy. (4) Despite the mischaracterization of the 2.125% Notes, the answer correctly infers improved financial flexibility and lower interest expense, showing sound directional logic. Contextual relevance is high as it directly addresses capital strategy and financial positioning. The core financial facts are mostly accurate, but the misrepresentation of the 2.125% Notes as part of a new debt issuance rather than a retiring liability prevents a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 446,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Duke Energy's approach to preferred equity financing evolve between 2023 and 2024, particularly with regard to the redemption of its Series A Preferred Stock and its associated Depositary Shares?",
      "original_answer": "In 2023, Duke Energy disclosed its existing capital structure, which included Series A Preferred Stock and its corresponding Depositary Shares, each representing a 1/1,000th interest in a share of that preferred stock. By January 31, 2024, the company announced a definitive plan to redeem all 20,000 outstanding shares of the Series A Preferred Stock and all 20,000,000 associated Depositary Shares on March 15, 2024, at a redemption price of $25,000 per preferred share ($25.00 per Depositary Share). This indicates a strategic shift in Duke Energy’s capital structure management, moving away from this particular preferred equity instrument. In the 2024 filings, while the Certificate of Designations for Series A Preferred Stock was still referenced, there was no new issuance or structural change announced, suggesting the redemption marked a discontinuation of this specific financing vehicle.",
      "llm_answer": "In the 2023 10‑K, Duke Energy described an **optional** redemption of its Series A Preferred Stock: the company could redeem the shares at its option—at $25,500 per share (equivalent to $25.50 per depositary share) if a rating‑agency or regulatory‑capital event occurred before March 15, 2024, or at $25,000 per share thereafter. By the 2024 10‑K, the company announced a **definitive** redemption of all 20,000 shares and the 20 million depositary shares on March 15, 2024 at a fixed $25,000 per share ($25.00 per depositary share), moving from an optional, higher‑priced plan to a scheduled, lower‑priced full redemption.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general evolution of Duke Energy's preferred equity financing approach—shifting from an optional redemption structure in 2023 to a definitive redemption in 2024—and correctly identifies the redemption date (March 15, 2024), the number of shares (20,000 preferred shares and 20 million depositary shares), and the redemption price of $25,000 per preferred share ($25.00 per depositary share). However, there are critical quantitative inaccuracies: the LLM incorrectly states that the optional redemption price was $25,500 per share ($25.50 per depositary share) in the event of a rating or regulatory event before March 15, 2024. The ground truth does not mention any such conditional pricing or event-based trigger; instead, it presents the redemption as a definitive action announced in January 2024 at a flat $25,000/$25.00 rate. This introduces a fabricated financial term not present in the original data. Additionally, the characterization of the 2023 filing as describing an 'optional redemption' is misleading—the original answer states only that the capital structure included the Series A Preferred Stock and depositary shares, with no indication of an optional redemption clause. Thus, while the core event (redemption in 2024) and key numbers (share counts, final price, date) are correct, the inclusion of unverified conditional pricing and redemption terms significantly undermines factual accuracy. The reasoning is partially sound in tracking a shift in capital structure, but the multi-hop synthesis is flawed due to the introduction of non-existent conditions. Contextual relevance is high as the answer directly addresses the evolution in financing approach.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 462,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did the selection of Imbruvica for government price setting in 2023 influence AbbVie's 2024 financial strategy and expected revenue trajectory for the drug ahead of the 2026 pricing implementation?",
      "original_answer": "In 2023, Imbruvica was selected as one of the first 10 medicines subject to government-set prices under the Inflation Reduction Act, with pricing set to begin in 2026. This regulatory development introduced significant risk to AbbVie's revenue outlook for the drug. By 2024, AbbVie had adjusted its financial and strategic planning accordingly, emphasizing pipeline diversification and on-market product investment while noting the potential for accelerated revenue erosion due to the new pricing framework. The company reported $56.3 billion in worldwide net revenues for 2024, but also highlighted the looming impact of the CMS-published Part D prices for Imbruvica, which will take effect in 2026, signaling a strategic shift to mitigate future revenue losses from government price setting.",
      "llm_answer": "AbbVie’s 2024 strategy explicitly acknowledges the impact of the 2023 selection of Imbruvica for Medicare price‑setting.  The company already recorded a $2.1 billion pre‑tax impairment for the drug (page 70) and noted that the new pricing will “significantly impact our results of operations” (page 37).  Accordingly, AbbVie is incorporating the expected 2026 price cuts into its 2024 revenue forecasts, tightening cost management and accelerating other growth drivers while monitoring the Medicare Part B/Part D pricing environment to mitigate the erosion of Imbruvica’s revenue trajectory.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer includes a $2.1 billion pre-tax impairment for Imbruvica in 2024, which is not present in the original answer (ground truth). This specific figure and its sourcing to 'page 70' and 'page 37' of a document are not supported by the provided ground truth, making it a significant factual inaccuracy. The original answer mentions no such impairment charge or specific financial impact beyond strategic adjustments. (2) Quantitatively, the LLM introduces a number ($2.1 billion) that cannot be verified against the ground truth, which only states that AbbVie reported $56.3 billion in total net revenues for 2024—this total revenue figure is accurate but not mentioned in the LLM response, indicating a selective and incomplete use of data. The LLM fails to include this key aggregate revenue figure, which is central to the original answer. (3) Qualitatively, the reasoning is partially sound: the LLM correctly identifies the causal chain—Imbruvica’s 2023 selection for government price setting under the Inflation Reduction Act influenced AbbVie’s 2024 financial strategy with implications for 2026 pricing. It accurately reflects the strategic response, such as incorporating price cuts into forecasts, tightening cost management, and accelerating growth drivers. These align with the original answer’s mention of pipeline diversification and strategic shifts. (4) Contextually, the answer is highly relevant and addresses the core of the multi-hop question—linking 2023 regulatory action to 2024 strategy and 2026 revenue impact. However, the introduction of unsupported financial figures undermines factual correctness. While the LLM captures the directional impact and strategic response, the inclusion of unverified quantitative claims reduces overall accuracy. Hence, a score of 6 is justified: partially correct with significant factual overreach on numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 512,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did the change in Dutch corporate tax rates for the Innovation Box Tax between 2022 and 2023 impact BKNG's effective tax rate, and what does this reveal about their reliance on this tax benefit over time?",
      "original_answer": "In 2022, BKNG benefited from the Netherlands Innovation Box Tax, which applied to a portion of Booking.com's earnings at a 9% rate, down from a previous 7% but below the Dutch statutory rate of 25.8%. This contributed to a lower effective tax rate compared to the U.S. federal statutory rate. In 2023, BKNG again benefited from the Innovation Box Tax at the same 9% rate, but the benefit decreased compared to 2022. This decrease, despite lower international tax rates and a lower valuation allowance, contributed to a relatively stable effective tax rate year-over-year. This reveals BKNG's continued but slightly diminishing reliance on the Innovation Box Tax benefit to reduce its global tax burden.",
      "llm_answer": "The Innovation Box Tax rate stayed at 9 % for both 2022 and 2023 (page 68), but the amount of earnings qualifying for the benefit fell in 2023, which reduced the tax advantage and pushed the effective tax rate slightly higher relative to 2022 (21.8 % vs 22.1 %) before other factors (lower valuation allowances, lower unrecognized benefits, lower international rates) offset it (page 49). This pattern shows that Booking.com has historically relied on the Innovation Box Tax, yet its influence on the effective tax rate is diminishing over time, signalling a potential risk if the benefit were to disappear.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: the Innovation Box Tax rate remained at 9% in both 2022 and 2023, and the effective tax rate increased slightly from 21.8% to 22.1%, which matches the direction and magnitude implied in the original answer (stable year-over-year despite downward pressures). The LLM correctly notes that other factors—lower valuation allowances, lower unrecognized tax benefits, and lower international rates—offset the reduced Innovation Box benefit. (2) The entity identification is accurate: BKNG (Booking.com) is correctly referenced, and the Netherlands Innovation Box Tax is properly contextualized. (3) The reasoning is sound and reflects multi-hop synthesis: the model infers that a reduced benefit from the Innovation Box would increase the effective tax rate, but this was counterbalanced by other favorable items, leading to stability—this matches the original answer’s logic. (4) The conclusion about diminishing reliance over time is consistent with the ground truth’s statement of 'continued but slightly diminishing reliance.' The only minor shortcoming is that the LLM does not explicitly mention the prior rate of 7% or the Dutch statutory rate of 25.8%, which adds context to the benefit’s value. However, this omission does not undermine the core correctness. Overall, the answer is factually precise, contextually relevant, and semantically equivalent to the original.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 409,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Chevron's 2022 reliance on crude oil as a raw material influence its strategic positioning in the TCO crude oil fields by 2023, particularly in light of TCO's 2023 production levels and Chevron's 2023 stake in TCO reserves?",
      "original_answer": "Chevron's 2022 reliance on crude oil as a core raw material directly influenced its continued strategic focus on TCO's crude oil fields in 2023. In 2023, TCO achieved mechanical completion of the Future Growth Project (FGP), with start-up expected in early 2025, and maintained a majority of its crude oil exports through the Caspian Pipeline Consortium (CPC), which transported an average of 1.4 million barrels per day. Chevron maintained a significant stake in TCO, with its proved reserves interest in TCO increasing from 1,263 billion cubic feet (BCF) in 2022 to 1,295 BCF in 2023, reflecting Chevron's ongoing commitment to the project despite broader portfolio adjustments elsewhere. This demonstrates a clear strategic continuity in Chevron's crude oil focus through its sustained investment in TCO.",
      "llm_answer": "Chevron’s 2022 operations were heavily dependent on crude oil as a raw material, with imported crude accounting for roughly 60 % of its U.S. refinery inputs (page_17). This reliance reinforced a strategy to secure stable crude supplies, which by 2023 translated into a stronger position in Tengizchevroil (TCO) – a joint venture where Chevron holds a 50 % stake and where TCO’s production averaged about 1.4 million barrels per day via the CPC pipeline (page_16). Chevron’s 50 % share of TCO’s 1,004 million‑barrel proved reserves reported at year‑end (page_111) further underscored the alignment of its crude‑oil dependence with the TCO fields.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies that significantly impact correctness. (1) Quantitative Accuracy: The LLM claims Chevron holds a 50% stake in TCO and that TCO’s proved reserves are 1,004 million barrels, but the ground truth states Chevron's interest in TCO reserves was 1,295 BCF (billion cubic feet) in 2023—note both the unit (BCF vs. barrels) and the value are incorrect. Additionally, the 60% imported crude figure from page 17 is not in the ground truth and appears irrelevant to the TCO strategic positioning. The 1.4 million barrels per day via CPC is correct and aligns with the ground truth. (2) Completeness: The LLM fails to mention the Future Growth Project (FGP) mechanical completion in 2023 and its expected 2025 start-up, a key strategic development. It also omits the increase in Chevron’s proved reserves interest from 1,263 BCF to 1,295 BCF, which demonstrates growing commitment. (3) Entity Accuracy: While 'Tengizchevroil (TCO)' and 'Caspian Pipeline Consortium (CPC)' are correctly identified, the conflation of cubic feet (gas measure) with barrels (oil measure) suggests a misunderstanding of reserve metrics. (4) Reasoning: The logic connecting crude reliance to TCO positioning is plausible, but the flawed data undermines the synthesis. The use of a 50% stake, while commonly known, is not confirmed in the ground truth and is used to incorrectly calculate reserve shares. (5) Semantic Equivalence: The overall narrative of strategic alignment is present, but due to incorrect metrics and missing key developments (FGP), the answer is only partially aligned. The contextual relevance is high as it addresses crude reliance and TCO positioning, but factual errors reduce overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 470,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did the voting rights structure of META's Class B Common Stock in 2023 affect the governance implications of the first-ever dividend initiation in 2024?",
      "original_answer": "In 2023, META disclosed that Class B Common Stock was not publicly traded and had only 23 stockholders of record, compared to 3,098 for Class A Common Stock. Class B Common Stockholders had limited voting rights, only applicable in specific circumstances such as mergers or amendments to the certificate of incorporation, and their voting power was tied to the conversion rate of Class A stock. In 2024, META initiated its first-ever cash dividend of $0.50 per share for both Class A and Class B Common Stock. Since Class B stockholders were not active participants in regular corporate governance matters and held a minority stake, the dividend initiation had limited impact on governance dynamics. However, the equal dividend treatment across both classes may have aligned interests slightly, despite the structural governance imbalance favoring Class A stockholders.",
      "llm_answer": "In 2023 Meta’s Class B common stock carried limited voting rights—holders could vote only on a few defined matters (e.g., core‑payments exit, mergers, or certain charter amendments)【page_90】. When the company announced its first cash dividend in February 2024, the payment applied to both Class A and Class B shares, but it did not alter the Class B voting structure; holders still had only the same restricted voting rights, so the dividend’s governance impact was limited to providing cash returns without expanding their influence over corporate decisions【page_57】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the limited voting rights of Meta's Class B Common Stock in 2023, specifying that voting was restricted to certain matters like mergers and charter amendments, which aligns with the ground truth. It accurately notes the February 2024 initiation of the first cash dividend at $0.50 per share (implied by context, though not explicitly stated as $0.50) and confirms equal treatment of both share classes. The conclusion that the dividend did not alter the governance structure or expand Class B influence is consistent with the original answer. (2) Quantitatively, while the exact dollar amount of the dividend ($0.50) is not mentioned in the LLM answer, this omission does not constitute a factual error—only a slight lack of specificity. All other temporal markers (2023 governance structure, 2024 dividend initiation) are correct. (3) The multi-hop reasoning is sound: the model correctly synthesizes information about Class B voting rights (from 2023 disclosures) with the 2024 dividend event and infers the limited governance implications due to structural continuity. It correctly links the unchanged voting rights post-dividend to the minimal impact on governance dynamics. (4) The answer is contextually precise, directly addressing how the voting structure affected governance implications of the dividend. The only minor shortcoming is the lack of explicit mention of the number of Class B stockholders (23) and comparison to Class A (3,098), which were in the ground truth and could have enriched completeness. However, this does not undermine the core correctness. Thus, the answer is highly accurate, with only slight room for added detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 464,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "What were the specific tax implications of AMD's 2022 acquisition of Xilinx as reflected in the $4.3 billion of net deferred tax liabilities recorded in AMD's 2023 financial statements?",
      "original_answer": "AMD's 2022 acquisition of Xilinx directly resulted in the recognition of $4.3 billion in net deferred tax liabilities in 2023, primarily due to the excess book basis over tax basis of acquired intangible assets. This includes $857 million in GILTI-related deferred tax liabilities, indicating the international tax impact of the acquisition. These liabilities emerged as part of the post-acquisition accounting process, showing how the acquisition affected AMD's tax position in the year following the deal's completion.",
      "llm_answer": "AMD’s 2022 acquisition of Xilinx generated a $4.3 billion net deferred tax liability in the 2023 statements.  The liability arose from the excess of the book basis over the tax basis of the acquired intangible assets, including a $857 million GILTI net deferred tax liability, and is broken down into $3.1 billion on acquired intangibles, $175 million on right‑of‑use assets, $524 million on GILTI, and $135 million on other items.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $4.3 billion net deferred tax liability from AMD's 2022 acquisition of Xilinx as reflected in the 2023 financial statements and correctly attributes it to the excess book basis over tax basis of acquired intangible assets, including GILTI. However, it introduces specific breakdowns—$3.1 billion on acquired intangibles, $175 million on right-of-use assets, $524 million on GILTI, and $135 million on other items—that are not present in the ground truth. The ground truth specifies only $857 million in GILTI-related liabilities, not $524 million, which is a direct contradiction. Additionally, the sum of the provided breakdown ($3.1B + $0.175B + $0.524B + $0.135B = $3.934B) does not total $4.3B, indicating a calculation or reporting inconsistency. (2) The key number $4.3 billion is correct, and the mention of GILTI is relevant, but the specific allocation of $524 million to GILTI conflicts with the ground truth’s $857 million. The additional line items (right-of-use assets, other items) are not mentioned in the original answer and appear to be fabricated or misattributed. (3) The multi-hop reasoning is partially sound—the model connects the acquisition to deferred tax liabilities and correctly cites intangible assets and GILTI as drivers—but the inclusion of unsupported sub-components undermines the accuracy. It fails to reflect that the $857 million GILTI liability is part of the total $4.3 billion, not a separate or lesser component. (4) The contextual relevance is high because the answer addresses the tax implications of the acquisition and focuses on deferred tax liabilities. Qualitative accuracy is moderate due to correct conceptual framing but incorrect details. Quantitative accuracy is low due to conflicting numbers and internal inconsistency in the sum. Correctness score is 6 due to correct core facts but significant errors in specifics and calculations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 524,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How did Disney's 50% stake in A+E in 2024 enable them to realize a financial gain from the termination of a content license agreement, given FYI's subscriber base as part of the A+E portfolio in 2022?",
      "original_answer": "Disney's 50% ownership in A+E allowed them to capture 50% of the $112 million gain (resulting in $56 million to Disney) from the termination of a content license agreement in fiscal 2023. This financial benefit was possible because FYI, which had 42 million domestic subscribers in 2022, was one of the cable channels under the A+E portfolio. As part of the joint venture structure, Disney's stake entitled them to a proportional share of A+E's financial outcomes, including gains from content licensing decisions.",
      "llm_answer": "Disney’s 50 % ownership of A+E meant that when A+E recorded a $56 million gain from terminating a content‑license agreement, Disney received half of that amount. FYI, a channel within A+E, had 42 million subscribers in 2022, underscoring the size of the portfolio that contributed to the agreement and the resulting gain.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the quantitative description of the gain. The ground truth states that A+E recorded a $112 million gain, of which Disney received 50%, or $56 million. However, the LLM incorrectly states that A+E recorded a $56 million gain and that Disney received half of that (which would be $28 million), reversing the correct logic and halving the actual gain. This is a major calculation and factual error. (2) The subscriber number (42 million for FYI in 2022) is correctly cited, and the ownership stake (50%) is accurate. However, the core financial outcome is wrong, undermining the answer's correctness. (3) The multi-hop reasoning is partially sound—linking Disney's stake to A+E, FYI as part of the portfolio, and the termination gain—but fails in accurately representing the financial flow: the gain was $112M at the A+E level, not $56M. The LLM misattributes the $56M as the total gain rather than Disney's share. (4) Contextual relevance is high because the answer addresses all components of the question (stake, termination gain, FYI subscribers), but the quantitative inaccuracy severely limits correctness. Thus, correctness and quantitative accuracy are low; qualitative accuracy is moderate due to correct entities and structure; relevance is high.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 368,
        "total_tokens": 1591
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did the financial risk profile of Boeing's fixed-price development contracts, particularly the KC-46A Tanker program, evolve from 2022 to 2023, and what impact did ongoing supply chain and labor disruptions have on cost estimation uncertainties in 2023 compared to prior-year challenges like those from the pandemic?",
      "original_answer": "In 2022, Boeing faced significant financial risk from fixed-price development contracts, especially the KC-46A Tanker, where $402 million in additional losses were recorded in Q4 due to factory and supply chain disruptions, including the impact of the pandemic. By 2023, while the structure of risk remained, the nature of challenges evolved with ongoing supply chain and labor disruptions becoming central to cost estimation uncertainties. Auditors noted increased complexity in estimating final costs for the KC-46A Tanker and other programs, with these disruptions compounding the inherent financial risks of fixed-price development contracts. This indicates a transformation in the risk profile from pandemic-driven volatility to persistent operational constraints affecting cost predictability.",
      "llm_answer": "In 2022 Boeing’s fixed‑price development contracts, especially the KC‑46A Tanker, were flagged as high‑risk because pandemic‑related supply‑chain and labor disruptions caused a $402 million reach‑forward loss (2022 10‑K, p. 19). By 2023 the risk profile remained elevated, but the audit now cites ongoing global supply‑chain bottlenecks and labor shortages as the primary drivers of cost‑estimate uncertainty for these contracts (2023 10‑K, p. 114), shifting the focus from a one‑off pandemic shock to persistent disruptions that broaden the range of reasonable cost outcomes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $402 million loss in 2022 related to the KC-46A Tanker program due to pandemic-driven disruptions, and accurately notes the shift in 2023 to ongoing supply chain and labor issues as primary cost-estimation risks. The dollar amount, program name, and risk classification are all factually correct. (2) Quantitative accuracy is perfect: the $402 million figure is correctly cited from 2022, and no other numerical claims are made that contradict the ground truth. Format is consistent and precise. (3) The multi-hop reasoning is sound—LLM synthesizes information across 2022 and 2023 10-K filings to show an evolution in risk drivers, correctly identifying the transition from pandemic-specific shocks to persistent operational disruptions. It accurately reflects auditors’ increasing concern about cost estimation uncertainty. The only minor gap is that the original answer explicitly mentions 'auditors noted increased complexity,' which the LLM implies but does not directly attribute to auditors, slightly weakening qualitative completeness. (4) Contextual relevance is excellent—the response directly addresses both parts of the question: evolution of financial risk profile and impact of disruptions on cost estimation. Wording differs but semantic meaning fully aligns with the ground truth. Minor deduction in qualitative accuracy due to slightly less explicit attribution of auditor concerns, but overall highly accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 410,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Apple's revenue concentration in the Greater China segment in 2022 relate to its continued geographic manufacturing dependency on China Mainland in 2024, and what does this imply about its geographic diversification strategy?",
      "original_answer": "In 2022, Apple reported $74.2 billion in net sales from the Greater China segment, which includes China Mainland, Hong Kong, and Taiwan, indicating a significant revenue concentration in the region. This segment was managed as a single geographic unit, with China Mainland being a core component. By 2024, Apple's manufacturing operations remained heavily concentrated in China Mainland, despite efforts to expand in other countries like India and Vietnam. This continued reliance on China Mainland for manufacturing, despite its geopolitical and supply chain risks, suggests that Apple's geographic diversification strategy has not significantly reduced its operational exposure to the region, even as it maintains substantial revenue dependence on Greater China.",
      "llm_answer": "Apple’s 2022 segment data show Greater China generated $74.2 bn of net sales—about 19 % of its $394.3 bn total—highlighting a notable revenue concentration in that region【page_52】.  In 2024, Greater China sales fell to $66.9 bn (≈17 % of $391.0 bn), yet the company’s 2024 note still states that “substantially all of the Company’s hardware products are manufactured by outsourcing partners that are located primarily in China mainland…”【page_49】【page_50】.  These facts imply that while Apple is modestly diversifying its revenue geography, it continues to rely heavily on China Mainland for manufacturing, reflecting a cautious geographic diversification strategy that balances revenue spread against supply‑chain concentration risk.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Apple's 2022 Greater China revenue as $74.2 billion, matching the ground truth. It also accurately notes the continued manufacturing concentration in China Mainland in 2024, citing the correct qualitative statement from the filing. However, the LLM introduces data not present in the original answer—specifically, total revenue figures ($394.3B in 2022 and $391.0B in 2024) and the derived percentages (19% and 17%)—which, while plausible and consistent with public data, are not part of the ground truth provided. This addition, though not factually incorrect, goes beyond the scope of the original answer and introduces unverified calculations. (2) The quantitative values for Greater China sales in 2022 ($74.2B) are correct. The 2024 sales figure of $66.9B is not mentioned in the ground truth, making it an unsupported addition. The total revenue and percentage calculations are accurate if based on external data but are not corroborated by the provided knowledge graph. (3) The multi-hop reasoning is sound: the LLM correctly links revenue concentration in Greater China with ongoing manufacturing dependency in China Mainland and draws a reasonable conclusion about Apple’s diversification strategy. The implication of a 'cautious' strategy is a slight interpretive extension but logically consistent. (4) The answer is contextually excellent, addressing all parts of the question with relevant synthesis. The correctness score is 8 due to the introduction of unverified figures and percentages not in the ground truth, though core facts and reasoning remain accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 445,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did MET's approach to product differentiation in 2024 evolve in response to regulatory constraints documented in 2022, particularly regarding their ability to use brand equity and pricing power as competitive tools?",
      "original_answer": "In 2022, MET was subject to regulatory constraints that limited its ability to differentiate products through branding and communication, as seen in the PM filing which noted that such regulation could 'materially adversely impact' differentiation efforts and pricing power, especially during economic uncertainty when consumers tend to down-trade to lower-priced options. By 2024, MET's filing shows a strategic pivot toward 'product development focused on differentiation' as a response to these pressures, despite continued 'intense competition with respect to product features and services.' MET emphasized investments in 'brand equity, product development, technology optimization, and innovation' as fundamentals for growth, even as they faced ongoing regulatory scrutiny. This represents a clear evolution from being passively impacted by regulation in 2022 to proactively shaping their competitive strategy around differentiation in 2024.",
      "llm_answer": "In 2022, MetLife noted that regulatory constraints limited its ability to differentiate products through branding, communication, and pricing power (pages 15–16). By 2024, the company’s strategy had shifted to emphasize product‑design features and risk‑management tools—such as ALM and interest‑rate derivatives—to differentiate offerings while staying compliant, as reflected in the 2024 “Regulatory Developments” section (page 54) and the use of interest‑rate derivatives (page 52). This evolution preserves brand equity and pricing power as competitive tools, but only within the regulatory limits identified in 2022.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 2022 regulatory constraints on branding, communication, and pricing power, aligning with the ground truth. It also correctly references a strategic shift by 2024. However, it introduces specific details not present in the original answer, such as 'product-design features and risk-management tools—such as ALM and interest-rate derivatives' and cites page numbers (52, 54) that are not part of the provided ground truth. These specifics may be accurate in the actual filings but are not supported by the knowledge graph answer, which emphasizes 'product development, technology optimization, and innovation' rather than derivatives or ALM. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not applicable—scored as 10 by default since no numbers are misstated. (3) The multi-hop reasoning is partially sound: the model connects 2022 constraints to 2024 strategy, but the nature of the evolution is misrepresented. The original answer describes a proactive investment in brand equity and innovation despite regulation, while the LLM answer suggests differentiation is achieved through compliance-focused tools like derivatives, which shifts the emphasis. This misaligns with the core idea of leveraging brand and product development as competitive tools within regulatory bounds. (4) Contextual relevance is high because the answer addresses the evolution of differentiation strategy in response to regulation. However, qualitative accuracy is low due to incorrect synthesis of the 2024 strategy—confusing financial risk tools with product differentiation mechanisms. The original answer focuses on product development and brand equity as central, not derivatives. Thus, while the structure and intent are correct, key factual elements of the strategic pivot are inaccurate, warranting a correctness score of 6 for partial accuracy with significant factual deviation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 532,
        "total_tokens": 1942
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Southern Company's approach to goodwill impairment testing for PowerSecure evolve from 2022 to 2023, and what were the financial implications of this change?",
      "original_answer": "In 2022, Southern Company performed a quantitative assessment for PowerSecure, which revealed that its fair value was lower than its carrying amount due to declining macroeconomic conditions, resulting in a $119 million goodwill impairment. In contrast, for the 2023 annual impairment test, PowerSecure management again performed the quantitative assessment, but this time the fair value exceeded the carrying amount, indicating an improvement in financial health. This shift from impairment in 2022 to no impairment in 2023 suggests that PowerSecure's cash flow projections and macroeconomic outlook improved, reducing the need for further write-downs.",
      "llm_answer": "In 2022 Southern Company performed a quantitative goodwill impairment test for PowerSecure and found the fair value below carrying amount, resulting in a $119 million impairment recorded in Q4 2022 [page_175]. In 2023 the company again used a quantitative assessment but determined the fair value exceeded carrying amount, so no impairment was recorded [page_175]. Consequently, the 2022 charge reduced earnings and goodwill, while the 2023 year saw no goodwill hit, leaving the goodwill balance unchanged [page_176].",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Southern Company performed a quantitative goodwill impairment test for PowerSecure in both 2022 and 2023. In 2022, the fair value was below carrying amount, resulting in a $119 million impairment — this matches the ground truth exactly in amount and outcome. In 2023, the fair value exceeded carrying amount, so no impairment was recorded — again, factually correct. The financial implications are accurately described: the 2022 charge reduced earnings and goodwill, while 2023 had no goodwill impact. (2) All numeric values are correct: $119 million impairment in 2022, no impairment in 2023. Dates (Q4 2022) are consistent with typical reporting timelines and supported by citation. No calculations are required beyond comparison of fair value vs. carrying amount, which is correctly interpreted. (3) The multi-hop reasoning is sound: the model synthesizes changes in impairment testing outcomes across two years and correctly infers the financial implications (impact on earnings and goodwill balance). It correctly attributes the change to updated fair value assessments without misattributing to a methodological shift (e.g., no mention of qualitative test, which would be incorrect). (4) The only minor limitation is that the LLM does not explicitly mention the underlying reason for the change — improvement in cash flow projections and macroeconomic outlook — which is included in the original answer. However, this does not affect factual correctness, only completeness of explanatory context. All entities (Southern Company, PowerSecure, goodwill, impairment, fair value, carrying amount) are accurate. The answer is highly relevant and factually aligned with the ground truth, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 481,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did the evolution of COP's financial guarantees tied to APLNG from 2023 to 2024 reflect changes in their joint venture risk exposure through Origin Energy?",
      "original_answer": "In 2023, COP maintained a 47.5% ownership stake in APLNG, a joint venture focused on producing coal bed methane (CBM) and exporting LNG, with Origin Energy holding 27.5% and operating the production and pipeline system. By 2024, COP had multiple guarantees tied to APLNG, including a $210 million guarantee related to a project finance reserve account withdrawal, a $610 million (up to $1.0 billion in case of intentional breach) guarantee tied to natural gas delivery commitments, and a $480 million guarantee for performance on other contracts. These guarantees, with terms ranging from 6 to 21 years, indicate that COP's exposure to APLNG's operational risks increased from 2023 to 2024, despite the long-standing partnership with Origin Energy.",
      "llm_answer": "In 2023 ConocoPhillips did not record any APLNG‑related guarantees, as the 10‑K note on guarantees omitted any APLNG entries (see the 2023 “APLNG” section on page 92). By 2024 the company had three APLNG guarantees with a combined maximum potential liability of roughly $1.3 billion and carrying values of about $48 million, reflecting a higher risk exposure through its 47.5 % stake in the joint venture with Origin Energy (see page 104).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies compared to the ground truth. It claims that in 2023, ConocoPhillips (COP) did not record any APLNG-related guarantees, directly contradicting the original answer which states that COP maintained a 47.5% ownership stake in APLNG in 2023 — implying ongoing financial involvement and risk exposure, even if specific guarantees aren't itemized. The absence of a listed guarantee in a footnote does not equate to zero risk exposure, especially given the joint venture structure. (2) Quantitatively, the LLM misrepresents the guarantee amounts. The original answer specifies three distinct guarantees: $210M, $610M (up to $1B), and $480M. The LLM incorrectly sums these into a 'combined maximum potential liability of roughly $1.3 billion', which is inaccurate — the maximum could exceed $1.8 billion when considering the $1B upper cap on the $610M guarantee. Additionally, the LLM introduces a '$48 million carrying value' not mentioned in the ground truth, with no supporting evidence. (3) The multi-hop reasoning is flawed: while the LLM correctly identifies COP’s 47.5% stake and the increased disclosure of guarantees in 2024, it fails to synthesize the correct implication — that explicit financial guarantees in 2024 reflect increased formalized risk exposure, not that no risk existed in 2023. The conclusion that risk increased is aligned with the ground truth, but the reasoning path is unsound due to the false premise of zero 2023 exposure. (4) Contextual relevance is strong — the answer addresses the evolution of guarantees and ties them to risk exposure through Origin Energy. However, due to major quantitative errors and a flawed premise about 2023, the overall correctness score is low despite some accurate elements like the ownership percentage and directional risk increase.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 504,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Disney's use of pay-fixed interest rate swaps to hedge floating-rate borrowings evolve from 2022 to 2024, and what does the absence of designated cash flow hedges in 2024 imply about their interest rate risk management strategy?",
      "original_answer": "In 2022, Disney disclosed floating-rate borrowings with a weighted-average coupon rate and noted the notional values of interest rate and cross-currency swaps outstanding as of October 1, 2022, which were used to manage interest rate exposure. By 2024, although the company still had the capacity to use pay-fixed interest rate swaps to convert floating-rate borrowings to fixed-rate, it explicitly stated that it had no pay-fixed interest rate swaps designated as cash flow hedges at September 28, 2024, or September 30, 2023. This indicates a strategic shift or reduced emphasis on active interest rate hedging, suggesting Disney may have opted to bear more interest rate risk or found alternative methods to manage it. The absence of designated hedges in 2024 implies a more passive approach to interest rate risk compared to 2022, despite the ongoing presence of floating-rate debt.",
      "llm_answer": "Disney used pay‑fixed interest‑rate swaps as part of its interest‑rate risk management in 2022 (see 2022 page 97). By 2024, the company had no pay‑fixed swaps designated as cash‑flow hedges of floating‑rate borrowings (see 2024 page 121). The absence of such hedges in 2024 signals a shift away from using pay‑fixed swaps to hedge floating‑rate exposure, implying a more passive approach or reliance on other hedging instruments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) It correctly states that Disney used pay-fixed interest rate swaps in 2022 and had none designated as cash flow hedges in 2024, which matches the original answer's timeline and key facts. The fiscal years (2022 and 2024) and the specific absence of designated hedges as of September 28, 2024, and September 30, 2023, are accurately reflected in substance, even if not explicitly dated in the LLM response. (2) There are no numerical inaccuracies—while exact notional values or coupon rates from 2022 are not repeated, the LLM correctly references the use of swaps without misstating figures, so quantitative accuracy is preserved. (3) The multi-hop reasoning is sound: the model correctly infers a strategic shift from active to passive interest rate risk management based on the absence of designated hedges in 2024 compared to their presence in 2022. (4) The answer is contextually relevant and addresses both parts of the question: the evolution of swap usage and the implication of no designated hedges in 2024. The only minor shortcoming is the lack of explicit mention of Disney’s ongoing capacity to use swaps or the continued presence of floating-rate debt in 2024, which slightly reduces completeness. However, the core implications about risk management strategy are correctly interpreted, warranting a high but not perfect qualitative and overall correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 400,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did MMM's allocation of PFAS-related liabilities to Solventum after the April 2024 spin-off impact MMM's contingent liability disclosures for unresolved litigation compared to 2023?",
      "original_answer": "In 2023, MMM disclosed facing PFAS-related liabilities, including those tied to the proposed class-action settlement with public water systems and uncertainties around opt-outs and appeals. Following the April 2024 spin-off, the separation agreement allocated future PFAS liabilities arising from Solventum’s operations post-April 1, 2024, to Solventum, while MMM retained legacy liabilities. This led to MMM’s 2024 disclosures reflecting a reduced contingent liability exposure for PFAS-related litigation, as Solventum assumed responsibility for new liabilities, although MMM still maintained accruals for legacy claims and certain product liabilities sold by Solventum before 2026. The change in liability structure is evident in MMM’s 2024 10-K, where the focus shifted from broad PFAS exposure to more defined legacy risk retention.",
      "llm_answer": "After the April 2024 spin‑off, 3M transferred most PFAS‑related liabilities to Solventum under the separation and distribution agreement, leaving only a limited set of PFAS claims on its books.  Consequently, 3M’s 2024 contingent‑liability disclosures for unresolved litigation were lower than in 2023, because the transferred liabilities are no longer disclosed by 3M.  The 2024 10‑K notes the allocation (page 85) and explains that 3M discloses only those liabilities that remain probable or estimable (page 84).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. It correctly identifies the April 2024 spin-off as the key event and accurately states that Solventum assumed most PFAS-related liabilities, resulting in reduced contingent liability disclosures by 3M (MMM) in 2024 compared to 2023. The answer correctly references the separation agreement and cites specific pages from the 2024 10-K (pages 84 and 85), supporting its claims. Quantitatively, there are no numerical inaccuracies—dates and events are correctly stated. The reasoning is sound: it logically connects the spin-off and liability allocation to the reduction in disclosed contingent liabilities. The answer captures the core impact on disclosures and correctly notes that only retained liabilities are still reported by MMM. One minor omission is that it does not explicitly mention MMM’s retention of legacy liabilities or the nuance that Solventum assumes liabilities for post-April 2024 operations, while MMM retains responsibility for certain pre-spin-off claims (e.g., product liabilities sold by Solventum before 2026). This detail is included in the original answer and adds depth to the liability structure change. However, the LLM conveys the essential outcome—reduced disclosure due to liability transfer—accurately and concisely. Wording differs but semantic meaning is equivalent. Multi-hop synthesis (MMM → PFAS liabilities → 2023 vs 2024 disclosures → spin-off impact) is correctly executed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 409,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did Chevron's $0.7 billion investment in Nigerian offshore and gas projects in 2023 relate to the exploration and production activities and regulatory framework described in their 2022 filing?",
      "original_answer": "Chevron's $0.7 billion investment in Nigeria in 2023 focused on offshore development and natural gas projects, continuing its exploration and production activities outlined in the 2022 filing. In 2022, Chevron detailed its exploration and production activities in Nigeria, particularly in deepwater offshore areas governed by 30-year production sharing contracts (PSCs) with the Nigerian National Petroleum Corporation (NNPC). These PSCs included a 10-year exploration period and a 20-year production period, with partial relinquishment required at the end of the exploration phase. In 2023, Chevron's investment in Nigeria was part of its broader international development strategy, which included advancing proved undeveloped reserves, particularly in offshore and gas projects. The investment aligns with Chevron's long-term approach to operate within Nigeria's regulatory framework, which allows for extended production periods under negotiated terms, ensuring the company can develop reserves efficiently while complying with local regulations.",
      "llm_answer": "Chevron’s $0.7 billion spent in 2023 on offshore development and gas projects in Nigeria was a direct extension of the company’s 2022 strategy, which outlined that Nigerian assets are governed by production‑sharing contracts (PSCs) with NNPC under the Petroleum Industry Act. The 2022 filing explained that these PSCs run for 30 years, with a 10‑year exploration phase, partial relinquishment at the end of that phase, and a 20‑year production period that can be extended. Thus, the 2023 investment falls squarely within that regulatory framework, advancing development of assets under those PSCs and adding to Chevron’s proved‑undeveloped reserves in the region.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Chevron's $0.7 billion investment in Nigeria in 2023 and accurately links it to offshore and gas projects, consistent with the original answer. All key entities—Chevron, Nigeria, NNPC, production-sharing contracts (PSCs), 30-year duration, 10-year exploration phase, 20-year production period, partial relinquishment, and proved undeveloped reserves—are correctly mentioned. The regulatory framework is accurately described, including the structure of PSCs and their alignment with the 2023 investment. (2) Quantitative accuracy is perfect: the $0.7 billion figure is correctly cited, and the timeframes (10-year exploration, 20-year production, 30-year total) match the ground truth. No calculations are required, but temporal and financial figures are precise and consistent. (3) The multi-hop reasoning is sound: the model correctly connects the 2023 investment to the regulatory and strategic framework detailed in the 2022 filing, demonstrating synthesis across years and domains (investment, operations, regulation). The only minor shortcoming is the mention of the 'Petroleum Industry Act'—which is plausible but not present in the original answer—potentially adding a detail not confirmed in the ground truth. This does not contradict the truth but introduces a specificity not in the source. (4) Scores reflect near-perfect factual alignment, with full contextual relevance and excellent qualitative reasoning. The 9 in qualitative accuracy accounts for the slight over-specificity on the Petroleum Industry Act, while all other aspects are fully accurate and well-synthesized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 448,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did the progression of BMY's nivolumab-based combination therapy from its 2022 regulatory review status to the 2024 commercial performance of Opdualag reflect the strategic evolution of its melanoma treatment portfolio?",
      "original_answer": "In 2022, BMY's nivolumab was positioned as part of a novel fixed-dose combination with relatlimab for melanoma treatment, with regulatory submissions accepted by both the FDA and EMA based on the RELATIVITY-047 trial data showing improved progression-free survival. By 2024, this combination had been commercialized as Opdualag, generating $928 million in revenue, a 48% increase from the prior year, indicating strong market adoption and strategic emphasis on this therapeutic area. The evolution from a regulatory focus in 2022 to a high-growth product in 2024 demonstrates BMY's successful transition of the nivolumab-relatlimab combination into a key asset within its oncology portfolio.",
      "llm_answer": "In 2022, the nivolumab‑relatlimab combination was still in regulatory review – the FDA had accepted the BLA for priority review (PDUFA goal March 19 2022) and the EMA had validated its MAA (page 95). By 2024, Opdualag had been approved and was generating revenue, with U.S. sales up 41 % and total sales up 48 % versus 2023 (page 52 and 50). This transition from a product in review to a commercial revenue driver shows BMS’s strategic shift to broaden its melanoma portfolio beyond Opdivo alone, using combination therapy to enhance efficacy and capture new market share.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the 48% revenue increase matches the original answer exactly, and the mention of U.S. sales up 41% adds detail not in the ground truth but does not contradict it—this specificity may come from the cited pages (50, 52). The PDUFA date of March 19, 2022, is consistent with regulatory timelines, though the original answer does not specify the exact date, only that submissions were accepted in 2022. (2) The $928 million revenue figure is missing in the LLM answer, which is a minor omission affecting completeness but not overall correctness. (3) Entity accuracy is strong: BMY/BMS, nivolumab-relatlimab, Opdualag, FDA, EMA, and correct years (2022 regulatory review, 2024 commercial performance) are all correctly identified. (4) Reasoning is sound: the answer traces the progression from regulatory review to commercial success and correctly infers strategic portfolio expansion in melanoma via combination therapies, demonstrating proper multi-hop synthesis across time and data points. (5) Semantic equivalence is maintained—while the LLM uses slightly different phrasing (e.g., 'strategic shift to broaden...'), the core message about portfolio evolution through Opdualag’s success is preserved. The only deduction is for the missing revenue figure, which is material but not central to the overall conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 389,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did ConocoPhillips' increased stake in APLNG through its preemption right from Origin Energy in 2021 impact the valuation and financial performance of its equity investment in APLNG by 2023?",
      "original_answer": "In 2021, ConocoPhillips exercised its preemption right to acquire an additional 10% stake in APLNG from Origin Energy for $1.645 billion, which led to a fair value reassessment of its total investment. As a result, ConocoPhillips wrote down its APLNG investment to a fair value of $5,574 million, recognizing a before-tax charge of $688 million in 2021. By 2023, ConocoPhillips' investment in APLNG remained significant, with $2,684 million in dividends received during the year, indicating continued operational performance from the joint venture. The evolution of the stake through Origin Energy to a larger direct investment in APLNG reflects a strategic shift toward strengthening its LNG position in the Asia Pacific region, despite the near-term financial charge.",
      "llm_answer": "The preemption right let ConocoPhillips buy an additional 10 % stake in APLNG, raising its ownership to 47.5 % (page 39, 40). Because APLNG’s fair value fell below its carrying value, ConocoPhillips recorded a $688 million impairment in Q4 2021 (page 91). By 2023 the investment’s carrying value was still about $5.4 billion, with only a $33 million basis difference and an $8 million amortization expense, indicating the impairment had a one‑time hit to earnings but the valuation remained relatively stable (page 92).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several correct elements but also key inaccuracies. It correctly identifies that ConocoPhillips exercised a preemption right to acquire an additional 10% stake in APLNG and mentions the $688 million impairment charge in 2021, aligning with the ground truth. However, it incorrectly states that the ownership increased to 47.5%—the original answer does not specify the final ownership percentage, so this figure is unsupported. More critically, the LLM claims that by 2023 the investment’s carrying value was 'about $5.4 billion,' whereas the ground truth states that the fair value was written down to $5,574 million in 2021 and provides no update on the 2023 carrying value. Instead, the ground truth highlights $2,684 million in dividends received in 2023 as evidence of financial performance, which the LLM omits entirely. The mention of a '$33 million basis difference' and '$8 million amortization expense' appears to come from document pages but is not present in the ground truth and does not address the question's focus on valuation and financial performance impact. (2) Quantitative accuracy is compromised: while $688 million impairment is correct, the $5.4 billion 2023 valuation is inconsistent with the ground truth’s lack of such data and introduces unsupported figures. The original answer emphasizes dividend income in 2023, which the LLM fails to report. (3) The reasoning partially follows a logical path—recognizing the one-time impairment impact—but fails the multi-hop synthesis by not connecting the 2021 stake increase and write-down to the 2023 financial performance via dividend receipts, which is central to the original answer. (4) Contextual relevance is high as the LLM addresses the stake increase and its financial impact, but the omission of dividend data and introduction of unverified valuation metrics reduce factual correctness. Scores reflect partial accuracy with significant gaps in key financial reporting and synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 538,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did the contingent consideration liability tied to Significant Unobservable Inputs (Level 3) for Clif Bar in 2023 evolve into 2024, and what impact did it have on MDLZ's segment operating income performance?",
      "original_answer": "In 2023, MDLZ reported a contingent consideration liability of $548 million for Clif Bar, entirely attributed to Significant Unobservable Inputs (Level 3). By 2024, this liability contributed positively to segment operating income through a favorable contingent consideration adjustment. This adjustment was a key driver in the $400 million (19.1%) increase in segment operating income year-over-year, alongside other factors like lower integration costs and productivity gains. The shift from a liability in 2023 to a favorable adjustment in 2024 reflects a change in the valuation assumptions tied to Level 3 inputs, likely indicating better-than-expected performance or revised forecasts for Clif Bar.",
      "llm_answer": "In 2023 the Level 3 contingent consideration for Clif Bar was $548 million; in 2024 it rose to $680 million after a $128 million fair‑value gain and a $90 million payment, netting a $38 million increase in the liability (page 99).  The favorable adjustment was a key driver of the $400 million (19.1%) rise in segment operating income in 2024 versus 2023 (page 55).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly states the 2023 Level 3 contingent consideration liability for Clif Bar as $548 million, it incorrectly claims that in 2024 the liability rose to $680 million due to a $128 million fair-value gain and a $90 million payment, resulting in a $38 million net increase. The original answer (ground truth) does not mention any of these specific figures—$680 million, $128 million gain, $90 million payment, or $38 million increase—and instead describes a favorable contingent consideration adjustment that positively impacted segment operating income. There is no indication in the ground truth that the liability increased; rather, a favorable adjustment implies a reduction in liability or a gain, which would decrease the liability, not increase it. (2) The calculation of a $38 million increase is unsupported and contradicts the direction implied by a 'favorable adjustment.' Additionally, the $400 million (19.1%) increase in segment operating income is correctly cited, but the explanation tying it to an increase in liability is logically flawed—increasing a liability would negatively impact income, not positively. A favorable adjustment typically results from a decrease in the contingent consideration liability (i.e., a gain), not an increase. (3) The multi-hop reasoning is partially sound in linking the contingent consideration to segment operating income performance, but the synthesis is flawed due to incorrect data and misinterpretation of the financial impact. The model fails to correctly interpret how changes in contingent consideration affect income: a downward revision (reduction) in liability leads to a gain, boosting income. (4) The contextual relevance is high because the answer addresses both parts of the question—evolution of the liability and impact on operating income—and references the correct entities (Clif Bar, MDLZ) and time frame (2023–2024). However, the quantitative inaccuracies and flawed financial logic severely undermine correctness, warranting a low overall score despite relevant structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 571,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did RTX's net program share interest in the IAE LLC-managed PW1100G-JM engine program change from 2023 to 2024, and what does this imply about their ongoing financial exposure and control in the program?",
      "original_answer": "RTX's net program share interest in the IAE LLC-managed PW1100G-JM engine program remained stable at 51% in both 2023 and 2024, despite adjustments for sub-collaborator participation. This consistency suggests that RTX maintained a controlling financial stake and exposure in the program across both years, with no significant shift in their risk profile or market influence.",
      "llm_answer": "RTX’s net program share interest in the IAE LLC‑managed PW1100G‑JM engine program stayed the same at **51 %** in 2024 as it had been in 2023【page_97】【page_101】.  The unchanged percentage indicates that RTX’s financial exposure to the program’s economics and its control as the primary beneficiary have remained stable.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that RTX's net program share interest in the PW1100G-JM engine program remained at 51% in both 2023 and 2024, matching the ground truth exactly. The percentage is accurate and consistent with the original answer. (2) All numeric values—specifically the 51% stake—are correct, and no calculations are required beyond comparison across years, which is accurately reflected. Format variations (e.g., '51 %' vs '51%') are acceptable and do not affect meaning. (3) The reasoning is sound: the LLM correctly infers that a stable ownership percentage implies stable financial exposure and control, aligning with the ground truth's conclusion about ongoing control and risk profile. It references the correct entity (RTX), program (PW1100G-JM), managing body (IAE LLC), and time frame (2023 to 2024). (4) The only minor shortcoming is that the LLM omits the nuance about 'adjustments for sub-collaborator participation' mentioned in the original answer, which adds context to why the stability is notable despite underlying changes. This does not undermine the core accuracy but slightly reduces completeness in qualitative reasoning. Overall, the answer is factually correct, contextually appropriate, and logically sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1188,
        "completion_tokens": 353,
        "total_tokens": 1541
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did the legal outcomes involving Mylan Pharmaceuticals, Inc. in JNJ's patent litigation cases evolve from 2023 to 2024, and what does this indicate about JNJ's ability to defend its drug patents in court?",
      "original_answer": "In 2023, JNJ (via its subsidiary Janssen Pharmaceuticals, Inc.) was involved in litigation against Mylan Pharmaceuticals, Inc. regarding the patent infringement of INVEGA TRINZA (U.S. Patent No. 10,143,693). The District Court ruled in May 2023 that Mylan's proposed generic product infringed the patent and that the patent was valid. Mylan appealed the decision. By 2024, the appeal was still pending, with oral arguments held in February 2025, indicating that the legal battle had extended beyond the initial ruling. This evolution shows that JNJ initially succeeded in defending its patent in district court, but the continuation of the appeal suggests ongoing uncertainty and the need for sustained legal efforts to protect its intellectual property.",
      "llm_answer": "In 2023, a U.S. district court ruled that Mylan’s generic for **INVEGA TRINZA** infringed J&J’s patent and that the patent was not invalid (page 107), while the USPTO had found a related XARELTO patent invalid (page 103). By 2024 the XARELTO litigation was settled and dismissed, and the INVEGA TRINZA case remained pending on appeal (no new 2024 court decision). These outcomes show that J&J can secure favorable rulings and ultimately dismiss challenges, though the appellate process can extend the litigation timeline.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 2023 district court ruling that Mylan's generic INVEGA TRINZA infringed J&J's patent (U.S. Patent No. 10,143,693) and that the patent was valid, aligning with the ground truth. It accurately notes that the appeal was pending in 2024 with no new decision, which matches the original answer’s timeline. However, the LLM introduces information about XARELTO—a separate drug and patent dispute—not mentioned in the question or the ground truth answer. This is a factual overreach, as the question specifically asks about INVEGA TRINZA litigation with Mylan, not XARELTO. The mention of USPTO invalidating a XARELTO patent and its settlement in 2024, while possibly true, is irrelevant to the specific legal evolution asked about and distracts from the core issue. (2) Quantitatively, all dates (2023 ruling, 2024 pending appeal) are correct. The LLM does not provide incorrect numbers or miscalculations, though it references 'page 107' and 'page 103', which may be source citations but are not part of the factual content being evaluated—these do not affect accuracy but suggest reliance on document excerpts. (3) The multi-hop reasoning is partially sound: the model correctly synthesizes the initial win and ongoing appeal for INVEGA TRINZA. However, the inclusion of XARELTO undermines the reasoning by conflating two distinct patent disputes, indicating a failure to isolate the relevant litigation thread. This weakens the qualitative accuracy. (4) The conclusion that J&J can secure favorable rulings but faces extended timelines is semantically aligned with the ground truth’s point about initial success but ongoing uncertainty. Despite the extraneous XARELTO content, the core answer about INVEGA TRINZA is factually correct and contextually relevant, warranting a score of 7 for correctness—minor but significant deviation due to irrelevant information.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 515,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did GM's investment in nonconsolidated affiliates in 2022, which exceeded underlying net assets by $4.2 billion, influence the production and market availability of crossovers in 2024, given the ongoing involvement of these affiliates in crossover development and GM's strategic focus on vehicle-level profitability metrics?",
      "original_answer": "In 2022, GM held significant investments in nonconsolidated affiliates, with the carrying amount exceeding net assets by $4.2 billion, indicating a strong financial commitment to these partnerships. These affiliates were directly involved in the development and production of crossovers, among other vehicle types. By 2024, GM's segment reporting emphasized a strategic focus on vehicle-level profitability metrics during planning and program lifecycle stages. This suggests that the earlier investment in nonconsolidated affiliates likely supported the production capacity and possibly the design or cost structure of crossovers, enabling GM to better align with its profitability goals in 2024. The continuity of crossovers in GM’s product lineup and the emphasis on optimizing their profitability indicates a strategic evolution from financial investment in affiliates to tangible product outcomes and margin improvements.",
      "llm_answer": "GM’s $4.2 billion equity excess in non‑consolidated affiliates (Note 8) gave it continued financial backing and direct access to the affiliates’ crossover‑development and manufacturing capabilities, which helped sustain production volumes and keep crossovers on the market in 2024.  The affiliates remain engaged in crossover design and supply‑chain activities (see Note 75), and GM’s vehicle‑level profitability focus (Note 23, page 103) means those production decisions are driven by forecasted profitability at the individual vehicle level.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the $4.2 billion excess investment is correctly stated, and the years (2022 investment influencing 2024 outcomes) are accurate. No calculations are required, and all financial figures match. (2) The LLM correctly identifies the key entities: GM, nonconsolidated affiliates, crossovers, and the relevant strategic focus on vehicle-level profitability. It also references specific notes (8, 75, 23), which, while not required for correctness, suggest proper sourcing and enhance credibility. (3) The reasoning is sound: it connects GM’s 2022 financial commitment to ongoing affiliate involvement in crossover development and production, and links this to GM’s 2024 strategic emphasis on profitability—exactly as the ground truth describes. The synthesis across time and entities (investment → production capacity → strategic profitability focus) is logically coherent. (4) The only minor shortcoming is that the LLM does not explicitly mention the 'strategic evolution from financial investment to tangible product outcomes and margin improvements' as emphasized in the original answer, slightly reducing qualitative completeness. However, the core causal chain and implications are clearly conveyed. Wording differs but semantic meaning is equivalent. All parts of the multi-hop question are addressed: the investment size, its relation to affiliate activities, and the impact on 2024 crossover availability and profitability strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 418,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did Qualcomm's dependency on Chinese OEMs in 2022 influence its integrated circuit production commitments by 2024, particularly in light of potential vertical integration by those OEMs and Qualcomm's multi-year capacity purchase obligations?",
      "original_answer": "In 2022, Qualcomm identified a significant portion of its revenue as being dependent on Chinese OEMs, many of whom were under pressure from the Chinese government's Made in China 2025 campaign to develop their own integrated circuit products. This posed a risk of vertical integration that could reduce Qualcomm's semiconductor sales. By 2024, Qualcomm had multi-year capacity purchase commitments totaling $12.8 billion for integrated circuit products, with $3.0 billion in advance payments recorded on its balance sheet. These figures indicate that despite the risk of OEMs developing their own chips, Qualcomm increased its production commitments, likely to secure supply chain stability and maintain market position amid evolving OEM strategies and geopolitical tensions.",
      "llm_answer": "In 2022 Qualcomm’s revenue was heavily concentrated in China (43 % of total), and the company warned that Chinese OEMs could vertically integrate and produce their own ICs, potentially eroding Qualcomm’s demand.  To hedge against that risk and secure supply for a still‑large Chinese customer base (which rose to 46 % of revenue in 2024), Qualcomm entered into multi‑year capacity purchase commitments with foundry suppliers, amounting to $12.8 billion in inventory obligations in 2024—$9.6 billion of which were due within the next 12 months—ensuring it could meet customers’ needs even if OEMs began making their own chips.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Qualcomm's dependency on Chinese OEMs in 2022 and the risk of vertical integration due to Made in China 2025, which aligns with the ground truth. It also accurately reports the $12.8 billion in multi-year capacity purchase commitments by 2024. However, it introduces two figures not present in the ground truth: $9.6 billion due within 12 months and revenue concentration rising to 46% in 2024. These specific numbers are unsupported by the original answer and may be fabricated or misattributed. Additionally, the 43% revenue dependency in 2022 is not mentioned in the ground truth, making it an unsupported addition. (2) While the $12.8 billion obligation is correctly stated, the breakdown into $9.6 billion short-term and $3.2 billion long-term (implied) does not match the ground truth, which states $3.0 billion in advance payments recorded on the balance sheet—likely a different financial category than near-term obligations. The LLM confuses 'advance payments' with 'short-term obligations,' which are not equivalent. (3) The multi-hop reasoning is generally sound: it connects Chinese OEM dependency, vertical integration risk, and Qualcomm’s response via capacity commitments. However, it omits the strategic rationale provided in the ground truth—securing supply chain stability amid geopolitical tensions and OEM strategy shifts—and instead frames the move primarily as hedging demand risk, which is less comprehensive. (4) Despite these issues, the core of the answer—Qualcomm increasing production commitments despite vertical integration risk—is correct and contextually relevant. The reasoning is logical and addresses the main thrust of the question, but the inclusion of unverified quantitative details reduces factual accuracy. Hence, a score of 7 is justified: major facts are correct, but significant quantitative inaccuracies prevent a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 519,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did the adoption of ASU 2020-06 impact T's diluted earnings per share calculations in 2022 versus 2024, particularly in relation to the treatment of convertible instruments like the Mobility II preferred interests?",
      "original_answer": "In 2022, T announced its intent to adopt ASU 2020-06 for convertible instruments starting with interim reporting, noting that settlement of the Mobility II preferred interests in stock would increase dilutive impact depending on the fair value of the instrument and the average AT&T stock price during the reporting period. ASU 2020-06 eliminated certain separation models and required instruments that may be settled in cash or stock to be presumed settled in stock for diluted EPS calculations. By 2024, T had fully adopted ASU 2020-06 through retrospective application, and specifically referenced that prior to the April 2023 repurchase, the dilutive impact of the Mobility preferred interests continued to vary with stock price and fair value fluctuations. The change in accounting policy from 2022 to 2024 reflects a shift from preparation and evaluation to full implementation, with measurable effects on diluted EPS calculations due to the presumed stock settlement method.",
      "llm_answer": "In 2022, ASU 2020‑06 required AT&T to add back the $560 annual distribution on its Mobility II preferred interests to the diluted‑EPS numerator and to include the potential issuance of 320 million common shares to the denominator, because the instrument could be settled in stock. By 2024, after the April 2023 repurchase of those preferred interests, the dilutive impact from Mobility II was no longer present, so the numerator and denominator adjustments were omitted; the standard still presumes stock settlement for any remaining convertible instruments and requires the if‑converted method for diluted EPS.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in quantitative details. The $560 million annual distribution and 320 million common shares are not mentioned or supported in the ground truth, making these fabricated figures that severely undermine correctness. The original answer does not specify any exact dollar amounts or share counts related to the Mobility II preferred interests, so introducing such precise numbers without basis is a critical error. Additionally, while the LLM correctly notes that the dilutive impact was removed after the April 2023 repurchase, it misrepresents the mechanism of ASU 2020-06 by implying that the standard was already fully applied in 2022 with specific numerator and denominator adjustments, whereas the ground truth states that in 2022, T was only announcing intent and evaluating interim application. The full retrospective adoption occurred by 2024, which the LLM partially captures but fails to frame as a transition from preparation to implementation. The reasoning around presumed stock settlement is directionally correct but oversimplified and incorrectly tied to specific if-converted method application without mention of the elimination of separation models, a key aspect of ASU 2020-06. Contextually, the answer addresses the comparative impact on diluted EPS and the role of convertible instruments, so it remains relevant and structured appropriately, but the inclusion of false quantitative data and incomplete qualitative synthesis limits its accuracy. Multi-hop reasoning is attempted—linking ASU adoption, instrument treatment, and temporal change—but flawed due to unsupported numbers and incomplete policy evolution description.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 464,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How has PepsiCo's beverage business performance in APAC evolved between 2022 and 2024, particularly regarding revenue proportions and pension expenses?",
      "original_answer": "PepsiCo's beverage business in APAC maintained a consistent revenue proportion of 23% in both 2022 and 2024, indicating stable performance in this region relative to total global beverage sales. However, pension expenses tied to APAC operations decreased from $16 million in 2022 to $10 million in 2024, suggesting improved cost efficiency or adjustments in pension liabilities. This reduction in pension costs, despite stable revenue proportions, could signal better financial management or strategic reallocation of resources within the APAC region.",
      "llm_answer": "PepsiCo’s APAC division has kept its beverage mix steady, with beverage revenue representing 23 % of the division’s net revenue in 2022, 2023 and 2024【page_73】.  Pension and retiree‑medical‑benefits expense for APAC fell modestly from $31 million in 2022 to $29 million in 2024 (after a $1 million income in 2023)【page_82】, indicating a slight reduction in pension costs.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key quantitative data. While it correctly states that the beverage revenue proportion in APAC was 23% in 2022 and 2024 (matching the ground truth), it incorrectly claims this was also true in 2023 — a year not mentioned in the original answer, introducing unsupported information. More critically, the pension expense figures are entirely wrong: the LLM reports $31 million in 2022 and $29 million in 2024, whereas the ground truth states $16 million in 2022 and $10 million in 2024. This represents a major quantitative discrepancy that undermines the financial analysis. Additionally, the mention of '$1 million income in 2023' for pension/retiree benefits is not corroborated by the original answer and introduces unverified detail. (2) The revenue proportion is correctly cited at 23%, aligning with the ground truth, but the pension numbers are off by over 90% in 2022 and 190% in 2024, which constitutes a severe error. The direction of change (decrease) is correct, but the magnitude and actual values are not. (3) The reasoning structure is sound — the model attempts to synthesize revenue proportions and pension trends over time for APAC — but the multi-hop synthesis fails due to reliance on incorrect data. It incorrectly implies consistency across three years when only 2022 and 2024 were confirmed. (4) Contextual relevance is high as the answer addresses both revenue proportions and pension expenses for PepsiCo’s APAC beverage business over the specified period. However, due to major factual errors in pension expenses and overextension into 2023 without evidence, the correctness score is low. The qualitative accuracy is moderate because the framework of analysis is logical, but the conclusions about 'slight reduction' are misleading given the original data shows a more significant 37.5% decrease, not a modest $2M drop.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 518,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How did Caterpillar's application of ASU 2022-06 on reference rate reform in 2023 reflect changes in their hedging relationship accounting policies compared to 2022, particularly regarding the extension of optional relief for LIBOR replacements?",
      "original_answer": "In 2022, Caterpillar disclosed detailed hedging relationship accounting policies, including the designation of derivatives as fair value or cash flow hedges, with specific documentation and effectiveness testing requirements. They used foreign currency forwards and options to manage exchange rate risks and interest rate contracts to manage interest rate exposure. In 2023, Caterpillar applied ASU 2022-06, which extended the sunset date for reference rate reform optional expedients and exceptions to December 31, 2024. This allowed Caterpillar to continue using relief provisions for contract modifications replacing reference rates affected by reform (e.g., LIBOR) in hedging relationships entered into or evaluated before the new deadline. The adoption of ASU 2022-06 reduced operational complexity and financial impact of replacing reference rates in contracts modified between March 12, 2020, and December 31, 2024, without materially affecting consolidated financial statements. This reflects a policy evolution where Caterpillar benefits from extended regulatory flexibility in managing reference rate transitions within their hedging framework.",
      "llm_answer": "In 2023 Caterpillar adopted ASU 2022‑06, which extended the optional relief for contracts and hedging relationships that replace LIBOR until December 31, 2024.  This change allowed the company to continue applying the optional expedients to LIBOR‑replacement modifications and hedges that were entered into or evaluated after December 31, 2022, whereas in 2022 the relief had not yet been extended and was limited to the original sunset date.  The adoption of the guidance did not materially affect Caterpillar’s financial statements, but it provided greater flexibility in its hedging‑accounting policy by reducing the operational and financial impact of LIBOR replacements. (See CAT 10‑K 2023, page 68.)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: ASU 2022-06 was adopted in 2023, extending optional relief for LIBOR replacements to December 31, 2024—this date is correctly stated and matches the ground truth. The statement that the adoption did not materially affect financial statements is also consistent. (2) Quantitative accuracy is perfect: the date December 31, 2024, is correctly cited, and there are no numerical errors. (3) The reasoning is sound: the LLM correctly identifies the policy change as an extension of relief that allows continued use of expedients for hedging relationships modified during the reform period, reflecting a multi-hop synthesis between the standard (ASU 2022-06), its application year (2023), and the prior state in 2022. The only minor shortcoming is that the LLM does not explicitly mention that the relief applies to contracts modified as early as March 12, 2020, which is included in the original answer and adds completeness. (4) The answer is contextually fully relevant, directly addressing how Caterpillar’s hedging accounting policies evolved due to the ASU. Wording differs but semantic meaning is equivalent. The citation to page 68 of the 10-K adds credibility. Overall, this is a strong, factually correct response with only a slight omission in completeness, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1489,
        "completion_tokens": 393,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How did BMY's operational presence in Switzerland in 2022 influence its ability to leverage Project Orbis regulatory pathways by 2024, and what impact did this have on the approval timeline for oncology drugs like Opdivo in international markets?",
      "original_answer": "BMY's operational presence in Switzerland in 2022, particularly through its Revlimid and Thalomid manufacturing facility in Zofingen, positioned the company to benefit from Switzerland's participation in Project Orbis—a global collaborative review program for oncology drugs. By 2024, this strategic alignment enabled BMY to accelerate regulatory approvals for oncology products like Opdivo in international markets. For instance, under Project Orbis, earlier approvals were granted by the Australian TGA, Health Canada, and the UK’s MHRA in 2022 for Opdivo in combination with platinum-doublet chemotherapy, which directly contributed to the FDA approval in March 2022—four months ahead of the priority review PDUFA date. This demonstrates how BMY’s Swiss operations in 2022 facilitated faster global regulatory alignment and expedited market access by 2024.",
      "llm_answer": "BMY’s 2022 Swiss manufacturing site—located in Zofingen—provided an EU‑registered, cGMP‑compliant production hub for Opdivo and other biologics, ensuring that the company could meet European regulatory requirements and support its participation in the FDA’s Project Orbis program【page_27】. By 2024, this infrastructure enabled BMY to coordinate concurrent reviews with Australian, Canadian, UK and Swiss authorities, resulting in earlier approvals of Opdivo combinations and shortening the overall approval timeline for oncology drugs in international markets【page_19】.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies BMY's Zofingen facility in Switzerland and its role in supporting regulatory pathways like Project Orbis, and it accurately links this to accelerated international approvals for Opdivo combinations. However, it introduces a minor inaccuracy by implying the Zofingen site produces Opdivo—ground truth specifies the facility manufactures Revlimid and Thalomid, not Opdivo. This misattribution of product manufacturing affects entity accuracy. (2) Quantitatively, the LLM avoids specific dates and numbers (e.g., March 2022 FDA approval, four-month acceleration ahead of PDUFA), which were present in the original answer. While this omission doesn't introduce false numbers, it reduces quantitative precision and fails to confirm the timeline impact explicitly. The absence of specific approval dates and the extent of timeline shortening (four months) results in partial credit. (3) The multi-hop reasoning is generally sound: the model connects Swiss operations → regulatory compliance → Project Orbis participation → faster international reviews. However, it misses the causal chain that Switzerland’s own participation in Project Orbis (via alignment with TGA, Health Canada, MHRA) in 2022 directly enabled earlier approvals that fed into FDA timing, which is a key nuance in the original answer. The LLM instead frames the Swiss site as an EU-compliant hub aiding coordination, which is contextually relevant but less precise on the Project Orbis mechanism. (4) Contextual relevance is high—the answer stays focused on the question, uses appropriate regulatory bodies, and correctly identifies the strategic benefit. The core conclusion about accelerated timelines is supported, even if specific evidence is generalized. Overall, the answer is factually aligned in spirit but lacks precision in product attribution and timeline specifics, warranting a 7 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 519,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How did Cisco's shift from a $15.0 billion commercial paper program in 2023 to the issuance of $13.5 billion in senior fixed-rate notes in 2024 reflect a change in its debt financing strategy, particularly in relation to interest rate risk management through hedging?",
      "original_answer": "In 2023, Cisco maintained a $15.0 billion short-term commercial paper program used for general corporate purposes. By 2024, the company shifted toward issuing $13.5 billion in senior fixed-rate notes, indicating a strategic move toward longer-term financing. This shift was accompanied by the use of interest rate swaps on $0.5 billion of fixed-rate notes, converting them to floating rates based on SOFR to manage interest rate risk. The senior notes ranked at par with the commercial paper notes, suggesting a deliberate rebalancing of debt structure to optimize risk and cost. This evolution shows Cisco adapting its capital structure by blending short- and long-term instruments while actively hedging exposure.",
      "llm_answer": "Cisco moved from a $15.0 billion short‑term commercial‑paper program (page 88) to issuing $13.5 billion of senior fixed‑rate notes in 2024 (page 89), shifting its debt profile from variable‑rate, short‑maturity borrowing to longer‑term, fixed‑rate debt.  The company also introduced an interest‑rate swap with a $0.5 billion notional amount as a fair‑value hedge of part of the new notes, converting the fixed rate to SOFR‑based floating and offsetting market‑rate changes (page 89).  This reflects a more proactive interest‑rate risk management strategy, tightening its exposure to rate fluctuations compared with the unhedged commercial‑paper program.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Cisco shifted from a $15.0 billion commercial paper program in 2023 to issuing $13.5 billion in senior fixed-rate notes in 2024. The use of a $0.5 billion notional interest rate swap to convert fixed-rate debt to SOFR-based floating rate is accurately reported. These numbers match the original answer exactly, with acceptable formatting (e.g., $13.5 billion). (2) Quantitative accuracy is perfect—dollar amounts, the presence of hedging on $0.5 billion, and the shift in debt maturity are all correct. (3) The reasoning is sound: the LLM correctly infers that moving from short-term, variable-rate commercial paper to long-term fixed-rate debt—while selectively swapping part back to floating—represents a more proactive interest rate risk management strategy. It logically concludes this tightens exposure compared to the unhedged commercial paper, which is consistent with the original answer’s emphasis on active hedging. (4) The only minor omission is that the original answer notes the senior notes rank at par with commercial paper, indicating a balanced debt structure—a nuance not mentioned in the LLM response. However, this does not detract significantly from the overall correctness. The answer fully addresses the question about financing strategy and hedging, with excellent contextual relevance and semantic equivalence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 397,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How did the subscriber base evolution of ESPNU in 2023 compared to ESPN+'s subscriber growth in 2024 reflect the strategic shift in Disney's sports content distribution model?",
      "original_answer": "In 2023, ESPNU had 47 million subscribers as part of Disney's traditional linear sports channel lineup under ESPN's domestic branded channels. By 2024, Disney emphasized ESPN+, a direct-to-consumer platform, which gained approximately 26 million paid subscribers by September 2024. This reflects a strategic shift from linear cable channels like ESPNU to digital streaming through ESPN+, aligning with broader industry trends and suggesting Disney's prioritization of DTC distribution over traditional MVPD models.",
      "llm_answer": "ESPNU had 47 million subscribers in 2023 (SNL Kagan estimate as of December 2023), while ESPN+ grew to about 26 million paid subscribers by September 2024 (internal management reports)【page_10】. The contrast between a largely static linear‑channel base and a rapidly expanding streaming subscriber base underscores Disney’s strategic pivot from traditional sports channels toward a direct‑to‑consumer streaming model.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and dates are correct: ESPNU's 47 million subscribers in 2023 and ESPN+'s 26 million paid subscribers by September 2024 match the original answer. The sources (SNL Kagan, internal management reports) are appropriately cited, and the page reference 【page_10】 adds traceability. (2) The answer is complete, addressing both the subscriber base evolution of ESPNU and ESPN+ and linking it to Disney's strategic shift. (3) Entity accuracy is strong: correct platforms (ESPNU, ESPN+), correct parent company (Disney), and accurate timeframes (2023 vs. 2024). (4) The reasoning is sound—highlighting the contrast between a static linear channel (ESPNU) and growing streaming platform (ESPN+) effectively illustrates the strategic pivot to direct-to-consumer distribution. The only minor shortcoming is a slightly less explicit mention of the broader industry trends compared to the original answer, but the core strategic implication is clearly conveyed. Thus, the answer achieves semantic equivalence with excellent factual and logical fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 323,
        "total_tokens": 1563
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did the sequential expiration of JNJ's 2005 and 2012 Long-Term Incentive Plans affect executive equity compensation by 2024?",
      "original_answer": "In 2022, JNJ was operating under the 2012 Long-Term Incentive Plan, as the 2005 plan had expired on April 26, 2012, with all new grants issued under the 2012 plan thereafter. By 2024, the 2012 plan had also expired on April 26, 2022, and all new options and restricted shares were subsequently issued under the 2022 Long-Term Incentive Plan. This sequential expiration and replacement of plans directly shaped the equity compensation structure available to executives, transitioning from the 2005 plan to the 2012 plan, and finally to the 2022 plan by the 2024 reporting period.",
      "llm_answer": "The 2005 Long‑Term Incentive Plan expired on April 26, 2012, after which all new options and restricted shares were granted under the 2012 plan (see page 118).  The 2012 plan then expired on April 26, 2022, shifting all subsequent equity awards to the new 2022 Long‑Term Incentive Plan (see page 121).  By 2024, the 2022 plan was the only active plan, with its remaining equity pool at 111,042,139 shares and a weighted average exercise price of $127.63—down from the 240,344,013 shares and $109.96 price available under the 2012 plan in 2022—reflecting a tighter, higher‑priced equity compensation structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: the 2005 plan expired on April 26, 2012, leading to the use of the 2012 plan; the 2012 plan expired on April 26, 2022, after which the 2022 plan became active. By 2024, only the 2022 plan was in effect. These dates and transitions match the original answer exactly. (2) Quantitative details—111,042,139 remaining shares and $127.63 weighted average exercise price under the 2022 plan, compared to 240,344,013 shares and $109.96 under the 2012 plan—are specific and factually consistent with typical disclosures, though the ground truth does not include these figures. Their inclusion enhances detail but cannot be verified against the provided ground truth; however, they do not contradict it and appear contextually plausible. (3) The multi-hop reasoning is sound: the model correctly traces the sequential expiration and replacement of incentive plans and links this to the executive equity compensation structure by 2024. (4) The answer goes beyond the original by adding quantitative context about the equity pools and exercise prices, which improves completeness without introducing errors. The only reason for not scoring a 10 is that the original answer does not confirm the specific numbers (e.g., 111 million vs. 240 million shares), so there is a small risk of hallucination, though likely the LLM is citing actual data. Overall, the answer is factually correct, well-reasoned, and directly responsive.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 415,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did the change in NKE's foreign currency exposure related to NTC-sourced product costs in 2024 compare to 2023, and what does this indicate about the company's hedging strategy evolution?",
      "original_answer": "In 2023, NKE's foreign currency exposure from NTC-sourced product costs arose primarily from intercompany purchases denominated in U.S. Dollars, which were then sold to international NIKE entities in their respective functional currencies, creating foreign exchange risk. By 2024, the company continued this sourcing model but refined its hedging strategy by designating more derivatives as cash flow hedges, aiming to reduce the volatility of currency fluctuations on consolidated results. This evolution indicates a more strategic and proactive approach to managing foreign exchange risk, particularly around product cost exposures, by aligning hedge accounting more closely with forecasted transactions and extending hedging periods under rare extenuating circumstances.",
      "llm_answer": "Nike’s foreign‑currency exposure that is tied to product costs sourced through its NIKE Trading Company (NTC) fell in 2024.  The total notional amount of foreign‑currency derivatives designated as cash‑flow hedges – which largely cover NTC‑sourced product‑cost exposure – dropped from **$18.2 billion in 2023 to $16.2 billion in 2024** (a $2 billion reduction)【page_85】.  This decline indicates Nike has trimmed its hedging exposure, reflecting a shift toward a more focused and efficient hedging strategy as it adjusts to changes in sourcing and currency usage【page_84】.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly identifies NTC-sourced product costs as a source of foreign currency exposure, it incorrectly states that exposure and hedging notional amounts decreased from $18.2B in 2023 to $16.2B in 2024. The ground truth does not mention any specific dollar amounts related to hedging notional values or a reduction in exposure—this data is fabricated or misattributed. There is no support in the original answer for these figures, and they contradict the qualitative direction of the actual response, which indicates an evolution toward more strategic and expanded hedging (including extended periods under rare circumstances), not a reduction. (2) The quantitative claims are entirely unsupported: no numbers appear in the original answer regarding notional amounts or changes between years. The $2 billion difference is therefore incorrect, and the citation of 'page_85' and 'page_84' suggests sourcing from a document not aligned with the ground truth knowledge graph. (3) The multi-hop reasoning is flawed. The original answer describes a qualitative evolution in hedging strategy—increased use of cash flow hedges and better alignment with forecasted transactions—while the LLM interprets a supposed decrease in notional hedging as evidence of a 'more focused and efficient' strategy. This misrepresents the relationship between hedge volume and strategy effectiveness. The LLM fails to capture the actual progression from basic risk recognition to proactive, accounting-aligned hedging. (4) Due to major factual errors in both numerical data and strategic interpretation, the correctness score is low at 3. Quantitative accuracy is scored at 4 because while numbers are presented precisely, they are entirely incorrect. Qualitative accuracy is 3 due to mischaracterization of the strategy evolution. Contextual relevance is 6 because the answer addresses the right topic (NTC sourcing, foreign exchange, hedging strategy) and attempts to compare 2023 to 2024, but draws incorrect conclusions from invented data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 563,
        "total_tokens": 1910
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Southern Company's approach to goodwill impairment testing for PowerSecure evolve between 2022 and 2023, and what were the financial implications of this change?",
      "original_answer": "In 2022, Southern Company conducted a quantitative assessment for PowerSecure, which revealed that its fair value was lower than its carrying amount, primarily due to declining macroeconomic conditions. This led to a goodwill impairment of $119 million. In contrast, during 2023, PowerSecure's management again performed a quantitative assessment, which showed that its fair value exceeded its carrying amount, avoiding any impairment. This reversal indicates that the financial health of PowerSecure improved over the year, reducing the need for further impairment charges.",
      "llm_answer": "In 2022, PowerSecure’s goodwill was tested with a quantitative impairment assessment that found the fair value below carrying value, leading to a $119 million impairment charge【page_175】. In 2023 the same quantitative test was applied but the fair value exceeded carrying value, so no impairment was recorded, effectively reversing the 2022 charge and improving earnings by that amount【page_175】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key facts: in 2022, a quantitative goodwill impairment test for PowerSecure resulted in a $119 million impairment due to fair value being below carrying value, and in 2023, the same test showed fair value exceeded carrying value, leading to no impairment. These facts align with the ground truth. (2) Quantitative accuracy is perfect: the $119 million figure is correct, years (2022 and 2023) are accurate, and the description of the test outcomes (below in 2022, above in 2023) matches. Format variation ( million) is acceptable. (3) The multi-hop reasoning is sound—comparing the outcomes of two consecutive years’ impairment tests and inferring financial implications. The LLM correctly synthesizes that avoiding an impairment in 2023 effectively reversed the prior year’s charge and improved earnings, which is a reasonable interpretation of the financial impact. However, the phrase 'reversing the 2022 charge' is slightly imprecise—impairments are not reversed; rather, no new impairment was required. This is a minor overstatement but does not undermine the core correctness. (4) The answer is contextually relevant, directly addressing both the evolution in testing approach and the financial implications. The qualitative accuracy is slightly reduced due to the minor mischaracterization of 'reversing' the charge, but overall reasoning and entity identification (Southern Company, PowerSecure, goodwill, impairment) are accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 412,
        "total_tokens": 1661
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did the $500 million in capitalized Comirnaty sales milestones paid to BioNTech in 2022 influence Pfizer's licensing and collaborative arrangements with BioNTech in 2023, particularly in relation to the Omicron XBB.1.5-adapted monovalent vaccine approval?",
      "original_answer": "In 2022, Pfizer capitalized $500 million in Comirnaty sales milestones to BioNTech, reflecting the ongoing financial commitment and dependency on their partnership for vaccine development and commercialization. By 2023, this relationship had evolved into a broader collaborative framework, including the development of the Omicron XBB.1.5-adapted monovalent vaccine, which received FDA approval. The partnership also included shared development costs and global commercialization rights, with Pfizer holding a 2.7% equity stake in BioNTech as of December 31, 2023. This indicates that the earlier financial investment in Comirnaty milestones likely strengthened the strategic alignment and collaborative innovation between the two companies, enabling the rapid development and regulatory approval of updated vaccine formulations in 2023.",
      "llm_answer": "The $500 million of Comirnaty sales milestone payments that Pfizer capitalized in 2022 increased the carrying value of its intangible assets, underscoring the financial depth of its licensing and collaborative relationship with BioNTech【page_92】.  This financial foundation underpinned the 2023 partnership, which continued to share revenue and milestone payments under the same licensing framework and ultimately enabled the FDA approval of the Omicron XBB.1.5‑adapted monovalent vaccine【page_77】【page_47】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers and dates are correct: the $500 million in capitalized Comirnaty sales milestones paid in 2022 is accurately reported, and the reference to the 2023 Omicron XBB.1.5-adapted monovalent vaccine FDA approval is factually sound. No calculations were required, and the dollar amount and years match the original answer exactly. (2) The LLM correctly identifies the entities involved—Pfizer, BioNTech, Comirnaty, and the Omicron XBB.1.5-adapted monovalent vaccine—and the timeline (2022 milestone payment influencing 2023 collaboration). (3) The reasoning is logically sound: the capitalized milestone payment is correctly interpreted as reinforcing the financial and strategic foundation of the collaboration, which enabled continued joint development and regulatory success in 2023. The LLM references shared revenue and milestone payments and links them to the FDA approval, which is consistent with the original answer’s claim about strengthened strategic alignment. (4) The only minor omission is that the LLM does not mention Pfizer’s 2.7% equity stake in BioNTech as of December 31, 2023—a detail included in the ground truth that further supports the depth of the partnership. While this adds context, its absence does not undermine the core factual accuracy or reasoning. The LLM answer is semantically equivalent in conveying the causal influence of the 2022 payment on the 2023 collaboration outcome. Thus, the answer is excellent but not fully complete, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 442,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did the evolution of Starbucks' reliance on Nestlé through the Global Coffee Alliance from 2022 to 2024 impact the risk profile of the Channel Development segment, particularly in light of concerns around Nestlé's ability to meet distribution and marketing commitments?",
      "original_answer": "In 2022, Starbucks' Channel Development segment relied heavily on Nestlé through the Global Coffee Alliance, with most revenues coming from product sales and royalties. By 2024, while the partnership remained central, Starbucks explicitly highlighted increased risk tied to Nestlé's ability to meet distribution and marketing commitments, signaling a shift from a primarily operational relationship to one with heightened dependency risk. This evolution suggests that although the alliance continued to be a key revenue driver, Starbucks became more sensitive to Nestlé's performance under the agreement, particularly regarding brand protection and market expansion in international channels.",
      "llm_answer": "Starbucks’ 2024 filing echoes the 2022 risk‑factor that the Channel Development segment is “heavily reliant on Nestlé, which has the global right to sell and distribute our packaged goods and food‑service products.”  The 2024 text adds that if Nestlé fails to meet its distribution and marketing commitments, the Channel Development business could be “adversely impacted for a period of time, present long‑term challenges to our brand, limit our ability to grow, and have a material adverse impact on our financial results.”  Thus, the evolution of the Global Coffee Alliance has not reduced the dependence on Nestlé but has heightened the segment’s exposure to Nestlé’s performance, making distribution and marketing failures a more pronounced risk to growth and brand protection.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) All key facts are correct: Starbucks remained heavily reliant on Nestlé in both 2022 and 2024, the Channel Development segment's risk profile increased due to concerns over Nestlé’s distribution and marketing commitments, and the 2024 filing explicitly heightened the language around potential brand and growth impacts. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not applicable—no discrepancies exist. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across years (2022 to 2024), identifies the evolution in risk disclosure, and infers that dependence did not decrease but rather the consequences of Nestlé’s underperformance became more explicitly framed as a strategic risk. (4) The LLM captures the core evolution—increased sensitivity to Nestlé’s performance—even quoting risk factors accurately in spirit. The only minor gap is that it does not explicitly mention the continued centrality of the alliance as a revenue driver (e.g., royalties and product sales), which is present in the original answer. However, this omission does not undermine the main conclusion about risk profile evolution. Wording differs but semantic meaning is equivalent. Thus, correctness is high—9/10—with full marks for contextual relevance and quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 399,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did UNP's allocation to limited partnerships in 2023 influence its real estate fund valuation methodology in 2024, particularly in terms of unfunded commitments and NAV-based reporting?",
      "original_answer": "In 2023, UNP disclosed that its pension plan had approximately $3.3 billion in unfunded commitments to limited partnerships, including real estate funds, which were valued using NAV due to the lack of readily observable market data. These limited partnerships were primarily invested in private companies and real estate, with valuations derived from property appraisals and partnership financial reports. In 2024, UNP continued to rely on NAV-based valuation for real estate funds, indicating a consistent methodology dependent on private appraisals and partnership structures. The persistence of NAV-based reporting and the presence of unfunded commitments in 2023 suggest that UNP’s reliance on limited partnerships in 2023 directly shaped its continued valuation practices for real estate funds in 2024.",
      "llm_answer": "UNP’s 2023 allocation to limited partnerships—amounting to roughly $3.3 billion in unfunded commitments—required the master trust to value those interests at NAV based on the partnership’s audited statements. In 2024 the same NAV‑based valuation was applied to its real‑estate funds, with the 2023 unfunded commitments factored into the NAV calculations and overall asset allocation, ensuring the real‑estate fund’s fair value reflected the expected future contributions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the $3.3 billion unfunded commitments in 2023 are correctly reported, and the use of NAV-based valuation in both 2023 and 2024 is accurately reflected. (2) The LLM correctly identifies that NAV was used due to lack of market data, though it specifies 'audited statements'—a detail not explicitly in the original, but not factually incorrect, as financial reports from partnerships may be audited. (3) The multi-hop reasoning is sound: it connects UNP’s 2023 allocation to limited partnerships with the continued use of NAV in 2024 for real estate funds, correctly inferring that the 2023 structure influenced 2024 methodology. (4) The answer captures the core causal relationship—unfunded commitments and NAV reliance in 2023 shaping 2024 practices—though it slightly simplifies the explanation of valuation sources (e.g., property appraisals, partnership reports) mentioned in the original. However, it does convey that NAV incorporates future commitments, which is contextually valid. Minor omission of detail on valuation inputs (appraisals) prevents a perfect 10, but overall factual correctness, synthesis, and relevance are excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 344,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did Southern Company's stake in FP&L in 2023 relate to FP&L's ownership of Plant Scherer Unit 3, and how did this connection influence Southern Company's 2024 request to extend the operation of Plant Scherer Unit 3 through 2035?",
      "original_answer": "In 2023, Southern Company had a stake in FP&L, which jointly owned Plant Scherer Unit 3 with Georgia Power (75%) and FP&L (25%). By 2024, Southern Company, through its stake in FP&L and the broader Georgia Power entity, requested an operational extension of Plant Scherer Unit 3 through at least December 31, 2035 as part of the 2025 Integrated Resource Plan (IRP). This request was tied to FP&L’s ownership stake in the plant and Georgia Power’s broader operational strategy, showing a strategic alignment between Southern Company’s subsidiaries and its long-term energy planning.",
      "llm_answer": "Southern Company owned a 3.5 % stake in FP&L in 2023, and FP&L owned 25 % of Plant Scherer Unit 3.  That indirect ownership gave Southern Company a small but non‑trivial interest in the coal‑fired unit, which it cited as part of the rationale for its 2024 request to Georgia PSC to extend the operation of Plant Scherer Unit 3 through 2035.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but contains a critical quantitative inaccuracy: it states that Southern Company owned a 3.5% stake in FP&L in 2023, which is not supported by the ground truth. The original answer does not specify the size of Southern Company's stake in FP&L, only that it had a stake. This specific percentage (3.5%) is factually unsupported and introduces a significant error, even if the general direction of reasoning is sound. However, the LLM correctly identifies that FP&L owned 25% of Plant Scherer Unit 3 and that Southern Company’s indirect ownership via FP&L was part of the rationale for the 2024 request to extend operations through 2035. The connection to the Georgia PSC and the 2035 extension is contextually accurate and aligns with the strategic reasoning in the ground truth. The multi-hop logic—linking Southern Company’s stake in FP&L to FP&L’s ownership of the plant and then to Southern Company’s operational request—is qualitatively sound and shows appropriate synthesis. The mention of the 2024 request tied to the 2025 IRP (implied in the original) is reasonably reflected. While the core narrative of indirect ownership influencing the extension request is preserved, the unsupported 3.5% figure undermines quantitative accuracy. This is a minor factual overprecision rather than a complete fabrication, so the answer remains largely plausible but not fully accurate. Hence, correctness is reduced to 7 due to this unverified number, though completeness and reasoning are strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 417,
        "total_tokens": 1669
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did the voting power dynamics between Class A and Class B common stock evolve from 2022 to 2024, and what impact did this have on GOOGL's shareholder equity structure?",
      "original_answer": "In 2022, holders of Class A common stock held approximately 66⅔% of the combined voting power, while Class B common stock, which had 15 votes per share, represented approximately 33⅓% of the combined voting power. By 2024, Class B common stock voting rights were adjusted to 10 votes per share, signaling a shift in internal governance dynamics. Additionally, GOOGL repurchased $59.3 billion of shares in 2022 and $62.0 billion in 2024, primarily targeting Class A and Class C shares, which further influenced equity distribution. This evolution reflects a strategic recalibration of shareholder influence and capital structure.",
      "llm_answer": "Alphabet’s 2024 10‑K (page 82) confirms that each Class A share still carries one vote while each Class B share carries ten votes, the same ratio that applied in 2022.  The weighted‑average number of shares used in per‑share calculations fell from 5,994 Class A and 887 Class B shares in 2022 (page 83) to 5,855 Class A and 866 Class B shares in 2024 (page 84), reflecting a 2024 repurchase of 73 million Class A shares (page 84).  This reduction in outstanding shares concentrated voting power among the remaining Class B holders and tightened Alphabet’s shareholder‑equity structure, boosting earnings‑per‑share metrics while keeping the Class A‑to‑Class B vote ratio unchanged.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies in quantitative details. While it correctly states that Class B shares had 10 votes per share in 2024 (matching the ground truth), it fails to mention that in 2022, Class B shares had 15 votes per share — a critical change in voting power dynamics. Instead, the LLM claims the ratio was the same in 2022 and 2024, which contradicts the ground truth. This is a major factual error affecting the core of the question about evolution in voting power. (2) The share repurchase amounts are misrepresented: the LLM cites only a 73 million Class A share repurchase in 2024 and omits the actual dollar amounts of $59.3 billion in 2022 and $62.0 billion in 2024 from the ground truth. The weighted-average share numbers (e.g., 5,994 Class A shares) appear to be misinterpreted — these are likely in millions, but presenting them as absolute numbers without units or context introduces confusion and inaccuracy. The $62B repurchase in 2024 is a significant figure that should have been included. (3) The reasoning about concentrated voting power due to repurchases has merit and reflects sound logic — reducing outstanding shares, especially Class A, does increase relative influence of Class B holders. However, the model fails to mention that repurchases targeted Class A and Class C shares specifically, which is a key point in equity structure impact. Also, the multi-hop synthesis between voting rights change (15→10 votes) and repurchase activity is incomplete because the LLM denies the voting power change occurred. (4) Despite these issues, the answer is contextually relevant, addresses the shareholder equity structure, cites correct document locations (10-K pages), and correctly identifies current voting rights. It captures part of the equity concentration effect but misses the broader strategic recalibration described in the ground truth. Hence, correctness is partially accurate but undermined by key omissions and one major factual error on vote ratio stability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 546,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did JPMorgan Chase's compliance with EU CRR capital requirements through J.P. Morgan Securities plc evolve from 2023 to 2024?",
      "original_answer": "In 2023, J.P. Morgan Securities plc was required to meet a minimum Tier 1 leverage ratio of 3.25%, plus regulatory buffers, under the PRA capital rules aligned with the EU CRR. By 2024, JPMorgan Chase reported that J.P. Morgan Securities plc continued to exceed the minimum Pillar 1 capital requirements specified by the EU CRR, including additional capital buffers imposed by EU regulators. This indicates that while the firm remained compliant in both years, its capital position relative to the EU CRR requirements strengthened from 2023 to 2024.",
      "llm_answer": "In 2023, J.P. Morgan Securities plc was fully compliant with EU CRR and PRA, reporting a CET1 ratio of 16.9 % (vs. 4.5 % minimum), Tier 1 of 22.3 % (vs. 6.0 %), total capital ratio of 28.1 % (vs. 8.0 %) and a Tier 1 leverage of 7.3 % (vs. 3.3 %). By December 31 2024 the firm remained compliant, with a slight uptick in CET1 to 17.0 % but modest declines in Tier 1 to 22.1 %, total capital ratio to 27.1 % and leverage to 7.1 %, all still well above the regulatory minimums, and it continued to meet its MREL obligations. Thus, compliance persisted unchanged, with only minor adjustments in the capital ratios between the two years.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that in 2023, J.P. Morgan Securities plc was subject to a minimum Tier 1 leverage ratio of 3.25% plus buffers under PRA rules aligned with EU CRR, but the LLM fabricates specific capital ratios (e.g., CET1 of 16.9%, Tier 1 of 22.3%, total capital of 28.1%, leverage of 7.3%) that are not present in the original answer and cannot be verified from the provided truth. Similarly, the 2024 figures (CET1 17.0%, Tier 1 22.1%, etc.) are entirely invented. There is no mention in the ground truth of actual reported ratios—only that the firm exceeded requirements. (2) The quantitative values in the LLM answer are completely unsupported by the original answer. The original does not provide any specific percentages for capital ratios, only that the firm met or exceeded minimums. The LLM incorrectly introduces precise numbers and even compares them year-over-year (e.g., 'slight uptick', 'modest declines'), which is a hallucination. (3) The multi-hop reasoning is flawed: while the LLM correctly identifies the entity (J.P. Morgan Securities plc) and the regulatory framework (EU CRR, PRA), it fails to base its synthesis on actual data from the knowledge graph. Instead, it invents a detailed quantitative narrative that contradicts the ground truth's more cautious and general assessment. The conclusion that 'compliance persisted unchanged' also contradicts the original answer’s assertion that the capital position 'strengthened' from 2023 to 2024. (4) Despite the factual errors, the answer is contextually relevant—addressing the right entity, regulation, and time frame—and uses appropriate financial terminology. Hence, contextual relevance is high, but correctness and quantitative accuracy are severely compromised due to hallucinated data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 500,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did the relationship between UPS's Class B shares in 2023 and Class A shares evolve by 2024, particularly in terms of their authorization quantities and voting rights structure?",
      "original_answer": "In 2023, UPS maintained two classes of common stock—Class A and Class B—with Class B shares being publicly traded and having one vote per share, while Class A shares had 10 votes per share and were primarily held by employees, retirees, and founder-related entities. By 2024, the company still authorized 4.6 billion Class A shares and 5.6 billion Class B shares, indicating no change in the quantity of shares authorized for either class. However, the continued existence of the same voting rights structure (10 votes for Class A and 1 vote for Class B) and the convertibility of Class A to Class B shares suggests a consistent governance framework. This reflects a stable relationship between the share classes despite the transition from 2023 to 2024.",
      "llm_answer": "UPS continued to authorize the same number of shares in 2024 as it had in 2023—4.6 billion Class A shares and 5.6 billion Class B shares (see 2023 Note 12, page 112 and 2024 Note 12, page 116). The voting‑rights structure also stayed unchanged: Class A shares carry 10 votes each and are fully convertible into Class B shares, while Class B shares carry one vote each.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately conveyed: the authorization quantities of 4.6 billion Class A shares and 5.6 billion Class B shares remained unchanged from 2023 to 2024, and the voting rights structure (10 votes for Class A, 1 vote for Class B) was preserved. (2) Quantitative accuracy is perfect—both share counts are correctly reported with no discrepancies in numbers or units. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two years (2023 and 2024) and compares authorization levels and voting rights, drawing a valid conclusion about stability in the share structure. (4) The answer addresses all parts of the question—evolution of authorization quantities and voting rights—and includes relevant context such as convertibility. Minor omission of explicit mention of 'founder-related entities' or 'employees/retirees' does not detract from the core factual accuracy or completeness regarding the structural evolution. The inclusion of specific footnote references (Note 12) enhances credibility. Overall, the response is concise, factually precise, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 339,
        "total_tokens": 1628
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did Southern Company's reliance on commercial paper programs in 2022 compare to Nicor Gas' working capital financing structure in 2024, and what does this reveal about the evolution of short-term liquidity strategies within the Southern Company system?",
      "original_answer": "In 2022, Southern Company relied on commercial paper programs through its subsidiaries, with Nicor Gas maintaining its own separate program to support working capital needs due to regulatory restrictions preventing it from making money pool loans to affiliates. By 2024, Nicor Gas remained a borrower under its own $100 million credit arrangement expiring in 2025 and also benefited from a $700 million allocation under Southern Company Gas' $1.5 billion credit arrangement expiring in 2029, specifically restricted for its working capital needs. This shows a continued reliance on dedicated short-term financing for Nicor Gas, but with increased integration into a broader Southern Company Gas liquidity framework, suggesting a strategic shift toward more coordinated liquidity management while maintaining regulatory compliance.",
      "llm_answer": "In 2022 Southern Company relied almost exclusively on commercial‑paper programs for its traditional electric operating companies, SEGCO, and its own subsidiary Southern Company Gas Capital, with no cross‑affiliate credit support (see pages 111–112). By 2024 Nicor Gas’ working‑capital financing had evolved to a dedicated $700 million credit line (restricted to working‑capital needs) plus a commercial‑paper program that is now backed by the system’s bank‑credit arrangements (see pages 223–224). This shift illustrates the Southern Company system’s move from a pure commercial‑paper strategy toward a more structured, bank‑backed liquidity mix that integrates credit lines and commercial paper for working‑capital needs.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies. First, it claims Southern Company in 2022 relied 'almost exclusively' on commercial paper for SEGCO and Southern Company Gas Capital — but the ground truth does not state 'almost exclusively' nor specify SEGCO’s financing structure in that way; it focuses on subsidiaries generally and specifically mentions Nicor Gas’s separate program. The LLM incorrectly implies a system-wide pure commercial paper strategy, which is not supported. (2) Quantitatively, the LLM states Nicor Gas had a 'dedicated $700 million credit line' in 2024. This is incorrect: the $700 million is an allocation under Southern Company Gas’ $1.5 billion facility, not a standalone $700 million line. The ground truth also mentions Nicor Gas has its own $100 million credit arrangement — a key detail entirely omitted by the LLM. These are significant quantitative and structural errors. (3) The multi-hop reasoning is partially sound — the LLM correctly infers a strategic shift toward integrated, bank-backed liquidity — but it misrepresents the evolution by omitting Nicor’s dual-layer structure and overstating the role of commercial paper backing. It fails to mention regulatory restrictions (a key driver in the ground truth), weakening the explanation of why separate structures exist. (4) Despite these flaws, the LLM captures the broader trend of increased integration and shift toward coordinated liquidity, which is contextually relevant and aligns with the question’s intent. However, due to missing key facts, incorrect dollar amounts, and flawed entity-specific details, the answer is only partially correct. Hence, a score of 6/10 for correctness: core direction of evolution is right, but execution and factual grounding are flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 484,
        "total_tokens": 1899
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did the changes in CMS Innovation Center model participation requirements between 2023 and 2024 affect Oak Street Health's ability to achieve shared savings, and what does this imply for CVS's strategic integration of value-based care models?",
      "original_answer": "In 2023, CVS highlighted Oak Street Health's expected growth as part of its strategic expansion into value-based care. However, by 2024, the company disclosed increasing regulatory and operational risks tied to CMS Innovation Center models like ACO REACH, including annual payment benchmark reductions and lack of long-term model continuity. These changes directly impacted Oak Street Health's ability to reliably achieve shared savings, as CMS adjustments made it harder to predict and capture cost savings. This evolution suggests that CVS's integration of value-based care models faces growing uncertainty due to shifting CMS policies, potentially affecting the long-term ROI of its Oak Street Health acquisition.",
      "llm_answer": "The 2024 filing notes that CMS Innovation Center models (e.g., ACO REACH) now have annual changes that reduce available payments, allow benchmarks to be altered after the performance year, and lack a plan for continued participation, which directly limits Oak Street Health’s ability to realize shared‑savings targets【44】【45】.  In contrast, the 2023 filing did not highlight such changes, implying that the new regulatory shifts have tightened the financial upside for Oak Street Health.  Consequently, CVS must strengthen its value‑based care integration—by enhancing data‑analytics and risk‑adjustment capabilities and exploring alternative payment models—to mitigate the impact of these CMS changes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the key changes in CMS Innovation Center models between 2023 and 2024—specifically annual payment reductions, post-hoc benchmark adjustments, and lack of long-term continuity—which directly impact Oak Street Health's shared savings potential. These points are consistent with the original answer. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or answers, so quantitative accuracy is not compromised; dates (2023 vs. 2024) are used correctly. (3) The multi-hop reasoning is sound: the model connects CMS policy changes to Oak Street Health’s operational challenges, then links this to CVS’s strategic response in integrating value-based care. The LLM adds a forward-looking implication—CVS must enhance analytics and explore alternative models—that is logically derived and consistent with the original answer’s conclusion about increased uncertainty and ROI risk. (4) The only minor gap is that the LLM answer does not explicitly mention the 'strategic expansion' narrative from 2023 or frame the implications in terms of the acquisition’s long-term ROI as directly as the original answer. However, this is a nuance in emphasis, not a factual error. Overall, the answer is semantically equivalent, contextually precise, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 389,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did AIG's pension risk transfer business in 2022 relate to its favorable mortality experience and subsequent financial performance in 2023?",
      "original_answer": "In 2022, AIG reported $1.3 billion in premiums from pension risk transfer transactions, which contributed to business growth and higher average invested assets. This segment was linked to favorable mortality trends, particularly in the pension risk transfer portion of the business, which positively impacted adjusted earnings by $81 million in 2022. By 2023, favorable mortality continued to play a key role in financial performance, contributing $232 million to adjusted pre-tax income. This indicates that the mortality experience tied to the pension risk transfer business in 2022 had a sustained positive effect on AIG's financial outcomes in the following year.",
      "llm_answer": "In 2022, AIG’s pension‑risk transfer (RIS) business benefited from favorable mortality, which lowered policy‑holder benefits and lifted premiums, helping raise adjusted pre‑tax income by $68 million【page 83】【page 87】.  In 2023 the same line continued to be a key driver: new pension‑risk transfer premiums of $2.7 billion and $536 million of higher net investment income pushed adjusted pre‑tax income up $45 million, though higher policy‑holder benefits ($2.9 billion) and interest‑credited expenses partially offset the gain【page 84】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key numbers compared to the ground truth. The ground truth states that favorable mortality contributed $81 million to adjusted earnings in 2022, but the LLM claims $68 million. For 2023, the ground truth reports $232 million contribution from favorable mortality to adjusted pre-tax income, while the LLM incorrectly states only $45 million and attributes it to different drivers (premiums and investment income), missing the mortality link entirely. Additionally, the LLM reports $2.7 billion in new pension-risk transfer premiums in 2023, which is not mentioned in the original answer and contradicts the 2022 figure of $1.3 billion without supporting continuity. (2) The calculation and attribution of financial impacts are incorrect: the LLM fails to connect the sustained favorable mortality experience from 2022 to 2023, instead introducing unrelated figures like $536 million in net investment income and $2.9 billion in policyholder benefits not present in the ground truth. These numbers appear fabricated or misattributed. (3) The multi-hop reasoning is flawed. While the question asks how the 2022 pension risk transfer business (and its favorable mortality) related to 2023 financial performance, the LLM does not establish this causal or sustained link. Instead, it treats 2023 performance as driven by new premiums and investment income, breaking the logical chain. The original answer emphasizes continuity in favorable mortality experience; the LLM misses this synthesis entirely. (4) Despite these issues, the answer is contextually relevant—focused on AIG, pension risk transfer, mortality, and financial performance—and uses appropriate terminology. However, due to major quantitative errors and failure to correctly trace the multi-hop relationship between 2022 mortality trends and 2023 results, the correctness score is low. Minor score for qualitative accuracy reflects correct general domain understanding but flawed execution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 545,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did Duke Energy's reliance on Indiana operations in 2022 relate to the significant increase in tax-exempt bond disclosures for Duke Energy Indiana by 2023?",
      "original_answer": "In 2022, Duke Energy Indiana contributed $6 million to the company's net periodic post-retirement benefit costs, indicating a notable operational presence in the state. By 2023, this operational footprint was mirrored in the capital structure, with Duke Energy Indiana holding $285 million in tax-exempt bonds—part of a broader $1.331 billion total tax-exempt bond portfolio disclosed across the company. This suggests a strategic alignment where Indiana operations, which were financially material in 2022, became a key component of Duke Energy's tax-advantaged financing structure in 2023.",
      "llm_answer": "Duke Energy’s 2022 10‑K shows that its Indiana subsidiary issued a large amount of tax‑exempt debt—$854 million of tax‑exempt bonds were issued by Duke Energy Indiana in 2022 (page 223).  Because the company continued to rely heavily on its Indiana operations, the 2023 10‑K reports a markedly larger tax‑exempt bond portfolio for the same subsidiary—$4,543 million of tax‑exempt bonds maturing 2024‑2028 and thereafter (pages 164‑165)—reflecting the need for long‑term financing to support those operations.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies. According to the ground truth, Duke Energy Indiana held $285 million in tax-exempt bonds by 2023 as part of a $1.331 billion total portfolio, not $4,543 million as claimed. Additionally, the LLM states that $854 million in tax-exempt bonds were issued in 2022, which is not supported by the original answer or implied timeline. These numbers are wildly off and completely undermine the factual basis of the response. (2) The quantitative inaccuracies are severe: the LLM inflates the bond amount by more than 15 times ($285M vs $4,543M) and introduces a figure ($854M issued in 2022) with no basis in the ground truth. There is no indication in the original answer that such large issuances occurred in 2022 or 2023. (3) The reasoning is partially sound in structure—linking operational reliance to financing decisions—but fails on multi-hop synthesis because it does not reference the actual 2022 operational metric (the $6 million post-retirement cost contribution) that grounded the original inference. Instead, it fabricates bond issuance data to support a narrative. (4) While the LLM attempts to address the relationship between Indiana operations and tax-exempt bonds, it does so with fabricated numbers and incorrect timelines, leading to a very low correctness and quantitative accuracy score. Contextual relevance is moderate because it addresses the right entities and general theme, but the answer is ultimately misleading.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 414,
        "total_tokens": 1692
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did ConocoPhillips' 2022 equity investment write-down in APLNG impact its 2024 valuation and stake in CBM production capacity through the APLNG joint venture?",
      "original_answer": "In 2022, ConocoPhillips wrote down its investment in APLNG to a fair value of $5,574 million, recognizing a before-tax charge of $688 million due to the sale of Origin Energy’s 10% interest and the resulting market valuation being below carrying value. By 2024, ConocoPhillips held a 47.5% stake in APLNG, which produces CBM from the Bowen and Surat basins in Australia. The carrying value of this investment had increased to approximately $5.0 billion by the end of 2024, indicating a recovery and revaluation of the APLNG asset. This suggests that despite the earlier impairment, the company maintained and potentially strengthened its position in CBM production and LNG export capacity through APLNG.",
      "llm_answer": "The 2022 write‑down of ConocoPhillips’ equity investment in APLNG lowered the carrying value of the investment, which is reflected in the 2024 balance sheet as a $5.0 billion equity‑method valuation【page_94】.  The write‑down did not alter ConocoPhillips’ ownership in the joint venture; it still holds a 47.5 % stake that gives it access to the CBM production from the Bowen and Surat basins【page_93】.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is mostly correct but omits a key detail from the original answer: the 2022 write-down involved a before-tax charge of $688 million due to the sale of Origin Energy’s 10% interest and the resulting fair value adjustment to $5,574 million. While the LLM correctly states that the 2024 valuation was $5.0 billion and that ConocoPhillips maintains a 47.5% stake in APLNG with access to CBM production in the Bowen and Surat basins, it fails to mention the initial post-write-down fair value in 2022 or the reason for the impairment. This omission affects completeness and slightly weakens the multi-hop synthesis, particularly around the cause of the write-down and the trajectory of revaluation. However, the core facts—ownership stake, geographic production access, and 2024 carrying value—are accurate. The reasoning is sound in linking the write-down to carrying value without affecting ownership, and the entities and years are correctly identified. Number formats are consistent and semantically equivalent ($5.0 billion = $5,574 million in context of recovery). Thus, while factually aligned in outcome, the answer lacks full depth on the 2022 event, warranting a high but not perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 338,
        "total_tokens": 1618
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did MS's 2023 structured products funding strategy relate to its 2024 CMBS investment positioning, particularly in terms of changes in CMBS holdings between agency and non-agency securities?",
      "original_answer": "In 2023, MS emphasized a diversified funding strategy for both standard and structured products, including CMBS, to manage refinancing risk and ensure liquidity (Hop 1). Structured Products, which include CMBS, are a key part of MS's fixed maturity AFS securities portfolio (Hop 2). By 2024, MS held $1,154 million in agency CMBS and $1,450 million in non-agency CMBS under HTM securities, with respective fair values of $1,066 million and $1,340 million, indicating a strategic allocation to both types of CMBS (Hop 3). This suggests that MS's earlier funding diversification efforts enabled targeted CMBS investments in 2024, balancing agency and non-agency exposure.",
      "llm_answer": "MS’s 2023 structured‑products funding strategy positioned CMBS as a key liquidity and risk‑management tool (see the structured‑products definition on page 49) and was part of a broader diversification of secured and unsecured funding sources (page 51). In 2024 the firm shifted its CMBS mix, cutting agency CMBS from $5.87 bn (AFS) and $1.34 bn (HTM) in 2023 to $5.70 bn (AFS) and $1.15 bn (HTM) (page 109), while boosting non‑agency CMBS from $1.24 bn to $1.45 bn (HTM) (page 109), reflecting a tilt toward higher‑yield, higher‑risk non‑agency securities.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. It claims MS held $5.87 billion in agency CMBS (AFS) and $1.34 billion (HTM) in 2023, then reduced to $5.70 billion (AFS) and $1.15 billion (HTM) in 2024. However, the ground truth states that in 2024, MS held $1,154 million ($1.154 billion) in agency CMBS and $1,450 million ($1.45 billion) in non-agency CMBS — both under HTM securities — with no mention of AFS holdings for agency CMBS in 2024 or comparative 2023 figures. The LLM incorrectly introduces AFS agency CMBS holdings and misrepresents the magnitude of holdings (e.g., $5.87B vs actual $1.154B). The non-agency CMBS increase from $1.24B to $1.45B is partially correct but lacks context — the ground truth does not specify 2023 non-agency CMBS levels. (2) Calculations and comparisons are flawed: the LLM implies a shift from higher agency to non-agency CMBS, but overstates agency CMBS by 5x. The actual data shows a balanced allocation, not a 'shift' or 'tilt'. (3) Multi-hop reasoning is partially sound — the LLM correctly links 2023 funding strategy to 2024 CMBS positioning and identifies structured products as part of risk management. It also correctly infers a strategic focus on non-agency CMBS. However, it fails to reflect that structured products are part of AFS portfolios (Hop 2) and mischaracterizes the security types and accounting categories (AFS vs HTM). (4) Despite incorrect numbers, the answer is contextually relevant and captures the general strategic direction — using diversified funding to enable CMBS investments and increasing non-agency exposure. However, the severe quantitative errors undermine factual correctness, warranting a low correctness score. Semantic equivalence fails on key metrics, though the qualitative insight about strategic allocation has partial validity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 500,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did the change in the Netherlands Innovation Box Tax's impact on BKNG's effective tax rate between 2022 and 2023 reflect the company's evolving reliance on Dutch corporate income tax law incentives?",
      "original_answer": "In 2022, BKNG's effective tax rate was positively impacted by the Netherlands Innovation Box Tax, which offset factors like higher international tax rates and increased unrecognized tax benefits. However, by 2023, the benefit from the Innovation Box Tax decreased, even though BKNG remained subject to Dutch corporate income tax law, which taxes qualifying innovative income at 9% compared to the statutory rate of 25.8%. This decline in tax benefit suggests a reduced reliance on or availability of the Innovation Box Tax incentive, despite continued eligibility under Dutch law. The effective tax rate for 2023 was lower than 2022 due to a reduced valuation allowance and lower international tax rates, but this was partially offset by the declining benefit from the Innovation Box Tax.",
      "llm_answer": "Between 2022 and 2023 the Netherlands Innovation Box Tax benefit rose from $452 million to $544 million, which helped lower BKNG’s effective tax rate from 22.1 % to 21.8 % (see 2023 10‑K, p. 49 and p. 106).  The larger benefit—despite the Dutch statutory rate rising to 25.8 %—indicates that the company continued to generate a greater share of qualifying innovative earnings in the Netherlands and kept relying on the Innovation Box incentive to manage its global tax profile.  The modest decline in effective tax rate, driven by the increased benefit, reflects BKNG’s ongoing strategy of leveraging Dutch corporate‑income‑tax law incentives to reduce its overall tax burden.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in nearly all key aspects. The ground truth states that the benefit from the Netherlands Innovation Box Tax *decreased* between 2022 and 2023, but the LLM claims it *increased* from $452 million to $544 million—this is directly contradicted by the original answer and represents a fundamental factual error. Additionally, the effective tax rate change is misrepresented: the LLM claims it decreased from 22.1% to 21.8%, but the original answer does not provide exact rates and instead explains that the 2023 rate was lower due to other factors (reduced valuation allowance, lower international rates), partially offset by a *declining* Innovation Box benefit. (2) The dollar amounts ($452M to $544M) and tax rates (22.1% to 21.8%) are entirely fabricated and not supported by the ground truth. There is no mention of these specific figures in the original answer, and they contradict its core message. (3) The multi-hop reasoning is flawed: the LLM incorrectly infers increasing reliance on the Innovation Box due to a supposed rise in benefit, while the ground truth indicates a *reduced* reliance or availability of the incentive despite continued eligibility. The conclusion about BKNG’s ongoing strategy is therefore based on false premises. (4) The contextual relevance is low but not zero—the response addresses the right topic (Innovation Box impact on tax rate and Dutch tax incentives) and attempts to analyze trends, so it stays on theme. However, due to pervasive quantitative and qualitative inaccuracies, the answer misrepresents the situation entirely. Correctness, quantitative, and qualitative scores are near-minimal due to these severe errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 467,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did the redesign of Medicare Part D under the IRA, which began in 2024, impact CVS's ability to forecast and manage health care benefit costs in 2024 compared to 2022, particularly in light of the new manufacturer discount obligations and capped out-of-pocket costs for beneficiaries?",
      "original_answer": "In 2022, CVS was subject to Medicare Part D regulations and expressed uncertainty about its ability to recoup increased costs from regulatory changes, including those related to mandated coverage or benefits, through higher premiums or expanded membership. By 2024, under the Inflation Reduction Act (IRA), Medicare Part D was redesigned to cap beneficiary out-of-pocket costs and shift more financial responsibility to Part D plans and manufacturers, including requiring manufacturer discounts on certain drugs. This change, combined with the IRA’s mechanism for collecting rebates from manufacturers if price increases outpace inflation, directly affected CVS's health plan cost structure and forecasting accuracy. In 2024, CVS noted that regulatory changes—including those from the IRA—added complexity to forecasting health care benefit costs, which are based on projections made months in advance and are sensitive to external factors like drug pricing and utilization trends. The redesign of Medicare Part D under the IRA thus introduced new financial pressures and forecasting challenges for CVS in 2024 that were not present in 2022, particularly in managing drug costs and predicting rebate obligations.",
      "llm_answer": "The IRA’s Medicare Part D redesign, effective 2024, capped beneficiary out‑of‑pocket limits and required manufacturers to provide discounts on certain drugs, shifting more cost burden to Part D plans and manufacturers.  This added uncertainty forces CVS to model potential rebates and discount obligations and the impact of capped out‑of‑pocket limits, making 2024 benefit‑cost forecasting more complex than in 2022 when those provisions were absent (Amgen 10‑K, p. 17; CVS 10‑K, p. 40).  CVS’s 2024 risk discussion notes that forecasting health‑care benefit costs is already difficult, and the new IRA mandates further complicate that process.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core information from the ground truth with strong semantic equivalence. (1) All factual elements are correct: the IRA's Medicare Part D redesign began in 2024, it capped beneficiary out-of-pocket costs, required manufacturer discounts, and shifted financial responsibility to Part D plans and manufacturers—this directly impacted CVS's cost forecasting. These points align with the original answer. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the ground truth or LLM response, so quantitative accuracy is not compromised; dates (2022 vs 2024) are correctly used. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes the impact of the IRA on drug cost structure, rebate modeling, and forecasting complexity for CVS, comparing 2024 to 2022 conditions. It references external factors like manufacturer obligations and plan-level risk, showing appropriate cross-entity understanding (CVS and Amgen 10-Ks). (4) The only minor shortcoming is that the LLM does not explicitly mention CVS’s prior uncertainty in 2022 about recouping costs through premiums or membership growth—a nuance present in the ground truth that adds context to the evolution of risk. However, this omission does not undermine the central conclusion about increased forecasting complexity in 2024. The answer remains contextually precise, focused, and factually aligned with the source.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1499,
        "completion_tokens": 399,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did the disproportionate voting power in Nike's Class B shares, disclosed in 2023, continue to serve as an anti-takeover mechanism in 2024 despite the significant disparity in market value between Class A and Class B shares?",
      "original_answer": "In 2023, Nike disclosed that its dual-class structure, where Class A shareholders elect 75% of the board and Class B shares carry more voting power, was designed to protect against coercive takeovers. This structure remained unchanged in 2024, as evidenced by the continued existence of two separately voting classes. Despite Class B shares having a market value of $133.5 billion compared to Class A's $7.4 billion as of November 30, 2023, the governance framework still concentrated control in Class B holders. This power asymmetry continued to act as an anti-takeover mechanism by enabling Class B shareholders to maintain board control and resist unsolicited acquisition attempts, even though the extreme market valuation gap raised potential concerns about minority shareholder influence and value alignment.",
      "llm_answer": "Nike’s 2023 filing disclosed that the two classes of stock vote separately, with Class B shares carrying 15 votes each and thus holding roughly one‑third of the company’s voting power, while Class A shares—though they represent the bulk of the market value—have only one vote per share【page_27】.  The 2024 filing reiterated that the same anti‑takeover provisions (control‑share acquisition and freeze‑out statutes and the separate voting of the two classes) remain in force, so the disproportionate voting power of the relatively few Class B shares continues to deter hostile takeovers【page_27】.  This remains true even though the market value of Class B shares ($133 billion) far exceeds that of Class A shares ($7 billion)【page_1】.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core anti-takeover mechanism of Nike's dual-class structure, correctly noting that Class B shares carry disproportionate voting power (15 votes per share) and that this structure remained in place in 2024. It accurately references the continued application of anti-takeover provisions like control-share acquisition and freeze-out statutes, and correctly identifies the separate voting of classes as a deterrent to hostile takeovers. The answer also correctly states the market values of Class B ($133 billion) and Class A ($7 billion) shares, aligning closely with the ground truth values of $133.5 billion and $7.4 billion as of November 30, 2023. However, there is a minor quantitative inaccuracy: the claim that Class B shares hold 'roughly one-third of the company’s voting power' contradicts the intended design where Class B holds *majority* voting control (since Class A elects only 75% of the board, implying Class B elects the remaining 25%, but more critically, the structure concentrates control in Class B). In fact, the ground truth emphasizes that Class B's voting power enables it to maintain board control—suggesting majority influence—so describing it as 'one-third' is factually misleading. This error affects the precision of the quantitative and logical interpretation of voting power distribution, though the overall reasoning about anti-takeover effects remains sound. The answer is contextually relevant, addresses all parts of the question, and synthesizes information across years and governance mechanisms appropriately. Minor wording differences (e.g., 'reiterated' vs 'remained unchanged') are acceptable under semantic equivalence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 464,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did the increase in Disney's notional amount of foreign exchange cash flow hedges from $7.4 billion in 2022 to $9.9 billion in 2024 reflect a change in their hedging strategy related to firm commitments, and what does this imply about their exposure to foreign currency fluctuations?",
      "original_answer": "Disney increased its notional amount of foreign exchange cash flow hedges from $7.4 billion in 2022 to $9.9 billion in 2024, indicating a more aggressive hedging strategy to protect against foreign currency fluctuations. This increase specifically relates to their firm commitments and forecasted foreign currency transactions, suggesting that the company has expanded its hedging activities to manage a broader or larger volume of such exposures. The growth in hedge notional amounts implies that Disney has either increased its international operations or is facing greater volatility in foreign exchange markets, prompting a stronger risk management posture.",
      "llm_answer": "Disney increased the notional amount of its foreign‑exchange cash‑flow hedges from $7.4 billion in 2022 to $9.9 billion in 2024, reflecting a deliberate expansion of hedge coverage to protect a larger share of firm commitments (e.g., long‑term contracts and forecasted transactions)【page_121】. This shift indicates that Disney’s exposure to foreign‑currency fluctuations has grown—likely due to higher international commitments—and the company is proactively managing earnings and cash‑flow volatility by hedging more of that exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the increase in Disney's notional amount of foreign exchange cash flow hedges from $7.4 billion in 2022 to $9.9 billion in 2024, matching the ground truth exactly in both numbers and years. There are no calculation errors, and the formatting ($7.4 billion, $9.9 billion) is consistent and acceptable. (2) All numeric values are accurate and correctly cited; the time frame (2022 to 2024) and the metric (notional amount of foreign exchange cash flow hedges) are precisely aligned with the original answer. (3) The reasoning is sound and reflects multi-hop synthesis: the LLM correctly infers that the increase reflects a broader hedging strategy related to firm commitments and forecasted transactions, and links this to increased exposure due to international operations. It accurately concludes that Disney is proactively managing earnings and cash-flow volatility, which aligns with the implication in the ground truth about a stronger risk management posture. (4) The only minor shortcoming is that the LLM does not explicitly mention 'forecasted foreign currency transactions' in the same breadth as 'firm commitments,' though it does reference 'forecasted transactions'—a semantically equivalent phrase. Additionally, while the ground truth suggests Disney may be responding to greater FX market volatility, the LLM focuses more on increased international commitments, which is valid but slightly narrower. Overall, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning, warranting a high score with only a small deduction for slight incompleteness in covering all implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 460,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did the net basis presentation of Level 3 derivatives impact the percentage of Level 3 liabilities as a proportion of total firm liabilities at fair value for JPM from 2023 to 2024?",
      "original_answer": "In 2023, Level 3 liabilities at fair value accounted for 8% of total firm liabilities at fair value, and this increased to 9% in 2024. This change occurred despite the consistent application of the net basis presentation policy for Level 3 derivatives across both years, indicating a relative increase in the significance of Level 3 liabilities within JPM’s overall fair value liability structure.",
      "llm_answer": "The net‑basis presentation of Level 3 derivatives means JPM reports those liabilities net of offsetting positions.  Even with this net treatment, the share of Level 3 liabilities in the firm’s total fair‑value liabilities rose from 8 % at December 31, 2023 to 9 % at December 31, 2024, indicating that net Level 3 liabilities grew relative to total liabilities during that period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers and dates are correct: the percentages (8% in 2023 and 9% in 2024) match the original answer exactly, and the time points (December 31, 2023 and 2024) are correctly specified. (2) The entity identification is accurate—JPM is correctly referenced, and the metric 'Level 3 liabilities as a proportion of total firm liabilities at fair value' is properly interpreted. (3) The reasoning is sound: the LLM correctly notes that despite net-basis presentation (which would reduce reported liabilities), the proportion still increased, implying a relative growth in net Level 3 liabilities. This captures the core inference from the original answer. (4) The only minor shortcoming is that the LLM does not explicitly mention the 'consistent application of the net basis presentation policy across both years,' which slightly weakens the qualitative completeness of the multi-hop reasoning. However, the implication is present. Overall, the answer is factually correct, contextually relevant, and semantically equivalent to the ground truth, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1204,
        "completion_tokens": 327,
        "total_tokens": 1531
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did the FDA market authorization for NJOY's e-vapor products in 2023 influence the valuation and strategic positioning of NJOY within MO's portfolio as reflected in the 2024 financial statements?",
      "original_answer": "The FDA market authorization for NJOY's e-vapor products in 2023 positioned NJOY as the only e-vapor manufacturer with a pod-based product authorized for sale in the U.S., giving MO a competitive edge. This unique regulatory advantage was reflected in the 2024 financial statements, where NJOY-related goodwill and intangible assets remained a significant part of MO’s e-vapor reporting unit. The $2.9 billion acquisition in 2023, including $2.75 billion in cash and contingent consideration, signaled MO’s strategic commitment to strengthening its presence in the evolving e-vapor market, with the 2024 disclosures indicating continued investment in this segment.",
      "llm_answer": "In 2023, NJOY became the only pod‑based e‑vapor manufacturer to receive FDA market authorization, a milestone that underpinned the valuation of its e‑vapor reporting unit in Altria’s 2024 statements. The 2024 annual impairment test shows the e‑vapor unit’s fair value exceeded carrying value by 28 % ($0.3 B), and the $1.768 B goodwill recorded for the NJOY transaction reflects its strategic positioning as a high‑growth segment within Altria’s portfolio.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core strategic significance of the FDA authorization correctly: NJOY becoming the only pod-based e-vapor product authorized by the FDA in 2023, which enhanced its strategic positioning within Altria's (MO) portfolio. This regulatory advantage is appropriately linked to the 2024 financial statements and goodwill, addressing the question's intent. However, there are significant quantitative inaccuracies that undermine factual correctness. The LLM states the goodwill for NJOY is $1.768B, but the ground truth reports a $2.9B total acquisition value with $2.75B in cash and contingent consideration—no explicit goodwill amount is given, but $1.768B does not align with disclosed figures. Additionally, the 28% fair value excess over carrying value ($0.3B) cited in the LLM answer is not present in the original answer and cannot be verified against the ground truth, suggesting fabrication or misattribution. The original answer emphasizes the continued strategic commitment and investment signaled by the acquisition, while the LLM focuses on an impairment test detail absent from the ground truth. Entity accuracy is mostly correct (Altria/MO, NJOY, 2023 authorization, 2024 statements), and the reasoning correctly connects FDA authorization to valuation and strategic positioning. However, the inclusion of unverified financial figures and the omission of the $2.9B acquisition context reduce quantitative accuracy. The answer is contextually relevant and semantically aligned in direction but fails on key numerical fidelity, warranting a partial correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 435,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did Southern Company's reduced investment in SNG from $1,243 million in 2022 to $1,202 million in 2023 relate to the regulatory uncertainty surrounding SNG's proposed $3 billion pipeline project requiring FERC approval, and how does this inform SO's 2024 capital allocation strategy reflected in its equity ratio target of 55% by 2025?",
      "original_answer": "Southern Company's investment in SNG declined from $1,243 million in 2022 to $1,202 million in 2023, indicating a cautious approach to capital deployment in this joint venture. This reduction coincided with SNG's development of a $3 billion pipeline project requiring FERC approval, which introduced regulatory uncertainty and long-term financial exposure, as the project is not expected to be completed until 2029. In response, Southern Company adjusted its capital strategy in 2024, aiming to increase its equity ratio to approximately 55% by the end of 2025 (up from 53.9% in 2024 and 52.3% in 2023), signaling a strategic de-leveraging effort to strengthen financial flexibility in light of uncertain regulatory outcomes and long-term infrastructure commitments.",
      "llm_answer": "Southern Company Gas cut its equity‑method investment in SNG from $1,243 million in 2022 to $1,202 million in 2023, a decline that reflects the regulatory uncertainty surrounding SNG’s $3 billion pipeline, which still requires FERC approval and whose outcome is undetermined (page 92). This cautious re‑valuation is part of the company’s 2024 capital‑allocation strategy to strengthen its balance sheet, as shown by its goal to lift the equity ratio to about 55 % by 2025 (pages 181‑182).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key factual elements: Southern Company's investment in SNG decreased from $1,243 million in 2022 to $1,202 million in 2023, the $3 billion pipeline project requiring FERC approval, and the equity ratio target of approximately 55% by 2025. These numbers match the ground truth exactly, with acceptable formatting (e.g., $1,243 million). (2) Quantitative accuracy is perfect: the dollar amounts, years, and percentage target are all correct. The reduction of $41 million is implied and accurate. (3) The reasoning correctly links the investment reduction to regulatory uncertainty and connects it to the broader capital allocation strategy focused on balance sheet strength via increasing equity ratio. The multi-hop synthesis—connecting SNG investment changes, FERC-related uncertainty, and SO’s long-term capital structure goals—is logically sound and well-supported. (4) Minor deduction in qualitative accuracy because the LLM refers to 'Southern Company Gas' instead of 'Southern Company' (SO), which is a slight entity inaccuracy—Southern Company Gas is a subsidiary, but the parent company is the relevant entity for the equity ratio and capital strategy. Also, the original answer provides additional context about the project completion in 2029, which adds clarity on long-term exposure and is missing in the LLM response. However, this does not undermine the core correctness. Contextual relevance is full—every part of the question is addressed with precise, relevant information.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 425,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did the fair value of MDT's equity commingled trusts measured at net asset value change from 2022 to 2023, and what does this indicate about MDT's investment strategy in these instruments?",
      "original_answer": "In 2022, MDT reported a fair value of $1,281 million for equity commingled trusts measured at net asset value. By 2023, this figure decreased to $1,211 million, indicating a reduction of $70 million. This decline suggests a potential strategic shift or rebalancing in MDT's portfolio allocation toward equity commingled trusts, possibly to manage risk or reallocate capital to other investment opportunities.",
      "llm_answer": "The fair value of Medtronic’s equity commingled trusts measured at net asset value fell from **$1.281 billion in 2022 to $1.211 billion in 2023** (a decline of about $70 million)【page_96】. This modest drop reflects market‑driven changes in the underlying equity funds rather than a shift in strategy, underscoring the company’s continued use of net‑asset‑value as a practical valuation expedient and its long‑term, diversified equity‑allocation approach.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the fair value amounts for 2022 ($1.281 billion = $1,281 million) and 2023 ($1.211 billion = $1,211 million), and accurately calculates the $70 million decrease, satisfying quantitative accuracy. Entity accuracy is also correct—MDT (Medtronic) and the financial instrument (equity commingled trusts measured at net asset value) are properly identified, and the years 2022 and 2023 are correctly referenced. (2) All numbers and calculations are factually correct and match the ground truth; format variation (billion vs. million) is acceptable and semantically equivalent. (3) However, the reasoning and interpretation diverge from the original answer. While the ground truth suggests the decline 'indicates a potential strategic shift or rebalancing' in portfolio allocation, the LLM attributes the change to 'market-driven changes' and asserts there is no strategic shift, which contradicts the inference in the original answer. This reflects a failure in multi-hop reasoning or misinterpretation of the implication, reducing qualitative accuracy. (4) The answer is highly relevant and factually precise, but the incorrect qualitative interpretation of the investment strategy impact prevents a higher score. Thus, correctness is partially compromised on reasoning, not facts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1227,
        "completion_tokens": 370,
        "total_tokens": 1597
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did ConocoPhillips' investment in APLNG in 2022, including the fair value write-down, influence its operational positioning in Queensland, Australia in 2023, particularly in relation to its equity stake and LNG export activities?",
      "original_answer": "In 2022, ConocoPhillips exercised its preemption right to purchase an additional 10% interest in APLNG, which led to a fair value write-down of its investment to $5,574 million, resulting in a $688 million before-tax charge. This investment positioned ConocoPhillips more strongly in APLNG, a joint venture focused on producing coal bed methane (CBM) and exporting LNG from Queensland, Australia. By 2023, ConocoPhillips held a 47.5% ownership stake in APLNG, which directly supported its operational presence in Queensland. APLNG's LNG export activities, primarily targeting Asia Pacific markets, were a key part of ConocoPhillips' broader LNG strategy, with the company operating the LNG facility while Origin Energy managed production and pipelines. The increased stake and continued involvement in APLNG in 2023 reflected a strategic commitment to maintaining a strong foothold in Queensland’s LNG sector.",
      "llm_answer": "ConocoPhillips’ 2022 equity investment in APLNG was written down to fair value in 2021, a $688 million impairment that reduced the carrying value to roughly $5.4 billion by December 31 2023 (page 92).  The write‑down did not alter its 47.5 % stake in the Queensland joint venture (page 91), and APLNG continued to produce CBM and export LNG under long‑term agreements and additional cargoes to Asia‑Pacific markets, sustaining ConocoPhillips’ LNG export positioning in Queensland (page 91).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. First, it incorrectly states that the fair value write-down occurred in 2021, while the ground truth confirms it happened in 2022. Second, the written-down fair value is stated as $5,574 million in the original answer, but the LLM reports it as 'roughly $5.4 billion by December 31, 2023', which is both numerically inaccurate and misdated. The $688 million before-tax charge is correctly mentioned, but its timing is tied to the wrong year. (2) The LLM claims the carrying value was $5.4 billion as of December 31, 2023, which contradicts the ground truth that the write-down to $5,574 million occurred in 2022 — not 2023 — and there is no support for a further reduction to $5.4 billion. The stake (47.5%) is correctly reported, and APLNG’s activities in Queensland are generally accurate. (3) The multi-hop reasoning is partially sound: the model connects the investment and write-down to ConocoPhillips’ operational positioning in Queensland and LNG exports. However, it fails to mention the key event — ConocoPhillips exercising its preemption right to buy an additional 10% in 2022 — which is central to the investment’s influence. It also misattributes the timing of the write-down, breaking the causal chain. (4) The contextual relevance is fair because the answer addresses ConocoPhillips’ stake and LNG activities in Queensland, but the incorrect dates and values undermine the factual foundation. Due to major quantitative and temporal errors, the correctness score is low despite some accurate elements.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 434,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did the voting power dynamics between Class B and Class A Common Stock at CMCSA change from 2022 to 2023, and what does this imply about the potential for future stock conversion activity?",
      "original_answer": "In 2022, CMCSA disclosed that Class B Common Stock had only 3 record holders, indicating concentrated ownership. By 2023, the structure remained such that Class B shares retained 33⅓% of the total voting power, with each share carrying 15 votes, while Class A shares' voting power was diluted based on the total number of shares outstanding. This non-dilutable voting structure for Class B shares, combined with their convertibility into Class A shares, suggests that any future conversions would likely be strategic decisions by the concentrated holders of Class B stock to either maintain control or gradually shift voting influence to broader ownership through conversion. The fact that Class A Common Stock was registered on Nasdaq in 2023 further supports the infrastructure for such a strategic shift.",
      "llm_answer": "The voting‑power split stayed the same: in both 2022 and 2023 holders of Class A common stock controlled 66 ⅓ % of the combined voting power, while holders of the 9 outstanding Class B shares controlled 33 ⅓ % (each Class B share carries 15 votes)【page_38】【page_91】. Because the conversion right—share‑for‑share conversion of Class B into Class A—remains unchanged and the number of Class B shares is tiny, the relative control between the classes is unlikely to shift, and any future conversion activity would be limited in scope and impact.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that the voting power split remained unchanged from 2022 to 2023, with Class B holding 33⅓% and Class A 66⅔%, and that each Class B share carries 15 votes. These quantitative details match the ground truth exactly. It also correctly notes the conversion right of Class B to Class A shares. However, it omits key contextual information present in the original answer—specifically, the fact that in 2022, Class B had only 3 record holders (indicating concentrated ownership), and that Class A was registered on Nasdaq in 2023, which supports infrastructure for strategic conversion. These omissions reduce completeness and weaken the qualitative reasoning about future conversion implications. (2) All numbers—33⅓%, 66⅔%, 15 votes per Class B share—are accurate and correctly interpreted. The claim about '9 outstanding Class B shares' is not in the ground truth and may be an over-precision or error, but since the ground truth does not specify the exact number, this cannot be fully verified; however, it does not contradict known facts. (3) The reasoning is partially sound: the LLM correctly infers that because Class B shares are few and conversion rights unchanged, control dynamics are stable. But it concludes that future conversion activity would be 'limited in scope and impact,' which underestimates the strategic potential emphasized in the original answer—namely, that conversions could be used deliberately by concentrated holders to shift voting influence. The original answer frames conversion as a strategic tool, while the LLM downplays its significance. (4) The answer is contextually relevant and factually grounded, but lacks full multi-hop synthesis: it fails to connect ownership concentration (3 holders) and Nasdaq registration to the strategic implications of conversion, which are critical for fully addressing the second part of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 517,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How did the change in Southern Company's use of energy-related derivatives designated as regulatory hedges from 2022 to 2023 affect the recognition of gains and losses in fuel expense under their fuel-hedging programs?",
      "original_answer": "In 2022, Southern Company's energy-related derivatives were largely designated as regulatory hedges, with gains and losses initially recorded as regulatory liabilities or assets and later included in fuel expense as the underlying fuel was used (from Hop 1 and Hop 2). By 2023, the company disclosed the pre-tax effects of energy-related derivatives not designated as hedging instruments, indicating a shift in strategy where some derivatives were recognized directly in income rather than being deferred under regulatory mechanisms (from Hop 3). This evolution suggests a reduced reliance on regulatory hedges and a more immediate financial impact on fuel expense in 2023 compared to 2022.",
      "llm_answer": "The shift in regulatory‑hedge use turned a $65 million net loss in fuel expense in 2022 into a $59 million net gain in 2023, indicating a more favorable hedging outcome (page_295). This reflects Southern Company’s policy that gains and losses on regulatory‑hedged energy derivatives are recorded in fuel expense as the underlying fuel is consumed (page_122).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific financial figures—$65 million net loss in 2022 and $59 million net gain in 2023—that are not present in the original ground truth answer and cannot be verified from the provided context. These numbers appear to be fabricated or extracted from a source not reflected in the knowledge graph, making them factually unsupported. The original answer discusses a strategic shift in hedge designation but does not quantify the impact on fuel expense in dollar terms. (2) Quantitative accuracy is low because the dollar amounts and implied change ($65M loss to $59M gain) are not corroborated by the ground truth. There is no mention of these figures in the original answer or the cited 'Hop' references, and no calculation or source (e.g., page_295, page_122) is available for validation. The use of such precise numbers without support undermines factual correctness. (3) Qualitatively, the LLM captures part of the correct reasoning—namely, that gains and losses on regulatory-hedged derivatives are recognized in fuel expense as fuel is consumed—but fails to reflect the core multi-hop insight: the change in designation from regulatory hedges to non-designated instruments in 2023, leading to more immediate income recognition. This shift in accounting treatment is the central point of the original answer, but the LLM only implies a change in outcome, not in methodology or policy. (4) Contextual relevance is high because the answer addresses Southern Company, fuel expense, regulatory hedges, and the 2022–2023 timeframe. However, the emphasis on unverified financial figures distracts from the actual qualitative shift in hedge designation and its accounting implications. The answer substitutes a numerical narrative for the correct conceptual evolution, resulting in partial correctness but significant factual deviation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 507,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How did Merck's alliance revenue from Lenvima in 2024 reflect the evolution of their collaboration with Eisai, considering the milestone payments made in 2022?",
      "original_answer": "In 2022, Merck had accrued $600 million in sales-based milestone payments to Eisai for Lenvima, with potential future payments of $2.6 billion not yet accrued. By 2024, Merck's alliance revenue from Lenvima reached $1,010 million, indicating that the collaboration had matured and generated significant returns. This suggests that the earlier milestone payments were part of a strategic investment in the partnership, which translated into measurable revenue growth by 2024.",
      "llm_answer": "Merck’s alliance revenue from Lenvima climbed to **$1,010 million in 2024** from **$876 million in 2022**, showing a clear expansion of the partnership with Eisai.  \nThe milestone payments Merck made in 2022—both sales‑based and regulatory—were capitalized as intangible assets and fully amortized, thereby boosting Merck’s share of profits from Lenvima sales and driving the higher 2024 revenue.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly states that Merck's alliance revenue from Lenvima was $1,010 million in 2024 (matching the ground truth), it incorrectly claims that the 2022 revenue was $876 million. The original answer does not provide Merck’s 2022 alliance revenue—only that $600 million in sales-based milestone payments were accrued to Eisai in 2022. This $600 million was a payment *by* Merck, not revenue *to* Merck, and thus the comparison between $876M and $1,010M in alliance revenue is fabricated and misleading. (2) The LLM introduces a number ($876 million in 2022) not present in the ground truth and mischaracterizes the nature of the $600 million milestone payment (as an amortizable intangible asset), which is not supported by the original answer. The original does not state that milestone payments were fully amortized or directly caused the 2024 revenue increase. (3) The multi-hop reasoning is flawed: the LLM incorrectly infers a causal link between amortization of milestone payments and higher alliance revenue in 2024, which is not stated or implied in the ground truth. The original answer frames the milestone payments as part of a strategic investment that preceded revenue growth, not as an accounting item directly boosting profits via amortization. (4) Despite these major errors, the LLM correctly identifies the 2024 revenue figure and the general trend of partnership maturation, maintaining contextual relevance. However, the quantitative and qualitative inaccuracies severely undermine the correctness, warranting a low overall score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1220,
        "completion_tokens": 446,
        "total_tokens": 1667
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How did Qualcomm's dependency on Taiwan-based foundry partners evolve between 2023 and 2024, as reflected in asset distribution and geopolitical risk disclosures?",
      "original_answer": "In 2023, Qualcomm highlighted significant reliance on foundry partners in Taiwan for chipset supply, noting that geopolitical tensions involving China and Taiwan could severely limit or prevent receiving supply, materially affecting the business. By 2024, Qualcomm's long-lived tangible assets in Taiwan and the Asia-Pacific region slightly decreased from $3.6 billion to $3.5 billion, while U.S.-based assets also declined from $2.0 billion to $1.9 billion. This modest reduction may signal a strategic shift or risk mitigation effort, though the company remains heavily dependent on Taiwan's stability for manufacturing continuity.",
      "llm_answer": "Qualcomm’s net‑book value of long‑lived tangible assets outside the U.S. fell modestly from $3.6 B in 2023 to $3.5 B in 2024, while U.S. assets declined from $2.0 B to $1.9 B, indicating a slight shift but still a majority of non‑U.S. assets in Taiwan【page_83】. The 2024 10‑K reports $12.8 B in purchase obligations tied to integrated‑circuit inventory, underscoring continued reliance on foundry capacity【page_82】, and the geopolitical‑risk section still flags supply‑chain disruptions from Taiwan as a material risk【page_36】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports the quantitative changes in long-lived tangible assets: from $3.6B to $3.5B outside the U.S. (primarily in Taiwan/Asia-Pacific) and from $2.0B to $1.9B in the U.S., matching the ground truth exactly. These figures are accurately represented with acceptable formatting ($3.6 B = $3.6 billion). The mention of $12.8B in purchase obligations tied to integrated-circuit inventory is an additional accurate detail from the 2024 10-K that supports continued foundry reliance, though not in the original answer; it strengthens the conclusion without contradicting it. 2) All numbers are correct and consistent with the source. The slight decrease in asset values is properly characterized. There are no calculation or date errors. 3) The reasoning is sound: the LLM correctly infers that despite a modest reduction in asset value, Qualcomm remains heavily reliant on Taiwan-based foundries, especially given the large purchase obligations and unchanged geopolitical risk disclosures. It synthesizes information across asset distribution (pages 83, 82) and risk factors (page 36), demonstrating multi-hop reasoning. 4) The answer is semantically equivalent to the ground truth—while it adds a specific figure ($12.8B in purchase obligations) not in the original, this enhances rather than distorts the narrative. The core message—that Qualcomm remains dependent on Taiwan despite slight asset shifts—is preserved. Only a minor deduction in qualitative accuracy due to not explicitly naming the 'Asia-Pacific' region as part of the asset location (refers to 'outside the U.S.' instead), though contextually this is reasonable. Overall, highly accurate, relevant, and well-supported.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 463,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How did the utilization of repurchase agreements as a source of short-term liquidity evolve from 2022 to 2023, and what role did CSC's commercial paper issuance capacity play in this shift?",
      "original_answer": "In 2022, Schwab had no borrowings under repurchase agreements, while CSC had $250 million in commercial paper notes outstanding. By 2023, Schwab had $4.9 billion in repurchase agreements, and CSC had no commercial paper notes outstanding. This indicates a shift from commercial paper as a liquidity source in 2022 to increased reliance on repurchase agreements in 2023, with CSC's previously available $5.0 billion issuance capacity no longer being utilized.",
      "llm_answer": "Schwab increased its repurchase‑agreement borrowing from $4.4 billion at year‑end 2022 to $4.9 billion at year‑end 2023, with all repos maturing between January and July 2024, indicating a greater reliance on repos for short‑term liquidity. CSC’s commercial‑paper capacity stayed at $5 billion, but the company had no outstanding commercial paper in 2023 (down from $250 million in 2022), so the unused capacity allowed Schwab to shift liquidity sourcing toward repurchase agreements rather than commercial paper.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, Schwab had *no* borrowings under repurchase agreements in 2022, not $4.4 billion as stated in the LLM answer. This is a major factual error. The 2023 repurchase agreement amount ($4.9 billion) is correct. CSC's commercial paper outstanding was $250 million in 2022 (correctly stated by LLM) and $0 in 2023 (also correct), but the LLM incorrectly implies that the $5 billion issuance capacity was still available and actively unused, while the ground truth states it was 'no longer being utilized'—a subtle but important distinction in intent and context. (2) The calculation of change in repurchase agreements is incorrect due to the wrong baseline: LLM claims an increase from $4.4B to $4.9B, but ground truth shows a shift from $0 to $4.9B, which is a much more significant change. The commercial paper decrease from $250M to $0 is correctly captured. (3) The multi-hop reasoning is partially sound: the LLM correctly identifies a shift from commercial paper to repurchase agreements and connects CSC's capacity to Schwab's liquidity strategy. However, the reasoning is undermined by the incorrect starting value for repos in 2022, leading to flawed interpretation of the evolution. (4) Contextual relevance is high—the answer addresses both parts of the question and attempts correct synthesis. Qualitative accuracy is moderate due to correct entity identification (Schwab, CSC, commercial paper, repos) and logical structure, but weakened by incorrect data. Quantitative accuracy is low due to the critical error in the 2022 repurchase agreement amount. Correctness score is 6 because core elements (shift in instruments, commercial paper drop, capacity figure) are present, but the foundational quantitative claim about the evolution of repo usage is factually wrong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 509,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How did MO's approach to PMTA authorizations for oral nicotine pouches evolve between 2022 and 2024, and what does this suggest about their regulatory risk management strategy and potential market expansion opportunities?",
      "original_answer": "In 2022, MO (through Helix) had already submitted PMTAs for on! oral nicotine pouches in May 2020, indicating a proactive regulatory compliance strategy for newer products. By 2024, MO had submitted additional PMTAs for on! PLUS oral nicotine pouches in tobacco, mint, and wintergreen flavors in June 2024, showing a continued emphasis on expanding their portfolio of FDA-reviewed products. Additionally, MO's acquisition of NJOY Holdings in June 2023 brought e-vapor products with existing MGOs (Marketing Granted Orders), including NJOY ACE and DAILY, and in May 2024, NJOY re-submitted flavored pod-based e-vapor PMTAs that previously received MDOs (Marketing Denial Orders). This evolution suggests that MO is increasingly prioritizing regulatory risk mitigation by pursuing formal FDA authorization pathways, while also seeking to expand into new product categories with differentiated features like Bluetooth-enabled underage use prevention technology. However, as of February 24, 2025, the FDA had not issued marketing decisions for any on! or on! PLUS products, indicating ongoing regulatory uncertainty.",
      "llm_answer": "Between 2022 and 2024, MO shifted from filing a single PMTA for its on! oral nicotine pouch (submitted in May 2020, with no marketing‑order decisions by Feb 22 2022) to adding multiple PMTAs for new flavored variants—on! PLUS in tobacco, mint and wintergreen (filed June 2024)【36†L1-L6】【35†L1-L6】. This evolution shows a proactive regulatory‑risk strategy that seeks FDA approval for each new product before launch, reducing the risk of denial or withdrawal, and signals a deliberate effort to broaden its oral nicotine pouch portfolio and tap new consumer segments.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of MO's PMTA strategy for oral nicotine pouches between 2022 and 2024. It accurately notes the initial PMTA submission for on! in May 2020 (contextual to 2022 status) and the June 2024 submission for on! PLUS in tobacco, mint, and wintergreen flavors, which aligns with the ground truth. The dates and sequence of events are factually sound, and the interpretation of MO’s regulatory risk management as proactive is well-supported. However, the LLM omits a key multi-hop element: the acquisition of NJOY Holdings in June 2023 and the re-submission of flavored e-vapor PMTAs in May 2024, which are critical to fully addressing the question about MO’s broader regulatory strategy and market expansion. This omission reduces completeness and slightly weakens the qualitative accuracy, as the answer does not reflect MO’s expansion beyond oral nicotine into e-vapor with differentiated technology (e.g., Bluetooth-enabled underage use prevention). The contextual relevance is high, as the response directly addresses the question’s focus on regulatory risk and market expansion. Wording differences are acceptable under semantic equivalence, and all cited numbers and dates are accurate (e.g., May 2020, June 2024), with no calculation errors. The conclusion about proactive risk mitigation is logically sound based on the evidence provided, though slightly less comprehensive than the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 402,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How did GILD's regulatory strategy for Bulevirtide evolve from 2022 to 2023, particularly in terms of its Breakthrough Therapy designation and projected market exclusivity timelines?",
      "original_answer": "In 2022, GILD's Bulevirtide was under the Breakthrough Therapy designation, indicating that the FDA recognized its potential as a significant treatment for chronic hepatitis delta virus (HDV) infection and was expediting its development and review. However, approval was pending due to unresolved manufacturing and delivery concerns cited in a complete response letter from October 2022. By 2023, despite these unresolved issues, Bulevirtide was listed with an expected U.S. exclusivity period through 2030 and in the EU through 2029, suggesting that GILD had made progress in addressing regulatory concerns or had secured interim exclusivity protections. This evolution reflects a strategic shift from regulatory expedited status to a more defined commercialization timeline, even in the absence of final approval.",
      "llm_answer": "In 2022, Gilead’s 10‑K listed Bulevirtide’s projected patent exclusivity as expiring in 2030 in the U.S. and 2029 in the EU, with no regulatory designation noted. By 2023, the company had filed a Biologics License Application and secured FDA Breakthrough Therapy (and Orphan Drug) designation for the HDV indication, while the projected exclusivity dates remained unchanged at 2030 U.S. and 2029 EU.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that contradict the ground truth. (1) QUANTITATIVE ACCURACY: The exclusivity dates (2030 U.S., 2029 EU) are correctly stated and match the original answer, earning partial credit. However, the claim that in 2022 'no regulatory designation was noted' is incorrect — the ground truth states that Bulevirtide was under Breakthrough Therapy designation in 2022. Conversely, the LLM incorrectly claims that Breakthrough Therapy designation was secured in 2023, while the truth is it was already in place in 2022. This reversal of timeline is a critical error. (2) COMPLETENESS: The answer fails to mention the complete response letter from October 2022 citing manufacturing and delivery concerns, which is central to GILD's regulatory challenges. It also omits that approval was pending due to unresolved issues — a key part of the 2022 status. (3) ENTITY ACCURACY: The company (Gilead/GILD) and drug (Bulevirtide) are correct, as are the regions (U.S., EU). However, the regulatory designations are misattributed to the wrong year. (4) REASONING: The multi-hop reasoning is flawed — the model incorrectly infers that Breakthrough Therapy was granted in 2023, when it was already active in 2022. It also implies progress in 2023 due to new designations, whereas the original answer indicates that despite lack of progress on approval, exclusivity timelines were maintained. This misrepresents the strategic evolution. (5) SEMANTIC EQUIVALENCE: The answer is not semantically equivalent — it describes regulatory advancement in 2023 when the truth reflects stagnation with maintained exclusivity. The core narrative is inverted. Thus, while some numbers are correct, the key regulatory timeline and reasoning are fundamentally wrong, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 491,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How did Microsoft's acquisition of Activision Blizzard in 2023 influence the structural handling of its 3.400% Senior Notes due 2026 in 2024?",
      "original_answer": "Microsoft acquired Activision Blizzard in October 2023, which was reflected in its 2024 financial reporting cycle. The acquisition included Activision Blizzard’s existing debt instruments, such as the 3.400% Senior Notes due 2026. In 2024, Microsoft filed a new Indenture agreement dated November 6, 2023, under which it assumed responsibility for these notes through a supplemental indenture with The Bank of New York Mellon Trust Company, N.A. This structural change indicates that Microsoft integrated Activision Blizzard’s debt obligations into its own capital structure, aligning the management of these notes with its broader debt portfolio.",
      "llm_answer": "Microsoft’s acquisition of Activision Blizzard on October 13, 2023 required it to treat Activision’s 3.400% Senior Notes due 2026 as part of its consolidated debt. The 2024 10‑K includes a supplemental indenture (Exhibit 4.23) dated October 27, 2023, reflecting the change in ownership and the notes’ new status as part of Microsoft’s debt (page_98, page_106, page_107).",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and conveys the essential information regarding Microsoft's acquisition of Activision Blizzard and its impact on the 3.400% Senior Notes due 2026. (1) The acquisition date (October 13, 2023) is accurate and aligns with public records, though the original answer cites October 2023 without a specific day—this specificity is acceptable and not incorrect. (2) The LLM correctly identifies that the 3.400% Senior Notes due 2026 were incorporated into Microsoft’s consolidated debt, which matches the ground truth. (3) It references a supplemental indenture dated October 27, 2023, while the original answer cites November 6, 2023—this discrepancy in dates affects quantitative accuracy slightly but may reflect different filing vs. effective dates; the existence of a supplemental indenture with The Bank of New York Mellon is correctly inferred. (4) The mention of Exhibit 4.23 in the 2024 10-K and page references (98, 106, 107) adds precision and supports the claim, demonstrating proper multi-hop reasoning from acquisition to debt integration to documentation. (5) The core entity names (Microsoft, Activision Blizzard, 3.400% Senior Notes due 2026) and financial terms are accurate. (6) The answer omits explicit mention of the indenture trustee (The Bank of New York Mellon Trust Company, N.A.) and the structural integration into Microsoft’s broader capital structure, which slightly reduces completeness and qualitative depth. However, the omission does not invalidate the central claim. Overall, the answer is factually sound, contextually relevant, and semantically equivalent in intent and substance, warranting a high score with minor deductions for date variance and slight incompleteness in structural explanation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 476,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How did the voting power distribution between Class A and Class B common stock at META evolve from 2023 to 2024, and what implications did this have for shareholder influence and corporate governance?",
      "original_answer": "In 2023, holders of META's Class A common stock held approximately 66.67% of the combined voting power, while the Class B common stock, which is non-dilutable and controlled by a small group of stockholders (23 as of December 31, 2023), held the remaining 33.33%. By 2024, the total shares of Class A common stock outstanding were 2,189,898,148, with Class B common stock at 343,761,117, maintaining the same 15:1 voting power ratio per share between Class B and Class A. This structure continued to concentrate significant control with Class B holders, despite the broader ownership base of Class A shares. The introduction of a dividend policy in 2024 applied equally to both classes, aligning financial incentives across shareholder groups while preserving the existing governance imbalance.",
      "llm_answer": "In 2023, Meta’s dual‑class structure gave each Class B share 15 votes, representing roughly one‑third of the company’s total voting power, while Class A shares had one vote each and accounted for the remaining two‑thirds (page 57). The 2024 filing confirms the same split, with Class B shares still holding 15 votes per share and about one‑third of the voting power (page 5). This unchanged arrangement keeps the founding shareholders in a dominant position, limiting public shareholder influence and reinforcing a governance model that concentrates decision‑making authority among a small group of insiders.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core facts from the ground truth. (1) Quantitatively, it correctly states that Class B shares had 15 votes per share and held about one-third of voting power in both 2023 and 2024, while Class A held two-thirds—this aligns with the 33.33% and 66.67% split in the original answer. The 15:1 voting ratio is accurately reflected. While the LLM does not cite the exact share counts (2,189,898,148 Class A and 343,761,117 Class B in 2024), these specific numbers were not essential to convey the unchanged voting power distribution, and the answer correctly infers the structural continuity. (2) The answer correctly identifies the key implication: ongoing concentration of control with Class B holders (founders/insiders), limiting influence for public (Class A) shareholders. (3) Multi-hop reasoning is sound—comparing the structure across 2023 and 2024 and drawing implications for governance. (4) The only minor omission is the mention of the 2024 dividend policy that applied equally to both classes, which added nuance about aligning financial incentives despite governance imbalance. This contextual detail is missing but does not undermine the core correctness. Wording differs but semantic meaning matches. Overall, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 370,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How did the UK's Overseas Fund Regime (OFR) equivalence requirements influence BlackRock's compliance strategy for EU-domiciled funds in 2024, and how does this reflect a shift from their 2023 foreign tax exposure in the UK?",
      "original_answer": "In 2023, BlackRock reported foreign income before taxes in jurisdictions with differing statutory tax rates, including the UK, which directly affected their tax expense reconciliation at the 21% US federal rate. By 2024, the UK's Overseas Fund Regime (OFR), enacted in February 2022, required that consumer protection regimes in EU countries where BlackRock funds are domiciled be found equivalent to the UK’s regime in order to market those funds in the UK. This regulatory shift compelled BlackRock to reassess its compliance strategy for EU-domiciled funds, particularly those marketed to UK retail investors. The firm had to ensure alignment with UK consumer protection standards, which now directly influenced their fund distribution and compliance costs. This reflects a strategic pivot from a primarily tax-focused exposure in 2023 to a broader regulatory compliance challenge in 2024, particularly around equivalence determinations for EU jurisdictions under OFR.",
      "llm_answer": "In 2024 BlackRock’s compliance strategy for EU‑domiciled funds was driven by the OFR equivalence rule, which requires that the consumer‑protection regime in the EU where a fund is domiciled be deemed equivalent to the UK’s before the fund can be marketed to UK retail investors.  The firm therefore increased due‑diligence, monitoring and FCA reporting on EU consumer‑protection standards to satisfy the equivalence test (page 18).  This represents a shift from the 2023 period, when BlackRock’s foreign‑tax exposure in the UK was a significant concern – reflected in a $538 million foreign tax expense – to a new focus on regulatory compliance around consumer‑protection equivalence rather than tax exposure (page 105).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the UK's OFR equivalence requirements as a driver of BlackRock's 2024 compliance strategy for EU-domiciled funds, emphasizing the need for consumer protection regimes in EU countries to be deemed equivalent to the UK’s for marketing to UK retail investors. This matches the original answer’s core claim. (2) The LLM introduces a specific dollar amount—$538 million foreign tax expense in 2023—which is not present in the original answer. While this figure may be factually correct in context, it is an addition not supported by the provided ground truth, slightly reducing quantitative accuracy. However, no incorrect numbers are stated, and the temporal focus (2023 tax exposure vs. 2024 regulatory shift) is sound. (3) The multi-hop reasoning is strong: the model correctly synthesizes a shift from tax-related exposure in 2023 to regulatory compliance under OFR in 2024, linking changes in external environment (OFR) to internal strategy (due diligence, FCA reporting). The reference to page numbers (18, 105) suggests grounding in source material, though not required for correctness. (4) Semantic equivalence is largely preserved: the LLM captures the strategic pivot from tax to regulatory compliance, accurately reflecting the essence of the original answer. Only the addition of an unsupported specific figure prevents a perfect score, but the overall factual correctness, completeness, and reasoning remain excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 418,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did Merck's strategic valuation of MK-7962 (sotatercept) in 2022 relate to the regulatory exclusivity timeline confirmed in 2023, and what implications does this have for the long-term revenue protection of the drug post-approval?",
      "original_answer": "In 2022, Merck valued MK-7962 (sotatercept) at $6.4 billion as part of its in-process research and development (IPR&D) assets, indicating a high strategic priority and expectation for future revenue generation. By 2023, the company confirmed that as a biologic, MK-7962 would be eligible for 12 years of data exclusivity upon U.S. approval, with an expected expiration in July 2033. This exclusivity, combined with patents covering the method of treatment for pulmonary arterial hypertension set to expire in 2037 (absent patent term extension), provides a clear regulatory framework that supports the earlier high valuation. The alignment of financial investment with regulatory strategy suggests Merck anticipates a protected revenue stream for MK-7962 through at least the early 2030s, reinforcing the long-term strategic importance of the drug in Merck’s portfolio.",
      "llm_answer": "Merck’s 2022 10‑K listed MK‑7962 (sotatercept) as an IPR&D intangible asset valued at $6.4 B (page 115), reflecting the company’s view that the drug will generate substantial future cash flows.  In the 2023 filing, Merck confirmed that, once approved, the product will receive 12 years of U.S. data exclusivity and a patent that expires in 2037 (page 16), giving the company a protected market window that matches the 2022 valuation and provides a multi‑year revenue shield against generic entry.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and dates are correct: the $6.4 billion valuation of MK-7962 in 2022 as an IPR&D asset and the 12-year U.S. data exclusivity confirmed in 2023 are accurately reported. The mention of a patent expiring in 2037 matches the ground truth, which specifies method-of-treatment patents expiring in 2037 absent extension. (2) The LLM correctly identifies that data exclusivity begins upon approval and implies a protected market period, though it does not explicitly state the expected approval date (July 2021) or calculate the exact exclusivity expiration (July 2033), which is a minor omission. However, the core timeline and protection period are correctly conveyed. (3) The reasoning is sound: the LLM synthesizes information across the 2022 and 2023 10-K filings, linking the high valuation to regulatory protections, demonstrating proper multi-hop logic. (4) The answer is contextually relevant and directly addresses the relationship between the 2022 valuation and 2023 exclusivity confirmation, as well as the implication for long-term revenue protection. The only minor gap is the lack of explicit mention of the biologic classification or the distinction between data exclusivity and patent protection, but the overall meaning and strategic implication are preserved. Thus, the answer earns a 9 for correctness due to high factual accuracy and strong reasoning, with only slight room for added detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 414,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did the change in the percentage of proved reserves reviewed by DeGolyer and MacNaughton from 2022 to 2024 reflect on the evolution of ConocoPhillips' internal reserves estimation processes and their alignment with SEC compliance standards?",
      "original_answer": "In 2022, DeGolyer and MacNaughton (D&M) reviewed processes and controls used to assess over 90% of ConocoPhillips' proved reserves as of December 31, 2021. By 2024, this percentage had decreased to over 85% of proved reserves as of December 31, 2024. This reduction indicates a slight shift in the scope of D&M’s involvement, suggesting that ConocoPhillips may have increased internal confidence in its reserves estimation processes, which are governed by a comprehensive SEC-compliant policy. D&M's continued involvement, as evidenced by their report included as Exhibit 99 in both years and their consent referenced in the 2024 10-K filing, confirms the ongoing alignment of these processes with SEC regulations, while the reduced percentage may signal a strategic adjustment in the reliance on third-party reviews.",
      "llm_answer": "In 2022, DeGolyer & MacNaughton reviewed **over 90 %** of ConocoPhillips’ proved reserves (page 152), whereas in 2024 the review covered **over 85 %** (page 140). The modest decline reflects an evolution of the company’s internal controls—greater confidence in its own reserves‑estimation procedures and a shift toward more internal oversight—while still maintaining the independent review required by SEC regulations and continuing to affirm that its processes comply with SEC reserve‑definition standards.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the key percentages (over 90% in 2022 and over 85% in 2024) and maps them accurately to the respective years and reserves as of December 31, 2021 and December 31, 2024, respectively. The minor discrepancy is that the LLM attributes the 2022 review to '2022' rather than clarifying it was for reserves as of December 31, 2021 (as stated in the original), but this is a common shorthand and does not materially misrepresent the data. 2) Quantitatively, all figures are correct: 'over 90%' and 'over 85%' match the ground truth exactly. No calculations are required, but the comparison (a modest decline) is accurate. 3) The reasoning is sound: the LLM correctly infers that the reduced scope suggests increased internal confidence and continued SEC compliance through independent review. It appropriately links the reduced percentage to evolving internal controls and oversight while affirming ongoing alignment with SEC standards. The original answer adds that D&M’s report is included as Exhibit 99 and referenced in the 10-K, which the LLM omits, but this detail is contextual and not critical to the core inference. 4) The answer is semantically equivalent and highly relevant, addressing both the quantitative change and its implications for internal processes and SEC compliance. The omission of the exhibit/consent detail slightly reduces completeness but does not affect the correctness of the central claim. Thus, the answer is excellent with only minor room for added context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 417,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did the voting power distribution between Class A and Class B common stock in CMCSA change from 2022 to 2023, and what does this imply about the company's ownership structure stability given that Mr. Brian L. Roberts still holds all Class B shares?",
      "original_answer": "In 2022, CMCSA's Class A common stockholders held 66 2/3% of the combined voting power, while Class B common stockholders held 33 1/3%. This distribution remained consistent in 2023, as CMCSA's 2023 filing confirms that Class A stockholders retained 66 2/3% of the voting power, and Class B stockholders maintained 33 1/3%. Despite the non-dilutable nature of Class B stock, the total issued and outstanding shares of Class A common stock decreased from 5,083,466,045 in 2022 to 4,842,108,959 in 2023, while Class B shares remained unchanged at 9,444,375. This suggests that the ownership structure remained stable, with Mr. Brian L. Roberts continuing to hold all Class B shares, preserving his concentrated voting power.",
      "llm_answer": "From 2022 to 2023 the split of voting power stayed the same – Class A common stock continued to represent 66 ⅓ % of the combined voting power of all common shares, while Class B common stock represented the remaining 33 ⅓ %【page_33】. Because Mr. Brian L. Roberts still owns every Class B share, the company’s ownership structure remains highly concentrated and stable; the fixed block of Class B voting power is not diluted by other shareholders, preserving Roberts’ control over the firm.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the essential information from the ground truth. (1) Quantitatively, the percentages (66 1/3% and 33 1/3%) are correctly reported, matching the original answer (note: 66 2/3% is equivalent to 66 1/3% when expressed as a rounded fraction—this appears to be a typographical inconsistency in formatting, but the intended meaning is clear and contextually accepted as correct; however, strictly speaking, 66 2/3% is the precise value used in filings and differs slightly from 66 1/3%. Despite this, the LLM likely meant 66 2/3%, as 66 1/3% would not sum to 100% with 33 1/3%. Given the context and the fact that the split is standard (2:1), this is interpreted as a formatting error rather than a factual one). The key point—that the voting power distribution remained unchanged—is correct. (2) The LLM correctly identifies that Mr. Brian L. Roberts holds all Class B shares and emphasizes the stability and concentration of control, which aligns with the original answer’s implication about ownership structure stability. (3) The multi-hop reasoning is sound: it connects the unchanged voting power split with Roberts’ continued ownership to infer stability in control. (4) While the LLM omits the specific share count changes (Class A decreasing from 5.08B to 4.84B shares), this detail, though present in the ground truth, is secondary to the core question about voting power distribution and its implication. Its omission does not undermine the correctness of the conclusion. The answer remains semantically equivalent in intent and key facts. Thus, the answer earns a 9 for correctness due to the minor ambiguity in fractional percentage expression and omission of share count data, but is otherwise fully accurate, relevant, and logically sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 484,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did the allocation of MDT's short-term investments measured using Level 1 inputs change from fiscal year 2022 to 2024, and what does this indicate about their short-term investment strategy?",
      "original_answer": "In fiscal year 2022, MDT's short-term investments measured using Level 1 inputs were valued at $73 million, while in fiscal year 2024, this value increased to $114 million. This indicates a strategic shift toward more liquid and transparent investments, as Level 1 inputs are based on quoted prices in active markets. The increase of $41 million (56%) in short-term investments measured under Level 1 inputs suggests a deliberate move toward greater transparency and liquidity in MDT’s short-term investment approach over the two-year period.",
      "llm_answer": "MDT’s short‑term investments that are measured at Level 1 increased from **$73 million in FY 2022 to $80 million in FY 2024**【page_96】. Because all short‑term holdings are Level 1, the proportion of Level 1 assets stayed at 100 %, indicating the company continues to focus on highly liquid, actively traded securities and maintains a conservative short‑term investment strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the quantitative data. According to the ground truth, MDT's Level 1 short-term investments increased from $73 million in FY 2022 to $114 million in FY 2024, but the LLM incorrectly reports the 2024 value as $80 million. This results in a major inaccuracy in both the final amount and the implied change over time. The correct increase is $41 million (56%), whereas the LLM implies only a $7 million increase, which distorts the interpretation of strategic shift. (2) The citation reference [page_96] suggests a source, but the numbers do not align with the ground truth, indicating either a misreading of the data or incorrect extraction. (3) While the LLM correctly identifies that Level 1 inputs reflect highly liquid, transparent investments and connects this to a conservative strategy, it fails to recognize the significance of the substantial increase—missing the key insight about a strategic shift toward greater liquidity and transparency. The claim that 'all short-term holdings are Level 1' may be contextually plausible but is not supported or mentioned in the original answer, adding unsupported assumptions. (4) Despite incorrect numbers, the answer addresses the right entities (MDT, Level 1 inputs, short-term investments) and attempts reasoning about investment strategy, maintaining some contextual relevance. However, due to the critical error in financial figures and the resulting flawed interpretation of strategy, the correctness and quantitative accuracy scores are low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 429,
        "total_tokens": 1671
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did the structure and terms of NKE's redeemable preferred stock held by Sojitz America in 2023 influence the company's dividend policy and capital structure decisions in 2024, particularly given the unchanging nature of the preferred stock and its implications on common stock dividend distributions?",
      "original_answer": "In 2023, Sojitz America remained the sole holder of NKE's redeemable preferred stock, which carried a cumulative dividend of $0.10 per share payable annually on May 31. This structure meant that no dividends could be declared or paid on common stock unless preferred dividends were paid in full. By 2024, this arrangement had not changed, reinforcing a rigid capital structure constraint. As a result, NKE's dividend policy for common stock in 2024 had to account for this mandatory prior obligation, potentially limiting flexibility in returning capital to common shareholders. The lack of change in the preferred stock structure also meant that the company could not issue additional preferred shares, preserving Sojitz America’s unique position while constraining strategic capital adjustments.",
      "llm_answer": "The redeemable preferred stock issued to Sojitz America is cumulative, paying a $0.10‑per‑share dividend each year that must be fully paid before any common‑stock dividend can be declared. Because the preferred stock was unchanged in 2023 and 2024, Nike’s capital structure was not altered by new preferred equity; the only impact was the fixed obligation to meet the preferred dividend and the option to redeem the shares at par. Consequently, the 2024 dividend policy was constrained by the priority of the preferred dividend, limiting cash available for common‑stock distributions while maintaining the same capital‑structure profile.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core elements of the ground truth. (1) All factual information is correct: the preferred stock is cumulative, pays a $0.10-per-share annual dividend, and must be paid in full before any common stock dividends can be declared. The holder, Sojitz America, and the unchanging nature of the structure in 2023–2024 are correctly reflected. (2) Quantitative accuracy is perfect: the $0.10 dividend amount is correctly stated, and no erroneous calculations are made. (3) The reasoning is sound—LLM correctly infers that the fixed obligation constrains common dividend distributions and limits capital structure flexibility. It notes the lack of new preferred issuance and the redemption option, aligning with the ground truth. (4) Minor omission: the original answer specifies the dividend payment date (May 31), which the LLM omits. Additionally, the ground truth emphasizes Sojitz America’s unique position and strategic constraint on issuing additional preferred shares, which is slightly more nuanced than the LLM’s phrasing. However, the semantic meaning and key implications are preserved. The answer is fully relevant and directly addresses the question’s focus on dividend policy and capital structure impacts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 352,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did AMD's reliance on third-party manufacturers in 2023 contribute to manufacturing inefficiencies that negatively impacted gross margins in 2024, especially during the transition to 7 nm and smaller process technologies?",
      "original_answer": "In 2023, AMD's operations heavily depended on third-party manufacturers like TSMC and UMC for critical semiconductor fabrication, particularly for its 7 nm and lower-node microprocessor and GPU portfolio. These manufacturers were responsible for implementing leading-edge process technologies, but faced disruptions and inefficiencies during production, including delays in transitioning to smaller process nodes. These inefficiencies directly led to lower manufacturing yields, increasing per-unit production costs for AMD in 2024. As a result, AMD experienced a negative impact on its gross margins, as noted in the 2024 filings, due to both higher production costs and potential supply constraints affecting customer fulfillment.",
      "llm_answer": "AMD’s 2023 filing noted that it relies on third‑party foundries—primarily TSMC for all 7 nm and smaller‑node microprocessors and GPUs—so any yield shortfalls or capacity constraints at those fabs would raise per‑unit costs and compress gross margin.  The company warned that “any decrease in manufacturing yields could result in an increase in per‑unit costs, which would adversely impact our gross margin” and that “during periods when our third‑party manufacturers are implementing new process or packaging technologies, their manufacturing facilities may not be fully productive” (2023 Risk Factors, pages 24‑25).  In 2024, those manufacturing inefficiencies manifested as lower yields and supply constraints during the transition to advanced nodes, directly contributing to a decline in gross margin.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: AMD relied on third-party manufacturers like TSMC (specifically named) for 7 nm and smaller nodes in 2023, and manufacturing inefficiencies during the transition to advanced nodes led to lower yields and higher per-unit costs in 2024, negatively impacting gross margins. The LLM correctly cites AMD’s 2023 Risk Factors (pages 24–25) to support the claim, enhancing credibility. (2) There are no numeric values (e.g., percentages, dollar amounts) in either the original or LLM answer, so quantitative accuracy is not compromised—score reflects full compliance where data exists. (3) Multi-hop reasoning is sound: the model connects AMD’s 2023 reliance on foundries → process transition challenges → 2024 yield and cost issues → margin impact, correctly synthesizing cause and effect across time and entities. (4) The only minor shortcoming is that the original answer explicitly names UMC as another third-party manufacturer, while the LLM only mentions TSMC. However, since TSMC is the primary foundry for 7 nm and below, and the core reasoning and impact remain intact, this omission does not significantly detract from accuracy. Wording differs but semantic meaning and factual content are equivalent. Contextual relevance is perfect—the response directly addresses all parts of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 388,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did the treatment of dividend equivalents on deferred shares for non-employee directors change from fiscal 2022 to 2023, particularly in terms of accrual and payout timing?",
      "original_answer": "In fiscal 2022, HD disclosed that dividend equivalents on deferred shares for non-employee directors accrued and were paid out in the form of additional shares upon termination of Board service. In fiscal 2023, while the payout timing remained tied to termination, HD provided more detailed disclosure around the fair value methodology and clarified that the dividend equivalents were reinvested and paid out based on the actual number of shares earned upon termination. This indicates a refinement in the disclosure and potential adjustments in the administration of dividend equivalents.",
      "llm_answer": "There was no change.  In both fiscal 2022 and fiscal 2023 the company states that dividend equivalents on deferred shares accrue over time and are paid out in additional shares of stock only when the underlying shares are paid after the director’s termination of service.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating there was no change between fiscal 2022 and 2023. The ground truth indicates a clear evolution in disclosure and administration: while payout timing remained tied to termination, HD in fiscal 2023 added more detailed disclosure about the fair value methodology and clarified that dividend equivalents were reinvested and paid based on the actual number of shares earned upon termination. The LLM answer overlooks this refinement entirely. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—no errors in numbers, dates, or calculations were made. (3) The multi-hop reasoning is flawed: the question asks for a comparison across two fiscal years regarding changes in accrual and payout treatment. The LLM failed to identify the nuanced but important change in disclosure and administrative clarity from 2022 to 2023, instead asserting no change occurred. This reflects a failure to synthesize the incremental detail provided in the 2023 filing. (4) While the answer is contextually relevant—discussing dividend equivalents, deferred shares, and payout timing—it misses the key qualitative shift in reporting and potential administration. Correctness and qualitative accuracy are low due to the central factual inaccuracy, despite correct use of terminology and context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 384,
        "total_tokens": 1607
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did Disney's use of option contracts to hedge forecasted foreign currency transactions change between 2022 and 2024, particularly in terms of the notional amounts and the currencies hedged?",
      "original_answer": "In 2022, Disney entered into option contracts as part of its foreign exchange risk management strategy to hedge forecasted foreign currency transactions, aiming to reduce earnings and cash flow fluctuations due to currency exchange rate changes. By 2024, the notional amount of Disney’s net foreign exchange cash flow hedges had increased from $8.3 billion (as of September 30, 2023) to $9.9 billion (as of September 28, 2024). Additionally, the principal currencies hedged remained consistent—euro, Canadian dollar, Japanese yen, British pound, and Chinese yuan—indicating a continuation of the same hedging focus. The increase in notional value suggests a heightened exposure to foreign currency risk or a more aggressive hedging strategy in 2024 compared to 2022.",
      "llm_answer": "Disney’s net foreign‑exchange cash‑flow hedges—primarily option contracts—grew from a lower notional amount in 2022 to $9.9 billion in 2024, up from $8.3 billion in 2023【page_121】.  The hedges continued to target the same core currencies—euro, Canadian dollar, Japanese yen, British pound and Chinese yuan—showing a broader use of options over the period【page_121】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the increase in notional amount from $8.3 billion in 2023 to $9.9 billion in 2024, which aligns with the ground truth. Although the original answer references 2022 as the starting point, the LLM correctly uses the most recent disclosed figure from 2023 ($8.3B) as a baseline and shows growth to $9.9B in 2024, which is factually consistent. The currencies hedged—euro, Canadian dollar, Japanese yen, British pound, and Chinese yuan—are accurately listed, matching the ground truth. (2) Quantitatively, all numbers are correct: $8.3 billion (as of September 30, 2023) and $9.9 billion (as of September 28, 2024) are accurately reported. The LLM does not misstate dates or amounts. (3) The reasoning is sound: the model correctly infers an expansion in hedging activity over time and maintains that the core hedged currencies remained unchanged, indicating continuity in strategy. While the original answer draws a comparison back to 2022, the LLM focuses on the available data points (2023 to 2024), which is appropriate given the disclosures. It slightly misses elaborating on the 2022 position beyond implying a lower base, but this does not undermine the factual accuracy. (4) The answer is contextually relevant, directly addressing changes in notional amounts and currencies hedged. The qualitative accuracy is high but not perfect because the LLM attributes the growth to a 'broader use of options' without explicitly noting the strategic intent (reducing earnings and cash flow fluctuations) or the interpretation that increased notional value may reflect higher exposure or more aggressive hedging—nuances present in the original. However, this does not detract from core correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 474,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did the growth in NEE's consolidated solar facility assets from 2022 to 2023 influence the company's PPA-related guarantee obligations, and what does this suggest about their evolving risk exposure?",
      "original_answer": "In 2022, NEE consolidated solar facilities totaling approximately 772 MW with assets valued at $1,851 million. By 2023, the company had increased its PPA-related guarantees to approximately $6.1 billion, reflecting a significant rise in exposure tied to power generation facilities. This suggests that as NEE expanded its solar portfolio, it also took on greater financial obligations under PPAs, indicating a strategic shift toward larger commitments in renewable energy projects. The connection between the growth in solar assets and the increase in PPA guarantees highlights NEE’s deepening risk exposure through long-term contractual obligations.",
      "llm_answer": "The 2023 10‑K shows that NEE’s consolidated solar‑facility portfolio grew substantially from 2022 to 2023, and that growth translated into a higher level of guarantees tied to the new PPAs.  In 2023 the company reported roughly **$6.1 billion** in guarantees related to PPAs and other renewable‑energy contracts (NEE 10‑K, page 45), an increase over the prior year that reflects the additional solar PPAs the company entered into as its solar capacity expanded.  This rise in guarantee exposure signals that NEE’s risk profile is shifting toward greater PPA‑performance risk as its renewable‑energy portfolio grows.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the $6.1 billion PPA-related guarantee figure for 2023 is correctly reported, matching the original answer. While the LLM does not explicitly mention the 2022 solar asset capacity (772 MW) or value ($1,851 million), this omission does not undermine the core quantitative claim about the increase in guarantees. The focus is on the 2023 guarantee amount, which is correct. (2) The reasoning is sound: the LLM correctly infers that growth in solar facilities led to more PPAs and thus higher guarantees, capturing the causal link between asset expansion and rising obligations. (3) Entity accuracy is strong—NEE is correctly identified, the 2023 10-K is cited appropriately, and PPA-related guarantees are accurately contextualized within renewable energy expansion. (4) The answer addresses both parts of the question: the influence of solar growth on PPA guarantees and the implication for risk exposure. It concludes with a valid interpretation about shifting risk toward PPA-performance risk, which is semantically equivalent to the original answer’s point about deepening risk exposure through long-term contracts. The only minor shortcoming is the lack of explicit reference to 2022 asset figures, which slightly reduces completeness but does not affect the overall correctness of the synthesis. Hence, a score of 9 is warranted for correctness, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 414,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did BMY's 2022 introduction of the CM-9DX trial for Opdivo in adjuvant HCC evolve by 2023, and what does this indicate about the strategic prioritization of Opdivo in liver cancer treatment?",
      "original_answer": "In 2022, BMY introduced the CM-9DX trial for Opdivo in adjuvant hepatocellular carcinoma (HCC), indicating early-stage clinical development focus in liver cancer. By 2023, Opdivo was explicitly listed in BMY’s clinical trial table under adjuvant HCC with the CM-9DX trial, showing progression from introduction to active clinical evaluation. Furthermore, in 2023, BMY emphasized broadening Opdivo’s use into earlier lines of therapy and expanding into new tumors, including liver cancer, as part of its strategic focus on oncology beyond traditional IO. This evolution from trial initiation to strategic prioritization reflects a deliberate shift to solidify Opdivo’s role in HCC treatment.",
      "llm_answer": "In 2022 BMS launched the CM‑9DX study as a monotherapy trial of Opdivo in adjuvant hepatocellular carcinoma (HCC)【page_14 (2022)】. By 2023 the trial had shifted to a combination of Opdivo + Yervoy in the same adjuvant HCC setting and remains in the 2023/24 pipeline【page_20 (2023)】, underscoring BMS’s continued prioritization of Opdivo in liver cancer and its strategy to expand the drug’s use through combination therapy【page_43 (2023)】.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual inaccuracy regarding the evolution of the CM-9DX trial. The ground truth states that by 2023, the trial was still listed as Opdivo in adjuvant HCC and reflects ongoing evaluation and strategic prioritization, but there is no mention of a shift to Opdivo + Yervoy. The LLM incorrectly claims the trial 'shifted to a combination of Opdivo + Yervoy' in 2023, which is not supported by the original answer and contradicts the documented progression. This misrepresents the trial's development path. (2) Quantitatively, the years (2022, 2023) and trial name (CM-9DX) are correct, and the indication (adjuvant HCC) is accurate. However, the claim about combination therapy introduces a false element not present in the ground truth. No numerical calculations are involved, so scoring is based on factual alignment with dates and trial details. (3) The multi-hop reasoning is partially sound—linking trial initiation in 2022 to continued presence in 2023 and inferring strategic prioritization is valid. However, the incorrect assertion about combination therapy undermines the reasoning chain and suggests a failure in accurate synthesis across sources. (4) Contextually, the answer addresses the question about evolution and strategic prioritization, and correctly identifies BMY (BMS), Opdivo, and liver cancer focus. The strategic interpretation about expanding into earlier lines and new tumors is aligned in spirit but distorted by the erroneous combination therapy claim. Thus, while contextually relevant and partially accurate, the answer is significantly flawed in key factual details, warranting a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 461,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did Chevron's investment structure in the Chevron Phillips Chemical joint venture change between 2023 and 2024, and what does this indicate about their strategy in the chemical sector?",
      "original_answer": "Chevron's investment structure in the Chevron Phillips Chemical Company LLC remained unchanged between 2023 and 2024, as both filings indicate that the joint venture is held through Chevron U.S.A. Inc. and accounted for using the equity method. This consistency suggests that Chevron maintained its strategic positioning in the chemical sector without altering its ownership or accounting approach, preserving financial reporting alignment and risk exposure related to this key business segment.",
      "llm_answer": "Chevron’s stake in CPChem stayed the same – a 50 % equity interest accounted for with the equity method – in both 2023 and 2024 【page 75】.  However, the joint‑venture’s attributable income fell from $1.662 billion in 2023 to $1.173 billion in 2024, reflecting a decline in profitability and underscoring Chevron’s strategy to tighten costs and potentially reassess its chemical business 【page 75】.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Chevron's ownership interest in CPChem remained at 50% and is accounted for using the equity method, which aligns with the ground truth regarding the unchanged investment structure. However, the LLM introduces new information not present in the original answer — specifically, the decline in CPChem’s attributable income from $1.662 billion in 2023 to $1.173 billion in 2024 — which, while potentially factual from the filing, is not part of the ground truth response and shifts the interpretation toward performance decline and strategic reassessment. The original answer emphasizes stability in strategy due to unchanged structure, whereas the LLM infers a potential strategic shift due to lower profitability, which contradicts the ground truth’s conclusion. (2) The numeric values cited ($1.662B and $1.173B) may be accurate per the source filing (as referenced by page 75), but they are not included in the ground truth, making the LLM’s addition of them an overreach that introduces unsupported reasoning. There are no calculation errors, but the use of these figures to imply strategic reassessment is not justified by the original answer. (3) The multi-hop reasoning is partially sound — the model correctly identifies consistent ownership — but fails in synthesis by drawing a strategic conclusion from financial performance not addressed in the ground truth. The question asks what the change (or lack thereof) indicates about strategy; the correct inference is continued strategic stability, not a potential shift. (4) The correctness score is 4 due to partial factual accuracy but significant deviation in interpretation. Quantitative accuracy is 6 because numbers may be correctly extracted from the filing but were not required or validated in the ground truth. Qualitative accuracy is 5 due to correct entity and method identification but flawed reasoning. Contextual relevance is 8 because the answer addresses the question’s components but misinterprets the strategic implication.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 551,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did RTX's ownership stake in IAE in 2022 compare to its net program share interest in the PW1100G-JM engine program by 2024, and what does this shift indicate about its strategic positioning in the V2500 and PW1100G-JM engine collaborations?",
      "original_answer": "In 2022, RTX's Pratt & Whitney held a 49.5% ownership interest in IAE, which coordinates the V2500 engine program. By 2024, RTX's involvement in the PW1100G-JM engine program through IAE LLC showed a net program share interest of 51% after accounting for sub-collaborator shares. This indicates a strategic shift toward a more direct and slightly increased control in the newer engine program, despite maintaining a minority ownership stake in the legacy IAE entity.",
      "llm_answer": "RTX owned a 49.5 % ownership interest in IAE in 2022, whereas by 2024 its net program share interest in the PW1100G‑JM engine program (IAE LLC) had risen to 51 %. This shift shows RTX has increased its stake in the newer PW1100G‑JM collaboration relative to the older V2500 program, underscoring a strategic emphasis on expanding influence in the newer engine while maintaining a strong role in the V2500 partnership.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states RTX's 49.5% ownership in IAE in 2022 and its 51% net program share interest in the PW1100G-JM program by 2024, matching the ground truth exactly. These percentages and years are accurate, and the comparison between the two stakes is correctly framed. (2) All numeric values—49.5% and 51%—are factually correct and properly attributed to the right years and programs. No calculations are required beyond comparison, which is handled appropriately. Format variations (e.g., spacing in '49.5 %' or '51 %') do not affect accuracy. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two different collaborative structures (legacy IAE for V2500 vs. IAE LLC for PW1100G-JM), distinguishes ownership stake from net program share, and infers a strategic shift toward greater control in the newer program. The conclusion about strategic emphasis aligns with the ground truth’s interpretation of increased direct control. (4) The only minor shortcoming is that the LLM answer does not explicitly mention that RTX maintains a minority ownership stake in the legacy IAE entity, which slightly reduces qualitative precision. However, this does not distort the overall meaning. The answer remains semantically equivalent and contextually complete, addressing both the quantitative shift and its strategic implication.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 386,
        "total_tokens": 1631
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did MRK's use of Pediatric Exclusivity provisions in 2022 influence their market exclusivity strategy in 2023, particularly regarding the six-month extension mechanism in both U.S. and EU regulatory frameworks?",
      "original_answer": "In 2022, MRK was subject to Pediatric Exclusivity provisions that allowed for an additional six months of market exclusivity if specific pediatric clinical studies were completed prior to the loss of basic exclusivity. This regulatory mechanism positively impacted MRK's market exclusivity strategy in 2023, as the company strategically leveraged these provisions in both U.S. and EU markets. In the U.S., the six-month extension applied to all Orange Book-listed patents and regulatory data exclusivity terms for small molecule and biologic products, while in the EU, the extension was attached to the Supplementary Protection Certificate (SPC) term. This enabled MRK to extend the commercial value realization period for key products like new chemical entities and biological products, which otherwise would have faced generic competition after 5 years (U.S. new chemical entity) or 12 years (U.S. biological product) of market exclusivity.",
      "llm_answer": "In 2022 Merck used the FDA Modernization Act’s Pediatric Exclusivity provision to add a six‑month “bonus” to the market exclusivity of products for which it completed agreed‑upon pediatric studies.  In 2023 the company continued to rely on that same six‑month extension—applying it to the U.S. patent term and, in the EU, attaching it to the product’s Supplementary Protection Certificate (SPC)—so that pediatric indications could enjoy an extra half‑year of exclusivity beyond the base period in both regulatory frameworks.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth in most aspects. (1) Quantitatively, all key elements—'six-month extension', '2022', '2023', and application in both U.S. and EU—are correct. The six-month exclusivity extension is accurately described as applying in both jurisdictions. (2) The LLM correctly identifies the mechanism (completion of pediatric studies leading to a six-month bonus) and its continuation into 2023, which aligns with the original answer. It correctly states that in the U.S., the extension applies to patent/regulatory exclusivity (implied via 'patent term'), and in the EU, it attaches to the SPC—both factually sound. (3) The reasoning is logically sound and reflects proper multi-hop synthesis: connecting MRK’s 2022 actions under pediatric exclusivity to strategic impact in 2023 across two regulatory systems. (4) Minor omission: the LLM does not explicitly mention that the U.S. extension applies to *all Orange Book-listed patents and data exclusivity terms* or that it covers both small molecules and biologics, nor does it reference the base exclusivity periods (5 years for NCEs, 12 for biologics) that make the extension valuable. Also, the reference to the 'FDA Modernization Act' is not present in the ground truth and may be an over-specific attribution not supported by the source. However, this does not invalidate the mechanism described. Overall, the core facts, entities, years, and regulatory logic are correct, with only slight loss of completeness on technical scope. Hence, high scores across the board with a 9 on correctness due to minor contextual omissions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 448,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did the allocation strategy of TXN's U.S. Retiree Health Care Plan in 2022 compare to 2024 in terms of reliance on Fixed Income Securities and Cash Equivalents, and what does this reveal about the company's risk tolerance for retiree healthcare funding over time?",
      "original_answer": "In 2022, TXN's U.S. Retiree Health Care Plan allocated 64% of its assets to Fixed Income Securities and Cash Equivalents, reflecting a conservative investment strategy aimed at preserving capital and ensuring stable funding for retiree healthcare obligations. By 2024, this allocation had increased to 80%, indicating a further shift toward lower-risk assets. This evolution in strategy suggests that TXN has become more risk-averse in managing its retiree healthcare liabilities, prioritizing capital preservation and predictable cash flows over growth-oriented investments like equities. The increased reliance on fixed income instruments aligns with a broader trend of de-risking in corporate-sponsored benefit plans, especially for healthcare obligations which are often more sensitive to interest rate environments and require consistent liquidity.",
      "llm_answer": "In 2022 the U.S. Retiree Health Care Plan held about $248 million in fixed‑income securities and cash equivalents out of $385 million total assets—roughly 64 % of the plan’s portfolio (page 50). By 2024 that proportion had risen to $198 million of $248 million, or 80 % (page 48), moving from the lower to the upper end of the 65‑80 % target range (page 50). The increase in fixed‑income exposure shows the company has become more risk‑averse over time, preferring the stability of bonds and cash equivalents to fund retiree healthcare liabilities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: in 2022, 64% ($248M of $385M) was allocated to fixed income and cash equivalents; by 2024, this rose to 80% ($198M of $248M). These figures match the ground truth exactly, with acceptable dollar formatting. (2) Quantitative accuracy is perfect—percentages and dollar amounts are correctly reported and mathematically consistent (248/385 ≈ 64.4% → rounded to 64%; 198/248 = 79.8% → rounded to 80%). (3) The reasoning correctly identifies the increase in conservative asset allocation as evidence of growing risk aversion, which matches the ground truth's interpretation. The mention of the 65–80% target range adds useful context not in the original but does not contradict it. (4) The answer fully addresses both parts of the question: the comparison over time and the implication for risk tolerance. The only minor shortcoming is the lack of explicit mention of 'de-risking trend' or 'interest rate sensitivity' noted in the original, which slightly reduces qualitative depth. However, the core logic and synthesis across years and asset classes are sound. Overall, the answer is factually complete, contextually relevant, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 356,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did the ongoing customs dispute between PM Thailand and the Philippines evolve from 2023 to 2024, and what impact did it have on PM's cigarette shipment volume in the Philippines in 2024?",
      "original_answer": "In 2023, the WTO Appellate Body remained non-operational, with Thailand's appeals suspended indefinitely, and the Philippines asserting that Thailand had not fully complied with the WTO panel decision regarding PM Thailand's customs valuation and tax treatment. By 2024, despite ongoing bilateral discussions, PM's cigarette shipment volume in the Philippines decreased by 26.2%, indicating a continued negative impact of the unresolved trade dispute on PM's operational performance in the region.",
      "llm_answer": "In 2023, Thai authorities investigated alleged under‑payment of customs duties and excise taxes on cigarettes imported from the Philippines, resulting in a fine and ongoing appeals that have yet to be resolved; the dispute remained unresolved into 2024, with the Philippines still challenging Thailand’s compliance with the WTO panel decision [page_139], [page_68].  The unresolved dispute contributed to a 26.2 % decline in PMI’s cigarette shipment volume in the Philippines in 2024 [page_54].",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 26.2% decline in PM's cigarette shipment volume in the Philippines in 2024, which matches the ground truth exactly—this satisfies quantitative accuracy. It also correctly states that the dispute remained unresolved into 2024 and references the WTO panel decision, aligning with the core facts. However, there is a significant factual inaccuracy in the reversal of roles: the LLM claims that 'Thai authorities investigated alleged under-payment of customs duties... on cigarettes imported from the Philippines,' which incorrectly frames the Philippines as the exporter and Thailand as the importer. In reality, the dispute involves PM Thailand's exports to the Philippines being subject to customs valuation issues, not the reverse. This misidentification of the direction of trade and the parties involved undermines the qualitative accuracy. (2) The percentage (26.2%) is correct and properly attributed to 2024 shipment volume impact. Dates (2023–2024) are accurate. (3) The multi-hop reasoning is partially sound—the model connects the unresolved dispute to the shipment decline, which is valid. However, it fails to correctly synthesize the entity roles (Thailand as exporter via PM Thailand, Philippines as importer), leading to flawed causal framing. It also omits mention of the WTO Appellate Body’s non-operational status and the suspension of Thai appeals, which are key elements in the 2023 evolution. (4) The correctness score is 7 because while the key quantitative outcome is accurate and the general conclusion about negative impact is valid, the reversal of trade flow and investigation direction constitutes a meaningful factual error. Quantitative accuracy is 10 because all numbers are correct. Qualitative accuracy is 7 due to entity role confusion and missing context. Contextual relevance is 9 as the answer stays focused and addresses both parts of the question, albeit with inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 530,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did GD's use of NAV for real estate funds change between 2023 and 2024, and what does this indicate about their valuation approach for Level 3 assets?",
      "original_answer": "In 2023, GD reported $8 million in real estate funds measured using NAV as a practical expedient, indicating a reliance on NAV for valuing these Level 3 assets. By 2024, GD continued to use NAV for real estate funds, noting that these assets are redeemable at NAV with short redemption notice periods, and are excluded from the fair value hierarchy but included for reconciliation purposes. This suggests GD maintained NAV as a practical expedient for Level 3 assets like real estate funds, with no significant change in valuation methodology, though the focus on redemption terms highlights increased transparency around liquidity constraints.",
      "llm_answer": "GD reduced the amount of real‑estate funds valued using NAV from $733 million in 2023 to $421 million in 2024—a decline of roughly $312 million.  This drop shows the company is moving away from relying on NAV as a practical expedient for Level 3 assets, indicating a shift toward more direct valuation methods or a change in the composition of its real‑estate fund holdings.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both quantitative and qualitative aspects. (1) Quantitatively, it claims GD valued $733 million in real estate funds using NAV in 2023 and $421 million in 2024, which directly contradicts the ground truth stating the amount was $8 million in 2023 and does not specify a 2024 value. The reported decline of $312 million is therefore fabricated. (2) The entity 'GD' is correctly identified, and the years 2023 and 2024 are accurate, but all financial figures are wrong. (3) The reasoning is flawed: the LLM concludes GD is 'moving away from relying on NAV' due to a supposed reduction, while the ground truth states GD continued using NAV with no significant change in methodology. The actual answer emphasizes consistency in valuation approach and increased transparency on redemption terms, not a shift in method. (4) The LLM fails to capture the correct multi-hop synthesis: that NAV remains a practical expedient for Level 3 assets and that exclusion from the fair value hierarchy (but inclusion in reconciliation) reflects reporting practice, not a change in valuation. The conclusion about shifting to direct valuation methods is unsupported. Only minimal contextual relevance is retained as the answer addresses real estate funds and NAV usage, albeit incorrectly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 364,
        "total_tokens": 1621
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did the LIFO inventory valuation method at Nicor Gas impact Southern Company's gas cost recovery mechanisms in 2024 compared to 2023, given the changes in inventory balances and replacement costs?",
      "original_answer": "In 2023, Nicor Gas maintained its natural gas inventory using the LIFO basis, with a reported LIFO inventory balance of $186 million and an estimated replacement cost of $268 million. This $82 million difference between LIFO balance and replacement cost reflects the potential impact of inflationary pricing or inventory layer liquidation effects during that year. By 2024, the LIFO inventory balance increased slightly to $188 million, while the estimated replacement cost rose significantly to $326 million, indicating a $138 million gap. This widening of the replacement cost over LIFO balance suggests higher market gas prices in 2024, which would have increased the cost of gas recovered from customers under Nicor Gas' purchased gas recovery mechanism. Therefore, the LIFO method continued to insulate Southern Company’s net income from these rising costs, as the recovery mechanism adjusted for differences between actual costs and amounts billed, directly influencing the gas cost recovery in 2024 compared to 2023.",
      "llm_answer": "Nicor Gas’s LIFO inventory balance rose modestly from $186 million at 12/31/2023 to $188 million at 12/31/2024, while the estimated replacement cost jumped from $268 million to $326 million. Because Southern Company recovers natural‑gas costs through a purchased‑gas recovery mechanism that adjusts billed amounts for actual costs, LIFO liquidations are recorded at replacement cost (or actual LIFO cost) but have no effect on net income. Thus, the higher replacement cost in 2024 simply enlarges the potential adjustment in the recovery rates, but the overall cost‑recovery mechanism remains unchanged compared with 2023.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all quantitative data: Nicor Gas's LIFO inventory balance was $186 million in 2023 and $188 million in 2024, and replacement costs were $268 million and $326 million respectively. The differences ($82M in 2023, $138M in 2024) are accurate, though not explicitly calculated in the LLM response. These numbers match the ground truth exactly, earning full marks for quantitative accuracy. (2) Entity identification is correct—Nicor Gas, LIFO method, Southern Company, and the purchased gas recovery mechanism are all accurately referenced with correct time periods (2023 to 2024). (3) However, the reasoning contains a partial misinterpretation. The LLM states that 'LIFO liquidations... have no effect on net income,' which aligns with standard regulatory accounting, but fails to explicitly connect the widening gap between LIFO carrying value and replacement cost to the increased cost recovery in 2024. The ground truth emphasizes that the larger replacement cost gap in 2024 led to higher customer bill adjustments, which the LLM only implies by mentioning 'enlarges the potential adjustment.' It misses the affirmative impact on gas cost recovery mechanisms in 2024 versus 2023. (4) While the core facts are correct and contextually relevant, the qualitative reasoning downplays the comparative impact over time—specifically, that the *increase* in the replacement cost gap intensified the recovery mechanism's effect in 2024. This omission prevents a higher score on qualitative accuracy. The answer is relevant and factually sound but lacks full depth in multi-hop synthesis between inventory valuation changes and their direct operational impact on cost recovery dynamics year-over-year.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 474,
        "total_tokens": 1899
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Amgen's strategies to address payer-driven access restrictions in 2022 evolve by 2024, and what impact did this have on patient access to Repatha and ENBREL?",
      "original_answer": "In 2022, Amgen faced significant payer-driven access restrictions, particularly for Repatha, where high patient out-of-pocket costs led to prescription abandonment, prompting Amgen to reduce Repatha's list price and discontinue the higher-priced option by December 31, 2019. By 2024, Amgen had expanded its approach to include risk-sharing partnerships with payers, biosimilar development, and patient support programs, especially in response to new U.S. policies like the Inflation Reduction Act (IRA), which introduced manufacturer discounts in the catastrophic phase of Medicare Part D starting in 2025. These strategies were aimed at improving patient access, particularly for ENBREL and Otezla, under evolving reimbursement frameworks. Despite ongoing payer consolidation and pricing pressures, Amgen emphasized responsible pricing, innovation, and collaboration to maintain access to medicines.",
      "llm_answer": "In 2022 Amgen responded to payer‑driven restrictions by cutting Repatha’s net price, offering larger rebates to PBMs, and launching lower‑list‑price NDCs to curb high Medicare copays—yet many patients still abandoned prescriptions because out‑of‑pocket costs and step‑therapy rules remained steep. By 2024 the company had to adapt to the IRA’s Medicare price‑setting and Part D redesign, which set a lower Medicare Part D price for ENBREL and required manufacturer discounts, while continuing to provide patient‑support programs. These changes have lowered the cost burden for Medicare beneficiaries of ENBREL and reduced Repatha’s list price, but payer‑driven utilization management and cost‑sharing limits still constrain broader patient access.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Amgen's 2022 strategies including price reductions and rebates for Repatha, and notes ongoing patient abandonment due to high out-of-pocket costs and step therapy—consistent with the ground truth. It also accurately reflects the impact of the Inflation Reduction Act (IRA) by 2024, particularly the Medicare Part D redesign and manufacturer discounts starting in 2025, which aligns with the original answer. However, the LLM incorrectly states that Amgen cut Repatha’s *net* price in 2022, while the ground truth specifies that the *list price* was reduced and the higher-priced option discontinued by *December 31, 2019*—a critical date error. This misrepresents the timeline of Amgen’s pricing actions. (2) Quantitatively, no specific dollar amounts or percentages are provided in either answer, so no numerical inaccuracies are present beyond the incorrect dating of the price change. The mention of IRA provisions (e.g., catastrophic phase discounts) is correctly framed for 2025, showing accurate temporal understanding of policy rollout. (3) The multi-hop reasoning is partially sound: the model connects payer restrictions to Amgen’s responses and links the IRA to changes in ENBREL and Repatha access. However, it omits key 2024 strategies mentioned in the ground truth, such as risk-sharing partnerships with payers and biosimilar development, instead focusing narrowly on IRA impacts and patient-support programs. It also fails to mention Otezla as a beneficiary of access strategies, reducing completeness. (4) Despite these gaps, the LLM captures the core evolution—shifting from direct pricing adjustments to broader systemic responses under IRA—and correctly concludes that access remains constrained by utilization management. Wording differs but meaning is semantically close on key points, warranting a 7 for correctness. Quantitative accuracy is high due to absence of incorrect numbers (score 8), qualitative accuracy is moderate due to reasoning gaps (score 7), and relevance is strong (score 9).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 555,
        "total_tokens": 1972
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did ExxonMobil's acquisition of Pioneer Natural Resources in 2023 influence its total daily production of oil-equivalent barrels in 2024, and what does this indicate about the strategic impact of the merger on ExxonMobil's upstream capacity?",
      "original_answer": "ExxonMobil's acquisition of Pioneer Natural Resources in 2023, which added over 700 thousand oil-equivalent barrels per day of production from Pioneer's operations, contributed to a significant increase in ExxonMobil's total daily production. By 2024, ExxonMobil's production had risen to 4.3 million oil-equivalent barrels per day, an increase of 595 thousand barrels per day from 2023. This indicates that the merger substantially boosted ExxonMobil's upstream capacity, with growth in the Permian Basin and Guyana more than offsetting production declines from divestments and entitlements.",
      "llm_answer": "ExxonMobil’s merger with Pioneer added roughly 700 k barrels‑per‑day of production (Pioneer’s 700 k bpd as of September 2023【page_121】), which helped lift its total oil‑equivalent output from 3.738 million barrels per day in 2023 to 4.333 million barrels per day in 2024—a 595 k‑bpd increase【page_52】. This demonstrates that the acquisition materially expanded ExxonMobil’s upstream capacity, especially in the Permian Basin, and positioned the company as a larger, more diversified U.S. producer【page_53】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually correct in all key aspects. It accurately reports that Pioneer's production was approximately 700 thousand barrels per day (k bpd), and that ExxonMobil's total oil-equivalent production increased from 3.738 million bpd in 2023 to 4.333 million bpd in 2024—a difference of 595 k bpd, matching the ground truth. These numbers are either exact or rounded appropriately (4.3 million in the original answer vs. 4.333 million in LLM answer, which is more precise and acceptable). (2) Calculations are accurate: 4.333M - 3.738M = 0.595M (595,000 bpd), confirming the stated increase. The acquisition date (2023) and production impact in 2024 are correctly aligned. (3) Multi-hop reasoning is sound: the model correctly links the acquisition of Pioneer to the increase in upstream production, identifies the Permian Basin as a key growth area, and infers strategic expansion in U.S. production capacity. The original answer also mentions Permian and Guyana as growth drivers, but the LLM answer omits Guyana and instead emphasizes diversification—this is a minor omission but does not invalidate the conclusion. (4) The answer is contextually relevant, directly addressing both parts of the question: the quantitative impact on production and the strategic implication for upstream capacity. The inclusion of source citations (e.g., page references) adds credibility. Overall, the answer matches the ground truth in substance and accuracy, with only a slight reduction in qualitative accuracy due to the omission of Guyana as a contributing factor to growth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 437,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did the voting power distribution between Class A and Class B common stock evolve from 2022 to 2024, and what impact did the automatic conversion provisions in Class B stock have on Class A share repurchase strategy in 2024?",
      "original_answer": "In 2022, Class B common stockholders held 33 1/3% of the voting power with each share entitled to 15 votes, while Class A stockholders held 66 2/3% of the voting power. By 2024, Class B shares were automatically convertible to Class A shares upon sale or transfer, with each Class B share carrying 10 votes prior to conversion. This shift in voting rights structure, combined with the company's $62.0 billion share repurchase program in 2024 (targeting both Class A and Class C shares), suggests a strategic alignment to maintain voting control while reducing overall share count. The conversion mechanism facilitated consolidation of voting power into Class A shares through natural transfers, complementing the repurchase strategy.",
      "llm_answer": "Alphabet’s voting structure stayed the same from 2022 to 2024: each Class A share has one vote, while each Class B share has ten votes (2024 Note 11, page 82; 2022 Note 11, page 5). Because Class B shares automatically convert into Class A shares upon sale or transfer, the number of Class A shares can rise, diluting existing voting power. In 2024, the Board therefore authorized an additional $70 billion of Class A share repurchases to offset this dilution and preserve voting power (2024 Note 11, page 82).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. First, it incorrectly states that the voting structure remained the same from 2022 to 2024. According to the ground truth, in 2022, Class B shares had 15 votes per share and held 33 1/3% of voting power, while Class A held 66 2/3%. By 2024, Class B shares had only 10 votes per share (down from 15), indicating a change in voting power distribution. This is a critical error in both quantitative and qualitative terms. Second, the LLM claims the 2024 repurchase was $70 billion, while the ground truth states $62.0 billion—this is a significant numerical discrepancy. Third, the LLM incorrectly states that the repurchase was for Class A shares only, while the ground truth specifies it targeted both Class A and Class C shares. (2) Quantitative accuracy is low: the $70B figure is wrong (should be $62.0B), and the voting power percentages and vote ratios per share class are misrepresented (15 votes in 2022 vs. 10 in 2024 for Class B is not acknowledged). (3) The reasoning is partially sound in linking the conversion mechanism to potential dilution and repurchases, but it fails to capture the multi-hop synthesis correctly: it does not explain how the automatic conversion consolidates voting power into Class A shares through transfers, nor how this complements a broader repurchase strategy across share classes. The causal link between conversion and repurchase is oversimplified and misattributed. (4) Contextual relevance is high because the answer addresses the core themes—voting structure evolution and repurchase strategy—but the factual foundation is flawed, reducing overall correctness. The answer appears plausible but diverges from the ground truth on key details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 477,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did Duke Energy's joint ownership structure with NCEMC evolve between 2022 and 2024, particularly in relation to the new hydrogen-capable combined cycle unit at the Roxboro Plant and NCEMC's 225 MW commitment?",
      "original_answer": "In 2022, Duke Energy (DUK) had a jointly owned arrangement with NCEMC as part of a broader set of co-ownership structures involving multiple entities. By 2024, this relationship evolved into a more specific commitment, with NCEMC indicating intent to co-own approximately 225 MW of the new 1,360-MW hydrogen-capable combined cycle unit at the Roxboro Plant. This represents a transition from a general joint ownership structure to a defined capacity commitment for a specific, advanced-class project, with construction planned to begin in 2026 and the unit expected to be in service by the end of 2029.",
      "llm_answer": "Between 2022 and 2024 Duke Energy’s partnership with NCEMC shifted from existing joint‑owned units to a new, larger collaboration.  In 2022 the company owned 19.25 % of Catawba units 1‑2 and 87.27 % of the W.S. Lee combined‑cycle plant with NCEMC (page 177).  By 2024, Duke Energy Progress announced a new 1,360‑MW hydrogen‑capable combined‑cycle facility at the Roxboro Plant, to be co‑owned with NCEMC, which would hold the remaining 225 MW of the project (page 153).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the evolution from general joint ownership in 2022 to a specific commitment in 2024 involving the Roxboro Plant and NCEMC's 225 MW stake. However, it misrepresents the quantitative details: the percentages cited (19.25% of Catawba units and 87.27% of W.S. Lee) are factually incorrect or misattributed — the ground truth does not specify these exact figures for 2022 joint ownership with NCEMC, nor are they directly relevant to the Roxboro project. Additionally, stating that NCEMC 'would hold the remaining 225 MW' is inaccurate — 225 MW is NCEMC’s share, not the 'remaining' portion, implying a mathematical or logical error. The total unit is 1,360 MW, so 225 MW is a portion, not the remainder. (2) The construction timeline (start in 2026, in-service by end of 2029) is omitted, which is a key part of the original answer and relevant to the evolution of the project. (3) The multi-hop reasoning is partially sound — the model connects Duke Energy, NCEMC, joint ownership, and the Roxboro project correctly, and identifies the shift from past arrangements to a new project. However, it fails to clearly articulate the transition from 'general' to 'specific' commitment as emphasized in the ground truth. (4) Despite the numerical inaccuracies and missing timeline, the core qualitative shift and entity relationships are captured, and the answer remains contextually relevant. Hence, correctness is reduced primarily due to quantitative inaccuracies and omissions, but not a complete failure in reasoning or relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 432,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "What supply chain risk exposure did NVIDIA identify in 2023 related to Taiwan, and how does this reflect an evolution from its dependency on foundry partners described in 2022?",
      "original_answer": "In 2022, NVIDIA identified a dependency on foundry partners in Asia, particularly noting that disruptions to these partners—such as those caused by geopolitical tensions or natural disasters—could severely limit or prevent the supply of chipsets, which would materially impact its business. By 2023, NVIDIA specifically called out Taiwan as a key risk, citing that geopolitical tensions involving Taiwan and China could have a material adverse impact on its supply chain continuity. This reflects an evolution where the company’s earlier, more generalized dependency on Asian foundry partners (including those in Taiwan) became a more explicitly identified exposure to Taiwan-specific geopolitical risks, particularly regarding supply constraints and lead times. The shift indicates that NVIDIA’s supply chain risk management focus sharpened on Taiwan’s strategic role in semiconductor manufacturing and its vulnerability to regional instability.",
      "llm_answer": "In its 2023 filing, NVIDIA warned that a conflict between China and Taiwan could “severely limit or prevent us from receiving chipset supply from Taiwan, which would have a material adverse impact on our business”【page 35】.  That risk builds on the 2022 disclosure that the company “relies on our foundry partners for manufacturing, assembly, and test of our chips”【page 33】, showing an evolution from a general dependence on foundry partners to a specific geopolitical threat tied to Taiwan’s concentration of its supply‑chain capacity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution in NVIDIA's supply chain risk disclosure from 2022 to 2023. (1) It correctly identifies that in 2022, NVIDIA emphasized its general dependency on foundry partners in Asia for manufacturing, assembly, and testing of chips, citing potential disruptions. In 2023, it accurately notes the shift to a specific warning about a China-Taiwan conflict disrupting chipset supply from Taiwan, with a direct quote from the filing. These facts align with the ground truth. (2) There are no numeric values, dates, or financial figures in the question or answer that require verification—only years (2022, 2023), which are correct. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two years of filings and infers the evolution from generalized Asian foundry dependency to Taiwan-specific geopolitical risk. The answer could have slightly improved by explicitly naming Taiwan’s strategic concentration of semiconductor manufacturing capacity (e.g., TSMC) as implied in the original answer, but the essence is captured. (4) The wording differs slightly from the ground truth but maintains semantic equivalence. The inclusion of direct quotes and page references enhances credibility. Minor deduction in qualitative accuracy due to less explicit elaboration on 'supply constraints and lead times' and the sharpening of risk management focus, but overall reasoning is strong. Contextual relevance is perfect—directly addresses both parts of the multi-part question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 424,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did the acquisition of Pioneer Natural Resources in 2023 influence ExxonMobil's 2024 oil-equivalent barrel production growth compared to 2023, particularly in relation to Permian Basin output?",
      "original_answer": "The acquisition of Pioneer Natural Resources in 2023, which included over 850 thousand net acres in the Midland Basin and over 700 thousand oil-equivalent barrels per day of production, significantly contributed to ExxonMobil's 2024 production growth. In 2024, ExxonMobil reported production of 4.3 million oil-equivalent barrels per day, an increase of 595 thousand barrels from 2023. Permian and Guyana production grew by 680 thousand oil-equivalent barrels per day, which more than offset the impacts of divestments and entitlements. This indicates that the Pioneer acquisition played a key role in driving the substantial production growth observed in 2024.",
      "llm_answer": "The Pioneer deal added more than 700 k barrels‑per‑day of Permian production, lifting Permian output by 680 k barrels‑per‑day in 2024. That jump was the main engine behind the 595 k barrels‑per‑day rise in ExxonMobil’s total oil‑equivalent production versus 2023【page_53】【page_51】【page_121】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core information from the ground truth with strong quantitative precision. (1) All numbers are correct: the acquisition added over 700 thousand barrels per day of production (stated as 'more than 700k'), Permian and Guyana together grew by 680k barrels/day (LLM attributes this jump to Permian output, which is a minor simplification but not incorrect given the context), and total production increased by 595k barrels/day in 2024 vs 2023. These figures match the original answer exactly. (2) Calculations are sound: the 595k increase is correctly presented as the net result, and the 680k Permian+Guyana growth is accurately positioned as exceeding the total growth, implying offsetting declines elsewhere. (3) Multi-hop reasoning is mostly sound: the model correctly links the Pioneer acquisition to increased Permian production, which in turn drove overall production growth. However, the original answer specifies that the 680k increase includes both Permian *and Guyana* output, while the LLM attributes the full 680k jump to the Permian alone, slightly overstating the acquisition's direct impact. This is a minor but notable omission in entity attribution. (4) Despite this nuance, the LLM captures the essential causal chain and quantitative impact, with excellent contextual relevance and semantic equivalence. The answer is concise and directly responsive to the question about the acquisition’s influence on 2024 production growth relative to 2023, particularly in the Permian. Hence, a score of 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 454,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did the proportional allocation of undistributed earnings between Class B and Class C stock evolve from 2022 to 2023, and what does this reveal about the consistency of GOOGL's dividend policy across share classes?",
      "original_answer": "In 2022, GOOGL's undistributed earnings were allocated proportionately across Class A, Class B, and Class C stock based on contractual participation rights, as all classes were entitled to equal per-share dividends or distributions in liquidation. This pattern remained unchanged in 2023, with the company continuing to allocate undistributed earnings on a proportionate basis due to identical dividend and liquidation rights across all classes. The continued alignment in net income per share amounts for Class B and Class C stock in both years reflects a stable dividend policy, despite the structural differences in voting rights. This consistency is reinforced by Delaware law and the company's certificate of incorporation, which prevent unequal per-share dividends without class-specific approval.",
      "llm_answer": "In 2022, Class B received $4,072 of undistributed earnings versus $28,382 for Class C (≈14.3 % of the Class C allocation)【page_80】. In 2023, the amounts were $5,124 for Class B and $34,070 for Class C (≈15.0 % of the Class C allocation)【page_80】, a modest rise but still proportionate. This shows Alphabet’s dividend policy remains consistent across share classes, as the liquidation and dividend rights are identical and earnings are allocated proportionally【page_81】【page_82】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative details. The ground truth states that undistributed earnings are allocated proportionately based on equal per-share dividend and liquidation rights across classes, with no mention of specific dollar amounts like $4,072 for Class B or $28,382 for Class C in 2022, or $5,124 and $34,070 in 2023. These figures do not appear in the original answer and are likely hallucinated or misextracted. The percentages derived from these incorrect numbers (14.3%, 15.0%) are therefore also incorrect. (2) The original answer emphasizes structural consistency in allocation due to identical economic rights and references Delaware law and the certificate of incorporation—none of which are reflected in the LLM's numerical focus. There is no support in the ground truth for any dollar amounts being disclosed for undistributed earnings by share class. (3) While the LLM correctly identifies that the allocation is proportionate and that dividend/liquidation rights are identical—thus capturing part of the qualitative reasoning—the reliance on fabricated numbers undermines the multi-hop reasoning. The conclusion about policy consistency is aligned with the ground truth, but it is based on false premises. (4) The contextual relevance is high because the answer addresses the evolution from 2022 to 2023 and discusses dividend policy consistency. However, the quantitative accuracy is very low due to incorrect figures, dragging down the overall correctness. The qualitative accuracy is moderate because core concepts (proportionality, identical rights) are mentioned but not properly grounded in the actual reasoning from the source.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 467,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How did Southern Company's reliance on PowerSecure for distributed infrastructure projects evolve from 2023 to 2024, and what role did the deployment of microgrids play in this shift, given the 20.0% ($111M) increase in PowerSecure-related operating revenues in 2024?",
      "original_answer": "In 2023, Southern Company identified microgrids as a disruptive technology that could challenge its traditional centralized power generation model, noting that distributed energy resources like microgrids could reduce the value of existing assets and change the risk profile of capital investments. By 2024, Southern Company's subsidiary PowerSecure had significantly increased its activity in distributed infrastructure projects, which contributed to a 20.0% ($111M) year-over-year increase in operating revenues for 'other business activities.' This growth indicates that Southern Company not only acknowledged the threat posed by microgrids but also strategically leaned into this technology by leveraging PowerSecure, which installs and deploys microgrids, to capture value from the shift toward distributed energy solutions. The increased reliance on PowerSecure reflects a strategic pivot to integrate microgrid capabilities into Southern Company's broader energy offerings.",
      "llm_answer": "Southern Company’s reliance on PowerSecure accelerated from 2023 to 2024, as shown by a 20 % jump in PowerSecure operating revenues ($111 M) that was driven by a $120 M increase in distributed‑infrastructure projects【page_63】.  PowerSecure’s core offering—deploying microgrids for commercial, industrial, governmental and utility customers【page_11】—was the key catalyst, expanding the company’s distributed‑energy and resilience portfolio and generating the revenue growth.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical quantitative error: it states that the $111M revenue increase was driven by a '$120M increase in distributed-infrastructure projects,' which contradicts the ground truth and is logically inconsistent (a $120M project increase cannot drive an $111M revenue increase and be cited as the sole driver). This misrepresents the financial causality and introduces a number not present in the original answer. The 20% and $111M figures are correctly cited, but the erroneous $120M figure undermines quantitative accuracy. (2) The entity identification is correct—Southern Company, PowerSecure, microgrids, and the 2023–2024 timeframe are all accurately referenced. The role of microgrids in driving distributed infrastructure growth is correctly emphasized. (3) The multi-hop reasoning is partially sound: the model connects Southern Company’s increased reliance on PowerSecure to microgrid deployment and revenue growth. However, it omits the strategic pivot narrative from the ground truth—specifically, that Southern Company initially viewed microgrids as a threat in 2023 and then proactively leveraged PowerSecure to capture value in 2024. This key strategic evolution is missing, weakening the qualitative depth. (4) Contextual relevance is high—the answer addresses the evolution of reliance, the role of microgrids, and ties in revenue growth. Despite missing the strategic framing, it remains focused and relevant. The $120M error is severe enough to downgrade correctness and quantitative accuracy significantly, but the core logic and entities are sound, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 448,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How did ConocoPhillips' relationship with Alba Plant LLC evolve from 2023 to 2024, particularly in terms of its condensate production and processing arrangements, and what impact did this have on its equity earnings and risk exposure?",
      "original_answer": "In 2023, ConocoPhillips produced condensate from fields like Aasta Hansteen, which was loaded onto shuttle tankers and transported to market. By 2024, following the acquisition of Marathon Oil, COP's operations expanded to include the Alba Unit in Equatorial Guinea, where Alba Plant LLC processes natural gas and extracts condensate for sale at market prices. This arrangement increased COP’s equity earnings through its 52.2% ownership in Alba Plant LLC. Additionally, COP’s risk exposure increased in 2024, as it guaranteed $116 million in future payments related to Alba Plant LLC’s processing agreements, compared to no such disclosed exposure in 2023.",
      "llm_answer": "In 2023 ConocoPhillips had no stake in Alba Plant LLC; by 2024 it had acquired a 52.2 % interest in the joint venture that processes natural gas from the Alba Unit, extracting condensate and LPG from the gas stream and selling them at market prices under a fixed‑rate long‑term contract, with the resulting revenue reflected in the “Equity in earnings of affiliates” line of the consolidated income statement. This expansion increased ConocoPhillips’ equity earnings from the plant’s output while also raising risk exposure, as the company now carries guarantee obligations under Equatorial Guinea guarantees with potential future payments of $116 million and a carrying value of $4 million.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the evolution of ConocoPhillips' relationship with Alba Plant LLC from no stake in 2023 to a 52.2% interest in 2024, aligning with the ground truth. It accurately notes the processing of natural gas and extraction of condensate (and adds LPG, which is consistent but not contradicted by the original). The impact on equity earnings and increased risk exposure due to a $116 million guarantee is correctly stated. However, the LLM introduces a 'fixed-rate long-term contract' and a 'carrying value of $4 million' not present in the original answer, which slightly over-specifies terms not confirmed in the ground truth. (2) All numeric values—52.2%, $116 million, and the implied 2023–2024 timeline—are factually accurate and match the original. The $4 million carrying value is the only number not in the original and thus lacks corroboration, but it does not contradict the core facts. (3) The multi-hop reasoning is sound: the model connects the Marathon Oil acquisition (implied context) to the new stake in Alba Plant LLC, links ownership to equity earnings, and ties the guarantee to increased risk exposure—correctly synthesizing cause-effect across entities and time. (4) The answer is highly relevant, directly addressing all parts of the question: evolution of the relationship, condensate processing, impact on earnings, and risk. The addition of LPG and contract details slightly exceeds the original but doesn't detract from correctness. Overall, the answer is factually strong with only minor over-specification, warranting a 9/10 on correctness and qualitative accuracy, full marks on quantitative accuracy and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 460,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How did the performance of Trademark Coca-Cola in EMEA evolve between 2023 and 2024, and what does this suggest about KO's market strategy and operational adjustments in the region?",
      "original_answer": "In 2023, Trademark Coca-Cola negatively impacted unit case volume in EMEA, contributing to a 1% decline in the region, which was part of a broader 2% overall decline in EMEA unit case volume. By 2024, Trademark Coca-Cola experienced a more moderate 1% decline in EMEA, while the region's overall unit case volume stabilized (even performance). This suggests that KO's market strategy and operational adjustments, such as focusing on other beverage categories like water, sports, coffee, and tea (which saw 4% growth in 2024), helped offset the continued softness in Trademark Coca-Cola. Additionally, KO's refranchising activities and balance sheet adjustments in EMEA (e.g., asset balances decreased from $1,153M in 2023 to $1,087M in 2024) reflect strategic realignments that may have contributed to stabilizing the region despite ongoing challenges with its flagship brand.",
      "llm_answer": "Trademark Coca‑Cola in EMEA saw a 1 % decline in unit‑case volume in 2023 and a similar 1 % decline in 2024, leaving the flagship brand’s performance essentially flat over the two years【page_46】【page_48】.  This stability suggests KO is keeping its core brand presence steady while shifting focus to other categories that are growing, and it is tightening operations—through refranchising bottling partners and pricing‑mix initiatives—to sustain profitability and adapt to local market dynamics【page_46】【page_48】.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual inaccuracy in the 2023 performance of Trademark Coca-Cola in EMEA. The ground truth states that Trademark Coca-Cola contributed to a 1% decline in unit case volume in EMEA in 2023, but the overall region saw a 2% decline. In 2024, the brand declined by 1%, while the region stabilized (even performance). However, the LLM incorrectly states that Trademark Coca-Cola declined by 1% in both 2023 and 2024, implying stability, but fails to note that the 2023 decline was part of a broader 2% regional drop, and misrepresents the evolution as 'flat' when in fact the brand's relative impact improved as the region stabilized despite its continued decline. (2) Quantitative accuracy is partially correct: the 1% decline in 2024 is accurate, and the 1% decline in 2023 for the brand is directionally correct, but the answer omits the key context of the 2% overall EMEA decline in 2023, which is critical for assessing performance evolution. The LLM also fails to include the financial data on asset balances decreasing from $1,153M to $1,087M, a concrete operational adjustment. (3) The reasoning is sound in interpreting that KO is shifting focus to other categories and tightening operations, and correctly infers strategic implications from refranchising and pricing-mix. However, it misses the explicit evidence that other categories (water, sports, coffee, tea) grew 4% in 2024, which directly supports the strategy shift—this multi-hop link is absent. (4) Scores reflect that core facts are partially correct but key quantitative and contextual details are missing or misrepresented, reducing correctness. The answer is contextually relevant and reasonably interprets strategy, but lacks completeness and precision in multi-hop synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 488,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How did the shift in NEE's use of option models for power derivatives between 2023 and 2024 impact the fair value and volatility assumptions applied to their Options - Power portfolio?",
      "original_answer": "In 2023, NEE used option models for its 'Options - Power' portfolio, which had a fair value of $48 million in assets and $5 million in liabilities, with implied volatilities ranging from 33% to 310% and a weighted average of 119%. By 2024, the fair value of the 'Options - Power' portfolio dropped significantly to $9 million in assets and $6 million in liabilities, while the implied volatilities increased, ranging from 78% to 360% with a weighted average of 186%. This indicates that NEE's use of option models in 2024 involved higher volatility assumptions, likely reflecting increased market uncertainty or a strategic shift in risk exposure, which directly influenced the valuation and risk profile of their power derivatives.",
      "llm_answer": "The 2024 valuation of NEE’s Options‑Power portfolio moved away from the 2023 model that used both implied correlations (50% weighted average) and implied volatilities (119% weighted average).  In 2024 the model relied only on implied volatilities, with a weighted‑average assumption of 186%, and the implied‑correlation input was dropped.  Consequently, the fair value of the portfolio fell sharply (assets dropped from $48 million to $9 million, liabilities rose from $5 million to $6 million), reflecting the higher volatility assumption and the change in input methodology.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly around the modeling assumptions. The original answer states that NEE used option models in both 2023 and 2024 with implied volatilities (119% and 186% weighted averages respectively), but does not mention implied correlations at all—especially not a 50% weighted average in 2023 or its removal in 2024. This detail is entirely fabricated and not supported by the ground truth. Additionally, the claim that the model 'moved away' from prior inputs or 'dropped' implied correlation is unsupported, making the causal reasoning between model changes and valuation shifts speculative and incorrect. (2) Quantitatively, the dollar amounts are correct: $48M to $9M in assets, $5M to $6M in liabilities. The volatility figures (119% to 186% weighted average) are also accurate, and the direction of change (increase in volatility, decrease in fair value) is correctly noted. However, the addition of 'implied correlations' introduces false quantitative claims. (3) The multi-hop reasoning is partially sound—linking higher volatility assumptions to lower fair value can be logical, but the reasoning is built on a false premise about model structure changes. The synthesis between valuation changes and modeling assumptions is relevant but based on incorrect inputs. (4) The contextual relevance is high because the answer addresses the core question about model use, fair value, and volatility. However, the correctness score is reduced due to significant qualitative inaccuracies in the modeling methodology description, which distort the actual cause-effect relationship. While the financial data is accurate, the explanatory framework is flawed, leading to a partially correct but misleading answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 483,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How did the voting power distribution between Class A and Class B common stock at CMCSA change from 2023 to 2024, and what implications does the fixed convertibility of Class B shares into Class A shares have on shareholder control?",
      "original_answer": "In 2023, CMCSA disclosed that holders of Class A common stock had 66 2/3% of the voting power, while Class B common stockholders held 33 1/3%. By 2024, the structure remained intact, with Class A still holding 66 2/3% and Class B maintaining 33 1/3% of voting power. This stability was preserved despite the fact that Class B shares are convertible, share for share, into Class A shares. The 2024 filing clarified that the 33 1/3% aggregate voting power of Class B common stock cannot be diluted by additional issuances of any other class of common stock, ensuring that the relative control balance remains fixed even if conversions occur. This suggests a deliberate governance strategy to maintain long-term control dynamics.",
      "llm_answer": "Between 2023 and 2024 the voting‑power split between the two classes stayed the same: Class A shares represented 66 ⅓ % and Class B 33 ⅓ % of total voting power (non‑dilutable) (2023 10‑K, pages 1‑5; 2024 10‑K, page 91). Because Class B shares are convertible share‑for‑share into Class A, B holders can increase their voting influence by converting, but the fixed 33 ⅓ % allocation protects their voting stake from dilution and preserves the 66/33 control balance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, all numbers are correct: the 66 1/3% and 33 1/3% voting power allocations for Class A and Class B shares in both 2023 and 2024 are accurately reported. The use of '66 1/3%' instead of '66 2/3%' is a typographical error in formatting but likely intended to represent 66.67%; however, '66 1/3%' equals ~66.33%, which is incorrect. This is a minor but notable discrepancy. The ground truth specifies 66 2/3% (i.e., ~66.67%), which is the correct value per SEC filings. Despite this, the rest of the percentages (33 1/3%) are correct and sum to 100%, suggesting the model understood the intended split but made a fractional notation error. (2) The answer correctly notes that the structure remained unchanged from 2023 to 2024, addressing the first part of the question. (3) The explanation of convertibility is sound: Class B shares are indeed convertible share-for-share into Class A, and the non-dilutable nature of the 33 1/3% voting power is correctly highlighted, preserving control balance. (4) The reasoning correctly synthesizes multi-hop information across the 2023 and 2024 10-Ks, referencing both years and the governance implications. The only shortcoming is the fractional error in stating Class A's voting power, which slightly undermines quantitative precision. However, the overall implications on shareholder control are accurately interpreted. Hence, a score of 9 is warranted—very high accuracy with a minor factual inaccuracy in notation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 428,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How did Duke Energy Progress' storm cost financing strategy evolve between 2022 and 2024, particularly in relation to the expansion of storm recovery property acquisitions by its special purpose subsidiaries?",
      "original_answer": "In 2022, Duke Energy Progress NC Storm Funding (DEPNCSF) had already issued $770 million in senior secured bonds to acquire storm recovery property related to 2018–2019 storm costs in North Carolina. By 2024, Duke Energy Progress expanded its storm cost financing strategy by forming a new subsidiary, Duke Energy Progress SC Storm Funding (DEPSCSF), which issued $177 million in bonds to finance storm costs incurred from 2014 through 2022, extending the geographic scope to South Carolina. This reflects a strategic evolution where Duke Energy Progress leveraged the existing storm recovery property mechanism in North Carolina as a model and replicated it in South Carolina to address a broader historical range of storm costs.",
      "llm_answer": "Between 2022 and 2024, Duke Energy Progress shifted from using only its existing DEPNCSF special‑purpose subsidiary to also creating a new subsidiary, DEPSCSF, in 2024 to finance storm costs in South Carolina.  DEPSCSF issued $177 million of senior secured bonds to acquire storm‑recovery property from Duke Energy Progress, expanding the geographic scope of the company’s storm‑cost financing beyond North Carolina.  The long‑term debt of the original DEPNCSF fell from $747 million in 2023 to $646 million in 2024, while the new DEPSCSF added $163 million of long‑term debt, reflecting a more diversified and regionally expanded financing structure【page_205】.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core strategic evolution—expansion from North Carolina to South Carolina via a new special-purpose subsidiary (DEPSCSF)—which aligns with the ground truth and shows correct multi-hop reasoning about geographic and structural expansion. However, there are significant quantitative inaccuracies that undermine factual correctness. The ground truth states DEPNCSF issued $770 million in bonds (not referenced directly in LLM's timeline), but the LLM incorrectly reports DEPNCSF's long-term debt as $747M in 2023 and $646M in 2024—figures not present in the original answer and potentially misrepresenting the financing activity. Additionally, the LLM claims DEPSCSF added $163 million in debt, whereas the original answer specifies $177 million in bonds issued—this is a material numerical discrepancy. The LLM also introduces debt reduction in DEPNCSF not mentioned in the ground truth, adding unsupported detail. While the formation of DEPSCSF and the expansion into South Carolina are correctly identified, the incorrect bond amounts and introduction of unverified debt trends reduce quantitative accuracy. The answer is contextually relevant and semantically aligned in structure and intent, and the reasoning about strategic diversification is sound, but the incorrect numbers prevent a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 368,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How did Microsoft's acquisition of Activision Blizzard in 2023 influence its debt financing strategy with Wells Fargo Bank in 2024, particularly in terms of bond issuance structures and trustee relationships?",
      "original_answer": "In 2023, Microsoft acquired Activision Blizzard, which became part of its consolidated financial reporting and brought with it existing debt obligations managed through Wells Fargo Bank as trustee, including bonds like the 3.400% Senior Notes due 2027 and 1.350% Senior Notes due 2030. By 2024, Microsoft's own debt financing strategy evolved, evidenced by the continued use of Wells Fargo Bank in bond structures—such as the September 19, 2024, indenture for Activision Blizzard’s 3.400% Senior Notes due 2026—indicating a strategic alignment in leveraging Wells Fargo’s trustee services across both legacy and acquired entities. This reflects a coordinated approach to capital structure and debt management post-acquisition.",
      "llm_answer": "After acquiring Activision Blizzard in October 2023, Microsoft issued new senior notes in 2024 that mirrored the structure of the acquired company’s debt, with Wells Fargo Bank, National Association, acting as trustee.  The 2024 bond issuance comprised multiple senior notes—3.400 % due 2027, 1.350 % due 2030, 4.500 % due 2047 and 2.500 % due 2050—matching Activision’s maturities and coupon rates and shifting the trustee relationship from the Bank of New York Mellon to Wells Fargo to align with the newly integrated entity’s existing debt framework (Exhibit 4.20‑4.26, 2024 10‑K).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly identifies the 2023 acquisition of Activision Blizzard and the involvement of Wells Fargo Bank as trustee, it incorrectly states that Microsoft issued new senior notes in 2024 with identical coupon rates and maturities (3.400% due 2027, 1.350% due 2030, etc.) as part of a new issuance mirroring Activision's debt. The ground truth does not support that Microsoft issued new notes with those exact terms in 2024; rather, it continued to use Wells Fargo as trustee for existing Activision-issued bonds post-acquisition, such as the 3.400% Senior Notes due 2026 (not 2027) under a September 19, 2024 indenture. The LLM fabricates additional tranches (4.500% due 2047, 2.500% due 2050) not mentioned in the original answer or implied by the knowledge graph. (2) Quantitative accuracy is low: the maturities are incorrect (2027 vs. 2026), and the new bonds cited (2047, 2050) are entirely unsupported. The original answer only references Activision’s 3.400% due 2027 and 1.350% due 2030 as pre-existing debt, not newly issued by Microsoft in 2024. (3) The multi-hop reasoning is partially sound—linking the acquisition to debt integration and trustee alignment—but flawed in execution, as it invents bond structures rather than accurately describing Microsoft’s continuation of Wells Fargo’s trustee role for legacy Activision debt. (4) Contextual relevance is high because the answer addresses the core themes: acquisition impact, debt structure, and trustee relationship. However, due to major factual and quantitative errors, the correctness score is low despite relevant framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 456,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How did the change in COP's application of ASC Topic 815 accounting for commodity sales contracts in 2023 relate to the evolution of their financial hedging strategy with PALNG in 2024, particularly in light of PALNG's de-designation of interest rate swaps?",
      "original_answer": "In 2023, COP applied ASC Topic 815 for certain physical gas sales contracts at market prices for which they did not elect NPNS, treating them as derivatives. This accounting treatment was noted alongside a receivables balance of $4,414 million from contracts with customers. In 2024, PALNG, in which COP holds a $1.5 billion equity investment, de-designated a portion of its interest rate swaps previously accounted for under ASC Topic 815 as cash flow hedges. This change resulted in $35 million of unrealized losses being recognized directly in 'Equity in earnings of affiliates' on COP’s consolidated income statement. The shift in PALNG’s hedging strategy suggests a recalibration of financial risk management in line with evolving LNG market conditions, which may have influenced COP’s broader approach to commodity contract accounting under ASC Topic 815.",
      "llm_answer": "In 2023, ConocoPhillips began treating commodity sales contracts that fell outside ASC 606 as derivatives under ASC 815 (rather than electing the NPNS exception) 【page_131】.  That derivative‑accounting framework enabled the company to designate PALNG’s interest‑rate swaps as cash‑flow hedges under ASC 815 in 2024, with fair‑value changes initially recorded in OCI 【page_107】.  In 2024 PALNG de‑designated part of those swaps, moving the fair‑value changes from OCI to earnings and signaling a shift in the hedging strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly states that COP's application of ASC 815 in 2023 'enabled' PALNG to designate interest rate swaps as cash flow hedges in 2024, implying a causal relationship that is not supported by the ground truth. The original answer clarifies that PALNG de-designated swaps (not designated), which contradicts the LLM's claim. Additionally, the LLM omits key quantitative facts: the $4,414 million receivables balance from 2023 and the $35 million unrealized loss recognized in 'Equity in earnings of affiliates' due to de-designation—both critical to the financial impact. The $1.5 billion equity investment in PALNG is also missing. (2) No numeric values in the LLM answer match the ground truth: it fails to mention $4,414 million, $1.5 billion, or $35 million. These omissions severely undermine quantitative accuracy. (3) The multi-hop reasoning is flawed: the LLM incorrectly frames COP’s commodity contract accounting as enabling PALNG’s hedging, when in reality, PALNG’s de-designation affected COP’s financial statements through equity accounting. The causal and directional logic is reversed. The connection between COP’s commodity contracts and PALNG’s interest rate swaps is misrepresented rather than properly synthesized. (4) While the answer touches on relevant topics (ASC 815, NPNS, cash flow hedges, de-designation), the factual and logical errors reduce correctness and qualitative accuracy. Contextual relevance is moderate because it addresses the right standards and entities but misrepresents their relationships.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 441,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How did the structural relationship between GOOGL's Class A and Class B common stock voting rights influence the company's share repurchase strategy in 2024, compared to 2023, given the automatic conversion of Class B shares upon transfer?",
      "original_answer": "In 2023, GOOGL repurchased $62.2 billion of Class A and Class C shares, while in 2024, it repurchased $62.0 billion of the same classes. The share structure shows that Class B shares automatically convert to Class A shares upon transfer, giving Class A holders 1 vote per share and Class B holders 10 votes per share. Despite the significant voting power tied to Class B shares, the company's sustained repurchase activity focused on Class A and C shares, likely to consolidate equity without directly impacting the high-vote Class B structure. This suggests a strategy to maintain the current voting balance while reducing overall share count.",
      "llm_answer": "Alphabet’s voting structure gives each Class B share ten votes while Class A shares have one vote, and Class B shares automatically convert to Class A upon sale or transfer【page_81】. Because repurchasing Class B shares would convert them to Class A and dilute existing voting power, the company’s share‑repurchase program in both 2023 and 2024 targeted only Class A and Class C shares【page_81】. In 2024 the program bought $62.0 billion of Class A and Class C shares, slightly less than the $62.2 billion repurchased in 2023, but the strategy remained unchanged【page_82】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the voting structure (Class B: 10 votes, Class A: 1 vote, automatic conversion upon transfer) and accurately reports the repurchase amounts: $62.2 billion in 2023 and $62.0 billion in 2024 for Class A and Class C shares. These figures match the ground truth exactly, with acceptable formatting. (2) Quantitative accuracy is perfect—both dollar amounts and the comparison (slightly less in 2024) are correct. (3) The reasoning is sound: the model correctly infers that repurchasing Class B shares would convert them to Class A, potentially altering voting control, and thus the company avoids this by targeting only Class A and C shares. This aligns with the ground truth’s implication of preserving voting balance. The only minor shortcoming is that the LLM states repurchases 'targeted only Class A and Class C shares' with a definitive tone, while the original answer frames it as 'focused on'—a slight difference in certainty, but factually consistent. (4) The answer is contextually fully relevant, addressing the structural influence on repurchase strategy across both years and synthesizing voting rights, conversion rules, and financial actions correctly. The qualitative score is 9 due to the slightly stronger claim about exclusivity of targeting, though the core logic and facts are accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 377,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did Merck's investment in Daiichi Sankyo's ADC platform in 2023 shape the strategic evolution of their oncology collaboration as evidenced by developments in 2024?",
      "original_answer": "In 2023, Merck made a $4.0 billion investment in Daiichi Sankyo’s DXd ADC platform, covering three candidates—patritumab deruxtecan (MK-1022), ifinatamab deruxtecan (MK-2400), and raludotatug deruxtecan (MK-5909)—with potential first-in-class treatments for solid tumors. This partnership included future contingent payments of up to $5.5 billion per candidate based on sales milestones. By 2024, the collaboration had expanded to include MK-6070, reflecting a deepened strategic alignment. Merck also recognized $170 million in income from Daiichi Sankyo related to the satisfaction of a contingent obligation under the original agreement, indicating the evolving financial and strategic dynamics of the partnership. The initial investment catalyzed an expanded co-development and co-commercialization framework, demonstrating how Merck leveraged its early commitment to ADC innovation to strengthen its oncology pipeline and commercial reach through Daiichi Sankyo.",
      "llm_answer": "Merck’s 2023 investment of $4.0 billion in Daiichi Sankyo’s ADC platform—paying upfront and continuation fees for three DXd ADCs—established a global co‑development and co‑commercialization framework (page 91).  In 2024 the partnership expanded to include the T‑cell engager MK‑6070, with Merck receiving a $170 million upfront cash payment and satisfying a contingent obligation from the original agreement (page 65), illustrating the collaboration’s strategic deepening and diversification into additional oncology modalities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core facts from the ground truth. (1) Quantitative accuracy: All numbers are correct—$4.0 billion investment, $170 million payment, and correct candidate names (MK-1022, MK-2400, MK-5909 implied via 'three DXd ADCs', and MK-6070 explicitly). The mention of 'upfront cash payment' aligns with the $170M income Merck received due to a contingent obligation being satisfied. (2) Completeness: The answer addresses the 2023 investment, the co-development framework, the 2024 expansion to include MK-6070, and the financial milestone of $170M. It omits the detail about potential future payments of up to $5.5 billion per candidate, which is a minor but notable omission in completeness. (3) Entity accuracy: All companies (Merck, Daiichi Sankyo), platform (DXd ADC), and drug candidates (including MK-6070) are correctly identified. Years (2023, 2024) are accurate. (4) Reasoning: The multi-hop synthesis is sound—linking the 2023 investment to the 2024 expansion and interpreting the $170M as tied to a contingent obligation shows correct inference. The answer also correctly infers strategic deepening and diversification into new modalities (T-cell engager). (5) Semantic equivalence: The meaning matches the original answer, though slightly more concise. The phrase 'paying upfront and continuation fees' is not in the original but does not contradict it. Overall, the answer is factually correct, well-reasoned, and contextually precise, warranting a 9 due to the omission of the $5.5B per candidate milestone potential.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 429,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did the value and strategic emphasis of GM's transactions with nonconsolidated affiliates for automobile parts change from 2023 to 2024, and what does this suggest about GM's evolving supply chain management priorities?",
      "original_answer": "In 2023, GM explicitly reported transactions with nonconsolidated affiliates for the purchase and sale of automobile parts and vehicles, indicating a material operational reliance on these entities for component supply. By 2024, while no specific transaction values were disclosed, the filing emphasized a strategic focus on 'driving an efficient, consolidated fixed cost structure' and managing the 'global purchasing and supply chain' at a consolidated functional level. This shift in language suggests a potential strategic move toward greater vertical integration or centralized control of supply chain functions, reducing reliance on nonconsolidated partners for parts production. The lack of specific affiliate transaction figures in 2024, contrasted with their explicit mention in 2023, implies a reorientation of supply chain strategy toward internal coordination.",
      "llm_answer": "GM’s 2023 10‑K shows that it purchased $2.766 billion of automobile parts from nonconsolidated affiliates, with equity in those affiliates at $10.613 billion (page 78). In 2024, the equity in nonconsolidated affiliates fell to $7.102 billion (page 104) and the net purchases of parts were lower, indicating a strategic shift away from heavy reliance on joint‑venture partners toward greater internal sourcing and tighter supply‑chain control. This trend reflects GM’s evolving priority of building a more integrated, cost‑efficient, and resilient supply chain.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific numerical values—$2.766 billion in purchases and equity figures of $10.613 billion (2023) and $7.102 billion (2024)—that are not present in the original ground truth. The ground truth does not provide any dollar amounts for transactions with nonconsolidated affiliates, only stating that such transactions were explicitly reported in 2023 but not in 2024. Therefore, these precise figures are factually unsupported and incorrect. (2) The claim that 'net purchases of parts were lower' in 2024 is an inference based on unreported data, but the original answer emphasizes the absence of disclosure rather than quantified decreases. While the trend toward reduced reliance is plausible, the LLM presents it as confirmed by numerical decline, which overstates the evidence. (3) The multi-hop reasoning is partially sound: the LLM correctly infers a strategic shift away from nonconsolidated affiliates and toward internal supply chain control, aligning with the ground truth's interpretation of changing language and emphasis on consolidated supply chain management. However, it fabricates quantitative support for this conclusion, undermining factual accuracy. (4) Despite the incorrect numbers, the LLM captures the qualitative direction of change—toward greater integration and centralized control—and addresses both parts of the question (change in value/emphasis and implications for supply chain priorities). Thus, while the reasoning trajectory is reasonable, the inclusion of false specifics severely reduces correctness. Quantitative accuracy is low due to invented figures; qualitative accuracy is moderate due to correct strategic interpretation; contextual relevance is high as the response stays focused and relevant to the question’s intent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 489,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did the delay of the Final Foreign Tax Credit Regulations, first effective in 2022 and later postponed by Notice 2023-55 in 2024, impact Microsoft's effective tax rate and cash tax obligations across these fiscal years?",
      "original_answer": "In fiscal year 2022, the Final Foreign Tax Credit Regulations became effective and were expected to increase Microsoft's cash tax payments unless postponed. By fiscal year 2024, Notice 2023-55 delayed the effective date of these regulations to 2024, and Notice 2023-80 later postponed it indefinitely. This delay contributed to a decrease in Microsoft's effective tax rate from 19% in 2023 to 18% in 2024, as the company benefited from tax law changes that reduced immediate cash tax liabilities associated with foreign tax credits. The postponement allowed Microsoft to maintain a more favorable tax position in the short term, avoiding an increase in cash taxes that would have occurred had the regulations taken full effect.",
      "llm_answer": "The final foreign‑tax‑credit (FTC) rules, set to take effect on July 1 2022, would have pushed Microsoft’s cash tax outlays higher in FY 2023 unless the rules were delayed. Notice 2023‑55, issued in FY 2024, postponed the FTC rules to FY 2024, and Notice 2023‑80 further delayed them indefinitely. As a result, Microsoft’s effective tax rate fell from 19 % in FY 2023 to 18 % in FY 2024, while cash paid for taxes rose modestly from $23.1 billion in FY 2023 to $23.4 billion in FY 2024. The delay therefore lowered the effective rate and averted a larger cash‑tax increase that would have occurred had the FTC regulations taken effect earlier.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key regulatory developments—Final FTC Regulations effective July 1, 2022, postponement via Notice 2023-55 in FY 2024, and indefinite delay via Notice 2023-80—and correctly states the drop in Microsoft's effective tax rate from 19% in FY 2023 to 18% in FY 2024. However, it introduces specific cash tax figures ($23.1B in 2023, $23.4B in 2024) that are not present in the original answer and cannot be verified from the provided ground truth. The original answer states the delay reduced immediate cash tax liabilities, but the LLM claims cash taxes rose modestly, which contradicts the ground truth implication of avoided cash tax increases. (2) The percentages (19% to 18%) are accurate, but the dollar amounts are unsupported and likely incorrect in context, as the original emphasizes avoidance of higher cash taxes, not an increase. The fiscal years are correctly mapped. (3) The multi-hop reasoning is mostly sound: the model connects regulatory delays to tax rate and cash tax outcomes, correctly inferring a causal link between postponement and favorable tax treatment. However, the erroneous claim about rising cash taxes undermines the quantitative reasoning. (4) The contextual relevance is high—the answer addresses all parts of the question and uses appropriate terminology. The qualitative accuracy is good due to correct entity and timeline identification, but quantitative accuracy is reduced due to unsupported cash tax figures. Correctness score is 7 because core facts (regulatory impact, effective tax rate change) are correct, but significant error in cash tax direction (increase vs. avoidance of increase) affects financial interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 468,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did ConocoPhillips' 2021 impairment of its APLNG investment relate to the evolution of COP's financial guarantees tied to APLNG from 2022 to 2024?",
      "original_answer": "In 2021, COP recorded a $688 million noncash impairment on its APLNG investment due to a decline in fair value below carrying value, triggered by Origin Energy's sale of a 10% stake at a lower valuation. By 2024, COP's financial guarantees tied to APLNG totaled $1.3 billion in maximum potential exposure, including $210 million for a project finance reserve guarantee, $610 million for natural gas delivery commitments, and $480 million for performance guarantees. This indicates that while the investment was impaired in 2021, COP's financial exposure to APLNG remained significant through guarantees two years later, suggesting continued strategic commitment despite earlier valuation concerns.",
      "llm_answer": "In 2021 ConocoPhillips recorded a $688 million impairment of its APLNG investment, cutting the carrying value to $5.574 billion (page 100, 2022 10‑K).  From 2022 through 2024 the company continued to maintain substantial financial guarantees for APLNG—maximum potential liabilities of roughly $1.3 billion (including $210 million for a project‑finance reserve, $610 million for sales‑agreement contingencies, and $480 million for performance contracts) with carrying values of about $82 million (page 102, 2024 10‑K).  The impairment did not change the guarantee amounts but highlighted the need for COP to manage its exposure to APLNG, which is reflected in the ongoing guarantee commitments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $688 million 2021 impairment of ConocoPhillips' APLNG investment and accurately reports the 2024 financial guarantees totaling $1.3 billion, broken down into $210 million (project-finance reserve), $610 million (sales-agreement contingencies, equivalent to natural gas delivery commitments), and $480 million (performance contracts/guarantees). These figures match the ground truth exactly. The mention of the carrying value post-impairment ($5.574 billion) and the $82 million carrying value of guarantees in 2024 adds detail not in the original answer but does not contradict it and appears consistent with 10-K disclosures. (2) All numeric values are correct and properly attributed to specific line items. The sum of the guarantees ($210M + $610M + $480M = $1.3B) is accurate. No calculation errors. (3) The multi-hop reasoning is sound: the model connects the 2021 impairment event to the persistence of financial guarantees through 2024, correctly inferring that despite the impairment (indicating valuation concerns), COP maintained significant exposure, signaling ongoing strategic commitment. The reasoning about continued guarantees reflecting risk management and commitment aligns with the ground truth’s implication. (4) The only minor gap is that the original answer explicitly frames the continued guarantees as evidence of 'continued strategic commitment despite earlier valuation concerns,' a synthesis slightly more explicit than the LLM’s 'highlighted the need to manage exposure.' While the LLM’s interpretation is valid, it’s slightly less precise in capturing the strategic implication. However, the core facts, numbers, and logical flow are fully correct and well-supported. Hence, a score of 9 is warranted—excellent accuracy with only a slight nuance missing in qualitative framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 504,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did the structure of voting rights tied to Class B Common Stock in 2022 evolve by 2023, and what safeguards in the Certificate of Incorporation continued to ensure equal dividend treatment across all stock classes?",
      "original_answer": "In 2022, GOOGL disclosed that Class B common stockholders had limited voting rights, including on certain defined matters such as exiting the core payments business, mergers, or amendments to the Certificate of Incorporation. By 2023, these voting rights remained largely unchanged, with Class B stockholders continuing to vote only on those defined matters, often as a separate class. Meanwhile, the Certificate of Incorporation, as referenced in 2023, included safeguards that required any amendment adversely altering the rights of a stock class to be approved by the affected class, and further required unanimous board approval before such amendments could be put to a stockholder vote. These provisions ensured that all stock classes—A, B, and C—continued to receive equal per-share dividends or distributions in liquidation, as confirmed by the consistent net income per share across all classes for the years 2021 through 2023.",
      "llm_answer": "In 2022 each Class B share carried ten votes per share on all matters. By 2023, Alphabet limited Class B voting to a handful of defined events (e.g., exiting the core payments business, mergers or amendments to the charter) and the votes were calculated as the number of shares times the applicable conversion rate. The company’s certificate of incorporation—supported by Delaware law—continues to require that any amendment that would adversely alter a class’s rights be approved by that class and that the board give unanimous consent before the amendment can be voted on, thereby preserving equal dividend and liquidation treatment across all stock classes.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly regarding the structure of voting rights in 2022. The claim that 'each Class B share carried ten votes per share on all matters' in 2022 directly contradicts the ground truth, which states that Class B shares had limited voting rights only on specific defined matters (e.g., mergers, charter amendments), not full voting rights with 10x weight. This is a critical error in both entity and structural understanding. By 2023, the LLM correctly notes that voting was limited to defined events, aligning with the ground truth, though the phrasing about 'conversion rate' is vague and not supported in the original. (2) Quantitatively, there are no verifiable numbers (e.g., vote counts, financial figures) that can be confirmed as accurate; the 'ten votes per share' claim is incorrect and not present in the ground truth, which makes no mention of vote multiples. This severely undermines quantitative accuracy. (3) The multi-hop reasoning is partially sound: the LLM correctly identifies the continuation of certain safeguards in the Certificate of Incorporation across years and links board approval and class voting to amendments affecting rights. It also correctly infers that these mechanisms protect equal dividend treatment across classes, which is consistent with the ground truth. However, the reasoning is built on a false premise about 2022 voting rights, weakening the overall logic. (4) Contextual relevance is high—the answer addresses both parts of the question (evolution of voting rights and dividend safeguards)—and uses appropriate terminology (e.g., charter amendments, class approval). Despite incorrect core facts, the structure and intent of the response are aligned with the question. Due to major factual errors in the foundational claim about 2022 voting rights, the correctness score is low, though not zero due to accurate elements in the 2023 description and safeguards.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 534,
        "total_tokens": 1951
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did AIG's treatment of losses related to Extended Warranty products within Personal Lines change from 2023 to 2024, particularly in terms of reinsurance coverage and loss adjustment expense recovery?",
      "original_answer": "In 2023, AIG specifically noted that losses reported in certain tables were not covered by the ADC (likely referring to reinsurance or loss recovery mechanisms), indicating a lack of offset for incurred losses in Personal Lines, which include Extended Warranty products. In 2024, while the structure of UK/Europe and Japan Personal Insurance remained consistent—still including Extended Warranty—there was no explicit mention of unrecovered losses or ADC exclusions, suggesting a potential improvement in loss recovery mechanisms or a change in reinsurance strategy. The absence of a statement about uncovered losses in 2024 implies that AIG may have adjusted its reinsurance or internal loss adjustment practices for the Personal Lines segment, particularly affecting Extended Warranty products.",
      "llm_answer": "In 2024 AIG’s extended‑warranty losses within Personal Lines were lower after reinsurance than in 2023 – the net‑of‑reinsurance amount fell from **$1.552 billion in 2023 to $1.416 billion in 2024** (a $136 million decline).  Correspondingly, cumulative paid losses and allocated loss‑adjustment expenses net of reinsurance dropped from **$1.290 billion in 2023 to $1.260 billion in 2024** (a $30 million decrease), indicating a smaller recovery of loss‑adjustment expenses in 2024.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both quantitative and qualitative aspects. (1) There are no dollar amounts mentioned in the original answer or ground truth regarding AIG's Extended Warranty losses—specifically, the figures of $1.552 billion in 2023 and $1.416 billion in 2024, and the corresponding $1.290 billion and $1.260 billion, are entirely fabricated and not supported by the source. The original answer does not provide any numerical data on losses, reinsurance recoveries, or loss adjustment expenses. (2) The LLM invents precise financial figures and trends (e.g., a $136 million decline, $30 million decrease) that do not appear in the ground truth, failing the quantitative accuracy check completely. (3) Qualitatively, the original answer discusses a shift in disclosure—specifically, that in 2023 AIG noted certain losses were not covered by ADC (likely a reinsurance or recovery mechanism), while in 2024 there was no such statement, implying a possible change in reinsurance or recovery practices. The LLM misrepresents this qualitative disclosure-based inference as a quantitative improvement in net losses, which is not stated or implied in the original. (4) The LLM fails to correctly interpret the nature of the change—this is not about actual loss reduction but about the absence of a negative disclosure in 2024, suggesting potential improvements in reinsurance or internal practices. The model incorrectly assumes and fabricates financial data instead of synthesizing the disclosed information about coverage and recovery mechanisms. Thus, the answer is factually wrong, lacks grounding in the source, and misrepresents the reasoning, warranting a very low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 463,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "Given UPS's $3.3 billion in unfunded commitments to private equity funds by 2023, how did the increased exposure to these alternative investments impact the complexity of NAV-based valuations for U.S. benefit plans compared to 2022?",
      "original_answer": "In 2022, UPS disclosed that private equity funds were among the alternative investments valued using NAV as a practical expedient due to the lack of readily determinable fair value. The pension plan assets were actively managed with a long-term focus on growth and funded status stability, though the expected rate of return on assets had already declined from 7.77% in 2020 to 6.50% in 2021, signaling increased reliance on alternative assets. By 2023, UPS had $3.3 billion in unfunded commitments to private equity and similar funds, which are subject to NAV-based valuations that rely on audited or unaudited financial reports from fund managers, adjusted for activity through year-end. These investments are not actively traded and require subjective assumptions, increasing valuation complexity. Additionally, the 2023 audit highlighted that the U.S. pension plans held $9.9 billion in such alternative investments, further emphasizing the growing reliance on NAV-based valuations. Therefore, the increased exposure to private equity funds from 2022 to 2023 significantly heightened the complexity and subjectivity involved in valuing these assets using NAV.",
      "llm_answer": "UPS’s $3.3 billion in unfunded commitments to private‑equity, private‑debt and real‑estate funds in 2023 (up from roughly $3.0 billion in 2022) heightened the company’s exposure to alternative investments.  Because these assets lack readily determinable market prices, the U.S. plans’ NAV‑based valuations now rely on more subjective estimates and require greater auditor judgment, making the valuation process more complex than in 2022【page_89】【page_63】【page_103】.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $3.3 billion in unfunded commitments in 2023 and notes an increase from $3.0 billion in 2022, which aligns with the trend in the ground truth, though the original answer does not specify the 2022 unfunded commitment amount—this is a minor addition not contradicted by the source. The core financial figure ($3.3 billion in 2023) is accurate. However, the ground truth emphasizes that by 2023, U.S. pension plans held $9.9 billion in alternative investments subject to NAV-based valuations, a key quantitative point missing in the LLM response, reducing completeness. (2) The LLM correctly states that these investments lack readily determinable market prices and rely on NAV-based valuations with subjective estimates and auditor judgment. This captures the essence of increased complexity. However, it omits specific context from the original answer about the declining expected rate of return on assets (from 7.77% to 6.50%) and the active management strategy focused on long-term growth and funded status stability, which provide important background for the shift toward alternatives. (3) The multi-hop reasoning is sound: the model connects increased unfunded commitments → greater exposure to alternatives → reliance on NAV → increased subjectivity and complexity. It correctly synthesizes the valuation challenges and references auditor judgment, which is consistent with the 2023 audit mention in the original. However, it does not fully incorporate the longitudinal comparison from 2022 to 2023 in terms of plan asset composition or valuation methodology evolution. (4) The answer is contextually highly relevant and conveys the central idea that increased exposure to private equity heightened valuation complexity. While it misses some supporting details (e.g., $9.9 billion in alternative investments, rate of return trend), the core factual claims are correct and logically presented. Minor omissions prevent a top score, but the answer is substantially accurate and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 551,
        "total_tokens": 1979
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How did the LIFO inventory valuation method at Nicor Gas impact Southern Company's gas cost recovery mechanisms in 2024 compared to 2023, given the changes in LIFO inventory balances and replacement costs?",
      "original_answer": "In 2023, Nicor Gas maintained a LIFO inventory balance of $186 million, with an estimated replacement cost of $268 million. By 2024, the LIFO inventory balance increased slightly to $188 million, while the estimated replacement cost rose significantly to $326 million. This widening gap between LIFO balance and replacement cost suggests higher inflationary pressure on natural gas inventory costs in 2024. Since Nicor Gas uses the LIFO method for inventory valuation and recovers gas costs through a purchased gas recovery mechanism, the increased replacement cost in 2024 would have resulted in higher customer bill adjustments compared to 2023, despite LIFO liquidations having no direct impact on net income. This reflects a greater need for cost recovery in 2024 due to rising natural gas prices.",
      "llm_answer": "In 2024 Nicor Gas’s LIFO inventory balance rose to $188 million from $186 million, while its estimated replacement cost climbed to $326 million from $268 million, expanding the LIFO reserve from $82 million to $138 million. The purchased gas‑recovery mechanism, which adjusts billed amounts for the difference between actual costs and LIFO‑based inventory costs, had to account for this larger reserve, but because the mechanism is designed to recover costs, the LIFO liquidations had no impact on Southern Company’s net income.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key numerical values from the ground truth: Nicor Gas’s LIFO inventory balance increased from $186 million in 2023 to $188 million in 2024, and the estimated replacement cost rose from $268 million to $326 million. The calculated LIFO reserve (difference between replacement cost and LIFO balance) is accurately implied: $268M - $186M = $82M in 2023 and $326M - $188M = $138M in 2024. These calculations are correct and match the ground truth implications. (2) The answer correctly identifies the entities (Nicor Gas, Southern Company), the inventory valuation method (LIFO), the cost recovery mechanism (purchased gas recovery), and the relevant years (2023 vs 2024). (3) The multi-hop reasoning is sound: it connects Nicor Gas’s LIFO accounting, the growing gap between book value and replacement cost, the function of the purchased gas recovery mechanism, and the conclusion that LIFO liquidations do not affect net income—consistent with the ground truth. (4) The only minor omission is that the LLM does not explicitly state that the higher replacement cost in 2024 led to higher customer bill adjustments compared to 2023, which is a key point in the original answer. While implied by the larger reserve and the recovery mechanism, this comparative impact on customer bills is not directly articulated. Otherwise, the answer is factually accurate, well-reasoned, and contextually appropriate. Hence, a high score of 9 is justified, with full marks in quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 428,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How did CVS's 2022 investments in Common Collective Trusts (valued at $266 million and primarily invested in equity securities) translate into the 2023 Separate Accounts Assets valuation, and what does this indicate about the continuity of their pension investment strategy?",
      "original_answer": "In 2022, CVS reported a $266 million investment in Common Collective Trusts, which were described as funds primarily investing in equity securities through underlying funds and valued at net asset value per share/unit. These Common Collective Trusts are explicitly stated to be part of the Separate Accounts Assets, which are maintained to meet specific objectives of contract holders in large case pensions products. In 2023, the valuation methodologies and structure of Separate Accounts Assets remained consistent, with investments in common/collective trusts still carried at fair value and classified in Level 2 based on the NAV of the underlying equity-focused funds. The continuity in valuation methods, legal segregation of assets, and alignment with contract holders' objectives indicates that CVS maintained a consistent pension investment strategy from 2022 to 2023, preserving the role of Common Collective Trusts within the broader framework of Separate Accounts Assets.",
      "llm_answer": "CVS’s pension plan held $266 million in common/collective trusts in 2022, a vehicle that is largely equity‑heavy. In 2023 the Separate Accounts assets report $529 million in common/collective trusts (Level 2), a sizable increase from the 2022 pension‑plan amount, showing that the company continues to allocate significant capital to these equity‑focused trusts. This continuity indicates that CVS maintains a consistent pension‑investment strategy that emphasizes equity exposure through common/collective trusts.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in quantitative accuracy—the 2023 Separate Accounts Assets value of $529 million in common/collective trusts is not supported by the ground truth. The original answer does not state any specific dollar amount for 2023, only that the valuation methodology and structure remained consistent. The LLM incorrectly introduces a new figure ($529M) not present in the ground truth, which fundamentally undermines the factual basis of the response. Additionally, the ground truth does not mention a 'pension plan' directly holding the $266M; rather, it describes Common Collective Trusts as part of Separate Accounts Assets used in large case pensions products, which is a more nuanced structure. (2) The $266 million figure for 2022 is correct and properly cited, but the $529 million figure for 2023 is unsupported and likely erroneous. There is no calculation or comparison provided in the ground truth to validate this increase. The LLM fabricates a data point that changes the interpretation—implying growth in investment—where the ground truth only confirms continuity in strategy and valuation method, not magnitude. (3) The reasoning partially captures the multi-hop element by linking 2022 investments to 2023 strategy, but it fails to accurately represent the nature of Separate Accounts Assets as legally segregated vehicles for contract holders, and mischaracterizes the role of common/collective trusts within them. The conclusion about 'continued allocation' implies active reinvestment or expansion, whereas the ground truth only supports consistency in treatment and classification, not increased funding. (4) Despite the significant quantitative inaccuracy, the answer is contextually relevant and correctly identifies the equity focus of the trusts and the broader strategic continuity in using such vehicles. The qualitative reasoning is plausible but based on incorrect data, leading to a misleading narrative. Hence, correctness is scored low due to the fabricated 2023 figure, which invalidates the core comparative claim.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 563,
        "total_tokens": 1970
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How did Southern Company's approach to managing energy-related derivatives evolve between 2022 and 2024, particularly in terms of regulatory hedge designation and financial statement presentation?",
      "original_answer": "In 2022, Southern Company designated energy-related derivatives as regulatory hedges, primarily as part of fuel-hedging programs, with gains and losses initially recorded as regulatory assets or liabilities and later included in fuel expense as the underlying fuel was used (SO_10k_2022.pdf:page_122:chunk_3). These contracts were accounted for under three methods—regulatory hedges, cash flow hedges, or not designated—with regulatory hedges being the most common for traditional electric and gas utilities (SO_10k_2022.pdf:page_318:chunk_1). By 2024, the fair value of these energy-related derivatives was reflected in the balance sheets either under 'Other' or as a separate line item for 'Risk Management Activities' (SO_10k_2024.pdf:page_283:chunk_1). This evolution shows a continued use of regulatory hedges for fuel cost management but with a more transparent presentation in financial statements in 2024, aligning with broader risk management disclosures.",
      "llm_answer": "Between 2022 and 2024 Southern Company kept using regulatory hedges for its fuel‑hedging program but expanded the scope of those contracts – the net volume of energy‑related derivatives rose from 311 mmBtu (2022: page 122) to 431 mmBtu (2024: page 281) and the longest non‑hedge date extended from 2025 to 2028. In 2024 the company’s balance sheet now separates regulatory hedges (current $33 m, non‑current $42 m) and cash‑flow hedges (current $4 m, non‑current $4 m) as distinct line items (2024: pages 283‑284), whereas the 2022 filing grouped all derivatives under a single “Other” or “Risk Management Activities” line (2022: page 317).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in quantitative details, despite addressing the right topic and showing an attempt at multi-hop reasoning. (1) Quantitative Accuracy: The reported derivative volumes (311 mmBtu in 2022 and 431 mmBtu in 2024) are not present in the ground truth and cannot be verified from the cited pages; these numbers are likely hallucinated. The dollar amounts for regulatory hedges ($33M current, $42M non-current) and cash flow hedges ($4M each) are not mentioned in the original answer or supported by the provided evidence. The claim that the longest non-hedge date extended from 2025 to 2028 is absent from the ground truth and unsupported. (2) Completeness: The answer attempts to address both regulatory hedge designation and financial statement presentation, which aligns with the question. However, it introduces unsupported metrics instead of accurately reflecting the evolution in presentation (e.g., shift to 'Risk Management Activities' as a separate line item). (3) Entity Accuracy: The company (Southern Company), years (2022, 2024), and concepts (regulatory hedges, cash flow hedges) are correctly identified. (4) Reasoning: The model attempts to compare financial statement presentation across years, but the logic is flawed due to incorrect data. It reverses the actual evolution: the 2022 filing already mentions 'Risk Management Activities' or 'Other' as presentation categories, while 2024 shows more granular disclosure — the LLM incorrectly states that 2022 grouped all derivatives under those lines and 2024 separated them, which contradicts the ground truth. (5) Semantic Equivalence: The overall theme of continued use of regulatory hedges with improved transparency is partially aligned, but the specific evidence used is inaccurate. Due to major quantitative errors and incorrect synthesis of financial statement evolution, the correctness score is low despite relevant structure and context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 530,
        "total_tokens": 1943
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How did ConocoPhillips' investment decision in APLNG in 2022 affect its production capacity and exposure to CBM in 2023, particularly in terms of equity stake and resource access?",
      "original_answer": "In 2022, ConocoPhillips exercised its preemption right to purchase an additional 10% stake in APLNG, increasing its total ownership (as evidenced by the $1.645 billion purchase and the resulting write-down of its investment to $5,574 million). By 2023, ConocoPhillips held a 47.5% equity stake in APLNG, which directly enhanced its access to coal bed methane (CBM) resources in Queensland, Australia. APLNG's core activity of producing CBM from the Bowen and Surat basins provided COP with a strategic foothold in the Australian CBM market, which in turn strengthened COP’s LNG export capabilities to the Asia Pacific region. This evolution reflects a deliberate strategic move to increase both equity control and upstream resource exposure over a one-year period.",
      "llm_answer": "In 2022 ConocoPhillips exercised its preemption right to acquire an additional 10 % of APLNG, raising its ownership to 47.5 % (page 119).  This stake gives the company direct access to CBM resources in Queensland’s Bowen and Surat basins, thereby expanding its production capacity and CBM exposure for 2023 and strengthening its LNG position (page 91).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that ConocoPhillips exercised its preemption right in 2022 to acquire an additional 10% stake in APLNG, increasing its ownership to 47.5%—this matches the ground truth. The mention of CBM access in Queensland’s Bowen and Surat basins and the strategic benefit to LNG exports is factually accurate. However, the LLM omits specific financial details such as the $1.645 billion purchase price and the write-down of investment to $5,574 million, which are part of the original answer and relevant to the investment decision’s scale. (2) All numeric values—10%, 47.5%, 2022, 2023—are correct and contextually accurate. No calculations are required, but the percentages align with the ground truth. (3) The multi-hop reasoning is sound: the model connects the 2022 investment decision to increased equity stake, which leads to greater CBM resource access and production capacity in 2023. It correctly synthesizes cause (investment) and effect (enhanced CBM exposure and LNG position). The only minor gap is the lack of financial transaction details, which weakens completeness slightly. (4) The answer is semantically equivalent in key aspects and highly relevant to the question. The omission of dollar amounts prevents a perfect score, but core facts, entities, and logic are correct. Hence, high scores across all categories with a 9 in correctness and qualitative accuracy due to partial completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 401,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How did MetLife's exposure to RMBS within their Structured Securities portfolio change from 2022 to 2023, and what does this indicate about their risk positioning in Level 3 fixed maturity securities AFS?",
      "original_answer": "In 2022, MetLife disclosed $4,269 million in Structured Securities AFS, which included RMBS as a key component. By 2023, this exposure increased to $4,551 million. This reflects a strategic shift or continued emphasis on structured products, particularly those backed by residential mortgages, within their Level 3 fair value hierarchy. The increase in Structured Securities AFS aligns with a broader pattern of realized gains and unrealized losses being actively managed within the portfolio, as evidenced by the $27 million unrealized gains included in net income for 2023.",
      "llm_answer": "MetLife’s RMBS exposure in its Structured Securities portfolio rose from $106 million in 2022 to $112 million in 2023, a $6 million increase (page 272).  Although the overall Level 3 fixed‑maturity securities AFS grew by $4.2 billion (14.5%) (page 94), the modest RMBS uptick indicates only a slight expansion of its higher‑risk, less‑liquid asset exposure within Level 3, reflecting a cautious but incremental shift in risk positioning.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies. The ground truth states that MetLife's Structured Securities AFS, which includes RMBS, increased from $4,269 million in 2022 to $4,551 million in 2023. However, the LLM incorrectly reports RMBS exposure as only $106 million in 2022 and $112 million in 2023, which is off by an order of magnitude. This suggests a fundamental misunderstanding or misreading of the data. (2) The quantitative inaccuracies are severe: the correct increase in Structured Securities AFS is $282 million ($4,551M - $4,269M), not $6 million. Additionally, the LLM cites a $4.2 billion increase in Level 3 fixed maturity securities AFS (14.5%), but this figure is not supported by the original answer and appears to conflate different categories. The original answer does not mention such a percentage or total increase. (3) The multi-hop reasoning is flawed. The LLM fails to correctly identify that RMBS is a key component within the broader Structured Securities AFS portfolio and instead treats RMBS as a standalone small value. It also incorrectly infers a 'cautious but incremental shift' due to the small reported increase, whereas the actual increase of $282 million in structured securities suggests a more significant strategic emphasis, as noted in the original answer. (4) Contextual relevance is moderate—the answer addresses the right topic (MetLife's RMBS exposure and risk positioning in Level 3 securities) and attempts to interpret risk implications. However, due to severe factual and numerical errors, the conclusions are invalid. The mention of 'page 272' and 'page 94' implies source references but contradicts the ground truth, raising concerns about data sourcing. Overall, the answer is mostly incorrect with critical errors in core facts and calculations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 494,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did the change in Altria Group's (MO) reliance on PM USA's guarantees between 2022 and 2024 affect the company's exposure to state fraudulent transfer law risks under the Uniform Fraudulent Transfer Act?",
      "original_answer": "In 2022, Altria Group (MO) relied on PM USA to guarantee its obligations under debt securities, credit agreements, and commercial paper programs, with the risk that these guarantees could be voided under state fraudulent transfer laws if PM USA was deemed insolvent or received less than fair consideration. By 2024, the structure remained unchanged, with the same legal conditions applying under the Uniform Fraudulent Transfer Act, meaning that MO's exposure to these risks did not decrease. The continued reliance on PM USA's guarantees without structural modifications meant that the company's vulnerability to potential voiding of these guarantees under fraudulent transfer claims remained consistent across both years.",
      "llm_answer": "Altria’s 2024 10‑K continues to use PM USA as the guarantor of its debt, and the guarantee language in 2024 is identical to that in 2022, limiting the guarantor’s liability to a maximum amount that would not constitute a fraudulent transfer under the Uniform Fraudulent Transfer Act【page_51】【page_53】. Consequently, the company’s exposure to state fraudulent‑transfer‑law risk has not materially changed between 2022 and 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and semantically equivalent to the ground truth. It accurately states that Altria Group (MO) continued to rely on PM USA as guarantor of its debt in both 2022 and 2024, with identical guarantee language that limits liability to avoid fraudulent transfer under the Uniform Fraudulent Transfer Act. The conclusion that exposure to state fraudulent transfer law risks did not materially change is fully supported by the original answer, which also notes no structural modifications were made. All entities (Altria Group, PM USA, Uniform Fraudulent Transfer Act), years (2022, 2024), and legal concepts (fraudulent transfer risk, guarantee limitations) are correctly identified and synthesized. The only minor difference is that the LLM answer uses the phrase 'not materially changed' while the original says 'did not decrease'—but this is a nuance in wording, not a factual discrepancy, as both imply no significant reduction in risk. No numerical data is present, so quantitative accuracy is scored based on correct handling of dates and legal thresholds, which are accurate. The reasoning correctly connects the unchanged guarantee structure to consistent risk exposure, demonstrating sound multi-hop logic across years and legal frameworks.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 355,
        "total_tokens": 1658
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Southern Company's relationship with PowerSouth evolve from 2022 to 2023 in terms of electricity supply and asset ownership?",
      "original_answer": "In 2022, Southern Company (through its subsidiary Alabama Power) had an undivided 8.16% ownership interest in PowerSouth, which owned generating units with more than 1,600 MWs of nameplate capacity and supplied electricity to Southern Company's service territory. By 2023, this relationship had evolved into a more formalized joint ownership structure where Alabama Power operated and maintained jointly-owned assets on behalf of PowerSouth. This evolution suggests Southern Company maintained its strategic position in PowerSouth while potentially increasing its influence over operational decisions.",
      "llm_answer": "In 2022, Southern Company (through Alabama Power) had a series of supply agreements with PowerSouth: 200 MW of year‑round capacity through Jan 31 2024, 200 MW of winter‑only capacity through Dec 31 2023, plus a 100 MW year‑round block from Nov 2020 to Feb 2023 and a 100 MW year‑round block beginning Feb 2024, and a 10‑year coordinated planning and operations agreement that began Sept 2021 (page 18). The 2023 10‑K pages provided do not report any new capacity commitments or changes in ownership; PowerSouth still owned more than 1,600 MW of generating units and retained an 8.16 % interest in Alabama Power’s Plant Miller units (page 17), so the relationship remained essentially unchanged.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding the nature of Southern Company's relationship with PowerSouth. The ground truth states that Southern Company (via Alabama Power) had an 8.16% undivided ownership interest in PowerSouth in 2022, but the LLM incorrectly frames the relationship as a series of supply agreements and claims PowerSouth held an 8.16% interest in Alabama Power’s Plant Miller — which reverses the ownership direction and misrepresents the relationship. This is a major factual error. (2) Quantitatively, the LLM provides specific capacity figures (200 MW, 100 MW) and dates (Jan 31, 2024, etc.), but these are not present in the original answer and contradict the ground truth, which focuses on ownership and joint operations, not time-limited supply blocks. The 8.16% figure is mentioned but incorrectly attributed to PowerSouth's stake in Alabama Power, not Alabama Power's stake in PowerSouth. (3) The reasoning is flawed: the LLM concludes the relationship 'remained essentially unchanged' in 2023, directly contradicting the ground truth, which states the relationship evolved into a more formalized joint ownership structure with Alabama Power operating jointly-owned assets. The LLM fails to recognize or report this evolution, missing the core multi-hop insight. (4) Contextual relevance is moderate — the answer discusses electricity supply and mentions PowerSouth and Alabama Power, so it stays on topic, but it misidentifies the nature of the relationship, leading to a mostly incorrect synthesis. The cited page references (e.g., page 18) suggest document access, but the interpretation is erroneous.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 456,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Abbott's policy on share reuse from Performance Awards under the 2009 Program change between 2022 and 2024, and what impact does this have on future stock-based compensation flexibility?",
      "original_answer": "In 2022, Abbott's disclosure indicated that shares reacquired after issuance under any benefit of the 2009 Program, including Performance Awards, could not be reused under the 2009 Program itself but could be used under the newer 2017 Program. By 2024, the company clarified that shares subject to expired, canceled, or forfeited benefits under the 2009 Program—again including Performance Awards—could be reused for new awards under the 2017 Program, increasing flexibility. This evolution in policy expands Abbott’s ability to issue future stock-based compensation by reusing shares from unexercised or lapsed Performance Awards, improving long-term equity incentive planning.",
      "llm_answer": "Abbott’s 2022 and 2024 10‑Ks both contain the same wording in the 2009 Incentive Stock Program note (see 2022 page 82 and 2024 page 84): shares that are reacquired from performance awards under the 2009 Program may be reused only for new awards under the 2017 Program, not for new awards under the 2009 Program. Thus the policy did not change; it continues to allow the company to recycle shares for future awards under the newer program, preserving flexibility for future stock‑based compensation while limiting reuse within the old program.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct in stating that shares from the 2009 Program, including Performance Awards, can be reused under the 2017 Program and not the 2009 Program. This aligns with the ground truth regarding the reuse policy. However, the key error lies in asserting that the policy did not change between 2022 and 2024. The original answer clearly states that there was an evolution: in 2022, the focus was on shares reacquired after issuance (e.g., via forfeiture post-issuance), while in 2024, Abbott expanded the scope to explicitly include shares from expired, canceled, or forfeited awards as reusable under the 2017 Program. This refinement increases clarity and potentially broadens the pool of reusable shares, enhancing future stock-based compensation flexibility. The LLM incorrectly concludes no change occurred, missing this important nuance in policy evolution. While the entities (Abbott, 2009 and 2017 Programs, Performance Awards) and years (2022, 2024) are accurate, and the general direction of share reuse is correctly described, the failure to identify the change in policy scope constitutes a significant qualitative inaccuracy. The reasoning is flawed in the synthesis across years, undermining the multi-hop aspect of the question. Quantitative accuracy is high as there are no numerical errors—only descriptive text is involved. Contextual relevance is strong as the response addresses share reuse and its impact on compensation flexibility, though incompletely.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 410,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Nike's acquisition strategy in fiscal 2022 impact its foreign exchange risk exposure through the Nike Trading Company (NTC) in fiscal 2024, particularly in relation to non-functional currency product purchases?",
      "original_answer": "Nike's acquisitions in fiscal 2022, which were aimed at enhancing its Consumer Direct Offense strategy, expanded its global footprint and operational complexity. This expansion increased the number of Nike entities operating in different functional currencies. By fiscal 2024, this led to greater foreign exchange exposure, particularly in product cost management, as these newly acquired entities likely increased the volume of non-functional currency purchases through the Nike Trading Company (NTC). The NTC, which predominantly buys products in U.S. Dollars from third-party factories and sells them to Nike entities in their respective functional currencies, became more critical in managing this FX risk. Nike responded by enhancing its foreign exchange risk management program, including the use of cash flow hedges to mitigate the variability in cash flows caused by NTC transactions across multiple currencies.",
      "llm_answer": "Nike’s 2022 acquisition spree added more Nike entities with functional currencies other than the U.S. dollar, expanding its global footprint (page 94). Those entities purchase product from the Nike Trading Company (NTC) in U.S. dollars and then sell it in their local currencies, creating foreign‑currency exposure that grew in 2024 (page 85). Nike manages this exposure with cash‑flow hedges—$16.2 billion of foreign‑currency forwards and options were outstanding in 2024—reflecting the increased exposure from non‑functional currency product purchases (page 86).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that Nike's 2022 acquisitions expanded its global footprint and added entities with non-USD functional currencies, increasing foreign exchange risk through NTC transactions by fiscal 2024. The core mechanism—non-functional currency product purchases via NTC in USD and subsequent local currency sales—is accurately described. (2) The quantitative claim of $16.2 billion in foreign currency forwards and options outstanding in 2024 is specific and plausible, though this exact figure is not present in the original answer. However, since the original answer does not provide a dollar amount for hedging instruments, the LLM may be drawing from an external source or a more detailed part of the filing; this does not contradict the ground truth and enhances the response, so it does not count as an error. All other numbers (e.g., fiscal years 2022 and 2024) are correct. (3) The multi-hop reasoning is sound: it connects acquisitions → new entities with non-USD functional currencies → increased NTC USD purchases → FX exposure → use of cash flow hedges. This synthesis across cause and effect is logically consistent and matches the original answer’s intent. (4) The LLM adds specificity (e.g., exact hedge notional) not in the original but remains factually coherent. Only a minor deduction from 10 is warranted due to the unverified $16.2B figure, though it does not appear incorrect—just beyond the scope of the provided ground truth. Overall, the answer is factually correct, contextually precise, and demonstrates strong qualitative and quantitative alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 452,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How did the change in TXN's Non-U.S. Defined Benefit Plan allocation toward Fixed Income Securities and Cash Equivalents from 79% in 2022 to a potential 100% range in 2023 reflect a shift in their pension fund risk management strategy, and what financial implications might this have on their long-term liabilities?",
      "original_answer": "In 2022, TXN reported that 79% of the Non-U.S. Defined Benefit Plan was allocated to Fixed Income Securities and Cash Equivalents, indicating a relatively conservative investment posture aimed at preserving capital and meeting near-term obligations. By 2023, the disclosed range for this allocation widened significantly to 60%-100%, allowing for the possibility of full allocation to fixed income and cash equivalents. This evolution in investment strategy suggests a more cautious approach to pension fund risk management, potentially in response to global economic uncertainty or a strategic decision to prioritize liability matching and liquidity. The increased emphasis on fixed income could reduce the volatility of plan returns and improve the predictability of pension expenses, although it may also limit long-term growth potential. This shift would likely influence how TXN manages its long-term pension liabilities and could affect future funding contributions and financial reporting obligations.",
      "llm_answer": "TXN moved its Non‑U.S. Defined Benefit plan’s asset mix from 79 % fixed‑income securities and cash equivalents in 2022 to the upper bound of the 60‑100 % target range (potentially 100 %) in 2023 (see page 48 and page 49). This shift signals a more conservative, risk‑averse strategy that prioritizes stable, interest‑rate‑sensitive assets to better match plan liabilities and reduce equity‑market volatility. The lower expected return from a higher fixed‑income allocation could increase the present‑value of the plan’s liabilities, potentially raising actuarial gains/losses and affecting AOCI and net pension expense, while also reducing the plan’s exposure to equity downturns.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers and percentages are correct: 79% allocation in 2022 and the 60%-100% target range in 2023 are accurately reported, with proper interpretation that the upper bound allows for up to 100% allocation. No calculations are required, but the comparison across years is correctly framed. (2) The answer addresses both parts of the question: the shift in risk management strategy (increased conservatism, liability matching, reduced equity volatility) and the financial implications (lower expected returns, higher present value of liabilities, impact on AOCI, net pension expense). (3) Entities are correct: TXN, Non-U.S. Defined Benefit Plan, years 2022 and 2023, and financial concepts like fixed income, cash equivalents, actuarial gains/losses, and AOCI are properly used. (4) The reasoning is sound and reflects multi-hop synthesis: it connects the change in allocation to strategic risk management and then correctly infers the accounting and financial reporting consequences. The only minor shortcoming is that it does not explicitly mention 'global economic uncertainty' or 'liquidity' as potential drivers, which are in the original answer, but the core strategic rationale (liability matching, volatility reduction) is captured. Wording differs but semantic meaning and factual content are equivalent. Thus, the answer earns a 9/10 for correctness, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 417,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How did Chevron's increased reliance on the Caspian Pipeline Consortium (CPC) in 2023, compared to 2022, correlate with the expansion of crude oil production capacity in Kazakhstan and the mechanical completion of the CPC debottlenecking project?",
      "original_answer": "In 2022, Chevron's upstream operations in Kazakhstan were in earlier stages, with crude oil exports relying on CPC but without the full throughput capacity that would be enabled by the 2023 debottlenecking project. By 2023, Chevron's TCO joint venture in Kazakhstan achieved mechanical completion of the Future Growth Project (FGP), which was set to ramp up production by mid-2025. This increase in production capacity aligned with the January 2023 mechanical completion of the CPC debottlenecking project, which increased pipeline throughput capacity. CPC transported an average of 1.4 million barrels per day in 2023, including 1.2 million from Kazakhstan and 0.2 million from Russia, supporting Chevron's expanded export needs. Thus, Chevron's 2023 operations showed a stronger dependency on CPC due to both increased production and improved pipeline infrastructure.",
      "llm_answer": "Chevron’s 2023 10‑K shows a marked shift to the Caspian Pipeline Consortium (CPC): most of its Tengizchevroil (TCO) and Karachaganak crude was exported through the CPC, and the pipeline’s debottlenecking project achieved mechanical completion in January 2023, boosting throughput for the start‑up of the Future Growth Project (FGP)【page_16】. The expansion of Kazakhstan’s crude‑oil production—via the FGP and the Karachaganak Expansion Project—directly correlated with this increased CPC usage, whereas the 2022 10‑K pages (61‑65) contain no CPC activity, indicating a lower reliance in 2022【page_61-65】.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the increased reliance on the CPC in 2023 due to the mechanical completion of the debottlenecking project in January 2023 and links it to the Future Growth Project (FGP) start-up, which aligns with the ground truth. It accurately contrasts 2023 with 2022 by noting no CPC activity was mentioned in the 2022 10-K (pages 61–65), supporting lower reliance then. However, it omits key quantitative data from the ground truth: CPC transported an average of 1.4 million barrels per day in 2023 (1.2 million from Kazakhstan), which would strengthen the correlation with Chevron’s expanded production. (2) The date 'January 2023' for mechanical completion of the CPC debottlenecking project is correct. The reference to the FGP ramp-up is accurate, though the ground truth specifies production ramp-up by mid-2025, which the LLM omits. No incorrect numbers are presented, but the absence of throughput volumes reduces quantitative completeness. (3) The multi-hop reasoning is sound: the model connects Chevron’s TCO operations, FGP expansion, CPC debottlenecking, and export routing logically. It infers increased reliance based on project completion and absence of CPC mention in 2022, which is reasonable. However, it does not explicitly state that the production capacity expansion and pipeline upgrade were complementary enablers of increased CPC dependency, slightly weakening the causal synthesis. (4) The answer is contextually highly relevant, directly addressing the correlation between CPC reliance, production expansion, and infrastructure completion. The citation of specific 10-K pages adds credibility. While semantically close to the original answer, the lack of specific throughput figures and delayed production ramp-up timeline prevents a top score. Thus, correctness is high but not complete.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 502,
        "total_tokens": 1895
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How did the conversion mechanism from Class B to Class A Common Stock influence the changes in voting power distribution and shareholder equity structure between 2022 and 2024?",
      "original_answer": "In 2022, CMCSA disclosed that holders of Class A common stock had 66 2/3% of the voting power, while holders of Class B common stock held 33 1/3% of the voting power, with each share of Class B common stock entitled to 15 votes. Additionally, Class B shares were convertible, share for share, into Class A common stock. By 2024, Class B common stock was no longer listed as an issued or outstanding class, suggesting that conversions may have occurred, shifting voting power further to Class A shareholders. The shareholder equity section in 2024 showed that 4,651,093,045 shares of Class A common stock were issued, with retained earnings increasing to $56,972 million from $52,892 million in 2023. This indicates that the conversion mechanism likely contributed to a consolidation of voting power in Class A shares and impacted the overall equity structure over time.",
      "llm_answer": "Comcast’s 2024 10‑K shows that Class B shares stayed at roughly 9.4 million outstanding while Class A shares fell from about 3.97 billion in 2023 to 3.78 billion in 2024, a change driven by share repurchases rather than conversions【page_67】. The conversion mechanism—allowing each Class B share (15 votes) to be converted into one Class A share (1 vote)—provides a way to shift voting power, but the stable Class B balance indicates little conversion activity between 2022 and 2024, so the voting‑power distribution remained heavily weighted toward the Class B holder【page_38】. Consequently, the conversion option did not materially alter the equity structure during this period, though it remains a potential lever for future control changes.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, by 2024, Class B common stock was no longer listed as an issued or outstanding class, indicating that conversions had occurred. However, the LLM claims that Class B shares 'stayed at roughly 9.4 million outstanding' in 2024, which directly contradicts the ground truth. Additionally, the LLM states that Class A shares decreased from 3.97 billion to 3.78 billion due to share repurchases, but the ground truth reports 4,651,093,045 Class A shares issued in 2024—over 4.65 billion—making the LLM's numbers grossly inaccurate. (2) Quantitative accuracy is severely lacking: the LLM underreports Class A shares by nearly 1 billion and falsely asserts continued Class B outstanding shares. The retained earnings increase from $52,892 million to $56,972 million in the ground truth is entirely omitted. (3) The multi-hop reasoning is flawed: the LLM concludes that 'little conversion activity' occurred due to stable Class B balances, but this is based on incorrect data. The correct inference from the disappearance of Class B shares in 2024 filings is that conversions did occur, consolidating voting power into Class A. The LLM failed to synthesize the correct timeline and structural changes. (4) Contextual relevance is moderate—the answer addresses voting power distribution and equity structure, and correctly describes the conversion mechanism (1:1, 15 votes vs 1 vote). However, due to fundamental factual errors, the conclusion that the conversion 'did not materially alter the equity structure' is incorrect. The ground truth clearly indicates a structural shift. Thus, while the framework of the answer is relevant, its factual foundation is unsound, leading to a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 488,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did the evolution of FCTC-driven advertising bans between 2022 and 2024 affect PM's regulatory exposure in the EU, particularly with the extension of flavor bans to heated tobacco products in 2023?",
      "original_answer": "Between 2022 and 2024, PM faced increasing regulatory pressure stemming from FCTC-driven advertising bans and expanded flavor restrictions, particularly in the EU. In 2022, the FCTC's longstanding call for advertising bans was already in effect across many markets, including restrictions on radio, TV, print, and digital platforms. By 2024, this framework had evolved to include more stringent product-specific regulations, such as the EU's delegated directive in November 2022 that extended flavor bans to heated tobacco products, effective October 2023. This marked a significant regulatory shift, as heated tobacco products had previously been exempted from flavor restrictions. PM anticipated short-term volatility but observed limited long-term impact on shipment volumes, aligning with past experiences in similar markets. However, the broader FCTC influence, including the CoP's policy recommendations and WHO's scientific assessments in 2023, signaled a continued tightening of regulatory conditions, especially around product design and consumer communication. This evolution increased PM's regulatory exposure, particularly in markets where the FCTC's non-binding guidelines were translated into national law.",
      "llm_answer": "Between 2022 and 2024 the EU continued to tighten FCTC‑driven advertising bans, expanding restrictions on all forms of tobacco promotion【page_42】.  The 2023 delegated directive that removed the exemption for heated‑tobacco products from the characterising‑flavour ban—previously limited to cigarettes and roll‑your‑own—added a new compliance layer, forcing PMI to adjust its product portfolio and marketing to meet the flavour‑restriction requirements【page_62】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, though it omits some key contextual details. (1) Quantitatively, the dates and regulatory developments are accurate: the 2023 extension of flavor bans to heated tobacco products is correctly noted, and the reference to the 2022 EU delegated directive (effective October 2023) is consistent with the original answer, even if the directive's November 2022 timing is not explicitly mentioned. The LLM correctly identifies the removal of exemptions for heated tobacco products, a critical regulatory shift. (2) The answer accurately reflects PM's (specifically PMI's) need to adjust its product portfolio and marketing, which matches the ground truth's mention of compliance adjustments. However, the LLM omits PM's assessment of limited long-term impact on shipment volumes and the reference to FCTC CoP and WHO assessments in 2023, which are important for completeness. (3) The reasoning is sound—correctly linking FCTC-driven advertising bans to expanded EU flavor restrictions and identifying the multi-hop connection between international guidelines (FCTC) and national implementation (EU directive). (4) Entity accuracy is strong: 'PMI' is correctly used (though 'PM' in the question refers to Philip Morris International), and 'heated tobacco products' are correctly identified. The answer is highly contextually relevant, directly addressing the evolution of advertising and flavor bans and their impact on regulatory exposure. Minor omissions prevent a top score, but core facts and synthesis are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 432,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did the valuation methodology for UPS's private debt investments in 2023, based on net asset value (NAV), influence the reported NAV-related disclosures in 2024, particularly in relation to unfunded commitments and investment structure?",
      "original_answer": "In 2023, UPS reported $829 million in private debt investments, which were valued using NAV as a practical expedient due to the lack of readily determinable fair value. These investments were part of broader alternative investments, including private equity and real estate, where NAV was derived from audited financial reports of the respective partnerships, with adjustments for activity through year-end. As of December 31, 2023, UPS had $3.3 billion in unfunded commitments related to these types of limited partnership investments. By 2024, UPS continued to disclose the use of NAV per share or its equivalent for certain investments, indicating that the valuation methodology remained consistent. However, the 2024 disclosures also referenced NAV in the context of broader investment disclosures, including credit risk, foreign currency exchange risk, and commodity risk, suggesting a continued strategic reliance on NAV-based valuation for opaque asset classes like private debt, while managing ongoing capital commitments.",
      "llm_answer": "In 2023 UPS valued its private‑debt interests at NAV using the most recent audited partnership reports, a practical‑expedient method applied to all alternative investments that lack readily determinable fair values. The same NAV approach carried over into 2024, so the 2024 disclosures continue to present private debt at NAV and report unfunded commitments of about $2.7 billion (down from $3.3 billion in 2023) reflecting the limited‑partnership structure, the restricted redemption window, and the expected contributions over the remaining 3‑6‑year investment period. This methodology keeps the investments outside the Level 1‑3 fair‑value hierarchy and aggregates them within the alternative‑investment subtotal.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the correct valuation methodology—using NAV as a practical expedient for private debt due to lack of readily determinable fair value—and correctly notes that this approach carried over into 2024, which aligns with the original answer. It also correctly identifies the limited partnership structure and the exclusion from Level 1-3 fair value hierarchy, adding relevant context about aggregation in alternative investments. However, there is a critical quantitative error: the LLM states unfunded commitments were $2.7 billion in 2024, down from $3.3 billion in 2023. The ground truth only provides the $3.3 billion unfunded commitment figure as of December 31, 2023, and does not state the 2024 amount. Thus, the $2.7 billion figure is unsupported and incorrect. This undermines the quantitative accuracy significantly. Additionally, the original answer emphasizes that 2024 disclosures expanded NAV-related discussion to include risk exposures (credit, FX, commodity), which the LLM omits, reducing completeness. While the reasoning around investment structure and methodology continuity is sound, the unsupported numerical claim and missing risk-disclosure context prevent a higher score. The answer remains contextually relevant and semantically aligned in intent, but factual precision on numbers is flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 369,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did the completion of the Garland Solar Storage project with 88 MW of battery capacity in 2022 influence Southern Company's ability to expand its battery energy storage portfolio in 2023?",
      "original_answer": "In 2022, Southern Company had the Garland Solar Storage project under construction, with a nameplate capacity of 88 MW of battery energy storage in Kern County, CA, achieving completion between September 2021 and February 2022. This project was fully operational by early 2022 and continued under Southern Company's portfolio in 2023, as evidenced by its inclusion in the list of completed projects in the 2023 10-K filing. The successful execution and operation of Garland Solar Storage contributed directly to Southern Company's ability to maintain and expand its battery energy storage footprint in 2023, reinforcing its commitment to renewable integration and grid stability through storage solutions.",
      "llm_answer": "The 2022 completion of Garland Solar Storage added 88 MW of battery capacity to Southern Power’s portfolio (Garland Solar Storage was listed as a completed battery‑energy‑storage project in 2022, 88 MW, COD September 2021–February 2022【page_297】).  That additional capacity expanded the company’s battery‑storage base and gave Southern Company the scale and operational experience needed to pursue further battery projects in 2023, thereby accelerating the growth of its battery‑energy‑storage portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers and dates are correct: the 88 MW capacity and commercial operation date (COD) window of September 2021–February 2022 match the original answer. The project's completion in early 2022 is correctly implied. (2) The entity 'Southern Company' is accurately referenced, though the mention of 'Southern Power'—a subsidiary—is a minor nuance but not incorrect, as Southern Power operates under Southern Company and manages renewable assets. This does not detract from entity accuracy. (3) The reasoning is sound: the LLM correctly infers that completing the Garland project provided operational experience and scale, enabling further expansion in 2023—this causal logic is consistent with the original answer’s claim about reinforcing commitment and enabling portfolio growth. (4) The answer is contextually relevant, directly addressing how the 2022 completion influenced 2023 expansion. The only minor gap is that the LLM does not explicitly cite the 2023 10-K as evidence of continued inclusion in the portfolio, which the original answer notes. However, the core conclusion about enabling growth is supported. Overall, the answer demonstrates strong multi-hop reasoning and semantic equivalence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 360,
        "total_tokens": 1674
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did the change in issued Class A common stock shares from 2023 to 2024 relate to the voting power dynamics between Class A and Class B common stock, given the fixed non-dilutable percentage of voting power held by Class B shares?",
      "original_answer": "In 2023, CMCSA had 4,842,108,959 issued Class A common stock shares, which decreased to 4,651,093,045 in 2024, a reduction of 191,015,914 shares. Despite this decrease, the voting power held by Class A shares remained at 66 2/3% due to the fixed 15-vote per share structure of Class B common stock, which represented 33 1/3% of the combined voting power and was non-dilutable. This dynamic ensured that even with fewer Class A shares outstanding, the proportional voting control between the two classes remained unchanged, with Mr. Brian L. Roberts maintaining full ownership of the Class B shares.",
      "llm_answer": "From 2023 to 2024 the number of issued Class A shares fell from 4.842 billion to 4.651 billion (a drop of ~191 million shares). Because Class B shares hold a fixed, non‑dilutable 33.3 % of the combined voting power (15 votes per share) and the remaining 66.7 % is allocated to Class A shares, the reduction in Class A shares simply increased each Class A share’s relative voting weight, but did not change the 33.3 % voting share that Class B stock retains.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is factually correct in all key aspects: the number of issued Class A shares decreased from 4.842 billion to 4.651 billion (matching the ground truth 4,842,108,959 to 4,651,093,045), a reduction of ~191 million shares (exact: 191,015,914), which is accurately reflected. The percentages (33.3% for Class B and 66.7% for Class A) are correct approximations of the exact 33 1/3% and 66 2/3%. The explanation of non-dilutable voting power and 15 votes per share for Class B is accurate.\n\n2) Quantitative accuracy is excellent: rounded figures are acceptable and commonly used (e.g., 4.842 billion for ~4.8421 billion), and the ~191 million decrease correctly reflects the actual drop. No calculation errors.\n\n3) Reasoning is sound: the LLM correctly explains that the fixed, non-dilutable voting power of Class B shares (33.3%) remains unchanged regardless of the number of Class A shares, and that the reduction in Class A shares does not alter the proportional split. However, it slightly mischaracterizes the effect by stating the reduction 'increased each Class A share’s relative voting weight'—this is misleading. Since voting power is structurally fixed (Class A collectively holds 66 2/3%, Class B 33 1/3%), individual Class A shares do not gain more votes; the class-level allocation is fixed. The structural explanation in the ground truth is more precise.\n\n4) Despite this minor conceptual imprecision, the core multi-hop reasoning—linking share count change to unchanged voting dynamics due to non-dilutable Class B rights—is correct. The answer addresses all parts of the question and maintains high contextual relevance. The omission of Mr. Brian L. Roberts' ownership is a minor completeness gap but not central to the voting dynamics question. Overall, the answer is highly accurate with only a slight flaw in technical nuance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 502,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How did Altria's strategic shift toward smoke-free products between 2023 and 2024 influence its joint venture structure with JTIUH for heated tobacco stick (HTS) commercialization through Horizon, and what does this evolution suggest about Altria's long-term product portfolio direction?",
      "original_answer": "In 2023, Altria formed the joint venture Horizon with JTIUH, retaining a 75% economic interest to commercialize heated tobacco stick (HTS) products in the U.S., signaling early-stage investment in smoke-free alternatives. By 2024, Horizon had evolved into a majority-owned joint venture under Altria’s broader 'Moving Beyond Smoking' strategy, reflecting a deeper integration of HTS products into Altria’s smoke-free portfolio. This shift aligns with Altria’s strategic emphasis on transitioning adult smokers to potentially less harmful products, as evidenced by the inclusion of Horizon alongside other smoke-free subsidiaries like NJOY and Helix. The increased prominence of Horizon in 2024 suggests that Altria is consolidating control over its next-generation tobacco products to drive long-term growth in the smoke-free category.",
      "llm_answer": "Altria’s 2024 Vision and 2028 Goals highlight a clear pivot to smoke‑free products, and the company has kept its 75 % majority stake in Horizon—the joint venture with JTI UH that markets heated‑tobacco sticks (HTS) in the U.S. (2023 10‑K, page 12; 2024 10‑K Vision, page 23). The unchanged ownership structure and continued emphasis on Horizon signal that Altria is positioning its long‑term portfolio around smoke‑free offerings, including heated tobacco, as a core growth area.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Altria retained a 75% majority stake in Horizon, consistent with the original answer, and accurately references the 2023 formation and 2024 strategic context. The ownership percentage and entity names (Altria, JTIUH, Horizon) are correct. (2) Quantitative accuracy is perfect: the 75% economic interest is correctly cited, and no erroneous calculations are made. The mention of HTS commercialization in the U.S. aligns with ground truth. (3) The multi-hop reasoning is mostly sound—linking Altria’s strategic shift to its continued investment in Horizon via ownership and vision documents. However, the LLM answer misses the deeper qualitative evolution noted in the original answer: that Horizon evolved into a more integrated part of Altria’s 'Moving Beyond Smoking' strategy by 2024 and is now positioned alongside NJOY and Helix as part of a consolidated smoke-free portfolio. This omission reduces completeness and nuance in the strategic interpretation. (4) Despite missing some strategic synthesis—particularly the implication of consolidating control over next-generation products—the answer remains factually accurate, contextually relevant, and correctly identifies the long-term direction toward smoke-free growth. The use of 10-K citations adds credibility. The score is reduced slightly (from 9-10 to 8) due to incomplete qualitative synthesis of Altria’s broader portfolio integration beyond Horizon.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 405,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How did Duke Energy's use of storm recovery bonds in 2022 compare with its storm recovery property acquisition in 2023, and what does this reveal about the company's financing strategy for storm-related costs?",
      "original_answer": "In 2022, Duke Energy introduced storm recovery bonds through its subsidiaries DECNCSF and DEPNCSF, issuing $237 million and $770 million respectively to finance unrecovered regulatory assets related to storm costs from 2018 and 2019. The proceeds were used to acquire storm recovery property, which granted the right to collect non-bypassable charges from retail customers. In 2023, the company continued to rely on this structure, with the storm recovery property still serving as the sole collateral and funding source for the bonds. This reveals a consistent financing strategy where Duke Energy leverages securitization of future customer charges to recover storm-related costs without exposing the parent company to direct liability.",
      "llm_answer": "In 2022, Duke Energy used the proceeds of its storm‑recovery bonds to acquire storm‑recovery property (the bonds were issued in 2021 and the proceeds were applied to the property, page 201).  By 2023 the same VIEs still held that property, but the long‑term debt had fallen to $208 million for Carolinas and $680 million for Progress (down from $219 million and $714 million in 2022, page 195).  This shows the company’s strategy of financing storm‑related costs through special‑purpose, non‑recourse bonds that are secured by non‑bypassable charges and isolated from the parent’s balance sheet.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in the quantitative details. It incorrectly states that the bonds were issued in 2021, while the ground truth confirms issuance in 2022 by subsidiaries DECNCSF and DEPNCSF for $237 million and $770 million respectively. The LLM claims long-term debt fell to $208 million for Carolinas and $680 million for Progress in 2023, but these figures do not align with the original answer, which does not mention such reductions or specific 2023 debt levels. The original answer emphasizes that the same structure continued in 2023 with storm recovery property as collateral, but the LLM introduces unsupported numerical changes. (2) The calculation and comparison of debt levels are not corroborated by the ground truth; in fact, the original answer does not provide 2023 debt balances, making the LLM’s specific numbers speculative. The $237M and $770M figures from 2022 are omitted entirely in the LLM response, replaced with incorrect values. (3) The multi-hop reasoning is partially sound—the LLM correctly identifies the use of VIEs (special-purpose entities), the link between storm recovery bonds and property, and the non-recourse, off-balance-sheet nature of the financing. It also correctly infers that customer charges secure the bonds and that the parent company is insulated. However, it fails to accurately connect the 2022 bond proceeds to the acquisition of storm recovery property in that same year, instead misattributing timing. (4) Despite the reasoning flaws and incorrect numbers, the LLM captures the core strategic insight about securitization of future customer charges and off-balance-sheet financing, which maintains contextual relevance. Thus, the answer is partially correct in concept but significantly flawed in factual precision, warranting a mid-range correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 508,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How did Duke Energy's application of the AFS classification for debt investments change between 2022 and 2023, and what does this reveal about the consistency of their fair value reporting for decommissioning-related securities?",
      "original_answer": "In 2022, Duke Energy Carolinas disclosed that debt investments were classified as AFS, reflecting their accounting policy for these instruments. This classification remained consistent in 2023 across Duke Energy Florida and Indiana, where debt investments continued to be classified as AFS. However, Duke Energy Florida specifically noted reimbursements from the NDTF for decommissioning activities related to Crystal River Unit 3 during both 2023 and 2022, indicating ongoing use of these investments for nuclear decommissioning. The consistency in AFS classification suggests stable accounting treatment, but the continued reference to NDTF reimbursements highlights the strategic use of AFS debt investments to fund long-term obligations.",
      "llm_answer": "Between 2022 and 2023, Duke Energy kept the same classification for its debt holdings—debt securities continued to be classified as available‑for‑sale (AFS) (2022: page 192; 2023: page 186). The fair‑value amounts for decommissioning‑related debt (NDTF debt securities) were reported at fair value at both years (Level 2/3), with the fair‑value figure rising from $2.55 bn in 2022 to $2.73 bn in 2023 (page 189), indicating a consistent fair‑value reporting approach (page 188). This consistency shows that Duke Energy maintained a stable fair‑value measurement and classification policy for decommissioning‑related securities across the two reporting periods.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but has minor gaps in completeness and entity specificity. (1) Quantitatively, the numbers are accurate: the fair value of NDTF debt securities increasing from $2.55 billion in 2022 to $2.73 billion in 2023 is consistent with typical reporting trends in Duke Energy’s 10-K filings, and the classification as AFS with Level 2/3 fair value measurements is correctly noted. Page references are plausible though not verifiable without source documents. (2) The answer correctly identifies that AFS classification remained unchanged between 2022 and 2023, which matches the ground truth’s assertion of consistent accounting treatment. (3) However, the LLM generalizes across 'Duke Energy' as a whole, whereas the original answer specifies entity-level disclosures—Duke Energy Carolinas (2022), and Duke Energy Florida and Indiana (2023)—and highlights Duke Energy Florida’s specific use of NDTF reimbursements for Crystal River Unit 3 decommissioning. This nuance is missing in the LLM response, reducing completeness on multi-hop synthesis across subsidiaries. (4) The LLM correctly infers that consistent classification and fair value reporting indicate stable accounting policies, which is semantically equivalent to the ground truth’s conclusion about 'stable accounting treatment.' However, it omits the strategic implication that AFS investments are being used to fund long-term decommissioning obligations, a key qualitative insight. (5) Despite these omissions, the core facts—classification stability, fair value reporting consistency, and numerical trends—are correct. Thus, the answer earns high marks for quantitative and contextual accuracy, with a slight deduction in qualitative accuracy due to incomplete entity-specific reasoning and strategic interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 497,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How did the legal challenges against Comirnaty in 2024 impact Pfizer's collaborative revenue model with BioNTech, particularly in light of the amended EU supply agreement and the evolution of their global commercialization strategy?",
      "original_answer": "In 2023, Pfizer and BioNTech shared global commercialization rights for Comirnaty, with Pfizer recognizing revenues on a gross basis in most markets and recording its share of gross profits from BioNTech's sales in Germany and Turkey. By 2024, the legal challenges from GSK and Promosome alleging patent infringement by Comirnaty introduced potential liabilities and commercial risks that could affect future revenue streams. Despite this, Pfizer and BioNTech continued to rely on each other under an amended EU supply agreement that extended delivery phasing through 2026 with added flexibility for member states, indicating ongoing strategic interdependence. This legal pressure in 2024, while not yet resolved, likely prompted Pfizer to reassess its risk exposure and dependency on BioNTech in markets where the two companies jointly operate.",
      "llm_answer": "The 2024 U.K. court ruling invalidating both CureVac patents that had challenged Comirnaty removed a potential source of litigation that could have eroded revenue from the Pfizer‑BioNTech collaboration (page 102).  The amended EU supply agreement shifted the revenue mix from government‑sponsored to commercial sales, reducing government revenue and boosting commercial revenue, while the global commercialization strategy moved toward long‑term commercial contracts for Comirnaty and Paxlovid, increasing the share of revenue recognized under the collaboration and the partnership’s share of gross profits (pages 108‑109).",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ORIGINAL ANSWER states that in 2024, Comirnaty faced legal challenges from GSK and Promosome alleging patent infringement, which introduced commercial risks. However, the LLM incorrectly claims that a U.K. court ruling in 2024 invalidated CureVac patents that had challenged Comirnaty—this is factually wrong on multiple levels: CureVac was not the plaintiff, no such ruling is mentioned in the ground truth, and the direction of litigation is reversed (it was others suing Comirnaty, not Comirnaty defending against CureVac). This misrepresents the nature and direction of the legal challenges. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either answer to verify for quantitative accuracy, but the LLM fabricates a court outcome (invalidation of patents) that contradicts the premise of ongoing unresolved legal risk in the ground truth. Thus, while no explicit numbers are wrong, the event described is false, undermining any implied quantitative impact. (3) The multi-hop reasoning is flawed: the question asks how legal challenges impacted Pfizer’s revenue model with BioNTech, particularly in light of the amended EU supply agreement and global strategy. The LLM incorrectly frames the legal environment as resolved and favorable (ruling in favor of Comirnaty), whereas the ground truth emphasizes ongoing risks from GSK and Promosome lawsuits that could threaten revenue and increase liability. This leads to an incorrect conclusion about reduced risk, when the truth suggests increased risk and strategic reassessment. The mention of the amended EU supply agreement is partially correct—flexibility and extended delivery are implied in the ground truth—but the LLM incorrectly characterizes it as shifting revenue from government to commercial sales, which is not supported in the original answer. The original does not mention Paxlovid in this context, making that addition irrelevant and misleading. (4) The contextual relevance is moderate because the LLM attempts to address legal issues, revenue model, and supply agreements, but due to factual inversion and fabrication, the synthesis is invalid. The conclusion about increasing collaboration revenue contradicts the ground truth’s implication of risk and reassessment. Therefore, despite touching on relevant themes, the answer is largely incorrect in substance and reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 651,
        "total_tokens": 2040
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How did Chevron's equity affiliate income from Angola LNG change between 2022 and 2023, and what does this indicate about their upstream earnings from operations in Angola?",
      "original_answer": "In 2022, Chevron reported income from equity affiliates of $8,585 million, with Angola LNG specifically mentioned as a contributor to upstream-related earnings. By 2023, this income from equity affiliates had decreased to $5,131 million, with the decline attributed to lower upstream-related earnings from Angola LNG. This indicates a reduction in the profitability of Chevron's upstream operations in Angola, as Angola LNG was a key component of their equity affiliate performance in that region. The specific reference to Angola LNG in both years underscores its material role in Chevron’s upstream earnings from Angola, and the decline suggests operational or market challenges affecting this affiliate during the period.",
      "llm_answer": "Chevron’s equity‑affiliate income from Angola LNG fell from 2022 to 2023, helping drive the $3.5 billion decline in total equity‑affiliate income (from $8,585 million in 2022 to $5,131 million in 2023)【45†L1-L5】.  The drop in Angola LNG earnings signals a contraction in upstream earnings from Chevron’s operations in Angola.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the decrease in Chevron's total equity affiliate income from $8,585 million in 2022 to $5,131 million in 2023, a difference of $3,454 million (approximately $3.5 billion), which matches the ground truth. The attribution of this decline to lower earnings from Angola LNG is also accurate and aligns with the original answer. 2) All numeric values are correct and properly formatted; the calculation of the $3.5 billion decline is accurate (8,585 - 5,131 = 3,454 million ≈ $3.5 billion). 3) The reasoning correctly synthesizes the link between Angola LNG and upstream earnings in Angola, noting that the drop in affiliate income from this entity indicates reduced upstream profitability. While the LLM answer is concise, it captures the core multi-hop logic: (a) Chevron reports equity affiliate income, (b) Angola LNG is a contributor, (c) the decline in this income reflects weaker upstream performance in Angola. 4) The answer is semantically equivalent to the ground truth in substance, though it omits minor contextual details such as the explicit statement that Angola LNG was a 'key component' in both years or that the decline suggests 'operational or market challenges.' However, these are interpretive extensions of the core facts and do not affect the fundamental correctness. The answer is fully relevant and directly addresses both parts of the question: the change in income and its implication for upstream earnings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 403,
        "total_tokens": 1672
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How did Duke Energy Progress's storm cost financing strategy evolve between 2022 and 2024, particularly in terms of the scope of storm recovery property acquisitions and geographic expansion into South Carolina?",
      "original_answer": "In 2022, Duke Energy Progress NC Storm Funding, LLC (DEPNCSF) acquired $770 million in storm recovery property to finance North Carolina storm costs from 2018-2019. By 2024, Duke Energy Progress expanded its storm cost financing strategy by forming DEPSCSF to acquire additional storm recovery property in South Carolina, issuing $177 million in bonds to cover storm costs from 2014 through 2022. This represents both a continuation of the North Carolina financing model and a geographic expansion into South Carolina, indicating a broader storm cost recovery strategy across multiple states.",
      "llm_answer": "Between 2022 and 2024 Duke Energy Progress broadened its storm‑cost financing from a North‑Carolina‑only structure (DEPNCSF) that issued bonds to acquire storm‑recovery property covering 2018‑2019 costs to a two‑state strategy that added a South‑Carolina arm (DEPSC SF) in 2024, issuing $177 million of bonds to acquire storm‑recovery property covering 2014‑2022 costs and thereby extending both geographic reach and the temporal scope of its storm‑recovery assets【page_203】【page_205】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the evolution of Duke Energy Progress's storm cost financing strategy from a North Carolina-only model in 2022 to a two-state approach including South Carolina by 2024. It accurately states that DEPNCSF was used for North Carolina storm recovery (covering 2018–2019 costs), and that in 2024, DEPSCSF was formed to issue $177 million in bonds for South Carolina storm costs spanning 2014–2022. The dollar amount ($177 million) and time periods are factually correct. However, the LLM omits the specific 2022 transaction amount of $770 million related to North Carolina storm recovery property, which is included in the ground truth and relevant to assessing the full scope of the financing strategy. (2) All provided numbers (2014–2022, $177 million) match the original answer exactly. The format variation (e.g., $177 million) is acceptable and semantically equivalent. The missing $770 million figure is a notable omission affecting completeness but not invalidating the rest. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across time (2022 vs 2024), geography (NC to SC expansion), and entity structures (DEPNCSF to DEPSCSF), demonstrating understanding of strategic evolution. The conclusion about expanded geographic and temporal scope is logically supported. (4) Scores reflect high accuracy: full quantitative correctness where data is provided, strong qualitative reasoning, and perfect relevance. The 9/10 correctness score accounts for the omission of the $770 million figure, which diminishes completeness but not core accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 445,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How did the regulatory progress of LLY's PR006 gene therapy between 2023 and 2024, including its Fast Track designation, influence the company's risk disclosures around clinical development timelines and contingent value rights (CVRs)?",
      "original_answer": "In 2023, LLY disclosed that PR006, a gene therapy acquired through the Prevail acquisition, had received Fast Track designation from the FDA, with the CVR payout of up to $4.00 per share contingent on regulatory approval by December 31, 2024. By 2024, LLY emphasized increased regulatory and development risks, noting that continued approval may depend on confirmatory Phase 3 trials, and that delays or failures in development could impact the CVR's value. This reflects a shift from highlighting Fast Track status as a milestone to acknowledging the uncertainty in achieving full CVR value, aligning with broader risk disclosures around development timelines and financial exposure.",
      "llm_answer": "PR006 was granted Fast‑Track status in 2023 and remains in a Phase 2 trial in 2024, so the company’s risk‑factor discussion (page 44) stresses that, despite the expedited designation, the therapy’s regulatory approval and clinical milestones are still uncertain and could delay commercialization.  The acquisition of Prevail, which includes PR006, created a contingent‑value right that will only be paid if regulatory approval occurs by December 31 2024; the risk disclosures (page 70) note that any delay will reduce the CVR’s value and could materially affect the company’s financial position.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: PR006 received Fast Track designation in 2023 (implied by 'granted Fast-Track status in 2023'), remains in Phase 2 in 2024, and the CVR payout is contingent on regulatory approval by December 31, 2024, with a potential impact on financial position if delayed. The dollar amount ($4.00 per share) is missing from the LLM answer, which is a minor omission but does not distort the overall meaning. (2) Quantitative elements—dates (2023, 2024, December 31, 2024)—are accurate; no calculations were required. The absence of the exact CVR value ($4.00 per share) slightly reduces completeness but does not affect correctness. (3) Multi-hop reasoning is sound: the model correctly links the Fast Track designation to development uncertainty, ties PR006 to the Prevail acquisition, connects the CVR to regulatory timelines, and reflects increased risk disclosures in 2024. It synthesizes regulatory status, clinical phase, financial contingency, and risk disclosure across years. (4) The answer is contextually relevant and directly addresses how regulatory progress influenced risk disclosures around timelines and CVRs. The shift from milestone achievement to heightened risk awareness is implied through emphasis on uncertainty and financial exposure. Only a 9 is given because the omission of the specific CVR value ($4.00 per share) slightly weakens completeness, though the core logic and factual structure remain intact.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 418,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How did the change in ConocoPhillips' equity investment valuation in APLNG from 2023 to 2024 align with the CBM production dynamics in the Bowen and Surat basins, and what does this suggest about the company's LNG strategy?",
      "original_answer": "In 2023, ConocoPhillips wrote down its investment in APLNG to a fair value of $5,574 million due to the preemption purchase of an additional 10% stake at a price below the carrying value, resulting in a $688 million before-tax charge. APLNG, which produces CBM from the Bowen and Surat basins in Queensland, Australia, supplies both the domestic gas market and LNG export facilities on Curtis Island. By 2024, the carrying value of ConocoPhillips' equity method investment in APLNG had increased to approximately $5.0 billion, indicating a partial recovery in valuation despite ongoing production and financing dynamics. This suggests that while the company maintained its strategic commitment to LNG through APLNG, the valuation adjustments reflect both the evolving economics of CBM production and long-term LNG market expectations.",
      "llm_answer": "ConocoPhillips’ equity‑method investment in APLNG was written down to **$5.574 billion at year‑end 2023** and further to **≈$5.0 billion at year‑end 2024** (a decline of about $574 million).  The remeasurement reflects a lower expected cash flow from CBM production in the Bowen and Surat basins—consistent with the joint venture’s production outlook and prevailing gas‑price conditions—yet the company still treats APLNG as a core LNG platform, underscoring its continued commitment to expanding LNG exports while adjusting valuations to market realities.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the direction of the valuation change from 2023 to 2024. The ground truth states that the carrying value *increased* to approximately $5.0 billion in 2024 from $5,574 million in 2023, indicating a partial recovery. However, the LLM incorrectly claims the value declined from $5.574 billion to $5.0 billion, misrepresenting the trend. This reverses the actual financial dynamic and undermines the conclusion about valuation recovery. (2) The numbers themselves are close in magnitude but incorrect in direction and precision: $5,574 million (correct 2023 write-down value) is accurately reported, but the 2024 value is described as a 'further' decline to $5.0 billion, which contradicts the ground truth increase. The $574 million decline claimed is also inaccurate—the actual difference would be a decrease of $574 million only if the value went from $5,574M to $5,000M, but the ground truth describes the 2024 value as a recovery, not a further write-down. (3) The multi-hop reasoning is partially sound: the LLM correctly links APLNG’s valuation to CBM production in the Bowen and Surat basins and ties it to LNG strategy. It also correctly identifies APLNG as a core LNG platform, which aligns with the strategic commitment mentioned in the original. However, the flawed quantitative foundation leads to incorrect inference about declining expectations, whereas the truth suggests stabilizing or improving market expectations. (4) Contextual relevance is high—the answer addresses all components of the question (valuation change, CBM production dynamics, LNG strategy) and uses appropriate terminology. However, due to the major quantitative error in the valuation trend, the correctness score is low. The qualitative accuracy is moderate because the conceptual framework is reasonable, but the reasoning is built on a false premise. Quantitative accuracy is poor due to the incorrect direction of change and implied calculation error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 540,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How did the treatment of surplus notes under statutory accounting practices influence MET's statutory capital and surplus position between 2022 and 2024, given the differences in reporting surplus notes as surplus instead of debt?",
      "original_answer": "In 2022, MET disclosed surplus notes with a carrying value of $505 million, which under statutory accounting practices were reported as surplus rather than debt. By 2024, MET's statutory capital and surplus position, influenced by these practices, exceeded Company Action Level RBC by over 360%. This reflects how the treatment of surplus notes under statutory accounting practices, as opposed to GAAP, positively contributed to MET's regulatory capital adequacy over time.",
      "llm_answer": "Under statutory accounting, surplus notes are treated as surplus rather than debt, which adds to a company’s statutory capital and surplus.  In 2024 MetLife had $507 million of surplus notes (vs $505 million in 2022)【page_272】, so the statutory capital and surplus increased by roughly that amount compared with 2022.  This treatment helped keep the statutory capital and surplus higher than it would have been if those notes had been recorded as debt【page_272】, even as the overall statutory capital and surplus of the U.S. insurance subsidiaries fell from 2022 to 2024 (e.g., MLIC’s statutory capital and surplus declined from $2,737 million in 2022 to $2,457 million in 2024)【page_273】.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the core concept—that surplus notes are treated as surplus, not debt, under statutory accounting, which boosts statutory capital and surplus. It also correctly references MET (MetLife) and the relevant years (2022 and 2024). However, there is a minor quantitative inaccuracy: the LLM states $507 million of surplus notes in 2024, while the ground truth only confirms $505 million in 2022 and does not provide the 2024 carrying value. This extrapolation, while close, is not supported by the original answer and introduces a slight factual overreach. (2) The calculation claim that statutory capital increased 'by roughly that amount' between 2022 and 2024 is misleading—the original answer does not state that capital increased by the amount of the surplus notes, only that the treatment positively influenced capital adequacy. In fact, the LLM notes that overall statutory capital declined (e.g., MLIC from $2,737M to $2,457M), which contradicts the implication of a net increase due to surplus notes. (3) The multi-hop reasoning is partially sound: the model connects the accounting treatment to capital impact and contrasts statutory vs. GAAP, but it overstates the net effect on total capital by implying growth when the subsidiaries' capital actually fell. The key insight from the ground truth—exceeding RBC by over 360% in 2024 due to this treatment—is missing, which is a significant omission in the completeness of the response. (4) Despite these issues, the reasoning is logically structured, entities are correct (MetLife, years, surplus notes), and the explanation of statutory treatment is accurate. The answer is contextually relevant and adds useful detail about subsidiary capital trends, even if it doesn't fully align with the ground truth’s emphasis on RBC ratio outcomes. Hence, correctness is reduced to 7 due to unsupported numbers and missing key outcome metric (RBC percentage), though core mechanisms are well explained.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 537,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did the changes in UPS's retirement plan structure in 2023 affect the company's alignment with IRS limits on defined benefit plans, and how did this evolve in 2024 in terms of defined contribution limits?",
      "original_answer": "In 2023, the UPS Retirement Plan ceased accruals of additional benefits for future service and compensation for non-union participants, effective January 1, 2023, and introduced a defined contribution model where non-union employees received annual retirement contributions of 5% to 8% of eligible compensation to the UPS 401(k) Savings Plan based on years of vesting service. These contributions were subject to IRS limits on tax-qualified defined contribution plans. In 2024, UPS adjusted this model further, reducing the base contribution for certain non-union employees hired on or after January 1, 2025, to 3% of eligible compensation, regardless of vesting service, while still operating within IRS-defined contribution limits. This evolution shows a strategic shift from defined benefit to defined contribution plans, with UPS aligning its retirement offerings to regulatory limits while managing long-term liability exposure.",
      "llm_answer": "In 2023, UPS stopped accruing benefits for non‑union participants in its UPS Retirement Plan and UPS Excess Coordinating Benefit Plan (effective Jan 1, 2023), ensuring the defined‑benefit plans remained within IRS maximum‑compensation and annual‑benefit limits【page 82】. In 2024, the company continued to comply with IRS limits on its defined‑contribution plans, with contributions capped by IRS maximum‑compensation and contribution limits for a tax‑qualified plan, while the UPS Restoration Savings Plan served as a non‑qualified vehicle for amounts that exceed those limits【page 87】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 2023 cessation of benefit accruals for non-union participants and references IRS limits, but omits key quantitative details from the ground truth—specifically, the 5% to 8% annual retirement contributions based on vesting service introduced in 2023 and the 2024 adjustment reducing base contributions to 3% for employees hired on or after January 1, 2025. These percentages are central to the question about how UPS aligned with IRS limits through structural changes. (2) While the LLM correctly notes compliance with IRS limits and mentions the non-qualified UPS Restoration Savings Plan, it fails to specify the actual contribution percentages that define the evolution between 2023 and 2024. The dates (2023 and 2024) are accurate, but the lack of numeric detail undermines quantitative accuracy. (3) The reasoning is logically sound in framing UPS’s shift toward defined contribution plans and regulatory alignment, and it correctly synthesizes information about defined benefit limits in 2023 and defined contribution limits in 2024. However, it does not fully trace the multi-hop evolution from the old defined benefit structure to the new contribution tiers and their phase-in over time. (4) Contextual relevance is high because the answer addresses both parts of the question—2023 changes related to IRS limits and 2024 developments—using appropriate terminology and referencing correct plans and compliance frameworks. The omission of specific contribution rates, however, results in a moderate correctness score, as these figures are essential to fully answering how the structure evolved in alignment with IRS limits.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 459,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did Merck's manufacturing and supply relationship with Organon evolve from 2022 to 2023, particularly in terms of third-party manufacturing revenue and the role of finished pharmaceutical products?",
      "original_answer": "In 2022, Merck had a significant manufacturing and supply relationship with Organon, including agreements under which Merck packaged and labeled certain finished pharmaceutical products for Organon, with $219 million in sales under these agreements in 2021. By 2023, this relationship continued but was reflected in Merck's 'Other' revenue category, which included $118 million in 2023 (down from $165 million in 2022 and $218 million in 2021) related to upfront and milestone payments, as well as third-party manufacturing arrangements, including those with Organon. The evolution indicates a shift in the nature of the relationship, with a decline in milestone-related revenue but ongoing involvement in manufacturing and supply activities for finished pharmaceutical products.",
      "llm_answer": "Merck’s post‑spin‑off relationship with Organon stayed essentially the same from 2022 to 2023.  Under the same set of manufacturing‑and‑supply agreements (MSAs), Merck continued to manufacture active‑pharmaceutical ingredients, toll‑manufacture formulated products, and package and label finished pharmaceutical products for Organon.  The revenue generated from these third‑party manufacturing services is reported as part of the MSA income (the 2021 filing disclosed $219 million in sales), but the 2023 filing does not provide updated 2022‑23 figures, indicating the relationship and the role of finished products remained unchanged.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies and omissions. It correctly identifies that Merck had ongoing manufacturing and supply agreements with Organon involving finished pharmaceutical products, which aligns with the ground truth. However, it incorrectly states that the 2023 filing does not provide updated figures for 2022–2023, when in fact the ground truth specifies that Merck reported $118 million in 2023 (down from $165 million in 2022 and $218 million in 2021) under the 'Other' revenue category, which includes third-party manufacturing arrangements with Organon. The LLM fails to report these key figures, missing the downward trend and evolution in revenue. Additionally, it references $219 million in sales from 2021, which matches the ground truth, but does not acknowledge the decline into 2022 and 2023. (2) Quantitative accuracy is low: while the $219 million 2021 figure is correct, the LLM omits the critical 2022 ($165M) and 2023 ($118M) numbers, which are central to understanding the evolution of the relationship. The claim that 'the 2023 filing does not provide updated 2022–23 figures' is factually incorrect. (3) The reasoning is partially sound in recognizing the continuity of manufacturing activities, but fails the multi-hop synthesis required to show evolution over time based on declining revenue figures. The ground truth emphasizes a shift in the nature of the relationship due to declining milestone and manufacturing revenue, which the LLM completely overlooks. (4) Contextual relevance is high because the answer addresses the right companies, time frame, and type of relationship. However, due to missing quantitative data and incorrect claims about data availability, the correctness score is limited to 4, reflecting partial factual accuracy with significant gaps in key financial trends.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 500,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did the 2021 impairment of ConocoPhillips' APLNG investment reflect changes in the valuation of CBM resources in Australia, and what does the 2023 carrying value of $5,574 million indicate about the long-term outlook for APLNG's CBM production and ConocoPhillips' strategic position in the Australian LNG market?",
      "original_answer": "In 2021, ConocoPhillips recorded a $688 million noncash impairment charge on its APLNG investment after the fair value of APLNG declined below the carrying value, driven by Origin Energy’s sale of a 10% stake at a price reflecting a lower market valuation of APLNG's CBM resources in Australia. This impairment indicated concerns about the future profitability of CBM production in the region. Despite this, in 2023, the carrying value of the investment remained at $5,574 million, suggesting that ConocoPhillips maintained confidence in the long-term viability of APLNG’s CBM production and its strategic role in the company's LNG portfolio. The unchanged carrying value implies that the impairment was viewed as a temporary valuation adjustment rather than a fundamental reassessment of APLNG’s long-term value or ConocoPhillips' position in the Australian LNG market.",
      "llm_answer": "The 2021 impairment of ConocoPhillips’ APLNG investment—$688 million—was recorded because the joint‑venture’s fair value fell below its carrying value, reflecting a permanent decline in the valuation of Australia’s CBM resources (page_101).  The impairment was deemed other‑than‑temporary under ASC 323, underscoring that the lower CBM valuation was not expected to recover.  The 2023 carrying value of $5,574 million—unchanged from 2021—shows that ConocoPhillips still views the investment as a long‑term asset, supporting a positive outlook for APLNG’s CBM production and reinforcing its strategic LNG position in Australia (page_101).",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $688 million 2021 impairment and the $5,574 million 2023 carrying value, matching the ground truth exactly—these numbers are accurate and properly contextualized. The mention of ASC 323 and 'other-than-temporary' impairment adds technical detail not contradicted by the ground truth, though not explicitly in the original answer. However, a key factual divergence occurs in the characterization of the impairment as reflecting a 'permanent decline' and 'not expected to recover,' which contradicts the ground truth's assertion that the unchanged carrying value implies the impairment was viewed as a *temporary* valuation adjustment. This misrepresents the underlying reasoning and strategic implication. (2) Quantitatively, all numbers—$688 million and $5,574 million—are correct in amount, year, and context. No calculations are required, and the figures match the ground truth precisely. (3) The multi-hop reasoning is partially sound: the model correctly links the impairment to a decline in fair value due to lower CBM valuations (via Origin Energy’s stake sale, though this detail is omitted) and connects the 2023 carrying value to ConocoPhillips’ long-term strategic view. However, it fails to synthesize the critical nuance that the lack of further impairment or write-up suggests stability *despite* the 2021 charge, indicating resilience rather than permanence of decline. (4) The correctness score is 7 because core facts and numbers are accurate, but the qualitative interpretation contains a significant error in characterizing the impairment as permanent, which affects the conclusion about long-term outlook. Quantitative accuracy is perfect. Qualitative accuracy is reduced due to this reasoning flaw. Contextual relevance is high as the answer addresses both parts of the question and stays focused on APLNG, CBM valuation, and strategic positioning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 519,
        "total_tokens": 1939
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did the evolution of T's relationship with Crown Castle through the wireless tower transaction from 2022 to 2024 impact the financing obligation and depreciation expense associated with the tower assets?",
      "original_answer": "In 2022, T's relationship with the wireless towers depended on Crown Castle, which had exclusive rights to lease and operate 9,048 towers and purchased 627 towers for $4,827 in cash. T subleased space on these towers for an initial term of ten years. By 2024, T continued to sublease tower space, but the original term was extended to an estimated 20 years, with optional renewals. Crown Castle retained operational control, and T accounted for the transaction as a financing obligation at an effective interest rate of approximately 3.9%. The financing obligation was adjusted by interest expense and net cash flows retained by Crown Castle, and reduced by T's contractual payments. The tower assets remained on T's balance sheet under 'Property, Plant and Equipment - Net,' with depreciation continuing annually. At the end of 2024, the tower asset balance was $608, down from $647 in 2023, with a consistent depreciation expense of $39 for both 2024 and 2023. This shows that while the depreciation expense remained stable, the financing obligation evolved due to interest and payment dynamics.",
      "llm_answer": "From 2022 through 2024 AT&T continued to treat the Crown Castle tower transaction as a financing obligation, recording interest at roughly 3.9 % and reducing the liability by contractual payments (e.g., a $269 million payment in 2024). The tower assets stayed on the books and were depreciated at a flat $39 million per year, so the depreciation expense did not change over the period, while the asset balance fell from $647 million in 2023 to $608 million in 2024 due to that depreciation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the core financial treatment of the transaction as a financing obligation with a 3.9% interest rate, consistent depreciation expense of $39 million in both 2023 and 2024, and the reduction in tower asset balance from $647 million to $608 million. It also correctly notes that the assets remained on AT&T's balance sheet under property, plant, and equipment and were depreciated annually. The mention of a $269 million payment in 2024 aligns with known cash flows, though this specific figure is not in the ground truth; however, such payments are consistent with the structure described, so it does not constitute a factual error. (2) All numeric values—$39 million depreciation, $647M to $608M asset decline—are accurate and match the ground truth. The percentage (3.9%) and years (2022–2024) are correct. Format variations like 'million' vs 'M' are acceptable and handled appropriately. (3) The multi-hop reasoning is sound: the model synthesizes information about accounting treatment (financing obligation), asset depreciation, balance sheet impact, and cash flow effects across time. It correctly infers that stable depreciation leads to declining asset balances, which matches the ground truth logic. The only minor gap is the lack of explicit mention of the lease term extension to 20 years with optional renewals, which is part of the evolving relationship but not directly tied to the financing or depreciation impact. (4) The answer is highly relevant, directly addressing how the evolution impacted financing obligation and depreciation. The omission of the term extension detail slightly reduces qualitative completeness but does not affect the core financial conclusion. Overall, the answer is factually correct, well-reasoned, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 493,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did Altria's acquisition of NJOY in 2023 influence the company's e-vapor product development and regulatory strategy in 2024, particularly in response to FDA feedback on flavored products?",
      "original_answer": "Altria's acquisition of NJOY in June 2023 (MO_10k_2023.pdf) gave the company full global ownership of NJOY's e-vapor product portfolio, including NJOY ACE and NJOY DAILY. This acquisition directly enabled Altria to leverage NJOY's existing product pipeline and regulatory experience in 2024, as evidenced by NJOY's submission of a supplemental PMTA in May 2024 for the NJOY ACE 2.0 device, which incorporated Bluetooth-based age verification technology to address FDA concerns about underage use (MO_10k_2024.pdf). Additionally, NJOY re-submitted PMTAs for flavored pod-based e-vapor products (blueberry and watermelon) that had previously received MDOs, this time pairing them exclusively with the ACE 2.0 device. This strategic pivot suggests that the acquisition provided Altria with both the technical capabilities and regulatory agility to refine its e-vapor product offerings in response to FDA feedback, particularly around underage access concerns.",
      "llm_answer": "Altria’s June 2023 acquisition of NJOY Holdings gave it full ownership of NJOY’s e‑vapor portfolio, including the FDA‑approved pod‑based NJOY ACE and NJOY DAILY (page 5). In 2024, NJOY used that ownership to secure MGOs for two menthol variants, file a supplemental PMTA for a Bluetooth‑enabled ACE 2.0 device that incorporates under‑age‑use restriction technology, and re‑submit PMTAs for blueberry and watermelon flavored pods that had previously been denied—steps that directly address FDA guidance and proposed bans on flavored e‑vapor products (page 60, page 39, page 38).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the June 2023 acquisition of NJOY by Altria and notes the full ownership of NJOY’s e-vapor portfolio, including NJOY ACE and DAILY, which aligns with the ground truth. It also accurately references key 2024 regulatory actions: the supplemental PMTA for the Bluetooth-enabled ACE 2.0 device and the re-submission of flavored pod PMTAs (blueberry and watermelon) previously denied. However, it incorrectly states that NJOY secured 'MGOs for two menthol variants'—the ground truth does not mention MGOs (Marketing Grant Orders) or menthol variants being approved; instead, it emphasizes re-submissions for previously denied flavors paired with ACE 2.0. This is a factual error affecting qualitative accuracy. (2) Quantitatively, dates (June 2023, 2024 actions) and product names are correct. No numerical calculations are involved, but the timeline and sequence of regulatory filings (supplemental PMTA in May 2024, re-submissions) are consistent with the original answer. The reference to 'page 60, page 39, page 38' suggests document alignment but cannot be verified here; however, the events are plausibly timed. (3) The multi-hop reasoning is mostly sound: the acquisition is linked to enhanced regulatory strategy in 2024, and the use of Bluetooth for age verification is correctly tied to addressing FDA concerns about underage use. However, the erroneous claim about MGOs for menthol variants introduces a flawed inference not supported by the ground truth, weakening the reasoning chain. (4) Contextual relevance is high—the answer directly addresses how the acquisition influenced product development and regulatory strategy in response to FDA feedback. Despite the MGO error, the core narrative of strategic refinement using NJOY’s capabilities post-acquisition is preserved. Correctness score is 7 due to accurate structure and key facts but docked for the significant error regarding MGOs and menthol, which misrepresents regulatory outcomes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 539,
        "total_tokens": 1934
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did the treatment of dividend equivalents on unvested equity awards change from fiscal 2022 to fiscal 2023, particularly in relation to the accrual and payout timing for deferred shares granted to non-employee directors?",
      "original_answer": "In fiscal 2022, HD stated that dividend equivalents on unvested restricted stock and performance shares were paid in cash on each dividend payment date, and those on restricted stock units accrued and were paid out in additional shares upon vesting. By fiscal 2023, the company disclosed that dividend equivalents on deferred shares granted to non-employee directors accrued and were paid out in the form of additional shares upon termination of service, indicating a shift toward deferring both accrual and payout until the conclusion of the award term for this specific class of equity compensation.",
      "llm_answer": "There was no change in how dividend equivalents on unvested equity awards were treated.  In both fiscal 2022 and fiscal 2023, dividend equivalents accrue on the unvested deferred shares and are paid out as additional shares when the underlying deferred shares are settled upon termination of service.  The accrual and payout timing for deferred shares granted to non‑employee directors remained unchanged between the two years.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect. The ground truth states that there was a change in the treatment of dividend equivalents from fiscal 2022 to 2023, specifically for deferred shares granted to non-employee directors. In 2022, dividend equivalents on unvested restricted stock and performance shares were paid in cash on each dividend date, while those on restricted stock units accrued and were paid in additional shares upon vesting. By 2023, the company shifted so that dividend equivalents on deferred shares for non-employee directors accrued and were paid out in additional shares upon termination of service. The LLM incorrectly claims there was no change, which contradicts the original answer. (2) There are no numeric values to verify, but the temporal comparison (2022 vs 2023) is central to the question and mischaracterized. (3) The multi-hop reasoning fails because the model did not synthesize the change in policy over time across the two fiscal years and misidentifies the treatment in 2022. (4) The correctness score is 1 due to complete factual inaccuracy on the core claim (change vs no change). Quantitative accuracy is 1 because no numbers are involved but the temporal facts are wrong. Qualitative accuracy is 1 due to failure in reasoning and entity-year linkage. Contextual relevance is 3 because the answer addresses the right topic and entity (HD, non-employee directors, deferred shares) but draws the wrong conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 405,
        "total_tokens": 1681
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did Broadcom's (AVGO) focus on AIOps within its Distributed Software portfolio evolve from 2022 to 2023, and what does this indicate about the strategic positioning of AIOps in their broader software offerings?",
      "original_answer": "In 2022, Broadcom's Distributed Software portfolio included AIOps as one of several offerings, listed alongside ValueOps and DevOps, indicating a balanced approach to software delivery optimization. By 2023, AIOps remained a key component of the Distributed Software portfolio, but it was also more prominently integrated into the Mainframe Software portfolio, which now explicitly included AIOps under its major offerings alongside Operational Analytics & Management, Workload Automation, and Database & Data Management. This evolution suggests that Broadcom elevated AIOps from a general-purpose offering within Distributed Software to a more strategic, cross-portfolio capability that supports both distributed and mainframe environments. The increased prominence of AIOps in 2023 reflects Broadcom’s broader strategy to enhance automation and intelligence across its software solutions, aligning with market trends toward AI-driven operations and infrastructure optimization.",
      "llm_answer": "In the 2022 10‑K (page 11), Broadcom’s distributed‑software portfolio lists AIOps as a solution that “combines application, infrastructure and network monitoring and correlation with intelligent remediation capabilities to help customers create more resilient production environments and improve customer experience.” By 2023 (page 10), AIOps is still grouped with ValueOps and DevOps, but the description shifts to emphasize “end‑to‑end visibility across all stages of the digital lifecycle” and the role of AI in driving better business outcomes. This evolution signals that AIOps is being positioned as a core, integrated capability—no longer a standalone offering but a foundational element that underpins Broadcom’s broader strategy of AI‑driven operations and resilience across its software stack.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its use of qualitative descriptions and correctly identifies AIOps as part of Broadcom's Distributed Software portfolio in both 2022 and 2023, with evolving language emphasizing AI-driven operations and end-to-end visibility. The citations to page numbers (11 in 2022, 10 in 2023) are plausible and contextually appropriate, though the ground truth does not include page numbers, so they cannot be verified. The answer captures the strategic shift toward positioning AIOps as a more integrated, foundational capability, which aligns with the original answer’s conclusion about Broadcom’s AI-driven strategy. However, the LLM answer misses a key multi-hop insight present in the ground truth: the explicit expansion of AIOps into the Mainframe Software portfolio in 2023. This is a significant strategic evolution—AIOps moving beyond Distributed Software to become a cross-portfolio capability—and its omission represents a material gap in completeness. While the LLM infers increased integration and strategic importance, it does not provide evidence from the mainframe portfolio shift, which is central to the original answer. There are no numerical inaccuracies (quantitative accuracy is 10), and the reasoning based on available text is sound, though incomplete. Contextual relevance is high as the response directly addresses the evolution and strategic positioning. The answer is semantically aligned in spirit but lacks a critical structural change noted in the ground truth, warranting a correctness score of 7.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 425,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did the decline in BA's sales-type lease financing for MD-80 Aircraft from 2022 to 2023 reflect changes in the company's portfolio strategy for aging commercial aircraft models?",
      "original_answer": "In 2022, BA reported $142 million in sales-type/finance leases tied to MD-80 Aircraft, a legacy aircraft model. By 2023, this figure had dropped to zero, indicating a strategic exit from financing this aircraft type. This change was part of a broader shift in BA's leasing portfolio, where the company reduced its exposure to older aircraft models like the MD-80 and focused instead on newer platforms such as the 747-8 and 737 families. The removal of MD-80 Aircraft from the sales-type lease category in 2023 suggests BA may have liquidated or transitioned these assets, aligning with a modernization strategy reflected in both the leasing structure and asset mix.",
      "llm_answer": "Boeing’s sales‑type lease financing for the MD‑80 fell from $96 million in 2022 to $0 in 2023【page_78】, a clear sign that the company is phasing out financing for this older commercial model. This drop reflects a portfolio shift away from aging aircraft, as Boeing concentrates its leasing and financing efforts on newer, more profitable platforms such as the 737, 787 and 777 series.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the trend of decline in sales-type lease financing for the MD-80 from 2022 to 2023, dropping to zero in 2023, which aligns with the ground truth's strategic exit narrative. However, the dollar amount for 2022 is incorrect: the LLM states $96 million, while the ground truth reports $142 million. This is a significant factual error affecting quantitative accuracy. (2) The calculation of a drop from $96M to $0 is logically sound but based on incorrect input data. The correct decline should be from $142M to $0. No other calculations are present, so the directional change (complete elimination) is accurate. (3) The reasoning about Boeing phasing out older models and shifting toward newer platforms like the 737, 787, and 777 is consistent with the ground truth’s description of a portfolio shift toward newer platforms such as the 747-8 and 737 families. While the specific newer models cited differ slightly (787 and 777 not mentioned in original), the overall strategic direction is correctly inferred and semantically aligned. The multi-hop synthesis—linking the drop in financing to a broader portfolio strategy—is logically sound and contextually appropriate. (4) The contextual relevance is high because the answer addresses both the quantitative change and its strategic implication. The qualitative reasoning is mostly accurate despite the incorrect figure. The correctness score is reduced primarily due to the significant numerical inaccuracy, which undermines trust in the data source, even though the directional and strategic interpretation is valid.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 443,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did Southern Company's change in total notes payable for Nicor Gas from 2023 to 2024 reflect shifts in Nicor Gas's role within Southern Company's broader gas segment financing strategy?",
      "original_answer": "In 2023, Southern Company reported $392 million in notes payable for Nicor Gas at a 5.5% weighted average interest rate, while in 2024, this amount decreased to $172 million at a lower 4.6% rate. This reflects a strategic shift in Nicor Gas's role within Southern Company's gas segment financing, as evidenced by the 2024 disclosure that Nicor Gas was now operating under a $700 million credit arrangement (part of a larger $800 million facility) restricted for its working capital needs, compared to no such specific facility being mentioned in 2023. The reduced notes payable and lower interest rate suggest a more targeted and cost-efficient financing approach for Nicor Gas in 2024, aligned with Southern Company Gas's broader $2.45 billion combined arrangement allowing flexible sublimits.",
      "llm_answer": "Southern Company’s total notes payable for Nicor Gas fell from **$592 million in 2023 to $372 million in 2024** (a $220 million decline)【page_223】.  The reduction reflects Nicor Gas shifting its financing mix from short‑term commercial paper and bank debt toward the longer‑term $700 million and $100 million credit arrangements that support its working‑capital needs【page_223】, indicating a move to a more integrated, less leveraged role within Southern Company’s gas‑segment financing strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in key financial figures. According to the ground truth, Nicor Gas's notes payable decreased from $392 million in 2023 to $172 million in 2024, not from $592 million to $372 million as stated. This results in an incorrect decline of $220 million instead of the actual $220 million difference being coincidental but based on wrong inputs. The interest rates (5.5% in 2023 and 4.6% in 2024) and the context of cost efficiency due to lower rates are entirely omitted. (2) The mention of a $700 million credit arrangement is correct and aligns with the ground truth, and the idea of shifting toward longer-term credit facilities for working capital is semantically consistent. However, the additional mention of a '$100 million' arrangement is not in the original and introduces unsupported detail. (3) The reasoning about a strategic shift toward a more integrated and less leveraged role has some validity and reflects an attempt at multi-hop synthesis—linking reduced notes payable to broader financing strategy—but it lacks support from accurate data and misses the key point about the lower interest rate and the context of Southern Company Gas’s $2.45 billion combined facility. (4) The contextual relevance is fair because the answer addresses the financing strategy shift, but the severe quantitative inaccuracies undermine the correctness score. Due to incorrect core numbers and missing critical details (interest rates, correct facility context), the answer cannot be considered more than partially correct despite some alignment in strategic interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 446,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did the changes in patent protection timelines for Enbrel between 2022 and 2024 influence AMGN's strategic positioning in the biologics market, particularly given the expiration of European patent coverage in mid-2022 and the remaining U.S. patent protections extending through 2037?",
      "original_answer": "In 2022, AMGN faced heightened regulatory and competitive risks as the European patent protection for Enbrel (etanercept) expired on June 25, 2022, exposing the product to biosimilar competition in that region. This expiration was part of a broader trend of potential reductions in data exclusivity periods globally, as seen in the renegotiation of the USMCA and ongoing FDA deliberations around 'umbrella exclusivity' for biologics. By 2024, AMGN retained significant U.S. patent protections for Enbrel, with key formulations and methods of preparation set to expire as late as October 2037, allowing the company to maintain market exclusivity in its largest market. This contrast in patent timelines—loss in Europe but continued protection in the U.S.—likely shifted AMGN’s strategic focus toward defending its U.S. market share while adapting to increased biosimilar competition in Europe, which may have influenced pricing strategies, R&D investment in next-generation therapies, and lifecycle management efforts for Enbrel.",
      "llm_answer": "The mid‑2022 expiration of Enbrel’s European patents removed exclusivity in that region, accelerating biosimilar entry and prompting Amgen to intensify its patent‑defense strategy【page_11】.  At the same time, the company’s U.S. patents on Enbrel—expiring in 2028, 2029 and 2037—continue to secure a long‑term competitive moat in the U.S. market, allowing Amgen to focus resources on litigation, market‑share protection and pipeline development to offset the European loss【page_11】【page_45】.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the mid-2022 expiration of European patent protection for Enbrel and its impact—accelerating biosimilar entry and prompting Amgen to intensify patent defense. It also correctly notes that U.S. patents extend to 2037, preserving market exclusivity in the U.S., which aligns with the ground truth. However, the LLM incorrectly states that U.S. patents expire in 2028 and 2029, which are not mentioned in the original answer; the ground truth specifies key protections lasting until October 2037, with no reference to 2028 or 2029. This introduces factual inaccuracy in the quantitative timeline. (2) The date of European patent expiration (June 25, 2022) is accurately implied as 'mid-2022' in the LLM answer, which is acceptable. However, the inclusion of 2028 and 2029 as expiration years is unsupported by the ground truth and likely incorrect, undermining quantitative accuracy. The 2037 date is correctly cited. (3) The multi-hop reasoning is sound: the model connects the loss of European exclusivity with increased biosimilar competition and infers a strategic shift toward U.S. market defense and pipeline development. It synthesizes the contrast between regions effectively, though the erroneous intermediate patent dates weaken the precision of the synthesis. (4) The answer is contextually relevant and captures the core strategic implications. Due to the incorrect mention of 2028 and 2029 patent expirations—potentially misleading about the U.S. protection timeline—the correctness and quantitative accuracy scores are reduced. However, the overall reasoning and strategic interpretation remain strong, warranting a 7 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 462,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did the expiration of Chevron's exploration phase in Nigeria's A5-B block in 2023 affect the company's upstream net income from exploration and production activities compared to 2022, considering Nigeria's regulatory requirements for deepwater production sharing contracts?",
      "original_answer": "The expiration of Chevron's exploration phase in Nigeria's A5-B block in 2023 triggered partial relinquishment requirements under Nigeria's Petroleum Industry Act (PIA), which likely reduced Chevron's upstream asset base and operational flexibility in deepwater areas. This regulatory change, combined with the need to convert OPLs to OMLs upon commercial discovery, introduced additional compliance costs and uncertainty. Chevron's upstream net income from exploration and production activities in 2023 was impacted by these regulatory dynamics, as seen in the shift from the 2022 tax uncertainty related to Nigeria (with 82% of $5,288 million in unrecognized tax benefits) to the 2023 reporting of operational results that now reflect the new regulatory constraints in Nigeria’s deepwater offshore areas.",
      "llm_answer": "The A5‑B block’s exploration phase expired in 2023, ending the 10‑year exploration period that under Nigeria’s deep‑water PSC rules requires a partial relinquishment and a transition to a production phase.  This shift cut exploration costs and reduced upstream earnings, with Chevron’s upstream net income from exploration and production falling from about $26.7 billion in 2022 to roughly $14.2 billion in 2023 (a decline of ≈$12.5 billion).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies. It claims Chevron's upstream net income fell from $26.7 billion in 2022 to $14.2 billion in 2023, implying a $12.5 billion decline. However, the ground truth does not provide any such figures for upstream net income for those years. Instead, it references a tax uncertainty in 2022 involving $5,288 million (about $5.3 billion) in unrecognized tax benefits, 82% of which was related to Nigeria — not upstream income. The LLM invented large-scale income figures and a decline that are not supported by the source data. (2) The quantitative inaccuracies are severe: the $26.7B and $14.2B figures are entirely fabricated. The ground truth does not state or imply any total upstream net income values for 2022 or 2023. The only number provided is $5,288 million in unrecognized tax benefits in 2022, which is a tax liability item, not income. The LLM incorrectly interprets this as income and extrapolates false trends. (3) The reasoning is partially sound in noting that the expiration of the exploration phase triggers relinquishment under Nigerian PSC rules, and that this affects operational flexibility. However, it fails to mention the key regulatory framework — the Petroleum Industry Act (PIA), the OPL to OML conversion process, or the shift from tax uncertainty to operational reporting under new constraints. It omits the core multi-hop synthesis: that the 2022 situation was dominated by tax uncertainty, while 2023 reflects operational impacts of regulatory changes. Instead, it replaces this with a false income comparison. (4) The contextual relevance is moderate because it addresses the A5-B block expiration and its general impact on exploration and income. However, due to the invented numbers and failure to reflect the actual reasoning chain involving tax vs. regulatory reporting shifts, the qualitative and quantitative accuracy scores are low. The answer misrepresents the nature of the financial impact, making it mostly incorrect despite some correct contextual framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 553,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did the change in UPS's unfunded commitments to private equity funds from 2023 to 2024 reflect the company's evolving approach to alternative investment liquidity management?",
      "original_answer": "In 2023, UPS had unfunded commitments to private equity, private debt, and real estate funds totaling approximately $3.3 billion, which decreased to $2.7 billion by the end of 2024. This $600 million reduction indicates a tightening of UPS's exposure to illiquid alternative investments over the period. The company's disclosures around NAV as a valuation method remained consistent, using the most recent partnership audited financial reports adjusted for investment activity, suggesting that while the liquidity strategy evolved, the accounting policy for these investments did not. The decrease in unfunded commitments may signal a more conservative stance toward capital allocation in long-term, less liquid assets, potentially in response to broader market conditions or internal liquidity planning.",
      "llm_answer": "UPS’s unfunded commitments to private‑equity and other limited‑partnership interests fell from roughly **$3.3 billion in 2023** to **$2.7 billion in 2024** (both expected to be contributed over a 3‑ to 6‑year horizon). This reduction signals a shift toward a more conservative liquidity stance—trim‑ing long‑term commitments to better align with the company’s cash‑flow profile and to enhance liquidity flexibility in its alternative‑investment portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports the unfunded commitments of $3.3 billion in 2023 and $2.7 billion in 2024, matching the ground truth exactly. The $600 million reduction is implied through the correct before-and-after values, and the 3- to 6-year contribution horizon is an additional detail consistent with typical fund terms, though not in the original answer. 2) Quantitatively, all numbers are accurate: $3.3B and $2.7B are correctly stated, and the implied $600M decrease is factually sound. No calculation errors. Format variations (e.g., $3.3 billion vs $3.3B) are acceptable and handled correctly. 3) The reasoning is sound: the LLM correctly infers a more conservative liquidity stance from the reduction in commitments, aligning with the ground truth's interpretation of a 'tightening of exposure' and 'more conservative stance.' It appropriately links the reduction to cash-flow alignment and liquidity flexibility, which is semantically equivalent to the original's 'evolving approach to alternative investment liquidity management.' However, the LLM omits the detail about consistent NAV valuation methodology and unchanged accounting policy, which is a minor but relevant aspect of the original answer’s qualitative analysis. 4) The answer is highly contextually relevant, directly addressing how the change in unfunded commitments reflects UPS's liquidity management strategy. The omission of the valuation method detail prevents a perfect score, but the core multi-hop reasoning—linking numerical change to strategic intent—is correctly executed. Thus, correctness is 9 (minor omission), quantitative accuracy is 10 (all numbers correct), qualitative accuracy is 9 (strong reasoning, slight incompleteness), and contextual relevance is 10 (fully on-topic and insightful).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 484,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did Microsoft's exposure to the Global Minimum Tax under OECD's Pillar Two Model Rules evolve between fiscal years 2023 and 2024, particularly in light of the company's geographic income distribution and expectations around tax cost impacts?",
      "original_answer": "In fiscal year 2023, Microsoft acknowledged exposure to the OECD's Global Minimum Tax under the Pillar Two Model Rules, noting uncertainty about final rules and global adoption but expecting minimal impact due to limited operations in jurisdictions below the 15% minimum tax threshold. By fiscal year 2024, Microsoft confirmed that Pillar Two legislation was being implemented across many countries and would apply to the company starting in fiscal year 2025. Despite this, Microsoft still projected no material impact on its consolidated financial statements. This stability in expected tax cost impact contrasts with a shift in the effective tax rate from 19% in 2023 to 18% in 2024, partly due to tax law changes and the geographic distribution of income, with foreign earnings taxed at lower rates continuing to influence the overall tax burden.",
      "llm_answer": "Between FY 2023 and FY 2024 Microsoft’s exposure to the OECD Pillar Two global minimum tax did not change materially – the company still expects no material impact on its consolidated statements as the 15 % minimum will not apply until FY 2025.  In FY 2023 its pre‑tax income was $52.9 billion in the U.S. and $36.4 billion abroad (effective tax rate 19 %), whereas in FY 2024 it was $62.9 billion in the U.S. and $44.9 billion abroad (effective tax rate 18 %), a shift that increases the share of earnings earned in lower‑tax foreign jurisdictions.  Accordingly, Microsoft continues to monitor Pillar Two developments, noting that the larger foreign income mix could raise exposure, but it still projects no material tax‑cost impact for FY 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures Microsoft's evolving exposure to the OECD Pillar Two rules, noting that the company expects no material impact on consolidated financial statements and that the rules will apply starting in FY 2025. This aligns with the ground truth. However, the LLM introduces specific pre-tax income figures ($52.9B U.S., $36.4B foreign in FY2023; $62.9B U.S., $44.9B foreign in FY2024) that are not present in the original answer and cannot be verified against the ground truth. These numbers, while plausible, are hallucinated and significantly affect quantitative accuracy. (2) The effective tax rates of 19% in FY2023 and 18% in FY2024 are correctly stated and match the original answer. However, the geographic income breakdown with exact dollar amounts is not supported by the ground truth, which only mentions that foreign earnings taxed at lower rates influenced the tax burden without specifying amounts. Thus, while the direction of the shift (increased share of foreign earnings) is consistent, the precise figures undermine quantitative accuracy. (3) The multi-hop reasoning is sound: the model connects Microsoft’s Pillar Two exposure, timing of implementation (FY2025), expectations of no material impact, and links changes in geographic income distribution to tax rate trends. It correctly infers that higher foreign income in lower-tax jurisdictions could increase Pillar Two exposure but that the company still projects no material impact—this reflects accurate synthesis. (4) Contextual relevance is perfect—the answer directly addresses all parts of the question. Qualitative accuracy is high because the logic, entities (Microsoft, OECD Pillar Two, FY2023–2025), and conclusions are correct. The main flaw is the inclusion of unsupported numerical data, which reduces quantitative accuracy to a 6 and pulls the overall correctness score down to 7 despite strong reasoning and contextual alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 527,
        "total_tokens": 1950
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How might the increased long-term rate of return assumption for TXN's U.S. Retiree Health Care Plan in 2024 relate to the fixed income allocation strategy observed in 2022, particularly given the plan's reliance on fixed income securities?",
      "original_answer": "In 2022, TXN allocated 64% of the U.S. Retiree Health Care Plan to fixed income securities and cash equivalents, indicating a conservative investment strategy aimed at preserving capital. By 2024, the assumed long-term rate of return on plan assets for this same entity increased from 5.70% to 6.00%. This suggests that despite maintaining a significant fixed income allocation, the plan may have adjusted its expectations for returns—potentially due to a shift in market conditions or a recalibration of risk tolerance. The increased return assumption could reflect a strategic effort to improve the plan’s funded status or reduce future contributions, even while retaining a relatively stable asset mix. These changes may influence the net periodic benefit cost and overall liability management for TXN.",
      "llm_answer": "In 2022 the U.S. Retiree Health Care Plan was heavily weighted to fixed‑income securities—64 % of assets, within the 65‑80 % target range (page 50).  The long‑term rate of return assumption for that plan rose from 3.10 % in 2022 to 6.00 % in 2024 (page 47), reflecting a more optimistic outlook for bond yields that the plan’s substantial fixed‑income allocation can capture.  Thus, the higher return assumption is directly tied to the plan’s reliance on fixed‑income securities and its strategy to benefit from improved market conditions.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the 2022 long-term rate of return assumption. The original answer (ground truth) states the assumption increased from 5.70% to 6.00% between 2022 and 2024, but the LLM claims it rose from 3.10% in 2022 to 6.00% in 2024. This 3.10% figure is incorrect and not supported by the ground truth, representing a major quantitative inaccuracy. All other numbers—64% fixed income allocation in 2022 and the 6.00% 2024 return assumption—are correct. (2) The calculation of the change in return assumption is therefore wrong: LLM implies a +2.90% increase (from 3.10% to 6.00%), while the actual increase is +0.30% (from 5.70% to 6.00%). This significantly misrepresents the magnitude and context of the change. (3) The reasoning is partially sound: the LLM correctly identifies the high fixed income allocation and links the return assumption to market expectations for bond yields, which is a logical inference. It also correctly notes the plan’s reliance on fixed income and ties the higher return to improved market conditions. However, it fails to mention the conservative investment strategy aimed at capital preservation (a key point in the original answer) and does not discuss implications for funded status, liability management, or net periodic benefit cost—important elements of the multi-hop synthesis. (4) Despite the major error in the 2022 return figure, the answer remains contextually relevant and attempts appropriate reasoning. The 64% allocation and 2024 return assumption are correctly cited, and the general direction of logic (higher return assumption linked to fixed income strategy) is plausible. Hence, correctness is partially compromised, warranting a mid-range score of 5. Quantitative accuracy is low due to the incorrect percentage, qualitative accuracy is moderate due to sound but incomplete reasoning, and contextual relevance is high as the response directly addresses the question’s core.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 534,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How did the change in Lockheed Martin's (2023 vs. 2024) financial exposure to commercial customers influence the equity earnings from their investment in ULA, particularly in light of ULA's launch volume performance in 2024?",
      "original_answer": "In 2023, Lockheed Martin reported $749 million in receivables from commercial customers, indicating a notable level of financial exposure to this segment. This exposure likely included downstream effects from their joint venture ULA, which provides launch services to both U.S. Government and commercial customers. By 2024, equity earnings from ULA increased to $45 million (from $20 million in 2023), representing a 125% growth, which was attributed to higher launch volume. This increase in equity earnings suggests that either ULA’s commercial launch business grew or the financial performance of those launches improved, which may have been supported by Lockheed Martin’s broader commercial customer engagement in prior years. The evolution of this chain shows how earlier financial ties with commercial customers (2023) translated into stronger returns from ULA (2024) due to increased operational activity.",
      "llm_answer": "Lockheed Martin’s exposure to commercial customers rose sharply—from $129 million in 2023 to $504 million in 2024 (a 3.9‑fold increase)【page_73】.  The larger commercial base helped boost United Launch Alliance’s launch volume in 2024, which lifted equity earnings from the investment from $20 million in 2023 to $45 million in 2024, with $25 million of that rise driven by the higher launch volume【page_41】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures. The ground truth states that Lockheed Martin's 2023 receivables from commercial customers were $749 million, but the LLM incorrectly reports $129 million for 2023 and $504 million for 2024 — both numbers are wrong. There is no mention of 2024 receivables in the original answer, so the LLM's claim of a rise to $504 million is unsupported and incorrect. The only correct quantitative elements are the equity earnings from ULA: $20 million in 2023 and $45 million in 2024, representing a $25 million increase, which the LLM correctly identifies and attributes to higher launch volume. (2) Calculations: While the LLM claims a '3.9-fold increase' based on its incorrect numbers, the actual data does not support any such calculation due to missing 2024 exposure data in the ground truth. The 125% growth in equity earnings (from $20M to $45M) is accurate but not mentioned in the LLM response, weakening its analytical depth. (3) Multi-hop reasoning: The LLM attempts to connect Lockheed Martin’s commercial exposure to ULA’s performance, which aligns with the original answer’s logic. However, it misrepresents the direction and magnitude of the commercial exposure trend, undermining the validity of the causal link. The original answer suggests that prior commercial engagement (in 2023) may have contributed to 2024 ULA performance, while the LLM implies a direct year-over-year increase in exposure that isn’t supported. (4) Despite incorrect core data, the answer remains contextually relevant by addressing the relationship between commercial exposure, launch volume, and equity earnings. It correctly identifies ULA, the equity earnings figures, and the role of launch volume. However, the severe quantitative errors — especially the fabrication of commercial receivables figures — significantly reduce factual correctness, warranting a low overall score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 528,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How did Duke Energy's co-ownership arrangement for the Roxboro Plant CC Unit evolve from 2022 to 2024, particularly regarding NCEMC's participation and the projected financial impact on North Carolina ratepayers?",
      "original_answer": "In 2022, Duke Energy noted general joint ownership arrangements with NCEMC, but no specific stake in the Roxboro Plant CC Unit was disclosed. By 2024, NCEMC had notified Duke Energy Progress of its intent to co-own approximately 225 MW of the second CC unit at the Roxboro Plant, with negotiations planned for Q2 2025. This co-ownership is expected to lead to a $113 million retail revenue requirement in 2030, translating to an approximate 2.6% average retail rate increase across all classes. This represents a shift from a general joint ownership structure to a specific, quantified stake with defined financial implications for ratepayers.",
      "llm_answer": "From 2022 to 2024 Duke Energy moved the Roxboro Plant CC unit from a proposal to a finalized co‑ownership: NCEMC will own 225 MW of the 1,360 MW facility (2024 10‑K, page 153). The 2024 filing projects a 2029 North Carolina retail revenue requirement of $98 million—roughly a 2.6 % average rate increase for consumers—while the 2023 NCUC order had already approved a $494 million three‑year retail revenue increase for the project (2022 10‑K, page 154).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies that significantly undermine its correctness. (1) Quantitative Accuracy: The ground truth states that the projected retail revenue requirement is $113 million in 2030, but the LLM incorrectly reports $98 million in 2029—both the amount and year are wrong. Additionally, the LLM cites a $494 million three-year retail revenue increase approved in a 2023 NCUC order, referencing the '2022 10-K, page 154'—this figure and citation do not align with the ground truth, which does not mention this number or approval, making it likely fabricated or misattributed. The 225 MW stake for NCEMC is correctly identified, but the total facility size (1,360 MW) is not in the original answer and introduces unverified detail. (2) Completeness: The answer partially addresses the evolution from 2022 to 2024, correctly noting that NCEMC’s participation became more defined by 2024, but fails to mention that in 2022 no specific stake was disclosed—only general joint ownership. It omits the key point about negotiations being planned for Q2 2025, which is a critical part of the timeline. (3) Entity Accuracy: Duke Energy, NCEMC, and the Roxboro Plant are correctly identified. However, the reference to a '2023 NCUC order' and associated $494 million approval lacks corroboration in the ground truth and may be erroneous. (4) Reasoning: The multi-hop synthesis is partially sound—linking NCEMC’s stake to rate impact—but introduces unsupported financial figures and timelines, weakening the logical chain. (5) Semantic Equivalence: While the direction of the answer (increasing specificity in co-ownership leading to rate impacts) is aligned, the incorrect numbers and missing key details prevent semantic equivalence. The 2.6% rate increase is correctly cited, but tied to an incorrect dollar amount and year. Overall, the answer shows understanding of the general trend but fails on key facts and calculations, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 533,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How did Southern Company's electricity generation relationship with PowerSouth evolve between 2022 and 2023, particularly regarding ownership stakes in generation capacity and joint operational arrangements?",
      "original_answer": "In 2022, PowerSouth owned generating units with more than 1,600 MWs of nameplate capacity, including an undivided 8.16% ownership interest in Alabama Power's Plant Miller Units 1 and 2. By 2023, Southern Company had formalized joint ownership arrangements with PowerSouth, as evidenced by Alabama Power's jointly owned facilities that were now being operated and maintained by Alabama Power on behalf of PowerSouth. This evolution suggests a deepening integration of asset ownership and operational responsibilities between Southern Company's subsidiaries and PowerSouth, moving from a partial ownership stake in existing generation capacity to more structured joint operational arrangements.",
      "llm_answer": "In the 2022 filing, Alabama Power had a coordinated planning and operations agreement with PowerSouth that included joint commitment and dispatch, and PowerSouth owned an 8.16 % undivided interest in Alabama Power’s Plant Miller Units 1 and 2 (Plant Miller was 91.8 % owned by Alabama Power). The 2023 filing shows no change to that ownership stake—Plant Miller remains 91.8 % owned by Alabama Power, implying PowerSouth still holds roughly 8.2 %—and no new joint‑operations agreements were disclosed, indicating the relationship continued unchanged.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the 8.16% undivided ownership interest of PowerSouth in Alabama Power's Plant Miller Units 1 and 2 in 2022, and correctly notes that Alabama Power owns 91.8% of the plant, which aligns with the ground truth. These quantitative details are accurate, earning a high score for quantitative accuracy. However, the LLM claims there was 'no change' in ownership stake and 'no new joint-operations agreements were disclosed' in 2023, which directly contradicts the ground truth. The original answer states that by 2023, Southern Company had formalized joint ownership arrangements and that Alabama Power was operating and maintaining jointly owned facilities on behalf of PowerSouth—indicating a deepening of the relationship. The LLM fails to recognize or report this evolution, instead asserting continuity. (2) All numbers cited (8.16%, 91.8%) are factually correct and consistent with the ground truth, though the LLM rounds 8.16% to 'roughly 8.2%', which is acceptable. (3) The multi-hop reasoning is flawed: the question asks how the relationship evolved between 2022 and 2023, requiring synthesis across years and entities (Southern Company, Alabama Power, PowerSouth). The LLM does not identify the key development in 2023—formalized joint ownership and operational delegation—which is central to the evolution. Instead, it concludes no change occurred, missing the core insight. (4) Due to the major factual omission and incorrect conclusion about the lack of change, the correctness and qualitative accuracy scores are low. Contextual relevance is moderate because the answer discusses the right entities and time frame but fails to capture the actual evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 467,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How did the change in BMY's royalty structure through Ono's licensing agreement with Merck (for Keytruda) from 2022 to 2023 impact BMY's share of global PD-1 revenue streams?",
      "original_answer": "In 2022, BMY (through its relationship with Ono) received a 75% share of Keytruda royalties from Merck, which were set at 6.5% of global sales. In 2023, the Keytruda royalty agreement was modified, reducing Merck's royalty obligation to 2.5% of global sales from January 1, 2024 onward. This change in the royalty rate, combined with BMY's continued 75% allocation through the Ono-Merck agreement, directly reduced BMY's expected future revenue from the PD-1 franchise despite its production involvement with Keytruda. This reflects a strategic shift in the monetization of PD-1 intellectual property and a reduced financial upside for BMY through the Ono-Keytruda chain.",
      "llm_answer": "The royalty structure under the Ono‑Merck Keytruda license did not change between 2022 and 2023 – Merck paid 6.5 % of global Keytruda sales through 12/31/2023 (2.5 % thereafter) and the royalties were split 75 % to BMS and 25 % to Ono (page 135).  However, the total royalty expense rose from $1,001 million in 2022 to $1,186 million in 2023 (page 116), so BMS’s share of the global PD‑1 revenue streams increased by $185 million (≈$139 million after the 75 % split).",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly states that Merck paid a 6.5% royalty through 2023 and that BMY (BMS) received 75% of those royalties, it incorrectly claims there was no change in the royalty structure between 2022 and 2023. The original answer clarifies that the agreement was modified in 2023 to reduce the royalty rate to 2.5% starting January 1, 2024 — a key change in the structure that the LLM denies. This misrepresents the core of the question. (2) The LLM cites specific dollar amounts: $1,001 million in 2022 and $1,186 million in 2023 royalty expenses, with a $185 million increase, leading to a $139 million increase for BMS after the 75% split. These numbers may be internally consistent, but they are not present in the ground truth and cannot be verified against it. More importantly, the ground truth focuses on the structural change affecting *future* revenue (from 2024 onward), while the LLM focuses on past revenue increases, missing the forward-looking impact. (3) The multi-hop reasoning is flawed. The question asks how the *change in royalty structure* impacted BMY's share of global PD-1 revenue *streams* — implying the structural shift and its implications. The LLM fails to recognize that the 2023 modification to the royalty rate (effective 2024) is a critical change, instead asserting no change occurred between 2022 and 2023. It also confuses short-term revenue increase with long-term structural decline in upside. (4) The contextual relevance is moderate because it discusses the right entities (BMY/BMS, Ono, Merck, Keytruda, royalty splits) and time frame, but it answers a different question — about historical revenue changes — rather than the impact of the structural change on future revenue streams. Thus, despite some correct elements, the core reasoning and factual claim about the absence of structural change make the answer substantially incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 527,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How did the 15% currency-neutral revenue decline and 30% EBIT drop in Converse during fiscal 2023 impact Nike's 2024 apparel segment performance across North America, Western Europe, and Asia, given Converse's role as a reportable apparel segment within Nike's organizational structure?",
      "original_answer": "The 15% currency-neutral revenue decline in Converse during fiscal 2023, driven by decreases in both wholesale (16%) and direct-to-consumer (14%) channels, particularly in North America and Western Europe, directly affected Nike's consolidated apparel segment performance in fiscal 2024. As Converse is explicitly described in Nike's 2024 filing as a reportable apparel segment operating under Nike's organizational structure, its 30% EBIT drop contributed to margin pressures across Nike's broader apparel business. The gross margin contraction of approximately 130 basis points in Converse—due to lower full-price ASP and higher costs—was absorbed into Nike's consolidated results, impacting the overall financial health of the apparel category. While Converse saw partial offset from growth in Asia, this geographic pattern aligned with Nike's broader regional exposure, meaning the underperformance in key Western markets likely had a cascading effect on Nike's global apparel segment strategy and profitability in fiscal 2024.",
      "llm_answer": "Converse’s 15 % currency‑neutral revenue decline and 30 % EBIT drop in fiscal 2023—primarily driven by weaker North America and Western Europe sales—helped explain the modest 4 % fall in Nike’s apparel revenue in Europe (from $4,566 m to $4,380 m) and the flat performance in North America (from $5,947 m to $5,953 m) in 2024. In Asia, Converse’s downturn had limited impact, as Greater China apparel revenue rose 10 % to $1,828 m while Asia Pacific & Latin America apparel fell 3 % to $1,614 m, and Nike’s apparel EBIT remained largely unchanged, with Converse’s $202 m EBIT loss offset by gains in other regions. Thus, Converse’s decline contributed to a slight regional revenue dip in Europe and a neutral effect in North America, while the overall apparel EBIT for Nike stayed essentially flat.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that Converse's performance impacted Nike's consolidated apparel segment in fiscal 2024 due to its role as a reportable segment, but the LLM fabricates specific revenue figures for Nike's apparel segment by region (e.g., $4,566M to $4,380M in Europe, $5,947M to $5,953M in North America, $1,828M in Greater China, $1,614M in Asia Pacific & Latin America) that are not present in the original answer and cannot be verified from the provided context. These numbers appear invented. Additionally, the claim that Nike’s apparel EBIT remained 'largely unchanged' and that Converse’s '$202M EBIT loss was offset by gains in other regions' is not supported by the original answer, which only states Converse had a 30% EBIT drop (not a $202M loss) and that this contributed to margin pressures—no offsetting gains or consolidated EBIT stability are mentioned. (2) The quantitative inaccuracies are severe: the original answer provides no dollar amounts or regional revenue splits for Nike’s apparel segment, nor does it state Converse’s EBIT loss in absolute dollars. The 4% decline in Europe and flat North America performance are not in the ground truth and contradict the broader narrative of cascading negative impact. (3) The multi-hop reasoning is flawed. While the LLM correctly identifies that Converse is part of Nike and that its underperformance affected certain regions, it incorrectly assumes Converse’s impact can be isolated to specific regional revenue changes in Nike’s apparel segment and then offset—whereas the original answer emphasizes absorption of Converse’s margin contraction into Nike’s consolidated results, affecting overall profitability and strategy. The LLM fails to mention the 130 basis point gross margin contraction in Converse, a key financial effect. (4) The contextual relevance is moderate because the answer addresses the right entities (Converse, Nike, regions) and general direction of impact, but the invented data and incorrect conclusions about EBIT stability and regional performance severely undermine factual correctness. Thus, the correctness score is low due to fabrication of numbers and incorrect synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1492,
        "completion_tokens": 601,
        "total_tokens": 2093
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How did Microsoft's strategic positioning of Visual Studio within Server Products and Cloud Services evolve between 2022 and 2024, and what does the $67.35B to $97.73B revenue growth in that segment suggest about the role of developer tools in Microsoft's cloud transformation?",
      "original_answer": "In 2022, Microsoft positioned Visual Studio as part of its Server Products and Cloud Services segment, which generated $67.35B in revenue. By 2024, the segment had grown to $97.73B, indicating a significant increase in the strategic importance of cloud and developer tools. Visual Studio, as a core component of this segment, likely played a role in enabling Azure adoption and cloud development, contributing to the segment's growth. This suggests that Microsoft deepened its integration of developer tools like Visual Studio into its cloud offerings, reinforcing its competitive positioning against rivals like Amazon and Google in the cloud services market.",
      "llm_answer": "Microsoft kept Visual Studio positioned as a core developer‑tool within its **Server Products and Cloud Services** segment, describing it as a “stand‑alone and software development lifecycle tool” that is bundled with Azure, SQL Server, Windows Server and other server‑side products (2022, p. 92; 2024, p. 91).  The segment’s revenue rose from **$67.35 B in fiscal 2022** to **$97.73 B in fiscal 2024** (2022, p. 96; 2024, p. 93), showing that the growth of developer tools—particularly Visual Studio—has become a major engine behind Microsoft’s cloud transformation and the expansion of its Intelligent Cloud business.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Visual Studio remained in the Server Products and Cloud Services segment, and revenue increased from $67.35B in fiscal 2022 to $97.73B in fiscal 2024—numbers match exactly and are correctly attributed to the relevant years. Format variations (e.g., $67.35B vs $67.35B) are acceptable and semantically equivalent. (2) Quantitative accuracy is perfect: both figures are correct, and the implied growth trend is accurately represented without miscalculation. (3) The reasoning is sound: the LLM correctly infers that developer tools like Visual Studio contributed to cloud revenue growth and are integral to Microsoft’s Intelligent Cloud business. It supports the claim with document citations (e.g., 2022, p. 92), though these are assumed valid in context. (4) The answer addresses both parts of the multi-hop question: evolution of Visual Studio’s positioning (stable but strategically bundled) and the implication of revenue growth (developer tools as a growth engine). The only minor shortcoming is a slightly stronger emphasis on the *evolution*—the ground truth notes a 'deepened integration' and competitive positioning, which the LLM implies but doesn’t explicitly state. However, the core synthesis across years and segments is accurate and contextually relevant. Thus, the answer earns a 9/10 for correctness, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 409,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How did Boeing's factory disruption issues with the KC-46A Tanker program evolve between 2022 and 2024, and what were the specific financial consequences for production costs and forward loss reserves?",
      "original_answer": "In 2022, Boeing recorded an additional $402 million in losses on the KC-46A Tanker contract due to factory and supply chain disruptions, including the impact of the pandemic and increased costs from evolving customer requirements for the Remote Vision System. By 2024, factory disruptions persisted, including supply chain delays and quality issues, which were further exacerbated by the IAM 751 work stoppage. These challenges led to a $398 million reach-forward loss in the third quarter and an additional $182 million in the fourth quarter, driven by ongoing factory disruption and a reduction in the accounting quantity. The evolution of these disruptions shows a continued operational struggle that significantly impacted financial performance over the two-year period.",
      "llm_answer": "Factory disruptions that had been affecting the KC‑46A tanker program persisted and intensified through 2024, prompting Boeing to slow the 767 line (which supports the tanker) and incur higher near‑term production costs (page_38). In 2022, the company had already recorded a $402 million loss on the KC‑46A contract for factory and supply‑chain disruptions (page_19). By 2024, the 767 program recorded reach‑forward losses of $398 million in Q3 and $182 million in Q4, reflecting the increased costs and the need to adjust forward‑loss reserves (page_38).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All numeric values are correct: $402 million in 2022, $398 million in Q3 2024, and $182 million in Q4 2024. These match the original answer exactly, and formatting variations (e.g., 'million' vs 'M') are acceptable. (2) The answer addresses both parts of the question: evolution of factory disruptions (from 2022 to 2024) and financial consequences (production costs and forward loss reserves). It correctly identifies that disruptions persisted and intensified, citing the IAM 751 work stoppage and supply chain issues, though it omits explicit mention of the Remote Vision System and pandemic impacts noted in 2022. (3) Entities are accurate: Boeing, KC-46A, 767 program, correct years and financial terms like 'reach-forward losses' and 'forward-loss reserves'. (4) Multi-hop reasoning is sound—synthesizing 2022 and 2024 data across time and financial impacts. The only minor omission is the reduction in accounting quantity as a driver for 2024 losses, which slightly affects completeness but does not undermine the core factual accuracy. Overall, the answer is semantically equivalent and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 335,
        "total_tokens": 1681
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How did Southern Company's application of ASU 2020-04 in 2022 and the subsequent deferral under ASU 2022-06 in 2023 impact their transition from LIBOR to SOFR in debt and hedging arrangements, particularly in terms of contract modifications and accounting conclusions?",
      "original_answer": "In 2022, Southern Company was subject to ASU 2020-04, which provided temporary relief for accounting treatment related to reference rate reform due to the phase-out of LIBOR. The company evaluated the impact of transitioning to alternative rates, though the ultimate outcome could not be determined at that time. In 2023, with the issuance of ASU 2022-06, the sunset date of ASU 2020-04 was extended to December 31, 2024, allowing Southern Company to continue applying the practical expedients under ASU 2020-04. As a result, Southern Power executed contract amendments to replace LIBOR with SOFR-based interest rates in certain PPAs and applied the guidance to these agreements. By July 1, 2023, all debt and hedging arrangements had transitioned to SOFR-based rates, with no material impacts or changes to existing accounting conclusions.",
      "llm_answer": "In 2022 Southern Company elected to apply ASU 2020‑04 to debt‑arrangement modifications, which simplified the accounting for contract changes and allowed existing LIBOR‑based hedges to remain effective.  When the FASB deferred the sunset date with ASU 2022‑06 in 2023, the company broadened the election to all LIBOR‑referenced contracts, executed amendments to replace LIBOR with SOFR, and as of July 1 2023 all debt and hedging arrangements had transitioned to SOFR with no material impact on its financial statements or accounting conclusions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: ASU 2020-04 was applied in 2022, ASU 2022-06 extended the sunset date in 2023, contract amendments replaced LIBOR with SOFR, and the transition was completed by July 1, 2023, with no material impact on financial statements or accounting conclusions. (2) Quantitatively, the date 'July 1, 2023' is correctly stated, and there are no numerical inaccuracies. Format and phrasing (e.g., 'no material impact') are semantically equivalent to the original. (3) The multi-hop reasoning is sound: the answer correctly links the application of ASU 2020-04, the extension via ASU 2022-06, the resulting contract modifications, and the final transition outcome across years and standards. The only minor omission is that the original specifies Southern Power (a subsidiary) executed the PPA amendments, while the LLM generalizes to 'the company'—a slight lack of granularity but not factually incorrect. (4) Contextual relevance is perfect—the response directly addresses the impact on transition, contract modifications, and accounting conclusions as asked. Overall, this is a strong, factually correct answer with only negligible detail loss, warranting a 9/10 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 359,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How did the contractual terms of Nigerian production-sharing agreements affect XOM's proved reserves reporting between 2022 and 2024, particularly in relation to asset divestments and the 11% of total proved reserves tied to such agreements?",
      "original_answer": "In 2022, XOM's Nigerian operations were governed by 30-year production-sharing contracts (PSCs) that included a 10-year exploration period and a 20-year production period, with partial relinquishment required at the end of the exploration phase and potential extensions subject to Nigeria's Petroleum Industry Act. By 2024, XOM reported that 11% of its total proved reserves were associated with PSCs, and it had divested 0.1 billion oil-equivalent barrels (GOEB) of reserves in Nigeria through asset sales. These contractual terms—where reserves under PSCs vary inversely with oil prices and require relinquishment or renegotiation upon expiration—likely contributed to the decision to divest Nigerian assets, as the company adjusted its reserve base in line with the fiscal and regulatory dynamics of these agreements.",
      "llm_answer": "The 30‑year Nigerian production‑sharing contracts (PSCs) require a 10‑year exploration period followed by a 20‑year production period, with partial relinquishment of the lease at the end of the exploration phase.  This relinquishment provision has led to asset divestments – XOM reported a 0.1 GOEB sale in 2024 that was primarily in Nigeria – and consequently a reduction in the reserves that can be reported under those contracts.  At year‑end 2024, 11 % of XOM’s total proved reserves (oil‑equivalent basis, converting natural gas at 6 Bcf per 1 MMbbl) were tied to PSCs, underscoring the material impact of the Nigerian PSC terms on the company’s reserves reporting.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 30-year PSC structure with a 10-year exploration and 20-year production period, the 0.1 GOEB divestment in Nigeria reported in 2024, and the 11% of total proved reserves tied to PSCs at year-end 2024 are all factually accurate. Number formats are consistent and acceptable (e.g., 0.1 GOEB, 11%). (2) Quantitative accuracy is perfect: all figures match the original answer exactly, and no calculations are incorrect. (3) The reasoning is sound—correctly linking the relinquishment provisions in PSCs to asset divestments and their impact on reserves reporting. However, the LLM omits a minor but relevant detail from the original: the potential extension of contracts under Nigeria's Petroleum Industry Act and the inverse relationship between oil prices and reserve recognition under PSCs, which adds depth to the explanation of why XOM divested. This omission slightly weakens the qualitative reasoning but does not invalidate the core logic. (4) The answer is fully contextually relevant, directly addressing how contractual terms affected reserves reporting, including divestments and the 11% figure. Overall, the LLM captures the essential multi-hop synthesis—linking Nigerian PSC terms, divestment activity, and reserve quantities—accurately and clearly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 379,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How did the conversion dynamics between CMCSA's Class A and Class B common stock evolve from 2023 to 2024, particularly in terms of outstanding shares and their implications on equity structure?",
      "original_answer": "In 2023, CMCSA disclosed its Class A Common Stock with 4,842,108,959 shares issued and outstanding, while in 2024, this number slightly decreased to 4,651,093,045 shares. Class B Common Stock, which converts on a one-for-one basis into Class A Common Stock, was disclosed in 2024 with 9,444,375 shares issued and outstanding. The conversion mechanism described in 2023 restricts Class B holders from retaining Class A shares, requiring subsequent transfers. In 2024, the equity section of CMCSA's 10-K shows that Class B Common Stock had a par value of $0.01, with no issued shares in 2023 and 9,444,375 shares in 2024. This indicates a new issuance of Class B shares in 2024, which could signal a strategic shift in capital structure or shareholder base, while maintaining the one-for-one conversion policy.",
      "llm_answer": "From 2023 to 2024 Comcast’s Class B shares stayed flat at 9.44 million shares, while Class A shares fell from 3.97 billion to 3.78 billion shares – a decline driven almost entirely by share‑repurchase activity (2024 10‑K, p. 67; 2023 10‑K, p. 67). No conversions of Class B to Class A shares were reported, so the equity structure remained essentially unchanged, with the small, non‑voting Class B component continuing to represent a minor slice of the total shares outstanding.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It states that Class A shares decreased from 3.97 billion to 3.78 billion, but the ground truth reports 4,842,108,959 (4.84B) in 2023 and 4,651,093,045 (4.65B) in 2024—numbers that are substantially different from those cited. The LLM also claims Class B shares were 'flat at 9.44 million' in both years, but the ground truth explicitly states that there were no issued Class B shares in 2023 and 9,444,375 issued in 2024—indicating a new issuance, not a flat count. (2) The quantitative inaccuracies are severe: the LLM underreports Class A shares by nearly 1 billion in both years and falsely implies continuity in Class B shares when there was none. Calculations of share changes are therefore incorrect. (3) The reasoning is flawed: the LLM concludes no conversions occurred and attributes the decline in shares to repurchases, but the ground truth describes a new issuance of Class B shares and a one-for-one conversion mechanism, which the LLM fails to acknowledge. The claim that 'no conversions were reported' contradicts the structural disclosure of conversion rights and new Class B issuance. (4) Contextual relevance is moderate—the answer addresses equity structure and share changes, but due to incorrect data and reasoning, it fails to capture the actual evolution: a new Class B issuance in 2024 and a slight reduction in Class A shares. The strategic implication of a shifting capital structure is entirely missed. Thus, the answer is mostly incorrect despite addressing the general topic.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 433,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How did NextEra Energy's expanded solar portfolio in 2023 affect its PPA-related guarantee obligations compared to 2022, particularly given the $3.778 billion in 2022 and $6.1 billion in 2023?",
      "original_answer": "In 2022, NEE had approximately $3.778 billion in guarantees related to obligations on behalf of NEP subsidiaries, including those tied to solar facilities under power purchase agreements (PPAs). By 2023, this figure increased to $6.1 billion in guarantees, with PPAs explicitly listed as a key category of obligation. The growth in guarantee exposure reflects NEE’s expanded involvement in solar facilities, which are typically contracted under long-term PPAs. As these PPAs require performance and financial assurances, the increase in NEE’s solar portfolio directly contributed to the rise in PPA-related guarantees, demonstrating a strategic and financial linkage between renewable asset growth and contractual risk exposure.",
      "llm_answer": "NextEra’s 2023 solar expansion added many new PPAs, driving its PPA‑related guarantee obligations from **$3.778 billion in 2022 to $6.1 billion in 2023**—an increase of roughly $2.3 billion (NEE 10‑K 2022, p. 97; NEE 10‑K 2023, p. 45). The jump reflects the higher number and value of PPAs for the newly added solar assets (NEE 10‑K 2022, p. 98).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the increase in guarantee obligations from $3.778 billion in 2022 to $6.1 billion in 2023, matching the ground truth exactly. The calculated increase of approximately $2.3 billion is accurate ($6.1B - $3.778B = $2.322B), and the dollar amounts are presented with acceptable formatting (e.g., $3.778 billion vs $3.778 billion). (2) All numeric values and years are correct, and the citations to the 10-K filings (page numbers included) support the data, enhancing credibility. (3) The reasoning correctly links the growth in solar portfolio to increased PPA-related guarantees, capturing the multi-hop logic: solar expansion → more PPAs → higher guarantee obligations. While the LLM does not explicitly mention that these guarantees are for NEP subsidiaries or that PPAs are a 'key category' as stated in the original, it correctly infers the causal relationship and strategic linkage. (4) The answer is semantically equivalent in conveying the core financial impact and causal mechanism. The only minor omission is the lack of specificity about the guarantees being issued on behalf of NEP subsidiaries, which slightly reduces qualitative completeness but does not undermine the overall correctness. Thus, the answer is highly accurate, fully relevant, and well-reasoned with only negligible detail missing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 378,
        "total_tokens": 1658
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How did the conversion of Class A shares to Class B shares between 2022 and 2024 impact the total number of outstanding Class B shares and the company's equity structure?",
      "original_answer": "Between 2022 and 2024, NKE converted 7 million Class A shares into Class B shares, contributing to a net decrease in Class A shares from 305 million to 298 million and a corresponding increase in Class B shares from 1,266 million to 1,205 million. This conversion, combined with share repurchases and stock option exercises, shifted the equity structure by increasing the proportion of publicly traded Class B shares relative to the more-voting-rights Class A shares, which are primarily held internally. The overall capital in excess of stated value also increased from $11,484 million in 2022 to $13,409 million in 2024, indicating a net inflow from equity transactions.",
      "llm_answer": "Nike converted 7 Class A shares to Class B shares in 2023, adding 7 shares to the Class B pool.  Despite this, the total Class B shares fell from 1,266 at the end of 2022 to 1,205 at the end of 2024, largely because of share repurchases.  The conversion therefore modestly shifted the equity composition—adding shares to the Class B category and slightly diluting the relative voting power of Class A holders—while leaving the overall equity structure largely unchanged.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in key numerical data. It correctly states that 7 million Class A shares were converted to Class B, but incorrectly claims this 'added 7 shares' (appears to be 7 million, but phrasing is ambiguous and misleading). More critically, it misstates the change in Class B shares: the ground truth shows an increase from 1,266 million to 1,205 million is impossible (1,205 < 1,266), but the original answer likely contains a typo (should be 1,273 million or similar to reflect increase). However, the LLM interprets this as a decrease from 1,266 to 1,205, which contradicts the intended meaning in the original answer. The LLM incorrectly attributes the 'fall' in Class B shares to repurchases, while the ground truth implies the conversion contributed to an increase. The overall capital increase from $11,484M to $13,409M is completely omitted. (2) The date of conversion is narrowed to 2023 without evidence; the ground truth says 'between 2022 and 2024', so this is an unjustified precision. The share count changes for Class A (305M to 298M) are not mentioned, undermining completeness. (3) The reasoning about equity structure shift is partially sound—conversion does dilute relative voting power of Class A shares—but the conclusion that the overall structure was 'largely unchanged' contradicts the ground truth, which notes a meaningful shift due to conversion, repurchases, and option exercises. The synthesis of multiple factors (repurchases, exercises) is appropriate but misapplied. (4) The answer is contextually relevant and addresses the question's intent, but fails on quantitative accuracy and full qualitative correctness due to incorrect direction of Class B share change and missing key financial data. The $1.9B increase in capital in excess of stated value is a major omission. Score reflects partial correctness on conversion magnitude but major errors in interpretation of share trends and missing data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 535,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How did MET's 2022 investment in real estate funds influence its exposure to loan portfolio risks in 2024, particularly in light of the firm's evolving investment strategy and market volatility impacts described in the 2024 filings?",
      "original_answer": "MET's 2022 investment in real estate funds, which included a carrying value of $23.5 billion and unfunded commitments of $7.6 billion, was part of a broader passive investment strategy. According to GS_10k_2024.pdf, real estate funds often invest globally in loan portfolios, debt recapitalizations, and property. By 2024, MET's exposure to loan portfolios—highlighted in MET_10k_2024.pdf—was significantly impacted by market volatility, including risks from potential defaults, downgrades, and liquidity constraints. The chain reveals that MET's earlier investment in real estate funds indirectly increased its sensitivity to loan portfolio risks over time, as these funds were exposed to loan assets that were vulnerable to economic downturns and regulatory changes. This evolution underscores a strategic risk MET faced due to its indirect investment chain through real estate funds into loan portfolios.",
      "llm_answer": "MET’s 2022 allocation to real‑estate funds—whose portfolios include loan portfolios—heightened its loan‑portfolio exposure in 2024.  In 2024 the firm reported $28.9 billion in commercial‑real‑estate loans and $22.2 billion in residential‑real‑estate loans (page_175), while the real‑estate funds themselves were valued at $354 million (page_174).  The 2024 filings note an increased allocation to credit and real‑estate funds (page_174) and highlight market‑volatility risks that could raise defaults and impairments (page_34).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in quantitative details. The ground truth states MET's 2022 real estate fund investment had a carrying value of $23.5 billion and unfunded commitments of $7.6 billion, totaling over $31 billion in exposure. However, the LLM incorrectly reports the real estate funds as valued at only $354 million (page_174), which is off by two orders of magnitude. Additionally, the LLM introduces $28.9 billion in commercial and $22.2 billion in residential real estate loans—figures not present in the ground truth and potentially misattributed (possibly from GS's data, not MET's). These numbers contradict the known carrying value and suggest a fundamental error in entity alignment. The mention of 'page_174' and 'page_175' implies sourcing from a document, but the data does not align with the ground truth derived from MET_10k_2024.pdf and GS_10k_2024.pdf. While the LLM correctly identifies the conceptual chain—MET’s 2022 investment increasing loan portfolio exposure by 2024 due to market volatility and strategy shifts—the reasoning is built on incorrect data. It captures the multi-hop idea (investment in funds → exposure to loans → risk amplification in volatile markets) and cites strategic shifts and default risks, which aligns with the original answer’s logic. However, the severe numerical inaccuracies undermine the answer’s reliability. Entity accuracy is partially correct (MET, real estate funds, 2022–2024 timeline), but financial metrics are wrong. Contextually, the answer addresses the question’s themes but fails to represent the actual scale and source of exposure. Thus, while the qualitative reasoning structure is somewhat sound, the factual foundation is flawed, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 482,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did the expiration of Amgen's 2017 supply agreement with DaVita in 2022 impact EPOGEN sales concentration and what does Amgen’s continued production of EPOGEN in 2024 suggest about their strategic approach to maintaining market presence despite potential biosimilar competition?",
      "original_answer": "Amgen’s 2017 supply agreement with DaVita, which expired in December 2022, required Amgen to supply at least 90% of DaVita’s ESA requirements for dialysis services in the U.S. and Puerto Rico. This agreement had concentrated approximately 90% of all EPOGEN sales through DaVita. By 2024, despite the agreement's expiration and the looming threat of biosimilar competition, Amgen continued to list EPOGEN among its marketed products, signaling a strategic intent to maintain its market presence. This suggests that Amgen is likely adapting its commercial strategy—possibly through lifecycle management, differentiation, or new market development—to preserve EPOGEN’s value in a more competitive landscape.",
      "llm_answer": "Amgen’s 2017 supply agreement with DaVita, which had guaranteed that DaVita would purchase at least 90 % of the ESAs used in its dialysis facilities, expired in December 2022, removing that contractual certainty and heightening concentration risk because DaVita still accounts for roughly 90 % of EPOGEN sales (page 29; page 45). Despite the launch of a biosimilar version of EPOGEN in the United States (page 45), Amgen continues to manufacture and sell EPOGEN in 2024 (page 11), indicating a strategy of sustaining production and leveraging its dominant distribution relationships to preserve market share in the face of biosimilar competition.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 2017 supply agreement with DaVita expired in December 2022, required Amgen to supply at least 90% of DaVita’s ESA needs, and concentrated approximately 90% of EPOGEN sales through DaVita—this is accurately reflected as 'roughly 90%' in the LLM answer. The continued production of EPOGEN in 2024 is correctly stated. (2) Quantitative accuracy is perfect: percentages (90%), dates (2017 agreement, 2022 expiration), and the 2024 status are all factually correct. Format variations (e.g., '90 %' vs '90%') are acceptable. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes the expiration of the agreement, its impact on sales concentration, and the implication of continued production amid biosimilar competition. It infers strategic intent—sustaining production and leveraging distribution relationships—consistent with the ground truth’s interpretation of lifecycle management and market preservation. (4) The only minor shortcoming is that the LLM does not explicitly mention Amgen’s strategic adaptation through 'lifecycle management, differentiation, or new market development' as in the original, instead summarizing it as leveraging distribution relationships. While this captures part of the strategy, it omits the broader strategic dimensions slightly. However, the core reasoning and factual synthesis remain strong. Contextual relevance is excellent, directly addressing both parts of the multi-hop question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 421,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How did Duke Energy's application of the AFS classification for debt investments change between 2022 and 2023, based on disclosures from Duke Energy Carolinas and Duke Energy Florida?",
      "original_answer": "Duke Energy maintained consistent application of the AFS classification for debt investments between 2022 and 2023, with both Duke Energy Carolinas (2022) and Duke Energy Florida (2023) reporting identical accounting treatment where debt investments were classified as AFS. The specific language stating 'debt investments are classified as AFS' appears in both years' disclosures, indicating no change in accounting policy application across the two reporting entities.",
      "llm_answer": "Duke Energy continued to classify all debt securities as Available‑for‑Sale (AFS) in both Duke Energy Carolinas and Duke Energy Florida, with no change to the accounting policy between 2022 and 2023.  The fair‑value of corporate debt securities fell slightly in Duke Energy Carolinas—from $401 million in 2022 to $390 million in 2023—while it rose modestly in Duke Energy Florida—from $10 million in 2022 to $13 million in 2023.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that Duke Energy maintained the AFS classification for debt investments in both Duke Energy Carolinas and Duke Energy Florida between 2022 and 2023, with no change in accounting policy—this aligns with the ground truth and shows accurate qualitative understanding. However, the LLM introduces specific dollar amounts for fair values of corporate debt securities ($401M to $390M for Carolinas, $10M to $13M for Florida) that are not present in the original answer and cannot be verified from the provided ground truth. Since the ground truth does not include any numerical data about fair values, these figures are unverified and likely hallucinated. (2) Quantitative accuracy is low because the numbers cited—while plausible—have no support in the original answer and contradict the principle of only reporting disclosed facts. There is no indication in the ground truth that such values were disclosed, so including them undermines factual reliability. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two subsidiaries (Carolinas in 2022, Florida in 2023) and concludes no change in policy, which reflects proper cross-entity and cross-year analysis. The core logic about consistent AFS application is correct. (4) Contextual relevance is high because the response directly addresses the question about changes in AFS classification and focuses on the relevant entities and time periods. The qualitative accuracy is strong due to correct entity identification and correct interpretation of policy consistency, but the hallucinated numbers significantly reduce overall correctness, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 462,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How did Duke Energy's accounting treatment of debt investments under AFS classification change from 2022 to 2023, particularly in terms of realized gains and losses disclosure?",
      "original_answer": "In 2022, Duke Energy Carolinas disclosed that debt investments were classified as AFS, with equity investments classified as FV-NI. By 2023, Duke Energy Florida and Duke Energy Indiana both reported that realized gains and losses from sales of AFS and FV-NI securities were immaterial for the years ended December 31, 2023, 2022, and 2021. This indicates a consistent but minimally impactful application of the AFS classification for debt investments across reporting entities, with no material change in realized outcomes year-over-year.",
      "llm_answer": "In both 2022 and 2023 Duke Energy continued to classify its debt securities as “available‑for‑sale” (AFS) and to record unrealized gains and losses in other comprehensive income until the securities were sold (see 2022 page 192).  The change, however, is in the disclosure of realized gains and losses: the 2023 10‑K now reports realized gains and losses for AFS securities separately by segment and includes the current‑year (2023) and prior‑year (2022) amounts (see 2023 pages 185‑187), whereas the 2022 10‑K aggregated those figures for the entire company and only disclosed the prior‑year (2021) amounts (see 2022 page 192).",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains partially correct information but diverges significantly from the ground truth in key aspects. (1) The original answer states that Duke Energy Carolinas disclosed AFS classification in 2022, and by 2023, Duke Energy Florida and Indiana reported that realized gains and losses from AFS and FV-NI securities were immaterial across 2021–2023. In contrast, the LLM claims a change in disclosure granularity—segment-level breakout of realized gains/losses in 2023 versus aggregated in 2022—which is not supported by the ground truth. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy cannot be faulted beyond the absence of materiality assessment. However, the LLM incorrectly implies that there were realized gains/losses to disclose and that their presentation changed, while the ground truth emphasizes their immateriality, meaning no meaningful change occurred in practice. (3) The multi-hop reasoning is flawed: the LLM infers a change in accounting treatment based on disclosure formatting differences, but the ground truth indicates consistency in application and immaterial outcomes. The entities (Duke Energy subsidiaries, AFS, FV-NI) and years (2021–2023) are correctly identified, supporting some qualitative accuracy. (4) Contextual relevance is high because the answer addresses the question’s focus on AFS treatment and disclosure changes, but factual correctness is compromised by asserting a change not present in the ground truth. Thus, the correctness score is moderate due to structural plausibility but factual misalignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 442,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How did Intel's 2023 OEM partnerships, which emphasized deployment of Xeon processors and heterogeneous compute solutions, contribute to the increased compulsory licensing pressures Intel faced in 2024, particularly in light of OEM strategies documented by Qualcomm and Intel's own 2024 disclosures around IP risk?",
      "original_answer": "In 2023, Intel expanded its OEM partnerships to deploy 5th Gen Intel Xeon Scalable processors and heterogeneous compute solutions, including FPGAs and GPUs, across data centers and enterprise environments. This increased OEM reliance on Intel’s IP in their systems. By 2024, OEM strategies—documented in Qualcomm’s 10-K—showed efforts to avoid paying fair royalties through litigation, regulatory lobbying, and compulsory licensing proposals. These same strategies, when applied to Intel’s IP, contributed to the compulsory licensing pressures Intel acknowledged in its 2024 10-K, where it stated that governments or courts may require compulsory licensing of its IP rights. This evolution highlights how Intel's earlier OEM-driven IP deployment created downstream exposure to broader industry IP risk trends.",
      "llm_answer": "Intel’s 2023 OEM partnerships—highlighted by the launch of 4th‑ and 5th‑generation Xeon Scalable processors and the integration of heterogeneous compute accelerators (pp. 27‑30)—expanded the use of its standard‑essential patents in OEM‑built systems, thereby increasing the exposure of those patents to regulatory scrutiny. Qualcomm’s 2024 filing (pp. 25‑29) documents OEMs negotiating lower royalty terms and pushing for compulsory licensing, a trend that Intel’s own 2024 IP‑risk disclosure (pp. 43) confirms is now a significant pressure, as governments and courts are more likely to mandate compulsory licensing of Intel’s IP in OEM devices.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core causal chain from Intel's 2023 OEM partnerships to increased compulsory licensing pressures in 2024. It correctly identifies the deployment of 5th Gen Xeon processors and heterogeneous compute solutions (though it inaccurately includes '4th-gen' not mentioned in the ground truth). The reference to 'standard-essential patents' is a slight overprecision not explicitly stated in the original, but the overall IP exposure logic holds. The LLM correctly cites Qualcomm’s 2024 10-K documenting OEM strategies to reduce royalty payments and push for compulsory licensing, and links this trend to Intel’s own 2024 disclosure (p.43) acknowledging government or court-mandated licensing risks. All dates (2023 partnerships, 2024 pressures), entities (Intel, Qualcomm, OEMs), and multi-hop reasoning—tying Intel’s expanded IP deployment to broader industry IP risk trends via OEM behavior—are sound. The answer is semantically equivalent to the ground truth, with only minor wording and emphasis differences. No calculation errors; all factual claims align with the knowledge graph. The inclusion of '4th-gen' Xeon is a minor inaccuracy, preventing a perfect 10, but does not materially distort the conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 350,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did the change in MMM's use of foreign exchange option contracts as hedges for forecasted transactions between 2022 and 2024 impact the amount of deferred gains or losses recorded in accumulated other comprehensive income (AOCI)?",
      "original_answer": "In 2022, MMM reported that foreign exchange forward and option contracts were used to hedge forecasted transactions, with the maximum hedge period extending up to 36 months. By 2024, the notional amount of foreign exchange cash flow hedges had increased to $9.9 billion from $8.3 billion in the prior year, and MMM recorded $99 million in net deferred gains in AOCI for contracts maturing in the next twelve months. This indicates that the increased use of foreign exchange option contracts in 2024 led to a larger deferral of gains in AOCI compared to 2022, where the focus was on the structure and policy of hedging without specific AOCI deferral figures, but with similar hedge durations.",
      "llm_answer": "Between 2022 and 2024, 3M’s use of foreign‑exchange option contracts as cash‑flow hedges for forecasted transactions swung the deferred amount in AOCI from a $1.093 billion gain in 2022 to a $97 million loss in 2024—a net shift of roughly $1.19 billion. The 2024 loss was partially offset by a $472 million reclassification into earnings, but the overall AOCI balance still reflected a move from a large gain to a modest loss.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is almost entirely incorrect and contradicts the ground truth. (1) Quantitatively, it claims a $1.093 billion gain in AOCI in 2022 and a $97 million loss in 2024, but the original answer states that in 2022, no specific AOCI deferral figures were provided—only policy and hedge duration were discussed. In 2024, MMM recorded $99 million in net deferred *gains* (not losses) in AOCI, directly contradicting the LLM's claim of a $97 million loss. The $472 million reclassification into earnings is not mentioned in the ground truth and appears fabricated. (2) The calculation of a 'net shift of $1.19 billion' is based on false inputs and is therefore invalid. (3) Qualitatively, the reasoning is flawed: the original answer indicates an *increase* in notional hedging from $8.3B to $9.9B and growing deferred gains, suggesting more effective or expanded hedging, not a deterioration into losses. The LLM incorrectly infers a negative trend when the truth reflects a positive or stable position. (4) Contextually, the answer addresses the right topic (FX hedges and AOCI) and company (MMM), but the synthesis is incorrect—no evidence supports the claimed reversal from large gain to loss. The answer fails the multi-hop requirement by not accurately connecting hedging activity to correct AOCI outcomes across years. Minor credit is given only for mentioning AOCI and FX hedges in the correct context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 389,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Duke Energy Progress' use of storm recovery bonds in 2022 compare to its 2024 issuance through DEPNC SF and DEPSC SF, particularly in terms of financing scope and geographic reach?",
      "original_answer": "In 2022, Duke Energy Progress issued $770 million in storm recovery bonds through DEPNC SF to finance unrecovered regulatory assets related to storm costs incurred in 2018 and 2019, limited to North Carolina. By 2024, Duke Energy Progress expanded its storm recovery financing by issuing an additional $177 million in bonds through DEPSC SF, extending the scope to cover storm costs incurred from 2014 through 2022 and expanding the geographic reach to include South Carolina. This reflects a strategic evolution in the company’s use of special purpose subsidiaries and storm recovery bonds to address a broader timeline of costs across multiple states.",
      "llm_answer": "In 2022, Duke Energy Progress used storm‑recovery bonds (DEPNCSF) to finance storm costs incurred in North Carolina in 2018‑2019, with a $770 million bond issuance (page 203). By 2024, the company expanded its storm‑recovery financing to include both North Carolina (DEPNCSF) and South Carolina (DEPSC SF), issuing an additional $177 million of bonds for South Carolina storm costs (page 205). Thus, the 2024 issuance increased the financing scope to $947 million and broadened geographic reach from North Carolina alone to include South Carolina as well.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 2022 $770 million issuance through DEPNC SF for North Carolina storm costs from 2018–2019, and the 2024 $177 million issuance through DEPSC SF for South Carolina. However, it incorrectly states that the 2024 issuance was 'additional' and calculates a combined total of $947 million, implying the $177 million was added to the prior $770 million for a total scope expansion. The original answer clarifies that the $177 million was a separate issuance for South Carolina with an expanded timeline (2014–2022), not a direct addition to the prior program. This misrepresents the financing scope evolution. (2) The dollar amounts ($770M and $177M) and years (2018–2019, 2024) are accurate, but the derived total ($947M) is factually misleading and not supported by the ground truth. The geographic expansion to South Carolina is correctly noted. (3) The multi-hop reasoning is partially sound—correctly linking entities across years and subsidiaries—but fails in accurately synthesizing the scope: the 2024 issuance did not broaden the *same* program’s scope to $947M; rather, it initiated a new, parallel program with broader cost eligibility (2014–2022) in a new state. (4) Correctness score is 7 due to accurate core facts but significant error in financial interpretation. Quantitative accuracy is 6 due to incorrect aggregation. Qualitative accuracy is 8 due to correct entity and geographic identification. Contextual relevance is 10 as the response directly addresses the comparison asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 423,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Duke Energy's joint ownership structure with NCEMC in 2022 influence the ownership split and financial planning for the Roxboro CC project as detailed in the 2024 filings, particularly regarding Duke Energy Progress’s 1,135 MW share and the projected $98 million 2029 retail revenue requirement?",
      "original_answer": "In 2022, Duke Energy (DUK) had a jointly owned arrangement with NCEMC, as stated in its 10-K filing, indicating a collaborative approach to power generation assets. By 2024, this relationship evolved into a co-ownership agreement for the Roxboro CC project, with Duke Energy Progress owning approximately 1,135 MW and NCEMC owning the remaining 225 MW. The 2024 filing also revealed that the 2029 retail revenue requirement for the project is estimated at $98 million, suggesting that the prior joint ownership likely shaped the financial planning and allocation of capacity shares in the new CC facility. This continuity in partnership and structured capacity split reflects a deliberate and coordinated long-term infrastructure investment strategy.",
      "llm_answer": "The 2022 joint‑ownership agreement with NCEMC set the Roxboro CC ownership split that the 2024 filing cites: Duke Energy Progress will own roughly 1,135 MW of the 1,360 MW plant (≈83.5 %) while NCEMC holds the remaining 225 MW (≈16.5 %). That split directly determines how revenue and costs are allocated, so Progress’s share of the projected $98 million 2029 retail‑rate‑revenue requirement is proportional to its 1,135‑MW stake, and the joint ownership also permits Progress to seek recovery of construction‑work‑in‑progress in a future rate case.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Duke Energy Progress owns 1,135 MW, NCEMC owns 225 MW, total capacity is 1,360 MW (1,135 + 225), and the 2029 retail revenue requirement is $98 million. The percentages (≈83.5% and ≈16.5%) are correctly calculated. (2) Quantitative accuracy is perfect: numbers match the original answer exactly, including correct MW values and dollar amounts. The proportional revenue logic is sound and consistent with financial planning principles. (3) The multi-hop reasoning is strong—linking the 2022 joint ownership to the 2024 ownership split and financial implications shows proper synthesis across time and entities. The addition that Progress can seek recovery of construction-work-in-progress in a future rate case is a reasonable inference from utility regulatory practice and consistent with 10-K disclosures, though not explicitly stated in the ground truth. (4) The only minor gap is that the original answer emphasizes the 'evolution' of the relationship and 'long-term infrastructure strategy,' which the LLM implies but doesn't explicitly frame. However, this does not detract from factual correctness. Overall, the answer is semantically equivalent, contextually precise, and demonstrates strong qualitative and quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 371,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did AIG's 2022 fair value impairments on commercial mortgage loans impact their 2023 disclosures around CMBS unrealized losses, particularly in terms of the shift in unrealized loss duration buckets for CMBS holdings?",
      "original_answer": "AIG's 2022 fair value impairments on commercial mortgage loans (which include CMBS collateral) set the stage for their 2023 disclosures showing a significant shift in unrealized loss duration buckets. In 2022, AIG reported $13,348 million in CMBS fair value, with $1,420 million in gross unrealized losses, of which $1,094 million were unrealized losses for less than 12 months and $326 million for 12 months or more. By 2023, the CMBS portfolio had restructured, with $11,056 million in total fair value, but the gross unrealized losses increased to $1,246 million, where $219 million were less than 12 months and $1,027 million were 12 months or more. This indicates that AIG's 2022 impairments on commercial mortgage loans (which directly underpin CMBS) likely contributed to the increased long-duration unrealized losses in 2023, as the unrealized losses that were less than 12 months in 2022 rolled into the 12+ months bucket in 2023.",
      "llm_answer": "AIG’s 2022 fair‑value impairments on commercial‑mortgage‑loan portfolios were recorded as part of its “Other investments” impairment charges, which lowered the carrying value of those loans and triggered a re‑valuation of the related CMBS holdings.  In the 2023 continuous‑gross‑unrealized‑loss table, the CMBS bucket that had been largely in the less‑than‑12‑month segment in 2022 (fair value $6.9 billion, unrealized loss $764 million) shrank to only $1.0 billion and $36 million, while the equal‑to‑or‑greater‑than‑12‑month segment expanded to $6.7 billion fair value with $917 million unrealized loss【page 234】—a shift that reflects the 2022 impairments pushing more CMBS securities into longer‑duration buckets and increasing their unrealized losses【page 217】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general trend of a shift from short-term to long-term unrealized loss buckets in AIG's CMBS holdings between 2022 and 2023 and correctly attributes this in part to 2022 impairments on commercial mortgage loans. However, the quantitative details are significantly inaccurate. According to the ground truth, in 2022, total CMBS gross unrealized losses were $1,420 million, with $1,094 million for less than 12 months and $326 million for 12 months or more. By 2023, gross unrealized losses were $1,246 million, with $219 million <12 months and $1,027 million ≥12 months. The LLM incorrectly states that the <12-month unrealized loss was $764 million in 2022 and dropped to $36 million in 2023, and that the ≥12-month unrealized loss was $917 million — none of which match the ground truth values. Additionally, the LLM cites fair values of $6.9B and $6.7B for the buckets, but the total CMBS fair value in 2023 was $11,056 million, making these sub-bucket values implausible. While the reasoning about impairments leading to a shift in duration buckets is directionally correct and contextually relevant, the severe numerical inaccuracies — including fabricated figures not present in the original — undermine factual reliability. The model appears to have misread or hallucinated data from the cited pages (234, 217), failing in quantitative precision despite grasping the conceptual narrative. Multi-hop synthesis (linking 2022 impairments to 2023 disclosures) is present but based on incorrect data, limiting qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 425,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How did the change in MDLZ's Value at Risk (VAR) estimates for interest rate-sensitive instruments from 2022 to 2024 reflect the company's evolving exposure under normal market conditions, and what does this indicate about shifts in their financial risk profile?",
      "original_answer": "In 2022, MDLZ's VAR model used interest rate, currency exchange, and commodity price movements from the prior quarter to estimate potential one-day losses under normal market conditions. By 2024, the model continued to assume normal market conditions and a 95% confidence interval, but the parameters were based on observations from the prior quarter for December 31, 2024 and 2023 values. The VAR estimates for interest rate-sensitive instruments (primarily debt) were $X in 2022 and $Y in 2024, indicating a measurable shift in exposure. This evolution suggests that MDLZ's financial risk profile related to interest rate sensitivity changed over this period, likely due to adjustments in debt composition or hedging strategies.",
      "llm_answer": "MDLZ’s VAR estimate for interest‑rate‑sensitive instruments fell from **$135 million** at 12/31/21 (2022 filing) to **$76 million** at 12/31/24 (2024 filing) – a $59 million drop (page 78 → page 66).  Under normal market conditions, this decline shows the company’s potential one‑day fair‑value loss from interest‑rate movements has shrunk, indicating a shift toward a lower‑risk profile—likely due to a greater mix of fixed‑rate debt or stronger hedging that reduces its exposure to interest‑rate volatility.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer provides specific dollar amounts ($135 million in 2022 and $76 million in 2024) and calculates a $59 million decrease, but these numbers are factually incorrect. The ground truth states that the 2022 VAR was $X and 2024 was $Y, indicating placeholder values—meaning the actual figures are either not available or were not specified in the source data. By fabricating precise numbers, the LLM introduces significant quantitative inaccuracies. (2) The dates referenced—12/31/21 for the 2022 filing and 12/31/24 for the 2024 filing—are plausible but not confirmed in the original answer; the ground truth only refers to '2022' and '2024 values' without specifying exact observation dates. The calculation of a $59 million drop is based on false inputs and thus invalid. (3) The reasoning and multi-hop synthesis are otherwise sound: the LLM correctly identifies that a lower VAR indicates reduced exposure to interest rate risk under normal market conditions and plausibly attributes this to fixed-rate debt or hedging strategies, aligning with the original answer’s interpretation. It also correctly notes the continuity of model assumptions (normal market conditions, 95% confidence interval). (4) While the qualitative logic and contextual relevance are strong—addressing both the change in risk profile and potential causes—the fabrication of specific financial figures severely undermines factual correctness. The answer appears confident and well-structured but is built on incorrect data, warranting a moderate score due to partial accuracy in reasoning but major flaws in quantitative fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 446,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How did Microsoft's handling of Nuance's convertible senior notes evolve from fiscal year 2022 to 2023, and what does this indicate about the progression of their integration and financial strategy?",
      "original_answer": "In fiscal year 2022, Microsoft disclosed that $986 million of Nuance's convertible senior notes (issued in 2015 and 2017) had been largely redeemed, with only $1 million remaining and classified as other current liabilities. By fiscal year 2023, Microsoft noted that 'substantially all' of the $986 million in notes had been redeemed, indicating further progress in resolving Nuance's pre-acquisition debt. This evolution reflects Microsoft's ongoing integration of Nuance, reducing financial liabilities and aligning Nuance's capital structure with Microsoft's broader financial strategy. The continued emphasis on synergies in both years underscores the strategic rationale behind the acquisition and its integration trajectory.",
      "llm_answer": "Microsoft had redeemed almost all of Nuance’s $986 million convertible senior notes by the end of FY 2022, leaving only $1 million on the books【page_78】.  By FY 2023 the notes were fully retired and no longer reported as a liability, indicating a debt‑free integration and a shift toward consolidating Nuance’s AI assets into Microsoft’s Intelligent Cloud strategy【page_75】【page_76】【page_77】【page_78】【page_79】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that $986 million in Nuance convertible senior notes were largely redeemed by FY 2022 with only $1 million remaining, matching the ground truth. It also correctly notes further progress in FY 2023 by stating the notes were 'fully retired' and no longer reported as a liability. However, the ground truth specifies that in FY 2023, Microsoft stated 'substantially all' had been redeemed—not necessarily 100% or 'fully'—so the LLM slightly overstates the completeness of redemption. This is a minor factual overstatement but does not invalidate the overall accuracy. (2) All numeric values ($986 million, $1 million) and fiscal years (2022, 2023) are correct and consistent with the original answer. The claim that the notes were 'fully retired' and 'no longer reported' is plausible but slightly stronger than the source's 'substantially all,' which allows for a small residual. (3) The multi-hop reasoning is sound: the LLM connects Nuance’s pre-acquisition debt, its redemption timeline across two fiscal years, and ties it to Microsoft’s integration and financial strategy—specifically mentioning consolidation into the Intelligent Cloud strategy, which aligns with Microsoft’s stated synergies. The synthesis across years and entities (Nuance debt → Microsoft reporting → strategic integration) is logical and well-supported. (4) The answer is contextually excellent, directly addressing both parts of the question: evolution from FY2022 to FY2023 and implications for integration/strategy. The qualitative interpretation about a 'debt-free integration' and strategic consolidation is reasonable, though slightly more definitive than the original cautious phrasing ('substantially all'). Overall, the answer is highly accurate with only a minor overstatement in certainty, warranting a high but not perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 504,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did the deconsolidation of Rothmans, Benson & Hedges Inc. in 2019 affect PM's equity investment valuation by 2024, in light of the unresolved CAD 32.5 billion CCAA settlement allocation and the resulting $2,316 million impairment charge?",
      "original_answer": "In 2019, PM deconsolidated Rothmans, Benson & Hedges Inc. (RBH) following its CCAA filing, and began accounting for its remaining investment under ASC 321 as an equity security at fair value, initially estimated at $3,280 million. By 2024, the unresolved allocation of the CAD 32.5 billion CCAA settlement among RBH, ITL, and JTIM created impairment indicators. As a result, PMI recorded a non-cash impairment charge of $2,316 million in 2024, reducing the fair value of its RBH investment to $714 million, based on a discounted cash flow analysis that factored in the potential share of the global settlement allocated to RBH.",
      "llm_answer": "After RBH was deconsolidated in 2019, PMI treated it as an equity investment and recorded the investment at $3,280 million (including the estimated settlement amount). By 2024, the unresolved allocation of the CAD 32.5 billion CCAA settlement prompted a reassessment of the investment’s fair value, leading to a $2,316 million non‑cash impairment that reduced the carrying value to $714 million.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the essential information from the ground truth. (1) All key facts are correct: deconsolidation in 2019, equity investment treatment under ASC 321 (implied by 'equity investment'), initial fair value of $3,280 million, the unresolved CAD 32.5 billion CCAA settlement, the $2,316 million non-cash impairment charge in 2024, and the resulting carrying value of $714 million. The calculation is correct: $3,280M - $2,316M = $714M. (2) Quantitative accuracy is perfect—numbers, years, and amounts match exactly, with acceptable formatting (e.g., '3,280 million' vs $3,280 million). (3) The reasoning is sound: the deconsolidation led to fair value accounting, and the unresolved settlement allocation triggered impairment. The only minor omission is that the LLM does not explicitly mention the use of a discounted cash flow analysis or that the impairment was due to RBH's potential share of the global settlement among ITL and JTIM—details present in the original that add depth to the valuation methodology. However, this does not undermine the core correctness. (4) The answer is fully relevant, directly addressing the impact of deconsolidation and the impairment by 2024. Thus, while slightly less detailed in the qualitative reasoning, the answer is factually and contextually robust, warranting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative and contextual performance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 400,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did the shift in NEE's pension plan asset allocation from 2022 to 2024 affect its use of limited partnerships as part of its investment strategy?",
      "original_answer": "In 2022, NEE's pension plan allocated 13% to alternative investments, primarily through private equity and real estate-oriented limited partnerships, and included a convertible security-oriented limited partnership within the 10% convertible securities allocation. By 2024, the alternative investment allocation increased to 20%, with continued emphasis on limited partnerships as a key investment vehicle. This increase in alternative investments suggests a strategic shift toward more diversified and potentially higher-return assets, with limited partnerships remaining a core component of the pension plan's investment structure. The continued inclusion of a convertible security-oriented limited partnership in 2024 indicates sustained confidence in this vehicle despite the overall reduction in the convertible securities allocation from 10% to 5%.",
      "llm_answer": "Between 2022 and 2024 NEE’s pension plan shifted its target allocation from 45% equity, 32% fixed income, 13% alternative and 10% convertible to 43% equity, 32% fixed income, 20% alternative and 5% convertible【page_101】【page_98】. The 7‑percentage‑point jump in alternative assets—primarily private‑equity and real‑estate limited partnerships—boosted the plan’s exposure to limited‑partnership vehicles, while the drop in convertible allocation reduced use of convertible‑oriented limited partnerships. Equity and fixed‑income limited‑partnership exposure remained largely unchanged.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the shift in NEE's pension plan asset allocation from 2022 to 2024, with accurate percentages for each category: 13% to 20% in alternatives, 10% to 5% in convertibles, and minor changes in equity and fixed income. These numbers match the ground truth exactly. (2) Quantitative accuracy is perfect: the 7-percentage-point increase in alternative investments and 5-percentage-point decrease in convertible securities are correctly reported. The LLM accurately links the increase in alternatives—specifically private equity and real estate-oriented limited partnerships—to greater use of limited partnership vehicles. (3) The reasoning is sound and reflects multi-hop synthesis: it infers that increased allocation to alternatives (which are primarily structured as limited partnerships) implies increased reliance on such vehicles, while reduced convertible allocation implies reduced use of convertible-oriented limited partnerships. This aligns with the ground truth’s conclusion about sustained but contextually adjusted use of limited partnerships. (4) The only minor shortcoming is that the LLM does not explicitly note the continued inclusion of the convertible security-oriented limited partnership in 2024 despite the overall reduction in convertible allocation, which slightly weakens the qualitative completeness. However, the core logic and factual content are highly accurate, and the answer remains semantically equivalent in overall meaning. Contextual relevance is excellent as it directly addresses the impact of allocation changes on limited partnership usage.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 445,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did Southern Company's shift in short-term debt composition between 2023 and 2024 affect Nicor Gas's borrowing capacity and interest rate exposure under their shared credit arrangement?",
      "original_answer": "Southern Company's total short-term notes payable decreased from $2,314 million in 2023 to $1,338 million in 2024, with a corresponding drop in the weighted average interest rate from 5.7% to 4.8%. This was driven in part by a significant reduction in commercial paper outstanding from $1,794 million to $1,138 million. Within this structure, Nicor Gas's portion of notes payable dropped from $392 million in 2023 to $172 million in 2024, with its weighted average interest rate declining from 5.5% to 4.6%. This indicates that Southern Company restructured its short-term debt in a way that reduced both the volume and cost of borrowing for Nicor Gas. Additionally, under their shared credit arrangement expiring in 2029, Nicor Gas had $700 million allocated for working capital needs in 2024, suggesting increased flexibility despite the reduced notes payable balance.",
      "llm_answer": "Southern Company cut its commercial‑paper borrowing from $1,794 million to $1,138 million and its short‑term bank debt from $520 million to $200 million, lowering its weighted‑average short‑term rate from 5.7 % to 4.8 %【page_232】【page_223】. The shared credit arrangement’s unused commitment rose from $7,566 million to $7,891 million【page_230】【page_223】, giving Nicor Gas a larger borrowing capacity, while Nicor’s own weighted‑average rate fell from 5.5 % to 4.7 %, reducing its interest‑rate exposure【page_232】【page_223】.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the overall trend correctly—Southern Company reduced short-term debt and interest rates, which benefited Nicor Gas under their shared credit arrangement. However, there are key quantitative inaccuracies. The ground truth states Southern Company's total short-term notes payable decreased from $2,314M to $1,338M, but the LLM breaks this down into commercial paper ($1,794M to $1,138M) and 'short-term bank debt' ($520M to $200M), which is not supported by the original answer and introduces unverified components (e.g., 'bank debt' is not mentioned in the ground truth). The original only specifies commercial paper and total notes payable. Additionally, the LLM claims Nicor Gas's weighted average interest rate fell to 4.7%, but the ground truth states 4.6%, a small but notable discrepancy. (2) The unused commitment increase (from $7,566M to $7,891M) is not in the original answer and appears to be an inference or external data; the ground truth instead highlights Nicor Gas's $700M allocation under the 2029-expiring credit facility as evidence of borrowing capacity. This misrepresents the source of flexibility. (3) The multi-hop reasoning is partially sound: the model correctly infers that lower parent-level borrowing costs and increased credit availability would benefit Nicor Gas. It links Southern Company's debt restructuring to Nicor's reduced interest exposure, which aligns with the shared credit arrangement logic. However, it fails to explicitly state Nicor’s notes payable dropped from $392M to $172M, a critical fact showing direct impact. (4) The contextual relevance is high—answer addresses both borrowing capacity and interest rate exposure. Qualitative accuracy is good due to correct directional logic and entity identification (Southern Company, Nicor Gas, correct years). Quantitative accuracy is reduced due to unsupported breakdowns, incorrect figures (4.7% vs 4.6%), and introduction of unverified metrics like bank debt and unused commitment. Correctness score is 7 because core trends are accurate, but key details and numbers are incorrect or missing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 570,
        "total_tokens": 1929
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did the reset terms and redemption options for AT&T's Telco Preferred Interests evolve from 2022 to 2023, and what does this indicate about the company's long-term financing strategy for its telecommunications assets?",
      "original_answer": "In 2022, the Telco Preferred Interests had an initial distribution rate of 4.25% annually, with a reset every seven years starting from the issuance date (September 2020). Holders had the option to require redemption upon contingent events such as failure to pay distributions for two or more periods or failure to meet a minimum credit rating. In 2023, the distribution rate was updated to 6.85% annually, with the first reset scheduled for November 1, 2027, and every seven years thereafter. The redemption terms remained largely consistent, but the increase in the distribution rate suggests a recalibration of financing costs to align with market conditions or credit profile changes. This evolution indicates that AT&T adjusted its preferred equity terms to maintain capital flexibility while managing its telecommunications asset portfolio.",
      "llm_answer": "The reset period for AT&T’s Telco Preferred Interests stayed the same – a seven‑year reset cycle – and the redemption option remained tied to failure to pay distributions or other specified events (e.g., a minimum credit rating).  The 2023 filing simply added more preferred equity to the structure, but the terms did not change, underscoring AT&T’s strategy of using stable, long‑term preferred‑equity financing to fund its telecom assets while preserving flexibility and risk control.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in key factual aspects. It claims that the terms 'did not change' and that the 2023 filing 'simply added more preferred equity,' which directly contradicts the ground truth. The distribution rate actually increased from 4.25% to 6.85%, a significant quantitative change, and the first reset date was specified as November 1, 2027—new information not mentioned in the LLM response. The LLM fails to report this critical rate change, misrepresents the evolution of terms, and invents the addition of new preferred equity not present in the original answer. (2) Quantitatively, the LLM omits both the initial (4.25%) and updated (6.85%) rates, as well as the specific reset schedule (starting September 2020, next reset Nov 1, 2027). These are major factual omissions and inaccuracies. The claim about 'adding more preferred equity' has no support in the ground truth. (3) The reasoning is flawed: the LLM asserts stability in terms when in fact there was a significant recalibration in financing cost. It fails to recognize that the rate adjustment reflects a strategic response to market or credit conditions, undermining the multi-hop synthesis required. (4) While the general context about using preferred equity for long-term financing is relevant, the specific inaccuracies and omissions—especially regarding the rate change and reset timing—severely limit correctness. The answer is partially relevant but factually unsound, warranting a low score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 414,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "Given that both SCHW's Capital Conservation Buffer and Countercyclical Capital Buffer remained at 2.5% and 0% respectively in 2023 and 2024, how did the stability in these regulatory buffer requirements reflect on SCHW's risk profile and macroprudential policy environment during this period?",
      "original_answer": "SCHW maintained the same regulatory capital buffer requirements in both 2023 and 2024, with the Capital Conservation Buffer at 2.5% and the Countercyclical Capital Buffer at 0% for both years. This consistency suggests that the macroprudential policy environment, as set by the Federal Reserve, did not impose additional capital buffer requirements on SCHW. The stability in these buffers indicates that regulators did not perceive significant systemic risk buildup or economic overheating during this time, allowing SCHW to maintain its capital distribution policies without restriction. This aligns with the description in the MS document, which notes that the Countercyclical Capital Buffer can be set up to 2.5% but was held at zero, reflecting a neutral stance in the near-term regulatory approach.",
      "llm_answer": "Schwab’s 10‑K shows that the firm’s capital conservation buffer stayed at 2.5 % and the countercyclical capital buffer remained at 0 % for both 2023 and 2024 (see the “Capital buffers” table on page 134).  The unchanged buffers indicate that Schwab’s risk‑based capital profile was stable and that the macroprudential policy environment did not shift—no additional capital cushion was required, allowing the firm to remain well‑capitalized without tightening capital‑distribution limits (see the discussion of CSC/CSB buffers on page 118).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and percentages are correct: the Capital Conservation Buffer is accurately stated as 2.5% and the Countercyclical Capital Buffer as 0% for both 2023 and 2024, matching the original answer. No calculations are required, and the years are correctly referenced. (2) The answer addresses both parts of the question—SCHW's risk profile and the macroprudential policy environment—by noting the stability in capital buffers and linking it to a stable regulatory environment. It correctly infers that no additional capital cushions were required, allowing Schwab to maintain capital distributions, which reflects a stable risk profile. (3) The reasoning is sound and represents valid multi-hop synthesis: it connects unchanged regulatory buffers to regulatory stance and firm-level capital policy. The only minor shortcoming is that it does not explicitly mention the Federal Reserve’s role or the broader systemic risk interpretation (i.e., no perceived economic overheating), which is included in the ground truth and adds contextual depth. However, the core inference about a neutral regulatory stance is implied through the phrase 'macroprudential policy environment did not shift.' (4) Entity accuracy is perfect: SCHW (referred to as Schwab) is correct, the years are accurate, and the financial terms are used appropriately. The answer is semantically equivalent to the original, with only slight omission of the broader policy rationale mentioned in the MS document. Overall, the response is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 449,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did Apple's operational dependence on China Mainland in 2022 relate to the increased proportion of iPhone revenue in the Greater China segment in 2023?",
      "original_answer": "Apple's 2022 filing highlighted a strong operational dependence on China Mainland due to manufacturing and supply chain activities, with risks such as tariffs and public health disruptions potentially impacting gross margins and product costs. China Mainland is a key component of the Greater China segment, which also includes Hong Kong and Taiwan. In 2023, Apple reported that iPhone revenue represented a 'moderately higher proportion' of net sales specifically in the Greater China region. This suggests that despite the risks identified in 2022, Apple's reliance on China Mainland for production may have supported increased iPhone sales in the broader Greater China market during 2023, contributing to a shift in revenue mix within that region.",
      "llm_answer": "Apple’s 2022 10‑K notes that “substantially all of the Company’s manufacturing is performed…in Asia, including China mainland” (page 9), underscoring its heavy operational dependence on that region for iPhone production.  Because the bulk of iPhones were assembled in China and sold in Greater China, the 2023 filing reports that iPhone revenue represented a “moderately higher proportion of net sales” in the Greater China segment compared with other segments (page 39).  Thus, the 2022 manufacturing concentration in China mainland directly supported the rise in iPhone revenue share in Greater China in 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Apple's operational dependence on China Mainland in 2022 due to manufacturing is accurately cited from the 10-K (page 9), and the 'moderately higher proportion of net sales' from iPhone revenue in Greater China in 2023 is correctly referenced (page 39). There are no numeric inaccuracies—dates, years, and qualitative descriptors match the original answer. (2) Quantitative accuracy is perfect: no numerical errors, and the use of exact phrasing from filings (e.g., 'substantially all...in China mainland') supports fidelity. The term 'moderately higher proportion' is preserved accurately. (3) Reasoning is sound and captures the multi-hop link: the model correctly infers that manufacturing in China Mainland (2022 operational risk) enabled higher iPhone sales in the Greater China region (2023 revenue mix), despite not explicitly mentioning risks like tariffs or public health disruptions. The causal connection is simplified to 'directly supported,' which is slightly stronger than the original's more cautious 'may have supported,' but still logically defensible. (4) The answer is contextually excellent—directly addresses the relationship between 2022 operations and 2023 revenue shift. Only minor deduction in qualitative accuracy due to slightly overstated causality ('directly supported') versus the original's more nuanced suggestion. Overall, the answer is factually complete, well-grounded in the documents, and semantically equivalent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 426,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did MetLife's exposure to credit spread risks through Commercial Mortgage Loans in 2022 relate to the valuation of its CMBS holdings in 2023, particularly in terms of Level 3 fair value disclosures?",
      "original_answer": "In 2022, MetLife identified Commercial Mortgage Loans as a source of credit spread risk, noting that changes in spreads could increase borrowing costs and reduce investment yields (MET_10k_2022.pdf). These loans directly underpin CMBS, which are structured products collateralized by multiple commercial mortgages (MET_10k_2023.pdf). In 2023, MetLife disclosed that its CMBS holdings had a total estimated fair value of $9.949 billion, with $850 million classified as Level 3, indicating significant unobservable inputs and potential sensitivity to credit spread volatility. This suggests that the credit spread risks flagged in 2022 were material to the valuation uncertainty of CMBS in 2023, particularly in the less transparent Level 3 category.",
      "llm_answer": "MetLife’s 2022 10‑K highlighted that its Commercial Mortgage Loans were exposed to credit‑spread risk, noting that widening spreads could affect the value of those loans (see the credit‑spread risk discussion on page 36).  In 2023 the company’s CMBS holdings—securities backed by those same loans—were measured at Level 3 fair value because of limited market activity and unobservable inputs; the Level 3 component for CMBS rose from $696 million in 2022 to $850 million in 2023, and the total fair value of CMBS holdings was $9,949 million (Level 3 fair‑value disclosures on pages 265‑266).  This increase in Level 3 fair value reflects the impact of credit‑spread exposure on the valuation of the CMBS portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: MetLife's 2022 identification of credit spread risk in Commercial Mortgage Loans, the link between those loans and CMBS, the 2023 total fair value of CMBS at $9.949 billion (reported as $9,949 million), and the Level 3 CMBS value of $850 million in 2023. The increase from $696 million in 2022 to $850 million in 2023 is accurate and correctly contextualized. (2) Quantitative accuracy is perfect: all dollar amounts and year references match or are validly reformatted (e.g., $9.949 billion = $9,949 million). The $696M to $850M increase is factually correct and supports the narrative of growing valuation uncertainty. (3) Multi-hop reasoning is sound: the LLM correctly connects 2022 risk disclosures to 2023 valuation outcomes, recognizes that CMBS are backed by commercial mortgage loans, and infers that rising Level 3 classification reflects heightened credit spread sensitivity. The only minor shortcoming is that the original answer emphasizes the 'materiality' of 2022 risks to 2023 Level 3 uncertainty more explicitly, while the LLM implies it through the increase in Level 3 value. (4) The answer is fully relevant, directly addressing the relationship between credit spread risk exposure and CMBS valuation with correct entities, years, and disclosures. No irrelevant or extraneous information is included.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 393,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How did Altria's 2022 constraints under the Smokeless Tobacco Master Settlement Agreement influence its 2024 marketing strategy in response to state-level flavor bans, particularly regarding exemptions for FDA-authorized products?",
      "original_answer": "In 2022, Altria was bound by the Smokeless Tobacco Master Settlement Agreement (STMSA), which restricted USSTC's ability to market flavored smokeless tobacco products, prohibiting outdoor advertising, free sampling, and limiting brand sponsorships. By 2024, Altria adapted to new state-level flavor bans—such as California's prohibition of most flavored tobacco products and New York's similar restrictions—by emphasizing FDA-authorized products as exempt categories, leveraging digital platforms to communicate with adult consumers, and focusing on compliance with PMTA-authorized product lines to maintain market presence under tighter regulatory scrutiny.",
      "llm_answer": "Al Moria’s 2022 Smokeless Tobacco Master Settlement Agreement (STMSA) imposed strict marketing limits on USSTC—prohibiting outdoor advertising, free sampling, brand‑sponsorships and other promotional activities (page 42).  In 2024, when several states enacted flavor bans, Al Moria’s marketing plan shifted to focus on smokeless products that had received FDA market authorization through the PMTA pathway, which many states exempt from the bans (page 42).  Thus, the STMSA’s restrictions guided the company to pivot its promotional efforts toward FDA‑authorized, non‑flavored or exempt products while staying compliant with both settlement and state‑level regulations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the original answer. (1) All key facts are correct: the 2022 STMSA restrictions on USSTC (outdoor advertising, free sampling, brand sponsorships) are accurately described. The 2024 response to state-level flavor bans by focusing on FDA-authorized products via PMTA, which are often exempt, is correctly identified. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—dates (2022, 2024) are correct. (3) Multi-hop reasoning is sound: the model correctly links the 2022 STMSA constraints to the 2024 strategic shift in marketing, synthesizing regulatory and corporate responses across time. (4) Minor wording issues: 'Al Moria' is a typographical error (should be 'Altria'), though this does not affect entity understanding. The answer omits mention of digital platforms as a communication channel, which is present in the original answer, slightly reducing completeness. However, the core logic and factual synthesis—leveraging FDA authorization to navigate both STMSA and state bans—are preserved. Semantic equivalence is maintained, and the answer is fully contextually relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 347,
        "total_tokens": 1700
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How did the relationship between UPS's Class B shares in 2022 and Class A shares in 2024 evolve, particularly in terms of their voting rights and convertibility, and what does this imply about the company's ownership structure over time?",
      "original_answer": "In 2022, UPS's Class B shares had one vote per share and were publicly traded, while Class A shares, which were primarily held by employees, retirees, and founder-related trusts, had 10 votes per share and were fully convertible into Class B shares. By 2024, the structure remained consistent in terms of voting rights and convertibility, with no changes to the number of authorized shares (4.6 billion Class A and 5.6 billion Class B). This indicates that UPS maintained a dual-class share structure with no structural changes to the relationship between Class B and Class A shares over this period, preserving the concentrated voting power among long-term stakeholders.",
      "llm_answer": "In both the 2022 and 2024 10‑Ks, UPS’s Class A shares still carry 10 votes per share while Class B shares carry only one vote, and Class A shares remain fully convertible into Class B shares at any time【page 133】【page 116】. The authorized share counts (4.6 B Class A, 5.6 B Class B) stayed the same, so the ownership structure has remained stable: the majority of voting power is held by Class A shareholders (employees, retirees, trusts, and founders), with Class B shares publicly traded but possessing limited voting rights.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: Class A shares have 10 votes per share, Class B have 1 vote; Class A are fully convertible into Class B; authorized shares are 4.6 billion for Class A and 5.6 billion for Class B—unchanged from 2022 to 2024. (2) Quantitative accuracy is perfect: the numbers match exactly and are correctly attributed across years. (3) Multi-hop reasoning is sound—the model correctly synthesizes information from both the 2022 and 2024 10-Ks to conclude that the dual-class structure and ownership dynamics remained stable over time. (4) The answer addresses all parts of the question: evolution (or lack thereof) in voting rights and convertibility, and the implication for ownership structure (continued concentration of voting power among long-term stakeholders). Wording differs slightly but meaning is identical. No errors in entities, years, or financial terms. Citations to page numbers add verifiability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 292,
        "total_tokens": 1614
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How did Southern Company's 2023 impairment charges at Nicor Gas impact the subsidiary's retained earnings available for dividend payments in 2024, and what does this suggest about the financial constraints facing the gas segment under regulatory requirements?",
      "original_answer": "Southern Company recorded a $131 million pre-tax impairment charge ($99 million after tax) related to Nicor Gas' sale of natural gas storage facilities in 2023, which reduced the subsidiary's retained earnings. By December 31, 2024, this contributed to a regulatory restriction limiting Nicor Gas' available retained earnings for dividend payments to affiliates at $1.6 billion. This reflects how impairment charges directly constrain a regulated utility's ability to distribute capital under the dividend restriction framework, impacting Southern Company's overall cash flow strategy.",
      "llm_answer": "Southern Company’s 2023 impairment charge at Nicor Gas—$96 million pre‑tax (≈$72 million after tax)【page_302】—cut the subsidiary’s retained earnings, leaving only $1.6 billion available for dividends in 2024【page_226】.  This reflects the gas segment’s tight regulatory constraints, which limit dividend and loan activity to retained earnings and mean that impairment losses directly shrink the dividend pool, constraining the segment’s financial flexibility.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. The ground truth states a $131 million pre-tax ($99 million after tax) impairment charge, but the LLM reports $96 million pre-tax and ~$72 million after tax, which is factually incorrect. These numbers do not match any variation of the correct figures and suggest either misreading or miscalculation. (2) The $1.6 billion available retained earnings for dividends in 2024 is correctly reported, aligning with the original answer and indicating partial quantitative accuracy on this key outcome. However, the incorrect impairment amount undermines confidence in the financial causality. (3) The reasoning and qualitative synthesis are largely sound: the model correctly identifies that the impairment reduced retained earnings, which in turn constrained dividend capacity under regulatory requirements, reflecting an understanding of the multi-hop relationship between impairment charges, retained earnings, and dividend restrictions in regulated utilities. (4) Contextually, the answer is highly relevant, addressing both parts of the question—impact on retained earnings/dividends and implications for financial constraints—and uses appropriate terminology (e.g., regulatory constraints, dividend pool, financial flexibility). Despite incorrect input figures, the logical flow and conceptual explanation are consistent with the ground truth. The correctness score is reduced primarily due to the material error in the impairment charge amounts, which are central to the question’s financial analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 433,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How did Southern Company's reliance on third-party managers for nuclear decommissioning fund investments evolve between 2022 and 2024, particularly in terms of governance structure and investment discretion?",
      "original_answer": "In 2022, Southern Company maintained a governance structure where neither the company nor its subsidiaries (e.g., Alabama Power and Georgia Power) were allowed to engage in day-to-day management or mandate individual investment decisions for nuclear decommissioning funds. These responsibilities were delegated to unrelated third-party managers who operated within certain investment guidelines and had discretion to actively buy and sell securities to maximize returns. By 2024, this governance framework remained unchanged, with the same restrictions on Southern Company and its subsidiaries and continued delegation to third-party managers. The consistency in governance and investment discretion between the years indicates a stable and long-standing approach to managing nuclear decommissioning funds, with no evidence of structural changes or increased internal control introduced in the 2024 filings.",
      "llm_answer": "Between 2022 and 2024 Southern Company’s arrangement with third‑party managers did not change.  The 2024 filing reiterates that the company and its subsidiaries have no day‑to‑day control of the nuclear decommissioning trust funds; management of the investments is delegated to unrelated third‑party managers, who are overseen by Alabama Power and Georgia Power.  Those managers retain discretionary authority to trade securities within the investment guidelines set by the parent utilities, and Southern Company’s governance role remains purely supervisory.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: Southern Company and its subsidiaries did not have day-to-day management authority over nuclear decommissioning funds in both 2022 and 2024, with investment discretion fully delegated to unrelated third-party managers. The governance structure remained unchanged, which is correctly conveyed. (2) There are no numeric values (e.g., dollar amounts, percentages) in the original or LLM answer, so quantitative accuracy is not applicable—scored as 10 by default. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes information across years (2022 to 2024) and entities (Southern Company, Alabama Power, Georgia Power), confirming consistent delegation and oversight. One minor nuance: the original specifies that third-party managers operate 'within certain investment guidelines' set by the company, while the LLM says 'set by the parent utilities'—this is a slight rephrasing but factually consistent, as Alabama Power and Georgia Power are subsidiaries acting under Southern Company’s framework. (4) The answer is fully relevant, directly addressing governance structure and investment discretion over time. No irrelevant or extraneous information is included. The only reason for not scoring a perfect 10 is the slight rewording of guideline-setting authority, though it does not constitute a factual error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 396,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How did the voting power dynamics between META's Class B and Class A common stock evolve from 2023 to 2024, and what implications did this have for shareholder influence and equity structure?",
      "original_answer": "In 2023, META disclosed that Class B common stock was not publicly traded and that holders of Class A common stock had 66 2/3% of the voting power, while holders of Class B common stock held 33 1/3% of the voting power. Each share of Class B common stock was entitled to 15 votes, and the voting power of Class B shares was non-dilutable. By 2024, META had 2,189,898,148 shares of Class A common stock and 343,761,117 shares of Class B common stock outstanding, which shifted the practical voting influence due to the significant difference in the number of shares outstanding between the two classes. This evolution suggests a continued concentration of voting power among Class B shareholders, despite the larger number of Class A shares held by the public.",
      "llm_answer": "In 2023, holders of Class A common stock controlled 66.7 % of voting power while holders of Class B held 33.3 % (each Class B share entitled to 15 votes)【page_91】. The 2024 filing shows no change to that allocation, but the equity base shifted dramatically: Class A shares fell from ~3.97 bn to 2.19 bn, whereas Class B shares rose from 9 m to 343.8 m, increasing the proportion of non‑voting shares【page_1】. Thus, the control hierarchy remained intact, yet the ownership mix altered, potentially affecting dilution and the relative influence of shareholders on a per‑share basis.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative details. It incorrectly states that Class A shares fell from ~3.97 billion to 2.19 billion between 2023 and 2024, and that Class B shares rose from 9 million to 343.8 million. The original answer (ground truth) does not mention prior share counts in 2023—only the voting power percentages. The 2024 share counts (2.19B Class A and 343.8M Class B) are approximately correct (matching 2,189,898,148 and 343,761,117), but the LLM fabricates 2023 share counts not present in the ground truth, leading to a false narrative of a 'dramatic shift' in equity base. This undermines the quantitative accuracy. (2) The voting power percentages (66.7% for Class A, 33.3% for Class B in 2023) are correctly reported, and the 15-vote entitlement per Class B share is accurate. However, the claim that 'the 2024 filing shows no change to that allocation' is unsupported—the ground truth does not confirm whether the percentage allocation remained the same in 2024, only that the outstanding shares were reported. The LLM incorrectly infers stability in voting power distribution without evidence. (3) The multi-hop reasoning is partially sound: it attempts to link share count changes to voting influence and equity structure. However, it misrepresents the evolution by inventing 2023 share numbers, leading to flawed synthesis. The conclusion about 'increasing proportion of non-voting shares' is misleading—Class A shares are voting (1 vote each), Class B have more votes (15 each), so Class A are not 'non-voting'. The LLM confuses voting power with public float. (4) Despite these errors, the answer addresses the core question about voting dynamics and shareholder influence, correctly identifying the disproportionate voting rights and concentration of control among Class B holders. Wording and structure are relevant and mostly clear. Hence, contextual relevance is high, qualitative reasoning has merit but with flaws, and quantitative accuracy is low due to fabricated numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 554,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How did Altria's regulatory challenges under the FSPTCA in 2022 influence its PMTA submission strategy for newly regulated tobacco products in 2024, particularly regarding the timing and scope of applications for products like oral nicotine pouches and e-vapor devices?",
      "original_answer": "In 2022, Altria (MO) faced significant regulatory constraints under the FSPTCA, particularly around pre-market authorization requirements for tobacco products introduced after February 15, 2007, including oral nicotine pouches and e-vapor products. The company was subject to strict PMTA and SE pathways, with enforcement deadlines such as the September 9, 2020 filing requirement for products first regulated in 2016. By 2024, Altria had submitted PMTAs for on! oral nicotine pouches in May 2020 and on! PLUS in June 2024, while also re-submitting flavored e-vapor products (blueberry and watermelon) for the NJOY ACE 2.0 device in May 2024. These actions reflect a strategic focus on aligning with the FSPTCA’s PMTA process, particularly after earlier denials due to concerns about underage use. The company’s approach in 2024 demonstrates a continuation and refinement of its 2022 compliance strategy, emphasizing adherence to FDA timelines and addressing prior feedback to improve the likelihood of PMTA approval.",
      "llm_answer": "Al Martia’s 2022 regulatory challenges – the April 2022 statutory expansion to cover synthetic‑nicotine products and the FDA’s aggressive review that resolved >99 % of timely PMTA applications (most denied) – prompted a more cautious, staggered PMTA strategy. In 2024 the company filed a supplemental PMTA for its on! PLUS oral‑nicotine pouches (tobacco, mint, wintergreen) in June 2024, after the original on! product had been pending since 2020, and focused e‑vapor device submissions on products with enhanced under‑age‑use safeguards to improve approval prospects, aligning timing with FDA deadlines and guidance (page_36; page_35; page_34).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core strategic shift in Altria's PMTA submissions due to 2022 regulatory challenges and correctly identifies the 2024 filings for on! PLUS and e-vapor devices. However, it introduces a significant factual inaccuracy by claiming a 'April 2022 statutory expansion to cover synthetic-nicotine products'—this is not supported by the ground truth, which makes no mention of such an April 2022 statutory change. Additionally, the claim that the FDA resolved '>99% of timely PMTA applications (most denied)' is not present in the original answer and lacks verification; the ground truth notes earlier denials but does not quantify FDA resolution rates. (2) The date for the on! PLUS submission (June 2024) is correct and matches the ground truth. However, the LLM incorrectly states that the original on! product was 'pending since 2020'—the ground truth specifies it was submitted in May 2020, which is accurate, but 'pending since' is semantically acceptable. The flavored e-vapor re-submission (blueberry and watermelon for NJOY ACE 2.0) in May 2024 is omitted in the LLM answer, replaced with a vague reference to 'enhanced under-age-use safeguards' without naming the products or timing. (3) The multi-hop reasoning is generally sound: the LLM correctly infers that 2022 regulatory pressure influenced a more cautious 2024 strategy, including staggered submissions and focus on compliance. It correctly links FSPTCA constraints to PMTA timing and risk mitigation. However, it fabricates a statutory change and overgeneralizes FDA PMTA outcomes, weakening the reasoning foundation. (4) The contextual relevance is high—the answer directly addresses the influence of 2022 regulations on 2024 strategy, timing, and scope. The qualitative accuracy is good due to correct entity identification (Altria, on! PLUS, oral nicotine pouches, e-vapor) and logical flow, but docked for unsupported claims. Quantitative accuracy is reduced due to the unverified >99% statistic and incorrect characterization of the April 2022 event. Overall, the answer is partially correct with key factual errors, warranting a 7 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 578,
        "total_tokens": 2024
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How might the significant increase in interest rates on Nicor Gas's commercial paper financing from 2022 to 2023 (from 0.3% to 5.5%) have influenced its decision to completely discontinue short-term bank debt, and what does this suggest about SO's broader financing strategy for its natural gas operations?",
      "original_answer": "The weighted average interest rate on Nicor Gas's commercial paper financing increased dramatically from 0.3% in 2022 to 5.5% in 2023, yet Nicor Gas still chose to discontinue its short-term bank debt entirely (which had carried a 0.7% rate in 2022). This suggests that despite rising interest costs, SO may have prioritized flexibility or other strategic considerations in its financing approach for natural gas distribution operations, potentially signaling a shift toward more market-responsive capital structures.",
      "llm_answer": "Nicor Gas’s commercial‑paper rate leapt from 0.3 % in 2022 to 5.5 % in 2023 (page 259 → page 232), making the cost of its short‑term bank debt (4.9 % in 2022) comparatively high and less attractive.  As a result, Nicor Gas eliminated its short‑term bank debt in 2023 (page 232) and relied solely on its commercial‑paper program, which is supported by a committed bank‑credit line.  This shift shows Southern Company’s broader strategy of consolidating short‑term financing for its natural‑gas operations into a single, bank‑backed commercial‑paper facility to simplify debt management and control borrowing costs.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Nicor Gas discontinued short-term bank debt entirely in 2023, but the LLM incorrectly states that Nicor Gas relied solely on its commercial-paper program after eliminating short-term bank debt. This misrepresents the actual decision: the company discontinued short-term bank debt despite rising commercial paper rates, not by shifting into it. Additionally, the LLM claims the 2022 short-term bank debt rate was 4.9%, but the ground truth states it was 0.7%, a major discrepancy. The commercial paper rate increase from 0.3% to 5.5% is correctly cited. (2) Quantitative accuracy fails on key metrics: the 4.9% figure for short-term bank debt in 2022 is incorrect (should be 0.7%), and the implication that commercial paper became cheaper than bank debt is false—5.5% is much higher than 0.7%. The model incorrectly frames commercial paper as a lower-cost alternative when in reality both instruments became more expensive, and the strategic move was to eliminate bank debt despite cost increases. (3) The multi-hop reasoning is flawed: the model fails to recognize the counterintuitive nature of the decision—discontinuing short-term debt even as commercial paper rates spiked—suggesting strategic motives beyond cost minimization. Instead, it fabricates a cost-saving rationale that contradicts the evidence. It also misattributes the strategy to Southern Company (SO), but the original answer refers to SO in the context of its broader natural gas operations, not direct control over Nicor Gas’s financing. (4) Contextual relevance is moderate because the answer addresses financing strategy and cost dynamics, but the incorrect facts and reasoning undermine the conclusion. The suggestion of 'simplifying debt management' is not supported in the ground truth, which emphasizes strategic flexibility rather than operational simplification. Overall, major factual and logical errors reduce correctness significantly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 544,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How did the absence of covenant violations in GM's 2022 and 2023 financial reports influence lenders' ability to enforce collateral claims, and what does this suggest about GM's borrowing stability across these years?",
      "original_answer": "In 2022, GM noted that failure to meet covenants could result in an event of default, allowing lenders to declare amounts due, enforce collateral claims, or restrict additional borrowing. However, GM reported no technical defaults or covenant violations at the end of 2022. This pattern continued into 2023, where GM again stated that no covenant violations existed by year-end, limiting lenders' ability to enforce collateral or accelerate debt. This consistent compliance with covenants across both years suggests stable borrowing conditions and minimized lender-triggered risks for GM.",
      "llm_answer": "GM reported that **no technical defaults or covenant violations existed** in both the 2022 and 2023 filings (2022 filing, page 80; 2023 filing, page 82). Because covenant breaches are the trigger that would let lenders declare an event of default and enforce collateral claims, the absence of violations meant lenders could not force collateral claims or accelerate debt. This consistency indicates that GM maintained borrowing stability and met the covenants required by its lenders throughout those years.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the original answer. (1) It correctly states that GM reported no technical defaults or covenant violations in both 2022 and 2023, which matches the ground truth. (2) There are no numerical values requiring calculation (e.g., dollar amounts, percentages), but the years (2022, 2023) and their associated disclosures are correctly cited with page references (page 80 for 2022, page 82 for 2023), aligning with the expected data provenance. (3) The multi-hop reasoning is sound: the model correctly infers that the absence of covenant violations prevented lenders from triggering default actions such as enforcing collateral claims or accelerating debt, and links this to borrowing stability—exactly as in the original answer. (4) All entities (GM, lenders, covenant compliance) and financial concepts (events of default, collateral enforcement, borrowing stability) are accurately identified and logically synthesized across the two years. The answer fully addresses both parts of the question: the impact on lenders’ rights and the implication for GM’s borrowing stability. Minor wording differences do not affect meaning; the core information is complete, correct, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 352,
        "total_tokens": 1644
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How did AT&T's 2023 use of the VEBA Trust for postretirement benefit payments influence the allocation of assets in the combined pension and postretirement benefit trust by 2024, and what does this imply about the company's long-term retirement funding strategy?",
      "original_answer": "In 2023, AT&T indicated that postretirement benefits could be paid from its cash accounts without reducing VEBA Trust assets, or alternatively, future benefit payments may come directly from the VEBA Trust, reducing its balances. By 2024, the pension and postretirement benefit plans were shown to be commingled in a single trust, with the postretirement benefit plan (including the VEBA Trust) holding only 2.0% of the trust's assets, compared to 98.0% allocated to the pension plan. Additionally, AT&T securities represented less than 1% of the pension trust's assets in 2024, indicating a strategic de-emphasis on company stock in retirement funding. This shift suggests a broader reallocation of retirement liabilities toward the pension trust, potentially reducing reliance on the VEBA Trust for postretirement benefits over time.",
      "llm_answer": "AT&T’s 2023 use of the VEBA Trust to fund post‑retirement benefit payments reduced the trust’s cash‑equivalent holdings, prompting the combined pension‑and‑post‑retirement trust to increase its liquid assets in 2024.  The combined trust’s cash and short‑term investments rose from $11 million to $46 million, while debt securities fell from $5,731 million to $5,145 million and the “Other” (cash‑equivalent) portion of the post‑retirement allocation grew from 1 % to 3 %.  This shift signals a long‑term strategy that prioritizes liquidity and risk mitigation—using the VEBA trust to meet benefit payouts while maintaining a diversified portfolio with a larger fixed‑income and real‑asset tilt to support sustainable returns.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and contains significant factual and quantitative errors. (1) Quantitative Accuracy: The dollar amounts and percentages cited (e.g., cash rising from $11M to $46M, debt securities falling from $5,731M to $5,145M, 'Other' allocation increasing from 1% to 3%) are not supported by the ground truth and appear fabricated. The ground truth states that by 2024, the postretirement benefit plan (including VEBA Trust) held only 2.0% of the combined trust's assets, with 98.0% allocated to the pension plan—this key allocation is entirely missing in the LLM response. (2) Completeness: The answer fails to mention the commingling of pension and postretirement benefit plans into a single trust by 2024, a central point in the original answer. It also omits the fact that AT&T securities represented less than 1% of pension trust assets, which is critical to understanding the company's de-emphasis on company stock. (3) Entity Accuracy: While AT&T and the VEBA Trust are correctly identified, the timeframes (2023–2024) are used appropriately but applied to incorrect data. (4) Reasoning: The LLM constructs a narrative about increasing liquidity and shifting to cash equivalents, but this contradicts the ground truth, which shows a structural reallocation of assets toward the pension plan, not a tactical shift in asset classes. The conclusion about prioritizing liquidity and risk mitigation is speculative and not aligned with the actual implication—reducing reliance on the VEBA Trust over time through structural reallocation. (5) Semantic Equivalence: The LLM answer discusses different financial dynamics (asset class shifts within the trust) rather than the actual structural change in allocation between pension and postretirement plans. Thus, it does not convey the same information. Overall, the answer reflects a fundamental misunderstanding of the data and introduces unsupported figures, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 528,
        "total_tokens": 1947
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How did MET's use of equity market derivatives in 2023, which showed a $522 million impact from a 10% decrease in equity prices, relate to their strategy in 2024 to reduce equity market risk through equity index options and futures?",
      "original_answer": "In 2023, MET disclosed a $522 million impact from a 10% decrease in equity prices linked to their equity market derivatives, indicating a strong sensitivity to equity market risk. By 2024, MET actively used equity index options and futures to hedge against this risk, particularly to offset exposure from minimum guarantees in variable annuity products. The shift from a passive sensitivity to an active hedging strategy reflects a deliberate evolution in MET's approach to managing equity market risk.",
      "llm_answer": "In 2023, MetLife’s sensitivity analysis showed that a 10 % decline in equity prices would have a $522 million impact on its fair value, underscoring the significant exposure of its equity‑derivative portfolio.  In 2024 the company responded by expanding its equity‑market hedges, using equity index options (gross notional $12.7 bn) and equity futures (gross notional $1.84 bn) to reduce that exposure and mitigate potential losses.  Thus, the 2023 impact directly informed the 2024 strategy to hedge equity risk with index options and futures.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the $522 million impact from a 10% decline in equity prices in 2023 is correctly stated. The LLM adds specific notional values for equity index options ($12.7 billion) and futures ($1.84 billion) in 2024, which are not present in the original answer but do not contradict it and may reflect additional data from the filing; their inclusion enhances detail without introducing error. (2) The entities—MetLife (MET), equity market derivatives, equity index options, futures, and the years 2023 and 2024—are correctly identified. (3) The reasoning correctly synthesizes the cause-effect relationship: the 2023 sensitivity informed the 2024 hedging strategy, representing a multi-hop connection across time and strategy evolution. The LLM captures the logical progression from passive risk exposure to active hedging. (4) Semantically, the answer conveys the same core message as the original: MET transitioned to active risk management using derivatives in response to prior sensitivity. The only minor shortcoming is the lack of explicit mention of 'minimum guarantees in variable annuity products' as the source of exposure, which is a contextual detail present in the ground truth. However, this does not undermine the overall correctness. Thus, the answer is factually sound, well-reasoned, and contextually appropriate, warranting a high score with only a slight deduction for partial completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 409,
        "total_tokens": 1692
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did the evolving FSPTCA regulatory requirements impact MO's ability to maintain product availability and associated revenue streams from new tobacco products in 2023 compared to 2022?",
      "original_answer": "In 2022, MO was subject to the FSPTCA regulatory framework, which required compliance with PMTA pathways for new or modified tobacco products introduced after specific market cutoff dates. This created a complex regulatory environment that MO had to navigate for product authorizations. By 2023, the impact of these requirements became evident as MO faced challenges in maintaining market availability for certain products. For example, Helix, a subsidiary, had submitted PMTAs for on! oral nicotine pouches in May 2020, but as of February 2024, no marketing orders had been issued, leaving these products in regulatory limbo. Additionally, MO was forced to remove IQOS devices and Marlboro HeatSticks from the market following an ITC cease-and-desist order in late 2021, which was directly tied to the inability to secure timely regulatory clarity. In response, MO agreed to assign exclusive U.S. commercialization rights to the IQOS system to PMI in April 2024 in exchange for $2.7 billion. This strategic pivot reflects the financial pressure of navigating PMTA requirements and the need to monetize stalled product lines, directly impacting revenue streams and market positioning in 2023.",
      "llm_answer": "In 2023, Altria’s ability to keep new products on the market was bolstered by the FDA’s expanded definition of tobacco products to include synthetic nicotine (effective April 2022) and the agency’s accelerated PMTA review, which led to authorizations for USSTC’s Verve oral‑nicotine line and a modified‑risk claim for Copenhagen Classic Snuff MST (page 36).  However, the same regulatory environment also produced ongoing enforcement actions—such as marketing‑denial orders for flavored e‑vapor products (e.g., NJOY) and the potential for adverse FDA determinations on new products (pages 35‑37)—that continued to constrain product availability and introduced uncertainty relative to 2022, when many new‑product applications remained pending or denied and the regulatory framework was less developed.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and fails to correctly represent the impact of FSPTCA regulatory requirements on MO (Altria) in 2023 compared to 2022. (1) It incorrectly claims that Altria's ability to keep new products on the market was 'bolstered' in 2023 by FDA actions, including authorizations for USSTC’s Verve and Copenhagen Classic Snuff. However, the ground truth states that MO faced challenges maintaining availability, with key products like on! oral pouches in regulatory limbo and IQOS devices removed from the market. There is no mention in the ground truth of Verve or Copenhagen receiving PMTA authorizations in 2023. (2) The LLM references 'pages 35–37' and specific FDA actions on NJOY and flavored e-vapor products, which are not supported by the provided ground truth and introduce unverified details. (3) The answer mischaracterizes the regulatory timeline: while synthetic nicotine regulation began in April 2022, the ground truth emphasizes ongoing PMTA delays and enforcement actions that harmed MO’s product availability in 2023, not improvements. (4) Critical facts from the ground truth are missing: the ITC cease-and-desist order forcing removal of IQOS and HeatSticks, the lack of marketing orders for on! pouches as of February 2024 despite 2020 submissions, and the $2.7 billion deal with PMI in April 2024 to assign IQOS rights—all of which reflect financial and strategic consequences of regulatory failure. (5) The LLM implies regulatory progress in 2023, whereas the ground truth shows deterioration in product availability and revenue pressure. Quantitative accuracy is very low due to fabricated dollar amounts, page references, and implied authorizations with no basis. Qualitative accuracy is poor due to incorrect entity mappings (e.g., USSTC authorizations), flawed reasoning, and failure to synthesize the multi-hop chain: regulatory requirement → PMTA delays → product removals → revenue impact → strategic divestment. Contextual relevance is moderate because the answer addresses regulatory impacts on product availability but does so with incorrect examples and directionality.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1508,
        "completion_tokens": 573,
        "total_tokens": 2081
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did the impact of mild winter weather on UNP's coal shipments in 2023 evolve into 2024, and what was the resulting effect on bulk freight revenues given the continued decline in coal usage for electricity generation?",
      "original_answer": "In 2023, UNP's coal shipments declined due to mild winter weather and low natural gas prices, contributing to a 1% volume decrease in bulk freight and negatively impacting freight revenues. This trend intensified in 2024, where coal shipment volumes fell by 4% year-over-year, again influenced by mild winter weather and low natural gas prices, which further reduced electricity generation demand. As a result, bulk freight revenues continued to decline in 2024, despite some offsetting factors like increased fertilizer and export grain shipments. The mild winter weather's impact on coal demand persisted and deepened, contributing to a more pronounced decline in bulk freight revenues in 2024 compared to 2023.",
      "llm_answer": "In 2023, mild winter weather cut coal shipments, and that same weather pattern persisted into 2024, compounding the decline in coal usage for electricity generation caused by low natural‑gas prices and reduced coal‑fired plant capacity. The continued drop in coal shipments led to a 4 % fall in bulk volumes and a 2 % decline in bulk freight revenues—down $151 million from $7,358 million in 2023 to $7,207 million in 2024—though the loss was partially offset by core pricing gains and higher fertilizer shipments.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the persistence of mild winter weather from 2023 into 2024 and its compounding effect on declining coal shipments due to low natural gas prices and reduced coal-fired plant capacity, aligning with the ground truth. It accurately notes the 4% year-over-year decline in coal shipment volumes in 2024, which matches the original answer. However, the LLM introduces specific revenue figures—$7,358 million in 2023 and $7,207 million in 2024, a $151 million decrease—and a 2% decline in bulk freight revenues—that are not present in the ground truth. Since the original answer does not provide exact revenue numbers or a percentage decline, the inclusion of these precise figures cannot be verified and may be fabricated or inferred beyond available data, reducing quantitative accuracy. (2) The 4% volume decline is correct, but the 2% revenue decline and associated dollar amounts lack corroboration in the ground truth, making them potentially inaccurate or unsupported. There is no indication in the original answer that revenues fell by exactly 2% or by $151 million, so these specifics represent over-precision. (3) The multi-hop reasoning is strong: the model correctly links mild weather in 2023 to continued impacts in 2024, connects coal shipment declines to broader energy market trends (low gas prices, reduced coal plant use), and acknowledges offsetting factors like fertilizer and grain shipments. This demonstrates sound synthesis across time and causal factors. (4) The answer is contextually complete and relevant, addressing both the evolution of weather impacts and the resulting effect on bulk freight revenues. While the qualitative reasoning and entity accuracy (UNP, coal, bulk freight, 2023–2024 timeline) are excellent, the unverified numerical claims prevent a top score in correctness and quantitative accuracy. A score of 8 is justified due to correct core facts and logic, but with notable overreach in unsupported metrics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 538,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did the increase in Disney's notional amounts of foreign exchange cash flow hedges from $8.3 billion in 2023 to $9.9 billion in 2024 impact the company's hedging strategy for forecasted foreign currency transactions?",
      "original_answer": "The increase in Disney's notional amounts of foreign exchange cash flow hedges from $8.3 billion in 2023 to $9.9 billion in 2024 indicates a more aggressive hedging strategy aimed at mitigating the risks associated with forecasted foreign currency transactions. This expansion in hedging volume suggests that Disney anticipated greater foreign exchange volatility or sought to protect a larger portion of its forecasted transactions, particularly those denominated in the euro, Canadian dollar, Japanese yen, British pound, and Chinese yuan. The mark-to-market gains and losses on these contracts are deferred in AOCI and recognized in earnings when the hedged transactions occur, helping to stabilize earnings fluctuations caused by currency movements.",
      "llm_answer": "Disney increased its coverage of forecasted foreign‑currency transactions by raising the notional amount of net cash‑flow hedges from $8.3 billion in 2023 to $9.9 billion in 2024, a roughly 19 % expansion.  This shift reflects a more aggressive hedging policy—or a rise in forecasted exposure—within the company’s existing framework of hedging for up to four years at a set minimum‑to‑maximum annual exposure range, thereby providing greater protection against currency‑rate swings and stabilizing earnings and cash flows.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is factually correct and aligns well with the ground truth. It accurately reports the increase in notional amounts from $8.3 billion in 2023 to $9.9 billion in 2024. The calculated 19% increase is correct: (9.9 - 8.3) / 8.3 ≈ 0.1928 or ~19%, which is properly rounded. These values match the original answer's data.\n\n2) Quantitative accuracy is perfect: both dollar amounts and the implied percentage change are correct. No formatting issues or calculation errors.\n\n3) The qualitative reasoning is sound and captures the essence of Disney's more aggressive hedging strategy. It correctly infers that the increase reflects either greater hedging intent or higher forecasted exposure, which is consistent with the original answer’s interpretation. It also correctly references the purpose of stabilizing earnings and cash flows, and mentions the multi-year hedging framework (up to four years), which adds contextual depth not explicitly in the ground truth but plausibly inferred from typical hedging practices.\n\n4) The only minor shortcoming is that the LLM answer does not explicitly name the specific currencies hedged (euro, Canadian dollar, Japanese yen, British pound, Chinese yuan), which are mentioned in the original answer and represent a detail that enhances completeness. While not critical to the core conclusion, this omission slightly reduces qualitative completeness.\n\n5) Contextual relevance is excellent—the response directly addresses the impact of the increase on Disney’s hedging strategy, interprets the strategic implication, and ties it to financial stability, fully satisfying the question’s intent. Overall, this is a highly accurate, well-reasoned answer with only a minor omission in entity specificity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 475,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did Duke Energy Progress' use of storm recovery bonds evolve between 2022 and 2024, particularly in terms of the geographic scope of storm cost recovery and the structure of its special purpose subsidiaries?",
      "original_answer": "In 2022, Duke Energy Progress utilized DEPNC SF to issue $770 million in storm recovery bonds to recover costs from storms in North Carolina between 2018 and 2019. By 2024, the company expanded its storm cost recovery efforts by forming DEPSC SF to issue an additional $177 million in bonds, this time focused on recovering costs from storms that occurred in South Carolina between 2014 and 2022. This represents a geographic expansion of the storm recovery financing mechanism from North Carolina to include South Carolina, while maintaining the use of bankruptcy-remote, wholly owned special purpose subsidiaries to issue bonds secured by storm recovery property and customer charges.",
      "llm_answer": "Between 2022 and 2024, Duke Energy Progress expanded its storm‑recovery bond program from a single North Carolina vehicle (DEPNCSF) to a second South Carolina vehicle (DEPSCSF) created in 2024 (page 205). Both DEPNCSF and DEPSCSF are bankruptcy‑remote, wholly‑owned VIEs that issue senior secured bonds, use proceeds to acquire storm‑recovery property, and are secured by that property with cash collections as the sole repayment source, and Duke Energy Progress consolidates both (page 205). The 2024 addition broadened the geographic scope of storm‑cost recovery from North Carolina to also cover South Carolina storm costs incurred from 2014‑2022 (page 205).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the evolution of Duke Energy Progress' storm recovery bond usage between 2022 and 2024, noting the creation of DEPSC SF in 2024 to expand geographic scope to South Carolina. The core facts—use of DEPNCSF (North Carolina) in 2022 and DEPSCSF (South Carolina) in 2024, both as bankruptcy-remote, wholly-owned VIEs—are accurate and align with the ground truth. (2) Quantitative accuracy: The LLM answer omits the specific dollar amounts ($770 million in 2022 and $177 million in 2024), which are present in the original answer. This is a minor but notable omission affecting completeness and precision. All other dates and time ranges (storms from 2014–2022 in SC) are correct. (3) Multi-hop reasoning is sound: the model correctly synthesizes that the use of special purpose subsidiaries remained consistent in structure (VIEs, secured by storm recovery property, customer charges as repayment source), while the geographic scope expanded from NC to SC. It also correctly notes consolidation and structural consistency. (4) The answer is semantically very close to the original, with only the missing dollar figures preventing a perfect score. Wording differences (e.g., 'VIEs' vs 'special purpose subsidiaries') are acceptable and technically equivalent in context. Contextual relevance is full—every part of the question is addressed: evolution over time, geographic scope, and subsidiary structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 401,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did AMD's reliance on third-party supply chain logistics in 2022 exacerbate gray market sales, and how did this impact their ability to forecast demand accurately in 2023?",
      "original_answer": "In 2022, AMD outsourced portions of its product distribution and transportation management to third-party providers, which introduced risks related to operational inefficiencies and lack of control over distribution channels. This reliance contributed to gray market sales, where products were diverted from authorized channels and sold at heavy discounts, creating shadow inventory that AMD could not track. By 2023, this lack of visibility and control over gray market sales made it increasingly difficult for AMD to forecast demand accurately, as the company could not reliably predict how many genuine products were in circulation or how gray market activity would distort legitimate demand patterns. The continued presence of gray market products also competed with AMD’s authorized channels, negatively impacting margins and customer satisfaction.",
      "llm_answer": "AMD’s 2022 strategy of outsourcing key supply‑chain logistics—distribution, transportation and IT support—to third‑party providers meant the company had limited visibility and control over where its products were shipped.  This lack of control allowed a larger share of AMD’s inventory to be diverted into gray‑market channels, creating “shadow inventory” that was invisible to the company.  As a result, in 2023 AMD found it difficult to forecast demand accurately because the true inventory levels and sales patterns were obscured by gray‑market activity, which also competed with its own products and eroded margins【page_30】【page_31】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the original ground truth. (1) All factual elements are correct: AMD's reliance on third-party logistics in 2022 led to reduced control and visibility, contributing to gray market sales and shadow inventory, which in turn impaired demand forecasting in 2023. The impact on margins and competition with authorized channels is also correctly noted. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised—dates (2022 and 2023) are correct. (3) The multi-hop reasoning is sound: the answer correctly links outsourcing in 2022 → loss of control → gray market diversion → shadow inventory → forecasting challenges in 2023. The synthesis across cause and effect over time is logically coherent. (4) The only minor shortcoming is that the LLM answer does not explicitly mention 'customer satisfaction' as a negatively impacted area, which is included in the original answer. However, the core impacts—forecasting inaccuracy, margin erosion, and channel competition—are all covered. Wording differs slightly but maintains semantic equivalence. Overall, the response is factually correct, complete in key aspects, and highly relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 355,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did the governance risks associated with META's Class A Common Stock in 2023 relate to the voting power structure between Class A and Class B Common Stock, and how did this dynamic appear to evolve in META's 2024 disclosures?",
      "original_answer": "In 2023, META's Class A Common Stock was negatively impacted by the company's controlled company status, which limited investor protections and potentially harmed stock price due to the dominance of Class B shareholders, who held 66⅔% of the combined voting power. The dual-class structure gave Class B shares 15 votes per share, reinforcing the influence of the controlling stockholder. In 2024, META's disclosures reaffirmed this structure, with 343,761,117 shares of Class B Common Stock outstanding, maintaining the non-dilutive 66⅔% / 33⅓% voting power split. Despite the potential for investor concern, the continued emphasis on this governance model suggests a stable strategic posture, with no indication of structural changes that would alleviate the earlier-mentioned risks to Class A shareholders.",
      "llm_answer": "In 2023, Meta’s risk‑factor disclosure explained that its dual‑class structure concentrates voting power: each Class B share has 15 votes and represents roughly one‑third of the combined voting power, while Class A shares have one vote each and hold about two‑thirds, giving the controlling shareholder significant influence (page 48). The 2024 filing does not change this arrangement; it simply reports the updated share counts (≈2.19 bn Class A and 344 m Class B) and retains the same dual‑class voting structure, indicating that the governance risk and voting dynamics remained unchanged (page 1).",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative details, particularly regarding the voting power distribution. The ground truth states that Class B shareholders held 66⅔% of the combined voting power (not 'one-third' as claimed by the LLM), while Class A held 33⅓%. The LLM reverses this split, incorrectly stating that Class B has 'roughly one-third' and Class A 'about two-thirds' of voting power, which fundamentally misrepresents the governance risk. This error undermines the core of the question about governance risks tied to disproportionate voting power. Additionally, the LLM reports '≈2.19 bn Class A' shares, but the ground truth does not provide Class A share count, so this number cannot be verified and appears speculative. However, the Class B share count (344 million) is close to the correct figure (343,761,117), which supports partial credit. (2) The calculation of voting power is incorrect due to the reversed percentages, and the 15-votes-per-share detail is accurate but misapplied due to the flawed overall framework. (3) The multi-hop reasoning is partially sound—the model correctly identifies that the dual-class structure persisted into 2024 and that no structural changes were disclosed. It also correctly links concentrated voting power to governance risk. However, the reversal of voting power percentages indicates a failure in synthesizing the correct relationship between share class and control, which is central to the question. (4) Contextually, the answer addresses both years and the evolution (or lack thereof) of the governance structure, making it relevant. Despite correct terminology and citation of pages, the critical numerical and conceptual error in voting power allocation reduces the correctness score to 5—partially correct but with major factual flaws.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 501,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did the evolution of Target's credit card profit-sharing arrangement with TD between 2022 and 2023 reflect changes in the company's loyalty program liabilities tied to the Target™ MasterCard?",
      "original_answer": "In 2022, Target reported $89 million in deferred revenue related to the Target Circle loyalty program, which offered 1% rewards on non-RedCard purchases and included benefits for using the Target™ MasterCard. By 2023, this liability had increased to $112 million, indicating growth in the program's participation or redemption obligations. This growth aligns with the ongoing credit card profit-sharing agreement with TD, under which Target receives a percentage of profits from Target™ MasterCard receivables in exchange for marketing and servicing functions. The continued partnership with TD to manage the card program supported Target’s ability to maintain and expand loyalty incentives tied to the RedCard suite, including the Target™ MasterCard, despite the increasing deferred revenue liability.",
      "llm_answer": "Target’s credit‑card profit‑sharing agreement with TD Bank (described on page 46 of the 2022 10‑K and page 48 of the 2023 10‑K) stayed the same—Target receives a share of the profits from its Credit Card and MasterCard receivables in exchange for servicing and marketing.  However, profit‑sharing revenue fell from $734 million in 2022 to $667 million in 2023, while deferred revenue tied to the Target Circle loyalty program (which is linked to the MasterCard) rose from $89 million to $117 million, indicating that Target is accruing larger loyalty‑related liabilities as it expands or adjusts rewards commitments on the MasterCard.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the continuity of the profit-sharing arrangement with TD and links it to Target Circle loyalty program liabilities tied to the Target™ MasterCard, which addresses the core of the question. However, there are key quantitative inaccuracies: the deferred revenue increase is stated as rising from $89M to $117M, while the ground truth reports $112M in 2023, making the $117M figure incorrect. Additionally, the LLM introduces profit-sharing revenue figures ($734M in 2022 and $667M in 2023) that are not present in the original answer or implied by the ground truth, which does not mention specific profit-sharing revenue amounts. These numbers may be factually accurate in external filings but are not supported by the provided ground truth, leading to a mismatch in the evaluation context. (2) The calculation of the change in deferred revenue is based on incorrect end values ($89M → $117M vs. correct $89M → $112M), introducing a $5M error. The drop in profit-sharing revenue is presented as evidence of evolving arrangements, but the ground truth states the arrangement 'continued' without change, so implying a reflection of change due to declining revenue is a misinterpretation. (3) The multi-hop reasoning is partially sound—linking the TD partnership to loyalty liabilities is valid, and recognizing that growing deferred revenue may reflect expanded rewards is reasonable. However, the conclusion that the evolution 'reflects changes' is overstated, as the ground truth emphasizes continuity in the arrangement, not change. The LLM incorrectly infers a shift based on revenue decline and rising liabilities, whereas the original answer frames both as coexisting under a stable agreement. (4) The contextual relevance is high because the answer engages directly with the loyalty program, the MasterCard, TD partnership, and financial trends. Qualitative accuracy is moderate due to correct entity identification and logical flow but penalized for unsupported numerical claims and flawed inference. Quantitative accuracy is low due to incorrect figures. Correctness score reflects partial accuracy with significant factual and inferential issues.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 589,
        "total_tokens": 1960
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did the regulatory uncertainties surrounding Georgia Power's Plant Vogtle Units 3 and 4 in 2022 evolve into financial statement disclosures and audit considerations by 2024, and what impact did this have on the evaluation of cost recovery and regulatory asset treatment?",
      "original_answer": "In 2022, Georgia Power faced significant regulatory uncertainties regarding the recovery of its investment in Plant Vogtle Units 3 and 4, including risks related to construction delays, cost overruns, and potential challenges from regulators and co-owners. These uncertainties led to a $1.692 billion pre-tax charge in 2021. By 2024, these matters had evolved into formal financial statement disclosures and became a focal point in the audit process, particularly around the treatment of regulatory assets and liabilities. The audit firm explicitly evaluated the impact of rate regulation on Georgia Power’s financial statements, including how regulatory decisions by the Georgia Public Service Commission and Federal Energy Regulatory Commission affected the recovery of costs and the reasonableness of management’s disclosures. This shows a shift from uncertainty and risk assessment in 2022 to formalized financial reporting and audit scrutiny in 2024.",
      "llm_answer": "In 2022, Georgia Power disclosed the uncertainties surrounding Plant Vogtle Units 3 and 4 as a critical audit matter and recorded a $1.692 billion pre‑tax charge (page 128‑129), reflecting the risk that regulators might not approve full cost recovery. By 2024, the audit report again highlighted the same regulatory risk (Note 1 and Note 2, pages 132‑133) and the financial statements now show a reversal of that loss to a $21 million estimated loss (page 134), indicating a reassessment of cost recovery and a reduced need for impairment of regulatory assets. The audit considered the potential for regulatory liabilities and the treatment of regulatory assets, noting that future regulatory decisions could still affect cost recovery and the valuation of those assets (page 136).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in the quantitative claims. While it correctly identifies the $1.692 billion pre-tax charge (from 2021, not 2022), it incorrectly states that this was disclosed as a 'critical audit matter' in 2022—this is not supported by the ground truth, which does not mention audit classification in 2022. More critically, the claim that by 2024 there was a 'reversal of that loss to a $21 million estimated loss' is factually incorrect and unsupported by the original answer. The ground truth makes no mention of any reversal or updated loss figure; instead, it emphasizes ongoing audit scrutiny of regulatory asset treatment and cost recovery, not a quantitative change in impairment. This introduces a major error in financial data and implies a resolution or improvement in the situation that is not confirmed. The mention of 'Note 1 and Note 2, pages 132–133' and 'page 134' and 'page 136' suggests fabricated document references not present in the ground truth. However, the answer does capture the qualitative evolution from regulatory uncertainty to audit focus on regulatory assets and liabilities, showing some correct multi-hop reasoning about how initial risks evolved into financial reporting and audit considerations. It correctly identifies the role of regulatory decisions in cost recovery and the ongoing uncertainty, aligning with the original answer’s emphasis on audit evaluation of regulatory treatment. Thus, while the conceptual trajectory is partially sound, the inclusion of false numerical data and specific disclosures severely undermines factual correctness. Quantitative accuracy is low due to the invented $21 million figure and incorrect timing of the charge. Qualitative accuracy is moderate due to correct framing of audit focus and regulatory asset treatment. Contextual relevance is high as the response stays on topic and addresses the evolution of regulatory issues into financial reporting and audit concerns.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1466,
        "completion_tokens": 537,
        "total_tokens": 2003
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did Qualcomm's 2022 strategic investments in XR influence its 2024 risk exposure related to 5G technology commercialization, especially in light of the company's stated expectations for new product areas?",
      "original_answer": "In 2022, Qualcomm Ventures made strategic investments in XR as part of broader efforts to expand opportunities for its technologies and support the development of new products, including XR devices (QCOM_10k_2022.pdf). By 2024, the company positioned XR as a key enabler of immersive experiences powered by 5G, such as ultra-high-definition video streaming and cloud gaming (QCOM_10k_2024.pdf). However, Qualcomm explicitly warned in its 2024 risk factors that its growth depends on extending technologies into new product areas like XR, and that these investments may not generate expected returns (QCOM_10k_2024.pdf). This indicates that while XR was seen as a strategic lever to drive 5G adoption, it also increased exposure to risks around commercialization success in emerging markets.",
      "llm_answer": "Qualcomm’s 2022 QSI segment invested in early‑stage XR companies (page 14), positioning the firm to deliver XR experiences on its Snapdragon platforms.  In 2024 the risk‑factor summary (page 4) stresses that growth depends on extending technology into new product areas—XR, automotive, IoT—and that such investments may not generate the expected income, thereby amplifying commercial risk.  The 2024 outlook (page 8) notes that 5G‑enabled AI is expected to power immersive XR experiences, so the XR investments heighten Qualcomm’s exposure to the risks of 5G technology commercialization.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Qualcomm made strategic XR investments in 2022 via Qualcomm Ventures (referred to as QSI segment, which is consistent with 'Qualcomm Strategic Investments' in filings), and by 2024, XR was positioned as a key 5G-enabled experience. The 2024 risk factors correctly highlight dependence on new product areas (XR, automotive, IoT) and the uncertainty of returns. (2) Quantitative accuracy is perfect: years (2022, 2024) are correct, no numerical errors, and references to page numbers (14, 4, 8) are plausible and consistent with typical 10-K structures. (3) Multi-hop reasoning is sound: the model correctly links 2022 XR investments to 2024 risk exposure around 5G commercialization, synthesizing across time and strategic domains. (4) Semantic equivalence is strong—though the LLM uses 'QSI' instead of 'Qualcomm Ventures' and adds IoT/automotive (which are in the actual 2024 risk factors), these do not detract from accuracy. One minor point: the original answer emphasizes XR as a 'strategic lever to drive 5G adoption,' which is slightly more explicit than the LLM's phrasing, but the core logic is preserved. No calculation errors. Overall, this is a factually correct, well-reasoned, and contextually appropriate response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 371,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did MetLife's introduction of new pricing strategies for annuity products in 2022 influence the growth and liability structure of pension risk transfers in 2023?",
      "original_answer": "In 2022, MetLife introduced pricing strategies for annuity products that included adjustments based on mortality, longevity, and investment return assumptions, with periodic reevaluations of guarantee features (MET_10k_2022.pdf:page_15:chunk_1). These pricing strategies were linked to pension risk transfers, which are a key component of MetLife’s RIS annuity business and are priced based on similar actuarial assumptions (MET_10k_2023.pdf:page_179:chunk_1). By 2023, this pricing framework contributed to an increase in the estimated cash flows for pension risk transfers, with total obligations reaching $310.4 billion, significantly exceeding the recorded liability of $219.7 billion, partly due to updated mortality assumptions and the time value of money (MET_10k_2023.pdf:page_113:chunk_1). This indicates that the 2022 pricing decisions had a measurable impact on the growth and liability structure of pension risk transfers in 2023.",
      "llm_answer": "MetLife’s 2022 “new pricing strategies” for annuity products—specifically, the periodic reevaluation of guarantee features and pricing levels (page 15)—helped drive a 10 % rise in the net liability for pension‑risk‑transfer (RIS) annuities in 2023, increasing from $58.5 B to $64.3 B (page 179). The new approach also shifted the liability structure, as 2023 saw a $284 M negative effect from changes in cash‑flow assumptions and a $270 M negative effect from actual variances, which were offset by other factors, resulting in a higher overall liability (page 179).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly identifies that MetLife introduced new pricing strategies in 2022 involving periodic reevaluation of guarantee features (citing MET_10k_2022.pdf:page_15), the quantitative claims about a '10% rise in net liability' from $58.5B to $64.3B are not supported by the ground truth. The original answer states that total obligations for pension risk transfers reached $310.4 billion with a recorded liability of $219.7 billion in 2023—numbers completely absent from the LLM response. The LLM’s cited figures ($58.5B, $64.3B, $284M, $270M) do not appear in the ground truth and are therefore incorrect. (2) Calculations are also flawed: the claimed 10% increase from $58.5B to $64.3B is mathematically inaccurate (actual increase is ~9.9%), but more importantly, these numbers are not mentioned in the source documents per the ground truth. The negative effects of $284M and $270M are not present in the provided ground truth and appear to be hallucinated. (3) The multi-hop reasoning is partially sound in linking 2022 pricing strategies to 2023 liability impacts, and the LLM correctly associates pricing with RIS annuities and pension risk transfers. However, it fails to incorporate the key causal mechanism from the ground truth—updated mortality assumptions and time value of money driving the gap between estimated cash flows ($310.4B) and recorded liability ($219.7B). This core insight is missing. (4) Despite incorrect numbers, the answer is contextually relevant, addressing the influence of 2022 pricing on 2023 liability growth and structure. The qualitative reasoning framework is plausible but based on incorrect data. Hence, correctness and quantitative accuracy are low; qualitative accuracy is moderate due to correct entity and conceptual linkage; contextual relevance is high as it attempts the right synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 517,
        "total_tokens": 1899
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did the shift in NEE's pension plan asset allocation from 2022 to 2024 impact its use of limited partnerships as part of its investment strategy?",
      "original_answer": "In 2022, NEE's pension plan allocated 13% to alternative investments, which were primarily held in limited partnerships focused on private equity, real estate, and absolute return strategies. By 2024, the target allocation for alternative investments increased to 20%, indicating a strategic emphasis on expanding exposure to alternative assets, many of which are accessed through limited partnerships. This evolution in asset allocation reflects a broader strategic shift toward enhancing long-term returns while managing risk through increased diversification into alternative asset classes, which are largely structured through limited partnership vehicles.",
      "llm_answer": "NEE’s pension plan shifted its target allocation from 2022 to 2024 by raising equity from 43 % to 45 % and doubling convertible‑security holdings from 5 % to 10 %, while cutting alternative investments from 20 % to 13 %【page_100】【page_101】. Because the plan’s alternative investments are mainly private‑equity and real‑estate limited partnerships and its convertible securities are held through a convertible‑security‑oriented limited partnership【page_101】, the rebalancing increased the use of convertible‑security limited partnerships and reduced the reliance on alternative‑investment limited partnerships.",
      "correctness_score": 1,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim. The original answer states that NEE's allocation to alternative investments increased from 13% in 2022 to 20% in 2024, indicating a strategic expansion in alternative assets, primarily accessed through limited partnerships. However, the LLM answer falsely claims that alternative investments were reduced from 20% to 13%, which is the inverse of the truth. Additionally, it incorrectly states that equity allocation increased from 43% to 45% and convertible securities doubled from 5% to 10%, none of which are supported by the ground truth. (2) The quantitative inaccuracies are severe: the percentages cited for equity, convertible securities, and alternative investments are either reversed or fabricated. The direction of change (increase vs decrease) is wrong for the key metric (alternative investments), which directly contradicts the ground truth. (3) The reasoning is flawed because it builds a narrative around a misrepresentation of the data. While the LLM correctly identifies that alternative investments are held in limited partnerships (e.g., private equity, real estate), it incorrectly infers that reliance on such partnerships decreased, when the actual strategy was to increase exposure. The mention of convertible securities being held in limited partnerships introduces a detail not present in the original and distracts from the main trend. (4) The contextual relevance is moderate because the answer discusses pension plan asset allocation and limited partnerships, which are relevant topics, but the factual foundation is so incorrect that the conclusion is invalid. The multi-hop synthesis fails due to incorrect input data. Thus, the correctness score is very low at 1, with similarly low scores for quantitative and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 497,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How did Mississippi Power Company's continued use of the Reduced Disclosure Format in 2023 compare to its 2022 reporting structure, and what does this indicate about its regulatory compliance strategy under The Southern Company's umbrella?",
      "original_answer": "In 2022, Mississippi Power Company, a subsidiary of The Southern Company, filed its 10-K using the reduced disclosure format under General Instructions I(2)(b), (c), and (d) of Form 10-K, a structure also followed in 2023. This consistent use of the reduced disclosure format across both years indicates that Mississippi Power maintained its regulatory compliance strategy aligned with the parent company's broader approach, leveraging streamlined reporting requirements available to subsidiaries. The continuation of this format suggests no significant change in its internal governance or external disclosure obligations during this period.",
      "llm_answer": "Mississippi Power Company filed its 2023 Form 10‑K under the same reduced‑disclosure format it used in 2022 (see the 2022 filing, page 4, and the 2023 filing, page 1).  The unchanged reporting structure shows the company is deliberately following The Southern Company’s consolidated filing strategy, keeping its reporting streamlined and cost‑effective while still meeting SEC requirements.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. (1) Quantitative accuracy: The years (2022 and 2023) are correctly identified, and there are no numerical inaccuracies—both filings are correctly referenced in terms of format and continuity. The mention of specific page numbers (page 4 for 2022, page 1 for 2023) adds precision and matches the source data. (2) Completeness: The answer addresses both parts of the question—comparison of reporting structures across 2022 and 2023, and the implication for regulatory compliance strategy. It correctly notes the unchanged use of the reduced disclosure format. (3) Entity accuracy: 'Mississippi Power Company' and 'The Southern Company' are correctly identified, and the context of subsidiary reporting under a parent company is accurately portrayed. (4) Reasoning: The inference that the consistent format reflects a deliberate, streamlined compliance strategy aligned with the parent’s approach is logically sound and consistent with the ground truth. The only minor shortcoming is that it does not explicitly name the regulatory basis (General Instructions I(2)(b), (c), and (d) of Form 10-K), which is included in the original answer and adds technical completeness. However, this omission does not undermine the core correctness. (5) Semantic equivalence: The LLM conveys the same essential meaning—continued use of reduced disclosure indicates strategic alignment with The Southern Company’s reporting efficiency—using slightly different but equivalent phrasing. Overall, the answer is highly accurate, contextually relevant, and demonstrates strong multi-hop reasoning by linking subsidiary behavior to parent company strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 463,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How did Southern Company's 2022 investment in PowerSecure influence the company's 2023 infrastructure spending patterns, particularly in relation to microgrid deployment activities?",
      "original_answer": "In 2022, Southern Company held goodwill related to its acquisition of PowerSecure and performed its annual impairment test, confirming no impairment was required (chunk 1). PowerSecure, a subsidiary focused on deploying microgrids for various customers, played a central role in Southern Company's broader infrastructure strategy (chunk 2). By 2023, this strategic emphasis was reflected in a $23 million (4.1%) increase in depreciation and amortization expenses, driven by infrastructure investments—including those related to microgrid deployment through PowerSecure—indicating that the 2022 investment had translated into tangible capital spending the following year (chunk 3).",
      "llm_answer": "Southern Company’s 2022 investment in PowerSecure—recorded as a $10 million payment for a federal energy‑efficiency contract—set the stage for a higher infrastructure‑spending focus in 2023.  In 2023 the company increased its payments to PowerSecure to $29 million, reflecting a continued partnership that underpins distributed‑energy and microgrid deployment projects and signals a strategic shift toward resilience‑focused infrastructure.  (See Southern Company Gas payments to PowerSecure in 2022‑23【page_170】)",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The $10 million payment for a federal energy-efficiency contract is not mentioned in the ground truth and misrepresents the nature of Southern Company's 2022 investment in PowerSecure, which was an acquisition-related goodwill holding, not a contract payment. The claim of a $29 million payment in 2023 is unsupported by the original answer and contradicts the documented $23 million increase in depreciation and amortization expenses. These figures are not equivalent or comparable, making the quantitative claims incorrect. (2) The original answer reports a $23 million (4.1%) increase in depreciation and amortization expenses in 2023 due to infrastructure investments linked to PowerSecure. The LLM instead fabricates specific payments ($10M and $29M), which are not only absent from the ground truth but also mischaracterize capital spending as direct payments. There is no verification of calculations because the numbers themselves are incorrect. (3) The multi-hop reasoning is flawed: the LLM fails to connect the 2022 goodwill and impairment test to the subsequent capital deployment in 2023. Instead, it invents a transactional relationship (payments for contracts) that does not align with the strategic subsidiary-driven investment model described in the original. The role of PowerSecure in microgrid deployment is partially correct but framed incorrectly around contract payments rather than organic capital investment through a subsidiary. (4) Contextual relevance is moderate—the answer addresses infrastructure spending and microgrids, and correctly identifies PowerSecure as a key player. However, due to major factual and quantitative errors, the qualitative reasoning is weak, resulting in a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 490,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How did the shift in ACN's 2023 contract terms, which included limited enforceability and early termination clauses, influence client retention and competitive vulnerability observed in ACN's 2024 performance?",
      "original_answer": "In 2023, ACN disclosed that the majority of their contracts were terminable by clients with little or no penalties, and only non-cancelable portions were included in performance obligations. This lack of binding enforceability likely contributed to the competitive pressures and client retention risks outlined in 2024, where ACN noted that competitors were offering more aggressive pricing and contractual terms, increasing the risk of losing clients and market share. The 2024 report also highlighted that contract terminations or non-renewals could lead to significant revenue loss and difficulty in quickly replacing that revenue, reinforcing the vulnerability introduced by the 2023 contract structure.",
      "llm_answer": "The 2023 shift to contracts that were terminable on short notice with little or no penalty made it easier for clients to exit or renegotiate, eroding client retention (page_43). In 2024 this manifested as slower client spending—particularly on smaller, short‑duration contracts—and lower pricing amid a competitive market, underscoring the company’s heightened vulnerability to client churn and competitive pressure (page_26, page_45).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth, with only minor omissions in detail. (1) All entities—ACN, 2023 contract terms, 2024 performance—are correctly identified. The shift to easily terminable contracts in 2023 and the resulting client retention and competitive risks in 2024 are accurately described. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised; dates (2023, 2024) are correct. (3) The multi-hop reasoning is sound: the LLM correctly links the 2023 contract structure (limited enforceability, early termination) to 2024 outcomes (client retention issues, competitive vulnerability). It references specific impacts like slower client spending, lower pricing, and increased churn, which align with the ground truth’s emphasis on revenue loss risk and competitive pricing pressures. (4) The only reason for not scoring a perfect 10 is that the LLM omits explicit mention of the accounting treatment (i.e., only non-cancelable portions counted in performance obligations) and the specific risk of difficulty in replacing lost revenue quickly—details present in the original. However, the core causal chain and business implications are correctly and concisely conveyed. Wording differs but meaning is preserved. Contextual relevance is full, as all parts of the question are addressed with appropriate synthesis across years and contractual effects.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 406,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How did the elimination of Class B shares between 2022 and 2024 impact the concentration of voting power and governance dynamics in CMCSA's corporate structure?",
      "original_answer": "In 2022, CMCSA disclosed that Class B Common Stock had only 3 record holders and carried limited voting rights for specific matters like mergers or amendments to the certificate of incorporation. By 2024, Class B common stock was no longer listed in the equity disclosures, indicating its elimination. This change, combined with the fact that Class A common stockholders retained full voting rights on all matters, suggests a shift toward more centralized governance. The voting rights framework from the 2024 filing emphasized that Class A shareholders would now hold exclusive voting power on most corporate decisions, effectively concentrating decision-making authority within fewer hands. This structural change likely increased the influence of broader shareholder bases represented by Class A shares while removing the special voting provisions previously tied to Class B shares.",
      "llm_answer": "Between 2022 and 2024 Comcast eliminated the Class B shares that had carried 15 votes per share and represented 33 % of the company’s combined voting power—entirely held by CEO Brian L. Roberts【page_39】.  The 2024 certificate of incorporation redesignates those shares as Class B‑1 and removes their voting rights except for a few defined matters, thereby diluting the CEO’s concentrated influence and shifting governance toward a more balanced, board‑controlled structure【page_90】.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that deviate from the ground truth. (1) Quantitative Accuracy: The claim that Class B shares carried '15 votes per share' and represented '33% of the company’s combined voting power' is not supported by the original answer, which states only that Class B had limited voting rights for specific matters and does not mention vote multiples or percentage of voting power. Additionally, there is no mention in the ground truth of CEO Brian L. Roberts holding all Class B shares, nor that they were 'entirely held' by him—this is a critical factual error. (2) Completeness: While the question asks about the impact on voting power concentration and governance dynamics, the LLM incorrectly frames the elimination as diluting the CEO's influence, whereas the original answer suggests governance became more centralized under Class A shareholders, not less. The LLM also introduces a 'Class B-1' redesignation not mentioned in the ground truth, which states Class B stock was simply no longer listed in 2024. (3) Entity Accuracy: The company (CMCSA) and time frame (2022–2024) are correct, but the attribution of shareholding to Brian Roberts and the creation of 'Class B-1' are unsupported. (4) Reasoning: The multi-hop reasoning fails—the LLM incorrectly infers that removing Class B shares reduced CEO power, while the original answer implies a consolidation of voting authority in Class A, which may have broader ownership. The conclusion of a 'more balanced, board-controlled structure' contradicts the ground truth's indication of increased concentration in Class A shareholders. (5) Semantic Equivalence: The overall message is not equivalent; the LLM inverts the governance impact. Despite addressing the topic of voting power and structural change, the core facts and implications are incorrect, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 508,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did the change in Altria Group's (MO) reliance on PM USA as a guarantor from 2022 to 2024 affect the potential exposure of its debt obligations under Bankruptcy Law, particularly in relation to the solvency thresholds outlined in the filings?",
      "original_answer": "In 2022, Altria Group (MO) relied heavily on PM USA as a full and unconditional guarantor of its debt obligations, with the guarantee subject to potential voiding under Bankruptcy Law if PM USA was insolvent or received less than fair consideration. The 2022 filing defined insolvency as when the sum of debts exceeded the fair value of assets or when debts could not be paid as they matured. By 2024, while the guarantee structure remained in place, the filings continued to emphasize the same solvency thresholds under Bankruptcy Law, indicating no structural change in the exposure risk. However, the continued presence of these provisions suggests that MO’s reliance on PM USA's financial strength remained a key risk factor, with no evidence of reduced exposure to Bankruptcy Law scrutiny over the two-year period.",
      "llm_answer": "Altria’s 2024 10‑K shows the same guarantee language and solvency thresholds that were in the 2022 filing (see pages 51 and 49).  The 2024 supplemental financials report PM USA’s net assets at $724 million versus $785 million in the 2021 data (page 52), indicating a modest decline in the guarantor’s solvency.  This brings the guarantor closer to breaching the insolvency thresholds that could void or subordinate the guarantees under Title 11, modestly raising Altria’s potential exposure under bankruptcy law.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a mix of correct and incorrect information. While it correctly identifies that the guarantee language and solvency thresholds remained unchanged from 2022 to 2024, it introduces a factual error regarding PM USA's net assets. The LLM claims PM USA’s net assets were $724 million in 2024 and $785 million in 2021, but the ground truth does not support these specific figures or the comparison across those years. Moreover, the 2024 filing would not contain 2021 data as a direct comparison point, making the analysis misleading. There is no mention in the original answer of actual asset values or a decline in solvency, so this quantitative claim is unsupported. (2) The numbers cited ($724M and $785M) do not appear in the ground truth and cannot be verified; their inclusion undermines quantitative accuracy. Additionally, referencing '2021 data' in a 2024 analysis is inconsistent with the question’s 2022–2024 scope. (3) The reasoning partially follows a logical path—unchanged guarantee language implies persistent exposure—but incorrectly infers increased risk due to a supposed decline in net assets not present in the original answer. This misrepresents the multi-hop synthesis: the ground truth emphasizes continuity in legal structure and risk, not evolving financial deterioration. (4) Despite the factual inaccuracies, the LLM captures the core idea that solvency thresholds under Bankruptcy Law remain a risk factor, and the guarantee structure did not change, which maintains contextual relevance. However, the unsupported numerical claims and incorrect temporal comparison reduce correctness and quantitative accuracy significantly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 460,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How has GD's approach to valuing real estate funds evolved between 2023 and 2024, particularly regarding NAV disclosures and fair value hierarchy categorization?",
      "original_answer": "In 2023, GD reported $13 million in real estate funds as part of its pension plan assets, categorized under Level 3 in the fair value hierarchy due to the use of unobservable inputs in valuation models. These funds were valued using NAV as a practical expedient, with typical redemption terms between 8 and 10 years. By 2024, GD continued using NAV for valuation but provided more detailed disclosures about the fair value hierarchy. While real estate funds remained in Level 3, GD clarified that these assets were now explicitly excluded from the formal fair value hierarchy presentation, though still included in total plan asset reconciliations. The 2024 filing also emphasized that most NAV-based investments, including real estate funds, were redeemable at NAV with notice periods generally up to 90 days, showing increased transparency around liquidity terms compared to 2023.",
      "llm_answer": "GD kept real‑estate funds in the same fair‑value hierarchy position – Level 3 – and continued to value them using NAV as a practical expedient in both 2023 and 2024.  The 2024 filing added a note that NAV‑valued investments are excluded from the fair‑value hierarchy and are disclosed separately for reconciliation, and the NAV amount for real‑estate funds fell from $581 million in 2023 to $421 million in 2024 while the fair‑value amount rose modestly from $13 million to $14 million.  Thus, the categorization stayed the same, but the disclosure of NAV values and the reconciliation tables were clarified and updated.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies in key quantitative values. According to the ground truth, GD reported $13 million in real estate funds in 2023, not $581 million as stated by the LLM. The LLM incorrectly claims the NAV amount fell from $581M to $421M, which is entirely unsupported by the original answer. Additionally, the LLM introduces a 'fair-value amount' rising from $13M to $14M, which is misleading and not mentioned in the ground truth—there is no separate fair value amount distinct from the NAV-based reporting. (2) The original answer does not mention any change in dollar amounts between 2023 and 2024 beyond the continued $13M reference; thus, the LLM fabricated significant numerical changes. The only accurate number is the $13 million in 2023, but even that is misrepresented as part of a declining trend. (3) Qualitatively, the LLM correctly identifies that real estate funds remained in Level 3 and that NAV was used as a practical expedient in both years. It also correctly notes the increased disclosure in 2024 about excluding NAV-valued investments from the formal fair value hierarchy and their separate reconciliation—this aligns with the ground truth. However, it fails to mention the key evolution in liquidity disclosures (redemption terms changing from 8–10 years to up to 90 days), which is a critical part of the 2024 update. (4) Contextually, the answer addresses the right topic and attempts to compare 2023 and 2024 disclosures, so relevance is moderate. However, due to severe quantitative errors and omission of key qualitative details (especially regarding liquidity), the overall correctness score is low. The model appears to confuse actual fair value with NAV amounts and invents financial figures not present in the source, indicating a failure in multi-hop synthesis and data retrieval accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 506,
        "total_tokens": 1885
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did Microsoft's acquisition and integration of LinkedIn in 2022 influence the monetization strategy for AI-enabled Premium Subscriptions in 2023, particularly in light of LinkedIn's 34% revenue growth during the prior fiscal year?",
      "original_answer": "Microsoft's acquisition of LinkedIn in 2022, which was highlighted by a 34% revenue growth for LinkedIn that year, laid the foundation for a more aggressive monetization strategy in 2023. By 2023, LinkedIn's Premium Subscriptions were explicitly positioned as a key monetized solution with AI-enabled features such as enhanced search and professional development tools. The integration allowed Microsoft to leverage LinkedIn's growing user base and engagement metrics to introduce advanced, AI-driven capabilities within Premium Subscriptions, directly tying member growth and platform engagement to increased monetization opportunities. This evolution in strategy reflects Microsoft's intent to transform LinkedIn from a high-growth platform into a more robust revenue driver through targeted, value-added services.",
      "llm_answer": "Microsoft’s acquisition of LinkedIn and its subsequent integration into the Productivity and Business Processes segment enabled the company to embed AI capabilities into LinkedIn’s Premium Subscriptions. The 34 % revenue growth in LinkedIn during the prior fiscal year (FY 2022) showed that this monetization model was effective, prompting Microsoft to focus on AI‑enabled Premium Subscriptions as a key growth driver in FY 2023 (page 9, page 7, page 10).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers and dates are correct: the 34% revenue growth for LinkedIn in FY 2022 is accurately cited, and the reference to FY 2023 as the year of strategic focus on AI-enabled Premium Subscriptions matches the original. No calculations were required, but temporal references are correct. (2) The entity identification is accurate—Microsoft, LinkedIn, Premium Subscriptions, AI-enabled features, and the correct fiscal years (FY 2022 and FY 2023) are all properly referenced. (3) The reasoning is sound and reflects multi-hop synthesis: the acquisition in 2022, LinkedIn's strong revenue growth, and the subsequent strategic pivot in 2023 to leverage AI in monetizing Premium Subscriptions are logically connected. The mention of integration into the 'Productivity and Business Processes segment' adds contextual detail not in the original but is factually consistent. (4) Semantically, the LLM conveys the core message of the original answer—using LinkedIn’s growth as a springboard for AI-driven monetization—though it omits some nuance about leveraging user engagement and platform metrics to drive member growth. This minor omission prevents a perfect 10 on qualitative accuracy. Overall, the answer is factually correct, relevant, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 373,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did the structure of META's dual-class voting rights evolve from 2023 to 2024, and what does the persistence of Class B common stock majority voting power indicate about ongoing corporate governance risks?",
      "original_answer": "In 2023, META disclosed that its dual-class structure, where Class B common stock controlled key governance decisions, contributed to its status as a 'controlled company' under Nasdaq rules. This allowed the company to bypass certain corporate governance requirements and potentially made Class A common stock less attractive to investors due to reduced shareholder protections. The 2024 voting rights evidence confirmed that Class A common stockholders retained full voting rights, while Class B common stockholders had limited but decisive voting power on specific matters such as mergers and charter amendments. As of January 2025, META still had 343,761,117 shares of Class B common stock outstanding, maintaining the dual-class structure. This persistence indicates that the corporate governance risks identified in 2023—such as concentrated control and limited investor protections—remained unchanged in 2024, continuing to pose potential concerns for Class A shareholders.",
      "llm_answer": "Meta’s 2023 10‑K explained that the company’s dual‑class structure gives Class B shares ten votes each versus one vote for Class A, and that holders of Class B (including Zuckerberg, the board chair and CEO) retain majority voting power as long as they own at least 9.1 % of the combined shares (see pages 48‑50).  The 2024 filing does not report any change to that arrangement, indicating that Class B still dominates the vote and that the controlling shareholder can override other shareholders—an ongoing corporate‑governance risk.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the core structure of Meta's dual-class voting system and its implications for corporate governance, aligning well with the ground truth in terms of reasoning and context. It accurately notes that Class B shares have ten votes per share versus one for Class A, and that the controlling shareholder (Zuckerberg) retains majority voting power with as little as 9.1% ownership—a key quantitative detail not present in the original answer but factually correct and relevant. However, this specific percentage (9.1%) is not mentioned in the ground truth and cannot be verified from the provided knowledge graph, making it an unsupported addition; hence, quantitative accuracy is slightly reduced. The LLM correctly states there was no change in the 2024 filing, which matches the persistence of the dual-class structure described in the original answer, including ongoing governance risks due to concentrated control. While the original answer includes specific data on outstanding Class B shares (343,761,117 as of Jan 2025), the LLM omits this figure, resulting in partial completeness. Nevertheless, the absence does not undermine the central conclusion. The reasoning is sound, synthesizing information across years and governance dimensions, and the answer remains highly relevant to both parts of the question: structural evolution (no change) and governance risk implications. Semantic equivalence is largely preserved, with only minor omissions and one unverified but plausible statistic.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 418,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did LMT's growing reliance on fixed-price contracts in 2023 impact their exposure to cost overruns and consolidated net profit booking rate adjustments compared to 2022?",
      "original_answer": "In 2022, LMT was already subject to cost overruns due to supplier delays and fixed-price contracts that constrained their ability to recover increased costs. By 2023, this exposure intensified as seen in specific programs like the classified fixed-price incentive fee contract and the ground-based radar program, which each accumulated approximately $270 million and $280 million in cumulative losses, respectively. RTX's 2023 evidence further explains that fixed-price contracts are particularly vulnerable to cost overruns driven by inflation, supply chain disruptions, and labor cost increases—factors LMT faced directly. This led to a decline in LMT's consolidated net profit booking rate adjustments, which increased net sales by $1.6 billion in 2023 compared to $2.0 billion in 2022, reflecting the growing financial strain from fixed-price contract risks.",
      "llm_answer": "LMT’s 2023 10‑K notes that the company was bidding more contracts that combine cost‑reimbursable development work with fixed‑price production options, a shift that “increases the risk that we may experience lower margins than expected, or a loss, on the production options because we must estimate the cost of producing a product before it has been developed” and that “under fixed‑price contracts, if our actual costs exceed our estimates our profits are reduced and we could incur a loss”【page 34】.  At the same time, the company’s consolidated net‑profit booking‑rate adjustments were smaller in 2023 than in 2022 – $1.6 billion versus $1.8 billion – a $200 million decline that reduced the boost to net sales and operating profit【page 64】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the increasing reliance on fixed-price contracts and their impact on cost overruns and profit margins, citing relevant risk language from LMT's 10-K (page 34). It also correctly notes that consolidated net-profit booking-rate adjustments declined from 2022 to 2023, which aligns with the ground truth's narrative of growing financial strain. However, there is a critical error in the 2022 adjustment value: the LLM states $1.8 billion, while the ground truth reports $2.0 billion. This leads to an incorrect difference of $200 million instead of the actual $400 million decline ($2.0B to $1.6B). (2) The quantitative inaccuracy undermines the financial comparison, even though the $1.6 billion figure for 2023 is correct. The ground truth also includes specific program-level losses (e.g., $270M and $280M on classified and radar programs), which the LLM omits entirely, reducing completeness. Additionally, the reference to RTX’s 2023 evidence explaining macro risks (inflation, supply chain) is missing in the LLM response, breaking a key multi-hop link between LMT’s exposure and external validation from RTX. (3) The reasoning is partially sound—LLM correctly infers that fixed-price contracts increase cost overrun risks and that lower booking-rate adjustments reflect financial pressure. However, it fails to connect specific program losses or external industry evidence (RTX) that strengthen the causal argument, indicating incomplete synthesis across sources. (4) Despite missing key data points and containing a significant numerical error, the LLM captures the overall trend and direction of impact (increased risk, reduced profit adjustments), and uses correct terminology and context from the 10-K. Hence, correctness is partially accurate but not fully aligned with the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 500,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did the shift in NEE's use of option models for power derivatives between 2022 and 2024 affect the fair value and implied volatility metrics of their Options - Power portfolio?",
      "original_answer": "In 2022, NEE reported a fair value of $52 million for Options - Power with a weighted-average implied volatility of 81%. By 2024, the fair value of Options - Power had decreased to $9 million in assets and $6 million in liabilities, while the weighted-average implied volatility significantly increased to 186%. This indicates that NEE's use of option models evolved to reflect higher volatility expectations in the power market, which likely contributed to the reduced fair value of these instruments due to increased risk premiums.",
      "llm_answer": "The 2024 10‑K (page 86) shows the Options‑Power portfolio valued at $9 million in assets and $6 million in liabilities, with implied volatilities ranging 78 %–360 % and a weighted‑average of 186 %. In contrast, the 2022 10‑K (page 86) lists the same portfolio at $52 million in assets and a $1 million liability, with implied volatilities 8 %–368 % and a weighted‑average of 81 %. Thus, the shift in NEE’s option‑model usage lowered the fair‑value balance of the portfolio while markedly raising its implied‑volatility metrics.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key quantitative figures from the ground truth: the 2022 fair value of $52 million in assets and $1 million in liabilities (vs. ground truth $52M fair value and unspecified liability; note: ground truth does not specify liability amount for 2022, only that fair value was $52M), and 2024 values of $9M in assets and $6M in liabilities, with weighted-average implied volatilities of 81% (2022) and 186% (2024). The range of implied volatilities (78%–360% in 2024, 8%–368% in 2022) are accurately cited from the 10-Ks, though the ground truth only mentions the weighted averages. These additional details do not contradict but add context. (2) All numbers match the original answer and filing data; minor discrepancy in 2022 liability: LLM reports $1M liability, which is consistent with the 2022 10-K but not explicitly mentioned in the ground truth. This is a reporting nuance, not an error. Calculations are not required beyond comparison, and the directional changes (decrease in fair value, increase in volatility) are correctly observed. (3) The multi-hop reasoning is sound: the model compares data across two years (2022 and 2024), identifies the shift in modeling approach via changes in volatility and valuation, and infers that model usage evolved to reflect higher volatility expectations. The conclusion that this shift lowered fair value while increasing implied volatility is logically supported. (4) The answer is semantically equivalent to the ground truth, with slightly more granular detail from the filings. The only minor shortcoming is that the LLM does not explicitly state that the model shift 'likely contributed to reduced fair value due to increased risk premiums'—a causal interpretation in the ground truth—but the implication is clearly drawn. Thus, the answer is highly accurate, complete, and contextually appropriate, warranting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative and contextual performance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 544,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "How did the implementation of Federal Acquisition Regulation (FAR) cost accounting standards in 2022 influence Lockheed Martin's revenue recognition methodology for U.S. Government Contracts in 2023, particularly in relation to performance obligations and variable consideration?",
      "original_answer": "In 2022, Lockheed Martin applied FAR cost accounting standards which governed how revenue was recognized for U.S. Government Contracts, particularly requiring that standalone selling prices for products or services were typically equal to the contractually stated price due to the cost-plus-reasonable-profit framework. By 2023, this regulatory influence persisted, with Lockheed Martin continuing to treat most contracts as a single performance obligation due to the complex interrelationships between deliverables. However, the company refined its approach to variable consideration, such as incentive fees and claims, by estimating these at the most likely amount only when it was probable that a significant reversal of cumulative revenue would not occur. This evolution indicates a more cautious and risk-adjusted revenue recognition strategy under the continued constraints of FAR, especially regarding contracts with performance-based incentives.",
      "llm_answer": "The 2022 implementation of the FAR Cost Accounting Standards required Lockheed Martin to set U.S. government contract prices on the basis of estimated or actual costs plus a reasonable profit margin, so the contract’s “stand‑alone” selling price is essentially the contract price itself【page_77】.  Consequently, in 2023 the company treated most U.S. government contracts as a single performance obligation and estimated any variable consideration at the most‑likely amount, including it in the transaction price only when it was probable that a significant reversal would not occur and constraining the amount if that risk was high【page_78】【page_79】.  Revenue is then recognized over time using the percentage‑of‑completion cost‑to‑cost method for obligations with continuous transfer of control.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the 2022 FAR implementation influenced Lockheed Martin's revenue recognition by anchoring standalone selling prices to contract prices due to the cost-plus framework, which is correctly stated. In 2023, the company continued treating most U.S. government contracts as a single performance obligation, and refined variable consideration estimation using the most likely amount, constrained when a significant reversal of revenue was probable—this matches the original answer. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised; dates (2022, 2023) are correct. (3) Multi-hop reasoning is sound: the model correctly links FAR standards to pricing methodology, then to performance obligations and variable consideration under ASC 606, while acknowledging the continued regulatory influence into 2023. (4) The only minor omission is the lack of explicit mention of 'performance-based incentives' as a specific source of variable consideration (e.g., incentive fees and claims), which is included in the ground truth and adds slight contextual nuance. However, the core concepts are semantically equivalent, and the LLM references variable consideration broadly and its constraint logic accurately. The addition of the percentage-of-completion cost-to-cost method, while not in the original answer, is contextually relevant and consistent with industry practice for such contracts, and does not detract from accuracy. Overall, the answer is factually correct, complete in key aspects, and highly relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1470,
        "completion_tokens": 459,
        "total_tokens": 1930
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "How did the accrual and payout structure of dividend equivalents on deferred shares for non-employee directors change between fiscal years 2023 and 2024, and what does this indicate about HD's director compensation strategy?",
      "original_answer": "In 2023, HD disclosed that dividend equivalents on deferred shares for non-employee directors accrued and were paid out in the form of additional shares upon termination of Board service. This structure remained consistent in 2024, with no explicit changes to the accrual or payout mechanics. However, the continued use of dividend equivalents suggests a sustained strategy of aligning director compensation with long-term shareholder interests by reinvesting dividends into additional equity, reinforcing retention and performance alignment. The lack of structural changes indicates stability in HD’s non-employee director compensation framework year-over-year.",
      "llm_answer": "Between FY 2023 and FY 2024 the accrual and payout structure of dividend equivalents on deferred shares for non‑employee directors did not change – dividends continue to accrue on the deferred shares and are paid out as additional shares of common stock when the underlying shares are paid upon termination of service, with the fair value expensed immediately at grant. The only change was a reduction in the number of deferred shares granted (from 19,000 to 15,000), indicating a more restrained, equity‑centric director‑compensation strategy that keeps the same payout mechanics while tightening the overall equity grant size.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that the accrual and payout structure of dividend equivalents did not change between FY2023 and FY2024, which aligns with the ground truth. However, it introduces a specific quantitative claim—that deferred shares granted were reduced from 19,000 to 15,000—that is not present in the original answer and cannot be verified from the provided ground truth. This number discrepancy is a critical error, as no such figures appear in the original response, suggesting fabrication or incorrect inference. (2) The quantitative accuracy is low because the LLM asserts precise share numbers (19,000 and 15,000) without support from the ground truth, which makes no mention of any change in grant size. There is no basis for this comparison, and thus the calculation or observation is factually unsupported. (3) The reasoning is partially sound: the model correctly infers that unchanged payout mechanics suggest consistency in compensation strategy. However, the conclusion about a 'more restrained, equity-centric strategy' is based on unverified data, undermining the validity of the multi-hop synthesis. The original answer emphasizes stability and long-term alignment without commenting on restraint or reduction in grants. (4) Contextual relevance is high because the LLM addresses both parts of the question—change in structure and strategic implication—and focuses on the correct entities (dividend equivalents, deferred shares, non-employee directors, HD’s compensation strategy). Despite incorrect specifics, the overall framing matches the intent of the question. The correctness score is moderate due to accurate structure description but major deduction for unsupported numerical claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 473,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "How did the evolution of BAC's use of ECL models in 2023, which relied on contractual terms to forecast principal cash flows, influence their treatment of contractual terms in 2024 for estimating credit losses on commercial loans and unfunded commitments?",
      "original_answer": "In 2023, BAC used ECL models that relied heavily on contractual terms to forecast principal cash flows for commercial loans, including expected prepayments and borrower behavior for open-ended commitments. This modeling approach was further grounded in contractual life and borrower-specific attributes. By 2024, BAC continued to use contractual terms as a foundation but expanded their application to include more nuanced borrower-specific factors such as delinquency status, credit scores, and collateral values, particularly for unfunded commitments like revolving lines of credit. The 2024 models also incorporated broader economic indicators like unemployment rates and GDP forecasts, indicating a more integrated and dynamic use of contractual terms within the ECL estimation process. This shows a clear evolution from a primarily structure-based modeling approach in 2023 to a more behaviorally and economically sensitive framework in 2024.",
      "llm_answer": "In 2023, BAC’s ECL models for commercial loans used the contractual terms of each loan to forecast future principal cash flows and set the loan’s life (2023 p. 99).  The 2024 filing shows that the bank continued to apply the same contract‑centric approach to both funded commercial loans and unfunded commitments, using the contractual maturity to determine the exposure life and incorporating the same models and utilization‑at‑default assumptions for unfunded commitments (2024 p. 99‑100).  Thus, the evolution in 2023 reinforced a consistent, contractual‑terms‑based methodology that carried forward unchanged into 2024 for estimating credit losses on all commercial exposures.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains some factual elements, such as the correct reference to BAC's use of contractual terms in 2023 to forecast principal cash flows and determine loan life (citing 2023 p. 99), and the continuation of contract-centric modeling in 2024 (citing 2024 pp. 99–100). These references align with the general context of ECL models relying on contractual terms. However, the core of the question asks about the *evolution* of BAC’s treatment of contractual terms from 2023 to 2024, particularly regarding commercial loans and unfunded commitments. The ground truth states that in 2024, BAC *expanded* beyond contractual terms to include borrower-specific behavioral factors (e.g., delinquency, credit scores, collateral) and macroeconomic indicators (e.g., unemployment, GDP), indicating a more dynamic and integrated approach. In contrast, the LLM claims the methodology 'carried forward unchanged into 2024,' which directly contradicts the ground truth. This is a major qualitative error in reasoning and synthesis, as it fails to recognize the multi-hop evolution from a structure-based (2023) to a behaviorally and economically sensitive framework (2024). While the citations and general topic are relevant, the conclusion is factually incorrect. Quantitative accuracy is high because there are no numerical claims to dispute—only page references, which appear plausible. Contextual relevance is moderate because the answer discusses the right topic and documents but draws an incorrect inference. The failure to capture the key evolution in modeling approach severely undermines correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 437,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How did PepsiCo's strategic positioning in the Beverages segment across Africa and Middle East (AMESA) change from 2023 to 2024, and what does this suggest about their regional focus?",
      "original_answer": "In 2023, PepsiCo's Beverages segment accounted for 29% of revenue in the Africa and Middle East (AMESA) region, down slightly from 30% in 2022, indicating a small decline in the importance of beverages in that region. By 2024, the company maintained the Beverages segment at 30% of AMESA revenue, reversing the previous year's decline. This suggests a renewed or stabilized emphasis on beverages in the region, as PepsiCo likely adjusted strategies to strengthen its beverage portfolio in AMESA after a slight dip in 2023.",
      "llm_answer": "PepsiCo nudged its AMESA beverage mix up by one percentage point – from 29 % of AMESA net revenue in 2023 to 30 % in 2024 – while AMESA’s total net revenue rose modestly from $6.14 bn to $6.22 bn and operating profit slipped slightly from $807 m to $798 m [PEP_10k_2023.pdf page 72][PEP_10k_2024.pdf page 72]. This small shift indicates a deliberate, though measured, emphasis on expanding its beverage portfolio in Africa and the Middle East, suggesting the company is prioritizing beverage growth while maintaining a balanced convenient‑foods presence in the region.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the increase in the Beverages segment from 29% in 2023 to 30% in 2024, aligning with the ground truth that shows a reversal of the prior decline and stabilization at 30%. However, the ground truth references 2022 as the baseline (30% in 2022, down to 29% in 2023), while the LLM answer omits 2022 and frames the change as a 'nudge up' from 2023 to 2024 without acknowledging the prior year's decline from 30% to 29%. This omission slightly weakens completeness. (2) The LLM introduces specific dollar figures—$6.14B and $6.22B for net revenue, and $807M to $798M for operating profit—which are not present in the original answer. While these may be factually correct (and cited from 10-Ks), they are extraneous and not required by the question or ground truth. Their inclusion does not detract from correctness but adds detail beyond the scope. (3) The multi-hop reasoning is sound: the model correctly infers that a percentage point increase in beverage revenue share, despite a slight drop in operating profit, suggests a strategic re-emphasis on beverages. This aligns with the ground truth’s interpretation of renewed focus. (4) The qualitative reasoning and contextual relevance are strong—the answer directly addresses how PepsiCo’s strategic positioning changed and interprets what it suggests about regional focus. The omission of the 2022 context slightly reduces completeness and quantitative accuracy, but core facts and synthesis are correct. Hence, a score of 8 is justified: factually accurate on key metrics and reasoning, with minor omissions and added detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 445,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How did the conversion dynamics between UPS Class A and Class B shares evolve from 2022 to 2023, particularly in terms of the total number of shares authorized and their voting rights structure?",
      "original_answer": "In 2022, UPS had 4.6 billion Class A shares and 5.6 billion Class B shares authorized, with Class A shares carrying 10 votes per share and Class B shares carrying one vote per share. Class A shares were primarily held by employees, retirees, and founder-related trusts, and were fully convertible into Class B shares. By 2023, the number of authorized shares for both classes remained unchanged at 4.6 billion for Class A and 5.6 billion for Class B, indicating a stable structure in terms of voting rights and convertibility. However, the unchanged authorization levels suggest no expansion in share structure despite potential conversions, which could imply a balanced approach to capital structure management.",
      "llm_answer": "UPS kept the same authorized capital structure from 2022 to 2023, with 4.6 billion Class A shares and 5.6 billion Class B shares authorized, each Class A share carrying 10 votes and each Class B share carrying 1 vote, and Class A shares remaining fully convertible into Class B shares at any time (Note 12, page 112). Conversion activity rose modestly, with 12 conversions of Class A to Class B shares in 2022 and 14 in 2023 (roll‑forward table on page 112). Thus, while the authorized shares and voting‑rights structure stayed constant, the number of conversions increased slightly.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states the authorized shares for both Class A and Class B in 2022 and 2023 (4.6 billion and 5.6 billion respectively), the voting rights (10 votes for Class A, 1 vote for Class B), and the convertibility of Class A into Class B shares—matching the ground truth. However, the ground truth does not mention specific conversion activity (12 in 2022, 14 in 2023), nor does it reference 'Note 12, page 112' or a 'roll-forward table.' These details are absent from the original answer and appear to be fabricated or over-specified, introducing information not supported by the ground truth. (2) Quantitatively, the core numbers (4.6B, 5.6B, 10 votes, 1 vote) are accurate and consistent with the original. The conversion counts (12 and 14) are specific but not verifiable from the ground truth, which only notes that the authorization levels remained unchanged and implies conversions may have occurred without quantifying them. This introduces a risk of hallucination, reducing quantitative accuracy slightly. (3) The reasoning is mostly sound: the LLM correctly infers that the stable authorization levels indicate a consistent structure, and it attempts to add value by discussing conversion trends. However, the multi-hop synthesis is compromised by introducing unverified data (conversion counts), which undermines the reliability of the reasoning. The ground truth emphasizes the stability of the structure and its implications for capital management, while the LLM shifts focus to conversion volume, which was not part of the original insight. (4) Contextual relevance is high—the answer directly addresses the evolution of conversion dynamics, share authorization, and voting rights. Despite the hallucinated details, the core response remains on-topic and informative. The correctness score is 7 due to accurate foundational facts but penalized for unsupported specifics that affect overall trustworthiness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 526,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How did GM's strategic focus on trucks in 2022 influence its financial stake and production collaboration with nonconsolidated affiliates in 2023, particularly in relation to its $35.0 billion EV investment commitment?",
      "original_answer": "In 2022, GM emphasized the importance of trucks in its product portfolio and identified them as critical to maintaining profitability during its transition to electric vehicles (EVs), with a strategic commitment of over $35.0 billion from 2020 through 2025 to accelerate this shift. Trucks were central to this strategy, as they represented a historically strong segment for GM and were expected to play a key role in funding the EV transformation. This strategic focus on trucks directly influenced GM's continued collaboration with nonconsolidated affiliates, as these partners were involved in the development, production, and marketing of trucks and other vehicles. In 2023, GM maintained financial stakes in these affiliates and engaged in ongoing transactions involving component parts and vehicles, indicating that nonconsolidated affiliates remained integral to truck production. The continuity in affiliate relationships across both years suggests that GM leveraged these partnerships to support its broader strategic goals, including the production and cost-reduction efforts for EVs, particularly as it worked to scale its Ultium battery platform and integrate learnings from ICE-based truck production into its electrified future.",
      "llm_answer": "GM’s 2022 strategy to double‑down on full‑size trucks and SUVs was designed to preserve higher‑margin sales and generate the cash needed to fund its $35.0 billion EV and AV investment plan (see 2022 10‑K, page 17). In 2023 that truck focus translated into a larger financial stake in non‑consolidated affiliates—evidenced by a $10.6 billion investment in automotive China joint ventures and Ultium Cells Holdings LLC and a $2.766 billion net purchase of vehicles from those affiliates (2023 10‑K, pages 78‑79)—and deeper production collaboration, with $209 million of sales back to the affiliates. These moves secure the supply‑chain and production capacity required to execute the $35.0 billion EV commitment.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant quantitative inaccuracies that undermine its factual correctness. First, it claims GM made a '$10.6 billion investment in automotive China joint ventures and Ultium Cells Holdings LLC' in 2023, which is not supported by the ground truth and misrepresents GM's financial stake in nonconsolidated affiliates. The original answer does not specify any such dollar amount for 2023 investments, nor does it break down investments by entity in this way. Second, the figures '$2.766 billion net purchase of vehicles' and '$209 million of sales back' are presented with false precision and are not mentioned in the ground truth; while GM did engage in transactions with nonconsolidated affiliates, the original answer does not provide specific numbers, making these claims unverifiable and likely fabricated. These numerical errors severely impact the correctness score. On qualitative grounds, the LLM correctly identifies the strategic link between truck profitability and EV funding, and plausibly connects ongoing affiliate collaboration to production capacity for EVs. It also correctly references the $35.0 billion EV investment timeframe (2020–2025), though it mischaracterizes it as including AV (autonomous vehicles) without confirmation from the ground truth. The reasoning partially captures the multi-hop logic—linking 2022 strategy to 2023 financial and production outcomes via affiliate relationships—but does so with invented data. Contextually, the answer stays focused on the question and attempts to synthesize across years and entities, earning a higher relevance score. However, the inclusion of unsourced, precise financial figures constitutes hallucination, leading to a low quantitative accuracy score and an overall partially correct but significantly flawed response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1506,
        "completion_tokens": 490,
        "total_tokens": 1996
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How did Netflix's use of foreign exchange forward contracts evolve from 2023 to 2024 in response to changes in firm commitments related to foreign currency-denominated content licensing?",
      "original_answer": "In 2023, Netflix entered into foreign exchange forward contracts to manage foreign exchange risk on forecasted transactions and firm commitments related to foreign currency-denominated content assets. By 2024, the company expanded its hedging activities, with the notional amounts of foreign exchange cash flow hedges increasing from $8.3 billion (as of September 30, 2023) to $9.9 billion (as of September 28, 2024), reflecting a growing need to hedge against currency fluctuations on content-related firm commitments. Additionally, in 2024, Netflix specifically noted that foreign exchange forward contracts were used to mitigate fluctuations in forecasted and firmly committed U.S. dollar-equivalent transactions related to content licensing and production, with $187 million and $71 million in AOCI impacts as of December 31, 2024 and 2023, respectively, showing an increased hedging impact year-over-year.",
      "llm_answer": "Netflix expanded its forward‑hedging program for firm commitments tied to foreign‑currency content licensing.  The notional amount of net foreign‑exchange cash‑flow hedges rose from $8.3 billion in 2023 to $9.9 billion in 2024 (page 121), and the AOCI impact of those hedges for a 10 % dollar‑strengthening scenario increased from $71 million to $187 million (pages 28–29).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the evolution of Netflix's use of foreign exchange forward contracts from 2023 to 2024, noting the increase in notional amounts from $8.3 billion to $9.9 billion and the rise in AOCI impact from $71 million to $187 million, which aligns with the ground truth. All numeric values (dollar amounts, years) are accurate and match the original answer. (2) Quantitative accuracy is perfect: $8.3B to $9.9B increase and $71M to $187M AOCI impact are correctly reported. The mention of a '10% dollar-strengthening scenario' contextualizes the AOCI figures, consistent with typical hedging disclosures, though the original answer does not explicitly state the scenario—this is a minor addition but not factually incorrect. (3) The multi-hop reasoning is sound: the model connects the increase in notional hedges and AOCI impact to expanded hedging activities in response to firm commitments on foreign currency content, correctly inferring the cause-effect relationship. However, the LLM omits the specific mention that hedges were used for both forecasted and firmly committed transactions related to content licensing and production, slightly reducing completeness. (4) The answer is highly relevant, directly addressing how Netflix’s hedging evolved in response to content-related firm commitments. The only minor gap is the lack of explicit mention of 'forecasted transactions' alongside firm commitments, which slightly affects qualitative accuracy. Overall, the answer is factually correct, well-synthesized, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 434,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How did the distribution of PepsiCo's beverage segment revenue across regions in 2023 compare to 2024, particularly in the APAC region, and how does this align with PepsiCo's disclosed APAC segment financial performance in 2024?",
      "original_answer": "In 2023, PepsiCo's beverage segment accounted for 23% of revenue in the APAC region, a figure that remained unchanged in 2024. Despite this stability in revenue contribution, the APAC segment's disclosed financial performance in 2024 showed an increase in operating profit to $10 million from $8 million in 2023. This suggests that while the beverage segment's proportional revenue in APAC remained constant, operational efficiencies or strategic adjustments may have contributed to improved profitability in the region.",
      "llm_answer": "In 2023 PepsiCo’s beverage revenue was split roughly 23 % in APAC, 48 % in Europe, 29 % in AMESA and 9 % in LatAm (see the 2023 disaggregation table on page 73). The 2024 table shows the same mix – APAC still 23 % of beverage revenue, Europe 48 %, AMESA 30 % and LatAm 10 % – indicating little change in regional distribution (page 73). This stability is reflected in the APAC segment’s 2024 results, which posted net revenue of $4.85 billion and operating profit of $811 million versus $4.80 billion and $713 million in 2023 (page 72), a modest improvement that aligns with the unchanged beverage mix.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that the APAC beverage segment revenue share was 23% in both 2023 and 2024, which the LLM correctly identifies. However, the LLM fabricates detailed regional breakdowns (Europe 48%, AMESA 29%/30%, LatAm 9%/10%) not present in the original answer, which only discusses APAC. More critically, the LLM invents specific financial figures for APAC segment performance—$4.85 billion net revenue and $811 million operating profit in 2024 versus $4.80 billion and $713 million in 2023—which directly contradict the ground truth: APAC operating profit was $10 million in 2024 and $8 million in 2023. These are off by two orders of magnitude. (2) The quantitative inaccuracies are severe: the correct operating profit figures are $8M (2023) and $10M (2024), but the LLM reports $713M and $811M—over 70 times larger. There is no indication in the original answer of APAC net revenue being in the billions. These are not formatting differences but fundamental factual errors. (3) The reasoning is flawed: while the LLM attempts multi-hop synthesis by linking beverage revenue mix to segment performance, it does so using fabricated data. The conclusion that 'unchanged beverage mix aligns with modest improvement' is reasonable in logic but based on false premises. The original answer draws a more nuanced inference about operational efficiencies despite stable revenue share, which the LLM fails to replicate accurately. (4) Scores reflect major factual errors in numbers and entities (hence low quantitative and correctness scores), partially sound reasoning structure but based on false data (low qualitative accuracy), and moderate relevance as it addresses the right topic but with incorrect details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 486,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How did Southern Company's accounting treatment for wind facilities under PPAs change between 2022 and 2023, particularly regarding lease structure and asset retirement obligations?",
      "original_answer": "In 2022, Southern Power's PPAs related to wind facilities were accounted for as operating leases with remaining terms of up to 25 years. By 2023, Southern Power's wind facilities became subject to asset retirement obligations (AROs), requiring land restoration at the end of the lease term. This indicates a shift in accounting treatment where wind facilities under PPAs transitioned from standard operating leases to leases with explicit long-term land restoration liabilities, reflecting a more detailed accounting of end-of-life obligations for these assets.",
      "llm_answer": "Southern Company continued to classify its wind‑facility PPAs as **operating leases** with up‑to‑25‑year remaining terms (see 2022 Note 268).  Between 2022 and 2023 the company’s **asset‑retirement obligation for those wind assets rose from $131 million to $150 million** (see 2023 Note 219).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains partially correct information but introduces significant inaccuracies. (1) Quantitatively, the claim that Southern Company's asset retirement obligation (ARO) for wind assets increased from $131 million to $150 million between 2022 and 2023 is not supported by the ground truth. The original answer does not provide any specific dollar amounts for AROs in either year, so this numerical assertion cannot be verified and appears to be fabricated or misattributed. There is no mention of 'Note 268' or 'Note 219' in the ground truth, raising concerns about source accuracy. (2) While the LLM correctly identifies that wind-facility PPAs were treated as operating leases with up to 25-year terms in 2022, it fails to clearly articulate the key change in 2023: the imposition of explicit asset retirement obligations requiring land restoration. The increase in ARO is presented as a quantitative fact rather than a qualitative shift in accounting treatment. (3) The reasoning is partially sound in linking operating leases to AROs, but it misses the conceptual shift—namely, that the accounting now includes long-term land restoration liabilities where they may not have been previously recognized or disclosed. This reflects a failure in multi-hop synthesis: the model reports numbers instead of explaining the change in treatment. (4) Contextually, the answer is relevant and addresses both lease structure and AROs, but the inclusion of unverified figures undermines factual correctness. The core idea—that AROs became applicable—is aligned with the ground truth, but the execution lacks accuracy and proper support. Thus, the answer is partially correct but significantly flawed in quantitative claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 467,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How did Merck's 2023 strategic focus on alliance revenue growth reflect the anticipated 2028 loss of U.S. market exclusivity for Keytruda, particularly given that Keytruda and Gardasil/Gardasil 9 represented 56% of total sales in 2023?",
      "original_answer": "Merck's 2023 strategic emphasis on alliance revenue growth, including an 8% increase in revenue from the Bayer collaboration, reflects a proactive shift toward diversifying revenue streams in anticipation of Keytruda's 2028 loss of U.S. market exclusivity. This is critical given that Keytruda and Gardasil/Gardasil 9 together accounted for 56% of total sales in 2023, making the company highly vulnerable to revenue declines once Keytruda's exclusivity ends. The focus on strengthening partnerships and expanding revenue from collaborations suggests a strategic realignment aimed at mitigating the future financial impact of losing Keytruda’s exclusivity.",
      "llm_answer": "Merck’s 2023 strategy emphasized boosting alliance‑derived revenue—Lynparza, Lenvima and Reblozyl alliances grew 7 %, 10 % and 28 % respectively (page 52)—as a deliberate effort to diversify its income base in anticipation of the 2028 loss of U.S. market exclusivity for Keytruda (page 30).  Because Keytruda and Gardasil/Gardasil 9 together accounted for 56 % of total sales in 2023 (page 28), the company viewed alliance growth as a hedge against the expected post‑2028 decline in Keytruda sales.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Merck's 2023 strategic focus on alliance revenue growth as a response to the anticipated 2028 loss of U.S. market exclusivity for Keytruda, and notes that Keytruda and Gardasil/Gardasil 9 represented 56% of total sales in 2023—this aligns with the ground truth. However, the quantitative details differ: the LLM cites specific alliance growth percentages for Lynparza (7%), Lenvima (10%), and Reblozyl (28%), which are not mentioned in the original answer. While these figures may be factually correct in the source document (as suggested by page references), they were not part of the ground truth synthesis, and their inclusion introduces specificity not present in the verified answer. The original answer highlights an 8% increase in revenue from the Bayer collaboration, which the LLM omits entirely. This substitution of different alliance examples affects quantitative accuracy. (2) The dates (2023 strategy, 2028 exclusivity loss) and the 56% sales figure are correct and match the ground truth. However, the LLM replaces the key quantitative example (Bayer collaboration +8%) with unrelated alliance growth figures, which constitutes a factual divergence rather than mere rewording. There is no indication that the Lynparza, Lenvima, or Reblozyl alliances were emphasized in the original answer as central to the strategic shift. (3) The multi-hop reasoning is sound: the LLM correctly links the high dependency on Keytruda and Gardasil (56% of sales) with the need to diversify via alliances ahead of 2028 exclusivity loss. The logic of using alliance revenue as a hedge is well-articulated and consistent with the original. (4) The contextual relevance is perfect—the answer directly addresses the strategic rationale in light of future risk. Qualitative accuracy is high due to correct entities, years, and logical flow. The correctness score is 8 because while the core strategic narrative is accurate and well-reasoned, the replacement of the Bayer +8% figure with other alliance growth metrics introduces incorrect specificity, reducing quantitative accuracy to 7. Overall, the answer captures the essence but substitutes key numerical evidence, preventing a top score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 597,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How did the growth in Microsoft's Server products and cloud services revenue from $79,970M in 2023 to $97,726M in 2024 reflect the strategic positioning of SQL Server within the Intelligent Cloud segment?",
      "original_answer": "The significant revenue growth in Server products and cloud services from $79,970M in 2023 to $97,726M in 2024 indicates that SQL Server played a key role in Microsoft's Intelligent Cloud segment. According to the 2024 filing, SQL Server is explicitly included within Server products and cloud services, which form a core component of the Intelligent Cloud strategy. This growth suggests that SQL Server, alongside Azure and other cloud offerings, contributed to Microsoft's ability to provide integrated, scalable, and secure infrastructure solutions that align with enterprise demand for hybrid cloud capabilities.",
      "llm_answer": "Microsoft’s Server products and cloud services revenue grew 22 % from $79,970 million in 2023 to $97,726 million in 2024, driven largely by Azure and other cloud services. This increase underscores SQL Server’s strategic positioning as a hybrid, multi‑cloud database platform within the Intelligent Cloud segment, where it continues to generate demand for on‑premises and cloud‑based workloads and contributes to the segment’s overall revenue expansion.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is factually correct in all quantitative aspects: the revenue figures ($79,970M in 2023 and $97,726M in 2024) are accurate, and the calculated growth rate of approximately 22% is correct ((97,726 - 79,970) / 79,970 ≈ 0.222 or 22.2%, which rounds to 22%). Minor formatting differences (e.g., 'million' vs 'M') are acceptable and do not affect accuracy. 2) The entity identification is correct—Microsoft, Server products and cloud services, Intelligent Cloud segment, and SQL Server are all properly referenced with correct fiscal years (2023 to 2024). 3) The reasoning is sound and reflects multi-hop synthesis: the LLM correctly infers that SQL Server contributes to the growth within the Server products and cloud services category, which is part of the Intelligent Cloud segment. It appropriately positions SQL Server as a hybrid, multi-cloud platform, aligning with enterprise demand—consistent with the ground truth’s emphasis on integrated, scalable, secure infrastructure and hybrid capabilities. 4) While the LLM mentions Azure as a primary driver (which is plausible and often stated in filings), it still correctly emphasizes SQL Server’s strategic role, though slightly less explicitly than the original answer in linking SQL Server directly to the revenue growth. However, it does not contradict the ground truth and maintains semantic equivalence in intent and factual content. The omission of an explicit statement that 'SQL Server is included within Server products and cloud services' (as per the 2024 filing) is a minor gap but not a factual error. Overall, the answer is highly accurate, contextually relevant, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 452,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How did the governance thresholds tied to Class B common stock's voting power influence investor protections for Class A shareholders between META's 2023 and 2024 filings, particularly in light of the 35% voting power threshold for change-of-control approvals?",
      "original_answer": "In 2023, META disclosed that as long as Class B common stock represented at least 35% of the combined voting power, any transaction resulting in a change of control required approval from a majority of Class B shareholders. This governance threshold limited investor protections for Class A shareholders, who held less voting power and were subject to a dual-class structure that favored Class B ownership. By 2024, while the exact percentage of Class B voting power had not yet dropped below 35%, the structure remained unchanged, continuing to concentrate decision-making authority with Class B shareholders. The CMCSA_2023 evidence further contextualizes this by showing that such dual-class structures commonly allocate disproportionate voting power (e.g., 66 2/3% for Class A and 33 1/3% for Class B in that case), reinforcing how META’s governance model preserved control concentration, thus perpetuating reduced investor protections for Class A shareholders across both years.",
      "llm_answer": "Meta’s 2023 Form 10‑K disclosed that if Class B common stock represents less than 35 % of the combined voting power of its common stock, any transaction that would change control requires majority approval of Class B shareholders as a separate class—providing Class A shareholders a protective veto over change‑of‑control deals (see page 50). The 2024 filing kept the same 35 % threshold, preserving that protective mechanism for Class A shareholders (see page 1 for the continued dual‑class structure and share counts).",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in reasoning: it incorrectly states that the 35% threshold triggers Class B shareholder approval *if* Class B falls *below* 35%, implying that Class A gains a protective veto when Class B loses dominance. However, the ground truth states the opposite — as long as Class B holds *at least* 35%, a change of control requires approval from a majority of Class B shareholders, which *limits* Class A protections by entrenching Class B control. The LLM flips the governance mechanism, misrepresenting the direction of investor protection. (2) Quantitatively, the 35% threshold and references to the 2023 and 2024 filings are correctly cited, and the dual-class structure is accurately noted, so numeric accuracy is high. (3) The multi-hop reasoning fails: the LLM does not correctly synthesize the implication of the threshold — it misunderstands the conditional logic (‘at least 35%’ vs ‘less than 35%’) and thus draws the opposite conclusion about investor protections. It also fails to reference the CMCSA_2023 evidence that supports the broader context of dual-class voting concentration. (4) While the answer addresses the years and threshold correctly, the core conclusion about Class A shareholder protections is factually inverted, leading to a low correctness and qualitative accuracy score. Contextual relevance is moderate because it discusses the right structure but with flawed interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 405,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How did the shift in UPS's reliance on the U.S. Postal Service for final-mile delivery through UPS SurePost in 2022 compare with its competitive positioning against the USPS in 2024, and what does this suggest about UPS's evolving domestic delivery strategy?",
      "original_answer": "In 2022, UPS utilized the U.S. Postal Service as a key component of its final-mile delivery for lightweight residential packages via UPS SurePost, leveraging USPS's extensive network to handle non-urgent shipments efficiently. By 2024, the relationship had evolved, with UPS explicitly identifying the U.S. Postal Service as a competitor in its 10-K filing, signaling a strategic shift toward direct competition in the domestic delivery space. This evolution suggests that UPS is moving away from outsourcing certain delivery segments to USPS and is instead investing in its own infrastructure to maintain market share and profitability in a rapidly changing logistics environment.",
      "llm_answer": "In 2022 UPS expanded its UPS SurePost service, which “offers the consistency and reliability of the UPS ground network, with final delivery often provided by the U.S. Postal Service” for lightweight residential shipments【page_6】. By 2024 UPS still lists the U.S. Postal Service as a competitor in its risk‑factor discussion, indicating it continues to compete on speed, technology and broader service offerings while using USPS for certain deliveries【page_11】. This dual approach shows UPS is moving toward a hybrid domestic strategy that leverages USPS for cost‑efficient last‑mile volume while preserving its own network for premium, time‑sensitive services.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains a significant misinterpretation of the strategic shift between 2022 and 2024. (1) It correctly states that in 2022, UPS used the U.S. Postal Service for final-mile delivery via UPS SurePost for lightweight residential packages, citing the appropriate context about leveraging USPS for cost efficiency. This aligns with the ground truth. (2) However, the LLM incorrectly interprets the 2024 relationship: while it notes that USPS is listed as a competitor in the 2024 10-K, it frames this as part of a 'dual approach' or 'hybrid strategy' that continues to rely on USPS for last-mile delivery. The ground truth emphasizes that by 2024, UPS explicitly identifies USPS as a competitor, signaling a strategic pivot *away* from reliance on USPS and toward direct competition through investment in its own network. The LLM underplays this strategic evolution and instead suggests ongoing operational reliance without evidence of reduced dependence. (3) The multi-hop reasoning is flawed: the model fails to synthesize the contrast between collaboration in 2022 and competitive positioning in 2024 as a deliberate strategic shift. Instead, it concludes a hybrid model persists, which contradicts the ground truth’s implication of reduced outsourcing. (4) Quantitative accuracy is perfect—no numbers, dates, or entities are incorrect (years: 2022, 2024; entities: UPS, USPS, SurePost—all accurate). Contextual relevance is high as the answer addresses both time points and the broader strategy. However, qualitative accuracy suffers due to incorrect inference about the nature of the 2024 relationship. Thus, while factually consistent in parts, the overall conclusion misrepresents the strategic evolution, warranting a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 483,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How did the valuation of NextEra Energy's (NEE) Full Requirements and Unit Contingent Contracts using Discounted Cash Flow analysis change from 2022 to 2024, particularly in terms of fair value liabilities and the weighted-average forward price assumptions?",
      "original_answer": "In 2022, NEE reported fair value liabilities of $566 million for Full Requirements and Unit Contingent Contracts, with a weighted-average forward price of $64 per MWh. By 2024, these contracts were valued at $203 million in liabilities, with an increase in the weighted-average forward price to $76 per MWh. This shift indicates a significant decrease in the financial exposure associated with these contracts over the two-year period, despite an increase in the key pricing assumption used in the Discounted Cash Flow valuation.",
      "llm_answer": "The fair‑value liability for Full Requirements and Unit Contingent Contracts dropped markedly, falling from about **$566 million in 2022** to **$203 million in 2024**【page_86 (2021)†L1-L6】【page_86 (2024)†L1-L6】.  At the same time, the weighted‑average forward‑price assumption used in the discounted‑cash‑flow valuation rose from roughly **$64 per MWh in 2022** to **$76 per MWh in 2024**【page_86 (2021)†L1-L6】【page_86 (2024)†L1-L6】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers and dates are accurate: the fair value liabilities decreased from $566 million in 2022 to $203 million in 2024, and the weighted-average forward price increased from $64 per MWh to $76 per MWh. These values match the original answer exactly, with acceptable formatting (e.g., $566 million vs $566 million). (2) The answer is complete, addressing both parts of the question: the change in fair value liabilities and the change in the weighted-average forward price assumption. (3) Entity accuracy is correct—NextEra Energy (NEE) is properly referenced via context, and the financial instruments (Full Requirements and Unit Contingent Contracts) and valuation method (Discounted Cash Flow) are accurately mentioned. (4) The reasoning is sound and reflects proper multi-hop synthesis: the model correctly infers that despite rising forward prices (which could increase liabilities), the actual fair value liabilities decreased significantly, indicating reduced financial exposure. The cited sources (page_86 from 2021 and 2024 filings) appear to be referencing the correct data points, even if the 2021 document is used for 2022 data (common in filings released the following year). Overall, the LLM answer conveys the same semantic meaning as the ground truth with precise factual alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 386,
        "total_tokens": 1654
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How did the discontinuation of the wholesale gas services segment following Sequent's sale impact Southern Company Gas' financial reporting structure, particularly in relation to Nicor Gas' prior tax expense increases and segment revenue reconciliation?",
      "original_answer": "The discontinuation of the wholesale gas services segment following the sale of Sequent on July 1, 2021, significantly impacted Southern Company Gas' financial reporting structure. In 2021, Nicor Gas experienced a $15 million increase in revenue tax expenses due to higher natural gas revenues, which were passed through to customers and had no impact on net income. Prior to the sale, wholesale gas services played a key role in providing natural gas asset management and logistics services for Southern Company Gas' utilities (except Nicor Gas) and non-affiliated companies, as well as engaging in gas storage and pipeline arbitrage. After the sale, wholesale gas services was no longer a reportable segment in 2023, and its prior revenues were netted with costs from energy and risk management activities. This led to a structural change in how operating revenues and intercompany revenues were reconciled, reflecting a more consolidated reporting approach post-sale.",
      "llm_answer": "After Sequent was sold, the wholesale gas services segment was removed from Southern Company Gas’s reportable segments, so its revenue and costs were folded into the “All Other” column and the separate revenue‑reconciliation table that had netted third‑party and intercompany revenues was no longer presented.  The Nicor Gas prior‑tax expense increases were recorded as pre‑tax charges in the gas distribution operations segment, while the additional tax expense from Sequent’s sale was captured in the “All Other” column.  This restructuring simplified segment reporting and consolidated the tax and revenue reconciliation that had previously been attributed to wholesale gas services.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures some correct elements but contains significant inaccuracies in reasoning and completeness. (1) Quantitatively, the answer does not include the specific $15 million tax expense increase for Nicor Gas mentioned in the ground truth, though it correctly references tax expenses and the 2021 sale of Sequent (implied by context). The date of the sale (July 1, 2021) is omitted. (2) The LLM correctly identifies that wholesale gas services was removed as a reportable segment and folded into 'All Other', which aligns with the structural change described. However, it incorrectly implies that the revenue-reconciliation table was eliminated solely because of netting practices, while the ground truth specifies that prior revenues were netted with costs from energy and risk management activities, reflecting a deeper operational and reporting shift. (3) The LLM misattributes the 'additional tax expense from Sequent’s sale' to 'All Other', which is unsupported—the ground truth states Nicor Gas’s tax increase was due to higher natural gas revenues passed through to customers, not from the sale of Sequent. This reflects a critical error in multi-hop reasoning: conflating Sequent’s sale with Nicor’s tax expense, which are separate events. (4) The answer misses the role of wholesale gas services pre-sale (e.g., asset management, logistics, arbitrage) and fails to explain how its removal changed intercompany and operating revenue reconciliation. While the general direction of consolidation is noted, the specific cause-and-effect between Sequent’s sale and the revised reporting structure is inaccurately portrayed. (5) Despite these flaws, the answer remains contextually relevant and captures the high-level outcome: simplified reporting and consolidation into 'All Other'. Hence, partial credit is given for structural understanding but docked for factual conflation and omissions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 513,
        "total_tokens": 1954
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How did the availability of shares under Tesla's 2019 Equity Incentive Plan in 2022 (49.0 million) compare to 2023 (131.1 million), and what does this indicate about the company's use of Performance Units as part of its equity compensation strategy over this period?",
      "original_answer": "In 2022, Tesla had 49.0 million shares available for issuance under the 2019 Plan, while in 2023, this number increased to 131.1 million shares. This significant increase suggests that Tesla either issued fewer shares than previously projected or received additional share authorizations during the period. Since the 2019 Plan includes Performance Units as a form of equity compensation and Tesla continued to issue them in 2023, the expanded share availability likely supported ongoing or expanded use of Performance Units as part of Tesla's broader incentive compensation strategy.",
      "llm_answer": "In 2022, Tesla had 49.0 million shares reserved and available under the 2019 Equity Incentive Plan, which rose to 131.1 million shares by the end of 2023 (page 83, page 81). This more than doubling reflects a substantial expansion in the allocation of performance units and performance shares—key components of the 2019 Plan—indicating that Tesla is increasingly relying on performance‑based equity to align employee incentives with company performance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the share availability under Tesla's 2019 Equity Incentive Plan for both 2022 (49.0 million) and 2023 (131.1 million), matching the ground truth exactly. These numbers are critical and accurately presented. (2) The quantitative comparison — describing the increase as 'more than doubling' — is mathematically sound: 131.1M is approximately 2.67 times 49.0M, so the characterization is reasonable and accurate. (3) The reasoning correctly identifies the rise in available shares and links it to Tesla's use of performance-based equity compensation, specifically Performance Units and Performance Shares, which are components of the 2019 Plan. While the LLM emphasizes 'expansion in allocation' of performance units, the ground truth suggests the increase could also stem from lower-than-expected share usage or additional authorizations. The LLM's interpretation leans toward active expansion, which is plausible but slightly narrower than the original answer’s more balanced view. However, the core inference — that increased availability supports ongoing or expanded use of performance-based incentives — is semantically aligned. (4) All entities (Tesla, 2019 Equity Incentive Plan, Performance Units) and years (2022, 2023) are correct. The answer is fully relevant and addresses both parts of the question: the numerical comparison and the implication for equity strategy. The only minor gap is not acknowledging alternative explanations for increased share availability, but the overall reasoning remains strong. Hence, full marks for quantitative accuracy and contextual relevance, near-perfect for qualitative accuracy, and a 9/10 for overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 464,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How did Broadcom's (AVGO) allocation strategy toward Treasury Inflation-Protected Securities within its fixed income portfolio evolve from fiscal year 2023 to 2024, and what does this indicate about its liability-driven investment approach?",
      "original_answer": "In both fiscal years 2023 and 2024, Broadcom maintained a 100% fixed income allocation for its U.S. qualified pension plan, consistent with its liability-driven investment strategy aimed at minimizing market and interest rate risks. Within that fixed income allocation, Treasury Inflation-Protected Securities (TIPS) were included as a smaller component alongside long-term core bonds and high-yield bonds. The consistent inclusion of TIPS in both years suggests a stable tactical approach to inflation hedging within the broader fixed income framework, indicating that Broadcom did not materially alter its risk/return profile or inflation protection stance year-over-year.",
      "llm_answer": "Broadcom’s fixed‑income allocation stayed 100 % of its U.S. qualified pension plan assets in both FY 2023 and FY 2024, with Treasury Inflation‑Protected Securities remaining a small, unchanged portion of that portfolio (page 78, 2024; page 78, 2023). This consistency shows that the company’s liability‑driven strategy continues to prioritize core bonds to match pension liabilities, using TIPS only as a modest inflation hedge.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key facts are correct: Broadcom maintained a 100% fixed income allocation in both FY2023 and FY2024 for its U.S. qualified pension plan, and TIPS remained a small, unchanged component. The fiscal years and percentages are correctly stated. (2) The answer correctly identifies the entities (Broadcom/AVGO, TIPS, U.S. qualified pension plan) and time periods (FY2023 and FY2024), with no factual errors. (3) The reasoning is sound: the consistent allocation reflects a stable liability-driven investment (LDI) strategy focused on matching liabilities with fixed income, using TIPS as a modest inflation hedge. The LLM correctly infers that the lack of change indicates no material shift in risk or inflation protection stance. (4) The only minor shortcoming is that the original answer provides slightly more context—mentioning long-term core bonds and high-yield bonds as other components and explicitly stating the goal of minimizing market and interest rate risks. The LLM mentions 'core bonds' but omits high-yield bonds, making its description of the portfolio composition slightly less complete. However, this does not affect the core correctness. Overall, the answer is factually accurate, contextually relevant, and demonstrates proper multi-hop synthesis across two fiscal years and investment strategy implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 392,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How did the adoption of LDTI in 2023 impact MET's accounting for embedded derivatives tied to equity-indexed annuities, and how did this affect the presentation of annuity liabilities in 2024?",
      "original_answer": "In 2023, MET adopted the LDTI accounting standard, which changed the measurement model for embedded derivatives, causing most of them to meet the criteria to be accounted for as Market Risk Benefits (MRBs), leading to their exclusion from critical accounting estimates. These embedded derivatives were specifically tied to equity-indexed annuities, as noted in the 2023 disclosures. By 2024, the annuity liabilities continued to include embedded derivatives related to equity-indexed annuities, indicating that while the accounting treatment evolved post-LDTI adoption, the structural relationship between these products and derivatives remained intact. This reflects a transformation in how MET reported and managed these liabilities across the two years.",
      "llm_answer": "LDTI, adopted effective January 1 , 2023, changed the accounting for the embedded derivatives that are part of equity‑indexed annuities – they are now measured and reported as market‑risk‑based liabilities (MRBs) rather than as part of deferred policy acquisition costs or VOBA (see page 56).  In the 2024 filing the annuity liabilities are presented as a single annuity PAB balance that includes those embedded derivatives, with the MRBs disclosed separately in the footnotes and the total annuity liability shown as the sum of the PAB balance and the MRB amounts (see page 188).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the adoption of LDTI effective January 1, 2023, which matches the 2023 adoption timeline in the original answer. (2) It accurately describes the change in accounting treatment: embedded derivatives tied to equity-indexed annuities are now measured as Market Risk Benefits (MRBs), consistent with the ground truth stating they meet criteria to be accounted for as MRBs and are excluded from critical accounting estimates. (3) The 2024 presentation is correctly explained: annuity liabilities are presented as a single PAB balance that includes embedded derivatives, with MRBs disclosed separately in footnotes and the total liability being the sum of PAB and MRB—this reflects the continued inclusion of embedded derivatives in annuity liabilities post-LDTI, as noted in the original answer. (4) The LLM adds specific page references (56 and 188), which are not in the ground truth but do not contradict it and suggest document fidelity. The only minor gap is that the LLM does not explicitly mention the removal of these items from 'critical accounting estimates,' a nuance present in the original answer. However, this does not undermine the core correctness. All entities (MET, LDTI, MRB, equity-indexed annuities), years (2023, 2024), and financial concepts are accurate. Quantitative elements (dates, structure of liability presentation) are correct. Multi-hop reasoning—linking LDTI adoption to changes in derivative accounting and then to 2024 financial statement presentation—is sound and well-articulated. Semantic equivalence is strong, with no factual discrepancies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 455,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How did the devaluation of the Argentinean peso in late 2023 impact MDLZ's non-GAAP constant currency growth rate measures in 2024, and what specific adjustment did the company make in response to hyperinflationary conditions in Argentina?",
      "original_answer": "In late 2023, MDLZ experienced a significant devaluation of the Argentinean peso, which introduced distortions into its non-GAAP constant currency growth rate measures. In response, beginning in Q1 2024, MDLZ adjusted its non-GAAP reporting methodology by excluding the impact of pricing increases exceeding 26% year-over-year in Argentina—reflecting the level at which hyperinflation generally occurs cumulatively over a 3-year period. This adjustment was made to preserve the integrity of its financial performance metrics and ensure meaningful comparisons across periods. The company also noted that Argentina's revenue growth in 2024 was driven by hyperinflation, indicating a direct link between the macroeconomic condition and its financial reporting adjustments.",
      "llm_answer": "The peso’s sharp devaluation in December 2023 distorted MDLZ’s constant‑currency growth calculations.  Beginning in Q1 2024, the company excluded “extreme pricing” in Argentina—defined as pricing increases of more than 26 % year‑over‑year, the level at which hyperinflation typically accumulates over three years—from its constant‑currency calculations of Organic Net Revenue, Organic Net Revenue growth and other non‑GAAP growth measures, and made a corresponding adjustment to the currency‑exchange‑rate adjustments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures all key factual elements from the ground truth. (1) It correctly identifies the December 2023 devaluation of the Argentinean peso and its impact on MDLZ's constant currency growth measures. (2) The quantitative details are precise: the 26% year-over-year threshold for pricing increases is correctly stated, and the timing (beginning in Q1 2024) matches the original. (3) The multi-hop reasoning is sound—the model connects the peso devaluation to distortions in non-GAAP metrics and correctly explains the company's response by excluding extreme pricing from Organic Net Revenue and other growth measures. (4) The LLM mentions 'corresponding adjustment to the currency-exchange-rate adjustments,' which aligns with the intent to preserve metric integrity, though this phrasing is slightly less specific than the ground truth's emphasis on 'preserving meaningful comparisons.' One minor omission: the LLM does not explicitly state that Argentina's 2024 revenue growth was driven by hyperinflation, which is part of the original answer and reinforces the rationale. However, this does not undermine the core accuracy. Overall, the answer is factually correct, well-reasoned, and contextually complete, warranting a high score with only slight room for added context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 364,
        "total_tokens": 1709
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How did the shift in AVGO's valuation methodology for developed technology related to VMware Cloud Foundation between 2023 and 2024 impact its intangible asset reporting strategy?",
      "original_answer": "In 2023, AVGO valued developed technology related to VMware Cloud Foundation (VCF) using the multi-period excess earnings method, assigning $24,156 million to this category as part of the VMware acquisition. This approach factored in projected revenues, technology obsolescence rates, and discount rates specific to VCF. By 2024, AVGO shifted its developed technology valuation methodology from the multi-period excess earnings method to the relief-from-royalty method, applying the latter to SoC controller products for hard disk drive applications. This change in methodology reflects a broader strategic pivot in how AVGO reports intangible assets, moving toward a royalty-based income approach that aligns with different product lines and cash flow expectations. The shift suggests a recalibration of asset valuation practices in response to evolving business focus and forecasting models.",
      "llm_answer": "AVGO did not change its valuation approach for the VMware Cloud Foundation “developed technology” intangible assets between the two periods.  In both the 2023 and 2024 10‑Ks the company states that the assets were valued with the multi‑period excess‑earnings method under the income approach, and the fair‑value ($24,156 m) and amortization period (8 years) disclosed in the notes are identical【page_68_2023】【page_68_2024】.  Consequently, the intangible‑asset reporting strategy—presenting the assets as part of “intangible assets, net” with the same fair‑value and amortization schedule—remained unchanged.",
      "correctness_score": 1,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim. While it correctly reports that AVGO used the multi-period excess earnings method for VMware Cloud Foundation (VCF) developed technology in both 2023 and 2024, and correctly cites the $24,156 million fair value and 8-year amortization period, it fails to recognize the broader shift in AVGO's valuation methodology for *other* developed technology assets. The original answer states that AVGO *shifted its methodology from the multi-period excess earnings method to the relief-from-royalty method* for SoC controller products for hard disk drive applications — not for VCF. The question asks about the impact of the *shift in valuation methodology* on intangible asset reporting strategy, not whether the VCF valuation method changed. The LLM misinterprets the scope of the shift, concluding no change occurred, when in fact the shift did occur — just for a different product line. (2) Quantitatively, all numbers are accurate: $24,156 million, 8-year amortization, and consistent presentation in both 10-Ks are correctly cited. (3) The multi-hop reasoning is flawed: the model fails to synthesize that a change in methodology for one category of developed technology (SoC controllers) reflects a strategic shift in intangible asset reporting, even if VCF valuation remained constant. This is a critical misunderstanding of the question’s intent — evaluating the impact of a methodological shift in *AVGO’s overall strategy*, not just for VCF. (4) The correctness score is low because the answer contradicts the ground truth by denying any strategic shift, despite evidence of a methodological change elsewhere. Quantitative accuracy is perfect. Qualitative accuracy is very low due to incorrect reasoning and entity mapping (confusing applicability across product lines). Contextual relevance is low because the answer focuses narrowly on VCF without addressing the broader strategic implication of methodology changes in other areas.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 540,
        "total_tokens": 1924
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How did the decline in MET's holdings of pass-through mortgage-backed securities from 2023 to 2024 impact the overall size and risk profile of their RMBS portfolio?",
      "original_answer": "MET's holdings of pass-through mortgage-backed securities decreased from $12,392 million in 2023 to $10,890 million in 2024, representing a reduction of $1,502 million. This decline contributed to a broader shift in the RMBS portfolio, which saw its total estimated fair value drop from $29,096 million in 2023 to $26,165 million in 2024. Despite this reduction, the RMBS portfolio remained diversified across security types and risk profiles. The proportion of non-agency RMBS within the portfolio increased slightly from 36.5% in 2023 to 37.7% in 2024, suggesting a potential shift toward higher-risk assets within the RMBS category even as overall exposure to pass-through securities declined.",
      "llm_answer": "MET’s pass‑through RMBS fell from 42.6 % of the RMBS portfolio in 2023 to 36.8 % in 2024 (the dollar amount rose only modestly from $12.4 B to $12.6 B).  The overall RMBS balance grew from $29.1 B to $34.1 B, and the decline in pass‑throughs coincided with a larger share of collateralized mortgage obligations and a 3‑percentage‑point rise in non‑agency exposure (from 36.5 % to 39.5 %), slightly increasing the portfolio’s risk profile.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains multiple critical factual errors. First, it incorrectly states that the dollar amount of MET's pass-through RMBS increased from $12.4B to $12.6B, while the ground truth shows a decline from $12,392 million ($12.392B) in 2023 to $10,890 million ($10.89B) in 2024—a reduction of $1.502B. Second, the LLM claims the overall RMBS portfolio grew from $29.1B to $34.1B, but the truth is it decreased from $29,096 million ($29.096B) to $26,165 million ($26.165B). Third, the LLM reports non-agency RMBS rose from 36.5% to 39.5% (a 3-percentage-point increase), but the correct figures are 36.5% in 2023 and 37.7% in 2024—an increase of only 1.2 percentage points. (2) The percentage breakdowns are also inconsistent: the LLM says pass-throughs fell from 42.6% to 36.8%, but using ground truth numbers, the correct 2023 proportion is $12,392 / $29,096 ≈ 42.6%, which matches; however, in 2024, $10,890 / $26,165 ≈ 41.6%, not 36.8% as claimed. Thus, both dollar values and derived percentages are incorrect. (3) The multi-hop reasoning is flawed: the LLM infers increased risk due to higher non-agency exposure, which aligns conceptually with the original answer, but the magnitude of change is overstated, and the overall portfolio trend is misrepresented (growth vs. actual contraction). The synthesis fails because it uses incorrect base figures. (4) Despite these issues, the answer attempts to address both size and risk profile, showing some contextual understanding. However, the severe quantitative inaccuracies—especially in core financial figures and trends—undermine the factual correctness, warranting a low correctness score. Minor credit is given for correctly identifying the direction of non-agency RMBS increase and the general idea of risk profile shift.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 489,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How did Duke Energy's application of the AFS classification to debt investments evolve between 2022 and 2024, and what does this reveal about the company’s changing approach to managing its debt securities across different business segments?",
      "original_answer": "In 2022, Duke Energy Carolinas classified its debt investments as AFS, indicating a strategy of holding these investments for the long term while recognizing changes in fair value in other comprehensive income. This classification was consistent across entities, as Duke Energy Florida also applied the AFS treatment to debt investments in the same year. By 2024, Duke Energy Florida continued to apply the AFS classification, but the context expanded to include reimbursement activities from the NDTF related to decommissioning costs, suggesting a more complex interplay between investment strategy and regulatory funding mechanisms. Meanwhile, Duke Energy Indiana also maintained the AFS classification for debt investments in 2024, showing consistency in accounting policy application across segments despite evolving operational contexts. This reveals that while the classification remained stable, the underlying rationale and external influences on debt investment management evolved over time.",
      "llm_answer": "Between 2022 and 2024 Duke Energy kept all debt securities classified as available‑for‑sale (AFS) but shifted the mix of those holdings.  In 2024 the AFS debt portfolio (page 197) totaled $272 m for Duke Energy, $506 m for Duke Energy Carolinas, $323 m for Progress Energy, $256 m for Duke Energy Progress, $41 m for Duke Energy Florida and $6 m for Duke Energy Indiana, whereas 2022 unrealized losses were $86 m versus $40 m in 2024 (page 195).  This evolution shows a more concentrated, lower‑risk debt strategy in the Carolinas and Progress segments and a reduced exposure in Florida and Indiana, indicating a more conservative approach to managing debt securities across its business units.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and introduces data not present in the original answer, indicating a failure to correctly represent the ground truth. (1) Quantitatively, the dollar amounts listed for 2024 (e.g., $272M for Duke Energy, $506M for Carolinas, etc.) and the unrealized losses in 2022 ($86M) and 2024 ($40M) are not found in the original answer and cannot be verified against it; these figures appear fabricated or misattributed. The original answer does not provide any portfolio values or unrealized gains/losses, so these numbers are incorrect by contradiction. (2) The entity usage is partially correct—Duke Energy Carolinas, Florida, and Indiana are mentioned in both—but the LLM incorrectly includes 'Progress Energy' and 'Duke Energy Progress', which are not referenced in the original answer for this context. (3) The reasoning is flawed: the original answer emphasizes the consistent application of AFS classification across years and entities, with evolving regulatory context (e.g., NDTF reimbursements), whereas the LLM claims a strategic shift in holdings and risk exposure based on unsupported numerical comparisons. There is no mention in the original answer of a 'shift in mix', 'concentrated strategy', or 'reduced exposure'—these are speculative interpretations. (4) Contextually, the LLM addresses the question’s timeframe and topic (AFS classification), but misrepresents the core insight: the original focuses on accounting policy stability amid changing regulatory influences, while the LLM invents a narrative around portfolio size and risk. The multi-hop synthesis fails because it does not connect AFS use to regulatory mechanisms like the NDTF, a key point in the ground truth. Overall, the answer is largely incorrect despite touching on relevant entities and the general topic.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 496,
        "total_tokens": 1943
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How did the fair value of MDT's mutual funds measured using Level 1 inputs change from fiscal year 2022 to 2023, and what does this indicate about their short-term investment strategy?",
      "original_answer": "In fiscal year 2022, MDT reported $125 million in mutual funds measured using Level 1 inputs, while in fiscal year 2023, this amount decreased to $106 million. This indicates a reduction in the company's short-term investment exposure to mutual funds that are directly observable and actively traded. The decline aligns with a relatively stable use of Level 1 inputs overall, suggesting a strategic shift toward alternative investment vehicles such as equity and fixed income commingled trusts, which are measured at net asset value and increased in total fair value.",
      "llm_answer": "The fair value of Medtronic’s mutual funds measured with Level 1 inputs fell from **$125 million in FY 2022 to $114 million in FY 2023** (a decline of $11 million)【page_96 2022】【page_96 2023】. This drop, coupled with a rise in short‑term investments, suggests the company is shifting its short‑term portfolio toward more liquid, cash‑like assets—indicating a more conservative, short‑term investment strategy.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical error in the reported value for FY 2023: it states $114 million instead of the correct $106 million from the ground truth. The FY 2022 value ($125 million) is correct. This results in an incorrect decline of $11 million instead of the actual $19 million decrease. These quantitative inaccuracies significantly affect the reliability of the answer. (2) The calculation of the difference is mathematically correct based on the numbers provided by the LLM, but since one of the inputs is wrong, the overall calculation is factually incorrect. The ground truth shows a $19 million drop (125M - 106M), not $11M. (3) The reasoning about a strategic shift is partially sound but diverges from the ground truth explanation. While the LLM infers a move toward 'more liquid, cash-like assets' due to rising short-term investments, the original answer attributes the change to a shift toward equity and fixed income commingled trusts measured at NAV—not cash-like instruments. This misrepresents the nature of the strategic shift. However, the LLM does correctly identify a change in short-term investment strategy, showing some valid multi-hop reasoning. (4) The contextual relevance is high because the answer addresses both parts of the question—change in fair value and strategic implication—and attempts to synthesize across years. Despite incorrect numbers and a flawed rationale, it maintains focus and structure. Quantitative accuracy is low due to the incorrect dollar amount; qualitative accuracy is moderate because the direction of change (decrease) and the idea of strategy shift are correct, but the supporting logic does not align with the source. Correctness score is 5 due to partial factual correctness but major errors in key data and interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 490,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did the decline in PEP's U.S. plan assets tied to contracts with insurance companies from 2022 to 2023 reflect changes in their overall U.S. plan asset allocation strategy?",
      "original_answer": "In 2022, PEP's U.S. plan assets included $9 million in contracts with insurance companies, which dropped to just $1 million in 2023, representing an 89% decrease. This reduction occurred alongside a broader shift in U.S. plan asset composition, where total assets grew from $11,344 million in 2022 to $11,724 million in 2023. During this period, PEP increased its holdings in equity securities (from $4,387 million to $4,698 million) and cash and equivalents (from $157 million to $349 million), while maintaining relatively stable allocations in corporate bonds. This suggests a strategic reallocation away from insurance-linked instruments toward more liquid or equity-based investments.",
      "llm_answer": "The U.S. plan assets tied to contracts with insurance companies fell from $9 million in 2022 to $1 million in 2023—a decline of $8 million. This reduction reflects a rebalancing away from Level 3 insurance contracts toward the broader diversified mix that PEP’s target allocation emphasizes (56 % fixed‑income, 22 % U.S. equity, 18 % international equity, 4 % real estate), thereby reducing risk and aligning the portfolio with its stated investment policy.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the decline in insurance contract assets from $9 million in 2022 to $1 million in 2023, accurately reflecting an $8 million drop. This matches the ground truth quantitatively. However, it fails to mention the overall growth in total U.S. plan assets from $11,344 million to $11,724 million, which is a key part of the strategic context. The LLM introduces a target allocation breakdown (56% fixed-income, etc.) that is not present in the original answer and cannot be verified from the provided ground truth, introducing potentially inaccurate qualitative information. It also references 'Level 3 insurance contracts,' a detail absent from the ground truth and not supported by the source data. (2) All provided numbers (dollar amounts and the implied 89% decrease, though not explicitly stated) are accurate. The $8 million decline is correct. (3) The reasoning partially aligns with the ground truth—there is evidence of a shift away from insurance contracts—but the LLM attributes this to a move toward a specific target allocation that was not mentioned in the original answer. The ground truth emphasizes increased allocations to equity securities and cash, which the LLM omits entirely, missing a critical multi-hop connection between the decline in insurance assets and the rise in equities and cash. (4) The correctness score is 7 because core quantitative facts are accurate and the general direction of strategic shift is plausible, but the answer introduces unverified details (target allocation, Level 3) and omits key factual changes in asset classes (equity, cash) that were central to the actual strategy shift. Quantitative accuracy is high (9) due to correct dollar figures. Qualitative accuracy is lower (6) due to unsupported inferences. Contextual relevance remains high (9) as the response addresses the strategic reallocation theme directly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 515,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did Lockheed Martin's increased exposure to fixed-price contracts in 2022, which limited its ability to pass through cost increases, affect its financial performance in 2023 amid industry-wide inflationary pressures and supply chain disruptions?",
      "original_answer": "In 2022, Lockheed Martin disclosed that a significant portion of its contracts were fixed-price in nature, under which the company agreed to perform specified work for a predetermined price, bearing the risk of cost overruns (LMT 10-K 2022). This contract structure became increasingly problematic in 2023 as industry-wide inflationary pressures and global supply chain disruptions led to higher material and labor costs. As noted in Raytheon's 2023 10-K, companies in the aerospace and defense sector faced rising input costs that could not always be offset due to the constraints of fixed-price contracts. Lockheed Martin itself acknowledged in its 2023 filing that fixed-price contracts exposed it to losses in the event of cost overruns, particularly when the U.S. Government used contract structures that shifted risk to the contractor. The combination of these factors likely constrained Lockheed Martin’s profitability and cash flow in 2023, especially on programs where cost growth exceeded original estimates from 2022.",
      "llm_answer": "Lockheed Martin’s 2022 exposure to fixed‑price contracts meant that any cost overruns were absorbed by the company, as the contracts “carry the burden of any cost overruns” and “our margins and profits are reduced” when actual costs exceed estimates【page 13】.  In 2023, industry‑wide inflation and supply‑chain disruptions pushed material, labor and component costs higher, but the company could not raise contract prices because of its fixed‑price exposure【page 34‑35】.  Consequently, operating profit fell from $5.5 billion (8.2 % margin) in 2022 to $3.6 billion (5.2 % margin) in 2023, even though net sales grew modestly【page 36】【page 10‑14】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that Lockheed Martin's fixed-price contracts in 2022 required the company to absorb cost overruns, limiting its ability to pass through increased costs—a key point from the original answer. (2) It accurately reflects the impact of 2023 inflationary pressures and supply chain disruptions, noting that rising material, labor, and component costs could not be offset due to fixed-price constraints. (3) The quantitative data is correct: operating profit decreased from $5.5 billion (8.2% margin) in 2022 to $3.6 billion (5.2% margin) in 2023, with net sales growing modestly—this matches reported financial trends and is consistent with the expected negative impact on profitability. (4) The reasoning is sound and multi-hop: it connects contract structure (from 2022 disclosures) to financial outcomes in 2023 under external macro pressures, synthesizing cause and effect across time and business conditions. (5) While the original answer references Raytheon’s 10-K to support sector-wide trends, the LLM answer focuses solely on Lockheed Martin’s disclosures, which slightly reduces completeness in cross-company contextualization but does not detract from factual correctness. No calculation errors; number formats are consistent and clear. Overall, the answer is factually robust, contextually appropriate, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 400,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did Southern Company's 2023 focus on distributed energy solutions, as demonstrated through PowerSecure's microgrid deployments, influence the financial performance of PowerSecure in 2024, particularly in terms of revenue growth and cost increases tied to distributed infrastructure projects?",
      "original_answer": "In 2023, Southern Company emphasized distributed energy solutions through PowerSecure, which develops microgrids for commercial, industrial, and utility customers. This strategic focus led to significant activity in distributed infrastructure projects, which directly contributed to PowerSecure experiencing a $120 million (20.0%) increase in operating revenues in 2024. However, this growth came with a corresponding $82 million (15.8%) rise in cost of sales in 2024, reflecting the capital and operational intensity of scaling these distributed energy initiatives. The evolution from strategic emphasis in 2023 to measurable financial outcomes in 2024 demonstrates a clear causal chain through the entity relationship.",
      "llm_answer": "Southern Company’s 2023 push for distributed‑energy solutions—shown by PowerSecure’s microgrid deployments—set the stage for 2024 gains.  In 2024 the other‑business segment’s operating revenues jumped $111 million (20 %) and $120 million of that lift came directly from PowerSecure’s distributed‑infrastructure projects.  The same expansion raised costs: cost of other sales climbed $56 million (15.8 %) in 2024, largely because PowerSecure’s distributed‑infrastructure work added $82 million in outlays, reflecting higher capital and operating expenses for the expanded microgrid portfolio.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the causal chain between Southern Company's 2023 strategic focus on distributed energy via PowerSecure and the 2024 financial outcomes. It accurately captures that PowerSecure's distributed infrastructure projects contributed $120 million to revenue growth and $82 million to cost increases. However, there are key quantitative inaccuracies: the LLM states that 'operating revenues jumped $111 million (20%)' and then says '$120 million of that lift came directly from PowerSecure'—this is logically inconsistent, as a segment cannot contribute $120 million to a $111 million total increase. The ground truth states PowerSecure itself saw a $120 million (20.0%) increase in operating revenues, not that it contributed $120 million to a smaller total. Similarly, the LLM says 'cost of other sales climbed $56 million (15.8%)' but then attributes $82 million in outlays to PowerSecure—again, a component cannot exceed the total. The ground truth states cost of sales rose $82 million (15.8%), meaning the $82M and 15.8% correspond directly. (2) The percentages (20% revenue growth, 15.8% cost growth) are correctly paired with the right metrics in intent, but attached to incorrect totals. The $120M revenue impact and $82M cost impact are factually correct per ground truth, but embedded in flawed aggregate statements. (3) The multi-hop reasoning is sound: the model connects Southern Company’s 2023 strategy to PowerSecure’s 2024 financials, correctly identifying the entity relationship and causal timeline. It synthesizes across strategy and financial performance appropriately. (4) The contextual relevance is perfect—the answer directly addresses both revenue growth and cost increases tied to distributed infrastructure. Due to the significant quantitative inconsistencies in totals versus components, the correctness score is reduced to 7, as the core facts (PowerSecure’s $120M revenue lift and $82M cost increase) are present and correctly attributed, but embedded in logically flawed statements that misrepresent the financial aggregates.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 563,
        "total_tokens": 1928
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did Tesla's 2017 acquisition of SolarCity establish its ongoing liability for SolarCity's 2016 5.00% Solar Bonds, as evidenced in Tesla's 2022 and 2023 filings?",
      "original_answer": "Tesla's 2017 acquisition of SolarCity, formalized through the Purchase Agreement dated August 11, 2017 (Exhibit 10.56 in Tesla's 2022 10-Q filing), created a legal and financial linkage between Tesla and SolarCity's pre-existing obligations. SolarCity had issued 5.00% Solar Bonds, Series 2016/4-10, through a Supplemental Indenture dated January 29, 2016 (Exhibit 4.79 in Tesla's 2022 10-K filing). As part of the acquisition, Tesla assumed responsibility for SolarCity's financial instruments, including these bonds. The ongoing liability is evidenced in Tesla's 2023 10-K filing, which continues to list the January 29, 2016 Supplemental Indenture related to the 5.00% Solar Bonds (Exhibit 4.72 in Tesla's 2023 10-K filing), indicating that Tesla remains bound by the bond obligations post-acquisition.",
      "llm_answer": "Tesla’s 2017 acquisition of SolarCity included the assumption of SolarCity’s outstanding debt, including the 2016 5.00 % Solar Bonds.  Tesla’s 2022 10‑K (page 104, exhibit 4.72) and its 2023 10‑K (page 104, exhibit 4.72) attach the supplemental indentures for those bonds, confirming that Tesla remains liable for them as part of its debt.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the core fact: Tesla assumed liability for SolarCity's 2016 5.00% Solar Bonds through the 2017 acquisition and remains liable, as evidenced by the inclusion of the supplemental indenture in Tesla's 2022 and 2023 10-K filings. The percentage (5.00%) and years (2016 bonds, 2022 and 2023 filings) are accurate. However, there are minor inaccuracies in exhibit numbers and sourcing: the 2022 10-K lists the Supplemental Indenture as Exhibit 4.79 (not 4.72), and the 2023 10-K lists it as Exhibit 4.72 (correctly cited by LLM). The LLM incorrectly references the 2022 10-K for Exhibit 4.72, when it should be Exhibit 4.79 in that year. Additionally, the LLM omits mention of the Purchase Agreement (Exhibit 10.56 in the 2022 10-Q) that formalized the acquisition and legal assumption of liabilities, which is a key part of the multi-hop reasoning linking the acquisition to ongoing liability. While the answer captures the essential financial linkage and ongoing liability, it lacks full completeness in documenting the legal mechanism (the August 11, 2017 Purchase Agreement) and misattributes the exhibit number in the 2022 filing. These issues affect quantitative and qualitative accuracy but do not undermine the central conclusion, hence a score of 7 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 362,
        "total_tokens": 1652
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "Given the decline in Microsoft's Enterprise and Partner Services revenue from $7,900M in 2023 to $7,594M in 2024, what strategic role did the Microsoft Partner Network continue to play in the company's broader services ecosystem as described in the 2024 filing?",
      "original_answer": "Despite a drop in Enterprise and Partner Services revenue from $7,900M in 2023 to $7,594M in 2024, the Microsoft Partner Network remained a core component of Microsoft’s services strategy. According to the 2024 filing, the Partner Network was explicitly listed as part of Enterprise and Partner Services, which also included offerings like Enterprise Support Services, Industry Solutions, and the Learning Experience. This indicates that Microsoft continued to rely on the Partner Network to support customer deployment and management of Microsoft solutions, even amid revenue contraction, suggesting a strategic intent to maintain ecosystem depth and partner-driven value delivery despite short-term financial pressures.",
      "llm_answer": "In the 2024 filing, the Microsoft Partner Network is described as a core element of the Enterprise and Partner Services segment. It helps customers develop, deploy, and manage Microsoft server and desktop solutions, as well as Nuance conversational‑AI and ambient‑intelligent solutions, while also delivering training and certification to developers and IT professionals 【page 10】. This role reinforces Microsoft’s broader services ecosystem by extending its reach through partner expertise and support.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, no explicit numbers beyond the context of the revenue decline are mentioned in the LLM answer, but the question did not require a calculation or numerical response beyond acknowledging the decline, which is implied. The revenue figures ($7,900M in 2023 to $7,594M in 2024) are not repeated in the LLM answer, but they were provided in the question and not required to be restated for correctness—thus, their absence does not constitute an error. (2) Entity accuracy is correct: Microsoft Partner Network, Enterprise and Partner Services, and the associated offerings (e.g., training, deployment support) are accurately identified. The mention of Nuance conversational-AI and ambient-intelligent solutions, as well as server/desktop solutions and certification programs, reflects specific details from the filing and adds value. (3) Reasoning is sound: the LLM correctly infers the strategic role of the Partner Network within the broader services ecosystem despite revenue decline, emphasizing extension of reach through partners. (4) The answer is semantically equivalent to the ground truth in intent and factual content, though it omits explicit mention that the Partner Network is 'listed as part of' the Enterprise and Partner Services segment in the filing (a minor omission). However, by stating it is a 'core element of the Enterprise and Partner Services segment,' the LLM captures the same structural relationship. The citation of page 10 adds precision. Overall, the response is factually correct, contextually relevant, and demonstrates proper multi-hop understanding of the strategic role amid financial trends.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 465,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How did the composition and application of JPM's capital buffer requirements change between 2023 and 2024, particularly in terms of the relationship between the Capital Conservation Buffer and the Countercyclical Capital Buffer?",
      "original_answer": "In 2023, JPM's capital buffer requirements under the Basel III Standardized approach included a 2.9% Stress Capital Buffer (SCB), a 4.0% GSIB surcharge, and a fixed 2.5% Capital Conservation Buffer, while the Countercyclical Capital Buffer (CCyB) was set at 0%. By 2024, the regulatory framework still allowed for a discretionary CCyB of up to 2.5%, though it remained at 0%. The capital buffer requirement computed under the Advanced Approach was equal to the sum of the Capital Conservation Buffer (2.5%), GSIB surcharge, and CCyB, indicating that while the structure of the buffer components remained consistent, the emphasis on the macro financial environment increased in 2024, with ongoing annual reviews of the CCyB. This evolution shows a stable buffer structure with increased regulatory focus on macroeconomic conditions.",
      "llm_answer": "Between 2023 and 2024 JPM’s capital buffer mix shifted mainly through a lower variable Stress Capital Buffer (SCB) for the Standardized approach (from 5.4 % to 3.3 %) while the discretionary Countercyclical Capital Buffer (CCyB) stayed at 0 % in both years. The fixed 2.5 % capital‑conservation buffer for the Advanced approach remained unchanged, and the GSIB surcharge rose from 4.0 % to 4.5 %, so the overall buffer requirement for Standardized credit risk fell, with the CCyB still unused and the SCB remaining the primary variable component.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2023 JPM had a 2.9% Stress Capital Buffer (SCB), not 5.4% as stated in the LLM answer. The 2024 SCB is reported as 3.3% in the LLM response, but the ground truth does not specify a change in SCB value for 2024—only that the structure remained consistent with ongoing reviews. The GSIB surcharge is incorrectly stated as rising from 4.0% to 4.5%, while the ground truth confirms it remained at 4.0%. The CCyB is correctly noted to remain at 0% in both years. (2) The quantitative inaccuracies are severe: the SCB values are completely wrong (5.4% and 3.3% vs actual 2.9% in 2023 and no change specified for 2024), and the GSIB surcharge is falsely increased to 4.5%. Only the 2.5% Capital Conservation Buffer is correctly reported. (3) The multi-hop reasoning is flawed—the LLM incorrectly infers a shift in buffer composition due to changing SCB and GSIB values that are not supported by the ground truth. It also fails to capture the key conceptual evolution highlighted in the original answer: the increased regulatory emphasis on macroeconomic conditions and annual CCyB reviews, despite the buffer remaining at 0%. Instead, it fabricates numerical changes to explain a 'shift' that isn't documented. (4) The contextual relevance is moderate because the answer addresses the right topic—capital buffer components and their changes—but the incorrect data and reasoning undermine its validity. The qualitative accuracy is low due to incorrect entity values and flawed synthesis. Quantitative accuracy is very low due to multiple incorrect percentages. Correctness score is 3 due to mostly incorrect numbers and reasoning, with only minor correct elements (CCyB at 0%, existence of buffers).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 488,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How did Southern Company Gas' responsibilities for the Dalton Pipeline evolve between 2022 and 2023, particularly regarding the $26 million annual lease and the lessee's obligation under FERC-regulated tariff provisions?",
      "original_answer": "In 2022, Southern Company Gas leased a 50% undivided ownership interest in the Dalton Pipeline for approximately $26 million annually through 2042, with the lessee responsible for maintaining the pipeline and providing service under FERC-regulated tariff provisions. By 2023, the filing reiterated the same $26 million lease amount but placed greater emphasis on the lessee’s ongoing accountability for maintaining the pipeline and delivering service under the FERC-regulated tariff, suggesting a continued focus on compliance and service delivery responsibilities tied to this regulatory framework. This indicates that while the financial terms remained stable, the operational accountability and regulatory compliance focus increased slightly over the period.",
      "llm_answer": "Southern Company Gas’s role on the Dalton Pipeline did not change between 2022 and 2023.  In both years it continued to lease its 50 % ownership for **≈ $26 million per year through 2042**, and the lessee remained responsible for maintaining the pipeline and for providing service to transportation customers under its FERC‑regulated tariff【page_218】【page_218】.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the key facts: Southern Company Gas leased a 50% undivided interest in the Dalton Pipeline for approximately $26 million annually through 2042, and the lessee remained responsible for maintenance and FERC-regulated service in both 2022 and 2023. These quantitative and entity details match the ground truth exactly. (2) All numbers, dates, and dollar amounts are accurate—$26 million annual lease, 50% ownership, through 2042—and properly attributed. Format variations (e.g., ≈$26 million) are acceptable and semantically equivalent. (3) However, the LLM answer states that the role 'did not change,' which oversimplifies the evolution described in the ground truth. The original answer notes that while financial terms were stable, there was increased emphasis in 2023 on the lessee’s accountability for compliance and service delivery under FERC regulations. This qualitative shift in focus is missing in the LLM response, indicating a failure in full multi-hop synthesis across years to detect evolving regulatory emphasis. (4) Therefore, while factually correct on core data, the LLM lacks completeness in capturing the nuanced evolution of responsibilities, particularly the heightened focus on regulatory compliance in 2023. This justifies a 7 for correctness and qualitative accuracy, but full marks for quantitative accuracy and high marks for relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 389,
        "total_tokens": 1688
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How did Amgen's strategic collaboration with BeiGene in 2022, particularly around BLINCYTO commercialization in China, influence Amgen's direct production focus on BLINCYTO by 2024, especially in light of the equal profit-sharing arrangement and potential reversion of product rights?",
      "original_answer": "In 2022, Amgen entered into a strategic collaboration with BeiGene, under which BeiGene began selling BLINCYTO in China and shared profits and losses equally during the initial commercialization period. The agreement allowed for product rights to revert to Amgen after this phase, with Amgen then paying royalties to BeiGene on Chinese sales. By 2024, Amgen had refocused its internal pipeline to include BLINCYTO in Phase 3 trials for Ph-negative B-ALL, indicating a shift toward direct production and global development. This evolution suggests that Amgen may have regained control over BLINCYTO following the initial phase with BeiGene, aligning with the contractual provision for rights reversion and royalty-based compensation to BeiGene. The $2.8 billion investment in BeiGene in 2020 and the $1.25 billion R&D cost-sharing commitment further underscore the strategic intent behind this transition.",
      "llm_answer": "Amgen’s 2022 collaboration with BeiGene gave BeiGene the right to commercialize BLINCYTO in China, with the two companies sharing profits and losses equally during the initial product‑specific commercialization period (see page 28 and page 122).  After that period, the product rights revert to Amgen, allowing Amgen to assume full control of manufacturing and sales and shift its focus to direct production of BLINCYTO by 2024 (page 28, 122).  This arrangement positions Amgen to capture the full profit margin and streamline its production strategy once the collaboration ends.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but has minor omissions affecting completeness. (1) All entities—Amgen, BeiGene, BLINCYTO, China commercialization, 2022 collaboration, equal profit/loss sharing, rights reversion to Amgen—are accurately identified and correctly contextualized. The timeline (2022 agreement, shift by 2024) is consistent. (2) There are no numeric values explicitly mentioned in the LLM answer (e.g., $2.8 billion investment, $1.25 billion R&D commitment), so while there is no inaccuracy (thus quantitative accuracy is 10), the omission of these key financial figures from the original answer reduces completeness. These numbers are critical to demonstrating the depth of strategic intent. (3) The multi-hop reasoning is sound: the model correctly infers that profit-sharing during initial commercialization, followed by rights reversion, enables Amgen to refocus on direct production by 2024. It logically connects contractual terms to strategic outcomes. However, it omits the specific evidence of Amgen’s renewed focus—namely, BLINCYTO being in Phase 3 trials for Ph-negative B-ALL by 2024—which strengthens the claim of pipeline reintegration. (4) Contextual relevance is perfect: every part of the response addresses the question about how the collaboration influenced Amgen’s production focus. The explanation of reversion enabling direct control is on point. Overall, the answer captures the core logic and facts but lacks supporting details that would make it fully comprehensive, warranting a correctness score of 8.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 431,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 140,
      "question": "How did the change in MRK's investment in MK-7962 (sotatercept) from 2022 to 2023 reflect in the company's patent protection strategy and expected exclusivity timeline for this drug candidate?",
      "original_answer": "In 2022, MRK had a $6.4 billion investment in MK-7962 (sotatercept) as part of its IPR&D portfolio, indicating a strong commitment to the drug's development. By 2023, this investment had progressed to the point where the FDA issued a Complete Response Letter in December 2023, signaling that the drug was nearing regulatory review. Concurrently, MRK secured granted patents covering methods of treating pulmonary arterial hypertension with MK-7962, which are set to expire in 2037 (absent PTE), providing a clear exclusivity timeline. This shows that MRK's initial financial stake in 2022 evolved into a more defined regulatory and intellectual property strategy by 2023, with a focus on securing long-term exclusivity to protect future revenue streams.",
      "llm_answer": "Merck’s intangible‑asset value for MK‑7962 (sotatercept) stayed at $6.4 billion from 2022 through 2023, indicating no impairment or revaluation was recorded (page 115).  The company’s patent strategy remains focused on the compound patents that expire in 2037 (absent a patent‑term extension) and a 12‑year data‑exclusivity period, giving the drug an expected exclusivity window that extends through 2037 or beyond (page 16).",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer correctly states the $6.4 billion intangible asset value for MK-7962 (sotatercept) in both 2022 and 2023, matching the ground truth. It also accurately notes the 2037 patent expiration (absent PTE), which aligns with the original answer. However, it incorrectly implies that the investment value remained unchanged due to no impairment, whereas the ground truth emphasizes a strategic evolution — from a development-phase investment in 2022 to a near-regulatory-review status in 2023, marked by the FDA's Complete Response Letter in December 2023. This key development is entirely missing in the LLM answer.\n\n2) Quantitatively, the $6.4 billion figure and 2037 expiry date are correct. There are no calculation errors. The mention of a 12-year data exclusivity period is plausible but not present in the ground truth, introducing unverified information.\n\n3) The multi-hop reasoning is partially flawed. While the LLM identifies the financial commitment and patent expiry, it fails to connect the change in investment context (from R&D valuation to regulatory milestone) between 2022 and 2023. The original answer highlights progression in development (regulatory review), which reflects a shift in strategy, but the LLM treats the stable valuation as static, missing the dynamic shift in MRK's strategy. This undermines the qualitative accuracy.\n\n4) Contextual relevance is high because the answer addresses patent protection and exclusivity timeline. However, it omits the critical regulatory event (FDA Complete Response Letter) and misrepresents the significance of the unchanged $6.4B valuation, failing to reflect the strategic maturation of the drug candidate. Thus, while some facts are correct, the synthesis and interpretation are incomplete, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 487,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 140,
      "question": "How did Tesla's 2022 involvement with SolarCity influence its 2024 financial obligations under the indentures governed by U.S. Bank National Association, particularly in relation to the 5.00% Solar Bonds, Series 2015/6-10?",
      "original_answer": "Tesla's 2022 involvement with SolarCity, as evidenced by the Purchase Agreement dated August 11, 2017 (Exhibit 10.56), created a legacy financial linkage that directly influenced Tesla's 2024 obligations under the indentures administered by U.S. Bank National Association. Specifically, SolarCity's 5.00% Solar Bonds, Series 2015/6-10, governed by the Tenth Supplemental Indenture dated March 9, 2015 (Exhibit 4.17), remained part of Tesla's consolidated financial responsibilities by 2024. This is further reinforced by Tesla's direct indenture relationship with U.S. Bank National Association, established on May 22, 2013 (Exhibit 4.15), which likely provided a structural framework for managing such obligations post-acquisition.",
      "llm_answer": "Tesla’s 2022 10‑K continues to report the SolarCity debt that Tesla inherited when it acquired SolarCity in 2016, including the 5.00% Solar Bonds, Series 2015/6‑10 (see Exhibits 10.12–10.13).  In the 2024 10‑K Tesla lists the indentures with U.S. Bank National Association that cover this debt (Exhibit 4.15, 4.16 and 4.17), indicating that the 5.00% Solar Bonds, Series 2015/6‑10 are now part of Tesla’s 2024 debt‑service obligations under those indentures.  Thus, Tesla’s SolarCity involvement directly added the 5.00% Solar Bonds to its 2024 financial commitments for interest and principal payments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and conveys the same core information as the ground truth. (1) All key entities are correct: Tesla, SolarCity, 5.00% Solar Bonds Series 2015/6-10, U.S. Bank National Association, and the relevant indentures. The debt was indeed inherited from SolarCity and remains part of Tesla's obligations in 2024. (2) Quantitative accuracy is perfect: the bond interest rate (5.00%) and series designation (2015/6-10) are correct. While the LLM references Exhibits 10.12–10.13 and 4.15–4.17, and the ground truth cites Exhibit 10.56 (Purchase Agreement) and 4.15/4.17, the exhibit numbers differ slightly but refer to structurally equivalent documents—this is acceptable variation in citation, not a factual error. (3) The multi-hop reasoning is sound: the model correctly links Tesla’s 2016 acquisition of SolarCity to the ongoing 2024 financial obligations under indentures with U.S. Bank, demonstrating synthesis across time and legal structures. (4) The only minor shortcoming is that the LLM does not explicitly mention the 2017 Purchase Agreement (Exhibit 10.56) or the Tenth Supplemental Indenture date (March 9, 2015), which slightly reduces qualitative completeness, but the core causal chain and financial impact are accurately conveyed. Overall, the answer is semantically equivalent and highly accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 371,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 140,
      "question": "How did Microsoft's continued use of BNY Mellon as trustee in its 2024 debt indentures reflect the evolution of its relationship with the institution compared to 2023, particularly in light of the shift to U.S. Bank National Association for certain notes?",
      "original_answer": "In 2023, Microsoft continued to reference The Bank of New York Mellon Trust Company, N.A. as trustee in its filings for existing indentures, including the 0.875% Notes due 2013. In 2024, while BNY Mellon remained a key trustee in earlier indentures, newer supplemental indentures—such as those dated February 12, 2015, and November 3, 2015—listed U.S. Bank National Association as trustee instead. This indicates a strategic diversification or transition in Microsoft’s trustee relationships over time, with BNY Mellon maintaining a legacy role while U.S. Bank assumed responsibility for newer debt instruments. The 2024 filings show that Microsoft maintained a durable relationship with BNY Mellon for older notes while evolving its financial structuring practices by engaging new trustees for subsequent issuances.",
      "llm_answer": "Microsoft’s 2024 10‑K continues to list BNY Mellon as trustee for the bulk of its debt indentures (e.g., the 2024 2.875 % notes, 2025 2.675 % notes, and the 2027 2.125 % notes), mirroring the 2023 filing and underscoring a stable, long‑standing partnership. At the same time, the 2024 filing adds U.S. Bank National Association as trustee for newer notes (the 2050 and 2060 notes, see Exhibit 4.16), indicating a strategic diversification of trustee arrangements while still relying on BNY Mellon for most of its debt.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core evolution in Microsoft's trustee relationship correctly: BNY Mellon remains a key trustee for most debt instruments in both 2023 and 2024, while U.S. Bank National Association is newly introduced as trustee for certain long-term notes (2050 and 2060) in 2024, indicating strategic diversification. This aligns with the ground truth’s emphasis on a durable legacy relationship with BNY Mellon and a transition toward new trustees for newer issuances.\n\nHowever, there are notable quantitative inaccuracies. The LLM claims BNY Mellon is trustee for the '2024 2.875% notes, 2025 2.675% notes, and 2027 2.125% notes' — but the ground truth does not confirm these specific coupon rates or maturities being under BNY Mellon in 2024. Instead, the ground truth references older indentures (e.g., 0.875% Notes due 2013 — likely a typo or mislabeling in the original, possibly meant to be a longer-dated note) and emphasizes that newer supplemental indentures from 2015 (not 2024) already used U.S. Bank. The LLM incorrectly implies that the shift to U.S. Bank occurred in 2024 for the 2050/2060 notes, whereas the ground truth indicates the shift began earlier (2015), suggesting the 2024 filing reflects continuation rather than initiation of this trend.\n\nEntity accuracy is mostly correct: BNY Mellon, U.S. Bank National Association, and Microsoft are properly identified. The years 2023 and 2024 are used appropriately in context, though the LLM misattributes the timing of the trustee shift. The reasoning is logically sound in interpreting the coexistence of trustees as strategic diversification, which matches the ground truth’s conclusion. However, the failure to note that the transition started before 2024 weakens the multi-hop synthesis.\n\nOverall, the answer is semantically close and contextually relevant, with correct high-level interpretation, but loses points for imprecise dates and unverified note specifics, which affect quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 534,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 140,
      "question": "How did the allocation of undistributed earnings across Alphabet's stock classes in 2022 compare to 2023, and what does this reveal about the consistency of Class C stock's relationship to Class B stock in terms of dividend rights and income distribution?",
      "original_answer": "In 2022, the net income per share amounts were the same for Class A, Class B, and Class C stock due to equal dividend rights, as stated in the Amended and Restated Certificate of Incorporation. This consistency carried over into 2023, where the same principle applied, ensuring that all stock classes received equal per-share distributions. Despite potential changes in stock repurchase activity and market conditions, the relationship between Class C and Class B stock remained stable in terms of dividend rights, as both were treated proportionately under the company's income allocation policy.",
      "llm_answer": "In 2022 Alphabet allocated undistributed earnings of $28,382 to Class C and $4,072 to Class B (Class A received $27,518).  In 2023 the amounts were $34,070 for Class C and $5,124 for Class B (Class A received $34,601).  The Class C allocation remained roughly seven‑times that of Class B in both years, showing that Class C shares are treated identically to Class B shares for dividend rights and income distribution, with only the voting rights differing.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both quantitative and qualitative aspects. (1) The numbers provided—$28,382 for Class C and $4,072 for Class B in 2022, and $34,070 and $5,124 in 2023—are not accurate representations of per-share net income or undistributed earnings allocations from Alphabet’s 10-K filings. These figures appear fabricated or misinterpreted, as Alphabet does not report undistributed earnings allocated by stock class in such absolute dollar terms. (2) The claim that Class C allocation is 'roughly seven-times' that of Class B is false; according to the ground truth, all classes (A, B, and C) have equal per-share dividend rights and income distribution due to Alphabet’s corporate charter. The Amended and Restated Certificate of Incorporation explicitly states that differences are limited to voting rights, not economic rights. (3) The multi-hop reasoning fails: the model incorrectly infers a proportional but unequal relationship from erroneous data, when the correct synthesis is that all classes are treated equally per share. (4) While the answer attempts to address the question’s structure—comparing 2022 to 2023 and drawing conclusions about dividend rights—the factual foundation is unsound. The conclusion about identical treatment for dividend rights is correct in direction but based on invalid reasoning and false data, so it cannot be credited. The original answer emphasizes equal per-share treatment, which the LLM contradicts with fabricated disproportionate allocations. Thus, despite some contextual relevance, the answer is mostly incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 435,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How did the integration challenges BMY faced with Celgene's manufacturing infrastructure in 2022 impact REVLIMID's production capacity and expanded indications in 2023?",
      "original_answer": "In 2022, BMY highlighted significant risks related to integration challenges with Celgene, particularly around the complexity of aligning Celgene’s manufacturing and supply chain systems with BMY’s own, including potential disruptions in product supply and patient access (BMY_10k_2022.pdf, page 40). Celgene, known for producing REVLIMID (AMGN_10k_2022.pdf, page 7), likely contributed its manufacturing infrastructure for this key drug. By 2023, REVLIMID had expanded into new therapeutic indications, including 1L Multiple Myeloma and Mantle Cell Lymphoma (BMY_10k_2023.pdf, page 11), suggesting that despite the earlier integration risks, BMY was able to stabilize and scale Celgene's production capabilities for this critical asset. However, the 2022 filings caution that even slight deviations in manufacturing could lead to product loss, indicating that the successful integration of Celgene’s infrastructure was a prerequisite for REVLIMID’s 2023 expansion.",
      "llm_answer": "In 2022 BMY warned that integrating Celgene’s manufacturing infrastructure was a complex, costly and time‑consuming process that could “cause a failure to meet demand for our products” and affect its ability to meet financial reporting obligations (BMY 2022 10‑K, p. 40).  The resulting production‑capacity constraints likely limited the company’s ability to scale supply for REVLIMID, which in 2023 gained several new approved indications – 1L multiple myeloma, mantle‑cell lymphoma, MDS, previously treated follicular lymphoma and relapsed/refractory adult T‑cell leukemia/lymphoma (BMY 2023 10‑K, pp. 9‑13).",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its core facts and captures the key multi-hop relationship between BMY's 2022 integration challenges with Celgene and REVLIMID's 2023 expanded indications. It correctly cites BMY's 2022 10-K (p.40) regarding risks to manufacturing integration and potential failure to meet product demand, aligning with the ground truth. The 2023 expanded indications for REVLIMID are mostly accurate, with the LLM listing 1L multiple myeloma and mantle-cell lymphoma (which matches the original answer), plus additional indications (MDS, previously treated follicular lymphoma, and relapsed/refractory adult T-cell leukemia/lymphoma) drawn from BMY’s 2023 10-K (pp.9–13). However, the original answer does not mention these extra indications, and while they may be factually correct, their inclusion suggests a broader interpretation than supported by the ground truth, which focuses only on the two named indications as evidence of post-integration success. The LLM implies production-capacity constraints 'likely limited' supply scaling, but the original answer does not state that constraints actually occurred—only that risks were acknowledged and that expansion in 2023 suggests successful resolution. This introduces a slight overinterpretation of causality. Quantitatively, all dates, page numbers, and drug names are accurate. Entity accuracy is strong: BMY, Celgene, REVLIMID, correct years, and proper sourcing from 10-K filings. Reasoning is mostly sound but slightly overreaches by framing capacity constraints as a likely outcome, whereas the ground truth emphasizes risk and successful post-hoc integration. Contextual relevance is high as all information directly addresses the question’s focus on impact. Minor deduction in qualitative accuracy due to speculative causal language ('likely limited') not present in the original.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 502,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How did Tesla's battery supply agreements with Panasonic, as disclosed in their 2022 and 2023 filings, evolve from earlier arrangements, and what does this indicate about Tesla's strategic reliance on Panasonic for battery production capacity?",
      "original_answer": "Tesla's relationship with Panasonic around battery supply deepened from 2022 to 2023, reflecting a continued strategic reliance on Panasonic for production capacity. In 2022, Tesla referenced a long-standing 2011 Supply Agreement with Panasonic, which had undergone multiple amendments (e.g., Amendment No. 1 dated October 29, 2013). By 2023, Tesla disclosed further amendments, including the Amended and Restated General Terms and Conditions for Gigafactory (June 10, 2020) and the 2021 Pricing Agreement (executed December 29, 2020), indicating an expansion of joint operational frameworks. These developments suggest Tesla and Panasonic extended their collaboration beyond basic supply to include co-investment in Gigafactory infrastructure and pricing frameworks tailored to long-term production scaling, reflecting Tesla’s strategic decision to deepen its dependency on Panasonic for critical battery components.",
      "llm_answer": "Tesla’s 2022 10‑K cites the original 2011 Panasonic supply agreement and its subsequent amendments (Exhibits 10.25–10.32). The 2023 10‑K expands this foundation with new pricing agreements for Japan cells (Exhibit 10.35) and Gigafactory 2170 cells (Exhibit 10.36) and updated lease terms for the Gigafactory (Exhibits 10.38–10.40) (see Exhibit list on pages 107‑109). This progression—from a single supply contract to a suite of pricing, production, and lease agreements—underscores Tesla’s deepening reliance on Panasonic to secure battery cell supply and production capacity, especially at its Gigafactory and for its global supply chain.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the evolution of Tesla's agreements with Panasonic from the original 2011 supply agreement through subsequent amendments, citing specific exhibits in the 2022 and 2023 10-Ks. The mention of the 2022 reference to the 2011 agreement and amendments matches the ground truth. In 2023, the LLM correctly notes new pricing agreements (Exhibits 10.35–10.36) and updated lease terms (Exhibits 10.38–10.40), which correspond to the 'Amended and Restated General Terms and Conditions' and '2021 Pricing Agreement' in the original answer—though it does not explicitly name those documents, it accurately infers their existence and significance. (2) All dates and exhibit numbers are factually consistent with the filings and correctly reflect the progression of agreements. There are no calculation errors, and all numeric references (e.g., exhibit numbers, years) are accurate. (3) The multi-hop reasoning is sound: the LLM synthesizes information across two years of filings, identifies the expansion from a single supply contract to multiple operational agreements, and correctly infers that this indicates deepening strategic reliance. The conclusion about Tesla’s reliance on Panasonic for Gigafactory production and global supply chain capacity is logically supported. (4) While the LLM does not explicitly name the June 10, 2020 or December 29, 2020 agreements as in the ground truth, it captures their substance through references to updated pricing and lease terms. The omission of the specific amendment names is a minor detail that does not undermine the factual or semantic accuracy. Overall, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 486,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How did MDLZ's revenue contribution from Gum & Candy in the AMEA region change between 2022 and 2024, and what does this reveal about the company's regional product strategy?",
      "original_answer": "In 2022, MDLZ generated $861 million in Gum & Candy revenue from the AMEA region, which represented 2.8% of the segment's total net revenues. By 2024, this figure decreased to $947 million, despite a significant increase in AMEA's total net revenues from $5,770 million in 2022 to $7,296 million in 2024. This indicates that while the AMEA region grew overall, the Gum & Candy category did not scale proportionally, suggesting a potential strategic shift away from this product category in the region.",
      "llm_answer": "MDLZ’s Gum & Candy revenue in the AMEA region grew from **$780 million in 2022 to $947 million in 2024**—a **~21 % increase** (page 121). This uptick reflects the company’s strategic emphasis on expanding higher‑growth, consumer‑driven categories in emerging markets, indicating a deliberate shift to strengthen its Gum & Candy portfolio in AMEA.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It states that MDLZ's Gum & Candy revenue in the AMEA region was $780 million in 2022, but the ground truth is $861 million. This error affects the validity of the 21% increase claim, which is based on incorrect input values. The 2024 figure of $947 million is correct. (2) The calculation of a ~21% increase is therefore inaccurate: using the correct numbers, the change from $861M to $947M represents a ~10% increase, not 21%. Additionally, the LLM fails to mention that AMEA's total net revenues grew from $5,770M to $7,296M, and that Gum & Candy's share of segment revenue dropped from 2.8% in 2022 to an implied lower percentage in 2024 (not stated by LLM). (3) The reasoning is flawed and contradicts the ground truth. While the original answer suggests a strategic shift *away* from Gum & Candy due to its underperformance relative to overall regional growth, the LLM incorrectly infers a strategic *emphasis* on the category due to absolute revenue growth, ignoring the proportional decline. This reflects a failure in multi-hop synthesis—specifically, comparing category revenue growth against total regional revenue growth and segment share. (4) Scores are low due to major quantitative and qualitative errors. The contextual relevance is moderate because the answer addresses the right region, product category, and time frame, and attempts to interpret strategy, but the conclusion is factually and logically unsound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1218,
        "completion_tokens": 414,
        "total_tokens": 1633
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How did the change in GE's use of morbidity assumptions in premium deficiency testing between 2022 and 2024 affect the company's exposure to potential capital contributions in its run-off insurance operations?",
      "original_answer": "In 2022, GE disclosed that morbidity assumptions in premium deficiency testing no longer included issue age adjustments after 2017, as recent claim experience showed minimal impact of age differences on claim cost projections. This shift simplified the actuarial modeling but increased sensitivity to general morbidity trends. By 2024, GE's exposure to adverse changes in morbidity assumptions became more pronounced, as noted in its risk factors, with the potential for increased future policy benefit reserves and required capital contributions to insurance subsidiaries. Specifically, the 2024 disclosures highlighted that future adverse changes in morbidity (among other assumptions) could necessitate additional capital infusions, such as the $X million already contributed in Q1 2024 under the KID-approved statutory permitted practice. This indicates that the streamlined morbidity assumptions from 2022 increased GE's financial exposure to unexpected morbidity trends by 2024, heightening the risk of further capital needs.",
      "llm_answer": "GE eliminated issue‑age adjustments in its morbidity assumptions (see 2022 10‑K, page 51), moving to a single morbidity assumption for all ages.  The 2024 10‑K (page 33) notes that adverse changes to these morbidity assumptions could raise future policy‑benefit reserves and, under statutory testing, trigger additional capital contributions to its run‑off insurance subsidiaries.  Thus, the shift in morbidity assumptions has heightened GE’s exposure to potential capital contributions in its run‑off insurance operations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core of the ground truth. (1) It correctly identifies that GE eliminated issue-age adjustments in morbidity assumptions in 2022, citing the correct document (2022 10-K, p.51), and notes the shift to a single morbidity assumption across ages. It accurately reflects that by 2024, adverse changes in these assumptions could increase policy benefit reserves and trigger capital contributions, citing the 2024 10-K (p.33). (2) There are no numeric values in the LLM answer that conflict with the ground truth; while the original answer references a '$X million' capital contribution in Q1 2024, this placeholder suggests the exact figure was redacted or unspecified, so the LLM's omission is not an error. All dates and document references are correct. (3) The multi-hop reasoning is sound: the model connects the 2022 assumption change to the 2024 increased exposure to capital contributions, correctly inferring heightened risk due to simplified assumptions. (4) The only minor shortcoming is the lack of explicit mention that the 2022 change was based on observed minimal impact of age on claims and that it increased sensitivity to general morbidity trends—context that strengthens the causal logic. However, the core conclusion about increased exposure is clearly stated and supported. Wording differs but semantic meaning aligns fully. Thus, the answer is factually correct, contextually relevant, and well-reasoned, meriting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 435,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How did the $96 million pre-tax disallowance of capital investments at Nicor Gas in 2023 relate to the prior role of Wholesale Gas Services in managing natural gas logistics for Nicor Gas before its sale in 2021, and what does this imply about Southern Company's gas segment strategy evolution?",
      "original_answer": "In 2022, Wholesale Gas Services managed natural gas logistics and asset management for Southern Company Gas' utilities, including Nicor Gas, which contributed to operational efficiency and cost control. However, after the sale of Sequent (the entity under Wholesale Gas Services) on July 1, 2021, Southern Company Gas no longer had that internal wholesale function. By 2023, Nicor Gas faced a $96 million pre-tax disallowance of certain capital investments, suggesting regulatory pushback or inefficiencies in capital deployment post-wholesale services exit. This indicates a shift in strategy where Southern Company may have moved toward a more streamlined, regulated utility model, accepting short-term financial penalties in exchange for simplified operations or reduced exposure to market volatility.",
      "llm_answer": "The $96 million pre‑tax disallowance recorded in 2023 for Nicor Gas reflects capital‑investment costs that were previously handled by the Wholesale Gas Services segment—an arm that, until its sale in 2021, managed logistics and asset‑management for Nicor and other Southern Company Gas utilities. With Wholesale Gas Services no longer reportable, Southern Company Gas now absorbs those capital‑investment activities directly, resulting in the disallowance charge. This shift signals a strategic evolution toward a more integrated, streamlined gas segment that focuses on core distribution and pipeline assets rather than maintaining a separate wholesale‑logistics division.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $96 million pre-tax disallowance in 2023 and links it to the sale of Wholesale Gas Services in 2021, specifically noting that this segment previously managed logistics and asset management for Nicor Gas. The core facts—dollar amount, timing of the disallowance, and the 2021 sale—are accurate. (2) Quantitatively, the $96 million figure is correctly stated, and the timeline (sale in 2021, disallowance in 2023) aligns with the ground truth. No calculations are required, and all numbers are presented accurately. (3) The multi-hop reasoning is mostly sound: the model connects the absence of Wholesale Gas Services post-2021 to increased capital investment scrutiny at Nicor Gas in 2023. However, it misses the explicit mention that Sequent was the entity sold and does not fully articulate the regulatory pushback or inefficiencies as a consequence, which is a key implication in the ground truth. It also omits the nuance that the strategy shift may involve accepting short-term penalties to reduce market volatility exposure. (4) Despite these omissions, the LLM captures the strategic evolution toward a streamlined, regulated utility model. The answer is semantically close and contextually relevant, with only minor gaps in depth and specificity, warranting a high but not perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 374,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How did the change in Southern Company's gas distribution net income from $29M decrease in 2023 to a $109M increase in 2024 relate to shifts in customer consumption patterns influenced by weather conditions across those years?",
      "original_answer": "In 2023, Southern Company Gas' gas distribution segment experienced a $29M decrease in net income due to lower gas volumes sold, which was influenced by customer consumption patterns affected by weather conditions. In 2024, net income rebounded with a $109M increase, despite lower gas cost recovery, due to rate increases and reduced exposure to weather variability through mechanisms like weather normalization and derivative instruments. The improvement in financial performance indicates that Southern Company's mitigation strategies helped stabilize earnings despite ongoing weather sensitivity in customer consumption patterns.",
      "llm_answer": "Southern Company Gas’s gas‑distribution net income swung from a $29 million decline in 2023 to a $109 million gain in 2024 largely because weather‑driven shifts in customer consumption altered volumes and costs. In 2023, cooler weather and lower volumes sold cut revenue and cost recovery, driving a net‑income drop, whereas in 2024 warmer weather and lower volumes reduced operating‑expense costs (especially the cost of natural gas) more than revenue fell, producing a net‑income increase. The company’s weather‑derivative hedging helped mitigate but did not eliminate these weather‑related impacts【page_86】【page_86】.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $29M decrease in 2023 and $109M increase in 2024, matching the ground truth quantitatively. These figures are accurately represented with acceptable formatting ($29 million = $29M). (2) However, the reasoning for the 2024 improvement is factually inconsistent with the original answer. The LLM claims that warmer weather and lower volumes reduced operating expenses (especially natural gas costs) more than revenue fell, leading to higher net income. This contradicts the ground truth, which states that the 2024 improvement occurred despite lower gas cost recovery and was primarily due to rate increases and weather mitigation mechanisms like weather normalization and derivatives—not lower operating costs from reduced consumption. (3) The multi-hop reasoning is flawed: while the LLM correctly links weather to consumption and financial performance, it misattributes the cause of the 2024 net income increase. The original answer emphasizes structural mitigation strategies (rate increases, weather normalization), whereas the LLM incorrectly suggests a direct operational cost-saving effect from warmer weather. This misrepresents the causal mechanism. (4) The contextual relevance is high because the answer addresses weather impacts, customer consumption, and financial outcomes across both years. Quantitative accuracy is perfect. However, qualitative accuracy is low due to incorrect causal reasoning and omission of key factors (rate increases, weather normalization tariffs), which are central to the ground truth. Hence, the correctness score is moderate—partially correct but with significant factual inaccuracies in explanation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 463,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How did AMD's introduction of Versal™ FPGAs in 2023 influence their exposure to U.S. export control regulations under EAR in 2024, particularly in relation to restrictions on shipments to China and D5 countries?",
      "original_answer": "In 2023, AMD introduced Versal™ FPGAs as part of its adaptive computing product portfolio, positioning them for high-performance applications in data centers and AI environments. By 2024, these FPGAs were explicitly named in U.S. export control regulations under the Export Administration Regulations (EAR), specifically ECCN 4A090, which restricted their export to China and other D5 countries without a license. The introduction of these advanced FPGAs increased AMD's regulatory exposure, as the company was now subject to BIS requirements including the Notified Advanced Computing (NAC) notification process for shipments to these regions. This regulatory burden limited AMD’s ability to forecast and execute international shipments, particularly in markets like China, where export controls were tightened in response to national security concerns around AI and high-performance computing technologies.",
      "llm_answer": "AMD’s 2023 launch of Versal™ FPGAs (page 7) added a new product line that falls under the export‑control classification ECCN 3A090/4A090.  In 2024, those devices became subject to new BIS requirements (page 32), meaning AMD must file a Notified Advanced Computing (NAC) notice 25 days before shipping Versal FPGAs to China or to customers whose ultimate parent is headquartered in a D5 country, and must obtain an export license for such shipments—otherwise the shipments are prohibited.  This increased AMD’s exposure to EAR‑related export controls and limited its ability to sell Versal FPGAs to those markets without proper clearance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: AMD introduced Versal™ FPGAs in 2023, which fell under ECCN 4A090 (LLM also mentions 3A090, which may be a minor overstatement but 4A090 is the correct classification per ground truth), and in 2024 these were subject to BIS export controls including the NAC notification requirement and license restrictions for shipments to China and D5 countries. (2) Quantitative accuracy is perfect: no incorrect numbers, dates, or financial figures; the 25-day NAC notice is consistent with regulatory timelines. (3) Multi-hop reasoning is sound: the model correctly links product introduction (2023) to regulatory impact (2024), identifies the correct regulatory framework (EAR, via ECCN and NAC), and explains the operational consequence (prohibited shipments without license). (4) The only minor shortcoming is that the LLM mentions ECCN 3A090 alongside 4A090, which is not in the ground truth and could be misleading—Versal FPGAs are specifically classified under 4A090. Otherwise, the answer captures the increased regulatory exposure and market limitations accurately. Wording differs but semantic meaning matches. Contextual relevance is excellent, directly addressing all parts of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 362,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How did Netflix's use of foreign exchange forward contracts to hedge forecasted transactions evolve from 2023 to 2024, and what impact did this have on the company's foreign currency risk exposure?",
      "original_answer": "In 2023, Netflix used foreign exchange forward contracts to manage foreign exchange risk on forecasted revenue transactions and content licensing/production costs, with a notional hedging exposure of $8.3 billion as of September 30, 2023. By 2024, this notional amount increased to $9.9 billion as of September 28, 2024, indicating a more aggressive hedging strategy. The company also reported that a 10% weakening of the U.S. dollar would have reduced AOCI by $958 million in 2023, but this potential impact increased to $1.9 billion in 2024, showing greater sensitivity to exchange rate fluctuations despite expanded hedging. This suggests that while Netflix increased its hedge coverage, the underlying foreign currency exposure also grew, particularly with significant exposure to the euro, British pound, and emerging market currencies like the Argentine peso, which contributed to a $1.424 billion unfavorable FX impact on 2024 revenues.",
      "llm_answer": "Netflix increased its use of foreign‑exchange forward contracts to hedge forecasted revenue and content‑licensing/production transactions from 2023 to 2024.  The AOCI impact of these hedges rose from about $958 million in 2023 to roughly $1.9 billion in 2024 for revenue hedges, and from $71 million to $187 million for content hedges, indicating a larger hedging coverage.  This expansion reduced the company’s foreign‑currency risk exposure, offsetting potential adverse U.S. dollar movements and stabilizing earnings and revenue in foreign currencies.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies. While it correctly notes that Netflix increased its use of foreign exchange forward contracts from 2023 to 2024 and mentions the correct $958 million and $1.9 billion AOCI figures for revenue hedges, it introduces incorrect data about content hedges increasing from $71 million to $187 million, which is not present in the ground truth and cannot be verified. The ground truth does not break down AOCI impact by revenue vs. content hedges. Additionally, the LLM claims the expanded hedging 'reduced the company’s foreign-currency risk exposure' and 'stabilized earnings,' but the original answer states that despite increased hedging, sensitivity to FX fluctuations grew (AOCI impact doubled), and the company experienced a $1.424 billion unfavorable FX impact on 2024 revenues—indicating increased, not reduced, net risk exposure. (2) The notional hedging exposure figures—$8.3 billion in 2023 and $9.9 billion in 2024—are missing entirely from the LLM answer, a major omission in quantitative accuracy. The AOCI figures for 2023 ($958M) and 2024 ($1.9B) are correctly cited for revenue hedges, but the additional content hedge numbers are fabricated. (3) The multi-hop reasoning is flawed: the model incorrectly infers that more hedging equals lower risk, failing to recognize the key insight from the ground truth—that underlying exposure grew faster than hedging, leading to greater overall sensitivity. It also misses the connection between emerging market currencies (e.g., Argentine peso) and the large FX revenue impact. (4) Contextual relevance is high as the answer addresses hedging evolution and risk exposure, but factual correctness is compromised by missing key numbers, introducing false breakdowns, and drawing an incorrect conclusion about risk reduction.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 497,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How did MetLife's exposure to the Orderly Liquidation Authority under Dodd-Frank evolve from 2022 to 2024, particularly in relation to its OTC derivative transactions and the regulatory changes affecting margin requirements and counterparty risk?",
      "original_answer": "In 2022, MetLife was subject to the Orderly Liquidation Authority under Title II of Dodd-Frank, which governed its ability to apply close-out netting and set off receivables against payables in the event of counterparty bankruptcy, particularly for OTC-bilateral derivatives governed by ISDA Master Agreements. The company was also required to pledge initial margin for certain new OTC-bilateral derivatives starting September 1, 2021. By 2024, regulatory developments under Dodd-Frank included the re-proposal of Basel III capital standards by U.S. federal banking agencies, which could increase capital charges and the cost of derivatives-based risk mitigation. Additionally, the 2023 SEC rule requiring clearing of eligible U.S. Treasury transactions by 2025–2026 introduced new counterparty risk dynamics, potentially increasing MetLife's reliance on cleared derivatives and altering its exposure under the broader Dodd-Frank framework.",
      "llm_answer": "In its 2022 filing, MetLife explained that its OTC‑bilateral derivatives were governed by ISDA Master Agreements and that, under Title II of Dodd‑Frank, close‑out netting and set‑off could be applied even in a counterparty’s bankruptcy (page 253), but the firm still had to maintain collateral thresholds tied to investment‑grade ratings. By 2024, the company faced new margin and clearing mandates—initial margin for new OTC‑bilateral trades, SEC rules requiring Treasury‑security clearing, and re‑proposed Basel III capital standards (page 22)—which increased the cost of risk mitigation and heightened counterparty‑risk limits and collateral requirements.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: MetLife's 2022 exposure under Title II of Dodd-Frank, the applicability of close-out netting and set-off in bankruptcy for OTC-bilateral derivatives under ISDA agreements, and the requirement to pledge initial margin for new OTC-bilateral derivatives (effective September 1, 2021, though not explicitly dated in the LLM answer, the reference to ongoing margin requirements is accurate). By 2024, the LLM correctly identifies the re-proposed Basel III capital standards, the SEC's new clearing mandate for U.S. Treasury transactions, and the resulting increase in cost of risk mitigation, collateral requirements, and counterparty risk management. (2) Quantitatively, no specific numbers (e.g., dollar amounts, percentages) are misstated; the absence of the exact September 1, 2021 date for initial margin is a minor omission but does not affect correctness as the requirement was ongoing in 2022 and continued into 2024. (3) The multi-hop reasoning is sound: the LLM synthesizes regulatory developments across years (2022 to 2024), connects OTC derivatives to Dodd-Frank’s Orderly Liquidation Authority, and links new rules (Basel III, SEC clearing) to increased costs and risk exposure. (4) The answer is contextually relevant and fully addresses the evolution of MetLife’s regulatory exposure. The only minor shortcoming is slightly less detail on the 2023 SEC rule and its 2025–2026 timeline, but the essence is captured. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 454,
        "total_tokens": 1878
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did SEGCO's cross-acceleration provisions and debt covenant compliance evolve from 2023 to 2024, and what does this indicate about Southern Company's broader credit risk management strategy?",
      "original_answer": "In 2023, SEGCO had long-term debt with variable interest tied to a November 2024 maturity, but no short-term debt outstanding. By 2024, SEGCO remained subject to cross-acceleration provisions under Southern Company's broader credit arrangements, which limit debt levels to 65% of total capitalization for subsidiaries like SEGCO. At the end of 2024, SEGCO was in compliance with these covenants, and a portion of Southern Company’s unused credit was allocated to support SEGCO’s commercial paper program. This evolution shows that Southern Company maintained tight credit risk controls across its subsidiaries, ensuring SEGCO remained within defined leverage limits while preserving liquidity flexibility through shared credit facilities.",
      "llm_answer": "At December 31 2023, SEGCO had no short‑term debt and was therefore not subject to debt‑covenant monitoring (page 211). By December 31 2024, SEGCO had a $30 million credit facility and was explicitly noted as being in compliance with all covenants, including cross‑acceleration provisions that would trigger default if the borrower defaulted on any indebtedness (page 223). This evolution reflects Southern Company’s broader credit‑risk strategy of enforcing strict debt limits and embedding cross‑acceleration clauses across its subsidiaries to safeguard the system’s financial health.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies and omissions compared to the ground truth. It incorrectly states that SEGCO had a $30 million credit facility at the end of 2024, which is not mentioned in the original answer and introduces a specific dollar amount not supported by the ground truth. The original answer emphasizes that Southern Company allocated unused credit to support SEGCO’s commercial paper program but does not specify a $30M facility. Additionally, the LLM claims that in 2023, SEGCO was 'not subject to debt-covenant monitoring' due to no short-term debt, but the original answer does not state this exemption—only that there was no short-term debt and that long-term debt existed with variable interest. (2) The dates (2023, 2024) and page references (211, 223) appear consistent with document-based reasoning, but the $30 million figure is factually unsupported in the ground truth and thus a critical quantitative error. The 65% debt-to-capitalization covenant limit, a key metric in the original answer, is entirely missing in the LLM response, undermining quantitative and qualitative accuracy. (3) The multi-hop reasoning is partially sound: the LLM correctly infers that cross-acceleration provisions are part of Southern Company’s risk management and links covenant compliance across years. However, it fails to synthesize the key point about the 65% capitalization limit and shared credit support structure, which are central to Southern Company’s strategy. (4) The contextual relevance is high—the answer addresses the evolution of provisions and ties it to credit risk strategy. However, due to the missing 65% covenant threshold, incorrect $30M facility claim, and erroneous assertion about covenant monitoring exemption, the correctness score is reduced to 6, reflecting partial accuracy with significant factual gaps.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 505,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How did the shift in NEE's use of option models for power derivatives between 2022 and 2024 impact the fair value and implied volatility metrics of their 'Options - Power' portfolio?",
      "original_answer": "In 2022, NEE's 'Options - Power' portfolio had a fair value of $52 million in assets and $1 million in liabilities, with a weighted average implied volatility of 81%. By 2024, the fair value of 'Options - Power' had decreased significantly to $9 million in assets and $6 million in liabilities. During this time, the company continued to use option models for valuation, but the implied volatilities increased to a weighted average of 186%, with a range of 78% to 360%. This indicates that while the portfolio size shrank, the underlying power market became more volatile, influencing NEE's modeling assumptions and resulting in higher implied volatility inputs in their option models.",
      "llm_answer": "NEE’s switch to a new option‑model approach for power derivatives cut the portfolio’s fair value sharply—from $52 million in assets (and $1 million in liabilities) in 2022 to $9 million in assets (and $6 million in liabilities) in 2024, shrinking the net fair value from $51 million to $3 million【page_86 2022】【page_86 2024】.  At the same time, the implied‑volatility inputs used in the models shifted to higher levels: the weighted‑average implied volatility rose from 81 % to 186 %, and the lower bound of implied volatilities climbed from 8 % to 78 % (with the upper bound staying near 360 %)【page_86 2022】【page_86 2024】.  This change in modeling assumptions—higher implied volatilities—driven the lower fair‑value outcome for the Options‑Power portfolio.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the fair value figures for NEE's 'Options - Power' portfolio in 2022 ($52M assets, $1M liabilities) and 2024 ($9M assets, $6M liabilities), as well as the implied volatility metrics: weighted average rising from 81% to 186%, and the range increasing from not explicitly stated lower bound in 2022 (but implied at 8% in LLM answer) to 78%-360% in 2024. However, the original answer does not mention a 'switch to a new option-model approach'—rather, it states NEE continued using option models, with updated assumptions due to increased market volatility. This mischaracterization of a methodological 'switch' is a significant qualitative error. (2) Quantitatively, all dollar amounts and percentages are accurate or reasonably inferred. The net fair value calculation (from $51M to $3M) is correct and adds useful context. The implied volatility lower bound in 2022 is cited as 8% in the LLM answer, but the original answer does not specify this—only that the 2024 range is 78% to 360%. This addition is unsupported and incorrect. (3) The multi-hop reasoning is partially sound—linking changes in implied volatility to valuation outcomes is logical, but the causal claim that 'higher implied volatilities drove the lower fair-value outcome' oversimplifies and potentially inverts the relationship: higher volatility typically increases option value, all else equal. The actual reason for the fair value decline may be portfolio run-off or reduced positions, not modeling changes. The LLM incorrectly implies the modeling change caused the decline, whereas the original answer attributes the higher volatility inputs to more volatile underlying markets, not a model switch. (4) Scores reflect high quantitative accuracy and relevance, but reduced qualitative accuracy due to incorrect causal reasoning and unsupported claims about model changes and volatility bounds.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 517,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How did AXP's 2022 regulatory constraints influence AENB's ability to offer competitive deposit rates in 2024, given that AENB paid $5.0 billion in dividends to its parent during that year?",
      "original_answer": "AXP's 2022 regulatory environment emphasized strict capital adequacy standards and the requirement for AXP to act as a 'source of strength' to AENB. These constraints directly affected AENB's capital flexibility in 2024, especially in light of the $5.0 billion in dividends it paid to its parent during that year. Banking regulations limited AENB’s ability to distribute capital if it would cause the bank to fall below required capital levels or be considered an unsafe banking practice. This regulatory pressure, combined with the significant dividend outflow, constrained AENB’s ability to maintain high deposit interest rates, as doing so could have further impacted its capital ratios and triggered additional regulatory scrutiny or restrictions.",
      "llm_answer": "The 2022 regulatory constraints required AENB to maintain capital ratios and limit dividend distributions, which reduced the capital available for deposit funding (page_12).  In 2024, after paying $5.0 billion in dividends to its parent (page_158), AENB’s capital base was further constrained, limiting its ability to offer competitive deposit rates because FDIC rules cap rates on brokered deposits and require sufficient capital to support higher rates (page_40, page_39).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers and dates are correct: the $5.0 billion dividend in 2024 is accurately cited, and the reference to 2022 regulatory constraints matches the original. No calculations were required, and all financial figures are consistent. (2) The answer correctly identifies the entities: AXP (parent) and AENB (subsidiary bank), and correctly associates the regulatory environment with capital adequacy and dividend limitations. (3) The reasoning is sound and captures the multi-hop logic: 2022 regulations → capital constraints on AENB → impact of $5B dividend in 2024 → reduced ability to offer high deposit rates due to capital limitations and FDIC rules. The mention of FDIC rules capping brokered deposit rates and requiring sufficient capital (citing pages 39 and 40) adds regulatory specificity that supports the conclusion. (4) While the original answer emphasizes AXP’s 'source of strength' obligation and the risk of unsafe banking practices, the LLM answer omits this nuance but still conveys the core causal chain accurately. This minor omission in qualitative depth does not undermine the factual correctness. The answer is contextually relevant, directly addressing how past regulations and dividend outflows affected AENB’s rate competitiveness in 2024. Overall, the response is factually correct, well-supported, and semantically equivalent to the ground truth with only slight room for deeper regulatory context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 416,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "How did changes in Disney's international content distribution strategy between 2022 and 2024 affect its use of National Geographic programming to maintain competitive positioning in global DTC markets?",
      "original_answer": "In 2022, Disney integrated National Geographic programming as a top-level tile within the Disney+ interface, signaling its strategic importance in content bundling and global DTC expansion. By 2024, Disney maintained its 73% ownership stake in National Geographic, continuing to leverage its brand across international linear networks and Disney+ services outside the U.S. and Latin America. Despite increased global competition and economic headwinds that pressured DTC pricing and subscriber retention in 2022, Disney preserved National Geographic's role in its content portfolio, suggesting a deliberate effort to sustain brand differentiation and subscriber appeal through high-quality, recognizable non-fiction programming. This continuity in content strategy implies that National Geographic remained a cornerstone of Disney’s international DTC positioning even as the company navigated rising costs and distribution challenges.",
      "llm_answer": "Disney’s 2022 filing shows National Geographic titles as a core “tile” on Disney+ (page 13), underscoring the brand’s role in the company’s global streaming lineup.  By 2024, the company explained that its “increased focus on DTC distribution in international markets” would shift the monetization of content—including National Geographic titles—from licensed linear channels to Disney+ Hotstar, Star+ and other DTC platforms (page 78), using the National Geographic brand to differentiate its global streaming offering and sustain competitive positioning.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) It accurately identifies the 2022 integration of National Geographic as a top-level tile on Disney+ (citing page 13), matching the original answer's claim about strategic interface placement. It also correctly notes the 2024 shift toward DTC monetization in international markets, referencing Disney+ Hotstar and Star+, which reflects Disney’s evolving distribution strategy. (2) There are no numeric values (e.g., percentages, dollar amounts) in either answer, so quantitative accuracy is not compromised—score is 10. (3) The LLM omits Disney’s 73% ownership stake in National Geographic, a specific detail from the ground truth that confirms continued control, which slightly weakens completeness and multi-hop synthesis. However, the core reasoning—using National Geographic to differentiate Disney’s global DTC offering—is sound and logically derived from the cited strategic shift. (4) The answer is highly contextually relevant, directly addressing how changes in distribution strategy affected the use of National Geographic programming for competitive positioning. While the omission of ownership percentage and lack of mention of economic headwinds or subscriber retention pressures results in a slight deduction, the overall factual and strategic narrative is consistent with the ground truth. Hence, correctness and qualitative accuracy are scored high but not perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 400,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "How did the structure of Schwab's common equity evolve from 2022 to 2023 in relation to TD Bank's stake in nonvoting common stock, and what impact did this have on earnings per share calculations?",
      "original_answer": "In 2022, Schwab remained under constraints from its acquisition of TD Ameritrade, including a Stockholder Agreement that limited TD Bank and its affiliates to owning no more than 9.9% of Schwab common stock. As part of the acquisition, Schwab issued both voting and nonvoting common stock, with TD Bank holding approximately 79 million shares of nonvoting common stock as of December 31, 2021. By 2023, Schwab had transitioned to using the if-converted method for calculating diluted earnings per share (EPS), which assumed the conversion of all nonvoting common stock into voting common stock for EPS reporting purposes. This evolution reflects how Schwab’s capital structure matured post-acquisition, with nonvoting shares—originally issued to TD Bank—now playing a defined role in financial reporting and dilution analysis, even as TD Bank’s ownership remained capped.",
      "llm_answer": "Schwab’s common‑equity structure changed in 2023 as the number of non‑voting shares outstanding fell from 67 million in 2022 to 51 million in 2023—reflecting a reduction in TD Bank’s stake in the non‑voting class (TD Bank had held about 79 million non‑voting shares as of 2021【page_112】). Because the diluted‑EPS calculation uses the “if‑converted” method for non‑voting shares, the smaller non‑voting pool in 2023 reduced the additional shares added to the diluted denominator, narrowing the gap between basic and diluted EPS (basic $3.52 vs diluted $3.50 in 2022; basic $2.55 vs diluted $2.54 in 2023【page_125】).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative claims. The ground truth states that TD Bank held approximately 79 million nonvoting shares as of December 31, 2021, but does not provide Schwab's total nonvoting shares outstanding in 2022 or 2023. The LLM incorrectly asserts that nonvoting shares dropped from 67 million in 2022 to 51 million in 2023, which is not supported by the original answer and introduces false precision. Additionally, the EPS figures cited ($3.52 basic / $3.50 diluted in 2022; $2.55 / $2.54 in 2023) are not present in the ground truth and appear fabricated. (2) The original answer does not include any specific share count for 2022 or 2023 outstanding nonvoting shares, nor any EPS numbers, so the LLM's inclusion of such data represents a hallucination rather than inference. The only numeric fact in the ground truth is the 79 million nonvoting shares held by TD Bank as of 2021. (3) The reasoning about the if-converted method is partially correct and aligns with the original answer—Schwab did adopt this method for diluted EPS calculation in 2023. However, the LLM incorrectly links the reduction in nonvoting shares to TD Bank’s stake without evidence of disposal or reduction by TD Bank. The original answer emphasizes structural evolution in reporting, not actual share reduction. (4) While the LLM captures the general context—transition to if-converted method and relevance of nonvoting shares to EPS—it fails on core factual accuracy, especially regarding numbers and ownership changes. The contextual relevance is high because it addresses both parts of the question (equity structure evolution and EPS impact), but correctness is low due to unsupported quantitative claims. Correctness score is 4 due to partial factual alignment but major numerical errors; quantitative accuracy is 3 due to multiple incorrect figures; qualitative accuracy is 5 for correct use of financial concepts but flawed synthesis; contextual relevance is 8 because the response stays on topic and attempts proper multi-hop reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 565,
        "total_tokens": 1949
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did the acquisition of Swedish Match in 2022 and the subsequent full redemption of shares in early 2023 impact the positioning and commercialization strategy of ZYN nicotine pouches in the U.S. market by 2024?",
      "original_answer": "In 2022, PM acquired Swedish Match, gaining control of the ZYN nicotine pouch brand and establishing a leadership position in oral nicotine delivery in the U.S. market. By February 2023, PM completed the full redemption of remaining shares of Swedish Match for a total of $883 million, securing full ownership and integration of ZYN into its smoke-free portfolio. By 2024, this acquisition enabled PM to accelerate the commercialization of ZYN, leveraging its own scientific and regulatory capabilities to obtain FDA marketing authorization for ZYN nicotine pouches. This allowed PM to strengthen its smoke-free business strategy, combining ZYN with IQOS to offer a comprehensive alternative to smoking, particularly in the U.S., where ZYN became a key growth driver.",
      "llm_answer": "The November 2022 acquisition of Swedish Match gave PMI a market‑leader in oral nicotine delivery, positioning ZYN as the flagship nicotine‑pouch brand in the U.S. and allowing the company to integrate ZYN into its global smoke‑free portfolio [page_4]. The February 2023 compulsory redemption of the remaining shares gave PMI 100 % ownership, enabling full control over ZYN’s U.S. commercialization—including a unified distribution network (direct sales, independent distributors, zonified territories, wholesalers, e‑commerce and brand retail)—and expanding ZYN’s presence to 37 markets by 2024 [page_92, page_5, page_7].",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the November 2022 acquisition of Swedish Match by PM (PMI), which gave it control of ZYN and established its leadership in oral nicotine delivery in the U.S. It also accurately notes the February 2023 full share redemption, resulting in 100% ownership—consistent with the ground truth. However, the $883 million redemption cost mentioned in the original answer is missing, representing a minor quantitative omission. The LLM claims ZYN expanded to 37 markets by 2024, but this detail is not present in the ground truth and cannot be verified from the provided context, introducing a potential inaccuracy or unsupported addition. (2) Dates (November 2022, February 2023) are correct. The $883 million figure is absent in the LLM answer, which affects quantitative completeness. The 37 markets claim lacks corroboration in the original answer and may be extraneous or incorrect. (3) The multi-hop reasoning is largely sound: the acquisition enabled full integration, which in turn allowed enhanced commercialization and distribution strategy. The LLM correctly links ownership control to strategic commercialization moves. However, it omits the key point about FDA marketing authorization achieved by 2024, which is a critical outcome of PM’s regulatory capabilities post-acquisition and central to ZYN’s commercial positioning. This omission affects completeness and qualitative accuracy. (4) Despite missing the FDA authorization point and including an unverified '37 markets' claim, the LLM captures the core strategic impact: full ownership enabled unified distribution and stronger commercialization. Wording and structure differ but maintain semantic proximity on major points. Contextual relevance is high as all content directly addresses the question’s focus on positioning and commercialization strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 504,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did UPS's allocation to private debt investments in 2023 relate to the use of NAV-based reporting in 2024, particularly in light of the $2.7 billion in unfunded commitments disclosed for alternative investments?",
      "original_answer": "In 2023, UPS reported $829 million in private debt investments, accounting for 2.0% of U.S. plan assets. In 2024, the company disclosed that private debt, along with private equity and real estate, was valued using NAV as a practical expedient due to the lack of readily determinable fair value. This NAV-based reporting included $2.7 billion in unfunded commitments to limited partnerships, which are expected to be funded over the next 3–6 years. The continued inclusion of private debt in the portfolio, combined with the NAV valuation methodology, reflects UPS's ongoing reliance on alternative investments despite the liquidity constraints and valuation challenges associated with these assets.",
      "llm_answer": "In 2023 UPS invested $948 million in private debt, an alternative asset that is measured at NAV rather than a market‑observable fair value. The 2024 filing kept the same NAV‑based reporting for all alternative investments and disclosed that it had $2.7 billion in unfunded commitments to private debt, private equity, and real‑estate funds, showing that the 2023 allocation was part of a broader NAV‑measured strategy that includes future capital commitments.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains several inaccuracies, most notably the private debt investment amount in 2023, which is stated as $948 million instead of the correct $829 million from the ground truth. This is a significant numerical error. Additionally, the LLM incorrectly attributes the $2.7 billion in unfunded commitments specifically to private debt, whereas the original answer clarifies that the $2.7 billion covers unfunded commitments across alternative investments (private debt, private equity, and real estate), not private debt alone. The LLM also omits the key detail that private debt accounted for 2.0% of U.S. plan assets in 2023, which is a relevant contextual metric. (2) Quantitative accuracy is low due to the incorrect dollar figure for private debt investments and the misattribution of the $2.7 billion commitment. While the $2.7 billion figure itself is correct, its application is not: it is not specific to private debt but to all alternative investments. The years (2023 and 2024) are correctly used, and the NAV-based reporting is correctly attributed to 2024. (3) The reasoning is partially sound: the LLM correctly identifies that NAV-based reporting was used in 2024 for alternative investments and links the 2023 allocation to a broader NAV-measured strategy. It also correctly notes that unfunded commitments imply future capital calls. However, it fails to fully synthesize the multi-hop connection between the 2023 allocation, the 2024 valuation methodology, and the broader portfolio strategy involving liquidity constraints and valuation challenges, which is central to the original answer. (4) Contextual relevance is high because the LLM addresses the core relationship between 2023 investments and 2024 reporting practices and correctly frames NAV use and unfunded commitments. However, due to key factual errors in numbers and misrepresentation of the scope of unfunded commitments, the overall correctness score is moderate at 5, reflecting partial accuracy with significant flaws.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 541,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did Lowe's utilization of payroll tax deferrals under the CARES Act in 2022 compare with its use of IRS tax relief related to Hurricane Ian in 2023, in terms of deferred amounts and timing of payments?",
      "original_answer": "In 2022, Lowe's deferred $73 million of payroll taxes under the CARES Act, with $37 million paid by December 2021 and the remainder due by December 2022. In contrast, in 2023, the company deferred $1.2 billion in federal income taxes due to IRS relief following Hurricane Ian, with payment postponed until February 15, 2023. This shows a significant increase in the scale of tax deferrals and a shift from payroll-related deferrals to broader income tax relief, with a shorter deferral period of approximately four months in the latter case.",
      "llm_answer": "Under the CARES Act, Lowe’s deferred $240 million of qualifying employer payroll taxes in 2022, with half of that amount scheduled for payment by December 31 2021 and the remaining half due by December 31 2022. By contrast, the IRS Hurricane‑Ian relief in 2023 deferred $1.2 billion of federal income taxes that were originally due in October 2022 and January 2023, and the company postponed those payments to a single due date of February 15 2023. Thus, the CARES Act deferral was split over two years for payroll taxes, while the Hurricane‑Ian relief consolidated a larger amount of income‑tax deferral into one payment.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key quantitative figures. According to the ground truth, Lowe's deferred $73 million in payroll taxes under the CARES Act in 2022, with $37 million paid by December 2021 and the remainder due by December 2022. However, the LLM states that $240 million was deferred, with half due by December 31, 2021, and half by December 31, 2022. This misrepresents both the total amount and the payment schedule. The $240 million figure appears to be incorrect and not supported by the ground truth. (2) The $1.2 billion deferral related to Hurricane Ian is correctly reported in amount and due date (February 15, 2023), which matches the original answer. However, the LLM incorrectly states that the original due dates were October 2022 and January 2023, while the ground truth does not specify original due dates—only the new deadline. This introduces unsupported detail. (3) The reasoning and synthesis are partially sound: the LLM correctly identifies a shift from payroll tax deferrals (CARES Act) to income tax deferrals (Hurricane Ian relief), and notes the difference in timing structure (split payments vs. single payment). However, the claim of a 'shorter deferral period of approximately four months' in the ground truth is missing from the LLM response, weakening the comparative analysis. (4) Despite incorrect core numbers for the CARES Act deferral, the LLM captures the broader context and intent of the question—comparing scale, type, and timing of tax deferrals—and maintains relevant structure and terminology. Hence, correctness and quantitative accuracy are penalized heavily due to the incorrect $240M figure, but qualitative and contextual scores remain moderate due to correct framing and accurate reporting of the $1.2B Hurricane Ian deferral.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 496,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did Microsoft's shift in cloud services strategy from 2022 to 2024 influence Azure's revenue growth trajectory, particularly in relation to its Intelligent Cloud segment positioning and consumption-based service expansion?",
      "original_answer": "In 2022, Microsoft sold cloud services directly and through partners, with a focus on expanding its Microsoft Cloud Solution Provider program, indicating a broad channel strategy. By 2024, Azure—Microsoft’s flagship cloud platform—was central to the Intelligent Cloud segment, with revenue reaching $137.4 billion in fiscal year 2024, up from $91.4 billion in 2022. This growth was driven by consumption-based services like infrastructure-as-a-service and platform-as-a-service, as well as per-user services such as Enterprise Mobility + Security. The evolution of Microsoft's cloud services strategy—emphasizing Azure's AI-optimized infrastructure and developer tools—allowed the company to deepen its market position and drive significant year-over-year revenue growth through a more integrated and scalable cloud ecosystem.",
      "llm_answer": "Microsoft’s 2024 filing (page 10) highlights a strategic pivot toward consumption‑based pricing and a broadened Azure AI portfolio—an emphasis that was absent in the 2022 filing (page 10).  This repositioning is reflected in a 40 % jump in Intelligent Cloud revenue (from $74,965 m in 2022 to $105,362 m in 2024, page 91) and a 45 % rise in server‑products‑and‑cloud‑services revenue (from $67,350 m to $97,726 m, page 93), underscoring Azure’s accelerated growth within the Intelligent Cloud segment.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, Intelligent Cloud revenue was $91.4 billion in 2022 and $137.4 billion in 2024, representing a ~50.3% increase. However, the LLM claims $74,965 million ($74.965B) in 2022 and $105,362 million ($105.362B) in 2024, which is both factually incorrect and understates the actual growth. Similarly, the LLM cites server-products-and-cloud-services revenue increasing from $67.35B to $97.726B (45%), but this metric is not in the ground truth and appears to be a misinterpretation or substitution for Azure-specific or Intelligent Cloud revenue. (2) Calculations are internally consistent (40% and 45% increases based on cited numbers), but since the base figures are wrong, the conclusions are misleading. The actual revenue growth from $91.4B to $137.4B is ~50.3%, not 40%. (3) Qualitatively, the LLM correctly identifies the strategic shift toward consumption-based services and Azure AI expansion, aligning with the ground truth’s emphasis on AI-optimized infrastructure and developer tools. It also correctly situates Azure within the Intelligent Cloud segment and notes the strategic evolution between 2022 and 2024. However, it fails to mention the role of the Microsoft Cloud Solution Provider program in 2022 or the mix of per-user services like Enterprise Mobility + Security, missing part of the multi-hop synthesis. (4) Contextually, the answer is relevant and addresses the core question about strategy shift and revenue impact. Despite incorrect numbers, it attempts to link strategic changes to financial outcomes. The citation of specific pages suggests document grounding, but the data does not match the ground truth. Overall, partial credit is given for correct reasoning and relevance, but major deductions are made for factual and numerical inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 508,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How did the funding structure of the UPS Excess Coordinating Benefit Plan change between 2023 and 2024, based on the variable life insurance policy disclosures and Level 3 investment transfer activity?",
      "original_answer": "In 2023, UPS disclosed a variable life insurance policy as part of the funding structure for the Excess Coordinating Benefit Plan. This same policy continued to fund the plan in 2024, with no transfers of investments into or out of Level 3 during either 2023 or 2024, indicating a stable funding mechanism with no material changes in the investment structure over the two-year period.",
      "llm_answer": "The UPS Excess Coordinating Benefit Plan’s funding shifted dramatically: the variable‑life insurance policy that funded the plan fell from about $2.885 billion in 2023 to roughly $206 million in 2024, indicating a move away from that asset class. No Level 3 investment transfers were recorded in either year, so the plan’s Level 3 mix remained unchanged.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both quantitative and qualitative aspects. (1) Quantitatively, the LLM claims the variable life insurance policy value dropped from $2.885 billion in 2023 to $206 million in 2024, which contradicts the ground truth stating that the same policy continued to fund the plan with no material changes. The ground truth contains no such dollar amounts, nor any indication of a decline. These figures appear fabricated. (2) The claim of a 'dramatic shift' and 'move away from that asset class' is unsupported and directly contradicts the original answer, which states there were no transfers into or out of Level 3 investments in either year, indicating stability. (3) While the LLM correctly notes that no Level 3 investment transfers occurred, this accurate detail is overshadowed by the major misrepresentation of funding changes. (4) The reasoning fails multi-hop synthesis: instead of concluding stability from consistent policy use and no Level 3 activity, it invents a narrative of drastic change. The contextual relevance is low because the answer misrepresents the core finding—funding stability—despite referencing relevant concepts (variable life insurance, Level 3 transfers).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1198,
        "completion_tokens": 342,
        "total_tokens": 1540
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How did the shift in valuation techniques and unobservable inputs for NEE's gas-related options between 2022 and 2024, as modeled by Option Models, affect the fair value of these instruments and the company's exposure to implied volatility fluctuations?",
      "original_answer": "In 2022, NEE's 'Options - primarily gas' had a fair value of $356 million in assets and $347 million in liabilities, with Option Models relying on implied correlations (52% weighted average) and implied volatilities (36% weighted average). By 2024, the fair value of these gas-related options dropped significantly to $100 million in assets and $102 million in liabilities. During this time, the Option Models began using higher implied correlations (99% weighted average) and lower implied volatilities (52% weighted average), suggesting a strategic shift in modeling assumptions. This evolution indicates a reduced exposure to volatility swings but increased dependency on correlation assumptions, directly impacting the fair value outcomes and risk profile of NEE's gas options portfolio.",
      "llm_answer": "The 2024 10‑K shows that NEE’s gas‑related options, still valued with option‑model techniques, fell from roughly $356 million in assets and $347 million in liabilities (2021) to $100 million in assets and $102 million in liabilities (2024).  The weighted average of unobservable inputs jumped from 52 % to 99 %, driven by a higher implied‑correlation input (56 % vs. 32 %) and a slightly lower implied‑volatility input (15 % vs. 17 %).  This shift means the fair value is now more heavily driven by unobservable assumptions, making the instruments more sensitive to changes in implied volatility even though the volatility input itself has modestly declined.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. First, it incorrectly states that the 2022 asset/liability values are from 2021, which misaligns the time frame and undermines temporal accuracy. The original answer specifies 2022 as the starting point, not 2021. Second, the LLM reports incorrect percentages for implied correlations and implied volatilities: it claims implied correlation increased from 32% to 56% and implied volatility decreased from 17% to 15%, but the ground truth states that the weighted averages for implied correlations were 52% in 2022 and 99% in 2024, and for implied volatilities, 36% in 2022 and 52% in 2024. These numbers are not only wrong but reversed in direction (e.g., volatility input increased, not decreased). Additionally, the LLM conflates 'unobservable inputs' with a single metric jumping from 52% to 99%, while the original answer breaks this down into specific components (correlation and volatility), and the 52% in 2022 refers to implied correlation, not total unobservable inputs. (2) Calculations and comparisons are flawed: the LLM suggests implied volatility inputs declined, which contradicts the ground truth showing an increase from 36% to 52%. This leads to an incorrect conclusion about sensitivity. (3) The multi-hop reasoning is partially sound—linking modeling assumption changes to fair value and risk exposure—but based on incorrect data, leading to invalid conclusions. The LLM correctly identifies that higher reliance on unobservable inputs affects sensitivity, but incorrectly infers increased sensitivity to volatility despite lowering volatility input, which contradicts the original answer’s logic of reduced volatility exposure. (4) Scores reflect that core facts (direction of fair value change) are correct, but quantitative accuracy is severely compromised, dragging down overall correctness. Contextual relevance is high as the answer addresses the right instruments and general trend, but qualitative accuracy is limited by flawed reasoning stemming from wrong inputs.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 554,
        "total_tokens": 1943
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How did the fair value of full requirements and unit contingent contracts for NEE change from 2022 to 2024, and what role did the use of discounted cash flow valuation techniques play in reflecting shifts in forward pricing assumptions over this period?",
      "original_answer": "In 2022, the fair value of full requirements and unit contingent contracts for NEE was $200 million in assets and $566 million in liabilities. By 2024, this had shifted to $209 million in assets and $203 million in liabilities, indicating a significant decrease in liability valuation. The discounted cash flow technique was consistently used across both years, relying on forward price per MWh assumptions that evolved from a weighted average of $64 in 2022 to $76 in 2024. This suggests that while the forward pricing assumptions increased, the overall liability decreased, likely due to changes in market expectations or contract positions.",
      "llm_answer": "From 2022 to 2024, NEE’s fair value of full‑requirements and unit‑contingent contracts rose from $200 million (assets) and $566 million (liabilities) to $209 million (assets) and $203 million (liabilities), improving the net fair value by roughly $6 million.  The discounted‑cash‑flow method was used to value these Level‑3 contracts, and the shift in forward‑price assumptions—elevating the forward price per MWh from $2 to $20—was reflected in the valuation, driving the observed fair‑value changes.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the fair value figures for 2022 ($200M assets, $566M liabilities) and 2024 ($209M assets, $203M liabilities), which matches the ground truth. However, it incorrectly states that the forward price per MWh increased from $2 to $20, whereas the ground truth reports a rise from $64 to $76. This is a major factual error in quantitative accuracy. Additionally, the claim that the 'net fair value improved by roughly $6 million' is incorrect: the net change is from a net liability of $366M ($566M - $200M) in 2022 to a net liability of $-6M ($203M - $209M), meaning an improvement of about $360M, not $6M. (2) The numbers for asset and liability values are correct, but the forward pricing assumptions are wildly inaccurate ($2 to $20 vs. $64 to $76), and the net change calculation is flawed. These errors severely undermine the quantitative accuracy. (3) The reasoning correctly identifies the use of discounted cash flow (DCF) techniques for Level-3 fair value measurements and links valuation changes to forward price assumptions, which aligns with the ground truth. However, due to the incorrect forward price inputs, the explanation misrepresents the economic drivers behind the valuation shift. The multi-hop synthesis across years and valuation methods is structurally sound but based on false data. (4) The contextual relevance is high because the answer addresses both parts of the question—changes in fair value and the role of DCF techniques—but the severe quantitative inaccuracies, especially in the forward price assumptions and net change calculation, limit correctness. The qualitative reasoning is partially sound but built on incorrect facts, leading to a low overall correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 476,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How did Merck's strategic positioning of Bravecto evolve from 2022 to 2023, particularly in the context of its patent protection outlook and new regulatory approvals?",
      "original_answer": "In 2022, Merck emphasized its dependency on key products like Bravecto for profitability, with the company noting that the loss of patent protection could significantly impact sales. By 2023, Bravecto remained a key product, but the company experienced a shift in its strategic positioning as it secured an EC approval in January 2024 for an injectable formulation with 12 months of persistent flea and tick control. This regulatory development, mentioned in the 2023 filing, likely extended Bravecto's commercial lifecycle and reinforced its role in Merck's animal health portfolio despite looming patent risks for other major products like Keytruda and Bridion.",
      "llm_answer": "Merck’s 2022 10‑K positioned Bravecto as a key product with robust patent protection, showing that no loss of exclusivity was expected until 2026 (see the patent‑protection chart on page 30).  In the 2023 10‑K the company reaffirmed that Bravecto’s patents remained strong and added a new regulatory milestone – an EU approval for an injectable formulation in January 2024 – which expands the product line and reinforces its market position (see the product‑approval table on page 6).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all dates and years are correct: the January 2024 EU approval for the injectable formulation is accurately cited, and the 2026 patent expiry (implied in the 2022 filing) matches the context of patent protection outlook. Though the original answer does not specify the 2026 date, the LLM’s inclusion of it is consistent with the idea of 'looming patent risks' elsewhere and adds precision without contradiction. (2) The LLM correctly identifies the evolution: Bravecto was a key product in 2022 with strong patent protection, and in 2023, Merck highlighted a new regulatory approval that extended its lifecycle. (3) Multi-hop reasoning is sound—synthesizing information from 2022 and 2023 filings about strategic positioning, patent outlook, and regulatory developments across time. (4) The only minor gap is that the original answer contextualizes Bravecto’s strengthened position relative to patent risks for other products like Keytruda and Bridion, which the LLM omits. However, this is a secondary contextual point and does not undermine the core accuracy. Wording differs but semantic meaning is equivalent. The LLM cites specific document locations (page 30, page 6), which are plausible but not verifiable from the ground truth; however, this does not affect factual correctness. Overall, the answer is factually precise, relevant, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 399,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How did Disney's hedging strategy for forecasted foreign currency transactions evolve from 2022 to 2024, particularly in terms of the notional value of foreign exchange forward contracts used to manage exposure?",
      "original_answer": "In 2022, Disney used derivatives, including foreign exchange forward contracts, to hedge forecasted foreign currency transactions as part of its risk management strategy. By 2024, the company had specifically designated foreign exchange forward and option contracts as cash flow hedges for forecasted and firmly committed foreign currency transactions, with a notional value of $9.9 billion as of September 28, 2024, up from $8.3 billion in the prior year. This reflects an increase in the scale of Disney’s hedging activity over the two-year period, indicating a more aggressive approach to managing foreign exchange risk.",
      "llm_answer": "Disney’s forecast‑based foreign‑currency hedging has expanded over the past two years.  In 2024 the company’s net foreign‑exchange cash‑flow hedges—primarily forward contracts and options—were worth $9.9 billion, up from $8.3 billion in 2023 (and a lower amount in 2022), showing a more aggressive use of forward contracts to manage exposure.  The policy remained the same: forward and option contracts are designated as cash‑flow hedges of forecasted transactions, with gains and losses deferred in AOCI until the hedged transaction occurs.  (See 2024 10‑K, Note 17, “Foreign Exchange Risk Management.”)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: the notional value of $9.9 billion as of September 28, 2024, and $8.3 billion in the prior year (2023) are accurately reported. Although the original answer references 2022 data as a baseline, the LLM correctly infers that the $8.3 billion amount is from 2023 and implies a lower amount in 2022, which is consistent with the upward trend. (2) The answer correctly identifies the instruments used (foreign exchange forwards and options), their designation as cash flow hedges, and the accounting treatment (gains/losses deferred in AOCI), which matches the original answer’s qualitative details. (3) The multi-hop reasoning is sound: the LLM synthesizes information across years (2022 to 2024), identifies the evolution in scale (increasing notional value), and maintains consistency in policy while noting increased hedging activity. (4) Minor deduction in qualitative accuracy due to slightly imprecise phrasing—'a lower amount in 2022' is vague and could have specified that the strategy existed in 2022 but with a smaller notional value, as stated in the original. However, this does not undermine the overall correctness. The answer is fully contextually relevant, directly addressing the evolution of Disney’s hedging strategy in terms of notional value and instrument use.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 386,
        "total_tokens": 1709
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How did the application of the Bornhuetter-Ferguson Method in 2022 influence the unpaid claims liability assumptions for Protection Life in 2023, and how did this translate into the percentage development pattern seen in the Protection Life incurred and paid claims over the first five years?",
      "original_answer": "In 2022, MetLife introduced the Bornhuetter-Ferguson Method for estimating unpaid claims liabilities for Protection Life, relying on historical claim experience with higher credibility on expected loss ratios in more recent incurral months. This methodology was carried forward in 2023, where it continued to shape the assumptions used in calculating unpaid claims and claim adjustment expenses. The Protection Life segment's incurred and paid claim development pattern in 2023 showed a cumulative development of 95.8% over the first five years (58.2% + 31.7% + 4.2% + 1.2% + 0.7%), indicating that most claims were settled early, consistent with the method’s reliance on both expected loss ratios and historical data. This reflects a stable application of the method year-over-year, with no major changes in the claim settlement patterns.",
      "llm_answer": "In 2022 MetLife applied the Bornhuetter‑Ferguson method to estimate IBNR for Protection Life, updating the expected loss ratios and credibility factors that feed the 2023 unpaid‑claims liability.  The revised assumptions raised the unpaid‑claims liability for Protection Life to $481 million at December 31 2023 (see page 198).  The resulting claim‑development pattern shows that 58.2 % of incurred claims are paid in year 1, 31.7 % in year 2, 4.2 % in year 3, 1.2 % in year 4, and 0.7 % in year 5 (page 195).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the application of the Bornhuetter-Ferguson method in 2022 for Protection Life and its continuation into 2023, which aligns with the ground truth. The yearly development percentages (58.2%, 31.7%, 4.2%, 1.2%, 0.7%) are accurately reported and match the original answer. However, the $481 million unpaid claims liability figure at year-end 2023 is not present in the ground truth and introduces a specific dollar amount that was not part of the original answer, which may be factually correct but is unverifiable against the provided truth and distracts from the focus on development patterns and methodology impact. (2) Quantitatively, all percentages are correct and sum to 95.8% cumulatively as in the ground truth, demonstrating accurate reporting. The only discrepancy is the inclusion of a liability dollar amount not referenced in the original answer, which risks overprecision without corroboration. (3) The reasoning correctly links the method’s use in 2022 to updated assumptions in 2023, showing appropriate multi-hop synthesis between years and methodologies. However, it omits explicit mention that the method relies on higher credibility for recent incurral months and expected loss ratios, a key nuance in the original answer. It also does not note the stability of the method year-over-year or that the early settlement pattern is consistent with the method’s design. (4) The answer is contextually relevant and addresses both parts of the question—impact on liability assumptions and translation into development patterns—but lacks some qualitative depth in explaining *how* the method influenced assumptions beyond stating that it updated them. The inclusion of a precise dollar figure not in the ground truth slightly undermines quantitative accuracy, though it may reflect external data. Overall, core facts are correct, but minor omissions and an unsupported number prevent a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 529,
        "total_tokens": 1902
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How did the evolution of RTX's compliance with the Federal Acquisition Regulation (FAR) requirements in 2022 influence the structure and payment terms of its U.S. Government Contracts in 2024, particularly regarding progress payments and contract asset recognition?",
      "original_answer": "In 2022, RTX operated under the FAR, which governed cost allowability and payment structures in U.S. government contracts, leading to progress payments capped at 80-90% of incurred costs and the creation of contract assets due to revenue recognized in excess of billings. By 2024, RTX continued to apply FAR-based pricing and payment mechanisms, maintaining the same 80-90% progress payment structure. However, the increased use of percentage-of-completion revenue recognition for long-term contracts under FAR guidelines in 2024 led to a more structured build-up of contract assets, reflecting a more consistent alignment between cost incurrence and revenue recognition over time. This shows that RTX's adherence to FAR in 2022 directly shaped the financial structure and payment dynamics of its U.S. Government Contracts in 2024.",
      "llm_answer": "RTX’s 2022 compliance evolution strengthened its application of FAR’s cost‑allowability and pricing rules, which in 2024 continued to shape the company’s U.S. government contracts.  Fixed‑price contracts still employ progress payments capped at 80‑90 % of incurred costs and recognize contract assets when revenue recognized exceeds billings, reflecting the FAR requirement that the government retain a portion of the contract price until completion【page_79 of RTX_10k_2022】【page_79 of RTX_10k_2024】.  This consistent structure ensures compliance with FAR and accurate recognition of contract assets on the balance sheet.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: RTX's compliance with FAR in 2022 influenced its 2024 U.S. government contracts, with progress payments capped at 80-90% of incurred costs and contract assets arising from revenue recognized in excess of billings. These figures and terms match the original answer exactly. (2) Quantitative accuracy is perfect: the 80-90% progress payment range is correctly cited, and no erroneous calculations are present. (3) The reasoning is sound and reflects multi-hop synthesis between 2022 compliance and 2024 outcomes, correctly citing continuity in FAR application. The only minor omission is that the LLM does not explicitly mention the increased use of percentage-of-completion revenue recognition in 204 as a driver for more structured contract asset buildup—a nuance present in the original answer that explains *why* the asset recognition became more consistent. (4) Despite this omission, the LLM captures the core causal relationship and financial implications, maintains semantic equivalence on all major points, and supports claims with correct document citations (page_79 of both 10-Ks). Thus, the answer is factually complete and contextually relevant, warranting a high score with only a slight deduction in qualitative accuracy for missing a subtle but important detail in the evolution of revenue recognition practices.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 394,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How did the shift in NEE's pension plan asset allocation from 2022 to 2024 affect its use of registered investment companies within the broader investment strategy?",
      "original_answer": "In 2022, NEE's pension plan allocated 45% to equity investments and 10% to convertible securities, with registered investment companies being a key vehicle for diversification across global markets. By 2024, the equity allocation decreased to 43%, while alternative investments increased to 20% and convertible securities dropped to 5%. This reallocation reflects a strategic pivot toward alternative assets and away from convertible securities, which in turn influenced the relative importance and usage of registered investment companies as part of the overall investment structure. The continued use of registered investment companies in 2024 shows their ongoing role in diversification, though within a modified asset mix.",
      "llm_answer": "NEE’s 2024 target allocation (43% equity, 32% fixed‑income, 20% alternative, 5% convertible) shows a shift from the 2021 allocation (45% equity, 32% fixed‑income, 13% alternative, 10% convertible)【page 100】【page 101】—the plan is moving toward a larger alternative‑investment component and a smaller convertible‑security component.  Registered investment companies are still described as part of the equity and fixed‑income holdings in both years, so the strategy’s use of them remains unchanged in scope, but their relative weight in the portfolio has likely diminished as alternative assets grow.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the shift in asset allocation toward alternatives and away from convertible securities, and notes the continued use of registered investment companies. However, it incorrectly references 2021 data instead of 2022 as stated in the question and ground truth, which undermines temporal accuracy. The 2024 allocation numbers (43% equity, 20% alternative, 5% convertible) are correct, but the 2022 equity (45%) and convertible (10%) figures are misattributed to 2021, introducing a factual error in year alignment. (2) The percentages for 2024 are accurate and sum correctly (43+32+20+5=100), and the 2021 allocation cited (45% equity, 13% alternative, 10% convertible) may be factually present in the document, but it does not address the required 2022–2024 comparison. The fixed-income allocation (32%) is consistent across years in the LLM answer, which aligns with typical pension plan reporting, but was not mentioned in the original answer, so its relevance is secondary. (3) The reasoning correctly infers that the growing share of alternative investments likely reduces the relative weight of registered investment companies, even if their strategic role remains. This reflects sound multi-hop logic—connecting asset class shifts to vehicle-level implications. However, the failure to use the correct base year (2022 vs. 2021) breaks the direct comparative chain required by the question. (4) Despite the year mismatch, the LLM captures the core strategic trend and maintains contextual focus on how allocation changes affect the role of registered investment companies. The conclusion about unchanged scope but diminished relative weight is semantically close to the ground truth’s emphasis on modified usage within a changed mix. Hence, correctness is partially compromised by a key date error, but qualitative and contextual reasoning remain strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 515,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How did Microsoft's 22.2% year-over-year revenue growth in Server Products and Cloud Services ($79.97B in 2023 to $97.73B in 2024) influence the strategic positioning of System Center within hybrid cloud environments, as reflected in the 2024 Intelligent Cloud segment disclosures?",
      "original_answer": "Microsoft's significant 22.2% year-over-year revenue growth in Server Products and Cloud Services—from $79.97 billion in 2023 to $97.73 billion in 2024—enabled greater investment in hybrid cloud capabilities, as evidenced by the 2024 filing's description of System Center as a key tool for managing hybrid cloud environments. The 2024 Intelligent Cloud segment explicitly states that Server Products and Cloud Services include Azure and hybrid infrastructure tools like System Center, which are designed to support modern business and developers across both public and private cloud deployments. This indicates that the revenue growth directly supported Microsoft’s strategic emphasis on hybrid cloud management through System Center, reinforcing its role in enabling seamless integration and operations across on-premises and cloud environments.",
      "llm_answer": "The 22.2 % YoY jump in Server Products and Cloud Services (from $79.97 B in 2023 to $97.73 B in 2024) underscored Microsoft’s focus on hybrid‑cloud workloads.  In the 2024 Intelligent Cloud disclosures, Microsoft notes that Server products and cloud services revenue grew 3 % driven by “continued demand for our hybrid solutions, including Windows Server and SQL Server running in multi‑cloud environments” – a statement that places System Center, a core component of the Server products portfolio, at the heart of hybrid‑cloud management 【page_10】【page_44】【page_93】.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the 22.2% year-over-year revenue growth in Server Products and Cloud Services, with accurate figures of $79.97B in 2023 and $97.73B in 2024, matching the ground truth exactly—this satisfies quantitative accuracy. (2) However, the LLM introduces a conflicting claim that Server Products and Cloud Services revenue grew only 3%, which directly contradicts the 22.2% growth stated earlier and present in the ground truth. This discrepancy undermines the reasoning and suggests a failure in data synthesis or misquotation from the source document. (3) While the LLM correctly identifies System Center as part of Microsoft’s hybrid cloud strategy and links it to hybrid-cloud management, it fails to explicitly state that System Center is named in the 2024 Intelligent Cloud segment as a key tool for hybrid environments, as required by the question. Instead, it infers this through mention of Windows Server and SQL Server, which are related but not equivalent to System Center. This represents a gap in multi-hop reasoning: the model connects revenue growth to hybrid focus but does not directly tie the growth to increased investment in System Center capabilities. (4) The contextual relevance is high because the answer addresses Microsoft’s hybrid cloud strategy and references appropriate segments and products, but the qualitative accuracy is low due to the internal contradiction in growth rates and the indirect, potentially misleading attribution of strategic emphasis. The answer is partially correct but contains a critical factual inconsistency that affects interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 446,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How did the shift in MET's Separate Accounts exposure to Level 3 assets from 2023 to 2024 reflect changes in the company's pension plan investment strategy, particularly in terms of fair value estimation methods and liquidity characteristics?",
      "original_answer": "In 2023, MET's Separate Accounts held $1,147 million in Level 3 assets, which are characterized by low price transparency and infrequent trading, requiring significant unobservable inputs for valuation. By 2024, the company continued to disclose Level 3 assets within Separate Accounts, noting that these accounts invest in assets with little or no price transparency, often requiring additional time to liquidate. The Level 3 asset category in 2024 specifically included alternative asset classes such as private equity and real estate funds, which are inherently less liquid and more reliant on unobservable inputs. This evolution suggests a continued strategic emphasis on alternative investments despite their valuation complexity, with the company maintaining a significant exposure to less transparent, longer-duration assets.",
      "llm_answer": "MET cut its Level 3 separate‑account exposure from $1.147 billion at 12/31/2023 to $680 million at 12/31/2024, a $467 million reduction that signals a shift away from illiquid alternative assets that require significant unobservable inputs for fair‑value estimation (see page 286).  The company correspondingly increased its allocation to fixed‑maturity securities AFS (from 82 % to 83 %) and lowered alternative‑security exposure (12 % to 10 %) (page 284), moving more of its pension‑plan assets into Level 2 categories that rely on observable market data and are more liquid.  This change reflects a strategic pivot to reduce valuation uncertainty and improve liquidity in its pension‑plan investment portfolio.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth. (1) Quantitatively, the LLM claims MET reduced Level 3 Separate Accounts from $1.147 billion in 2023 to $680 million in 2024, implying a $467 million decrease. However, the original answer states that MET continued to hold Level 3 assets in 2024 without specifying a reduction, and no dollar amount for 2024 is provided in the ground truth—only a qualitative description of ongoing exposure. The $680 million figure and the claimed reduction are unsupported. Additionally, the LLM cites specific allocation shifts (e.g., fixed-maturity AFS increasing from 82% to 83%, alternatives from 12% to 10%) that are not present in the original answer and cannot be verified against the provided truth. (2) The qualitative reasoning is flawed: the LLM interprets the change as a 'strategic pivot' to reduce valuation uncertainty and improve liquidity, but the ground truth indicates a *continued* emphasis on alternative investments like private equity and real estate funds, which are inherently illiquid and valuation-complex. Thus, the conclusion about a strategic shift is incorrect. (3) Multi-hop reasoning fails—the LLM fabricates data points (specific 2024 values, percentage allocations, page references) not present in the original answer and draws an opposite inference about strategy. (4) Contextual relevance is moderate because the answer addresses fair value estimation methods and liquidity characteristics correctly in definition, but applies them to a false narrative of de-risking. Overall, the answer is factually wrong on key numbers and strategic interpretation, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 455,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 149,
      "question": "How did the evolution of CL's compliance with financial covenants between 2022 and 2024 affect its exposure to cross-default provisions under its credit facilities?",
      "original_answer": "In 2022, CL was in full compliance with its financial covenants, which were tied to its $3,000 five-year revolving credit facility expiring in 2026, and believed the likelihood of noncompliance was remote. These covenants were linked to cross-default provisions that could trigger acceleration of debt if not met. By 2024, CL had not only maintained compliance but also extended the credit facility twice—first to 2028 and then to 2029—indicating stronger long-term covenant stability. This consistent compliance reduced the risk of triggering cross-default provisions, even as the company refinanced $500 million in medium-term notes and issued $1.5 billion in new senior notes across 3-, 5-, and 10-year maturities. Thus, despite increased debt issuance, the company’s adherence to financial covenants minimized its exposure to cross-default risks over time.",
      "llm_answer": "Between 2022 and 2024, CL continued to meet all financial covenants attached to its credit facilities, and it had no outstanding borrowings under the Credit Facility by the end of 2024. Because the company remained in full compliance, the cross‑default clauses that could accelerate repayment were never triggered, leaving its exposure to such provisions effectively nil throughout the period【page_87】【page_89】【page_104】.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that CL remained in full compliance with its financial covenants between 2022 and 2024, which aligns with the ground truth. It accurately notes that cross-default provisions were not triggered due to continued compliance, correctly capturing the core relationship between covenant adherence and reduced cross-default risk. However, the LLM omits key details present in the original answer, particularly regarding the extension of the credit facility to 2028 and then 2029, and the refinancing activities involving $500 million in medium-term notes and $1.5 billion in new senior notes. These omissions reduce completeness and weaken the multi-hop synthesis. (2) Quantitatively, the LLM does not include any incorrect numbers. It avoids stating dollar amounts or dates that conflict with the ground truth, though it fails to mention the $3,000 million credit facility, the $500M refinancing, or the $1.5B new issuance. Since it doesn’t misstate numbers but omits them, quantitative accuracy is high but not perfect. (3) The reasoning is logically sound—compliance prevents triggering cross-defaults—but lacks the full multi-hop synthesis: the connection between refinancing, facility extensions, and sustained covenant compliance is missing. The claim of 'no outstanding borrowings by end of 2024' is not contradicted in the ground truth but is an additional detail not verifiable from the original answer, potentially sourced from external data. (4) Contextual relevance is strong as the answer directly addresses the question’s focus on covenant evolution and cross-default exposure. The omission of refinancing and extension details prevents a higher score, but the central logic remains valid and relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 477,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 149,
      "question": "How did Southern Company's financial exposure to Plant Vogtle Units 3 and 4 evolve from 2022 to 2024, considering Georgia Power's $42 million capacity purchase commitment tied to MEAG Power's stake in 2022 and the increase in Georgia Power's reported investment from $24 million in 2023 to $41 million in 2024?",
      "original_answer": "In 2022, Southern Company's subsidiary Georgia Power had a $42 million capacity purchase commitment linked to MEAG Power's ownership interest in Plant Vogtle Units 1 and 2, with MEAG Power also having a stake in Units 3 and 4. This created a financial exposure through MEAG Power’s involvement in the new units. By 2023, Georgia Power reported a $24 million investment in Plant Vogtle Units 3 and 4, which increased to $41 million in 2024. This represents a 70.8% increase in exposure from 2023 to 2024, indicating growing financial commitment to the project. The connection through MEAG Power in 2022 laid the groundwork for this increased exposure, showing a clear evolution of Southern Company's financial stake in Plant Vogtle Units 3 and 4 over the three-year period.",
      "llm_answer": "In 2022 Georgia Power’s only Vogtle‑related financial obligation was a $42 million capacity‑purchase commitment tied to MEAG Power’s 5 % stake in Units 1‑2, which represented a Southern Company exposure to that portion of the plant. By 2023 Georgia Power’s direct investment in the still‑under‑construction Units 3‑4 rose to $24 million, and it more than doubled to $41 million in 2024, effectively expanding Southern Company’s financial exposure to the construction, operating and decommissioning costs of those units.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the essential evolution of Southern Company's financial exposure to Plant Vogtle Units 3 and 4 from 2022 to 2024. (1) Quantitatively, all numbers are correct: the $42 million 2022 capacity purchase commitment, the $24 million investment in 2023, and $41 million in 2024 are accurately reported. The increase from $24M to $41M is correctly implied (though not explicitly calculated), and no calculation errors are present. (2) The entity identification is accurate—Georgia Power as Southern Company’s subsidiary, MEAG Power’s stake, and correct unit designations (Units 1-2 vs. 3-4) are properly distinguished. (3) The reasoning is sound: the LLM correctly identifies the 2022 commitment as indirect exposure tied to MEAG Power’s interest in older units, while the 2023–2024 investments represent direct exposure to the new units under construction. It logically frames this as an expansion of financial exposure. (4) The only minor shortcoming is the omission of the explicit 70.8% increase calculation mentioned in the ground truth, which adds precision to the 'more than doubled' phrasing (actual increase is ~70.8%, not over 100%). However, 'more than doubled' is a slight overstatement but may be interpreted as emphasizing growth. Despite this, the core facts, timeline, and multi-hop synthesis across MEAG Power’s stake and Georgia Power’s direct investments are correctly and coherently presented. The answer is contextually complete and relevant, addressing all key aspects of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 422,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 149,
      "question": "How did the revenue growth in Microsoft's Server Products and Cloud Services segment from $79.97 billion in 2023 to $97.73 billion in 2024 reflect the continued strategic emphasis on Windows Server as a foundational component of Microsoft's hybrid cloud offerings?",
      "original_answer": "The revenue growth in Microsoft's Server Products and Cloud Services segment from $79.97 billion in 2023 to $97.73 billion in 2024 demonstrates that Windows Server remained a central element in Microsoft’s hybrid cloud strategy. In both the 2023 and 2024 filings, Windows Server was explicitly included as a core part of the Server Products and Cloud Services portfolio, which powers modern business and developers through public, private, and hybrid environments. The 22.2% year-over-year increase in this segment suggests that Microsoft's focus on integrating on-premises infrastructure with Azure-based services resonated with enterprise customers, reinforcing the strategic positioning of Windows Server as a bridge between traditional IT and cloud-native operations. This aligns with Microsoft’s description of Server Products as integrated infrastructure and middleware supporting applications built on Windows Server, indicating a consistent and effective strategic emphasis.",
      "llm_answer": "Microsoft’s Server Products & Cloud Services revenue jumped from $79.97 billion in 2023 to $97.73 billion in 2024, a $17.8 billion increase that underscores the company’s focus on Windows Server as the backbone of its hybrid‑cloud strategy. The segment definition (page 10) lists Windows Server alongside Azure, SQL Server and other server‑software licenses, and the growth reflects higher adoption of hybrid workloads that run Windows Server on Azure and on‑premises, reinforcing Windows Server’s role as a foundational component of Microsoft’s hybrid‑cloud offering.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is factually correct and aligns closely with the ground truth. All key numbers are accurate: revenue increased from $79.97 billion in 2023 to $97.73 billion in 2024, representing a $17.76 billion increase (rounded to $17.8 billion by the model, which is acceptable). The implied growth rate is approximately 22.2%, consistent with the original answer. 2) Quantitative accuracy is perfect—values match exactly or are reasonably rounded. The calculation of the dollar increase ($97.73B - $79.97B = $17.76B) is correctly approximated as $17.8B. No errors in figures or time periods. 3) The reasoning correctly identifies Windows Server as part of the Server Products & Cloud Services segment and links its growth to hybrid cloud adoption, citing integration with Azure and on-premises deployments. It references the segment definition (page 10), suggesting proper sourcing, and correctly infers strategic emphasis. While it omits explicit mention of 'middleware' or 'public, private, and hybrid environments' from the original, the core multi-hop logic—linking revenue growth to strategic positioning via hybrid workloads—is sound and well-synthesized. 4) The answer is contextually relevant, directly addressing how revenue growth reflects strategic emphasis on Windows Server. Only minor qualitative omissions prevent a perfect 10: the LLM does not explicitly note that Windows Server was consistently highlighted in both 2023 and 2024 filings as a core component, slightly reducing completeness in narrative depth. However, the omission does not undermine factual correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 435,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 149,
      "question": "How did the structure and redemption terms of AT&T's Telco preferred interests evolve from 2022 to 2024, particularly in relation to the reset periods, initial distribution rates, and call provisions tied to the redemption option?",
      "original_answer": "In 2022, AT&T's Telco preferred interests had an initial distribution rate of 4.25% annually, with reset periods every seven years and a call provision exercisable after seven years. By 2024, AT&T introduced a new series (Class A-4) with a significantly higher initial distribution rate of 5.94%, a shorter reset period of four years starting in 2028, and a corresponding call provision beginning in 2028. This reflects a strategic shift toward shorter-term instruments with higher yields, likely to address evolving financing needs and investor expectations, while maintaining the same redemption and liquidation rights as prior series.",
      "llm_answer": "From 2022 to 2024 AT&T added a new Telco preferred class that changed the timing of resets and the call window.  In the 2022 filing (page 129) the existing Telco Class A‑1 paid 4.25 % and reset every 7 years, and the A‑2/A‑3 paid 6.85 % and reset on Nov 1 2027 and every 7 years thereafter; each class could be called at issue price beginning seven years after issuance.  By 2024 (page 88) AT&T announced a new Telco Class A‑4 that will pay 5.94 % initially, reset on Nov 1 2028 and every 4 years thereafter, and can be called at issue price starting Nov 1 2028—shifting the reset interval to a shorter period and moving the call date forward while keeping the redemption option tied to the call provision.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key numbers are correct: 4.25% initial rate (2022), 5.94% for Class A-4 (2024), reset periods of 7 years (2022) and 4 years starting Nov 1, 2028 (2024), and call provisions beginning seven years after issuance in 2022 and on Nov 1, 2028 in 2024. The mention of A-2/A-3 paying 6.85% is factually accurate but not directly relevant to the core evolution of structure from 2022 to 2024 focused on reset and call changes—this adds detail beyond the ground truth but does not contradict it. (2) Quantitative accuracy is perfect: percentages, reset intervals, and dates match or are consistent with the original answer (e.g., Nov 1, 2028 aligns with 'by 2024' and 'starting in 2028'). (3) Multi-hop reasoning is sound: the model correctly synthesizes changes across years and classes, identifying the shift to shorter reset periods (7 to 4 years) and earlier call alignment (from 'after seven years' to a fixed 2028 date). (4) The answer captures the structural evolution accurately, though it omits explicit mention of 'same redemption and liquidation rights' preserved in the new series—a minor omission affecting completeness but not core correctness. Wording differs but semantic meaning matches. Contextual relevance is excellent, directly addressing all aspects of the question: reset periods, distribution rates, and call provisions tied to redemption.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 395,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 150,
      "question": "How did the voting power distribution between Class A and Class B common stock at CMCSA change from 2023 to 2024, and what implications does this have for shareholder influence given the convertible nature of Class B shares?",
      "original_answer": "In 2023, CMCSA disclosed that holders of Class A common stock had 66 2/3% of the voting power, while Class B common stockholders held 33 1/3%. By 2024, this structure remained unchanged, with Class A still holding 66 2/3% and Class B maintaining 33 1/3%. However, the number of issued Class A shares decreased from 4,842,108,959 in 2023 to 4,651,093,045 in 2024, while Class B shares remained constant at 9,444,375. Since Class B shares are convertible into Class A shares on a share-for-share basis, this slight reduction in Class A shares could marginally increase the relative voting influence of Class B shareholders unless conversion occurs. The non-dilutable nature of Class B voting power ensures that their 33 1/3% share of total voting rights cannot be diluted by additional issuances of other stock classes.",
      "llm_answer": "From 2023 to 2024 the voting‑power split stayed the same: 66 ⅓ % of the voting power is held by Class A shares and 33 ⅓ % by Class B shares (see 2024 Note 11, page 91). Because each Class B share is convertible share‑for‑share into Class A and carries 15 votes, holders can increase their influence by converting, while the 33 ⅓ % aggregate voting power of Class B shares is protected from dilution by new issuances of other classes.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "(1) The LLM answer correctly states that the voting power distribution remained unchanged from 2023 to 2024, with Class A holding 66 2/3% and Class B holding 33 1/3%, which matches the ground truth. However, it introduces a significant factual error by claiming that each Class B share carries '15 votes', a detail not present in the original answer and unsupported by the provided context. This misrepresents the voting mechanism and undermines quantitative accuracy. Additionally, the LLM fails to mention the actual decrease in the number of issued Class A shares (from 4,842,108,959 to 4,651,093,045) and the constant number of Class B shares (9,444,375), which are key quantitative changes affecting relative influence. (2) While percentages are correctly reported (allowing for formatting variation: '66 2/3%' vs '66 1/3%' — though note that '66 1/3%' is itself a minor error as it should be '66 2/3%'), the '15 votes' claim is entirely incorrect and unsupported. The ground truth emphasizes the convertible nature and non-dilutable voting power but does not mention differential vote counts per share. (3) The reasoning about convertibility and non-dilution is partially sound and reflects correct synthesis of implications: the LLM correctly notes that Class B shares are convertible share-for-share and that their aggregate voting power is protected from dilution. However, it misses the nuance that the reduction in Class A shares could marginally increase Class B's relative influence — a key implication in the original answer. (4) The contextual relevance is high because the answer addresses voting power distribution, convertibility, and shareholder influence. However, due to the introduction of false quantitative data ('15 votes') and omission of actual share count changes, the correctness score is limited to 6, with quantitative accuracy penalized more heavily.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 506,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 150,
      "question": "How did the reduction in Corebridge's drawdowns from the DDTL Facility in 2023 impact AIG's equity method income from Corebridge in 2024, given the changes in Corebridge's liquidity structure and dividend policy?",
      "original_answer": "In 2023, Corebridge reduced its drawdowns under the DDTL Facility by repaying $1.25 billion, leaving only $250 million outstanding by year-end. This liquidity optimization allowed Corebridge to increase shareholder returns, as evidenced by the $307 million special dividend paid in December 2023. By 2024, AIG reported equity method income from Corebridge based on dividends received and stock price changes since June 9, 2024, indicating that the prior year's deleveraging improved Corebridge's capacity to distribute capital to shareholders, directly benefiting AIG's investment returns.",
      "llm_answer": "Corebridge repaid $1.25 bn of its DDTL Facility in 2023, cutting its borrowing needs and strengthening its liquidity. The improved liquidity allowed Corebridge to continue paying dividends to AIG and supported a more favorable stock‑price performance, which together produced AIG’s $601 m equity‑method income in 2024 (the sum of dividends received and fair‑value gains). The equity‑method income was lower than the $1.1 bn dividend paid in 2023, reflecting a modest shift in Corebridge’s dividend policy and stock‑price dynamics.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly states that Corebridge repaid $1.25 billion of the DDTL Facility in 2023, it fabricates a $601 million equity-method income for AIG in 2024 and incorrectly claims a $1.1 billion dividend in 2023. The ground truth states a $307 million special dividend in December 2023, not $1.1 billion. The $601 million figure for equity method income is not supported by the original answer, which does not provide a specific dollar amount for AIG's 2024 equity income. (2) The quantitative inaccuracies are severe: the LLM invents numbers not present in the ground truth (e.g., $601M income, $1.1B dividend) and misrepresents the dividend amount by more than 3x. While the $1.25 billion repayment is correct, the rest of the financial figures are either incorrect or unsupported. (3) The reasoning partially captures the multi-hop logic: it links reduced DDTL drawdowns to improved liquidity and then to dividends and equity income. However, it incorrectly frames the equity method income as including 'fair-value gains'—the original answer specifies it is based on dividends received and stock price changes since June 9, 2024, which is a different accounting treatment. The LLM also fails to mention the $250 million outstanding balance at year-end, a key detail showing the extent of deleveraging. (4) The contextual relevance is high because the answer addresses the core causal chain: DDTL repayment → liquidity → dividends → AIG's income. However, due to major quantitative errors and incorrect financial figures, the correctness score is low. The qualitative accuracy is moderate because the logical structure is somewhat sound, but the entities and financial outcomes are misrepresented.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 482,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How did Boeing's increased reliance on fixed-price contracts in 2023, which exposed them to cost overruns, impact their financial performance in 2024, particularly in relation to their Commercial Airplanes segment?",
      "original_answer": "In 2023, Boeing's BDS and BGS defense businesses generated 58% and 65% of their revenues from fixed-price contracts, which exposed them to significant cost overruns. This led to $1,585 million in additional losses on major fixed-price development programs such as the KC-46A Tanker and Commercial Crew. These cost overruns were exacerbated by production disruptions, supplier instability, and technical challenges. By 2024, Boeing's Commercial Airplanes (BCA) business remained exposed to similar risks, particularly through firm fixed-price contracts with indexed price escalation clauses. The inability to fully offset cost increases—especially under high inflationary pressures—negatively impacted operating margins, highlighting a continuation of the financial strain from 2023 into 2024.",
      "llm_answer": "Boeing’s 2023 risk‑factor disclosures made clear that a large share of its revenue came from fixed‑price contracts, which expose the company to losses if costs exceed estimates (page 15).  In 2024 the Commercial Airplanes segment faced higher supplier prices, production‑quality issues and FAA‑led production slow‑downs (pages 9–10), and the fixed‑price exposure amplified these cost overruns, leading to higher earnings charges and a decline in the segment’s operating margin.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Boeing's increased reliance on fixed-price contracts as a risk factor in 2023 and links it to financial strain in 2024, particularly in the Commercial Airplanes segment. It accurately notes that fixed-price contracts expose Boeing to cost overruns and that in 2024, the segment faced supplier price increases, production-quality issues, and production slowdowns—factors that align with the ground truth. However, the LLM omits all specific quantitative data from the original answer, including the 58% and 65% revenue shares from fixed-price contracts in BDS and BGS, and the critical $1,585 million in additional losses on major programs like the KC-46A Tanker and Commercial Crew. These omissions significantly reduce quantitative accuracy. (2) The ground truth includes precise financial impacts and program-specific losses that are entirely missing in the LLM response. While the LLM mentions 'higher earnings charges' and 'decline in operating margin,' it fails to quantify them or tie them to the documented $1.585 billion loss, which is central to the financial impact. (3) The multi-hop reasoning is partially sound: the model connects fixed-price contract risks from 2023 to 2024 performance in Commercial Airplanes and recognizes that cost pressures under fixed-price models hurt margins. However, it incorrectly shifts focus to BCA as the primary bearer of fixed-price risk, while the original answer emphasizes that BDS and BGS were the main sources of fixed-price revenue and losses in 2023. The spillover to BCA in 2024 is valid, but the LLM does not clearly explain the cross-segment risk transmission or mention the indexed price escalation clauses that limit cost recovery. (4) Despite missing key numbers and misallocating emphasis across business segments, the LLM captures the core qualitative narrative—fixed-price contracts amplified cost overruns from supply chain and production issues, hurting profitability in 2024. Hence, correctness is moderate (6), quantitative accuracy is low (4) due to missing figures, qualitative reasoning is fair (7), and relevance is high (9) as it stays on topic and addresses the causal chain.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 588,
        "total_tokens": 1922
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How did the change in Amgen's collaboration cost-sharing with UCB between 2022 and 2023 reflect the evolving commercialization dynamics of EVENITY in light of its regulatory risk profile?",
      "original_answer": "In 2022, Amgen highlighted EVENITY's regulatory risk due to cardiovascular safety concerns observed in clinical trials, which led to post-marketing requirements and potential labeling restrictions. Under the collaboration with UCB, Amgen shared global development and commercialization profits and losses equally. By 2023, Amgen's cost-sharing with UCB increased significantly, with global profit and loss share expenses rising from $255 million in 2022 to $396 million in 2023. This increase indicates a more active commercialization phase for EVENITY, particularly in Europe where UCB led marketing efforts, despite the ongoing regulatory scrutiny. The growth in shared costs suggests that Amgen and UCB expanded their joint investment in EVENITY, likely to support market access and mitigate earlier regulatory risks.",
      "llm_answer": "Amgen and UCB continue to share global development and commercialization costs for EVENITY on an equal‑share basis (see page 30), but the amount of profit‑and‑loss share expense rose from **$255 million in 2022 to $396 million in 2023** (page 132). This jump reflects a shift toward greater commercialization activity as EVENITY’s market presence expanded, while the product’s regulatory risk—highlighted by a mandatory five‑year post‑marketing observational study (page 50)—has increased the need for shared marketing, compliance and monitoring costs, driving the higher cost‑sharing figure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key quantitative change in cost-sharing—$255 million in 2022 rising to $396 million in 2023—which matches the ground truth exactly. These figures are accurately cited and reflect the increased financial commitment in the collaboration. (2) Quantitative accuracy is perfect: both dollar amounts and the implied increase (from $255M to $396M) are correct, with no calculation errors. Format is consistent and acceptable. (3) The reasoning is sound and captures the multi-hop logic: it links the increased cost-sharing to heightened commercialization activity and ties this to ongoing regulatory risks, specifically referencing the mandatory post-marketing study (aligned with ground truth’s mention of cardiovascular safety concerns and post-marketing requirements). The LLM correctly infers that higher costs reflect expanded joint investment to support market access and compliance under regulatory scrutiny. (4) The only minor shortcoming is that the LLM does not explicitly name Europe as the region where UCB led marketing efforts—a detail present in the original answer that adds geographic context to the commercialization dynamics. However, this omission does not undermine the core factual or inferential accuracy. Overall, the answer is semantically equivalent, well-reasoned, and highly relevant, warranting a high correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 388,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How did Microsoft's treatment of the $986 million in Nuance convertible senior notes evolve from 2023 to 2024, and what does this indicate about the integration progress of Nuance and its impact on Microsoft's Intelligent Cloud segment?",
      "original_answer": "In 2023, Microsoft disclosed that the $986 million in Nuance convertible senior notes, issued in 2015 and 2017, had been substantially redeemed, signaling early integration steps. By 2024, the continued reference to these redeemed notes in the context of Nuance's integration into the Intelligent Cloud segment suggests that Microsoft is aligning Nuance's financial structure with its broader cloud strategy. The fact that the goodwill from the acquisition remained non-deductible and was tied to synergies expected from Nuance's integration indicates a strategic focus on long-term value creation rather than short-term tax benefits. This evolution reflects a deepening operational and financial integration of Nuance into Microsoft's cloud infrastructure.",
      "llm_answer": "Microsoft’s 2023 10‑K listed the $986 million of convertible senior notes issued by Nuance as a liability under the purchase‑price allocation, noting that “substantially all of which have been redeemed” (page 77). By the 2024 10‑K the notes had been fully redeemed and removed from the balance sheet, reflecting the completion of the redemption process (page 77). This evolution shows that Microsoft is progressing the integration of Nuance into its Intelligent Cloud segment, reducing the debt load and strengthening the segment’s financial position.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $986 million Nuance convertible senior notes and their treatment from 2023 to 2024. It accurately states that in 2023, substantially all were redeemed, and by 2024, they were fully redeemed and removed from the balance sheet—this aligns with the ground truth. The numbers, years, and entities (Microsoft, Nuance, $986 million, 2023 and 2024 10-Ks) are all factually correct. (2) Quantitative accuracy is perfect: the dollar amount ($986 million), the years (2023 and 2024), and the redemption status are correctly reported with no calculation errors. (3) However, the reasoning and completeness fall short on multi-hop synthesis. The LLM answer omits key qualitative insights from the ground truth, such as the non-deductible goodwill, tax strategy implications, and the strategic alignment of Nuance with Microsoft’s broader cloud value creation. It simplifies the integration impact to 'reducing debt load and strengthening financial position,' missing the deeper indication about operational integration and long-term synergy focus. (4) While the answer is factually sound and contextually relevant, it lacks the full depth of the original answer’s strategic interpretation, which is essential for a complete multi-hop understanding. Hence, correctness is reduced to 7 for missing key inferential components, though quantitative accuracy remains high.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 389,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 153,
      "question": "How did the increase in MDLZ's forecasted transactions from $5,470 million in 2022 to $5,550 million in 2023 influence the evolution of their Value-at-Risk (VAR) model metrics by December 31, 2024, particularly in light of the VAR model's exclusion of forecasted transactions and the shift in modeling methodology from variance/co-variance to delta-gamma approximation?",
      "original_answer": "MDLZ reported forecasted transactions of $5,550 million as of December 31, 2023, up from $5,470 million in 2022, which were explicitly excluded from the VAR model as noted in the DIS 2023 filing that described the VAR modeling methodology in use at that time. By December 31, 2024, MDLZ had transitioned to using a parametric delta-gamma approximation technique for calculating VAR, replacing the prior variance/co-variance method. Despite the growth in forecasted transactions, the VAR model showed a decrease in estimated maximum potential one-day loss from $284 million (as of September 30, 2023) to $255 million (as of September 28, 2024), attributed to reduced interest rate volatility. This suggests that while forecasted transactions were growing, broader market conditions and modeling refinements had a more significant impact on the firm's assessed financial risk exposure.",
      "llm_answer": "The $80 million rise in forecasted transactions (from $5,470 m in 2022 to $5,550 m in 2023, page 97) had no direct effect on MDLZ’s VAR figures because the VAR model explicitly excludes forecasted transactions, inter‑company payables, and net‑investment hedges (page 60).  By 12/31/24 the combined‑portfolio VAR had fallen to $255 m from $284 m at 12/31/23, a decline driven mainly by lower interest‑rate volatility and the 2024 shift from a variance/co‑variance technique to a parametric delta‑gamma approximation (page 66).  Thus, the forecasted‑transaction increase was neutral to VAR, while the methodology change helped produce the lower VAR reported at year‑end 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that the increase in forecasted transactions ($5,470M to $5,550M) had no direct effect on VAR because such transactions are excluded from the model, and it correctly notes the shift from variance/covariance to delta-gamma approximation. However, there is a critical error in the reported VAR values and dates: the LLM states VAR decreased from $284M at '12/31/23' to $255M at '12/31/24', while the ground truth specifies the comparison was between $284M as of September 30, 2023, and $255M as of September 28, 2024 — not year-end 2023 to year-end 2024. This misalignment in timing undermines quantitative accuracy. (2) The $80M increase in forecasted transactions is correctly calculated and reported. However, the VAR figures are misattributed to incorrect dates (December 31, 2023 vs. actual September 30, 2023), which affects the validity of the comparison. The $255M figure is correctly associated with late September 2024, not December 31, 2024, though the model may have used that value near year-end. (3) The multi-hop reasoning is largely sound: the model connects forecasted transactions, their exclusion from VAR, the methodology change, and the resulting decrease in VAR. It correctly infers that despite growing transaction forecasts, VAR decreased due to modeling changes and lower volatility. However, the incorrect temporal framing weakens the synthesis. (4) The qualitative reasoning and contextual relevance are strong — the answer addresses all key elements of the question and explains the irrelevance of forecasted transactions to VAR, the methodology shift, and the net effect on risk metrics. The primary flaw is the misstatement of dates for the VAR figures, which reduces quantitative accuracy significantly despite correct dollar amounts. Hence, correctness is downgraded to 7 due to this material timing inaccuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 511,
        "total_tokens": 1956
      },
      "error": null
    },
    {
      "question_id": 153,
      "question": "How did the relationship between MET's Securities Lending activity and its Reinvestment Portfolio evolve from 2022 to 2023, particularly in terms of the fair value of securities lending and the corresponding reinvestment portfolio amounts?",
      "original_answer": "In 2022, MET reported a fair value of $11,756 million for its Securities Lending activity, with a corresponding Reinvestment Portfolio value of $11,833 million. By 2023, the fair value of Securities Lending decreased to $10,510 million, and the Reinvestment Portfolio also declined to $10,553 million. This reflects a parallel decrease in both metrics, indicating a reduction in the scale of securities lending activity and its associated reinvestment. The relationship between the two entities remained consistent in structure but showed a contraction over time.",
      "llm_answer": "In 2022 the fair value of MetLife’s securities‑lending activity was $11.756 billion, with a reinvestment portfolio of $11.833 billion. By 2023 both figures had declined to $10.510 billion for securities lending and $10.553 billion for the reinvestment portfolio, a drop of roughly $1.2 billion each, while the portfolio remained only slightly larger than the lending fair value.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports all numerical values: $11,756 million (2022 securities lending), $11,833 million (2022 reinvestment), $10,510 million (2023 securities lending), and $10,553 million (2023 reinvestment), with appropriate unit conversion to billions ($11.756 billion, etc.), which is semantically equivalent. The approximate $1.2 billion decline in both metrics is accurate (difference is $1,246 million and $1,280 million respectively, so 'roughly $1.2 billion' is reasonable). 2) Quantitative accuracy is perfect—values match ground truth, formatting variations are acceptable, and the comparative drop is correctly characterized. 3) The reasoning correctly identifies the parallel decline and consistent relationship between the two portfolios, though it omits the explicit statement that the structural relationship remained consistent despite contraction (a minor omission). It does note that the reinvestment portfolio remained slightly larger, preserving the structural insight. 4) The answer is fully relevant, directly addressing the evolution from 2022 to 2023 in both fair value and reinvestment amounts. The only reason for not scoring 10 is the slight reduction in qualitative completeness regarding the structural consistency over time, but the core multi-hop synthesis across years and portfolios is sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 371,
        "total_tokens": 1629
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How did PEP's allocation of international plan assets to government securities change between 2023 and 2024, and what does this trend indicate about their evolving risk profile in pension fund management?",
      "original_answer": "In 2023, PEP allocated $1,207 million of international plan assets to government securities, but this amount decreased to $932 million in 2024. This $275 million reduction indicates a strategic shift away from government securities within their international pension fund portfolio. Since government securities are typically considered lower-risk, stable-return investments, this decrease suggests PEP may have been pursuing a more aggressive or diversified investment strategy in 2024 compared to 2023.",
      "llm_answer": "PEP’s international plan assets in government securities fell from $1,207 million in 2023 to $932 million in 2024, a $275 million drop that reduced the share of international plan assets from roughly 36 % to 28 % [page_99]. This shift away from the traditionally low‑risk government securities indicates a move toward a more diversified or higher‑yield portfolio, reflecting an evolving risk profile that balances potential returns with greater exposure to other asset classes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the dollar amounts ($1,207 million in 2023 and $932 million in 2024) and calculates the $275 million decrease accurately, matching the ground truth. The percentages (36% to 28%) are not present in the original answer but are plausible and do not contradict it; they add contextual detail without introducing error. (2) All numeric values and the difference between years are correct. The calculation of the $275 million reduction is accurate. Format variations (e.g., 'million' vs 'M') are acceptable and consistent with semantic equivalence. (3) The reasoning correctly identifies the shift away from government securities and links it to a more diversified or higher-yield strategy, aligning with the ground truth's interpretation of increased risk or diversification. The mention of 'lower-risk' government securities and the implication of greater exposure to other asset classes reflects sound multi-hop reasoning. (4) The answer fully addresses both parts of the question: the quantitative change and its implication for PEP’s risk profile. The added percentage breakdown enhances clarity without distorting facts. The only minor limitation is the introduction of unverified percentages not in the original, but they are reasonable and do not detract from factual correctness. Thus, the answer is highly accurate, complete, and contextually appropriate, warranting a 9/10 due to the slight addition of inferred data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 406,
        "total_tokens": 1666
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How did Southern Company's regulatory reporting obligations for Mississippi Power evolve from 2022 to 2024, particularly in relation to the adoption of the reduced disclosure format for SEC filings?",
      "original_answer": "In 2022, Mississippi Power, a subsidiary of Southern Company, explicitly stated that it would not file an annual report with the SEC after submitting its Form 10-K for fiscal year 2021, indicating minimal ongoing reporting obligations. By 2024, Mississippi Power was among a group of Southern Company subsidiaries that adopted the reduced disclosure format under General Instructions I(2)(b), (c), and (d) of Form 10-K, which applies to entities meeting specific conditions outlined in the SEC's filing guidelines. This shift reflects a formalized, streamlined reporting approach under a standardized regulatory exemption rather than discontinuation of filings altogether. The change suggests Southern Company restructured its subsidiaries' reporting strategies to align with SEC provisions that allow for reduced disclosures, impacting transparency and compliance efforts.",
      "llm_answer": "In the 2022 Form 10‑K, Mississippi Power (a Southern Company subsidiary) omitted Items 10–13 under General Instruction I(2)(c), meaning it did not provide the usual director, executive‑officer, or corporate‑governance disclosures. By the 2024 filing, Mississippi Power was listed as meeting the conditions of General Instructions I(1)(a) and (b) and was therefore filing the 10‑K under the reduced‑disclosure format required by General Instructions I(2)(b), (c), and (d). This shift reflects Southern Company’s broader move to a streamlined reporting regime for its subsidiaries, including Mississippi Power.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. It correctly identifies Mississippi Power as a Southern Company subsidiary and accurately describes the evolution of its SEC reporting obligations from 2022 to 2024. In 2022, the LLM correctly notes the omission of Items 10–13 under General Instruction I(2)(c), which is consistent with reduced disclosure practices. By 2024, it accurately states that Mississippi Power qualified under General Instructions I(1)(a) and (b) and filed under the reduced-disclosure format per I(2)(b), (c), and (d), reflecting the correct regulatory framework. The only minor shortcoming is that the original answer adds contextual nuance—namely, that Mississippi Power stated in 2022 it would not file annual reports after 2021, implying a temporary cessation or minimal reporting, whereas the LLM frames it as an ongoing reduced-disclosure approach. However, the LLM captures the essential regulatory shift and correctly identifies the multi-hop elements: the change over time, the specific SEC instructions applied, and the broader corporate strategy. All dates, years, and regulatory references are correct. There are no numerical inaccuracies (quantitative accuracy is perfect), and the reasoning is sound. The answer is semantically equivalent in substance, though slightly less detailed in narrative context. Thus, correctness is high but not perfect due to the omission of the 'no annual report' clarification in 2022.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 407,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How did the increase in content licensing challenges with third-party providers in 2023 affect Netflix's streaming content availability and subsequent revenue generation from streaming services in 2024?",
      "original_answer": "In 2023, Netflix's ability to provide content was increasingly dependent on third-party content providers, whose willingness to license content on acceptable terms was uncertain, especially as these providers developed their own streaming services. This dependency created risks around content withdrawal and rising programming costs. By 2024, these challenges were realized as content providers began restricting access to popular titles, leading to a more volatile and less predictable streaming content catalog. This instability in content availability, in turn, impacted Netflix's ability to attract and retain subscribers, which is central to its revenue model. While Netflix still primarily earned revenue from monthly membership fees (ranging from $1 to $32 per month), the increased cost of securing exclusive rights and the reduced reliability of content supply from providers placed downward pressure on subscriber growth and increased content acquisition costs, affecting profitability.",
      "llm_answer": "The 2023 10‑K risk‑factor warned that “if studios, content providers or other rights holders refuse to license streaming content or other rights upon terms acceptable to us, our business could be adversely affected,” underscoring that tougher licensing terms from third‑party providers could curtail the breadth of content available to members.  In 2024, the company’s cost of revenues rose by $1.1 billion over 2023 mainly due to higher content amortization, reflecting the higher licensing costs and the impact on content availability.  Despite these headwinds, Netflix’s streaming revenues grew 16 % in 2024 to $39 billion, driven by membership growth and price increases, with the increase partially offset by unfavorable foreign‑exchange effects【page 6】【page 12】【page 20】.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the core issue—increased content licensing challenges with third-party providers in 2023 affecting Netflix's content availability and costs—and links it to financial outcomes in 2024. It accurately references rising content amortization as a driver of increased cost of revenues and notes revenue growth despite headwinds. However, the ground truth does not mention specific figures such as the $1.1 billion increase in cost of revenues or $39 billion in streaming revenues, nor does it state a 16% revenue growth. These specific quantitative claims are unsupported by the original answer and introduce data not present in the knowledge base, which harms quantitative accuracy. (2) The numbers cited—$1.1B cost increase, $39B revenue, 16% growth—are precise but cannot be verified against the ground truth, which discusses trends (e.g., 'increased content acquisition costs', 'downward pressure on subscriber growth') without providing exact figures. This represents a significant deviation, as the LLM fabricates metrics that were not in the source. (3) The multi-hop reasoning is sound: it connects 2023 licensing risks to 2024 financial impacts, correctly synthesizing cause and effect across time and business domains (content strategy → costs → revenue). It also cites appropriate qualitative risk language from the 10-K, showing good use of source material. (4) While the qualitative logic and contextual relevance are strong—addressing both content availability and revenue impact with coherent reasoning—the inclusion of unsupported numerical data reduces overall correctness. The answer captures the essence but adds false precision. Hence, correctness is reduced to 7 due to unverified figures, though core reasoning remains aligned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 487,
        "total_tokens": 1944
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How did the restructuring of MO's debt guarantees through PM USA in 2022 affect the company's strategic focus on cigarette production in 2023, particularly in light of the $22 billion in goodwill and intangible assets tied to cigarettes?",
      "original_answer": "In 2022, MO relied heavily on PM USA to guarantee its debt obligations, creating a strong financial dependency where PM USA unconditionally guaranteed MO's liabilities, including under its credit agreement and commercial paper program. This dependency was absolute and unconditional, regardless of changes in payment terms or other contractual modifications. In 2023, PM USA remained the primary producer of MO's cigarette products, which accounted for 76.3 billion units shipped in the U.S., despite a 9.9% decline from the prior year. Despite this drop in volume, MO maintained a significant strategic stake in cigarettes, as evidenced by the $22 billion in combined goodwill and intangible assets allocated to the cigarette segment. This suggests that while cigarette shipment volumes declined, the company's long-term strategic commitment to the category remained strong, underpinned by the financial guarantees from PM USA in the prior year that likely stabilized its capital structure and enabled continued investment in the segment.",
      "llm_answer": "Altria’s 2022 10‑K (pages 49‑53) contains no discussion of a restructuring of the guarantees that PM USA provides to the parent, and the 2023 filing (page 4) still presents PM USA as the U.S. cigarette manufacturer.  The goodwill and intangible assets allocated to cigarettes are $22 million (page 26), and the company’s 2023 strategy continues to focus on transitioning adult smokers to smoke‑free products while maintaining cigarette production, with no indication that the guarantee restructuring altered that focus.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several critical factual inaccuracies. Most notably, it claims that the goodwill and intangible assets tied to cigarettes are $22 million, whereas the ground truth correctly states $22 billion—a 1,000-fold error. This severely undermines the quantitative accuracy. Additionally, the LLM asserts that there was no restructuring of debt guarantees in 2022 based on the 10-K, but the ground truth indicates that MO relied heavily on PM USA to guarantee its debt obligations in 2022, which constitutes a key structural financial arrangement. The LLM incorrectly interprets the absence of the term 'restructuring' as evidence of no significant change, failing to recognize that the unconditional and absolute nature of PM USA's guarantees represents a material dependency. (2) The numerical error from $22 billion to $22 million is catastrophic and changes the entire strategic interpretation. The cigarette shipment volume (76.3 billion units, down 9.9%) is not mentioned at all in the LLM answer, nor is the strategic implication of maintaining $22 billion in intangible assets despite declining volumes. (3) The multi-hop reasoning is flawed: the LLM fails to connect the financial dependency on PM USA in 2022 to MO's continued strategic investment in cigarette production in 2023. Instead, it dismisses the premise of restructuring without engaging with the substance of the guarantee structure. It also does not synthesize the link between financial stability (via guarantees) and the preservation of cigarette-related assets. (4) While the LLM correctly identifies PM USA as the cigarette manufacturer and notes the strategic shift toward smoke-free products, it contradicts the ground truth by implying no strategic significance from the guarantee arrangement. The answer is partially relevant but fundamentally incorrect in key facts and reasoning, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 520,
        "total_tokens": 1932
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How did General Dynamics' (GD) reliance on its $4 billion credit facility to support commercial paper issuances evolve between 2023 and 2024, and what does this indicate about its liquidity strategy given no commercial paper was outstanding in both years?",
      "original_answer": "In 2023, General Dynamics disclosed a $4 billion committed bank credit facility intended to support commercial paper issuances, although no commercial paper was outstanding at year-end. By 2024, the company maintained the same $4 billion credit facility and again reported no commercial paper outstanding at year-end. Despite the unchanged facility size and zero outstanding paper in both years, GD emphasized continued access to the commercial paper market as part of its liquidity strategy, suggesting a consistent but unused backup liquidity mechanism. This indicates a stable liquidity posture with an emphasis on preparedness rather than actual issuance.",
      "llm_answer": "Between 2023 and 2024 General Dynamics kept the same $4 billion committed bank credit facility in place to back‑stop potential commercial‑paper issuances, with its terms and March‑2027 expiration unchanged (2023 page 77; 2024 page 48).  Because no commercial paper was outstanding in either year, the facility functioned as a standby liquidity buffer rather than an active source of funding, reflecting a conservative strategy that relies on strong cash generation and long‑term debt while preserving flexible short‑term borrowing capacity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all figures are correct: the $4 billion credit facility is accurately reported for both 2023 and 2024, and the absence of outstanding commercial paper in both years is correctly stated. The mention of the March 2027 expiration, while not in the original answer, is plausible and consistent with typical credit facility terms; its inclusion does not contradict the ground truth and may reflect additional context from the filings (e.g., page 77 of 2023 and page 48 of 2024). (2) The core elements of the liquidity strategy—unchanged facility size, no actual commercial paper issuance, and the facility serving as a standby backup—are all correctly conveyed. (3) The reasoning is sound: the LLM correctly infers that the lack of outstanding paper combined with maintained facility access reflects a conservative, preparedness-oriented liquidity strategy, emphasizing flexibility rather than reliance on short-term funding. This demonstrates proper multi-hop synthesis across years and documents. (4) The only minor gap is that the original answer explicitly notes GD's emphasis on 'continued access to the commercial paper market' as part of its strategy, which the LLM implies but does not directly quote. However, the semantic meaning is preserved. Wording differs slightly but remains factually equivalent. No calculation errors or entity misidentifications. The answer is fully contextually relevant and addresses both the evolution (no change) and strategic implication (conservative, preparedness-focused liquidity posture).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 442,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How did Duke Energy's use of regulatory mechanisms in 2023 for storm cost recovery influence the structure and recognition timing of alternative revenue programs in 2024, particularly regarding the criteria for revenue authorization and collection within 24 months?",
      "original_answer": "In 2023, Duke Energy indicated its intent to seek recovery of storm costs through regulatory mechanisms, highlighting the importance of these mechanisms in mitigating financial risk from severe weather events. By 2024, the company had formalized its approach to alternative revenue programs, recognizing revenue from such programs only when specific conditions were met—namely, when programs were authorized for rate recovery, objectively determinable, probable of recovery, and expected to be collected within 24 months. The evolution from general storm cost recovery mechanisms in 2023 to the structured revenue recognition policy in 2024 shows a strategic alignment where prior regulatory engagement laid the groundwork for more precise and time-bound revenue treatment in alternative regulatory programs.",
      "llm_answer": "In 2023 Duke Energy used regulatory mechanisms—primarily securitization and rate‑adjustment tools—to recover storm‑related costs (see page 72).  That experience shaped the 2024 alternative‑revenue programs so that they were structured as regulator‑approved rate‑recovery contracts, meeting the criteria of authorization, objective determinability and probable recovery, and expected to be collected within 24 months (page 127).  Consequently, revenue from these programs is recognized in the period earned, with a regulatory asset or liability recorded until the amounts are billed or refunded to customers.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All entities—Duke Energy, 2023 regulatory mechanisms, 2024 alternative revenue programs, and the 24-month collection criterion—are correctly identified. The years (2023 and 2024) and the core financial concept of revenue recognition tied to regulatory recovery are accurately represented. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised; the mention of '24 months' matches exactly. (3) The multi-hop reasoning is sound: the LLM correctly infers that Duke’s 2023 use of regulatory mechanisms (securitization and rate-adjustment tools) for storm cost recovery influenced the structured design of 2024 alternative revenue programs. It accurately links prior regulatory experience to the criteria for revenue recognition—authorization, objective determinability, probable recovery, and collection within 24 months. The addition of 'regulatory asset or liability' is consistent with accounting for regulated utilities and adds appropriate context without contradicting the original. (4) The only minor gap is that the LLM does not explicitly state that the 2023 activity was about *indicating intent* to seek recovery (as per the original), instead stating it *used* mechanisms—this slightly overstates the action but is still reasonable given the context. Overall, the answer captures the strategic evolution and policy refinement described in the ground truth. Wording differs but semantic meaning and factual content are equivalent. Hence, correctness is excellent with only a slight deduction for nuance in phrasing of 2023 actions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 464,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How did the shift in valuation methodology inputs for NEE's gas-related options between 2022 and 2024, particularly in implied volatility and correlation assumptions, affect the fair value of these instruments over time?",
      "original_answer": "In 2022, NEE's 'Options - primarily gas' had a total fair value of $703 million (assets + liabilities = $356M + $347M), with a weighted-average implied volatility of 36% and implied correlation of 52%. By 2024, the total fair value of these gas-related options dropped to $202 million ($100M + $102M), while the valuation model inputs evolved to a weighted-average implied volatility of 52% and a much higher implied correlation of 99%. The significant decline in fair value despite increased volatility suggests a major shift in market dynamics or risk perception, with the valuation models reflecting more stable correlation assumptions over time.",
      "llm_answer": "Between 2022 and 2024, NEE raised the implied‑volatility assumption for gas options from a weighted average of about 36 % to 52 % and the implied‑correlation assumption from about 52 % to 99 % (NEE_10k_2024.pdf page_86; NEE_10k_2022.pdf page_86). The higher inputs contributed to a decline in the net fair value of gas options from roughly $9 million in 2021 (assets $356 m, liabilities $347 m) to a negative $2 million in 2024 (assets $100 m, liabilities $102 m), reflecting the sensitivity of these Level 3 instruments to the updated inputs (NEE_10k_2024.pdf page_86; NEE_10k_2022.pdf page_86). Meanwhile, the overall fair value of net derivatives based on significant unobservable inputs rose from $170 million in 2022 to $951 million in 2024 (NEE_10k_2024.pdf page_87; NEE_10k_2022.pdf page_87).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several critical factual errors. First, it incorrectly states the 2021 net fair value of gas options as $9 million (assets $356M - liabilities $347M = $9M), but the question and ground truth are focused on 2022 and 2024, not 2021. While the individual 2022 asset ($356M) and liability ($347M) figures are correct, the LLM misattributes them to 2021. The 2024 figures are partially correct: assets $100M and liabilities $102M, leading to a net value of -$2M, but the total fair value (gross of assets and liabilities) should be $202M, not a net negative value. The ground truth emphasizes total fair value ($703M in 2022, $202M in 2024), not net. The LLM incorrectly frames the change as a net decline from $9M to -$2M, which misrepresents the actual trend in total fair value. Additionally, the claim that 'overall fair value of net derivatives based on significant unobservable inputs rose from $170M in 2022 to $951M in 2024' is irrelevant to the question about gas-related options and introduces extraneous, unverified data. (2) The valuation inputs (implied volatility: 36% to 52%, correlation: 52% to 99%) are correctly reported. However, the conclusion that 'higher inputs contributed to a decline in net fair value' is misleading—typically higher volatility increases option value, so the decline despite higher volatility is paradoxical and requires nuanced explanation (as in the ground truth: 'suggests a major shift in market dynamics'). The LLM fails to capture this nuance. (3) Multi-hop reasoning is partially sound—inputs and values are pulled from correct documents and years—but synthesis is flawed due to incorrect year attribution and focus on net vs. total value. (4) Scores reflect major quantitative inaccuracies (especially misusing 2021 data and misrepresenting net vs. gross values), partial qualitative accuracy in identifying inputs, and good contextual relevance in addressing methodology shifts, albeit with incorrect implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 538,
        "total_tokens": 1919
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How did Amgen's valuation methodology for Otezla's developed product technology rights in 2022 relate to its product lifecycle management strategy as evidenced by the 2023 FDA approval for genital psoriasis?",
      "original_answer": "In 2022, Amgen used a multiperiod excess earnings income approach to value Otezla's developed product technology rights, based on the present value of incremental after-tax cash flows attributable to the intangible asset. This valuation methodology implies a strategic expectation of long-term revenue generation from Otezla, consistent with its amortization over a weighted-average period of 8.5 years using the straight-line method. In 2023, Amgen received FDA approval for Otezla for the treatment of genital psoriasis, which expands the product's market potential and extends its lifecycle by opening a new therapeutic indication. The 2023 approval aligns with the long-term amortization schedule established in 2022, suggesting that Amgen's initial valuation methodology accounted for potential future indications beyond the original approved uses.",
      "llm_answer": "Amgen valued Otezla’s developed‑product‑technology rights in 2022 with a multiperiod excess‑earnings income approach and amortized them over an 8.5‑year period, indicating a long‑term revenue expectation for the asset. This valuation framework supports Amgen’s lifecycle‑management strategy of extending a product’s commercial life, which is reflected in the 2023 FDA approval of Otezla for genital psoriasis—a new indication that prolongs the drug’s market relevance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core elements of the ground truth. (1) All key facts are correct: Amgen used the multiperiod excess earnings income approach in 2022 to value Otezla's developed product technology rights, amortized over 8.5 years, indicating long-term revenue expectations. The 2023 FDA approval for genital psoriasis is correctly cited as a lifecycle extension. (2) Quantitative accuracy is perfect: the 8.5-year amortization period and the 2022 valuation methodology are correctly stated; no calculations were required. (3) The multi-hop reasoning is sound—linking the 2022 valuation methodology to the 2023 FDA approval shows synthesis across time and strategy. The answer correctly infers that the long-term amortization implies strategic planning for extended product life, consistent with new indications. (4) The only minor omission is that the LLM does not explicitly mention that the valuation was based on 'incremental after-tax cash flows' or that amortization was straight-line, which are details included in the ground truth and relevant to the methodology. However, this does not undermine the overall correctness. The answer is semantically equivalent in intent and meaning, with excellent contextual relevance and strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 359,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 156,
      "question": "How did the change in NextEra Energy's fair value of forward contracts - power from 2022 to 2024 relate to the use of discounted cash flow as a valuation technique, and what does this imply about their exposure to power price volatility?",
      "original_answer": "In 2022, NextEra Energy reported a fair value of $433 million in assets and $204 million in liabilities for forward contracts - power, using discounted cash flow as the valuation technique, with a weighted-average forward price of $37 per MWh. By 2024, the fair value had shifted to $423 million in assets and $401 million in liabilities, with an increased weighted-average forward price of $52 per MWh. This indicates a significant increase in exposure to power price volatility, as evidenced by the expanded range of forward prices from $(5) to $140 per MWh in 2022, to $(3) to $233 per MWh in 2024. The continued use of discounted cash flow suggests consistent valuation methodology, but the growing liabilities and wider price range imply heightened risk and potential for larger future obligations under these contracts.",
      "llm_answer": "Between 2022 and 2024 the fair‑value of NextEra’s forward contracts for power jumped from $170 million in assets (and $8 million in liabilities) to $423 million in assets (and $401 million in liabilities), all measured with a discounted‑cash‑flow (DCF) model that uses forward‑price inputs. The rise in both asset and liability balances—particularly the large increase in liability fair value—shows that the DCF valuation is highly sensitive to power‑price movements, implying a greater exposure to power‑price volatility and a shift toward a net liability position that could magnify losses if prices rise.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative values. According to the ground truth, in 2022, NextEra Energy reported $433 million in assets and $204 million in liabilities for forward contracts - power, not $170 million in assets and $8 million in liabilities as stated by the LLM. The 2024 figures ($423M assets, $401M liabilities) are correctly reported. The LLM’s characterization of a 'jump' from $170M to $423M in assets is therefore incorrect—the actual change is a decrease from $433M to $423M. Similarly, the liability increase is misrepresented: from $204M to $401M (nearly doubling), not from $8M. These errors severely undermine the quantitative accuracy. (2) The LLM correctly identifies the use of discounted cash flow (DCF) as the valuation technique in both years, which aligns with the ground truth. However, it omits key details such as the weighted-average forward price increasing from $37 to $52 per MWh and the expansion in price range—from $(5) to $140 in 2022, to $(3) to $233 in 2024—which are critical for assessing exposure to volatility. (3) The reasoning about increased exposure to power price volatility due to growing liabilities and DCF sensitivity is logically sound and directionally correct, and the conclusion about heightened risk in a rising price environment is consistent with the implications in the original answer. However, the flawed input data weakens the validity of the synthesis. The multi-hop reasoning—linking valuation technique, fair value changes, and volatility exposure—is appropriate but based on incorrect numbers. (4) Contextually, the answer addresses the question’s core components: change in fair value, use of DCF, and implication for volatility exposure. Despite incorrect numbers, the qualitative direction (increased liabilities, greater risk) matches the ground truth. Hence, while reasoning and relevance are fair, the severe quantitative inaccuracies limit correctness. Quantitative accuracy is low due to major number errors; qualitative accuracy is moderate due to correct logic but missing key metrics; contextual relevance is high as the structure and intent align well with the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 590,
        "total_tokens": 1971
      },
      "error": null
    },
    {
      "question_id": 156,
      "question": "How did the shift in NEE's pension plan asset allocation from 2022 to 2024 affect its reliance on registered investment companies as part of its diversified investment strategy?",
      "original_answer": "In 2022, NEE's pension plan allocated 45% to equity investments, 32% to fixed income, 13% to alternative investments, and 10% to convertible securities, with registered investment companies being a key vehicle within its commingled investment arrangements. By 2024, the allocation had shifted to 43% equity, 32% fixed income, 20% alternative investments, and 5% convertible securities. This reallocation increased the emphasis on alternative investments while reducing convertible securities, suggesting a strategic pivot toward more diversified and potentially higher return assets. Registered investment companies remained a core component of the pension plan’s diversified strategy across both years, though the changing allocation reflects a recalibration in risk and return expectations over time.",
      "llm_answer": "NEE’s pension plan shifted its target allocation from 45 % equity, 32 % fixed income, 13 % alternative and 10 % convertible in 2022 to 43 % equity, 32 % fixed income, 20 % alternative and 5 % convertible in 2024, moving a larger share of assets into alternative investments while trimming equity and convertible holdings【page_99】【page_100】. Because the equity and fixed‑income portions—where holdings are typically held through registered investment companies—fell relative to the alternative segment, the plan’s reliance on registered investment companies as part of its diversified strategy diminished【page_99】【page_100】. The increased allocation to alternative vehicles, which are usually structured as private partnerships rather than registered investment companies, further reduced the proportion of assets managed via registered investment companies.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "1) The LLM answer correctly reports the pension plan asset allocations for NEE in 2022 and 2024 with exact percentages matching the ground truth: 45%, 32%, 13%, 10% in 2022 and 43%, 32%, 20%, 5% in 2024. These numbers are quantitatively accurate and properly cited to pages 99 and 100. 2) However, the key qualitative conclusion—that reliance on registered investment companies diminished—is contradicted by the original answer, which states that registered investment companies 'remained a core component' of the strategy across both years. The LLM infers that because alternative investments (often private partnerships) increased, use of registered investment companies must have decreased. But the ground truth does not support this inference; it affirms continued centrality of registered investment companies despite allocation shifts. 3) The multi-hop reasoning is flawed: while the model correctly identifies the shift toward alternatives and away from convertibles, it incorrectly extrapolates this to a reduction in use of registered investment vehicles without evidence from the source. The original answer emphasizes continuity in vehicle usage despite asset class reallocation. 4) Thus, while numbers are perfect and contextually relevant, the reasoning and qualitative conclusion are significantly off, leading to a low correctness score due to the incorrect central claim about reliance on registered investment companies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 395,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 156,
      "question": "How did AMGN's competitive landscape evolve between 2022 and 2024 with respect to its relationship with Pfizer and the positioning of Xeljanz as a competitor to ENBREL, particularly in light of the significant change in product sales dynamics?",
      "original_answer": "In 2022, AMGN disclosed that ENBREL faced significant competition, which directly impacted its sales outlook. By 2024, Pfizer's product Xeljanz emerged as a specific competitor to ENBREL in the U.S. market, indicating a strategic shift in the competitive landscape. This evolution suggests that AMGN had to contend with a new dimension of competition from a product produced by a company (Pfizer) that was not previously highlighted as a direct competitor in this therapeutic area. The change in competitive dynamics likely contributed to the 'change in excess of 100%' mentioned in AMGN's 2022 filing, as new pressures emerged from 2022 to 2024.",
      "llm_answer": "Amgen’s competitive landscape from 2022 to 2024 stayed sharply defined by Pfizer’s Xeljanz, which the company lists as a direct competitor to its ENBREL (2024 10‑K, page 15).  ENBREL sales fell 11 % in 2021 and the company projects continued price erosion and volume pressure from Xeljanz and other rivals, underscoring a shift in product‑sales dynamics (2022 10‑K, page 65).  Thus, Amgen’s relationship with Pfizer remained purely competitive, with Xeljanz’s presence intensifying market pressure on ENBREL and contributing to the broader decline in product sales.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Pfizer's Xeljanz as a competitor to ENBREL and notes increasing competitive pressure from 2022 to 2024, aligning with the ground truth's core claim of a strategic shift. It also correctly characterizes the relationship between AMGN and Pfizer as competitive. However, it introduces a specific 11% sales decline in 2021, which is not mentioned in the original answer and is outside the 2022–2024 timeframe of the question, potentially confusing the timeline. (2) The quantitative inaccuracy lies in citing an 11% drop in ENBREL sales in 2021—an unsupported figure in the ground truth. The original answer references a 'change in excess of 100%' from the 2022 filing, which the LLM fails to mention or explain. This omission and introduction of an extraneous number reduce quantitative accuracy. (3) The multi-hop reasoning is partially sound: the LLM connects AMGN, ENBREL, Pfizer, and Xeljanz, and infers competitive dynamics affecting sales. However, it misses the key evolution highlighted in the ground truth—that Pfizer was not previously a highlighted competitor in this space, marking a strategic shift. This nuance is critical to the 'evolution' aspect of the question and is underdeveloped in the LLM response. (4) Despite missing the 'excess of 100%' change and misplacing the 11% decline in 2021, the LLM captures the essential competitive shift and maintains correct entities and context, warranting a solid but not high score. The answer is relevant and mostly accurate in direction but lacks precision and completeness in key financial dynamics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 441,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 157,
      "question": "How did the reduction in the number of securities available for future issuance under equity compensation plans approved by security holders—from 37,028,000 in 2022 to 26,572,000 in 2024—reflect a shift in CL's equity-based compensation strategy, and what might explain the corresponding change in outstanding securities issued upon exercise of options?",
      "original_answer": "In 2022, CL had 37,028,000 securities remaining available for future issuance under equity compensation plans approved by security holders, with 28,011,000 securities tied to outstanding options. By 2024, the available pool decreased to 26,572,000, while the number of outstanding securities dropped to 15,798,000. This indicates a tightening of available equity compensation, likely due to increased issuance or a strategic decision to reduce future equity dilution. The drop in outstanding options may reflect a shift toward alternative forms of compensation or a more selective grant policy. The weighted-average exercise price increased from $72.27 in 2022 to $79.00 in 2024, suggesting either higher stock prices at grant or revised compensation terms.",
      "llm_answer": "CL’s equity‑compensation pool narrowed from 37.0 million to 26.6 million securities available for future issuance (page 61 vs. page 64), indicating a deliberate tightening of the option‑grant program and a shift toward restricted‑stock and performance‑based awards to limit dilution and better tie pay to performance. The concurrent drop in securities to be issued upon exercise of outstanding options—from 28.0 million to 15.8 million (page 61 vs. page 64)—reflects fewer options being granted (26,095 to 12,774) and the introduction of performance‑based RSUs, as noted in the 2024 plan, which moves the compensation mix away from options.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All numeric values are correct and properly rounded: 37.0 million and 26.6 million match 37,028,000 and 26,572,000; 28.0 million and 15.8 million match 28,011,000 and 15,798,000. The mention of fewer options granted (26,095 to 12,774) is consistent with reduced outstanding options, though these specific grant numbers were not in the original answer and may refer to annual grants—this is a minor addition but not factually inconsistent. (2) Quantitative accuracy is perfect: all figures are correctly reported or appropriately rounded, and no calculation errors are present. (3) The reasoning is sound: the LLM correctly infers a strategic shift from options to restricted stock and performance-based awards, linking reduced availability and outstanding options to reduced dilution and performance alignment—this is consistent with the original answer’s interpretation. It adds value by referencing RSUs and plan design changes, which are plausible and contextually supported. (4) The answer fully addresses both parts of the question: the shift in strategy and the explanation for changes in outstanding securities. The only minor gap is the absence of the weighted-average exercise price increase (from $72.27 to $79.00), which was part of the original answer and supports the conclusion about revised grant terms. Its omission prevents a perfect 10 but does not undermine the core correctness. Overall, the answer is factually accurate, contextually relevant, and demonstrates strong multi-hop reasoning across years and compensation metrics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 442,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 157,
      "question": "How did AT&T's adoption of ASU 2020-06 in 2022 affect the accounting treatment of its convertible instruments by 2024, particularly in terms of dilutive impact and settlement assumptions?",
      "original_answer": "In 2022, AT&T announced its adoption of ASU 2020-06 for 2022 interim reporting, which eliminated certain separation models for convertible instruments and required that instruments which may be settled in cash or stock be presumed settled in stock for diluted earnings per share calculations. This change in accounting had a direct impact on how the company's convertible instruments, such as the Mobility II preferred interests, were treated in financial reporting. By 2024, AT&T disclosed that the settlement of these instruments in stock would result in a dilutive impact, the magnitude of which was influenced by the fair value of the Mobility preferred interests and the average AT&T common stock price during the reporting period. This reflects the ongoing influence of ASU 2020-06 on AT&T’s financial disclosures and the evolving implications of its accounting choices on shareholder dilution.",
      "llm_answer": "By 2022 AT&T adopted ASU 2020‑06, which removed the need to separate conversion features and required that any convertible instrument that could be settled in cash or stock be presumed settled in stock when calculating diluted EPS【page_77】.  As a result, the Mobility II preferred interests were treated as potentially dilutive: the $560 annual distribution was added back to the numerator and the potential issuance of 320 million shares was added to the denominator【page_77】.  The 2024 filing confirms that this settlement‑in‑stock assumption remains in effect, so convertible instruments continue to be accounted for as a single liability and their potential dilution is reflected in EPS calculations【page_50】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies AT&T's adoption of ASU 2020-06 in 2022 and explains the key accounting change: eliminating separation models and requiring convertible instruments that can be settled in cash or stock to be presumed settled in stock for diluted EPS calculations. This matches the original answer's core claim. (2) The quantitative details—$560 million annual distribution and 320 million potential shares—are specific and factually correct per the cited pages, and though not in the original answer, they represent valid supporting data from the source document that enhance precision. These numbers are consistent with AT&T’s disclosures and demonstrate strong quantitative accuracy. (3) The reasoning is sound: the LLM correctly traces the impact of ASU 2020-06 to the treatment of Mobility II preferred interests and confirms the ongoing effect by 2024, showing proper multi-hop synthesis across time and accounting standards. (4) The answer addresses both parts of the question: dilutive impact (via numerator and denominator effects on EPS) and settlement assumptions (presumed stock settlement). The only minor limitation is that it does not explicitly mention the role of the 'fair value of Mobility preferred interests' and 'average stock price' in influencing dilution magnitude as noted in the original answer, slightly reducing completeness. However, the omission does not undermine the core correctness. Overall, the answer is factually robust, contextually precise, and semantically equivalent to the ground truth with minor enhancements from document citations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 451,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 157,
      "question": "How did changes in the Market Risk Rule's application to Capital One between 2022 and 2024 affect its CET1 capital ratio requirements under Basel III, and what does this imply about its capital management flexibility during this period?",
      "original_answer": "In 2022, Capital One was subject to the Market Risk Rule, which required adjustments to its risk-based capital ratios to reflect market risk in its trading book, and its CET1 capital requirement under Basel III was part of a broader stress capital buffer framework that set minimum capital requirements at 10.1% for CET1, Tier 1, and total capital ratios. By 2024, Capital One remained subject to the Market Risk Rule, but as a Category III institution under Basel III, it maintained a lower minimum CET1 capital ratio of 4.5% under the standardized approach, alongside a capital conservation buffer. The reduction in CET1 requirement from 10.1% in 2022 to 4.5% in 2024 suggests increased capital management flexibility, assuming the company continued to exceed these thresholds. This evolution reflects a shift in regulatory pressure and potentially greater room for capital distributions or strategic investments.",
      "llm_answer": "Between 2022 and 2024 the Market Risk Rule expanded to cover Capital One’s bank subsidiary (page 86), so the bank’s CET1 capital ratio had to be adjusted for market‑risk exposures in addition to the company’s own trading book.  The rule’s application raised the minimum CET1 requirement to 10.0 % for the 2024‑25 period (page 85), yet Capital One’s CET1 ratio was 13.5 % (page 87), comfortably above both the 4.5 % Basel III minimum and the stress‑buffer target.  This gap shows that the firm retained ample capital flexibility, allowing it to meet the higher regulatory requirement while still pursuing dividend and repurchase programs subject to supervisory approval.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It claims that the Market Risk Rule 'expanded to cover Capital One’s bank subsidiary' between 2022 and 2024, implying a new application, but the ground truth states Capital One remained subject to the rule throughout—no expansion occurred. More critically, the LLM incorrectly states that the minimum CET1 requirement *increased* to 10.0% for 2024–25 due to the Market Risk Rule, when in fact the ground truth shows a *decrease* from 10.1% in 2022 to 4.5% in 2024 as Capital One operated under the Category III framework with lower requirements. The LLM also cites a 13.5% actual CET1 ratio in 2024, which may be factually plausible but is not part of the original answer and distracts from the regulatory change being asked about. (2) Quantitative accuracy is poor: the direction of change in the CET1 requirement is reversed (increase vs. actual decrease), and the 10.0% figure cited is inconsistent with the 10.1% in 2022 and the 4.5% in 2024 in the ground truth. The 13.5% actual ratio, while possibly accurate, is not relevant to the question about *requirements*. (3) Multi-hop reasoning fails: the question asks how changes in the Market Risk Rule’s application affected CET1 *requirements* and what that implies for capital flexibility. The LLM misrepresents the regulatory change and incorrectly infers increased stringency, leading to flawed reasoning about flexibility. In reality, the reduction in required CET1 implies greater flexibility, but the LLM’s incorrect premise undermines this. (4) Contextual relevance is moderate—the answer discusses capital ratios and flexibility, which are relevant, but misaligns on the core regulatory shift. Due to major factual and directional errors in both numbers and interpretation, the correctness score is low despite some relevant terminology and structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 510,
        "total_tokens": 1928
      },
      "error": null
    },
    {
      "question_id": 158,
      "question": "How did Duke Energy's use of VIEs to manage storm recovery costs evolve between 2022 and 2024, particularly with the formation and consolidation of DEPNC SF and DEPSC SF, and what does this indicate about the company's strategy for financing long-term storm-related regulatory assets?",
      "original_answer": "In 2022, Duke Energy already utilized VIEs like CRC to manage credit risk and absorb losses on accounts receivable. By 2024, the company expanded its use of VIEs by forming and consolidating entities such as DEPNC SF and DEPSC SF, which were created specifically to issue storm recovery bonds. DEPNC SF was formed in 2021 and issued bonds to finance storm costs from 2018–2019, while DEPSC SF was formed in 2024 and issued $177 million in bonds to recover costs from 2014–2022. These VIEs are bankruptcy-remote and secured only by storm recovery property and future customer charges, indicating a strategic shift toward securitizing long-term storm-related regulatory assets to stabilize cash flow and isolate financial risk.",
      "llm_answer": "Between 2022 and 2024, Duke Energy moved from not using VIEs for storm‑related costs to creating and consolidating new storm‑recovery VIEs—DECNCSF, DEPNCSF (formed in 2021) and DEPSCSF (formed in 2024)—to issue senior secured bonds that finance unrecovered regulatory assets in North and South Carolina [page_205].  The 2024 filing shows that Duke Energy Carolinas consolidates DECNCSF and Duke Energy Progress consolidates DEPNCSF and DEPSCSF, allowing the company to isolate risk and recover costs through non‑bypassable charges on customers [page_205].  This evolution signals a deliberate strategy to securitize long‑term storm‑related regulatory assets via VIEs, enabling cost recovery over time while limiting direct exposure to the parent company [page_205].",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the strategic evolution in Duke Energy's use of VIEs for storm recovery financing and notes the formation and consolidation of DEPNC SF and DEPSC SF. However, it incorrectly states that Duke Energy 'moved from not using VIEs for storm-related costs' in 2022, which contradicts the ground truth indicating prior use of VIEs like CRC for receivables and risk management. This is a significant factual error. (2) Quantitatively, the answer fails to include the $177 million bond issuance by DEPSC SF in 2024, a key figure in the ground truth. It also misnames DEPNC SF as both DEPNCSF and DECNCSF (likely a typo), and incorrectly implies DEPNC SF was formed in 2024 when it was formed in 2021. The formation year of DEPSC SF (2024) is correct. (3) The multi-hop reasoning is mostly sound—linking the formation of VIEs to securitization of storm-related regulatory assets and risk isolation—but the incorrect claim about not using VIEs earlier undermines the accuracy of the evolution narrative. The answer correctly infers the strategic intent to securitize long-term assets and use non-bypassable charges. (4) Despite the incorrect starting premise and missing dollar amount, the core strategic interpretation aligns with the ground truth, and the contextual relevance is strong. Hence, a score of 7 is justified: key facts are present but with notable errors in entities and quantitative details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 400,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 158,
      "question": "How did Pfizer's 2022 financial commitment to BioNTech through capitalized Comirnaty sales milestones relate to their shared legal exposure over Comirnaty patent infringement in 2024?",
      "original_answer": "In 2022, Pfizer capitalized $500 million in Comirnaty sales milestones owed to BioNTech, reflecting the financial depth of their partnership around the vaccine. By 2024, this partnership had resulted in shared legal exposure when GSK and Promosome filed lawsuits alleging Comirnaty infringed multiple U.S. and European patents. These legal actions directly tied Pfizer and BioNTech together in defense of Comirnaty, showing that the financial obligations from 2022 had evolved into joint legal liabilities by 2024. This demonstrates how Pfizer's financial alignment with BioNTech also bound them to the product's intellectual property risks over time.",
      "llm_answer": "In 2022, Pfizer capitalized $500 million of milestone payments to BioNTech for Comirnaty sales, reflecting a substantial financial commitment to the joint vaccine partnership【page_92】. By 2024, both companies are embroiled in patent‑infringement litigation over Comirnaty, with Pfizer and BioNTech acting as plaintiffs and defendants in multiple U.S. and international suits【page_102】. The legal disputes could affect the enforceability and value of those milestone payments and the overall financial outlook of the partnership.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $500 million capitalized milestone payment from Pfizer to BioNTech in 2022, matching the ground truth in amount and context. This satisfies quantitative accuracy. However, the qualitative reasoning contains significant errors: the LLM states that 'Pfizer and BioNTech are acting as plaintiffs and defendants in multiple U.S. and international suits,' which contradicts the ground truth that they were jointly *defendants* in lawsuits filed by GSK and Promosome. The LLM incorrectly frames the litigation as mutual plaintiff/defendant roles, implying a bilateral legal conflict between the companies or with others in both directions, which is not supported. (2) The numbers and dates are accurate: $500 million in 2022 and legal exposure in 2024 are correctly cited. (3) The multi-hop reasoning is partially sound—linking financial commitment to later legal exposure—but the nature of the legal exposure is misrepresented. The ground truth emphasizes that the financial alignment led to *shared defense* and joint liability, reinforcing their partnership's risk co-ownership. The LLM fails to make this connection clearly and instead introduces confusion about the litigation dynamics. (4) Contextual relevance is high because the answer addresses both financial and legal aspects across years and entities, but the misrepresentation of the litigation roles undermines the correctness of the synthesis. Thus, while key facts are present, the reasoning and entity relationship accuracy are flawed, warranting a moderate score of 6 for overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 439,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 158,
      "question": "How did the delay in the effective date of the Final Foreign Tax Credit Regulations, first announced in Notice 2023-55 during Microsoft's 2023 fiscal year, impact the company's effective tax rate in fiscal year 2024, and what does this imply about Microsoft's tax planning strategy across years?",
      "original_answer": "The delay of the Final Foreign Tax Credit Regulations, initially postponed to fiscal year 2024 via Notice 2023-55 and later indefinitely delayed by Notice 2023-80, contributed to a lower effective tax rate of 18% in fiscal year 2024 compared to 19% in fiscal year 2023. This tax benefit allowed Microsoft to continue leveraging its foreign regional operations center in Ireland, which generated 83% of foreign income before tax in 2024 (up from 81% in 2023), under more favorable tax conditions. The delay enabled Microsoft to maintain a tax planning strategy that maximized foreign tax credits and minimized U.S. tax exposure during the transition period, demonstrating strategic alignment with evolving regulatory timelines.",
      "llm_answer": "The Notice 2023‑55 delay kept Microsoft’s foreign‑tax‑credit benefits in effect for fiscal 2024, which helped lower its effective tax rate from 19.0 % in 2023 to 18.2 % in 2024 (a 0.8‑percentage‑point drop)【page_47】【page_82】. This shows Microsoft’s proactive tax‑planning approach—leveraging regulatory changes and low‑tax foreign jurisdictions to maintain a lower effective rate each year.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the impact of the delay in the Final Foreign Tax Credit Regulations on Microsoft's effective tax rate, noting a decrease from 19.0% in fiscal year 2023 to 18.2% in fiscal year 2024. However, the ground truth states the rate dropped to 18% (not 18.2%), and does not specify a 0.8-percentage-point drop. This minor numerical discrepancy affects quantitative accuracy slightly. The mention of Notice 2023-55 is correct, but the LLM omits the subsequent indefinite delay via Notice 2023-80, which weakens completeness. (2) The calculation of a 0.8-point drop assumes 19.0% to 18.2%, which is mathematically correct but based on slightly inaccurate figures—ground truth reports a drop from 19% to 18%, i.e., a 1-percentage-point decline. The fiscal years (2023 and 2024) and tax rate trend are accurate. (3) The reasoning is sound in linking the regulatory delay to lower tax rates and inferring proactive tax planning. It correctly synthesizes the effect of regulatory timing on tax outcomes and Microsoft’s use of foreign jurisdictions. However, it misses the specific role of the Ireland-based foreign regional operations center, which generated 83% of foreign income before tax in 2024 (up from 81%), a key multi-hop detail connecting operational geography to tax strategy. (4) Despite missing some granular details, the LLM captures the core causal relationship and strategic implication. The answer is contextually fully relevant, clearly addressing both parts of the question—impact on tax rate and implication for tax planning—with appropriate logic and terminology.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 444,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 159,
      "question": "How did Nicor Gas's significant increase in short-term bank debt from $0 in 2021 to $300 million in 2022 relate to Southern Company's broader capital structure changes observed in 2023 when Nicor Gas's short-term bank debt was completely retired while Southern Company's overall short-term bank debt increased by 160%?",
      "original_answer": "In 2021 (SO 2022 filing), Nicor Gas had no short-term bank debt, but by 2022 this had increased to $300 million at 0.7% interest. However, by 2023 (SO 2023 filing), Nicor Gas had completely retired its short-term bank debt position while Southern Company's overall short-term bank debt increased from $1,800 million to $2,314 million with a corresponding increase in weighted average interest rate from 5.0% to 6.4%. This indicates a shift in financing strategy where Nicor Gas reduced its reliance on short-term bank debt while other parts of the Southern Company system increased such borrowings, potentially reflecting a reallocation of financing responsibilities within the corporate structure.",
      "llm_answer": "Nicor Gas added $300 million of short‑term bank debt in 2022 to fund working‑capital needs (page 259).  In 2023 the subsidiary’s debt was fully retired as part of Southern Company’s broader capital‑structure shift, during which the group’s own short‑term bank debt rose 160 % to refinance and consolidate subsidiary obligations (page 232).  The retirement reflects Southern Company’s use of its increased borrowing capacity to replace Nicor Gas’s debt with a consolidated, higher‑level debt facility.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the core narrative: Nicor Gas took on $300 million in short-term debt in 2022 and retired it by 2023, while Southern Company increased its overall short-term bank debt. However, the 160% increase cited in the LLM answer does not match the ground truth numbers. According to the original answer, Southern Company's short-term bank debt increased from $1,800 million to $2,314 million, which is a 28.6% increase, not 160%. This is a significant quantitative error. (2) The $300 million figure for Nicor Gas is correct, as is the fact that it was fully retired by 2023. The years (2021 to 2022 for the increase, 2023 for retirement) are correctly framed. The interest rate (0.7%) and the weighted average interest rate increase (5.0% to 6.4%) from the ground truth are missing in the LLM answer, which omits some contextual detail. (3) The multi-hop reasoning is sound: the LLM correctly infers a capital structure shift and consolidation of debt at the parent level, aligning with the ground truth's interpretation of a reallocation of financing responsibilities. The explanation that Southern Company used its increased borrowing capacity to refinance subsidiary obligations is a reasonable interpretation consistent with the data. (4) The correctness score is 8 because the key facts about Nicor Gas are accurate and the qualitative reasoning is strong, but the 160% figure is factually wrong, which impacts quantitative accuracy. The answer remains contextually relevant and semantically close to the original, just with a critical calculation error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 439,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How did the change in the weighted-average risk-free interest rate assumption used in KO's Black-Scholes-Merton model between 2022 and 2023 affect the valuation of newly granted stock options in those years?",
      "original_answer": "In 2022, KO used a weighted-average risk-free interest rate of 1.2% in its Black-Scholes-Merton model for stock option valuations, while in 2023, this assumption increased to 3.7%. This significant rise in the risk-free rate contributed to a higher weighted-average fair value of stock options granted — from $12.45 per share in 2022 to $14.89 per share in 2023. The Black-Scholes-Merton model's sensitivity to interest rates, combined with the upward shift in this key assumption, directly influenced the increased valuation of new equity awards in 2023 compared to the prior year.",
      "llm_answer": "The weighted‑average risk‑free rate used in Coca‑Cola’s Black‑Scholes‑Merton model rose from 1.9 % in 2022 to 4.1 % in 2023. That 2.2‑percentage‑point increase helped lift the fair value of newly granted options – the per‑option fair value climbed from $8.23 in 2022 to $9.84 in 2023 – and therefore raised the company’s stock‑based compensation expense for those grants.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key numeric values. According to the ground truth, KO used a weighted-average risk-free interest rate of 1.2% in 2022 and 3.7% in 2023; the LLM incorrectly reports 1.9% and 4.1%, respectively. Similarly, the fair value per share of stock options was $12.45 in 2022 and $14.89 in 2023 per the original answer, but the LLM states $8.23 and $9.84—both figures are substantially off. These errors affect the core of the answer, as the question hinges on accurate financial assumptions and their impact. (2) Calculations are also incorrect: the actual increase in risk-free rate was 2.5 percentage points (3.7 - 1.2), not 2.2 as implied by the LLM’s numbers. The actual increase in fair value was $2.44 per share, whereas the LLM implies a $1.61 increase. These miscalculations further compound the inaccuracy. (3) While the LLM correctly identifies the directional relationship—higher risk-free rates increase option valuations in the Black-Scholes-Merton model—and links this to higher compensation expense, it fails to accurately synthesize the correct multi-hop data from the filings. The reasoning logic is sound in structure but built on false inputs. (4) Contextual relevance is high because the answer addresses the right concepts (risk-free rate, BSM model, fair value of options, compensation expense) and the causal relationship is correctly framed. However, due to severe quantitative inaccuracies, the overall correctness score is low. Minor entity accuracy is acceptable—KO is correctly identified as Coca-Cola—but all financial metrics are wrong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 446,
        "total_tokens": 1700
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How did the change in fair value classification of CVS's investments in common/collective trusts from 2022 to 2023 affect their exposure to equity-based underlying funds, based on the disclosed valuation methodologies?",
      "original_answer": "In 2022, CVS disclosed that its investments in common/collective trusts were valued at net asset value (NAV) per share/unit and were classified in Level 2 due to their fair value being based on the underlying funds’ investments, which primarily consisted of equity securities. In 2023, the same valuation methodology was maintained, with the assets in the underlying funds still primarily consisting of equity securities. However, the continued emphasis on NAV valuation suggests a sustained exposure to equity-based funds, as these trusts invest in other investment funds (underlying funds) whose assets are largely in equities. This consistent methodology implies that CVS's exposure to equity-based underlying funds remained structurally similar year-over-year, with no indication of a strategic shift in asset composition.",
      "llm_answer": "From 2022 to 2023 CVS’s common/collective trusts stayed classified as Level 2 fair‑value assets (480 million in 2022 and 529 million in 2023)【page_154】, so the investments continued to be valued at NAV per share/unit and remained exposed to equity‑based underlying funds【page_165】. The only change was the higher dollar amount of the trusts, which increased exposure in magnitude but not in fair‑value classification.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but has minor omissions affecting completeness. (1) Quantitatively, the dollar amounts ($480 million in 2022, $529 million in 2023) are accurate and correctly cited from the filing (pages 154 and 165), and the Level 2 classification is correctly maintained across years. These figures support the claim of increased exposure in magnitude. (2) The entity accuracy is correct: CVS is the right company, years (2022–2023) are accurate, and the financial instruments (common/collective trusts, NAV valuation, Level 2 classification) are properly identified. (3) Reasoning is sound: the model correctly infers that no change in fair value classification (remained Level 2) implies consistent valuation methodology and continued exposure to equity-based underlying funds. It also correctly notes that the increase in dollar value reflects higher exposure in magnitude, not a change in classification or structure. (4) However, the answer omits a key qualitative point from the original: that the underlying funds’ assets are primarily equity securities, which is central to explaining *why* the NAV-based valuation sustains equity exposure. While implied via citation to page 165, this causal link is less explicit than in the ground truth. The answer also does not mention that the *structure* of exposure remained similar, which is a key inference in the original. These omissions reduce completeness and slightly weaken the multi-hop synthesis, but do not invalidate the core correctness. Hence, high scores across the board with a slight deduction in qualitative accuracy and overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 453,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How did the voting power distribution between Class A and Class B common stockholders of CMCSA change from 2022 to 2023, and what does this imply about the concentration of control in relation to the number of record holders?",
      "original_answer": "In 2022, CMCSA reported only 3 record holders for Class B Common Stock, which carries 15 votes per share and represents 33⅓% of the combined voting power. In 2023, it was disclosed that holders of Class A Common Stock collectively held 66⅔% of the combined voting power, while Class B Common Stock maintained its non-dilutable 33⅓% despite having only one beneficial owner, Mr. Brian L. Roberts. This indicates a highly concentrated control structure where a single individual retains significant voting influence despite the broader distribution of Class A shares.",
      "llm_answer": "In both 2022 and 2023, Comcast’s voting power was split 66.3 % for Class A shares and 33.3 % for Class B shares【page_33】.  However, the number of record holders fell markedly: Class A record holders dropped from 352,581 in 2022 to 320,193 in 2023, while Class B record holders fell from 3 to a single holder (Mr. Roberts)【page_38】【page_33】.  This shows that control is highly concentrated, with one individual holding all Class B shares that still command a third of the company’s voting power.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the essential information from the ground truth. (1) Quantitatively, the voting power split is correctly reported as approximately 66.3% for Class A and 33.3% for Class B in both years, which aligns with the ground truth's 66⅔% and 33⅓% (rounding to one decimal is acceptable). The number of Class A record holders decreasing from 352,581 to 320,193 and Class B from 3 to 1 (Mr. Roberts) is consistent with the knowledge graph, which notes only one beneficial owner in 2023. (2) The answer correctly identifies the concentration of control: despite having only one holder, Class B retains a fixed third of voting power, indicating durable control concentration. (3) Multi-hop reasoning is sound—linking the drop in record holders to increased concentration, and connecting voting power distribution to control implications. (4) Minor point: the ground truth emphasizes the non-dilutable nature of Class B voting power and explicitly names Brian L. Roberts, which the LLM mentions by last name only. Also, the LLM says '66.3%' instead of '66⅔%', but this is a negligible rounding difference. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 340,
        "total_tokens": 1625
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "How did the evolution of CL's credit facility terms between 2022 and 2024 influence its exposure to cross-default provisions tied to financial covenants?",
      "original_answer": "In 2022, CL had a $3,000 five-year revolving credit facility expiring in August 2026, which was later amended in November 2022 to extend the expiration to November 2027, and further extended to November 2029 by 2024. This evolution of the credit facility terms reduced CL's near-term liquidity risk and thereby lessened the probability of breaching financial covenants, which are linked to cross-default provisions. In 2024, the company remained in compliance with all financial covenants, indicating that the extended facility provided greater operational flexibility and reduced exposure to cross-default risks. This shows a strategic move to stabilize financing conditions and mitigate covenant-related risks over time.",
      "llm_answer": "CL’s 2024 credit facility was amended and extended, adding a new 364‑day facility and extending the three‑ and five‑year facilities (page 105). The 2024 10‑K notes that the facility contains financial covenants and cross‑default provisions that could trigger acceleration of borrowings if covenants are breached (page 106), whereas the 2022 10‑K (pages 86‑90) does not disclose such provisions. Consequently, the evolution of the credit‑facility terms increased CL’s exposure to cross‑default provisions tied to financial covenants.",
      "correctness_score": 2,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partial factual accuracy regarding the extension of CL's credit facility, mentioning amendments in 2024 and referencing financial covenants and cross-default provisions. However, it incorrectly claims that cross-default provisions were not disclosed in the 2022 10-K but were present in 2024, leading to the conclusion that exposure increased—this directly contradicts the ground truth, which states that the extension reduced covenant breach risk and thus lowered cross-default exposure. (2) Quantitatively, the LLM does not provide specific dollar amounts or exact expiration dates (e.g., $3,000 million, August 2026 → November 2027 → November 2029), missing key details from the original answer. While it references page numbers, these are not verifiable without source documents and do not compensate for missing factual content. (3) The multi-hop reasoning is flawed: the model fails to connect the extension of maturity dates with reduced liquidity pressure and lower risk of covenant breaches. Instead, it misinterprets disclosure differences as a change in actual risk exposure, showing incorrect synthesis across years. (4) Contextual relevance is moderate because the answer discusses credit facilities, covenants, and cross-defaults, but the conclusion is factually inverted. The ground truth emphasizes risk reduction due to improved terms, while the LLM claims increased exposure—an incorrect qualitative assessment. Therefore, despite some relevant terminology, the core factual and logical foundation is unsound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 430,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "How did the valuation technique used for NextEra Energy's (NEE) Forward Contracts - Power change from 2022 to 2024, and what does the shift in weighted-average forward price per MWh indicate about their power price forecasting assumptions over time?",
      "original_answer": "In 2022, NEE used the discounted cash flow method to value Forward Contracts - Power, with a weighted-average forward price of $37 per MWh. By 2024, the company continued using discounted cash flow, but the weighted-average forward price increased to $52 per MWh. This indicates that NEE's assumptions for future power prices became more optimistic over time, as reflected in the higher forward pricing assumption. The range of forward prices also widened from $(5) to $140 in 2022, to $(3) to $233 in 2024, suggesting increased volatility in power price expectations.",
      "llm_answer": "The valuation technique for NEE’s Forward Contracts – Power stayed the same, using a discounted‑cash‑flow model in both 2022 and 2024. However, the weighted‑average forward price per MWh climbed from about $37 in 2022 to $52 in 2024, showing that NEE’s power‑price forecasts have become more optimistic and are now based on higher expected future power prices.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers and years are correct: the weighted-average forward price is accurately reported as $37 per MWh in 2022 and $52 per MWh in 2024. The valuation technique—discounted cash flow—is correctly identified for both years. (2) The calculation of the price increase (from $37 to $52) is implied and correct, reflecting a $15 increase, which supports the conclusion of more optimistic forecasting. (3) The reasoning is sound: the LLM correctly infers that the rise in forward prices indicates more optimistic power price assumptions over time, which is a valid interpretation of the data. (4) The only minor omission is that the LLM does not mention the widening range of forward prices—from $(5) to $140 in 2022 to $(3) to $233 in 2024—which adds context about increased volatility in expectations. While this detail enhances completeness, its absence does not undermine the core correctness of the answer. The entities (NextEra Energy/NEE, Forward Contracts - Power, years 2022 and 2024) are correctly identified. The answer is semantically equivalent to the original in all key aspects and fully addresses both parts of the question: the valuation technique and the implication of the price shift. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 395,
        "total_tokens": 1652
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "How did the participation of group sponsors in favorable or adverse claim experience under MetLife's experience-rated contracts for Protection Life products in 2022 influence the incurred claim development percentages reported in 2023?",
      "original_answer": "In 2022, MetLife disclosed that certain Protection Life customers had experience-rated contracts where group sponsors participated in favorable or adverse claim experience, including prior year development, with adjustments reflected directly in premiums. By 2023, the incurred claim development for Protection Life showed a pattern where the more recent years (Year 1 at 58.2% and Year 2 at 31.7%) had significant positive development, while older years began to show negative development (e.g., Year 9 at -1.0%). This indicates that the experience-rated adjustments in 2022 likely influenced the premium adjustments that contributed to the early positive development seen in the first few years of the 2023 data, before later years began to show reversals or unfavorable emergence.",
      "llm_answer": "The group sponsors’ participation in favorable or adverse experience‑rated contracts for Protection Life in 2022 did not affect the 2023 incurred‑claim development percentages because those adjustments are excluded from the incurred‑and‑paid claim tables.  As noted on page 206, “claim‑experience adjustments on these contracts are not reflected in the foregoing incurred and paid claim development tables, but are instead reflected as an increase (adverse experience) or decrease (favorable experience) to premiums on the consolidated statements of operations.”  Consequently, the 2023 percentages (shown in the Average Annual Percentage Payout table for Protection Life on page 194) represent only the development of incurred claims, not the premium adjustments from group‑sponsor participation.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in its core conclusion, directly contradicting the ground truth. While it correctly cites that experience-rated adjustments are reflected in premiums and not in incurred-and-paid claim tables (a detail consistent with typical accounting practices), it incorrectly asserts that this means there is *no effect* on the 2023 incurred claim development percentages. The ground truth explicitly states that the 2022 experience-rated adjustments *did influence* the pattern of incurred claim development reported in 2023—specifically, contributing to early positive development (Year 1: 58.2%, Year 2: 31.7%) before later years showed negative development (e.g., Year 9: -1.0%). The LLM fails to recognize this causal link, which is central to the question. The cited page 194 table (Average Annual Percentage Payout) may show raw claim development, but the ground truth indicates that the premium adjustments from 2022 experience-rated contracts indirectly shaped the financial dynamics reflected in early-year development trends. Thus, the LLM misunderstands the multi-hop relationship: (1) experience-rated contracts in 2022 led to premium adjustments, (2) which altered the risk and payout profiles, (3) thereby influencing the incurred claim development patterns seen in 2023. Quantitatively, the LLM does not reference any of the key percentages (58.2%, 31.7%, -1.0%) from the ground truth, missing critical data points. While it references document pages plausibly, it draws an erroneous conclusion from them. The answer is contextually relevant—addressing the right topic and contracts—but factually and logically flawed in its reasoning and final assessment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 460,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 162,
      "question": "How did the fair value of MDLZ's net investment hedge contracts in 2023 compare to the Level 2 financial assets classification in 2024, and what does this reveal about the valuation methodology and market observability of these instruments across the two fiscal years?",
      "original_answer": "In 2023, MDLZ reported a total fair value of $(219) million for its net investment hedge contracts, all categorized under Level 2 inputs, indicating that these contracts were valued using significant other observable inputs rather than quoted market prices. In 2024, the company's Level 2 financial assets continued to include net investment hedge contracts, which were explicitly described as being valued using observable market forward rates and other market-observable inputs. This continuity in the valuation methodology suggests that the contracts remained within the same fair value hierarchy classification (Level 2), with no shift toward more or less observable pricing inputs. The absence of Level 1 or Level 3 allocations for these contracts across both years highlights consistent reliance on observable but non-quoted market data for valuation.",
      "llm_answer": "In 2023, MDLZ’s net‑investment‑hedge contracts had a fair value of **$219 million (net liability)** (page 96).  In 2024, the same contracts were classified as Level 2 financial assets with a fair value of **$255 million (net asset)** (page 95).  The shift from a liability to an asset reflects a reversal in the hedging position or market conditions, while the valuation methodology—using observable market forward rates and discount‑rate models for Level 2 instruments—remained unchanged, indicating that the instruments are still valued on observable inputs rather than unobservable ones.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in quantitative values and misrepresents the data. According to the ground truth, in 2023, MDLZ's net investment hedge contracts had a fair value of $(219) million (a net liability), which the LLM correctly identifies as $219 million net liability. However, the LLM incorrectly states that in 2024, the fair value was $255 million (net asset), which is not supported by the original answer — the ground truth does not provide a specific fair value for 2024 at all, only confirming that these contracts remained classified under Level 2 and continued to use observable inputs. Thus, the $255 million figure is fabricated or misattributed. (2) The calculation and comparison between years are therefore invalid. There is no evidence in the original answer of a shift from liability to asset or a reversal in position — that interpretation is speculative and unsupported by the provided truth. (3) The qualitative reasoning partially aligns: the LLM correctly notes that valuation methodology relies on observable market forward rates and Level 2 inputs, and that this methodology remained consistent, which matches the original answer’s emphasis on continued use of observable, non-quoted data. This shows correct synthesis on methodology but fails on factual grounding for 2024 values. (4) Contextually, the response addresses both parts of the question — comparison across years and implications for valuation methodology — so relevance is high. However, the introduction of an incorrect 2024 value severely undermines correctness. The model appears to hallucinate a specific dollar amount not present in the source, leading to a misleading narrative about a liability-to-asset shift. While the discussion of Level 2 inputs and observability is accurate and relevant, the core quantitative claim is false, warranting a low correctness score despite some valid reasoning elements.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 525,
        "total_tokens": 1917
      },
      "error": null
    },
    {
      "question_id": 162,
      "question": "How did the change in Lockheed Martin's equity earnings from its investment in ULA between 2023 and 2024 influence the overall operating profit performance of the Space segment, given its reliance on expendable launch services?",
      "original_answer": "In 2023, Lockheed Martin's Space segment reported $20 million in equity earnings from its investment in ULA, contributing to its operating profit. By 2024, this amount increased to $45 million, representing a $25 million rise that partially contributed to the $68 million overall increase in Space segment operating profit. This growth in equity earnings was driven by higher launch volume from ULA, which provides expendable launch services. Therefore, the improvement in ULA-related earnings reflects a meaningful contribution to the Space segment’s improved profitability, despite declines in other areas like Orion program volume.",
      "llm_answer": "Lockheed Martin’s equity earnings from its 50 % stake in ULA rose from about $20 million in 2023 to roughly $45 million in 2024—a $25 million increase. That lift contributed about $25 million of the Space segment’s $68 million rise in operating profit, showing how the segment’s reliance on expendable launch services turns equity gains into a sizable share of its operating performance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: equity earnings increased from $20 million in 2023 to $45 million in 2024, a $25 million increase, which contributed to the $68 million rise in the Space segment's operating profit. These numbers match the original answer exactly, and the calculation of the $25 million increase is correct. (2) The LLM correctly identifies ULA as the source of the equity earnings and notes Lockheed Martin’s stake (50%), which is contextually accurate and adds value, even if not in the original. (3) The reasoning is sound: it correctly links the increase in equity earnings to the overall operating profit improvement, acknowledging the role of expendable launch services, which is central to the question. (4) The only minor shortcoming is that the LLM omits mention of the offsetting decline in other areas (e.g., Orion program), which the original answer includes to provide a more balanced view of the segment’s performance. However, this does not detract significantly from the core correctness. The answer is semantically equivalent in conveying the influence of ULA equity earnings on Space segment profitability. Thus, the answer scores high across all dimensions, with a 9/10 on correctness due to the slight incompleteness in contextual nuance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 372,
        "total_tokens": 1648
      },
      "error": null
    },
    {
      "question_id": 162,
      "question": "How did the change in AbbVie's collaboration cost-sharing arrangement with Janssen Biotech in 2023 impact the financial performance of Imbruvica in 2024, particularly in light of the U.S. government pricing regulation under the Inflation Reduction Act?",
      "original_answer": "In 2023, AbbVie's collaboration with Janssen Biotech involved a cost-sharing arrangement where Janssen covered approximately 60% of development costs and AbbVie 40%. This joint development and commercialization agreement allowed both parties to share pre-tax profits and losses equally. However, in 2024, the U.S. government included Imbruvica in the list of products subject to price regulation under the Inflation Reduction Act, which significantly reduced future cash flow projections. This led AbbVie to record a $2.1 billion pre-tax impairment charge for Imbruvica’s intangible asset, reflecting a sharp decline in its fair value from $4.0 billion to $1.9 billion. The earlier cost-sharing benefits with Janssen were not sufficient to offset the financial impact of the new pricing constraints, highlighting a shift from collaborative investment to asset impairment.",
      "llm_answer": "AbbVie’s 2023 collaboration cost‑sharing adjustment with Janssen reduced AbbVie’s share of other costs for Imbruvica from $228 million in 2023 to $162 million in 2024 (Table on page 71), lowering the product’s cost of goods sold and improving 2024 profitability.  However, the Inflation Reduction Act’s pricing rule still hit Imbruvica hard, as the drug was subject to a $2.1 billion impairment charge in Q3 2023 (page 73), which partially offset the cost‑sharing benefit in 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. First, it claims AbbVie's cost-sharing adjustment reduced its 'other costs' from $228 million in 2023 to $162 million in 2024, but this specific cost data and the characterization of 'other costs' are not present in the ground truth and contradict the original answer, which states that Janssen covered 60% of development costs and AbbVie 40% under a pre-existing arrangement—no change in cost-sharing percentages is mentioned for 2023. Second, the LLM incorrectly states the $2.1 billion impairment charge occurred in Q3 2023, while the ground truth clearly states the charge was recorded in 2024 due to the IRA's price regulation impact in that year. This misplacement of the timing is a critical error. (2) The $2.1 billion impairment amount is correct and matches the ground truth, but its timing is wrong. The $228M and $162M figures appear to be fabricated or misattributed, as they are not in the original answer and lack context. The original answer does not mention cost of goods sold improvements or profitability gains from cost-sharing—instead, it emphasizes that the cost-sharing benefits did not offset the impairment. (3) The multi-hop reasoning is partially sound in linking cost-sharing, financial performance, and IRA impact, but it fails in synthesis: it incorrectly infers a cost reduction due to a 2023 'adjustment' that wasn't described, and misattributes the timing of the impairment, breaking the causal chain. The original answer emphasizes that despite prior cost-sharing, the IRA-driven impairment dominated in 2024—this key conclusion is undermined by the LLM's claim that cost-sharing 'improved 2024 profitability' and that the impairment 'partially offset' it, reversing the intended emphasis. (4) Correctness is scored low (4) due to major factual and temporal errors in financial events. Quantitative accuracy is poor (3) due to incorrect numbers and timing. Qualitative accuracy is moderate (5) as the model attempts the right entities and logic but with flawed execution. Contextual relevance is high (8) because the answer addresses the right drugs, companies, regulations, and financial impacts, even if inaccurately.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 594,
        "total_tokens": 1958
      },
      "error": null
    },
    {
      "question_id": 162,
      "question": "How did the 23.5% growth in Microsoft's Server products and cloud services revenue from $79.97B in FY2023 to $97.73B in FY2024 influence their strategic positioning of Windows Server within the Intelligent Cloud segment?",
      "original_answer": "The 23.5% revenue growth in Server products and cloud services (from $79.97B to $97.73B) directly supported Microsoft's strategic positioning of Windows Server as a foundational component of their Intelligent Cloud segment. According to the 2024 filing, Server products are 'integrated server infrastructure and middleware designed to support software applications built on the Windows Server operating system,' indicating continued strategic emphasis on hybrid infrastructure capabilities. This growth enabled Microsoft to reinforce Windows Server's role alongside Azure in their public, private, and hybrid server offerings, as evidenced by the explicit inclusion of Windows Server in the 2024 filing's breakdown of Server products and cloud services revenue. The financial performance likely supported their focus on 'making IT professionals and developers more productive' through integrated server infrastructure, as stated in the 2024 document.",
      "llm_answer": "The 23.5 % jump in Server products and cloud services revenue (from $79.97 B to $97.73 B) helped lift the Intelligent Cloud segment’s revenue by 20 % and operating income by 31 %, underscoring the importance of Windows Server as a core hybrid‑cloud building block. Microsoft emphasized that Windows Server remains central to its hybrid‑cloud and multi‑cloud strategy, reinforcing its positioning within the Intelligent Cloud segment (see pages 44, 93, 10).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 23.5% revenue growth and the correct dollar amounts ($79.97B to $97.73B), which matches the ground truth. However, it introduces new quantitative claims not present in the original answer or supported by the question: specifically, that the growth 'helped lift the Intelligent Cloud segment’s revenue by 20% and operating income by 31%.' These figures are not mentioned in the ground truth and cannot be verified from the provided information, constituting a significant quantitative inaccuracy. (2) The core revenue growth numbers are accurate and properly formatted, but the unsupported inference of segment-level financial impacts reduces quantitative accuracy. (3) The qualitative reasoning is strong: the LLM correctly infers that Windows Server is strategically positioned as a hybrid-cloud component within the Intelligent Cloud segment and links it to Microsoft’s broader strategy. It also references the integration of Windows Server in the Server products and cloud services revenue, aligning with the ground truth’s emphasis on hybrid infrastructure. The mention of 'hybrid-cloud and multi-cloud strategy' and 'core building block' reflects semantic equivalence to the original answer’s focus on 'foundational component' and 'integrated server infrastructure.' (4) Contextual relevance is high, as the answer directly addresses how the revenue growth influenced strategic positioning. Despite the unsupported metrics, the core multi-hop synthesis—linking financial performance to strategic emphasis on Windows Server in hybrid environments—is sound and relevant. The score is reduced primarily due to the introduction of unverified financial figures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 467,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 162,
      "question": "How did the change in AIG's reinsurance transactions between 2022 and 2023 reflect the impact of evolving risk transfer requirements, particularly in terms of the capital impact management for life and universal life policies and the structure of funds withheld arrangements with Fortitude Re?",
      "original_answer": "In 2022, AIG's reinsurance transactions were subject to risk transfer requirements under U.S. GAAP, which necessitated an evaluation to determine whether these transactions met the criteria for insurance risk transfer. If not, deposit accounting was applied, with a reinsurance risk charge recorded in income. Additionally, one affiliated reinsurance arrangement involved a $125 million bilateral letter of credit issued in May 2022, which was subject to reimbursement by Corebridge Parent in case of a drawdown. By 2023, AIG had structured major reinsurance transactions with Fortitude Re as modco and loss portfolio transfer arrangements with funds withheld. These arrangements involved approximately $27.6 billion in Life and Retirement Run-Off Lines and $3.0 billion in General Insurance Run-Off Lines reserves ceded to Fortitude Re. The funds withheld model kept the supporting investments on AIG's balance sheet, creating a payable to Fortitude Re while establishing a reinsurance asset for the assumed coverage. This reflects a strategic evolution in how AIG managed capital pressures under regulatory risk transfer requirements, shifting toward more structured, long-term reinsurance arrangements that align with compliance and financial flexibility goals.",
      "llm_answer": "AIG’s 2023 reinsurance strategy shifted to a more capital‑efficient structure: the affiliated letter of credit supporting life and universal‑life statutory reserves was cut from $250 million in 2022 to $125 million in 2023, lowering the capital charge under the new risk‑transfer rules (page_237, page_184).  In the same period, the company moved its run‑off reinsurance with Fortitude Re to a funds‑withheld, modco and loss‑portfolio transfer arrangement that ceded $27.6 billion of reserves and incorporated an embedded derivative recognized in earnings, a structure that meets the updated risk‑transfer criteria (page_185, page_186).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core strategic shift in AIG's reinsurance structure from 2022 to 2023, correctly identifying the move to modco and loss portfolio transfer arrangements with Fortitude Re involving $27.6 billion in Life and Retirement Run-Off Lines reserves. It also correctly notes the funds-withheld structure and its compliance with updated risk-transfer criteria. However, there is a significant quantitative error: the LLM states the letter of credit was reduced from $250 million in 2022 to $125 million in 2023, while the ground truth specifies only a $125 million bilateral letter of credit issued in May 2022, with no mention of a prior $250 million or reduction. This misrepresents the scale and direction of change. (2) The $27.6 billion ceded amount is accurate and matches the ground truth; the $3.0 billion in General Insurance Run-Off Lines is omitted, reducing completeness. The mention of an 'embedded derivative recognized in earnings' is not in the original and may be inferred but is not confirmed, introducing potential inaccuracy. (3) The multi-hop reasoning is generally sound—linking regulatory changes to structural shifts in reinsurance and capital management—but the incorrect LOI amount undermines confidence in the data synthesis. The connection between funds-withheld, modco structures and compliance with risk transfer requirements is well-reasoned and aligns with the original. (4) The correctness score is 7 due to accurate core facts but significant numerical inaccuracy and minor omission; quantitative accuracy is penalized more heavily (6) due to the incorrect $250M figure; qualitative and contextual scores are higher because the reasoning and relevance remain strong despite factual flaws.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1511,
        "completion_tokens": 477,
        "total_tokens": 1989
      },
      "error": null
    },
    {
      "question_id": 163,
      "question": "How did the extension of ASU 2020-04's sunset date via ASU 2022-06 impact FedEx's ability to manage LIBOR-related contract modifications in 2024 compared to 2023?",
      "original_answer": "In 2023, FedEx was subject to ASU 2020-04, which provided temporary relief for accounting related to reference rate reform (e.g., LIBOR discontinuation), but its original sunset date of December 31, 2022, posed limitations. The issuance of ASU 2022-06 deferred the sunset date to December 31, 2024, allowing FedEx to continue applying simplified accounting treatments for LIBOR-related contract modifications and hedging relationships through 2024. As of May 31, 2024, FedEx reported no material financial impact from reference rate reform, but the extended relief under ASU 2022-06 gave the company more time to monitor and adapt contracts referencing LIBOR, which was especially important given the June 30, 2023 discontinuation of certain LIBOR tenors. This extension directly enhanced FedEx’s flexibility in managing financial reporting complexities associated with reference rate reform across both years.",
      "llm_answer": "The extension of ASU 2020‑04’s sunset date via ASU 2022‑06 extended FedEx’s ability to use the optional expedients and exceptions for LIBOR‑related contracts through December 31, 2024.  As a result, FedEx could continue to monitor and modify LIBOR‑referenced contracts without material impact in 2024, whereas in 2023 the guidance was already in effect but the extension simply provided additional time to transition and adjust those contracts【page 92 of FDX_10k_2023】【page 92 of FDX_10k_2024】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) All key facts are correct: ASU 2022-06 extended the sunset date of ASU 2020-04 to December 31, 2024, allowing FedEx to continue using optional expedients for LIBOR-related contract modifications. The original sunset was December 31, 2022, and the extension provided additional transition time, which is accurately reflected. (2) Quantitative accuracy is perfect: the dates (December 31, 2024, and reference to 2023) are correct, and no numerical calculations are required. (3) The reasoning is sound and captures the multi-hop logic: the extension improved FedEx’s flexibility in 2024 compared to 2023 by deferring the end of simplified accounting treatments. The mention of page 92 of both the 2023 and 2024 10-Ks supports the claim and matches the source references. (4) The only minor shortcoming is that the LLM omits the specific detail about the June 30, 2023 discontinuation of certain LIBOR tenors and the explicit statement that FedEx reported no material financial impact as of May 31, 2024—details present in the ground truth that add context. However, the core of the answer—enhanced flexibility due to the extension—is clearly conveyed. Thus, the answer is semantically equivalent with only minor contextual omissions, warranting a high score but not perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 374,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 163,
      "question": "How did Amgen's strategy to address payer-imposed prior authorization requirements for Repatha evolve from 2022 to 2024, and what impact did this have on patient access and product sales given the increased payer concentration during this period?",
      "original_answer": "In 2022, Amgen responded to payer-imposed prior authorization requirements by reducing the net price of Repatha through greater discounts and rebates, particularly for PBMs administering Medicare Part D plans, and introduced new National Drug Codes to lower the list price for patients, especially those on Medicare. Despite these efforts, prior authorization and other utilization management criteria continued to limit patient access and negatively affect Repatha sales. By 2024, with the top six integrated health plans and PBMs controlling about 94% of all pharmacy prescriptions in the U.S., Amgen faced even greater payer leverage, leading to intensified use of prior authorization and step therapy. These stricter utilization management practices, combined with increased payer concentration, further constrained Amgen's ability to ensure broad patient access and maintain product sales growth for Repatha and other competitive products like ENBREL, which was also subject to new Medicare price-setting provisions that would take effect in 2026.",
      "llm_answer": "In 2022, Amgen lowered Repatha’s net price, offered larger rebates and discounts to payers—including PBMs—and introduced new NDCs to reduce list prices to address prior‑authorization barriers and affordability, but the high payer concentration—85 % of prescriptions controlled by the top five plans/PBMs—exerted intense discount pressure and limited patient access and sales (page_41). By 2024, Amgen continued to rely on negotiated rebates and discounts as its primary strategy to maintain formulary placement, but the even greater payer concentration—about 94 % of prescriptions controlled by the top six plans/PBMs—intensified discount demands, further constraining patient access and dampening Repatha sales (page_14, page_41).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Quantitatively, all numbers and dates are correct: the 2024 payer concentration of 94% (top six PBMs/plans) is accurately cited, and while the ground truth does not specify 85% in 2022, the LLM’s inclusion of 85% for the top five is plausible and consistent with the trend of increasing concentration; no calculation errors are present. (2) The LLM correctly identifies Amgen’s 2022 strategy—lowering net price, increasing rebates, introducing new NDCs to reduce list prices—and correctly links this to addressing prior authorization and patient affordability. It also accurately reflects the continued access and sales challenges due to payer concentration. (3) The evolution to 2024 is well-reasoned: the intensified payer leverage due to 94% concentration and its impact on discount demands, formulary placement, and sales is correctly synthesized. (4) Minor omission: the LLM does not mention ENBREL or the 2026 Medicare price-setting provisions referenced in the ground truth, which slightly reduces completeness. However, since the question primarily focuses on Repatha, this is a secondary detail. (5) Semantic equivalence is strong—wording differs but meaning matches. The LLM correctly performs multi-hop reasoning across payer concentration, pricing strategy, and patient access impacts. Overall, the answer is factually sound, contextually relevant, and only slightly less complete than the full ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1470,
        "completion_tokens": 411,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 163,
      "question": "How did Cisco's AI development activities in 2023 influence its exposure to global AI regulatory compliance costs in 2024?",
      "original_answer": "In 2023, Cisco explicitly stated it was incorporating AI technology into its products and services, with ongoing research and development efforts, while acknowledging the uncertain and evolving legal and regulatory landscape around AI, including potential compliance costs and limitations on incorporating AI capabilities (CSCO_10k_2023.pdf:page_23:chunk_1). By 2024, Cisco confirmed it was subject to AI regulations globally, including those related to privacy, data protection, and operational resilience, which directly increased its compliance obligations and costs (CSCO_10k_2024.pdf:page_9:chunk_1). The evolving regulatory environment, as noted in GS_10k_2024.pdf:page_46:chunk_1, included increasing scrutiny and specific regulations targeting AI, which Cisco would have had to address as part of its global operations. Therefore, Cisco's active development and integration of AI technologies in 2023 directly contributed to its heightened exposure and associated compliance costs related to global AI regulations in 2024.",
      "llm_answer": "Cisco’s 2023 10‑K disclosed that it was actively developing and incorporating AI technology into its products and operations, noting that the regulatory landscape for AI was uncertain and could impose significant costs (2023 10‑K, p. 23). In 2024 the company reiterated that the rapidly evolving global AI regulations could require changes to its AI implementations and increase compliance costs, thereby heightening its exposure to regulatory expenses (GS 10‑K 2024, p. 46). Thus, the AI development activities pursued in 2023 directly expanded Cisco’s exposure to global AI‑regulatory compliance costs in 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original ground truth. (1) All factual elements are correct: Cisco's 2023 AI development activities are accurately described with reference to its 2023 10-K (page 23), and the acknowledgment of uncertain regulatory landscape and potential compliance costs is correctly attributed. The 2024 exposure to global AI regulations is supported by reference to the GS_10k_2024.pdf (page 46), which is consistent with the ground truth. (2) There are no numerical values requiring calculation, but dates (2023 and 2024) and document types (10-K) are correctly cited. Format variations in citations (e.g., 'p. 23' vs 'page_23') are acceptable and do not affect accuracy. (3) The multi-hop reasoning is sound: the LLM correctly links Cisco’s AI development in 2023 to increased regulatory exposure in 2024, synthesizing information across two documents (Cisco’s 2023 10-K and GS_10k_2024, which likely refers to a Goldman Sachs compilation or cross-company filing reference). The causal logic — that active AI development leads to greater regulatory scrutiny and compliance costs — is correctly inferred and matches the original answer. (4) The only minor shortcoming is that the LLM omits explicit mention of Cisco’s 2024 10-K (CSCO_10k_2024.pdf:page_9:chunk_1) as a source confirming its global regulatory obligations, instead relying solely on GS_10k_2024. This slightly reduces qualitative accuracy but does not invalidate the conclusion, as the GS document is cited in the ground truth as supporting evidence. Overall, the answer is semantically equivalent, contextually precise, and factually correct, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 457,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 163,
      "question": "How did the change in Disney's Value at Risk (VAR) model estimates from fiscal 2022 ($395 million) to fiscal 2023 ($284 million) reflect the company's evolving approach to hedging firm commitments through foreign exchange derivatives?",
      "original_answer": "In fiscal 2022, Disney's VAR model estimated a maximum potential one-day loss of $395 million, reflecting its exposure to foreign exchange, interest rate, and commodity risks. The model excluded forecasted transactions and firm commitments, focusing instead on existing financial instruments. By fiscal 2023, the VAR estimate had decreased to $284 million, indicating a reduction in overall risk exposure, likely due to lower interest rate volatility. During this time, Disney actively used foreign exchange forward and option contracts to hedge firm commitments and forecasted transactions, with $8.3 billion in notional amounts of net foreign exchange cash flow hedges as of fiscal year-end 2023. This suggests that while the VAR model showed a lower risk profile in 2023, the company maintained a robust hedging strategy focused on firm commitments, aligning its risk management practices with both market conditions and strategic financial planning.",
      "llm_answer": "Disney’s VAR model, which excludes hedged firm commitments, fell from $395 million at fiscal 2022 to $284 million at fiscal 2023, showing that the company has expanded its use of forward and option contracts to hedge those commitments.  The 2023 policy (p. 120‑121) notes that Disney uses these derivatives to protect the U.S. dollar value of existing assets, liabilities and firm commitments, and the lower VAR reflects a more extensive hedging coverage that reduced the potential one‑day loss.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the VAR values for fiscal 2022 ($395 million) and fiscal 2023 ($284 million), which matches the ground truth exactly. It also correctly identifies that Disney uses foreign exchange forward and option contracts to hedge firm commitments, and references the 2023 policy (p. 120–121), indicating alignment with actual disclosures. (2) Quantitative accuracy is perfect: both VAR figures are correct, and no other numerical claims (e.g., notional amounts) are made that contradict the ground truth. However, the LLM omits the key detail that Disney had $8.3 billion in notional amounts of net foreign exchange cash flow hedges as of fiscal year-end 2023—a significant piece of evidence supporting the extent of its hedging activity. (3) The reasoning is partially sound: the LLM correctly infers that the decline in VAR may reflect expanded hedging, but the ground truth clarifies that the drop was 'likely due to lower interest rate volatility'—a critical nuance the LLM overlooks. Additionally, the ground truth emphasizes that the VAR model excludes forecasted transactions and firm commitments, so the lower VAR does not necessarily indicate more extensive hedging coverage, contrary to the LLM’s causal claim. This misattributes causality and oversimplifies the relationship between VAR changes and hedging activity. (4) The answer is contextually relevant and well-structured, but the omission of the $8.3 billion figure and the incorrect implication that reduced VAR directly reflects expanded hedging lead to a moderate deduction in qualitative accuracy and overall correctness. The answer captures the main trend but lacks key supporting data and introduces a potentially misleading inference.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 473,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How did Altria's reliance on PM USA's guarantee framework under the Uniform Fraudulent Conveyance Act evolve from 2022 to 2024, particularly in relation to the financial thresholds and insolvency risk metrics outlined in their 10-K filings?",
      "original_answer": "In 2022, Altria's (MO) subsidiary PM USA was fully and unconditionally guaranteeing the Parent's debt obligations, with explicit disclosures that these guarantees could be voided under the Uniform Fraudulent Conveyance Act if PM USA was insolvent or received less than fair consideration at the time of the guarantee. Insolvency was defined based on three metrics: (1) total debts exceeding the fair value of assets, (2) fair saleable value of assets being less than the amount required to pay debts, or (3) inability to pay debts as they mature. The obligations under the guarantees were limited to amounts that would not constitute fraudulent conveyances under applicable laws. By 2024, the same legal framework applied, but the filings emphasized that the Parent’s access to operating cash flows from subsidiaries depended on dividends and intercompany loans, and that neither PM USA nor other subsidiaries faced contractual restrictions on making such distributions. This suggests Altria maintained its guarantee structure but refined its financial risk disclosures to reflect ongoing compliance with the Uniform Fraudulent Conveyance Act, particularly around solvency metrics and the absence of restrictive covenants on subsidiary distributions.",
      "llm_answer": "Altria’s 2024 10‑K simply reiterates the same PM USA guarantee language that appeared in the 2022 filing, with no new financial thresholds or insolvency metrics introduced. Both filings define insolvency as (i) debts, including contingent liabilities, exceeding the fair‑saleable value of assets; (ii) the fair‑saleable value of assets being less than the amount needed to cover probable liabilities; or (iii) an inability to pay debts as they mature, and limit the guarantor’s exposure to a maximum amount that would not constitute a fraudulent transfer. Consequently, the reliance on PM USA’s guarantee framework and its associated thresholds remained unchanged from 2022 to 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in describing the continuity of PM USA's guarantee framework and the three insolvency metrics under the Uniform Fraudulent Conveyance Act from 2022 to 2024. It correctly identifies the legal definition of insolvency and the limitation on guarantee amounts to avoid fraudulent conveyance, which aligns with the ground truth. All entities (Altria, PM USA), legal framework (Uniform Fraudulent Conveyance Act), and financial thresholds are accurately represented. There are no numerical inaccuracies, and the semantic meaning matches the original answer on the core legal and financial structure. However, the LLM answer states that 'no new financial thresholds or insolvency metrics were introduced' and that the language was 'simply reiterated,' which slightly understates the evolution noted in the original answer: the 2024 filing added emphasis on Altria's reliance on dividends and intercompany loans from subsidiaries and clarified the absence of contractual restrictions on distributions. This refinement in disclosure around financial risk and subsidiary liquidity represents a qualitative evolution in how the guarantee framework's sustainability is communicated, even if the core legal language remained unchanged. The LLM answer misses this nuance, resulting in a minor gap in completeness and reasoning. Thus, while quantitatively and contextually strong, the qualitative accuracy is slightly reduced due to incomplete synthesis of the multi-hop element regarding disclosure evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1506,
        "completion_tokens": 419,
        "total_tokens": 1926
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How did GE's shift in investment focus from commercial mortgage loans in 2023 to CMBS in 2024 reflect changes in their asset-backed securities strategy, particularly in terms of sector diversification and risk profile?",
      "original_answer": "In 2023, GE's insurance operations held commercial mortgage loans, which were part of their run-off portfolio and referenced in Note 12 (GE_10k_2023.pdf). These loans directly contributed to the composition of CMBS, as evidenced by MET_10k_2023.pdf, which states that CMBS are securities collateralized by multiple commercial mortgage loans. By 2024, GE had transitioned toward direct investments in CMBS, as noted in GE_10k_2024.pdf, where it was reported that CMBS investments were part of a broader portfolio including residential MBS, non-U.S. bonds, and government debt. This evolution indicates a strategic shift from holding individual commercial mortgage loans to investing in diversified, structured CMBS instruments, suggesting a move toward broader sector exposure and potentially more risk-managed asset-backed investments.",
      "llm_answer": "GE’s 2023 insurance operations were concentrated in a commercial‑mortgage‑loan portfolio of $1.947 billion, largely office‑sector loans with a 68 % loan‑to‑value ratio and only one delinquent loan (page 58). By 2024 GE shifted its asset‑backed‑securities focus to CMBS, moving from a single‑loan concentration to a securitized structure that pools many commercial mortgages across sectors, thereby reducing concentration risk while exposing the portfolio to broader market and pre‑payment risk (page 233). This transition reflects a strategic pivot toward greater sector diversification and a different risk profile—balancing loan‑level default risk with the credit‑enhanced, market‑sensitive nature of CMBS.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies GE's shift from commercial mortgage loans in 2023 to CMBS investments in 2024 and frames it as a strategic move toward diversification and altered risk profile, aligning with the ground truth. However, the specific quantitative details—$1.947 billion portfolio, 68% loan-to-value ratio, and 'one delinquent loan'—are not present in the original answer and cannot be verified from the provided ground truth. These numbers may be factually accurate but are not supported by the cited knowledge graph, raising concerns about hallucination or unsupported precision. (2) The ground truth does not include any dollar amounts, percentages, or delinquency statistics, so the inclusion of such specifics in the LLM answer introduces unverified data. While format variations are acceptable, introducing unsupported numbers reduces quantitative accuracy. (3) The multi-hop reasoning is sound: the LLM correctly infers that moving from individual loans to CMBS implies pooling, sector diversification, and a shift in risk from concentration to market and prepayment risk. It logically connects the structural difference between direct loans and securitized instruments, reflecting a valid synthesis across time and financial concepts. (4) Contextual relevance is perfect—the answer directly addresses the question about GE's strategic shift, sector diversification, and risk profile evolution. The qualitative reasoning is strong and semantically aligned with the ground truth, despite the unsupported specifics. Thus, the correctness score is 7: core facts and strategic interpretation are correct, but significant unverified numbers reduce confidence in full factual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 468,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How has NextEra Energy's use of Replacement Capital Covenants through FPL Group Capital Inc evolved between 2023 and 2024, and what does this imply about their long-term capital structure strategy?",
      "original_answer": "In 2023, NEE, through its subsidiary FPL Group Capital Inc, maintained multiple Replacement Capital Covenants tied to junior subordinated debentures issued as far back as 2006 (e.g., Series B due 2066 and Series C due 2067), with amendments dated November 9, 2016, reflecting a long-standing commitment to structured capital arrangements. In 2024, NEE continued to comply with these covenants, as evidenced by the presence of the same Replacement Capital Covenants in the filings, including the 2006 Series B and 2007 Series C instruments. This continuity implies that NEE has preserved a consistent capital structure strategy anchored in long-dated, covenant-backed debt instruments, potentially to ensure capital flexibility and regulatory compliance over extended horizons. The persistence of these covenants across years suggests a deliberate approach to capital management rather than a reactive stance.",
      "llm_answer": "NextEra Energy’s 2024 filing still cites the same Replacement Capital Covenant that was originally issued in 2006 and amended in 2016 (Exhibits *4(ccc), *4(ddd), *4(fff), *4(ggg) on page 122), indicating no new covenant has been introduced since 2023.  Instead, the company issued new long‑term debentures (Series Q, R, O, etc.) under separate indentures (Exhibits *4(pp), *4(qq), *4(rr) on page 121).  This continuity shows a long‑term capital‑structure strategy that maintains a stable, long‑dated debt base while selectively adding new instruments without altering the existing replacement‑covenant framework.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all dates (2006 issuance, 2016 amendment) are correct, and the reference to specific exhibits (e.g., *4(ccc), *4(pp)) supports factual precision. No numerical errors are present. (2) The answer correctly identifies that no new Replacement Capital Covenants were introduced in 2024, confirming continuity from 2023—consistent with the original answer’s claim of maintained covenants. (3) The reasoning is sound: the LLM correctly infers that issuing new debentures (Series Q, R, O) under separate indentures, while preserving existing covenants, reflects a stable capital structure strategy. This matches the ground truth’s conclusion about a deliberate, long-term approach. (4) Minor deduction in qualitative accuracy due to omission of specific mention of 'junior subordinated debentures' and the exact series (e.g., Series B due 2066, Series C due 2067), which are part of the original detail. However, the core entities (FPL Group Capital Inc, NEE, long-dated debt) and strategic implication (stable, covenant-backed structure) are accurately conveyed. (5) Contextual relevance is perfect—the response directly addresses both the evolution (no change) and strategic implication (stability, selective additions). Wording differs but semantic meaning is equivalent. Overall, a strong multi-hop synthesis with only minor detail omissions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 394,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How did the advancement of MK-1654 (clesrovimab) through Merck's R&D pipeline from 2022 to 2024 impact the company's patent disclosures, particularly regarding its anticipated U.S. expiration date?",
      "original_answer": "In 2022, MK-1654 (clesrovimab) was in Merck's pipeline as a monoclonal antibody being evaluated for the prevention of RSV medically attended lower respiratory tract infection in infants and certain children over 2 years of age. By 2024, the drug had progressed to the point of being listed in Merck's patent disclosures with an anticipated U.S. patent expiration date of 2036. This indicates that as MK-1654 advanced through clinical development, Merck updated its patent disclosures to reflect the drug's progress and longer-term commercial prospects, aligning its intellectual property strategy with the product's development trajectory.",
      "llm_answer": "In the 2022 10‑K, MK‑1654 (clesrovimab) is mentioned only as an RSV monoclonal antibody in development, and it does not appear in the company’s patent‑expiration tables. By the 2024 filing, the candidate had advanced to “under review” status, so it was added to the key U.S. patent table with an anticipated expiration year of 2036 (and a note that the FDA issued a Complete Response Letter in June 2024). Thus, the pipeline progression moved MK‑1654 from a development‑stage product to a listed patent‑protected candidate, establishing its U.S. expiration date in the disclosures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: MK-1654 (clesrovimab) was in development in 2022 without patent table inclusion, and by 2024 it appeared in Merck's patent disclosures with an anticipated U.S. expiration date of 2036. The addition of the Complete Response Letter (CRL) from the FDA in June 2024 is an extra detail not in the original answer but is factually plausible and contextually relevant, enhancing rather than contradicting the narrative. (2) Quantitative accuracy is perfect: the 2036 expiration date is correctly cited, and the timeline (2022 to 2024) matches. (3) Multi-hop reasoning is sound—LLM correctly infers that progression in the R&D pipeline (from early development to 'under review') triggered inclusion in patent disclosures, reflecting IP strategy alignment. (4) The only minor gap is that the original emphasizes the drug’s indication (prevention of RSV in infants and children over 2), which the LLM omits, slightly reducing completeness. However, this does not detract from the core focus on patent disclosure impact. Wording differs but semantic meaning is equivalent. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 363,
        "total_tokens": 1681
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How did the increase in Cisco's issuance of senior fixed-rate notes from $0 in 2022 to $13.5 billion in 2024 affect the relationship between their short-term commercial paper program and long-term debt structure?",
      "original_answer": "In 2022, Cisco disclosed a $10.0 billion short-term commercial paper program with $0.6 billion outstanding, while no senior fixed-rate notes were issued at that time. By 2024, Cisco issued $13.5 billion in senior fixed-rate notes, which now rank at par with the commercial paper notes. This significant issuance of long-term debt in 2024 altered the capital structure by introducing a large fixed-rate debt component, which now coexists with the short-term commercial paper program, potentially affecting liquidity strategy and interest rate risk exposure.",
      "llm_answer": "Cisco’s 2024 issuance of $13.5 billion in senior fixed‑rate notes added a new class of senior debt that “rank[s] at par with the commercial paper notes” (page 89).  The short‑term commercial paper program remains a separate financing tool capped at $15 billion (page 88), but the long‑term debt structure now includes the newly issued notes, raising total long‑term debt while preserving the same seniority relationship between the two.  In 2022 no new senior notes were issued, so this 2024 issuance expanded the long‑term debt base without altering the commercial paper program’s status.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $13.5 billion issuance of senior fixed-rate notes in 2024 and the absence of such notes in 2022, aligning with the ground truth. It accurately notes that these notes rank at par with commercial paper, preserving seniority. The commercial paper program is correctly described as ongoing, though the LLM cites a $15 billion cap (from the 2024 filing) versus the ground truth's $10 billion in 2022—this reflects updated information rather than inaccuracy, as programs can be amended over time. (2) All numeric values—$13.5 billion issuance, no senior notes in 2022—are factually correct. The reference to page 88 and 89 suggests document grounding, though not required for scoring. There are no calculation errors. (3) The multi-hop reasoning is sound: the model connects the introduction of long-term debt in 2024 to the pre-existing short-term commercial paper program, infers the coexistence of both instruments, and correctly concludes that the seniority relationship remains unchanged. It captures the structural shift in debt composition without overstating changes to the commercial paper program. (4) The answer is contextually precise, directly addressing how the new long-term debt affects the relationship between short-term and long-term obligations. The only minor gap is the lack of mention of the $0.6 billion outstanding commercial paper in 2022, which adds context about actual usage versus capacity. However, this omission does not undermine the core correctness. Overall, the answer is factually accurate, well-reasoned, and semantically equivalent to the ground truth with high completeness and precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 458,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How did American Express's exposure to operational risk in 2022, particularly around fraud vulnerabilities, influence its fraud risk management strategies and outcomes in 2024?",
      "original_answer": "In 2022, American Express identified operational risk as a key exposure, particularly tied to fraud, theft, and cyberattacks, which could result from inadequate systems or third-party mismanagement. This risk was further defined in 2024, where fraud was explicitly called out as a growing threat, especially due to increased targeting by bad actors and reliance on third parties with inconsistent compliance practices. Between these years, AXP faced rising regulatory scrutiny and operational complexity, leading to a strategic shift toward enhanced third-party oversight, improved data governance, and stronger cybersecurity controls to mitigate fraud risk. The evolution from general operational risk awareness in 2022 to targeted fraud risk mitigation in 2024 reflects a direct response to the increasing frequency and sophistication of fraud incidents.",
      "llm_answer": "In its 2022 filing, American Express identified operational‑risk exposure that included third‑party oversight challenges and potential fraud vulnerabilities, underscoring the need for tighter controls (see AXP_10k_2022, pages 35‑39).  By 2024 the company had reinforced its fraud‑risk management framework—adding more robust monitoring, controls and technology—to better detect and mitigate fraud, a shift reflected in the updated risk‑management disclosures (see AXP_10k_2024, pages 34‑38).",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in terms of entities, years, and risk themes, correctly identifying American Express's operational risk exposure in 2022 related to fraud and third-party vulnerabilities, and the subsequent enhancement of fraud risk management by 2024. It appropriately references the correct filings (AXP_10k_2022 and AXP_10k_2024) and page ranges, and there are no numerical inaccuracies—since the question and ground truth do not involve specific numbers (e.g., dollar amounts, percentages), quantitative accuracy is not compromised. The answer captures the core evolution in risk strategy: from general operational risk awareness in 2022 to more targeted fraud controls in 2024. However, it omits key qualitative details present in the ground truth, such as the increasing regulatory scrutiny, the growing sophistication and frequency of fraud incidents, and the explicit mention of inconsistent third-party compliance practices driving the strategic shift. While the LLM notes 'tighter controls' and 'robust monitoring,' it lacks the depth of synthesis regarding how rising threats directly influenced specific strategic responses like improved data governance and cybersecurity controls. Thus, while the reasoning is sound and contextually relevant, the qualitative completeness is slightly lacking, preventing a perfect score. The answer remains semantically aligned and fully relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 393,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did the allocation to Mortgage-Backed Securities within PEP's U.S. Plan Assets change between 2023 and 2024, and what does this shift indicate about the company's investment strategy evolution in managing pension fund risk?",
      "original_answer": "In 2023, PEP's U.S. Plan Assets included $133 million in Mortgage-Backed Securities, which decreased to $125 million in 2024—a reduction of $8 million. This decline occurred alongside a broader reallocation in the U.S. plan assets, where equity securities decreased from $4,698 million to $4,270 million, government securities fell from $1,812 million to $1,538 million, and corporate bonds dropped from $4,233 million to $3,903 million. Meanwhile, cash and cash equivalents rose significantly from $349 million to $732 million. This pattern suggests a strategic shift toward more liquid and potentially less volatile assets, indicating a more conservative posture in managing pension fund risk in 2024 compared to 2023.",
      "llm_answer": "Mortgage‑backed securities fell from $133 million in 2023 to $125 million in 2024 (page 99 vs. page 100), a $8 million decline, but their share of U.S. plan assets rose from about 1.13 % to 1.16 % (133/11,724 m vs. 125/10,772 m). This modest shift shows PEP is keeping a small but slightly larger fixed‑income exposure to mortgage‑backed securities, underscoring a continued emphasis on high‑quality, diversified debt to manage pension‑fund risk while maintaining a broadly diversified portfolio.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the decrease in Mortgage-Backed Securities from $133 million in 2023 to $125 million in 2024, matching the ground truth. However, it introduces a significant error by claiming the share of these securities in U.S. plan assets increased from 1.13% to 1.16%, which is factually incorrect. The total U.S. plan assets in 2023 were $11,724 million and in 2024 were $10,772 million (sums of all asset categories provided in ground truth), so the actual percentages are 133/11,724 ≈ 1.13% (correct) and 125/10,772 ≈ 1.16% — while mathematically close, this interpretation misrepresents the strategic shift. More critically, the LLM fails to mention the broader reallocation context — the large drop in equities, corporate bonds, and government securities, and the significant increase in cash and cash equivalents from $349M to $732M — which is central to understanding the conservative shift. (2) The dollar amounts for MBS are accurate, but the percentage analysis is misleading without acknowledging the overall decline in total plan assets and the dramatic rise in cash holdings. The calculation of percentages is numerically close but used to support an incorrect conclusion. (3) The multi-hop reasoning is flawed: while the model pulls data from two years (2023 and 2024), it fails to synthesize the full asset class movements across equities, bonds, and cash, leading to an incorrect inference about investment strategy. Instead of recognizing a move toward liquidity and conservatism, it suggests a continued or slightly increased emphasis on MBS, which contradicts the broader trend of de-risking via cash buildup. (4) The correctness score is 4 due to partial factual accuracy on MBS values but major omissions and misinterpretations in strategic implications. Quantitative accuracy is 6 because core numbers are right but derived metrics (percentages) are used inappropriately. Qualitative accuracy is 4 due to flawed reasoning and failure to capture the true strategy shift. Contextual relevance is 7 as the answer addresses the question’s focus on strategy but draws the wrong conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 573,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did Southern Company's $30 million stake in SEGCO in 2022 influence the reported decline in the value of electric generating units on its consolidated balance sheet from $760 million in 2022 to $670 million in 2023?",
      "original_answer": "Southern Company's $30 million stake in SEGCO in 2022, which was fully consolidated, included SEGCO's ownership of electric generating units with a total rated capacity of 1,020 MWs. These units were part of Southern Company’s consolidated asset base in 2022, contributing to the $760 million reported value of electric generating units. By 2023, the consolidated value of electric generating units decreased to $670 million, a $90 million drop. This decline may reflect either asset impairments, revaluation adjustments, or changes in the operating profile of the generating units—including those owned through SEGCO—impacting the consolidated balance sheet. Given that Southern Company consolidates SEGCO, the reduction in asset value is directly tied to how the SEGCO units were valued and reported in the consolidated financial statements in 2023.",
      "llm_answer": "Southern Company’s $30 million commitment to SEGCO—recorded as a bank‑credit arrangement that expired in 2022 (page 258)—was removed from the balance sheet in 2023.  The elimination of that liability, together with the re‑measurement of lease‑related electric‑generating‑unit assets, lowered the reported carrying amount of those units from $760 million in 2022 to $670 million in 2023 (page 235).",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The $30 million stake in SEGCO is misrepresented as a 'bank-credit arrangement that expired in 2022' and described as a liability being removed, whereas the ground truth states it was an equity stake in a fully consolidated entity that contributed generating assets to the balance sheet. This mischaracterization fundamentally undermines the explanation. (2) Quantitatively, the $760 million to $670 million decline (a $90 million drop) is correctly stated, but the reasoning for the decline—'elimination of a liability' and 're-measurement of lease-related assets'—is unsupported by the ground truth, which cites possible impairments, revaluations, or operational changes in the generating units, particularly those owned through SEGCO. There is no mention in the original answer of lease re-measurements or liability removal. (3) The multi-hop reasoning is flawed: the model fails to correctly link Southern Company’s consolidation of SEGCO’s generating units (1,020 MWs) to the asset base in 2022 and does not explain how changes in valuation of those consolidated assets could lead to the $90 million decline. Instead, it invents a mechanism (removal of a credit arrangement) not present in the source. (4) While the answer addresses the numerical change in asset value and attempts to explain the decline, the core entities and mechanisms are incorrect, leading to a low correctness score. The contextual relevance is moderate because it discusses the right companies and the correct asset value change, but the explanation is factually unsound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 444,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did Amgen's use of interest rate swap contracts in 2022 relate to the repayment of the 3.625% 2024 Notes in 2024, and what does this reveal about their debt management strategy over time?",
      "original_answer": "In 2022, Amgen disclosed interest rate swap contracts with a fair value of $66 million in assets and $15 million in liabilities, indicating active hedging of fixed-rate debt. By 2024, these swaps were used to convert fixed-rate coupons to floating-rate SOFR-based coupons, specifically hedging $6.7 billion in long-term debt. Of this, $1.4 billion in interest rate swaps matured in 2024 in connection with the repayment of the 3.625% 2024 Notes. This aligns with Amgen repaying the full $1.4 billion principal of those notes in 2024, showing a coordinated strategy where derivative instruments were used to manage interest rate exposure in advance of scheduled debt maturities. The evolution from holding swaps as part of a broader hedging strategy in 2022 to their direct linkage with the repayment of specific notes in 2024 suggests a deliberate, time-phased approach to debt management.",
      "llm_answer": "In 2022, Amgen used interest‑rate swap contracts to convert fixed‑rate coupons on its debt to floating SOFR‑based coupons, a strategy described in the 2022 10‑K (page 142). In 2024, the company repaid the full $1.4 billion principal of its 3.625% 2024 Notes, and the swap contracts that had been hedging those notes matured in connection with that repayment (page 148, page 149). This alignment shows Amgen’s disciplined debt‑management approach: it actively uses swaps to shape its fixed‑to‑floating debt mix and synchronizes hedge maturities with debt repayments to minimize hedging costs and maintain a desired interest‑rate profile over time (page 142).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Amgen used interest rate swaps in 2022 to convert fixed-rate debt to floating SOFR-based rates, repaid $1.4 billion of the 3.625% 2024 Notes in 2024, and the corresponding $1.4 billion in swaps matured in connection with that repayment. The dollar amounts ($1.4 billion), interest rate (3.625%), years (2022, 2024), and financial instruments (SOFR-based swaps) are all accurate. (2) Quantitative accuracy is perfect: no calculations are required beyond correct reporting of values, all of which match the original answer. (3) The multi-hop reasoning is sound—linking 2022 hedging activity to 2024 debt repayment shows synthesis across time and documents. The LLM correctly infers a coordinated debt management strategy, though it omits mention of the total $6.7 billion hedged and the $66M asset / $15M liability values from 2022, which were part of the broader hedging context. This is a minor omission that slightly reduces completeness but does not affect the core correctness. (4) The answer is contextually relevant, directly addressing both parts of the question—how swaps related to the note repayment and what this reveals about debt strategy. The conclusion about a disciplined, time-phased approach is semantically equivalent to the ground truth’s 'deliberate, time-phased approach.' Minor deduction in qualitative accuracy due to omitted detail on total hedged debt and fair values, but reasoning remains strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 418,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did NVIDIA's 2023 export control challenges influence its 2024 reliance on third-party manufacturers, and what impact did this have on inventory provisioning and gross margin in fiscal year 2024?",
      "original_answer": "In 2023, NVIDIA faced significant export restrictions from the U.S. government targeting China and other regions, particularly affecting products like the A100, H100, and L40S GPUs. These restrictions disrupted demand forecasting and supply chain planning, as NVIDIA could no longer reliably serve certain international markets. By 2024, NVIDIA's reliance on third-party manufacturers remained high, with long lead times—some exceeding twelve months—requiring early, non-cancellable inventory orders and capacity commitments. This dependency, combined with the unpredictable demand caused by export controls, led to inventory provisioning challenges. Specifically, NVIDIA reported an unfavorable impact of 2.7% on gross margin in fiscal year 2024 due to inventory provisions and the sale of previously written-down items. This reflects how the 2023 export constraints indirectly exacerbated inventory risk and gross margin pressure in 2024 through a chain of supply chain dependency and demand forecasting instability.",
      "llm_answer": "NVIDIA’s 2023 export‑control restrictions on high‑performance GPUs and AI chips forced the company to move testing, validation and distribution out of China and Hong Kong and to tighten its use of existing third‑party foundries and package‑assembly partners (see NVDA 10‑K 2023, pp. 27‑28).  The resulting supply constraints and longer lead times required larger inventory provisions and write‑downs, which produced a 2.7 % unfavorable impact on gross margin in fiscal year 2024 (NVDA 10‑K 2024, pp. 39‑41).",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) Quantitatively, the 2.7% unfavorable impact on gross margin in fiscal year 2024 is accurately reported, matching the original answer exactly. The fiscal year and percentage are correct, and no other numerical discrepancies exist. (2) The answer correctly identifies the 2023 export control restrictions and their effect on NVIDIA’s operations, including the shift of testing, validation, and distribution away from China and Hong Kong. It also correctly notes the reliance on third-party manufacturers and the resulting supply constraints and longer lead times. (3) The multi-hop reasoning is sound: it connects 2023 export controls to supply chain adjustments, which in turn led to inventory provisioning challenges and a measurable gross margin impact in 2024. However, the LLM answer omits specific details about the products affected (A100, H100, L40S GPUs) and does not explicitly mention the non-cancellable inventory orders or the over 12-month lead times, which are key elements in the original answer explaining the depth of dependency and forecasting instability. (4) Despite these omissions, the core causal chain and financial impact are accurately conveyed, and the references to the 10-K filings support the claims. The answer is contextually relevant and factually accurate where it provides information, but minor completeness gaps prevent a perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 398,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did the voting power distribution between Class A and Class B Common Stockholders change from 2022 to 2023, and what does this imply about CMCSA's shareholder control structure?",
      "original_answer": "In 2022, CMCSA disclosed that Class B Common Stock had only 3 record holders, indicating concentrated ownership. By 2023, it was revealed that Class B Common Stock, all beneficially owned by Mr. Brian L. Roberts, retained 33⅓% of the combined voting power, while Class A Common Stockholders collectively held 66⅔%. This implies that despite the disparity in voting power, the control structure remained stable, with Class B maintaining non-dilutable voting rights.",
      "llm_answer": "Between 2022 and 2023, the voting‑power split between Class A and Class B common stockholders stayed the same: Class A holders control roughly 66.7 % of the combined voting power, while Class B holders hold the remaining 33.3 % (2023: page 33; 2022: page 39). This unchanged distribution shows that the control structure remains heavily weighted toward the Class B shares, which are held by Mr. Roberts, preserving his significant influence over corporate governance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the percentages (66.7% and 33.3%) match the ground truth's 66⅔% and 33⅓%, with acceptable decimal formatting. The claim that the split remained unchanged from 2022 to 2023 is consistent with the original answer, which implies stability in voting power distribution. (2) The LLM correctly identifies Mr. Brian L. Roberts as the beneficial owner of Class B shares, maintaining the correct entity linkage. (3) The reasoning is sound: it correctly synthesizes that the unchanged voting split implies continued concentrated control, particularly by Mr. Roberts, which reflects the original answer’s point about stable control structure and non-dilutable rights. (4) The only minor shortcoming is that the LLM does not explicitly mention the 'non-dilutable voting rights' language or the 2022 detail about only 3 record holders of Class B stock, which adds slight contextual depth in the original. However, the core implications about control are accurately conveyed. Thus, the answer is factually complete and semantically equivalent, warranting a high score with only a small deduction in qualitative accuracy for missing a nuance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 341,
        "total_tokens": 1583
      },
      "error": null
    },
    {
      "question_id": 166,
      "question": "How did the adoption and implementation of ASU 2022-04 affect Colgate-Palmolive's disclosure and management of supplier finance program obligations from 2023 to 2024, particularly regarding the roll-forward information requirement?",
      "original_answer": "In 2023, Colgate-Palmolive (CL) was subject to ASU 2022-04, which required enhanced disclosures for supplier finance programs, including roll-forward information. CL adopted the guidance starting January 1, 2023, but delayed the roll-forward requirement until January 1, 2024. By 2024, CL fully complied with ASU 2022-04, including the previously deferred roll-forward disclosures, which indicates a more comprehensive reporting framework for supplier finance obligations. This evolution shows that the company transitioned from partial compliance in 2023 to full disclosure in 2024 under the new accounting standard.",
      "llm_answer": "Colgate‑Palmolive adopted ASU 2022‑04 on January 1 2023, which required it to disclose the key terms, balance‑sheet presentation and the confirmed amount outstanding of its supplier‑finance program obligations each year.  The roll‑forward information—showing how those obligations changed during the period—was not required until the guidance’s roll‑forward provision became effective on January 1 2024, so the company added that disclosure for 2024, giving stakeholders a clearer view of the evolution of its supplier‑finance obligations and enabling management to monitor those changes more closely.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) It correctly states that Colgate-Palmolive adopted ASU 2022-04 on January 1, 2023, and deferred the roll-forward disclosure requirement until January 1, 2024—matching the original answer's timeline. (2) All dates (January 1, 2023 and January 1, 2024) are correct and consistent with the knowledge graph; no numerical inaccuracies exist, satisfying quantitative accuracy. (3) The multi-hop reasoning is sound: the model correctly synthesizes the phased implementation of ASU 2022-04—initial adoption in 2023 without roll-forward, then full compliance in 2024 with the added roll-forward disclosures. (4) The LLM captures the core impact: enhanced transparency for stakeholders and improved management monitoring due to the new disclosures. The only minor shortcoming is a slight omission of explicitly stating the transition from 'partial' to 'full' compliance, which is implied but not directly articulated. However, the semantic meaning and factual content are equivalent. Wording differs slightly but remains contextually precise and fully relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 324,
        "total_tokens": 1649
      },
      "error": null
    },
    {
      "question_id": 166,
      "question": "What does the change in TXN's U.S. Defined Benefit Plan allocation between Fixed Income Securities and Cash Equivalents versus Equity Securities from 2022 to 2024 indicate about the company's pension investment strategy?",
      "original_answer": "In 2022, TXN's U.S. Defined Benefit Plan allocated 70% of its portfolio to Fixed Income Securities and Cash Equivalents. By 2024, this allocation had decreased to 61%, while the allocation to Equity Securities increased from 30% to 39%. This shift indicates a strategic move toward a more growth-oriented investment approach in the pension fund, reducing the emphasis on capital preservation through fixed income instruments in favor of higher-risk, higher-return equity investments over the two-year period.",
      "llm_answer": "TXN’s U.S. Defined Benefit Plan moved from a 70% fixed‑income/30% equity mix in 2022 (the same mix reported for 2021) to a 61% fixed‑income/39% equity mix in 2024【page_49】. This shift toward a higher equity allocation signals a more growth‑oriented, higher‑risk strategy aimed at boosting expected returns and better matching the plan’s discount‑rate sensitivity, consistent with its investment policy and target allocation ranges.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the key percentages: 70% Fixed Income and 30% Equity in 2022, shifting to 61% Fixed Income and 39% Equity in 2024, matching the ground truth exactly. All numeric values and years are accurate. (2) Quantitative accuracy is perfect—percentages are correct, sum to 100% in both years, and the directional change (9% decrease in fixed income, 9% increase in equity) is consistent. (3) The reasoning is sound: the shift toward higher equity allocation is correctly interpreted as a move toward a more growth-oriented, higher-risk strategy. The LLM adds context not in the original—mentioning discount-rate sensitivity and alignment with investment policy—which is plausible and consistent with typical pension strategy, though not explicitly in the ground truth. This does not detract from accuracy but slightly extends beyond the provided information. (4) The answer fully addresses the question about what the change indicates about TXN’s pension investment strategy. It synthesizes data across years and asset classes correctly. The only reason for not scoring a 10 is that the original answer emphasizes the reduced emphasis on capital preservation, which the LLM omits, though the core conclusion about growth orientation is identical. All entities (TXN, U.S. Defined Benefit Plan, asset classes, years) are correct. Semantic equivalence is high.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 387,
        "total_tokens": 1641
      },
      "error": null
    },
    {
      "question_id": 166,
      "question": "How did the implementation of the Dodd-Frank Act's derivatives market regulations influence AIG's compliance strategy and risk exposure between 2022 and 2024, particularly in light of the increased regulatory reporting and margin requirements introduced under Title VII?",
      "original_answer": "Between 2022 and 2024, AIG's exposure to derivatives market regulation intensified due to the continued enforcement of Title VII of the Dodd-Frank Act, which mandated increased regulatory reporting for swaps, required central clearing for certain transactions, and imposed margin and collateral requirements. In 2022, AIG's 10-K filing emphasized the company's ongoing efforts to comply with a complex and evolving regulatory environment, including potential costs and operational burdens associated with regulatory changes. By 2024, AIG was formally subject to the Group Capital Calculation (GCC) requirement under New York State law, which was incorporated into U.S. insurance regulation as part of broader Dodd-Frank-related reforms. This requirement, effective from 2024, added a new layer of consolidated capital oversight, directly linking Dodd-Frank’s regulatory framework to AIG's derivatives risk exposure and capital planning processes. The evolution of these regulations under the Dodd-Frank Act required AIG to adapt its compliance strategy, particularly in areas of derivatives reporting and margin management, reflecting a shift from general regulatory preparedness in 2022 to operational implementation by 2024.",
      "llm_answer": "Between 2022 and 2024 AIG shifted its derivatives compliance from a largely internal hedging program (using swaps, options and futures as noted in the 2022 risk‑management discussion on page 46) to a system that must meet the new Dodd‑Frank Title V II requirements—mandatory swap reporting, central‑counterparty clearing and margin/collateral posting (see page 7 of the 2024 filing).  The added reporting and collateral obligations increased AIG’s compliance costs and capital‑holding needs, while the clearing mandate reduced counter‑party risk but required tighter risk‑management controls and real‑time margin monitoring.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of key regulatory developments under Dodd-Frank Title VII and their impact on AIG's compliance strategy and risk exposure between 2022 and 2024. It accurately identifies the core requirements: mandatory swap reporting, central clearing, and margin/collateral posting, which are central to Title VII. The mention of increased compliance costs, capital-holding needs, and operational adjustments such as real-time margin monitoring reflects accurate qualitative understanding. The reference to AIG’s 2022 and 2024 filings (pages 46 and 7) adds document-level support, though these page numbers are not verifiable from the ground truth and may be hallucinated; however, they do not contradict the overall narrative. The answer correctly captures the shift from internal hedging to regulated compliance and notes the risk trade-offs (reduced counterparty risk vs. tighter controls). However, it omits a key element from the original answer: the 2024 implementation of the Group Capital Calculation (GCC) requirement under New York State law, which is a significant multi-hop connection between Dodd-Frank-related reforms and AIG’s consolidated capital oversight. This omission prevents a top score, as it misses a critical regulatory evolution directly tied to Dodd-Frank’s influence on AIG’s capital planning. There are no numerical inaccuracies—dates (2022–2024) and regulatory components are correctly stated. The reasoning is sound and contextually relevant, demonstrating synthesis across time and regulatory domains, but the missing GCC component limits completeness in multi-hop synthesis. Thus, while factually accurate and contextually strong, the answer falls slightly short on full qualitative and structural completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1493,
        "completion_tokens": 489,
        "total_tokens": 1982
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How did the change in MMM's use of foreign exchange option contracts between 2022 and 2024 affect the notional value of their hedged forecasted transactions, and what does this indicate about their foreign exchange risk exposure management strategy?",
      "original_answer": "In 2022, MMM entered into foreign exchange option contracts as part of its cash flow hedging program to manage foreign exchange risk on forecasted transactions. By 2024, the notional value of these hedges had increased from $8.3 billion to $9.9 billion, indicating a strategic expansion in hedging activity. This increase suggests that MMM responded to ongoing currency volatility by extending greater protection over forecasted foreign currency transactions, aligning with their objective to reduce earnings volatility due to exchange rate fluctuations.",
      "llm_answer": "MMM’s use of foreign‑exchange option contracts has expanded, with the notional value of its hedged forecasted transactions rising to **$9.9 billion in 2024** from **$8.3 billion in 2023** (a $1.6 billion increase).  This growth—building on a lower 2022 level that was not disclosed—shows that MMM is extending its hedging coverage to a larger share of forecasted foreign‑currency transactions, reflecting a more proactive and robust foreign‑exchange risk‑management strategy.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the increase in notional value from $8.3 billion to $9.9 billion and the resulting $1.6 billion increase, which matches the ground truth. However, it incorrectly states that the $8.3 billion figure is from 2023 instead of 2022, introducing a factual error in the time period. The ground truth explicitly states the change was between 2022 and 2024, but the LLM shifts the baseline to 2023, which misrepresents the timeline and undermines the accuracy of the comparison. (2) While the dollar amounts are correct, the misattribution of the $8.3 billion to 2023 instead of 2022 breaks the correct multi-year trend and affects the validity of the change over the intended period. The calculation of the $1.6 billion difference is accurate, but it is based on incorrect years. (3) The reasoning about MMM expanding its hedging strategy and adopting a more proactive approach to foreign exchange risk management is sound and aligns with the ground truth’s interpretation. The synthesis of increased notional value indicating greater risk protection is logically valid and contextually appropriate. (4) The answer is mostly complete and relevant, addressing both the quantitative change and strategic implication. However, the incorrect year significantly impacts quantitative accuracy. Despite this, the core message about increased hedging and risk management strategy remains semantically aligned, warranting a score of 7 for overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 412,
        "total_tokens": 1695
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "What was the value of Southern Company's stake in Georgia Power Company in 2022, and did Georgia Power Company continue to meet the conditions for reduced disclosure format in its 2023 Form 10-K filing?",
      "original_answer": "In 2022, Southern Company's stake in Georgia Power Company had an intrinsic value of $17 million. In both 2022 and 2023, Georgia Power Company met the conditions set forth in General Instructions I(1)(a) and (b) of Form 10-K, allowing it to file using the reduced disclosure format specified in General Instructions I(2)(b), (c), and (d).",
      "llm_answer": "In 2022 Southern Company’s 100 % ownership of Georgia Power was valued at **$64.1 billion** (the aggregate market value of Southern Company’s common stock held by non‑affiliates).  Georgia Power continued to meet the reduced‑disclosure format requirements in its 2023 Form 10‑K filing.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains major factual errors in quantitative accuracy. The ground truth states that Southern Company's stake in Georgia Power Company had an intrinsic value of $17 million in 2022, but the LLM incorrectly reports it as $64.1 billion, which is the aggregate market value of Southern Company’s common stock held by non-affiliates — a completely different metric unrelated to the value of the stake in Georgia Power. This represents a fundamental misinterpretation of financial data. Regarding the second part, the LLM correctly states that Georgia Power continued to meet the reduced-disclosure format requirements in its 2023 Form 10-K, aligning with the ground truth that it met conditions under General Instructions I(1)(a) and (b) for both 2022 and 2023. However, the answer fails to mention the specific conditions or instructions, missing contextual detail. The entity identification (Southern Company, Georgia Power, Form 10-K) and time frame (2022–2023) are correct, showing some qualitative accuracy. The reasoning is partially sound in recognizing the reduced disclosure status but flawed in the valuation synthesis, failing the multi-hop requirement to correctly link ownership stake to intrinsic value rather than an unrelated market metric. Overall, the answer is contextually relevant but severely compromised by incorrect financial figures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1169,
        "completion_tokens": 378,
        "total_tokens": 1548
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How did AbbVie's reliance on Cardinal Health, Inc. as a key wholesaler in 2022 compare to its broader U.S. wholesaler concentration risk in 2024, and what does the lack of change in its top-three wholesaler dependency (81% in both years) suggest about its distribution risk mitigation strategy in light of industry-wide pressures on pricing and payment terms?",
      "original_answer": "In 2022, AbbVie identified Cardinal Health, Inc. as one of its three key U.S. wholesalers, noting that if any of these distributors faced financial difficulties, it could negatively impact AbbVie’s business through delayed or uncollected receivables or reduced sales. By 2024, AbbVie continued to rely heavily on the same three wholesalers, which accounted for 81% of total net accounts receivable—unchanged from the prior year. The lack of diversification in its distribution network, despite ongoing industry-wide pressures such as increased pricing competition and payment term risks from concentrated wholesaler power, suggests that AbbVie did not materially alter its distribution strategy between 2022 and 2024. This continuity implies a persistent exposure to wholesaler concentration risk, with no evidence of strategic shifts to reduce dependency or diversify its U.S. distribution channels during this period.",
      "llm_answer": "In the 2022 10‑K AbbVie identified Cardinal Health as one of its three key U.S. wholesalers, with the top three distributors (McKesson, Cardinal Health, AmerisourceBergen) accounting for the vast majority of U.S. sales【page_41】. The 2024 10‑K shows the same concentration, with the top three wholesalers representing 81 % of net accounts receivable and all U.S. pharmaceutical net revenues【page_86】. The unchanged 81 % concentration suggests AbbVie is deliberately maintaining a highly concentrated distribution network—leveraging strong relationships to negotiate pricing and payment terms amid industry‑wide pressures—while accepting the inherent risk of limited diversification.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Cardinal Health as one of AbbVie's key wholesalers in 2022 and accurately states that the top three wholesalers accounted for 81% of net accounts receivable and U.S. pharmaceutical net revenues in 2024, matching the ground truth. The percentage (81%) and years (2022, 2024) are correct, and the entity names (Cardinal Health, McKesson, AmerisourceBergen) are accurately inferred as the top three, consistent with industry context. (2) Quantitative accuracy is perfect: the 81% figure is correctly cited for both years, and no calculations are required beyond comparison, which is handled accurately. (3) The multi-hop reasoning is mostly sound—linking 2022 and 2024 disclosures to assess continuity in concentration risk. However, the LLM interprets the lack of change as a 'deliberate' strategy to 'leverage strong relationships' and 'negotiate pricing,' which goes beyond the ground truth. The original answer states there is 'no evidence of strategic shifts,' implying passivity rather than active strategic choice. The LLM's inference of intent ('deliberately maintaining') introduces speculative reasoning not supported in the source. (4) Despite this interpretive overreach, the core facts, synthesis across years, and entity identification are correct, and the answer addresses all parts of the question. Thus, correctness is high but not perfect due to the unsupported implication of strategic intent, warranting a score of 8. Quantitative accuracy is flawless (10), qualitative accuracy is strong but slightly compromised by assumption (8), and contextual relevance is excellent (10).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 450,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How did the composition of AVGO's fixed income allocation, including its high-yield bond investments, support its liability-driven investment strategy in both fiscal years 2023 and 2024?",
      "original_answer": "AVGO maintained a 100% fixed income allocation for its U.S. qualified pension plan in both fiscal years 2023 and 2024 as part of a liability-driven investment strategy aimed at minimizing market and interest rate risks. Within this fixed income allocation, the company directed investments primarily toward long-term core bonds, with smaller portions allocated to Treasury Inflation-Protected Securities and high-yield bonds. This consistent approach across both years reflects AVGO's focus on aligning its asset allocation with forecasted liabilities and liquidity needs while balancing risk and return through a diversified mix of fixed income instruments, including high-yield bonds.",
      "llm_answer": "In FY 2023 and FY 2024, AVGO’s U.S. qualified pension plan allocated 100 % of its assets to fixed‑income securities, with the bulk invested in long‑term core bonds and smaller positions in Treasury‑inflation‑protected securities and high‑yield bonds (page 77).  The high‑yield portion—part of the corporate‑bond allocation shown on page 78—provides additional yield to help meet the plan’s expected return on assets while still fitting within a liability‑driven framework that matches the plan’s duration and cash‑flow profile and limits market and interest‑rate risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all key facts are correct: AVGO maintained a 100% fixed income allocation in both fiscal years 2023 and 2024 for its U.S. qualified pension plan. The breakdown into long-term core bonds, TIPS, and high-yield bonds is consistent with the original answer. No numerical inaccuracies are present. (2) The LLM correctly identifies that high-yield bonds are part of the corporate bond allocation and contribute additional yield while still supporting the liability-driven investment (LDI) strategy—this reflects proper synthesis of risk-return tradeoffs within an LDI framework. (3) The multi-hop reasoning is sound: it connects the asset allocation (100% fixed income), sub-allocations (including high-yield), and the strategic objective (matching duration, managing interest rate risk, achieving expected return) across both years. (4) The only minor shortcoming is that the LLM does not explicitly mention the alignment with forecasted liabilities and liquidity needs, which is a small but relevant nuance in the original answer. However, the mention of matching duration and cash-flow profile captures much of this intent. Overall, the answer is factually correct, contextually appropriate, and semantically equivalent to the ground truth with only slight omission of a secondary detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 381,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 168,
      "question": "How did Southern Company's 2023 strategic emphasis on microgrids influence PowerSecure's 2024 financial performance, particularly the $120 million revenue increase and $82 million cost of sales rise?",
      "original_answer": "In 2023, Southern Company identified microgrids as a critical emerging technology that could reshape its business model and drive future growth. This strategic emphasis led to increased deployment of microgrids through its subsidiary PowerSecure. In 2024, PowerSecure's revenue grew by $120 million, primarily driven by distributed infrastructure projects, which include microgrid installations. Correspondingly, the cost of sales for PowerSecure increased by $82 million, also tied to these distributed infrastructure projects, indicating that the strategic push toward microgrids significantly influenced both the top-line growth and the associated cost increases in 2024.",
      "llm_answer": "Southern Company’s 2023 10‑K highlighted a strategic push toward distributed energy resources and microgrids (page 30), positioning the company to grow its microgrid portfolio.  In 2024, PowerSecure—Southern’s distributed‑energy arm—captured that momentum, reporting a $120 million lift in operating revenues and an $82 million rise in cost of sales (page 64) that were both driven by new microgrid and other distributed‑infrastructure projects.  The microgrid emphasis thus directly translated into higher project volumes for PowerSecure, boosting revenue while also increasing related costs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Southern Company's 2023 strategic emphasis on microgrids, PowerSecure's $120 million revenue increase, and $82 million cost of sales rise in 2024 are accurately reported. Number formats match ($120 million, $82 million), and no calculation errors exist. (2) Quantitative accuracy is perfect—both dollar amounts and years (2023 strategy, 2024 financial impact) are correct. (3) The multi-hop reasoning is sound: the model correctly links Southern Company’s 2023 strategic focus (from its 10-K) to PowerSecure’s 2024 financial performance, recognizing PowerSecure as the subsidiary executing on that strategy. The causal connection between microgrid deployment and both revenue and cost increases is logically and accurately drawn. (4) The only minor shortcoming is slightly less explicit detail on the categorization of 'distributed infrastructure projects' as including microgrids—while implied, the original answer makes this link more explicit. However, the LLM answer still captures the core causal mechanism and financial impact. Wording differs but semantic meaning is equivalent. Contextual relevance is excellent, directly addressing all parts of the multi-hop question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 357,
        "total_tokens": 1687
      },
      "error": null
    },
    {
      "question_id": 168,
      "question": "How did the expiration of MRK's key U.S. patent for Januvia in January 2023 and subsequent court rulings affect the company's market exclusivity strategy in 2024, and what was the resulting impact on sales trends in both the U.S. and international markets?",
      "original_answer": "In 2022, MRK disclosed the material importance of patent rights to maintaining market exclusivity for its pharmaceutical products, emphasizing that loss of patent protection typically leads to significant sales declines due to generic competition. In early 2023, the key U.S. patent for Januvia expired; however, favorable court rulings and settlement agreements extended market exclusivity in the U.S. for Januvia and Janumet until May 2026, and for Janumet XR until July 2026. Despite this extension, in 2024, MRK experienced a 33% decline in global sales of Januvia and Janumet, primarily driven by lower U.S. pricing and demand due to competitive pressures, as well as the ongoing impact of lost exclusivity in Europe, the Asia Pacific region, and Canada. The company also faced additional regulatory pressures from the IRA’s government price-setting program, which is expected to further impact sales starting in 2026. Thus, while patent litigation and settlements temporarily preserved market exclusivity in the U.S., the erosion of exclusivity in other regions and regulatory changes contributed to significant sales declines by 2024.",
      "llm_answer": "The key U.S. patent for Januvia expired in January 2023, but favorable court rulings and settlement agreements on a later‑expiring sitagliptin‑salt patent kept U.S. market exclusivity until May 2026, allowing Merck to preserve its 2024 exclusivity strategy (MRK 10‑K 2024, p. 57).  However, exclusivity had already lapsed in the EU, China, Canada and other markets, and worldwide Januvia/Janumet sales fell 33 % in 2024—driven by lower U.S. pricing/demand and generic competition abroad (MRK 10‑K 2024, p. 57; MRK 10‑K 2022, p. 33).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the January 2023 patent expiration, favorable court rulings extending U.S. exclusivity to May 2026 (for Januvia/Janumet) and July 2026 (for Janumet XR, though the latter is omitted), and the 33% decline in global sales in 2024. The mention of lost exclusivity in the EU, Canada, China, and other markets matches the ground truth's reference to Europe, Asia Pacific, and Canada. (2) Quantitative accuracy is perfect: the 33% sales decline and correct dates (January 2023 expiration, May 2026 extension) are accurately reported. Format variations (e.g., '33 %' with space) do not affect correctness. (3) Multi-hop reasoning is sound: the model correctly synthesizes information from MRK’s 2022 and 2024 10-Ks to explain how U.S. exclusivity was preserved via litigation while international losses drove sales declines. (4) The only minor omission is the specific mention of Janumet XR’s exclusivity until July 2026 and the IRA’s price-setting impact starting in 2026, which slightly reduces completeness but does not undermine the core accuracy. Wording differs but semantic meaning is equivalent. Contextual relevance is excellent—every part of the question is addressed with precise, evidence-backed information.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 366,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 168,
      "question": "How did the governance protections for GOOGL's voting rights structure evolve from 2022 to 2023, particularly regarding amendments affecting different stock classes?",
      "original_answer": "In 2022, GOOGL disclosed the voting rights structure, indicating that Class A common stockholders had full voting rights while Class B and C common stockholders had limited rights, especially concerning amendments to the certificate of incorporation. By 2023, the certificate of incorporation included additional safeguards that required approval by the affected class of stock for any amendments that would adversely alter their rights, powers, or preferences. Furthermore, in 2023, the Board of Directors had to unanimously approve any such amendment before it could be put to a stockholder vote. These changes reflect an increased emphasis on protecting stockholder rights, especially in the context of potential amendments affecting different stock classes.",
      "llm_answer": "Alphabet’s 2023 10‑K added a clear governance safeguard: any amendment to its certificate of incorporation that would adversely alter a class’s rights, powers or preferences must first be approved by that class, and the Board must give unanimous consent before the amendment can be put to a shareholder vote【page 82】.  That requirement was not disclosed in the 2022 10‑K (pages 1‑5 contain only share‑count and forward‑looking statements, with no such amendment‑approval clause【page 2】), indicating a strengthening of voting‑rights protections between the two periods.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly identifies that in 2023, Alphabet's 10-K introduced a new governance safeguard requiring class-specific approval and unanimous board consent for amendments adversely affecting stock class rights, which was not present in the 2022 filing. This matches the original answer's claim about enhanced protections for different stock classes. (2) There are no numeric values (e.g., dollar amounts, percentages) in the question or ground truth, so quantitative accuracy is not applicable—no errors here. (3) The multi-hop reasoning is sound: the model correctly contrasts the 2022 and 2023 10-K disclosures, infers the evolution of governance protections by noting the absence of the clause in 2022 and its presence in 2023, and correctly identifies the two key requirements (class approval and unanimous board consent). (4) The answer is fully contextually relevant, directly addressing how voting rights governance evolved between the two years with precise reference to amendment procedures and stock class protections. Minor wording differences (e.g., 'Alphabet' vs 'GOOGL') are acceptable as they refer to the same entity. The citation of page numbers adds verifiability and does not contradict the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 364,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 169,
      "question": "How did the change in Disney's Value at Risk (VAR) exposure from 2022 ($395 million) to 2024 ($255 million) relate to their treatment of forecasted transactions in risk modeling, given that forecasted transactions were consistently excluded from the VAR model across both years?",
      "original_answer": "Disney's VAR exposure decreased from $395 million in 2022 to $255 million in 2024, reflecting a reduction in market risk, particularly due to lower interest rate volatility. Despite this decline, the company consistently excluded forecasted transactions from its VAR model in both years, meaning the model did not account for future expected exposures in its risk estimation. However, the company actively hedges forecasted foreign exchange transactions using forward and option contracts, with notional amounts increasing from $8.3 billion in 2023 to $9.9 billion in 2024. This suggests that while forecasted transactions were not part of the VAR model, they were still managed through direct hedging strategies, indicating a dual approach: modeling only current exposures while proactively mitigating future ones.",
      "llm_answer": "Disney’s VAR exposure fell from $395 million in 2022 to $255 million in 2024, but forecasted transactions were excluded from the VAR model in both periods (see the 2022 and 2024 VAR tables on page 60). Because the treatment of forecasted transactions did not change, the decline in VAR reflects other factors—primarily lower interest‑rate volatility and a shift in the company’s derivative portfolio—rather than any change in how forecasted transactions were modeled.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in all quantitative aspects: the VAR values ($395 million in 2022 and $255 million in 2024) are correct, and the statement that forecasted transactions were excluded from the VAR model in both years aligns with the ground truth. The explanation that the decline in VAR was due to factors like lower interest-rate volatility and changes in the derivative portfolio is consistent with the original answer. However, the LLM answer omits a key part of the multi-hop reasoning present in the ground truth: Disney’s active hedging of forecasted foreign exchange transactions using forward and option contracts, with notional amounts increasing from $8.3 billion in 2023 to $9.9 billion in 2024. This omission reduces completeness and weakens the full synthesis of how forecasted transactions—though excluded from VAR—are still managed via direct hedging. While the core logic about unchanged modeling treatment is sound, the absence of this hedging context limits the depth of the qualitative analysis. The answer remains highly relevant and correctly interprets the unchanged exclusion of forecasted transactions, but the missed connection to proactive hedging strategies prevents a perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 343,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 169,
      "question": "How did the change in BAC's exposure to Collateralized Debt Obligations (CDOs) between 2023 and 2024 relate to the role of embedded derivatives in their structured liabilities, and what does this imply about their risk management strategy?",
      "original_answer": "In 2023, BAC reported that embedded derivatives in structured liabilities led to net gains (losses) in market-making activities, which were typically offset by gains (losses) on derivatives and securities used for hedging. These embedded derivatives were linked to structured instruments like CDOs, as noted in the 2024 evidence from another firm's filing, which described CDOs as hybrid instruments containing embedded derivatives. By 2024, BAC's maximum loss exposure to consolidated and unconsolidated CDOs had decreased from $80 million (2023) to $65 million (2024), indicating a reduction in risk exposure. This suggests that BAC may have adjusted its structuring and hedging strategies involving CDOs and embedded derivatives to better manage credit and market risk.",
      "llm_answer": "BAC’s maximum‑loss exposure to CDOs fell from **$80 million in 2023 to $65 million in 2024** (page 131).  CDOs are hybrid instruments that embed credit‑protection derivatives, and BAC’s structured liabilities also contain embedded derivatives that the firm offsets with derivative positions (page 109; page 164).  The reduction in CDO exposure, coupled with active hedging of embedded‑derivative risk, indicates a risk‑management strategy that trims credit exposure while maintaining hedges to control volatility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the reduction in BAC's maximum-loss exposure to CDOs from $80 million in 2023 to $65 million in 2024, matching the ground truth exactly. All numeric values and years are accurate, with acceptable formatting ($80 million vs $80 million). (2) Quantitative accuracy is perfect: the dollar amounts and years are correct, and the implied $15 million decrease is consistent with the data. (3) The reasoning correctly links CDOs as hybrid instruments containing embedded derivatives, and notes BAC’s use of offsetting derivative positions—this aligns with the ground truth’s description of hedging gains/losses on embedded derivatives in structured liabilities. The LLM infers a risk management strategy focused on reducing credit exposure while managing volatility via hedges, which is a valid interpretation of the evidence. (4) The answer is contextually fully relevant, addressing both the change in exposure and its implication for risk management. The only minor shortcoming is that the LLM does not explicitly mention that the 2024 evidence came from another firm’s filing (a small gap in provenance), but it correctly uses the information in context. Overall, the answer is factually correct, well-reasoned, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 366,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 170,
      "question": "How did the composition and valuation methodology of MDLZ's Level 1 Financial Assets in 2024 reflect changes in their use of commodity futures compared to 2023?",
      "original_answer": "In 2023, MDLZ used commodity futures as part of its hedging strategy to manage price risk related to forecasted purchases of raw materials, entering into forward, futures, and option contracts. By 2024, Level 1 Financial Assets, which include exchange-traded commodity futures and listed options, were valued based on quoted market prices on commodity exchanges. This indicates that MDLZ maintained its use of commodity futures but aligned their valuation methodology more directly with observable market pricing, reinforcing their reliance on standardized, exchange-traded instruments for risk mitigation.",
      "llm_answer": "In 2024 MDLZ’s Level 1 financial assets—exchange‑traded commodity futures and listed options—had a fair value of $111 million versus $28 million in 2023, a jump that signals a larger use of commodity futures. The valuation methodology stayed the same, relying on quoted market prices on commodity exchanges. Overall, the fair value of all commodity contracts rose from $135 million to $683 million, even though the notional amount fell slightly from 16,631 million to 16,210 million, reflecting a shift toward higher‑priced futures positions.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific numerical values—$111 million and $28 million for Level 1 financial assets in 2024 and 2023, respectively, and total commodity contract values rising from $135 million to $683 million—that are not present in the original answer (ground truth) and cannot be verified from the provided context. These figures appear fabricated or misattributed, as the ground truth does not include any dollar amounts for financial assets or commodity contracts. Additionally, the claim that the notional amount decreased from 16,631 million to 16,210 million is numerically implausible (likely meant to be in millions or another unit) and unsupported by the original answer. (2) The quantitative inaccuracies are severe and pervasive, with multiple invented figures and a nonsensical notional amount presentation (e.g., 16,631 million instead of ~$16.6 billion), indicating a failure in data fidelity. No calculations can be verified because the source data is incorrect. (3) The reasoning is partially sound in linking Level 1 assets to exchange-traded commodity futures and recognizing that valuation is based on quoted market prices, which aligns with the ground truth. However, the conclusion that there was a 'larger use of commodity futures' due to increased fair value is speculative and not supported by the original answer, which emphasizes consistency in use and a methodological alignment with market pricing, not a quantitative increase in usage. The multi-hop synthesis is flawed because it invents trends rather than reflecting the qualitative shift in valuation emphasis. (4) The contextual relevance is moderate because the answer addresses the right topic—MDLZ's use and valuation of commodity futures—and correctly identifies Level 1 assets as exchange-traded instruments valued at market prices. However, the qualitative accuracy is low due to incorrect reasoning based on false numbers, and the overall correctness score is very low because the core factual claims are unsupported and inaccurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 550,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 170,
      "question": "How did Southern Company's ownership structure in Plant Scherer Unit 3 change from 2022 to 2024, and what role did FP&L's stake play in this evolution?",
      "original_answer": "In 2022, Southern Company's Georgia Power subsidiary owned 75.0% of Plant Scherer Unit 3. By 2024, the ownership structure had evolved such that FP&L held a 25.0% stake in the plant, alongside Georgia Power's 75.0% ownership. This indicates a shift in the joint ownership model, where FP&L became a co-owner, potentially influencing the plant's operational and financial responsibilities. The involvement of FP&L in Plant Scherer Unit 3 reflects a broader pattern of shared ownership in Southern Company's facilities, as seen in other plants like Hatch and Vogtle.",
      "llm_answer": "In 2022 Plant Scherer Unit 3 was 75 % owned by Georgia Power (Southern Company) and 25 % by FP&L. By 2024 the percentages were unchanged—Southern Company retained its 75 % stake through Georgia Power, while FP&L continued to hold the remaining 25 %. FP&L’s stake supplied the residual ownership interest that kept the unit jointly owned and operated by Georgia Power and FP&L, ensuring its continued operation under a joint‑ownership structure.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in its core claim about ownership changes. According to the ground truth, in 2022, FP&L did NOT own any stake in Plant Scherer Unit 3—Georgia Power (Southern Company) owned 75.0% alone. The key change from 2022 to 2024 was that FP&L acquired a 25.0% stake by 2024, creating a new joint ownership structure. However, the LLM incorrectly states that FP&L already held 25% in 2022 and that the ownership percentages were 'unchanged' by 2024, which directly contradicts the original answer. This is a critical factual error in both quantitative accuracy and reasoning. While the LLM correctly identifies the 75%/25% split in 2024 and mentions the joint ownership structure, it completely fails to recognize the evolution (i.e., the addition of FP&L as a new co-owner), which is the central point of the question. The multi-hop reasoning is flawed because it did not detect the change over time. Contextual relevance is moderate because it discusses the right plant, companies, and ownership model, but the incorrect timeline undermines the entire response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 309,
        "total_tokens": 1562
      },
      "error": null
    },
    {
      "question_id": 170,
      "question": "How did Southern Company's strategic focus on PowerSecure's microgrid deployments evolve between 2023 and 2024, and what does this indicate about the company's shifting investment priorities in distributed energy solutions?",
      "original_answer": "In 2023, Southern Company held a stake in PowerSecure, which had previously undergone a $119 million goodwill impairment in 2022 due to declining macroeconomic conditions affecting its cash flows. By 2024, PowerSecure was still a key part of Southern Company's portfolio, specifically highlighted for its deployment of microgrids for commercial, industrial, governmental, and utility customers. Southern Company's 2024 financial statements further emphasized the integration of microgrids as a strategic initiative, indicating a renewed investment focus on distributed energy and resilience solutions. This evolution suggests that despite prior financial setbacks, Southern Company doubled down on its commitment to PowerSecure's microgrid capabilities as a core growth driver in its diversified energy offerings.",
      "llm_answer": "Southern Company’s 2024 filing shows a clear uptick in focus on PowerSecure’s microgrid work – PowerSecure’s operating revenues rose $120 million in 2024 versus 2023, largely from distributed‑infrastructure projects that include microgrid deployments【page_64】.  The 2024 notes describe PowerSecure as a microgrid developer for commercial, industrial, governmental and utility customers【page_164】, and the company’s agreements with PowerSecure for distributed‑energy services remained in place【page_166】.  Together, these changes indicate a shift in Southern Company’s investment priorities toward distributed energy solutions, especially resilience‑focused microgrids, beyond its traditional generation portfolio.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Southern Company's continued strategic focus on PowerSecure's microgrid deployments in 2024 and links it to a broader shift toward distributed energy solutions, aligning with the ground truth. It accurately notes PowerSecure’s role serving commercial, industrial, governmental, and utility customers, and confirms ongoing agreements, supporting the conclusion of sustained investment. However, the key quantitative claim—that PowerSecure’s operating revenues rose by $120 million in 2024 versus 2023—is not present in the ground truth and contradicts the known context of a $119 million goodwill impairment in 2022 due to declining performance. This revenue increase is unsupported and likely incorrect, introducing a significant factual error. (2) The $120 million revenue increase is presented as fact but does not appear in the original answer or logical inference from it; the original emphasizes strategic recommitment despite prior setbacks, not a documented revenue surge. This misrepresents financial performance and undermines quantitative accuracy. (3) The multi-hop reasoning is otherwise sound: the model connects Southern Company’s portfolio strategy with PowerSecure’s microgrid activities and infers shifting investment priorities in distributed energy, correctly synthesizing entity relationships and strategic implications. (4) Despite the major numerical inaccuracy, the qualitative assessment of strategic evolution and contextual relevance to distributed energy priorities is strong, warranting a correctness score of 7—core facts are right, but the inclusion of an unsupported and potentially misleading financial figure reduces overall accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 468,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 170,
      "question": "How did BMY's strategic positioning of Yervoy in 2023, particularly its market exclusivity timeline, influence the expanded use of Opdivo in combination therapies approved in 2024, such as the first-line treatment of unresectable or metastatic urothelial carcinoma?",
      "original_answer": "In 2023, BMY maintained a strategic stake in Yervoy, with defined market exclusivity timelines (U.S.: 2025, EU: 2026, Japan: 2025), ensuring continued control over its use in combination therapies. Yervoy's well-established role as a CTLA4 inhibitor complemented Opdivo's PD-1 inhibition, forming the backbone of multiple regimens. In 2024, BMY expanded Opdivo's indications, including its FDA approval in March for use with cisplatin and gemcitabine in first-line treatment of unresectable or metastatic urothelial carcinoma. This strategic expansion of Opdivo's therapeutic footprint aligns with and builds upon the foundational positioning of Yervoy in the oncology portfolio, leveraging the exclusivity and clinical strength of Yervoy to support Opdivo's broader adoption in new combination regimens.",
      "llm_answer": "BMY positioned Yervoy in 2023 so that its U.S. market exclusivity would extend through 2025 (see the exclusivity table on page 47).  This protected window allowed the company to combine Opdivo with Yervoy for new indications and secure FDA approvals in 2024—including the first‑line treatment of unresectable or metastatic urothelial carcinoma (page 45)—before generic competition could erode the combination’s market share.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies BMY's strategic positioning of Yervoy in 2023 with U.S. market exclusivity through 2025, which aligns with the ground truth (U.S.: 2025, EU: 2026, Japan: 2025). However, it omits the EU and Japan exclusivity timelines, reducing completeness. The FDA approval of Opdivo in combination for first-line treatment of unresectable or metastatic urothelial carcinoma in 2024 is correctly mentioned, though the specific March 2024 timing is missing. (2) Quantitatively, the 2025 U.S. exclusivity date is accurate, and no incorrect numbers or calculations are present. The reference to 'page 47' and 'page 45' suggests document-based support but cannot be verified here; these do not contradict the ground truth. (3) The reasoning correctly links Yervoy’s exclusivity to the strategic expansion of Opdivo combination therapies, demonstrating sound multi-hop logic between Yervoy’s positioning and Opdivo’s 2024 approval. However, it oversimplifies by implying Opdivo was combined with Yervoy in the urothelial carcinoma regimen, whereas the approved regimen is Opdivo with cisplatin and gemcitabine—not Yervoy. This is a significant factual error in therapeutic combination, undermining qualitative accuracy. (4) Despite this error, the answer remains contextually relevant and captures the core strategic intent. The correctness score is 7 due to accurate dates and strategic rationale but docked for incorrect combination therapy attribution and missing international exclusivity details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 421,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 170,
      "question": "How did the evolution of redemption options tied to AT&T's subsidiary preferred interests change between 2022 and 2024, particularly in relation to the Telco LLC preferred interests?",
      "original_answer": "In 2022, AT&T disclosed that holders of preferred interests in its subsidiaries, including Telco LLC, had the option to require redemption upon contingent events such as failure to pay distributions for two or more periods or not meeting minimum credit ratings. The redemption mechanism allowed AT&T to settle these obligations with cash or AT&T common stock, with a cap of 250 million shares of stock. By 2024, AT&T had expanded its issuance of preferred interests in Telco LLC, increasing the total from $2,000 (in 2020) to $7,250, with new classes (A-2 and A-3) introduced in April 2023. These new classes carried a higher initial preferred distribution rate of 6.85%, subject to reset in 2027. The redemption terms remained largely consistent, with AT&T retaining the right to call the interests after seven years from issuance, but the increased scale and complexity of the preferred interests structure suggest a strategic shift toward leveraging these instruments more heavily in capital planning.",
      "llm_answer": "Between 2022 and 2024 AT&T expanded its Telco LLC preferred‑interest structure. In 2022 the existing Class A‑1, A‑2 and A‑3 interests could only be called at issue price after seven years, with holders able to demand redemption on certain contingent events. By 2024 the company announced a new Class A‑4 issuance that can be called at issue price beginning on November 1, 2028 (roughly four years after issuance) and carries the same redemption and liquidation rights as the earlier classes; the 2024 filing also states that the proceeds from the new issuance will be used to fund the redemption of other preferred‑equity securities, reflecting a shift toward using new preferred equity to retire existing obligations.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and misrepresents key aspects of the evolution of AT&T's redemption options tied to Telco LLC preferred interests between 2022 and 2024. (1) Incorrect entity and class timeline: The LLM claims that Class A-1, A-2, and A-3 interests existed in 2022, but according to the ground truth, A-2 and A-3 were introduced in April 2023, not present in 2022. (2) Fabricated issuance: The LLM invents a 'Class A-4' issuance with a call date of November 1, 2028, which is not mentioned in the original answer or supported by the knowledge graph. (3) Incorrect redemption mechanics: The original answer states that holders could require redemption upon contingent events (e.g., failure to pay distributions or credit rating downgrades), and AT&T could settle in cash or stock (capped at 250 million shares). The LLM omits this critical detail and instead focuses only on AT&T's call right after seven years, mischaracterizing the bilateral nature of redemption. (4) Misstated purpose: The LLM claims proceeds from a new issuance will be used to redeem other preferred securities, suggesting a refinancing strategy, but the original answer does not state this; instead, it notes an increase in total preferred interests from $2,000 to $7,250 and a strategic shift in capital planning. (5) Missing key financial data: The LLM fails to mention the $7,250 total issuance by 2024, the 6.85% distribution rate, or the 2027 reset date—critical quantitative details. (6) Reasoning flaws: The multi-hop synthesis is unsound—no evidence supports the existence of Class A-4 or its terms. While the answer correctly identifies a trend of expanding preferred interest usage, this is overshadowed by factual errors. Contextual relevance is moderate as it addresses structural evolution, but accuracy is severely compromised.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 499,
        "total_tokens": 1938
      },
      "error": null
    },
    {
      "question_id": 170,
      "question": "How did the treatment and presentation of Separate Account Assets and Liabilities in BlackRock's consolidated financial statements evolve from 2023 to 2024, particularly in terms of their exclusion from the adjusted statement of financial condition?",
      "original_answer": "In 2023, BlackRock disclosed that Separate Account Assets were maintained by BlackRock Life Limited and represented segregated assets held for pension contracts, with equal and offsetting Separate Account Liabilities recorded on the consolidated statements of financial condition. These assets and liabilities were not subject to general claims of BlackRock’s creditors. By 2024, BlackRock explicitly excluded Separate Account Assets and Liabilities (along with related securities lending collateral) from its adjusted statement of financial condition, noting that these items have equal and offsetting liabilities or non-controlling interests and do not impact stockholders' equity or cash flows. This shift in presentation reflects a more refined approach to isolating economically irrelevant items for investor clarity.",
      "llm_answer": "In 2023, BlackRock reported separate‑account assets and their offsetting liabilities on the consolidated statements of financial condition (see Note on Separate Account Assets and Liabilities, page 81) but expressly omitted them from the “as‑adjusted” statement of financial condition.  The 2024 filing keeps the same accounting treatment—separate‑account assets and collateral are still shown on the GAAP balance sheet (page 56)—but the as‑adjusted table now lists a dedicated column for “Separate Account Assets/Collateral” and marks it as excluded, making the omission explicit.  Thus, the exclusion of these items from the adjusted statement has remained, with the 2024 presentation simply clarifying the exclusion in the table.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that in 2023, Separate Account Assets and Liabilities were included in the consolidated financial statements but excluded from the adjusted statement of financial condition, and that in 2024, this exclusion was made more explicit in presentation. The mention of 'securities lending collateral' in the ground truth is slightly underemphasized in the LLM answer, though it is referenced as 'collateral'—a reasonable shorthand. (2) There are no numeric values to verify (e.g., dollar amounts), but the years (2023, 2024) and document references (page 81, page 56) are factually consistent with typical 10-K structures and do not contradict the ground truth; these page numbers are plausible and contextually appropriate. (3) The multi-hop reasoning is sound: the model correctly synthesizes the evolution of presentation across two years, noting continuity in accounting treatment and a refinement in disclosure clarity. (4) The LLM captures the core insight—that the exclusion existed in both years but was made more transparent in 2024—matching the ground truth’s emphasis on improved investor clarity. The only minor shortcoming is slightly less emphasis on the equal and offsetting nature of liabilities and their lack of impact on equity and cash flows, which is a key rationale in the original answer. However, the exclusion logic is still well conveyed. Thus, the answer is factually correct, contextually relevant, and semantically equivalent with only slight nuance missing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 432,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 171,
      "question": "How did the fair value of MDT's mutual funds measured using Level 1 inputs change from 2022 to 2023, and what does this indicate about their short-term investment strategy?",
      "original_answer": "In 2022, MDT reported $125 million in mutual funds that were entirely measured using Level 1 inputs, indicating a full reliance on actively quoted market prices for valuation. By 2023, the fair value of mutual funds decreased to $106 million, still entirely measured using Level 1 inputs. This $19 million decline suggests a strategic reduction in mutual fund exposure, with the company likely reallocating capital toward other investment categories such as fixed income commingled trusts or partnership units, which saw increases in fair value. The continued use of Level 1 inputs for mutual funds shows MDT maintained a preference for highly liquid, transparently valued assets despite the portfolio size reduction.",
      "llm_answer": "Medtronic’s Level‑1 mutual‑fund holdings rose from **$106 million in 2022 to $114 million in 2023**—an $8 million increase (see 2022 10‑K table on page 96 and 2023 10‑K table on page 96).  The modest rise reflects a continued emphasis on highly liquid, actively traded instruments as part of the company’s short‑term investment strategy, indicating a slight expansion of its liquid‑asset allocation rather than a shift toward riskier or longer‑dated holdings.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both direction and magnitude of change. The ground truth states that MDT's Level 1 mutual fund holdings decreased from $125 million in 2022 to $106 million in 2023—a $19 million decline. The LLM incorrectly claims an increase from $106 million in 2022 to $114 million in 2023, reversing the trend entirely. This fundamental error invalidates the conclusion. (2) Quantitative accuracy is severely lacking: the starting value ($106M vs $125M), ending value ($114M vs $106M), and resulting change (+$8M vs -$19M) are all wrong. Even allowing for format variations, the numbers do not match the ground truth. (3) The reasoning is flawed due to incorrect data. The LLM infers a 'slight expansion' in liquid assets, while the actual data indicates a strategic reduction in mutual fund exposure. The multi-hop synthesis fails because it draws conclusions from fabricated numbers. While the general concept of Level 1 inputs indicating liquidity is correct, applying it to an incorrect trend undermines the analysis. (4) Correctness and quantitative accuracy are scored very low due to complete inversion of the financial trend. Qualitative accuracy is minimal because the logic, while structurally sound, is based on false premises. Contextual relevance is moderate since the answer addresses the right topic (Level 1 mutual funds and investment strategy) and attempts proper interpretation, but with wrong data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 404,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 171,
      "question": "How did the voting power dynamics between CMCSA's Class A and Class B common stock evolve from 2022 to 2024, and what does the unchanged 33 1/3% non-dilutable voting stake of Class B shares imply about long-term control concentration despite potential share conversions?",
      "original_answer": "In 2022, CMCSA's Class A common stock held 66 2/3% of the combined voting power, while Class B common stock maintained a non-dilutable 33 1/3% voting stake representing 15 votes per share. By 2024, this structural relationship remained unchanged despite the convertibility of Class B shares into Class A stock on a share-for-share basis. The consistent 33 1/3% voting allocation for Class B shares, which cannot be diluted by new issuances, suggests continued control concentration under Brian L. Roberts, who owns all Class B shares, even as potential conversions could alter the total share distribution without affecting the fixed voting power allocation.",
      "llm_answer": "Between 2022 and 2024 Comcast’s voting structure stayed the same: Class A shares continued to hold 66 ⅓ % of the combined voting power and Class B shares 33 ⅓ % (CMCSA_10k_2024.pdf page 91; CMCSA_10k_2022.pdf page 36). The 33 ⅓ % stake of Class B shares is explicitly non‑dilutable, so even if those shares are converted to Class A, the holders retain a guaranteed one‑third of total voting power, preserving a concentrated long‑term control for the current Class B owners.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, all numbers are correct: the 66 1/3% and 33 1/3% voting allocations for Class A and Class B shares, respectively, are accurately reported for both 2022 and 2024, matching the original answer. The non-dilutable nature of the 33 1/3% stake is correctly emphasized. (2) The answer cites specific sources (10-K filings for 2024 and 2022), confirming multi-hop verification across years. (3) The reasoning is sound: it correctly explains that despite convertibility of Class B to Class A shares, the fixed and non-dilutable voting power preserves control concentration. (4) The only minor shortcoming is that the LLM does not explicitly name Brian L. Roberts as the sole owner of Class B shares, which is part of the ground truth and relevant to the long-term control implication. While the phrase 'current Class B owners' is not incorrect, it lacks the specificity of the original answer regarding concentrated individual control. This omission slightly affects qualitative accuracy but does not undermine the overall correctness. The answer remains semantically equivalent in substance and fully addresses the question’s components.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 347,
        "total_tokens": 1660
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How did the fair value of MDLZ's net investment hedge contracts in 2022, categorized under Level 2 financial assets, compare to the valuation methodology and exposure characteristics described in 2024?",
      "original_answer": "In 2022, MDLZ reported a $71 million fair value for its net investment hedge contracts, which were classified under Level 2 financial assets. These contracts were primarily over-the-counter (OTC) instruments, valued using observable market inputs such as forward rates and contract terms. By 2024, MDLZ continued to categorize net investment hedge contracts under Level 2 financial assets and maintained a similar valuation methodology, relying on income-based approaches that incorporate observable market data. However, the 2024 disclosures emphasized enhanced risk management practices, including counterparty credit risk controls and exposure limits, suggesting a more structured approach to managing these Level 2 instruments over time.",
      "llm_answer": "In 2022 MDLZ’s net‑investment‑hedge contracts had a net fair value of **$(219) million**, recorded as a Level 2 liability.  The 2024 filing still classifies these contracts as Level 2, valuing them with observable inputs such as forward rates and discounting, and the exposure remains cross‑currency interest‑rate swaps and forwards that hedge net investments in non‑U.S. operations.  Thus, the 2022 fair value was negative, but the 2024 methodology and exposure characteristics are consistent with the Level 2 classification and foreign‑investment hedging strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the fair value amount for 2022. The ground truth states that MDLZ reported a $71 million fair value (positive) for its net investment hedge contracts in 2022, classified as a Level 2 financial asset. However, the LLM incorrectly reports a net fair value of $(219) million, characterizing it as a liability, which contradicts the original answer. This is a major quantitative and directional error (asset vs. liability, positive vs. negative). (2) The 2024 valuation methodology and exposure characteristics are accurately described: Level 2 classification, use of observable inputs (forward rates, discounting), and instruments such as cross-currency interest rate swaps and forwards hedging non-U.S. operations. This aligns with the ground truth’s description of continued use of income-based approaches with observable market data. (3) The multi-hop reasoning is partially sound—linking 2022 valuation with 2024 methodology and exposure—but fails at the foundational step due to the incorrect 2022 value and mischaracterization of the position. The synthesis across years is logically structured but based on incorrect data. (4) Despite correct contextual framing and entity identification (MDLZ, Level 2, net investment hedges, 2022 and 2024), the severe numerical inaccuracy significantly undermines the answer's correctness. The qualitative accuracy is moderate because the conceptual understanding of the instruments and methodology is present, and contextual relevance is high as the response directly addresses the comparison asked. However, the incorrect dollar amount and sign (negative vs. positive) result in a low overall correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 468,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How did the voting rights structure of GOOGL's Class B common stock in 2022 influence the distribution and repurchase strategy of Class A common stock by 2024, especially in light of the $62.0 billion in share repurchases during 2024?",
      "original_answer": "In 2022, GOOGL disclosed the distinct voting rights structure of its Class B common stock, which granted 10 votes per share and could be converted to Class A common stock upon sale or transfer. This structural feature likely influenced the company's strategic repurchase of Class A and Class C shares, as seen in 2024, where $62.0 billion worth of shares were repurchased. The emphasis on Class A shares in repurchase decisions may reflect efforts to manage voting control while optimizing shareholder value, particularly as Class B stockholders retain significant influence due to their higher voting power.",
      "llm_answer": "In 2022, Alphabet’s Class B shares carried 10 votes each and could be converted to Class A shares on sale or transfer, giving the company a concentrated voting power while allowing it to issue more shares (see page 82).  This structure enabled Alphabet to manage dilution from Class B conversions by actively repurchasing Class A shares—its 2024 program bought 73 million Class A shares for $11.9 billion as part of a $62.0 billion total repurchase of Class A and C shares, a strategy designed to return capital and preserve voting‑power balance (page 82).",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the voting rights structure of GOOGL's Class B stock (10 votes per share, convertible to Class A upon sale/transfer) and links it to the company's share repurchase strategy, particularly in preserving voting power balance. It accurately references the $62.0 billion total repurchase in 2024 involving Class A and Class C shares. However, the LLM introduces a specific figure not present in the original answer—73 million Class A shares repurchased for $11.9 billion—which is not mentioned in the ground truth. There is no way to verify this breakdown from the provided original answer, making this an unsupported addition. (2) While the $62.0 billion total repurchase amount is correct and matches the original, the $11.9 billion and 73 million share figures are unverified and likely over-specific, reducing quantitative accuracy. The original answer does not provide such granular data, so including it risks misinformation. (3) The multi-hop reasoning is sound: the model correctly connects the 2022 voting structure to the 2024 repurchase strategy, inferring that repurchasing Class A shares helps maintain voting control amid Class B's dominance. This synthesis across time and structure is logically valid and aligns with the original's intent. (4) The contextual relevance is perfect—the answer directly addresses how the voting structure influenced repurchase strategy. Qualitative accuracy is high due to correct entities (Alphabet/GOOGL, Class A/B/C shares, 2022 and 2024 timelines), but quantitative accuracy is docked because of the unverified $11.9 billion and 73 million figures. Overall, the core facts and reasoning are correct, but the added specifics reduce factual precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 475,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 173,
      "question": "How did MO's continued ownership of USSTC shape its exposure to and response against state-level marketing restrictions on flavored smokeless tobacco products across 2022–2023?",
      "original_answer": "MO's continued ownership of USSTC exposed the company to the Smokeless Tobacco Master Settlement Agreement (STMSA), which imposed long-standing marketing and advertising restrictions on USSTC’s smokeless tobacco products. In 2022, MO noted that USSTC was the only smokeless tobacco manufacturer under the STMSA, limiting its ability to market flavored products, including mint and wintergreen. As of February 2022, six states and D.C. had enacted flavor bans, with California’s ban delayed pending a referendum. By 2023, the situation intensified: California’s flavor ban became effective in December 2022, and Rhode Island joined the list of states with passed legislation. MO responded by challenging certain laws through litigation while supporting others that aligned with its Vision to transition adult smokers to smoke-free products. The STMSA’s restrictions remained in place throughout both years, constraining MO’s marketing strategies and influencing its dual approach of legal opposition and legislative engagement.",
      "llm_answer": "Altria’s continued ownership of USSTC kept the company directly subject to the Smokeless Tobacco Master Settlement Agreement (STMSA), which imposes marketing and advertising restrictions on all USSTC products.  In 2022, state‑level bans on flavored tobacco—most notably California’s 2022 ban—further limited Altria’s ability to market flavored smokeless products.  In response, Altria engaged regulators, state and federal lawmakers, trade partners and stakeholders to raise awareness of the issue and pursued legal action to protect its lawful product lines while adjusting its marketing to comply with the STMSA and state restrictions.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct in conveying that Altria's (MO) ownership of USSTC subjects it to the Smokeless Tobacco Master Settlement Agreement (STMSA), which restricts marketing of flavored smokeless products, and that state-level flavor bans—particularly in California—impacted its operations in 2022–2023. The response correctly notes Altria’s dual strategy of legal action and engagement with regulators and lawmakers. However, there are key quantitative and completeness issues: (1) The original answer specifies that as of February 2022, six states and D.C. had enacted flavor bans, and by 2023, California’s ban took effect in December 2022 and Rhode Island joined—details missing in the LLM answer. (2) The LLM incorrectly implies California’s ban was enacted in 2022, while the ground truth states it was delayed pending a referendum and became effective in December 2022—important nuance lost. (3) The LLM omits that USSTC was the only smokeless tobacco manufacturer under the STMSA, a critical differentiator shaping MO’s unique exposure. (4) The response lacks mention of MO’s support for certain legislation aligned with its Vision for smoke-free transition, which is a key part of its strategic response. While the core reasoning and entity identification (MO, USSTC, STMSA, California ban) are accurate, and the general strategy is well-summarized, the missing specifics and slight misrepresentation of timing reduce quantitative accuracy. The answer remains contextually relevant and semantically close but falls short on full multi-hop synthesis across states, timeline, and strategic nuance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 439,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 173,
      "question": "How did LLY's 340B Program obligations affecting 23.1% of sales in 2023 influence its exposure to new federal regulatory developments in 2024, particularly regarding contract pharmacy policies and potential enforcement actions?",
      "original_answer": "In 2023, LLY was subject to the 340B Program, which required it to provide discounts to covered entities, impacting an increasing percentage of sales—starting at a minimum of 23.1% plus adjustments for price increases. This growing exposure was compounded by regulatory uncertainty, as highlighted in Pfizer’s 2023 filing, where HHS HRSA was actively enforcing 340B Program compliance, issuing letters to manufacturers over contract pharmacy policies and referring some for potential enforcement actions. By 2024, LLY explicitly listed 'regulatory changes and developments' and 'regulatory compliance problems or government investigations' as material risk factors, indicating that the company faced heightened exposure to federal scrutiny—likely including 340B-related enforcement—due to its expanding obligations under the program. This shows a clear 3-hop chain: LLY’s 2023 340B obligations → increased regulatory focus on 340B compliance → LLY’s 2024 exposure to new enforcement risks.",
      "llm_answer": "Because 23.1 % of Lilly’s 2023 sales were subject to the 340B program, the company’s compliance obligations were large and heightened its regulatory exposure (see page 16).  Lilly has implemented a contract‑pharmacy limited‑distribution system to meet 340B requirements, but the system remains under ongoing HRSA scrutiny and litigation (see pages 17–18).  In 2024, the company continues to face potential new federal regulatory developments—such as HRSA letters, OIG referrals, and state‑level contract‑pharmacy restrictions—that could trigger enforcement actions and further affect its 340B discount obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the 23.1% figure for LLY's 2023 sales exposure to the 340B Program is correctly stated, and no other numerical inaccuracies are present. (2) The answer correctly identifies that LLY’s significant 340B obligations increased its regulatory exposure, referencing HRSA scrutiny and ongoing litigation—consistent with the ground truth’s mention of HHS HRSA enforcement and Pfizer’s 2023 filing context. (3) The multi-hop reasoning is sound: it connects LLY’s 2023 340B obligations (23.1% of sales) → use of contract pharmacies under scrutiny → heightened risk of federal enforcement actions in 2024. While the LLM does not explicitly cite Pfizer’s filing as a source of broader regulatory context (a minor omission), it accurately infers the regulatory environment and LLY’s risk exposure. (4) The LLM correctly identifies LLY’s risk factors in 2024, including potential HRSA letters, OIG referrals, and state-level restrictions, which aligns semantically with the original answer’s emphasis on 'regulatory changes,' 'compliance problems,' and 'government investigations.' The only minor gap is the lack of explicit mention that LLY listed these risks in its own 2024 filing, but the substance and implication are preserved. Overall, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 392,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 173,
      "question": "How did Apple's increased reliance on Taiwan as a supply chain hub in 2022 relate to the higher proportion of iPhone revenue from Greater China in 2023, and what does this imply about the strategic alignment between Apple's supply chain risk exposure and regional revenue concentration?",
      "original_answer": "In 2022, Apple specifically called out Taiwan as part of its supply chain risk exposure due to geopolitical tensions and pandemic-related disruptions, noting that manufacturing in Asia—including Taiwan—was critical to its operations. The 2022 filing also clarified that Greater China includes Taiwan, linking supply chain dependencies directly to a reportable segment. By 2023, Apple disclosed that iPhone revenue represented a 'moderately higher proportion' of net sales in Greater China compared to other regions. This implies that Apple's strategic positioning in Greater China—where it saw growing iPhone revenue—was partially underpinned by manufacturing operations in Taiwan, a region it had flagged as a risk in the prior year. This creates a situation where Apple's financial performance in a key growth region is tightly coupled with a jurisdiction it identifies as a supply chain vulnerability.",
      "llm_answer": "Apple’s 2022 10‑K notes a heightened reliance on Taiwan for manufacturing (page 9). In 2023, iPhone revenue from Greater China accounted for a higher share of total iPhone sales (page 39). This alignment shows that Apple’s supply‑chain risk exposure is tightly coupled with its revenue concentration in Greater China—concentrating both production and sales in the same region, which can amplify risk but also enables efficient local output.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) It correctly identifies that Apple's 2022 10-K highlighted increased reliance on Taiwan for manufacturing and that in 2023, iPhone revenue from Greater China represented a higher proportion of sales—consistent with the original answer's 'moderately higher proportion' phrasing. (2) No specific numerical values (e.g., dollar amounts, percentages) are present in either answer, so quantitative accuracy is not compromised; references to page numbers (9 and 39) are plausible and do not contradict the knowledge graph. (3) The multi-hop reasoning is sound: the model correctly links Apple’s supply chain dependency on Taiwan (a risk factor noted in 2022) with revenue concentration in Greater China (reported in 2023), and notes the strategic implication of coupling production and sales in the same region. (4) The only minor shortcoming is that the LLM omits the explicit clarification from the original answer that 'Greater China includes Taiwan'—a key point that strengthens the logical connection between supply chain risk and revenue concentration. Despite this, the core strategic insight about risk amplification due to geographic concentration is present. Wording differs but semantic meaning is equivalent. All entities (Apple, Taiwan, Greater China, iPhone revenue, 2022 and 2023 timeframes) are correct. The answer is highly contextually relevant and synthesizes across years and domains (supply chain and revenue).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 412,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 174,
      "question": "How did the value of PEP's international plan assets associated with contracts with insurance companies change from 2022 to 2023, and what does this indicate about their investment strategy in this category?",
      "original_answer": "In 2022, PEP's international plan assets included $27 million in contracts with insurance companies, which increased to $30 million in 2023. This represents a $3 million (11.1%) increase in this specific asset category. The growth suggests a strategic decision to expand exposure to insurance-related instruments within their international plan assets, despite an overall decline in total international plan assets from $3,195 million in 2022 to $3,528 million in 2023. This selective increase indicates a targeted shift in investment focus toward insurance contracts despite broader portfolio adjustments.",
      "llm_answer": "International plan assets tied to contracts with insurance companies increased from **$27 million in 2022 to $30 million in 2023** (a $3 million rise). This modest uptick indicates that PEP is maintaining or slightly expanding its exposure to this Level 3 asset class within its international plan portfolio, reflecting a strategy of diversifying risk while pursuing potential higher returns in that category【page_99】.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the key numbers: $27 million in 2022 and $30 million in 2023, representing a $3 million increase, which matches the ground truth exactly. The percentage increase (11.1%) is not mentioned in the LLM answer, but the absolute change is accurate, so quantitative accuracy is fully preserved. (2) The entity (PEP), metric (international plan assets in contracts with insurance companies), and years (2022 to 2023) are all correctly identified. (3) The reasoning is mostly sound: the LLM correctly infers a strategic intent to maintain or slightly expand exposure. However, it misses a critical nuance from the original answer — that total international plan assets actually declined overall (from $3,195M to $3,528M is an increase, not a decline — note: there is a factual error in the original answer here, as $3,528M > $3,195M). The original answer incorrectly states there was an overall decline, but the numbers show an increase. Therefore, the LLM’s failure to mention an 'overall decline' is not a flaw, since that claim is factually incorrect. Thus, the LLM avoids propagating a false comparison. (4) The LLM answer is contextually relevant and semantically aligned with the core of the question. It correctly addresses both parts: the change in value and the strategic implication. The only minor shortcoming is the lack of percentage increase (11.1%), which adds precision, and slightly less detailed strategic interpretation than the original. However, the conclusion about diversification and potential returns is reasonable. The citation of 'Level 3 asset class' adds detail not in the original, possibly from source material, which enhances credibility. Final scores reflect high accuracy with minor room for elaboration.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 482,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 174,
      "question": "How did UPS's compliance with FIP requirements in 2023 influence its contribution levels to the Alaska Teamster-Employer Pension Plan in 2024, given the plan remained in the red funding zone?",
      "original_answer": "In 2023, UPS satisfied the FIP requirements for the Alaska Teamster-Employer Pension Plan, which was in the red zone, contributing $10 million. By 2024, despite the plan remaining in the red zone and FIP requirements still being in place, UPS increased its contribution to $11 million. This suggests that UPS's ongoing compliance with FIP obligations under the red zone classification led to a modest increase in contributions year-over-year, reflecting either a tightening of the FIP terms or a strategic decision to support the plan's financial recovery.",
      "llm_answer": "UPS met the rehabilitation‑plan (FIP) requirement for the Alaska Teamster‑Employer Pension Plan in 2023, so its 2024 contribution stayed at the required level without incurring a surcharge.  The plan remained in the red zone, and UPS’s compliance allowed it to increase its contribution from $10 million in 2023 to $11 million in 2024 (see the 2023 and 2024 contribution tables and the FIP compliance note).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers and dates are correct: UPS contributed $10 million in 2023 and $11 million in 2024, and the plan remained in the red zone. The increase from $10M to $11M is accurately reported. (2) The entity identification is correct—UPS, the Alaska Teamster-Employer Pension Plan, FIP requirements, and the red funding zone are all properly referenced. (3) The reasoning is mostly sound: the answer correctly links UPS's 2023 FIP compliance to its 2024 contribution level and notes the absence of a surcharge, which is consistent with compliance. It also correctly observes the year-over-year increase. However, it slightly underdevelops the implication of the increase—while the original answer infers a possible tightening of FIP terms or strategic decision, the LLM answer states compliance allowed the increase, which is less precise in causal direction (compliance doesn't enable an increase; rather, increased contributions support compliance). This is a minor qualitative nuance. (4) The answer is contextually relevant, directly addressing the influence of 2023 compliance on 2024 contributions despite the plan remaining in the red zone. Overall, the answer is factually correct and conveys the core information with only slight room for improved reasoning depth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 377,
        "total_tokens": 1629
      },
      "error": null
    },
    {
      "question_id": 174,
      "question": "What does Southern Company's continued use of master netting agreements in 2023 reveal about their strategy for managing derivative risks identified in the previous year, particularly in light of the $13 million pre-tax loss from foreign currency derivatives in 2022?",
      "original_answer": "Southern Company's continued reliance on master netting agreements in 2023 suggests a consistent strategy to mitigate counterparty credit risk and streamline derivative asset/liability presentation, especially after experiencing a $13 million pre-tax loss from foreign currency derivatives in 2022. The 2022 loss demonstrated active use of derivatives, particularly by Southern Power, and the persistence of netting across product lines in 2023 indicates that the company did not materially alter its risk management framework in response to that loss. Instead, Southern maintained its approach of netting derivative positions under master agreements, which allows for clearer balance sheet presentation and better risk control across energy, interest rate, and foreign currency derivatives.",
      "llm_answer": "Southern Company’s continued use of master netting agreements in 2023 shows that it is actively managing counter‑party credit risk by netting derivative positions across product lines and against cash collateral【page 290】.  This approach directly addresses the volatility that produced the $13 million pre‑tax loss from foreign‑currency derivatives in 2022【page 320】, indicating a proactive effort to limit future losses by reducing net exposure and ensuring derivative positions are netted and collateralized.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in all quantitative aspects: the $13 million pre-tax loss in 2022 and its attribution to foreign currency derivatives are correctly stated, and the years (2022 loss, 2023 strategy) are accurate. The entity 'Southern Company' and reference to derivative risk management via master netting agreements are correct. The answer correctly identifies that master netting agreements are used to manage counterparty credit risk and net derivative positions, which aligns with the ground truth. However, while the LLM describes the strategy as 'proactive' and says it 'directly addresses the volatility' that caused the 2022 loss, the original answer takes a more neutral stance, noting that the continued use of netting indicates no material change in risk management framework—implying continuity rather than a reactive or enhanced measure. This subtle shift in interpretation slightly weakens the qualitative accuracy, as the LLM implies a stronger causal link between the loss and the strategy than supported by the ground truth. Nonetheless, the core multi-hop reasoning—linking the 2022 loss to the persistence of netting agreements in 2023—is sound and contextually relevant. The answer is concise and directly responsive to the question, earning high marks for contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 365,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 174,
      "question": "How did the vesting terms for stock options under MA's LTIP change from 2022 to 2023, and what does this indicate about the company's equity compensation strategy evolution?",
      "original_answer": "In 2022, stock options under MA's LTIP vested ratably over four years for awards granted before March 1, 2022. By 2023, the vesting terms had changed to a three-year ratable vesting schedule for awards granted on or after March 1, 2022. This indicates a strategic shift toward shorter vesting periods, potentially aimed at enhancing employee retention and aligning compensation more closely with near-term performance goals.",
      "llm_answer": "In 2022, options granted under Mastercard’s LTIP vested ratably over **four years** (page 100).  By 2023 the plan was amended so that options granted on or after March 1, 2022 vest ratably over **three years** (page 102), while older awards still vest over four years.  This shortening of the vesting period reflects a shift toward more immediate equity incentives, aimed at improving talent retention and aligning rewards with shorter‑term performance goals.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the key numbers and dates are accurate: the shift from a four-year to a three-year ratable vesting schedule for awards granted on or after March 1, 2022, is correctly stated. The LLM correctly notes that pre-March 2022 awards still follow the four-year vesting, which adds precision and aligns with the original answer's implication. (2) The answer addresses both parts of the question: it describes the change in vesting terms from 2022 to 2023 and interprets the strategic implication—shorter vesting to enhance retention and align with near-term performance. (3) Entity accuracy is correct: 'Mastercard’s LTIP' (MA) is properly identified, and the years (2022, 2023) and dates (March 1, 2022) are accurate. (4) The reasoning is sound and reflects proper multi-hop synthesis: it connects the change in vesting schedule to a strategic shift in equity compensation, drawing a logical conclusion consistent with the original answer. Minor wording differences (e.g., 'more immediate equity incentives' vs. 'shorter vesting periods') do not affect semantic equivalence and are acceptable. All criteria are met at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1227,
        "completion_tokens": 343,
        "total_tokens": 1570
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "What does the maintenance of identical voting rights structures between Class A and Class B shares in UPS's 2023 and 2024 filings indicate about the company's long-term governance control strategy?",
      "original_answer": "The voting rights structure remained unchanged between 2023 and 2024, with Class A shares maintaining 10 votes per share and Class B shares retaining 1 vote per share. This continuity indicates that UPS preserved its governance control framework, ensuring that long-term stakeholders—primarily employees, retirees, and founder-related trusts—retain significant influence over corporate decisions. The fact that Class A shares remained fully convertible into Class B shares at any time further supports a strategic balance between maintaining insider control and providing public market liquidity through Class B shares.",
      "llm_answer": "UPS’s 2023 and 2024 filings both state that Class A shares carry 10 votes per share while Class B shares carry one vote per share, and that Class A shares are fully convertible into Class B (page_112; page_116). The unchanged dual‑class structure shows a deliberate long‑term strategy to keep control in the hands of founders, employees and retirees while still providing public liquidity, thereby preserving governance stability and aligning management with long‑term shareholder interests.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Class A shares have 10 votes per share, Class B have 1 vote per share, and Class A shares are fully convertible into Class B—this matches the original answer exactly. The years (2023 and 2024) and the continuity of the structure are correctly referenced. (2) Quantitative accuracy is perfect: vote ratios (10:1) are correctly stated, and no calculations are required beyond these ratios, which are accurately reported. Format and references (e.g., page numbers) are appropriately included. (3) Reasoning is sound: the LLM correctly infers that the unchanged structure reflects a deliberate long-term governance strategy to maintain control among founders, employees, and retirees while allowing public liquidity via Class B shares. This captures the core multi-hop synthesis—linking structural continuity to governance intent. (4) The only minor shortcoming is that the LLM does not explicitly name 'founder-related trusts' or 'long-term stakeholders' as a distinct group, slightly reducing completeness in qualitative nuance. However, mentioning 'founders, employees and retirees' effectively covers the key constituencies. The answer is contextually excellent, directly addressing the governance implications of voting structure stability. Thus, the answer earns a 9/10 for correctness due to near-perfect factual and inferential alignment with the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 406,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How did Southern Power's transition from capacity+energy PPAs to energy-only contracts for wind facilities between 2023 and 2024 impact their ability to utilize production tax credits through 2028?",
      "original_answer": "In 2023, Southern Power's PPAs for wind facilities included capacity charges designed to recover fixed and variable operational costs, with a weighted-average remaining contract term of approximately 15 years tied to production tax credits (PTCs). By 2024, the structure shifted to energy-only PPAs that eliminated capacity charges, making Southern Power's recovery of fixed and variable operations and maintenance expenses dependent on energy generation levels. This structural change, combined with the time-bound nature of PTCs (first 10 years of production), created a direct link between generation performance and tax credit utilization. With $765 million in unutilized federal ITCs and PTCs projected to be fully used by 2028, the shift in PPA structure likely increased Southern Power's exposure to generation volatility, potentially affecting the pace and certainty of PTC utilization over the next four years.",
      "llm_answer": "Southern Power’s shift from capacity‑plus‑energy PPAs to energy‑only contracts for its wind facilities means the company no longer receives capacity revenue, so its ability to recover fixed costs and claim production tax credits (PTCs) depends solely on actual energy output【page_93】.  The 2024 10‑K notes that the $384 million of unutilized federal ITCs and PTCs are projected to be fully used by 2028 but “could be further delayed,” implying that the transition to energy‑only PPAs may postpone PTC utilization beyond the 10‑year window【page_94】.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core shift in PPA structure and its implication on PTC utilization, which is contextually relevant and correctly identifies the key risk—linking tax credit recovery to energy output. However, it contains a critical factual error in the dollar amount: it states '$384 million' in unutilized federal ITCs and PTCs, while the ground truth specifies '$765 million'. This discrepancy is significant and undermines quantitative accuracy. (2) The year 2028 is correctly cited as the projected full utilization date, and the reference to PTCs being time-bound (first 10 years of production) is implied though not explicitly stated. However, the claim that PTCs 'may be postponed beyond the 10-year window' misrepresents the nature of PTCs—once a facility is operational, the credit eligibility period is fixed and cannot be extended; underutilization due to low generation could result in lost credits, not delayed ones. This reflects a flaw in reasoning. (3) The multi-hop synthesis is partially sound: the model connects the PPA structure change to revenue dependency on generation and links that to tax credit utilization. But it fails to mention the 15-year weighted-average contract term from 2023 or clarify that the shift increases exposure to generation volatility, weakening the qualitative accuracy. (4) Despite the major quantitative error and flawed interpretation of PTC timing, the answer addresses the central theme—increased risk to PTC utilization due to energy-only contracts—earning moderate scores in qualitative accuracy and high relevance. Correctness is limited primarily by the incorrect dollar figure and misunderstanding of PTC mechanics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 463,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How did the anticipated loss of U.S. market exclusivity for Keytruda in 2028, highlighted in 2023 disclosures, influence BMY's 2024 U.S. revenue growth of 9% compared to 2023, and what strategic implications does this have for the company's reliance on Keytruda in its oncology portfolio?",
      "original_answer": "In 2023, BMY's Keytruda was noted to lose U.S. market exclusivity in 2028, which is expected to significantly impact sales due to generic competition. Despite this long-term risk, BMY reported a 9% increase in U.S. revenue in 2024 compared to 2023, with U.S. sales reaching $34,105 million in 2024 from $31,210 million in 2023. This growth suggests that Keytruda continued to drive strong performance in the near term, reinforcing its critical role in BMY's oncology portfolio. However, the anticipated exclusivity loss underscores the urgency for BMY to diversify its revenue streams or develop new products to offset future declines.",
      "llm_answer": "Bristol‑Myers Squibb’s 2024 U.S. revenue grew 9 % (page 48) largely because of higher demand in its growth portfolio, Eliquis and Pomalyst, even as generic erosion in legacy products offset some gains.  The company’s 2023 filing (page 30) warned that Keytruda’s U.S. market exclusivity will lapse in 2028, after which sales are expected to decline sharply, underscoring the risk of a future revenue hit from its flagship oncology drug.  In response, BMS is accelerating diversification of its oncology pipeline—investing in new IO assets, radiopharmaceuticals, cell‑therapy programs and other therapeutic areas (page 46)—to reduce reliance on Keytruda and sustain long‑term growth once the patent protection ends.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly attributes BMY's 9% U.S. revenue growth in 2024 to Eliquis and Pomalyst, while the ground truth states that Keytruda continued to drive strong performance. This misattribution undermines the core of the answer. Additionally, the LLM implies that Keytruda is a flagship drug for BMY, but Keytruda is actually a Merck drug, not a Bristol-Myers Squibb (BMY) product. This is a critical entity error. (2) Quantitative accuracy is poor: while the 9% growth figure is correct, the actual U.S. revenue numbers ($31,210M in 2023 and $34,105M in 2024) are omitted, and no verification of the 9% calculation is provided. More importantly, the entire revenue attribution is wrong due to the misidentification of Keytruda as a BMY drug. (3) Multi-hop reasoning fails because the model conflates two different companies—Bristol-Myers Squibb and Merck. The disclosure about Keytruda’s exclusivity loss in 2028 is real, but it pertains to Merck, not BMY. Therefore, the synthesis between Keytruda’s patent cliff and BMY’s revenue growth is fundamentally flawed. The strategic diversification efforts described may be accurate for BMY, but they are incorrectly tied to a drug (Keytruda) that is not part of its portfolio. (4) Contextual relevance is moderate because the answer addresses revenue growth, patent exclusivity, and pipeline diversification—topics relevant to the question—but the incorrect drug-company linkage renders the analysis invalid. The reasoning would be sound if the entities were correct, so qualitative accuracy is partially met. However, due to the major factual and entity errors, the correctness score is low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 466,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "What does Disney's approach to pay-fixed interest rate swaps and floating-rate borrowings between 2022 and 2024 reveal about their interest rate risk management strategy, particularly in light of the $0.9 billion market value adjustment on borrowings at the end of fiscal 2024?",
      "original_answer": "Disney's approach to interest rate risk management remained largely consistent between 2022 and 2024, with the company not designating pay-fixed interest rate swaps as cash flow hedges in either year. In 2022, the company noted that it did not have any pay-fixed swaps designated for hedging interest payments, and gains or losses from such instruments were not material. This pattern continued in 2024, with similar disclosures indicating no material changes in the use of pay-fixed swaps for interest rate hedging. However, by 2024, there was a visible impact of $0.9 billion in market value adjustments for debt with qualifying hedges, suggesting that while Disney wasn't actively using pay-fixed swaps to hedge interest payments, it still had interest rate derivatives in place that affected the valuation of its floating-rate borrowings. This indicates a shift from direct cash flow hedging to a more passive management of interest rate exposure through embedded derivative instruments rather than active swap strategies.",
      "llm_answer": "Disney’s interest‑rate strategy is to use pay‑floating swaps to hedge its fixed‑rate debt, effectively converting it to floating‑rate borrowings, and it has not employed pay‑fixed swaps to hedge floating‑rate debt (gains/losses on pay‑fixed swaps were immaterial)【page_121】【page_120】.  The $0.9 billion market‑value adjustment at the end of fiscal 2024 reflects the fair‑value benefit of these hedges, reducing the carrying amount of borrowings and underscoring Disney’s proactive approach to align debt structure with expected rate movements【page_99】【page_121】.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in describing Disney's swap strategy. It claims Disney uses 'pay-floating swaps to hedge its fixed-rate debt,' which contradicts the ground truth stating that Disney did not designate pay-fixed interest rate swaps as hedges and had no material use of such instruments for cash flow hedging. The ground truth indicates Disney did not actively hedge interest payments with pay-fixed swaps, whereas the LLM incorrectly frames Disney as proactively using pay-floating swaps (which are economically equivalent to receiving fixed, paying floating) to convert fixed-rate debt to floating. This misrepresents the core strategy. (2) Quantitatively, the $0.9 billion market value adjustment is correctly cited and attributed to fiscal 2024, satisfying numerical accuracy. However, the interpretation of this figure as a 'fair-value benefit' due to active hedging is incorrect — the ground truth clarifies it reflects adjustments on debt with qualifying hedges, not necessarily from active pay-fixed or pay-floating swap usage, and may stem from embedded derivatives rather than standalone swap positions. (3) Multi-hop reasoning is partially sound — the model connects the market value adjustment to hedging activity and references floating-rate borrowings — but fails to accurately synthesize the evolution (or lack thereof) in Disney’s hedging designations between 2022 and 2024. It misses the key point that the absence of cash flow hedges for pay-fixed swaps persisted, indicating a passive rather than proactive strategy. (4) Contextual relevance is fair: the answer addresses interest rate risk management and cites the $0.9B adjustment, but misattributes the mechanism and strategic intent, leading to a misleading conclusion about Disney’s approach. While some facts are correct, the central reasoning about Disney’s hedging strategy is inverted, warranting a low correctness score despite accurate numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 531,
        "total_tokens": 1960
      },
      "error": null
    },
    {
      "question_id": 176,
      "question": "How did the submission of PMTAs by Helix for on! oral nicotine pouches in 2020 and the subsequent filing of PMTAs for on! PLUS in 2024 impact MO's regulatory risk exposure and product strategy evolution in the oral nicotine pouch category between 2022 and 2024?",
      "original_answer": "In 2022, Helix had submitted PMTAs for on! oral nicotine pouches in May 2020, but as of February 22, 2022, the FDA had not issued marketing order decisions, leaving the product in regulatory limbo. This uncertainty contributed to MO's broader regulatory risk exposure, as the company disclosed that unfavorable FDA determinations could materially impact business results. By 2024, Helix had expanded its regulatory engagement by submitting PMTAs for on! PLUS in June 2024, indicating a strategic shift toward product diversification and flavor expansion within the oral nicotine pouch category. However, as of February 24, 2025, the FDA still had not issued marketing orders for any on! or on! PLUS products, suggesting continued regulatory risk. This evolution shows that while MO increased its regulatory engagement through additional PMTAs, the lack of FDA decisions maintained a high level of regulatory uncertainty, influencing MO's product strategy and risk exposure in the oral nicotine pouch market.",
      "llm_answer": "Helix’s May 2020 PMTA for on! and the June 2024 PMTAs for on! PLUS (tobacco, mint, wintergreen) kept the oral‑nicotine pouch line in a pending regulatory state; as of February 2025 the FDA had issued no marketing orders, so MO’s regulatory‑risk exposure remained elevated through 2022‑24 (page 36‑37). The filings also signaled a product‑strategy shift toward expanding the on! portfolio with new flavors and variants, positioning MO to capture growing share in the oral‑nicotine pouch market while navigating ongoing FDA uncertainty.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: Helix submitted the original PMTA for on! in May 2020 (not 2022, correctly attributed to prior action), and PMTAs for on! PLUS (with specific flavors) were submitted in June 2024. The FDA had issued no marketing orders as of February 2025, maintaining regulatory limbo—this aligns with the original answer’s timeline and implications. (2) Quantitative accuracy is perfect: dates (May 2020, June 2024, February 2025) are correct and match the ground truth; no numerical calculations are required. (3) Multi-hop reasoning is sound: the answer correctly links Helix’s PMTA submissions to MO’s ongoing regulatory risk exposure and infers a strategic shift toward product diversification in the oral nicotine pouch category. It synthesizes regulatory status with business strategy implications across 2022–2024. (4) The only minor shortcoming is that the LLM does not explicitly mention MO’s 2022 disclosure about material impact from unfavorable FDA decisions, which adds nuance to the risk exposure. However, stating that 'regulatory-risk exposure remained elevated' captures the essence. The mention of page 36–37 suggests source fidelity. Overall, the answer is semantically equivalent, contextually precise, and factually robust.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 374,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 176,
      "question": "How did the change in fair value of NEE's forward contracts - power from 2023 to 2024 reflect the application of the discounted cash flow valuation technique, particularly in relation to the weighted-average forward price per MWh?",
      "original_answer": "In 2023, NEE reported the fair value of forward contracts - power at $500 million in assets and $470 million in liabilities using the discounted cash flow valuation technique, with a weighted-average forward price of $49 per MWh. By 2024, the fair value decreased to $423 million in assets and $401 million in liabilities, while the weighted-average forward price per MWh increased slightly to $52. This indicates that despite a drop in overall fair value, the pricing assumptions used in the discounted cash flow model reflected a modest increase in expected future power prices, suggesting a recalibration of market expectations or risk factors embedded in the valuation.",
      "llm_answer": "The net fair value of NEE’s forward‑contract power position fell from about **$30 million (assets $500 m, liabilities $470 m)** in 2023 to **$22 million (assets $423 m, liabilities $401 m)** in 2024.  Under the discounted‑cash‑flow (DCF) valuation, the key unobservable input is the forward price per MWh; the weighted‑average forward price rose from **$49 to $52 per MWh**.  Although the higher forward price would normally lift the value of long positions, the net position shifted to a smaller, more short‑biased exposure, so the DCF‑based fair value actually declined by about **$8 million**.  Thus the change in fair value reflects the DCF technique’s sensitivity to the weighted‑average forward price input.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key numerical values from the ground truth: 2023 assets ($500M), liabilities ($470M), 2024 assets ($423M), liabilities ($401M), and the weighted-average forward price increase from $49 to $52 per MWh. The net fair value calculations (2023: $30M, 2024: $22M) are accurate and correctly derived. (2) All numbers match the original answer exactly, with acceptable formatting variations (e.g., $500 m = $500 million). The $8M decline in net fair value is correctly calculated ($30M - $22M). (3) The multi-hop reasoning is sound: the LLM correctly identifies that despite an increase in forward prices—which would typically increase fair value—the overall fair value decreased, and it plausibly explains this by referencing a shift in exposure (more short-biased), which aligns with the DCF model’s sensitivity to both price inputs and position structure. This interpretation goes beyond the original answer but is logically consistent and adds reasonable qualitative insight. (4) The only reason for not scoring a 10 is that the original answer emphasizes the recalibration of market expectations or risk factors, while the LLM attributes the decline to a shift in exposure (short-biased), which, while plausible, is not explicitly confirmed in the ground truth. However, this does not make the answer factually incorrect—just a slightly different emphasis. Overall, the answer is quantitatively perfect, contextually relevant, and qualitatively strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 414,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 176,
      "question": "How did AbbVie's litigation strategy involving Forest Laboratories Holdings Limited in 2022 relate to the performance of Vraylar in 2023, particularly in terms of revenue growth and patent protection efforts?",
      "original_answer": "In 2022, AbbVie, through its subsidiary Forest Laboratories Holdings Limited, was actively involved in litigation to enforce patent rights for Vraylar, specifically targeting companies attempting to market generic versions of the drug. This legal strategy aimed to protect Vraylar's market exclusivity. By 2023, Vraylar demonstrated strong revenue growth, increasing from $2,038 million in 2022 to $2,759 million in 2023, a 35.4% increase. The litigation efforts in 2022 likely contributed to maintaining Vraylar's market position by delaying generic competition, which in turn supported its revenue performance in 2023.",
      "llm_answer": "AbbVie’s 2022 litigation against Forest Laboratories was a key element of its broader patent‑protection strategy for Vraylar, aimed at preserving the drug’s exclusivity.  In 2023 Vraylar’s net revenues grew 35 % year‑over‑year—driven by continued market‑share uptake and a new regulatory approval—showing that the patent‑defense effort helped sustain the drug’s revenue performance【page_42】【page_44】.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 35% year-over-year revenue growth for Vraylar in 2023, which aligns closely with the ground truth calculation of a 35.4% increase from $2,038 million to $2,759 million. The percentage is acceptably rounded. However, the LLM incorrectly states that AbbVie was litigating *against* Forest Laboratories, when in fact Forest Laboratories Holdings Limited is a subsidiary of AbbVie and was the entity used by AbbVie to pursue litigation *against generic manufacturers*. This is a significant entity relationship error that distorts the legal strategy. (2) Quantitatively, the revenue growth figure is accurate within reasonable rounding, and the years referenced (2022 litigation, 2023 performance) are correct. The dollar amounts are not mentioned in the LLM answer, which reduces completeness but does not make the answer factually wrong. (3) The multi-hop reasoning is partially sound—linking patent litigation to revenue performance is valid and supported by the ground truth—but the flawed understanding of the corporate relationship undermines the reasoning chain. The mention of 'new regulatory approval' and 'market-share uptake' as drivers, while plausible, are not present in the original answer and introduce unverified factors, diluting the focus on patent protection as the primary link. (4) Despite the entity error, the answer remains contextually relevant and captures the core causal relationship between patent defense and revenue growth. The score is reduced primarily due to the misrepresentation of the litigation parties, which affects qualitative accuracy, though the key quantitative and strategic insights are preserved.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 462,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did the allocation to real estate commingled funds within PEP's U.S. pension plan assets change from 2023 to 2024, and what does this shift suggest about the company's investment strategy evolution for its pension portfolio?",
      "original_answer": "In 2023, PEP's U.S. pension plan assets included $411 million allocated to real estate commingled funds, which increased to $561 million in 2024—a $150 million rise. This increase occurred despite an overall decline in total U.S. plan assets from $11,724 million in 2023 to $10,772 million in 2024. The rise in real estate commingled funds allocation suggests a strategic shift toward real estate as part of the company's broader pension investment strategy, even as other asset classes like government securities and corporate bonds saw reductions. This reflects a potential recalibration of risk tolerance or return expectations for long-term pension fund performance.",
      "llm_answer": "PEP raised its real‑estate commingled‑fund holding in the U.S. pension plan from **$411 million (≈3.5 % of U.S. plan assets)** in 2023 to **$561 million (≈5.2 % of U.S. plan assets)** in 2024 – a $150 million increase (PEP_10k_2024, p. 98; PEP_10k_2023, p. 99). This shift indicates the company is moving toward a higher real‑estate exposure, reflecting a strategy to diversify beyond equities and fixed income and to potentially improve risk‑adjusted returns, even though its target allocation for real estate remains at 4 %.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the dollar amounts ($411 million in 2023 and $561 million in 2024) and calculates the $150 million increase accurately, matching the ground truth. Percentages (3.5% and 5.2%) are correctly derived from the disclosed allocations relative to total U.S. plan assets ($11,724M in 2023 → 411/11724 ≈ 3.5%; $10,772M in 2024 → 561/10772 ≈ 5.2%), which aligns with the context in the original answer about overall asset decline. (2) All numeric values, calculations, and references to source documents (page numbers and filings) are accurate. The $150 million increase is correctly computed. (3) The reasoning is sound: the LLM correctly infers a strategic shift toward real estate despite a drop in total assets, and adds value by noting that the target allocation remains at 4%, indicating the fund is now above target—this enhances the analysis beyond the original answer. However, the original answer emphasizes reductions in government securities and corporate bonds as part of the rebalancing, which the LLM omits; this is a minor gap in completeness but does not invalidate the conclusion. (4) The answer is contextually fully relevant, addressing both the quantitative change and the strategic implication. The slight deduction in qualitative accuracy is due to the omission of specific asset class reductions mentioned in the ground truth, though the core multi-hop synthesis (real estate increase vs. total assets decrease → strategic shift) is correctly executed. Overall, the answer is factually precise, well-reasoned, and semantically equivalent to the ground truth with minor augmentation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 451,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did Duke Energy Progress' use of storm recovery property to issue storm recovery bonds evolve from 2022 to 2024, particularly in terms of geographic scope and total bond issuance?",
      "original_answer": "In 2022, Duke Energy Progress used storm recovery property created from North Carolina storm costs (2018–2019) to issue $770 million in bonds via DEPNCSF. By 2024, the company expanded the scope to include South Carolina storm costs (from storms like Matthew, Florence, and Jasper) and issued an additional $177 million in bonds through DEPSCSF, indicating a geographic expansion and incremental increase in bond issuance tied to broader storm recovery efforts.",
      "llm_answer": "In 2022 Duke Energy Progress had only a storm reserve on its books and had not yet issued any storm‑recovery bonds. By 2024 it had used its storm‑recovery property to issue $177 million of senior‑secured bonds for South Carolina storm costs, expanding the use of that property to raise capital for storm recovery and increasing the total bond issuance to $177 million【page_152】【page_205】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and omits key information. (1) QUANTITATIVE ACCURACY: The claim that no bonds were issued in 2022 is incorrect — the ground truth states that $770 million in bonds were issued in 2022 via DEPNCSF using North Carolina storm costs. The $177 million figure for 2024 is correct, but the LLM incorrectly presents this as the 'total' issuance ($177M), when it is an incremental addition to the existing $770M, making total issuance $947M. (2) COMPLETENESS: The answer fails to mention the 2022 bond issuance entirely and misrepresents the evolution — it suggests bond issuance began in 2024, which contradicts the ground truth. It also omits the specific storms (Matthew, Florence, Jasper) and the fact that the 2022 bonds were tied to 2018–2019 North Carolina events. (3) ENTITY ACCURACY: While Duke Energy Progress and the $177M DEPSCSF issuance for South Carolina are correctly identified, the vehicle for the 2022 issuance (DEPNCSF) is omitted. (4) REASONING: The multi-hop synthesis is flawed — the model fails to connect the 2022 and 2024 events as part of an evolving, expanding program. Instead, it implies a starting point in 2024, missing the geographic expansion narrative (from NC to SC). (5) SEMANTIC EQUIVALENCE: The overall meaning is not equivalent — the core claim of 'no issuance in 2022' directly contradicts the ground truth. Despite correct mention of South Carolina and the $177M in 2024, the fundamental timeline and financial figures are misrepresented, leading to a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1221,
        "completion_tokens": 425,
        "total_tokens": 1647
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did the extension of regulatory exclusivity for Januvia and Janumet in the U.S. through May 2026 and July 2026 respectively, influenced by patent litigation outcomes in 2023, affect MRK's market exclusivity position and sales trajectory in 2024 compared to the expected exclusivity loss in 2023?",
      "original_answer": "In 2022, MRK was subject to standard regulatory exclusivity timelines, with the key U.S. patent for Januvia and Janumet expiring in January 2023. However, due to favorable court rulings and settlement agreements in 2023 regarding a later-expiring patent covering the sitagliptin salt form, MRK extended its market exclusivity in the U.S. until May 2026 for Januvia and Janumet, and July 2026 for Janumet XR. This regulatory exclusivity extension significantly delayed the expected loss of exclusivity, which in turn slowed the rate of sales erosion in 2024. Despite a 33% decline in combined sales of Januvia and Janumet in 2024 due to lower U.S. pricing and demand, the delay in exclusivity loss allowed MRK to maintain a stronger market position than would have been the case if exclusivity had ended in early 2023, as generic competition was postponed.",
      "llm_answer": "Favorable court rulings and settlement agreements in 2023 extended Merck’s U.S. regulatory exclusivity for Januvia and Janumet to May 2026 (and Janumet XR to July 2026), delaying the loss of exclusivity that would have followed the January 2023 expiration of the key sitagliptin patent. Despite this extension, 2024 sales of the Januvia/Janumet family fell 33% because lower pricing, demand, and competition—along with exclusivity loss in Europe, Asia‑Pacific and Canada—continued to erode revenue. Thus, the litigation‑driven extension preserved U.S. exclusivity longer, but did not reverse the downward sales trend that began in 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: favorable court rulings and settlements in 2023 extended U.S. exclusivity for Januvia and Janumet to May 2026, and Janumet XR to July 2026; the original patent expiration was January 2023; combined sales declined by 33% in 2024. These numbers and dates match the original answer exactly. (2) Quantitative accuracy is perfect: the 33% sales decline, January 2023 patent expiration, and May/July 2026 exclusivity end dates are all correctly reported. (3) The multi-hop reasoning is sound—LLM correctly links the 2023 litigation outcomes to delayed exclusivity, explains the continued sales decline despite the extension, and implies a counterfactual (stronger position vs. what would have occurred with 2023 loss). The only minor gap is that the original answer explicitly contrasts MRK’s 2024 market position *relative to the scenario where exclusivity ended in 2023*, emphasizing the benefit of the delay; the LLM mentions the extension preserved exclusivity but does not fully articulate the comparative advantage in market positioning. (4) Contextual relevance is excellent—the response directly addresses the impact on market exclusivity and sales trajectory in 2024 versus expectations under 2023 loss. Overall, the answer is semantically equivalent with only slight underemphasis on the comparative market position benefit, warranting a 9/10 on correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 403,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 178,
      "question": "How did Southern Company's 2016 acquisition of PowerSecure, which was still reflected in its 2022 goodwill evaluation, influence the development and reporting of distributed energy and resilience solutions within the 'All Other' segment by 2024?",
      "original_answer": "Southern Company's 2016 acquisition of PowerSecure, which was still evaluated for goodwill impairment in 2022, directly contributed to the development of distributed energy and resilience solutions by 2024. By 2024, PowerSecure was actively providing these services, which were explicitly disclosed within the 'All Other' segment. This segment included offerings such as deploying microgrids for commercial, industrial, governmental, and utility customers. The continuity of PowerSecure within Southern's portfolio, as evidenced by the lack of impairment in 2022, suggests the business was performing consistently and was positioned to deliver these specialized energy solutions by 2024, contributing to Southern Company's broader diversification strategy beyond traditional utility operations.",
      "llm_answer": "Southern Company’s 2016 purchase of PowerSecure added a distributed‑energy and resilience‑solutions business that remained part of its goodwill balance in the 2022 10‑K (see page 201).  By 2024, PowerSecure’s operations were fully integrated into the “All Other” segment, which now reports distributed‑energy, microgrid deployments and related telecom investments (page 292).  The segment’s 2024 financials even record a $119 million goodwill impairment at PowerSecure, underscoring the acquisition’s lasting impact on both the development of these solutions and their consolidated reporting.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error: it claims a $119 million goodwill impairment at PowerSecure in 2024, which directly contradicts the ground truth stating there was *no* impairment (the 2022 evaluation showed no impairment, indicating consistent performance). This is a major quantitative and qualitative inaccuracy. (2) The dates (2016 acquisition, 2022 goodwill evaluation, 2024 reporting) are correct, and the integration into the 'All Other' segment is accurately noted. However, the $119 million impairment figure is unsupported by the ground truth and fundamentally undermines the answer’s correctness. No such number appears in the original answer, and its inclusion suggests a fabrication or misreading of data. (3) The multi-hop reasoning is partially sound—linking the 2016 acquisition to ongoing operations in 2024 and segment reporting—but fails in the final inference: the presence of an impairment contradicts the original conclusion of sustained performance and successful integration. The logic should have emphasized continuity and lack of impairment as evidence of success, not a new impairment. (4) Contextual relevance is high—the answer addresses distributed energy solutions, microgrids, and segment reporting—but the core factual error in financial reporting severely reduces overall correctness. The answer misrepresents the financial health and strategic outcome of the acquisition, which is central to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 406,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 178,
      "question": "How did the shift in Disney's strategic focus from linear sports channels like the ACC Network in 2023 to ESPN+ in 2024 affect subscriber trends and investment allocation across these platforms?",
      "original_answer": "In 2023, the ACC Network had 44 million subscribers as part of Disney’s traditional ESPN linear channel lineup (chunk 2), reflecting continued reliance on MVPD and cable distribution. By 2024, Disney emphasized ESPN+ as a key growth driver, reporting 26 million paid subscribers to the DTC service (chunk 3), which suggests a strategic reallocation of resources toward direct-to-consumer distribution. This shift aligns with broader financial moves: ESPN+ revenue now comes primarily from subscription fees and bundles with Disney+ and Hulu, signaling a pivot away from traditional linear sports channels like the ACC Network. The earlier year’s cost structure (chunk 1) — dominated by programming rights and production costs — likely funded both linear and streaming offerings, but the 2024 focus on ESPN+ indicates a prioritization of scalable, lower-cost DTC infrastructure over linear channel maintenance.",
      "llm_answer": "In 2023 the ACC Network was estimated to have 44 million subscribers (SNL Kagan, Dec 2023), while by September 2024 ESPN+ had grown to roughly 26 million paid subscribers (internal management reports)【page_10】.  The 2024 10‑K underscores a strategic pivot toward the DTC model—bundling ESPN+ with Disney+ and Hulu and emphasizing subscription growth—implying a reallocation of capital toward ESPN+ to fuel its expansion, even as linear sports channels like the ACC Network remain part of the portfolio but receive comparatively less growth‑focused investment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the 2023 ACC Network subscriber count as 44 million and the 2024 ESPN+ paid subscriber count as 26 million, matching the ground truth. These figures are accurately attributed to appropriate sources (SNL Kagan and internal management reports), and the September 2024 timing aligns with typical reporting cycles. (2) All numbers and dates are factually correct and consistent with the original answer; no calculation errors are present. The format variations (e.g., '44 million' vs '44 million') are acceptable and semantically equivalent. (3) The reasoning correctly identifies the strategic shift from linear channels (ACC Network) to DTC (ESPN+) and infers a reallocation of investment based on subscriber trends and Disney’s bundling strategy. It acknowledges that linear channels remain in the portfolio but receive less growth-focused investment, which aligns with the ground truth’s implication of prioritization. However, the LLM omits explicit mention of the cost structure (programming rights and production costs) from the earlier year that funded both platforms, slightly weakening the multi-hop synthesis between financial inputs and strategic outcomes. (4) Despite this minor omission, the answer is highly accurate, contextually relevant, and conveys the core strategic shift, subscriber trends, and investment implications. The qualitative accuracy is slightly reduced due to the missing cost structure context, but all other elements—quantitative accuracy, entity identification (Disney, ESPN+, ACC Network, 2023–2024 timeline), and logical reasoning—are fully sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 446,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 179,
      "question": "How did Georgia Power Company's financial disclosure format in Southern Company's 10-K filings change from 2022, when it used the reduced disclosure format under Form 10-K General Instructions I(2)(b), to 2024, based on the inclusion of full cash flow statements for the years 2024, 2023, and 2022?",
      "original_answer": "In 2022, Georgia Power Company was subject to the reduced disclosure format under Form 10-K General Instructions I(2)(b), meaning it provided limited disclosures in the combined 10-K filing. By 2024, the filing included full Statements of Cash Flows for Georgia Power Company covering the years 2024, 2023, and 2022. This indicates a shift from reduced to more comprehensive financial reporting for Georgia Power Company within the same consolidated filing structure.",
      "llm_answer": "In the 2022 10‑K, Georgia Power was identified as a smaller reporting company and filed under the reduced‑disclosure format required by Form 10‑K General Instructions I(2)(b) (see pages 2‑6 of the 2022 filing), which did not include a separate cash‑flow statement. By the 2024 10‑K, the company presented full cash‑flow statements for 2024, 2023, and 2022 (pages 133‑137), indicating a shift to the full‑disclosure format and a more comprehensive financial presentation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) All key facts are correct: Georgia Power Company used the reduced disclosure format under Form 10-K General Instructions I(2)(b) in 2022, which excluded a separate cash flow statement, and by 2024, full Statements of Cash Flows were included for 2024, 2023, and 2022. The years and disclosure changes are accurately represented. (2) There are no numeric values requiring calculation (e.g., dollar amounts), but the temporal references (2022, 2023, 2024) are correct and consistent with the question and ground truth. Page references (e.g., pages 2-6, 133-137) add precision and are plausible, though not part of the ground truth; they do not detract from accuracy. (3) The multi-hop reasoning is sound: the model correctly infers a shift in disclosure status based on the presence of full cash flow statements in 2024 versus their absence in 2022 under the reduced format. The conclusion that this indicates a move to full disclosure is logically supported. (4) The only minor limitation is that the LLM mentions Georgia Power being a 'smaller reporting company,' a term not present in the ground truth, though consistent with reduced disclosure eligibility. This adds a detail not confirmed by the original answer but does not contradict it. Overall, the answer is semantically equivalent, highly relevant, and factually correct, warranting a high score with only slight deduction for introducing a plausible but unverified classification.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 417,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 180,
      "question": "How did changes in UNP's credit risk profile between 2022 and 2024 affect the utilization and cost dynamics of their Receivables Facility, particularly in light of the facility's $800 million capacity and the $1.3 billion (2021) and $1.6 billion (2024) of collateralized receivables?",
      "original_answer": "In 2022, UNP's Receivables Facility was impacted by credit risks, particularly default and dilution ratios, which influenced the allowable outstanding amount under the facility. Despite these risks, the facility was utilized to the extent of $300 million at the end of 2021. By 2024, the facility was not drawn upon, with $0 outstanding at year-end, although the Railroad issued and repaid the full $800 million during the year. The amount of accounts receivable pledged as collateral increased from $1.3 billion in 2021 to $1.6 billion in 2024, indicating a stronger collateral base. Meanwhile, the cost of the facility decreased slightly from $10 million in 2022 to $8 million in 2024, suggesting improved efficiency or favorable financing terms despite the ongoing sensitivity to credit risk metrics.",
      "llm_answer": "Union Pacific’s credit‑risk profile strengthened from 2022 to 2024, as shown by the rise in collateralized receivables from $1.3 billion in 2021 to $1.6 billion in 2024 and the ability to fully deploy its $800 million receivables securitization facility in 2024 (it was unused in 2023).  The facility’s cost fell from $10 million in 2022 to $8 million in 2024, reflecting lower benchmark rates and tighter credit spreads that accompany a better risk profile【page_61】.  The unchanged $800 million capacity remained available, but the improved collateral base and credit metrics allowed the railroad to utilize the full facility when needed.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies key trends—increased collateral from $1.3B to $1.6B, facility cost decreasing from $10M to $8M, and the $800M capacity—but contains a significant factual error regarding utilization. The ground truth states that in 2024, the facility had $0 outstanding at year-end, though the full $800M was issued and repaid during the year. The LLM incorrectly claims the facility was 'fully deployed' in 2024 and 'unused in 2023', but the original answer does not mention 2023 utilization at all, making this an unsupported inference. (2) Quantitatively, all cited numbers ($1.3B, $1.6B, $800M, $10M, $8M) are accurate and match the ground truth. However, the characterization of 'full deployment' implies a year-end balance of $800M, which is incorrect—the facility was fully drawn and repaid within the year but ended at $0. This misrepresents the utilization dynamic. (3) The reasoning correctly links stronger collateral and lower costs to an improved credit risk profile, which is supported by the ground truth. However, it adds an unsupported claim about 2023 (that the facility was unused), which is not in the original data, introducing an invalid multi-hop assumption. (4) The answer is contextually relevant and captures the main financial trends, but the incorrect utilization narrative and unsupported year comparison reduce its factual accuracy. Hence, correctness is scored 7 for mostly accurate data with a key error in interpretation, quantitative accuracy 8 for correct numbers but flawed usage context, qualitative accuracy 7 due to logical reasoning with invalid assumptions, and contextual relevance 9 for staying focused on the core dynamics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 464,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 180,
      "question": "How did SO's ownership structure and capacity allocation for the Skookumchuck wind project evolve from its initial construction in 2020 to 2024, and what does this reveal about its broader wind energy investment strategy?",
      "original_answer": "In 2020, SO began construction on the Skookumchuck wind project with a nameplate capacity of 136 MW, as shown in the 2022 10-K filing. By 2024, SO had become the controlling partner in the tax equity partnership owning Skookumchuck, consolidating it as part of its broader wind portfolio which includes other facilities like Reading and Glass Sands. This evolution from a newly constructed wind asset to a controlled and consolidated entity within a larger wind energy portfolio indicates a strategic shift toward long-term ownership and integration of wind energy into SO's core utility offerings. The 30-year useful life of wind assets (as noted in 2022) supports this long-term strategic positioning.",
      "llm_answer": "Southern Power’s Skookumchuck wind project began as a 100 % ownership in 2019, but in November 2020 it completed a tax‑equity transaction that gave it 100 % of the Class B membership interests and then sold a non‑controlling interest, leaving it as the controlling partner in a tax‑equity partnership (see page 330).  By 2024 the facility still lists a 136 MW (136,800 kW) nameplate capacity and remains under Southern Power’s controlling ownership (page 43).  This evolution—shifting from outright ownership to a tax‑equity partnership while retaining control—illustrates Southern Power’s broader strategy of leveraging tax equity to finance wind projects, maintain operational control, and steadily grow its long‑term wind portfolio.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains a minor discrepancy regarding the initial ownership structure. The ground truth states construction began in 2020 with SO as the developer, while the LLM claims 100% ownership starting in 2019 and a tax equity transaction in November 2020. The 2019 date and exact ownership shift timeline are not confirmed in the ground truth, which only confirms construction start in 2020 and controlling partnership by 2024. However, the 136 MW capacity is correctly reported, matching the original answer. (2) Quantitatively, the 136 MW (or 136,800 kW) figure is accurate and consistent with the ground truth. The dates (2020 construction, 2024 status) align broadly, though the specific November 2020 tax equity detail is not contradicted but not confirmed in the ground truth either. (3) The reasoning is sound: the LLM correctly infers that maintaining control via tax equity partnerships reflects a broader strategy of leveraging such structures to finance wind assets while consolidating long-term ownership. This aligns with the ground truth’s conclusion about strategic long-term integration. The multi-hop synthesis—linking ownership structure changes to strategic intent—is logically supported. (4) The answer is contextually excellent, directly addressing both the evolution of ownership/capacity and the implications for SO’s wind investment strategy. While the original answer does not mention page numbers or Class B interests (likely from the filing), the core facts and strategic interpretation are consistent. The minor overprecision on 2019 ownership and tax equity timing prevents a 9–10 score, but the key facts and strategic insight are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 467,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 180,
      "question": "How did the auditor's testing of Netflix's content amortization method in 2022 compare to their review in 2023, and what does this indicate about the consistency of Netflix's assumptions regarding future viewing patterns?",
      "original_answer": "In 2022, the auditor tested Netflix's content amortization method by evaluating management's review of the method and the significant assumptions, including historical and forecasted viewing hour consumption, used to develop estimated viewing patterns. They also tested the completeness and accuracy of the underlying data and performed sensitivity analyses. In 2023, the auditor continued to review the same method and assumptions, again testing the controls over the amortization process and comparing management's assumptions to current viewing trends and operating information. The consistency in the auditor's approach across both years indicates that Netflix's assumptions regarding future viewing patterns remained largely stable and were still based on historical and forecasted viewing data, despite the subjective and complex nature of content amortization.",
      "llm_answer": "In 2022 the auditor tested controls over management’s review of the content‑amortization method and the key assumptions—especially historical and forecasted viewing‑hour consumption—along with data completeness and performed sensitivity analyses (2022 10‑K, p. 41). The 2023 audit repeated the same procedures, again testing those controls, assumptions, data accuracy, and conducting sensitivity analyses (2023 10‑K, p. 40). The identical audit approach indicates that Netflix’s assumptions about future viewing patterns have remained consistent and that the company has not materially altered its methodology between the two years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) All factual elements are correct: the auditor tested Netflix's content amortization method in both 2022 and 2023, focusing on controls, key assumptions (especially historical and forecasted viewing-hour consumption), data completeness/accuracy, and sensitivity analyses. The LLM correctly cites the 10-K pages (p. 41 for 2022, p. 40 for 2023), which supports the accuracy of the claims. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—dates (2022, 2023) are correct. (3) The multi-hop reasoning is sound: the model correctly synthesizes that the repetition of audit procedures across years indicates consistency in Netflix’s assumptions and methodology. (4) The only minor shortcoming is that the LLM answer does not explicitly mention the auditor’s comparison of management’s assumptions to 'current viewing trends and operating information' in 2023, which is included in the ground truth and adds slight contextual depth. However, this omission does not undermine the core conclusion about consistency. The answer is semantically equivalent and conveys the same key message: Netflix’s assumptions and methods remained stable, as evidenced by the unchanged audit approach. Thus, the answer is excellent but not perfect, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 402,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 181,
      "question": "How did the reduction in securities remaining available under equity compensation plans approved by security holders—from 37,028,000 in 2022 to 28,522,000 in 2023—reflect changes in CL's equity compensation strategy and stakeholder engagement over the period?",
      "original_answer": "In 2022, CL reported 37,028,000 securities remaining available under equity compensation plans approved by security holders, indicating a larger pool for future issuance. By 2023, this number had decreased to 28,522,000, showing a reduction of 8,506,000 available securities. This decline suggests that CL utilized a significant portion of its approved equity compensation pool during this period, potentially reflecting increased issuance of equity-based compensation to employees or executives. The change implies a more active use of equity incentives in 2022–2023, which may have been part of a broader strategy to align employee interests with long-term shareholder value, as these plans are typically stakeholder-approved mechanisms designed to enhance retention and performance alignment.",
      "llm_answer": "The 2022 10‑K table (page 61) shows 37,028 000 securities available for future issuance under equity‑compensation plans approved by security holders, while the 2023 table (page 64) shows 28,522 000.  The drop reflects a deliberate narrowing of the equity‑compensation pool—options available fell from 26,038 000 to 19,951 000 and restricted‑stock units from 10,990 000 to 8,571 000—indicating a shift toward a more conservative, shareholder‑aligned strategy that limits dilution.  Because the plans are approved by security holders, the change also signals heightened stakeholder engagement and alignment of compensation with shareholder interests.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in both quantitative and qualitative aspects. While the starting and ending totals (37,028,000 in 2022 and 28,522,000 in 2023) are correctly reported, the breakdowns into options (26,038,000 to 19,951,000) and restricted stock units (10,990,000 to 8,571,000) are not present in the ground truth and cannot be verified. These specific sub-components were not mentioned in the original answer and appear to be fabricated or misattributed, undermining quantitative accuracy. The difference of 8,506,000 is correct (37,028,000 - 28,522,000), but the LLM’s use of this breakdown to support a 'more conservative, shareholder-aligned strategy' contradicts the ground truth interpretation. (2) The original answer interprets the reduction as increased utilization of the equity pool—suggesting active issuance for employee compensation—while the LLM frames it as a 'deliberate narrowing' implying restraint and reduced dilution. This is a fundamental reversal of logic. A decrease in available securities typically indicates usage (issuance), not a tightening of policy. (3) The multi-hop reasoning is flawed: the LLM incorrectly infers that a smaller available pool reflects a conservative strategy, when the ground truth suggests the opposite—that the company is actively using its approved pool, which reflects stakeholder-approved engagement through equity incentives. The mention of 'security holder approval' is contextually relevant but misapplied in reasoning. (4) Despite correct total numbers and relevance to the topic, the incorrect breakdowns and reversed interpretation of strategic intent severely reduce correctness and qualitative accuracy. The answer is contextually relevant but factually and logically unsound in its core conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 493,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 181,
      "question": "How did the change in Lockheed Martin's equity earnings from its investment in ULA between 2023 and 2024 reflect the performance of expendable launch services, and how does this compare to the earlier state of that business relationship in 2022?",
      "original_answer": "In 2022, Lockheed Martin's Space segment included earnings from its 50% ownership stake in ULA, which provides expendable launch services. By 2024, equity earnings from ULA had risen to $45 million (4% of Space's operating profit) from $20 million (2% of operating profit) in 2023, driven by higher launch volume. This increase in earnings suggests improved performance or utilization of expendable launch services in 2024 compared to 2023, building on the foundational relationship established in 2022 when ULA's services were already a contributing factor to Space segment profits.",
      "llm_answer": "Lockheed Martin’s equity earnings from its 50 % stake in United Launch Alliance jumped from about $20 million in 2023 to roughly $45 million in 2024, a 125 % rise that the company attributes to higher launch volume and improved performance of ULA’s expendable launch services (page 41). In 2022, the 10‑K noted that equity earnings were lower than in 2023 and 2024, reflecting a weaker launch‑volume mix and less robust performance of the ULA partnership (page 51).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the increase in equity earnings from $20 million in 2023 to $45 million in 2024, which matches the ground truth. The 125% increase is accurately calculated ((45-20)/20 = 1.25). However, the claim that 2022 earnings were 'lower than in 2023 and 2024' lacks specific support in the original answer — while the original does confirm ULA's contribution in 2022, it does not state that earnings were lower than in 2023, nor provide a specific figure for 2022. This introduces an unsupported inference. (2) Quantitatively, the $20M (2023) and $45M (2024) figures are correct, and the percentage increase is accurate. But no data about 2022 earnings is given in the ground truth, so asserting a decline or weaker performance in 2022 compared to 2023 is not verifiable and represents a factual overreach. (3) The multi-hop reasoning is partially sound — the model correctly links Lockheed’s equity earnings to ULA’s launch volume and performance, and connects this to expendable launch services. However, it incorrectly assumes a comparative decline in 2022 without evidence, weakening the qualitative accuracy. (4) The answer is contextually relevant and addresses all parts of the question, but the unsupported claim about 2022 performance reduces correctness and qualitative accuracy. The core facts for 2023–2024 are correct, warranting a score of 7 for overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 392,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 181,
      "question": "How did Southern Company's financial exposure to regulatory disallowances through Nicor Gas change from 2023 to 2024, given the $72 million after-tax charge in 2023 and the continued recognition of disallowances in property valuation in 2024?",
      "original_answer": "In 2023, Southern Company incurred a $72 million after-tax charge due to regulatory disallowances at Nicor Gas, reflecting the financial impact of capital investment decisions not being recoverable. By 2024, regulatory disallowances remained a material factor, as evidenced by their explicit inclusion in property, plant, and equipment valuations, indicating that the company continued to account for such risks in asset valuation. This shows a temporal evolution where regulatory disallowances transitioned from a realized financial loss in 2023 to a structural consideration in asset accounting by 2024.",
      "llm_answer": "In 2023 Southern Company recorded a $72 million after‑tax expense for regulatory disallowances at Nicor Gas (see Note 2, page 302).  In 2024 the company still faces those disallowances, but they are now reflected as a reduction in the carrying value of property, plant and equipment rather than as a separate charge (see the property, plant and equipment note, page 208).  Thus the exposure remains but the accounting treatment shifted from an expense to an asset‑valuation adjustment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the $72 million after-tax charge in 2023 is correctly stated, and the shift in accounting treatment in 2024 is accurately described. No calculations are required, and all numbers and years (2023, 2024) are correct. (2) The entity names—Southern Company and Nicor Gas—are correct, and the financial metrics (after-tax charge, property, plant and equipment valuation) are properly identified. (3) The multi-hop reasoning is sound: the model correctly synthesizes that the financial exposure evolved from a realized expense in 2023 to an embedded risk in asset valuation in 2024, reflecting a change in accounting presentation rather than elimination of exposure. (4) Semantically, the LLM conveys the same core information as the original answer—regulatory disallowances shifted from an income statement impact to a balance sheet valuation adjustment—though it omits the explicit term 'material factor' or 'structural consideration' used in the ground truth. However, this is a minor wording difference and does not affect factual accuracy. The inclusion of footnote references (Note 2, page 302; page 208) adds precision but is not required for correctness. Overall, the answer is factually complete, contextually relevant, and demonstrates strong qualitative reasoning with only negligible omission in descriptive nuance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 390,
        "total_tokens": 1687
      },
      "error": null
    },
    {
      "question_id": 181,
      "question": "How did the increase in available shares under the Amended 2009 Plan from 12 million in 2023 to 59 million in 2024 influence AMGN's future grant capacity and equity compensation strategy?",
      "original_answer": "In 2023, the Amended 2009 Plan provided for future grants and/or issuances of up to approximately 12 million shares. By 2024, this number had increased significantly to approximately 59 million shares. This increase suggests that AMGN's future grant capacity expanded considerably, likely due to the return of forfeited or canceled awards into the authorized pool under the plan’s rules. The larger pool of available shares in 2024 likely enabled a more aggressive equity compensation strategy, including the issuance of RSUs, stock options, and performance units, which are key tools for attracting and retaining talent. The plan’s fungible share-counting formula—where full-value awards such as RSUs consume 1.9 shares from the pool—also played a role in shaping how these shares were allocated and managed.",
      "llm_answer": "The 2024 10‑K shows that the Amended 2009 Plan’s authorized pool expanded from roughly 12 million shares in 2023 to about 59 million shares in 2024 (page 124, 2024), giving Amgen a much larger pool for future RSUs, options and performance units. This increase in available shares boosts the company’s grant capacity, allowing it to award more equity awards and adjust the mix of awards to support its talent‑retention and incentive strategy while using newly issued shares reserved for the plan (page 124, 2023; page 92).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: the increase from approximately 12 million shares in 2023 to 59 million in 2024 is accurately reported, and no calculations are required beyond this comparison. (2) The LLM correctly identifies the impact on future grant capacity and links it to equity compensation tools like RSUs, options, and performance units, which matches the original answer’s emphasis. (3) The reasoning is sound: the expanded share pool enables a more flexible and potentially aggressive equity compensation strategy, supporting talent retention—this is consistent with the ground truth. (4) The only minor omission is that the LLM does not mention the plan’s fungible share-counting formula (e.g., RSUs consuming 1.9 shares per award), which is a key detail in how the share pool is managed and affects strategic allocation. While this reduces completeness slightly, it does not undermine the core correctness. The citations to the 10-K pages add contextual support. Overall, the answer is factually correct, contextually relevant, and semantically equivalent to the original, with only a small gap in qualitative depth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 340,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 182,
      "question": "How did the vesting periods and compensation structure for AspenTech's stock-based awards evolve from fiscal 2022 to 2023, and what impact did this have on Emerson's post-combination financial reporting?",
      "original_answer": "In fiscal 2022, AspenTech's stock-based compensation plans included only stock options and restricted stock units (RSUs), with RSUs generally vesting over four years. By fiscal 2023, Emerson introduced performance stock units (PSUs) in addition to stock options and RSUs, with both RSUs and PSUs generally vesting over three years. The vesting conditions became more performance-linked in 2023, with PSUs tied to predefined goals based on annual contract value and free cash flows. ASC 805 required Emerson to allocate the fair value of these awards between pre- and post-combination service periods, with the post-combination portion recognized as stock-based compensation expense over the remaining service period. This evolution in compensation structure increased the complexity and forward-looking nature of Emerson’s financial reporting obligations related to AspenTech post-acquisition.",
      "llm_answer": "In fiscal 2022 AspenTech’s RSUs and options vested over a fixed three‑year and four‑year period, respectively, and its performance shares were recognized on a straight‑line basis over a three‑year period. By fiscal 2023 the company introduced performance‑stock units that vest on a cliff basis over three years but allow 25 % of the awards to vest early in each of the first two years, and the compensation mix shifted to include these performance units. Under ASC 805 Emerson had to re‑allocate the fair value of the converted awards between pre‑ and post‑combination service periods, so the portion attributable to the post‑combination period was recognized as stock‑based compensation expense in the post‑combination consolidated statements—raising Emerson’s total stock‑compensation expense from $144 million in 2022 to $271 million in 2023 and increasing the expense recognized in the post‑combination period.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. First, the original answer states that in fiscal 2022, RSUs generally vested over four years; however, the LLM claims RSUs had a three-year vesting period, which contradicts the ground truth. Additionally, the LLM introduces 'performance shares recognized on a straight-line basis over three years' in 2022, but the original answer does not mention performance shares in 2022—only stock options and RSUs. The introduction of PSUs in 2023 is correct, but the LLM adds specific details not in the original, such as 'cliff basis over three years' and '25% of awards vesting early in each of the first two years,' which are unsupported. (2) The LLM cites specific dollar amounts—$144 million in 2022 and $271 million in 2023—for Emerson’s stock compensation expense, but these figures are not present in the original answer and cannot be verified from the provided truth. This is a major quantitative error. (3) The reasoning around ASC 805 is partially correct: the allocation of fair value between pre- and post-combination service periods and the recognition of post-combination expense are accurately described and reflect proper multi-hop synthesis between AspenTech’s award structure and Emerson’s reporting obligations. However, the added details about vesting schedules and financial figures introduce unsupported complexity. (4) While the LLM addresses both parts of the question—evolution of vesting/compensation and impact on Emerson’s reporting—the inclusion of fabricated numbers and vesting mechanics significantly undermines factual correctness. The contextual relevance is high because the structure and intent align with the question, but accuracy is severely compromised by hallucinated data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1466,
        "completion_tokens": 482,
        "total_tokens": 1948
      },
      "error": null
    },
    {
      "question_id": 182,
      "question": "How did the change in Apple's VAR model results from 2022 to 2023 reflect the company's evolving use of foreign exchange derivatives as a risk management tool?",
      "original_answer": "Apple's VAR model estimated a maximum one-day loss in fair value of $1.0 billion as of September 24, 2022, up from $550 million in the prior year, indicating increased exposure or volatility in its foreign exchange derivative positions. By 2023, Apple was using a variance/co-variance technique in its VAR model, which showed a VAR of $255 million at September 28, 2024, down from $284 million at September 30, 2023, due to reduced interest rate volatility. This decrease suggests that Apple's hedging strategies involving foreign exchange derivatives had become more effective or were adjusted in response to market conditions. Supporting this, Apple's 2023 disclosures indicate active use of forwards, cross-currency swaps, and other instruments to hedge term debt and marketable securities from foreign exchange fluctuations, with hedges designated for up to 18 years into the future.",
      "llm_answer": "Apple’s VAR model estimated a maximum one‑day fair‑value loss of **$1.0 billion** in 2022 (page 30) versus **$284 million** in 2023 (page 60). The sharp decline reflects a shift toward a more extensive and efficient FX‑hedging program—Apple increased its use of forwards, options and cross‑currency swaps to cover a larger portion of its forecasted exposure, thereby reducing the potential loss captured by the VAR model (page 59). The 2023 10‑K also reports a higher notional amount of foreign‑exchange contracts ($74.7 billion) compared with 2022, underscoring the expanded hedging activity (page 41).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key numbers and time periods. It states that Apple's VAR was $284 million in 2023, but according to the ground truth, $284 million was the VAR as of September 30, 2023, not for the full year 2023 as implied. More critically, the LLM incorrectly claims a $1.0 billion VAR in 2022 and a drop to $284 million in 2023, which misrepresents the trend. The ground truth shows a $1.0 billion VAR in 2022 (up from $550 million in 2021), but then a further decline to $255 million by September 28, 2024 (not 2023), with $284 million being the 2023 figure. The LLM reverses the timeline and omits the 2024 data point entirely. Additionally, the LLM incorrectly implies the $284 million is the 2023 VAR result without clarifying it is from the prior year’s model or that a methodology shift occurred. (2) The notional amount of $74.7 billion in FX contracts is not contradicted by the ground truth, but the ground truth does not provide this number, so its accuracy cannot be verified. However, the core VAR figures are wrong: the LLM says 2022 VAR was $1.0B and 2023 was $284M, but ground truth shows 2022: $1.0B, 2023 (Sept 30): $284M, and 2024: $255M. The LLM conflates years and fails to mention the model shift to variance/covariance method in 2023. (3) The multi-hop reasoning is partially sound—linking lower VAR to increased hedging activity is consistent with the ground truth—but it is built on incorrect temporal and numerical foundations. The LLM fails to recognize that the $284M is not the 2023 model result but a prior-year figure, and it misses the fact that the 2023 model change (to variance/covariance) produced a $255M VAR in 2024. It also omits the reason for the decrease (reduced interest rate volatility) and Apple’s long-dated hedges (up to 18 years). (4) Scores reflect major quantitative errors (3/10), partial qualitative accuracy in reasoning but flawed entity/year mapping (5/10), high contextual relevance as it addresses FX derivatives and risk management (8/10), and an overall correctness score of 4 due to incorrect core facts despite some plausible narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 578,
        "total_tokens": 1954
      },
      "error": null
    },
    {
      "question_id": 182,
      "question": "How did the change in MetLife's repurchase agreements' reinvestment portfolio from $3,057 million in 2022 to $2,913 million in 2023 reflect the company's strategy adjustments in managing cash collateral received from counterpart?",
      "original_answer": "In 2022, MetLife reported a reinvestment portfolio of $3,057 million under repurchase agreements, which decreased to $2,913 million in 2023. This decline aligns with a reduction in cash collateral received from counterparties, which fell from $3,125 million in 2022 to $2,975 million in 2023. The decrease in both metrics suggests a contraction in the scale of repurchase agreements, potentially indicating a more conservative approach to reinvestment or a strategic reallocation of capital. The reinvestment portfolio's drop of $144 million mirrors the $150 million decline in cash collateral, showing a proportional relationship between the collateral received and how MetLife chose to deploy those funds into its reinvestment portfolio.",
      "llm_answer": "MetLife’s repurchase‑agreement reinvestment portfolio fell from $3,057 million in 2022 to $2,913 million in 2023—a $144 million reduction.  This shift indicates the company chose to hold a smaller portion of the cash collateral it receives in the reinvestment portfolio, thereby keeping more liquidity on hand or reducing exposure to market volatility, as the note on securities lending and repurchase agreements states that the portfolio is monitored and adjusted to maintain a high‑quality, liquid mix.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the reinvestment portfolio values of $3,057 million in 2022 and $2,913 million in 2023, and accurately calculates the $144 million decrease. These numbers match the ground truth exactly, and formatting (e.g., use of 'million') is consistent and acceptable. (2) Quantitative accuracy is perfect—values and the difference are correct. (3) However, the LLM answer does not mention the key multi-hop element: the change in cash collateral received from counterparties ($3,125 million in 2022 to $2,975 million in 2023), which is central to the original answer’s reasoning. While the LLM infers a plausible strategic rationale (increased liquidity, reduced market exposure), it fails to explicitly link the portfolio reduction to the decline in collateral received, missing the proportional relationship ($144M vs $150M drop) emphasized in the ground truth. This omission weakens the multi-hop synthesis required by the question. (4) The answer is contextually relevant and well-articulated, offering a reasonable interpretation based on available data, but lacks completeness in entity and data integration. Hence, correctness and qualitative accuracy are reduced, though quantitative accuracy remains full.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 351,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 183,
      "question": "How did the composition and valuation methodology of MDLZ's Level 1 Financial Assets change between 2022 and 2024, particularly in relation to their use of commodity futures for hedging raw material price risks?",
      "original_answer": "In 2022, MDLZ used commodity futures primarily to hedge forecasted purchases of raw materials like wheat, sugar, soybean oils, and cocoa, with these instruments forming part of their broader derivative portfolio. By 2024, these commodity futures were specifically categorized under Level 1 Financial Assets, which are defined as exchange-traded futures and listed options valued at quoted market prices. This shift indicates a more formalized classification and valuation framework, where the company's exposure to commodity futures became more transparently tied to observable market pricing on exchanges, as opposed to internal models or over-the-counter valuations. The move likely reflects a strategic emphasis on transparency and risk management in derivative instruments.",
      "llm_answer": "In 2022, MDLZ’s commodity contracts were all Level 2 and were valued using an income‑approach based on observable market commodity index prices less the contract rate multiplied by the notional amount (Note 10, 2022, p. 95). By 2024, the company had 683 Level 1 commodity contracts—exchange‑traded futures and listed options—valued at quoted market prices on commodity exchanges (Note 10, 2024, p. 95). This shift reflects a move toward using exchange‑traded commodity futures to hedge raw‑material price risks.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and classifications are correct: the shift from Level 2 in 2022 to 683 Level 1 commodity contracts in 2024 is precisely stated, and the valuation methodology (from income approach based on observable indices to quoted market prices for exchange-traded instruments) is correctly described. The references to Note 10 and page 95 in both years add verifiable detail. (2) The answer correctly identifies the entities (MDLZ), time periods (2022 vs 2024), and financial instruments (commodity futures for hedging raw material risks). (3) The reasoning is sound: it captures the multi-hop element by contrasting the valuation methodologies across years and infers a strategic shift toward exchange-traded instruments, which aligns with the ground truth’s emphasis on transparency and observable pricing. (4) While the LLM does not explicitly mention the specific raw materials (wheat, sugar, etc.) or the broader derivative portfolio context from 2022, these omissions are minor and do not detract from the core factual accuracy. The answer conveys the essential evolution in classification and valuation methodology. Thus, the correctness score is 9 due to slight incompleteness in contextual detail, but quantitative accuracy is perfect, qualitative reasoning is strong, and relevance is full.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 385,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 183,
      "question": "How did Southern Company's exposure to weather risk evolve from 2023 to 2024 as its business mix shifted from traditional gas distribution to expanded solar and wind operations, particularly considering the $1.2 billion decrease in gas distribution revenues in 2023 and the weather-dependent energy output of renewable facilities in 2024?",
      "original_answer": "In 2023, Southern Company Gas faced weather-related risk primarily through customer consumption patterns in its gas distribution operations, where lower-than-expected demand led to a $1.2 billion decrease in operating revenues. With the exception of Atlanta Gas Light, the company used weather normalization mechanisms to mitigate this exposure. By 2024, the company's weather risk profile expanded significantly through Southern Power’s growing solar and wind operations, where energy output—and thus revenue—became directly dependent on weather conditions like sunlight and wind levels. This shift indicates a transition from weather affecting demand in gas distribution to weather directly impacting supply and performance in renewable generation, creating a new dimension of operational and financial risk.",
      "llm_answer": "In 2023, Southern Company’s weather risk was largely contained in its gas‑distribution business, where a $1.2 billion decline in operating revenues was driven by lower gas prices and volumes rather than weather, and the company used weather‑derivative hedges and regulatory rate‑setting to smooth earnings【page_201】. By 2024, the company’s mix had shifted toward solar and wind, whose long‑term PPAs lack capacity charges and tie revenue directly to weather‑dependent output, thereby increasing its exposure to weather variability【page_93】. The company acknowledges this heightened risk and continues to rely on weather‑derivative instruments and other hedging strategies to mitigate it【page_87】.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $1.2 billion decrease in gas distribution revenues in 2023 and the shift toward solar and wind operations by 2024, which increases weather risk due to output dependency on sunlight and wind. However, it inaccurately states that the revenue decline was due to 'lower gas prices and volumes rather than weather,' which contradicts the ground truth that explicitly links the $1.2B decline to weather-related lower-than-expected demand. This is a significant factual error affecting the core reasoning. (2) Quantitatively, the $1.2 billion figure is correctly cited and attributed to 2023 gas distribution revenue decline. No other numbers are present, and their formatting is accurate. The year references (2023 and 2024) are correct. (3) The multi-hop reasoning is partially sound: the model correctly infers that renewable energy output is weather-dependent and that this shifts the nature of weather risk from demand-side (gas) to supply-side (renewables). However, it fails to mention the key detail about weather normalization mechanisms (except for Atlanta Gas Light), which is a critical part of how Southern Company managed risk in 2023. Additionally, the claim that the decline was not due to weather undermines the causal link the question hinges on. (4) The answer remains contextually relevant, addressing both the 2023 and 2024 risk profiles and the business mix shift. Despite correct structure and some accurate insights, the misattribution of the revenue decline reason reduces factual correctness, warranting a score of 6—partially correct but with significant errors in key causal reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 454,
        "total_tokens": 1878
      },
      "error": null
    },
    {
      "question_id": 183,
      "question": "How did Duke Energy Progress' 2024 issuance of $177 million in South Carolina storm recovery bonds relate to the evolution of storm recovery property rights originally established in 2022 for North Carolina storm costs?",
      "original_answer": "In 2022, Duke Energy Progress transferred storm recovery property rights related to North Carolina storm costs (incurred from 2018–2019) to a special purpose subsidiary, which issued bonds secured by the right to collect non-bypassable charges from retail customers. By 2024, Duke expanded this model to South Carolina, issuing $177 million in storm recovery bonds secured by property rights tied to storm costs from 2014–2022. This reflects a geographic and temporal extension of the same financing mechanism, using storm recovery property as the secured asset to fund outstanding regulatory liabilities.",
      "llm_answer": "In 2024, Duke Energy Progress issued $177 million of senior‑secured bonds through its special‑purpose subsidiary DEPSCSF to finance storm costs incurred in South Carolina from 2014‑2022 (page 205).  This issuance built on the storm‑recovery property‑rights framework that was first created in 2022 for North Carolina storm costs, extending the same non‑bypassable charge mechanism to South Carolina and thereby evolving the property rights to cover a broader geographic area.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitative accuracy: The $177 million amount, the 2024 issuance date, and the 2014–2022 storm cost period in South Carolina are all correct. The 2022 establishment of the framework for North Carolina is also correctly cited. (2) Completeness: The answer addresses the core of the question—how the 2024 South Carolina issuance relates to the 2022 North Carolina precedent—by identifying the extension of the financing mechanism across geography. It correctly notes the use of a special-purpose subsidiary and non-bypassable charges, key elements from the original model. (3) Entity accuracy: Duke Energy Progress, the correct timeframes, and the mechanism (storm recovery property rights via securitization) are all accurately identified. (4) Reasoning: The multi-hop synthesis is sound—linking the 2022 North Carolina structure to the 2024 South Carolina expansion—as both use storm recovery property rights secured by customer charges. The only minor omission is not explicitly naming the transferred property rights as the secured asset (though 'senior-secured bonds' implies this), and not mentioning the transfer of rights to a subsidiary in 2022, which slightly reduces qualitative completeness. However, the core logic and factual content are correct. (5) Semantic equivalence: The LLM conveys the same essential information—that Duke extended its established storm recovery financing model from North Carolina to South Carolina—using slightly different but accurate phrasing. Overall, this is a strong, factually correct response with only minor detail omissions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 449,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 183,
      "question": "How did the evolution of BMY's partnership with Ono from 2022 to 2024 influence the development and regulatory trajectory of Opdivo, particularly in light of increasing biosimilar competition risks identified in 2022?",
      "original_answer": "In 2022, BMY identified Opdivo as a key biologic product facing heightened risk from biosimilar competition due to evolving regulatory frameworks in both the U.S. and EU, which could shorten market exclusivity periods. During that year, Ono, as BMY's alliance partner in Japan, played a critical role in expanding Opdivo's indications, including approvals for pediatric Hodgkin lymphoma and combination therapies for RCC. By 2024, BMY had deepened its collaboration with Ono, explicitly listing multiple Opdivo-based regimens (e.g., OPDIVO, OPDUALAG, nivolumab + relatlimab HD) under its development partnerships, signaling a strategic shift toward combination therapies and broader oncology pipeline development. This evolution suggests that BMY leveraged its partnership with Ono to strengthen Opdivo’s lifecycle management in response to the biosimilar threats outlined in 2022.",
      "llm_answer": "BMY’s 2022 10‑K highlighted the growing risk of biosimilar challenges to its biologics, including Opdivo (page 9).  The alliance with Ono—already securing Japanese approvals for Opdivo in pediatric Hodgkin lymphoma, NSCLC and RCC (page 92)—was leveraged to submit supplemental applications and expand indications in 2024, such as adjuvant HCC and peri‑adjuvant MIUC (page 14) and new combination products (Opdualag, Opdivo + Yervoy) (page 15).  This evolution of the partnership accelerated regulatory approvals, broadened the product portfolio, and extended market exclusivity, thereby mitigating the biosimilar‑competition risk identified in 2022.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: BMY identified biosimilar risks to Opdivo in 2022 (per 10-K page 9), and the partnership with Ono supported expansion of indications, particularly in Japan (page 92). By 2024, the collaboration included new combination therapies like Opdualag and Opdivo + Yervoy (pages 14–15), which matches the ground truth’s emphasis on combination regimens such as nivolumab + relatlimab HD. (2) There are no numeric inaccuracies—dates (2022, 2024), drug names, and indications are correctly cited. Page references align with the source document structure, though exact page numbers are not part of the ground truth evaluation; their inclusion suggests fidelity to the filing. (3) The multi-hop reasoning is sound: the model correctly links the 2022 biosimilar threat to strategic lifecycle management via the Ono partnership, culminating in expanded development and regulatory efforts by 2024. (4) Minor deduction in qualitative accuracy due to slight conflation—ground truth emphasizes Ono’s role in Japanese approvals and BMY’s 2024 strategic shift toward combination therapies as a response, while the LLM generalizes the partnership’s output without specifying that some approvals (e.g., pediatric Hodgkin lymphoma) were Japan-specific. Also, the LLM mentions adjuvant HCC and peri-adjuvant MIUC, which are not in the ground truth, but these are plausible extensions and do not contradict it. Overall, the answer captures the core causal trajectory—biosimilar risk prompted deeper collaboration to broaden Opdivo’s portfolio—making it semantically equivalent and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 456,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 183,
      "question": "How did Microsoft's positioning of Learning Experience within Enterprise and Partner Services evolve between 2023 and 2024, and what does the change in reported revenue for this service line suggest about its strategic emphasis during this period?",
      "original_answer": "In 2023, Microsoft's Learning Experience was positioned as part of Enterprise and Partner Services, which included offerings like Enterprise Support Services and Nuance professional services, aimed at helping customers develop, deploy, and manage Microsoft solutions. By 2024, the Learning Experience remained explicitly listed within Enterprise and Partner Services, indicating continued strategic alignment with customer enablement and training. However, the reported revenue for Enterprise and Partner Services decreased from $7,900 million in 2023 to $7,594 million in 2024, suggesting a reduced financial emphasis or potential market saturation in this service area despite its ongoing inclusion in the strategic portfolio.",
      "llm_answer": "Microsoft kept Learning Experience firmly within its Enterprise and Partner Services offering in both years, with the description of that service line unchanged (2023 page 11; 2024 page 12).  However, the revenue reported for Enterprise and Partner Services fell from $7.9 billion in 2023 to $7.6 billion in 2024 (page 93), a modest decline that suggests Microsoft is shifting strategic emphasis away from training‑and‑certification services toward other high‑growth areas of its Intelligent Cloud portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: $7.9 billion in 2023 and $7.6 billion in 2024 match the original $7,900 million and $7,594 million (rounded appropriately). The revenue decline is accurately represented. (2) The entity identification is correct—Microsoft, Learning Experience, Enterprise and Partner Services, and the correct time frame (2023 to 2024) are all properly referenced. (3) The reasoning is sound: the LLM correctly notes that Learning Experience remained within the same service segment in both years, indicating continued strategic inclusion, while the revenue decline suggests reduced emphasis. The conclusion about shifting focus toward high-growth areas in Intelligent Cloud is a reasonable inference, though slightly more interpretive than the original answer’s neutral tone about 'reduced financial emphasis or potential market saturation.' This adds a plausible strategic interpretation not explicitly in the ground truth, but does not contradict it. (4) The answer fully addresses both parts of the question: evolution of positioning (unchanged) and what revenue change suggests about strategic emphasis. Only minor deduction in qualitative accuracy due to the slight shift in tone from descriptive to interpretive, but overall synthesis across years and service lines is correct and contextually relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 390,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 183,
      "question": "What was the impact of META's strategic prioritization of Reels in 2023, which monetized at a lower rate than Feed and Stories, on Facebook's average price per ad metric reported in the 2024 annual filing?",
      "original_answer": "META's strategic prioritization of Reels in 2023, which was explicitly stated to monetize at a lower rate than Feed and Stories, likely contributed to downward pressure on Facebook's average price per ad metric in 2024. The 2023 filing acknowledged that promoting Reels would 'monetize at a lower rate than our feed and Stories products for the foreseeable future,' while the 2024 filing showed Facebook remained central to ad delivery but did not report an increase in average price per ad. This suggests the shift in user engagement toward a less monetizable format may have constrained ad pricing power in the following year.",
      "llm_answer": "Meta’s 2023 filing noted that it would “continue to promote Reels, which we expect will continue to monetize at a lower rate than our feed and Stories products for the foreseeable future”【page_23】.  In the 2024 filing, the company’s average price per ad metric for Facebook – calculated as total advertising revenue divided by the number of ads delivered – was lower than in prior years, reflecting the impact of the lower‑rate Reels format on overall ad pricing【page_68】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) It correctly cites the 2023 filing's statement that Reels would 'monetize at a lower rate than our feed and Stories products for the foreseeable future' and references the correct page (23), supporting the strategic prioritization. (2) It accurately describes the average price per ad metric in the 2024 filing as being 'lower than in prior years' and ties it to the increased delivery of lower-monetizing Reels ads, citing page 68. While the original answer does not explicitly state a numerical decline, it correctly infers downward pressure, which the LLM captures as 'lower than in prior years'—a reasonable interpretation consistent with the knowledge graph. (3) The multi-hop reasoning is sound: it connects the 2023 strategic decision (promoting lower-monetizing Reels) to the 2024 financial outcome (decline in average price per ad), demonstrating correct synthesis across filings and time. (4) All entities—Meta, Facebook, Reels, Feed, Stories, average price per ad, 2023 and 2024 filings—are correctly identified. The only minor limitation is that the LLM states the metric was 'lower' as a definitive fact, while the original answer uses more cautious language ('likely contributed', 'suggests'), reflecting a slightly stronger claim. However, given the context and supporting citation, this does not constitute a factual error. Overall, the answer is semantically equivalent, contextually precise, and quantitatively accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 416,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 184,
      "question": "How did MDLZ's revenue contribution from Chocolate in the AMEA region change from 2022 to 2023, and what does this reveal about the company's regional product strategy?",
      "original_answer": "In 2022, MDLZ generated $2,082 million in Chocolate revenue from the AMEA region, which represented 8.3% of the region’s total net revenues. By 2023, Chocolate revenue in AMEA increased to $2,690 million, continuing to be a significant contributor to the region. This $608 million increase indicates a strategic emphasis on Chocolate in AMEA, aligning with MDLZ's broader focus on high-performing product categories across key geographic markets.",
      "llm_answer": "Chocolate revenue in the AMEA region rose from $2.52 billion in 2022 to $2.69 billion in 2023 – a $170 million increase (about 6.8 %). This uptick shows Mondelēz is actively expanding its chocolate portfolio in AMEA, underscoring a regional strategy that prioritizes growth in chocolate to meet local consumer demand and diversify its product mix.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. According to the ground truth, MDLZ's Chocolate revenue in AMEA was $2,082 million in 2022, but the LLM incorrectly states it as $2.52 billion—a substantial overstatement of $438 million. The 2023 figure of $2.69 billion ($2,690 million) is correct. The calculated increase is therefore wrong: the LLM reports a $170 million increase, whereas the actual increase is $608 million. The percentage growth is also incorrect—6.8% vs. the actual ~29.2% (608/2082 ≈ 0.292). (2) Calculations: The LLM’s $2.69B - $2.52B = $170M is mathematically correct, but based on incorrect inputs. The actual difference ($2,690M - $2,082M = $608M) is accurate in the ground truth. (3) Reasoning: The LLM correctly infers that growth in chocolate revenue reflects a strategic focus on chocolate in the AMEA region, which aligns with the ground truth’s interpretation. This shows sound qualitative reasoning and correct entity identification (MDLZ, Chocolate, AMEA region, 2022–2023). (4) Despite correct contextual understanding and strategic interpretation, the severe numerical inaccuracies—especially the wrong 2022 baseline—undermine the answer’s reliability. The answer is partially correct in direction and logic but fails on core factual precision, warranting a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1203,
        "completion_tokens": 381,
        "total_tokens": 1585
      },
      "error": null
    },
    {
      "question_id": 184,
      "question": "How did AMD's financial obligations under the Wafer Supply Agreement with GF in 2022 influence its dependency risk on GF in 2023, particularly in light of GF's minimum capacity allocation commitments?",
      "original_answer": "In 2022, AMD entered into a Wafer Supply Agreement (WSA) with GF that required AMD to meet annual wafer purchase targets through 2025, with financial penalties for shortfalls. This created a binding financial exposure, as AMD was also obligated to pre-pay GF certain amounts in 2022 and 2023. By 2023, AMD's dependency on GF remained significant, as GF was still required to provide minimum annual capacity allocations under the WSA. However, AMD retained the flexibility to work with other foundries, which partially mitigated dependency risk. Despite this flexibility, if GF failed to meet its capacity obligations, AMD faced significant shipment delays, highlighting that the 2022 agreement still shaped its operational risk profile in 2023.",
      "llm_answer": "AMD’s 2022 wafer‑supply agreement required it to pre‑pay GF for wafers and to hit annual purchase targets, with a penalty for any shortfall. Those financial obligations tied AMD’s wafer supply to GF’s minimum‑capacity allocation, so in 2023 the same terms kept AMD’s operations dependent on GF’s ability to deliver the agreed capacity. If GF failed to meet its minimum allocation, AMD could face shipment delays and a material adverse effect on its business.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core financial obligations and dependency risk described in the ground truth. (1) All factual elements are correct: AMD had pre-payment obligations and annual purchase targets with penalties in 2022 under the Wafer Supply Agreement with GF, which extended into 2023. The risk of shipment delays due to GF's failure to meet minimum capacity allocations is correctly identified. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised—dates (2022, 2023) are correct. (3) The multi-hop reasoning is sound: the model correctly links the 2022 financial commitments to ongoing operational dependency in 2023 and infers the risk of shipment delays if GF underperforms. (4) The only minor omission is that the LLM answer does not mention AMD’s ability to work with other foundries, which partially mitigates dependency risk—a point included in the original answer. This reduces completeness slightly but does not invalidate the overall correctness. The answer remains semantically equivalent in its core claims and is contextually fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 332,
        "total_tokens": 1646
      },
      "error": null
    },
    {
      "question_id": 184,
      "question": "How did the governance constraints in Alphabet's Certificate of Incorporation, which limited dividend differentiation across stock classes in 2022, influence the company's selective repurchase strategy targeting only Class A and Class C shares in 2023, given the differing voting rights structure between these classes?",
      "original_answer": "In 2022, Alphabet's Certificate of Incorporation, governed by Delaware law, included safeguards that prevented the Board from declaring unequal per-share dividends across Class A, B, and C stock without approval from affected stockholders and unanimous board consent (Chunk 1). This governance framework ensured dividend parity across all classes. In 2023, the Certificate of Incorporation was interpreted alongside the company's capital structure, which granted Class B shares 10 votes per share while Class A had 1 vote and Class C had none (Chunk 2). Given these voting rights disparities and the governance constraints on dividend differentiation, Alphabet's Board executed a $62.2 billion share repurchase program in 2023 that exclusively targeted Class A and Class C shares (Chunk 3), likely to avoid altering the existing voting power distribution held by Class B shareholders while still returning capital to less-voting stock classes.",
      "llm_answer": "Alphabet’s 2022 certificate of incorporation and Delaware law expressly barred the board from paying unequal per‑share dividends across its three classes, ensuring that all shares received the same dividend treatment【page_80】.  In 2023 the board therefore limited its share‑repurchase program to Class A and Class C shares—both of which have identical liquidation and dividend rights—because buying back Class B shares would reduce the 10‑vote‑per‑share power of Class B holders and trigger the certificate’s safeguards that require approval from the adversely affected class【page_82】.  Thus, the company could return capital while preserving the voting‑rights balance mandated by the governance constraints.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) All key facts are correct: Alphabet’s 2022 Certificate of Incorporation, governed by Delaware law, prevented unequal dividends across share classes without affected stockholder approval and unanimous board consent, ensuring dividend parity. In 2023, the repurchase program targeted only Class A and Class C shares. The dollar amount of $62.2 billion is not mentioned in the LLM answer, but the original answer includes it as contextual detail, and the LLM answer does not contradict it—its omission does not reduce correctness as the question does not explicitly ask for the amount. (2) Quantitative accuracy: No incorrect numbers; the absence of the $62.2B figure is not a factual error, as the LLM answer focuses on the rationale rather than the size of the repurchase. All dates (2022, 2023) and voting rights (10 votes for Class B, 1 for Class A, 0 for Class C) are correctly stated. (3) Reasoning is sound and reflects multi-hop synthesis: the LLM correctly links governance constraints on dividend differentiation to the strategic decision to exclude Class B shares from repurchases to avoid triggering approval requirements and altering voting power. It correctly infers that repurchasing Class B shares would dilute the concentrated voting power held by that class and potentially trigger governance safeguards. (4) The answer addresses all parts of the question: the influence of governance constraints, the selective repurchase strategy, and the role of differing voting rights. Wording differs slightly but meaning is preserved. Thus, all scores are 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1456,
        "completion_tokens": 453,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 184,
      "question": "How did the voting rights associated with Class C common stock change between 2022 and 2023, particularly in relation to the approval of amendments to Visa's certificate of incorporation?",
      "original_answer": "In 2022, Class C common stockholders had no voting rights except for specific matters such as exiting the core payments business or certain corporate transactions, but they could not vote on amendments to the certificate of incorporation that solely affected preferred stock. By 2023, Class C common stockholders gained the right to vote as a separate class alongside Class A and B common stockholders on the approval of certain amendments to the certificate of incorporation, including those affecting the terms of Class B or C common stock. This expansion of voting rights in 2023 increased the influence of Class C stockholders on corporate governance decisions.",
      "llm_answer": "In 2022, Visa’s Class C common stockholders had no voting rights on amendments to the certificate of incorporation (they could only vote on a few defined corporate actions).  By 2023, the company’s charter was amended to allow Class A, B and C common stockholders to vote separately on any amendment to the certificate of incorporation, giving Class C holders a new voting right on such amendments.  【page_93】【page_90】",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. (1) It accurately states that in 2022, Class C common stockholders had no voting rights on amendments to the certificate of incorporation, only on limited corporate actions. By 2023, they gained the right to vote as a separate class on such amendments—this matches the original answer’s core claim. (2) There are no numeric values (e.g., percentages, dollar amounts) in the question or ground truth, so quantitative accuracy is not applicable beyond correct use of years (2022 and 2023), which are accurate. (3) The multi-hop reasoning is sound: the model correctly synthesizes changes in voting rights across two years and links them to charter amendments. The only minor omission is that the original answer specifies that the new voting rights apply to amendments affecting Class B or C stock terms, which adds slight nuance the LLM answer doesn’t explicitly mention. However, stating that Class C now votes 'on any amendment' is broadly consistent with the expanded rights. (4) The answer is highly relevant, directly addressing the question about changes in voting rights related to certificate of incorporation amendments. The inclusion of citation tags like 【page_93】【page_90】 suggests grounding in source material. Overall, the answer is semantically equivalent with only minor detail omission, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 396,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 185,
      "question": "How did Southern Company's approach to goodwill impairment testing for PowerSecure evolve between 2022 and 2023, and what were the financial implications of this evolution?",
      "original_answer": "In 2022, Southern Company performed a quantitative assessment for PowerSecure, which revealed that its fair value was lower than its carrying amount, resulting in a $119 million goodwill impairment. In 2023, PowerSecure again underwent a quantitative assessment, but this time the fair value exceeded the carrying amount, indicating an improvement in its financial outlook. This evolution suggests that Southern Company's approach remained consistent in conducting quantitative assessments when necessary, but the change in outcome reflects a recovery in PowerSecure's performance or market conditions. The absence of an impairment in 2023 had a positive financial impact, avoiding further write-downs and signaling improved asset valuation.",
      "llm_answer": "Southern Company continued to use a **quantitative impairment test** for PowerSecure in both years, but the outcome changed. In 2022 the test found PowerSecure’s fair value below its carrying amount, resulting in a **$119 million goodwill impairment** recorded in Q4 2022【page 175】. In 2023 the same quantitative assessment was performed again, but the fair value exceeded the carrying amount, so **no impairment charge was recorded**【page 175】, improving reported earnings by the amount of the prior‑year impairment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Southern Company used a quantitative goodwill impairment test for PowerSecure in both 2022 and 2023; in 2022, a $119 million impairment was recorded due to fair value falling below carrying amount; in 2023, fair value exceeded carrying amount, so no impairment was recorded. The dollar amount ($119 million), years (2022 and 2023), and outcomes (impairment vs. no impairment) match the original answer exactly. (2) Quantitative accuracy is perfect—$119 million is correctly cited, and the absence of an impairment charge in 2023 is accurately stated. The reference to Q4 2022 and page 175 adds precision, though not required. (3) The multi-hop reasoning is sound: the model correctly synthesizes that the approach (quantitative test) remained consistent, but the outcome changed, reflecting improved financial conditions. It infers the positive financial impact of avoiding an impairment, which is logically valid and supported by the ground truth. (4) The only minor omission is a brief mention of the broader implication—while the LLM notes improved reported earnings, it doesn’t explicitly state that this signals improved asset valuation or recovery in performance, as in the original answer. However, this is implied. Wording differs slightly but maintains semantic equivalence. Contextual relevance is excellent—every part of the question is addressed directly and concisely.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 408,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 185,
      "question": "How did the expiration of MRK's distribution agreement with Janssen Pharmaceuticals in 2024 affect its exposure to the IRA's Medicare drug pricing pressures compared to 2022?",
      "original_answer": "In 2022, MRK maintained a distribution agreement with Janssen Pharmaceuticals, which was actively challenging the IRA's Medicare drug pricing provisions in court, signaling strategic resistance to the law's pricing constraints. By 2024, with the distribution agreement expired, MRK faced direct exposure to the IRA’s pricing mechanisms, including the government-set pricing for Januvia effective in 2026 and the anticipated inclusion of Keytruda in 2028. This transition removed any indirect buffer Janssen may have provided through litigation, leaving MRK to directly navigate the financial and regulatory risks associated with the IRA’s mandatory pricing scheme, which it now acknowledges will likely result in reduced U.S. sales for affected products.",
      "llm_answer": "The 2024 10‑K notes that MRK’s distribution agreement with Janssen expired on Oct. 1, 2024, and that the company now faces intensified Medicare pricing pressure under the IRA【MRK_10k_2024.pdf: page_32】. In 2022 the agreement was still in effect, so MRK had less exposure to the IRA’s Medicare pricing pressures【MRK_10k_2022.pdf: page_17】. Thus, the agreement’s expiration in 2024 increased MRK’s exposure to the IRA’s Medicare drug pricing pressures relative to 2022.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the expiration of MRK's distribution agreement with Janssen Pharmaceuticals on October 1, 2024, and notes reduced exposure to IRA pricing pressures in 2022 when the agreement was active. These core facts are accurate and supported by the cited 10-K pages. However, the LLM omits key qualitative details present in the ground truth, such as Janssen’s active legal challenge to the IRA in 2022, which provided a strategic buffer, and the specific future impact on MRK’s products like Januvia (2026) and Keytruda (2028) under government-set pricing. (2) Quantitatively, the dates (2022 agreement in effect, 2024 expiration) are correct, and no numerical calculations are required. The October 1, 2024 expiration date is accurately cited from MRK_10k_2024.pdf page 32, and the 2022 exposure context is correctly referenced. (3) The multi-hop reasoning is partially sound—LLM correctly infers increased IRA exposure post-expiration—but fails to fully synthesize the strategic implications of Janssen’s litigation as an indirect buffer, which is central to the ground truth’s explanation of reduced 2022 exposure. The answer simplifies the mechanism of reduced exposure without explaining *why* the agreement lessened IRA pressure. (4) The correctness score is 7 because while the main factual trajectory (less exposure in 2022, more in 2024) is correct, the answer lacks depth in explaining the *mechanism* of exposure change. Quantitative accuracy is high (9) due to correct dates and no numerical errors. Qualitative accuracy is 7 due to missing strategic context and product-specific impacts. Contextual relevance is 9 as the response directly addresses the question’s focus on comparative exposure over time.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 478,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 185,
      "question": "How did Apple's 2022 sales performance in Greater China influence its exposure to supply chain risks tied to Taiwan-based manufacturing partners in 2024?",
      "original_answer": "Apple reported $74.2 billion in net sales from Greater China in 2022, which includes Taiwan. This significant revenue contribution from the region likely reinforced Apple’s continued reliance on manufacturing partners based in Taiwan, as highlighted in the 2024 filing, where geopolitical tensions and supply chain disruptions in Taiwan were cited as material risks. The inclusion of Taiwan in the Greater China segment in 2022 shows Apple's operational integration of the region, which in 2024 translated into a strategic dependency on its manufacturing infrastructure, increasing exposure to potential geopolitical and operational disruptions.",
      "llm_answer": "Apple’s Greater China net sales rose 9 % to $74.2 billion in 2022, driven by stronger iPhone and services demand (page 52). That growth deepened the company’s reliance on manufacturing partners located in Greater China and Taiwan, a concentration the 2024 10‑K identifies as a key supply‑chain risk (pages 9 and 11). Consequently, the 2022 sales momentum in Greater China amplified Apple’s exposure to potential disruptions from Taiwan‑based partners in 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is factually correct and aligns closely with the ground truth. It accurately reports Apple's 2022 Greater China net sales as $74.2 billion and correctly notes the 9% growth (which matches the 2022 10-K, page 52). The reference to increased reliance on manufacturing partners in Taiwan and Greater China is consistent with the 2024 10-K risk disclosures (pages 9 and 11). The conclusion that strong 2022 sales amplified exposure to Taiwan-based supply chain risks in 2024 is logically sound and semantically equivalent to the original answer.\n\n2) Quantitative accuracy is perfect: $74.2 billion, 9% growth, and correct years (2022 sales, 2024 risk context) are all accurate. No calculations are required beyond what is reported, and the figures match the source.\n\n3) The multi-hop reasoning is strong: the model correctly links 2022 sales performance in Greater China to ongoing strategic reliance on Taiwan-based manufacturing, and then connects that dependency to supply chain risks disclosed in 2024. It correctly identifies the causal chain: high sales → deeper reliance → increased exposure to geopolitical and operational risks in Taiwan. The only minor shortcoming is that it does not explicitly clarify that 'Greater China' includes Taiwan in Apple's reporting segment (a nuance present in the ground truth), which slightly weakens the explanation of why Taiwan is grouped in the sales figure. However, this does not invalidate the reasoning.\n\n4) Contextual relevance is excellent—the answer directly addresses how 2022 sales performance influenced 2024 supply chain risk exposure, using appropriate evidence from both time periods. The qualitative accuracy is high but not perfect due to the omitted clarification about segment reporting, which slightly reduces precision in entity mapping. Overall, the answer is factually correct, well-supported, and logically structured.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 513,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 186,
      "question": "How did PepsiCo's acquisition of Sabra Dipping Company in December 2024 impact the structure and strategic positioning of Sabra's refrigerated dips and spreads business, compared to its joint venture status in 2023?",
      "original_answer": "In 2023, Sabra operated as a joint venture between PepsiCo and Strauss Group, producing refrigerated dips and spreads under the FLNA division. By December 2024, PepsiCo acquired the remaining 50% ownership stake from Strauss Group, making Sabra a wholly-owned subsidiary. This acquisition allowed PepsiCo to fully control the production, marketing, and distribution of Sabra refrigerated dips and spreads, likely enhancing integration with FLNA’s branded convenient foods portfolio and enabling more direct strategic alignment. The change in ownership structure reflects a shift from shared control to full internalization of the brand, which could improve operational efficiency and market responsiveness.",
      "llm_answer": "Before the December 2024 transaction, Sabra Dipping Company operated as a 50‑50 joint venture with the Strauss Group, with the joint venture handling the manufacturing, marketing and distribution of Sabra refrigerated dips and spreads under PepsiCo’s Frito‑Lay North America umbrella【page_5 of 2023】. The acquisition of Strauss’s stake turned Sabra into a wholly‑owned PepsiCo subsidiary, giving PepsiCo full ownership and control and allowing the dips and spreads line to be fully integrated into PepsiCo’s Frito‑Lay North America division and its broader strategic focus on convenient foods【page_5 of 2024】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Sabra was a 50-50 joint venture between PepsiCo and Strauss Group in 2023, and in December 2024, PepsiCo acquired the remaining stake to make Sabra a wholly-owned subsidiary. The business operated under Frito-Lay North America (FLNA), which is correctly referenced. (2) Quantitative elements—ownership percentages (50-50), timing (December 2024), and structural change (joint venture to wholly-owned)—are all factually accurate. No numerical calculations were required, but the dates and ownership stakes match exactly. (3) The reasoning is sound: the LLM correctly infers that full ownership enables full integration into FLNA and supports PepsiCo’s strategic focus on convenient foods, which is consistent with the original answer’s implication of improved operational efficiency and strategic alignment. (4) The only minor shortcoming is that the LLM does not explicitly mention Strauss Group by name in the context of the 2024 transaction (though it is mentioned in the 2023 context), and the original answer emphasizes 'production, marketing, and distribution' control, which the LLM summarizes as 'ownership and control'—a slight compression but not inaccurate. Overall, the answer is semantically equivalent, highly relevant, and demonstrates correct multi-hop reasoning across time and ownership structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 391,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 186,
      "question": "How did SO's ownership structure and capacity control of the Skookumchuck wind project evolve between 2022 and 2024, and what does this reveal about their long-term wind energy strategy given the typical 30-year useful life of wind assets?",
      "original_answer": "In 2022, SO's Skookumchuck wind project had a nameplate capacity of 136 MW and was listed as completed in November 2020. By 2024, SO maintained control of Skookumchuck through a tax equity partnership structure, where it acted as the controlling partner. This continuity in ownership aligns with SO's broader wind energy portfolio, which has a typical 30-year useful life for wind assets, suggesting a long-term strategic commitment to wind energy through structured partnerships.",
      "llm_answer": "Between 2022 and 2024 Southern Power shifted from owning the Skookumchuck wind facility outright to being the controlling partner in a tax‑equity partnership that owns the project, while a non‑controlling equity interest in the partnership is held by another partner (2022: 100 % ownership of the Class B membership; 2024: controlling partner with a non‑controlling equity stake). The nameplate capacity stayed the same at 136 MW (136,800 kW), showing that Southern Power has maintained full operational control of the asset. This evolution—retaining control while using tax‑equity structures to monetize equity—underscores a long‑term wind strategy that leverages the typical 30‑year useful life of wind assets to secure stable, renewable generation while optimizing capital structure.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 136 MW nameplate capacity and the shift to a tax-equity partnership structure by 2024, which aligns with the ground truth. However, the claim that SO (Southern Power) shifted from '100% ownership in 2022' to a controlling partner in 2024 is not supported by the original answer, which does not state SO had full ownership in 2022—only that it maintained control through a tax equity structure by 2024. This introduces an unsupported inference about ownership change that isn't in the ground truth. (2) Quantitatively, the 136 MW capacity is accurate and correctly formatted (including kW equivalent). No dates or financial figures are incorrect, though the original does not specify ownership percentages in 2022, so the '100%' claim lacks verification. (3) The multi-hop reasoning is partially sound: the model connects ownership structure, capacity stability, and long-term strategy using the 30-year asset life, which is consistent with the original’s conclusion. However, the reasoning overreaches by asserting a shift from full ownership to partnership without evidence in the ground truth, weakening the qualitative accuracy. (4) Despite this, the answer remains contextually relevant, addressing all parts of the question—evolution of ownership, capacity, and strategic implications—and draws a reasonable (though slightly overinterpreted) conclusion about long-term strategy. Thus, correctness is reduced due to unsupported ownership transition claim, but core facts and strategic insight remain largely aligned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 432,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 186,
      "question": "How did the fair value of MDT's investments in fixed income commingled trusts change from 2022 to 2023, and what was the corresponding impact on the total investments measured at net asset value across those years?",
      "original_answer": "In 2022, MDT reported $1,069 million in fair value for fixed income commingled trusts, which decreased to $968 million in 2023, a decline of $101 million. This reduction contributed to a broader trend where total investments measured at net asset value fell from $2,350 million in 2022 to $2,179 million in 2023, a decrease of $171 million. The drop in fixed income commingled trusts was a significant component of this overall decline, reflecting a strategic shift or market-driven revaluation in MDT's investment portfolio.",
      "llm_answer": "The fair value of Medtronic’s fixed‑income commingled trusts fell from **$1,069 million in 2022 to $968 million in 2023** – a decline of **$101 million**.  This drop was reflected in the overall net‑asset‑value‑measured investments, which decreased from **$2,350 million in 2022 to $2,179 million in 2023**, a **$171 million** reduction.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the fair value of fixed income commingled trusts decreased from $1,069 million in 2022 to $968 million in 2023, a difference of $101 million, and total investments measured at net asset value declined from $2,350 million to $2,179 million, a reduction of $171 million. These values and calculations are precisely correct. (2) The answer is complete, addressing both parts of the question: the change in fair value of fixed income commingled trusts and its impact on total NAV-measured investments. (3) Entity accuracy is correct—MDT (Medtronic) is properly identified, and the years (2022 to 2023) and financial metrics (fair value, investments at net asset value) are accurately used. (4) The reasoning is sound and reflects proper multi-hop synthesis: the decline in the specific asset class is correctly positioned as part of the broader decline in total NAV-based investments, logically implying its contribution without overclaiming causality. (5) While the LLM omits the interpretive phrase about 'strategic shift or market-driven revaluation,' this does not affect factual correctness, as the core data and relationships are preserved. The answer is semantically equivalent and fully aligned with the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 373,
        "total_tokens": 1605
      },
      "error": null
    },
    {
      "question_id": 187,
      "question": "How did changes in MetLife's application of Statutory Accounting Practices in 2022 affect the treatment and disclosure of Surplus Notes in 2023, particularly in relation to regulatory dividend restrictions and capital structure?",
      "original_answer": "In 2022, MetLife's statutory accounting practices treated surplus notes as surplus rather than debt, which directly influenced the statutory capital and surplus calculations of its U.S. insurance subsidiaries. This treatment impacted the calculation of dividend capacity, as statutory surplus levels were affected by these accounting practices. By 2023, surplus notes remained subordinate to other obligations but required prior regulatory approval for interest and principal payments, reflecting the ongoing influence of statutory accounting on capital structure and liquidity planning. The 2022 surplus levels, shaped by statutory accounting, directly influenced the 2023 disclosures around surplus note prioritization and regulatory constraints on capital distributions.",
      "llm_answer": "In 2022 MetLife changed its application of statutory accounting practices so that surplus notes are reported as surplus rather than debt (see Note 16 on pages 136 and 292).  This reclassification lowered the company’s reported debt load and altered the surplus base used in the statutory dividend‑restriction tests.  In 2023 the surplus notes are disclosed as part of the collateral‑financing arrangement with a carrying value of $637 million (down from $716 million in 2022) and are senior to MetLife’s own debt but subordinate to other obligations, with payment contingent on South Carolina regulatory approval—linking the notes to both the capital structure and the regulatory dividend limits.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key change in MetLife's statutory accounting in 2022—reclassifying surplus notes as surplus rather than debt—and links this to impacts on statutory capital, dividend restrictions, and capital structure, which aligns with the ground truth. However, it introduces a specific dollar amount ($637 million in 2023 and $716 million in 2022) that is not present in the original answer and cannot be verified against the provided ground truth, raising concerns about factual accuracy. Additionally, the claim that surplus notes are 'senior to MetLife’s own debt' contradicts the original answer, which states they are 'subordinate to other obligations' without mentioning seniority to MetLife’s debt—this is a significant qualitative error. (2) The quantitative values ($637M, $716M) are not supported by the ground truth and appear to be hallucinated or pulled from external data not referenced in the original answer; thus, quantitative accuracy is compromised. The years (2022, 2023) and note references (Note 16, pages 136, 292) are plausible but not confirmed in the ground truth, which does not include such citations. (3) The multi-hop reasoning is mostly sound: the model connects the 2022 accounting change to its effect on statutory surplus, dividend capacity, and 2023 disclosures around regulatory constraints. It correctly emphasizes the need for regulatory approval for payments, linking statutory treatment to capital planning. However, the erroneous claim about seniority undermines the reasoning chain. (4) The contextual relevance is high—the answer addresses regulatory dividend restrictions, capital structure, and disclosure impacts as required. Qualitative accuracy is good but reduced due to the incorrect seniority assertion. Correctness score is 7 because core facts about the accounting change and its implications are correct, but significant errors in entity relationships (seniority) and unsupported numerical data reduce confidence in full accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 545,
        "total_tokens": 1933
      },
      "error": null
    },
    {
      "question_id": 188,
      "question": "How did the change in KO's tax treatment related to the Tax Reform Act in 2022 affect its effective tax rate in relation to its operations in the Philippines, and how did this evolve in 2023 with the shift in KO's indefinite reinvestment assertion for those operations?",
      "original_answer": "In 2022, KO experienced a $375 million net tax charge (3.0% impact on effective tax rate) due to changes in tax laws in foreign jurisdictions, including the impact of the Tax Reform Act’s GILTI provisions. This regulation influenced KO’s tax exposure in the Philippines, where a corporate income tax rate reduction was enacted in Q1 2021. By 2023, KO recorded a $88 million tax benefit (0.7% impact) tied to a change in its indefinite reinvestment assertion for its Philippines and Bangladesh bottling operations, signaling a shift in how the company manages its foreign earnings in alignment with evolving tax policies and strategic positioning in the region.",
      "llm_answer": "In 2022, Coca‑Cola’s adoption of the Tax Reform Act’s GILTI rules increased the overall tax burden on its foreign earnings, but the company’s shift to an **indefinite‑reinvestment** policy for its Philippines (and Bangladesh) bottling operations produced a net tax benefit of **$88 million**—a 0.7 percentage‑point reduction in the effective tax rate for those operations (page 109, effective‑tax‑rate table on page 107).  In 2023 the same $88 million benefit from the indefinite‑reinvestment assertion was recorded again, and the company’s total effective tax rate fell to **17.4 %** from **18.1 %** in 2022, indicating a continued, though modest, tax‑rate decline for the Philippines operations (page 107).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly states that the $88 million tax benefit occurred in 2022 due to the indefinite reinvestment policy, when in fact this benefit was recorded in 2023. The ground truth indicates that in 2022, KO incurred a $375 million net tax charge (3.0% impact on ETR) due to tax law changes including GILTI, not a benefit. The $88 million benefit (0.7% impact) occurred in 2023 due to a change in reinvestment assertion for Philippines and Bangladesh operations. The LLM reverses the timeline and misattributes the benefit to 2022. Additionally, while the LLM correctly cites the drop in effective tax rate from 18.1% to 17.4%, it incorrectly links this change directly to the Philippines operations and the 2022 benefit, when the rate change is company-wide and the tax benefit in question occurred in 2023. (2) Quantitative inaccuracies include: misplacement of the $88 million benefit in 2022 instead of 2023, incorrect assignment of the benefit to the GILTI adoption (which was a charge, not a benefit), and incorrect causal linkage between the benefit and the ETR decline. The ETR numbers (18.1% in 2022, 17.4% in 2023) are accurate but misinterpreted in context. (3) The multi-hop reasoning is flawed: the model fails to correctly synthesize the sequence of events—2022 tax charge due to GILTI and foreign tax changes, followed by 2023 benefit due to reinvestment assertion change. It conflates two distinct events and misassigns causality and timing. (4) Despite these major errors, the answer is contextually relevant, addressing the right companies (KO), operations (Philippines), and tax concepts (GILTI, indefinite reinvestment). Some correct numbers are present but used incorrectly. Hence, partial credit is given for relevance and partial data accuracy, but major deductions for factual and logical errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 511,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 188,
      "question": "How did the change in NEE's discounted cash flow valuation technique for forward contracts - power between 2023 and 2024 affect the fair value of these contracts, particularly considering the shift in weighted-average forward price per MWh?",
      "original_answer": "In 2023, NEE valued forward contracts - power using discounted cash flow with a weighted-average forward price of $49 per MWh, resulting in a fair value of $500 million in assets and $470 million in liabilities. By 2024, the weighted-average forward price increased to $52 per MWh, yet the fair value of forward contracts - power decreased to $423 million in assets and $401 million in liabilities. This indicates that while the per-unit pricing increased slightly, broader market or volume adjustments likely contributed to a lower overall fair value of the contracts.",
      "llm_answer": "Between 2023 and 2024 NEE’s discounted‑cash‑flow valuation of power forward contracts shifted to a higher weighted‑average forward price per MWh (from $49 to $52).  Despite that, the fair‑value of the contracts fell—assets dropped from $500 million to $423 million and liabilities from $470 million to $401 million—showing that other valuation inputs (e.g., discount rates or volatilities) changed more significantly and offset the effect of the higher forward price.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All numeric values are correct: the weighted-average forward price increased from $49 to $52 per MWh; assets decreased from $500 million to $423 million; liabilities decreased from $470 million to $401 million. These match the original answer exactly, satisfying quantitative accuracy. (2) The answer is complete, addressing the change in valuation technique (implied through the shift in forward price), the actual change in fair value, and the apparent contradiction between rising prices and falling fair value. (3) Entities—NEE, forward contracts - power, years 2023 and 2024—are correctly identified. (4) The reasoning is sound: the LLM correctly infers that despite the increase in forward prices, the overall fair value declined, suggesting that other factors (e.g., discount rates, volume adjustments, or volatility) had a more significant negative impact. While the original answer references 'broader market or volume adjustments,' the LLM plausibly generalizes this to 'other valuation inputs (e.g., discount rates or volatilities),' which is a reasonable interpretation consistent with valuation theory. The only minor point is that the LLM does not explicitly mention 'volume adjustments' as in the original, slightly reducing qualitative precision, but the core logic and synthesis across years and metrics remain strong. Thus, the answer is factually correct, contextually relevant, and demonstrates proper multi-hop reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 416,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 188,
      "question": "How did Microsoft's acquisition of Activision Blizzard in October 2023 influence the transition of its senior note trusteeship from Wells Fargo Bank to Computershare Trust Company in October 2024, and what impact did this have on the internal control reporting for Microsoft's consolidated financial statements?",
      "original_answer": "Microsoft's acquisition of Activision Blizzard in October 2023 triggered a restructuring of its debt obligations, including the administration of senior notes. As evidenced in the 2024 10-K filing, by October 2024, Computershare Trust Company, N.A. replaced Wells Fargo Bank, National Association as the trustee for Activision Blizzard's 3.400% Senior Notes due 2026, 1.350% Senior Notes due 2030, and other obligations. This transition is directly linked to Microsoft's acquisition and subsequent integration of Activision Blizzard’s financial structure. Notably, the 2024 audit report explicitly states that Activision Blizzard’s internal controls were excluded from the assessment, representing less than 1% of Microsoft's total assets and 2% of total revenues, which may reflect the complexity and timing of integrating a newly acquired subsidiary’s financial reporting systems into Microsoft’s broader internal control framework.",
      "llm_answer": "Microsoft’s acquisition of Activision Blizzard on Oct 13 2023 prompted Microsoft to change the trustee for the senior notes tied to the deal from Wells Fargo Bank to Computershare Trust Company, as documented in the supplemental indentures filed in Oct 2023 (exhibits 4.23‑4.26)【page_107】.  The transition was reflected in the 2024 10‑K, but it did not materially affect Microsoft’s internal‑control assessment; management excluded Activision’s internal controls (less than 1 % of assets and 2 % of revenue) and still concluded that internal control over financial reporting was effective as of June 30 2024【page_98】【page_99】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers, dates, and percentages are correct: acquisition date (Oct 13, 2023), exclusion of less than 1% of assets and 2% of revenue, and the June 30, 2024 internal control assessment date are all factually consistent with the original answer and SEC filing details. The reference to supplemental indentures in October 2023 (exhibits 4.23–4.26) and 2024 10-K pages adds precision. (2) The entity names—Microsoft, Activision Blizzard, Wells Fargo Bank, Computershare Trust Company—are correctly identified, and the financial instruments (senior notes) are accurately contextualized. (3) The reasoning correctly links the acquisition to the trustee transition and explains the exclusion of Activision Blizzard’s internal controls from the audit, reflecting proper multi-hop synthesis between the acquisition event, debt administration changes, and internal control reporting. (4) The only minor shortcoming is that the LLM answer does not explicitly name the specific senior notes (e.g., 3.400% due 2026, 1.350% due 2030), which are mentioned in the ground truth, slightly reducing qualitative completeness. However, this omission does not undermine the core factual accuracy. The answer correctly concludes that internal control over financial reporting was deemed effective despite the exclusion, which is the key takeaway. Overall, the response is semantically equivalent, contextually precise, and factually sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 415,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 188,
      "question": "How did the conversion dynamics between Class A and Class B common stock in 2022 influence the voting power distribution in 2023, given the specific non-dilutable 33 1/3% voting threshold for Class B shares?",
      "original_answer": "In 2022, Class A common stockholders held 66 2/3% of the combined voting power, while Class B common stockholders held a non-dilutable 33 1/3%, with each Class B share carrying 15 votes. Class B shares were convertible into Class A shares on a one-to-one basis, subject to restrictions. By 2023, the issued and outstanding Class B common stock had decreased to 9,444,375 shares, while Class A shares issued increased from 4,842,108,959 in 2022 to 5,083,466,045 in 2023. This suggests potential conversions occurred, yet the non-dilutable voting threshold for Class B remained intact due to structural protections in the articles of incorporation. The voting power distribution remained stable at 66 2/3% for Class A and 33 1/3% for Class B, indicating that despite conversions, the entity chain preserved the foundational governance structure.",
      "llm_answer": "In 2022 Comcast’s Class B shares could be converted to Class A on a share‑for‑share basis, but no conversions occurred, so the Class B voting power stayed at the non‑dilutable 33 ⅓ % of the combined voting power in 2023【page_38】.  The only change to the voting mix in 2023 was the repurchase of Class A shares, which cut the Class A outstanding from 4.21 B to 3.97 B shares【page_69】, while the Class B shares remained at 9,444,375 and continued to represent 33 ⅓ % of voting power.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains multiple factual inaccuracies. It incorrectly states that 'no conversions occurred' between Class A and Class B shares in 2022, which directly contradicts the ground truth that indicates conversions likely occurred due to an increase in Class A shares (from 4,842,108,959 in 2022 to 5,083,466,045 in 2023) and a decrease in Class B shares to 9,444,375 by 2023. The LLM also incorrectly claims that Class A shares decreased due to repurchases, stating a drop from 4.21B to 3.97B, which is not supported by the ground truth and misrepresents the actual increase in Class A shares. (2) Quantitative accuracy is severely compromised: the ground truth reports Class A shares increasing by over 241 million, while the LLM asserts a reduction of 240 million shares due to repurchases—this is a complete reversal of the actual trend. Additionally, the LLM cites incorrect starting and ending figures for Class A shares (4.21B and 3.97B vs. actual 4.84B and 5.08B), and while the 9,444,375 Class B shares figure is correct, it is misinterpreted as static without conversion. The 33 1/3% non-dilutable voting threshold is correctly noted, but the reasoning for its preservation is flawed. (3) Multi-hop reasoning fails: the LLM does not correctly synthesize the relationship between share conversions, changes in outstanding shares, and the structural protection of voting power. It incorrectly infers no conversions due to stable voting power, ignoring the ground truth explanation that conversions can occur without diluting Class B's voting share due to charter protections. The model also introduces irrelevant information about share repurchases not present in the original data. (4) Contextual relevance is moderate because the answer addresses voting power distribution and the non-dilutable threshold, but the incorrect data and reasoning undermine the conclusion. The mention of Comcast (not named in the original) introduces an unverified entity, further reducing accuracy. Overall, the answer is factually incorrect on key quantitative and qualitative points, despite capturing the high-level concept of non-dilutable voting rights.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 581,
        "total_tokens": 1928
      },
      "error": null
    },
    {
      "question_id": 189,
      "question": "How did the change in MDLZ's VAR model assumptions between 2023 and 2024 impact the reported value of forecasted transactions in 2024, particularly in relation to the company's interest rate and commodity exposure?",
      "original_answer": "In 2023, MDLZ's VAR model used a parametric deltagamma approximation technique to estimate expected return distributions for interest rates, currencies, and commodities, based on prior quarter observations. By 2024, the VAR model showed a decrease in combined VAR from $284 million to $255 million, attributed to reduced interest rate volatility. This change in the VAR model's output coincided with a significant increase in the reported value of forecasted transactions from $2 million (2023) to $106 million (2024), particularly in interest payments and cost of sales, indicating a strategic shift toward more hedging of forecasted commodity and interest-related exposures.",
      "llm_answer": "The 2024 VAR model now incorporates forecasted transactions that were excluded in 2023 (see MDLZ 10‑K 2023, page 60).  As a result, the notional value of forecasted interest‑rate contracts rose sharply from $2.384 B in 2023 to $5.336 B in 2024, while commodity‑contract exposure fell slightly from $16.631 B to $16.210 B (MDLZ 10‑K 2024, page 96).  This shift reflects a larger interest‑rate exposure under the new VAR assumptions, with commodity exposure remaining relatively stable.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies and fails to align with the ground truth in key areas, particularly regarding the reported value of forecasted transactions and the interpretation of VAR model changes. (1) Quantitatively, the LLM cites notional values of interest-rate and commodity contracts ($2.384B to $5.336B and $16.631B to $16.210B), which are not mentioned in the original answer and appear to be fabricated or misattributed; the ground truth reports the value of forecasted transactions increasing from $2M to $106M, not billions. These numbers are off by orders of magnitude and fundamentally misrepresent the scale. (2) The original answer states that combined VAR decreased from $284M to $255M due to reduced interest rate volatility, but the LLM does not mention this key metric or its change at all, missing a core part of the question. (3) While the LLM correctly infers a shift toward greater interest rate hedging, it attributes this to 'new VAR assumptions' rather than correctly linking the decrease in VAR to reduced volatility and the increase in forecasted transaction hedging as a strategic shift. (4) The LLM references specific 10-K pages (60 and 96), which may exist in the actual filings, but the data extracted from them does not match the ground truth derived from the knowledge graph, suggesting either misinterpretation or hallucination of document content. (5) The answer is contextually relevant—addressing MDLZ, VAR model changes, interest rate and commodity exposures, and forecasted transactions—but the reasoning is flawed due to incorrect data. It partially captures the directional shift (increased interest rate hedging) but fails on factual accuracy, especially in numbers and model interpretation. Thus, while the qualitative direction is somewhat aligned, the quantitative inaccuracies severely undermine correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 505,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 189,
      "question": "How did Southern Company's use of master netting agreements in 2023 influence the presentation of derivative assets and liabilities across product lines in 2024, particularly in relation to foreign currency derivatives and cash collateral offsets?",
      "original_answer": "In 2023, Southern Company utilized master netting agreements that allowed for netting of derivative receivables and payables across product lines and against cash collateral, resulting in the net presentation of derivative assets and liabilities on the balance sheet. This policy carried into 2024, where the company continued to apply netting across product lines under the same framework. Notably, in 2024, Southern Power—a subsidiary—disclosed an estimated $25 million in pre-tax losses expected to be reclassified from AOCI to earnings related to foreign currency derivatives, highlighting the ongoing financial impact of these netting arrangements. The continuation and application of these agreements demonstrate a consistent risk mitigation strategy with tangible effects on financial reporting and future earnings.",
      "llm_answer": "In 2023 Southern Company’s master netting agreements allowed it to net derivative positions across product lines and against cash collateral, a feature that the 2024 statements present on a net basis (see page 290).  The netting reduced the gross amounts for foreign‑currency derivatives, with offsets that included $62 million and $41 million of cash collateral held in broker‑margin accounts (page 292).  Consequently, the 2024 balance sheet shows net foreign‑currency derivative amounts of $45 million assets and $554 million liabilities for Southern Company and $4 million assets and $51 million liabilities for Southern Power, reflecting the impact of the master netting arrangements.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in numbers not present in the original answer. The original answer does not mention specific net derivative amounts such as $45 million assets, $554 million liabilities, or $62 million and $41 million in cash collateral. These figures are entirely absent from the ground truth and appear to be fabricated or misattributed. The only quantitative element in the original answer is the $25 million pre-tax loss expected to be reclassified from AOCI to earnings by Southern Power in 2024 related to foreign currency derivatives, which the LLM answer omits entirely. (2) The LLM introduces precise numerical values (e.g., $62M, $41M, $45M, $554M) with page references (290, 292) that are not supported by the ground truth, indicating either hallucination or incorrect data sourcing. There is no verification of calculations because the numbers themselves are incorrect. (3) While the LLM correctly identifies the use of master netting agreements in 2023 and their continuation into 2024 for net presentation of derivatives across product lines and against cash collateral, it fails to connect this to the key qualitative point in the original answer: the $25 million AOCI reclassification impact for Southern Power. This omission represents a failure in multi-hop reasoning—linking the accounting policy to its forward-looking earnings impact. (4) The contextual relevance is high because the answer addresses the core topic—netting agreements and their effect on derivative presentation—but the severe quantitative inaccuracies and missing key financial implications reduce correctness significantly. The qualitative reasoning is partially sound but lacks the critical synthesis of policy and financial consequence emphasized in the original. Thus, the answer is partially correct in concept but deeply flawed in factual content.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 513,
        "total_tokens": 1916
      },
      "error": null
    },
    {
      "question_id": 189,
      "question": "What does the increase in intercompany payables related to CIFSA Senior Notes from $20.2 billion in 2022 to $46.4 billion in 2024 suggest about Medtronic's financial positioning and guarantee obligations across its subsidiary structure?",
      "original_answer": "The significant rise in intercompany payables tied to CIFSA Senior Notes indicates a deepening financial entanglement between CIFSA and the broader Medtronic group, particularly under the guarantee framework involving Medtronic plc, Medtronic Luxco, and other subsidiary guarantors. This suggests that Medtronic may have increased its internal financing support for CIFSA, potentially to strengthen liquidity positioning or consolidate debt obligations under a more unified guarantee structure. The doubling of payables from 2022 to 2024 aligns with the consistent inclusion of CIFSA within the broader Medtronic Senior Notes guarantee chain, implying a strategic shift toward reinforcing CIFSA’s financial standing through intercompany mechanisms.",
      "llm_answer": "The jump in intercompany payables tied to the CIFSA Senior Notes—from $20.2 billion in 2022 to $42.1 billion in 2024 (footnote 5)【page_52】—shows that Medtronic’s subsidiary network has taken on substantially more short‑term obligations.  This growth reflects a larger guarantee structure and higher leverage across its subsidiaries, indicating that Medtronic’s financial positioning is more heavily weighted toward intercompany debt and that its guarantee obligations have expanded, potentially tightening liquidity and increasing risk exposure.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical error in the reported value for 2024 intercompany payables: it states $42.1 billion instead of the correct $46.4 billion from the ground truth. This discrepancy affects the accuracy of the quantitative claim and undermines the reliability of the response. The 2022 figure ($20.2 billion) is correct. The comparison to 'doubling' in the original answer is accurate (as $20.2B to $46.4B is more than double), but the LLM’s use of $42.1B still implies significant growth, though less than actual. (2) Calculations: While no explicit calculation is performed, the implied growth rate is misrepresented due to the incorrect 2024 value. The actual increase is ~130%, whereas $20.2B to $42.1B suggests ~108%, which is materially different. (3) Multi-hop reasoning: The LLM correctly identifies the implication of increased intercompany payables—expanded guarantee obligations, greater leverage, and tighter liquidity risk—showing sound understanding of financial structure and subsidiary entanglement. It references the guarantee framework and subsidiary network appropriately, aligning with the multi-hop requirement to connect CIFSA’s obligations to Medtronic’s broader financial positioning. (4) Despite the incorrect number, the qualitative reasoning about financial positioning, intercompany debt reliance, and risk exposure is consistent with the original answer. However, the omission of specific entities like Medtronic plc and Medtronic Luxco, and the lack of mention of strategic debt consolidation or liquidity support intent, reduces completeness. The citation of 'footnote 5, page 52' suggests document grounding but does not compensate for factual inaccuracy. Overall, the answer captures the general direction and implications but fails on key quantitative precision, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 502,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 190,
      "question": "How did the shift in NEE's pension plan asset allocation from 2022 to 2024 affect its reliance on common trusts as part of its diversified investment strategy?",
      "original_answer": "In 2022, NEE's pension plan targeted a 10% allocation to convertible securities and included common and collective trusts as part of its commingled investment arrangements to achieve diversification. By 2024, the allocation to convertible securities decreased to 5%, while alternative investments increased from 13% to 20%, with common trusts still playing a key role in the pension fund's diversified investment strategy across global equity and fixed income markets. This indicates a strategic shift toward alternative investments at the expense of convertible securities, while maintaining the use of common trusts to support diversification and liquidity.",
      "llm_answer": "The 2022 target allocation was 45% equity, 32% fixed‑income, 13% alternative and 10% convertible, with equity and fixed‑income holdings “consisting of … common and collective trusts”【page_101】. By 2024 the plan had shifted to 43% equity, 32% fixed‑income, 20% alternative and 5% convertible, keeping the same trust‑based structure for equity and fixed‑income but increasing the alternative portion【page_98】. The larger alternative allocation and smaller convertible allocation therefore reduced the proportion of the portfolio that is held in common trusts, lowering the plan’s reliance on those vehicles relative to 2022.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but contains a key misinterpretation in reasoning that affects the overall conclusion. (1) Quantitatively, the percentages for 2022 and 2024 allocations are accurate: 10% convertible securities in 2022 decreasing to 5% in 2024, alternative investments increasing from 13% to 20%, and equity/fixed-income allocations correctly reported. These numbers align with the ground truth. (2) The entity (NEE), years (2022 to 2024), and financial instruments (convertible securities, alternative investments, common and collective trusts) are correctly identified. (3) However, the reasoning is flawed: the LLM concludes that reliance on common trusts decreased because the convertible securities allocation (which may or may not be held in trusts) was reduced. But the ground truth states that common trusts are used in commingled arrangements for global equity and fixed income—portions that remained stable (45% to 43% equity, 32% fixed income unchanged)—and that common trusts still play a 'key role' in 2024. Therefore, the conclusion that reliance on common trusts decreased is unsupported and likely incorrect. The shift toward alternatives may involve different vehicles, but the answer does not provide evidence that trust usage declined. (4) While the LLM synthesizes data across years and correctly reports numbers, the faulty inference lowers qualitative accuracy. Contextual relevance is high as it directly addresses the question’s focus on asset allocation shifts and common trusts. Thus, correctness is partially compromised due to incorrect causal reasoning despite accurate inputs.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 442,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 191,
      "question": "How did Amgen's strategic focus on polypeptide-based molecules like Rocatinlimab evolve from 2023 to 2024, particularly in terms of intellectual property positioning and partnership-driven commercialization models?",
      "original_answer": "In 2023, Amgen disclosed its intellectual property portfolio, which included polypeptide-based molecules such as Rocatinlimab, with U.S. and European patent expirations set for 2027 and 2026 respectively. By 2024, Amgen had entered into a global collaboration with Kyowa Kirin for Rocatinlimab, an anti-OX40 monoclonal antibody targeting atopic dermatitis, where Amgen leads global development and commercialization outside Japan while sharing global development costs and U.S. commercialization costs equally. This partnership reflects a strategic shift from internal IP protection to a co-development and co-commercialization model, leveraging external expertise while retaining global commercial rights outside Japan, which represents a more integrated and collaborative approach to managing its polypeptide-based pipeline.",
      "llm_answer": "In 2023 Rocatinlimab was a Phase‑3 polypeptide‑based antibody with U.S. and European patents expiring in 2027 and 2026, respectively (see the 2023 patent table). By 2024 Amgen had formalized a joint development and commercialization agreement with Kyowa Kirin that shares global development costs, allows Amgen to lead manufacturing and U.S. commercialization, and introduces milestone payments up to $850 million plus double‑digit royalties on global sales (see the 2024 collaboration details). This shift illustrates Amgen’s growing emphasis on polypeptide molecules and a partnership‑driven model that preserves strong IP positioning while accelerating market entry.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the patent expiration years (2027 in the U.S., 2026 in Europe) and the partnership with Kyowa Kirin in 2024, as well as the strategic shift toward a collaborative model. However, it introduces significant inaccuracies: Rocatinlimab is not a polypeptide-based molecule but an anti-OX40 monoclonal antibody (a protein therapeutic, not a polypeptide), which misrepresents the core scientific classification. Additionally, the claim about 'milestone payments up to $850 million plus double-digit royalties' is not present in the original answer and lacks support from the ground truth, making it a factual overreach. (2) Quantitatively, the patent dates are correct, but the $850 million milestone and royalty figures are unverified and not mentioned in the ground truth, leading to a deduction in quantitative accuracy. The Phase-3 status is plausible but not confirmed in the original answer. (3) The reasoning correctly infers a strategic evolution from IP protection to partnership-driven development, and the synthesis across 2023 (IP) and 2024 (partnership) is logically sound. However, the mischaracterization of the molecule type and addition of unsupported financial terms weaken the multi-hop accuracy. (4) The contextual relevance is high as the answer addresses both IP positioning and commercialization models over time, and the overall narrative aligns with the question’s intent, despite factual embellishments. Hence, a score of 7 is justified: core facts about timing, partnership, and strategy are correct, but key scientific and financial details are inaccurate or fabricated.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 449,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 191,
      "question": "How did the reduction in Louisiana's corporate income tax rate under 2024 legislation impact COF's deferred tax expense, given their exposure to Louisiana's retail banking operations in 2023?",
      "original_answer": "In 2023, COF had $234 million in Louisiana retail banking operations, representing 0.3% of total consumer banking. In 2024, Louisiana enacted legislation to reduce its corporate income tax rate, which resulted in a $34 million reduction in COF's deferred tax expense. This reflects a direct financial impact of the tax legislation on COF's financial position, as the company adjusted its deferred tax liabilities in response to the lower future tax rate applicable to its Louisiana operations.",
      "llm_answer": "The 2024 Louisiana corporate‑income‑tax cut reduced Capital One’s deferred‑tax expense by **$34 million** (page 29).  That benefit was driven by the company’s **$234 million** of retail‑banking operations in Louisiana in 2023, which were subject to the new lower tax rate (page 93).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the key figures—$34 million reduction in deferred tax expense and $234 million in Louisiana retail banking operations—are accurately reported with correct units and values. Minor formatting differences (e.g., use of thin spaces, bolding) do not affect accuracy. (2) The answer addresses all parts of the multi-hop question: it identifies the 2024 tax legislation, links it to the reduction in deferred tax expense, and ties that impact to COF’s 2023 Louisiana operations. (3) Entities are correctly identified: COF (Capital One), Louisiana, 2023 operations, 2024 tax change, and the financial metric (deferred tax expense) are all accurate. (4) The reasoning is sound: the model correctly infers that the lower future tax rate required a revaluation of deferred tax liabilities, leading to a direct expense reduction—this reflects proper synthesis across time periods and financial concepts. The inclusion of page references (29, 93) suggests grounding in source material. Overall, the answer is factually precise, complete, and logically coherent, achieving semantic equivalence with the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1205,
        "completion_tokens": 337,
        "total_tokens": 1542
      },
      "error": null
    },
    {
      "question_id": 192,
      "question": "How did General Dynamics' increased investment in Electric Boat's facilities between 2023 and 2024 impact the production capacity and delivery timelines for Navy nuclear-powered submarine programs, particularly the Columbia-class and Virginia-class programs?",
      "original_answer": "General Dynamics significantly increased its investment in Electric Boat's facilities between 2023 and 2024 to support growing demand for nuclear-powered submarines. In 2023, Electric Boat was already the prime contractor for all Navy nuclear-powered submarine programs, including the $115 billion Columbia-class program with delivery scheduled to begin in 2027. By 2024, the value of the Columbia-class program had increased to over $125 billion, with the first delivery now expected in 2028. This one-year delay in initial delivery, combined with the sustained pace of one Columbia-class and up to two Virginia-class submarines per year, indicates that GD's expanded facilities and workforce investments were critical to managing production complexity and scaling output. The company also expanded its supplier network to approximately 3,000 partners to support concurrent production of both submarine programs, showing a clear evolution in capacity and coordination needs from 2023 to 2024.",
      "llm_answer": "General Dynamics’ 2024 10‑K (page 8) reports that additional capital has been invested in Electric Boat’s expanded and modernized facilities, enabling a sustained production rate of one Columbia‑class submarine per year and up to two Virginia‑class submarines per year. This investment has allowed the company to keep a 16‑boat Virginia‑class backlog through 2032 while shifting the first Columbia‑class delivery from 2027 (as noted in the 2023 10‑K, page 7) to 2028.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the shift of the first Columbia-class delivery from 2027 to 2028, the sustained production rate of one Columbia-class and up to two Virginia-class submarines per year, and the investment in modernized facilities are all consistent with the original answer. The mention of the 16-boat Virginia-class backlog through 2032 adds useful context not in the ground truth but does not contradict it. (2) Quantitative accuracy is perfect: dates (2027 to 2028 delay), production rates, and reference to correct 10-K pages and years are all precise. Dollar values ($115B to $125B) are omitted in the LLM answer, which is a minor gap but not incorrect—just less complete. (3) Multi-hop reasoning is sound: the model correctly infers that increased investment enabled sustained production rates and links the delivery delay to capacity management, consistent with the ground truth’s implication that expansion helped manage complexity. (4) The answer is contextually relevant and directly addresses the impact of investment on production capacity and delivery timelines. The only reason for not scoring a 10 is the omission of the program’s increasing value (from $115B to $125B) and the expansion of the supplier network to ~3,000 partners, which are part of the full impact on capacity. These omissions reduce completeness slightly but do not affect factual correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 403,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 192,
      "question": "How did the evolution of BMY's royalty and co-promotion relationship with Ono from 2022 to 2024 impact the global revenue growth trajectory of Orencia, particularly in light of the 60% co-promotion fee structure and the product's $3,682 million revenue in 2024?",
      "original_answer": "In 2022, BMY's relationship with Ono centered around royalty agreements for Opdivo, with BMY paying Ono 15% royalties outside of Japan, South Korea, and Taiwan. By 2024, the relationship had expanded to include joint development and commercialization of Orencia in Japan, with a structured 60% co-promotion fee when one party sells to the other's assigned customer. Orencia reached $3,682 million in global revenue in 2024, up from undisclosed levels in 2022, indicating that the deepened collaboration with Ono contributed to its growth trajectory. The co-promotion model, with BMY handling the intravenous formulation and Ono the subcutaneous version, likely enhanced market penetration and revenue generation in key territories.",
      "llm_answer": "BMS’s co‑promotion arrangement with Ono has remained essentially unchanged from 2022 to 2024, with a 60 % fee paid on sales to Ono‑assigned customers (page 112).  That fee reduces BMS’s share of revenue from those sales, but the partnership still supports modest growth – Orencia’s global revenue rose 2 % from $3,601 million in 2023 to $3,682 million in 2024 (page 50).  Thus, while the fee limits incremental earnings, the alliance with Ono continues to underpin Orencia’s steady revenue trajectory.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partially correct information but introduces significant factual inaccuracies. It incorrectly states that the co-promotion arrangement between BMS (BMY) and Ono 'remained essentially unchanged' from 2022 to 2024, which contradicts the ground truth: in 2022, the relationship was focused on Opdivo royalties (15% paid by BMY to Ono), while in 2024 it evolved into a joint development and commercialization partnership for Orencia in Japan with a 60% co-promotion fee structure. This evolution is central to the question and is misrepresented. (2) Quantitatively, the LLM correctly reports Orencia’s 2024 revenue as $3,682 million and estimates 2023 revenue at $3,601 million, implying a 2% growth rate. While these figures are plausible and align with the ground truth’s 2024 number, the 2023 figure and growth calculation are not present in the original answer and cannot be verified against the provided ground truth, which states 2022 revenue was 'undisclosed'. Thus, introducing a 2023 figure and growth rate adds unverified precision. (3) The multi-hop reasoning is flawed: the model fails to recognize the shift in relationship focus from Opdivo (2022) to Orencia (2024), mischaracterizing the nature of the collaboration. It also does not mention the key detail that BMY handles the IV formulation and Ono the subcutaneous version—critical to explaining how the co-promotion model enhanced market penetration. (4) Despite these errors, the answer is contextually relevant, addressing the impact of the Ono relationship on Orencia’s revenue trajectory and correctly citing the 60% co-promotion fee. However, due to major inaccuracies in entity relationships and timeline evolution, the qualitative and overall correctness scores are significantly reduced.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 488,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 192,
      "question": "How did the shift in MS's investment strategy in CDOs from 2023 to 2024 influence their provision of credit protection through derivative instruments in 2024?",
      "original_answer": "In 2023, MS invested in CDOs that contained embedded derivatives where the firm sold credit protection to the issuer, exposing it to credit event risk where the principal balance of the note might not be repaid in full. By 2024, MS had evolved its approach to include more active provision of credit protection through structured derivative instruments like CDS, managing exposures through tranched structures and actively monitoring aggregate market risk limits. This indicates a strategic shift from passive investment-linked credit risk exposure (CDOs in 2023) to a more controlled and diversified derivative-based credit protection framework in 2024.",
      "llm_answer": "MS shifted its 2024 CDO strategy toward a lower‑volume, more selective portfolio, as shown by a drop in the notional of “Other credit contracts” (CDOs and CLNs) from $314 million in 2023 to $133 million in 2024【page_108】.  That change is reflected in the derivative side of the business: total credit protection sold fell from $4,591 million in 2023 to $3,896 million in 2024, with index/basket CDS exposure shrinking markedly【page_108】, while net derivative liabilities with credit‑risk contingent features rose modestly to $22.4 billion in 2024【page_107】.  The firm’s continued investment in CDOs is noted in both years, but the reduced exposure led to a smaller amount of credit protection provision through derivatives in 2024【page_112】【page_109】.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer includes specific numerical data such as the drop in 'Other credit contracts' from $314 million to $133 million and total credit protection sold decreasing from $4,591 million to $3,896 million, which are presented as factual with page references. However, the ground truth does not contain any of these specific numbers, nor does it mention CLNs, index/basket CDS exposure shrinking, or net derivative liabilities rising to $22.4 billion. These figures and trends are not supported by the original answer, suggesting the LLM may have hallucinated or misattributed data from an external source. (2) While the LLM claims quantitative precision with exact dollar amounts and page citations, none of these numbers appear in the ground truth, which focuses on qualitative strategic shifts rather than numerical changes. The calculations (e.g., decreases in notional amounts) are internally consistent but not grounded in the provided truth. (3) The multi-hop reasoning is flawed: the original answer describes a strategic evolution from passive CDO investments with embedded credit risk to active, structured credit protection via instruments like CDS — a shift in nature and control of exposure. The LLM interprets this as a simple reduction in volume and exposure, missing the core conceptual shift from passive to active risk management. It fails to capture the qualitative transformation (e.g., tranched structures, active monitoring of market risk limits) and instead frames the change as a quantitative drawdown. (4) The contextual relevance is moderate because the answer discusses CDOs, credit protection, and derivatives in the correct timeframe (2023–2024), but it misrepresents the nature of the strategic shift. The original answer emphasizes a move toward more controlled and diversified derivative frameworks, while the LLM suggests a general reduction in activity. Thus, while the topic is relevant, the factual and conceptual alignment is weak, warranting a low correctness score despite some plausible-sounding details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 554,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 193,
      "question": "How did Duke Energy's regulatory exposure to FERC through KO Transmission change from 2022 to 2023, particularly in light of the sale of KO Transmission's pipeline facilities in February 2023?",
      "original_answer": "In 2022, Duke Energy was subject to FERC regulations through its operational structure, including its regulated subsidiaries. In 2023, the subsidiary KO Transmission, which was wholly owned by Duke Energy Ohio and directly subject to FERC regulations, sold all of its pipeline facilities and related real property to Columbia Gas Transmission, LLC on February 1, 2023, for approximately book value. This divestiture significantly reduced Duke Energy's direct regulatory exposure to FERC in the natural gas transportation segment, as KO Transmission no longer operates these facilities. The change reflects a strategic shift in Duke Energy's asset portfolio and regulatory risk profile related to FERC oversight.",
      "llm_answer": "In 2022, Duke Energy’s regulatory exposure to FERC was tied to KO Transmission, an interstate pipeline company that was subject to FERC rules (see 2022 10‑K, page 187). By 2023, that exposure was largely eliminated because KO Transmission sold all of its pipeline facilities and related real property to Columbia Gas Transmission on February 1, 2023, removing the FERC‑regulated assets from Duke Energy’s ownership (see 2023 10‑K, pages 18 and 24).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) All key facts are correct: KO Transmission was subject to FERC in 2022, and on February 1, 2023, it sold all pipeline facilities and related real property to Columbia Gas Transmission, LLC, reducing Duke Energy's FERC exposure. The date (February 1, 2023) and counterparty (Columbia Gas Transmission) match the original answer. (2) Quantitative accuracy is perfect: no numerical values (e.g., sale price) are misstated, and the date is exact. The LLM correctly avoids asserting a dollar amount since the original answer only states 'approximately book value' and the LLM omits it appropriately. (3) Multi-hop reasoning is sound: the model correctly infers that because KO Transmission sold its FERC-regulated assets, Duke Energy’s regulatory exposure decreased—linking corporate structure (KO Transmission as a subsidiary), regulatory scope (FERC jurisdiction over interstate pipelines), and transaction impact. (4) The only minor omission is that the original answer notes KO Transmission was 'wholly owned by Duke Energy Ohio,' adding granularity about the ownership chain, and mentions the strategic shift in asset portfolio and risk profile—contextual depth that the LLM answer skips. However, the core factual and logical content is preserved with high fidelity. Wording differs but semantic equivalence is maintained. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 422,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 193,
      "question": "How did the reduction in Keytruda royalty rates from 6.5% to 2.5% at the start of 2024 impact the financial dynamics of BMY's partnership with Ono, especially considering their shared revenue allocation and ongoing collaboration in immuno-oncology programs?",
      "original_answer": "In 2023, BMY and Ono shared Keytruda royalty payments from Merck at a 75/25 split based on a 6.5% global royalty rate. Starting in 2024, this royalty rate dropped to 2.5%, significantly reducing the revenue stream both parties received from Keytruda. Despite this decline, BMY continued its collaboration with Ono in immuno-oncology programs such as OPDIVO and YERVOY, indicating that the strategic partnership remained intact despite the financial shift. This suggests that while the financial dynamics were impacted by the royalty rate reduction, the operational and developmental partnership persisted into 2024.",
      "llm_answer": "The Keytruda license with Merck pays 6.5 % royalties on global sales through Dec 31 2023 and 2.5 % from Jan 1 2024 onward, and the royalty revenue is split 75 % to BMS and 25 % to Ono after legal‑fee adjustments【page_90】.  The lower rate therefore reduces the total royalty income that both companies receive, but the 75/25 allocation remains unchanged, so BMS’s share declines proportionally.  Ono’s partnership with BMS continues to extend beyond Keytruda, including joint development of the Anti‑CCR8 + nivolumab immuno‑oncology program, so the collaboration structure and ongoing program work remain intact even as the Keytruda royalty contribution shrinks【page_13】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts: the Keytruda royalty rate dropped from 6.5% to 2.5% effective January 1, 2024, and the revenue split between BMY (BMS) and Ono remains 75/25. This matches the ground truth exactly in terms of percentages, timing, and allocation. The answer also correctly notes that the financial impact is a proportional reduction in royalty income for both parties, with BMS bearing the larger share of the decline due to its larger cut. (2) Quantitatively, all numbers are accurate: 6.5% pre-2024, 2.5% starting 2024, 75/25 split—no calculation errors or misstatements. Format variations (e.g., '75%' vs '75/25') are semantically equivalent and acceptable. (3) The multi-hop reasoning is sound: the model connects the royalty rate change to its impact on revenue distribution and correctly infers that despite the financial reduction, the broader collaboration persists. It supports this with specific evidence—the Anti-CCR8 + nivolumab immuno-oncology program—demonstrating continuity beyond Keytruda, which aligns with the ground truth’s mention of ongoing OPDIVO and YERVOY programs. (4) The only minor shortcoming is that the LLM references 'Anti-CCR8 + nivolumab' as the specific program, while the ground truth mentions OPDIVO (nivolumab) and YERVOY more generally. This is a slight shift in specificity but does not constitute an error, as Anti-CCR8 + nivolumab is a valid immuno-oncology collaboration. The core conclusion—that the partnership continues operationally despite financial changes—is fully supported and logically derived. Thus, the answer is factually excellent with near-perfect synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 455,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 194,
      "question": "How did RTX's ownership stake in IAE in 2022 compare to its collaborative relationship with Japanese Aero Engines Corporation in 2023, and what does this indicate about the evolution of its strategic involvement in the V2500 engine program?",
      "original_answer": "In 2022, RTX (via Pratt & Whitney) held a 61% program share interest and a 49.5% ownership interest in IAE, which coordinates the V2500 engine program alongside MTU and Japanese Aero Engines Corporation (JAEC). By 2023, RTX continued its collaboration with JAEC under the same IAE framework, but its effective program share interest in IAE was adjusted to 57% after accounting for sub-collaborator shares. This indicates a slight recalibration of RTX's strategic involvement in the V2500 engine program, maintaining its leadership role while possibly redistributing economic participation among collaborators.",
      "llm_answer": "In 2022, RTX (Pratt & Whitney) reported a 49.5 % ownership interest in International Aero Engines (IAE) (page 110). By 2023 the 10‑K frames RTX’s relationship with Japanese Aero Engines Corporation (JAEC) as part of the IAE collaboration, emphasizing a joint partnership rather than a direct ownership stake (page 99). This shift signals RTX’s evolution from a primarily ownership‑based role to a more collaborative, joint‑decision‑making involvement in the V2500 engine program.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies RTX's 49.5% ownership interest in IAE in 2022, which matches the ground truth. However, it fails to mention RTX's 61% program share interest in 2022 and the updated 57% program share in 2023, which are key quantitative metrics in the original answer. Instead, the LLM claims a 'shift' from ownership to a collaborative model in 2023, implying a structural change, but the ground truth states that the collaboration continued under the same IAE framework with only a recalibration of economic shares. (2) The LLM omits the specific 57% program share figure for 2023 and incorrectly frames the relationship as evolving from ownership to partnership, when in fact ownership and collaboration coexisted throughout. There is no evidence in the ground truth that RTX relinquished ownership in favor of a partnership model; rather, the collaboration with JAEC remained within the IAE structure. (3) The multi-hop reasoning is flawed: the model fails to synthesize that both ownership and program share interests are components of strategic involvement and that the change from 61% to 57% reflects a minor adjustment, not a fundamental shift in governance or control. The conclusion about 'evolution from ownership-based to joint-decision-making' is speculative and not supported by the data. (4) While the entities (RTX, IAE, JAEC, V2500) and years (2022, 2023) are correctly identified, and the general context of collaboration is relevant, the absence of key percentages and the misinterpretation of the nature of the relationship significantly reduce factual accuracy. The answer is contextually relevant but partially incorrect in both quantitative and qualitative dimensions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 469,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 194,
      "question": "How did Duke Energy Progress' consolidation of DEPNC SF in 2024 reflect changes in the structure and scale of storm recovery financing compared to the 2021 bond issuance?",
      "original_answer": "In 2021, DEPNC SF issued $770 million in senior secured bonds to finance unrecovered storm costs from 2018 and 2019, with collections from North Carolina retail customers as the sole repayment source. By 2024, Duke Energy Progress not only continued to consolidate DEPNC SF but also expanded its storm recovery financing framework by forming and consolidating a new entity, DEPSC SF, which issued an additional $177 million in bonds to cover storm costs dating back to 2014. This reflects both a continuation of the original financing structure and an expansion in both geographic scope (now including South Carolina) and time horizon of recoverable costs, indicating a strategic evolution in how Duke Energy Progress manages long-term storm-related regulatory asset recovery.",
      "llm_answer": "In 2024, Duke Energy Progress consolidated DEPNCSF and the newly formed DEPSC SF, the latter issuing $177 million of senior secured bonds for South Carolina storm recovery, whereas the 2021 issuance saw DEPNCSF alone raise $770 million for North Carolina storm costs (page 205). This shift reflects a move to a more geographically diversified and lower‑volume financing structure, with DEPNCSF’s long‑term debt falling from $680 million in 2023 to $646 million in 2024 while DEPSC SF added $163 million of debt, rebalancing the overall storm‑recovery portfolio.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core idea of expansion in storm recovery financing through the creation and consolidation of DEPSC SF in 2024, reflecting geographic diversification into South Carolina, which aligns with the ground truth. However, there are significant quantitative inaccuracies. The 2021 issuance was for $770 million, which the LLM correctly identifies, but it misstates the 2024 DEPSC SF issuance as $177 million in one part and then $163 million in debt added later, creating internal inconsistency and contradicting the ground truth of $177 million. Additionally, the LLM introduces specific debt figures for DEPNCSF—$680 million in 2023 falling to $646 million in 2024—which are not present in the original answer and appear to be fabricated or misattributed, as the ground truth does not mention these amounts or a decline in debt. (2) The calculation of net change in debt or rebalancing is unsupported by the ground truth and introduces false precision. The original answer emphasizes structural evolution and expanded scope (geographic and temporal), not debt rebalancing or volume reduction. (3) The multi-hop reasoning is partially sound: the model correctly infers that forming DEPSC SF represents a geographic expansion and continuation of the financing model. However, it fails to mention the key point about the time horizon of recoverable costs extending back to 2014, which is a critical element in the original answer showing strategic evolution. (4) While the LLM captures the shift to South Carolina and the new entity formation, it distorts the financial details and omits the extended time horizon of recoverable costs. The contextual relevance is high because it addresses the comparative structure and scale, but the quantitative inaccuracies and unsupported claims reduce overall correctness. Hence, a score of 6 is justified—partially correct but with significant factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 522,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 194,
      "question": "How did the voting power distribution between Class A and Class B common stock at CMCSA change from 2023 to 2024, and what implications did this have for shareholder influence?",
      "original_answer": "In 2023, CMCSA disclosed its Class A Common Stock structure, which forms the basis of shareholder voting rights. By 2024, the detailed explanation showed that holders of Class A common stock collectively held 66 2/3% of the combined voting power, while Class B common stock, which carries 15 votes per share, represented the remaining 33 1/3% of voting power. Notably, Mr. Brian L. Roberts beneficially owned all outstanding shares of Class B common stock, giving him outsized influence over corporate decisions. Additionally, the 2024 financial report showed that 4,651,093,045 shares of Class A common stock were issued, with 3,778,302,017 shares outstanding, compared to 9,444,375 shares of Class B common stock, which are non-dilutable. This structure reinforced the dual-class voting disparity, concentrating significant decision-making power in a single shareholder.",
      "llm_answer": "In 2024, Comcast’s 10‑K reports that holders of Class A common stock control 66 ⅓ % of the combined voting power, while the 9.4 million Class B shares—each worth 15 votes—represent 33 ⅓ % of voting power【page_31】.  The 2023 filing disclosed the same split, so the voting‑power allocation did not change year‑to‑year.  Because Class A shares still hold the majority of votes, ordinary shareholders retain the ability to influence corporate decisions, but the concentration of Class B shares in Mr. Roberts’ hands preserves a powerful block of voting power that can shape board elections and other major matters.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 66 2/3% and 33 1/3% voting power split between Class A and Class B shares in 2024, but incorrectly states that Class A holds '66 1/3%' instead of '66 2/3%'—a critical numerical error. It also correctly notes that Mr. Brian L. Roberts holds all Class B shares and that this gives him outsized influence. However, it claims the 2023 filing disclosed the 'same split', implying no change, but the original answer does not confirm the 2023 split was quantitatively identical—only that the Class A structure was disclosed. Thus, the conclusion of 'no change' is unsupported and potentially incorrect. (2) The LLM reports '9.4 million' Class B shares, which approximates the true value of 9,444,375—this is acceptable. However, it omits key quantitative details from the original answer: total issued (4,651,093,045) and outstanding (3,778,302,017) shares of Class A, and the non-dilutable nature of Class B shares. These omissions reduce completeness and quantitative accuracy. (3) The reasoning is mostly sound: it correctly synthesizes that Class B shares have 15 votes per share and that their concentration gives Mr. Roberts significant control. However, the claim of 'no change' from 2023 to 2024 overreaches, as the original answer does not provide enough 2023 data to confirm stability in the voting split. This is a flaw in multi-hop logic. (4) Despite the numerical inaccuracy and unsupported comparison, the LLM captures the core implications for shareholder influence—dual-class disparity and concentrated power—making the answer contextually relevant and qualitatively strong overall. The correctness score is reduced primarily due to the incorrect percentage (66 1/3% vs 66 2/3%) and missing key data points.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 479,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 194,
      "question": "How did the phase-in of the CECL Transition Rule impact Capital One's CET1 capital ratio in 2023, and how does this relate to their continued compliance with the Market Risk Rule under Basel III?",
      "original_answer": "In 2022, Capital One had added back $2.4 billion to regulatory capital under the CECL Transition Rule, with 50% of that amount phased in by the end of 2023. This contributed to a CET1 capital ratio of 12.9% in 2023, compared to 12.6% on a fully phased-in basis. As Capital One remained subject to the Market Risk Rule in 2023 due to its trading assets exceeding $1 billion, the phased-in CECL impact helped maintain stronger capital ratios, supporting compliance with the Market Risk Rule's adjustments to risk-based capital requirements.",
      "llm_answer": "The 50 % phase‑in of the CECL Transition Rule added $1.2 billion to Capital One’s regulatory capital in 2023, lifting its Common Equity Tier 1 (CET1) ratio to 12.9 % versus 12.6 % that would have been reported on a fully phased‑in basis【page_80】.  Because the CET1 ratio remains well above the Basel III minimum of 4.5 % and the additional adjustments required by the Market Risk Rule, the company continues to satisfy the Market Risk Rule’s capital‑conservation requirements and remains “well‑capitalized.”【page_81】【page_79】",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that 50% of the $2.4 billion CECL add-back was phased in, amounting to $1.2 billion in 2023, which aligns with the ground truth. The CET1 ratio of 12.9% (with phase-in) versus 12.6% (fully phased-in) is accurately reported. These numbers match the original answer exactly, and the calculation (50% of $2.4B = $1.2B) is correct. (2) All numeric values—$2.4B total CECL benefit in 2022, 50% phase-in by 2023, $1.2B impact in 2023, and CET1 ratios of 12.9% vs 12.6%—are quantitatively accurate. Format variations (e.g., $1.2 billion vs $1.2B) are acceptable and correctly interpreted. (3) The reasoning is sound: the LLM correctly links the CECL phase-in to higher regulatory capital, which supports a stronger CET1 ratio, and connects this to compliance with the Market Risk Rule under Basel III. It correctly notes that Capital One remains subject to the rule due to trading assets over $1B (implied context from knowledge graph), and that elevated CET1 helps meet capital conservation requirements. The only minor gap is that the LLM does not explicitly state that the Market Risk Rule imposes *additional* capital requirements due to trading activity, though this is implied in the reference to 'adjustments' and 'capital-conservation requirements.' (4) The answer is semantically equivalent to the ground truth, with slightly more emphasis on capital adequacy ('well-capitalized') not explicitly mentioned in the original but consistent with it. All parts of the multi-hop question are addressed: impact on CET1 ratio and relation to Market Risk Rule compliance. Thus, the answer is highly accurate, with only a slight deduction in qualitative accuracy for not fully elaborating the causal link between trading assets >$1B and Market Risk Rule applicability, though the compliance conclusion remains valid.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 504,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 195,
      "question": "How did the change in MDLZ's Value at Risk (VAR) estimates from 2022 to 2023 reflect the impact of evolving market conditions on their financial instruments, particularly in relation to interest rate sensitivity?",
      "original_answer": "In 2022, MDLZ's VAR model estimated a one-day potential loss in fair value of interest rate-sensitive instruments under normal market conditions using a parametric delta-gamma approximation technique based on prior quarter observations. By 2023, the VAR model continued to assume normal market conditions and a 95% confidence interval, but the VAR on a combined basis decreased from $284 million at September 30, 2023, to $255 million at September 28, 2024, partly due to reduced interest rate volatility. This indicates that despite similar modeling assumptions, the underlying market conditions had shifted, leading to a lower estimated risk exposure for MDLZ's interest rate-sensitive financial instruments.",
      "llm_answer": "MDLZ’s VAR for interest‑rate‑sensitive instruments fell sharply from **$196 million at 12/31/2022 to $119 million at 12/31/2023** (see MDLZ 10‑K 2023, page 64), indicating a lower potential one‑day loss from interest‑rate movements.  The overall VAR also dropped from $284 million to $258 million (MDLZ 10‑K 2023, page 60), reflecting reduced interest‑rate volatility and/or a shift in the company’s debt mix or hedging strategy that lessened its exposure to rate swings.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key numbers and dates. According to the ground truth, the combined VAR decreased from $284 million at September 30, 2023, to $255 million at September 28, 2024 — not from $284M to $258M as stated, and certainly not the $196M to $119M for interest-rate-sensitive instruments cited by the LLM. These figures do not match the ground truth at all; no such numbers appear in the correct context. (2) The dates are also incorrect: the LLM references December 31, 2022 and December 31, 2023, while the ground truth uses September 30, 2023 and September 28, 2024 — different fiscal reporting periods. This undermines the quantitative accuracy. (3) The reasoning is partially sound: the LLM correctly infers that a decline in VAR reflects reduced interest rate volatility and possibly changes in hedging or debt structure, which aligns with the qualitative interpretation in the original answer. It also correctly identifies that VAR relates to one-day potential loss under normal market conditions, showing understanding of the metric. (4) Contextual relevance is high because the answer addresses the core question about how changing VAR reflects evolving market conditions, particularly interest rate sensitivity, and attempts multi-hop reasoning by linking model assumptions to market shifts. However, due to major errors in dollar amounts and dates — which are central to the question —the correctness and quantitative accuracy scores are low. Minor format variations are acceptable, but these are outright mismatches. The answer may be drawing from incorrect sections of the 10-K or misquoting data, leading to a partially correct but factually flawed response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 472,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 195,
      "question": "What changes have occurred in UPS's Class A and Class B share structure between 2022 and 2024, and how do these changes impact voting power distribution among shareholders?",
      "original_answer": "In 2022, UPS disclosed that 718 shares of Class B Common Stock were issued, while in 2024, this number increased slightly to 733 shares. Conversely, the number of issued shares of Class A Common Stock decreased from 147 shares in 2022 to 121 shares in 2024. According to the V_10k_2024 filing, Class A common stockholders have full voting rights on all matters, while Class B common stockholders have limited voting rights, applicable only to specific defined matters such as exiting the core payments business or certain merger and consolidation scenarios. The shift in share structure—more Class B shares and fewer Class A shares—suggests a potential dilution of broad shareholder influence, as voting power becomes concentrated among fewer Class A shareholders. This evolution in the Class B → Class A relationship reflects a strategic capital structure adjustment that may align with UPS's governance priorities in 2024.",
      "llm_answer": "UPS issued 121 million Class A shares in 2024 (down from 127 million in 2023) and 733 million Class B shares in 2024 (up from 726 million in 2023)【page_69】.  In May 2024, an exchange offer retired 241 million Class B‑1 shares and issued 120 million Class B‑2 and 48 million Class C shares, reducing the number of Class B‑1 shares and shifting voting power toward Class A holders, who retain full voting rights while Class B and C shares have limited voting rights except for specific matters【page_89】【page_90】.  These changes concentrate voting power in the hands of Class A shareholders and diminish the influence of Class B shareholders.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, UPS issued 147 Class A shares in 2022 and 121 in 2024 (not millions), and 718 Class B shares in 2022 and 733 in 2024—again, not millions. The LLM incorrectly reports figures in millions (e.g., 121 million vs. 121 actual shares), which is a massive quantitative error. Additionally, the LLM references non-existent share classes (Class B-1, B-2, Class C) and an exchange offer in May 2024 that are not mentioned in the ground truth. (2) The numbers are entirely incorrect: the ground truth reports low three-digit share counts, while the LLM reports hundreds of millions, indicating a fundamental misunderstanding or hallucination. There is no support for the 241 million retirement or the creation of new share classes. (3) The multi-hop reasoning is flawed. The ground truth focuses on a shift from Class A to Class B shares over 2022–2024 and its impact on voting power concentration. The LLM invents a complex restructuring event not present in the original data, leading to an incorrect conclusion about voting power shifting toward Class A holders. In reality, the decrease in Class A and increase in Class B shares suggests dilution of broad voting power, not concentration in Class A. (4) The contextual relevance is moderate because the answer discusses voting rights and share structure, which are relevant, but the fabricated data and events severely undermine correctness. The qualitative reasoning would be acceptable if based on real data, but it is built on false premises. Thus, the correctness score is low due to catastrophic quantitative errors and hallucinated events.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 461,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 195,
      "question": "How did Medtronic's guarantee obligations for the CIFSA Senior Notes in FY2022 relate to its stake in Covidien Group Holdings Ltd. in FY2023, particularly in terms of financial liability structure and subsidiary interconnectivity?",
      "original_answer": "In FY2022, Medtronic plc and its subsidiary Medtronic Luxco provided full and unconditional guarantees for the CIFSA Senior Notes, alongside other subsidiary guarantors including Covidien Group Holdings Ltd. and Covidien Ltd. This formed a multi-layered liability structure where multiple subsidiaries were legally bound to CIFSA’s obligations. By FY2023, Medtronic maintained its stake in Covidien Group Holdings Ltd., which remained a subsidiary guarantor of the CIFSA Senior Notes. This continuity indicates that Medtronic preserved its indirect financial exposure through subsidiary interconnectivity, ensuring that its stake in Covidien Group Holdings Ltd. continued to serve as a legal backstop for CIFSA’s debt obligations. The structure remained stable across both years, with no indication of reduced liability burden or restructuring of these guarantees.",
      "llm_answer": "In FY 2022 Medtronic plc was the parent guarantor for the CIFSA Senior Notes, with the subsidiary issuer CIFSA and subsidiary guarantors Medtronic Luxco, Covidien Ltd., and Covidien Group Holdings Ltd. (a wholly‑owned subsidiary) providing full, unconditional guarantees【52†L1-L9】. In FY 2023 Medtronic’s stake in Covidien Group Holdings Ltd. remained a wholly‑owned subsidiary and continued to be part of the same guarantor group, thereby preserving the financial‑liability structure and inter‑company connectivity established in FY 2022【51†L1-L9】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) All entities are correctly identified: Medtronic plc, Medtronic Luxco, CIFSA, Covidien Ltd., and Covidien Group Holdings Ltd. are accurately named as parent and subsidiary guarantors in FY2022, and the continuation of Medtronic's ownership stake in Covidien Group Holdings Ltd. in FY2023 is correctly stated. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—dates (FY2022 and FY2023) are correct. (3) The multi-hop reasoning is sound: the answer connects Medtronic’s guarantee structure in FY2022 to the persistence of its subsidiary stake and liability role in FY2023, correctly concluding that the financial liability structure and subsidiary interconnectivity remained unchanged. (4) The only minor shortcoming is a slight lack of detail compared to the original answer—specifically, the LLM does not explicitly mention that the guarantees were 'full and unconditional' for all listed subsidiaries beyond naming them, though it implies this by referencing the same guarantor group. It also omits the phrase 'indirect financial exposure' and 'legal backstop,' which are conceptually present but not articulated. These are minor omissions that do not affect factual correctness. Overall, the answer is semantically equivalent, contextually precise, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 402,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 195,
      "question": "How did MetLife's use of Level 2 asset valuation methodology for separate accounts in 2022 compare to the treatment of those same separate accounts in 2024, particularly in terms of fair value estimation and reporting consistency?",
      "original_answer": "In 2022, MetLife categorized certain separate accounts under the Level 2 asset category, where their fair value was based on reported NAV provided by fund managers, reflecting transfer values and offering reasonable price transparency. By 2024, these separate accounts remained subject to the same valuation methodology but were explicitly governed by insurance laws that restricted their use for settling general liabilities and required separate reporting of assets and liabilities. The 2024 documentation reinforced that separate account assets were only accessible to general account claims if their value exceeded liabilities, indicating a more structured and legally bounded reporting consistency compared to 2022.",
      "llm_answer": "In 2022, MetLife described Level 2 separate accounts as being valued at the reported NAV supplied by fund managers, with that value being corroborated by observable market data (Note 21, pages 305‑307).  The 2024 filing repeats the same description (Note 21, pages 284‑285) and presents a fair‑value hierarchy table that lists Level 2 values for the same separate accounts under both pension and post‑retirement benefit plans.  Thus the fair‑value estimation method and the disclosure of Level 2 separate accounts remained consistent from 2022 through 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually accurate in stating that MetLife used the same Level 2 valuation methodology based on reported NAV from fund managers in both 2022 and 2024, and correctly references Note 21 and page numbers from the filings. Quantitatively, there are no errors—dates, years, and financial reporting details are correctly cited. However, the LLM answer fails to capture a key qualitative distinction highlighted in the ground truth: the evolution in legal and reporting framework by 2024, where separate accounts were explicitly governed by insurance laws restricting their use for general liabilities and requiring stricter reporting boundaries. While the valuation method remained consistent, the ground truth emphasizes increased structural and regulatory clarity in 2024 that enhanced reporting consistency beyond mere methodological repetition. The LLM answer correctly identifies the continuity in fair value estimation but omits this critical dimension of legal constraints and accessibility conditions, which is central to the question’s focus on 'reporting consistency' over time. This omission limits the depth of multi-hop reasoning, as it does not synthesize the regulatory context that differentiates the 2024 treatment. Thus, while factually sound on surface-level methodology, it lacks completeness in addressing the full scope of the comparative analysis requested.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 384,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 196,
      "question": "How did the change in the proportion of structured settlement annuities underwritten on impaired lives between 2023 and 2024 impact GE's exposure to mortality risk, and what does this suggest about the evolution of their risk profile?",
      "original_answer": "In 2023, GE reinsured approximately 24,600 structured settlement annuities, primarily underwritten on impaired lives, which are associated with shorter-than-average life expectancies and thus lower mortality risk. By 2024, the number of such annuities had decreased to 23,400, and only 27% were underwritten on impaired lives. This reduction in the proportion of impaired-life contracts increased GE's overall exposure to mortality risk, as more policies were now associated with average or longer life expectancies. The shift suggests a transformation in GE's risk profile, with a growing liability duration and higher sensitivity to longevity trends, which is further compounded by the lack of premium adjustment flexibility in structured settlement annuities.",
      "llm_answer": "GE’s structured‑settlement annuity portfolio shifted from a majority of contracts underwritten on impaired lives in 2023 to only **27 %** in 2024, which lowers its exposure to longevity (mortality) risk 【page_20】【page_19】.  The reduced proportion of impaired‑life annuities means fewer contracts are subject to the adverse effects of mortality improvement, indicating a more conservative underwriting mix and a portfolio that is increasingly less sensitive to mortality risk 【page_20】【page_19】.",
      "correctness_score": 2,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in reasoning and conclusion. While it correctly states that in 2024, only 27% of structured settlement annuities were underwritten on impaired lives (matching the ground truth), it incorrectly claims this *lowers* GE's exposure to mortality/longevity risk. The opposite is true: a decrease in impaired-life annuities (which have shorter life expectancies) increases exposure to mortality risk because more policies now cover individuals with average or longer life expectancies, increasing liability duration and longevity risk. This fundamental reversal of logic invalidates the core of the answer. (2) Quantitatively, the 27% figure is accurate, and the implied shift from a 'majority' in 2023 to 27% in 2024 is consistent with the ground truth (though exact 2023 percentage not given, 'majority' is reasonable). However, the LLM omits the total number of annuities (24,600 in 2023, 23,400 in 2024), which is part of the original answer and relevant context. (3) The multi-hop reasoning fails: the model incorrectly infers that fewer impaired-life annuities reduce mortality risk, when the correct inference is increased risk due to longer expected payout periods. It also mischaracterizes the underwriting mix as 'more conservative' and 'less sensitive to mortality risk,' which contradicts the ground truth. (4) Contextual relevance is moderate because the answer addresses the right topic and cites relevant data points, but the incorrect conclusion severely undermines usefulness. Due to the major error in risk directionality, the correctness score is low despite partial quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 455,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 196,
      "question": "How did NEE's shift from equity method earnings through its stake in NEP in 2022 to direct investments in solar projects by 2024 impact its consolidated earnings and strategic positioning in clean energy?",
      "original_answer": "In 2022, NEE held a noncontrolling interest in NEP, which owned a portfolio of solar and wind projects, and reported earnings through equity method investees. By 2024, NEE transitioned toward direct investments in solar generation and battery storage facilities, which contributed to a $494 million increase in operating revenues from new investments. However, equity in losses from equity method investees rose from $649 million in 2023 to $267 million in 2024, indicating a strategic pivot away from passive ownership in NEP-like entities toward active ownership of new solar assets. This shift likely reflects a broader strategic realignment to capitalize on growth in renewable energy markets directly, despite a $0.8 billion pre-tax impairment charge in 2024.",
      "llm_answer": "In 2022 NEE’s clean‑energy earnings were largely driven by equity‑method income from its non‑controlling stake in NEP, exposing the company to the volatility of NEP’s earnings and losses. By 2024, NEER had shifted to direct solar investments, with new solar and battery projects generating $983 million in earnings and equity‑method losses falling to $267 million (down from $649 million in 2023), improving the net income less non‑controlling interests to $2,299 million. This transition not only reduced earnings volatility from equity‑method investees but also expanded NEE’s own solar portfolio—enabled by regulatory incentives such as the SoBRA mechanism—solidifying its position as a leading direct generator of renewable power.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in key financial figures. The ground truth states that NEE saw a $494 million increase in operating revenues from new investments by 2024, but the LLM claims $983 million in earnings from new solar and battery projects—this number is not supported by the original answer and appears fabricated. Additionally, while the equity-method losses decreasing from $649 million in 2023 to $267 million in 2024 is correctly reported, the implication that this improved net income to $2,299 million is unsupported and not mentioned in the ground truth. The $0.8 billion pre-tax impairment charge in 2024, a critical financial event in the original answer, is entirely omitted. (2) Quantitative accuracy is low: the $983 million figure is incorrect (should be $494 million revenue increase), and the $2,299 million net income figure has no basis in the provided data. The only correct numbers are the equity-method losses in 2023 ($649M) and 2024 ($267M). (3) The multi-hop reasoning is partially sound—the model correctly infers a strategic shift from passive equity investments (via NEP) to direct ownership in solar and storage, and links this to reduced exposure to equity-method volatility. However, it overreaches by introducing unverified financial outcomes (e.g., net income) and regulatory mechanisms like 'SoBRA' not present in the original answer, undermining entity and reasoning accuracy. (4) Contextual relevance is high—the answer addresses the strategic pivot and its impact on earnings and positioning in clean energy. However, due to major quantitative errors and unsupported additions, the overall correctness score is low despite capturing the general direction of the strategic shift.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 483,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 196,
      "question": "How does Disney's 50% stake in A+E in 2023 compare with its direct partnership with Lifetime in 2022, particularly in terms of subscriber base and strategic positioning in the cable network market?",
      "original_answer": "In 2022, Lifetime was directly partnered with Disney and had 69 million subscribers, reflecting Disney's direct ownership and control over the channel. By 2023, Disney held a 50% stake in A+E, which operated Lifetime alongside A&E and HISTORY, each with 58 million subscribers as of September 2024. This shift from direct ownership to a joint venture reflects a strategic move toward shared risk and collaborative content production across multiple cable networks, rather than maintaining full control over individual channels.",
      "llm_answer": "Disney’s 50 % equity stake in A+E (disclosed in the 2023 10‑K) gives it indirect access to the combined domestic subscriber base of A+E’s channels—about 69 million for Lifetime, 70 million for History and 69 million for A&E (page 12)—and positions Disney as a diversified cable operator that earns affiliate‑fee and advertising revenue across multiple brands (page 4, page 13). By contrast, the 2022 direct partnership with Lifetime focused on a single female‑oriented network that served roughly 69 million subscribers (page 12) and was a content‑distribution collaboration, offering a narrower strategic reach and no ownership stake compared with the broader, revenue‑diversifying A+E investment.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in subscriber numbers and the nature of Disney's relationship with Lifetime. According to the ground truth, Lifetime had 69 million subscribers in 2022 under a direct partnership with Disney, implying Disney's control. However, the LLM incorrectly states that Disney had a 'direct partnership' in 2022 but then claims it was 'a content-distribution collaboration' with 'no ownership stake,' which contradicts the ground truth that Disney had direct ownership and control. This is a major error in entity and relationship accuracy. (2) Quantitatively, the LLM misrepresents A+E network subscriber counts: it claims Lifetime had 69 million, History 70 million, and A&E 69 million as of the 2023 10-K, but the ground truth states all three had 58 million subscribers as of September 2024. These numbers are both incorrect and misattributed to the wrong time period. The LLM also cites 'page 12' and 'page 13' as sources, which may reflect document hallucination since no such evidence was provided. (3) The multi-hop reasoning is partially sound in structure—comparing strategic positioning across years and ownership models—but fails in execution due to incorrect premises. The conclusion that Disney shifted from direct control to a joint venture is correct, but the LLM incorrectly frames the 2022 arrangement as non-ownership, undermining the validity of the comparison. (4) Contextual relevance is high because the answer addresses subscriber base and strategic positioning as asked, and attempts to contrast the two arrangements. However, due to major factual and quantitative errors, especially in subscriber counts and ownership structure, the correctness score is low. The answer appears plausible but is substantively incorrect on key points.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 497,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 197,
      "question": "How did the use of the parametric delta-gamma approximation technique in MDLZ's VAR model evolve between 2022 and 2023, and what does this indicate about the company's approach to modeling risk in interest rate-sensitive instruments?",
      "original_answer": "In 2022, MDLZ used the parametric delta-gamma approximation technique to estimate the expected return distribution for interest rates, currencies, and commodity prices by observing movements over the prior quarter for the calculation of VAR amounts at December 31, 2021 and 2020, and over each of the four prior quarters for average VAR amounts. In 2023, the company continued to use the same technique but updated the observation window to reflect the prior quarter for VAR amounts at December 31, 2023 and 2022, and again over each of the four prior quarters for average VAR amounts. This indicates that MDLZ maintained a consistent methodology for modeling risk in interest rate-sensitive instruments, primarily debt, while continuously updating the data inputs to reflect the most recent market conditions. The estimated one-day loss in fair value of interest rate-sensitive instruments remained within the modeled VAR framework, showing no significant structural changes in the risk profile year-over-year.",
      "llm_answer": "MDLZ’s 2022 10‑K (page 78) and 2023 10‑K (page 64) both describe the VAR model as using a **parametric delta‑gamma approximation technique** to estimate the expected return distribution for interest rates, currencies and commodities.  The only change between the years is the data window used for the parameters – the 2023 filing applies the technique to movements observed in the prior quarter for 12/31/2023 and 2022, whereas the 2022 filing applied it to the prior quarter for 12/31/2021 and 2020 (both still using a 95 % confidence interval and one‑day horizon).  This continuity shows that MDLZ maintains a stable, parametric framework for assessing risk in its interest‑rate‑sensitive debt portfolio, relying on a consistent methodology rather than shifting to a new modeling approach.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that MDLZ used the parametric delta-gamma approximation technique in both 2022 and 2023, with the only change being the data window—specifically, the prior quarter for the respective year-end values (e.g., 2023 filing uses data from the prior quarter for 12/31/2023 and 12/31/2022, while 2022 filing used it for 12/31/2021 and 12/31/2020). This matches the ground truth exactly. The confidence interval (95%) and one-day horizon are correctly noted as unchanged. (2) All quantitative elements—dates, time windows, confidence level, and risk measurement framework—are factually accurate and consistent with the original answer. No calculation errors or incorrect numbers are present. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two 10-K filings (2022 and 2023), compares the methodology over time, and infers that the company maintains a stable risk modeling approach. The conclusion about methodological consistency and reliance on updated data inputs is logically derived and aligns with the ground truth. (4) The only minor shortcoming is that the LLM answer does not explicitly mention the use of four prior quarters for average VAR amounts, which is included in the ground truth and adds slight completeness value. However, the core evolution and implication are fully captured. Thus, the answer is semantically equivalent with high factual precision, warranting a 9/10 on correctness and qualitative accuracy, and perfect scores on quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1472,
        "completion_tokens": 434,
        "total_tokens": 1906
      },
      "error": null
    },
    {
      "question_id": 197,
      "question": "How did Southern Company's utilization of federal tax credits related to solar facilities in 2022 influence the structure and revenue recognition of its power purchase agreements (PPAs) in 2023?",
      "original_answer": "In 2022, Southern Company had approximately $1.2 billion of unutilized federal ITCs and PTCs, with $0.8 billion held by Southern Power, primarily tied to solar and wind facilities. These tax credits were expected to be fully utilized by 2024, often through tax equity partnerships where a tax partner captures most of the federal tax benefits. This financing structure directly influenced the accounting and structure of PPAs, as Southern Power's PPAs for solar and wind facilities were accounted for as operating leases with terms up to 25 years. By 2023, lease income from PPAs for Southern Power was included in wholesale revenues, indicating that the earlier tax credit strategy enabled the company to finance and structure long-term PPAs more effectively, thereby supporting revenue generation through stable lease income tied to energy production.",
      "llm_answer": "In 2022 Southern Company used a 26 % federal ITC for solar projects through tax‑equity partnerships, shifting the tax benefits to the equity partner and reducing the company’s capital‑cost basis【97】.  That partnership structure caused the 2023 PPAs for solar facilities to be accounted as operating leases with variable lease payments tied to energy production, so revenue is recognized as lease income over the lease term rather than as a single energy‑sale transaction【238】【240】.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core mechanism—use of federal tax credits via tax equity partnerships influencing PPA accounting as operating leases—but omits key quantitative details from the ground truth. It correctly identifies the use of ITCs and tax equity structures, and correctly links this to operating lease accounting and variable lease revenue recognition in 2023. However, it introduces a specific percentage (26%) for the ITC that is not present in the original answer and may be factually inaccurate or unsourced from the knowledge graph. The original answer emphasizes $1.2 billion in unutilized ITCs/PTCs (with $0.8 billion at Southern Power), which the LLM omits entirely, missing a critical financial magnitude and context. (2) The quantitative accuracy is reduced because while the 26% ITC rate might reflect a real-world rate for certain solar projects in 2022, it is not stated in the ground truth and thus cannot be verified as part of the knowledge graph’s output. The absence of the $1.2B/$0.8B figures—central to the original answer—represents a significant omission. (3) The multi-hop reasoning is sound: the model correctly infers that tax equity partnerships lead to operating lease treatment and that this affects revenue recognition in PPAs. It connects 2022 tax strategy to 2023 PPA structure and revenue, satisfying the causal chain. However, it fails to mention Southern Power by name in the context of holding the majority of credits or that lease income was included in wholesale revenues, weakening completeness. (4) Scores reflect strong qualitative and contextual performance—reasoning is logical and relevant—but quantitative accuracy is penalized for introducing an unsupported percentage and omitting key dollar amounts, reducing overall correctness to a 7.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 491,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 197,
      "question": "What were the operational and financial implications of Southern Company's Nicor Gas operations in Illinois between 2022 and 2023, particularly regarding regulatory disallowance of capital investments despite stable customer and infrastructure metrics?",
      "original_answer": "In 2022, Southern Company's Nicor Gas continued to operate in Illinois, serving a significant customer base as part of its gas distribution utilities. By 2023, operational data showed that Nicor Gas maintained 34.7 thousand miles of pipe and served 2,276 thousand customers in Illinois, indicating stable infrastructure and customer metrics. However, despite this operational consistency, Southern Company reported a pre-tax charge of $96 million ($72 million after tax) in 2023 due to the disallowance of certain capital investments at Nicor Gas. This suggests that while the utility maintained its physical and customer footprint, regulatory decisions negatively impacted the financial treatment of capital expenditures, highlighting a disconnect between operational performance and regulatory approval of investment recovery.",
      "llm_answer": "Between 2022 and 2023 Nicor Gas served a stable 2,276 thousand customers on 34.7 thousand miles of pipe, so its operational footprint did not change.  However, a regulatory decision in Illinois disallowed the recovery of certain capital investments at Nicor, resulting in a pre‑tax charge of roughly $96 million (about $72 million after tax) reported in the distribution‑operations segment (Note 2, “Southern Company Gas”).  The charge cut the segment’s operating income and overall net income, illustrating how regulatory disallowances can materially affect financial results even when customer and infrastructure metrics remain unchanged.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Nicor Gas served 2,276 thousand customers and maintained 34.7 thousand miles of pipe in 2023, indicating stable operations. The pre-tax charge of $96 million ($72 million after tax) due to regulatory disallowance of capital investments is accurately reported. (2) Quantitative accuracy is perfect—numbers match exactly, including dollar amounts and units, with acceptable formatting (e.g., 'thousand' vs 'thousands'). (3) The reasoning correctly synthesizes operational stability with adverse financial impact from regulatory decisions, capturing the multi-hop link between stable infrastructure and negative financial implications. The mention of the charge affecting operating and net income adds useful context not in the original but is logically sound and consistent with financial reporting norms. (4) The only minor shortcoming is that the original specifies the charge was reported in 2023 due to regulatory action, while the LLM implies the decision timing without explicitly stating it was a 2023 event—though this is reasonably inferred. Overall, the answer is factually complete, contextually relevant, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 354,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 198,
      "question": "How did UPS's methodology for valuing private debt investments through net asset value (NAV) evolve from 2022 to 2024, and what does the $2.7 billion in unfunded commitments as of 2024 indicate about their long-term investment strategy in private debt funds?",
      "original_answer": "In 2022, UPS used estimated NAV to value its U.S. pension plan investments, including private debt, based on audited and unaudited financial reports from fund managers, with adjustments made for investment activity between the report date and year-end. By 2024, the company continued to rely on NAV as a practical expedient for valuing private debt investments, but the disclosure of $2.7 billion in unfunded commitments to limited partnerships indicates a strategic continuation and potential expansion of long-term commitments to private debt funds. The persistence of NAV as the valuation method shows consistency in accounting policy, while the unfunded commitments suggest UPS expects sustained involvement and potential returns from these illiquid, long-term private debt investments.",
      "llm_answer": "UPS has continued to value its private‑debt holdings by estimating the fund’s net asset value (NAV) from the most recent audited partnership statements and adjusting for activity between the report date and year‑end.  In 2024 the note clarified that this NAV is used as a practical expedient for alternative investments that are not classified in the Level‑1/2/3 fair‑value hierarchy, whereas the 2022 note simply described the same NAV‑based approach (page 66 vs. page 93).  The $2.7 billion of unfunded commitments recorded as of December 31 2024 signals a substantial, multi‑year commitment to private‑debt funds—underscoring UPS’s long‑term strategy to maintain exposure to these illiquid assets over a 3‑ to 6‑year horizon.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and dates are correct: the $2.7 billion unfunded commitments as of December 31, 2024, are accurately reported, and the reference to valuation methodology in 2022 and 2024 is consistent with the original. Format variations (e.g., $2.7 billion) are acceptable. (2) The answer addresses both parts of the multi-part question: it explains the evolution (or consistency) of NAV-based valuation from 2022 to 2024 and interprets the $2.7 billion unfunded commitments in the context of long-term strategy. (3) Entity accuracy is strong: UPS is correctly identified, the years 2022 and 2024 are properly referenced, and financial terms like NAV, practical expedient, and unfunded commitments are used accurately. (4) The reasoning is sound: the LLM correctly infers that the continued use of NAV as a practical expedient (with more explicit disclosure in 2024) reflects policy consistency, and the unfunded commitments indicate a strategic, long-term commitment to private debt—consistent with the ground truth. The only minor shortcoming is that the LLM does not explicitly mention that the 2022 approach included both audited and unaudited reports (it only references audited), which slightly reduces qualitative completeness. However, this does not undermine the overall correctness. The contextual relevance is excellent, as the answer directly addresses the evolution of methodology and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 415,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 198,
      "question": "How did Southern Company's approach to goodwill impairment testing for PowerSecure evolve from 2022 to 2023, and what were the financial implications of this evolution?",
      "original_answer": "In 2022, Southern Company conducted a quantitative assessment for PowerSecure, which revealed that its fair value was lower than its carrying amount due to declining macroeconomic conditions, resulting in a $119 million goodwill impairment. In contrast, by 2023, PowerSecure’s fair value exceeded its carrying amount during the quantitative assessment, indicating an improvement in its financial outlook. This evolution suggests that Southern Company's impairment testing process through the quantitative assessment directly influenced the recognition of impairment losses, with 2022 showing a significant impairment and 2023 showing recovery.",
      "llm_answer": "In 2022, PowerSecure’s goodwill was tested with a quantitative impairment assessment that found fair value below carrying value, leading to a $119 million impairment recorded in the fourth quarter. In 2023, the same quantitative test was performed but fair value exceeded carrying value, so no impairment was recorded. The result was that the company avoided a $119 million loss in 2023, preserving goodwill and improving earnings compared with the prior year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key facts: in 2022, a quantitative goodwill impairment test for PowerSecure resulted in a $119 million impairment due to fair value falling below carrying value, and in 2023, the same test showed fair value exceeded carrying value, leading to no impairment. These facts align with the ground truth. (2) Quantitative accuracy is perfect: the $119 million figure is correct, years (2022 and 2023) are accurate, and the implication of avoiding a loss in 2023 is logically derived. Format variations (e.g., $119 million) are acceptable. (3) The multi-hop reasoning is sound—comparing impairment outcomes across two years and linking the change in financial outcome to the testing approach. The LLM correctly infers that the quantitative method was used both years and that the reversal in result (impairment vs. no impairment) reflects an improved financial outlook, though it does not explicitly state the 'improvement in financial outlook' as in the original answer. (4) The answer is contextually relevant and fully addresses both parts of the question: evolution of testing approach and financial implications. The only minor omission is not explicitly attributing the 2022 impairment to 'declining macroeconomic conditions' as stated in the ground truth, which slightly reduces qualitative completeness. However, the core reasoning and facts are correct, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 398,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 198,
      "question": "How did the reduction in Class B common stock's voting power threshold from 35% in 2023 to below 35% in 2024 impact META's corporate governance structure and investor protections?",
      "original_answer": "In 2023, META's corporate governance structure limited investor protections because its dual-class stock arrangement gave Mark Zuckerberg outsized control, and any change in control required approval by a majority of Class B shareholders while Class B common stock represented at least 35% of the combined voting power. By 2024, Class B common stock had fallen below the 35% threshold, triggering structural changes: board vacancies could no longer be filled by stockholders, the board became classified into staggered three-year terms with directors removable only for cause, and stockholder actions became restricted to formal meetings. This shift reduced minority investor influence further, despite potential expectations that governance would become more balanced as Class B voting power declined.",
      "llm_answer": "In 2023 Meta’s charter required that any transaction changing control of the company be approved by a majority of Class B shareholders as long as those shares represented at least 35 % of the combined voting power (see page 50).  In 2024 the threshold was lowered to below 35 %, so the control provisions now apply when Class B shares represent a smaller share of voting power.  This shift reduces the concentration of voting power held by the controlling shareholder and gives other shareholders a greater say in corporate decisions, thereby strengthening investor protections.",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in reasoning and conclusion. While it correctly identifies the 35% threshold in 2023 and the change in 2024, it incorrectly interprets the effect of the threshold being crossed. The original answer states that falling below 35% triggered governance changes that *reduced* minority investor influence (e.g., board became classified, vacancies no longer fillable by stockholders, actions restricted to meetings), whereas the LLM claims this shift 'reduces concentration of voting power' and 'strengthens investor protections'—the exact opposite of the truth. (2) Quantitatively, the percentages (35%) and years (2023, 2024) are accurate, and no calculations are required, so quantitative accuracy is high. (3) The multi-hop reasoning is flawed: the model fails to synthesize the actual governance consequences triggered when Class B falls below 35%, instead assuming a more democratic outcome. It misses key structural changes like staggered board terms and removal of stockholder power to fill vacancies. (4) Correctness is severely penalized because the core conclusion is factually inverted. Contextual relevance is moderate as it addresses the right topic and threshold, but qualitative accuracy is low due to incorrect logic and entity-function mapping.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 370,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 199,
      "question": "How did the composition and valuation methodology of MDLZ's Level 1 Financial Liabilities tied to commodity futures evolve from 2022 to 2024, and what does this imply about their exposure to market price volatility?",
      "original_answer": "In 2022, MDLZ's Level 1 Financial Liabilities included exchange-traded commodity futures and listed options, with fair values determined based on quoted market prices on commodity exchanges. These liabilities were directly linked to commodity futures used to hedge input costs like cocoa, sugar, and wheat. By 2024, the composition remained consistent, with Level 1 liabilities still consisting of exchange-traded commodity futures and listed options, and valuation continuing to rely on quoted market prices. However, the continued reliance on Level 1 instruments suggests that MDLZ maintained a high degree of transparency and market alignment in its hedging practices, implying ongoing exposure to market price volatility but with a consistent and observable valuation framework across both years.",
      "llm_answer": "MDLZ’s Level 1 commodity‑futures liabilities grew markedly from 2022 to 2024 – the fair value of commodity contracts rose from $157 million in 2022 to $683 million in 2024, and the Level 1 portion climbed from $28 million in 2023 to $111 million in 2024, reflecting a higher share of exchange‑traded futures (page 97; page 95).  The valuation methodology stayed Level 1 throughout, with fair value determined by quoted market prices on commodity exchanges (page 112).  This shift indicates that MDLZ’s exposure to commodity‑price volatility has increased, as the liabilities are now more heavily weighted and larger in value at market‑price‑based valuations.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific numerical values ($157M in 2022, $683M in 2024, $28M in 2023, $111M in 2024) that are not present in the original ground truth answer and cannot be verified against it. The ground truth makes no mention of any dollar amounts or changes in liability size over time, so these figures are factually unsupported and likely hallucinated. This severely undermines quantitative accuracy. (2) The claim that 'Level 1 portion climbed from $28M in 2023 to $111M in 2024' implies a change in composition or allocation within Level 1 liabilities, but the original answer states that the composition and valuation methodology remained consistent from 2022 to 2024. There is no mention of a shift in the 'portion' of Level 1 liabilities, nor any data for 2023. (3) While the LLM correctly identifies that valuation methodology remained Level 1 and based on quoted market prices (aligning with the ground truth), it draws an unsupported conclusion that 'exposure to commodity-price volatility has increased' due to larger liabilities. The original answer does not make this claim; instead, it notes that the continued use of Level 1 instruments implies ongoing exposure but with transparency and consistency. The LLM overinterprets non-existent numerical trends to suggest increased exposure, which is not justified by the ground truth. (4) Contextually, the answer addresses the right topic—MDLZ's Level 1 liabilities, commodity futures, valuation methodology, and implications for volatility exposure—but the inclusion of fabricated numbers and incorrect inferences about evolving exposure significantly reduces factual correctness. The multi-hop reasoning fails because it synthesizes non-existent data points rather than correctly inferring from consistent qualitative information across years. Thus, while the general direction of analysis is relevant, the factual foundation is flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 520,
        "total_tokens": 1902
      },
      "error": null
    },
    {
      "question_id": 199,
      "question": "How did LLY's inclusion in Medicare's government-set pricing program for Jardiance in 2023 affect its exposure to pricing pressures in 2024, given the announced 66% discount effective in 2026?",
      "original_answer": "In 2023, LLY's Jardiance was selected under Medicare’s government-set pricing program as part of the Inflation Reduction Act (IRA), signaling early regulatory pressure on pricing (from hop1_evidence). This selection, which would result in a 66% discount from the 2023 list price effective in 2026, contributed to broader pricing pressures faced by the company in 2024 (from hop2_evidence). By 2024, LLY explicitly noted that this development accelerated revenue erosion concerns and intensified scrutiny over pricing, particularly for high-profile products like Jardiance, which is part of a key therapeutic area (diabetes) already under payer focus (from hop3_evidence). Thus, the 2023 Medicare inclusion directly shaped LLY’s 2024 risk profile by amplifying expectations of future revenue constraints and increasing current-year pricing sensitivity from both public and private payers.",
      "llm_answer": "LLY’s inclusion of Jardiance in Medicare’s government‑set pricing program in 2023 raised its exposure to pricing pressures in 2024.  The program, announced in August 2024, will apply a 66 % discount to Jardiance’s 2023 list price starting in 2026, accelerating revenue erosion and increasing the company’s pricing risk.  LLY therefore expects the discount to materially impact its business and consolidated results, with additional products likely to be selected in future years.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that LLY's Jardiance was included in Medicare’s government-set pricing program in 2023, which increases pricing pressures in 2024, and correctly states the 66% discount will be applied starting in 2026 based on the 2023 list price. However, it incorrectly states that the program was 'announced in August 2024', which contradicts the ground truth — the selection occurred in 2023 under the Inflation Reduction Act. This is a significant factual error affecting timing and source of the policy action. (2) Quantitative accuracy is partially compromised: while the 66% discount and 2026 effective date are correct, the erroneous August 2024 announcement date introduces a false timeline. All other numbers (percentages, years) are accurate. (3) The multi-hop reasoning is generally sound — the model connects 2023 inclusion to 2024 pricing pressures and future revenue impact — but fails to fully synthesize the causal chain from regulatory action (2023 IRA selection) to accelerated revenue erosion concerns and payer scrutiny in 2024 as noted in the ground truth. The mention of 'additional products likely to be selected' is plausible but not supported in the original answer, adding minor speculative content. (4) Despite the timing error, the core message about increased pricing pressure and future revenue impact is preserved, and key entities (LLY, Jardiance, Medicare, 66%, 2026) are correct. Hence, correctness is reduced to 7 due to the significant date inaccuracy, but qualitative and contextual scores remain high due to solid reasoning and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 442,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 199,
      "question": "How did AVGO's Identity Security offering evolve from its 2022 positioning as part of the Symantec Cyber Security portfolio to its 2024 presentation as a distinct enterprise security solution, and what specific capabilities were emphasized in the 2024 filing?",
      "original_answer": "In 2022, AVGO's Symantec Cyber Security portfolio included Identity Security as one of several offerings, alongside Endpoint Security, Network Security, and Information Security. By 2024, Identity Security had evolved into a standalone category within the Enterprise Security Portfolio, with a clear focus on mitigating identity-based attacks by enforcing granular access control policies and streamlining access governance. This shift suggests a strategic elevation of Identity Security within AVGO's product hierarchy, likely in response to increasing threats targeting user identities and the growing importance of access management in enterprise cybersecurity strategies.",
      "llm_answer": "AVGO repositioned Identity Security from a component of its 2022 Symantec Cyber Security portfolio to a standalone offering within the 2024 Enterprise Security portfolio. In the 2024 filing the solution was described as “positively identifying legitimate users, enforcing granular access‑control policies, and streamlining access governance to prevent unauthorized access to sensitive resources and data.”",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. (1) It accurately captures the evolution of AVGO's Identity Security offering from being a component within the 2022 Symantec Cyber Security portfolio to a standalone category in the 2024 Enterprise Security portfolio. The key shift in positioning is correctly identified. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not applicable beyond correct year references (2022 and 2024), which are accurate. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across time (2022 vs 2024) and organizational structure (Symantec portfolio vs Enterprise Security), demonstrating understanding of the strategic repositioning. (4) The specific capabilities emphasized in the 2024 filing—'positively identifying legitimate users, enforcing granular access-control policies, and streamlining access governance'—are directly quoted and match the intent and content of the original answer. The only minor limitation is that the LLM does not explicitly mention the other components of the 2022 portfolio (Endpoint, Network, Information Security), which slightly reduces completeness in contextual background, but this does not detract from the core accuracy of the response. Overall, the answer is semantically equivalent, contextually relevant, and factually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 394,
        "total_tokens": 1692
      },
      "error": null
    },
    {
      "question_id": 199,
      "question": "How did Disney's use of firm commitments in 2022 as part of its foreign exchange hedging strategy compare to its use of option contracts in 2024, particularly in terms of notional amounts and deferred gains recorded in AOCI?",
      "original_answer": "In 2022, Disney reported notional amounts of $7.4 billion for foreign exchange cash flow hedges, which included firm commitments, with $704 million in net deferred gains recorded in AOCI for contracts maturing in the next twelve months. By 2024, Disney's notional amounts for foreign exchange cash flow hedges increased to $9.9 billion, though the deferred gains decreased significantly to $99 million for the next twelve months. This indicates a substantial increase in the scale of hedging activities, particularly through option contracts, but a reduction in the near-term unrealized gains, potentially reflecting changes in foreign exchange market conditions or shifts in Disney's hedging strategy.",
      "llm_answer": "In 2024 Disney’s option‑based foreign‑exchange hedges had a notional value of $9.9 billion and generated $99 million of deferred gains in AOCI for contracts maturing in the next 12 months. The 2022 10‑K does not disclose the notional amount of firm‑commitment hedges or the AOCI deferred gains associated with them, so a direct comparison of those figures cannot be made from the supplied pages.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and fails to correctly represent the ground truth. (1) Quantitatively, the LLM incorrectly claims that Disney's 2022 10-K 'does not disclose' the notional amount or AOCI deferred gains for firm commitment hedges, when in fact the original answer (ground truth) explicitly states that in 2022, Disney reported $7.4 billion in notional amounts and $704 million in deferred gains in AOCI. These figures are entirely omitted due to a false assertion of non-disclosure, making the quantitative accuracy very low. The 2024 figures ($9.9 billion notional, $99 million deferred gains) are correctly stated. (2) The answer is incomplete—it fails to provide the 2022 data that is central to the comparison asked in the question. This omission prevents any valid comparison between 2022 firm commitments and 2024 option contracts. (3) The reasoning is flawed: the model asserts lack of disclosure without justification, and thus fails the multi-hop requirement to compare across years and instruments. It does not recognize that firm commitments in 2022 and option contracts in 2024 are both components of foreign exchange cash flow hedges and can be compared via notional amounts and AOCI impacts. (4) Contextual relevance is moderate because the answer addresses the right topic (Disney, FX hedging, AOCI, notional amounts) and correctly reports 2024 data, but the incorrect denial of 2022 data severely undermines usefulness. Overall, the answer is mostly incorrect due to a critical factual omission presented as a documentation gap.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 431,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 200,
      "question": "How did the evolution of PMI's PMTA submissions for IQOS devices between 2022 and 2023 impact MO's commercialization rights and regulatory risk exposure in the U.S. market?",
      "original_answer": "In 2022, PMI had already received FDA authorization for the original IQOS Tobacco Heating System under a PMTA and had also submitted an MRTP application for IQOS 3, which was under review. However, due to a patent dispute, MO was forced to remove IQOS devices and HeatSticks from the market in late 2021. By 2023, the FDA had authorized PMTAs for three new tobacco-flavored varieties of Marlboro HeatSticks and had also authorized the marketing of IQOS 3 as an MRTP with a reduced exposure claim. Despite this progress, the U.S. government challenged MO's agreement to assign exclusive U.S. commercialization rights to PMI, asserting that court approval was required. This regulatory uncertainty, combined with the evolving PMTA landscape and the potential for future product removals, increased MO's regulatory risk exposure even as product authorizations expanded.",
      "llm_answer": "Between 2022 and 2023, PMI’s PMTA submissions for the IQOS 3 system (FDA‑authorized March 2022) and for new Marlboro HeatSticks (FDA‑authorized January 2023) continued to advance the product line, but Altria (MO) agreed in October 2022 to assign its exclusive U.S. commercialization rights for the IQOS system to PMI, effective April 2024. This transfer stripped MO of its ability to market IQOS in the U.S. and shifted the regulatory risk of FDA approvals, potential denials, and the ITC cease‑and‑desist order to PMI, leaving MO’s remaining regulatory exposure focused on other products.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies that significantly undermine its correctness. First, it incorrectly states that the FDA authorized the IQOS 3 system in March 2022; the ground truth indicates that the MRTP application for IQOS 3 was under review in 2022 and was only authorized in 2023. Second, it claims FDA authorized new Marlboro HeatSticks in January 2023, but the original answer does not specify the exact date—only that authorizations occurred by 2023. Third, the LLM introduces a claim that Altria agreed in October 2022 to assign exclusive U.S. commercialization rights to PMI, effective April 2024, which is not present in the ground truth. While the original answer mentions a U.S. government challenge to MO's agreement to assign rights, it does not confirm the agreement was finalized or provide these dates. (2) Quantitative accuracy is low due to incorrect dates (March 2022, January 2023, October 2022, April 2024) that are either fabricated or misaligned with the source. The ground truth does not specify exact months for authorizations or agreements. (3) The reasoning is partially sound in linking PMTA progress to shifting regulatory risk, but it misrepresents the nature of the rights transfer. The original answer emphasizes ongoing regulatory uncertainty and court challenges, whereas the LLM portrays the transfer as definitive and risk-reducing for MO—contradicting the ground truth that MO’s regulatory exposure *increased* due to legal challenges and potential product removals. The model fails to capture the multi-hop nuance that expanded authorizations coincided with heightened legal and regulatory risks. (4) Contextual relevance is high because the answer addresses the core themes: PMTA evolution, commercialization rights, and regulatory risk. However, factual and reasoning errors reduce qualitative and overall correctness scores significantly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 518,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 200,
      "question": "How did BNY Mellon's expansion of BNY SA/NV's branch network between 2022 and 2024, including the addition of Wroclaw, Poland, align with changes in its Securities Services segment focus and global custody capabilities?",
      "original_answer": "In 2022, BNY SA/NV operated branches in key European cities including the City of Luxembourg, but had not yet expanded to Wroclaw, Poland. By 2024, BNY SA/NV added Wroclaw to its branch network, signaling a strategic geographic extension aimed at enhancing regional service delivery. During this period, BNY Mellon restructured its business segments, maintaining a strong emphasis on Securities Services, which includes global custody and asset servicing. In 2024, BNY SA/NV's activities remained focused on these core areas, with $52.1 trillion in assets under custody and/or administration, up from $46.7 trillion in 2022. This growth, combined with the Wroclaw expansion, reflects a deliberate alignment of geographic footprint with the growing demand for global custody services and the firm’s strategic commitment to enhancing its Securities Services capabilities.",
      "llm_answer": "BNY Mellon’s 2024 10‑K notes that BNY SA/NV now has a branch in Wroclaw, Poland—an addition that did not appear in the 2022 filing, which listed only Amsterdam, Copenhagen, Dublin, Frankfurt, Luxembourg, Madrid, Milan and Paris【page_7】.  Both filings describe BNY SA/NV’s activities as part of the Securities Services and Market‑and‑Wealth Services segments with a core focus on global custody, asset servicing and collateral management【page_6】【page_7】.  Thus, the network expansion directly supports the segment’s strategic emphasis on expanding custody and servicing capabilities across Europe, reinforcing BNY Mellon’s global custody platform.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the expansion of BNY SA/NV's branch network to include Wroclaw, Poland by 2024, noting its absence in the 2022 filing, which aligns with the ground truth. It accurately describes the continuity of BNY SA/NV’s focus on Securities Services, including global custody and asset servicing. However, the LLM answer omits key quantitative data from the ground truth—specifically the $52.1 trillion in assets under custody/administration in 2024 and the $46.7 trillion in 2022—which are central to demonstrating the growth in Securities Services capabilities. (2) While no incorrect numbers are stated, the failure to include these critical figures results in a partial loss of quantitative accuracy. The years (2022, 2024) and entity names (BNY SA/NV, Securities Services) are correct. (3) The reasoning is sound: the model correctly infers that the geographic expansion supports the strategic focus on custody and servicing, synthesizing information across two filings to show a deliberate extension of capabilities. This reflects valid multi-hop reasoning linking branch expansion to segment focus. (4) The answer is contextually excellent—directly addressing the alignment between network growth and business focus—but loses points on completeness due to missing asset figures that quantify the segment’s growth. Hence, correctness is high but not full, warranting an 8.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 393,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 201,
      "question": "How did Duke Energy Progress' consolidation of DEPNCSF in 2024 reflect the evolution of storm recovery financing strategies compared to the 2021 bond issuance for North Carolina storm costs?",
      "original_answer": "In 2021, DEPNCSF issued $770 million in senior secured bonds to finance unrecovered regulatory assets related to North Carolina storm costs from 2018 and 2019, with collections from non-bypassable charges serving as the sole source of repayment. By 2024, Duke Energy Progress had consolidated DEPNCSF, indicating ongoing responsibility for those obligations while also forming DEPSCSF to issue an additional $177 million in bonds for South Carolina storm costs spanning 2014 to 2022. This shows a strategic expansion of the storm recovery financing model both geographically and temporally, while maintaining the same financial structure of special purpose entities and non-recourse debt.",
      "llm_answer": "Duke Energy Progress consolidated DEPNCSF in its 2024 financial statements (page 205), moving the VIE from a stand‑alone entity to a fully integrated part of the company’s balance sheet.  This shift reflects an evolution from the 2021 bond issuance—where DEPNCSF was created solely to finance North Carolina storm costs incurred in 2018‑2019—to a broader, more consolidated storm‑recovery strategy that now covers costs from 2014‑2022 and aligns the financing more closely with Progress’s core operations.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution in Duke Energy Progress' storm recovery financing strategy. It correctly identifies the 2024 consolidation of DEPNCSF and references the shift from a standalone entity to integration into the balance sheet, citing the correct context (page 205). It accurately contrasts the 2021 bond issuance for North Carolina storm costs (2018–2019) with the expanded temporal scope (2014–2022) in the updated strategy. However, it omits key quantitative details from the ground truth: the $770 million bond issuance in 2021 and the $177 million issuance for South Carolina via DEPSCSF in 2024. While it mentions the broader geographic and temporal expansion, it fails to name DEPSCSF, a critical entity in the multi-hop reasoning. The financial structure (special purpose entities, non-recourse debt, non-bypassable charges) is underdeveloped in the response, weakening the completeness of the comparison. Despite these omissions, the reasoning is sound, and the semantic meaning aligns well with the original answer—just lacking specificity on numbers and entities. Hence, the correctness score is 8 due to missing key figures and entity names, though the overall interpretation is accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 347,
        "total_tokens": 1656
      },
      "error": null
    },
    {
      "question_id": 201,
      "question": "How did Microsoft's redemption of Nuance's convertible senior notes between 2022 and 2024 impact the financial structure of the Intelligent Cloud segment, particularly in relation to the remaining liabilities and goodwill attributed to Nuance?",
      "original_answer": "In 2022, Microsoft disclosed that $986 million of convertible senior notes issued by Nuance (mostly redeemed prior to June 30, 2022), with $1 million remaining and classified as other current liabilities. By 2024, the filing noted that 'substantially all' of these notes had been redeemed. This reduction in outstanding liabilities reflects a decrease in financial obligations tied to the Nuance acquisition. Simultaneously, goodwill attributed to Nuance remained in the Intelligent Cloud segment, indicating that despite the redemption progress, Microsoft continued to rely on Nuance for strategic synergies. The evolution of this liability and its relationship to Nuance highlights a shift in Microsoft's financial exposure to the subsidiary while maintaining operational dependency.",
      "llm_answer": "Microsoft’s redemption of Nuance’s convertible senior notes eliminated the $986 million liability that had been recorded in the Intelligent Cloud segment, leaving only a negligible $1 million (or none by 2024) on the balance sheet【page 78 (2022)】【page 78 (2024)】. The goodwill attributed to Nuance remained at roughly $16.3 billion and continued to be assigned to the Intelligent Cloud segment【page 78 (2022)】【page 78 (2024)】. This removal of the note liability tightened the segment’s leverage and improved its balance‑sheet structure without affecting the goodwill balance.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $986 million initial liability and the $1 million remaining in 2022, aligning with the ground truth. It accurately notes that by 2024, the remaining amount was negligible or zero, consistent with 'substantially all' being redeemed. However, the LLM introduces a specific goodwill figure of $16.3 billion, which is not present in the original answer and cannot be verified from the provided ground truth—this is an over-precision and unsupported addition. (2) Quantitative accuracy is high: $986M and $1M are correct, and the trend over time is accurately represented. The unsupported $16.3B goodwill value is the only numerical issue. (3) The multi-hop reasoning is sound—linking the redemption of notes to the Intelligent Cloud segment’s liabilities and distinguishing liability reduction from unchanged goodwill demonstrates correct synthesis across time and entities. The conclusion about improved balance sheet structure is reasonable but slightly interpretive. (4) Contextual relevance is excellent—the answer directly addresses the impact on financial structure, liabilities, and goodwill. The only deduction is for introducing an unverified numerical value for goodwill, which affects factual completeness and precision, hence the 8/10 on correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 367,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 201,
      "question": "How did the subscriber base for ESPNU, as reported through ESPN's channel ecosystem in 2023 and 2024, reflect continuity or change in Disney's sports content distribution strategy across these years?",
      "original_answer": "In 2023, ESPN reported that ESPNU had an estimated 47 million subscribers as part of its broader channel ecosystem, which included approximately 66 million subscribers for ESPN and 55 million for international ESPN channels. By 2024, the subscriber count for ESPNU remained consistent at 47 million across ESPN's distribution network. This stability suggests that Disney maintained its sports content strategy, preserving ESPNU's position within the ESPN portfolio without significant expansion or contraction in reach during this period.",
      "llm_answer": "Both the 2023 and 2024 10‑K filings list ESPNU with an estimated 47 million subscribers (SNL Kagan, December 2023; carried forward in the September 2024 estimate). The unchanged figure shows that Disney’s sports‑distribution strategy has remained steady, maintaining a robust college‑sports audience without a significant shift in reach over the two years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the subscriber count of 47 million for ESPNU in both 2023 and 2024 is correct, matching the original answer. The mention of SNL Kagan as the source and the December 2023 data point (carried forward to September 2024) adds detail not in the ground truth but does not contradict it and reflects plausible reporting methodology. (2) The calculation aspect is minimal here, but the comparison across years is correctly interpreted as showing no change, supporting the conclusion of strategic continuity. (3) The reasoning is sound: the stable subscriber base is correctly linked to Disney's consistent sports content distribution strategy, particularly in maintaining ESPNU’s college-sports-focused reach. The answer synthesizes the multi-hop elements—subscriber data across two years and its implication for corporate strategy—logically. (4) While the original answer includes additional context (e.g., ESPN’s 66M and international’s 55M subscribers), this information is not strictly necessary to answer the specific question about ESPNU’s subscriber base and its strategic implication. Its omission does not reduce factual correctness. (5) Semantic equivalence is maintained: 'unchanged figure', 'remained steady', and 'maintaining a robust college-sports audience' convey the same conclusion as the original. The only minor shortcoming is slightly less contextual detail compared to the ground truth, but the core facts, entities, years, and interpretation are fully accurate. Hence, a 9/10 on correctness and qualitative accuracy, with full marks for quantitative and contextual performance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 458,
        "total_tokens": 1695
      },
      "error": null
    },
    {
      "question_id": 202,
      "question": "How did Southern Company's investment in solar facilities in 2022, which included $1.2 billion in unutilized ITCs, influence the structure and revenue recognition of its power purchase agreements (PPAs) in 2023, particularly in terms of lease income included in wholesale revenues?",
      "original_answer": "In 2022, Southern Company had $1.2 billion in unutilized federal ITCs tied to investments in solar facilities, which were expected to be fully utilized by 2024. These investments were directly related to Power Purchase Agreements (PPAs), as solar facilities under PPAs were accounted for as operating leases. By 2023, lease income from PPAs—specifically for Alabama Power and Southern Power—was included in wholesale revenues, indicating that the earlier investments in solar facilities (supported by ITCs) had matured into revenue-generating PPAs. This shows a clear 3-hop chain: the company's 2022 investment in solar facilities (supported by ITCs) led to the development of PPAs, which in 2023 became a source of structured lease income within wholesale revenues.",
      "llm_answer": "Southern Company’s 2022 solar investment—backed by $1.2 billion of unutilized ITCs—was structured as operating‑lease PPAs. In 2023, the variable lease payments tied to energy production were recognized as lease income and reported as part of wholesale revenues for Alabama Power and Southern Power (see lease‑income table, 2023)【page_241】, while the lease classification and variable‑lease payment details are disclosed in the notes on leases and variable lease costs【page_268】【page_238】. This structure enabled the company to capture the tax‑credit benefits while providing a stable lease‑income stream that is included in wholesale revenues【page_97】【page_241】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Southern Company's $1.2 billion in unutilized ITCs from 2022 solar investments are accurately stated, and the use of operating leases for PPAs is correctly identified. The inclusion of lease income in wholesale revenues in 2023 for Alabama Power and Southern Power is factually consistent with the original answer. (2) Quantitative accuracy is perfect: the $1.2 billion figure is correctly cited, and no calculations are required beyond accurate reporting of amounts and years. (3) The multi-hop reasoning is sound: the answer traces the chain from 2022 solar investments supported by ITCs to the 2023 recognition of lease income in wholesale revenues via operating lease structures. It correctly identifies the cause-effect relationship between tax credit-supported investments and revenue recognition. (4) The only minor shortcoming is that the LLM does not explicitly state that the ITCs were expected to be fully utilized by 2024, which is a small but relevant detail from the ground truth. However, this omission does not undermine the core reasoning or factual accuracy. The answer is contextually rich, cites appropriate disclosures (e.g., lease-income table, notes), and correctly interprets the financial structure. Overall, the response is semantically equivalent to the original answer with high precision and strong multi-hop synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 399,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 202,
      "question": "How did the change in Amgen's profit and loss sharing arrangement with UCB for EVENITY between 2023 and 2024 reflect the evolution of their collaborative commercialization strategy across global markets?",
      "original_answer": "In 2023, Amgen disclosed its collaboration with UCB for EVENITY, under which UCB led commercialization in most European countries while Amgen led in all other territories, including the U.S., with global development costs and commercialization profits and losses shared equally. By 2024, this arrangement remained structurally unchanged, but the financial impact on Amgen increased significantly, as global profit and loss share expenses rose from $396 million in 2023 to $547 million in 2024. This increase suggests a deeper financial commitment or higher commercial performance of EVENITY under the existing collaborative framework, indicating a strategic reinforcement of the partnership's operational execution rather than a structural change.",
      "llm_answer": "Amgen’s profit‑and‑loss share expense for the EVENITY collaboration with UCB grew from **$396 million in 2023 to $547 million in 2024** (page 132), reflecting higher global sales and commercialization costs.  The partnership still shares development costs and profits/losses equally, with UCB leading in most European markets while Amgen leads elsewhere (pages 29‑30), indicating a shift toward a more integrated, globally balanced commercialization strategy that expands Amgen’s reach outside North America.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the key financial figures—$396 million in 2023 and $547 million in 2024—which match the ground truth exactly, satisfying quantitative accuracy. The entity identification (Amgen, UCB, EVENITY), time periods (2023 to 2024), and collaboration structure (equal profit/loss sharing, UCB leading in Europe, Amgen elsewhere) are all factually correct. (2) The numbers are accurate and properly cited to specific pages, with no calculation errors. The increase of $151 million is implied and consistent. (3) The reasoning is mostly sound: the model correctly identifies that the structural arrangement did not change. However, it interprets the increased expense as indicating a 'shift toward a more integrated, globally balanced commercialization strategy' and 'expands Amgen’s reach outside North America,' which goes beyond the evidence. The ground truth emphasizes that the structure remained unchanged and the increased cost reflects deeper financial commitment or higher performance—not a strategic shift or geographic expansion. This overinterpretation slightly misrepresents the evolution of the strategy. (4) The answer is highly factually accurate and contextually relevant, but the qualitative reasoning introduces a subtle mischaracterization of strategic evolution, preventing a perfect score. Thus, correctness is rated 8 for minor interpretive inaccuracy despite full factual and numerical alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 401,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 202,
      "question": "How did the voting power distribution between Class A and Class B common stockholders at CMCSA change from 2022 to 2023, and what does this imply about shareholder control concentration?",
      "original_answer": "In 2022, Class A common stockholders held 66 2/3% of the combined voting power, while Class B common stockholders held 33 1/3%. Notably, only 3 record holders owned Class B shares in 2022, and Mr. Brian L. Roberts beneficially owned all outstanding shares of Class B common stock, which carries 15 votes per share. By 2023, Class A Common Stock remained registered under SEC Section 12(b), indicating continued public trading, while Class B shares remained concentrated. This implies that despite the voting power split, control remained concentrated in a small group, particularly Mr. Roberts, due to the high per-share voting weight of Class B stock.",
      "llm_answer": "In both 2022 and 2023, Class A shareholders held 66 ⅓ % of the combined voting power while Class B shareholders held 33 ⅓ % (see page 38 of each filing). The unchanged split shows that control concentration remains high, with the single Class B shareholder (Mr. Roberts) retaining a significant share of voting power and therefore strong influence over corporate decisions.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states the voting power distribution between Class A and Class B shareholders as 66 1/3% and 33 1/3% respectively in both 2022 and 2023, which is close but not exactly accurate — the ground truth specifies 66 2/3% and 33 1/3%, a significant difference in fractional terms. This error in the Class A percentage (66 1/3% vs 66 2/3%) undermines quantitative precision. (2) The claim that the split is 'unchanged' is reasonable given both years report the same split in the LLM's view, but due to the incorrect percentage, the calculation basis is flawed. The reference to 'page 38 of each filing' adds apparent sourcing but isn't verifiable here. (3) The LLM correctly identifies Mr. Roberts as the key controlling shareholder and infers continued concentration of control, which aligns with the ground truth’s emphasis on control concentration despite unchanged structure. However, it omits key details: in 2022, there were 3 record holders of Class B stock (though Roberts owned all beneficially), and the Class B shares carry 15 votes per share — a critical structural reason for control concentration. The LLM mentions 'single Class B shareholder' which oversimplifies the record vs. beneficial ownership distinction. (4) Despite missing key nuances and containing a material fractional error in voting power percentages, the LLM captures the core implication about control concentration. Hence, correctness is partially impacted — core facts are directionally right but lack precision and completeness, warranting a 7. Quantitative accuracy is penalized for the 66 1/3% vs 66 2/3% error. Qualitative accuracy is reduced due to incomplete entity and structural detail. Contextual relevance remains high as the answer directly addresses the question’s intent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 486,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 203,
      "question": "How did the shift in NEE's pension plan asset allocation between 2022 and 2024 influence the role of common trusts in the plan's investment strategy?",
      "original_answer": "In 2022, NEE's pension plan targeted a 10% allocation to convertible securities and 13% to alternative investments, with common and collective trusts being a key vehicle for diversification across equity, fixed income, and alternative assets. By 2024, the allocation to convertible securities dropped to 5%, while alternative investments increased to 20%, signaling a strategic pivot toward higher-risk, higher-reward alternative strategies. This shift likely increased the reliance on common trusts, which were used to access diversified and alternative investment vehicles, such as limited partnerships and pooled accounts. The evolution in allocation and investment vehicles reflects a broader strategic emphasis on achieving higher returns through alternative exposures while maintaining diversification and liquidity.",
      "llm_answer": "The plan’s target allocation shifted from 45 % equity, 32 % fixed‑income, 13 % alternative and 10 % convertible in 2022 (same as the 2021 target) to 43 % equity, 32 % fixed‑income, 20 % alternative and 5 % convertible in 2024【page_101】【page_100】. This move increased the share of alternative investments—typically held in private‑equity and real‑estate limited partnerships rather than common trusts—while trimming equity and convertible holdings. Consequently, the proportion of assets held in common and collective trusts for equity and fixed‑income positions fell, reducing the role of common trusts in the overall investment strategy【page_100】.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "1) The LLM answer contains partially correct quantitative data but draws an incorrect conclusion about the role of common trusts. The percentages for asset allocation shifts are mostly accurate: in 2022, NEE targeted 10% convertible securities and 13% alternative investments, and by 2024, these shifted to 5% and 20% respectively, which aligns with the ground truth. The LLM correctly identifies the increase in alternative investments and decrease in convertible securities. However, the LLM incorrectly claims that the use of common and collective trusts decreased, stating that 'the proportion of assets held in common and collective trusts for equity and fixed-income positions fell, reducing the role of common trusts.' This contradicts the original answer, which states that the shift likely increased reliance on common trusts because they were used to access alternative vehicles like limited partnerships and pooled accounts. 2) Quantitatively, the LLM provides additional breakdowns (45% equity, 32% fixed income in 2022; 43%, 32% in 2024) not in the original answer, but these do not contradict known data and sum correctly (100% in both years). The core percentages for convertible and alternative investments match the ground truth. 3) The multi-hop reasoning is flawed: while the model correctly identifies the change in allocation, it fails to synthesize the connection between increased alternative investments and the use of common trusts as a vehicle for those investments. Instead, it assumes that because alternatives are held in limited partnerships, common trusts must have declined in importance—this is a logical error, as common trusts can hold or provide access to such partnerships. The original answer explicitly links the strategic pivot to greater use of common trusts for diversification into alternatives. 4) The contextual relevance is moderate—the answer addresses the shift in allocation and mentions common trusts, but misinterprets their evolving role. The citation of page references suggests source grounding, but the inference drawn is factually incorrect. Thus, despite accurate numbers, the core conclusion is wrong, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 584,
        "total_tokens": 1953
      },
      "error": null
    },
    {
      "question_id": 203,
      "question": "How did GILD's revenue share from Symtuza change between 2022 and 2023, and what impact did the timing of Janssen's sales have on Gilead's Product sales recognition during this period?",
      "original_answer": "In 2022, GILD disclosed that its revenue share from Symtuza was included in Product sales, based on the revenue recognition timing tied to Janssen's sales of the product. By 2023, the collaboration terms clarified that Gilead recognizes its share of Symtuza revenue in the period when Janssen's corresponding sales occur, as the license was deemed the predominant item tied to the revenue share. This shift in emphasis from general inclusion to specific timing alignment indicates a refinement in how Gilead accounts for Symtuza revenue, directly linking it to Janssen's commercial performance. This change in accounting interpretation likely affected the timing and predictability of Product sales reported by Gilead, especially in relation to Symtuza's market performance.",
      "llm_answer": "Gilead’s share of Symtuza revenue grew from 2022 to 2023 – the company recorded a higher amount of Symtuza‑related product sales in 2023 than in 2022.  Because Gilead recognizes its Symtuza revenue share only when Janssen actually sells the product, the timing of Janssen’s sales created a lag in Gilead’s product‑sales recognition; revenue was recorded in the period that Janssen’s sales occurred rather than when Gilead supplied the Gilead‑compounds.  (Symtuza revenue‑share policy – page 79; revenue‑share mention – page 7)",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Gilead recognizes its Symtuza revenue share based on the timing of Janssen's sales, which aligns with the ground truth. However, it incorrectly implies a quantitative increase in Symtuza-related revenue from 2022 to 2023 by stating 'Gilead’s share of Symtuza revenue grew' and 'recorded a higher amount...in 2023 than in 2022' — the original answer does not provide any such numerical comparison or growth claim, and no data is cited to support this. This introduces a factual inaccuracy not present in the ground truth. (2) There are no explicit numbers (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is assessed on the correctness of comparative statements. Since the LLM fabricates a revenue increase without evidence, this reduces quantitative accuracy. (3) The multi-hop reasoning is partially sound — the model correctly links Janssen's sales timing to Gilead's revenue recognition and references the accounting policy tied to product sales. However, it misses the key nuance in the original answer: the 2023 clarification that the license was deemed the 'predominant item,' which led to a refinement in accounting interpretation. This conceptual shift in revenue recognition policy is central to the original answer but absent in the LLM response. (4) Contextual relevance is high because the answer addresses both parts of the question — revenue share change and impact of timing — and stays focused on Symtuza, Gilead, and Janssen. However, the incorrect assertion of revenue growth and omission of the accounting rationale downgrade correctness and qualitative accuracy significantly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 459,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 204,
      "question": "How did the number of securities remaining available for future issuance under equity compensation plans approved by security holders change from 2022 to 2023, and what does this indicate about CL's capacity for future equity-based employee incentives?",
      "original_answer": "In 2022, CL had 37,028 thousand securities remaining available for future issuance under equity compensation plans approved by security holders. By 2023, this number decreased to 28,522 thousand. This reduction of 8,506 thousand securities indicates a decline in CL's available capacity for future equity-based employee incentives, suggesting either increased issuance of securities in 2023 or a strategic decision to limit future equity compensation.",
      "llm_answer": "The number of securities remaining available for future issuance under equity‑compensation plans approved by security holders fell from **37,028 thousand** in 2022 to **28,522 thousand** in 2023—an 8,506 thousand‑security decline (≈ 8.5 million). This drop signals a reduced capacity for future equity‑based employee incentives, as fewer shares are available for new grants.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports the number of securities available in 2022 (37,028 thousand) and 2023 (28,522 thousand), matching the ground truth exactly. The calculated decline of 8,506 thousand is accurate (37,028 - 28,522 = 8,506), though the LLM states '8,506 thousand-security decline' which is correct but rounds to '≈ 8.5 million'—a reasonable approximation. 2) All numeric values and dates are accurate; the calculation of the difference is correct. 3) The reasoning is sound: the decrease in available securities is correctly interpreted as a reduced capacity for future equity-based incentives. The LLM captures the core implication but omits the alternative explanation present in the ground truth—namely, that the decline could reflect either increased issuance or a strategic decision to limit equity compensation. This minor omission reduces completeness slightly. 4) Despite this, the answer is factually correct, contextually appropriate, and synthesizes the required multi-hop information (comparing two years of data for the same metric and drawing a logical conclusion). The semantic meaning is equivalent to the original answer, with only slight brevity in explanatory depth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 336,
        "total_tokens": 1569
      },
      "error": null
    },
    {
      "question_id": 204,
      "question": "How did Alphabet's approach to repurchasing Class A and Class C shares evolve between 2022 and 2023, particularly in terms of the stated factors influencing these decisions and the governance mechanisms ensuring equal treatment across share classes?",
      "original_answer": "In 2022, Alphabet disclosed the existence of both Class A and Class C shares, which have identical rights except for voting power, and indicated that repurchase decisions were guided by economic cost and prevailing market conditions. By 2023, the company clarified that repurchases of both Class A and Class C shares were executed based on relative trading prices and volumes, general business conditions, and other investment opportunities, with repurchase programs conducted through open market or privately negotiated transactions. The governance framework remained consistent across years: Delaware law and Alphabet’s certificate of incorporation prevented unequal dividend treatment, requiring unanimous board approval for any amendments that could adversely affect a class of stock. This governance structure ensured that undistributed earnings were allocated proportionally across share classes, aligning with the consistent net income per share reported for Class A, Class B, and Class C stock in 2021, 2022, and 2023.",
      "llm_answer": "Alphabet expanded its Class A and Class C share‑repurchase program from $59.3 billion in 2022 to $62.2 billion in 2023, and in April 2023 the Board authorized an additional $70 billion, leaving $36.3 billion available, reflecting a more aggressive program. The company continues to base repurchase decisions on economic cost, prevailing market conditions, relative trading prices and volumes, and other investment opportunities, executing purchases via open‑market or Rule 10b51 plans. Governance safeguards—Delaware law and the certificate of incorporation—require unanimous Board approval and affected‑class consent for any amendment, ensuring that liquidation and dividend rights are identical across Class A, B, and C shares.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific dollar amounts ($59.3 billion, $62.2 billion, $70 billion, $36.3 billion) and an April 2023 board authorization that are not present in the original answer (ground truth). These figures are unsupported by the provided ground truth and represent a significant factual deviation. The original answer does not mention any specific repurchase program sizes or authorizations, focusing instead on qualitative aspects of the repurchase approach and governance. (2) Quantitative accuracy is low because all cited numbers are fabricated or incorrectly inferred. There is no mention in the ground truth of program expansions, dollar figures, or remaining availability, making these claims entirely inaccurate. (3) Qualitatively, the LLM captures some correct elements: it notes that repurchase decisions consider economic cost, market conditions, relative trading prices and volumes, and other investment opportunities, which aligns with the 2023 disclosure in the original answer. It also correctly identifies the use of open-market transactions (though 'Rule 10b5-1 plans' is an addition not in the original). The governance description is partially accurate—Delaware law and the certificate of incorporation do require protections against adverse amendments, but the original specifies 'unanimous board approval' for such changes, not 'affected-class consent,' which is a misstatement. The original emphasizes proportional allocation of undistributed earnings and consistent net income per share across classes, which the LLM omits. (4) Contextual relevance is moderate: the LLM addresses the evolution of repurchase approach and governance mechanisms, but distracts with irrelevant quantitative claims. While it attempts multi-hop synthesis (linking governance to equal treatment), it fails to mention the key point about identical net income per share across years and classes, which is central to the original answer's argument for equal economic treatment. Overall, the inclusion of false quantitative data severely undermines correctness despite some accurate qualitative points.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 570,
        "total_tokens": 2035
      },
      "error": null
    },
    {
      "question_id": 205,
      "question": "How did the change in market volatility assumptions used in MDLZ's VAR model between 2022 and 2023 affect the estimated one-day loss in pre-tax earnings from currency and commodity instruments?",
      "original_answer": "In 2022, MDLZ's VAR model used observed interest rate, currency exchange, and commodity price movements from the prior quarter to estimate potential losses, resulting in a one-day loss estimate in pre-tax earnings from currency and commodity instruments based on those parameters. In 2023, the model continued to assume normal market conditions but updated the historical observation window dynamically—using the prior quarter for point-in-time VAR and four prior quarters for average VAR. This refinement in volatility assumptions led to a more responsive risk estimate, with the 2023 VAR amounts reflecting a broader and potentially more stable market view than in 2022, thereby influencing the magnitude of the estimated one-day loss.",
      "llm_answer": "The VAR model’s volatility assumptions were tightened in 2023, which lowered the one‑day loss estimate for currency and commodity instruments.  In 2022 the model projected a potential one‑day pre‑tax earnings loss of $20 million from currency rates and $63 million from commodity prices, whereas in 2023 the corresponding figures fell to $14 million and $21 million, respectively【page_78】【page_64】.  The model continues to assume normal market conditions, a 95 % confidence interval and a one‑day holding period, but the revised volatility inputs produced the smaller loss estimates【page_64】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific numerical values for one-day loss estimates in 2022 and 2023 (e.g., $20M and $63M in 2022, $14M and $21M in 2023) that are not present in the original ground truth answer. The ground truth does not provide any dollar amounts for VAR estimates in either year, nor does it state that the 2023 changes led to a 'lowered' or 'smaller' loss estimate. Therefore, these numbers are factually unsupported and incorrect. (2) There are no calculations in the ground truth to verify, but the LLM fabricates precise figures and implies a causal relationship (tightened assumptions led to lower losses) that is not confirmed in the original answer. The original only states that the model became more responsive with a broader market view, not that it reduced estimated losses. (3) The multi-hop reasoning is partially sound in that the LLM correctly identifies the continuity of normal market conditions, 95% confidence, and one-day horizon. It also correctly notes the change in observation window (prior quarter vs. four quarters). However, it overinterprets the impact of the change by asserting a definitive reduction in risk estimates without evidence. (4) While the LLM captures the general direction of model refinement, it adds quantitatively false details and draws conclusions not supported by the ground truth, severely undermining factual accuracy. The contextual relevance is moderate because it addresses the right topic and some correct aspects of the model change, but the invented numbers make the answer misleading. Correctness score is low due to major factual inaccuracies despite some correct qualitative elements.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 457,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 205,
      "question": "How did Boeing's methodology for adjusting net asset values (NAVs) of private debt investments for subsequent cash flows evolve between 2022 and 2024, and what does this suggest about their approach to valuing illiquid assets?",
      "original_answer": "In 2022, Boeing disclosed that for private debt investments reported on a one-quarter lagged basis, they used NAVs adjusted for subsequent cash flows and significant events. By 2024, Boeing maintained a similar approach, explicitly stating that NAVs for private debt were adjusted for subsequent cash flows and significant events, indicating a consistent methodology. However, the continued reliance on NAV as a practical expedient, without a readily determinable fair value, suggests Boeing's approach to valuing illiquid private debt remained dependent on fund managers' reporting and adjustments, with no indication of adopting more direct valuation techniques over time.",
      "llm_answer": "Boeing’s 2022 10‑K (page 114) and 2024 10‑K (page 102) both state that private‑debt NAVs are calculated from the underlying investment’s cost, operating results, discounted cash flows and comparable data, and that for LPs reported on a one‑quarter lagged basis the NAV is **adjusted for subsequent cash flows and significant events**.  The wording and approach are identical, indicating no change in methodology.  This consistency underscores a conservative, income‑based valuation policy that ensures illiquid assets’ NAVs reflect recent cash‑flow changes and material events.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that Boeing’s methodology for adjusting NAVs of private debt investments for subsequent cash flows remained unchanged between 2022 and 2024, citing both the 2022 and 2024 10-Ks (pages 114 and 102 respectively), which matches the original answer’s timeline and disclosure. (2) There are no numeric values requiring calculation, but the qualitative details—such as the use of cost, operating results, discounted cash flows, comparable data, and adjustments for subsequent cash flows and significant events—are factually correct and consistent with the filings. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two years of SEC filings to conclude there was no change in methodology. (4) The LLM captures the core implication—that Boeing maintains a consistent, conservative, income-based approach—but slightly underemphasizes the reliance on fund managers’ reporting and the lack of move toward direct valuation techniques, which is a minor omission in qualitative depth. However, the conclusion about conservative, income-based policy is semantically aligned. Thus, the answer is factually correct, complete in key aspects, and contextually appropriate, warranting a high score with only a slight deduction in qualitative accuracy for missing nuance about dependency on fund managers.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 393,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 205,
      "question": "How did Duke Energy's (DUK) ownership stake in NCEMC in 2023 relate to its co-ownership structure with NCEMC in the Roxboro Combined Cycle (CC) project approved in late 2024, and what does this imply about the evolution of their strategic partnership in North Carolina energy infrastructure?",
      "original_answer": "In 2023, Duke Energy Carolinas held an 87.27% ownership stake in a facility jointly owned with NCEMC, indicating a significant but not exclusive control in shared assets. By late 2024, Duke Energy Progress and NCEMC entered a new co-ownership arrangement for the Roxboro CC project, where Duke would own approximately 1,135 MW and NCEMC would own 225 MW of the 1,360 MW facility. This reflects a shift toward a more balanced partnership model in new infrastructure development, while maintaining Duke’s dominant role. The evolution from a high-controlling stake in 2023 to a more balanced MW split in 2024 suggests a strategic alignment to leverage NCEMC’s regional presence and financing capabilities for cleaner, hydrogen-capable generation projects.",
      "llm_answer": "In 2023 Duke Energy held a minority 19.25 % ownership interest in a facility jointly owned with NCEMC (page 38).  By the Roxboro Combined‑Cycle project approved in December 2024, Duke Energy Progress will own roughly 83 % of the 1,360‑MW plant (1,135 MW) while NCEMC will own the remaining 17 % (225 MW) (page 153).  This shift from a small stake to a majority co‑ownership role signals a deepening partnership and a strategic move toward joint investment in North Carolina’s generation capacity.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual errors. It incorrectly states that Duke Energy held a 'minority 19.25%' ownership stake in a facility with NCEMC in 2023, while the ground truth reports an 87.27% stake by Duke Energy Carolinas — a controlling, not minority, interest. This misrepresents the entire nature of the prior relationship. Additionally, the LLM cites a 'minority' stake without specifying which entity or facility, introducing confusion. (2) The Roxboro CC project figures are mostly correct: Duke Energy Progress owning ~1,135 MW (83%) and NCEMC 225 MW (17%) of the 1,360 MW plant aligns with the ground truth. However, the characterization of this as a 'shift from a small stake to a majority co-ownership role' is flawed because the premise (that Duke previously had only 19.25%) is false. In reality, Duke already held a dominant 87.27% stake in a prior joint facility, so the 2024 arrangement actually represents a relatively more balanced partnership compared to the prior highly asymmetric one — the opposite of what the LLM implies. (3) The multi-hop reasoning is unsound due to incorrect input data. The model fails to accurately synthesize the evolution of the partnership: it should have noted a move toward *more balanced* co-ownership in 2024 (from 87.27% to ~83%) rather than framing it as Duke moving from a small to large role. The strategic implication about leveraging NCEMC’s regional presence is missing entirely. (4) Scores are justified as follows: Correctness is low (3/10) due to critical factual errors in key percentages and misrepresentation of ownership dynamics. Quantitative accuracy is poor (2/10) because the 19.25% figure is entirely incorrect and contradicts the ground truth. Qualitative accuracy is low (3/10) due to flawed reasoning and missing strategic context. Contextual relevance is moderate (6/10) because the answer addresses the right topic and project, cites plausible sources, and discusses partnership evolution, albeit incorrectly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 541,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 205,
      "question": "How did Qualcomm's reliance on Chinese OEMs for licensing revenue in 2023 change compared to 2022, and what role did the development of in-house integrated circuit products by those OEMs play in this shift?",
      "original_answer": "In 2022, Qualcomm derived a significant portion of its licensing revenues from a limited number of licensees, including several Chinese OEMs, and noted concerns over potential vertical integration by these OEMs due to pressures from the Made in China 2025 campaign and trade tensions. By 2023, Qualcomm reiterated its dependence on Chinese OEMs for licensing revenue but highlighted increased risks as certain customers had already begun developing their own integrated circuit products, which could reduce their reliance on Qualcomm’s offerings and adversely impact future licensing revenue. This indicates a growing vulnerability in Qualcomm’s revenue model tied to Chinese OEMs, driven by their strategic moves toward self-sufficiency in semiconductor development.",
      "llm_answer": "Qualcomm’s reliance on Chinese OEMs for licensing revenue fell in 2023 versus 2022, as more OEMs began building their own integrated‑circuit (IC) products and thus reduced the volume of Qualcomm‑licensed devices sold by those OEMs.  The 2023 risk‑factor notes that Chinese OEMs are expanding device share and that some of Qualcomm’s largest customers are developing in‑house ICs, which could significantly cut Qualcomm’s licensing revenue from those OEMs【page 19】【page 20】.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key qualitative shift—increased development of in-house integrated circuits by Chinese OEMs posing a risk to Qualcomm’s licensing revenue—and references the correct context (Made in China 2025, strategic self-sufficiency). However, it incorrectly states that Qualcomm’s reliance on Chinese OEMs for licensing revenue 'fell' in 2023 compared to 2022. The ground truth does not assert an actual decline in reliance, but rather a continued dependence coupled with growing risk due to OEMs’ moves toward self-sufficiency. Thus, the conclusion that reliance decreased is an overinterpretation not supported by the original answer. (2) There are no numeric values, percentages, or financial figures in either answer, so quantitative accuracy is not applicable—no errors in this regard. The citation of page numbers (19, 20) is consistent with document referencing and does not contradict the ground truth. (3) The multi-hop reasoning is partially sound: the model connects Chinese OEMs’ in-house IC development to potential revenue impact, which is valid. However, it fails to accurately represent the continuity of reliance (still high in 2023) and instead frames it as reduced, which misrepresents the causal and temporal logic. The original answer emphasizes heightened risk despite ongoing dependence, not a realized drop in reliance. (4) The contextual relevance is high—the answer addresses both parts of the question (change in reliance and role of in-house IC development) and cites appropriate risk factors. The qualitative accuracy is reduced due to the incorrect inference about decreased reliance, though the core risk narrative is preserved. Correctness score is 7 due to accurate risk explanation but incorrect characterization of the change in reliance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 493,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 205,
      "question": "How did Disney's use of option contracts to hedge forecasted foreign currency transactions change between 2022 and 2024, particularly in terms of the notional amounts and the currencies hedged?",
      "original_answer": "In 2022, Disney used option contracts as part of its strategy to hedge forecasted foreign currency transactions, although specific notional amounts for that year are not provided. By 2024, the notional amount of Disney's net foreign exchange cash flow hedges had increased to $9.9 billion, up from $8.3 billion in 2023, indicating a growing hedge exposure. The principal currencies hedged remained consistent, including the euro, Canadian dollar, Japanese yen, British pound, and Chinese yuan. This evolution reflects a strategic increase in the scale of option contract usage to manage foreign exchange risk over the two-year period.",
      "llm_answer": "Disney’s option‑based hedges for forecasted foreign‑currency transactions expanded in 2024, with net notional amounts rising to **$9.9 billion** from **$8.3 billion** in 2023 (and lower in 2022, as not disclosed in the provided pages). The hedged currencies remained the **euro, Canadian dollar, Japanese yen, British pound, and Chinese yuan**.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: the notional amounts of $9.9 billion in 2024 and $8.3 billion in 2023 are accurately reported, and the statement that 2022 amounts were not disclosed matches the original answer. (2) The currencies hedged—euro, Canadian dollar, Japanese yen, British pound, and Chinese yuan—are correctly identified and consistent with the ground truth. (3) The reasoning is sound: the LLM correctly infers an increasing trend in hedge exposure from 2022 to 2024, even though the exact 2022 figure is not provided, and uses the 2023-to-2024 increase to support the conclusion of growing hedge usage. (4) The only minor shortcoming is that the original answer explicitly frames the change as a 'strategic increase in the scale of option contract usage,' which the LLM implies but does not fully elaborate. However, the core facts, multi-hop synthesis (trend over time, currencies hedged), and context are preserved with high fidelity. Wording differences do not affect semantic equivalence. All entities (Disney, option contracts, foreign currency hedges, correct years and currencies) are accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 337,
        "total_tokens": 1593
      },
      "error": null
    },
    {
      "question_id": 206,
      "question": "How did the fair value of MDLZ's Net Investment Hedge Contracts, which were categorized under Level 2 financial liabilities in 2022, change by 2024, and what does this indicate about the company's exposure to currency and investment risk management instruments?",
      "original_answer": "In 2022, MDLZ disclosed that Net Investment Hedge Contracts were valued using observable market inputs and were part of Level 2 financial liabilities, which also included currency exchange contracts, commodity forwards, and interest rate swaps. By 2024, the fair value of Net Investment Hedge Contracts had reached $(219) million, making it the largest single category of derivative liability on the balance sheet. This indicates that the company maintained a significant position in these instruments, suggesting a continued emphasis on hedging long-term foreign currency exposure tied to its international investments. The consistent use of observable inputs for valuation, as described in 2022, supports the transparency of this liability's measurement over time.",
      "llm_answer": "MDLZ’s net‑investment‑hedge contracts, which were recorded as Level 2 financial liabilities in 2022, moved from a liability of **$219 million** to an asset of **$255 million** by the end of 2024 – a swing of roughly **$474 million**【page_95】.  This shift from a net liability to a net asset indicates that the company has expanded its use of hedging instruments to manage currency and investment risk, thereby increasing its exposure to these risk‑management tools.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual errors. According to the ground truth, the fair value of MDLZ's Net Investment Hedge Contracts in 2024 was $(219) million (a liability), not an asset of $255 million. The LLM incorrectly states that the position moved from a $219 million liability to a $255 million asset, which is the opposite of the truth. There is no mention in the original answer of a $255 million asset or a swing of $474 million—these figures are entirely fabricated. (2) Quantitative accuracy is severely lacking: the only correct number is $219 million, but it is mischaracterized as a starting point (liability in 2022), whereas the ground truth does not provide a 2022 fair value—only the classification (Level 2) and context. The 2024 value is $(219) million (liability), not a positive $255 million asset. The calculation of a $474 million swing is therefore baseless. (3) The multi-hop reasoning is flawed: the LLM infers a shift from liability to asset indicating increased hedging, but the ground truth indicates continuity in significant hedging activity, not a directional shift in value sign. The correct interpretation is that the large liability reflects ongoing management of foreign currency exposure, not a change in strategy or exposure level. (4) Contextual relevance is moderate—the answer addresses the right topic (hedging, currency risk, Level 2 liabilities) and attempts to interpret implications—but due to fundamental factual and numerical errors, the conclusions are misleading. The mention of 'page_95' suggests a source reference, but the data does not align with the ground truth. Overall, the answer fails on correctness due to incorrect values, misrepresentation of direction (liability vs asset), and false calculations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 483,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 206,
      "question": "How did the change in NEE's pension plan allocation to convertible securities from 2022 (10%) to 2024 (5%) reflect a shift in investment strategy, and what does this imply about the company's risk tolerance and long-term funding priorities?",
      "original_answer": "In 2022, NEE's pension plan allocated 10% of its assets to convertible securities, indicating a relatively higher appetite for growth-oriented, hybrid instruments that offer both equity and fixed-income features. By 2024, this allocation dropped to 5%, with the remaining capital reallocated primarily to alternative investments (increasing from 13% to 20%). This shift suggests a strategic move toward more stable, diversified, and potentially lower-volatility asset classes, aligning with the pension plan’s objective of protecting funded status and reducing reliance on employer contributions. The reduction in convertible securities, which are more volatile than fixed income but less so than equities, reflects a more conservative risk posture by NEE in managing its pension liabilities over time.",
      "llm_answer": "The pension plan cut its target allocation in convertible securities from 10 % in 2022 to 5 % in 2024 (2022 target: 45 % equity, 32 % fixed income, 13 % alternative, **10 % convertible**【page 101】; 2024 target: 43 % equity, 32 % fixed income, 20 % alternative, **5 % convertible**【page 100】). This shift signals a move to a more conservative, lower‑risk mix—reducing exposure to the higher‑volatility hybrid instruments—while still pursuing a high total return within a prudent risk framework that prioritizes capital preservation and liquidity to keep the plan funded over the long term【page 100】【page 101】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the change in NEE's pension plan allocation to convertible securities from 10% in 2022 to 5% in 2024, matching the ground truth exactly. It also accurately references the broader asset allocation context (equity, fixed income, alternative investments), with correct percentages for both years, confirming quantitative accuracy. (2) All numbers are correct: 10% to 5% reduction in convertibles; alternative investments increased from 13% to 20% (implied by the context, though not explicitly restated in the LLM answer, this is still consistent with the source). No calculation errors. (3) The reasoning correctly interprets the shift as a move toward a more conservative, lower-risk strategy, emphasizing capital preservation and reduced exposure to volatile hybrid instruments—this aligns with the ground truth’s conclusion about reduced risk tolerance. The LLM mentions the goal of maintaining long-term funding, which reflects the original answer’s focus on protecting funded status and minimizing employer contributions. However, it does not explicitly mention the reallocation to alternative investments as the primary destination of the capital, which is a minor omission in the synthesis. (4) Despite this, the answer is semantically equivalent in intent and meaning, with strong multi-hop reasoning demonstrated through comparison across years and asset classes. The inclusion of source citations (page references) adds credibility. The answer is fully relevant to the question. Minor deduction in qualitative accuracy for not explicitly linking the freed-up allocation to alternatives, but overall reasoning remains sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 459,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 207,
      "question": "How did Microsoft's redemption of Nuance's convertible senior notes between 2022 and 2024 impact the financial structure of the Intelligent Cloud segment, particularly in relation to the remaining liabilities tied to Nuance?",
      "original_answer": "In 2022, Microsoft disclosed that $986 million of convertible senior notes were issued by Nuance, with $985 million redeemed prior to June 30, 2022, leaving $1 million remaining and classified as other current liabilities. By 2024, Microsoft noted that 'substantially all' of the $986 million in Nuance convertible notes had been redeemed, indicating a near-complete resolution of this liability. This evolution in the redemption status of the notes, linked to the integration of Nuance into the Intelligent Cloud segment, suggests a reduction in financial obligations that likely contributed to a more stable financial structure for the segment. The reduction in outstanding liabilities aligns with the strategic integration of Nuance and supports the realization of synergies cited in both years.",
      "llm_answer": "Microsoft redeemed almost all of the $986 million of Nuance’s convertible senior notes, shrinking the Intelligent Cloud segment’s liability to a residual $1 million by June 30 2022【page_78 (2022)】. By the 2024 filing the notes were “substantially all” redeemed, leaving only a negligible remaining liability tied to Nuance and thereby simplifying the segment’s balance‑sheet structure【page_78 (2024)】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and dates are correct: the initial $986 million in convertible senior notes, the redemption of $985 million by June 30, 2022, leaving $1 million remaining, and the 2024 update that 'substantially all' had been redeemed are all factually consistent with the original answer. The use of 'residual $1 million' and 'negligible remaining liability' is semantically equivalent to the ground truth's description. (2) The citations to page 78 of the 2022 and 2024 filings (though not part of the ground truth per se) suggest appropriate grounding and do not contradict the facts. (3) The reasoning correctly synthesizes the impact of the redemption on the Intelligent Cloud segment’s financial structure across two years, capturing the multi-hop nature of the question—linking Nuance’s liabilities to Microsoft’s segment reporting. (4) The only minor shortcoming is a slight lack of explicit mention of how this reduction supports strategic integration or synergy realization, which is included in the original answer and adds qualitative depth. However, the core financial and structural implications are clearly conveyed. Thus, the answer is factually complete and correct with only a small omission in strategic context, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 382,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 208,
      "question": "How did the integration of Swedish Match's ZYN brand in 2023 influence the final purchase price allocation for PM's full acquisition of Swedish Match, as finalized in 2024?",
      "original_answer": "In 2023, PM completed the integration of Swedish Match, which included the ZYN brand, a leading oral nicotine delivery product with a strong presence in the U.S. market. The acquisition was a key milestone in PMI’s transformation into a smoke-free company and was expected to accelerate the company's growth in the oral nicotine segment. In November 2023, PM finalized the purchase price allocation, which included the valuation of assets such as the ZYN brand and its market position. The final redemption price was set at SEK 115.07 per share, totaling approximately $883 million in cash paid, reflecting the strategic value of ZYN’s market leadership and its role in expanding PM’s smoke-free portfolio.",
      "llm_answer": "The 2024 purchase‑price allocation recognized the ZYN brand as a trademark with an indefinite life valued at **$3.133 billion** (page 93).  That valuation was included in the **$7.868 billion** of other intangible assets reported in the final allocation table (page 92), thereby raising the fair‑value of identifiable assets and reducing the goodwill balance to **$10.731 billion**.  The integration of ZYN in 2023 thus directly increased the intangible‑asset allocation and shaped the overall goodwill calculation for the full acquisition.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies in key financial figures, which undermines its correctness. The ground truth states the total cash paid was approximately $883 million, but the LLM claims a $3.133 billion valuation for ZYN alone and a total intangible asset allocation of $7.868 billion—figures not present in the original answer. There is no mention in the ground truth of goodwill being $10.731 billion or other intangible assets totaling $7.868 billion, nor is there any reference to page numbers (e.g., page 92/93), suggesting the LLM may have hallucinated data from an external source or confused it with another filing. The original answer does confirm that ZYN was valued as part of the purchase price allocation finalized in November 2023, but it does not specify how much of the $883 million was allocated to ZYN or any breakdown of intangibles or goodwill. While the LLM correctly identifies the relevance of ZYN’s integration to the purchase price allocation and the strategic rationale (e.g., strengthening PM’s smoke-free portfolio), the quantitative inaccuracies are severe and materially misrepresent the financial outcome. The reasoning structure is logically sound—linking brand integration to asset valuation and goodwill—but based on incorrect data. Thus, while contextually relevant and partially accurate in conceptual framing, the answer fails on core factual and numerical accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 393,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 208,
      "question": "How did GE's 2023 collaborative revenue-sharing model with Safran Aircraft Engines influence its 2024 financial dependency on CFM International during the LEAP engine production ramp-up?",
      "original_answer": "In 2023, GE's collaborative arrangement with Safran Aircraft Engines involved revenue and cost sharing for joint engine programs, including LEAP and CFM56 engines sold through CFM International. GE recognized revenue and costs based on its scope of work and made substantial arms-length sales of parts and services to CFM International. This revenue-sharing model laid the foundation for GE's continued financial interdependence with CFM International in 2024, as the LEAP engine entered a significant production ramp-up phase. By 2024, CFM International remained a critical joint venture, with GE making substantial sales of parts and services to support the LEAP engine's increasing shop visits and MRO demand. GE’s financial dependency on CFM International persisted, as reflected in its continued recognition of sales to CFM International within its Commercial Engines & Services segment, which represented 70% of total GE Aerospace revenue in 2024.",
      "llm_answer": "GE’s 2023 collaborative revenue‑sharing model with Safran Aircraft Engines—where GE and Safran share revenue and costs on parts and services sold to CFM International—established a financial relationship that deepened in 2024.  As the LEAP engine production ramp‑up accelerated, GE’s volume of parts and services sold to CFM International grew (cost of services sold rose from $3.78 bn in 2023 to $4.14 bn in 2024), making CFM a larger contributor to GE’s revenue and cash flows and thereby increasing GE’s financial dependency on the joint venture during the ramp‑up.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the collaborative revenue-sharing model between GE and Safran Aircraft Engines through CFM International and links it to increased financial dependency during the 2024 LEAP engine ramp-up. It also correctly notes that GE sells parts and services to CFM International, contributing to revenue and cash flows. However, the key quantitative claims—specifically the 'cost of services sold' rising from $3.78 billion in 2023 to $4.14 billion in 2024—are not present in the original answer and cannot be verified from the ground truth. These figures appear fabricated or misattributed, as the original answer does not mention cost of services sold or any such dollar figures. (2) The original answer emphasizes that CFM International represented 70% of total GE Aerospace revenue in 2024, a critical data point missing in the LLM response. This omission significantly weakens the completeness and factual accuracy of the financial dependency claim. (3) The reasoning is logically sound in connecting the 2023 revenue-sharing model to 2024 financial dependency via production ramp-up and increased sales, which aligns with the multi-hop structure of the question. However, the unsupported numerical figures undermine the quantitative accuracy. (4) While the LLM captures the general context and direction of the relationship, the inclusion of unverified financial data and omission of the 70% revenue dependency results in a partially correct answer. The contextual relevance is high as it directly addresses the question’s focus on financial dependency and production ramp-up, but the lack of key facts and introduction of incorrect numbers limits correctness. Thus, the correctness score is 6—partially correct with significant factual gaps and errors in quantification.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 492,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 208,
      "question": "How did Duke Energy's (DUK) ownership stake in Roxboro CC evolve from 2023 to 2024, and what role did NCEMC play in shaping the new co-ownership structure of the proposed 2024 Roxboro CC project?",
      "original_answer": "In 2023, Duke Energy Carolinas had a significant ownership stake of 87.27% in a facility jointly owned with NCEMC, indicating a strong but not exclusive control. By 2024, DUK (through Duke Energy Progress) proposed a new hydrogen-capable combined-cycle (CC) facility at the Roxboro site, with a co-ownership structure where DUK would own approximately 1,135 MW and NCEMC would own 225 MW of the 1,360 MW facility. This represents a strategic shift from prior arrangements, where NCEMC played a more passive role, to a more balanced co-ownership model in 2024. The evolution shows DUK's increased collaboration with NCEMC, likely to align with regulatory, environmental, and cost recovery strategies as coal-fired units 1 and 4 at Roxboro were slated for retirement.",
      "llm_answer": "In 2023, Duke Energy Progress owned 100 % of Roxboro CC (the table on page 38 notes that “ownership interest in all facilities is 100 % unless otherwise indicated”).  By 2024, the new Roxboro CC project was structured as a co‑ownership: Duke Energy Progress would own roughly 1,135 MW and the North Carolina Electric Membership Corporation (NCEMC) would own the remaining ~225 MW.  NCEMC’s role was to partner with Duke Energy Progress and agree to the 225‑MW stake, thereby shaping the new co‑ownership arrangement.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It claims Duke Energy Progress owned 100% of Roxboro CC in 2023, which directly contradicts the ground truth stating Duke Energy Carolinas had an 87.27% stake in a jointly owned facility with NCEMC. This misidentifies both the subsidiary (Progress vs. Carolinas) and the ownership percentage (100% vs. 87.27%). The 2024 co-ownership structure is correctly described: DUK (via Duke Energy Progress) owning ~1,135 MW and NCEMC 225 MW of a 1,360 MW facility, which aligns with the ground truth. (2) Quantitative accuracy is partially correct: the 1,135 MW and 225 MW figures are accurate and sum to 1,360 MW, showing correct arithmetic. However, the 2023 ownership percentage is completely wrong (100% vs. 87.27%), a critical error in financial ownership data. (3) Multi-hop reasoning is flawed. The model fails to correctly synthesize the 2023 ownership structure from the knowledge graph, instead asserting a default 100% ownership based on a document footnote not provided in the context. It also does not recognize the shift from Duke Energy Carolinas (2023) to Duke Energy Progress (2024) as part of a strategic transition. The role of NCEMC is understated—it was not merely agreeing to a stake but actively shaping a new co-ownership model, representing a strategic shift from a passive to a more balanced partnership. (4) Correctness is scored low (4) due to major factual errors in ownership percentages and entities. Quantitative accuracy is moderate (5) because half the numbers (2024) are correct but 2023 data is wrong. Qualitative accuracy is low (4) due to incorrect entity mapping and weak reasoning about the strategic evolution. Contextual relevance is high (8) as the answer addresses the right facilities, companies, and timeframes, and correctly describes the 2024 co-ownership model.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 507,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 209,
      "question": "How did GE's liability exposure from structured settlement annuities through Union Fidelity Life Insurance Company change from 2022 to 2023, particularly in relation to the inflexibility of adjusting premiums on these contracts?",
      "original_answer": "In 2022, GE's liability for structured settlement annuities through Union Fidelity Life Insurance Company (UFLIC) was $10.3 billion. By 2023, GE reinsured approximately 24,600 structured settlement annuities, primarily underwritten on impaired lives with projected payments extending decades into the future. A key risk highlighted in 2023 is that, unlike long-term care insurance, structured settlement annuities offer no ability to require additional premiums or reduce benefits, which constrains GE's ability to manage long-term liability exposure. This lack of flexibility, combined with the long duration of these contracts, means that GE must rely solely on initial pricing assumptions without the ability to adjust for changes in mortality or interest rates over time, potentially increasing the risk of liability growth beyond initial estimates.",
      "llm_answer": "GE’s run‑off liability for structured‑settlement annuities under UFLIC stayed essentially flat, with GAAP reserves at about $5.1 billion in 2023 versus the same level in 2022.  The contracts remain inflexible – they do not allow additional premiums to be required or benefits to be reduced.  【page_21】【page_21】",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors, particularly in quantitative accuracy. According to the ground truth, GE's liability for structured settlement annuities through UFLIC was $10.3 billion in 2022, not $5.1 billion as stated by the LLM. The LLM claims reserves were 'about $5.1 billion in 2023 versus the same level in 2022,' which contradicts the original answer indicating a $10.3 billion liability in 2022 and a major reinsurance transaction in 2023 involving approximately 24,600 annuities—suggesting a material change in exposure, not a flat reserve level. There is no mention in the ground truth of reserves being $5.1 billion or remaining flat, making this a critical error. The LLM correctly identifies the qualitative risk of inflexibility—namely, the inability to adjust premiums or reduce benefits—which aligns with the original answer and shows partial understanding of the contractual risk. However, it omits key context about the long duration of payments, reliance on initial pricing assumptions, and risks from mortality and interest rate changes. The entity (UFLIC) and general concept (structured settlement annuities) are correct, and the answer addresses the inflexibility point, so there is some contextual relevance. However, the severe numerical inaccuracy and failure to reflect the reinsurance event and liability magnitude result in a low correctness score. Multi-hop reasoning is weak: the model fails to connect the 2023 reinsurance action with liability exposure changes and misrepresents the financial figures entirely.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 427,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 209,
      "question": "How did Merck KGaA's ongoing corporate name infringement litigation against MRK evolve from 2023 to 2024, and what does this indicate about MRK's brand protection strategy in the U.S.?",
      "original_answer": "In 2023, MRK was engaged in ongoing litigation with Merck KGaA in the U.S. and abroad, where MRK alleged improper use of the 'Merck' name by KGaA in the U.S., while KGaA filed suits in other jurisdictions alleging trademark and corporate name infringement. By 2024, the litigation remained ongoing in both the U.S. and international jurisdictions, with no trial date set in the U.S., indicating that MRK continued to pursue its brand protection strategy without resolution. This persistence in litigation across years shows MRK's commitment to defending its U.S. brand identity against KGaA's global legal challenges.",
      "llm_answer": "The 2023 and 2024 10‑K filings both state that Merck KGaA’s lawsuit against Merck & Co. is still “ongoing in the U.S. with no trial date set” (see page 107 and page 111). No new settlement or court action is reported in 2024, indicating that MRK is continuing to defend its corporate name through litigation but has not accelerated the case, reflecting a defensive brand‑protection strategy in the U.S.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) It correctly states that the litigation between Merck KGaA and MRK (Merck & Co.) was ongoing in both 2023 and 2024 with no trial date set in the U.S., which matches the original answer. The page references (107 for 2023, 111 for 2024) add precision and are consistent with typical 10-K disclosure practices. (2) There are no numeric values requiring calculation, but the dates (2023, 2024) and the statement about lack of trial date are correct and consistent across filings—quantitative accuracy is perfect. (3) The multi-hop reasoning is sound: the model correctly infers from the unchanged status of litigation across two years that MRK is maintaining a consistent, defensive brand protection strategy in the U.S., which is a valid interpretation of the ongoing legal posture. The only minor shortcoming is that the LLM focuses more on MRK's defensive stance and does not explicitly mention KGaA’s reciprocal international lawsuits, which slightly reduces completeness in the qualitative synthesis. (4) The answer is highly contextually relevant, directly addressing the evolution of the litigation and its implications for MRK’s brand strategy. Overall, the answer is semantically equivalent to the ground truth with only slight omission of KGaA’s global legal actions, warranting a 9/10 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 384,
        "total_tokens": 1648
      },
      "error": null
    },
    {
      "question_id": 209,
      "question": "How did the reduction in Class A common stock shares outstanding from 925,723,131 in 2023 to 907,000,000 in 2024, alongside stable Class B stock voting power at 15 votes per share, affect the relative voting control dynamics at MA, and what implications does this have for corporate governance and treasury stock management given the increase in Class A treasury stock from $60,429M to $71,431M?",
      "original_answer": "The reduction in Class A common stock shares outstanding from 925,723,131 in 2023 to 907,000,000 in 2024, combined with the stable 15-vote per share structure for Class B common stock, increased the relative voting control of Class B shareholders. This is further amplified by the significant increase in Class A treasury stock from $60,429M in 2023 to $71,431M in 2024, which effectively removed more Class A shares from circulation, thereby concentrating voting power further in the hands of Class B shareholders. This shift in voting control has important implications for corporate governance, as it entrenches the influence of the Class B shareholder (Mr. Brian L. Roberts) over key decisions such as board elections and strategic direction. Additionally, the increased treasury stock reflects a strategic use of capital that may signal management’s confidence in long-term value, but also raises questions about potential dilution of minority shareholder influence.",
      "llm_answer": "Reducing Class A shares from 925,723,131 in 2023 [page_2] to 907,000,000 in 2024 [page_68] slightly increased the relative voting weight of the 15‑vote Class B shares, but the overall structure remains largely unchanged as Class B still accounts for 33⅓ % of combined voting power [page_33]. The concurrent rise in Class A treasury stock from $60.429 bn to $71.431 bn reflects a significant share‑repurchase program that further shrinks the voting pool, consolidating control for the existing major shareholders and supporting earnings per share while limiting dilution [page_70]. These moves reinforce corporate governance by concentrating voting power and enabling more strategic treasury stock management [page_68, page_70].",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the reduction in Class A shares outstanding (925,723,131 to 907,000,000) and the increase in Class A treasury stock from $60.429B to $71.431B (equivalent to $60,429M to $71,431M in original answer), so quantitative accuracy is high. Format variations (e.g., $60.429 bn vs $60,429M) are acceptable and semantically equivalent. (2) However, the LLM introduces a fact not present in the ground truth: that Class B accounts for '33⅓%' of combined voting power. This specific percentage is not mentioned in the original answer and cannot be verified from the provided data. More critically, the original answer emphasizes that the reduction in outstanding Class A shares and increase in treasury stock *increased the relative voting control of Class B shareholders*, which is logical given fewer Class A shares in circulation. The LLM downplays this by stating the 'overall structure remains largely unchanged', which contradicts the ground truth's emphasis on a meaningful shift in control. (3) The multi-hop reasoning is partially sound—linking share reduction, treasury stock increase, and voting power concentration—but the conclusion is weakened by the incorrect assertion about unchanged structure and the unsupported 33⅓% figure. The original answer correctly identifies the entrenchment of Mr. Brian L. Roberts’ control, which the LLM omits entirely, missing a key governance implication. (4) Contextual relevance is high as the answer addresses all components of the question: share reduction, voting power, treasury stock, and governance implications. However, the qualitative inaccuracy in reasoning and missing entity (Mr. Roberts) reduces the correctness score. Overall, the answer is factually mixed: numbers are correct, but key interpretive claims are either unsupported or contradictory to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1486,
        "completion_tokens": 505,
        "total_tokens": 1992
      },
      "error": null
    },
    {
      "question_id": 210,
      "question": "How did the change in Merck's collaboration profit-sharing with Eisai for Lenvima between 2022 and 2024 impact Merck's gross margin performance, given Eisai's role as principal on Lenvima sales and the associated amortization costs?",
      "original_answer": "In 2022, Merck disclosed that it shared Lenvima profits equally with Eisai, with Eisai acting as the principal on all Lenvima sales transactions. By 2024, Merck's cost of sales included $154 million in cumulative catch-up amortization related to the Eisai collaboration, up from $48 million in 2023, indicating increased financial activity tied to the partnership. This rise in amortization costs contributed to a 3.1 percentage point improvement in gross margin (from 73.2% in 2023 to 76.3% in 2024), despite higher amortization and restructuring costs, suggesting that the collaboration's financial structure and product mix had a net positive effect on Merck's profitability.",
      "llm_answer": "Merck’s share of Lenvima profits remained a 50/50 split with Eisai (Eisai is the principal on all Lenvima sales, so Merck’s portion is recorded as alliance revenue【page_103】).  The intangible asset tied to the collaboration was $1.0 billion at 2021 and is being amortized through 2026, but the catch‑up amortization for the Eisai partnership dropped from $154 million in 2023 to $48 million in 2024【page_60】.  That reduction in amortization cost helped lift Merck’s gross margin to 76.3 % in 2024 from 73.2 % in 2023 (and higher than in 2022), offsetting other margin‑pressing factors【page_60】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors, particularly in the direction and magnitude of the catch-up amortization costs. The ground truth states that catch-up amortization increased from $48M in 2023 to $154M in 2024, but the LLM incorrectly claims it dropped from $154M in 2023 to $48M in 2024—reversing both the trend and the year-to-year values. This is a critical quantitative error that undermines the entire analysis. Additionally, the LLM misattributes the impact of amortization: it claims the reduction in amortization helped lift gross margin, while the original answer states that despite higher amortization costs, gross margin improved—indicating other positive factors. (2) The gross margin figures (73.2% in 2023 to 76.3% in 2024) are correctly reported, and the 50/50 profit split and Eisai’s role as principal are accurate. However, the $1.0 billion intangible asset value and amortization period (2021–2026) are not mentioned in the original answer and appear to be extraneous or misattributed details. (3) The multi-hop reasoning fails because the LLM misinterprets the financial cause-effect relationship: it assumes lower amortization boosted margins, but the truth is that margins improved *despite* rising amortization, implying stronger underlying performance. This reflects flawed synthesis across financial statements and footnotes. (4) Contextually, the answer addresses the right topic—Lenvima collaboration, amortization, and gross margin—but due to major factual and logical errors, especially in the core quantitative trend, the correctness score is low. The contextual relevance is moderate because the structure and intent align with the question, but accuracy is severely compromised.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 474,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 210,
      "question": "How did Disney's use of foreign exchange option contracts as cash flow hedges for firm commitments change from 2023 to 2024, and what does this indicate about their foreign currency risk management strategy?",
      "original_answer": "In 2023, Disney had $8.3 billion in notional amounts of foreign exchange cash flow hedges, which increased to $9.9 billion in 2024. These hedges, which include option contracts, are used to protect the value of firm commitments and forecasted foreign currency transactions. The increase of $1.6 billion in hedge notional amounts suggests that Disney expanded its hedging activity in 2024, likely in response to greater foreign exchange exposure or more volatile currency markets. This indicates a more aggressive or expanded foreign currency risk management strategy in 2024 compared to 2023.",
      "llm_answer": "Disney increased the notional amount of its foreign‑exchange option contracts used as cash‑flow hedges for firm commitments from $8.3 billion in 2023 to $9.9 billion in 2024—a $1.6 billion rise. This expansion signals a more aggressive hedging posture, underscoring Disney’s intent to tighten control over currency risk on firm commitments and stabilize earnings and cash flows.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: Disney's notional amount of foreign exchange option contracts as cash flow hedges increased from $8.3 billion in 2023 to $9.9 billion in 2024, a $1.6 billion increase. These numbers match the original answer exactly, and the calculation ($9.9B - $8.3B = $1.6B) is accurate. (2) The answer addresses both parts of the multi-hop question: it identifies the change in hedge usage (quantitative shift) and interprets what this indicates about Disney's risk management strategy (qualitative inference). (3) Entities—Disney, 2023, 2024, foreign exchange option contracts, cash flow hedges, firm commitments—are correctly identified and used in context. (4) The reasoning is sound: the increase in notional value is correctly interpreted as signaling a more aggressive hedging posture, aligning with the original answer’s conclusion of an expanded or more aggressive foreign currency risk management strategy. Wording differs slightly (e.g., 'tighten control over currency risk' vs. 'expanded foreign currency risk management'), but the semantic meaning and factual content are identical. No errors in facts, calculations, or logic.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 349,
        "total_tokens": 1607
      },
      "error": null
    },
    {
      "question_id": 211,
      "question": "How did Duke Energy Progress' storm cost financing strategy evolve from 2023 to 2024, particularly in relation to the expansion of storm recovery property acquisitions and the role of DEPNC SF in securing debt obligations?",
      "original_answer": "In 2023, Duke Energy Progress (DEP) used DEPNC SF to secure $770 million in storm recovery bonds issued in 2021, which were backed by storm recovery property created to finance unrecovered costs from storms in 2018 and 2019. By 2024, DEP expanded its storm cost financing strategy by forming a new entity, DEPSC SF, which issued $177 million in bonds to recover storm costs incurred from 2014 through 2022. DEPNC SF continued to play a key role in 2024 as a consolidated VIE, with its storm recovery property still serving as the sole source of funds for debt repayment. This evolution reflects a broadening of the financing scope both temporally (covering a longer historical period of storm costs) and geographically (now including South Carolina), while maintaining the same legal and financial structure anchored by the storm recovery property mechanism.",
      "llm_answer": "In 2023 Duke Energy Progress financed storm‑cost recovery through the NC Storm Funding VIE (DEPNCSF), which issued senior secured bonds to acquire storm‑recovery property and secured the debt with that property and cash collections from the charge.  In 2024 the strategy expanded to include South‑Carolina storm costs via a new VIE (DEPSCSF) that also issued bonds to acquire additional storm‑recovery property, while DEPNCSF’s long‑term debt fell from $680 million to $646 million—reflecting partial repayment or refinancing.  Both VIEs remain non‑recourse, with the debt obligations secured solely by the storm‑recovery property and its cash collections.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer captures the core evolution of Duke Energy Progress' storm cost financing strategy by correctly identifying the expansion into South Carolina via a new VIE (DEPSCSF) in 2024 and the continued role of DEPNCSF. However, it contains significant quantitative inaccuracies: the original answer states that DEPNC SF secured $770 million in bonds (issued in 2021), but the LLM claims DEPNCSF's long-term debt was $680 million in 2023 and fell to $646 million in 2024—figures not present in the ground truth and potentially conflating outstanding balances with issuance amounts. Additionally, the $177 million bond issuance by DEPSC SF in 2024 is omitted entirely. 2) The numbers provided in the LLM answer ($680M → $646M) are not supported by the original answer and appear to be fabricated or misattributed; no repayment or refinancing activity is mentioned in the ground truth for 2023–2024. The correct issuance amount under DEPNC SF was $770M (not $680M), and the new DEPSC SF issued $177M—both critical omissions or distortions. 3) The multi-hop reasoning is partially sound: the model correctly infers that the financing strategy expanded geographically (to South Carolina) and structurally (via a new VIE), and it accurately describes the non-recourse, secured nature of the debt using storm recovery property. However, it fails to link the 2024 expansion to the broader temporal scope (covering storm costs from 2014–2022), which is a key element in the original answer. 4) Despite missing key figures and introducing incorrect ones, the LLM maintains contextual relevance and uses correct entity names (DEPNCSF, DEPSCSF) and accurate conceptual framing (VIEs, non-recourse debt, storm recovery property). The qualitative understanding of the mechanism is solid, but the quantitative errors significantly undermine factual correctness, warranting a moderate score of 6 for overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 514,
        "total_tokens": 1911
      },
      "error": null
    },
    {
      "question_id": 211,
      "question": "How did the $306 million decline in Enterprise and partner services revenue from $7,900 million in fiscal 2023 to $7,594 million in fiscal 2024 reflect changes in Microsoft's strategic focus within the Intelligent Cloud segment, particularly with regard to the Microsoft Partner Network?",
      "original_answer": "The $306 million decline in Enterprise and partner services revenue from $7,900 million in fiscal 2023 to $7,594 million in fiscal 2024 occurred despite Microsoft's overall Intelligent Cloud revenue growing from $79,970 million to $97,726 million, suggesting a relative de-emphasis on partner-centric services like the Microsoft Partner Network. While the 2024 filing still lists Microsoft Partner Network as part of Enterprise and partner services, the segment's contraction contrasts with robust growth in Azure and other cloud services, indicating a potential reallocation of resources toward direct cloud offerings rather than channel partner development.",
      "llm_answer": "The $306 million drop in Enterprise and partner services revenue (from $7,900 million in FY 2023 to $7,594 million in FY 2024) signals a shift in Microsoft’s Intelligent Cloud strategy away from partner‑centric services toward higher‑margin server products and cloud services—particularly Azure, whose revenue jumped $17.8 billion during the same period. Because the Microsoft Partner Network is bundled within Enterprise and partner services, the decline reflects a repositioning of the partner ecosystem to focus on accelerating cloud adoption and partner‑enabled solutions rather than driving direct revenue, aligning the segment more closely with Azure’s growth trajectory.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $306 million decline in Enterprise and partner services revenue from $7,900 million in FY 2023 to $7,594 million in FY 2024, with accurate dollar amounts and fiscal years. The calculation of the decline (7,900 - 7,594 = 306) is correct. It also references the significant growth in Azure, which aligns with the broader Intelligent Cloud growth from $79,970 million to $97,726 million in the ground truth, though it specifies a $17.8 billion Azure increase (which is consistent with public Microsoft filings). (2) All numeric values are accurate and properly contextualized. Format variations (e.g., $306 million) are acceptable and clear. (3) The reasoning is sound: the LLM correctly infers a strategic shift within the Intelligent Cloud segment, linking the decline in partner services to a prioritization of direct cloud offerings like Azure. It acknowledges that the Microsoft Partner Network is part of the declining segment and interprets the trend as a repositioning rather than abandonment—consistent with the ground truth’s suggestion of relative de-emphasis. The answer goes slightly beyond the original by introducing 'higher-margin server products' and 'partner-enabled solutions,' which are plausible but not explicitly stated in the ground truth. (4) The answer is semantically equivalent to the original, with only minor expansion on strategic rationale. It fully addresses the question about strategic focus and the role of the Microsoft Partner Network. Scores reflect high accuracy, with a minor deduction in qualitative accuracy due to slight interpretive addition not present in the ground truth, though still reasonable.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 463,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 212,
      "question": "How did the financial risk profile of Boeing's Commercial Crew program evolve between 2022 and 2024, particularly in relation to fixed-price development contract cost estimation challenges and supply chain disruptions?",
      "original_answer": "In 2022, Boeing's Commercial Crew program was already identified as a high-risk fixed-price development contract due to its technical complexity and limited historical data, which made cost estimation highly uncertain. The audit process highlighted extensive scrutiny over cost estimates, with auditors performing site visits, retrospective reviews, and inquiries into project status and challenges. By 2024, the financial risk had increased due to ongoing supply chain and labor disruptions, which compounded the existing technical complexities. Auditors noted that these disruptions significantly affected cost estimation processes, requiring even more judgment and specialized industry expertise to assess the evolving cost structures and margin forecasts. The program remained a critical audit matter both years, but the nature of the risk evolved from primarily technical uncertainty in 2022 to a combination of technical and operational (supply chain) volatility in 2024.",
      "llm_answer": "Between 2022 and 2024 the Commercial Crew program’s risk profile remained high, with fixed‑price development‑contract cost estimation challenges continuing to be a key concern.  In 2022 the company warned that the program’s complex design and supply‑chain volatility could trigger reach‑forward losses (see pages 18, 19, 134), while the 2024 audit notes explicitly state that cost and schedule estimates now routinely incorporate the effects of supply‑chain and labor disruptions (pages 123‑125), underscoring an ongoing or heightened risk of cost overruns and margin erosion.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, though it omits some key qualitative nuances. (1) All factual elements are accurate: the high-risk profile of Boeing's Commercial Crew program, fixed-price contract challenges, and the role of supply chain and labor disruptions in 2024 are correctly identified. The mention of 'reach-forward losses' in 2022 and auditors incorporating supply chain effects into estimates in 2024 matches the evolving risk narrative. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not applicable—scored as 10 by default since no errors exist. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across years and identifies the continuity and evolution of risk factors. However, it misses the explicit shift in audit focus—from technical uncertainty in 2022 to combined technical and operational volatility in 2024—and does not mention auditor site visits, retrospective reviews, or the increasing need for specialized judgment in cost estimation. These omissions reduce completeness and qualitative accuracy slightly. (4) The answer remains highly contextually relevant, directly addressing the evolution of financial risk, cost estimation challenges, and supply chain impacts. Wording differs but meaning is semantically equivalent on core points. Minor deduction from 9 to 8 due to missing depth in audit process evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 410,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 212,
      "question": "How did Duke Energy Progress' storm recovery financing strategy evolve between 2023 and 2024, particularly in relation to the storm recovery property acquired by DEPNC SF and the introduction of new special purpose subsidiaries?",
      "original_answer": "In 2023, Duke Energy Progress NC Storm Funding, LLC (DEPNCSF) had already acquired storm recovery property related to costs incurred in 2018 and 2019 through the issuance of $770 million in senior secured bonds. By 2024, Duke Energy expanded its storm recovery financing strategy by forming a new special purpose subsidiary, Duke Energy Progress SC Storm Funding, LLC (DEPSCSF), which issued $177 million in senior secured bonds to acquire storm recovery property tied to costs from 2014 through 2022. This indicates an extension of the financing mechanism into South Carolina and a broader temporal coverage of storm-related costs. The storm recovery property acquired by DEPNCSF in 2023 and DEPSCSF in 2024 both include the right to impose, bill, collect, and adjust non-bypassable charges from retail customers until the bonds are fully paid and financing costs recovered.",
      "llm_answer": "Between 2023 and 2024, Duke Energy Progress expanded its storm‑recovery financing by creating a new VIE, DEPSC SF, which issued $177 million of senior secured bonds to acquire storm‑recovery property for South Carolina; the existing NC VIE (DEPNCSF) saw its long‑term debt fall from $680 million to $646 million and regulatory assets drop from $643 million to $620 million, reflecting partial repayment and a leaner balance sheet. Both VIEs remain bankruptcy‑remote, wholly owned subsidiaries that finance storm‑recovery costs through bonds secured by the property and cash collections from a non‑bypassable charge on customers.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. While it correctly identifies the formation of a new special purpose subsidiary, DEPSC SF, and its $177 million bond issuance for South Carolina storm recovery property tied to costs from 2014–2022, it incorrectly states that DEPNCSF's long-term debt decreased from $680M to $646M and regulatory assets from $643M to $620M. The ground truth states that DEPNCSF issued $770 million in bonds in 2023, with no mention of balance sheet changes between 2023 and 2024. These figures ($680M, $646M, $643M, $620M) are not present in the original answer and contradict the known issuance amount of $770M. (2) The quantitative accuracy is low because the core dollar amounts related to DEPNCSF are fabricated or misstated. The $770M issuance in 2023 is entirely omitted and replaced with incorrect balance sheet figures. The $177M issuance by DEPSCSF is correct. (3) The reasoning partially captures the multi-hop element by recognizing the expansion into South Carolina and the use of VIEs/special purpose subsidiaries for securitizing storm recovery costs. However, it fails to mention that DEPNCSF’s 2023 financing covered 2018–2019 costs, and DEPSCSF’s 2024 financing extended coverage to 2014–2022, which reflects a broader temporal scope—this key evolution is missing. The answer incorrectly implies that DEPNCSF was being wound down due to debt reduction, which is unsupported. (4) Contextual relevance is high because the response addresses storm recovery financing, special purpose subsidiaries, and customer charges. However, due to major factual and numerical errors, especially regarding DEPNCSF’s financials, the overall correctness score is low. Semantic equivalence is not achieved on critical financial facts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 496,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 212,
      "question": "How did Duke Energy Florida's investment in 750 MW of new solar facilities in 2022 relate to the introduction of power purchase agreements (PPAs) classified as finance and operating leases in 2024?",
      "original_answer": "In 2022, Duke Energy Florida petitioned the FPSC for approval of a voluntary solar program consisting of 10 new solar facilities totaling approximately 750 MW of capacity, with an estimated investment of $1 billion over three years. These facilities were designed to be funded through subscription fees and included in base rates, with bill credits tied to actual generation. By 2024, Duke Energy Progress and Duke Energy Florida had entered into power purchase agreements (PPAs) that were classified as both finance and operating leases, indicating a strategic shift toward leveraging structured financing mechanisms to support renewable energy development. The 2022 investment in solar infrastructure laid the groundwork for the 2024 adoption of PPAs, which allowed Duke to manage capital exposure while expanding clean energy capacity. This reflects a deliberate evolution in how Duke financed and operated its solar assets over time.",
      "llm_answer": "In 2022 Duke Energy Florida invested roughly $1 billion to build 10 new solar facilities totaling 750 MW under its Clean Energy Connection program, a subscription‑based project approved by the FPSC.  Those solar assets later became the subject of power‑purchase agreements (PPAs), and in 2024 the company re‑classified those PPAs as finance and operating leases, creating lease liabilities and assets in the 2024 financial statements.  Thus the 2022 solar investment provided the underlying assets that were subsequently accounted for as leases under ASC 842.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) Quantitatively, all numbers and dates are accurate: the $1 billion investment, 750 MW capacity, 10 solar facilities, and 2022/2024 timeframes match the original answer. Format variations (e.g., '750 MW' vs 'approximately 750 MW') are acceptable. (2) The entity identification is correct—Duke Energy Florida, FPSC approval, and the classification of PPAs as finance and operating leases in 2024 are all accurately represented. The mention of the 'Clean Energy Connection program' adds specificity not in the original but is consistent with Duke Energy's known programs and does not contradict the ground truth. (3) The reasoning is mostly sound: the LLM correctly links the 2022 solar investment to the 2024 lease classification under ASC 842, capturing the multi-hop connection between infrastructure development and subsequent accounting treatment. However, it slightly mischaracterizes the nature of the PPAs by implying the original solar assets 'became the subject of' PPAs, which could suggest Duke Energy Florida entered into PPAs for its own facilities—this is misleading. In reality, the 2024 PPAs likely involved third-party projects structured as leases, not the monetization of the 2022 company-owned facilities. The original answer frames this as a strategic shift in financing mechanisms, not a reclassification of existing assets. (4) Despite this nuance, the core logic—that the 2022 investment laid the groundwork for evolving financing strategies reflected in 2024—is preserved. The answer is contextually relevant and conveys a high degree of semantic equivalence, warranting a high correctness score with a minor deduction for the inaccurate implication about PPA structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 479,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 212,
      "question": "How did Broadcom's (AVGO) focus on AIOps within its Distributed Software portfolio evolve from 2022 to 2024, and what specific enhancements in the AIOps solution in 2024 indicate a strategic shift in integrating intelligent remediation capabilities?",
      "original_answer": "In 2022, Broadcom's Distributed Software portfolio included AIOps as one of its major offerings, listed alongside ValueOps and DevOps, with a general description emphasizing optimization of business-critical services. By 2024, the AIOps solution had evolved significantly, with a clear emphasis on combining application, infrastructure, and network monitoring with intelligent remediation capabilities to improve production resilience and customer experience. This indicates a strategic shift toward enhancing automation and intelligence in IT operations. The specific enhancement in 2024—embedding intelligent remediation—suggests a deeper integration of AI and operational analytics, reflecting a more mature and targeted approach compared to the broader, less detailed inclusion in 2022.",
      "llm_answer": "Broadcom’s 2022 10‑K described AIOps as a core part of its Distributed Software portfolio, noting that the solution “combines application, infrastructure and network monitoring and correlation with intelligent remediation capabilities” to improve resilience and customer experience【page_11】. In the 2024 filing the same description is retained, but the language places a stronger emphasis on the “intelligent remediation capabilities” and frames them as a key feature of the AIOps offering, signalling a strategic shift toward embedding AI‑driven, automated remediation directly into the platform【page_11】.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual inaccuracy: it claims that Broadcom's 2022 10-K already described AIOps as combining monitoring with 'intelligent remediation capabilities,' which contradicts the ground truth stating that in 2022, AIOps was only generally described as optimizing business-critical services, without specific mention of intelligent remediation. This misrepresents the evolution timeline. The 2024 enhancement—embedding intelligent remediation—is correctly identified as a strategic shift, but the baseline in 2022 is inaccurately portrayed. (2) There are no numeric values, dates, or calculations in the response beyond years (2022, 2024), which are used correctly; thus, quantitative accuracy is high. (3) The multi-hop reasoning is partially sound—comparing language emphasis across years—but flawed because it assumes the same technical description existed in 2022, undermining the synthesis. The model fails to correctly trace the evolution from a broad offering in 2022 to a more advanced, AI-integrated solution in 2024. (4) Contextual relevance is strong—the response addresses both parts of the question (evolution and 2024 enhancements) and focuses on the right portfolio and capabilities. However, due to the core factual error about the 2022 description, the qualitative accuracy and overall correctness are significantly reduced despite correct framing of the 2024 shift.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 395,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 213,
      "question": "How did the valuation methodology for UPS's real estate investments in 2022 compare to 2023, and what implications did this have for the reported net asset value (NAV) of the company's U.S. pension plans?",
      "original_answer": "In 2022, UPS disclosed that its real estate investments were valued using NAV as a practical expedient, derived from the most recent partnership audited financial reports and adjusted for investment activity through December 31. By 2023, the company continued to rely on NAV for valuing these alternative investments but noted increased auditor scrutiny due to the subjective nature of estimating fair value for non-traded assets. As of December 31, 2023, the total value of U.S. pension plan investments in real estate, private debt, and private equity funds was $9.9 billion, indicating continued reliance on NAV-based valuation. The persistence of NAV as the primary valuation method, despite its limitations, suggests that UPS faced similar challenges in 2023 as in 2022 in obtaining market-based fair value measurements for these illiquid assets.",
      "llm_answer": "UPS used the same valuation approach for its real‑estate holdings in both years – valuing the assets at the net asset value (NAV) reported in the most recent audited partnership financial statements and then adjusting for any investment activity between that date and December 31 [page_102], [page_89]. Because the methodology did not change, the increase in the U.S. pension plans’ NAV reflects actual investment performance and contributions rather than a change in accounting policy: the NAV rose from $42.058 billion at year‑end 2022 to $43.491 billion at year‑end 2023 [page_87].",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) Quantitative Accuracy: The reported NAV figures of $42.058 billion in 2022 and $43.491 billion in 2023 are not supported by the ground truth, which does not provide total U.S. pension plan NAV values for those years. Instead, the ground truth states that as of December 31, 2023, the value of U.S. pension plan investments in real estate, private debt, and private equity funds was $9.9 billion — a much smaller subset of total plan assets. The LLM incorrectly presents the overall NAV of the entire U.S. pension plan as rising from $42B to $43.5B, which is unsupported and misrepresents the scope of the data. (2) Completeness: While the LLM correctly notes that NAV was used in both years as a valuation methodology, it omits the key qualitative shift in 2023 — increased auditor scrutiny due to the subjective nature of fair value estimation for non-traded assets — which is a central part of the original answer and directly addresses how the methodology 'compared' across years. (3) Entity Accuracy: The company (UPS) and metric (NAV) are correctly identified, and the reference to using audited financial statements is accurate. However, the conflation of 'real estate investments' with 'total U.S. pension plan NAV' is a critical error in entity scope. (4) Reasoning: The multi-hop synthesis is flawed — the LLM assumes no change in methodology implies no change in implications, but the original answer highlights ongoing challenges and heightened scrutiny, suggesting evolving implications despite methodological consistency. (5) Semantic Equivalence: The LLM gives the impression of consistency and stability, but misses the nuanced risk and audit-related implications emphasized in the ground truth. While the core idea of continued NAV use is correct, the incorrect numbers and missing context reduce the answer’s factual reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 520,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 214,
      "question": "How did the shift in U.S. dialysis organization preferences from EPOGEN to Aranesp between 2023 and 2024 affect Amgen's global Aranesp sales trends, considering the offsetting impact of foreign exchange rates and sales deductions in 2024?",
      "original_answer": "In 2023, U.S. Aranesp sales declined due to lower unit demand as independent and medium-sized dialysis organizations transitioned to EPOGEN, contributing to an overall decrease in global Aranesp sales driven by unfavorable foreign exchange rates. By 2024, global Aranesp sales remained relatively unchanged despite continued unfavorable changes in estimated sales deductions and foreign currency exchange rates, suggesting that volume growth outside the U.S. offset these negative factors. This indicates a geographic shift in demand and pricing pressure management strategies between the two years.",
      "llm_answer": "The shift of U.S. dialysis organizations from EPOGEN to Aranesp between 2023 and 2024 contributed to a 15 % drop in U.S. Aranesp sales (to $386 million from $452 million).  However, global Aranesp sales only fell 1 % to $1.34 billion because volume growth outside the United States and the negative impact of foreign‑currency moves and estimated sales‑deduction adjustments in 2024 largely offset the U.S. decline.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It claims that U.S. dialysis organizations shifted from EPOGEN to Aranesp, which is the opposite of the ground truth: in 2023, U.S. dialysis organizations moved *from Aranesp to EPOGEN*, causing U.S. Aranesp sales to decline. The LLM incorrectly frames the trend as a shift toward Aranesp, fundamentally misrepresenting the causal relationship. (2) The quantitative claims are unsupported and incorrect. The LLM states a 15% drop in U.S. Aranesp sales from $452M to $386M and a 1% global decline to $1.34B, but these figures are not present in the original answer and contradict its narrative. The ground truth states that global Aranesp sales were *relatively unchanged* in 2024 despite headwinds, not down 1%, and no specific dollar amounts or percentages for U.S. or global sales are provided in the original. Thus, the LLM fabricates precise numbers without basis. (3) The reasoning is flawed in its multi-hop logic: it fails to correctly identify the direction of the shift (EPOGEN gained share *at the expense of Aranesp* in the U.S.), misattributes the impact on sales, and incorrectly suggests that the U.S. shift *increased* Aranesp use, when it actually decreased it. The original answer emphasizes that non-U.S. volume growth offset U.S. declines and external headwinds like foreign exchange and sales deductions—this offsetting dynamic is partially captured but misrepresented in timing and cause. (4) While the LLM attempts to address the question’s components (U.S. shift, global sales, FX, deductions), its core facts and directionality are wrong, warranting a low correctness score. Quantitative accuracy is very low due to invented numbers. Qualitative accuracy is partially preserved in recognizing offsetting factors but undermined by incorrect entity relationships. Contextual relevance is moderate as it engages with the right themes but misrepresents them.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 526,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 214,
      "question": "What risks does AENB's $5.0 billion dividend payout in 2024 pose to AXP's ability to maintain its leverage ratio requirements, given AXP's reliance on AENB's capital levels for deposit funding?",
      "original_answer": "AXP's 2022 filing shows that both the company and its subsidiary AENB are subject to leverage ratio requirements by the Federal Reserve and OCC, respectively, and must maintain minimum Tier 1 capital to average adjusted on-balance sheet assets. In 2024, AENB paid a $5.0 billion dividend to its parent, which could reduce its retained earnings and, in turn, impact its capital levels. AXP's 2024 filing highlights that its ability to fund its business and offer competitive interest rates on deposits is directly dependent on AENB's capital levels. Therefore, the large dividend payout may strain AENB's capital adequacy, potentially affecting AXP's ability to meet its regulatory leverage ratio requirements and maintain sufficient deposit funding.",
      "llm_answer": "The $5.0 B dividend paid by AENB in 2024 cuts into its retained earnings and Tier‑1 capital, potentially lowering AENB’s risk‑based capital and leverage ratios toward the regulatory minimum (see the 2024 10‑K, pp. 159).  If AENB’s leverage ratio falls below the required threshold, regulators could restrict deposit growth or demand additional capital, which would shrink the deposit base that AXP relies on for funding (see pp. 38‑40).  A reduced deposit base would make it harder for AXP to meet its own leverage‑ratio requirements, creating a material risk to its financial condition.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: AENB paid a $5.0 billion dividend in 2024, which impacts its retained earnings and Tier 1 capital, potentially affecting leverage and risk-based capital ratios. The reference to regulatory minimums and potential restrictions by the Federal Reserve and OCC is consistent with the original answer. (2) Quantitative accuracy is perfect: the $5.0 billion amount and 2024 timing match exactly; no calculations are required, but the implications on capital levels are correctly inferred. (3) Multi-hop reasoning is sound: the model correctly links AENB's dividend payout → reduced capital → potential breach of leverage ratio → regulatory constraints → reduced deposit funding → adverse impact on AXP's own leverage ratio and financial condition. This synthesizes the interdependency between AENB’s capital levels and AXP’s funding model as described in the original. (4) The only minor shortcoming is that the LLM does not explicitly name the regulators (Federal Reserve and OCC) in connection with AXP and AENB’s requirements, though it references regulatory thresholds generally. It also cites specific page numbers (e.g., pp. 159, 38–40) not present in the ground truth, which may imply over-specificity, but this does not detract from factual correctness. Overall, the answer is semantically equivalent, contextually precise, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 405,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 215,
      "question": "How did General Dynamics' introduction of the Symmetry Flight Deck in 2023 influence the production ramp-up and market positioning of the G700 in 2024, particularly in relation to the timing of FAA certification and delivery commencement?",
      "original_answer": "In 2023, General Dynamics introduced the Symmetry Flight Deck as part of the G700 aircraft, highlighting it as the 'industry's most technologically advanced flight deck' and positioning the G700 to enter service after FAA certification in early 2024. By 2024, the G700 had indeed received FAA certification in March and began deliveries in the second quarter, marking a direct transition from development to production. This production ramp-up was noted in 2024 as the primary driver of an increase in total inventories, specifically tied to new Gulfstream models like the G700. The inclusion of the Symmetry Flight Deck not only defined the G700’s technological differentiation but also aligned with General Dynamics’ broader strategy of continuous R&D investment, which contributed to the aircraft’s best-in-class capabilities and market positioning.",
      "llm_answer": "The 2023 launch of Gulfstream’s Symmetry Flight Deck on the G500 and G600 (page 5) was carried forward to the new G700, giving the aircraft a cutting‑edge cockpit that helped it secure FAA certification in early 2024 (page 4).  That certification enabled Gulfstream to accelerate the G700’s production ramp‑up, with deliveries beginning in the second quarter of 2024 (page 70), positioning the G700 as the most technologically advanced ultra‑long‑range business jet and strengthening its competitive edge.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but contains a minor inaccuracy in entity attribution that slightly affects completeness and reasoning. (1) Correct elements: The FAA certification in early 2024 (specifically March in the original) and delivery commencement in Q2 2024 are accurately reflected. The role of the Symmetry Flight Deck in technological differentiation and market positioning as 'most advanced' is semantically equivalent to the original's 'industry's most technologically advanced flight deck.' The production ramp-up being tied to certification timing is logically and contextually sound. (2) Quantitative accuracy: All dates (early 2024, Q2 2024) match or are consistent with the ground truth (March 2024 certification, Q2 deliveries). No numerical values are misstated. (3) Multi-hop reasoning is mostly sound—linking the 2023 introduction of the flight deck to 2024 certification and production ramp-up shows correct synthesis. However, the LLM incorrectly states that the Symmetry Flight Deck was introduced on the G500 and G600 in 2023, which, while factually true historically, misrepresents the focus of the question and the original answer, which emphasizes its *introduction on the G700* as part of its development cycle. This distracts from the direct cause-effect between the G700’s configuration and its certification/production timeline. (4) Despite this, the core causal chain—Symmetry Flight Deck → certification → production ramp-up → deliveries → market positioning—is preserved, and the answer remains highly relevant and factually grounded. The minor error in contextual framing does not undermine the key facts but slightly reduces completeness and qualitative precision. Hence, a score of 8 is justified for correctness, with high marks in quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 501,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 215,
      "question": "How did the sale of Sequent in 2021 impact the financial relationship between Southern Company and Chattanooga Gas by 2024, particularly in terms of asset valuation and ongoing contractual dependencies?",
      "original_answer": "Southern Company sold Sequent in July 2021, which had previously contributed $30 million to operations and maintenance expenses and was responsible for $101 million in charitable contributions before the sale. Despite the divestiture, Chattanooga Gas continued to rely on Sequent under an asset management agreement through 2024, indicating ongoing contractual dependency. By 2024, Southern Company's financial stake in Chattanooga Gas had decreased to $7 million from $23 million in 2023, suggesting a strategic reduction in direct investment while maintaining operational ties through Sequent.",
      "llm_answer": "The July 2021 sale of Sequent removed Southern Company Gas’s wholesale‑gas‑services business from its balance sheet, generating a $121 million gain and shrinking its asset base.  However, the asset‑management agreements that Southern Company Gas had with Chattanooga Gas were not terminated; they remained in force through March 31 2025, so by 2024 Chattanooga Gas still relied on Southern Company Gas for gas supply under those contracts, preserving the ongoing contractual dependency even after Sequent’s divestiture.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies and omits key information from the ground truth. It incorrectly refers to 'Southern Company Gas' instead of 'Southern Company' or 'Sequent', which is a critical entity error. The $121 million gain is not mentioned in the original answer and contradicts the provided data—no such gain is stated in the ground truth. Instead, the original answer notes $30 million in O&M expenses and $101 million in charitable contributions attributed to Sequent before the sale, which the LLM completely omits. The LLM correctly identifies the ongoing contractual dependency through an asset management agreement extending beyond 2024 (citing March 31, 2025), which aligns with the original's claim of dependency through 2024. However, it fails to mention the reduction in Southern Company's financial stake in Chattanooga Gas from $23 million in 2023 to $7 million in 2024—a central part of the financial relationship impact. (2) Quantitative accuracy is low: the $121M gain is unsupported; the correct figures ($30M O&M, $101M charitable contributions, $23M to $7M investment drop) are missing or replaced. Dates (July 2021 sale) are correct, and the March 31, 2025 contract end date may be additional but not contradictory. (3) Multi-hop reasoning is partially sound—the model connects Sequent’s sale to continued contractual ties with Chattanooga Gas, showing understanding of post-divestiture operational continuity. However, it fails to link the sale to the measurable decline in Southern Company’s financial stake in Chattanooga Gas by 2024, a key analytical point requiring synthesis across years and entities. (4) Contextual relevance is high as the answer addresses asset valuation (via divestiture impact) and contractual dependencies. Qualitative accuracy is moderate due to correct logic about ongoing contracts but undermined by entity confusion and omission of core financial data. Correctness score is 5 due to partial factual alignment but significant gaps in numbers, entities, and completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 552,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 215,
      "question": "Given Southern Company's increased reliance on nuclear generation from 2022 to 2023, how has their exposure to environmental risks changed, and what additional financial safeguards might be necessary given the potential for damages exceeding decommissioning trusts or insurance coverage?",
      "original_answer": "In 2022, nuclear units represented approximately 26% and 28% of total KWHs generated by Alabama Power and Georgia Power, respectively. By 2023, this increased slightly to 27% and 29%, indicating a growing reliance on nuclear generation. As nuclear operations are subject to environmental risks such as radioactive material releases and decommissioning uncertainties, this increased reliance translates into heightened exposure to such risks. The 2023 filing notes that damages, decommissioning, or other costs could exceed the amount of decommissioning trusts or external insurance coverage, including statutorily required nuclear incident insurance. Therefore, Southern Company may need to consider additional financial safeguards, such as increasing capital reserves for decommissioning or securing supplemental insurance coverage, to address the potential liabilities associated with their increased exposure to environmental risks.",
      "llm_answer": "Southern Company’s 2023 10‑K shows nuclear generation rose to 27 % of Alabama Power’s output and 29 % of Georgia Power’s output (up from 26 % and 28 % in 2022【page_27 (2023)】【page_27 (2022)】), meaning a larger share of its portfolio is now subject to the inherent environmental, safety, regulatory and financial risks of nuclear plants【page_28 (2023)】.  The filing also warns that damages, decommissioning or other costs could exceed the amounts held in decommissioning trusts or available insurance, so the company may need to boost its nuclear decommissioning trust contributions, secure additional or re‑insurance coverage, and set aside contingency reserves to cover liabilities beyond existing coverage【page_29 (2023)】【page_29 (2022)】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the increase in nuclear generation from 2022 to 2023 for both Alabama Power (26% to 27%) and Georgia Power (28% to 29%), matching the ground truth exactly. All percentages and year references are accurate. (2) Quantitative accuracy is perfect—no calculation errors, and the numbers align precisely with the original answer. Format variations (e.g., spacing around %) do not affect correctness. (3) The reasoning correctly links increased nuclear reliance to heightened environmental and financial risks, and accurately cites the risk that damages or decommissioning costs could exceed trust funds or insurance. It appropriately infers the need for additional safeguards such as increased trust contributions, supplemental insurance, or contingency reserves—consistent with the original answer’s recommendations. The multi-hop synthesis across years and entities (Alabama Power, Georgia Power, Southern Company) is sound. (4) The only minor shortcoming is that the LLM answer slightly broadens the risk description to include 'safety, regulatory and financial risks' beyond the environmental risks emphasized in the original, which, while contextually valid, slightly extends beyond the specific focus on environmental risks. However, this does not detract significantly from factual correctness. Overall, the answer is semantically equivalent, highly relevant, and well-supported by the source material.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1454,
        "completion_tokens": 402,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 216,
      "question": "How did Duke Energy's investment in solar facilities in 2022 influence the structure and scale of its power purchase agreements (PPAs) in 2023, particularly in relation to the 750 MW solar program approved in early 2021?",
      "original_answer": "In 2022, Duke Energy Florida was actively investing in a 750 MW solar program involving 10 new solar facilities at an estimated cost of $1 billion over three years. This investment was directly tied to the Clean Energy Connection program approved by the FPSC in January 2021, which structured the cost recovery through base rates offset by subscription fees and fuel cost recovery clauses. By 2023, this investment had evolved into a broader engagement with PPAs, as Duke Energy Progress and Duke Energy Florida had entered into PPAs classified as finance and operating leases. These PPAs were part of the company's growing reliance on variable lease payments tied to asset usage, which were not included in the measurement of lease liabilities. The progression from a defined solar investment plan in 2022 to structured PPAs in 2023 shows Duke Energy's strategic shift toward leveraging long-term agreements to manage its renewable energy portfolio expansion.",
      "llm_answer": "Duke Energy Florida’s 2022 investment in 10 new solar plants—approved in January 2021 as the Clean Energy Connection program with a combined capacity of roughly 750 MW (page 153)—was structured as variable lease‑type PPAs tied to the energy produced.  In the 2023 10‑K, these PPAs are shown as operating/finance leases with variable lease payments (page 268) and the purchased‑power table lists a total minimum purchase amount of $177 million for the Florida portfolio (page 158), matching the 750 MW scale of the program.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the 750 MW capacity, 10 solar facilities, and $177 million minimum purchase amount are correctly reported. While the ground truth mentions a $1 billion estimated cost over three years for the solar program, the LLM does not contradict this but instead introduces a specific $177 million minimum purchase amount from the 2023 10-K, which is consistent with PPA commitments and adds granularity. The absence of the $1 billion figure is a minor omission but not an error. (2) The dates (January 2021 approval) and years (2022 investment, 2023 PPA classification) are correct. (3) Entity accuracy is strong: Duke Energy Florida and Duke Energy Progress are correctly identified, and the Clean Energy Connection program is accurately tied to FPSC approval. The use of 'variable lease-type PPAs' and classification as operating/finance leases matches the ground truth’s description of Duke’s lease accounting treatment. (4) Multi-hop reasoning is sound: the LLM connects the 2021 approval to the 2022 investment and then to the 2023 PPA structure, demonstrating synthesis across time and documents. It correctly infers that the $177 million minimum purchase relates to the 750 MW program, showing appropriate contextual linkage. (5) Semantic equivalence is maintained—though the LLM focuses more on lease accounting details and specific 10-K page references, it conveys the strategic shift toward structured PPAs as a continuation of the solar investment. The only minor gap is the lack of explicit mention of cost recovery mechanisms (base rates, subscription fees), but the core influence of the 2022 investment on 2023 PPA structure is correctly captured. Overall, the answer is factually robust, contextually relevant, and demonstrates strong multi-hop reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 499,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 216,
      "question": "How did Southern Company's continued ownership of Georgia Power from 2022 to 2024 influence the regulatory matters disclosed in the financial statements, particularly regarding the Georgia Public Service Commission's rate-setting decisions and their impact on financial reporting?",
      "original_answer": "Southern Company's continued ownership of Georgia Power, evidenced by its $17 million intrinsic value in outstanding options in 2022 and reaffirmed through the 2024 audit report, directly subjected Georgia Power to the regulatory framework overseen by the Georgia Public Service Commission and the Federal Energy Regulatory Commission. By 2024, Georgia Power’s financial statements reflected the impact of rate regulation on multiple line items, including regulatory assets and liabilities, as detailed in Note 2. The Commission’s decisions on rate recovery influenced Georgia Power’s ability to realize returns on investments and recover prudently incurred costs, which were material disclosures in the financial statements. Thus, Southern Company’s ongoing ownership structure ensured that Georgia Power remained under strict regulatory oversight, shaping financial reporting and disclosure practices over the two-year period.",
      "llm_answer": "Southern Company’s continued ownership of Georgia Power through 2024 meant that all of Georgia Power’s regulatory assets, liabilities and rate‑setting outcomes were consolidated into Southern Company’s financial statements.  The Georgia Public Service Commission’s decisions on retail rates directly affected Georgia Power’s recoverable costs and rate of return, which are disclosed in Note 2 (Regulatory Matters – Georgia Power) and highlighted as a critical audit matter on page 132; the PSC’s potential non‑approval of full cost recovery is also noted on page 133.  Consequently, any PSC‑approved rate changes or regulatory adjustments are reflected in the consolidated revenue, expense, and regulatory‑asset balances shown in the 2024 10‑K (see page 134 for revenue/expense and page 130 for regulatory‑liability balances).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Southern Company's continued ownership of Georgia Power through 2024 is correctly stated, and the regulatory oversight by the Georgia Public Service Commission (PSC) is accurately described. The impact on financial reporting—specifically on regulatory assets, liabilities, and rate-setting outcomes—is properly detailed, with correct references to Note 2 and specific page numbers (e.g., 132, 133, 134) in the 10-K, which supports contextual authenticity. (2) Quantitative accuracy is perfect: while no explicit dollar figures like the $17 million intrinsic value from the ground truth are mentioned, the LLM does not introduce any incorrect numbers and correctly references financial statement line items without misquoting values. The omission of the $17M figure is a minor gap but does not detract from the core financial reporting impact being accurately conveyed. (3) Multi-hop reasoning is sound: the LLM correctly links ownership → regulatory oversight → financial consolidation → disclosure in specific notes and audit matters, demonstrating proper synthesis across corporate structure, regulation, and financial reporting. (4) Semantic equivalence is strong: though the LLM emphasizes consolidation into Southern Company’s statements (a valid perspective) more than the ground truth’s focus on Georgia Power’s standalone disclosures, this reflects a different but equally valid reporting-level viewpoint. The core message—that PSC decisions affect cost recovery, returns, and are material to financial statements—is preserved. The answer is fully contextually relevant, directly addressing rate-setting influence and financial reporting impact.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1472,
        "completion_tokens": 477,
        "total_tokens": 1949
      },
      "error": null
    },
    {
      "question_id": 216,
      "question": "How did AbbVie's 2023 challenges with patent litigation and market exclusivity risks influence its strategic use of pediatric exclusivity in 2024 to extend protection for key biologics?",
      "original_answer": "In 2023, AbbVie faced significant risks to market exclusivity due to ongoing patent litigation and Paragraph IV certifications from generic manufacturers, threatening the commercial life of its key products and exposing them to early generic competition. These challenges, combined with regulatory and legislative pressures, heightened AbbVie’s reliance on alternative exclusivity mechanisms. In response, by 2024, AbbVie strategically leveraged the FDA's pediatric exclusivity provision, which allows for a 180-day extension of existing exclusivity periods when new clinical studies on pediatric use are conducted. This regulatory mechanism enabled AbbVie to extend market protection for several biologics, mitigating the revenue risk posed by the earlier patent challenges and aligning with its broader IP lifecycle management strategy.",
      "llm_answer": "AbbVie’s 2023 10‑K warned that patent expirations and litigation could erode exclusivity for key biologics such as Humira (see the risk‑factor discussion on page 17 and the litigation section on page 18).  In 2024 the company leveraged the FDA’s pediatric exclusivity provision (page 7), which adds 180 days to all existing patent and regulatory exclusivities, to extend the overall protection window for its biologics and blunt the impact of biosimilar entry and potential patent challenges.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies AbbVie's 2023 challenges with patent litigation and exclusivity risks, referencing its 2023 10-K and specifically citing Humira as a key biologic at risk, which is consistent with known facts. (2) Quantitatively, the 180-day extension from pediatric exclusivity is accurately stated, and the timeline (2023 challenges leading to 2024 strategic response) is correct. (3) The multi-hop reasoning is sound: it connects patent litigation and Paragraph IV risks in 2023 (implied in the 10-K reference) to the strategic use of FDA pediatric exclusivity in 2024. The mechanism—180-day extension applying to all existing exclusivities—is correctly described. (4) The answer is contextually relevant and directly addresses how AbbVie responded to exclusivity threats. The only minor shortcoming is that it does not explicitly mention 'Paragraph IV certifications' or 'clinical studies in pediatric populations' as the basis for earning the exclusivity, which is part of the regulatory mechanism described in the original answer. However, referencing the FDA provision and its effect demonstrates sufficient qualitative accuracy. Overall, the answer conveys the same core information with correct entities, numbers, and logical flow.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 368,
        "total_tokens": 1710
      },
      "error": null
    }
  ],
  "evaluation_summary": {
    "total_questions": 799,
    "successful_evaluations": 799,
    "failed_evaluations": 0,
    "average_correctness_score": 6.7,
    "average_quantitative_accuracy": 7.15,
    "average_qualitative_accuracy": 7.02,
    "average_contextual_relevance": 8.83,
    "score_distribution": {
      "excellent": 325,
      "good": 154,
      "fair": 205,
      "poor": 115
    }
  },
  "original_experiment_metadata": {
    "model": "gpt-oss-20b-reasoning",
    "experiment": "e5_page_window_relevance_asc",
    "pattern": "qualitative_3hop_cross_year_type1",
    "total_questions": 800,
    "successful": 799,
    "failed": 1,
    "elapsed_seconds": 25442.61,
    "timestamp": "2026-02-03T08:07:56.893924"
  }
}